<?xml version="1.0" encoding="UTF-8" ?>
<!-- DTS Export Terminology File Version 2 -->
<terminology type="namespace">
 <namespace type="Thesaurus">
  <name>MED-RT</name>
  <code>N32768</code>
  <id>32768</id>
  <version>2025.01.05</version>
  <authority>Apelon, Inc.</authority>
 </namespace>
 <proptype type="C">
  <content>MED-RT</content>
  <name>CTY</name>
  <id>1</id>
 </proptype>
 <proptype type="C">
  <content>MED-RT</content>
  <name>NUI</name>
  <id>2</id>
 </proptype>
 <assntype type="S" purpose="A">
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
  <id>2</id>
  <inverse_name>Preferred Term for</inverse_name>
 </assntype>
 <assntype type="S" purpose="A">
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
  <id>5</id>
  <inverse_name>Synonym for</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
  <id>1</id>
  <inverse_name>Child Of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
  <id>9</id>
  <inverse_name>Synonym Of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
  <id>10</id>
  <inverse_name>MoA_of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
  <id>11</id>
  <inverse_name>PE_of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
  <id>12</id>
  <inverse_name>may_be_treated_by</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>CI_with</name>
  <id>13</id>
  <inverse_name>[Inv] CI_with</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
  <id>14</id>
  <inverse_name>SC_of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
  <id>15</id>
  <inverse_name>may_be_prevented_by</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
  <id>16</id>
  <inverse_name>PK_of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
  <id>17</id>
  <inverse_name>[Inv] CI_PE</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>CI_ChemClass</name>
  <id>18</id>
  <inverse_name>[Inv] CI_ChemClass</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>may_diagnose</name>
  <id>19</id>
  <inverse_name>diagnosed_with</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
  <id>20</id>
  <inverse_name>TC_of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
  <id>21</id>
  <inverse_name>[Inv] CI_MoA</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>induces</name>
  <id>22</id>
  <inverse_name>induced_by</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>has_active_metabolites</name>
  <id>23</id>
  <inverse_name>active_metabolites_of</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
  <id>24</id>
  <inverse_name>metabolism_at_site</inverse_name>
 </assntype>
 <assntype type="C" purpose="A">
  <namespace>MED-RT</namespace>
  <name>effect_may_be_inhibited_by</name>
  <id>25</id>
  <inverse_name>may_inhibit_effect_of</inverse_name>
 </assntype>
 <qualtype type="CA">
  <content>MED-RT</content>
  <name>Authority</name>
  <id>1</id>
 </qualtype>
 <term>
  <namespace>MED-RT</namespace>
  <name> Cyclin-dependent Kinase 4 Inhibitors</name>
  <code>T58551</code>  <id>58551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name> Cyclin-dependent Kinase 6 Inhibitors</name>
  <code>T58554</code>  <id>58554</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>1-Compartment</name>
  <code>T82</code>  <id>82</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11 beta-Hydroxysteroid Dehydrogenase Inhibitors</name>
  <code>T58876</code>  <id>58876</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
  <code>T58869</code>  <id>58869</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11-beta Hydroxysteroid Dehydrogenase Inhibitors</name>
  <code>T58875</code>  <id>58875</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
  <code>T58868</code>  <id>58868</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11-beta-Hydroxysteroid Dehydrogenase Inhibitors</name>
  <code>T58877</code>  <id>58877</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
  <code>T58870</code>  <id>58870</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11beta-HSD Inhibitors</name>
  <code>T58878</code>  <id>58878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11beta-HSD1 Inhibitors</name>
  <code>T58871</code>  <id>58871</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11beta-Hydroxysteroid Dehydrogenase Inhibitors</name>
  <code>T58879</code>  <id>58879</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
  <code>T58872</code>  <id>58872</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11β Hydroxysteroid Dehydrogenase Inhibitors</name>
  <code>T58880</code>  <id>58880</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11β Hydroxysteroid Dehydrogenase Type 1 Inhibitors</name>
  <code>T58873</code>  <id>58873</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11βHSD Inhibitors</name>
  <code>T58881</code>  <id>58881</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>11βHSD-1 Inhibitors</name>
  <code>T58874</code>  <id>58874</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>14-alpha Demethylase Inhibitors</name>
  <code>T162</code>  <id>162</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>2-Compartment</name>
  <code>T309</code>  <id>309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>3-Compartment</name>
  <code>T438</code>  <id>438</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</name>
  <code>T618</code>  <id>618</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>4-Hydroxyphenylpyruvate Dioxygenase Inhibitor</name>
  <code>T616</code>  <id>616</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT1 Receptor Agonists</name>
  <code>T58494</code>  <id>58494</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT1a Receptor Agonists</name>
  <code>T58499</code>  <id>58499</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT3 Receptor Antagonist</name>
  <code>T48282</code>  <id>48282</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT3 Receptor Antagonists</name>
  <code>T48214</code>  <id>48214</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT4 Receptor Agonist</name>
  <code>T58484</code>  <id>58484</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT4 Receptor Agonists</name>
  <code>T58489</code>  <id>58489</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT4 Receptor Antagonist</name>
  <code>T48289</code>  <id>48289</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-HT4 Receptor Antagonists</name>
  <code>T48220</code>  <id>48220</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-Lipoxygenase Inhibitor</name>
  <code>T720</code>  <id>720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-Lipoxygenase Inhibitors</name>
  <code>T721</code>  <id>721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-alpha Reductase Inhibitor</name>
  <code>T739</code>  <id>739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5-alpha Reductase Inhibitors</name>
  <code>T740</code>  <id>740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1 Receptor Agonists</name>
  <code>T58495</code>  <id>58495</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1B Receptor Agonists</name>
  <code>T48198</code>  <id>48198</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1B and 5HT-1D Receptor Agonist</name>
  <code>T48259</code>  <id>48259</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1B/5HT-1D Receptor Agonist</name>
  <code>T48261</code>  <id>48261</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1D Receptor Agonists</name>
  <code>T48204</code>  <id>48204</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1a Receptor Agonists</name>
  <code>T58500</code>  <id>58500</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1b Receptor Agonists</name>
  <code>T48196</code>  <id>48196</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1b and 5HT-1d Receptor Agonist</name>
  <code>T48257</code>  <id>48257</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1b/5HT-1d Receptor Agonist</name>
  <code>T48264</code>  <id>48264</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-1d Receptor Agonists</name>
  <code>T48200</code>  <id>48200</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-2C Receptor Agonist</name>
  <code>T48272</code>  <id>48272</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-2C Receptor Agonists</name>
  <code>T48210</code>  <id>48210</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-2c Receptor Agonist</name>
  <code>T48268</code>  <id>48268</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-2c Receptor Agonists</name>
  <code>T48208</code>  <id>48208</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-3 Receptor Antagonist</name>
  <code>T48283</code>  <id>48283</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-3 Receptor Antagonists</name>
  <code>T48212</code>  <id>48212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-4 Receptor Agonist</name>
  <code>T58485</code>  <id>58485</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-4 Receptor Agonists</name>
  <code>T58490</code>  <id>58490</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-4 Receptor Antagonist</name>
  <code>T48291</code>  <id>48291</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT-4 Receptor Antagonists</name>
  <code>T48218</code>  <id>48218</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT1 Receptor Agonists</name>
  <code>T58496</code>  <id>58496</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT1a Receptor Agonists</name>
  <code>T58501</code>  <id>58501</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT3 Receptor Antagonist</name>
  <code>T48281</code>  <id>48281</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT3 Receptor Antagonists</name>
  <code>T48215</code>  <id>48215</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT4 Receptor Agonist</name>
  <code>T58486</code>  <id>58486</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT4 Receptor Agonists</name>
  <code>T58491</code>  <id>58491</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT4 Receptor Antagonist</name>
  <code>T48284</code>  <id>48284</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>5HT4 Receptor Antagonists</name>
  <code>T48217</code>  <id>48217</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>A [Preparations]</name>
  <code>T827</code>  <id>827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ABCC2 Inhibitors</name>
  <code>T58619</code>  <id>58619</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ACL Inhibitor</name>
  <code>T58537</code>  <id>58537</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ACL Inhibitors</name>
  <code>T58540</code>  <id>58540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ACh Transporter Interactions</name>
  <code>T1748</code>  <id>1748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ADP Receptor Inhibitors</name>
  <code>T2313</code>  <id>2313</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ALAS1-directed RNA Interaction</name>
  <code>T58776</code>  <id>58776</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>AMPA Receptor Antagonists</name>
  <code>T1283</code>  <id>1283</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ANGPTL3 Inhibitor</name>
  <code>T58566</code>  <id>58566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ANGPTL3 Inhibitors</name>
  <code>T58564</code>  <id>58564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>APOC-III RNA Antisense Inhibitor</name>
  <code>T59043</code>  <id>59043</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>APOC-III-directed RNA Interaction</name>
  <code>T59044</code>  <id>59044</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>APOC3 RNA Antisense Inhibitor</name>
  <code>T59042</code>  <id>59042</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ASBT Inhibitor</name>
  <code>T58630</code>  <id>58630</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ASBT Inhibitors</name>
  <code>T58635</code>  <id>58635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ATP Citrate Lyase Inhibitor</name>
  <code>T58538</code>  <id>58538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ATP Citrate Lyase Inhibitors</name>
  <code>T58541</code>  <id>58541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ATP-Binding Cassette (ABC) Transporter Interactions</name>
  <code>T1451</code>  <id>1451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Absorbs UVA Radiation</name>
  <code>T53636</code>  <id>53636</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Absorbs UVB Radiation</name>
  <code>T53640</code>  <id>53640</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Absorbs Ultraviolet A Radiation</name>
  <code>T53637</code>  <id>53637</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Absorbs Ultraviolet B Radiation</name>
  <code>T53639</code>  <id>53639</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Absorption</name>
  <code>T1565</code>  <id>1565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Absorption Half-Life</name>
  <code>T1564</code>  <id>1564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acellular Tissue Engineered Vessel</name>
  <code>T59075</code>  <id>59075</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetaminophen</name>
  <code>T1654</code>  <id>1654</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetaminophen-containing Agent</name>
  <code>T1653</code>  <id>1653</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetyl Aldehyde Dehydrogenase Inhibitors</name>
  <code>T1708</code>  <id>1708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Activity Alteration</name>
  <code>T1742</code>  <id>1742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Release Inhibitor</name>
  <code>T1745</code>  <id>1745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Release Inhibitors</name>
  <code>T1746</code>  <id>1746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Releasing Agent</name>
  <code>T1747</code>  <id>1747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Transporter Interactions</name>
  <code>T1749</code>  <id>1749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acetylcholinesterase Inhibitor</name>
  <code>T10829</code>  <id>10829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acid-Base Activity</name>
  <code>T1829</code>  <id>1829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acidifying Activity</name>
  <code>T1834</code>  <id>1834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acquired Active Immunity</name>
  <code>T2034</code>  <id>2034</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acquired Immunity</name>
  <code>T1903</code>  <id>1903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Acquired Passive Immunity</name>
  <code>T38970</code>  <id>38970</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Actinomycin</name>
  <code>T2001</code>  <id>2001</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Actinomycin-class Agent</name>
  <code>T2000</code>  <id>2000</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Activated Factor 10 Inhibitor</name>
  <code>T19439</code>  <id>19439</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Activated Factor 10 Inhibitors</name>
  <code>T19444</code>  <id>19444</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Activated Factor X Inhibitor</name>
  <code>T19440</code>  <id>19440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Activated Factor X Inhibitors</name>
  <code>T19443</code>  <id>19443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Actively Acquired Immunity</name>
  <code>T2035</code>  <id>2035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Activin Signaling Inhibitor</name>
  <code>T58944</code>  <id>58944</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Activin Signaling Inhibitors</name>
  <code>T58943</code>  <id>58943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adeno-associated Virus Vector</name>
  <code>T58378</code>  <id>58378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adeno-associated Virus Vector-based Gene Therapy</name>
  <code>T58888</code>  <id>58888</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Deaminase Inhibitors</name>
  <code>T2303</code>  <id>2303</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Diphosphate Receptor Inhibitors</name>
  <code>T2314</code>  <id>2314</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Agonist</name>
  <code>T2339</code>  <id>2339</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Agonists</name>
  <code>T2340</code>  <id>2340</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Antagonists</name>
  <code>T2341</code>  <id>2341</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Interactions</name>
  <code>T2342</code>  <id>2342</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Triphosphate-Citrate Lyase Inhibitor</name>
  <code>T58536</code>  <id>58536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenosine Triphosphate-Citrate Lyase Inhibitors</name>
  <code>T58539</code>  <id>58539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adenovirus Vector-Based Gene Therapy</name>
  <code>T58883</code>  <id>58883</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adjuvants, Immunologic</name>
  <code>T26299</code>  <id>26299</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenal Cortical Activity Alteration</name>
  <code>T2474</code>  <id>2474</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenal Medullary Activity Alteration</name>
  <code>T2485</code>  <id>2485</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenal Steroid Synthesis Inhibitor</name>
  <code>T2488</code>  <id>2488</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenal Steroid Synthesis Inhibitors</name>
  <code>T2489</code>  <id>2489</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Agonists</name>
  <code>T2490</code>  <id>2490</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Antagonists</name>
  <code>T2491</code>  <id>2491</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Decongestant</name>
  <code>T2492</code>  <id>2492</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Receptor Agonist</name>
  <code>T2493</code>  <id>2493</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Receptor Interactions</name>
  <code>T2494</code>  <id>2494</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-1 Agonists</name>
  <code>T2501</code>  <id>2501</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-1 Antagonists</name>
  <code>T2504</code>  <id>2504</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-2 Agonists</name>
  <code>T2507</code>  <id>2507</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-2 Antagonists</name>
  <code>T2509</code>  <id>2509</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-Agonists</name>
  <code>T2496</code>  <id>2496</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-Antagonists</name>
  <code>T2499</code>  <id>2499</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha1-Agonists</name>
  <code>T2502</code>  <id>2502</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha1-Antagonists</name>
  <code>T2505</code>  <id>2505</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha2-Agonists</name>
  <code>T2508</code>  <id>2508</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha2-Antagonists</name>
  <code>T2511</code>  <id>2511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-1 Agonists</name>
  <code>T2521</code>  <id>2521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-1 Antagonists</name>
  <code>T2523</code>  <id>2523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-2 Agonists</name>
  <code>T2527</code>  <id>2527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-2 Antagonists</name>
  <code>T2530</code>  <id>2530</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-3 Agonists</name>
  <code>T2532</code>  <id>2532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-Agonists</name>
  <code>T2513</code>  <id>2513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-Antagonists</name>
  <code>T2519</code>  <id>2519</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta1-Agonists</name>
  <code>T2522</code>  <id>2522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta1-Antagonists</name>
  <code>T2525</code>  <id>2525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta2-Agonists</name>
  <code>T2528</code>  <id>2528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta2-Antagonists</name>
  <code>T2531</code>  <id>2531</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta3-Agonists</name>
  <code>T2534</code>  <id>2534</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Adrenocorticotropic Hormone</name>
  <code>T2558</code>  <id>2558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Affected by concomitant drug administration</name>
  <code>T2596</code>  <id>2596</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Affected by food/other nutrients</name>
  <code>T2597</code>  <id>2597</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Affected by gastric pH</name>
  <code>T2598</code>  <id>2598</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Affected by intestinal surface area</name>
  <code>T2599</code>  <id>2599</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Agammaglobulinaemia Tyrosine Kinase Inhibitors</name>
  <code>T58610</code>  <id>58610</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>AhR agonist</name>
  <code>T58755</code>  <id>58755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>AhR agonists</name>
  <code>T58753</code>  <id>58753</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alcohol Dehydrogenase Inhibitors</name>
  <code>T2759</code>  <id>2759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aldehyde Dehydrogenase Inhibitor</name>
  <code>T2804</code>  <id>2804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aldosterone Antagonist</name>
  <code>T2825</code>  <id>2825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aldosterone Antagonist</name>
  <code>T2826</code>  <id>2826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aldosterone Antagonists</name>
  <code>T2827</code>  <id>2827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alkalinizing Activity</name>
  <code>T2920</code>  <id>2920</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alkaloid</name>
  <code>T58613</code>  <id>58613</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alkylating Activity</name>
  <code>T2936</code>  <id>2936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alkylating Drug</name>
  <code>T2937</code>  <id>2937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allergen</name>
  <code>T58515</code>  <id>58515</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allergenic Extract</name>
  <code>T58516</code>  <id>58516</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell (MSC) Therapy</name>
  <code>T59073</code>  <id>59073</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy</name>
  <code>T59072</code>  <id>59072</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cells</name>
  <code>T9768</code>  <id>9768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cellularized Scaffold Cell Therapy</name>
  <code>T58895</code>  <id>58895</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy</name>
  <code>T2954</code>  <id>2954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cultured Cell Scaffold</name>
  <code>T2955</code>  <id>2955</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cultured Cells</name>
  <code>T9772</code>  <id>9772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Dermal Fibroblast Cell Therapy</name>
  <code>T59063</code>  <id>59063</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Epidermal Keratinocyte Cell Therapy</name>
  <code>T59062</code>  <id>59062</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Pancreatic Islet Cellular Therapy</name>
  <code>T58893</code>  <id>58893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Processed Thymus Tissue-based Immunotherapy</name>
  <code>T58896</code>  <id>58896</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Allylamine Antifungal</name>
  <code>T2968</code>  <id>2968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alpha-adrenergic Blocker</name>
  <code>T2498</code>  <id>2498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alpha-glucosidase Inhibitor</name>
  <code>T55679</code>  <id>55679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alternative Complement Pathway Inhibitors</name>
  <code>T58940</code>  <id>58940</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aluminum Complex</name>
  <code>T3028</code>  <id>3028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alveolar Surface Tension Alteration</name>
  <code>T3046</code>  <id>3046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Alveolar Surface Tension Reduction</name>
  <code>T3047</code>  <id>3047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amide Local Anesthetic</name>
  <code>T3103</code>  <id>3103</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amino Acid</name>
  <code>T3212</code>  <id>3212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amino Acid Hypertonic Solution</name>
  <code>T3149</code>  <id>3149</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside</name>
  <code>T3285</code>  <id>3285</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside Antibacterial</name>
  <code>T3282</code>  <id>3282</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside Antimicrobial</name>
  <code>T3283</code>  <id>3283</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside-class Agent</name>
  <code>T3284</code>  <id>3284</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminoketone</name>
  <code>T3294</code>  <id>3294</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminolevulinate Synthase 1-directed RNA Interaction</name>
  <code>T58775</code>  <id>58775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminosalicylate</name>
  <code>T3343</code>  <id>3343</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aminosalicylate-containing Agent</name>
  <code>T3342</code>  <id>3342</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ammonia Binding Activity</name>
  <code>T3377</code>  <id>3377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ammonium Ion Binding Activity</name>
  <code>T3378</code>  <id>3378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amphenicol-class Antibacterial</name>
  <code>T3421</code>  <id>3421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amphenicols</name>
  <code>T3422</code>  <id>3422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amphetamine Anorectic</name>
  <code>T3423</code>  <id>3423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amylase Inhibitors</name>
  <code>T3472</code>  <id>3472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amylin Agonists</name>
  <code>T3476</code>  <id>3476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amylin Analog</name>
  <code>T3478</code>  <id>3478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amylin Analogue</name>
  <code>T3477</code>  <id>3477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amyloid Beta-directed Antibody</name>
  <code>T58644</code>  <id>58644</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Amyloid Beta-directed Antibody Interactions</name>
  <code>T58645</code>  <id>58645</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Analgesia</name>
  <code>T3536</code>  <id>3536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Analgesics</name>
  <code>T58408</code>  <id>58408</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anaplastic Lymphoma Kinase Inhibitors</name>
  <code>T59045</code>  <id>59045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen</name>
  <code>T3575</code>  <id>3575</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Agonists</name>
  <code>T3569</code>  <id>3569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Antagonists</name>
  <code>T3571</code>  <id>3571</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Inhibitor</name>
  <code>T3570</code>  <id>3570</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Inhibitor</name>
  <code>T3572</code>  <id>3572</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen Synthesis Inhibitors</name>
  <code>T3573</code>  <id>3573</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Androgen-class Agent</name>
  <code>T3574</code>  <id>3574</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anesthetic</name>
  <code>T58514</code>  <id>58514</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anesthetics</name>
  <code>T58409</code>  <id>58409</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiogenesis Inhibition</name>
  <code>T54399</code>  <id>54399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiopoietin-like 3 Inhibitor</name>
  <code>T58565</code>  <id>58565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiopoietin-like 3 Inhibitors</name>
  <code>T58563</code>  <id>58563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Receptor Antagonists</name>
  <code>T3764</code>  <id>3764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Receptor Blocker</name>
  <code>T3768</code>  <id>3768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Type 1 Receptor Antagonists</name>
  <code>T3773</code>  <id>3773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Type 1 Receptor Blockers</name>
  <code>T3771</code>  <id>3771</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin Converting Enzyme Inhibitor</name>
  <code>T3779</code>  <id>3779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin Converting Enzyme Inhibitor</name>
  <code>T3788</code>  <id>3788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin II Receptor Antagonists</name>
  <code>T3765</code>  <id>3765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin II Receptor Blocker</name>
  <code>T3767</code>  <id>3767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin II Receptor Blockers</name>
  <code>T3766</code>  <id>3766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin II Type 1 Receptor Antagonists</name>
  <code>T3772</code>  <id>3772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin II Type I Receptor Antagonists</name>
  <code>T3770</code>  <id>3770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin II Type I Receptor Blockers</name>
  <code>T3769</code>  <id>3769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Angiotensin-converting Enzyme Inhibitors</name>
  <code>T3789</code>  <id>3789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anion Transporter Interactions</name>
  <code>T3836</code>  <id>3836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anorectic Activity</name>
  <code>T5032</code>  <id>5032</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antacid</name>
  <code>T3931</code>  <id>3931</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anthelmintic</name>
  <code>T4672</code>  <id>4672</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anthracycline Topoisomerase Inhibitor</name>
  <code>T3964</code>  <id>3964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anthrax Protective Antigen-directed Antibody</name>
  <code>T3988</code>  <id>3988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anthrax Protective Antigen-directed Antibody Interactions</name>
  <code>T3987</code>  <id>3987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-IL-5 Receptor alpha mAb</name>
  <code>T58392</code>  <id>58392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-IL-5 Receptor alpha mAb Interactions</name>
  <code>T58389</code>  <id>58389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-IgE</name>
  <code>T3998</code>  <id>3998</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-IgE Antibody</name>
  <code>T3997</code>  <id>3997</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-anginal</name>
  <code>T4017</code>  <id>4017</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-anginal</name>
  <code>T4019</code>  <id>4019</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-anginal Agent</name>
  <code>T4018</code>  <id>4018</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-arrhythmic</name>
  <code>T4042</code>  <id>4042</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-arrhythmic</name>
  <code>T4021</code>  <id>4021</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-arrhythmic Agent</name>
  <code>T4022</code>  <id>4022</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-coagulant</name>
  <code>T4024</code>  <id>4024</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-coagulation</name>
  <code>T14368</code>  <id>14368</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-coagulation Activity</name>
  <code>T14370</code>  <id>14370</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-coagulation Activity Reversal</name>
  <code>T46817</code>  <id>46817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-coagulation Reversal</name>
  <code>T46818</code>  <id>46818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-emetic</name>
  <code>T4143</code>  <id>4143</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-emetic</name>
  <code>T4027</code>  <id>4027</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-emetic Agent</name>
  <code>T4028</code>  <id>4028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic</name>
  <code>T4030</code>  <id>4030</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic</name>
  <code>T4033</code>  <id>4033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic Agent</name>
  <code>T4031</code>  <id>4031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic Agent</name>
  <code>T4034</code>  <id>4034</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic Drug</name>
  <code>T4029</code>  <id>4029</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-infective</name>
  <code>T4036</code>  <id>4036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-infective Agent</name>
  <code>T4037</code>  <id>4037</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-inflammatory</name>
  <code>T4039</code>  <id>4039</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-inflammatory Agent</name>
  <code>T4040</code>  <id>4040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-inhibitor Coagulant Complex</name>
  <code>T4041</code>  <id>4041</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anti-sense Oligonucleotide</name>
  <code>T4735</code>  <id>4735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antianginal</name>
  <code>T4016</code>  <id>4016</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiarrhythmic</name>
  <code>T4043</code>  <id>4043</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiarrhythmic</name>
  <code>T4020</code>  <id>4020</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibacterial</name>
  <code>T4044</code>  <id>4044</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibacterial Agent</name>
  <code>T4045</code>  <id>4045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody Interactions</name>
  <code>T4119</code>  <id>4119</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody or Antibody Fragment</name>
  <code>T58506</code>  <id>58506</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Antibody Interactions</name>
  <code>T4120</code>  <id>4120</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Receptor Interactions</name>
  <code>T4121</code>  <id>4121</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Soluble Antigen Interactions</name>
  <code>T4122</code>  <id>4122</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Soluble Protein Interactions</name>
  <code>T4123</code>  <id>4123</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Surface Antigen Interactions</name>
  <code>T4124</code>  <id>4124</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Surface Glycolipid Interactions</name>
  <code>T4125</code>  <id>4125</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antibody-Surface Protein Interactions</name>
  <code>T4126</code>  <id>4126</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticholinergic</name>
  <code>T4130</code>  <id>4130</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticholinergic Agent</name>
  <code>T4128</code>  <id>4128</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticoagulant</name>
  <code>T4023</code>  <id>4023</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticoagulation</name>
  <code>T14369</code>  <id>14369</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticoagulation Activity</name>
  <code>T14367</code>  <id>14367</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticoagulation Activity Reversal</name>
  <code>T46814</code>  <id>46814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticoagulation Reversal</name>
  <code>T46819</code>  <id>46819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anticonvulsants</name>
  <code>T58410</code>  <id>58410</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidementia Agents</name>
  <code>T58411</code>  <id>58411</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidepressant</name>
  <code>T4135</code>  <id>4135</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidepressive</name>
  <code>T4134</code>  <id>4134</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidepressive Agent</name>
  <code>T4136</code>  <id>4136</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidiarrheal</name>
  <code>T4137</code>  <id>4137</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidiarrheal</name>
  <code>T4139</code>  <id>4139</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidiarrheal Agent</name>
  <code>T4138</code>  <id>4138</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidiuretic Activity</name>
  <code>T14407</code>  <id>14407</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidote</name>
  <code>T4140</code>  <id>4140</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidote for Acetaminophen Overdose</name>
  <code>T4142</code>  <id>4142</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antidotes, Deterrents, and Toxicologic Agents</name>
  <code>T4141</code>  <id>4141</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiemetic</name>
  <code>T4144</code>  <id>4144</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiemetic</name>
  <code>T4025</code>  <id>4025</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiemetic Agent</name>
  <code>T4026</code>  <id>4026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiepileptic</name>
  <code>T4032</code>  <id>4032</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antifibrinolysis</name>
  <code>T14455</code>  <id>14455</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antifibrinolytic Agent</name>
  <code>T4145</code>  <id>4145</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antifungal</name>
  <code>T4157</code>  <id>4157</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antifungal Agent</name>
  <code>T4158</code>  <id>4158</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antigen Neutralization</name>
  <code>T4159</code>  <id>4159</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antigout Agents</name>
  <code>T58412</code>  <id>58412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antihelminthic</name>
  <code>T4670</code>  <id>4670</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antihelminthic</name>
  <code>T4673</code>  <id>4673</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antihelminthic Agent</name>
  <code>T4671</code>  <id>4671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antihistamine</name>
  <code>T4675</code>  <id>4675</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antihistaminic</name>
  <code>T4674</code>  <id>4674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antihypoglycemic Agent</name>
  <code>T4676</code>  <id>4676</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiinfective</name>
  <code>T4035</code>  <id>4035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiinflammatory</name>
  <code>T4038</code>  <id>4038</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antileishmanial</name>
  <code>T4677</code>  <id>4677</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimalarial</name>
  <code>T4679</code>  <id>4679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimalarial</name>
  <code>T4681</code>  <id>4681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimalarial Agent</name>
  <code>T4680</code>  <id>4680</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimanic</name>
  <code>T4682</code>  <id>4682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimanic Agent</name>
  <code>T4683</code>  <id>4683</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimetabolite</name>
  <code>T4685</code>  <id>4685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimetabolite Immunosuppressant</name>
  <code>T4684</code>  <id>4684</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimicrobial</name>
  <code>T4686</code>  <id>4686</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimicrobial Agent</name>
  <code>T4687</code>  <id>4687</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimigraine Agents</name>
  <code>T58413</code>  <id>58413</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimyasthenic Agents</name>
  <code>T58414</code>  <id>58414</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimycobacterial</name>
  <code>T4703</code>  <id>4703</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimycobacterial</name>
  <code>T4705</code>  <id>4705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antimycobacterial Agent</name>
  <code>T4704</code>  <id>4704</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antineoplastic</name>
  <code>T4706</code>  <id>4706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antineoplastic Agent</name>
  <code>T4707</code>  <id>4707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiparasitic</name>
  <code>T4710</code>  <id>4710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiparasitic</name>
  <code>T4712</code>  <id>4712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiparasitic Agent</name>
  <code>T4711</code>  <id>4711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiparkinson Agents</name>
  <code>T58415</code>  <id>58415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiperspirant Activity</name>
  <code>T4713</code>  <id>4713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiporter Interactions</name>
  <code>T4719</code>  <id>4719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiprotozoal</name>
  <code>T4721</code>  <id>4721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiprotozoal</name>
  <code>T4723</code>  <id>4723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiprotozoal Agent</name>
  <code>T4722</code>  <id>4722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antipruritic Activity</name>
  <code>T4724</code>  <id>4724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antipsychotic</name>
  <code>T4725</code>  <id>4725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antipsychotic Agent</name>
  <code>T4726</code>  <id>4726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antirheumatic</name>
  <code>T4731</code>  <id>4731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antirheumatic Agent</name>
  <code>T4730</code>  <id>4730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antirheumatic Agent</name>
  <code>T4732</code>  <id>4732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antisense Oligonucleotide</name>
  <code>T4736</code>  <id>4736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiseptic</name>
  <code>T4737</code>  <id>4737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiseptic</name>
  <code>T4739</code>  <id>4739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiseptic Agent</name>
  <code>T4738</code>  <id>4738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antispasticity Agents</name>
  <code>T58416</code>  <id>58416</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antithrombin 3 Activators</name>
  <code>T4747</code>  <id>4747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antithrombin Activators</name>
  <code>T4748</code>  <id>4748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antithrombin III Activators</name>
  <code>T4746</code>  <id>4746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antithrombin-directed RNA Interaction</name>
  <code>T59065</code>  <id>59065</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antithrombins</name>
  <code>T4757</code>  <id>4757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antitussive</name>
  <code>T4759</code>  <id>4759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antitussive Agent</name>
  <code>T4760</code>  <id>4760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antivenin</name>
  <code>T4761</code>  <id>4761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiviral</name>
  <code>T4766</code>  <id>4766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Antiviral Agent</name>
  <code>T4767</code>  <id>4767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Anxiolytics</name>
  <code>T58417</code>  <id>58417</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Apical Sodium Bile Acid Transporter Inhibitor</name>
  <code>T58629</code>  <id>58629</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Apical Sodium Bile Acid Transporter Inhibitors</name>
  <code>T58634</code>  <id>58634</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Apolipoprotein B-100 Synthesis Inhibitor</name>
  <code>T4931</code>  <id>4931</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Appetite Alteration</name>
  <code>T5030</code>  <id>5030</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Appetite Stimulation</name>
  <code>T5031</code>  <id>5031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Appetite Suppression</name>
  <code>T5033</code>  <id>5033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatase Inhibitor</name>
  <code>T5249</code>  <id>5249</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatase Inhibitor</name>
  <code>T5250</code>  <id>5250</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatase Inhibitors</name>
  <code>T5251</code>  <id>5251</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatic Amino Acid</name>
  <code>T5265</code>  <id>5265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatic Amino Acid Decarboxylation Inhibitor</name>
  <code>T5264</code>  <id>5264</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatic Amino Acid Decarboxylation Inhibitors</name>
  <code>T5263</code>  <id>5263</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aromatic hydroxylation</name>
  <code>T5266</code>  <id>5266</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Arterial Vasoconstriction</name>
  <code>T5327</code>  <id>5327</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Arterial Vasodilation</name>
  <code>T5328</code>  <id>5328</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Arteriolar Vasoconstriction</name>
  <code>T5330</code>  <id>5330</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Arteriolar Vasodilation</name>
  <code>T5331</code>  <id>5331</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Arteriolar Vasodilator</name>
  <code>T5332</code>  <id>5332</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aryl Hydrocarbon Receptor Agonist</name>
  <code>T58754</code>  <id>58754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aryl Hydrocarbon Receptor Agonists</name>
  <code>T58752</code>  <id>58752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Asparagine-specific Enzyme</name>
  <code>T5506</code>  <id>5506</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Aspartate Activity Alteration</name>
  <code>T5511</code>  <id>5511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Astringent Activity</name>
  <code>T5619</code>  <id>5619</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Atrial Depolarization</name>
  <code>T5710</code>  <id>5710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Atrial Repolarization</name>
  <code>T5739</code>  <id>5739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Atypical Antipsychotic</name>
  <code>T5758</code>  <id>5758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Cellular Immunotherapy</name>
  <code>T5851</code>  <id>5851</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Chondrocyte Cell Therapy</name>
  <code>T59064</code>  <id>59064</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Cultured Cell</name>
  <code>T5852</code>  <id>5852</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Cultured Cells</name>
  <code>T9776</code>  <id>9776</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Fibroblast Cell Therapy</name>
  <code>T59056</code>  <id>59056</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy</name>
  <code>T59031</code>  <id>59031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous HSC Gene Therapy</name>
  <code>T58652</code>  <id>58652</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous HSC-Based Gene Therapy</name>
  <code>T58939</code>  <id>58939</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy</name>
  <code>T58651</code>  <id>58651</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autonomic Ganglionic Activity Alteration</name>
  <code>T5859</code>  <id>5859</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autonomic Ganglionic Blocker</name>
  <code>T5860</code>  <id>5860</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Autonomic Nervous System Activity Alteration</name>
  <code>T5861</code>  <id>5861</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Azole Antifungal</name>
  <code>T5966</code>  <id>5966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B Cell Maturation Antigen-directed Antibody Interactions</name>
  <code>T59088</code>  <id>59088</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B Cell Maturation Antigen-directed Genetically Modified Autologous T-cell Immunotherapy</name>
  <code>T58890</code>  <id>58890</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B Lymphocyte Stimulator (BLyS)-specific Inhibitor</name>
  <code>T5983</code>  <id>5983</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B Lymphocyte Stimulator-directed Antibody Interactions</name>
  <code>T5982</code>  <id>5982</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B Lymphocyte Stimulator-specific Inhibitor</name>
  <code>T5987</code>  <id>5987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B [Preparations]</name>
  <code>T5988</code>  <id>5988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Cell Lymphoma 2 Inhibitor</name>
  <code>T6046</code>  <id>6046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Cell Lymphoma 2 Protein Inhibitor</name>
  <code>T6045</code>  <id>6045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Cell Lymphoma-2 Inhibitor</name>
  <code>T6051</code>  <id>6051</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Cell Lymphoma-2 Protein Inhibitor</name>
  <code>T6047</code>  <id>6047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Lymphocyte Stimulator (BLyS)-specific Inhibitor</name>
  <code>T5986</code>  <id>5986</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Lymphocyte Stimulator-directed Antibody Interactions</name>
  <code>T5981</code>  <id>5981</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-Lymphocyte Stimulator-specific Inhibitor</name>
  <code>T5985</code>  <id>5985</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy</name>
  <code>T58889</code>  <id>58889</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCL 2 Inhibitor</name>
  <code>T6049</code>  <id>6049</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCL-2 Inhibitor</name>
  <code>T6052</code>  <id>6052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCMA-directed Antibody Interactions</name>
  <code>T59089</code>  <id>59089</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCMA-directed Genetically Modified Autologous T Cell Immunotherapy</name>
  <code>T58891</code>  <id>58891</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCMA-directed Genetically Modified Autologous T-cell Immunotherapy</name>
  <code>T58892</code>  <id>58892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCRP Inhibitors</name>
  <code>T7290</code>  <id>7290</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BCRP Interactions</name>
  <code>T7292</code>  <id>7292</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BLyS-directed Antibody Interactions</name>
  <code>T5980</code>  <id>5980</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BLyS-specific Inhibitor</name>
  <code>T5984</code>  <id>5984</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BRAF Serine/Threonine Kinase Inhibitors</name>
  <code>T6179</code>  <id>6179</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BSEP Inhibitors</name>
  <code>T58447</code>  <id>58447</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BSEP Interactions</name>
  <code>T58445</code>  <id>58445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>BTK Inhibitors</name>
  <code>T58611</code>  <id>58611</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bacterial Neurotoxin Neutralization</name>
  <code>T6276</code>  <id>6276</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bacterial Toxin Neutralization</name>
  <code>T6296</code>  <id>6296</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Barbiturate</name>
  <code>T6342</code>  <id>6342</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Barbiturate-class Agent</name>
  <code>T6341</code>  <id>6341</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bcl 2 Inhibitor</name>
  <code>T6050</code>  <id>6050</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bcl-2 Inhibitor</name>
  <code>T6048</code>  <id>6048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bcr-Abl Tyrosine Kinase Inhibitor</name>
  <code>T6420</code>  <id>6420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bcr-Abl Tyrosine Kinase Inhibitors</name>
  <code>T6421</code>  <id>6421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine</name>
  <code>T6545</code>  <id>6545</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine Antagonist</name>
  <code>T6543</code>  <id>6543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine Antagonist</name>
  <code>T20786</code>  <id>20786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine Receptor Antagonist</name>
  <code>T20787</code>  <id>20787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine-class Agent</name>
  <code>T6544</code>  <id>6544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzothiazole</name>
  <code>T6582</code>  <id>6582</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzothiazole-class Agent</name>
  <code>T6581</code>  <id>6581</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Benzylamine Antifungal</name>
  <code>T6621</code>  <id>6621</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Beta-adrenergic Blocker</name>
  <code>T2516</code>  <id>2516</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Beta-adrenergic Receptor Inhibitor</name>
  <code>T2517</code>  <id>2517</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Beta-globin Gene Transfer</name>
  <code>T58653</code>  <id>58653</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Biguanide</name>
  <code>T6712</code>  <id>6712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Biguanide-class Agent</name>
  <code>T6711</code>  <id>6711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Acid</name>
  <code>T6723</code>  <id>6723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Acid Binding Resin</name>
  <code>T6720</code>  <id>6720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Acid Sequestrant</name>
  <code>T6721</code>  <id>6721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Acid-class Agent</name>
  <code>T6722</code>  <id>6722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Salt Export Pump Inhibitors</name>
  <code>T58446</code>  <id>58446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Salt Export Pump Interactions</name>
  <code>T58444</code>  <id>58444</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Secretion Alteration</name>
  <code>T6732</code>  <id>6732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Secretion Composition Alteration</name>
  <code>T6733</code>  <id>6733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile Secretion Volume Alteration</name>
  <code>T6734</code>  <id>6734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile-acid Binding Activity</name>
  <code>T6735</code>  <id>6735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bile-acid Binding Resin</name>
  <code>T6719</code>  <id>6719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Binding Activity</name>
  <code>T6756</code>  <id>6756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Biological Macromolecular Activity</name>
  <code>T6779</code>  <id>6779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Biological Response Modifiers</name>
  <code>T6784</code>  <id>6784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bipolar Agents</name>
  <code>T58418</code>  <id>58418</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bismuth</name>
  <code>T6885</code>  <id>6885</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bismuth-containing Agent</name>
  <code>T6884</code>  <id>6884</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager</name>
  <code>T59090</code>  <id>59090</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific BCMA-directed CD3 T Cell Engager</name>
  <code>T59091</code>  <id>59091</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD19-directed CD3-directed T Cell Engager</name>
  <code>T6890</code>  <id>6890</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD20-directed CD3 T Cell Engager</name>
  <code>T58859</code>  <id>58859</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD20-directed CD3 T-Cell Engager</name>
  <code>T58860</code>  <id>58860</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD20-directed CD3-directed T Cell Engager</name>
  <code>T58861</code>  <id>58861</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD20-directed CD3-directed T-Cell Engager</name>
  <code>T58862</code>  <id>58862</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific Glycoprotein 100 Peptide-HLA-directed CD3 T Cell Engager</name>
  <code>T58693</code>  <id>58693</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</name>
  <code>T58694</code>  <id>58694</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific HER2-directed Antibody</name>
  <code>T59036</code>  <id>59036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager</name>
  <code>T58692</code>  <id>58692</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bispecific gp100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</name>
  <code>T58695</code>  <id>58695</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bisphosphonate</name>
  <code>T6903</code>  <id>6903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bisphosphonate-class Agent</name>
  <code>T6902</code>  <id>6902</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bladder Contractility Alteration</name>
  <code>T6928</code>  <id>6928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bladder Sphincter Tone Alteration</name>
  <code>T6934</code>  <id>6934</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blocking Agent for Diagnostic Imaging</name>
  <code>T6965</code>  <id>6965</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood &amp; Lymphatic Fluid Function Alteration</name>
  <code>T6966</code>  <id>6966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood Coagulation Factor</name>
  <code>T6984</code>  <id>6984</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood Glucose Regulator</name>
  <code>T58518</code>  <id>58518</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood Glucose Regulators</name>
  <code>T58419</code>  <id>58419</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood Pressure Alteration</name>
  <code>T7004</code>  <id>7004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood Products/Modifiers/Volume Expanders</name>
  <code>T58420</code>  <id>58420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Blood Viscosity Reducer</name>
  <code>T7008</code>  <id>7008</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Alteration</name>
  <code>T7026</code>  <id>7026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Formation Alteration</name>
  <code>T7048</code>  <id>7048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Formation Inhibition</name>
  <code>T7049</code>  <id>7049</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Formation Stimulation</name>
  <code>T7050</code>  <id>7050</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Resorption Alteration</name>
  <code>T7098</code>  <id>7098</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Resorption Inhibition</name>
  <code>T7099</code>  <id>7099</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Resorption Stimulation</name>
  <code>T7100</code>  <id>7100</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bone Surface Interactions</name>
  <code>T7113</code>  <id>7113</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bovine Intestinal Adenosine Deaminase</name>
  <code>T7155</code>  <id>7155</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bradykinin B2 Receptor Antagonist</name>
  <code>T7179</code>  <id>7179</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bradykinin B2 Receptor Antagonists</name>
  <code>T7180</code>  <id>7180</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bradykinin Receptor Antagonists</name>
  <code>T7181</code>  <id>7181</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bradykinin Receptor Interactions</name>
  <code>T7182</code>  <id>7182</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Brain Derived Neurotropic Factor Activity Alteration</name>
  <code>T7197</code>  <id>7197</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Cancer Resistance Protein Inhibitors</name>
  <code>T7291</code>  <id>7291</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Cancer Resistance Protein Interactions</name>
  <code>T7293</code>  <id>7293</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Function Alteration</name>
  <code>T7298</code>  <id>7298</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Glandular Development Alteration</name>
  <code>T7299</code>  <id>7299</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Milk Ejection</name>
  <code>T7300</code>  <id>7300</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Milk Excretion</name>
  <code>T7301</code>  <id>7301</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Breast Milk Secretion</name>
  <code>T7302</code>  <id>7302</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bronchial Smooth Muscle Tone Alteration</name>
  <code>T7432</code>  <id>7432</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bronchoconstriction</name>
  <code>T7442</code>  <id>7442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bronchodilation</name>
  <code>T7443</code>  <id>7443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Bruton&apos;s Tyrosine Kinase Inhibitors</name>
  <code>T58609</code>  <id>58609</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Butyrophenone</name>
  <code>T7682</code>  <id>7682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Butyrophenone-class Agent</name>
  <code>T7681</code>  <id>7681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>C [Preparations]</name>
  <code>T7697</code>  <id>7697</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>C-type Natriuretic Peptide Analog</name>
  <code>T58667</code>  <id>58667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>C5aR Antagonist</name>
  <code>T58666</code>  <id>58666</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>C5aR Antagonists</name>
  <code>T58664</code>  <id>58664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>C5aR Interactions</name>
  <code>T58662</code>  <id>58662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCK Activity Alteration</name>
  <code>T7888</code>  <id>7888</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCK Analog</name>
  <code>T10649</code>  <id>10649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCK Analogue</name>
  <code>T10648</code>  <id>10648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCR4 Interaction</name>
  <code>T58482</code>  <id>58482</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCR5 Co-receptor Antagonist</name>
  <code>T10323</code>  <id>10323</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCR5 Co-receptor Antagonist</name>
  <code>T7894</code>  <id>7894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCR5 Co-receptor Antagonists</name>
  <code>T10322</code>  <id>10322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CCR5 Co-receptor Interactions</name>
  <code>T10325</code>  <id>10325</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD-11a Directed Humanized IgG1 Antibody</name>
  <code>T7896</code>  <id>7896</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD-3 Blocker Immunosuppressant</name>
  <code>T7917</code>  <id>7917</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD11a-directed Antibody Interactions</name>
  <code>T7895</code>  <id>7895</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD11a-directed Humanized IgG1 Antibody</name>
  <code>T7897</code>  <id>7897</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD123 Interaction</name>
  <code>T58477</code>  <id>58477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD123 Interactions</name>
  <code>T58476</code>  <id>58476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19 Receptor Interactions</name>
  <code>T7898</code>  <id>7898</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19 directed Cytolytic Antibody</name>
  <code>T58748</code>  <id>58748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Antibody Interactions</name>
  <code>T7899</code>  <id>7899</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19-directed CD3-directed BiTE</name>
  <code>T6889</code>  <id>6889</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Chimeric Antigen Receptor</name>
  <code>T7900</code>  <id>7900</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Cytolytic Antibody</name>
  <code>T58747</code>  <id>58747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy</name>
  <code>T58887</code>  <id>58887</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD2 Directed LFA-3/Fc Fusion Protein</name>
  <code>T7904</code>  <id>7904</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD2-directed Antibody Interactions</name>
  <code>T7903</code>  <id>7903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD2-directed LFA-3/Fc Fusion Protein</name>
  <code>T7905</code>  <id>7905</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Antibody Interactions</name>
  <code>T7906</code>  <id>7906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Cytolytic Antibody</name>
  <code>T7909</code>  <id>7909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Cytotoxin</name>
  <code>T7907</code>  <id>7907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Radiotherapeutic Antibody</name>
  <code>T7911</code>  <id>7911</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD20-directed, Cytolytic Antibody</name>
  <code>T7908</code>  <id>7908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD20-directed, Radiotherapeutic Antibody</name>
  <code>T7910</code>  <id>7910</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD22-directed Antibody Interactions</name>
  <code>T7912</code>  <id>7912</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD22-directed Antibody-Drug Conjugate</name>
  <code>T7913</code>  <id>7913</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD22-directed Immunoconjugate</name>
  <code>T7914</code>  <id>7914</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD25-directed Cytotoxin</name>
  <code>T7915</code>  <id>7915</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD25-directed Receptor Interactions</name>
  <code>T7916</code>  <id>7916</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Blocker Immunosuppressant</name>
  <code>T7918</code>  <id>7918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Directed Antibody</name>
  <code>T58912</code>  <id>58912</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Agonists</name>
  <code>T7919</code>  <id>7919</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Antagonists</name>
  <code>T7922</code>  <id>7922</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Blockers</name>
  <code>T7920</code>  <id>7920</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Inhibitors</name>
  <code>T7921</code>  <id>7921</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Interactions</name>
  <code>T7923</code>  <id>7923</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3-directed Antibody</name>
  <code>T58911</code>  <id>58911</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD3-directed Antibody Interactions</name>
  <code>T7924</code>  <id>7924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD30-directed Antibody Interactions</name>
  <code>T7931</code>  <id>7931</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD30-directed Antibody-drug Conjugate</name>
  <code>T7932</code>  <id>7932</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD30-directed Immunoconjugate</name>
  <code>T7933</code>  <id>7933</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD319-directed Antibody Interactions</name>
  <code>T47389</code>  <id>47389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD319-directed Immunostimulatory Antibody</name>
  <code>T47393</code>  <id>47393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD33-directed Antibody Interactions</name>
  <code>T7934</code>  <id>7934</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD33-directed Cytolytic Antibody</name>
  <code>T7935</code>  <id>7935</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD33-directed Cytotoxin</name>
  <code>T7936</code>  <id>7936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD33-directed Immunoconjugate</name>
  <code>T7937</code>  <id>7937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD38-directed Antibody Interactions</name>
  <code>T7938</code>  <id>7938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD38-directed Cytolytic Antibody</name>
  <code>T7939</code>  <id>7939</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD4-directed Antibody Interactions</name>
  <code>T58402</code>  <id>58402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD4-directed Blocking Antibody</name>
  <code>T58400</code>  <id>58400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD52-directed Antibody Interactions</name>
  <code>T7964</code>  <id>7964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD52-directed Cytolytic Antibody</name>
  <code>T7967</code>  <id>7967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD52-directed Cytotoxin</name>
  <code>T7966</code>  <id>7966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD52-directed, Cytolytic Antibody</name>
  <code>T7965</code>  <id>7965</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD80-directed Antibody Interactions</name>
  <code>T7968</code>  <id>7968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CD86-directed Antibody Interactions</name>
  <code>T7969</code>  <id>7969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CDK 4 Inhibitors</name>
  <code>T58552</code>  <id>58552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CDK 6 Inhibitors</name>
  <code>T58555</code>  <id>58555</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CFTR Potentiator</name>
  <code>T12989</code>  <id>12989</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CGPR Antagonist</name>
  <code>T58572</code>  <id>58572</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CGPR Antagonists</name>
  <code>T58574</code>  <id>58574</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CLDN 18.2-directed Cytolytic Antibody</name>
  <code>T59029</code>  <id>59029</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CLDN 18.2-directed Cytolytic Antibody Interactions</name>
  <code>T59024</code>  <id>59024</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CLDN18.2-directed Cytolytic Antibody</name>
  <code>T59030</code>  <id>59030</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CLDN18.2-directed Cytolytic Antibody Interactions</name>
  <code>T59025</code>  <id>59025</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV DNA Terminase Complex Inhibitor</name>
  <code>T58383</code>  <id>58383</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T13420</code>  <id>13420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T13419</code>  <id>13419</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV Pyrophosphate Analog DNA Polymerase Inhibitor</name>
  <code>T13424</code>  <id>13424</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
  <code>T13425</code>  <id>13425</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV pUL97 Kinase Inhibitor</name>
  <code>T58658</code>  <id>58658</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CMV pUL97 Kinase Inhibitors</name>
  <code>T58660</code>  <id>58660</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CNS Agent</name>
  <code>T9838</code>  <id>9838</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CNS Stimulant</name>
  <code>T9873</code>  <id>9873</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>COMT Inhibitor</name>
  <code>T9541</code>  <id>9541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>COMT Inhibitors</name>
  <code>T9526</code>  <id>9526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>COVID-19 mRNA Vaccine</name>
  <code>T58936</code>  <id>58936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>COVID-19 messenger RNA Vaccine</name>
  <code>T58937</code>  <id>58937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>COX-2 Inhibitors</name>
  <code>T12817</code>  <id>12817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CPS1 Activator</name>
  <code>T8895</code>  <id>8895</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CPS1 Activators</name>
  <code>T8908</code>  <id>8908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRF 1 Receptor Antagonist</name>
  <code>T59053</code>  <id>59053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRF 1 Receptor Antagonists</name>
  <code>T59048</code>  <id>59048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRF Type 1 Receptor Antagonist</name>
  <code>T59054</code>  <id>59054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRF Type 1 Receptor Antagonists</name>
  <code>T59049</code>  <id>59049</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRF1 Receptor Antagonist</name>
  <code>T59055</code>  <id>59055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRF1 Receptor Antagonists</name>
  <code>T59050</code>  <id>59050</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRH Activity Alteration</name>
  <code>T8367</code>  <id>8367</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRH Alteration</name>
  <code>T12138</code>  <id>12138</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CRH Secretion Alteration</name>
  <code>T8368</code>  <id>8368</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CSF-1R Blocker</name>
  <code>T58959</code>  <id>58959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CSF1R Blocker</name>
  <code>T58960</code>  <id>58960</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CTLA 4-directed Antibody Interactions</name>
  <code>T8388</code>  <id>8388</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CTLA 4-directed Blocking Antibody</name>
  <code>T8396</code>  <id>8396</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CTLA-4-directed Antibody Interactions</name>
  <code>T8392</code>  <id>8392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CTLA-4-directed Blocking Antibody</name>
  <code>T8403</code>  <id>8403</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CTLA4-directed Antibody Interactions</name>
  <code>T8391</code>  <id>8391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CTLA4-directed Blocking Antibody</name>
  <code>T8397</code>  <id>8397</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CXC Chemokine Receptor 4 Antagonist</name>
  <code>T58974</code>  <id>58974</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CXC Chemokine Receptor 4 Antagonists</name>
  <code>T58969</code>  <id>58969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CXCR-4 Antagonist</name>
  <code>T58970</code>  <id>58970</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CXCR-4 Antagonists</name>
  <code>T58972</code>  <id>58972</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CXCR4 Antagonist</name>
  <code>T58971</code>  <id>58971</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CXCR4 Antagonists</name>
  <code>T58973</code>  <id>58973</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP11A1 Inhibitors</name>
  <code>T58674</code>  <id>58674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP11B1 Inhibitors</name>
  <code>T58584</code>  <id>58584</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP17 Inhibitor</name>
  <code>T13207</code>  <id>13207</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP17A1 Inhibitor</name>
  <code>T13205</code>  <id>13205</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP17A1 Inhibitors</name>
  <code>T13209</code>  <id>13209</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP1A1 Inhibitors</name>
  <code>T58647</code>  <id>58647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 11A1 Inhibitors</name>
  <code>T58675</code>  <id>58675</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 11B1 Inhibitors</name>
  <code>T58585</code>  <id>58585</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 17A1 Inhibitor</name>
  <code>T13206</code>  <id>13206</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 17A1 Inhibitors</name>
  <code>T13210</code>  <id>13210</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 1A Inducers</name>
  <code>T13212</code>  <id>13212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 1A1 Inhibitors</name>
  <code>T58648</code>  <id>58648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 1A2 Inducers</name>
  <code>T13214</code>  <id>13214</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 1A2 Inhibitors</name>
  <code>T13216</code>  <id>13216</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2B6 Inducers</name>
  <code>T13218</code>  <id>13218</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2B6 Inhibitors</name>
  <code>T13220</code>  <id>13220</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2C19 Inducers</name>
  <code>T13222</code>  <id>13222</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2C19 Inhibitors</name>
  <code>T13224</code>  <id>13224</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2C8 Inducers</name>
  <code>T13226</code>  <id>13226</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2C8 Inhibitors</name>
  <code>T13228</code>  <id>13228</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2C9 Inducers</name>
  <code>T13230</code>  <id>13230</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2C9 Inhibitors</name>
  <code>T13232</code>  <id>13232</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2D6 Inducers</name>
  <code>T13234</code>  <id>13234</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2D6 Inhibitor</name>
  <code>T13236</code>  <id>13236</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 2D6 Inhibitors</name>
  <code>T13238</code>  <id>13238</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A Inducers</name>
  <code>T13240</code>  <id>13240</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A Inhibitor</name>
  <code>T13242</code>  <id>13242</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A Inhibitors</name>
  <code>T13244</code>  <id>13244</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A4 Inducers</name>
  <code>T13246</code>  <id>13246</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A4 Inhibitors</name>
  <code>T13248</code>  <id>13248</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A5 Inducers</name>
  <code>T13250</code>  <id>13250</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 3A5 Inhibitors</name>
  <code>T13252</code>  <id>13252</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 Inducers</name>
  <code>T13309</code>  <id>13309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>CYP450 Inhibitors</name>
  <code>T13311</code>  <id>13311</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcineurin Inhibitor Immunosuppressant</name>
  <code>T8510</code>  <id>8510</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcineurin Inhibitors</name>
  <code>T8511</code>  <id>8511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcitonin</name>
  <code>T8529</code>  <id>8529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Antagonist</name>
  <code>T58615</code>  <id>58615</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Antagonists</name>
  <code>T58616</code>  <id>58616</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Receptor Antagonist</name>
  <code>T58571</code>  <id>58571</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Receptor Antagonists</name>
  <code>T58573</code>  <id>58573</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcitonin-class Agent</name>
  <code>T8528</code>  <id>8528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium</name>
  <code>T8634</code>  <id>8634</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Binder</name>
  <code>T8536</code>  <id>8536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Binding Activity</name>
  <code>T8591</code>  <id>8591</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Agent</name>
  <code>T58519</code>  <id>58519</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Agonists</name>
  <code>T8539</code>  <id>8539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Antagonists</name>
  <code>T8541</code>  <id>8541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Blocker</name>
  <code>T8542</code>  <id>8542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Blockers</name>
  <code>T8540</code>  <id>8540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Interactions</name>
  <code>T8543</code>  <id>8543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Chelating Activity</name>
  <code>T8593</code>  <id>8593</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Chelator</name>
  <code>T8592</code>  <id>8592</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Resorption Inhibitor</name>
  <code>T8625</code>  <id>8625</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium Sensing Receptor Agonist</name>
  <code>T8682</code>  <id>8682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium-Sensing Receptor Interactions</name>
  <code>T8671</code>  <id>8671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium-containing Agent</name>
  <code>T8633</code>  <id>8633</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calcium-sensing Receptor Agonist</name>
  <code>T8683</code>  <id>8683</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Calculi Dissolution Agent</name>
  <code>T8685</code>  <id>8685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid</name>
  <code>T8828</code>  <id>8828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid Receptor Agonists</name>
  <code>T8824</code>  <id>8824</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid Receptor Antagonists</name>
  <code>T8825</code>  <id>8825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid Receptor Interactions</name>
  <code>T8826</code>  <id>8826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid-class Agent</name>
  <code>T8827</code>  <id>8827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthase 1 (CPS1) Activator</name>
  <code>T8899</code>  <id>8899</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthase 1 (CPS1) Activators</name>
  <code>T8904</code>  <id>8904</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthase 1 Activator</name>
  <code>T8892</code>  <id>8892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthase 1 Activators</name>
  <code>T8903</code>  <id>8903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activator</name>
  <code>T8893</code>  <id>8893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activators</name>
  <code>T8901</code>  <id>8901</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthetase 1 Activator</name>
  <code>T8900</code>  <id>8900</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthetase 1 Activators</name>
  <code>T8909</code>  <id>8909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl-Phosphate Synthase 1 Activator</name>
  <code>T8898</code>  <id>8898</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl-Phosphate Synthase 1 Activators</name>
  <code>T8906</code>  <id>8906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl-Phosphate Synthetase 1 Activator</name>
  <code>T8897</code>  <id>8897</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl-Phosphate Synthetase 1 Activators</name>
  <code>T8902</code>  <id>8902</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoylphosphate Synthase 1 Activator</name>
  <code>T8894</code>  <id>8894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoylphosphate Synthase 1 Activators</name>
  <code>T8907</code>  <id>8907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoylphosphate Synthetase 1 Activator</name>
  <code>T8896</code>  <id>8896</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbamoylphosphate Synthetase 1 Activators</name>
  <code>T8905</code>  <id>8905</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbohydrate Metabolism Alteration</name>
  <code>T8982</code>  <id>8982</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbonic Anhydrase Inhibitor</name>
  <code>T9041</code>  <id>9041</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carbonic Anhydrase Inhibitors</name>
  <code>T9042</code>  <id>9042</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carboxypeptidase</name>
  <code>T9115</code>  <id>9115</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiac Contractility Alteration</name>
  <code>T9249</code>  <id>9249</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiac Glycoside</name>
  <code>T9250</code>  <id>9250</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiac Myosin Inhibitor</name>
  <code>T58813</code>  <id>58813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiac Myosin Inhibitors</name>
  <code>T58812</code>  <id>58812</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiac Rate Alteration</name>
  <code>T9261</code>  <id>9261</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiac Rhythm Alteration</name>
  <code>T9262</code>  <id>9262</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiovascular Activity Alteration</name>
  <code>T9296</code>  <id>9296</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cardiovascular Agent</name>
  <code>T9297</code>  <id>9297</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cariostatic Activity</name>
  <code>T9307</code>  <id>9307</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carnitine Analog</name>
  <code>T9339</code>  <id>9339</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Carnitine Analogue</name>
  <code>T9338</code>  <id>9338</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol O-Methyl Transferase Inhibitor</name>
  <code>T9538</code>  <id>9538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol O-Methyl Transferase Inhibitors</name>
  <code>T9524</code>  <id>9524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol O-Methyltransferase Inhibitor</name>
  <code>T9539</code>  <id>9539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol O-Methyltransferase Inhibitors</name>
  <code>T9527</code>  <id>9527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol-O-Methyl Transferase (COMT) Inhibitor</name>
  <code>T9540</code>  <id>9540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol-O-Methyl Transferase Inhibitors</name>
  <code>T9523</code>  <id>9523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol-O-Methyltransferase (COMT) Inhibitor</name>
  <code>T9542</code>  <id>9542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol-O-Methyltransferase Inhibitor</name>
  <code>T9543</code>  <id>9543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catechol-O-Methyltransferase Inhibitors</name>
  <code>T9525</code>  <id>9525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catecholamine</name>
  <code>T9555</code>  <id>9555</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catecholamine Synthesis Inhibitor</name>
  <code>T9551</code>  <id>9551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catecholamine Synthesis Inhibitor</name>
  <code>T9552</code>  <id>9552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catecholamine Synthesis Inhibitors</name>
  <code>T9553</code>  <id>9553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catecholamine-class Agent</name>
  <code>T9554</code>  <id>9554</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Catecholamine-depleting Sympatholytic</name>
  <code>T9556</code>  <id>9556</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cation Transporter Interactions</name>
  <code>T9600</code>  <id>9600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Death Inducer</name>
  <code>T9743</code>  <id>9743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Division Protein Kinase 4 Inhibitors</name>
  <code>T58553</code>  <id>58553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Division Protein Kinase 6 Inhibitors</name>
  <code>T58556</code>  <id>58556</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Glucose Transport Alteration</name>
  <code>T9745</code>  <id>9745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Membrane Alteration</name>
  <code>T9746</code>  <id>9746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Membrane Fusion Complex Interactions</name>
  <code>T9747</code>  <id>9747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Organelle Alteration</name>
  <code>T9748</code>  <id>9748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Therapy</name>
  <code>T58886</code>  <id>58886</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell Wall Alteration</name>
  <code>T9757</code>  <id>9757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cell-mediated Immunity</name>
  <code>T9762</code>  <id>9762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cells, Allogeneic</name>
  <code>T9769</code>  <id>9769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cells, Cultured, Allogeneic</name>
  <code>T9774</code>  <id>9774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cells, Cultured, Autologous</name>
  <code>T9777</code>  <id>9777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cells, Cultured, Autologous, Genetically-modified</name>
  <code>T9780</code>  <id>9780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cells, Epidermal</name>
  <code>T9783</code>  <id>9783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Activity Alteration</name>
  <code>T9784</code>  <id>9784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Communication Alteration</name>
  <code>T9791</code>  <id>9791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Cycle Alteration</name>
  <code>T9792</code>  <id>9792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Death Alteration</name>
  <code>T9793</code>  <id>9793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Degradation/Digestion Alteration</name>
  <code>T9794</code>  <id>9794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Division Phase Alteration</name>
  <code>T9795</code>  <id>9795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Growth Phase Alteration</name>
  <code>T9796</code>  <id>9796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Growth Phase Arrest</name>
  <code>T9797</code>  <id>9797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Growth Phase Reduction</name>
  <code>T9798</code>  <id>9798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Motion Alteration</name>
  <code>T9799</code>  <id>9799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Proliferation Alteration</name>
  <code>T9800</code>  <id>9800</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Structure Alteration</name>
  <code>T9801</code>  <id>9801</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Structure Molecule Interactions</name>
  <code>T9802</code>  <id>9802</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Synthetic Activity Alteration</name>
  <code>T9803</code>  <id>9803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Synthetic Phase Alteration</name>
  <code>T9804</code>  <id>9804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Synthetic Phase Arrest</name>
  <code>T9805</code>  <id>9805</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular Transport Alteration</name>
  <code>T9806</code>  <id>9806</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cellular or Molecular Interactions</name>
  <code>T9807</code>  <id>9807</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Muscle Relaxant</name>
  <code>T34193</code>  <id>34193</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Activity Alteration</name>
  <code>T9837</code>  <id>9837</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Agent</name>
  <code>T9839</code>  <id>9839</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Depressant</name>
  <code>T9845</code>  <id>9845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Depression</name>
  <code>T9846</code>  <id>9846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Stimulant</name>
  <code>T9874</code>  <id>9874</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Stimulation</name>
  <code>T9875</code>  <id>9875</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central a-2 Adrenergic Agonist</name>
  <code>T9893</code>  <id>9893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Central alpha-2 Adrenergic Agonist</name>
  <code>T9894</code>  <id>9894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Centrally-mediated Muscle Relaxation</name>
  <code>T9895</code>  <id>9895</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cephalosporin Antibacterial</name>
  <code>T9918</code>  <id>9918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cephamycin Antibacterial</name>
  <code>T9928</code>  <id>9928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arterial Vasoconstriction</name>
  <code>T9966</code>  <id>9966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arterial Vasodilation</name>
  <code>T9967</code>  <id>9967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arteriolar Vasoconstriction</name>
  <code>T9968</code>  <id>9968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arteriolar Vasodilation</name>
  <code>T9969</code>  <id>9969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cervical Dilation Alteration</name>
  <code>T10052</code>  <id>10052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cervical Function Alteration</name>
  <code>T10053</code>  <id>10053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cervical Smooth Muscle Tone Alteration</name>
  <code>T10060</code>  <id>10060</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chelating Activity</name>
  <code>T10162</code>  <id>10162</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chelator</name>
  <code>T10161</code>  <id>10161</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chemical Structure</name>
  <code>T58528</code>  <id>58528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chemokine Co-receptor 5 Antagonist</name>
  <code>T7893</code>  <id>7893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chemokine Co-receptor 5 Antagonists</name>
  <code>T10324</code>  <id>10324</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chemokine Co-receptor 5 Interactions</name>
  <code>T10326</code>  <id>10326</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chemokine Receptor Type 4 Interaction</name>
  <code>T58481</code>  <id>58481</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chemokine Receptor Type 4 Interactions</name>
  <code>T58480</code>  <id>58480</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activation Potentiators</name>
  <code>T10475</code>  <id>10475</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activator</name>
  <code>T10476</code>  <id>10476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activator</name>
  <code>T10477</code>  <id>10477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activators</name>
  <code>T10478</code>  <id>10478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Agonists</name>
  <code>T10479</code>  <id>10479</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Antagonists</name>
  <code>T10481</code>  <id>10481</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Blockers</name>
  <code>T10480</code>  <id>10480</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Interactions</name>
  <code>T10482</code>  <id>10482</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholagogue Activity</name>
  <code>T10627</code>  <id>10627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholecystokinin (CCK) Analog</name>
  <code>T10646</code>  <id>10646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholecystokinin (CCK) Analogue</name>
  <code>T10647</code>  <id>10647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholecystokinin Analog</name>
  <code>T10650</code>  <id>10650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Choleretic Activity</name>
  <code>T10671</code>  <id>10671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Absorption Alteration</name>
  <code>T10728</code>  <id>10728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Elimination Alteration</name>
  <code>T10729</code>  <id>10729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Metabolism Alteration</name>
  <code>T10738</code>  <id>10738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Secretion Alteration</name>
  <code>T10741</code>  <id>10741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Synthesis Alteration</name>
  <code>T10753</code>  <id>10753</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Synthesis Inhibitors</name>
  <code>T10754</code>  <id>10754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Agonist</name>
  <code>T10826</code>  <id>10826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Agonists</name>
  <code>T10803</code>  <id>10803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Antagonist</name>
  <code>T4129</code>  <id>4129</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Antagonists</name>
  <code>T10804</code>  <id>10804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Ganglionic Nicotinic Agonists</name>
  <code>T10805</code>  <id>10805</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Ganglionic Nicotinic Antagonists</name>
  <code>T10806</code>  <id>10806</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Interactions</name>
  <code>T10807</code>  <id>10807</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Agonist</name>
  <code>T10809</code>  <id>10809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Agonists</name>
  <code>T10810</code>  <id>10810</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Antagonist</name>
  <code>T10814</code>  <id>10814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Antagonists</name>
  <code>T10815</code>  <id>10815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Receptor Interactions</name>
  <code>T10816</code>  <id>10816</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Neuromuscular Nicotinic Agonists</name>
  <code>T10817</code>  <id>10817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Neuromuscular Nicotinic Antagonists</name>
  <code>T10818</code>  <id>10818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Agonist</name>
  <code>T10822</code>  <id>10822</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Agonists</name>
  <code>T10823</code>  <id>10823</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Antagonists</name>
  <code>T10824</code>  <id>10824</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Receptor Interactions</name>
  <code>T10825</code>  <id>10825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Receptor Agonist</name>
  <code>T10827</code>  <id>10827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Receptor Inhibitor</name>
  <code>T10828</code>  <id>10828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Inhibitor</name>
  <code>T10830</code>  <id>10830</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Inhibitors</name>
  <code>T10831</code>  <id>10831</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Reactivator</name>
  <code>T10832</code>  <id>10832</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Reactivators</name>
  <code>T10833</code>  <id>10833</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Classical Complement Inhibitor</name>
  <code>T58691</code>  <id>58691</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Classical Complement Inhibitors</name>
  <code>T58707</code>  <id>58707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Classical Complement Pathway Inhibitor</name>
  <code>T58690</code>  <id>58690</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Classical Complement Pathway Inhibitors</name>
  <code>T58706</code>  <id>58706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Claudin 18.2-directed Antibody Interactions</name>
  <code>T59021</code>  <id>59021</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Claudin 18.2-directed Cytolytic Antibody</name>
  <code>T59026</code>  <id>59026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Claudin-18.2-directed Cytolytic Antibody</name>
  <code>T59027</code>  <id>59027</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Claudin-18.2-directed Cytolytic Antibody Interactions</name>
  <code>T59022</code>  <id>59022</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Claudin18.2-directed Cytolytic Antibody</name>
  <code>T59028</code>  <id>59028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Claudin18.2-directed Cytolytic Antibody Interactions</name>
  <code>T59023</code>  <id>59023</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Clearance</name>
  <code>T11197</code>  <id>11197</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Clinical Kinetics</name>
  <code>T11226</code>  <id>11226</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Clinically Unimportant Route of Excretion</name>
  <code>T11227</code>  <id>11227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Co-methyltransferase</name>
  <code>T11360</code>  <id>11360</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coagulation Activity Alteration</name>
  <code>T11362</code>  <id>11362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coagulation Factor Activity Alteration</name>
  <code>T11363</code>  <id>11363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coagulation Factor Alteration</name>
  <code>T11364</code>  <id>11364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coagulation Factor Concentration Alteration</name>
  <code>T11365</code>  <id>11365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Collagen Formation Alteration</name>
  <code>T11521</code>  <id>11521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Collagen Formation Inhibition</name>
  <code>T11522</code>  <id>11522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Collagen Formation Promotion</name>
  <code>T11523</code>  <id>11523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Collagen-specific Enzyme</name>
  <code>T11560</code>  <id>11560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Collecting Duct Water Permeability Alteration</name>
  <code>T11566</code>  <id>11566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Colony Stimulating Factor 1 Receptor Blocker</name>
  <code>T58958</code>  <id>58958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors</name>
  <code>T11590</code>  <id>11590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Colony Stimulating Factor-1 Receptor Blocker</name>
  <code>T58957</code>  <id>58957</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Compartments</name>
  <code>T11635</code>  <id>11635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Competitive Cholinergic Nicotinic Antagonists</name>
  <code>T11642</code>  <id>11642</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Competitive N-methyl-D-aspartate Receptor Antagonists</name>
  <code>T11643</code>  <id>11643</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Competitive NMDA Receptor Antagonists</name>
  <code>T11644</code>  <id>11644</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Competitive Opioid Antagonists</name>
  <code>T11645</code>  <id>11645</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement 1 Inactivators</name>
  <code>T11646</code>  <id>11646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement 5 Inactivators</name>
  <code>T11647</code>  <id>11647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement 5a Receptor Antagonist</name>
  <code>T58665</code>  <id>58665</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement 5a Receptor Antagonists</name>
  <code>T58663</code>  <id>58663</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement 5a Receptor Interactions</name>
  <code>T58661</code>  <id>58661</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement C5 Inhibitor</name>
  <code>T58962</code>  <id>58962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement C5 Inhibitors</name>
  <code>T58961</code>  <id>58961</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Factor B Inhibitor</name>
  <code>T58994</code>  <id>58994</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Factor B Inhibitors</name>
  <code>T58993</code>  <id>58993</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Factor D Inhibitor</name>
  <code>T58942</code>  <id>58942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Factor D Inhibitors</name>
  <code>T58941</code>  <id>58941</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Inactivators</name>
  <code>T11845</code>  <id>11845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Inhibitor</name>
  <code>T11846</code>  <id>11846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Complement Inhibitors</name>
  <code>T11847</code>  <id>11847</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Conduction System Depolarization</name>
  <code>T11883</code>  <id>11883</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Conduction System Repolarization</name>
  <code>T11884</code>  <id>11884</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arterial Vasoconstriction</name>
  <code>T11927</code>  <id>11927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arterial Vasodilation</name>
  <code>T11928</code>  <id>11928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arteriolar Vasoconstriction</name>
  <code>T11929</code>  <id>11929</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arteriolar Vasodilation</name>
  <code>T11930</code>  <id>11930</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Alteration</name>
  <code>T11949</code>  <id>11949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Permeability Alteration</name>
  <code>T11960</code>  <id>11960</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Permeability Alteration Decrease</name>
  <code>T11958</code>  <id>11958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Permeability Alteration Increase</name>
  <code>T11959</code>  <id>11959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Contrast Agent for Ultrasound Imaging</name>
  <code>T11992</code>  <id>11992</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Copper Absorption Inhibitor</name>
  <code>T12003</code>  <id>12003</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Copper Chelating Activity</name>
  <code>T12005</code>  <id>12005</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Copper Chelator</name>
  <code>T12004</code>  <id>12004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Copper-containing IUD</name>
  <code>T12012</code>  <id>12012</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Copper-containing Intrauterine Device</name>
  <code>T12014</code>  <id>12014</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Copper-containing Intrauterine Device (IUD)</name>
  <code>T12013</code>  <id>12013</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coronary Arterial Vasoconstriction</name>
  <code>T12107</code>  <id>12107</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coronary Arterial Vasodilation</name>
  <code>T12108</code>  <id>12108</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coronary Arteriolar Vasoconstriction</name>
  <code>T12109</code>  <id>12109</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Coronary Arteriolar Vasodilation</name>
  <code>T12110</code>  <id>12110</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticosteroid</name>
  <code>T12135</code>  <id>12135</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticosteroid Hormone Receptor Agonists</name>
  <code>T12134</code>  <id>12134</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticotropin Releasing Factor Type 1 Receptor Antagonist</name>
  <code>T59052</code>  <id>59052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticotropin Releasing Factor Type 1 Receptor Antagonists</name>
  <code>T59047</code>  <id>59047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticotropin Releasing Hormone Alteration</name>
  <code>T12139</code>  <id>12139</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticotropin-releasing Factor Type 1 Receptor Antagonist</name>
  <code>T59051</code>  <id>59051</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Corticotropin-releasing Factor Type 1 Receptor Antagonists</name>
  <code>T59046</code>  <id>59046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cortisol Synthesis Inhibitor</name>
  <code>T58586</code>  <id>58586</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cultured Cells, Allogeneic</name>
  <code>T9773</code>  <id>9773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cultured Cells, Autologous</name>
  <code>T9775</code>  <id>9775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Current Non-smoker</name>
  <code>T12416</code>  <id>12416</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arterial Vasoconstriction</name>
  <code>T12420</code>  <id>12420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arterial Vasodilation</name>
  <code>T12421</code>  <id>12421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arteriolar Vasoconstriction</name>
  <code>T12422</code>  <id>12422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arteriolar Vasodilation</name>
  <code>T12423</code>  <id>12423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclic Pyranopterin Monophosphate</name>
  <code>T58542</code>  <id>58542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclic pyranopterin monophoshic acid</name>
  <code>T58544</code>  <id>58544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclic pyranopterin monophosphoric acid</name>
  <code>T58545</code>  <id>58545</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclic pyranopterin phosphate</name>
  <code>T58546</code>  <id>58546</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclic pyranopterin phosphoric acid</name>
  <code>T58547</code>  <id>58547</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase 2 Inhibitors</name>
  <code>T12819</code>  <id>12819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase II Inhibitors</name>
  <code>T12818</code>  <id>12818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase Inhibitor</name>
  <code>T12827</code>  <id>12827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase Inhibitors</name>
  <code>T12828</code>  <id>12828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cysteine Proteinase Inhibitors</name>
  <code>T12967</code>  <id>12967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator</name>
  <code>T12988</code>  <id>12988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator</name>
  <code>T12990</code>  <id>12990</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cystine Depleting Agent</name>
  <code>T12997</code>  <id>12997</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cystine Disulfide Reduction</name>
  <code>T12998</code>  <id>12998</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytidine Analog Deaminase Inhibitor</name>
  <code>T58701</code>  <id>58701</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytidine Analog Deaminase Inhibitors</name>
  <code>T58703</code>  <id>58703</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytidine Deaminase Inhibitor</name>
  <code>T58700</code>  <id>58700</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytidine Deaminase Inhibitors</name>
  <code>T58702</code>  <id>58702</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 11A1 Inhibitors</name>
  <code>T58673</code>  <id>58673</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 11B1 Inhibitors</name>
  <code>T58583</code>  <id>58583</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 17A1 Inhibitor</name>
  <code>T13208</code>  <id>13208</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 17A1 Inhibitors</name>
  <code>T13211</code>  <id>13211</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A Inducers</name>
  <code>T13213</code>  <id>13213</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A1 Inhibitors</name>
  <code>T58646</code>  <id>58646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A2 Inducers</name>
  <code>T13215</code>  <id>13215</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A2 Inhibitors</name>
  <code>T13217</code>  <id>13217</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2A6 Inhibitors</name>
  <code>T58582</code>  <id>58582</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2B6 Inducers</name>
  <code>T13219</code>  <id>13219</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2B6 Inhibitors</name>
  <code>T13221</code>  <id>13221</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C19 Inducers</name>
  <code>T13223</code>  <id>13223</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C19 Inhibitors</name>
  <code>T13225</code>  <id>13225</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C8 Inducers</name>
  <code>T13227</code>  <id>13227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C8 Inhibitors</name>
  <code>T13229</code>  <id>13229</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C9 Inducers</name>
  <code>T13231</code>  <id>13231</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C9 Inhibitors</name>
  <code>T13233</code>  <id>13233</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2D6 Inducers</name>
  <code>T13235</code>  <id>13235</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2D6 Inhibitor</name>
  <code>T13237</code>  <id>13237</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2D6 Inhibitors</name>
  <code>T13239</code>  <id>13239</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2E1 Inducers</name>
  <code>T58614</code>  <id>58614</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A Inducers</name>
  <code>T13241</code>  <id>13241</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A Inhibitor</name>
  <code>T13243</code>  <id>13243</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A Inhibitors</name>
  <code>T13245</code>  <id>13245</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A4 Inducers</name>
  <code>T13247</code>  <id>13247</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A4 Inhibitors</name>
  <code>T13249</code>  <id>13249</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A5 Inducers</name>
  <code>T13251</code>  <id>13251</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A5 Inhibitors</name>
  <code>T13253</code>  <id>13253</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 Inducers</name>
  <code>T13310</code>  <id>13310</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 Inhibitors</name>
  <code>T13312</code>  <id>13312</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytochromes</name>
  <code>T13344</code>  <id>13344</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytokine Receptor Superfamily Interactions</name>
  <code>T13398</code>  <id>13398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytolytic Agent</name>
  <code>T13413</code>  <id>13413</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus DNA Terminase Complex Inhibitor</name>
  <code>T58384</code>  <id>58384</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T13422</code>  <id>13422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T13421</code>  <id>13421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor</name>
  <code>T13426</code>  <id>13426</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
  <code>T13423</code>  <id>13423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus pUL97 Kinase Inhibitor</name>
  <code>T58657</code>  <id>58657</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus pUL97 Kinase Inhibitors</name>
  <code>T58659</code>  <id>58659</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytoprotective Agent</name>
  <code>T13434</code>  <id>13434</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytoskeleton Alteration</name>
  <code>T13442</code>  <id>13442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T Lymphocyte Antigen 4-directed Antibody Interactions</name>
  <code>T8390</code>  <id>8390</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T Lymphocyte Antigen 4-directed Blocking Antibody</name>
  <code>T8394</code>  <id>8394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T Lymphocyte Antigen-4-directed Antibody Interactions</name>
  <code>T8386</code>  <id>8386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T Lymphocyte Antigen-4-directed Blocking Antibody</name>
  <code>T8401</code>  <id>8401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T-Lymphocyte Antigen 4-directed Antibody Interactions</name>
  <code>T8389</code>  <id>8389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T-Lymphocyte Antigen 4-directed Blocking Antibody</name>
  <code>T8400</code>  <id>8400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T-Lymphocyte Antigen-4-directed Antibody Interactions</name>
  <code>T8387</code>  <id>8387</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxic T-Lymphocyte Antigen-4-directed Blocking Antibody</name>
  <code>T8393</code>  <id>8393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Cytotoxin</name>
  <code>T58472</code>  <id>58472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>D [Preparations]</name>
  <code>T13465</code>  <id>13465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>D2 Receptor Antagonist</name>
  <code>T16600</code>  <id>16600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Alteration</name>
  <code>T13767</code>  <id>13767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Gyrase Inhibitors</name>
  <code>T13773</code>  <id>13773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Gyrase Inhibitors</name>
  <code>T52385</code>  <id>52385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Integrity Alteration</name>
  <code>T13778</code>  <id>13778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Methylation</name>
  <code>T13786</code>  <id>13786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Methylation Decrease</name>
  <code>T13784</code>  <id>13784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Methylation Increase</name>
  <code>T13785</code>  <id>13785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Methyltransferase Inhibitors</name>
  <code>T13788</code>  <id>13788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Methytransferase Inhibitors</name>
  <code>T13787</code>  <id>13787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Polymerase Inhibitors</name>
  <code>T13816</code>  <id>13816</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Replication Alteration</name>
  <code>T13836</code>  <id>13836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNA Terminase Complex Inhibitors</name>
  <code>T58385</code>  <id>58385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DNRI</name>
  <code>T58815</code>  <id>58815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DOPA Decarboxylase Inhibitors</name>
  <code>T14005</code>  <id>14005</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DPP-4 Inhibitor</name>
  <code>T16259</code>  <id>16259</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>DPP-4 Inhibitors</name>
  <code>T16266</code>  <id>16266</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decarboxylase Inhibitor</name>
  <code>T14168</code>  <id>14168</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decarboxylase Inhibitors</name>
  <code>T14169</code>  <id>14169</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decorporation Agent</name>
  <code>T14181</code>  <id>14181</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decrease Spermatogenesis</name>
  <code>T14182</code>  <id>14182</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased ACTH Sectretion</name>
  <code>T14189</code>  <id>14189</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Acetylcholine Activity</name>
  <code>T14183</code>  <id>14183</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Adhesion Factor Activity</name>
  <code>T14184</code>  <id>14184</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Adhesion Factor Degradation</name>
  <code>T14185</code>  <id>14185</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Adhesion Factor Production</name>
  <code>T14186</code>  <id>14186</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Adrenal Epinephrine Secretion</name>
  <code>T14187</code>  <id>14187</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Adrenal Norepinephrine Secretion</name>
  <code>T14188</code>  <id>14188</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Adrenocorticotropic Hormone Secretion</name>
  <code>T14190</code>  <id>14190</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Amino Acid Synthesis</name>
  <code>T14191</code>  <id>14191</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Anal Sphincter Tone</name>
  <code>T14192</code>  <id>14192</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Antibody Activity</name>
  <code>T14193</code>  <id>14193</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Antibody Degradation</name>
  <code>T14194</code>  <id>14194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Antibody Production</name>
  <code>T14195</code>  <id>14195</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Aspartate Activity</name>
  <code>T14196</code>  <id>14196</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Ganglionic Activity</name>
  <code>T14197</code>  <id>14197</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Acetylcholine Activity</name>
  <code>T14198</code>  <id>14198</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Aspartate Activity</name>
  <code>T14199</code>  <id>14199</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity</name>
  <code>T14200</code>  <id>14200</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System CCK Activity</name>
  <code>T14201</code>  <id>14201</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Disorganized Electrical Activity</name>
  <code>T14202</code>  <id>14202</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Dopamine Activity</name>
  <code>T14203</code>  <id>14203</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Dynorphin Activity</name>
  <code>T14204</code>  <id>14204</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Endorphin Activity</name>
  <code>T14205</code>  <id>14205</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Enkephalin Activity</name>
  <code>T14206</code>  <id>14206</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Epinephrine Activity</name>
  <code>T14207</code>  <id>14207</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System GABA Activity</name>
  <code>T14208</code>  <id>14208</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Gastrin Activity</name>
  <code>T14209</code>  <id>14209</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Glutamate Activity</name>
  <code>T14210</code>  <id>14210</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Glycine Activity</name>
  <code>T14211</code>  <id>14211</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Histamine Activity</name>
  <code>T14212</code>  <id>14212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Nerve Growth Factor Activity</name>
  <code>T14213</code>  <id>14213</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Neurotensin Activity</name>
  <code>T14214</code>  <id>14214</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Nitric Oxide Activity</name>
  <code>T14215</code>  <id>14215</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Norepinephrine Activity</name>
  <code>T14216</code>  <id>14216</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Organized Electrical Activity</name>
  <code>T14217</code>  <id>14217</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Serotonin Activity</name>
  <code>T14218</code>  <id>14218</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Substance P Activity</name>
  <code>T14219</code>  <id>14219</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System VIP Activity</name>
  <code>T14220</code>  <id>14220</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased B Lymphocyte Activation</name>
  <code>T14221</code>  <id>14221</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased B Lymphocyte Destruction</name>
  <code>T14222</code>  <id>14222</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased B Lymphocyte Production</name>
  <code>T14223</code>  <id>14223</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Biliary Motility</name>
  <code>T14224</code>  <id>14224</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Bladder Contractility</name>
  <code>T14225</code>  <id>14225</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Bladder Sphincter Tone</name>
  <code>T14226</code>  <id>14226</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Blood Pressure</name>
  <code>T14227</code>  <id>14227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Blood Viscosity</name>
  <code>T14228</code>  <id>14228</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Bradykinin Activity</name>
  <code>T14229</code>  <id>14229</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Bradykinin Degradation</name>
  <code>T14230</code>  <id>14230</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Bradykinin Production</name>
  <code>T14231</code>  <id>14231</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Derived Neurotropic Activity</name>
  <code>T14232</code>  <id>14232</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Acetylcholine Activity</name>
  <code>T14233</code>  <id>14233</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Aspartate Activity</name>
  <code>T14234</code>  <id>14234</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Brain Derived Neurotropic Activity</name>
  <code>T14235</code>  <id>14235</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem CCK Activity</name>
  <code>T14236</code>  <id>14236</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Disorganized Electrical Activity</name>
  <code>T14237</code>  <id>14237</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Dopamine Activity</name>
  <code>T14238</code>  <id>14238</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Dynorphin Activity</name>
  <code>T14239</code>  <id>14239</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Endorphin Activity</name>
  <code>T14240</code>  <id>14240</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Enkephalin Activity</name>
  <code>T14241</code>  <id>14241</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Epinephrine Activity</name>
  <code>T14242</code>  <id>14242</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem GABA Activity</name>
  <code>T14243</code>  <id>14243</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Gastrin Activity</name>
  <code>T14244</code>  <id>14244</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Glutamate Activity</name>
  <code>T14245</code>  <id>14245</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Glycine Activity</name>
  <code>T14246</code>  <id>14246</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Histamine Activity</name>
  <code>T14247</code>  <id>14247</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Nerve Growth Factor Activity</name>
  <code>T14248</code>  <id>14248</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Neurotensin Activity</name>
  <code>T14249</code>  <id>14249</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Nitric Oxide Activity</name>
  <code>T14250</code>  <id>14250</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Norepinephrine Activity</name>
  <code>T14251</code>  <id>14251</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Organized Electrical Activity</name>
  <code>T14252</code>  <id>14252</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Serotonin Activity</name>
  <code>T14253</code>  <id>14253</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Substance P Activity</name>
  <code>T14254</code>  <id>14254</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem VIP Activity</name>
  <code>T14255</code>  <id>14255</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased CCK Activity</name>
  <code>T14256</code>  <id>14256</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased CRH Activity</name>
  <code>T14257</code>  <id>14257</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased CRH Secretion</name>
  <code>T14258</code>  <id>14258</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Calcitonin Secretion</name>
  <code>T14259</code>  <id>14259</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Calcium-sensing Receptor Sensitivity</name>
  <code>T14260</code>  <id>14260</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Capillary Permeability</name>
  <code>T14261</code>  <id>14261</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Acetylcholine Activity</name>
  <code>T14262</code>  <id>14262</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Aspartate Activity</name>
  <code>T14263</code>  <id>14263</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity</name>
  <code>T14264</code>  <id>14264</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle CCK Activity</name>
  <code>T14265</code>  <id>14265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Disorganized Electrical Activity</name>
  <code>T14266</code>  <id>14266</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Dopamine Activity</name>
  <code>T14267</code>  <id>14267</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Dynorphin Activity</name>
  <code>T14268</code>  <id>14268</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Endorphin Activity</name>
  <code>T14269</code>  <id>14269</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Enkephalin Activity</name>
  <code>T14270</code>  <id>14270</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Epinephrine Activity</name>
  <code>T14271</code>  <id>14271</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle GABA Activity</name>
  <code>T14272</code>  <id>14272</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Gastrin Activity</name>
  <code>T14273</code>  <id>14273</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Glutamate Activity</name>
  <code>T14274</code>  <id>14274</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Glycine Activity</name>
  <code>T14275</code>  <id>14275</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Histamine Activity</name>
  <code>T14276</code>  <id>14276</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Nerve Growth Factor Activity</name>
  <code>T14277</code>  <id>14277</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Neurotensin Activity</name>
  <code>T14278</code>  <id>14278</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Nitric Oxide Activity</name>
  <code>T14279</code>  <id>14279</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Norepinephrine Activity</name>
  <code>T14280</code>  <id>14280</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Organized Electrical Activity</name>
  <code>T14281</code>  <id>14281</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Serotonin Activity</name>
  <code>T14282</code>  <id>14282</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Substance P Activity</name>
  <code>T14283</code>  <id>14283</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle VIP Activity</name>
  <code>T14284</code>  <id>14284</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Membrane Integrity</name>
  <code>T14285</code>  <id>14285</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Membrane Synthesis &amp; Repair</name>
  <code>T14286</code>  <id>14286</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Wall Integrity</name>
  <code>T14287</code>  <id>14287</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Wall Synthesis &amp; Repair</name>
  <code>T14288</code>  <id>14288</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cellular Death</name>
  <code>T14289</code>  <id>14289</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cellular Locomotion</name>
  <code>T14290</code>  <id>14290</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cellular Migration</name>
  <code>T14291</code>  <id>14291</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Acetylcholine Activity</name>
  <code>T14292</code>  <id>14292</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Aspartate Activity</name>
  <code>T14293</code>  <id>14293</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Brain Derived Neurotropic Activity</name>
  <code>T14294</code>  <id>14294</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System CCK Activity</name>
  <code>T14295</code>  <id>14295</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Disorganized Electrical Activity</name>
  <code>T14296</code>  <id>14296</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Dopamine Activity</name>
  <code>T14297</code>  <id>14297</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Dynorphin Activity</name>
  <code>T14298</code>  <id>14298</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Endorphin Activity</name>
  <code>T14299</code>  <id>14299</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Enkephalin Activity</name>
  <code>T14300</code>  <id>14300</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Epinephrine Activity</name>
  <code>T14301</code>  <id>14301</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System GABA Activity</name>
  <code>T14302</code>  <id>14302</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Gastrin Activity</name>
  <code>T14303</code>  <id>14303</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Glutamate Activity</name>
  <code>T14304</code>  <id>14304</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Glycine Activity</name>
  <code>T14305</code>  <id>14305</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Histamine Activity</name>
  <code>T14306</code>  <id>14306</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Nerve Growth Factor Activity</name>
  <code>T14307</code>  <id>14307</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Neurotensin Activity</name>
  <code>T14308</code>  <id>14308</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Nitric Oxide Activity</name>
  <code>T14309</code>  <id>14309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Norepinephrine Activity</name>
  <code>T14310</code>  <id>14310</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Organized Electrical Activity</name>
  <code>T14311</code>  <id>14311</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Serotonin Activity</name>
  <code>T14312</code>  <id>14312</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Substance P Activity</name>
  <code>T14313</code>  <id>14313</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System VIP Activity</name>
  <code>T14314</code>  <id>14314</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Acetylcholine Activity</name>
  <code>T14315</code>  <id>14315</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Aspartate Activity</name>
  <code>T14316</code>  <id>14316</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Brain Derived Neurotropic Activity</name>
  <code>T14317</code>  <id>14317</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum CCK Activity</name>
  <code>T14318</code>  <id>14318</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Disorganized Electrical Activity</name>
  <code>T14319</code>  <id>14319</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Dopamine Activity</name>
  <code>T14320</code>  <id>14320</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Dynorphin Activity</name>
  <code>T14321</code>  <id>14321</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Endorphin Activity</name>
  <code>T14322</code>  <id>14322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Enkephalin Activity</name>
  <code>T14323</code>  <id>14323</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Epinephrine Activity</name>
  <code>T14324</code>  <id>14324</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum GABA Activity</name>
  <code>T14325</code>  <id>14325</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Gastrin Activity</name>
  <code>T14326</code>  <id>14326</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Glutamate Activity</name>
  <code>T14327</code>  <id>14327</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Glycine Activity</name>
  <code>T14328</code>  <id>14328</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Histamine Activity</name>
  <code>T14329</code>  <id>14329</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Nerve Growth Factor Activity</name>
  <code>T14330</code>  <id>14330</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Neurotensin Activity</name>
  <code>T14331</code>  <id>14331</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Nitric Oxide Activity</name>
  <code>T14332</code>  <id>14332</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Norepinephrine Activity</name>
  <code>T14333</code>  <id>14333</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Organized Electrical Activity</name>
  <code>T14334</code>  <id>14334</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Serotonin Activity</name>
  <code>T14335</code>  <id>14335</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Substance P Activity</name>
  <code>T14336</code>  <id>14336</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum VIP Activity</name>
  <code>T14337</code>  <id>14337</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Acetylcholine Activity</name>
  <code>T14338</code>  <id>14338</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Aspartate Activity</name>
  <code>T14339</code>  <id>14339</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity</name>
  <code>T14340</code>  <id>14340</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex CCK Activity</name>
  <code>T14341</code>  <id>14341</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Disorganized Electrical Activity</name>
  <code>T14342</code>  <id>14342</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Dopamine Activity</name>
  <code>T14343</code>  <id>14343</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Dynorphin Activity</name>
  <code>T14344</code>  <id>14344</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Endorphin Activity</name>
  <code>T14345</code>  <id>14345</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Enkephalin Activity</name>
  <code>T14346</code>  <id>14346</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Epinephrine Activity</name>
  <code>T14347</code>  <id>14347</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex GABA Activity</name>
  <code>T14348</code>  <id>14348</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Gastrin Activity</name>
  <code>T14349</code>  <id>14349</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Glutamate Activity</name>
  <code>T14350</code>  <id>14350</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Glycine Activity</name>
  <code>T14351</code>  <id>14351</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Histamine Activity</name>
  <code>T14352</code>  <id>14352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Nerve Growth Factor Activity</name>
  <code>T14353</code>  <id>14353</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Neurotensin Activity</name>
  <code>T14354</code>  <id>14354</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Nitric Oxide Activity</name>
  <code>T14355</code>  <id>14355</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Norepinephrine Activity</name>
  <code>T14356</code>  <id>14356</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Organized Electrical Activity</name>
  <code>T14357</code>  <id>14357</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Serotonin Activity</name>
  <code>T14358</code>  <id>14358</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Substance P Activity</name>
  <code>T14359</code>  <id>14359</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex VIP Activity</name>
  <code>T14360</code>  <id>14360</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cervical Dilation</name>
  <code>T14361</code>  <id>14361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cervical Smooth Muscle Tone</name>
  <code>T14362</code>  <id>14362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Absorption</name>
  <code>T14363</code>  <id>14363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Elimination</name>
  <code>T14364</code>  <id>14364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Secretion</name>
  <code>T14365</code>  <id>14365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Synthesis</name>
  <code>T14366</code>  <id>14366</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Coagulation Activity</name>
  <code>T14371</code>  <id>14371</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Coagulation Factor Activity</name>
  <code>T14372</code>  <id>14372</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Coagulation Factor Concentration</name>
  <code>T14373</code>  <id>14373</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Ca++ Excretion</name>
  <code>T14374</code>  <id>14374</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Cl- Excretion</name>
  <code>T14375</code>  <id>14375</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct H+ Excretion</name>
  <code>T14376</code>  <id>14376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct HCO3- Excretion</name>
  <code>T14377</code>  <id>14377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct K+ Excretion</name>
  <code>T14378</code>  <id>14378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Mg++ Excretion</name>
  <code>T14379</code>  <id>14379</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Na+ Excretion</name>
  <code>T14380</code>  <id>14380</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct PO4-- Excretion</name>
  <code>T14381</code>  <id>14381</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct SO4-- Excretion</name>
  <code>T14382</code>  <id>14382</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Water Permeability</name>
  <code>T14383</code>  <id>14383</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Complement Activity</name>
  <code>T14384</code>  <id>14384</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Complement Degradation</name>
  <code>T14385</code>  <id>14385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Complement Production</name>
  <code>T14386</code>  <id>14386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Copper Ion Absorption</name>
  <code>T14387</code>  <id>14387</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytokine Activity</name>
  <code>T14388</code>  <id>14388</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytokine Degradation</name>
  <code>T14389</code>  <id>14389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytokine Production</name>
  <code>T14390</code>  <id>14390</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytoskeleton Integrity</name>
  <code>T14391</code>  <id>14391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytoskeleton Synthesis &amp; Repair</name>
  <code>T14392</code>  <id>14392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased DHT Secretion</name>
  <code>T14395</code>  <id>14395</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased DNA Integrity</name>
  <code>T14393</code>  <id>14393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased DNA Replication</name>
  <code>T14394</code>  <id>14394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Dihydrotestosterone Secretion</name>
  <code>T14396</code>  <id>14396</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Disorganized Electrical Activity</name>
  <code>T14397</code>  <id>14397</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Ca++ Excretion</name>
  <code>T14398</code>  <id>14398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Cl- Excretion</name>
  <code>T14399</code>  <id>14399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule H+ Excretion</name>
  <code>T14400</code>  <id>14400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule HCO3- Excretion</name>
  <code>T14401</code>  <id>14401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule K+ Excretion</name>
  <code>T14402</code>  <id>14402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Mg++ Excretion</name>
  <code>T14403</code>  <id>14403</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Na+ Excretion</name>
  <code>T14404</code>  <id>14404</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule PO4-- Excretion</name>
  <code>T14405</code>  <id>14405</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule SO4-- Excretion</name>
  <code>T14406</code>  <id>14406</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Diuresis</name>
  <code>T14408</code>  <id>14408</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Diuresis at Loop of Henle</name>
  <code>T14409</code>  <id>14409</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Dopamine Activity</name>
  <code>T14410</code>  <id>14410</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Dynorphin Activity</name>
  <code>T14411</code>  <id>14411</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Eicosanoid Activity</name>
  <code>T14412</code>  <id>14412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Eicosanoid Degradation</name>
  <code>T14413</code>  <id>14413</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Eicosanoid Production</name>
  <code>T14414</code>  <id>14414</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Embryonic &amp; Fetal Growth</name>
  <code>T14415</code>  <id>14415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Embryonic &amp; Fetal Viability</name>
  <code>T14416</code>  <id>14416</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Embryonic Implantation</name>
  <code>T14417</code>  <id>14417</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Endocytosis</name>
  <code>T14418</code>  <id>14418</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Endorphin Activity</name>
  <code>T14419</code>  <id>14419</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Endothelial Coagulation Activity</name>
  <code>T14420</code>  <id>14420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Endothelial Proliferation</name>
  <code>T14421</code>  <id>14421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enkephalin Activity</name>
  <code>T14422</code>  <id>14422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Acetylcholine Activity</name>
  <code>T14423</code>  <id>14423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Aspartate Activity</name>
  <code>T14424</code>  <id>14424</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity</name>
  <code>T14425</code>  <id>14425</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System CCK Activity</name>
  <code>T14426</code>  <id>14426</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Disorganized Electrical Activity</name>
  <code>T14427</code>  <id>14427</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Dopamine Activity</name>
  <code>T14428</code>  <id>14428</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Dynorphin Activity</name>
  <code>T14429</code>  <id>14429</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Endorphin Activity</name>
  <code>T14430</code>  <id>14430</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Enkephalin Activity</name>
  <code>T14431</code>  <id>14431</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Epinephrine Activity</name>
  <code>T14432</code>  <id>14432</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System GABA Activity</name>
  <code>T14433</code>  <id>14433</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Gastrin Activity</name>
  <code>T14434</code>  <id>14434</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Glutamate Activity</name>
  <code>T14435</code>  <id>14435</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Glycine Activity</name>
  <code>T14436</code>  <id>14436</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Histamine Activity</name>
  <code>T14437</code>  <id>14437</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Nerve Growth Factor Activity</name>
  <code>T14438</code>  <id>14438</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Neurotensin Activity</name>
  <code>T14439</code>  <id>14439</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Nitric Oxide Activity</name>
  <code>T14440</code>  <id>14440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Norepinephrine Activity</name>
  <code>T14441</code>  <id>14441</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Organized Electrical Activity</name>
  <code>T14442</code>  <id>14442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Serotonin Activity</name>
  <code>T14443</code>  <id>14443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Substance P Activity</name>
  <code>T14444</code>  <id>14444</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System VIP Activity</name>
  <code>T14445</code>  <id>14445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Epinephrine Activity</name>
  <code>T14446</code>  <id>14446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Epithelial Proliferation</name>
  <code>T14447</code>  <id>14447</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Erythroid Cell Destruction</name>
  <code>T14448</code>  <id>14448</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Erythroid Cell Production</name>
  <code>T14449</code>  <id>14449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Erythropoetin Secretion</name>
  <code>T14450</code>  <id>14450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Esophageal Motility</name>
  <code>T14451</code>  <id>14451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Esophageal Muscle Tone</name>
  <code>T14452</code>  <id>14452</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Exocytosis</name>
  <code>T14453</code>  <id>14453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Extracellular Communication</name>
  <code>T14454</code>  <id>14454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased FSH Secretion</name>
  <code>T14460</code>  <id>14460</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Fibrinolysis</name>
  <code>T14456</code>  <id>14456</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Fibroblast Migration</name>
  <code>T14457</code>  <id>14457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Folate Modification</name>
  <code>T14458</code>  <id>14458</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Folic Acid Modification</name>
  <code>T14459</code>  <id>14459</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Follicle Stimulating Hormone Secretion</name>
  <code>T14461</code>  <id>14461</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GABA Activity</name>
  <code>T14462</code>  <id>14462</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GH Secretion</name>
  <code>T14487</code>  <id>14487</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GHRH Activity</name>
  <code>T14463</code>  <id>14463</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GHRH Secretion</name>
  <code>T14464</code>  <id>14464</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GI Motility</name>
  <code>T14465</code>  <id>14465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GI Smooth Muscle Tone</name>
  <code>T14466</code>  <id>14466</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Gallbladder Tone</name>
  <code>T14467</code>  <id>14467</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Gastric Motility</name>
  <code>T14468</code>  <id>14468</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Gastric Muscle Tone</name>
  <code>T14469</code>  <id>14469</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Gastrin Activity</name>
  <code>T14470</code>  <id>14470</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glomerular Filtration Pressure</name>
  <code>T14471</code>  <id>14471</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucagon Secretion</name>
  <code>T14472</code>  <id>14472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucocorticoid Clearance</name>
  <code>T14473</code>  <id>14473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucocorticoid Secretion</name>
  <code>T14474</code>  <id>14474</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Gluconeogenesis</name>
  <code>T14475</code>  <id>14475</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucose Transport into Cells</name>
  <code>T14476</code>  <id>14476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glutamate Activity</name>
  <code>T14477</code>  <id>14477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycine Activity</name>
  <code>T14478</code>  <id>14478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycogenesis</name>
  <code>T14479</code>  <id>14479</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycogenolysis</name>
  <code>T14480</code>  <id>14480</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycolysis</name>
  <code>T14481</code>  <id>14481</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GnRH Activity</name>
  <code>T14482</code>  <id>14482</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased GnRH Secretion</name>
  <code>T14483</code>  <id>14483</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Granulocytic Cell Destruction</name>
  <code>T14484</code>  <id>14484</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Granulocytic Cell Production</name>
  <code>T14485</code>  <id>14485</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Growth Factor Activity</name>
  <code>T14486</code>  <id>14486</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Growth Hormone Secretion</name>
  <code>T14488</code>  <id>14488</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Hair Growth</name>
  <code>T14489</code>  <id>14489</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Hematological Cell Destruction</name>
  <code>T14490</code>  <id>14490</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Hematopoiesis</name>
  <code>T14491</code>  <id>14491</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Hematopoietic Stem Cell Mobilization</name>
  <code>T14492</code>  <id>14492</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Activity</name>
  <code>T14493</code>  <id>14493</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Degradation</name>
  <code>T14494</code>  <id>14494</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Production</name>
  <code>T14495</code>  <id>14495</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Release</name>
  <code>T14496</code>  <id>14496</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased IgE Activity</name>
  <code>T14497</code>  <id>14497</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologic Activity</name>
  <code>T14502</code>  <id>14502</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Biogenic Amine Activity</name>
  <code>T14503</code>  <id>14503</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Biogenic Amine Degradation</name>
  <code>T14504</code>  <id>14504</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Biogenic Amine Production</name>
  <code>T14505</code>  <id>14505</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Molecule Activity</name>
  <code>T14506</code>  <id>14506</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Molecule Degradation</name>
  <code>T14507</code>  <id>14507</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Molecule Production</name>
  <code>T14508</code>  <id>14508</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Inorganic Ion Absorption</name>
  <code>T14509</code>  <id>14509</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Insulin Secretion</name>
  <code>T14510</code>  <id>14510</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Intercellular Communication</name>
  <code>T14511</code>  <id>14511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Intraocular Aqueous Secretion</name>
  <code>T14512</code>  <id>14512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Intraocular Fluid Pressure</name>
  <code>T14513</code>  <id>14513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Intravascular Volume</name>
  <code>T14514</code>  <id>14514</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Iodine Organification</name>
  <code>T14515</code>  <id>14515</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Iodine Uptake</name>
  <code>T14516</code>  <id>14516</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Kallidin Activity</name>
  <code>T14517</code>  <id>14517</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Kallidin Degradation</name>
  <code>T14518</code>  <id>14518</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Kallidin Production</name>
  <code>T14519</code>  <id>14519</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Kinin Activity</name>
  <code>T14520</code>  <id>14520</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Kinin Degradation</name>
  <code>T14521</code>  <id>14521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Kinin Production</name>
  <code>T14522</code>  <id>14522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased LES Tone</name>
  <code>T14523</code>  <id>14523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased LH Secretion</name>
  <code>T14543</code>  <id>14543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Large Intestinal Motility</name>
  <code>T14524</code>  <id>14524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Large Intestinal Muscle Tone</name>
  <code>T14525</code>  <id>14525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Leukotriene Activity</name>
  <code>T14526</code>  <id>14526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Leukotriene Degradation</name>
  <code>T14527</code>  <id>14527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Leukotriene Production</name>
  <code>T14528</code>  <id>14528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipid Derived Immunologically Active Molecule Activity</name>
  <code>T14529</code>  <id>14529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipid Derived Immunologically Active Molecule Degradation</name>
  <code>T14530</code>  <id>14530</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipid Derived Immunologically Active Molecule Production</name>
  <code>T14531</code>  <id>14531</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipogenesis</name>
  <code>T14532</code>  <id>14532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipolysis</name>
  <code>T14533</code>  <id>14533</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Ca++ Excretion</name>
  <code>T14534</code>  <id>14534</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Cl- Excretion</name>
  <code>T14535</code>  <id>14535</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle H+ Excretion</name>
  <code>T14536</code>  <id>14536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle HCO3- Excretion</name>
  <code>T14537</code>  <id>14537</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle K+ Excretion</name>
  <code>T14538</code>  <id>14538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Mg++ Excretion</name>
  <code>T14539</code>  <id>14539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Na+ Excretion</name>
  <code>T14540</code>  <id>14540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle PO4-- Excretion</name>
  <code>T14541</code>  <id>14541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle SO4-- Excretion</name>
  <code>T14542</code>  <id>14542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Luteinizing Hormone Secretion</name>
  <code>T14544</code>  <id>14544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lymphocyte Activation</name>
  <code>T14545</code>  <id>14545</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lymphocyte Cell Destruction</name>
  <code>T14546</code>  <id>14546</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lymphocyte Cell Production</name>
  <code>T14547</code>  <id>14547</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Lysosomal Function</name>
  <code>T14548</code>  <id>14548</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Medullary Respiratory Drive</name>
  <code>T14549</code>  <id>14549</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Megakaryocte Cell Destruction</name>
  <code>T14550</code>  <id>14550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Megakaryocte Cell Production</name>
  <code>T14551</code>  <id>14551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Megakaryocyte Maturation</name>
  <code>T14552</code>  <id>14552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Meiosis</name>
  <code>T14553</code>  <id>14553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Melatonin Activity</name>
  <code>T14554</code>  <id>14554</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Melatonin Secretion</name>
  <code>T14555</code>  <id>14555</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Metabolic Rate</name>
  <code>T14556</code>  <id>14556</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Acetylcholine Activity</name>
  <code>T14557</code>  <id>14557</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Aspartate Activity</name>
  <code>T14558</code>  <id>14558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Brain Derived Neurotropic Activity</name>
  <code>T14559</code>  <id>14559</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain CCK Activity</name>
  <code>T14560</code>  <id>14560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Disorganized Electrical Activity</name>
  <code>T14561</code>  <id>14561</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Dopamine Activity</name>
  <code>T14562</code>  <id>14562</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Dynorphin Activity</name>
  <code>T14563</code>  <id>14563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Endorphin Activity</name>
  <code>T14564</code>  <id>14564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Enkephalin Activity</name>
  <code>T14565</code>  <id>14565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Epinephrine Activity</name>
  <code>T14566</code>  <id>14566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain GABA Activity</name>
  <code>T14567</code>  <id>14567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Gastrin Activity</name>
  <code>T14568</code>  <id>14568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Glutamate Activity</name>
  <code>T14569</code>  <id>14569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Glycine Activity</name>
  <code>T14570</code>  <id>14570</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Histamine Activity</name>
  <code>T14571</code>  <id>14571</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Nerve Growth Factor Activity</name>
  <code>T14572</code>  <id>14572</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Neurotensin Activity</name>
  <code>T14573</code>  <id>14573</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Nitric Oxide Activity</name>
  <code>T14574</code>  <id>14574</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Norepinephrine Activity</name>
  <code>T14575</code>  <id>14575</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Organized Electrical Activity</name>
  <code>T14576</code>  <id>14576</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Serotonin Activity</name>
  <code>T14577</code>  <id>14577</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Substance P Activity</name>
  <code>T14578</code>  <id>14578</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain VIP Activity</name>
  <code>T14579</code>  <id>14579</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Mineralocorticoid Secretion</name>
  <code>T14580</code>  <id>14580</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Mitosis</name>
  <code>T14581</code>  <id>14581</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Monocytic Cell Destruction</name>
  <code>T14582</code>  <id>14582</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Monocytic Cell Production</name>
  <code>T14583</code>  <id>14583</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Acetylcholine Activity</name>
  <code>T14584</code>  <id>14584</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Aspartate Activity</name>
  <code>T14585</code>  <id>14585</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Brain Derived Neurotropic Activity</name>
  <code>T14586</code>  <id>14586</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System CCK Activity</name>
  <code>T14587</code>  <id>14587</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Disorganized Electrical Activity</name>
  <code>T14588</code>  <id>14588</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Dopamine Activity</name>
  <code>T14589</code>  <id>14589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Dynorphin Activity</name>
  <code>T14590</code>  <id>14590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Endorphin Activity</name>
  <code>T14591</code>  <id>14591</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Enkephalin Activity</name>
  <code>T14592</code>  <id>14592</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Epinephrine Activity</name>
  <code>T14593</code>  <id>14593</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System GABA Activity</name>
  <code>T14594</code>  <id>14594</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Gastrin Activity</name>
  <code>T14595</code>  <id>14595</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Glutamate Activity</name>
  <code>T14596</code>  <id>14596</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Glycine Activity</name>
  <code>T14597</code>  <id>14597</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Histamine Activity</name>
  <code>T14598</code>  <id>14598</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Nerve Growth Factor Activity</name>
  <code>T14599</code>  <id>14599</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Neurotensin Activity</name>
  <code>T14600</code>  <id>14600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Nitric Oxide Activity</name>
  <code>T14601</code>  <id>14601</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Norepinephrine Activity</name>
  <code>T14602</code>  <id>14602</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Organized Electrical Activity</name>
  <code>T14603</code>  <id>14603</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Serotonin Activity</name>
  <code>T14604</code>  <id>14604</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Substance P Activity</name>
  <code>T14605</code>  <id>14605</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System VIP Activity</name>
  <code>T14606</code>  <id>14606</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Myeloid Cell Destruction</name>
  <code>T14607</code>  <id>14607</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Myeloid Cell Production</name>
  <code>T14608</code>  <id>14608</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Nasal and Sinus Mucosal Edema</name>
  <code>T14609</code>  <id>14609</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Nasal and Sinus Secretions</name>
  <code>T14610</code>  <id>14610</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Nerve Growth Factor Activity</name>
  <code>T14611</code>  <id>14611</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Neurotensin Activity</name>
  <code>T14612</code>  <id>14612</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Nitric Oxide Activity</name>
  <code>T14613</code>  <id>14613</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Norepinephrine Activity</name>
  <code>T14614</code>  <id>14614</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Oncotic Pressure</name>
  <code>T14615</code>  <id>14615</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Organic Ion Degradation</name>
  <code>T14616</code>  <id>14616</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Organic Ion Synthesis</name>
  <code>T14617</code>  <id>14617</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Organized Electrical Activity</name>
  <code>T14618</code>  <id>14618</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Ovarian Estrogen Secretion</name>
  <code>T14619</code>  <id>14619</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Ovarian Progesterone Secretion</name>
  <code>T14620</code>  <id>14620</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Oxygen Carrying Capacity</name>
  <code>T14621</code>  <id>14621</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Oxytocin Secretion</name>
  <code>T14622</code>  <id>14622</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased PIF Activity</name>
  <code>T14623</code>  <id>14623</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased PIF Secretion</name>
  <code>T14624</code>  <id>14624</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased PRF Activity</name>
  <code>T14625</code>  <id>14625</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased PRF Secretion</name>
  <code>T14626</code>  <id>14626</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased PTH Secretion</name>
  <code>T14627</code>  <id>14627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Pancreatic Somatostatin Secretion</name>
  <code>T14628</code>  <id>14628</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Acetylcholine Activity</name>
  <code>T14629</code>  <id>14629</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Activity</name>
  <code>T14631</code>  <id>14631</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Aspartate Activity</name>
  <code>T14632</code>  <id>14632</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Brain Derived Neurotropic Activity</name>
  <code>T14633</code>  <id>14633</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic CCK Activity</name>
  <code>T14634</code>  <id>14634</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Disorganized Electrical Activity</name>
  <code>T14635</code>  <id>14635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Dopamine Activity</name>
  <code>T14636</code>  <id>14636</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Dynorphin Activity</name>
  <code>T14637</code>  <id>14637</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Endorphin Activity</name>
  <code>T14638</code>  <id>14638</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Enkephalin Activity</name>
  <code>T14639</code>  <id>14639</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Epinephrine Activity</name>
  <code>T14640</code>  <id>14640</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic GABA Activity</name>
  <code>T14641</code>  <id>14641</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Gastrin Activity</name>
  <code>T14642</code>  <id>14642</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Glutamate Activity</name>
  <code>T14643</code>  <id>14643</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Glycine Activity</name>
  <code>T14644</code>  <id>14644</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Histamine Activity</name>
  <code>T14645</code>  <id>14645</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Nerve Growth Factor Activity</name>
  <code>T14646</code>  <id>14646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Neurotensin Activity</name>
  <code>T14647</code>  <id>14647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Nitric Oxide Activity</name>
  <code>T14648</code>  <id>14648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Norepinephrine Activity</name>
  <code>T14649</code>  <id>14649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Organized Electrical Activity</name>
  <code>T14650</code>  <id>14650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Serotonin Activity</name>
  <code>T14651</code>  <id>14651</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Substance P Activity</name>
  <code>T14652</code>  <id>14652</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic VIP Activity</name>
  <code>T14653</code>  <id>14653</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Acetylcholine Activity</name>
  <code>T14654</code>  <id>14654</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Aspartate Activity</name>
  <code>T14655</code>  <id>14655</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity</name>
  <code>T14656</code>  <id>14656</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System CCK Activity</name>
  <code>T14657</code>  <id>14657</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Disorganized Electrical Activity</name>
  <code>T14658</code>  <id>14658</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Dopamine Activity</name>
  <code>T14659</code>  <id>14659</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Dynorphin Activity</name>
  <code>T14660</code>  <id>14660</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Endorphin Activity</name>
  <code>T14661</code>  <id>14661</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Enkephalin Activity</name>
  <code>T14662</code>  <id>14662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Epinephrine Activity</name>
  <code>T14663</code>  <id>14663</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System GABA Activity</name>
  <code>T14664</code>  <id>14664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Gastrin Activity</name>
  <code>T14665</code>  <id>14665</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Glutamate Activity</name>
  <code>T14666</code>  <id>14666</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Glycine Activity</name>
  <code>T14667</code>  <id>14667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Histamine Activity</name>
  <code>T14668</code>  <id>14668</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Nerve Growth Factor Activity</name>
  <code>T14669</code>  <id>14669</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Neurotensin Activity</name>
  <code>T14670</code>  <id>14670</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Nitric Oxide Activity</name>
  <code>T14671</code>  <id>14671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Norepinephrine Activity</name>
  <code>T14672</code>  <id>14672</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Organized Electrical Activity</name>
  <code>T14673</code>  <id>14673</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Serotonin Activity</name>
  <code>T14674</code>  <id>14674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Substance P Activity</name>
  <code>T14675</code>  <id>14675</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System VIP Activity</name>
  <code>T14676</code>  <id>14676</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Respiratory Drive</name>
  <code>T14677</code>  <id>14677</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Phagocytosis</name>
  <code>T14678</code>  <id>14678</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Pharyngeal Mucosal Edema</name>
  <code>T14679</code>  <id>14679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Pharyngeal Secretions</name>
  <code>T14680</code>  <id>14680</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Pinocytosis</name>
  <code>T14681</code>  <id>14681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Placental HCG Secretion</name>
  <code>T14682</code>  <id>14682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Placental Human Chorionic Gonadotropin Secretion</name>
  <code>T14683</code>  <id>14683</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Activating Factor Activity</name>
  <code>T14684</code>  <id>14684</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Activating Factor Degradation</name>
  <code>T14685</code>  <id>14685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Activating Factor Production</name>
  <code>T14686</code>  <id>14686</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Aggregation</name>
  <code>T14687</code>  <id>14687</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Production</name>
  <code>T14688</code>  <id>14688</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Polymorphonuclear Leukocyte Migration</name>
  <code>T14689</code>  <id>14689</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prolactin Secretion</name>
  <code>T14690</code>  <id>14690</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostaglandin Activity</name>
  <code>T14691</code>  <id>14691</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostaglandin Degradation</name>
  <code>T14692</code>  <id>14692</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostaglandin Production</name>
  <code>T14693</code>  <id>14693</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostatic Secretion</name>
  <code>T14694</code>  <id>14694</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostatic Size</name>
  <code>T14695</code>  <id>14695</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Protein Breakdown</name>
  <code>T14696</code>  <id>14696</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Protein Modification</name>
  <code>T14697</code>  <id>14697</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Protein Synthesis</name>
  <code>T14698</code>  <id>14698</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Prothrombin Activity</name>
  <code>T58743</code>  <id>58743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Ca++ Excretion</name>
  <code>T14699</code>  <id>14699</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Cl- Excretion</name>
  <code>T14700</code>  <id>14700</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule H+ Excretion</name>
  <code>T14701</code>  <id>14701</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule HCO3- Excretion</name>
  <code>T14702</code>  <id>14702</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule K+ Excretion</name>
  <code>T14703</code>  <id>14703</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Mg++ Excretion</name>
  <code>T14704</code>  <id>14704</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Na+ Excretion</name>
  <code>T14705</code>  <id>14705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule PO4-- Excretion</name>
  <code>T14706</code>  <id>14706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule SO4-- Excretion</name>
  <code>T14707</code>  <id>14707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Pyloric Sphincter Tone</name>
  <code>T14708</code>  <id>14708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased RNA Integrity</name>
  <code>T14709</code>  <id>14709</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased RNA Replication</name>
  <code>T14710</code>  <id>14710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Ca++ Excretion</name>
  <code>T14711</code>  <id>14711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Cl- Excretion</name>
  <code>T14712</code>  <id>14712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal H+ Excretion</name>
  <code>T14713</code>  <id>14713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal HCO3- Excretion</name>
  <code>T14714</code>  <id>14714</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Ion Excretion</name>
  <code>T14715</code>  <id>14715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal K+ Excretion</name>
  <code>T14716</code>  <id>14716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Mg++ Excretion</name>
  <code>T14717</code>  <id>14717</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Na+ Excretion</name>
  <code>T14718</code>  <id>14718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Organic Anion Excretion</name>
  <code>T14719</code>  <id>14719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Organic Cation Excretion</name>
  <code>T14720</code>  <id>14720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Organic Ion Excretion</name>
  <code>T14721</code>  <id>14721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal PO4-- Excretion</name>
  <code>T14722</code>  <id>14722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal SO4-- Excretion</name>
  <code>T14723</code>  <id>14723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Urea Excretion</name>
  <code>T14724</code>  <id>14724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Respiratory Mucosal Edema</name>
  <code>T14725</code>  <id>14725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Respiratory Secretion Viscosity</name>
  <code>T14726</code>  <id>14726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Respiratory Secretions</name>
  <code>T14727</code>  <id>14727</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Reverse Transcription to DNA</name>
  <code>T14728</code>  <id>14728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sebaceous Gland Activity</name>
  <code>T14729</code>  <id>14729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sebaceous Gland Quantity</name>
  <code>T14730</code>  <id>14730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity</name>
  <code>T14731</code>  <id>14731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Aspartate Activity</name>
  <code>T14732</code>  <id>14732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</name>
  <code>T14733</code>  <id>14733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System CCK Activity</name>
  <code>T14734</code>  <id>14734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity</name>
  <code>T14735</code>  <id>14735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Dopamine Activity</name>
  <code>T14736</code>  <id>14736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Dynorphin Activity</name>
  <code>T14737</code>  <id>14737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Endorphin Activity</name>
  <code>T14738</code>  <id>14738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Enkephalin Activity</name>
  <code>T14739</code>  <id>14739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Epinephrine Activity</name>
  <code>T14740</code>  <id>14740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System GABA Activity</name>
  <code>T14741</code>  <id>14741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Gastrin Activity</name>
  <code>T14742</code>  <id>14742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Glutamate Activity</name>
  <code>T14743</code>  <id>14743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Glycine Activity</name>
  <code>T14744</code>  <id>14744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Histamine Activity</name>
  <code>T14745</code>  <id>14745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity</name>
  <code>T14746</code>  <id>14746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Neurotensin Activity</name>
  <code>T14747</code>  <id>14747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity</name>
  <code>T14748</code>  <id>14748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity</name>
  <code>T14749</code>  <id>14749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity</name>
  <code>T14750</code>  <id>14750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Serotonin Activity</name>
  <code>T14751</code>  <id>14751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Substance P Activity</name>
  <code>T14752</code>  <id>14752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System VIP Activity</name>
  <code>T14753</code>  <id>14753</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Serotonin Activity</name>
  <code>T14754</code>  <id>14754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Serotonin Degradation</name>
  <code>T14755</code>  <id>14755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Serotonin Production</name>
  <code>T14756</code>  <id>14756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Skin Keratinization</name>
  <code>T14759</code>  <id>14759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Small Intestinal Motility</name>
  <code>T14760</code>  <id>14760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Small Intestinal Muscle Tone</name>
  <code>T14761</code>  <id>14761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Acetylcholine Activity</name>
  <code>T14762</code>  <id>14762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Aspartate Activity</name>
  <code>T14763</code>  <id>14763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Brain Derived Neurotropic Activity</name>
  <code>T14764</code>  <id>14764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle CCK Activity</name>
  <code>T14765</code>  <id>14765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Disorganized Electrical Activity</name>
  <code>T14766</code>  <id>14766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Dopamine Activity</name>
  <code>T14767</code>  <id>14767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Dynorphin Activity</name>
  <code>T14768</code>  <id>14768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Endorphin Activity</name>
  <code>T14769</code>  <id>14769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Enkephalin Activity</name>
  <code>T14770</code>  <id>14770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Epinephrine Activity</name>
  <code>T14771</code>  <id>14771</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle GABA Activity</name>
  <code>T14772</code>  <id>14772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Gastrin Activity</name>
  <code>T14773</code>  <id>14773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Glutamate Activity</name>
  <code>T14774</code>  <id>14774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Glycine Activity</name>
  <code>T14775</code>  <id>14775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Histamine Activity</name>
  <code>T14776</code>  <id>14776</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Nerve Growth Factor Activity</name>
  <code>T14777</code>  <id>14777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Neurotensin Activity</name>
  <code>T14778</code>  <id>14778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Nitric Oxide Activity</name>
  <code>T14779</code>  <id>14779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Norepinephrine Activity</name>
  <code>T14780</code>  <id>14780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Organized Electrical Activity</name>
  <code>T14781</code>  <id>14781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Serotonin Activity</name>
  <code>T14782</code>  <id>14782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Substance P Activity</name>
  <code>T14783</code>  <id>14783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle VIP Activity</name>
  <code>T14784</code>  <id>14784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Somatostatin (SRIF) Activity</name>
  <code>T14785</code>  <id>14785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Somatostatin (SRIF) Secretion</name>
  <code>T14786</code>  <id>14786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sperm Motility</name>
  <code>T14787</code>  <id>14787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sphincter of Odi Tone</name>
  <code>T14788</code>  <id>14788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Acetylcholine Activity</name>
  <code>T14789</code>  <id>14789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Aspartate Activity</name>
  <code>T14790</code>  <id>14790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Brain Derived Neurotropic Activity</name>
  <code>T14791</code>  <id>14791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord CCK Activity</name>
  <code>T14792</code>  <id>14792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Disorganized Electrical Activity</name>
  <code>T14793</code>  <id>14793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Dopamine Activity</name>
  <code>T14794</code>  <id>14794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Dynorphin Activity</name>
  <code>T14795</code>  <id>14795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Endorphin Activity</name>
  <code>T14796</code>  <id>14796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Enkephalin Activity</name>
  <code>T14797</code>  <id>14797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Epinephrine Activity</name>
  <code>T14798</code>  <id>14798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord GABA Activity</name>
  <code>T14799</code>  <id>14799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Gastrin Activity</name>
  <code>T14800</code>  <id>14800</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Glutamate Activity</name>
  <code>T14801</code>  <id>14801</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Glycine Activity</name>
  <code>T14802</code>  <id>14802</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Histamine Activity</name>
  <code>T14803</code>  <id>14803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Nerve Growth Factor Activity</name>
  <code>T14804</code>  <id>14804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Neurotensin Activity</name>
  <code>T14805</code>  <id>14805</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Nitric Oxide Activity</name>
  <code>T14806</code>  <id>14806</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Norepinephrine Activity</name>
  <code>T14807</code>  <id>14807</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Organized Electrical Activity</name>
  <code>T14808</code>  <id>14808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Serotonin Activity</name>
  <code>T14809</code>  <id>14809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Substance P Activity</name>
  <code>T14810</code>  <id>14810</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord VIP Activity</name>
  <code>T14811</code>  <id>14811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sterol Synthesis</name>
  <code>T14812</code>  <id>14812</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Acetylcholine Activity</name>
  <code>T14813</code>  <id>14813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Aspartate Activity</name>
  <code>T14814</code>  <id>14814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Brain Derived Neurotropic Activity</name>
  <code>T14815</code>  <id>14815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle CCK Activity</name>
  <code>T14816</code>  <id>14816</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Contraction</name>
  <code>T14817</code>  <id>14817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Disorganized Electrical Activity</name>
  <code>T14818</code>  <id>14818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Dopamine Activity</name>
  <code>T14819</code>  <id>14819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Dynorphin Activity</name>
  <code>T14820</code>  <id>14820</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Endorphin Activity</name>
  <code>T14821</code>  <id>14821</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Enkephalin Activity</name>
  <code>T14822</code>  <id>14822</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Epinephrine Activity</name>
  <code>T14823</code>  <id>14823</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle GABA Activity</name>
  <code>T14824</code>  <id>14824</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Gastrin Activity</name>
  <code>T14825</code>  <id>14825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Glutamate Activity</name>
  <code>T14826</code>  <id>14826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Glycine Activity</name>
  <code>T14827</code>  <id>14827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Histamine Activity</name>
  <code>T14828</code>  <id>14828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Nerve Growth Factor Activity</name>
  <code>T14829</code>  <id>14829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Neurotensin Activity</name>
  <code>T14830</code>  <id>14830</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Nitric Oxide Activity</name>
  <code>T14831</code>  <id>14831</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Norepinephrine Activity</name>
  <code>T14832</code>  <id>14832</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Organized Electrical Activity</name>
  <code>T14833</code>  <id>14833</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Serotonin Activity</name>
  <code>T14834</code>  <id>14834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Substance P Activity</name>
  <code>T14835</code>  <id>14835</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Tone</name>
  <code>T14836</code>  <id>14836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle VIP Activity</name>
  <code>T14837</code>  <id>14837</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Substance P Activity</name>
  <code>T14838</code>  <id>14838</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Acetylcholine Activity</name>
  <code>T14839</code>  <id>14839</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Activity</name>
  <code>T14841</code>  <id>14841</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Aspartate Activity</name>
  <code>T14842</code>  <id>14842</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Brain Derived Neurotropic Activity</name>
  <code>T14843</code>  <id>14843</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic CCK Activity</name>
  <code>T14844</code>  <id>14844</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Disorganized Electrical Activity</name>
  <code>T14845</code>  <id>14845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Dopamine Activity</name>
  <code>T14846</code>  <id>14846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Dynorphin Activity</name>
  <code>T14847</code>  <id>14847</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Endorphin Activity</name>
  <code>T14848</code>  <id>14848</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Enkephalin Activity</name>
  <code>T14849</code>  <id>14849</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Epinephrine Activity</name>
  <code>T14850</code>  <id>14850</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic GABA Activity</name>
  <code>T14851</code>  <id>14851</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Gastrin Activity</name>
  <code>T14852</code>  <id>14852</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Glutamate Activity</name>
  <code>T14853</code>  <id>14853</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Glycine Activity</name>
  <code>T14854</code>  <id>14854</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Histamine Activity</name>
  <code>T14855</code>  <id>14855</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Nerve Growth Factor Activity</name>
  <code>T14856</code>  <id>14856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Neurotensin Activity</name>
  <code>T14857</code>  <id>14857</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Nitric Oxide Activity</name>
  <code>T14858</code>  <id>14858</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Norepinephrine Activity</name>
  <code>T14859</code>  <id>14859</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Organized Electrical Activity</name>
  <code>T14860</code>  <id>14860</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Serotonin Activity</name>
  <code>T14861</code>  <id>14861</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Substance P Activity</name>
  <code>T14862</code>  <id>14862</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic VIP Activity</name>
  <code>T14863</code>  <id>14863</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased T Lymphocyte Activation</name>
  <code>T14864</code>  <id>14864</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased T Lymphocyte Destruction</name>
  <code>T14865</code>  <id>14865</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased T Lymphocyte Production</name>
  <code>T14866</code>  <id>14866</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased TRH Activity</name>
  <code>T14867</code>  <id>14867</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased TRH Secretion</name>
  <code>T14868</code>  <id>14868</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased TSH Secretion</name>
  <code>T14875</code>  <id>14875</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Testosterone Secretion</name>
  <code>T14869</code>  <id>14869</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Thromboxane Activity</name>
  <code>T14870</code>  <id>14870</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Thromboxane Degradation</name>
  <code>T14871</code>  <id>14871</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Thromboxane Production</name>
  <code>T14872</code>  <id>14872</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Thyroid Hormone Iodination</name>
  <code>T14873</code>  <id>14873</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Thyroid Hormone Secretion</name>
  <code>T14874</code>  <id>14874</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Thyroid Stimulating Hormone Secretion</name>
  <code>T14876</code>  <id>14876</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Tracheo-Bronchial Mucosal Edema</name>
  <code>T14877</code>  <id>14877</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Tracheo-Bronchial Secretions</name>
  <code>T14878</code>  <id>14878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Tracheobronchial Stretch Receptor Activity</name>
  <code>T14879</code>  <id>14879</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Transcription to RNA</name>
  <code>T14880</code>  <id>14880</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased UES Tone</name>
  <code>T14881</code>  <id>14881</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Urethra Smooth Muscle Tone</name>
  <code>T14882</code>  <id>14882</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Uric Acid Synthesis</name>
  <code>T14883</code>  <id>14883</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Uterine Smooth Muscle Contraction or Tone</name>
  <code>T14884</code>  <id>14884</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased VIP Activity</name>
  <code>T14885</code>  <id>14885</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Vaginal Muscle Tone</name>
  <code>T14886</code>  <id>14886</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Vaginal Secretion</name>
  <code>T14887</code>  <id>14887</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Vascular Permeability</name>
  <code>T14888</code>  <id>14888</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Vascular Smooth Muscle Tone</name>
  <code>T14889</code>  <id>14889</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Vasopressin Secretion</name>
  <code>T14890</code>  <id>14890</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Ventilatory Gas Flow</name>
  <code>T14891</code>  <id>14891</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased Vitamin Uptake and Modification</name>
  <code>T14892</code>  <id>14892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased by acidity</name>
  <code>T14893</code>  <id>14893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Decreased by food</name>
  <code>T14894</code>  <id>14894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dehydropeptidase Inhibitors</name>
  <code>T16255</code>  <id>16255</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Delay Conduction System Repolarization</name>
  <code>T14942</code>  <id>14942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Demulcent</name>
  <code>T14993</code>  <id>14993</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Demulcent Activity</name>
  <code>T14992</code>  <id>14992</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dental and Oral Agents</name>
  <code>T58421</code>  <id>58421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dephosphorylation Inhibitors</name>
  <code>T15284</code>  <id>15284</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Depigmenting Activity</name>
  <code>T15285</code>  <id>15285</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Depigmenting Agent</name>
  <code>T15286</code>  <id>15286</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Depolarizing Neuromuscular Blocker</name>
  <code>T15287</code>  <id>15287</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dermal Regeneration Activity</name>
  <code>T15305</code>  <id>15305</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dermatologic Activity Alteration</name>
  <code>T15358</code>  <id>15358</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dermatological Agents</name>
  <code>T58422</code>  <id>58422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diagnostic</name>
  <code>T15654</code>  <id>15654</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diagnostic Agent</name>
  <code>T15655</code>  <id>15655</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diagnostic Dye</name>
  <code>T15656</code>  <id>15656</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diarylquinoline Antimycobacterial</name>
  <code>T15693</code>  <id>15693</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dietary Cholesterol Absorption Inhibitor</name>
  <code>T15871</code>  <id>15871</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Digestive Alteration</name>
  <code>T15938</code>  <id>15938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Digestive/GI System Activity Alteration</name>
  <code>T15945</code>  <id>15945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Digoxin Binding Activity</name>
  <code>T15962</code>  <id>15962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor</name>
  <code>T16006</code>  <id>16006</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antibacterial</name>
  <code>T16002</code>  <id>16002</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antimalarial</name>
  <code>T16003</code>  <id>16003</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antimicrobial</name>
  <code>T16004</code>  <id>16004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antiprotozoal</name>
  <code>T16005</code>  <id>16005</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitors</name>
  <code>T16007</code>  <id>16007</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydroorotate Dehydrogenase Inhibitors</name>
  <code>T16036</code>  <id>16036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydropeptidase Inhibitors</name>
  <code>T16254</code>  <id>16254</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydropyridine Calcium Channel Blocker</name>
  <code>T16047</code>  <id>16047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dihydroxyphenylalanine Decarboxylase Inhibitors</name>
  <code>T14004</code>  <id>14004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diminish Penile Erection</name>
  <code>T16194</code>  <id>16194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidase Inhibitors</name>
  <code>T16256</code>  <id>16256</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase 4 Inhibitor</name>
  <code>T16264</code>  <id>16264</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase 4 Inhibitors</name>
  <code>T16270</code>  <id>16270</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase IV Inhibitor</name>
  <code>T16261</code>  <id>16261</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase IV Inhibitors</name>
  <code>T16267</code>  <id>16267</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase-4 (DPP-4) Inhibitor</name>
  <code>T16263</code>  <id>16263</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase-4 Inhibitor</name>
  <code>T16260</code>  <id>16260</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase-4 Inhibitors</name>
  <code>T16268</code>  <id>16268</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl-Peptidase IV Inhibitor</name>
  <code>T16262</code>  <id>16262</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl-Peptidase IV Inhibitors</name>
  <code>T16265</code>  <id>16265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Direct Renin Inhibitors</name>
  <code>T46550</code>  <id>46550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Direct Thrombin Inhibitor</name>
  <code>T16352</code>  <id>16352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Disclosing Agent</name>
  <code>T58758</code>  <id>58758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Disorganized Electrical Activity Alteration</name>
  <code>T16407</code>  <id>16407</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Distribution</name>
  <code>T16425</code>  <id>16425</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Disulfide Reduction</name>
  <code>T16426</code>  <id>16426</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diuresis Alteration</name>
  <code>T16471</code>  <id>16471</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diuretic</name>
  <code>T58504</code>  <id>58504</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Diuretic Activity</name>
  <code>T26590</code>  <id>26590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Activity Alteration</name>
  <code>T16566</code>  <id>16566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Agonist</name>
  <code>T16603</code>  <id>16603</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Agonists</name>
  <code>T16568</code>  <id>16568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Antagonists</name>
  <code>T16569</code>  <id>16569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine D2 Antagonists</name>
  <code>T16570</code>  <id>16570</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Receptor Interactions</name>
  <code>T16583</code>  <id>16583</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Reuptake Inhibitor Anorectic</name>
  <code>T16584</code>  <id>16584</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Transporter Interactions</name>
  <code>T16585</code>  <id>16585</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine Uptake Inhibitors</name>
  <code>T16586</code>  <id>16586</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine and Norepinephrine Reuptake Inhibitor</name>
  <code>T58814</code>  <id>58814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine-2 (D2) Receptor Antagonist</name>
  <code>T16601</code>  <id>16601</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine-2 Receptor Antagonist</name>
  <code>T16602</code>  <id>16602</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopamine-Norepinephrine Reuptake Inhibitor</name>
  <code>T58816</code>  <id>58816</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopaminergic Agonist</name>
  <code>T16567</code>  <id>16567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dopaminergic Agonist</name>
  <code>T16604</code>  <id>16604</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dyes</name>
  <code>T16785</code>  <id>16785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Dynorphin Activity Alteration</name>
  <code>T16813</code>  <id>16813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>E [Preparations]</name>
  <code>T16924</code>  <id>16924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>E3 Ubiquitin Ligase Inhibitors</name>
  <code>T16969</code>  <id>16969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EGFR Antagonist</name>
  <code>T18068</code>  <id>18068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EGFR Antagonists</name>
  <code>T23058</code>  <id>23058</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EGFR Family Antagonists</name>
  <code>T23035</code>  <id>23035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EGFR Family Inhibitors</name>
  <code>T23045</code>  <id>23045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EGFR Family Interactions</name>
  <code>T23047</code>  <id>23047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EGFR Inhibitors</name>
  <code>T23056</code>  <id>23056</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EP2 Receptor Agonist</name>
  <code>T58800</code>  <id>58800</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>EP2 Receptor Agonists</name>
  <code>T58797</code>  <id>58797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ESA</name>
  <code>T18446</code>  <id>18446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Echinocandin Antifungal</name>
  <code>T17227</code>  <id>17227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ectoparasiticide</name>
  <code>T58858</code>  <id>58858</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Electrical Activity Alteration</name>
  <code>T17414</code>  <id>17414</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Electrolyte</name>
  <code>T17417</code>  <id>17417</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Electrolyte Activity</name>
  <code>T17415</code>  <id>17415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Electrolytes</name>
  <code>T17416</code>  <id>17416</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Elimination</name>
  <code>T17466</code>  <id>17466</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Alteration</name>
  <code>T17508</code>  <id>17508</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Development Alteration</name>
  <code>T17509</code>  <id>17509</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Growth Alteration</name>
  <code>T17510</code>  <id>17510</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Viability Alteration</name>
  <code>T17511</code>  <id>17511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Embryonic Implantation Alteration</name>
  <code>T17512</code>  <id>17512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Emesis</name>
  <code>T17523</code>  <id>17523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Emesis Suppression</name>
  <code>T17522</code>  <id>17522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Emollient Activity</name>
  <code>T17536</code>  <id>17536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endocrine Activity Alteration</name>
  <code>T17724</code>  <id>17724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endocytosis Alteration</name>
  <code>T17730</code>  <id>17730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endogenous Antigen Neutralization</name>
  <code>T17734</code>  <id>17734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endoglycosidase</name>
  <code>T17738</code>  <id>17738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endonuclease Inhibitors</name>
  <code>T58458</code>  <id>58458</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endorphin Activity Alteration</name>
  <code>T17764</code>  <id>17764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelial Coagulation Activity Alteration</name>
  <code>T17778</code>  <id>17778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelial Proliferation Alteration</name>
  <code>T17785</code>  <id>17785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Agonists</name>
  <code>T17786</code>  <id>17786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Antagonist</name>
  <code>T17787</code>  <id>17787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Antagonist</name>
  <code>T17788</code>  <id>17788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Antagonists</name>
  <code>T17789</code>  <id>17789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Interactions</name>
  <code>T17790</code>  <id>17790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enhance Penile Erection</name>
  <code>T17809</code>  <id>17809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enhanced by acidity</name>
  <code>T17810</code>  <id>17810</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enkephalin Activity Alteration</name>
  <code>T17815</code>  <id>17815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enkephalinase Inhibitors</name>
  <code>T17856</code>  <id>17856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzymatic Activity</name>
  <code>T17945</code>  <id>17945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzymatic Pathway of Metabolism</name>
  <code>T17946</code>  <id>17946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme</name>
  <code>T58513</code>  <id>58513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Activator</name>
  <code>T58521</code>  <id>58521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Activators</name>
  <code>T17947</code>  <id>17947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Inducers</name>
  <code>T17948</code>  <id>17948</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Inhibitor</name>
  <code>T58522</code>  <id>58522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Inhibitors</name>
  <code>T17949</code>  <id>17949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Interaction</name>
  <code>T58520</code>  <id>58520</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Interactions</name>
  <code>T17950</code>  <id>17950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Reactivators</name>
  <code>T17954</code>  <id>17954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Replacements/Modifiers</name>
  <code>T58423</code>  <id>58423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Stabilizer</name>
  <code>T58902</code>  <id>58902</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Enzyme Stabilizers</name>
  <code>T58901</code>  <id>58901</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Cells</name>
  <code>T9781</code>  <id>9781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor (EGFR) Antagonist</name>
  <code>T18069</code>  <id>18069</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Antagonist</name>
  <code>T18070</code>  <id>18070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Antagonists</name>
  <code>T23053</code>  <id>23053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Family Antagonists</name>
  <code>T23040</code>  <id>23040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Family Inhibitors</name>
  <code>T23039</code>  <id>23039</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Family Interactions</name>
  <code>T23049</code>  <id>23049</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Inhibitors</name>
  <code>T23055</code>  <id>23055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermal and Animal Specific Allergenic Extract</name>
  <code>T58517</code>  <id>58517</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epidermis</name>
  <code>T9782</code>  <id>9782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epinephrine Activity Alteration</name>
  <code>T18202</code>  <id>18202</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epithelial Proliferation Alteration</name>
  <code>T18249</code>  <id>18249</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epoxide Hydrolase Inhibitors</name>
  <code>T18283</code>  <id>18283</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Epoxide hydrolases</name>
  <code>T18288</code>  <id>18288</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype A</name>
  <code>T18320</code>  <id>18320</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype B</name>
  <code>T18321</code>  <id>18321</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype C</name>
  <code>T18322</code>  <id>18322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype D</name>
  <code>T18323</code>  <id>18323</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype E</name>
  <code>T18324</code>  <id>18324</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype F</name>
  <code>T18325</code>  <id>18325</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype G</name>
  <code>T18326</code>  <id>18326</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ErbB2 Receptor Antagonist</name>
  <code>T58360</code>  <id>58360</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ergosterol Synthesis Inhibitors</name>
  <code>T18367</code>  <id>18367</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ergot Derivative</name>
  <code>T18375</code>  <id>18375</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ergot-derived Dopamine Receptor Agonist</name>
  <code>T18376</code>  <id>18376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ergotamine Derivative</name>
  <code>T18377</code>  <id>18377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Erythrocyte Function Alteration</name>
  <code>T58655</code>  <id>58655</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Erythroid Maturation Agent</name>
  <code>T58789</code>  <id>58789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Erythropoiesis-stimulating Agent</name>
  <code>T18447</code>  <id>18447</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Erythropoiesis-stimulating Agent (ESA)</name>
  <code>T18445</code>  <id>18445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ester Local Anesthetic</name>
  <code>T18514</code>  <id>18514</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Esterases</name>
  <code>T18516</code>  <id>18516</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estradiol Antagonists</name>
  <code>T18529</code>  <id>18529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen</name>
  <code>T18576</code>  <id>18576</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Agonist/Antagonist</name>
  <code>T18558</code>  <id>18558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Agonists</name>
  <code>T18559</code>  <id>18559</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Antagonist</name>
  <code>T18561</code>  <id>18561</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Antagonists</name>
  <code>T18563</code>  <id>18563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Inhibitor</name>
  <code>T18560</code>  <id>18560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Inhibitor</name>
  <code>T18562</code>  <id>18562</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Modulators</name>
  <code>T18564</code>  <id>18564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen Synthesis Inhibitors</name>
  <code>T18574</code>  <id>18574</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Estrogen-class Agent</name>
  <code>T18575</code>  <id>18575</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Exfoliant Acitivity</name>
  <code>T14758</code>  <id>14758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Exocytosis Alteration</name>
  <code>T18942</code>  <id>18942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Expectorant</name>
  <code>T58638</code>  <id>58638</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Extracellular Communication</name>
  <code>T18999</code>  <id>18999</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>F [Preparations]</name>
  <code>T19070</code>  <id>19070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FAK Inhibitors</name>
  <code>T59082</code>  <id>59082</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FGFR Inhibitors</name>
  <code>T58774</code>  <id>58774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FLT3 Inhibitors</name>
  <code>T58916</code>  <id>58916</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors</name>
  <code>T58914</code>  <id>58914</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FMS-like Receptor Tyrosine Kinase 3 Inhibitors</name>
  <code>T58917</code>  <id>58917</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FMS-related Receptor Tyrosine Kinase 3 Inhibitors</name>
  <code>T58919</code>  <id>58919</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FTIs</name>
  <code>T58602</code>  <id>58602</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Factor 10a Inhibitor</name>
  <code>T19441</code>  <id>19441</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Factor 10a Inhibitors</name>
  <code>T19445</code>  <id>19445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Factor VIII Activator</name>
  <code>T19356</code>  <id>19356</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Factor Xa Inhibitor</name>
  <code>T19442</code>  <id>19442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Factor Xa Inhibitors</name>
  <code>T19446</code>  <id>19446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Farnesoid X Receptor Agonist</name>
  <code>T19538</code>  <id>19538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Farnesoid X Receptor Agonists</name>
  <code>T19539</code>  <id>19539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Farnesyltransferase Inhibitor</name>
  <code>T58603</code>  <id>58603</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Farnesyltransferase Inhibitors</name>
  <code>T58601</code>  <id>58601</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fatty Acid Synthetase Inhibitors</name>
  <code>T19621</code>  <id>19621</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fatty Acid Transporter Interactions</name>
  <code>T19624</code>  <id>19624</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fc Receptor Interactions</name>
  <code>T58722</code>  <id>58722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FcRn Blocker</name>
  <code>T58721</code>  <id>58721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>FcRn Blockers</name>
  <code>T58723</code>  <id>58723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fecal Excretion</name>
  <code>T19664</code>  <id>19664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Feline McDonough Sarcoma-like Receptor Tyrosine Kinase 3 Inhibitors</name>
  <code>T58915</code>  <id>58915</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Female Reproductive System Activity Alteration</name>
  <code>T19704</code>  <id>19704</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fibrinolysis Alteration</name>
  <code>T19901</code>  <id>19901</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fibroblast Growth Factor Receptor Inhibitors</name>
  <code>T58773</code>  <id>58773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>First Order</name>
  <code>T20035</code>  <id>20035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fish Proteins, Dietary</name>
  <code>T20040</code>  <id>20040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fluorescence Contrast Activity</name>
  <code>T58671</code>  <id>58671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fluoroquinolone Antibacterial</name>
  <code>T20192</code>  <id>20192</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Focal Adhesion Kinase Inhibitors</name>
  <code>T59081</code>  <id>59081</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folate Analog</name>
  <code>T20311</code>  <id>20311</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folate Analog Metabolic Inhibitor</name>
  <code>T20309</code>  <id>20309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folate Analogue</name>
  <code>T20310</code>  <id>20310</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folate Analogue Metabolic Inhibitor</name>
  <code>T20308</code>  <id>20308</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folic Acid Antagonists</name>
  <code>T20326</code>  <id>20326</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folic Acid Metabolic Inhibitors</name>
  <code>T20327</code>  <id>20327</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Folic Acid Metabolism Inhibitors</name>
  <code>T20328</code>  <id>20328</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Free Radical Scavenging</name>
  <code>T20524</code>  <id>20524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Free Radical Scavenging Activity</name>
  <code>T20525</code>  <id>20525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fruit Proteins</name>
  <code>T20626</code>  <id>20626</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Full Cholinergic Nicotinic Agonists</name>
  <code>T20650</code>  <id>20650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Full Opioid Agonists</name>
  <code>T20651</code>  <id>20651</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fusion Protein Inhibitors</name>
  <code>T20725</code>  <id>20725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Fusion Protein Interactions</name>
  <code>T20726</code>  <id>20726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>G [Preparations]</name>
  <code>T20745</code>  <id>20745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>G-Protein-linked Receptor Interactions</name>
  <code>T20778</code>  <id>20778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>G-Protein-linked Receptor-Effector Interactions</name>
  <code>T20777</code>  <id>20777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Agonist</name>
  <code>T57002</code>  <id>57002</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Agonists</name>
  <code>T20785</code>  <id>20785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Antagonists</name>
  <code>T20789</code>  <id>20789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Modulators</name>
  <code>T20791</code>  <id>20791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Agonist</name>
  <code>T56998</code>  <id>56998</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Agonists</name>
  <code>T20784</code>  <id>20784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Antagonists</name>
  <code>T20788</code>  <id>20788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Interactions</name>
  <code>T20792</code>  <id>20792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Modulators</name>
  <code>T20790</code>  <id>20790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Positive Modulator</name>
  <code>T58904</code>  <id>58904</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Positive Modulators</name>
  <code>T58742</code>  <id>58742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Agonists</name>
  <code>T20794</code>  <id>20794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Antagonists</name>
  <code>T20796</code>  <id>20796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Modulators</name>
  <code>T20798</code>  <id>20798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Receptor Agonists</name>
  <code>T20793</code>  <id>20793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Receptor Antagonists</name>
  <code>T20795</code>  <id>20795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Receptor Interactions</name>
  <code>T20799</code>  <id>20799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA B Receptor Modulators</name>
  <code>T20797</code>  <id>20797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA-A Agonist</name>
  <code>T57000</code>  <id>57000</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA-A Receptor Agonist</name>
  <code>T57001</code>  <id>57001</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABA-ergic Agonist</name>
  <code>T57012</code>  <id>57012</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GABAergic Agonist</name>
  <code>T57013</code>  <id>57013</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GD2-directed Antibody</name>
  <code>T22374</code>  <id>22374</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GD2-directed Antibody Interactions</name>
  <code>T22370</code>  <id>22370</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRF Analog</name>
  <code>T22769</code>  <id>22769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRF Analogue</name>
  <code>T22767</code>  <id>22767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRH Activity Alteration</name>
  <code>T20889</code>  <id>20889</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRH Alteration</name>
  <code>T22774</code>  <id>22774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRH Analog</name>
  <code>T22770</code>  <id>22770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRH Analogue</name>
  <code>T22764</code>  <id>22764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GHRH Secretion Alteration</name>
  <code>T20890</code>  <id>20890</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GI Bulking Activity</name>
  <code>T49942</code>  <id>49942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GI Motility Alteration</name>
  <code>T20891</code>  <id>20891</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GI Smooth Muscle Tone Alteration</name>
  <code>T20892</code>  <id>20892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GIP Receptor Agonist</name>
  <code>T58750</code>  <id>58750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GIPR Agonist</name>
  <code>T58751</code>  <id>58751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-1 Agonists</name>
  <code>T21783</code>  <id>21783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-1 Antagonists</name>
  <code>T21786</code>  <id>21786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-1 Receptor Agonist</name>
  <code>T20908</code>  <id>20908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-1 Receptor Interactions</name>
  <code>T21789</code>  <id>21789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-2 Agonists</name>
  <code>T21792</code>  <id>21792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-2 Analog</name>
  <code>T20911</code>  <id>20911</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-2 Antagonists</name>
  <code>T21795</code>  <id>21795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GLP-2 Receptor Interactions</name>
  <code>T21797</code>  <id>21797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GNRH Alteration</name>
  <code>T22539</code>  <id>22539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GTP Phosphohydrolase Activators</name>
  <code>T20992</code>  <id>20992</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gadolinium-based Contrast Agent</name>
  <code>T21085</code>  <id>21085</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gamma Amino Butyric Acid (GABA) Activity Alteration</name>
  <code>T21215</code>  <id>21215</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gamma Secretase Inhibitor</name>
  <code>T58996</code>  <id>58996</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gamma Secretase Inhibitors</name>
  <code>T58995</code>  <id>58995</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gastric Acid Alteration</name>
  <code>T21265</code>  <id>21265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gastric Mucous Secretion Alteration</name>
  <code>T21282</code>  <id>21282</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gastrin Activity Alteration</name>
  <code>T21284</code>  <id>21284</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gastrointestinal Agent</name>
  <code>T21314</code>  <id>21314</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gastrointestinal Contents Bulking Activity</name>
  <code>T49943</code>  <id>49943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gastrointestinal Motility Inhibitor</name>
  <code>T21319</code>  <id>21319</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Alterations</name>
  <code>T58363</code>  <id>58363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Editing</name>
  <code>T58368</code>  <id>58368</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Editing or Modification</name>
  <code>T58366</code>  <id>58366</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Expression Interactions</name>
  <code>T58362</code>  <id>58362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Modification</name>
  <code>T58369</code>  <id>58369</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Replacement</name>
  <code>T58371</code>  <id>58371</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Therapy</name>
  <code>T58744</code>  <id>58744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Transcription Modulation</name>
  <code>T58364</code>  <id>58364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Transduction</name>
  <code>T58370</code>  <id>58370</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Transduction or Replacement</name>
  <code>T58367</code>  <id>58367</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gene Translation Modulation</name>
  <code>T58365</code>  <id>58365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>General Anesthesia</name>
  <code>T21433</code>  <id>21433</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>General Anesthetic</name>
  <code>T21434</code>  <id>21434</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Generalized Systemic Effects</name>
  <code>T21435</code>  <id>21435</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Autologous Cultured Cells</name>
  <code>T9779</code>  <id>9779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Autologous Cultured T Lymphocytes</name>
  <code>T50647</code>  <id>50647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Autologous T Cells</name>
  <code>T21453</code>  <id>21453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Cultured Cells, Autologous</name>
  <code>T9778</code>  <id>9778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Cultured T Lymphocytes, Autologous</name>
  <code>T50646</code>  <id>50646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Oncolytic Viral Therapy</name>
  <code>T21454</code>  <id>21454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Virus Vector</name>
  <code>T58377</code>  <id>58377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Agents</name>
  <code>T58424</code>  <id>58424</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arterial Vasoconstriction</name>
  <code>T21470</code>  <id>21470</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arterial Vasodilation</name>
  <code>T21471</code>  <id>21471</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arteriolar Vasoconstriction</name>
  <code>T21472</code>  <id>21472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arteriolar Vasodilation</name>
  <code>T21473</code>  <id>21473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ghrelin Receptor Agonist</name>
  <code>T58361</code>  <id>58361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ghrelin Receptor Agonists</name>
  <code>T58355</code>  <id>58355</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ghrelin Receptor Interactions</name>
  <code>T58357</code>  <id>58357</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glinide</name>
  <code>T21673</code>  <id>21673</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glinide-class Agent</name>
  <code>T21672</code>  <id>21672</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glinides</name>
  <code>T21674</code>  <id>21674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gliptins</name>
  <code>T16269</code>  <id>16269</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glomerular Filtration Pressure Alteration</name>
  <code>T21700</code>  <id>21700</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon Receptor Agonists</name>
  <code>T58548</code>  <id>58548</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon Receptor Interactions</name>
  <code>T21754</code>  <id>21754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide 1 Receptor Agonist</name>
  <code>T20906</code>  <id>20906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide 2 Analog</name>
  <code>T20909</code>  <id>20909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 (GLP-1) Agonists</name>
  <code>T21784</code>  <id>21784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 (GLP-1) Antagonists</name>
  <code>T21787</code>  <id>21787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions</name>
  <code>T21790</code>  <id>21790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 Agonists</name>
  <code>T21782</code>  <id>21782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 Antagonists</name>
  <code>T21785</code>  <id>21785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 Receptor Agonist</name>
  <code>T20907</code>  <id>20907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 Receptor Interactions</name>
  <code>T21788</code>  <id>21788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 (GLP-2) Agonists</name>
  <code>T21793</code>  <id>21793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 (GLP-2) Antagonists</name>
  <code>T21796</code>  <id>21796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions</name>
  <code>T21799</code>  <id>21799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 Agonists</name>
  <code>T21791</code>  <id>21791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 Analog</name>
  <code>T20910</code>  <id>20910</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 Antagonists</name>
  <code>T21794</code>  <id>21794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 Receptor Interactions</name>
  <code>T21798</code>  <id>21798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucan Synthase Inhibitors</name>
  <code>T21825</code>  <id>21825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucocorticoid Receptor Agonists</name>
  <code>T21836</code>  <id>21836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucocorticoid Receptor Antagonists</name>
  <code>T21837</code>  <id>21837</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucocorticoid Synthesis Inhibitors</name>
  <code>T21838</code>  <id>21838</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose Metabolism Alteration</name>
  <code>T21862</code>  <id>21862</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Cotransporter 1 Inhibitors</name>
  <code>T49110</code>  <id>49110</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Cotransporter 2 Inhibitor</name>
  <code>T49091</code>  <id>49091</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Cotransporter 2 Inhibitors</name>
  <code>T49120</code>  <id>49120</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Cotransporter Inhibitors</name>
  <code>T49126</code>  <id>49126</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Symporter 1 Inhibitors</name>
  <code>T49107</code>  <id>49107</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Symporter 2 Inhibitor</name>
  <code>T49094</code>  <id>49094</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Symporter 2 Inhibitors</name>
  <code>T49119</code>  <id>49119</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Symporter Inhibitors</name>
  <code>T49129</code>  <id>49129</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Transporter 1 Inhibitors</name>
  <code>T49106</code>  <id>49106</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Transporter 2 Inhibitor</name>
  <code>T49090</code>  <id>49090</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Transporter 2 Inhibitors</name>
  <code>T49116</code>  <id>49116</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-Sodium Transporter Inhibitors</name>
  <code>T49128</code>  <id>49128</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist</name>
  <code>T58749</code>  <id>58749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucosyl Transferase Inhibitors</name>
  <code>T21943</code>  <id>21943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucosylceramide Synthase Inhibitor</name>
  <code>T21953</code>  <id>21953</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucosylceramide Synthase Inhibitors</name>
  <code>T21954</code>  <id>21954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glucuronosyl transferases</name>
  <code>T21966</code>  <id>21966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glutamate Activity Alteration</name>
  <code>T21976</code>  <id>21976</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glutathione s-transferases</name>
  <code>T22101</code>  <id>22101</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycine Activity Alteration</name>
  <code>T22180</code>  <id>22180</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycine Agonists</name>
  <code>T22181</code>  <id>22181</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycine Antagonists</name>
  <code>T22182</code>  <id>22182</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycine Receptor Interactions</name>
  <code>T22212</code>  <id>22212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycogen Metabolism Alteration</name>
  <code>T22239</code>  <id>22239</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycolipid Disialoganglioside (GD2)-directed Antibody</name>
  <code>T22373</code>  <id>22373</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycolipid Disialoganglioside (GD2)-directed Antibody Interactions</name>
  <code>T22371</code>  <id>22371</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycolipid Disialoganglioside-directed Antibody</name>
  <code>T22375</code>  <id>22375</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycolipid Disialoganglioside-directed Antibody Interactions</name>
  <code>T22372</code>  <id>22372</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycopeptide Antibacterial</name>
  <code>T22378</code>  <id>22378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycoprotein 100 Peptide-HLA-directed Antibody Interactions</name>
  <code>T58697</code>  <id>58697</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</name>
  <code>T58696</code>  <id>58696</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan</name>
  <code>T22415</code>  <id>22415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan Metabolism Alteration</name>
  <code>T22412</code>  <id>22412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan Metabolism Decrease</name>
  <code>T22413</code>  <id>22413</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan Metabolism Increase</name>
  <code>T22414</code>  <id>22414</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosphingolipid Synthesis Alteration</name>
  <code>T22422</code>  <id>22422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosphingolipid Synthesis Decrease</name>
  <code>T22423</code>  <id>22423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Glycosphingolipid Synthesis Increase</name>
  <code>T22424</code>  <id>22424</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Activity Alteration</name>
  <code>T22472</code>  <id>22472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Antagonist</name>
  <code>T22541</code>  <id>22541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Receptor Agonist</name>
  <code>T22545</code>  <id>22545</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Receptor Agonists</name>
  <code>T22547</code>  <id>22547</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Receptor Antagonists</name>
  <code>T22549</code>  <id>22549</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Secretion Alteration</name>
  <code>T22473</code>  <id>22473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>GnRH Secretion Inhibitor</name>
  <code>T22551</code>  <id>22551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin</name>
  <code>T22553</code>  <id>22553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone (GnRH) Agonist</name>
  <code>T22544</code>  <id>22544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone (GnRH) Antagonist</name>
  <code>T22542</code>  <id>22542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Alteration</name>
  <code>T22540</code>  <id>22540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Agonist</name>
  <code>T22546</code>  <id>22546</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Agonists</name>
  <code>T22548</code>  <id>22548</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Antagonist</name>
  <code>T22543</code>  <id>22543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Antagonists</name>
  <code>T22550</code>  <id>22550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Secretion Inhibitor</name>
  <code>T22552</code>  <id>22552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Grain Proteins</name>
  <code>T22594</code>  <id>22594</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Factor</name>
  <code>T58512</code>  <id>58512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Agonists</name>
  <code>T22758</code>  <id>22758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Antagonist</name>
  <code>T22760</code>  <id>22760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Antagonists</name>
  <code>T22761</code>  <id>22761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Inhibitor</name>
  <code>T22759</code>  <id>22759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Factor (GHRF) Analog</name>
  <code>T22765</code>  <id>22765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Factor (GHRF) Analogue</name>
  <code>T22763</code>  <id>22763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Factor Analog</name>
  <code>T22773</code>  <id>22773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Factor Analogue</name>
  <code>T22768</code>  <id>22768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Hormone (GHRH) Analog</name>
  <code>T22771</code>  <id>22771</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Hormone (GHRH) Analogue</name>
  <code>T22772</code>  <id>22772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Hormone Alteration</name>
  <code>T22775</code>  <id>22775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Hormone Analog</name>
  <code>T22762</code>  <id>22762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Hormone Analogue</name>
  <code>T22766</code>  <id>22766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Secretagogue Receptor Agonist</name>
  <code>T58358</code>  <id>58358</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Secretagogue Receptor Agonists</name>
  <code>T58354</code>  <id>58354</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Secretagogue Receptor Interactions </name>
  <code>T58356</code>  <id>58356</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Guanylate Cyclase Activators</name>
  <code>T22916</code>  <id>22916</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Guanylate Cyclase Stimulators</name>
  <code>T22917</code>  <id>22917</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Guanylate Cyclase-C Agonist</name>
  <code>T22927</code>  <id>22927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H [Preparations]</name>
  <code>T22980</code>  <id>22980</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H. Pylori Diagnostic</name>
  <code>T23808</code>  <id>23808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H. pylori Diagnostic</name>
  <code>T23809</code>  <id>23809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H1 Receptor Antagonist</name>
  <code>T24679</code>  <id>24679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H1 Receptor Antagonist</name>
  <code>T24681</code>  <id>24681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H1 Receptor Antagonists</name>
  <code>T24655</code>  <id>24655</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H1 Receptor Blockers</name>
  <code>T24658</code>  <id>24658</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H1 Receptor Inhibitor</name>
  <code>T24678</code>  <id>24678</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H1 Receptor Inhibitor</name>
  <code>T24682</code>  <id>24682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H2 Receptor Antagonist</name>
  <code>T24684</code>  <id>24684</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H2 Receptor Antagonists</name>
  <code>T24661</code>  <id>24661</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H2 Receptor Blockers</name>
  <code>T24663</code>  <id>24663</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H3 Receptor Antagonist/Inverse Agonist</name>
  <code>T58841</code>  <id>58841</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H3 Receptor Antagonists</name>
  <code>T24666</code>  <id>24666</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H3 Receptor Blockers</name>
  <code>T24667</code>  <id>24667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>H3 Receptor Inverse Agonists</name>
  <code>T58838</code>  <id>58838</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HBV NRTI</name>
  <code>T24167</code>  <id>24167</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24164</code>  <id>24164</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI)</name>
  <code>T24165</code>  <id>24165</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HBV Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24163</code>  <id>24163</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCN Channel Agonists</name>
  <code>T25521</code>  <id>25521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCN Channel Antagonists</name>
  <code>T25526</code>  <id>25526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCN Channel Blocker</name>
  <code>T25536</code>  <id>25536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCN Channel Interactions</name>
  <code>T25538</code>  <id>25538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCV NS3/4A Protease Inhibitor</name>
  <code>T24183</code>  <id>24183</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCV NS3/4A Protease Inhibitors</name>
  <code>T23013</code>  <id>23013</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCV NS5A Inhibitor</name>
  <code>T24186</code>  <id>24186</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCV Non-Nucleoside NS5B Palm Polymerase Inhibitor</name>
  <code>T24188</code>  <id>24188</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HCV Nucleotide Analog NS5B Polymerase Inhibitor</name>
  <code>T24191</code>  <id>24191</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HDAC Inhibitor</name>
  <code>T24789</code>  <id>24789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Antagonists</name>
  <code>T23042</code>  <id>23042</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Family Antagonists</name>
  <code>T23044</code>  <id>23044</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Family Inhibitors</name>
  <code>T23036</code>  <id>23036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Family Interactions</name>
  <code>T23050</code>  <id>23050</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Inhibitors</name>
  <code>T23037</code>  <id>23037</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Receptor Family Antagonists</name>
  <code>T23046</code>  <id>23046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Receptor Family Inhibitors</name>
  <code>T23038</code>  <id>23038</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER Receptor Family Interactions</name>
  <code>T23051</code>  <id>23051</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-1 Antagonists</name>
  <code>T23057</code>  <id>23057</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-1 Inhibitors</name>
  <code>T23054</code>  <id>23054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-2 Antagonists</name>
  <code>T23063</code>  <id>23063</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-2 Inhibitors</name>
  <code>T23066</code>  <id>23066</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-2/Neu/cerbB2 Antagonists</name>
  <code>T23062</code>  <id>23062</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-2/Neu/cerbB2 Inhibitors</name>
  <code>T23065</code>  <id>23065</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-3 Antagonists</name>
  <code>T23071</code>  <id>23071</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER-3 Inhibitors</name>
  <code>T23069</code>  <id>23069</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER1 Antagonist</name>
  <code>T18067</code>  <id>18067</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER1 Antagonists</name>
  <code>T23059</code>  <id>23059</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER1 Inhibitors</name>
  <code>T23052</code>  <id>23052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2 Antagonists</name>
  <code>T23061</code>  <id>23061</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2 Inhibitors</name>
  <code>T23067</code>  <id>23067</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2 Receptor Antagonist</name>
  <code>T58359</code>  <id>58359</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2-directed Antibody Interactions</name>
  <code>T59035</code>  <id>59035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2/Neu/cerbB2 Antagonists</name>
  <code>T23068</code>  <id>23068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2/Neu/cerbB2 Inhibitors</name>
  <code>T23064</code>  <id>23064</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER2/neu Receptor Antagonist</name>
  <code>T23060</code>  <id>23060</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER3 Antagonists</name>
  <code>T23072</code>  <id>23072</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HER3 Inhibitors</name>
  <code>T23070</code>  <id>23070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIF Inhibitor</name>
  <code>T58711</code>  <id>58711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIF Inhibitors</name>
  <code>T58714</code>  <id>58714</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIF PH Inhibitor</name>
  <code>T58900</code>  <id>58900</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIF PH Inhibitors</name>
  <code>T58898</code>  <id>58898</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIF-2 alpha Inhibitors</name>
  <code>T58717</code>  <id>58717</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIF-2α Inhibitors</name>
  <code>T58718</code>  <id>58718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV 1 Post-attachment Fusion Inhibitors</name>
  <code>T58406</code>  <id>58406</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Capsid Inhibitors</name>
  <code>T58933</code>  <id>58933</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Entry Inhibitor</name>
  <code>T24934</code>  <id>24934</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Fusion Inhibitor</name>
  <code>T24937</code>  <id>24937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Fusion Inhibitor (HIV-1 FI)</name>
  <code>T24936</code>  <id>24936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Fusion Protein Inhibitors</name>
  <code>T23158</code>  <id>23158</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV INSTI</name>
  <code>T24962</code>  <id>24962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Integrase Inhibitors</name>
  <code>T23164</code>  <id>23164</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Integrase Strand Transfer Inhibitor</name>
  <code>T24959</code>  <id>24959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV NRTI</name>
  <code>T24966</code>  <id>24966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24964</code>  <id>24964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor (HIV NRTI)</name>
  <code>T24967</code>  <id>24967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24965</code>  <id>24965</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV PI</name>
  <code>T24970</code>  <id>24970</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Protease Inhibitor</name>
  <code>T24971</code>  <id>24971</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Protease Inhibitor</name>
  <code>T42334</code>  <id>42334</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Protease Inhibitor (HIV PI)</name>
  <code>T24972</code>  <id>24972</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV Protease Inhibitors</name>
  <code>T23172</code>  <id>23172</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Capsid Inhibitor</name>
  <code>T58932</code>  <id>58932</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 FI</name>
  <code>T24935</code>  <id>24935</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 INSTI</name>
  <code>T24961</code>  <id>24961</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Integrase Strand Transfer Inhibitor</name>
  <code>T24960</code>  <id>24960</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 NNRTI</name>
  <code>T24943</code>  <id>24943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 NNRTI and NRTI</name>
  <code>T24953</code>  <id>24953</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24947</code>  <id>24947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24942</code>  <id>24942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24949</code>  <id>24949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24955</code>  <id>24955</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24944</code>  <id>24944</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor (HIV-1 NNRTI)</name>
  <code>T24940</code>  <id>24940</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24946</code>  <id>24946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24954</code>  <id>24954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24956</code>  <id>24956</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Post-attachment Entry Inhibitor</name>
  <code>T58405</code>  <id>58405</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HIV-1 Post-attachment Fusion Inhibitor</name>
  <code>T58404</code>  <id>58404</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HMG-CoA Reductase Inhibitor</name>
  <code>T23353</code>  <id>23353</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HMG-CoA Reductase Inhibitor</name>
  <code>T25256</code>  <id>25256</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HMG-CoA Reductase Inhibitors</name>
  <code>T25255</code>  <id>25255</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HSV Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T24414</code>  <id>24414</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HSV Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T24410</code>  <id>24410</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HSV Pyrophosphate Analog DNA Polymerase Inhibitor</name>
  <code>T24433</code>  <id>24433</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HSV Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
  <code>T24429</code>  <id>24429</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hair Excretion</name>
  <code>T23589</code>  <id>23589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hair Follicle Alteration</name>
  <code>T23590</code>  <id>23590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Half-Life</name>
  <code>T23599</code>  <id>23599</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HbS Polymerization Inhibitor</name>
  <code>T58780</code>  <id>58780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>HbS Polymerization Inhibitors</name>
  <code>T58778</code>  <id>58778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hedgehog Pathway Inhibitor</name>
  <code>T23802</code>  <id>23802</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Helicobacter Pylori Diagnostic</name>
  <code>T23810</code>  <id>23810</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Helicobacter pylori Diagnostic</name>
  <code>T23811</code>  <id>23811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematologic Activity Alteration</name>
  <code>T23840</code>  <id>23840</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematological Cell Destruction Alteration</name>
  <code>T23852</code>  <id>23852</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematological Cell Function Alteration</name>
  <code>T23853</code>  <id>23853</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematological Cell Quantity Alteration</name>
  <code>T23854</code>  <id>23854</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematology Agent</name>
  <code>T58533</code>  <id>58533</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematopoiesis Alteration</name>
  <code>T23882</code>  <id>23882</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematopoietic Stem Cell Function Alteration</name>
  <code>T23887</code>  <id>23887</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hematopoietic Stem Cell Mobilizer</name>
  <code>T23888</code>  <id>23888</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hemic/Lymphatic Activity Alteration</name>
  <code>T23924</code>  <id>23924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hemoglobin Function Restoration</name>
  <code>T58656</code>  <id>58656</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hemoglobin S Polymerization Inhibitor</name>
  <code>T58779</code>  <id>58779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hemoglobin S Polymerization Inhibitors</name>
  <code>T58777</code>  <id>58777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hemorrheologic Alteration</name>
  <code>T24048</code>  <id>24048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hemostasis Alteration</name>
  <code>T24055</code>  <id>24055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Heparin Binding Activity</name>
  <code>T24073</code>  <id>24073</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Heparin Derivative</name>
  <code>T24081</code>  <id>24081</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Heparin Reversal Agent</name>
  <code>T24088</code>  <id>24088</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatic Excretion</name>
  <code>T24112</code>  <id>24112</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatic Glucagon Receptor Agonists</name>
  <code>T58549</code>  <id>58549</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatic Metabolism</name>
  <code>T24115</code>  <id>24115</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24168</code>  <id>24168</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor</name>
  <code>T24184</code>  <id>24184</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus (HCV) Nucleotide Analog NS5B Polymerase Inhibitor</name>
  <code>T24190</code>  <id>24190</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus NS3/4A Protease Inhibitor</name>
  <code>T24185</code>  <id>24185</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus NS3/4A Protease Inhibitors</name>
  <code>T23012</code>  <id>23012</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus NS5A Inhibitor</name>
  <code>T24187</code>  <id>24187</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor</name>
  <code>T24189</code>  <id>24189</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor</name>
  <code>T24192</code>  <id>24192</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hepatits B Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24166</code>  <id>24166</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T24415</code>  <id>24415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T24412</code>  <id>24412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor</name>
  <code>T24436</code>  <id>24436</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
  <code>T24432</code>  <id>24432</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy</name>
  <code>T58934</code>  <id>58934</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T24466</code>  <id>24466</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpes Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T24464</code>  <id>24464</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T24478</code>  <id>24478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Herpesvirus Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T24477</code>  <id>24477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine Activity Alteration</name>
  <code>T24653</code>  <id>24653</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine Agonists</name>
  <code>T24654</code>  <id>24654</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine Antagonists</name>
  <code>T24673</code>  <id>24673</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H1 Antagonists</name>
  <code>T24656</code>  <id>24656</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H1 Blockers</name>
  <code>T24657</code>  <id>24657</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H1 Receptor Antagonists</name>
  <code>T24659</code>  <id>24659</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H2 Antagonists</name>
  <code>T24660</code>  <id>24660</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H2 Blockers</name>
  <code>T24662</code>  <id>24662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H2 Receptor Antagonists</name>
  <code>T24664</code>  <id>24664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Antagonists</name>
  <code>T24668</code>  <id>24668</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Blockers</name>
  <code>T24665</code>  <id>24665</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Receptor Antagonist/Inverse Agonist</name>
  <code>T58842</code>  <id>58842</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Receptor Antagonists</name>
  <code>T24669</code>  <id>24669</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Receptor Inverse Agonists</name>
  <code>T58837</code>  <id>58837</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine Receptor Antagonists</name>
  <code>T24674</code>  <id>24674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine Receptor Interactions</name>
  <code>T24675</code>  <id>24675</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine Receptor Inverse Agonists</name>
  <code>T58836</code>  <id>58836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine-1 Receptor Antagonist</name>
  <code>T24680</code>  <id>24680</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine-1 Receptor Inhibitor</name>
  <code>T24683</code>  <id>24683</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine-2 (H2) Receptor Antagonist</name>
  <code>T24685</code>  <id>24685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine-2 Receptor Antagonist</name>
  <code>T24686</code>  <id>24686</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine-3 Receptor Antagonist/Inverse Agonist</name>
  <code>T58840</code>  <id>58840</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histamine-3 Receptor Inverse Agonists</name>
  <code>T58839</code>  <id>58839</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histone Deacetylase (HDAC) Inhibitor</name>
  <code>T24790</code>  <id>24790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histone Deacetylase Inhibitor</name>
  <code>T24791</code>  <id>24791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histone Deacetylase Inhibitor</name>
  <code>T24792</code>  <id>24792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Histone Deacetylase Inhibitors</name>
  <code>T24793</code>  <id>24793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant</name>
  <code>T58425</code>  <id>58425</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)</name>
  <code>T58426</code>  <id>58426</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)</name>
  <code>T58427</code>  <id>58427</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)</name>
  <code>T58428</code>  <id>58428</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)</name>
  <code>T58429</code>  <id>58429</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)</name>
  <code>T58430</code>  <id>58430</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant</name>
  <code>T58431</code>  <id>58431</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Parathyroid)</name>
  <code>T58432</code>  <id>58432</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Pituitary)</name>
  <code>T58433</code>  <id>58433</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers)</name>
  <code>T58434</code>  <id>58434</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Thyroid)</name>
  <code>T58435</code>  <id>58435</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormone</name>
  <code>T58508</code>  <id>58508</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Agonists</name>
  <code>T24893</code>  <id>24893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Antagonists</name>
  <code>T24894</code>  <id>24894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Interactions</name>
  <code>T24895</code>  <id>24895</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Modulators</name>
  <code>T24896</code>  <id>24896</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Anticoagulant Protein</name>
  <code>T24922</code>  <id>24922</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Antihemophilic Factor</name>
  <code>T24923</code>  <id>24923</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Blood Coagulation Factor</name>
  <code>T24924</code>  <id>24924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human C1 Esterase Inhibitor</name>
  <code>T24925</code>  <id>24925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein</name>
  <code>T24927</code>  <id>24927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human CTLA-4/Fc-IgG1 Recombinant Fusion Protein</name>
  <code>T24926</code>  <id>24926</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</name>
  <code>T8402</code>  <id>8402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</name>
  <code>T8398</code>  <id>8398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</name>
  <code>T8399</code>  <id>8399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</name>
  <code>T8395</code>  <id>8395</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Epidermal Growth Factor Receptor Family Antagonists</name>
  <code>T23041</code>  <id>23041</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Epidermal Growth Factor Receptor Family Inhibitors</name>
  <code>T23043</code>  <id>23043</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Epidermal Growth Factor Receptor Family Interactions</name>
  <code>T23048</code>  <id>23048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Capsid Inhibitor</name>
  <code>T58931</code>  <id>58931</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Fusion Inhibitor</name>
  <code>T24938</code>  <id>24938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24948</code>  <id>24948</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24939</code>  <id>24939</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24957</code>  <id>24957</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24952</code>  <id>24952</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24945</code>  <id>24945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24941</code>  <id>24941</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24950</code>  <id>24950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24951</code>  <id>24951</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor</name>
  <code>T58403</code>  <id>58403</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitors</name>
  <code>T58407</code>  <id>58407</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Fusion Protein Inhibitors</name>
  <code>T23157</code>  <id>23157</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Integrase Inhibitors</name>
  <code>T23163</code>  <id>23163</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor</name>
  <code>T24963</code>  <id>24963</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (HIV-1 INSTI)</name>
  <code>T24958</code>  <id>24958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor</name>
  <code>T24969</code>  <id>24969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</name>
  <code>T24968</code>  <id>24968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Protease Inhibitor</name>
  <code>T24973</code>  <id>24973</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Protease Inhibitors</name>
  <code>T23171</code>  <id>23171</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunoglobulin</name>
  <code>T24979</code>  <id>24979</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Immunoglobulin G</name>
  <code>T24978</code>  <id>24978</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Platelet-derived Growth Factor</name>
  <code>T24981</code>  <id>24981</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human Serum Albumin</name>
  <code>T24982</code>  <id>24982</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Human alpha-1 Proteinase Inhibitor</name>
  <code>T24983</code>  <id>24983</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Humanized Monoclonal Antibody Fragment</name>
  <code>T24984</code>  <id>24984</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Humoral Immunity</name>
  <code>T24987</code>  <id>24987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Humoral and Cellular Immune Response Activators</name>
  <code>T59069</code>  <id>59069</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrogen Ion Donor Activity</name>
  <code>T1832</code>  <id>1832</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrogen Ion Donors</name>
  <code>T1833</code>  <id>1833</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrogen Ion Scavengers</name>
  <code>T2918</code>  <id>2918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrogen Ion Scavenging Activity</name>
  <code>T2919</code>  <id>2919</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme</name>
  <code>T25142</code>  <id>25142</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal GAG-specific Enzyme</name>
  <code>T25148</code>  <id>25148</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme</name>
  <code>T25144</code>  <id>25144</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glycogen-specific Enzyme</name>
  <code>T25146</code>  <id>25146</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glycosaminoglycan (GAG)-specific Enzyme</name>
  <code>T25150</code>  <id>25150</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme</name>
  <code>T25151</code>  <id>25151</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase</name>
  <code>T25155</code>  <id>25155</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme</name>
  <code>T25157</code>  <id>25157</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme</name>
  <code>T25159</code>  <id>25159</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal Cholesteryl Ester-specific Enzyme</name>
  <code>T25141</code>  <id>25141</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal GAG-specific Enzyme</name>
  <code>T25147</code>  <id>25147</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal Glucocerebroside-specific Enzyme</name>
  <code>T25143</code>  <id>25143</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal Glycogen-specific Enzyme</name>
  <code>T25145</code>  <id>25145</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal Glycosaminoglycan (GAG)-specific Enzyme</name>
  <code>T25149</code>  <id>25149</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal Neutral Glycosphingolipid-specific Enzyme</name>
  <code>T25156</code>  <id>25156</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysozomal Triacylglycerol-specific Enzyme</name>
  <code>T25158</code>  <id>25158</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydroxylase Activators</name>
  <code>T25233</code>  <id>25233</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydroxymethylglutaryl-CoA Reductase Inhibitor</name>
  <code>T23352</code>  <id>23352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydroxymethylglutaryl-CoA Reductase Inhibitors</name>
  <code>T25257</code>  <id>25257</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</name>
  <code>T615</code>  <id>615</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydroxyphenylpyruvate Dioxygenase Inhibitor</name>
  <code>T617</code>  <id>617</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hydroxyphenylpyruvate Dioxygenase Inhibitors</name>
  <code>T25274</code>  <id>25274</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Agonists</name>
  <code>T25522</code>  <id>25522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Antagonists</name>
  <code>T25527</code>  <id>25527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Blocker</name>
  <code>T25533</code>  <id>25533</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Interactions</name>
  <code>T25540</code>  <id>25540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cation Channel Agonists</name>
  <code>T25523</code>  <id>25523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cation Channel Antagonists</name>
  <code>T25529</code>  <id>25529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cation Channel Blocker</name>
  <code>T25532</code>  <id>25532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cation Channel Interactions</name>
  <code>T25539</code>  <id>25539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists</name>
  <code>T25525</code>  <id>25525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists</name>
  <code>T25531</code>  <id>25531</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker</name>
  <code>T25537</code>  <id>25537</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions</name>
  <code>T25543</code>  <id>25543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarized Contrast Agent</name>
  <code>T58913</code>  <id>58913</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypothalamic Endocrine Activity Alteration</name>
  <code>T25706</code>  <id>25706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypothalamic Hormone Receptor Agonists</name>
  <code>T25707</code>  <id>25707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypothalamic Hormone Receptor Antagonists</name>
  <code>T25708</code>  <id>25708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypothalmic Hormone Interactions</name>
  <code>T25718</code>  <id>25718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia Inducible Factor Inhibitor</name>
  <code>T58712</code>  <id>58712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia Inducible Factor Inhibitors</name>
  <code>T58715</code>  <id>58715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia Inducible Factor- 2 alpha Inhibitors</name>
  <code>T58719</code>  <id>58719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors</name>
  <code>T58897</code>  <id>58897</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor 2 alpha Inhibitors</name>
  <code>T58716</code>  <id>58716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor Inhibitor</name>
  <code>T58710</code>  <id>58710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor Inhibitors</name>
  <code>T58713</code>  <id>58713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor</name>
  <code>T58899</code>  <id>58899</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I [Preparations]</name>
  <code>T25763</code>  <id>25763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Cation Channel Agonists</name>
  <code>T25524</code>  <id>25524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Cation Channel Antagonists</name>
  <code>T25528</code>  <id>25528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Cation Channel Blocker</name>
  <code>T25534</code>  <id>25534</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Cation Channel Interactions</name>
  <code>T25542</code>  <id>25542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Channel Agonists</name>
  <code>T25520</code>  <id>25520</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Channel Antagonists</name>
  <code>T25530</code>  <id>25530</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Channel Blocker</name>
  <code>T25535</code>  <id>25535</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>I(h) Channel Interactions</name>
  <code>T25541</code>  <id>25541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IBAT Inhibitor</name>
  <code>T58631</code>  <id>58631</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IBAT Inhibitors</name>
  <code>T58636</code>  <id>58636</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IDH1 Inhibitor</name>
  <code>T58685</code>  <id>58685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IDH1 Inhibitors</name>
  <code>T58688</code>  <id>58688</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IDH2 Inhibitor</name>
  <code>T28565</code>  <id>28565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IDH2 Inhibitors</name>
  <code>T28568</code>  <id>28568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IFN alpha-2B</name>
  <code>T58669</code>  <id>58669</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IFNγ Antagonists</name>
  <code>T58466</code>  <id>58466</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IFNγ Blocker</name>
  <code>T58468</code>  <id>58468</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IGF Type 1 Receptor Interactions</name>
  <code>T25790</code>  <id>25790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IGF-1 Receptor Interactions</name>
  <code>T58580</code>  <id>58580</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IGF-1R Inhibitor</name>
  <code>T58576</code>  <id>58576</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IGF-1R Inhibitors</name>
  <code>T58578</code>  <id>58578</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IGF-1R Interactions</name>
  <code>T58581</code>  <id>58581</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 13 Antagonist</name>
  <code>T58681</code>  <id>58681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 13 Antagonists</name>
  <code>T58677</code>  <id>58677</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 15 Receptor Agonist</name>
  <code>T58989</code>  <id>58989</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 15 Receptor Agonists</name>
  <code>T58984</code>  <id>58984</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 15 Receptor Interactions</name>
  <code>T58977</code>  <id>58977</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 15R Interactions </name>
  <code>T58978</code>  <id>58978</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 17A-directed Antibody</name>
  <code>T27942</code>  <id>27942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 36 Receptor Antagonist</name>
  <code>T58808</code>  <id>58808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 36 Receptor Antagonists</name>
  <code>T58803</code>  <id>58803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL 6-directed Antibody</name>
  <code>T28154</code>  <id>28154</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-12 Antagonist</name>
  <code>T27850</code>  <id>27850</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-12 Antagonists</name>
  <code>T27854</code>  <id>27854</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-13 Antagonist</name>
  <code>T58682</code>  <id>58682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-13 Antagonists</name>
  <code>T58678</code>  <id>58678</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-15 Receptor Agonist</name>
  <code>T58990</code>  <id>58990</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-15 Receptor Agonists</name>
  <code>T58985</code>  <id>58985</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-15 Receptor Interactions</name>
  <code>T58979</code>  <id>58979</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17 RA Antagonist</name>
  <code>T27924</code>  <id>27924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17 RA Antagonists</name>
  <code>T27729</code>  <id>27729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17 RA Interactions</name>
  <code>T27733</code>  <id>27733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17 Receptor Interactions</name>
  <code>T27741</code>  <id>27741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17A Antagonist</name>
  <code>T27930</code>  <id>27930</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17A Antagonists</name>
  <code>T27937</code>  <id>27937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17A-directed Antibody</name>
  <code>T27945</code>  <id>27945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17A-directed Antibody Interactions</name>
  <code>T27939</code>  <id>27939</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17RA Antagonist</name>
  <code>T27918</code>  <id>27918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17RA Antagonists</name>
  <code>T27726</code>  <id>27726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-17RA Interactions</name>
  <code>T27731</code>  <id>27731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-2 Receptor-directed Cytotoxin</name>
  <code>T28009</code>  <id>28009</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-23 Antagonist</name>
  <code>T28026</code>  <id>28026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-23 Antagonists</name>
  <code>T28030</code>  <id>28030</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-31 Receptor alpha Antagonists</name>
  <code>T58950</code>  <id>58950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-31R alpha Antagonists</name>
  <code>T58951</code>  <id>58951</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-36 Receptor Antagonist</name>
  <code>T58809</code>  <id>58809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-36 Receptor Antagonists</name>
  <code>T58804</code>  <id>58804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-36RA</name>
  <code>T58810</code>  <id>58810</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-36RAs</name>
  <code>T58805</code>  <id>58805</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-3RA Interaction</name>
  <code>T58479</code>  <id>58479</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4 Receptor Interactions</name>
  <code>T27758</code>  <id>27758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4 Receptor alpha Antagonist</name>
  <code>T28065</code>  <id>28065</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4 Receptor alpha Antagonists</name>
  <code>T27765</code>  <id>27765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4R Interactions</name>
  <code>T27757</code>  <id>27757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4R alpha Antagonist</name>
  <code>T28067</code>  <id>28067</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4R alpha Antagonists</name>
  <code>T27766</code>  <id>27766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-4R alpha-directed Antibody Interactions</name>
  <code>T27771</code>  <id>27771</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-5 Antagonist</name>
  <code>T28095</code>  <id>28095</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-5 Receptor alpha-directed Antibody</name>
  <code>T58393</code>  <id>58393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-5 Receptor alpha-directed Antibody Interactions</name>
  <code>T58387</code>  <id>58387</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-6 Antagonist</name>
  <code>T28114</code>  <id>28114</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-6 Antagonists</name>
  <code>T28120</code>  <id>28120</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-6 Receptor Antagonist</name>
  <code>T28126</code>  <id>28126</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-6-directed Antibody</name>
  <code>T28159</code>  <id>28159</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL-6-directed Antibody Interactions</name>
  <code>T28152</code>  <id>28152</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL1 Receptor Activators</name>
  <code>T27707</code>  <id>27707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL1 Receptor Agonists</name>
  <code>T27705</code>  <id>27705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL1 Receptor Antagonists</name>
  <code>T27716</code>  <id>27716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL1 Receptor Blockers</name>
  <code>T27715</code>  <id>27715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL1 Receptor Inhibitors</name>
  <code>T27718</code>  <id>27718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL1 Receptor Interactions</name>
  <code>T27721</code>  <id>27721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL12 Antagonist</name>
  <code>T27849</code>  <id>27849</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL12 Antagonists</name>
  <code>T27853</code>  <id>27853</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL15 Receptor Agonist</name>
  <code>T58991</code>  <id>58991</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL15 Receptor Agonists</name>
  <code>T58986</code>  <id>58986</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL15 Receptor Interactions</name>
  <code>T58980</code>  <id>58980</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL15R Interactions</name>
  <code>T58981</code>  <id>58981</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17 RA Antagonist</name>
  <code>T27920</code>  <id>27920</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17 RA Antagonists</name>
  <code>T27727</code>  <id>27727</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17 RA Interactions</name>
  <code>T27737</code>  <id>27737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17 Receptor Interactions</name>
  <code>T27739</code>  <id>27739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17A Antagonist</name>
  <code>T27932</code>  <id>27932</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17A Antagonists</name>
  <code>T27936</code>  <id>27936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17A-directed Antibody</name>
  <code>T27944</code>  <id>27944</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17A-directed Antibody Interactions</name>
  <code>T27940</code>  <id>27940</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17RA Antagonist</name>
  <code>T27922</code>  <id>27922</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17RA Antagonists</name>
  <code>T27723</code>  <id>27723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL17RA Interactions</name>
  <code>T27732</code>  <id>27732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Activators</name>
  <code>T27745</code>  <id>27745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Agonists</name>
  <code>T27744</code>  <id>27744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Antagonists</name>
  <code>T27749</code>  <id>27749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Blockers</name>
  <code>T27747</code>  <id>27747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Blocking Antibody</name>
  <code>T27977</code>  <id>27977</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Inhibitors</name>
  <code>T27748</code>  <id>27748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor Interactions</name>
  <code>T27753</code>  <id>27753</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor-directed Antibody Interactions</name>
  <code>T27755</code>  <id>27755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL2 Receptor-directed Cytotoxin</name>
  <code>T28007</code>  <id>28007</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL23 Antagonist</name>
  <code>T28024</code>  <id>28024</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL23 Antagonists</name>
  <code>T28029</code>  <id>28029</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL31 Receptor alpha Antagonists</name>
  <code>T58952</code>  <id>58952</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL31R alpha Antagonists</name>
  <code>T58953</code>  <id>58953</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL36 Receptor Antagonist</name>
  <code>T58811</code>  <id>58811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL36 Receptor Antagonists</name>
  <code>T58806</code>  <id>58806</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4 Receptor Interactions</name>
  <code>T27759</code>  <id>27759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4 Receptor alpha Antagonist</name>
  <code>T28064</code>  <id>28064</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4 Receptor alpha Antagonists</name>
  <code>T27764</code>  <id>27764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4 Receptor alpha-directed Antibody Interactions</name>
  <code>T27769</code>  <id>27769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4R Interactions</name>
  <code>T27761</code>  <id>27761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4R alpha Antagonist</name>
  <code>T28068</code>  <id>28068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4R alpha Antagonists</name>
  <code>T27767</code>  <id>27767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL4R alpha-directed Antibody Interactions</name>
  <code>T27770</code>  <id>27770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL5 Antagonist</name>
  <code>T28093</code>  <id>28093</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL5 Receptor alpha-directed Antibody</name>
  <code>T58394</code>  <id>58394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL5 Receptor alpha-directed Antibody Interactions</name>
  <code>T58388</code>  <id>58388</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Antagonist</name>
  <code>T28115</code>  <id>28115</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Antagonists</name>
  <code>T28121</code>  <id>28121</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Activators</name>
  <code>T27775</code>  <id>27775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Agonists</name>
  <code>T27774</code>  <id>27774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Antagonist</name>
  <code>T28123</code>  <id>28123</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Antagonists</name>
  <code>T27778</code>  <id>27778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Blockers</name>
  <code>T27781</code>  <id>27781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Inhibitors</name>
  <code>T27779</code>  <id>27779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6 Receptor Interactions</name>
  <code>T27783</code>  <id>27783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6-directed Antibody</name>
  <code>T28156</code>  <id>28156</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IL6-directed Antibody Interactions</name>
  <code>T28151</code>  <id>28151</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>IgE-directed Antibody Interactions</name>
  <code>T26054</code>  <id>26054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ileal Bile Acid Transporter Inhibitor</name>
  <code>T58628</code>  <id>58628</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ileal Bile Acid Transporter Inhibitors</name>
  <code>T58633</code>  <id>58633</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ileal Sodium Bile Acid Cotransporter Inhibitor</name>
  <code>T58632</code>  <id>58632</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ileal Sodium Bile Acid Cotransporter Inhibitors</name>
  <code>T58637</code>  <id>58637</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Imaging Agent</name>
  <code>T58505</code>  <id>58505</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Imaging Contrast Activity</name>
  <code>T26070</code>  <id>26070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immune Stimulation</name>
  <code>T26685</code>  <id>26685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immune Suppression</name>
  <code>T14499</code>  <id>14499</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immune System Stimulation</name>
  <code>T26688</code>  <id>26688</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immune System Suppression</name>
  <code>T14501</code>  <id>14501</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunity, Cellular</name>
  <code>T9761</code>  <id>9761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunoglobulin G</name>
  <code>T26181</code>  <id>26181</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic Activity Alteration</name>
  <code>T26298</code>  <id>26298</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic Adjuvants</name>
  <code>T26300</code>  <id>26300</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic Agent</name>
  <code>T58529</code>  <id>58529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic Factor Interactions</name>
  <code>T26306</code>  <id>26306</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic Stimulation</name>
  <code>T26686</code>  <id>26686</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic Suppression</name>
  <code>T14498</code>  <id>14498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologic and Biological Factor Interactions</name>
  <code>T26307</code>  <id>26307</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunological Agents</name>
  <code>T58436</code>  <id>58436</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologically Active Molecule Activity Alteration</name>
  <code>T26308</code>  <id>26308</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologically Active Molecule Degradation Alteration</name>
  <code>T26309</code>  <id>26309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunologically Active Molecule Production Alteration</name>
  <code>T26310</code>  <id>26310</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunostimulation</name>
  <code>T26687</code>  <id>26687</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunosuppression</name>
  <code>T14500</code>  <id>14500</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Immunotherapy</name>
  <code>T58885</code>  <id>58885</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Bordetella Pertussis Vaccine</name>
  <code>T26333</code>  <id>26333</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Clostridium Tetani Vaccine</name>
  <code>T26334</code>  <id>26334</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Corynebacterium Diphtheriae Vaccine</name>
  <code>T26335</code>  <id>26335</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Haemophilus Influenzae B Vaccine</name>
  <code>T26336</code>  <id>26336</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Hepatitis A Virus Vaccine</name>
  <code>T26337</code>  <id>26337</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Hepatitis B Virus Vaccine</name>
  <code>T26338</code>  <id>26338</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Human Papillomavirus Vaccine</name>
  <code>T26339</code>  <id>26339</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Influenza A Virus Vaccine</name>
  <code>T26340</code>  <id>26340</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Influenza B Virus Vaccine</name>
  <code>T26341</code>  <id>26341</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Japanese Encephalitis Virus Vaccine</name>
  <code>T26342</code>  <id>26342</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Meningococcal Vaccine</name>
  <code>T26343</code>  <id>26343</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Pneumococcal Vaccine</name>
  <code>T26344</code>  <id>26344</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Poliovirus Vaccine</name>
  <code>T26345</code>  <id>26345</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Rabies Virus Vaccine</name>
  <code>T26346</code>  <id>26346</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Salmonella Typhi Vaccine</name>
  <code>T26347</code>  <id>26347</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactivated Yersinia Pestis Vaccine</name>
  <code>T26348</code>  <id>26348</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inactive Preparations by FDA Established Pharmacologic Class</name>
  <code>T58503</code>  <id>58503</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increase Spermatogenesis</name>
  <code>T26361</code>  <id>26361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased ACTH Secretion</name>
  <code>T26368</code>  <id>26368</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Acetylcholine Activity</name>
  <code>T26362</code>  <id>26362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Adhesion Factor Activity</name>
  <code>T26363</code>  <id>26363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Adhesion Factor Degradation</name>
  <code>T26364</code>  <id>26364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Adhesion Factor Production</name>
  <code>T26365</code>  <id>26365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Adrenal Epinephrine Secretion</name>
  <code>T26366</code>  <id>26366</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Adrenal Norepinephrine Secretion</name>
  <code>T26367</code>  <id>26367</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Adrenocorticotropic Hormone Secretion</name>
  <code>T26369</code>  <id>26369</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Anal Sphincter Tone</name>
  <code>T26370</code>  <id>26370</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Antibody Activity</name>
  <code>T26371</code>  <id>26371</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Antibody Degradation</name>
  <code>T26372</code>  <id>26372</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Antibody Production</name>
  <code>T26373</code>  <id>26373</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Aspartate Activity</name>
  <code>T26374</code>  <id>26374</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Ganglionic Activity</name>
  <code>T26375</code>  <id>26375</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Acetylcholine Activity</name>
  <code>T26376</code>  <id>26376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Aspartate Activity</name>
  <code>T26377</code>  <id>26377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity</name>
  <code>T26378</code>  <id>26378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System CCK Activity</name>
  <code>T26379</code>  <id>26379</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Disorganized Electrical Activity</name>
  <code>T26380</code>  <id>26380</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Dopamine Activity</name>
  <code>T26381</code>  <id>26381</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Dynorphin Activity</name>
  <code>T26382</code>  <id>26382</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Endorphin Activity</name>
  <code>T26383</code>  <id>26383</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Enkephalin Activity</name>
  <code>T26384</code>  <id>26384</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Epinephrine Activity</name>
  <code>T26385</code>  <id>26385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System GABA Activity</name>
  <code>T26386</code>  <id>26386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Gastrin Activity</name>
  <code>T26387</code>  <id>26387</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Glutamate Activity</name>
  <code>T26388</code>  <id>26388</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Glycine Activity</name>
  <code>T26389</code>  <id>26389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Histamine Activity</name>
  <code>T26390</code>  <id>26390</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Nerve Growth Factor Activity</name>
  <code>T26391</code>  <id>26391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Neurotensin Activity</name>
  <code>T26392</code>  <id>26392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Nitric Oxide Activity</name>
  <code>T26393</code>  <id>26393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Norepinephrine Activity</name>
  <code>T26394</code>  <id>26394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Organized Electrical Activity</name>
  <code>T26395</code>  <id>26395</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Serotonin Activity</name>
  <code>T26396</code>  <id>26396</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Substance P Activity</name>
  <code>T26397</code>  <id>26397</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System VIP Activity</name>
  <code>T26398</code>  <id>26398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased B Lymphocyte Activation</name>
  <code>T26399</code>  <id>26399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased B Lymphocyte Destruction</name>
  <code>T26400</code>  <id>26400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased B Lymphocyte Production</name>
  <code>T26401</code>  <id>26401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Bile Iron Secretion</name>
  <code>T26402</code>  <id>26402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Biliary Motility</name>
  <code>T26403</code>  <id>26403</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Bladder Contractility</name>
  <code>T26404</code>  <id>26404</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Bladder Sphincter Tone</name>
  <code>T26405</code>  <id>26405</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Blood Pressure</name>
  <code>T26406</code>  <id>26406</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Blood Viscosity</name>
  <code>T26407</code>  <id>26407</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Bradykinin Activity</name>
  <code>T26408</code>  <id>26408</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Bradykinin Degradation</name>
  <code>T26409</code>  <id>26409</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Bradykinin Production</name>
  <code>T26410</code>  <id>26410</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Derived Neurotropic Activity</name>
  <code>T26411</code>  <id>26411</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Acetylcholine Activity</name>
  <code>T26412</code>  <id>26412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Aspartate Activity</name>
  <code>T26413</code>  <id>26413</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Brain Derived Neurotropic Activity</name>
  <code>T26414</code>  <id>26414</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem CCK Activity</name>
  <code>T26415</code>  <id>26415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Disorganized Electrical Activity</name>
  <code>T26416</code>  <id>26416</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Dopamine Activity</name>
  <code>T26417</code>  <id>26417</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Dynorphin Activity</name>
  <code>T26418</code>  <id>26418</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Endorphin Activity</name>
  <code>T26419</code>  <id>26419</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Enkephalin Activity</name>
  <code>T26420</code>  <id>26420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Epinephrine Activity</name>
  <code>T26421</code>  <id>26421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem GABA Activity</name>
  <code>T26422</code>  <id>26422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Gastrin Activity</name>
  <code>T26423</code>  <id>26423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Glutamate Activity</name>
  <code>T26424</code>  <id>26424</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Glycine Activity</name>
  <code>T26425</code>  <id>26425</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Histamine Activity</name>
  <code>T26426</code>  <id>26426</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Nerve Growth Factor Activity</name>
  <code>T26427</code>  <id>26427</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Neurotensin Activity</name>
  <code>T26428</code>  <id>26428</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Nitric Oxide Activity</name>
  <code>T26429</code>  <id>26429</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Norepinephrine Activity</name>
  <code>T26430</code>  <id>26430</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Organized Electrical Activity</name>
  <code>T26431</code>  <id>26431</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Serotonin Activity</name>
  <code>T26432</code>  <id>26432</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Substance P Activity</name>
  <code>T26433</code>  <id>26433</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem VIP Activity</name>
  <code>T26434</code>  <id>26434</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased CCK Activity</name>
  <code>T26435</code>  <id>26435</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased CRH Activity</name>
  <code>T26436</code>  <id>26436</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased CRH Secretion</name>
  <code>T26437</code>  <id>26437</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Calcitonin Secretion</name>
  <code>T26438</code>  <id>26438</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Calcium-sensing Receptor Sensitivity</name>
  <code>T26439</code>  <id>26439</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Capillary Permeability</name>
  <code>T26440</code>  <id>26440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Acetylcholine Activity</name>
  <code>T26441</code>  <id>26441</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Aspartate Activity</name>
  <code>T26442</code>  <id>26442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Brain Derived Neurotropic Activity</name>
  <code>T26443</code>  <id>26443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle CCK Activity</name>
  <code>T26444</code>  <id>26444</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Disorganized Electrical Activity</name>
  <code>T26445</code>  <id>26445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Dopamine Activity</name>
  <code>T26446</code>  <id>26446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Dynorphin Activity</name>
  <code>T26447</code>  <id>26447</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Endorphin Activity</name>
  <code>T26448</code>  <id>26448</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Enkephalin Activity</name>
  <code>T26449</code>  <id>26449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Epinephrine Activity</name>
  <code>T26450</code>  <id>26450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle GABA Activity</name>
  <code>T26451</code>  <id>26451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Gastrin Activity</name>
  <code>T26452</code>  <id>26452</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Glutamate Activity</name>
  <code>T26453</code>  <id>26453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Glycine Activity</name>
  <code>T26454</code>  <id>26454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Histamine Activity</name>
  <code>T26455</code>  <id>26455</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Nerve Growth Factor Activity</name>
  <code>T26456</code>  <id>26456</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Neurotensin Activity</name>
  <code>T26457</code>  <id>26457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Nitric Oxide Activity</name>
  <code>T26458</code>  <id>26458</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Norepinephrine Activity</name>
  <code>T26459</code>  <id>26459</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Organized Electrical Activity</name>
  <code>T26460</code>  <id>26460</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Serotonin Activity</name>
  <code>T26461</code>  <id>26461</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Substance P Activity</name>
  <code>T26462</code>  <id>26462</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle VIP Activity</name>
  <code>T26463</code>  <id>26463</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Membrane Integrity</name>
  <code>T26464</code>  <id>26464</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Membrane Synthesis &amp; Repair</name>
  <code>T26465</code>  <id>26465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Signaling</name>
  <code>T26637</code>  <id>26637</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Wall Integrity</name>
  <code>T26466</code>  <id>26466</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Wall Synthesis &amp; Repair</name>
  <code>T26467</code>  <id>26467</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cellular Death</name>
  <code>T26468</code>  <id>26468</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cellular Locomotion</name>
  <code>T26469</code>  <id>26469</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cellular Migration</name>
  <code>T26470</code>  <id>26470</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Acetylcholine Activity</name>
  <code>T26471</code>  <id>26471</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Aspartate Activity</name>
  <code>T26472</code>  <id>26472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Brain Derived Neurotropic Activity</name>
  <code>T26473</code>  <id>26473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System CCK Activity</name>
  <code>T26474</code>  <id>26474</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Disorganized Electrical Activity</name>
  <code>T26475</code>  <id>26475</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Dopamine Activity</name>
  <code>T26476</code>  <id>26476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Dynorphin Activity</name>
  <code>T26477</code>  <id>26477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Endorphin Activity</name>
  <code>T26478</code>  <id>26478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Enkephalin Activity</name>
  <code>T26479</code>  <id>26479</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Epinephrine Activity</name>
  <code>T26480</code>  <id>26480</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System GABA Activity</name>
  <code>T26481</code>  <id>26481</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Gastrin Activity</name>
  <code>T26482</code>  <id>26482</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Glutamate Activity</name>
  <code>T26483</code>  <id>26483</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Glycine Activity</name>
  <code>T26484</code>  <id>26484</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Histamine Activity</name>
  <code>T26485</code>  <id>26485</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Nerve Growth Factor Activity</name>
  <code>T26486</code>  <id>26486</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Neurotensin Activity</name>
  <code>T26487</code>  <id>26487</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Nitric Oxide Activity</name>
  <code>T26488</code>  <id>26488</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Norepinephrine Activity</name>
  <code>T26489</code>  <id>26489</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Organized Electrical Activity</name>
  <code>T26490</code>  <id>26490</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Serotonin Activity</name>
  <code>T26491</code>  <id>26491</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Substance P Activity</name>
  <code>T26492</code>  <id>26492</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System VIP Activity</name>
  <code>T26493</code>  <id>26493</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Acetylcholine Activity</name>
  <code>T26494</code>  <id>26494</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Aspartate Activity</name>
  <code>T26495</code>  <id>26495</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Brain Derived Neurotropic Activity</name>
  <code>T26496</code>  <id>26496</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum CCK Activity</name>
  <code>T26497</code>  <id>26497</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Disorganized Electrical Activity</name>
  <code>T26498</code>  <id>26498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Dopamine Activity</name>
  <code>T26499</code>  <id>26499</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Dynorphin Activity</name>
  <code>T26500</code>  <id>26500</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Endorphin Activity</name>
  <code>T26501</code>  <id>26501</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Enkephalin Activity</name>
  <code>T26502</code>  <id>26502</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Epinephrine Activity</name>
  <code>T26503</code>  <id>26503</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum GABA Activity</name>
  <code>T26504</code>  <id>26504</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Gastrin Activity</name>
  <code>T26505</code>  <id>26505</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Glutamate Activity</name>
  <code>T26506</code>  <id>26506</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Glycine Activity</name>
  <code>T26507</code>  <id>26507</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Histamine Activity</name>
  <code>T26508</code>  <id>26508</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Nerve Growth Factor Activity</name>
  <code>T26509</code>  <id>26509</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Neurotensin Activity</name>
  <code>T26510</code>  <id>26510</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Nitric Oxide Activity</name>
  <code>T26511</code>  <id>26511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Norepinephrine Activity</name>
  <code>T26512</code>  <id>26512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Organized Electrical Activity</name>
  <code>T26513</code>  <id>26513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Serotonin Activity</name>
  <code>T26514</code>  <id>26514</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Substance P Activity</name>
  <code>T26515</code>  <id>26515</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum VIP Activity</name>
  <code>T26516</code>  <id>26516</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Acetylcholine Activity</name>
  <code>T26517</code>  <id>26517</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Aspartate Activity</name>
  <code>T26518</code>  <id>26518</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Brain Derived Neurotropic Activity</name>
  <code>T26519</code>  <id>26519</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex CCK Activity</name>
  <code>T26520</code>  <id>26520</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Disorganized Electrical Activity</name>
  <code>T26521</code>  <id>26521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Dopamine Activity</name>
  <code>T26522</code>  <id>26522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Dynorphin Activity</name>
  <code>T26523</code>  <id>26523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Endorphin Activity</name>
  <code>T26524</code>  <id>26524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Enkephalin Activity</name>
  <code>T26525</code>  <id>26525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Epinephrine Activity</name>
  <code>T26526</code>  <id>26526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex GABA Activity</name>
  <code>T26527</code>  <id>26527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Gastrin Activity</name>
  <code>T26528</code>  <id>26528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Glutamate Activity</name>
  <code>T26529</code>  <id>26529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Glycine Activity</name>
  <code>T26530</code>  <id>26530</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Histamine Activity</name>
  <code>T26531</code>  <id>26531</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Nerve Growth Factor Activity</name>
  <code>T26532</code>  <id>26532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Neurotensin Activity</name>
  <code>T26533</code>  <id>26533</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Nitric Oxide Activity</name>
  <code>T26534</code>  <id>26534</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Norepinephrine Activity</name>
  <code>T26535</code>  <id>26535</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Organized Electrical Activity</name>
  <code>T26536</code>  <id>26536</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Serotonin Activity</name>
  <code>T26537</code>  <id>26537</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Substance P Activity</name>
  <code>T26538</code>  <id>26538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex VIP Activity</name>
  <code>T26539</code>  <id>26539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cervical Dilation</name>
  <code>T26540</code>  <id>26540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cervical Smooth Muscle Tone</name>
  <code>T26541</code>  <id>26541</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Absorption</name>
  <code>T26542</code>  <id>26542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Elimination</name>
  <code>T26543</code>  <id>26543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Secretion</name>
  <code>T26544</code>  <id>26544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Synthesis</name>
  <code>T26545</code>  <id>26545</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Activity</name>
  <code>T26550</code>  <id>26550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor Activity</name>
  <code>T26551</code>  <id>26551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor Concentration</name>
  <code>T26552</code>  <id>26552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor IX Activity</name>
  <code>T26553</code>  <id>26553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor IX Concentration</name>
  <code>T26554</code>  <id>26554</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor VII Concentration</name>
  <code>T26555</code>  <id>26555</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor VIII Activity</name>
  <code>T26556</code>  <id>26556</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor VIII Concentration</name>
  <code>T26557</code>  <id>26557</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor X Activity</name>
  <code>T26558</code>  <id>26558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor X Concentration</name>
  <code>T26559</code>  <id>26559</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Ca++ Excretion</name>
  <code>T26560</code>  <id>26560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Cl- Excretion</name>
  <code>T26561</code>  <id>26561</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct H+ Excretion</name>
  <code>T26562</code>  <id>26562</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct HCO3- Excretion</name>
  <code>T26563</code>  <id>26563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct K+ Excretion</name>
  <code>T26564</code>  <id>26564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Mg++ Excretion</name>
  <code>T26565</code>  <id>26565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Na+ Excretion</name>
  <code>T26566</code>  <id>26566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct PO4-- Excretion</name>
  <code>T26567</code>  <id>26567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct SO4-- Excretion</name>
  <code>T26568</code>  <id>26568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Water Permeability</name>
  <code>T26569</code>  <id>26569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Complement Activity</name>
  <code>T26570</code>  <id>26570</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Complement Degradation</name>
  <code>T26571</code>  <id>26571</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Complement Production</name>
  <code>T26572</code>  <id>26572</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cytokine Activity</name>
  <code>T26573</code>  <id>26573</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cytokine Degradation</name>
  <code>T26574</code>  <id>26574</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Cytokine Production</name>
  <code>T26575</code>  <id>26575</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased DHT Secretion</name>
  <code>T26578</code>  <id>26578</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased DNA Integrity</name>
  <code>T26576</code>  <id>26576</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased DNA Replication</name>
  <code>T26577</code>  <id>26577</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Dihydrotestosterone Secretion</name>
  <code>T26579</code>  <id>26579</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Disorganized Electrical Activity</name>
  <code>T26580</code>  <id>26580</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Ca++ Excretion</name>
  <code>T26581</code>  <id>26581</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Cl- Excretion</name>
  <code>T26582</code>  <id>26582</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule H+ Excretion</name>
  <code>T26583</code>  <id>26583</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule HCO3- Excretion</name>
  <code>T26584</code>  <id>26584</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule K+ Excretion</name>
  <code>T26585</code>  <id>26585</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Mg++ Excretion</name>
  <code>T26586</code>  <id>26586</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Na+ Excretion</name>
  <code>T26587</code>  <id>26587</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule PO4-- Excretion</name>
  <code>T26588</code>  <id>26588</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule SO4-- Excretion</name>
  <code>T26589</code>  <id>26589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Diuresis</name>
  <code>T26591</code>  <id>26591</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Diuresis at Loop of Henle</name>
  <code>T26592</code>  <id>26592</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Dopamine Activity</name>
  <code>T26593</code>  <id>26593</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Dynorphin Activity</name>
  <code>T26594</code>  <id>26594</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Eicosanoid Activity</name>
  <code>T26595</code>  <id>26595</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Eicosanoid Degradation</name>
  <code>T26596</code>  <id>26596</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Eicosanoid Production</name>
  <code>T26597</code>  <id>26597</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Embryonic &amp; Fetal Growth</name>
  <code>T26598</code>  <id>26598</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Embryonic &amp; Fetal Viability</name>
  <code>T26599</code>  <id>26599</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Embryonic Implantation</name>
  <code>T26600</code>  <id>26600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Endocytosis</name>
  <code>T26601</code>  <id>26601</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Endorphin Activity</name>
  <code>T26602</code>  <id>26602</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Endothelial Coagulation Activity</name>
  <code>T26603</code>  <id>26603</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Endothelial Proliferation</name>
  <code>T26604</code>  <id>26604</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enkephalin Activity</name>
  <code>T26605</code>  <id>26605</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Acetylcholine Activity</name>
  <code>T26606</code>  <id>26606</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Aspartate Activity</name>
  <code>T26607</code>  <id>26607</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Brain Derived Neurotropic Activity</name>
  <code>T26608</code>  <id>26608</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System CCK Activity</name>
  <code>T26609</code>  <id>26609</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Disorganized Electrical Activity</name>
  <code>T26610</code>  <id>26610</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Dopamine Activity</name>
  <code>T26611</code>  <id>26611</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Dynorphin Activity</name>
  <code>T26612</code>  <id>26612</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Endorphin Activity</name>
  <code>T26613</code>  <id>26613</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Enkephalin Activity</name>
  <code>T26614</code>  <id>26614</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Epinephrine Activity</name>
  <code>T26615</code>  <id>26615</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System GABA Activity</name>
  <code>T26616</code>  <id>26616</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Gastrin Activity</name>
  <code>T26617</code>  <id>26617</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Glutamate Activity</name>
  <code>T26618</code>  <id>26618</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Glycine Activity</name>
  <code>T26619</code>  <id>26619</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Histamine Activity</name>
  <code>T26620</code>  <id>26620</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Nerve Growth Factor Activity</name>
  <code>T26621</code>  <id>26621</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Neurotensin Activity</name>
  <code>T26622</code>  <id>26622</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Nitric Oxide Activity</name>
  <code>T26623</code>  <id>26623</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Norepinephrine Activity</name>
  <code>T26624</code>  <id>26624</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Organized Electrical Activity</name>
  <code>T26625</code>  <id>26625</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Serotonin Activity</name>
  <code>T26626</code>  <id>26626</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Substance P Activity</name>
  <code>T26627</code>  <id>26627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System VIP Activity</name>
  <code>T26628</code>  <id>26628</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Epinephrine Activity</name>
  <code>T26629</code>  <id>26629</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Epithelial Proliferation</name>
  <code>T26630</code>  <id>26630</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Erythroid Cell Destruction</name>
  <code>T26631</code>  <id>26631</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Erythroid Cell Production</name>
  <code>T26632</code>  <id>26632</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Erythropoetin Secretion</name>
  <code>T26633</code>  <id>26633</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Esophageal Motility</name>
  <code>T26634</code>  <id>26634</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Esophageal Muscle Tone</name>
  <code>T26635</code>  <id>26635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Exocytosis</name>
  <code>T26636</code>  <id>26636</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Extracellular Communication</name>
  <code>T26638</code>  <id>26638</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased FSH Secretion</name>
  <code>T26644</code>  <id>26644</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrin Concentration</name>
  <code>T26639</code>  <id>26639</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrin Polymerization Activity</name>
  <code>T26640</code>  <id>26640</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrinogen Concentration</name>
  <code>T26641</code>  <id>26641</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrinolysis</name>
  <code>T26642</code>  <id>26642</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Fibroblast Migration</name>
  <code>T26643</code>  <id>26643</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Follicle Stimulating Hormone Secretion</name>
  <code>T26645</code>  <id>26645</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GABA Activity</name>
  <code>T26646</code>  <id>26646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GH Secretion</name>
  <code>T26672</code>  <id>26672</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GHRH Activity</name>
  <code>T26647</code>  <id>26647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GHRH Secretion</name>
  <code>T26648</code>  <id>26648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GI Motility</name>
  <code>T26649</code>  <id>26649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GI Smooth Muscle Tone</name>
  <code>T26650</code>  <id>26650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Gallbladder Tone</name>
  <code>T26651</code>  <id>26651</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Gastric Motility</name>
  <code>T26652</code>  <id>26652</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Gastric Muscle Tone</name>
  <code>T26653</code>  <id>26653</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Gastrin Activity</name>
  <code>T26654</code>  <id>26654</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glomerular Filtration Pressure</name>
  <code>T26655</code>  <id>26655</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glucagon Secretion</name>
  <code>T26656</code>  <id>26656</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glucocorticoid Clearance</name>
  <code>T26657</code>  <id>26657</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glucocorticoid Secretion</name>
  <code>T26658</code>  <id>26658</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Gluconeogenesis</name>
  <code>T26659</code>  <id>26659</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glucose Transport into Cells</name>
  <code>T26660</code>  <id>26660</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glutamate Activity</name>
  <code>T26661</code>  <id>26661</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glutathione Concentration</name>
  <code>T26662</code>  <id>26662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glycine Activity</name>
  <code>T26663</code>  <id>26663</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glycogenesis</name>
  <code>T26664</code>  <id>26664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glycogenolysis</name>
  <code>T26665</code>  <id>26665</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Glycolysis</name>
  <code>T26666</code>  <id>26666</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GnRH Activity</name>
  <code>T26667</code>  <id>26667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased GnRH Secretion</name>
  <code>T26668</code>  <id>26668</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Granulocytic Cell Destruction</name>
  <code>T26669</code>  <id>26669</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Granulocytic Cell Production</name>
  <code>T26670</code>  <id>26670</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Growth Factor Activity</name>
  <code>T26671</code>  <id>26671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Growth Hormone Secretion</name>
  <code>T26673</code>  <id>26673</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Hair Growth</name>
  <code>T26674</code>  <id>26674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Hemagglutinin Inhibition Antibody Production</name>
  <code>T26675</code>  <id>26675</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Hematological Cell Destruction</name>
  <code>T26676</code>  <id>26676</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Hematopoiesis</name>
  <code>T26677</code>  <id>26677</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Hematopoietic Stem Cell Mobilization</name>
  <code>T26678</code>  <id>26678</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Activity</name>
  <code>T26679</code>  <id>26679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Degradation</name>
  <code>T26680</code>  <id>26680</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Production</name>
  <code>T26681</code>  <id>26681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Release</name>
  <code>T26682</code>  <id>26682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased IgG Production</name>
  <code>T26684</code>  <id>26684</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunoglobulin G Production</name>
  <code>T26683</code>  <id>26683</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologic Activity</name>
  <code>T26689</code>  <id>26689</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Biogenic Amine Activity</name>
  <code>T26690</code>  <id>26690</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Biogenic Amine Degradation</name>
  <code>T26691</code>  <id>26691</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Biogenic Amine Production</name>
  <code>T26692</code>  <id>26692</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Molecule Activity</name>
  <code>T26693</code>  <id>26693</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Molecule Degradation</name>
  <code>T26694</code>  <id>26694</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Molecule Production</name>
  <code>T26695</code>  <id>26695</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Insulin Secretion</name>
  <code>T26696</code>  <id>26696</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Intracellular Communication</name>
  <code>T26697</code>  <id>26697</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Intravascular Volume</name>
  <code>T26698</code>  <id>26698</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Iodine Organification</name>
  <code>T26699</code>  <id>26699</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Iodine Uptake</name>
  <code>T26700</code>  <id>26700</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Kallidin Activity</name>
  <code>T26701</code>  <id>26701</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Kallidin Degradation</name>
  <code>T26702</code>  <id>26702</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Kallidin Production</name>
  <code>T26703</code>  <id>26703</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Kinin Activity</name>
  <code>T26704</code>  <id>26704</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Kinin Degradation</name>
  <code>T26705</code>  <id>26705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Kinin Production</name>
  <code>T26706</code>  <id>26706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased LES Tone</name>
  <code>T26707</code>  <id>26707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased LH Secretion</name>
  <code>T26727</code>  <id>26727</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Large Intestinal Motility</name>
  <code>T26708</code>  <id>26708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Large Intestinal Muscle Tone</name>
  <code>T26709</code>  <id>26709</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Leukotriene Activity</name>
  <code>T26710</code>  <id>26710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Leukotriene Degradation</name>
  <code>T26711</code>  <id>26711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Leukotriene Production</name>
  <code>T26712</code>  <id>26712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lipid Derived Immunologically Active Molecule Activity</name>
  <code>T26713</code>  <id>26713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lipid Derived Immunologically Active Molecule Degradation</name>
  <code>T26714</code>  <id>26714</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lipid Derived Immunologically Active Molecule Production</name>
  <code>T26715</code>  <id>26715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lipogenesis</name>
  <code>T26716</code>  <id>26716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lipolysis</name>
  <code>T26717</code>  <id>26717</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Ca++ Excretion</name>
  <code>T26718</code>  <id>26718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Cl- Excretion</name>
  <code>T26719</code>  <id>26719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle H+ Excretion</name>
  <code>T26720</code>  <id>26720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle HCO3- Excretion</name>
  <code>T26721</code>  <id>26721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle K+ Excretion</name>
  <code>T26722</code>  <id>26722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Mg++ Excretion</name>
  <code>T26723</code>  <id>26723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Na+ Excretion</name>
  <code>T26724</code>  <id>26724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle PO4-- Excretion</name>
  <code>T26725</code>  <id>26725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle SO4-- Excretion</name>
  <code>T26726</code>  <id>26726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Luteinizing Hormone Secretion</name>
  <code>T26728</code>  <id>26728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lymphocyte Activation</name>
  <code>T26729</code>  <id>26729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lymphocyte Cell Destruction</name>
  <code>T26730</code>  <id>26730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lymphocyte Cell Production</name>
  <code>T26731</code>  <id>26731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Lysosomal Function</name>
  <code>T26732</code>  <id>26732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Macrophage Proliferation</name>
  <code>T26733</code>  <id>26733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Medullary Respiratory Drive</name>
  <code>T26734</code>  <id>26734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Megakaryocte Cell Destruction</name>
  <code>T26735</code>  <id>26735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Megakaryocte Cell Production</name>
  <code>T26736</code>  <id>26736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Megakaryocyte Maturation</name>
  <code>T26737</code>  <id>26737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Meiosis</name>
  <code>T26738</code>  <id>26738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Melatonin Activity</name>
  <code>T26739</code>  <id>26739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Melatonin Secretion</name>
  <code>T26740</code>  <id>26740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Metabolic Rate</name>
  <code>T26741</code>  <id>26741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Acetylcholine Activity</name>
  <code>T26742</code>  <id>26742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Aspartate Activity</name>
  <code>T26743</code>  <id>26743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Brain Derived Neurotropic Activity</name>
  <code>T26744</code>  <id>26744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain CCK Activity</name>
  <code>T26745</code>  <id>26745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Disorganized Electrical Activity</name>
  <code>T26746</code>  <id>26746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Dopamine Activity</name>
  <code>T26747</code>  <id>26747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Dynorphin Activity</name>
  <code>T26748</code>  <id>26748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Endorphin Activity</name>
  <code>T26749</code>  <id>26749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Enkephalin Activity</name>
  <code>T26750</code>  <id>26750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Epinephrine Activity</name>
  <code>T26751</code>  <id>26751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain GABA Activity</name>
  <code>T26752</code>  <id>26752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Gastrin Activity</name>
  <code>T26753</code>  <id>26753</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Glutamate Activity</name>
  <code>T26754</code>  <id>26754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Glycine Activity</name>
  <code>T26755</code>  <id>26755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Histamine Activity</name>
  <code>T26756</code>  <id>26756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Nerve Growth Factor Activity</name>
  <code>T26757</code>  <id>26757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Neurotensin Activity</name>
  <code>T26758</code>  <id>26758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Nitric Oxide Activity</name>
  <code>T26759</code>  <id>26759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Norepinephrine Activity</name>
  <code>T26760</code>  <id>26760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Organized Electrical Activity</name>
  <code>T26761</code>  <id>26761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Serotonin Activity</name>
  <code>T26762</code>  <id>26762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Substance P Activity</name>
  <code>T26763</code>  <id>26763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain VIP Activity</name>
  <code>T26764</code>  <id>26764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Mineralocorticoid Secretion</name>
  <code>T26765</code>  <id>26765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Mitosis</name>
  <code>T26766</code>  <id>26766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Monocyte Activation</name>
  <code>T26767</code>  <id>26767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Monocytic Cell Destruction</name>
  <code>T26768</code>  <id>26768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Monocytic Cell Production</name>
  <code>T26769</code>  <id>26769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Acetylcholine Activity</name>
  <code>T26770</code>  <id>26770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Aspartate Activity</name>
  <code>T26771</code>  <id>26771</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Brain Derived Neurotropic Activity</name>
  <code>T26772</code>  <id>26772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System CCK Activity</name>
  <code>T26773</code>  <id>26773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Disorganized Electrical Activity</name>
  <code>T26774</code>  <id>26774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Dopamine Activity</name>
  <code>T26775</code>  <id>26775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Dynorphin Activity</name>
  <code>T26776</code>  <id>26776</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Endorphin Activity</name>
  <code>T26777</code>  <id>26777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Enkephalin Activity</name>
  <code>T26778</code>  <id>26778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Epinephrine Activity</name>
  <code>T26779</code>  <id>26779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System GABA Activity</name>
  <code>T26780</code>  <id>26780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Gastrin Activity</name>
  <code>T26781</code>  <id>26781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Glutamate Activity</name>
  <code>T26782</code>  <id>26782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Glycine Activity</name>
  <code>T26783</code>  <id>26783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Histamine Activity</name>
  <code>T26784</code>  <id>26784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Nerve Growth Factor Activity</name>
  <code>T26785</code>  <id>26785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Neurotensin Activity</name>
  <code>T26786</code>  <id>26786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Nitric Oxide Activity</name>
  <code>T26787</code>  <id>26787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Norepinephrine Activity</name>
  <code>T26788</code>  <id>26788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Organized Electrical Activity</name>
  <code>T26789</code>  <id>26789</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Serotonin Activity</name>
  <code>T26790</code>  <id>26790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Substance P Activity</name>
  <code>T26791</code>  <id>26791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System VIP Activity</name>
  <code>T26792</code>  <id>26792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Myeloid Cell Destruction</name>
  <code>T26793</code>  <id>26793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Myeloid Cell Production</name>
  <code>T26794</code>  <id>26794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Nasal and Sinus Mucosal Edema</name>
  <code>T26795</code>  <id>26795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Nasal and Sinus Secretions</name>
  <code>T26796</code>  <id>26796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Nerve Growth Factor Activity</name>
  <code>T26797</code>  <id>26797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Neurotensin Activity</name>
  <code>T26798</code>  <id>26798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Nitric Oxide Activity</name>
  <code>T26799</code>  <id>26799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Norepinephrine Activity</name>
  <code>T26800</code>  <id>26800</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Oncotic Pressure</name>
  <code>T26801</code>  <id>26801</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Organic Ion Degradation</name>
  <code>T26802</code>  <id>26802</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Organic Ion Synthesis</name>
  <code>T26803</code>  <id>26803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Organized Electrical Activity</name>
  <code>T26804</code>  <id>26804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Ovarian Estrogen Secretion</name>
  <code>T26805</code>  <id>26805</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Ovarian Progesterone Secretion</name>
  <code>T26806</code>  <id>26806</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Oxygen Carrying Capacity</name>
  <code>T26807</code>  <id>26807</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Oxytocin Secretion</name>
  <code>T26808</code>  <id>26808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased PIF Activity</name>
  <code>T26809</code>  <id>26809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased PIF Secretion</name>
  <code>T26810</code>  <id>26810</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased PRF Activity</name>
  <code>T26811</code>  <id>26811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased PRF Secretion</name>
  <code>T26812</code>  <id>26812</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased PTH Secretion</name>
  <code>T26813</code>  <id>26813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Pancreatic Somatostatin Secretion</name>
  <code>T26814</code>  <id>26814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Acetylcholine Activity</name>
  <code>T26815</code>  <id>26815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Activity</name>
  <code>T26817</code>  <id>26817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Aspartate Activity</name>
  <code>T26818</code>  <id>26818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Brain Derived Neurotropic Activity</name>
  <code>T26819</code>  <id>26819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic CCK Activity</name>
  <code>T26820</code>  <id>26820</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Disorganized Electrical Activity</name>
  <code>T26821</code>  <id>26821</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Dopamine Activity</name>
  <code>T26822</code>  <id>26822</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Dynorphin Activity</name>
  <code>T26823</code>  <id>26823</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Endorphin Activity</name>
  <code>T26824</code>  <id>26824</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Enkephalin Activity</name>
  <code>T26825</code>  <id>26825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Epinephrine Activity</name>
  <code>T26826</code>  <id>26826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic GABA Activity</name>
  <code>T26827</code>  <id>26827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Gastrin Activity</name>
  <code>T26828</code>  <id>26828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Glutamate Activity</name>
  <code>T26829</code>  <id>26829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Glycine Activity</name>
  <code>T26830</code>  <id>26830</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Histamine Activity</name>
  <code>T26831</code>  <id>26831</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Nerve Growth Factor Activity</name>
  <code>T26832</code>  <id>26832</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Neurotensin Activity</name>
  <code>T26833</code>  <id>26833</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Nitric Oxide Activity</name>
  <code>T26834</code>  <id>26834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Norepinephrine Activity</name>
  <code>T26835</code>  <id>26835</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Organized Electrical Activity</name>
  <code>T26836</code>  <id>26836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Serotonin Activity</name>
  <code>T26837</code>  <id>26837</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Substance P Activity</name>
  <code>T26838</code>  <id>26838</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic VIP Activity</name>
  <code>T26839</code>  <id>26839</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Acetylcholine Activity</name>
  <code>T26840</code>  <id>26840</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Aspartate Activity</name>
  <code>T26841</code>  <id>26841</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity</name>
  <code>T26842</code>  <id>26842</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System CCK Activity</name>
  <code>T26843</code>  <id>26843</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Disorganized Electrical Activity</name>
  <code>T26844</code>  <id>26844</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Dopamine Activity</name>
  <code>T26845</code>  <id>26845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Dynorphin Activity</name>
  <code>T26846</code>  <id>26846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Endorphin Activity</name>
  <code>T26847</code>  <id>26847</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Enkephalin Activity</name>
  <code>T26848</code>  <id>26848</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Epinephrine Activity</name>
  <code>T26849</code>  <id>26849</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System GABA Activity</name>
  <code>T26850</code>  <id>26850</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Gastrin Activity</name>
  <code>T26851</code>  <id>26851</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Glutamate Activity</name>
  <code>T26852</code>  <id>26852</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Glycine Activity</name>
  <code>T26853</code>  <id>26853</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Histamine Activity</name>
  <code>T26854</code>  <id>26854</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Nerve Growth Factor Activity</name>
  <code>T26855</code>  <id>26855</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Neurotensin Activity</name>
  <code>T26856</code>  <id>26856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Nitric Oxide Activity</name>
  <code>T26857</code>  <id>26857</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Norepinephrine Activity</name>
  <code>T26858</code>  <id>26858</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Organized Electrical Activity</name>
  <code>T26859</code>  <id>26859</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Serotonin Activity</name>
  <code>T26860</code>  <id>26860</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Substance P Activity</name>
  <code>T26861</code>  <id>26861</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System VIP Activity</name>
  <code>T26862</code>  <id>26862</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Respiratory Drive</name>
  <code>T26863</code>  <id>26863</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Phagocytosis</name>
  <code>T26864</code>  <id>26864</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Pharyngeal Mucosal Edema</name>
  <code>T26865</code>  <id>26865</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Pharyngeal Secretions</name>
  <code>T26866</code>  <id>26866</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Pinocytosis</name>
  <code>T26867</code>  <id>26867</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Placental HCG Secretion</name>
  <code>T26868</code>  <id>26868</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Placental Human Chorionic Gonadotropin Secretion</name>
  <code>T26869</code>  <id>26869</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Activating Factor Activity</name>
  <code>T26870</code>  <id>26870</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Activating Factor Degradation</name>
  <code>T26871</code>  <id>26871</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Activating Factor Production</name>
  <code>T26872</code>  <id>26872</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Aggregation</name>
  <code>T26873</code>  <id>26873</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Production</name>
  <code>T26875</code>  <id>26875</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Polymorphonuclear Leukocyte Migration</name>
  <code>T26876</code>  <id>26876</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prolactin Secretion</name>
  <code>T26877</code>  <id>26877</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prostaglandin Activity</name>
  <code>T26878</code>  <id>26878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prostaglandin Degradation</name>
  <code>T26879</code>  <id>26879</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prostaglandin Production</name>
  <code>T26880</code>  <id>26880</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prostatic Secretion</name>
  <code>T26881</code>  <id>26881</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prostatic Size</name>
  <code>T26882</code>  <id>26882</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Protein Breakdown</name>
  <code>T26883</code>  <id>26883</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Protein Modification</name>
  <code>T26884</code>  <id>26884</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Protein Synthesis</name>
  <code>T26885</code>  <id>26885</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prothrombin Activity</name>
  <code>T26886</code>  <id>26886</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Prothrombin Concentration</name>
  <code>T26887</code>  <id>26887</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Ca++ Excretion</name>
  <code>T26888</code>  <id>26888</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Cl- Excretion</name>
  <code>T26889</code>  <id>26889</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule H+ Excretion</name>
  <code>T26890</code>  <id>26890</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule HCO3- Excretion</name>
  <code>T26891</code>  <id>26891</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule K+ Excretion</name>
  <code>T26892</code>  <id>26892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Mg++ Excretion</name>
  <code>T26893</code>  <id>26893</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Na+ Excretion</name>
  <code>T26894</code>  <id>26894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule PO4-- Excretion</name>
  <code>T26895</code>  <id>26895</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule SO4-- Excretion</name>
  <code>T26896</code>  <id>26896</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Pyloric Sphincter Tone</name>
  <code>T26897</code>  <id>26897</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased RNA Degradation</name>
  <code>T59041</code>  <id>59041</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased RNA Integrity</name>
  <code>T26898</code>  <id>26898</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased RNA Replication</name>
  <code>T26899</code>  <id>26899</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased RPE Function</name>
  <code>T58376</code>  <id>58376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Ca++ Excretion</name>
  <code>T26900</code>  <id>26900</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Cl- Excretion</name>
  <code>T26901</code>  <id>26901</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal H+ Excretion</name>
  <code>T26902</code>  <id>26902</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal HCO3- Excretion</name>
  <code>T26903</code>  <id>26903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Ion Excretion</name>
  <code>T26904</code>  <id>26904</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal K+ Excretion</name>
  <code>T26905</code>  <id>26905</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Mg++ Excretion</name>
  <code>T26906</code>  <id>26906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Na+ Excretion</name>
  <code>T26907</code>  <id>26907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Organic Anion Excretion</name>
  <code>T26908</code>  <id>26908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Organic Cation Excretion</name>
  <code>T26909</code>  <id>26909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Organic Ion Excretion</name>
  <code>T26910</code>  <id>26910</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal PO4-- Excretion</name>
  <code>T26911</code>  <id>26911</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal SO4-- Excretion</name>
  <code>T26912</code>  <id>26912</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Urea Excretion</name>
  <code>T26913</code>  <id>26913</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Respiratory Mucosal Edema</name>
  <code>T26914</code>  <id>26914</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Respiratory Secretion Viscosity</name>
  <code>T26915</code>  <id>26915</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Respiratory Secretions</name>
  <code>T26916</code>  <id>26916</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Retinal Pigment Epithelium Function</name>
  <code>T58374</code>  <id>58374</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Reverse Transcription to DNA</name>
  <code>T26917</code>  <id>26917</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sebaceous Gland Activity</name>
  <code>T26918</code>  <id>26918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sebaceous Gland Quantity</name>
  <code>T26919</code>  <id>26919</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System</name>
  <code>T26942</code>  <id>26942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Acetylcholine Activity</name>
  <code>T26920</code>  <id>26920</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Aspartate Activity</name>
  <code>T26921</code>  <id>26921</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</name>
  <code>T26922</code>  <id>26922</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System CCK Activity</name>
  <code>T26923</code>  <id>26923</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity</name>
  <code>T26924</code>  <id>26924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Dopamine Activity</name>
  <code>T26925</code>  <id>26925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Dynorphin Activity</name>
  <code>T26926</code>  <id>26926</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Endorphin Activity</name>
  <code>T26927</code>  <id>26927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Enkephalin Activity</name>
  <code>T26928</code>  <id>26928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Epinephrine Activity</name>
  <code>T26929</code>  <id>26929</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System GABA Activity</name>
  <code>T26930</code>  <id>26930</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Gastrin Activity</name>
  <code>T26931</code>  <id>26931</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Glutamate Activity</name>
  <code>T26932</code>  <id>26932</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Glycine Activity</name>
  <code>T26933</code>  <id>26933</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Histamine Activity</name>
  <code>T26934</code>  <id>26934</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity</name>
  <code>T26935</code>  <id>26935</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity</name>
  <code>T26936</code>  <id>26936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Norepinephrine Activity</name>
  <code>T26937</code>  <id>26937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Organized Electrical Activity</name>
  <code>T26938</code>  <id>26938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Serotonin Activity</name>
  <code>T26939</code>  <id>26939</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Substance P Activity</name>
  <code>T26940</code>  <id>26940</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System VIP Activity</name>
  <code>T26941</code>  <id>26941</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Serotonin Activity</name>
  <code>T26943</code>  <id>26943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Serotonin Degradation</name>
  <code>T26944</code>  <id>26944</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Serotonin Production</name>
  <code>T26945</code>  <id>26945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Skin Keratinization</name>
  <code>T26946</code>  <id>26946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Small Intestinal Motility</name>
  <code>T26947</code>  <id>26947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Small Intestinal Muscle Tone</name>
  <code>T26948</code>  <id>26948</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Acetylcholine Activity</name>
  <code>T26949</code>  <id>26949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Aspartate Activity</name>
  <code>T26950</code>  <id>26950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Brain Derived Neurotropic Activity</name>
  <code>T26951</code>  <id>26951</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle CCK Activity</name>
  <code>T26952</code>  <id>26952</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Disorganized Electrical Activity</name>
  <code>T26953</code>  <id>26953</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Dopamine Activity</name>
  <code>T26954</code>  <id>26954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Dynorphin Activity</name>
  <code>T26955</code>  <id>26955</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Endorphin Activity</name>
  <code>T26956</code>  <id>26956</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Enkephalin Activity</name>
  <code>T26957</code>  <id>26957</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Epinephrine Activity</name>
  <code>T26958</code>  <id>26958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle GABA Activity</name>
  <code>T26959</code>  <id>26959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Gastrin Activity</name>
  <code>T26960</code>  <id>26960</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Glutamate Activity</name>
  <code>T26961</code>  <id>26961</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Glycine Activity</name>
  <code>T26962</code>  <id>26962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Histamine Activity</name>
  <code>T26963</code>  <id>26963</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Nerve Growth Factor Activity</name>
  <code>T26964</code>  <id>26964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Neurotensin Activity</name>
  <code>T26965</code>  <id>26965</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Nitric Oxide Activity</name>
  <code>T26966</code>  <id>26966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Norepinephrine Activity</name>
  <code>T26967</code>  <id>26967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Organized Electrical Activity</name>
  <code>T26968</code>  <id>26968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Serotonin Activity</name>
  <code>T26969</code>  <id>26969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Substance P Activity</name>
  <code>T26970</code>  <id>26970</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle VIP Activity</name>
  <code>T26971</code>  <id>26971</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Somatostatin (SRIF) Activity</name>
  <code>T26972</code>  <id>26972</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Somatostatin (SRIF) Secretion</name>
  <code>T26973</code>  <id>26973</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sperm Death</name>
  <code>T26974</code>  <id>26974</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sperm Motility</name>
  <code>T26975</code>  <id>26975</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sphincter of Odi Tone</name>
  <code>T26976</code>  <id>26976</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Acetylcholine Activity</name>
  <code>T26977</code>  <id>26977</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Aspartate Activity</name>
  <code>T26978</code>  <id>26978</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Brain Derived Neurotropic Activity</name>
  <code>T26979</code>  <id>26979</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord CCK Activity</name>
  <code>T26980</code>  <id>26980</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Disorganized Electrical Activity</name>
  <code>T26981</code>  <id>26981</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Dopamine Activity</name>
  <code>T26982</code>  <id>26982</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Dynorphin Activity</name>
  <code>T26983</code>  <id>26983</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Endorphin Activity</name>
  <code>T26984</code>  <id>26984</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Enkephalin Activity</name>
  <code>T26985</code>  <id>26985</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Epinephrine Activity</name>
  <code>T26986</code>  <id>26986</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord GABA Activity</name>
  <code>T26987</code>  <id>26987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Gastrin Activity</name>
  <code>T26988</code>  <id>26988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Glutamate Activity</name>
  <code>T26989</code>  <id>26989</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Glycine Activity</name>
  <code>T26990</code>  <id>26990</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Histamine Activity</name>
  <code>T26991</code>  <id>26991</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Nerve Growth Factor Activity</name>
  <code>T26992</code>  <id>26992</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Neurotensin Activity</name>
  <code>T26993</code>  <id>26993</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Nitric Oxide Activity</name>
  <code>T26994</code>  <id>26994</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Norepinephrine Activity</name>
  <code>T26995</code>  <id>26995</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Organized Electrical Activity</name>
  <code>T26996</code>  <id>26996</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Serotonin Activity</name>
  <code>T26997</code>  <id>26997</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Substance P Activity</name>
  <code>T26998</code>  <id>26998</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord VIP Activity</name>
  <code>T26999</code>  <id>26999</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sterol Synthesis</name>
  <code>T27000</code>  <id>27000</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Acetylcholine Activity</name>
  <code>T27001</code>  <id>27001</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Aspartate Activity</name>
  <code>T27002</code>  <id>27002</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Brain Derived Neurotropic Activity</name>
  <code>T27003</code>  <id>27003</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle CCK Activity</name>
  <code>T27004</code>  <id>27004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Contraction</name>
  <code>T27005</code>  <id>27005</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Disorganized Electrical Activity</name>
  <code>T27006</code>  <id>27006</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Dopamine Activity</name>
  <code>T27007</code>  <id>27007</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Dynorphin Activity</name>
  <code>T27008</code>  <id>27008</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Endorphin Activity</name>
  <code>T27009</code>  <id>27009</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Enkephalin Activity</name>
  <code>T27010</code>  <id>27010</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Epinephrine Activity</name>
  <code>T27011</code>  <id>27011</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle GABA Activity</name>
  <code>T27012</code>  <id>27012</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Gastrin Activity</name>
  <code>T27013</code>  <id>27013</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Glutamate Activity</name>
  <code>T27014</code>  <id>27014</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Glycine Activity</name>
  <code>T27015</code>  <id>27015</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Histamine Activity</name>
  <code>T27016</code>  <id>27016</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Nerve Growth Factor Activity</name>
  <code>T27017</code>  <id>27017</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Neurotensin Activity</name>
  <code>T27018</code>  <id>27018</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Nitric Oxide Activity</name>
  <code>T27019</code>  <id>27019</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Norepinephrine Activity</name>
  <code>T27020</code>  <id>27020</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Organized Electrical Activity</name>
  <code>T27021</code>  <id>27021</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Serotonin Activity</name>
  <code>T27022</code>  <id>27022</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Substance P Activity</name>
  <code>T27023</code>  <id>27023</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Tone</name>
  <code>T27024</code>  <id>27024</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle VIP Activity</name>
  <code>T27025</code>  <id>27025</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Substance P Activity</name>
  <code>T27026</code>  <id>27026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Acetylcholine Activity</name>
  <code>T27027</code>  <id>27027</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Activity</name>
  <code>T27029</code>  <id>27029</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Aspartate Activity</name>
  <code>T27030</code>  <id>27030</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Brain Derived Neurotropic Activity</name>
  <code>T27031</code>  <id>27031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic CCK Activity</name>
  <code>T27032</code>  <id>27032</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Disorganized Electrical Activity</name>
  <code>T27033</code>  <id>27033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Dopamine Activity</name>
  <code>T27034</code>  <id>27034</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Dynorphin Activity</name>
  <code>T27035</code>  <id>27035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Endorphin Activity</name>
  <code>T27036</code>  <id>27036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Enkephalin Activity</name>
  <code>T27037</code>  <id>27037</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Epinephrine Activity</name>
  <code>T27038</code>  <id>27038</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic GABA Activity</name>
  <code>T27039</code>  <id>27039</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Gastrin Activity</name>
  <code>T27040</code>  <id>27040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Glutamate Activity</name>
  <code>T27041</code>  <id>27041</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Glycine Activity</name>
  <code>T27042</code>  <id>27042</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Histamine Activity</name>
  <code>T27043</code>  <id>27043</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Nerve Growth Factor Activity</name>
  <code>T27044</code>  <id>27044</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Neurotensin Activity</name>
  <code>T27045</code>  <id>27045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Nitric Oxide Activity</name>
  <code>T27046</code>  <id>27046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Norepinephrine Activity</name>
  <code>T27047</code>  <id>27047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Organized Electrical Activity</name>
  <code>T27048</code>  <id>27048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Serotonin Activity</name>
  <code>T27049</code>  <id>27049</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Substance P Activity</name>
  <code>T27050</code>  <id>27050</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic VIP Activity</name>
  <code>T27051</code>  <id>27051</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased T Lymphocyte Activation</name>
  <code>T27052</code>  <id>27052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased T Lymphocyte Destruction</name>
  <code>T27053</code>  <id>27053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased T Lymphocyte Production</name>
  <code>T27054</code>  <id>27054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased TRH Activity</name>
  <code>T27055</code>  <id>27055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased TRH Secretion</name>
  <code>T27056</code>  <id>27056</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased TSH Secretion</name>
  <code>T27064</code>  <id>27064</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Testosterone Secretion</name>
  <code>T27057</code>  <id>27057</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thrombolysis</name>
  <code>T27058</code>  <id>27058</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thrombopoiesis</name>
  <code>T26874</code>  <id>26874</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thromboxane Activity</name>
  <code>T27059</code>  <id>27059</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thromboxane Degradation</name>
  <code>T27060</code>  <id>27060</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thromboxane Production</name>
  <code>T27061</code>  <id>27061</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thyroid Hormone Iodination</name>
  <code>T27062</code>  <id>27062</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thyroid Hormone Secretion</name>
  <code>T27063</code>  <id>27063</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Thyroid Stimulating Hormone Secretion</name>
  <code>T27065</code>  <id>27065</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Tracheo-Bronchial Mucosal Edema</name>
  <code>T27066</code>  <id>27066</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Tracheo-Bronchial Secretions</name>
  <code>T27067</code>  <id>27067</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Tracheobronchial Stretch Receptor Activity</name>
  <code>T27068</code>  <id>27068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Transcription to RNA</name>
  <code>T27069</code>  <id>27069</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased UES Tone</name>
  <code>T27070</code>  <id>27070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Urethra Smooth Muscle Tone</name>
  <code>T27071</code>  <id>27071</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Uterine Smooth Muscle Contraction or Tone</name>
  <code>T27072</code>  <id>27072</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased VIP Activity</name>
  <code>T27073</code>  <id>27073</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Vaginal Muscle Tone</name>
  <code>T27074</code>  <id>27074</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Vaginal Secretion</name>
  <code>T27075</code>  <id>27075</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Vascular Permeability</name>
  <code>T27076</code>  <id>27076</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Vascular Smooth Muscle Tone</name>
  <code>T27077</code>  <id>27077</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Vasopressin Secretion</name>
  <code>T27078</code>  <id>27078</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Ventilatory Gas Flow</name>
  <code>T27079</code>  <id>27079</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased Vitamin Uptake and Modification</name>
  <code>T27080</code>  <id>27080</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Increased by food</name>
  <code>T27081</code>  <id>27081</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Indirect Lipase Activators</name>
  <code>T58562</code>  <id>58562</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inflammatory Bowel Disease Agents</name>
  <code>T58437</code>  <id>58437</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Influenza A M2 Protein Inhibitor</name>
  <code>T27211</code>  <id>27211</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Influenza Neuraminidase Inhibitor</name>
  <code>T27212</code>  <id>27212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhalation Diagnostic Agent</name>
  <code>T27236</code>  <id>27236</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Breast Glandular Development</name>
  <code>T27245</code>  <id>27245</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Breast Milk Ejection</name>
  <code>T27246</code>  <id>27246</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Breast Milk Secretion</name>
  <code>T27247</code>  <id>27247</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Embryonic &amp; Fetal Development</name>
  <code>T27248</code>  <id>27248</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovarian Follicular Phase</name>
  <code>T27249</code>  <id>27249</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovarian Luteal Phase</name>
  <code>T27250</code>  <id>27250</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovulation</name>
  <code>T27251</code>  <id>27251</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovum Fertilization</name>
  <code>T27252</code>  <id>27252</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Penile Development</name>
  <code>T27253</code>  <id>27253</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Uterine Menstrual Phase</name>
  <code>T27254</code>  <id>27254</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Uterine Proliferative Phase</name>
  <code>T27255</code>  <id>27255</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibit Uterine Secretory Phase</name>
  <code>T27256</code>  <id>27256</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Carbohydrate Digestion</name>
  <code>T27257</code>  <id>27257</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Fat Digestion</name>
  <code>T27258</code>  <id>27258</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Gastric Acid Secretion</name>
  <code>T27259</code>  <id>27259</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Gastric Mucous Secretion</name>
  <code>T27260</code>  <id>27260</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Large Intestine Fluid/Electrolyte Absorption</name>
  <code>T27261</code>  <id>27261</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Large Intestine Fluid/Electrolyte Secretion</name>
  <code>T27262</code>  <id>27262</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Pancreatic Enzymatic Secretion</name>
  <code>T27263</code>  <id>27263</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Pancreatic Fluid/Electrolyte Secretion</name>
  <code>T27264</code>  <id>27264</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Small Intestine Fluid/Electrolyte Absorption</name>
  <code>T27265</code>  <id>27265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inhibition Small Intestine Fluid/Electrolyte Secretion</name>
  <code>T27266</code>  <id>27266</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Inorganic Ion Absorption Alteration</name>
  <code>T27284</code>  <id>27284</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin</name>
  <code>T27386</code>  <id>27386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin Analog</name>
  <code>T27349</code>  <id>27349</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin Analogue</name>
  <code>T27348</code>  <id>27348</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin Receptor Agonists</name>
  <code>T27376</code>  <id>27376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin Receptor Antagonists</name>
  <code>T27377</code>  <id>27377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin Receptor Interactions</name>
  <code>T27378</code>  <id>27378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin-class Agent</name>
  <code>T27385</code>  <id>27385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin-like Growth Factor-1 Receptor Inhibitor</name>
  <code>T58575</code>  <id>58575</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin-like Growth Factor-1 Receptor Inhibitors</name>
  <code>T58577</code>  <id>58577</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Insulin-like Growth Factor-1 Receptor Interactions</name>
  <code>T58579</code>  <id>58579</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Integrase Inhibitors</name>
  <code>T27455</code>  <id>27455</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Integrin Receptor Antagonist</name>
  <code>T27461</code>  <id>27461</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Integrin Receptor Antagonists</name>
  <code>T27462</code>  <id>27462</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Integrin Receptor Interactions</name>
  <code>T27463</code>  <id>27463</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon Inducers</name>
  <code>T27622</code>  <id>27622</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon Receptor Interactions</name>
  <code>T58641</code>  <id>58641</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon alfa</name>
  <code>T27647</code>  <id>27647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon alfa-2B</name>
  <code>T58670</code>  <id>58670</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon alfa-2b</name>
  <code>T58668</code>  <id>58668</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon alpha</name>
  <code>T27648</code>  <id>27648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon alpha-class Agent</name>
  <code>T27646</code>  <id>27646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon beta</name>
  <code>T27650</code>  <id>27650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon beta-class Agent</name>
  <code>T27649</code>  <id>27649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma</name>
  <code>T27662</code>  <id>27662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma Antagonists</name>
  <code>T58465</code>  <id>58465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma Blocker</name>
  <code>T58467</code>  <id>58467</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma-class Agent</name>
  <code>T27661</code>  <id>27661</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 (IL1) Receptor Antagonist</name>
  <code>T27807</code>  <id>27807</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Activators</name>
  <code>T27708</code>  <id>27708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Agonists</name>
  <code>T27706</code>  <id>27706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Antagonist</name>
  <code>T27806</code>  <id>27806</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Antagonists</name>
  <code>T27720</code>  <id>27720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Blockers</name>
  <code>T27719</code>  <id>27719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Inhibitors</name>
  <code>T27717</code>  <id>27717</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Interactions</name>
  <code>T27722</code>  <id>27722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 12 Antagonist</name>
  <code>T27851</code>  <id>27851</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 12 Antagonists</name>
  <code>T27855</code>  <id>27855</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 13 Antagonist</name>
  <code>T58683</code>  <id>58683</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 13 Antagonists</name>
  <code>T58679</code>  <id>58679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 15 Receptor Agonist</name>
  <code>T58992</code>  <id>58992</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 15 Receptor Agonists</name>
  <code>T58987</code>  <id>58987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 15 Receptor Interactions</name>
  <code>T58982</code>  <id>58982</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor A Antagonist</name>
  <code>T27921</code>  <id>27921</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor A Antagonists</name>
  <code>T27730</code>  <id>27730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor A Interactions</name>
  <code>T27738</code>  <id>27738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor Interactions</name>
  <code>T27742</code>  <id>27742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17A (IL17A) Antagonist</name>
  <code>T27931</code>  <id>27931</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17A (IL17A)-directed Antibody</name>
  <code>T27947</code>  <id>27947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17A Antagonist</name>
  <code>T27933</code>  <id>27933</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17A-directed Antibody</name>
  <code>T27943</code>  <id>27943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17RA Antagonist</name>
  <code>T27923</code>  <id>27923</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17RA Antagonists</name>
  <code>T27725</code>  <id>27725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17RA Interactions</name>
  <code>T27735</code>  <id>27735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Activators</name>
  <code>T27743</code>  <id>27743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Agonists</name>
  <code>T27746</code>  <id>27746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Antagonists</name>
  <code>T27752</code>  <id>27752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Blockers</name>
  <code>T27750</code>  <id>27750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Blocking Antibody</name>
  <code>T27979</code>  <id>27979</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Inhibitors</name>
  <code>T27751</code>  <id>27751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Interactions</name>
  <code>T27754</code>  <id>27754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor-directed Antibody Interactions</name>
  <code>T27756</code>  <id>27756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor-directed Cytotoxin</name>
  <code>T28008</code>  <id>28008</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 23 Antagonist</name>
  <code>T28025</code>  <id>28025</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 23 Antagonists</name>
  <code>T28028</code>  <id>28028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 31 Receptor Interactions</name>
  <code>T58955</code>  <id>58955</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 31 Receptor alpha Antagonists</name>
  <code>T58954</code>  <id>58954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor Interactions</name>
  <code>T27762</code>  <id>27762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor alpha Antagonist</name>
  <code>T28066</code>  <id>28066</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor alpha Antagonists</name>
  <code>T27768</code>  <id>27768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor alpha-directed Antibody Interactions</name>
  <code>T27772</code>  <id>27772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody</name>
  <code>T58395</code>  <id>58395</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody Interactions</name>
  <code>T58391</code>  <id>58391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 5 Antagonist</name>
  <code>T28094</code>  <id>28094</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 5 Receptor alpha-directed Antibody</name>
  <code>T58396</code>  <id>58396</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 5 Receptor alpha-directed Antibody Interactions</name>
  <code>T58386</code>  <id>58386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 (IL6) Antagonist</name>
  <code>T28118</code>  <id>28118</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 (IL6) Receptor Antagonist</name>
  <code>T28124</code>  <id>28124</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 (IL6)-directed Antibody</name>
  <code>T28155</code>  <id>28155</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Antagonist</name>
  <code>T28117</code>  <id>28117</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Activators</name>
  <code>T27773</code>  <id>27773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Agonists</name>
  <code>T27776</code>  <id>27776</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Antagonist</name>
  <code>T28125</code>  <id>28125</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Antagonists</name>
  <code>T27782</code>  <id>27782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Blockers</name>
  <code>T27780</code>  <id>27780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Inhibitors</name>
  <code>T27777</code>  <id>27777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Interactions</name>
  <code>T27784</code>  <id>27784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6-directed Antibody</name>
  <code>T28158</code>  <id>28158</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin Agent</name>
  <code>T58530</code>  <id>58530</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-1 (IL-1) Receptor Antagonist</name>
  <code>T27808</code>  <id>27808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-1 Receptor Antagonist</name>
  <code>T27809</code>  <id>27809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-12 Antagonist</name>
  <code>T27852</code>  <id>27852</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-12 Antagonists</name>
  <code>T27856</code>  <id>27856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-13 Antagonist</name>
  <code>T58680</code>  <id>58680</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-13 Antagonists</name>
  <code>T58676</code>  <id>58676</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-15 Receptor Agonist</name>
  <code>T58988</code>  <id>58988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-15 Receptor Agonists</name>
  <code>T58983</code>  <id>58983</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-15 Receptor Interactions</name>
  <code>T58976</code>  <id>58976</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17 Receptor A Antagonist</name>
  <code>T27925</code>  <id>27925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17 Receptor A Antagonists</name>
  <code>T27724</code>  <id>27724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17 Receptor A Interactions</name>
  <code>T27736</code>  <id>27736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17 Receptor Interactions</name>
  <code>T27740</code>  <id>27740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A (IL-17A) Antagonist</name>
  <code>T27934</code>  <id>27934</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A (IL-17A)-directed Antibody</name>
  <code>T27946</code>  <id>27946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A Antagonist</name>
  <code>T27935</code>  <id>27935</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A Antagonists</name>
  <code>T27938</code>  <id>27938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A-directed Antibody</name>
  <code>T27948</code>  <id>27948</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A-directed Antibody Interactions</name>
  <code>T27941</code>  <id>27941</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17RA Antagonist</name>
  <code>T27919</code>  <id>27919</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17RA Antagonists</name>
  <code>T27728</code>  <id>27728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17RA Interactions</name>
  <code>T27734</code>  <id>27734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Blocker (Antibody)</name>
  <code>T27978</code>  <id>27978</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Receptor Blocking Antibody</name>
  <code>T27976</code>  <id>27976</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Receptor Blocking Antibody</name>
  <code>T27980</code>  <id>27980</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Receptor-directed Cytotoxin</name>
  <code>T28006</code>  <id>28006</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Receptor-directed Cytotoxin</name>
  <code>T28010</code>  <id>28010</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-23 Antagonist</name>
  <code>T28027</code>  <id>28027</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-23 Antagonists</name>
  <code>T28031</code>  <id>28031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-3 Receptor alpha-chain Interaction</name>
  <code>T58478</code>  <id>58478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-31 Receptor alpha Antagonist</name>
  <code>T58956</code>  <id>58956</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-31 Receptor alpha Antagonists</name>
  <code>T58949</code>  <id>58949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-36 Receptor Antagonist</name>
  <code>T58807</code>  <id>58807</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-36 Receptor Antagonists</name>
  <code>T58802</code>  <id>58802</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-4 Receptor Interactions</name>
  <code>T27760</code>  <id>27760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-4 Receptor alpha Antagonist</name>
  <code>T28069</code>  <id>28069</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-4 Receptor alpha Antagonists</name>
  <code>T27763</code>  <id>27763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Antagonist</name>
  <code>T28096</code>  <id>28096</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Antagonists</name>
  <code>T28097</code>  <id>28097</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Receptor alpha-directed Antibody Interactions</name>
  <code>T58398</code>  <id>58398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody</name>
  <code>T58379</code>  <id>58379</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 (IL-6) Antagonist</name>
  <code>T28116</code>  <id>28116</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 (IL-6) Receptor Antagonist</name>
  <code>T28127</code>  <id>28127</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 (IL-6)-directed Antibody</name>
  <code>T28157</code>  <id>28157</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 Antagonist</name>
  <code>T28119</code>  <id>28119</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 Antagonists</name>
  <code>T28122</code>  <id>28122</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 Receptor Antagonist</name>
  <code>T28128</code>  <id>28128</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6-directed Antibody</name>
  <code>T28160</code>  <id>28160</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6-directed Antibody Interactions</name>
  <code>T28153</code>  <id>28153</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Intestinal Lipase Inhibitor</name>
  <code>T28228</code>  <id>28228</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Intestinal Metabolism</name>
  <code>T28229</code>  <id>28229</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Intracellular Communication</name>
  <code>T28257</code>  <id>28257</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Intraocular Fluid Pressure Alteration</name>
  <code>T28293</code>  <id>28293</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Intraocular Irrigating Solution</name>
  <code>T28294</code>  <id>28294</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Intravascular Volume Alteration</name>
  <code>T28305</code>  <id>28305</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iodide Peroxidase Inhibitors</name>
  <code>T28324</code>  <id>28324</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iodinated Contrast Agent for Radiographic Imaging</name>
  <code>T28335</code>  <id>28335</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iodine Organification Alteration</name>
  <code>T28338</code>  <id>28338</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iodine Uptake Alteration</name>
  <code>T28340</code>  <id>28340</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ion Channel Interactions</name>
  <code>T28391</code>  <id>28391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ion Channel or Pump Agent</name>
  <code>T58535</code>  <id>58535</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ion Exchange Activity</name>
  <code>T28398</code>  <id>28398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ion Transporter Interactions</name>
  <code>T28401</code>  <id>28401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ionophoric Activity</name>
  <code>T28403</code>  <id>28403</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ionotropic Glutamate Receptor Antagonists</name>
  <code>T28404</code>  <id>28404</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ionotropic Glutamate Receptor Interactions</name>
  <code>T28405</code>  <id>28405</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iron Chelating Activity</name>
  <code>T28478</code>  <id>28478</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iron Chelator</name>
  <code>T28477</code>  <id>28477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iron Chelator</name>
  <code>T28479</code>  <id>28479</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iron Supplement</name>
  <code>T28499</code>  <id>28499</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Iron-containing Supplement</name>
  <code>T28498</code>  <id>28498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Irrigation</name>
  <code>T28513</code>  <id>28513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 1 Inhibitor</name>
  <code>T58684</code>  <id>58684</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 1 Inhibitors</name>
  <code>T58687</code>  <id>58687</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 2 Inhibitor</name>
  <code>T28566</code>  <id>28566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 2 Inhibitors</name>
  <code>T28569</code>  <id>28569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase-1 Inhibitor</name>
  <code>T58686</code>  <id>58686</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase-1 Inhibitors</name>
  <code>T58689</code>  <id>58689</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase-2 Inhibitor</name>
  <code>T28564</code>  <id>28564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase-2 Inhibitors</name>
  <code>T28567</code>  <id>28567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>J [Preparations]</name>
  <code>T28676</code>  <id>28676</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>JAK-3 Inhibitors</name>
  <code>T58864</code>  <id>58864</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>JAK-3 Protein Tyrosine Kinase Inhibitors</name>
  <code>T58865</code>  <id>58865</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>JAK3 Inhibitors</name>
  <code>T58866</code>  <id>58866</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>JAK3 Protein Tyrosine Kinase Inhibitors</name>
  <code>T58867</code>  <id>58867</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Janus Kinase 3 Inhibitors</name>
  <code>T58863</code>  <id>58863</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Janus Kinase Inhibitor</name>
  <code>T28715</code>  <id>28715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Janus Kinase Inhibitors</name>
  <code>T28716</code>  <id>28716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>K [Preparations]</name>
  <code>T28799</code>  <id>28799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>KOR Agonist</name>
  <code>T58731</code>  <id>58731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>KOR Agonists</name>
  <code>T58733</code>  <id>58733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kainate Receptor Antagonists</name>
  <code>T28835</code>  <id>28835</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kallikrein Inhibitors</name>
  <code>T28845</code>  <id>28845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kallikrein-Trypsin Inactivator</name>
  <code>T28846</code>  <id>28846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kappa Opioid Receptor Agonist</name>
  <code>T58730</code>  <id>58730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Keratin Alteration</name>
  <code>T28925</code>  <id>28925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Keratinocyte Growth Factor Receptor Agonists</name>
  <code>T28986</code>  <id>28986</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Keratinocyte Growth Factor Receptor Antagonists</name>
  <code>T28987</code>  <id>28987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Keratinocyte Growth Factor Receptor Interactions</name>
  <code>T28988</code>  <id>28988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Keratolytic Activity</name>
  <code>T14757</code>  <id>14757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ketolide Antibacterial</name>
  <code>T29082</code>  <id>29082</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kinase Inhibitor</name>
  <code>T29157</code>  <id>29157</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kinase Inhibitors</name>
  <code>T29158</code>  <id>29158</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Kinetics</name>
  <code>T29160</code>  <id>29160</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>L [Preparations]</name>
  <code>T29272</code>  <id>29272</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>L-Calcium Channel Receptor Antagonists</name>
  <code>T29286</code>  <id>29286</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>LAG-3 Antagonists</name>
  <code>T58738</code>  <id>58738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>LAG-3 Blocker</name>
  <code>T58735</code>  <id>58735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>LFA-1 Antagonist</name>
  <code>T31060</code>  <id>31060</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>LFA-1 Antagonists</name>
  <code>T31062</code>  <id>31062</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>LMWH</name>
  <code>T30882</code>  <id>30882</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>LTRA</name>
  <code>T30362</code>  <id>30362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Large Intestine Fluid/Electrolyte Absorption Alteration</name>
  <code>T29662</code>  <id>29662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Large Intestine Fluid/Electrolyte Alteration</name>
  <code>T29663</code>  <id>29663</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Large Intestine Fluid/Electrolyte Secretion Alteration</name>
  <code>T29664</code>  <id>29664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lead Chelating Activity</name>
  <code>T29765</code>  <id>29765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lead Chelator</name>
  <code>T29764</code>  <id>29764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lead Chelator</name>
  <code>T29766</code>  <id>29766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lengthen Conduction System Depolarization Time</name>
  <code>T29877</code>  <id>29877</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lengthen Conduction System Repolarization Time</name>
  <code>T29878</code>  <id>29878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leptin Analog</name>
  <code>T29906</code>  <id>29906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leptin Analogue</name>
  <code>T29905</code>  <id>29905</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leukocyte Growth Factor</name>
  <code>T30265</code>  <id>30265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Antagonist</name>
  <code>T30363</code>  <id>30363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Antagonist (LTRA)</name>
  <code>T30361</code>  <id>30361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Antagonists</name>
  <code>T30364</code>  <id>30364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Interactions</name>
  <code>T30365</code>  <id>30365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Synthesis Inhibitor</name>
  <code>T30366</code>  <id>30366</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ligand-Gated Ion Channel Interactions</name>
  <code>T30456</code>  <id>30456</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ligase Activators</name>
  <code>T30459</code>  <id>30459</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lincosamide</name>
  <code>T30494</code>  <id>30494</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lincosamide Antibacterial</name>
  <code>T30492</code>  <id>30492</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lincosamide-class Agent</name>
  <code>T30493</code>  <id>30493</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipase Activators</name>
  <code>T58561</code>  <id>58561</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipase Inhibitors</name>
  <code>T30535</code>  <id>30535</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipid Emulsion</name>
  <code>T30551</code>  <id>30551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipid Metabolism Alteration</name>
  <code>T30552</code>  <id>30552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipid-based Polyene Antifungal</name>
  <code>T30564</code>  <id>30564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipoglycopeptide Antibacterial</name>
  <code>T30596</code>  <id>30596</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipoglycopeptides</name>
  <code>T30597</code>  <id>30597</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipopeptide Antibacterial</name>
  <code>T30613</code>  <id>30613</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipotropic Activity Alteration</name>
  <code>T30667</code>  <id>30667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lipoxygenase Inhibitors</name>
  <code>T30670</code>  <id>30670</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated BCG Immunotherapy</name>
  <code>T30710</code>  <id>30710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated BCG Vaccine</name>
  <code>T30713</code>  <id>30713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Anthracis Vaccine</name>
  <code>T30708</code>  <id>30708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Calmette-Guerin (BCG) Immunotherapy</name>
  <code>T30709</code>  <id>30709</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Calmette-Guerin (BCG) Vaccine</name>
  <code>T30712</code>  <id>30712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy</name>
  <code>T30711</code>  <id>30711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Calmette-Guerin Vaccine</name>
  <code>T30714</code>  <id>30714</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Chickenpox Virus Vaccine</name>
  <code>T30722</code>  <id>30722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Herpes Zoster Virus Vaccine</name>
  <code>T30715</code>  <id>30715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Influenza A Virus Vaccine</name>
  <code>T30716</code>  <id>30716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Measles Virus Vaccine</name>
  <code>T30717</code>  <id>30717</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Mumps Virus Vaccine</name>
  <code>T30718</code>  <id>30718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Rotavirus Vaccine</name>
  <code>T30719</code>  <id>30719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Rubella Virus Vaccine</name>
  <code>T30720</code>  <id>30720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Salmonella Typhi Vaccine</name>
  <code>T30721</code>  <id>30721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Varicella Zoster Virus Vaccine</name>
  <code>T30723</code>  <id>30723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Yellow Fever Virus Vaccine</name>
  <code>T30724</code>  <id>30724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Human Adenovirus Type 4 Vaccine</name>
  <code>T30725</code>  <id>30725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Human Adenovirus Type 7 Vaccine</name>
  <code>T30726</code>  <id>30726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Mumps Virus Vaccine</name>
  <code>T30727</code>  <id>30727</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Rotavirus Vaccine</name>
  <code>T30728</code>  <id>30728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Live Vaccinia Virus Vaccine</name>
  <code>T30729</code>  <id>30729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Local Anesthesia</name>
  <code>T30795</code>  <id>30795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Local Anesthetic</name>
  <code>T30796</code>  <id>30796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Locally Acting Aminosalicylate</name>
  <code>T30797</code>  <id>30797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Locally-acting Aminosalicylate</name>
  <code>T30798</code>  <id>30798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Loop Diuretic</name>
  <code>T30817</code>  <id>30817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Low Molecular Weight Heparin</name>
  <code>T30884</code>  <id>30884</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Low Molecular Weight Heparin (LMWH)</name>
  <code>T30883</code>  <id>30883</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lyase Activators</name>
  <code>T31009</code>  <id>31009</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activation Gene 3 Antagonists</name>
  <code>T58739</code>  <id>58739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activation Gene 3 Blocker</name>
  <code>T58736</code>  <id>58736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activation Gene-3 Antagonists</name>
  <code>T58737</code>  <id>58737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activation Gene-3 Blocker</name>
  <code>T58734</code>  <id>58734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activity Modulation</name>
  <code>T31055</code>  <id>31055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Function Alteration</name>
  <code>T31059</code>  <id>31059</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Function-Associated Antigen-1 Antagonist</name>
  <code>T31061</code>  <id>31061</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Function-Associated Antigen-1 Antagonists</name>
  <code>T31063</code>  <id>31063</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Growth Factor</name>
  <code>T31068</code>  <id>31068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lysophospholipid Receptor Interactions</name>
  <code>T31266</code>  <id>31266</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lysosomal Function Alteration</name>
  <code>T31272</code>  <id>31272</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lysosomal N-terminal Tripeptidyl Peptidase</name>
  <code>T25153</code>  <id>25153</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lysosomal beta Glucuronidase</name>
  <code>T58382</code>  <id>58382</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Lysosphingolipid Receptor Interactions</name>
  <code>T31300</code>  <id>31300</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>M [Preparations]</name>
  <code>T31302</code>  <id>31302</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>M2 Protein Inhibitors</name>
  <code>T31303</code>  <id>31303</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>M2 Proton Pump Inhibitor</name>
  <code>T27210</code>  <id>27210</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAGE-A4-directed Genetically Modified Autologous T Cell Immunotherapy</name>
  <code>T59020</code>  <id>59020</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAO-A Inhibitors</name>
  <code>T33745</code>  <id>33745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAO-B Inhibitor</name>
  <code>T33738</code>  <id>33738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAO-B Inhibitors</name>
  <code>T33748</code>  <id>33748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAOI</name>
  <code>T33731</code>  <id>33731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAOI</name>
  <code>T33734</code>  <id>33734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAOI-A</name>
  <code>T33746</code>  <id>33746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAOI-B</name>
  <code>T33737</code>  <id>33737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAOI-B</name>
  <code>T33749</code>  <id>33749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAP Kinase Kinase 1 Inhibitors</name>
  <code>T58590</code>  <id>58590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAP Kinase Kinase 2 Inhibitors</name>
  <code>T58594</code>  <id>58594</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MAP Kinase Kinase Inhibitors</name>
  <code>T58588</code>  <id>58588</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MATE-2K Inhibitors</name>
  <code>T58558</code>  <id>58558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MATE1 Inhibitors</name>
  <code>T33997</code>  <id>33997</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MATE2 Inhibitors</name>
  <code>T58559</code>  <id>58559</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MATE2-K Inhibitiors</name>
  <code>T58560</code>  <id>58560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MC4 Receptor Agonist</name>
  <code>T58607</code>  <id>58607</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MC4 Receptor Agonists</name>
  <code>T58608</code>  <id>58608</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MCR Agonist</name>
  <code>T58788</code>  <id>58788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MCR Agonists</name>
  <code>T58786</code>  <id>58786</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MEK-1 Protein Kinase Inhibitors</name>
  <code>T58591</code>  <id>58591</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MEK-2 Protein Kinase Inhibitors</name>
  <code>T58595</code>  <id>58595</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MEK1 Protein Kinase Inhibitors</name>
  <code>T58592</code>  <id>58592</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MEK2 Protein Kinase Inhibitors</name>
  <code>T58596</code>  <id>58596</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MET Inhibitors</name>
  <code>T58568</code>  <id>58568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MRP2 Inhibitors</name>
  <code>T58620</code>  <id>58620</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MTTP Inhibitor</name>
  <code>T33317</code>  <id>33317</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>MTTP Inhibitors</name>
  <code>T33319</code>  <id>33319</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Macrolide</name>
  <code>T31793</code>  <id>31793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Macrolide Antibacterial</name>
  <code>T31790</code>  <id>31790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Macrolide Antimicrobial</name>
  <code>T31791</code>  <id>31791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Macrolide-class Agent</name>
  <code>T31792</code>  <id>31792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Macrophage Colony Stimulating Factor Receptor Interactions</name>
  <code>T31798</code>  <id>31798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Magnesium Ion Exchange Activity</name>
  <code>T31874</code>  <id>31874</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Magnetic Resonance Contrast Activity</name>
  <code>T31883</code>  <id>31883</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Male Reproductive System Activity Alteration</name>
  <code>T31923</code>  <id>31923</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mammalian Target of Rapamycin Inhibitor Immunosuppressant</name>
  <code>T57374</code>  <id>57374</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mammalian Target of Rapamycin Inhibitors</name>
  <code>T57376</code>  <id>57376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mast Cell Function Alteration</name>
  <code>T32135</code>  <id>32135</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mast Cell Stabilizer</name>
  <code>T32136</code>  <id>32136</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Meat Proteins</name>
  <code>T32308</code>  <id>32308</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Medium-chain TG</name>
  <code>T58760</code>  <id>58760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Medium-chain Triacylglycerol</name>
  <code>T58761</code>  <id>58761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Medium-chain Triglyceride</name>
  <code>T58759</code>  <id>58759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Medullary Respiratory Center Activity Alteration</name>
  <code>T32399</code>  <id>32399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Megakaryocyte Growth Factor</name>
  <code>T32419</code>  <id>32419</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Meiosis Alteration</name>
  <code>T32446</code>  <id>32446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanin Synthesis Inhibitor</name>
  <code>T32448</code>  <id>32448</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanin Synthesis Inhibitors</name>
  <code>T32449</code>  <id>32449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocortin 4 Receptor Agonist</name>
  <code>T58606</code>  <id>58606</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocortin 4 Receptor Agonists</name>
  <code>T58605</code>  <id>58605</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocortin Receptor Agonist</name>
  <code>T58787</code>  <id>58787</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocortin Receptor Agonists</name>
  <code>T58785</code>  <id>58785</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocortin Receptor Interactions</name>
  <code>T58604</code>  <id>58604</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocyte Destruction</name>
  <code>T32453</code>  <id>32453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanocyte Pigment Inhibitor</name>
  <code>T32447</code>  <id>32447</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy</name>
  <code>T59019</code>  <id>59019</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melatonin Activity Alteration</name>
  <code>T32472</code>  <id>32472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melatonin Alteration</name>
  <code>T32473</code>  <id>32473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melatonin Receptor Agonist</name>
  <code>T32474</code>  <id>32474</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melatonin Receptor Agonists</name>
  <code>T32475</code>  <id>32475</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melatonin Receptor Interactions</name>
  <code>T32476</code>  <id>32476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Melatonin Secretion Alteration</name>
  <code>T32477</code>  <id>32477</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Membrane Transporter Interactions</name>
  <code>T32532</code>  <id>32532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Menin Inhibitor</name>
  <code>T59038</code>  <id>59038</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Menin Inhibitors</name>
  <code>T59037</code>  <id>59037</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mesenchymal Epithelial Transition Inhibitors</name>
  <code>T58567</code>  <id>58567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metabolic Activity Alteration</name>
  <code>T32755</code>  <id>32755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metabolic Alkalinizer</name>
  <code>T32756</code>  <id>32756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metabolic Bone Disease Agents</name>
  <code>T58438</code>  <id>58438</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metabolic Rate Alteration</name>
  <code>T32760</code>  <id>32760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metabolism</name>
  <code>T32770</code>  <id>32770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metal Chelating Activity</name>
  <code>T32782</code>  <id>32782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metal Chelator</name>
  <code>T32781</code>  <id>32781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metal Chelator</name>
  <code>T32783</code>  <id>32783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metalloendopeptidase Inhibitors</name>
  <code>T32788</code>  <id>32788</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Metalloprotease Inhibitors</name>
  <code>T32800</code>  <id>32800</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methyl Donors</name>
  <code>T33054</code>  <id>33054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methylated Sulfonamide Antibacterial</name>
  <code>T33052</code>  <id>33052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methylated Sulfonamides</name>
  <code>T33053</code>  <id>33053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methylating Activity</name>
  <code>T33055</code>  <id>33055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methylating Agent</name>
  <code>T33056</code>  <id>33056</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methyltransferase Inhibitor</name>
  <code>T58569</code>  <id>58569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methyltransferase Inhibitors</name>
  <code>T58570</code>  <id>58570</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methylxanthine</name>
  <code>T33195</code>  <id>33195</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Methylxanthine-class Agent</name>
  <code>T33194</code>  <id>33194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Microsomal Triglyceride Transfer Protein Inhibitor</name>
  <code>T33318</code>  <id>33318</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Microsomal Triglyceride Transfer Protein Inhibitors</name>
  <code>T33320</code>  <id>33320</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Microsomal Triglyceride Transfer Protein Interactions</name>
  <code>T33321</code>  <id>33321</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Microtubule Inhibition</name>
  <code>T33328</code>  <id>33328</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Microtubule Inhibitor</name>
  <code>T33329</code>  <id>33329</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Receptor Agonists</name>
  <code>T33399</code>  <id>33399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Receptor Antagonist</name>
  <code>T58649</code>  <id>58649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Receptor Antagonists</name>
  <code>T33400</code>  <id>33400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Synthesis Inhibitors</name>
  <code>T33401</code>  <id>33401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors</name>
  <code>T58589</code>  <id>58589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors</name>
  <code>T58593</code>  <id>58593</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mitogen-Activated Protein Kinase Kinase Inhibitors</name>
  <code>T58587</code>  <id>58587</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mitosis Alteration</name>
  <code>T33632</code>  <id>33632</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Estrogen Agonist and Antagonist</name>
  <code>T18556</code>  <id>18556</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Antagonist</name>
  <code>T38945</code>  <id>38945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Antagonist</name>
  <code>T37311</code>  <id>37311</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Antagonist</name>
  <code>T38952</code>  <id>38952</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Antagonist</name>
  <code>T38959</code>  <id>38959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Opioid Antagonist</name>
  <code>T37315</code>  <id>37315</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Opioid Antagonist</name>
  <code>T38946</code>  <id>38946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist and Opioid Antagonist</name>
  <code>T38950</code>  <id>38950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist/Antagonist</name>
  <code>T38941</code>  <id>38941</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist/Antagonist</name>
  <code>T37316</code>  <id>37316</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist/Antagonist</name>
  <code>T38951</code>  <id>38951</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonist/Antagonist</name>
  <code>T38957</code>  <id>38957</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Opioid Agonists and Opioid Antagonists</name>
  <code>T38955</code>  <id>38955</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Progesterone Agonist and Antagonist</name>
  <code>T48069</code>  <id>48069</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed Progesterone Agonist and Antagonist</name>
  <code>T41909</code>  <id>41909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed alpha Adrenergic and beta Adrenergic Agonist</name>
  <code>T55712</code>  <id>55712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed alpha Adrenergic and beta Adrenergic Receptor Agonist</name>
  <code>T55715</code>  <id>55715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed alpha-Adrenergic and beta-Adrenergic Agonist</name>
  <code>T55713</code>  <id>55713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mixed alpha-Adrenergic and beta-Adrenergic Receptor Agonist</name>
  <code>T55714</code>  <id>55714</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Inhibitor</name>
  <code>T33733</code>  <id>33733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Inhibitor (MAOI)</name>
  <code>T33732</code>  <id>33732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Inhibitors</name>
  <code>T33735</code>  <id>33735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Type B (MAO-B) Inhibitor</name>
  <code>T33736</code>  <id>33736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Type B Inhibitor</name>
  <code>T33739</code>  <id>33739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase-A Inhibitors</name>
  <code>T33747</code>  <id>33747</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase-B Inhibitors</name>
  <code>T33750</code>  <id>33750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoamine oxidase</name>
  <code>T33751</code>  <id>33751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monobactam Antibacterial</name>
  <code>T33752</code>  <id>33752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monoclonal Antibody</name>
  <code>T58473</code>  <id>58473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monocyte Function Alteration</name>
  <code>T33773</code>  <id>33773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Monosaccharide Transporter Interactions</name>
  <code>T33803</code>  <id>33803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mood Stabilizer</name>
  <code>T33811</code>  <id>33811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucocutaneous Epithelial Cell Growth Factor</name>
  <code>T33919</code>  <id>33919</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucolytic</name>
  <code>T33928</code>  <id>33928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucopolysaccharide</name>
  <code>T22411</code>  <id>22411</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arterial Vasoconstriction</name>
  <code>T33976</code>  <id>33976</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arterial Vasodilation</name>
  <code>T33977</code>  <id>33977</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arteriolar Vasoconstriction</name>
  <code>T33978</code>  <id>33978</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arteriolar Vasodilation</name>
  <code>T33979</code>  <id>33979</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Multidrug Resistance-Associated Protein 2 Inhibitors</name>
  <code>T58618</code>  <id>58618</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Multidrug Resistance-Associated Protein Interactions</name>
  <code>T58617</code>  <id>58617</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors</name>
  <code>T33998</code>  <id>33998</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors</name>
  <code>T58557</code>  <id>58557</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Multivitamin Preparation</name>
  <code>T34131</code>  <id>34131</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscarinic Agonist</name>
  <code>T10808</code>  <id>10808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscarinic Antagonist</name>
  <code>T10813</code>  <id>10813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscarinic Anticholinergic Antagonist</name>
  <code>T10811</code>  <id>10811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscarinic Anticholinesterase Antagonist</name>
  <code>T10812</code>  <id>10812</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscle Relaxant</name>
  <code>T34194</code>  <id>34194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscular Arterial Vasoconstriction</name>
  <code>T34200</code>  <id>34200</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscular Arterial Vasodilation</name>
  <code>T34201</code>  <id>34201</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscular Arteriolar Vasoconstriction</name>
  <code>T34202</code>  <id>34202</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Muscular Arteriolar Vasodilation</name>
  <code>T34203</code>  <id>34203</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Musculoskeletal Activity Alteration</name>
  <code>T34261</code>  <id>34261</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N [Preparations]</name>
  <code>T34610</code>  <id>34610</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-Calcium Channel Receptor Antagonists</name>
  <code>T34653</code>  <id>34653</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-acetyl transferases</name>
  <code>T34721</code>  <id>34721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-methyl-D-aspartate (NMDA) Receptor Antagonist</name>
  <code>T34723</code>  <id>34723</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-methyl-D-aspartate Receptor Antagonist</name>
  <code>T34724</code>  <id>34724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-methyl-D-aspartate Receptor Antagonists</name>
  <code>T35019</code>  <id>35019</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-methyl-D-aspartate Receptor Glycine Antagonists</name>
  <code>T35021</code>  <id>35021</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>N-type Calcium Channel Antagonist</name>
  <code>T34727</code>  <id>34727</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NAI</name>
  <code>T35558</code>  <id>35558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NDRI</name>
  <code>T58817</code>  <id>58817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NHE Interactions </name>
  <code>T58820</code>  <id>58820</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NHE3 Inhibitor</name>
  <code>T58830</code>  <id>58830</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NHE3 Inhibitors</name>
  <code>T58825</code>  <id>58825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NK 1 Receptor Antagonists</name>
  <code>T35739</code>  <id>35739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NK 1 Receptor Interactions</name>
  <code>T35742</code>  <id>35742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NK3 Receptor Antagonist</name>
  <code>T58907</code>  <id>58907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NK3 Receptor Antagonists</name>
  <code>T58909</code>  <id>58909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NMDA Receptor Antagonist</name>
  <code>T34722</code>  <id>34722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NMDA Receptor Antagonists</name>
  <code>T35020</code>  <id>35020</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NMDA Receptor Glycine Antagonists</name>
  <code>T35022</code>  <id>35022</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NSAID</name>
  <code>T36395</code>  <id>36395</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NTCP Inhibitors</name>
  <code>T58625</code>  <id>58625</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>NTCP Interactions</name>
  <code>T58622</code>  <id>58622</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Na-K ATPase Interactions</name>
  <code>T49175</code>  <id>49175</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Na-K Exchanging ATPase Interactions</name>
  <code>T49176</code>  <id>49176</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nail Excretion</name>
  <code>T35070</code>  <id>35070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Narcotic Antitussive</name>
  <code>T35152</code>  <id>35152</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Natriuretic Peptide</name>
  <code>T35169</code>  <id>35169</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Negative Chronotropy</name>
  <code>T35238</code>  <id>35238</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Negative Inotropy</name>
  <code>T35239</code>  <id>35239</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neonatal Fc Receptor Blocker</name>
  <code>T58720</code>  <id>58720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neonatal Fc Receptor Blockers</name>
  <code>T58724</code>  <id>58724</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neonatal FcRn Blockers</name>
  <code>T58725</code>  <id>58725</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neprilysin Inhibitor</name>
  <code>T35449</code>  <id>35449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neprilysin Inhibitors</name>
  <code>T35450</code>  <id>35450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nerve Growth Factor Activity Alteration</name>
  <code>T35473</code>  <id>35473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nervous System Activity Alteration</name>
  <code>T35488</code>  <id>35488</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nervous System Agent</name>
  <code>T58531</code>  <id>58531</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuraminidase Inhibitor</name>
  <code>T35559</code>  <id>35559</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuraminidase Inhibitor (NAI)</name>
  <code>T35557</code>  <id>35557</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuraminidase Inhibitors</name>
  <code>T35560</code>  <id>35560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuroactive Steroid GABA A Receptor Positive Modulator</name>
  <code>T58741</code>  <id>58741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator</name>
  <code>T58740</code>  <id>58740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 1 Antagonists</name>
  <code>T35740</code>  <id>35740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 1 Receptor Interactions</name>
  <code>T35743</code>  <id>35743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 3 Receptor Antagonist</name>
  <code>T58906</code>  <id>58906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 3 Receptor Antagonists</name>
  <code>T58908</code>  <id>58908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 3 Receptor Interactions</name>
  <code>T58910</code>  <id>58910</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Activity Alteration</name>
  <code>T35772</code>  <id>35772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Blockade</name>
  <code>T35773</code>  <id>35773</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Blocker</name>
  <code>T58612</code>  <id>58612</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Depolarizing Blockade</name>
  <code>T35774</code>  <id>35774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Nondepolarizing Blockade</name>
  <code>T35782</code>  <id>35782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurotensin Activity Alteration</name>
  <code>T35829</code>  <id>35829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration</name>
  <code>T35844</code>  <id>35844</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurotransmitter Transporter Interactions</name>
  <code>T35848</code>  <id>35848</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Neurotrophic Factor Receptor (RET) Inhibitors</name>
  <code>T35849</code>  <id>35849</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy</name>
  <code>T58894</code>  <id>58894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nicotine Agonist</name>
  <code>T10820</code>  <id>10820</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nicotinic Acid</name>
  <code>T35968</code>  <id>35968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nicotinic Acid-containing Agent</name>
  <code>T35967</code>  <id>35967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nicotinic Agonist</name>
  <code>T10821</code>  <id>10821</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nicotinic Cholinergic Agonist</name>
  <code>T10819</code>  <id>10819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitrate Vasodilator</name>
  <code>T36087</code>  <id>36087</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitrate-class Vasodilator</name>
  <code>T36086</code>  <id>36086</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Activity Alteration</name>
  <code>T36096</code>  <id>36096</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Donors</name>
  <code>T36097</code>  <id>36097</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Releasing Agent</name>
  <code>T58945</code>  <id>58945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Synthase Inhibitors</name>
  <code>T36098</code>  <id>36098</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitrofuran Antibacterial</name>
  <code>T36163</code>  <id>36163</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitrogen Binding Agent</name>
  <code>T36170</code>  <id>36170</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitroimidazole</name>
  <code>T36197</code>  <id>36197</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitroimidazole Antimicrobial</name>
  <code>T36195</code>  <id>36195</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nitroimidazole-class Agent</name>
  <code>T36196</code>  <id>36196</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nodal Depolarization</name>
  <code>T36277</code>  <id>36277</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nodal Repolarization</name>
  <code>T36279</code>  <id>36279</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Nucleoside Analog</name>
  <code>T36315</code>  <id>36315</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Nucleoside Analogue</name>
  <code>T36312</code>  <id>36312</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Nucleoside Reverse Transcriptase Inhibitors</name>
  <code>T36316</code>  <id>36316</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Animal Dander Allergenic Extract</name>
  <code>T36320</code>  <id>36320</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Animal Hair Allergenic Extract</name>
  <code>T36321</code>  <id>36321</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Animal Skin Allergenic Extract</name>
  <code>T36322</code>  <id>36322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Bacterial Allergenic Extract</name>
  <code>T36323</code>  <id>36323</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Chemical Allergen</name>
  <code>T36324</code>  <id>36324</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Feather Allergenic Extract</name>
  <code>T36325</code>  <id>36325</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Food Allergenic Extract</name>
  <code>T36326</code>  <id>36326</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Fungal Allergenic Extract</name>
  <code>T36327</code>  <id>36327</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized House Dust Allergenic Extract</name>
  <code>T36328</code>  <id>36328</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Insect Allergenic Extract</name>
  <code>T36329</code>  <id>36329</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Insect Venom Allergenic Extract</name>
  <code>T36330</code>  <id>36330</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Plant Allergenic Extract</name>
  <code>T36331</code>  <id>36331</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Plant Fiber Allergenic Extract</name>
  <code>T36332</code>  <id>36332</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Pollen Allergenic Extract</name>
  <code>T36333</code>  <id>36333</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-competitive AMPA Glutamate Receptor Antagonist</name>
  <code>T36346</code>  <id>36346</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-competitive AMPA Receptor Antagonist</name>
  <code>T36347</code>  <id>36347</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-competitive Cholinergic Nicotinic Antagonists</name>
  <code>T36349</code>  <id>36349</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-competitive Opioid Antagonists</name>
  <code>T36353</code>  <id>36353</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-narcotic Antitussive</name>
  <code>T36339</code>  <id>36339</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-steroidal Anti-inflammatory Agent</name>
  <code>T36392</code>  <id>36392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-steroidal Anti-inflammatory Drug</name>
  <code>T36390</code>  <id>36390</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-steroidal Antiinflammatory Agent</name>
  <code>T36391</code>  <id>36391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Non-steroidal Antiinflammatory Drug</name>
  <code>T36393</code>  <id>36393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive AMPA Glutamate Receptor Antagonist</name>
  <code>T36348</code>  <id>36348</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive AMPA Receptor Antagonist</name>
  <code>T36345</code>  <id>36345</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive Cholinergic Nicotinic Antagonists</name>
  <code>T36350</code>  <id>36350</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive N-methyl-D-aspartate Receptor Antagonists</name>
  <code>T36351</code>  <id>36351</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive NMDA Receptor Antagonists</name>
  <code>T36352</code>  <id>36352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive Opioid Antagonists</name>
  <code>T36354</code>  <id>36354</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nondepolarizing Neuromuscular Blocker</name>
  <code>T36355</code>  <id>36355</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonergot Dopamine Agonist</name>
  <code>T36360</code>  <id>36360</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonnarcotic Antitussive</name>
  <code>T36338</code>  <id>36338</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonnucleoside Analog</name>
  <code>T36314</code>  <id>36314</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonnucleoside Analogue</name>
  <code>T36313</code>  <id>36313</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Anti-inflammatory Agent</name>
  <code>T36394</code>  <id>36394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Anti-inflammatory Drug</name>
  <code>T36396</code>  <id>36396</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Antiinflammatory Agent</name>
  <code>T36389</code>  <id>36389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Antiinflammatory Drug</name>
  <code>T36388</code>  <id>36388</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Mineralocorticoid-Receptor Antagonist</name>
  <code>T58650</code>  <id>58650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Activity Alteration</name>
  <code>T36429</code>  <id>36429</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Releasing Agent</name>
  <code>T36445</code>  <id>36445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Reuptake Inhibitor</name>
  <code>T36449</code>  <id>36449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Reuptake Inhibitor Anorectic</name>
  <code>T36446</code>  <id>36446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Transporter Interactions</name>
  <code>T36450</code>  <id>36450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Uptake Inhibitors</name>
  <code>T36451</code>  <id>36451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic</name>
  <code>T36457</code>  <id>36457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine-Dopamine Reuptake Inhibitor</name>
  <code>T58818</code>  <id>58818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nuclear Export Inhibitor</name>
  <code>T58757</code>  <id>58757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nuclear Export Inhibitors</name>
  <code>T58756</code>  <id>58756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Related Agent</name>
  <code>T58524</code>  <id>58524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Replication Alteration</name>
  <code>T36647</code>  <id>36647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Synthesis Inhibitor</name>
  <code>T58523</code>  <id>58523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Synthesis Inhibitors</name>
  <code>T36648</code>  <id>36648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Transcription Alteration</name>
  <code>T36649</code>  <id>36649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog</name>
  <code>T36667</code>  <id>36667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog</name>
  <code>T36669</code>  <id>36669</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Antifungal</name>
  <code>T36663</code>  <id>36663</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Antiviral</name>
  <code>T36665</code>  <id>36665</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog HSV DNA Polymerase Inhibitor</name>
  <code>T24411</code>  <id>24411</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Herpes Simplex Virus DNA Polymerase Inhibitor</name>
  <code>T24409</code>  <id>24409</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Herpes Zoster Virus DNA Polymerase Inhibitor</name>
  <code>T24457</code>  <id>24457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Herpesvirus DNA Polymerase Inhibitor</name>
  <code>T24475</code>  <id>24475</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog VZV DNA Polymerase Inhibitor</name>
  <code>T24462</code>  <id>24462</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Varicella Zoster Virus DNA Polymerase Inhibitor</name>
  <code>T24455</code>  <id>24455</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue</name>
  <code>T36666</code>  <id>36666</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue</name>
  <code>T36668</code>  <id>36668</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue Antifungal</name>
  <code>T36662</code>  <id>36662</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue Antiviral</name>
  <code>T36664</code>  <id>36664</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue HSV DNA Polymerase Inhibitor</name>
  <code>T24413</code>  <id>24413</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</name>
  <code>T24408</code>  <id>24408</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue Herpes Zoster Virus DNA Polymerase Inhibitor</name>
  <code>T24461</code>  <id>24461</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue Herpesvirus DNA Polymerase Inhibitor</name>
  <code>T24476</code>  <id>24476</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue VZV DNA Polymerase Inhibitor</name>
  <code>T24456</code>  <id>24456</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analogue Varicella Zoster Virus DNA Polymerase Inhibitor</name>
  <code>T24465</code>  <id>24465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Antifungal</name>
  <code>T36661</code>  <id>36661</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Metabolic Inhibitor</name>
  <code>T36675</code>  <id>36675</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Reverse Transcriptase Inhibitors</name>
  <code>T36681</code>  <id>36681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Synthesis Inhibitors</name>
  <code>T36682</code>  <id>36682</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nucleotide Metabolic Inhibitor</name>
  <code>T36703</code>  <id>36703</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Nut Proteins</name>
  <code>T36715</code>  <id>36715</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>O [Preparations]</name>
  <code>T36739</code>  <id>36739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OAT1 Inhibitors</name>
  <code>T37437</code>  <id>37437</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OAT3 Inhibitors</name>
  <code>T37439</code>  <id>37439</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OAT4L Inhibitor</name>
  <code>T53752</code>  <id>53752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OAT4L Inhibitors</name>
  <code>T53768</code>  <id>53768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OATP1B1 Inhibitors</name>
  <code>T37449</code>  <id>37449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OATP1B3 Inhibitors</name>
  <code>T37451</code>  <id>37451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OATP2B1 Inhibitors</name>
  <code>T37453</code>  <id>37453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OCT1 Inhibitors</name>
  <code>T37457</code>  <id>37457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>OCT2 Inhibitors</name>
  <code>T37464</code>  <id>37464</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ocular Smooth Muscle Activity Alteration</name>
  <code>T36974</code>  <id>36974</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oligonucleotide Telomerase Inhibitor</name>
  <code>T58968</code>  <id>58968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oligonucleotide Telomerase Inhibitors</name>
  <code>T58967</code>  <id>58967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Omega-3 Fatty Acid</name>
  <code>T37120</code>  <id>37120</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Omega-3 Fatty Acid-class Agent</name>
  <code>T37119</code>  <id>37119</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oncotic Pressure Alteration</name>
  <code>T37267</code>  <id>37267</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ophthalmic Agents</name>
  <code>T58439</code>  <id>58439</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Agonist</name>
  <code>T37310</code>  <id>37310</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Agonist/Antagonist</name>
  <code>T37317</code>  <id>37317</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Agonists</name>
  <code>T37318</code>  <id>37318</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Analgesic</name>
  <code>T37319</code>  <id>37319</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Antagonist</name>
  <code>T37321</code>  <id>37321</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Antagonists</name>
  <code>T37322</code>  <id>37322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Receptor Agonist</name>
  <code>T37309</code>  <id>37309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Receptor Antagonist</name>
  <code>T37320</code>  <id>37320</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Receptor Binder</name>
  <code>T37308</code>  <id>37308</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid Receptor Interactions</name>
  <code>T37326</code>  <id>37326</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid kappa Receptor Agonists</name>
  <code>T58732</code>  <id>58732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid mu-Receptor Agonist</name>
  <code>T57543</code>  <id>57543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Opioid mu-Receptor Agonists</name>
  <code>T37328</code>  <id>37328</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Optical Imaging Agent</name>
  <code>T58672</code>  <id>58672</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Order</name>
  <code>T37420</code>  <id>37420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Agonists</name>
  <code>T37421</code>  <id>37421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Antagonist</name>
  <code>T37422</code>  <id>37422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Antagonists</name>
  <code>T37423</code>  <id>37423</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Interactions</name>
  <code>T37424</code>  <id>37424</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organ System Specific Effects</name>
  <code>T37429</code>  <id>37429</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter 1 Inhibitors</name>
  <code>T37438</code>  <id>37438</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter 3 Inhibitors</name>
  <code>T37440</code>  <id>37440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter 4-like Inhibitor</name>
  <code>T53751</code>  <id>53751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter 4-like Inhibitors</name>
  <code>T53767</code>  <id>53767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter Interactions</name>
  <code>T37441</code>  <id>37441</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporting Polypeptide 1B1 Inhibitors</name>
  <code>T37450</code>  <id>37450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporting Polypeptide 1B3 Inhibitors</name>
  <code>T37452</code>  <id>37452</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporting Polypeptide 2B1 Inhibitors</name>
  <code>T37454</code>  <id>37454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Cation Transporter 1 Inhibitors</name>
  <code>T37458</code>  <id>37458</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Cation Transporter 2 Inhibitors</name>
  <code>T37465</code>  <id>37465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Cation Transporter Interactions</name>
  <code>T37466</code>  <id>37466</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Ion Degradation Alteration</name>
  <code>T37468</code>  <id>37468</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Ion Metabolism Alteration</name>
  <code>T37469</code>  <id>37469</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organic Ion Synthesis Alteration</name>
  <code>T37470</code>  <id>37470</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Organized Electrical Activity Alteration</name>
  <code>T37472</code>  <id>37472</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arterial Vasoconstriction</name>
  <code>T37537</code>  <id>37537</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arterial Vasodilation</name>
  <code>T37538</code>  <id>37538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arteriolar Vasoconstriction</name>
  <code>T37539</code>  <id>37539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arteriolar Vasodilation</name>
  <code>T37540</code>  <id>37540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor</name>
  <code>T58464</code>  <id>58464</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Osmotic Activity</name>
  <code>T37589</code>  <id>37589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Osmotic Diuretic</name>
  <code>T37590</code>  <id>37590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Osmotic Laxative</name>
  <code>T37591</code>  <id>37591</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Otic Agents</name>
  <code>T58440</code>  <id>58440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ovarian Endocrine Activity Alteration</name>
  <code>T37754</code>  <id>37754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ovarian Follicular Phase Alteration</name>
  <code>T37755</code>  <id>37755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ovarian Function Alteration</name>
  <code>T37756</code>  <id>37756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ovarian Luteal Phase Alteration</name>
  <code>T37758</code>  <id>37758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ovulation Alteration</name>
  <code>T37777</code>  <id>37777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ovum Fertilization Alteration</name>
  <code>T37778</code>  <id>37778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxaborole Antifungal</name>
  <code>T37779</code>  <id>37779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxazolidinone Antibacterial</name>
  <code>T37819</code>  <id>37819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxidation Activity</name>
  <code>T37829</code>  <id>37829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxidation-Reduction Activity</name>
  <code>T37832</code>  <id>37832</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxidation-Reduction Agent</name>
  <code>T37833</code>  <id>37833</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxygen Carrying Capacity Alteration</name>
  <code>T37892</code>  <id>37892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Oxytocic</name>
  <code>T37952</code>  <id>37952</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P [Preparations]</name>
  <code>T37961</code>  <id>37961</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P-Glycoprotein Inducers</name>
  <code>T37962</code>  <id>37962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P-Glycoprotein Inhibitors</name>
  <code>T37963</code>  <id>37963</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P-Glycoprotein Interactions</name>
  <code>T37964</code>  <id>37964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P-Selectin Blockers</name>
  <code>T58782</code>  <id>58782</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P2Y12 Platelet Aggregation Inhibitor</name>
  <code>T37984</code>  <id>37984</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P2Y12 Platelet Inhibitor</name>
  <code>T37985</code>  <id>37985</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>P2Y12 Receptor Antagonists</name>
  <code>T37986</code>  <id>37986</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PA Endonuclease Inhibitor</name>
  <code>T58461</code>  <id>58461</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PABA Inhibitor</name>
  <code>T38707</code>  <id>38707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PAR Receptor Interactions</name>
  <code>T42343</code>  <id>42343</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PAR-1 Antagonist</name>
  <code>T42346</code>  <id>42346</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PAR-1 Antagonists</name>
  <code>T42348</code>  <id>42348</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PAR-1 Interactions</name>
  <code>T42350</code>  <id>42350</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PARP Inhibitor</name>
  <code>T40962</code>  <id>40962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PARP Inhibitors</name>
  <code>T40974</code>  <id>40974</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PARP Polymerase Inhibitor</name>
  <code>T40960</code>  <id>40960</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PARP Polymerase Inhibitors</name>
  <code>T40972</code>  <id>40972</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PBP inhibitors</name>
  <code>T52709</code>  <id>52709</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PCSK9 Inhibitor</name>
  <code>T38078</code>  <id>38078</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PCSK9 Inhibitors</name>
  <code>T38080</code>  <id>38080</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PD-1 Blocking Antibody</name>
  <code>T41956</code>  <id>41956</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PD-1-directed Antibody Interactions</name>
  <code>T41958</code>  <id>41958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PD-L1 Antagonists</name>
  <code>T41950</code>  <id>41950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PD-L1 Blocker</name>
  <code>T41952</code>  <id>41952</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PD-L1-directed Antibody Interactions</name>
  <code>T41954</code>  <id>41954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PDE-5 Inhibitor</name>
  <code>T40048</code>  <id>40048</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PDGFR Inhibitors</name>
  <code>T40731</code>  <id>40731</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PDGFR alpha Antagonist</name>
  <code>T40733</code>  <id>40733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PDGFR alpha Inhibitors</name>
  <code>T40737</code>  <id>40737</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PDGFR beta Inhibitors</name>
  <code>T40740</code>  <id>40740</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PDGFR-alpha Antagonist</name>
  <code>T40734</code>  <id>40734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PGE-1 Agonist</name>
  <code>T42207</code>  <id>42207</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PGE1 Agonist</name>
  <code>T42206</code>  <id>42206</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PGE1 Analog</name>
  <code>T42215</code>  <id>42215</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PGE1 Analogue</name>
  <code>T42211</code>  <id>42211</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3K alpha Inhibitors</name>
  <code>T59013</code>  <id>59013</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3K delta Inhibitors</name>
  <code>T58856</code>  <id>58856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3K α Inhibitors</name>
  <code>T59014</code>  <id>59014</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3K-alpha Inhibitors</name>
  <code>T59015</code>  <id>59015</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3K-α Inhibitors</name>
  <code>T59016</code>  <id>59016</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3Ks Inhibitors</name>
  <code>T58852</code>  <id>58852</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3Kα Inhibitors</name>
  <code>T59017</code>  <id>59017</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PI3Kδ Inhibitors</name>
  <code>T58857</code>  <id>58857</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PIF Activity Alteration</name>
  <code>T38233</code>  <id>38233</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PIF Alteration</name>
  <code>T41988</code>  <id>41988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PIF Secretion Alteration</name>
  <code>T38234</code>  <id>38234</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PIK3CA Inhibitors</name>
  <code>T59018</code>  <id>59018</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR Activity</name>
  <code>T39575</code>  <id>39575</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR Agonist</name>
  <code>T58966</code>  <id>58966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR Agonists</name>
  <code>T58965</code>  <id>58965</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR alpha Agonists</name>
  <code>T39579</code>  <id>39579</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR beta Agonists</name>
  <code>T39581</code>  <id>39581</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR delta Agonist</name>
  <code>T58947</code>  <id>58947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR delta Agonists</name>
  <code>T39585</code>  <id>39585</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR gamma Agonists</name>
  <code>T39587</code>  <id>39587</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-alpha Agonist</name>
  <code>T39563</code>  <id>39563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-alpha Agonists</name>
  <code>T39577</code>  <id>39577</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-beta Agonists</name>
  <code>T39582</code>  <id>39582</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-delta Agonist</name>
  <code>T58948</code>  <id>58948</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-delta Agonists</name>
  <code>T39584</code>  <id>39584</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-gamma Agonist</name>
  <code>T39567</code>  <id>39567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PPAR-gamma Agonists</name>
  <code>T39588</code>  <id>39588</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PRF Activity Alteration</name>
  <code>T38421</code>  <id>38421</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PRF Alteration</name>
  <code>T41995</code>  <id>41995</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PRF Secretion Alteration</name>
  <code>T38422</code>  <id>38422</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PTK2 Inhibitors</name>
  <code>T59083</code>  <id>59083</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>PYK2 Inhibitors</name>
  <code>T59087</code>  <id>59087</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Enzymatic Replacement</name>
  <code>T38618</code>  <id>38618</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Enzymatic Secretion Alteration</name>
  <code>T38619</code>  <id>38619</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Fluid/Electrolyte Secretion Alteration</name>
  <code>T38625</code>  <id>38625</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Islet Activity Alteration</name>
  <code>T38627</code>  <id>38627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Secretion Alteration</name>
  <code>T38635</code>  <id>38635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Para-Aminobenzoic Acid Inhibitors</name>
  <code>T38708</code>  <id>38708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Paramagnetic Contrast Agent</name>
  <code>T38752</code>  <id>38752</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parasympathetic Activity Alteration</name>
  <code>T38828</code>  <id>38828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parasympatholytic Activity</name>
  <code>T14630</code>  <id>14630</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parasympathomimetic Activity</name>
  <code>T26816</code>  <id>26816</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathormone Receptor Agonists</name>
  <code>T38834</code>  <id>38834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathormone Receptor Antagonists</name>
  <code>T38835</code>  <id>38835</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathormone Receptor Interactions</name>
  <code>T38836</code>  <id>38836</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Gland Activity Alteration</name>
  <code>T38839</code>  <id>38839</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone</name>
  <code>T38848</code>  <id>38848</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone Analog</name>
  <code>T38841</code>  <id>38841</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone Analogue</name>
  <code>T38840</code>  <id>38840</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone-Related Peptide Analog</name>
  <code>T38850</code>  <id>38850</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone-Related Peptide Analogue</name>
  <code>T38849</code>  <id>38849</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parathyroid-class Hormone</name>
  <code>T38847</code>  <id>38847</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parenteral Iron Replacement</name>
  <code>T38869</code>  <id>38869</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Parenteral Iron Replacement Agent</name>
  <code>T38868</code>  <id>38868</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Cholinergic Nicotinic Agonist</name>
  <code>T38939</code>  <id>38939</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Cholinergic Nicotinic Agonists</name>
  <code>T38940</code>  <id>38940</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Nicotine Agonist</name>
  <code>T38937</code>  <id>38937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Nicotinic Agonist</name>
  <code>T38938</code>  <id>38938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Nicotinic Cholinergic Agonist</name>
  <code>T38936</code>  <id>38936</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist</name>
  <code>T38947</code>  <id>38947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Antagonist</name>
  <code>T38943</code>  <id>38943</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Antagonist</name>
  <code>T37314</code>  <id>37314</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Antagonist</name>
  <code>T38948</code>  <id>38948</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Antagonist</name>
  <code>T38954</code>  <id>38954</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Opioid Antagonist</name>
  <code>T38942</code>  <id>38942</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Opioid Antagonist</name>
  <code>T37313</code>  <id>37313</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist and Opioid Antagonist</name>
  <code>T38949</code>  <id>38949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist/Antagonist</name>
  <code>T38944</code>  <id>38944</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist/Antagonist</name>
  <code>T37312</code>  <id>37312</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist/Antagonist</name>
  <code>T38953</code>  <id>38953</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonists</name>
  <code>T38960</code>  <id>38960</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonists and Opioid Antagonists</name>
  <code>T38958</code>  <id>38958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonists/Antagonists</name>
  <code>T38956</code>  <id>38956</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Passively Acquired Immunity</name>
  <code>T38971</code>  <id>38971</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pediculicide</name>
  <code>T39028</code>  <id>39028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pediculocide</name>
  <code>T39027</code>  <id>39027</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penem Antibacterial</name>
  <code>T39090</code>  <id>39090</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penicillin Class Antibacterial</name>
  <code>T39133</code>  <id>39133</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penicillin-class Antibacterial</name>
  <code>T39134</code>  <id>39134</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penile Alteration</name>
  <code>T39138</code>  <id>39138</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penile Development Alteration</name>
  <code>T39139</code>  <id>39139</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penile Erectile Alteration</name>
  <code>T39142</code>  <id>39142</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Penile Venous Vasodilation</name>
  <code>T39153</code>  <id>39153</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peptide Metabolism Alteration</name>
  <code>T39289</code>  <id>39289</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peripheral Carotid Chemoreceptor Alteration</name>
  <code>T39482</code>  <id>39482</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peripheral Nervous System Activity Alteration</name>
  <code>T39485</code>  <id>39485</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor alpha (PPAR-alpha) Agonist</name>
  <code>T39564</code>  <id>39564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor alpha Agonist</name>
  <code>T39565</code>  <id>39565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor delta Agonist</name>
  <code>T58946</code>  <id>58946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor gamma (PPAR-gamma) Agonist</name>
  <code>T39566</code>  <id>39566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor gamma Agonist</name>
  <code>T39568</code>  <id>39568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor Activity</name>
  <code>T39576</code>  <id>39576</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor Agonist</name>
  <code>T58964</code>  <id>58964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor Agonists</name>
  <code>T58963</code>  <id>58963</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor alpha Agonists</name>
  <code>T39580</code>  <id>39580</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor beta Agonists</name>
  <code>T39583</code>  <id>39583</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor delta Agonists</name>
  <code>T39586</code>  <id>39586</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor gamma Agonists</name>
  <code>T39589</code>  <id>39589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Peroxisome-Proliferator Receptor alpha (PPAR-alpha) Agonists</name>
  <code>T39578</code>  <id>39578</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phagocytosis Alteration</name>
  <code>T39652</code>  <id>39652</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pharmaceutical and Biological Preparations</name>
  <code>T39658</code>  <id>39658</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pharmacologic Cardiac Stress Test Agent</name>
  <code>T58626</code>  <id>58626</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pharmacological Chaperone</name>
  <code>T58450</code>  <id>58450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phenothiazine</name>
  <code>T39750</code>  <id>39750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phenothiazine Derivative</name>
  <code>T39748</code>  <id>39748</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phenothiazine-class Agent</name>
  <code>T39749</code>  <id>39749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phenylalanine Hydroxylase Activator</name>
  <code>T39777</code>  <id>39777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phenylalanine Hydroxylase Activators</name>
  <code>T39778</code>  <id>39778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phenylalanine Metabolizing Enzyme</name>
  <code>T58471</code>  <id>58471</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphate Binder</name>
  <code>T39925</code>  <id>39925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphate Binding Activity</name>
  <code>T39926</code>  <id>39926</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphate Chelating Activity</name>
  <code>T39928</code>  <id>39928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphate Chelator</name>
  <code>T39927</code>  <id>39927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphatidylinositol 3-Kinase alpha Inhibitors</name>
  <code>T59012</code>  <id>59012</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphatidylinositol 3-Kinase delta Inhibitors</name>
  <code>T58854</code>  <id>58854</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphatidylinositol 3-Kinases Inhibitors</name>
  <code>T58850</code>  <id>58850</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 3 Inhibitor</name>
  <code>T40037</code>  <id>40037</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 3 Inhibitors</name>
  <code>T40040</code>  <id>40040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 4 Inhibitor</name>
  <code>T40042</code>  <id>40042</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 4 Inhibitors</name>
  <code>T40045</code>  <id>40045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 5 Inhibitor</name>
  <code>T40050</code>  <id>40050</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 5 Inhibitors</name>
  <code>T40053</code>  <id>40053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase III Inhibitor</name>
  <code>T40036</code>  <id>40036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase III Inhibitor</name>
  <code>T40039</code>  <id>40039</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase III Inhibitors</name>
  <code>T40038</code>  <id>40038</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase IV Inhibitor</name>
  <code>T40041</code>  <id>40041</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase IV Inhibitor</name>
  <code>T40044</code>  <id>40044</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase IV Inhibitors</name>
  <code>T40043</code>  <id>40043</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase Inhibitors</name>
  <code>T40061</code>  <id>40061</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase V Inhibitor</name>
  <code>T40046</code>  <id>40046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase V Inhibitor</name>
  <code>T40051</code>  <id>40051</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase V Inhibitors</name>
  <code>T40052</code>  <id>40052</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase-5 (PDE-5) Inhibitor</name>
  <code>T40047</code>  <id>40047</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase-5 Inhibitor</name>
  <code>T40049</code>  <id>40049</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide 3-Kinase alpha Inhibitors</name>
  <code>T59011</code>  <id>59011</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide 3-Kinase delta Inhibitors</name>
  <code>T58853</code>  <id>58853</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide 3-Kinases Inhibitors</name>
  <code>T58849</code>  <id>58849</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide-3-Kinase delta Inhibitors</name>
  <code>T58855</code>  <id>58855</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide-3-Kinases Inhibitors</name>
  <code>T58851</code>  <id>58851</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Photoabsorbtion</name>
  <code>T40285</code>  <id>40285</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Photoabsorption</name>
  <code>T40286</code>  <id>40286</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Photoactivated Radical Generator</name>
  <code>T40287</code>  <id>40287</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Photoenhancer</name>
  <code>T40288</code>  <id>40288</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Photosensitizing Activity</name>
  <code>T40299</code>  <id>40299</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Physical or Chemical Agent</name>
  <code>T58534</code>  <id>58534</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Physiochemical Activity</name>
  <code>T40323</code>  <id>40323</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Physiological Effects</name>
  <code>T40325</code>  <id>40325</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pineal Gland Activity Alteration</name>
  <code>T40432</code>  <id>40432</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pinocytosis Alteration</name>
  <code>T40440</code>  <id>40440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pituitary Gland Activity Alteration</name>
  <code>T40511</code>  <id>40511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pituitary Hormone Receptor Agonists</name>
  <code>T40512</code>  <id>40512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pituitary Hormone Receptor Antagonists</name>
  <code>T40513</code>  <id>40513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pituitary Hormones Receptor Interactions</name>
  <code>T40519</code>  <id>40519</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Placental Endocrine Activity Alteration</name>
  <code>T40547</code>  <id>40547</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plasma Kallikrein Inhibitor</name>
  <code>T40623</code>  <id>40623</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plasma Metabolism</name>
  <code>T40638</code>  <id>40638</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plasma Volume Expander</name>
  <code>T40639</code>  <id>40639</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plasmin Inhibitors</name>
  <code>T40647</code>  <id>40647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plasminogen Activators</name>
  <code>T40659</code>  <id>40659</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet Activating Factor Inhibitors</name>
  <code>T40674</code>  <id>40674</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet Aggregation Alteration</name>
  <code>T40685</code>  <id>40685</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet Aggregation Inhibitor</name>
  <code>T40686</code>  <id>40686</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet Glycoprotein 2b/3A Inhibitors</name>
  <code>T40705</code>  <id>40705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet Glycoprotein IIb/IIIA Inhibitors</name>
  <code>T40706</code>  <id>40706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet Reducing Agent</name>
  <code>T40743</code>  <id>40743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor Receptor Inhibitors</name>
  <code>T40732</code>  <id>40732</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor Receptor alpha (PDGFR-alpha) Antagonist</name>
  <code>T40735</code>  <id>40735</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor Receptor alpha Antagonist</name>
  <code>T40736</code>  <id>40736</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor alpha Receptor Inhibitors</name>
  <code>T40738</code>  <id>40738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor alpha Receptor Interactions</name>
  <code>T40739</code>  <id>40739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor beta Receptor Inhibitors</name>
  <code>T40741</code>  <id>40741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor beta Receptor Interactions</name>
  <code>T40742</code>  <id>40742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platelet-reducing Agent</name>
  <code>T40744</code>  <id>40744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platinum-based Drug</name>
  <code>T40750</code>  <id>40750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platinum-containing Agent</name>
  <code>T40749</code>  <id>40749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Platinum-containing Compounds</name>
  <code>T40751</code>  <id>40751</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pleuromutilin Antibacterial</name>
  <code>T40767</code>  <id>40767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plutonium Chelating Activity</name>
  <code>T40781</code>  <id>40781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Plutonium Chelator</name>
  <code>T40780</code>  <id>40780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pneumococcal 21-valent Conjugate Vaccine</name>
  <code>T59074</code>  <id>59074</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly (ADP Ribose) Polymerase Inhibitor</name>
  <code>T40958</code>  <id>40958</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly (ADP Ribose) Polymerase Inhibitors</name>
  <code>T40969</code>  <id>40969</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly (ADP-Ribose) Polymerase Inhibitor</name>
  <code>T40959</code>  <id>40959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly (ADP-Ribose) Polymerase Inhibitors</name>
  <code>T40968</code>  <id>40968</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly ADP Ribose Polymerase Inhibitor</name>
  <code>T40963</code>  <id>40963</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly ADP Ribose Polymerase Inhibitors</name>
  <code>T40971</code>  <id>40971</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly ADP-Ribose Polymerase Inhibitor</name>
  <code>T40961</code>  <id>40961</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly ADP-Ribose Polymerase Inhibitors</name>
  <code>T40973</code>  <id>40973</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitor</name>
  <code>T40964</code>  <id>40964</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitors</name>
  <code>T40967</code>  <id>40967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly(ADP-Ribose) Polymerase Inhibitor</name>
  <code>T40966</code>  <id>40966</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poly(ADP-Ribose) Polymerase Inhibitors</name>
  <code>T40975</code>  <id>40975</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitor</name>
  <code>T40965</code>  <id>40965</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitors</name>
  <code>T40970</code>  <id>40970</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polyene Antifungal</name>
  <code>T41066</code>  <id>41066</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polyene Antimicrobial</name>
  <code>T41067</code>  <id>41067</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polymerase Acidic Endonuclease Inhibitor</name>
  <code>T58460</code>  <id>58460</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polymerase Acidic Endonuclease Inhibitors</name>
  <code>T58459</code>  <id>58459</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polymyxin Class Antibacterial</name>
  <code>T41147</code>  <id>41147</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polymyxin-class Antibacterial</name>
  <code>T41148</code>  <id>41148</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Polysaccharide Metabolism Alteration</name>
  <code>T41201</code>  <id>41201</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Porphyrin Precursor</name>
  <code>T41301</code>  <id>41301</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Positive Chronotropy</name>
  <code>T41306</code>  <id>41306</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Positive Inotropy</name>
  <code>T41307</code>  <id>41307</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Positron Emitting Activity</name>
  <code>T41324</code>  <id>41324</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Post Translation Protein Modification Alteration</name>
  <code>T41325</code>  <id>41325</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Post-transcriptional RNA Interaction</name>
  <code>T59040</code>  <id>59040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Binder</name>
  <code>T41378</code>  <id>41378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Binding Activity</name>
  <code>T41444</code>  <id>41444</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Activator</name>
  <code>T41384</code>  <id>41384</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Activators</name>
  <code>T41386</code>  <id>41386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Agonists</name>
  <code>T41379</code>  <id>41379</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Antagonists</name>
  <code>T41381</code>  <id>41381</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Blocker</name>
  <code>T41382</code>  <id>41382</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Blockers</name>
  <code>T41380</code>  <id>41380</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Interactions</name>
  <code>T41383</code>  <id>41383</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Opener</name>
  <code>T41385</code>  <id>41385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Openers</name>
  <code>T41387</code>  <id>41387</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Exchange Resin</name>
  <code>T41440</code>  <id>41440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Ion Binding Activity</name>
  <code>T41445</code>  <id>41445</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Ion Exchange Activity</name>
  <code>T41446</code>  <id>41446</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium Salt</name>
  <code>T41454</code>  <id>41454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium-competitive Acid Blocker</name>
  <code>T59034</code>  <id>59034</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Potassium-sparing Diuretic</name>
  <code>T41463</code>  <id>41463</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Poultry Proteins</name>
  <code>T41468</code>  <id>41468</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Preparations by FDA Established Pharmacologic Class</name>
  <code>T16676</code>  <id>16676</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Preparations by Generic Ingredient</name>
  <code>T16677</code>  <id>16677</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pro-coagulation</name>
  <code>T26546</code>  <id>26546</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pro-coagulation Activity</name>
  <code>T26549</code>  <id>26549</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Procoagulation</name>
  <code>T26548</code>  <id>26548</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Procoagulation Activity</name>
  <code>T26547</code>  <id>26547</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestational Hormone Receptor Agonists</name>
  <code>T41906</code>  <id>41906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestational Hormone Receptor Antagonists</name>
  <code>T41907</code>  <id>41907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progesterone</name>
  <code>T41921</code>  <id>41921</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progesterone Agonist/Antagonist</name>
  <code>T48070</code>  <id>48070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progesterone Agonist/Antagonist</name>
  <code>T41910</code>  <id>41910</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progesterone-containing Agent</name>
  <code>T41920</code>  <id>41920</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestin</name>
  <code>T41927</code>  <id>41927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestin Antagonist</name>
  <code>T41925</code>  <id>41925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestin Synthesis Inhibitors</name>
  <code>T41926</code>  <id>41926</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestin-containing IUS</name>
  <code>T41928</code>  <id>41928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestin-containing Intrauterine System</name>
  <code>T41930</code>  <id>41930</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Progestin-containing Intrauterine System (IUS)</name>
  <code>T41929</code>  <id>41929</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Ligand-1 Antagonists</name>
  <code>T41951</code>  <id>41951</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Ligand-1 Blocker</name>
  <code>T41953</code>  <id>41953</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Ligand-1-directed Antibody Interactions</name>
  <code>T41955</code>  <id>41955</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Receptor-1 Blocking Antibody</name>
  <code>T41957</code>  <id>41957</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Receptor-1-directed Antibody Interactions</name>
  <code>T41959</code>  <id>41959</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prolactin Inhibiting Factor Alteration</name>
  <code>T41990</code>  <id>41990</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prolactin Inhibiting hormone Alteration</name>
  <code>T41989</code>  <id>41989</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prolactin Releasing Factor Alteration</name>
  <code>T41996</code>  <id>41996</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proline-rich Tyrosine Kinase 2 Inhibitors</name>
  <code>T59084</code>  <id>59084</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proline-rich Tyrosine Kinase-2 Inhibitors</name>
  <code>T59085</code>  <id>59085</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proprotein Convertase Inhibitors</name>
  <code>T42160</code>  <id>42160</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor</name>
  <code>T38077</code>  <id>38077</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors</name>
  <code>T38079</code>  <id>38079</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostacyclin Receptor Agonist</name>
  <code>T42193</code>  <id>42193</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostacyclin Receptor Agonists</name>
  <code>T42194</code>  <id>42194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostacycline</name>
  <code>T42198</code>  <id>42198</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostacycline Vasodilator</name>
  <code>T42196</code>  <id>42196</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostacycline-class Agent</name>
  <code>T42197</code>  <id>42197</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostacycline-class Vasodilator</name>
  <code>T42195</code>  <id>42195</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Analog</name>
  <code>T42200</code>  <id>42200</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Analogue</name>
  <code>T42199</code>  <id>42199</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E1 (PGE1) Analog</name>
  <code>T42213</code>  <id>42213</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E1 (PGE1) Analogue</name>
  <code>T42210</code>  <id>42210</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E1 Agonist</name>
  <code>T42208</code>  <id>42208</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E1 Analog</name>
  <code>T42217</code>  <id>42217</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E2 Receptor Agonist</name>
  <code>T58799</code>  <id>58799</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E2 Receptor Agonists</name>
  <code>T58796</code>  <id>58796</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin EP2 Receptor Agonist</name>
  <code>T58801</code>  <id>58801</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin EP2 Receptor Agonists</name>
  <code>T58798</code>  <id>58798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Receptor Agonists</name>
  <code>T42227</code>  <id>42227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Receptor Antagonists</name>
  <code>T42228</code>  <id>42228</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Receptor Interactions</name>
  <code>T42229</code>  <id>42229</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin-1 (PGE1) Analog</name>
  <code>T42212</code>  <id>42212</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin-1 (PGE1) Analogue</name>
  <code>T42216</code>  <id>42216</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin-1 Analog</name>
  <code>T42214</code>  <id>42214</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin-1 Analogue</name>
  <code>T42209</code>  <id>42209</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostatic Alteration</name>
  <code>T42299</code>  <id>42299</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostatic Secretion Alteration</name>
  <code>T42320</code>  <id>42320</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Prostatic Size Alteration</name>
  <code>T42322</code>  <id>42322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease Activator</name>
  <code>T59093</code>  <id>59093</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease Activators</name>
  <code>T59092</code>  <id>59092</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease Inhibitor</name>
  <code>T42335</code>  <id>42335</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease Inhibitors</name>
  <code>T42336</code>  <id>42336</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor Interactions</name>
  <code>T42344</code>  <id>42344</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 (PAR-1) Antagonist</name>
  <code>T42345</code>  <id>42345</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 Antagonist</name>
  <code>T42347</code>  <id>42347</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 Antagonists</name>
  <code>T42349</code>  <id>42349</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 Interactions</name>
  <code>T42351</code>  <id>42351</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proteasome Inhibitor</name>
  <code>T42360</code>  <id>42360</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proteasome Inhibitor</name>
  <code>T42362</code>  <id>42362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proteasome Inhibitors</name>
  <code>T42363</code>  <id>42363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protein Degradation Alteration</name>
  <code>T42402</code>  <id>42402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protein Kinase Inhibitors</name>
  <code>T42442</code>  <id>42442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Protein Synthesis Inhibitors</name>
  <code>T42481</code>  <id>42481</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proteolytic Enzyme</name>
  <code>T42588</code>  <id>42588</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proteosome Inhibitors</name>
  <code>T42361</code>  <id>42361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors</name>
  <code>T58920</code>  <id>58920</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proton Pump Inhibitor</name>
  <code>T42870</code>  <id>42870</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proton Pump Inhibitors</name>
  <code>T42871</code>  <id>42871</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Proton Pump Interactions</name>
  <code>T42872</code>  <id>42872</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Provitamin D2 Compound</name>
  <code>T42925</code>  <id>42925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Psoralen</name>
  <code>T42994</code>  <id>42994</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Psoralen-class Agent</name>
  <code>T42993</code>  <id>42993</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arterial Vasoconstriction</name>
  <code>T43056</code>  <id>43056</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arterial Vasodilation</name>
  <code>T43057</code>  <id>43057</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arteriolar Vasoconstriction</name>
  <code>T43058</code>  <id>43058</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arteriolar Vasodilation</name>
  <code>T43059</code>  <id>43059</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Excretion</name>
  <code>T43100</code>  <id>43100</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Metabolism</name>
  <code>T43114</code>  <id>43114</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Venous Vasoconstriction</name>
  <code>T43183</code>  <id>43183</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Venous Vasodilation</name>
  <code>T43184</code>  <id>43184</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pupillary Constriction</name>
  <code>T43190</code>  <id>43190</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pupillary Dilation</name>
  <code>T43191</code>  <id>43191</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Purine Antimetabolite</name>
  <code>T43198</code>  <id>43198</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyk2 Inhibitors</name>
  <code>T59086</code>  <id>59086</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrethroid</name>
  <code>T43305</code>  <id>43305</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrethroid-class Agent</name>
  <code>T43304</code>  <id>43304</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyridone</name>
  <code>T43313</code>  <id>43313</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Analog</name>
  <code>T43353</code>  <id>43353</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Analogue</name>
  <code>T43352</code>  <id>43352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Phosphorylase Inhibitors</name>
  <code>T43358</code>  <id>43358</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Synthesis Inhibitor</name>
  <code>T43361</code>  <id>43361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analog</name>
  <code>T43403</code>  <id>43403</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analog DNA Polymerase Inhibitor</name>
  <code>T43401</code>  <id>43401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analog HSV DNA Polymerase Inhibitor</name>
  <code>T24435</code>  <id>24435</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analog Herpes Simplex Virus DNA Polymerase Inhibitor</name>
  <code>T24431</code>  <id>24431</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analogue</name>
  <code>T43402</code>  <id>43402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analogue DNA Polymerase Inhibitor</name>
  <code>T43400</code>  <id>43400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analogue HSV DNA Polymerase Inhibitor</name>
  <code>T24430</code>  <id>24430</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</name>
  <code>T24434</code>  <id>24434</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyruvate Kinase Activator</name>
  <code>T58708</code>  <id>58708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Pyruvate Kinase Activators</name>
  <code>T58709</code>  <id>58709</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Q [Preparations]</name>
  <code>T43482</code>  <id>43482</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Quinolone Antibacterial</name>
  <code>T43564</code>  <id>43564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Quinolone Antimicrobial</name>
  <code>T43565</code>  <id>43565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>R [Preparations]</name>
  <code>T43583</code>  <id>43583</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RANK Ligand (RANKL) Inhibitor</name>
  <code>T43603</code>  <id>43603</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RANK Ligand Blocking Activity</name>
  <code>T43602</code>  <id>43602</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RANK Ligand Inhibitor</name>
  <code>T43606</code>  <id>43606</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RANKL Blocking Activity</name>
  <code>T43601</code>  <id>43601</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RANKL Inhibitor</name>
  <code>T43604</code>  <id>43604</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RET Inhibitors</name>
  <code>T58598</code>  <id>58598</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA Integrity Alteration</name>
  <code>T43708</code>  <id>43708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA Polymerase Inhibitor</name>
  <code>T58599</code>  <id>58599</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA Replicase Inhibitors</name>
  <code>T43734</code>  <id>43734</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA Replication Alteration</name>
  <code>T43739</code>  <id>43739</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA Synthetase Inhibitor Antibacterial</name>
  <code>T43743</code>  <id>43743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA Synthetase Inhibitors</name>
  <code>T43744</code>  <id>43744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RNA-dependent RNA Polymerase Inhibitors</name>
  <code>T43733</code>  <id>43733</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>ROS1 Inhibitors</name>
  <code>T58921</code>  <id>58921</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RPE Alteration</name>
  <code>T58373</code>  <id>58373</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RST Inhibitor</name>
  <code>T53753</code>  <id>53753</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RST Inhibitors</name>
  <code>T53763</code>  <id>53763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RSV Anti-F Protein Monoclonal (mAb)</name>
  <code>T46622</code>  <id>46622</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>RSV Anti-F Protein Monoclonal Antibody</name>
  <code>T46621</code>  <id>46621</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Agent</name>
  <code>T44072</code>  <id>44072</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Agent for Positron Emission Tomography</name>
  <code>T44073</code>  <id>44073</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Agent for gamma-Scintigraphy</name>
  <code>T44074</code>  <id>44074</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Antibody</name>
  <code>T44075</code>  <id>44075</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioactive Therapeutic Agent</name>
  <code>T44076</code>  <id>44076</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioactive alpha-Particle Emitting Therapeutic Agent</name>
  <code>T44079</code>  <id>44079</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radiocontrast Activity</name>
  <code>T55263</code>  <id>55263</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radiographic Contrast Agent</name>
  <code>T44083</code>  <id>44083</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioligand Activity</name>
  <code>T58745</code>  <id>58745</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radioligand Therapeutic Agent</name>
  <code>T58746</code>  <id>58746</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Radiopharmaceutical Activity</name>
  <code>T44087</code>  <id>44087</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Rearranged during Transfection (RET) Inhibitors</name>
  <code>T58597</code>  <id>58597</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Activator of Nuclear Factor-kappa B Ligand Blocking Activity</name>
  <code>T43600</code>  <id>43600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Activator of Nuclear Factor-kappa B Ligand Inhibitor</name>
  <code>T43605</code>  <id>43605</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Activity Modifying Protein Agonists</name>
  <code>T44153</code>  <id>44153</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Activity Modifying Protein Antagonists</name>
  <code>T44154</code>  <id>44154</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Activity Modifying Proteins</name>
  <code>T44155</code>  <id>44155</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Agonist</name>
  <code>T58510</code>  <id>58510</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Antagonist</name>
  <code>T58511</code>  <id>58511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Interaction</name>
  <code>T58509</code>  <id>58509</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Interactions</name>
  <code>T44165</code>  <id>44165</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Protein Kinase Interactions</name>
  <code>T44166</code>  <id>44166</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Receptor Tyrosine Kinase Inhibitors</name>
  <code>T44174</code>  <id>44174</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Activated Protein C</name>
  <code>T46388</code>  <id>46388</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Antithrombin</name>
  <code>T46389</code>  <id>46389</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human DNase 1</name>
  <code>T46396</code>  <id>46396</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human DNase I</name>
  <code>T46394</code>  <id>46394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease 1</name>
  <code>T46401</code>  <id>46401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease 1 (rhDNase) Enzyme</name>
  <code>T46393</code>  <id>46393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease 1 Enzyme</name>
  <code>T46400</code>  <id>46400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease I</name>
  <code>T46399</code>  <id>46399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease I (rhDNase) Enzyme</name>
  <code>T46395</code>  <id>46395</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease I Enzyme</name>
  <code>T46397</code>  <id>46397</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Growth Hormone</name>
  <code>T46402</code>  <id>46402</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Interferon beta</name>
  <code>T46404</code>  <id>46404</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Lysosomal alpha-Mannosidase</name>
  <code>T58905</code>  <id>58905</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Nerve Growth Factor</name>
  <code>T58457</code>  <id>58457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Redox Activity</name>
  <code>T37831</code>  <id>37831</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reducing and Complexing Thiol</name>
  <code>T46438</code>  <id>46438</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reduction Activity</name>
  <code>T46439</code>  <id>46439</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reduction-Oxidation Activity</name>
  <code>T37830</code>  <id>37830</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arterial Vasoconstriction</name>
  <code>T46511</code>  <id>46511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arterial Vasodilation</name>
  <code>T46512</code>  <id>46512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arteriolar Vasoconstriction</name>
  <code>T46513</code>  <id>46513</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arteriolar Vasodilation</name>
  <code>T46514</code>  <id>46514</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Arterial Vasoconstriction</name>
  <code>T46517</code>  <id>46517</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Arterial Vasodilation</name>
  <code>T46518</code>  <id>46518</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Arteriolar Vasoconstriction</name>
  <code>T46519</code>  <id>46519</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Arteriolar Vasodilation</name>
  <code>T46520</code>  <id>46520</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Calculi Dissolution Agent</name>
  <code>T8684</code>  <id>8684</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Dehydropeptidase Inhibitor</name>
  <code>T46525</code>  <id>46525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arterial Vasoconstriction</name>
  <code>T46526</code>  <id>46526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arterial Vasodilation</name>
  <code>T46527</code>  <id>46527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arteriolar Vasoconstriction</name>
  <code>T46528</code>  <id>46528</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arteriolar Vasodilation</name>
  <code>T46529</code>  <id>46529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Endocrine Activity Alteration</name>
  <code>T46530</code>  <id>46530</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Excretion</name>
  <code>T46531</code>  <id>46531</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Ion Transport Alteration</name>
  <code>T46538</code>  <id>46538</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Metabolism</name>
  <code>T46539</code>  <id>46539</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Organic Ion Transport Alteration</name>
  <code>T46542</code>  <id>46542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal Tubular Transport Inhibitor</name>
  <code>T59066</code>  <id>59066</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renal/Urological Activity Alteration</name>
  <code>T46548</code>  <id>46548</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renin Inhibitor</name>
  <code>T46549</code>  <id>46549</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Renin Inhibitors</name>
  <code>T46551</code>  <id>46551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reproductive System Activity Alteration</name>
  <code>T46572</code>  <id>46572</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Agent</name>
  <code>T58526</code>  <id>58526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arterial Vasoconstriction</name>
  <code>T46589</code>  <id>46589</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arterial Vasodilation</name>
  <code>T46590</code>  <id>46590</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arteriolar Vasoconstriction</name>
  <code>T46591</code>  <id>46591</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arteriolar Vasodilation</name>
  <code>T46592</code>  <id>46592</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Mucosal Edema Alteration</name>
  <code>T46610</code>  <id>46610</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Secretion Alteration</name>
  <code>T46614</code>  <id>46614</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Secretion Viscosity Alteration</name>
  <code>T46615</code>  <id>46615</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Smooth Muscle Tone Alteration</name>
  <code>T46616</code>  <id>46616</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Stimulant</name>
  <code>T46620</code>  <id>46620</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody</name>
  <code>T46623</code>  <id>46623</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Syncytial Virus mRNA</name>
  <code>T59070</code>  <id>59070</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory Syncytial Virus mRNA Vaccine</name>
  <code>T59071</code>  <id>59071</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory System Agent</name>
  <code>T46630</code>  <id>46630</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Respiratory/Pulmonary Activity Alteration</name>
  <code>T46638</code>  <id>46638</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Retinal Pigment Epithelium Alteration</name>
  <code>T58372</code>  <id>58372</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Retinoid</name>
  <code>T46761</code>  <id>46761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Retinoid-class Agent</name>
  <code>T46760</code>  <id>46760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reverse Transcriptase Inhibitors</name>
  <code>T46811</code>  <id>46811</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reverse Transcription to DNA Alteration</name>
  <code>T46812</code>  <id>46812</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reversed Anti-coagulation</name>
  <code>T46815</code>  <id>46815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reversed Anti-coagulation Activity</name>
  <code>T46816</code>  <id>46816</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reversed Anticoagulation</name>
  <code>T46813</code>  <id>46813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Reversed Anticoagulation Activity</name>
  <code>T46820</code>  <id>46820</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Rho Kinase Inhibitor</name>
  <code>T58353</code>  <id>58353</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Rho Kinase Inhibitors</name>
  <code>T58352</code>  <id>58352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ribonucleotide Reductase Inhibitors</name>
  <code>T46988</code>  <id>46988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Rifamycin Antibacterial</name>
  <code>T47076</code>  <id>47076</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Rifamycin Antimicrobial</name>
  <code>T47077</code>  <id>47077</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Rifamycin Antimycobacterial</name>
  <code>T47078</code>  <id>47078</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Route of Excretion</name>
  <code>T47175</code>  <id>47175</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>S [Preparations]</name>
  <code>T47227</code>  <id>47227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>S1P Receptor Interactions</name>
  <code>T49458</code>  <id>49458</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>S1P Receptor Modulators</name>
  <code>T49460</code>  <id>49460</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor</name>
  <code>T58600</code>  <id>58600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SARS-CoV-2 mRNA</name>
  <code>T58935</code>  <id>58935</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SERM</name>
  <code>T18557</code>  <id>18557</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SGLT Inhibitors</name>
  <code>T49131</code>  <id>49131</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SGLT1 Inhibitors</name>
  <code>T49105</code>  <id>49105</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SGLT2 Inhibitor</name>
  <code>T49093</code>  <id>49093</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SGLT2 Inhibitors</name>
  <code>T49121</code>  <id>49121</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLAMF7-directed Antibody Interactions</name>
  <code>T47391</code>  <id>47391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLAMF7-directed Immunostimulatory Antibody</name>
  <code>T47394</code>  <id>47394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLC22A12 Inhibitor</name>
  <code>T53754</code>  <id>53754</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLC22A12 Inhibitors</name>
  <code>T53765</code>  <id>53765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLC9 A3 Inhibitors</name>
  <code>T58826</code>  <id>58826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLC9 Interactions</name>
  <code>T58821</code>  <id>58821</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SLC9A3 Inhibitor</name>
  <code>T58831</code>  <id>58831</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SMN2 Splicing Modifier</name>
  <code>T58847</code>  <id>58847</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SMN2 Splicing Modifiers</name>
  <code>T58844</code>  <id>58844</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SMN2-directed RNA Interaction</name>
  <code>T50490</code>  <id>50490</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SNRI</name>
  <code>T48252</code>  <id>48252</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SNRI</name>
  <code>T36448</code>  <id>36448</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>SSRI</name>
  <code>T48238</code>  <id>48238</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Saliva Excretion</name>
  <code>T47705</code>  <id>47705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Saliva Production Alteration</name>
  <code>T47706</code>  <id>47706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Salivation Inhibition</name>
  <code>T47728</code>  <id>47728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Salivation Stimulation</name>
  <code>T47729</code>  <id>47729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sclerosing Activity</name>
  <code>T47970</code>  <id>47970</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sclerosing Agent</name>
  <code>T47971</code>  <id>47971</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sebaceous Gland Alteration</name>
  <code>T48012</code>  <id>48012</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Secretin Class Hormone</name>
  <code>T48035</code>  <id>48035</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Secretin Receptor Agonists</name>
  <code>T48031</code>  <id>48031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Secretin Receptor Antagonists</name>
  <code>T48032</code>  <id>48032</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Secretin Receptor Interactions</name>
  <code>T48033</code>  <id>48033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Secretin-class Hormone</name>
  <code>T48036</code>  <id>48036</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sedatives/Hypnotics</name>
  <code>T58441</code>  <id>58441</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selectin Blocker</name>
  <code>T58783</code>  <id>58783</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selectin Blockers</name>
  <code>T58781</code>  <id>58781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Estrogen Receptor Modulator</name>
  <code>T18555</code>  <id>18555</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Estrogen Receptor Modulators</name>
  <code>T48068</code>  <id>48068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Norepinephrine Reuptake Inhibitor</name>
  <code>T36447</code>  <id>36447</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Progesterone Receptor Modulator</name>
  <code>T41908</code>  <id>41908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Progesterone Receptor Modulators</name>
  <code>T48071</code>  <id>48071</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Serotonin Reuptake Inhibitor</name>
  <code>T48239</code>  <id>48239</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective Serotonin Reuptake Inhibitor (SSRI)</name>
  <code>T48240</code>  <id>48240</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective T Cell Costimulation Blocker</name>
  <code>T48072</code>  <id>48072</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective T Cell Costimulation Modulator</name>
  <code>T48073</code>  <id>48073</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Selective alpha2-Agonist</name>
  <code>T9891</code>  <id>9891</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Semifluorinated Alkane</name>
  <code>T58882</code>  <id>58882</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sensory System Activity Alteration</name>
  <code>T48129</code>  <id>48129</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serine Proteinase Inhibitors</name>
  <code>T48166</code>  <id>48166</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serine/Threonine Kinase Inhibitors</name>
  <code>T58550</code>  <id>58550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin (5-HT) 1B/1D Receptor Agonist</name>
  <code>T48262</code>  <id>48262</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin (5-HT) 1b/1d Receptor Agonist</name>
  <code>T48255</code>  <id>48255</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin (5-HT) 2C Receptor Agonist</name>
  <code>T48269</code>  <id>48269</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin (5-HT) 2c Receptor Agonist</name>
  <code>T48267</code>  <id>48267</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1 Receptor Agonists</name>
  <code>T58493</code>  <id>58493</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1B Receptor Agonists</name>
  <code>T48197</code>  <id>48197</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1B and 1D Receptor Agonist</name>
  <code>T48265</code>  <id>48265</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1B/1D Receptor Agonist</name>
  <code>T48258</code>  <id>48258</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1D Receptor Agonists</name>
  <code>T48202</code>  <id>48202</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1a Receptor Agonists</name>
  <code>T58498</code>  <id>58498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1b Receptor Agonists</name>
  <code>T48199</code>  <id>48199</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1b and 1d Receptor Agonist</name>
  <code>T48263</code>  <id>48263</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1b/1d Receptor Agonist</name>
  <code>T48260</code>  <id>48260</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1d Receptor Agonists</name>
  <code>T48205</code>  <id>48205</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 2C Receptor Agonist</name>
  <code>T48271</code>  <id>48271</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 2C Receptor Agonists</name>
  <code>T48209</code>  <id>48209</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 2c Receptor Agonist</name>
  <code>T48270</code>  <id>48270</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 2c Receptor Agonists</name>
  <code>T48211</code>  <id>48211</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 3 Receptor Antagonist</name>
  <code>T48279</code>  <id>48279</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 3 Receptor Antagonists</name>
  <code>T48216</code>  <id>48216</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 4 Receptor Agonists</name>
  <code>T58488</code>  <id>58488</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 4 Receptor Antagonist</name>
  <code>T48288</code>  <id>48288</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 4 Receptor Antagonists</name>
  <code>T48221</code>  <id>48221</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5-Hydroxytryptamine-1 Receptor Agonists</name>
  <code>T58497</code>  <id>58497</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5-Hydroxytryptamine-1a Receptor Agonists</name>
  <code>T58502</code>  <id>58502</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonist</name>
  <code>T58487</code>  <id>58487</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonists</name>
  <code>T58492</code>  <id>58492</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5HT-3 Agonists</name>
  <code>T48222</code>  <id>48222</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5HT-3 Antagonists</name>
  <code>T48223</code>  <id>48223</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5HT-3 Receptor Interactions</name>
  <code>T48224</code>  <id>48224</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Activity Alteration</name>
  <code>T48225</code>  <id>48225</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Agonists</name>
  <code>T48226</code>  <id>48226</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Antagonists</name>
  <code>T48227</code>  <id>48227</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Receptor Interactions</name>
  <code>T48235</code>  <id>48235</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Reuptake Inhibitor</name>
  <code>T48241</code>  <id>48241</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Reuptake Inhibitor (SSRI)</name>
  <code>T48237</code>  <id>48237</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Reuptake Inhibitor Anorectic</name>
  <code>T48236</code>  <id>48236</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Transporter Interactions</name>
  <code>T48243</code>  <id>48243</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin Uptake Inhibitors</name>
  <code>T48244</code>  <id>48244</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin and Norepinephrine Reuptake Inhibitor</name>
  <code>T48254</code>  <id>48254</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)</name>
  <code>T48253</code>  <id>48253</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 3 (5-HT3) Receptor Antagonist</name>
  <code>T48278</code>  <id>48278</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 3 (5HT-3) Receptor Antagonist</name>
  <code>T48280</code>  <id>48280</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 3 (5HT3) Receptor Antagonist</name>
  <code>T48276</code>  <id>48276</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 3 Receptor Antagonist</name>
  <code>T48275</code>  <id>48275</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 3 Receptor Antagonists</name>
  <code>T48213</code>  <id>48213</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 4 (5-HT4) Receptor Antagonist</name>
  <code>T48286</code>  <id>48286</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 4 (5HT-4) Receptor Antagonist</name>
  <code>T48290</code>  <id>48290</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 4 (5HT4) Receptor Antagonist</name>
  <code>T48287</code>  <id>48287</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 4 Receptor Antagonist</name>
  <code>T48285</code>  <id>48285</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin subtype 4 Receptor Antagonists</name>
  <code>T48219</code>  <id>48219</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1B Receptor Agonists</name>
  <code>T48195</code>  <id>48195</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1B and Serotonin-1D Receptor Agonist</name>
  <code>T48256</code>  <id>48256</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1D Receptor Agonists</name>
  <code>T48201</code>  <id>48201</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1b Receptor Agonists</name>
  <code>T48194</code>  <id>48194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1b and Serotonin-1d Receptor Agonist</name>
  <code>T48266</code>  <id>48266</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1d Receptor Agonists</name>
  <code>T48203</code>  <id>48203</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-2C Receptor Agonist</name>
  <code>T48273</code>  <id>48273</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-2C Receptor Agonists</name>
  <code>T48207</code>  <id>48207</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-2c Receptor Agonist</name>
  <code>T48274</code>  <id>48274</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-2c Receptor Agonists</name>
  <code>T48206</code>  <id>48206</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-3 Receptor Antagonist</name>
  <code>T48277</code>  <id>48277</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-4 Receptor Agonist</name>
  <code>T58483</code>  <id>58483</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Serotonin-4 Receptor Antagonist</name>
  <code>T48292</code>  <id>48292</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sex Hormone Receptor Agonists</name>
  <code>T48384</code>  <id>48384</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sex Hormone Receptor Antagonists</name>
  <code>T48385</code>  <id>48385</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sex Hormone Synthesis Inhibitors</name>
  <code>T48386</code>  <id>48386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Shellfish Proteins</name>
  <code>T48443</code>  <id>48443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Short interfering RNA</name>
  <code>T58455</code>  <id>58455</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Shorten Conduction System Depolarization Time</name>
  <code>T48494</code>  <id>48494</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Shorten Conduction System Repolarization Time</name>
  <code>T48495</code>  <id>48495</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Siderophore Iron Chelating Activity</name>
  <code>T48563</code>  <id>48563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sigma Receptor Interactions</name>
  <code>T48569</code>  <id>48569</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Agonist</name>
  <code>T48571</code>  <id>48571</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Agonist</name>
  <code>T48570</code>  <id>48570</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Agonists</name>
  <code>T48572</code>  <id>48572</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Antagonists</name>
  <code>T48573</code>  <id>48573</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Interactions</name>
  <code>T48574</code>  <id>48574</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Signaling Lymphocytic Activation Molecule Family member 7-directed Antibody Interactions</name>
  <code>T47390</code>  <id>47390</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Signaling Lymphocytic Activation Molecule Family member 7-directed Immunostimulatory Antibody</name>
  <code>T47392</code>  <id>47392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Silencing RNA</name>
  <code>T58456</code>  <id>58456</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Site of Metabolism</name>
  <code>T48742</code>  <id>48742</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Site of concentration</name>
  <code>T48743</code>  <id>48743</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Site of relative exclusion</name>
  <code>T48744</code>  <id>48744</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Skeletal Muscle Relaxant</name>
  <code>T48778</code>  <id>48778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Skeletal Muscle Relaxants</name>
  <code>T58442</code>  <id>58442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Skin Barrier Activity</name>
  <code>T48781</code>  <id>48781</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Skin Excretion</name>
  <code>T48808</code>  <id>48808</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Skin Lightening Agent</name>
  <code>T48809</code>  <id>48809</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Skin Test Antigen</name>
  <code>T48813</code>  <id>48813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Small Interfering RNA</name>
  <code>T58453</code>  <id>58453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Small Intestine Fluid/Electrolyte Absorption Alteration</name>
  <code>T48916</code>  <id>48916</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Small Intestine Fluid/Electrolyte Alteration</name>
  <code>T48917</code>  <id>48917</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Small Intestine Fluid/Electrolyte Secretion Alteration</name>
  <code>T48918</code>  <id>48918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Smooth Muscle Tone Alteration</name>
  <code>T48947</code>  <id>48947</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Smoothened Receptor Antagonists</name>
  <code>T48949</code>  <id>48949</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Smoothened Receptor Interactions</name>
  <code>T48950</code>  <id>48950</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Bile Acid Cotransporter Interactions</name>
  <code>T58621</code>  <id>58621</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Agonists</name>
  <code>T48985</code>  <id>48985</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Antagonists</name>
  <code>T48987</code>  <id>48987</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Blocker</name>
  <code>T59039</code>  <id>59039</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Blockers</name>
  <code>T48986</code>  <id>48986</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Interactions</name>
  <code>T48988</code>  <id>48988</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Chloride Symporter Inhibitors</name>
  <code>T48994</code>  <id>48994</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Chloride Symporter Interactions</name>
  <code>T48995</code>  <id>48995</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Potassium Chloride Symporter Inhibitors</name>
  <code>T49054</code>  <id>49054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Potassium Chloride Symporter Interactions</name>
  <code>T49055</code>  <id>49055</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors</name>
  <code>T58624</code>  <id>58624</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium Taurocholate Co-transporting Polypeptide Interactions</name>
  <code>T58623</code>  <id>58623</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Cotransporter 1 Inhibitors</name>
  <code>T49108</code>  <id>49108</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Cotransporter 2 Inhibitor</name>
  <code>T49096</code>  <id>49096</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Cotransporter 2 Inhibitors</name>
  <code>T49118</code>  <id>49118</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Cotransporter Inhibitors</name>
  <code>T49130</code>  <id>49130</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Symporter 1 Inhibitors</name>
  <code>T49109</code>  <id>49109</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Symporter 2 Inhibitor</name>
  <code>T49092</code>  <id>49092</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Symporter 2 Inhibitors</name>
  <code>T49117</code>  <id>49117</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Symporter Inhibitors</name>
  <code>T49127</code>  <id>49127</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter 1 Inhibitors</name>
  <code>T49111</code>  <id>49111</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter 2 Inhibitor</name>
  <code>T49095</code>  <id>49095</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter 2 Inhibitors</name>
  <code>T49122</code>  <id>49122</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter Inhibitors</name>
  <code>T49132</code>  <id>49132</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter Interactions</name>
  <code>T49133</code>  <id>49133</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Antiporter 3 Inhibitor</name>
  <code>T58832</code>  <id>58832</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Antiporter 3 Inhibitors</name>
  <code>T58827</code>  <id>58827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Antiporter Interactions</name>
  <code>T58822</code>  <id>58822</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger 3 (NHE3) Inhibitor</name>
  <code>T58833</code>  <id>58833</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger 3 Inhibitor</name>
  <code>T58829</code>  <id>58829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger 3 Inhibitors</name>
  <code>T58824</code>  <id>58824</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger Interactions</name>
  <code>T58819</code>  <id>58819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sodium-Potassium Exchanging ATPase Interactions</name>
  <code>T49177</code>  <id>49177</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Soluble Guanylate Cyclase Stimulator</name>
  <code>T49231</code>  <id>49231</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Solute Carrier 9 Interactions</name>
  <code>T58823</code>  <id>58823</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Solute Carrier Family 22 Member 12 Inhibitor</name>
  <code>T53755</code>  <id>53755</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Solute Carrier Family 22 Member 12 Inhibitors</name>
  <code>T53764</code>  <id>53764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitor</name>
  <code>T58834</code>  <id>58834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitors</name>
  <code>T58828</code>  <id>58828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Solute Carrier Family 9 Member 3 Inhibitor</name>
  <code>T58835</code>  <id>58835</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Activity Alteration</name>
  <code>T49304</code>  <id>49304</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Alteration</name>
  <code>T49305</code>  <id>49305</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Analog</name>
  <code>T49307</code>  <id>49307</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Analogue</name>
  <code>T49306</code>  <id>49306</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Receptor Agonists</name>
  <code>T49308</code>  <id>49308</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Receptor Interactions</name>
  <code>T49309</code>  <id>49309</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Secretion Alteration</name>
  <code>T49310</code>  <id>49310</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatotropin Receptor Agonists</name>
  <code>T49321</code>  <id>49321</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Somatotropin Receptor Interactions</name>
  <code>T49322</code>  <id>49322</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Special Sensory Systems Activity Alteration</name>
  <code>T49406</code>  <id>49406</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sperm Alteration</name>
  <code>T49418</code>  <id>49418</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sperm Death Alteration</name>
  <code>T49419</code>  <id>49419</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sperm Motility Alteration</name>
  <code>T49420</code>  <id>49420</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Spermatogenesis Alteration</name>
  <code>T49426</code>  <id>49426</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sphingosine 1-Phosphate Receptor Interactions</name>
  <code>T49459</code>  <id>49459</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sphingosine 1-Phosphate Receptor Modulators</name>
  <code>T49461</code>  <id>49461</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sphingosine 1-phosphate Receptor Modulator</name>
  <code>T49462</code>  <id>49462</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arterial Vasoconstriction</name>
  <code>T49550</code>  <id>49550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arterial Vasodilation</name>
  <code>T49551</code>  <id>49551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arteriolar Vasoconstriction</name>
  <code>T49552</code>  <id>49552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arteriolar Vasodilation</name>
  <code>T49553</code>  <id>49553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Squalene Epoxidase Inhibitors</name>
  <code>T49599</code>  <id>49599</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Squalene Monooxygenase Inhibitors</name>
  <code>T49600</code>  <id>49600</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stains</name>
  <code>T58762</code>  <id>58762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Standardized Animal Hair Allergenic Extract</name>
  <code>T49631</code>  <id>49631</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Standardized Animal Skin Allergenic Extract</name>
  <code>T49632</code>  <id>49632</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Standardized Chemical Allergen</name>
  <code>T49633</code>  <id>49633</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Standardized Insect Allergenic Extract</name>
  <code>T49634</code>  <id>49634</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Standardized Insect Venom Allergenic Extract</name>
  <code>T49635</code>  <id>49635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Standardized Pollen Allergenic Extract</name>
  <code>T49636</code>  <id>49636</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stem Cell Factor (KIT) Inhibitors</name>
  <code>T49713</code>  <id>49713</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stem Cell Factor (KIT) Receptor Inhibitors</name>
  <code>T49714</code>  <id>49714</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Steroid</name>
  <code>T58784</code>  <id>58784</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Steroid Hormone Receptor Agonists</name>
  <code>T49792</code>  <id>49792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Steroid Receptor Antagonists</name>
  <code>T49802</code>  <id>49802</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Steroid Receptor Modulators</name>
  <code>T49803</code>  <id>49803</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Steroid Synthesis Inhibitors</name>
  <code>T49804</code>  <id>49804</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sterol Metabolism Alteration</name>
  <code>T49843</code>  <id>49843</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sterol Synthesis Alteration</name>
  <code>T49859</code>  <id>49859</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sterol Synthesis Inhibitors</name>
  <code>T49860</code>  <id>49860</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulant</name>
  <code>T9872</code>  <id>9872</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulant Laxative</name>
  <code>T49897</code>  <id>49897</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Breast Glandular Development</name>
  <code>T49898</code>  <id>49898</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Breast Milk Ejection</name>
  <code>T49899</code>  <id>49899</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Breast Milk Secretion</name>
  <code>T49900</code>  <id>49900</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Embryonic &amp; Fetal Development</name>
  <code>T49901</code>  <id>49901</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Ovarian Follicular Phase</name>
  <code>T49902</code>  <id>49902</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Ovarian Luteal Phase</name>
  <code>T49903</code>  <id>49903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Ovulation</name>
  <code>T49904</code>  <id>49904</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Penile Development</name>
  <code>T49905</code>  <id>49905</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Uterine Menstrual Phase</name>
  <code>T49906</code>  <id>49906</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Uterine Proliferative Phase</name>
  <code>T49907</code>  <id>49907</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulate Uterine Secretory Phase</name>
  <code>T49908</code>  <id>49908</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Gastric Acid Secretion</name>
  <code>T49909</code>  <id>49909</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Gastric Mucous Secretion</name>
  <code>T49910</code>  <id>49910</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Large Intestine Fluid/Electrolyte Absorption</name>
  <code>T49911</code>  <id>49911</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Large Intestine Fluid/Electrolyte Secretion</name>
  <code>T49912</code>  <id>49912</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Pancreatic Enzymatic Secretion</name>
  <code>T49913</code>  <id>49913</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Pancreatic Fluid/Electrolyte Secretion</name>
  <code>T49914</code>  <id>49914</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Small Intestine Fluid/Electrolyte Absorption</name>
  <code>T49915</code>  <id>49915</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stimulation Small Intestine Fluid/Electrolyte Secretion</name>
  <code>T49916</code>  <id>49916</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Stool Bulking Activity</name>
  <code>T49944</code>  <id>49944</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Streptogramin Antibacterial</name>
  <code>T49962</code>  <id>49962</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Anabolism Alteration</name>
  <code>T50016</code>  <id>50016</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Catabolism Alteration</name>
  <code>T50017</code>  <id>50017</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Contraction Alteration</name>
  <code>T50018</code>  <id>50018</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Metabolic Alteration</name>
  <code>T50019</code>  <id>50019</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Tone Alteration</name>
  <code>T50020</code>  <id>50020</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Structural Macromolecules</name>
  <code>T50054</code>  <id>50054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Substance P Activity Alteration</name>
  <code>T50122</code>  <id>50122</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Substance P Receptor Antagonists</name>
  <code>T35738</code>  <id>35738</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Substance P Receptor Interactions</name>
  <code>T35741</code>  <id>35741</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Substance P/Neurokinin-1 (NK-1) Receptor Antagonist</name>
  <code>T50126</code>  <id>50126</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Substance P/Neurokinin-1 Receptor Antagonist</name>
  <code>T50127</code>  <id>50127</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sucrose-specific Enzyme</name>
  <code>T50189</code>  <id>50189</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfate Donors</name>
  <code>T50313</code>  <id>50313</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide</name>
  <code>T50366</code>  <id>50366</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide Antibacterial</name>
  <code>T50363</code>  <id>50363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide Antimicrobial</name>
  <code>T50364</code>  <id>50364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide-class Agent</name>
  <code>T50365</code>  <id>50365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfone</name>
  <code>T50369</code>  <id>50369</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfone-class Agent</name>
  <code>T50368</code>  <id>50368</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfonylurea</name>
  <code>T50376</code>  <id>50376</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfonylurea-class Agent</name>
  <code>T50375</code>  <id>50375</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sulfotransferases</name>
  <code>T50378</code>  <id>50378</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sunscreening Activity</name>
  <code>T50410</code>  <id>50410</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Surfactant</name>
  <code>T50474</code>  <id>50474</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Surfactant Activity</name>
  <code>T50473</code>  <id>50473</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival Motor Neuron 2 Splicing Modifier</name>
  <code>T58848</code>  <id>58848</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival Motor Neuron 2 Splicing Modifiers</name>
  <code>T58845</code>  <id>58845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival Motor Neuron 2-directed RNA Interaction</name>
  <code>T50489</code>  <id>50489</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival Motor Neuron-2-directed RNA Interaction</name>
  <code>T50488</code>  <id>50488</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival of Motor Neuron 2 Splicing Modifier</name>
  <code>T58846</code>  <id>58846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival of Motor Neuron 2 Splicing Modifiers</name>
  <code>T58843</code>  <id>58843</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Survival of Motor Neuron 2-directed RNA Interaction</name>
  <code>T50487</code>  <id>50487</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sweat Excretion</name>
  <code>T50509</code>  <id>50509</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sympathetic Activity Alteration</name>
  <code>T50532</code>  <id>50532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sympatholytic Activity</name>
  <code>T14840</code>  <id>14840</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic Activity</name>
  <code>T27028</code>  <id>27028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic Agent</name>
  <code>T58532</code>  <id>58532</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic Amine Anorectic</name>
  <code>T50533</code>  <id>50533</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic-like Agent</name>
  <code>T50534</code>  <id>50534</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Symporter Interactions</name>
  <code>T50535</code>  <id>50535</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Synaptic Fusion Complex Interactions</name>
  <code>T50544</code>  <id>50544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Systemic Arterial Vasoconstriction</name>
  <code>T50628</code>  <id>50628</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Systemic Arterial Vasodilation</name>
  <code>T50629</code>  <id>50629</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Systemic Arteriolar Vasoconstriction</name>
  <code>T50630</code>  <id>50630</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Systemic Arteriolar Vasodilation</name>
  <code>T50631</code>  <id>50631</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Systemic Venous Vasoconstriction</name>
  <code>T50636</code>  <id>50636</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Systemic Venous Vasodilation</name>
  <code>T50637</code>  <id>50637</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T Lymphocyte Activity Modulation</name>
  <code>T50643</code>  <id>50643</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T Lymphocyte Costimulation Activity Blockade</name>
  <code>T50644</code>  <id>50644</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T Lymphocyte Costimulation Activity Modulation</name>
  <code>T50645</code>  <id>50645</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T Lymphocytes, Cultured, Autologous, Genetically-modified</name>
  <code>T50648</code>  <id>50648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T [Preparations]</name>
  <code>T50649</code>  <id>50649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T-Calcium Channel Receptor Antagonists</name>
  <code>T50656</code>  <id>50656</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T3</name>
  <code>T57296</code>  <id>57296</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>T4</name>
  <code>T57292</code>  <id>57292</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TCA</name>
  <code>T52876</code>  <id>52876</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TFPI Antagonist</name>
  <code>T59060</code>  <id>59060</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TFPI Antagonists</name>
  <code>T59058</code>  <id>59058</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>THR-beta Agonist</name>
  <code>T59005</code>  <id>59005</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>THR-beta Agonists</name>
  <code>T58998</code>  <id>58998</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>THR-β Agonist</name>
  <code>T59006</code>  <id>59006</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>THR-β Agonists</name>
  <code>T58999</code>  <id>58999</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF Blocker</name>
  <code>T53317</code>  <id>53317</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF Blocker</name>
  <code>T53337</code>  <id>53337</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF Receptor Blocking Activity</name>
  <code>T53338</code>  <id>53338</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF Receptor Interactions</name>
  <code>T53340</code>  <id>53340</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF-a Receptor Blocking Activity</name>
  <code>T53343</code>  <id>53343</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF-alpha Receptor Blocking Activity</name>
  <code>T53344</code>  <id>53344</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF-b Receptor Blocking Activity</name>
  <code>T53350</code>  <id>53350</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TNF-beta Receptor Blocking Activity</name>
  <code>T53349</code>  <id>53349</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TPA Inhibitors</name>
  <code>T52201</code>  <id>52201</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRH Activity Alteration</name>
  <code>T50937</code>  <id>50937</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRH Alteration</name>
  <code>T52053</code>  <id>52053</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRH Secretion Alteration</name>
  <code>T50938</code>  <id>50938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRKA Inhibitors</name>
  <code>T58923</code>  <id>58923</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRKB Inhibitors</name>
  <code>T58926</code>  <id>58926</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRKC Inhibitors</name>
  <code>T58929</code>  <id>58929</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRKs Inhibitors</name>
  <code>T58470</code>  <id>58470</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRPM8 Thermoreceptor Agonist</name>
  <code>T59079</code>  <id>59079</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRPM8 Thermoreceptor Agonists</name>
  <code>T59077</code>  <id>59077</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRβ Agonist</name>
  <code>T59010</code>  <id>59010</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TRβ Agonists</name>
  <code>T59003</code>  <id>59003</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TSLP Blocker</name>
  <code>T58727</code>  <id>58727</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TSLP Blockers</name>
  <code>T58729</code>  <id>58729</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TTR-directed RNA Interaction</name>
  <code>T58452</code>  <id>58452</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TYK2 Inhibitor</name>
  <code>T58791</code>  <id>58791</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>TYK2 Inhibitors</name>
  <code>T58793</code>  <id>58793</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tear Excretion</name>
  <code>T51225</code>  <id>51225</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Terminology Extensions for Classification</name>
  <code>T1</code>  <id>1</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Testicular Endocrine Activity Alteration</name>
  <code>T51449</code>  <id>51449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tetracycline Class Antimicrobial</name>
  <code>T51498</code>  <id>51498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tetracycline-class Antibacterial</name>
  <code>T51497</code>  <id>51497</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tetracycline-class Antimicrobial</name>
  <code>T51499</code>  <id>51499</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tetracycline-class Drug</name>
  <code>T51500</code>  <id>51500</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thalidomide Analog</name>
  <code>T51588</code>  <id>51588</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thalidomide Analogue</name>
  <code>T51587</code>  <id>51587</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Therapeutic Categories</name>
  <code>T51616</code>  <id>51616</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Therapeutic Nutrients/Minerals/Electrolytes</name>
  <code>T58443</code>  <id>58443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thermoreceptor Interactions</name>
  <code>T59076</code>  <id>59076</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thiazide Diuretic</name>
  <code>T51666</code>  <id>51666</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thiazide-class Diuretic</name>
  <code>T51665</code>  <id>51665</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thiazide-like Diuretic</name>
  <code>T51667</code>  <id>51667</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thiazolidinedione</name>
  <code>T51672</code>  <id>51672</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thiazolidinedione-class Agent</name>
  <code>T51671</code>  <id>51671</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thiopurine methyltransferase</name>
  <code>T51749</code>  <id>51749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thioxanthene</name>
  <code>T51795</code>  <id>51795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thioxanthene-class Agent</name>
  <code>T51794</code>  <id>51794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thrombin Inhibitors</name>
  <code>T51834</code>  <id>51834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thrombolytic Agent</name>
  <code>T51856</code>  <id>51856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thrombopoiesis Stimulating Agent</name>
  <code>T51875</code>  <id>51875</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thrombopoietin Receptor Agonist</name>
  <code>T51876</code>  <id>51876</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thrombopoietin Receptor Agonists</name>
  <code>T51877</code>  <id>51877</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thrombopoietin Receptor Interactions</name>
  <code>T51878</code>  <id>51878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thymic Stromal Lymphopoietin Blocker</name>
  <code>T58726</code>  <id>58726</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thymic Stromal Lymphopoietin Blockers</name>
  <code>T58728</code>  <id>58728</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thymidine Phosphorylase Inhibitor</name>
  <code>T51924</code>  <id>51924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thymidine Phosphorylase Inhibitors</name>
  <code>T51925</code>  <id>51925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thymidylate Synthetase Inhibitors</name>
  <code>T51935</code>  <id>51935</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Gland Activity Alteration</name>
  <code>T51992</code>  <id>51992</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Iodination Alteration</name>
  <code>T51993</code>  <id>51993</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor Agonists</name>
  <code>T51994</code>  <id>51994</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor Antagonists</name>
  <code>T51995</code>  <id>51995</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor beta Agonist</name>
  <code>T59004</code>  <id>59004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor beta Agonists</name>
  <code>T58997</code>  <id>58997</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor β Agonist</name>
  <code>T59007</code>  <id>59007</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor β Agonists</name>
  <code>T59000</code>  <id>59000</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor-beta Agonist</name>
  <code>T59008</code>  <id>59008</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor-beta Agonists</name>
  <code>T59001</code>  <id>59001</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor-β Agonist</name>
  <code>T59009</code>  <id>59009</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor-β Agonists</name>
  <code>T59002</code>  <id>59002</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Secretion Alteration</name>
  <code>T52024</code>  <id>52024</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Synthesis Inhibitor</name>
  <code>T52025</code>  <id>52025</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Synthesis Inhibitors</name>
  <code>T52026</code>  <id>52026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Peroxidase Inhibitors</name>
  <code>T28323</code>  <id>28323</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyroid Stimulating Hormone</name>
  <code>T52031</code>  <id>52031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Thyrotropin Releasing Hormone Alteration</name>
  <code>T52054</code>  <id>52054</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tick-Borne Encephalitis Vaccine</name>
  <code>T59068</code>  <id>59068</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tissue Factor Pathway Inhibitor Antagonist</name>
  <code>T59059</code>  <id>59059</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tissue Factor Pathway Inhibitor Antagonists</name>
  <code>T59057</code>  <id>59057</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tissue Plasminogen Activator Inhibitors</name>
  <code>T52202</code>  <id>52202</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tissue Plasminogen Activators</name>
  <code>T52211</code>  <id>52211</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tissue-nonspecific Alkaline Phosphatase</name>
  <code>T52216</code>  <id>52216</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 1 Inhibitor</name>
  <code>T52379</code>  <id>52379</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 1 Inhibitors</name>
  <code>T52380</code>  <id>52380</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 2 Inhibitors</name>
  <code>T52381</code>  <id>52381</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 4 Inhibitors</name>
  <code>T52382</code>  <id>52382</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase Inhibitor</name>
  <code>T52383</code>  <id>52383</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase Inhibitor</name>
  <code>T52384</code>  <id>52384</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase Inhibitors</name>
  <code>T52386</code>  <id>52386</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tracheobronchial Stretch Receptor Alteration</name>
  <code>T52465</code>  <id>52465</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transcription Factor Activity</name>
  <code>T52542</code>  <id>52542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transcription to RNA Alteration</name>
  <code>T52627</code>  <id>52627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transient Receptor Potential Melastatin 8 Agonist</name>
  <code>T59080</code>  <id>59080</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transient Receptor Potential Melastatin 8 Agonists</name>
  <code>T59078</code>  <id>59078</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Translation Alteration</name>
  <code>T52699</code>  <id>52699</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transpepsidase Inhibitors</name>
  <code>T52711</code>  <id>52711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transpeptidase Inhibitors</name>
  <code>T52712</code>  <id>52712</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transthyretin Stabilizer</name>
  <code>T59033</code>  <id>59033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transthyretin Stabilizers</name>
  <code>T59032</code>  <id>59032</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Transthyretin-directed RNA Interaction</name>
  <code>T58451</code>  <id>58451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor</name>
  <code>T59061</code>  <id>59061</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tricyclic Antidepressant</name>
  <code>T52878</code>  <id>52878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tricyclic Antidepressant (TCA)</name>
  <code>T52877</code>  <id>52877</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Triglyceride Metabolism Alteration</name>
  <code>T52945</code>  <id>52945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tripeptidyl Peptidase I</name>
  <code>T25152</code>  <id>25152</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tripeptidyl Peptidase-1</name>
  <code>T25154</code>  <id>25154</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Triterpenoid Antifungal</name>
  <code>T58627</code>  <id>58627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Kinase A Inhibitors</name>
  <code>T58924</code>  <id>58924</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Kinase B Inhibitors</name>
  <code>T58927</code>  <id>58927</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Kinase C Inhibitors</name>
  <code>T58930</code>  <id>58930</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Kinases Inhibitors</name>
  <code>T58469</code>  <id>58469</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors</name>
  <code>T58922</code>  <id>58922</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors</name>
  <code>T58925</code>  <id>58925</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors</name>
  <code>T58928</code>  <id>58928</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Trypsin Inhibitors</name>
  <code>T53185</code>  <id>53185</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tryptophan Hydroxylase Inhibitor</name>
  <code>T53193</code>  <id>53193</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tryptophan Hydroxylase Inhibitors</name>
  <code>T53194</code>  <id>53194</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tuberculosis Skin Test</name>
  <code>T53229</code>  <id>53229</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tubulin Agent</name>
  <code>T58525</code>  <id>58525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tubulin Inhibiting Agent</name>
  <code>T53303</code>  <id>53303</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tubulin Interactions</name>
  <code>T53304</code>  <id>53304</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor (TNF) Blocker</name>
  <code>T53315</code>  <id>53315</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Blocker</name>
  <code>T53318</code>  <id>53318</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Receptor Blocker</name>
  <code>T53316</code>  <id>53316</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Receptor Blocking Activity</name>
  <code>T53339</code>  <id>53339</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Receptor Interactions</name>
  <code>T53341</code>  <id>53341</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor alpha Receptor Blocking Activity</name>
  <code>T53345</code>  <id>53345</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor beta Receptor Blocking Activity</name>
  <code>T53351</code>  <id>53351</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tumor-derived Autologous T Cell Immunotherapy</name>
  <code>T58938</code>  <id>58938</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Type I IFN Receptor Antagonist</name>
  <code>T58640</code>  <id>58640</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Type I IFN Receptor Antagonists</name>
  <code>T58643</code>  <id>58643</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Type I interferon Receptor Antagonist</name>
  <code>T58639</code>  <id>58639</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Type I interferon Receptor Antagonists</name>
  <code>T58642</code>  <id>58642</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Type II RAF Kinase Inhibitors</name>
  <code>T58975</code>  <id>58975</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Typical Antipsychotic</name>
  <code>T53484</code>  <id>53484</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tyrosine Kinase 2 Inhibitor</name>
  <code>T58790</code>  <id>58790</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tyrosine Kinase 2 Inhibitors</name>
  <code>T58792</code>  <id>58792</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Tyrosine Kinase Inhibitors</name>
  <code>T53498</code>  <id>53498</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>U [Preparations]</name>
  <code>T53521</code>  <id>53521</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-1A1 Inhibitors</name>
  <code>T53545</code>  <id>53545</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-1A3 Inhibitors</name>
  <code>T53549</code>  <id>53549</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-1A4 Inhibitors</name>
  <code>T53552</code>  <id>53552</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-1A6 Inhibitors</name>
  <code>T53554</code>  <id>53554</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-1A9 Inhibitors</name>
  <code>T53558</code>  <id>53558</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-2B15 Inhibitors</name>
  <code>T53564</code>  <id>53564</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferase-2B7 Inhibitors</name>
  <code>T53567</code>  <id>53567</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases (UGT) Inducers</name>
  <code>T53523</code>  <id>53523</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases (UGT) Inhibitors</name>
  <code>T53525</code>  <id>53525</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases Inducers</name>
  <code>T53524</code>  <id>53524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases Inhibitors</name>
  <code>T53527</code>  <id>53527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases-1A Inducers</name>
  <code>T58764</code>  <id>58764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases-1A Inhibitors</name>
  <code>T53542</code>  <id>53542</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases-2B Inhibitors</name>
  <code>T53561</code>  <id>53561</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP glucuronosyltransferase family 1 member A1 Inducers</name>
  <code>T58767</code>  <id>58767</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UDP-Glucuronosyltransferase 1A1 Inducers</name>
  <code>T58768</code>  <id>58768</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT Inducers</name>
  <code>T53522</code>  <id>53522</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT Inhibitors</name>
  <code>T53526</code>  <id>53526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A Inducers</name>
  <code>T58765</code>  <id>58765</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A Inhibitors</name>
  <code>T53543</code>  <id>53543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A1 Inhibitors</name>
  <code>T53546</code>  <id>53546</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A3 Inhibitors</name>
  <code>T53548</code>  <id>53548</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A4 Inhibitors</name>
  <code>T53551</code>  <id>53551</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A6 Inhibitors</name>
  <code>T53555</code>  <id>53555</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-1A9 Inhibitors</name>
  <code>T53557</code>  <id>53557</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-2B Inhibitors</name>
  <code>T53560</code>  <id>53560</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-2B15 Inhibitors</name>
  <code>T53563</code>  <id>53563</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT-2B7 Inhibitors</name>
  <code>T53566</code>  <id>53566</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A Inducers</name>
  <code>T58763</code>  <id>58763</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A Inhibitors</name>
  <code>T53544</code>  <id>53544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A1 Inducers</name>
  <code>T58766</code>  <id>58766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A1 Inhibitors</name>
  <code>T53547</code>  <id>53547</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A3 Inhibitors</name>
  <code>T53550</code>  <id>53550</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A4 Inhibitors</name>
  <code>T53553</code>  <id>53553</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A6 Inhibitors</name>
  <code>T53556</code>  <id>53556</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT1A9 Inhibitors</name>
  <code>T53559</code>  <id>53559</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT2B Inhibitors</name>
  <code>T53562</code>  <id>53562</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT2B15 Inhibitors</name>
  <code>T53565</code>  <id>53565</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>UGT2B7 Inhibitors</name>
  <code>T53568</code>  <id>53568</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>URAT-1 Inhibitor</name>
  <code>T53750</code>  <id>53750</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>URAT-1 Inhibitors</name>
  <code>T53760</code>  <id>53760</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>URAT1 Inhibitor</name>
  <code>T53749</code>  <id>53749</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>URAT1 Inhibitors</name>
  <code>T53761</code>  <id>53761</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ubiquitin Ligase Inhibitors</name>
  <code>T53602</code>  <id>53602</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ultrasound Contrast Activity</name>
  <code>T53635</code>  <id>53635</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ultraviolet A Radiation Absorption</name>
  <code>T53638</code>  <id>53638</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ultraviolet B Radiation Absorption</name>
  <code>T53641</code>  <id>53641</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Umbilical Lint Excretion</name>
  <code>T53644</code>  <id>53644</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive N-methyl-D-aspartate (NMDA) Receptor Antagonist</name>
  <code>T53647</code>  <id>53647</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist</name>
  <code>T53648</code>  <id>53648</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive N-methyl-D-aspartate Receptor Antagonists</name>
  <code>T53649</code>  <id>53649</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive NMDA Receptor Antagonist</name>
  <code>T53646</code>  <id>53646</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive NMDA Receptor Antagonists</name>
  <code>T53650</code>  <id>53650</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uncouplers</name>
  <code>T53654</code>  <id>53654</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Unfractionated Heparin</name>
  <code>T53679</code>  <id>53679</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Unknown Cellular or Molecular Interaction</name>
  <code>T53696</code>  <id>53696</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Unknown Physiological Effect</name>
  <code>T53697</code>  <id>53697</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urate Transporter 1 Inhibitor</name>
  <code>T53759</code>  <id>53759</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urate Transporter 1 Inhibitors</name>
  <code>T53770</code>  <id>53770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urate Transporter-1 Inhibitor</name>
  <code>T53758</code>  <id>53758</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urate Transporter-1 Inhibitors</name>
  <code>T53762</code>  <id>53762</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urease Inhibitor</name>
  <code>T53778</code>  <id>53778</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urease Inhibitor</name>
  <code>T53779</code>  <id>53779</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urease Inhibitors</name>
  <code>T53780</code>  <id>53780</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Urethra Smooth Muscle Tone Alteration</name>
  <code>T53800</code>  <id>53800</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uric Acid Specific Enzyme</name>
  <code>T53813</code>  <id>53813</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uric Acid Transporter 1 Inhibitor</name>
  <code>T53757</code>  <id>53757</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uric Acid Transporter 1 Inhibitors</name>
  <code>T53769</code>  <id>53769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uric Acid Transporter-1 Inhibitor</name>
  <code>T53756</code>  <id>53756</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uric Acid Transporter-1 Inhibitors</name>
  <code>T53766</code>  <id>53766</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uric Acid-specific Enzyme</name>
  <code>T53814</code>  <id>53814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uricosuric Activity</name>
  <code>T53815</code>  <id>53815</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uterine Function Alteration</name>
  <code>T54025</code>  <id>54025</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uterine Menstrual Phase</name>
  <code>T54033</code>  <id>54033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uterine Proliferative Phase Alteration</name>
  <code>T54040</code>  <id>54040</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uterine Secretory Phase Alteration</name>
  <code>T54045</code>  <id>54045</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Uterine Smooth Muscle Contraction or Tone</name>
  <code>T54046</code>  <id>54046</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>V [Preparations]</name>
  <code>T54075</code>  <id>54075</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGF Inhibitor</name>
  <code>T54349</code>  <id>54349</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGF Inhibitors</name>
  <code>T54351</code>  <id>54351</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGF-directed Antibody</name>
  <code>T54393</code>  <id>54393</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGF-directed Antibody Interactions</name>
  <code>T54391</code>  <id>54391</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR 2-directed Antibody</name>
  <code>T54360</code>  <id>54360</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR-2 Antagonist</name>
  <code>T54353</code>  <id>54353</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR-2-directed Antibody</name>
  <code>T54362</code>  <id>54362</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR-2-directed Antibody Interactions</name>
  <code>T54358</code>  <id>54358</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR1 Inhibitors</name>
  <code>T54117</code>  <id>54117</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR2 Antagonist</name>
  <code>T54354</code>  <id>54354</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR2 Inhibitors</name>
  <code>T54118</code>  <id>54118</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR2-directed Antibody Interactions</name>
  <code>T54357</code>  <id>54357</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VEGFR3 Inhibitors</name>
  <code>T54119</code>  <id>54119</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VMAT Antagonists</name>
  <code>T54624</code>  <id>54624</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VMAT Interactions</name>
  <code>T54626</code>  <id>54626</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VZV Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T24463</code>  <id>24463</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>VZV Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T24458</code>  <id>24458</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vaccine</name>
  <code>T58527</code>  <id>58527</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vaccines, Tick-Borne Encephalitis</name>
  <code>T59067</code>  <id>59067</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vaginal Function Alteration</name>
  <code>T54228</code>  <id>54228</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vaginal Muscle Tone Alteration</name>
  <code>T54229</code>  <id>54229</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vaginal Secretion Alteration</name>
  <code>T54233</code>  <id>54233</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Varicella Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</name>
  <code>T24460</code>  <id>24460</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Varicella Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</name>
  <code>T24459</code>  <id>24459</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Alterations</name>
  <code>T54317</code>  <id>54317</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Inhibitor</name>
  <code>T54350</code>  <id>54350</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Inhibitor</name>
  <code>T54364</code>  <id>54364</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Inhibitors</name>
  <code>T54352</code>  <id>54352</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor 2 Antagonist</name>
  <code>T54356</code>  <id>54356</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody</name>
  <code>T54363</code>  <id>54363</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions</name>
  <code>T54359</code>  <id>54359</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor Inhibitors</name>
  <code>T54365</code>  <id>54365</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor-2 Antagonist</name>
  <code>T54355</code>  <id>54355</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor-2-directed Antibody</name>
  <code>T54361</code>  <id>54361</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor-directed Antibody</name>
  <code>T54394</code>  <id>54394</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor-directed Antibody Interactions</name>
  <code>T54392</code>  <id>54392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Growth Alteration</name>
  <code>T54398</code>  <id>54398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Growth Decrease</name>
  <code>T54400</code>  <id>54400</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Growth Increase</name>
  <code>T54401</code>  <id>54401</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Permeability Alteration</name>
  <code>T54409</code>  <id>54409</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Sclerosing Activity</name>
  <code>T54411</code>  <id>54411</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Smooth Muscle Tone Alteration</name>
  <code>T54412</code>  <id>54412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vascular Tone Alteration</name>
  <code>T54415</code>  <id>54415</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration</name>
  <code>T54440</code>  <id>54440</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasoconstriction</name>
  <code>T54441</code>  <id>54441</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasoconstrictor</name>
  <code>T54442</code>  <id>54442</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasodilation</name>
  <code>T54443</code>  <id>54443</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasodilator</name>
  <code>T54444</code>  <id>54444</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Analog</name>
  <code>T54449</code>  <id>54449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Analogue</name>
  <code>T54448</code>  <id>54448</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Agonist</name>
  <code>T58795</code>  <id>58795</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Agonists</name>
  <code>T58794</code>  <id>58794</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Antagonist</name>
  <code>T54450</code>  <id>54450</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Antagonists</name>
  <code>T54451</code>  <id>54451</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V1 Receptor Antagonists</name>
  <code>T54453</code>  <id>54453</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V1A Receptor Antagonists</name>
  <code>T54452</code>  <id>54452</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V1B Receptor Antagonists</name>
  <code>T54456</code>  <id>54456</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V2 Receptor Antagonist</name>
  <code>T54454</code>  <id>54454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V2 Receptor Antagonists</name>
  <code>T54455</code>  <id>54455</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V3 Receptor Antagonists</name>
  <code>T54457</code>  <id>54457</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Venom Neutralization</name>
  <code>T54501</code>  <id>54501</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Venous Vasoconstriction</name>
  <code>T54511</code>  <id>54511</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Venous Vasodilation</name>
  <code>T54512</code>  <id>54512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ventilatory Gas Flow Alteration</name>
  <code>T54515</code>  <id>54515</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ventricular Depolarization</name>
  <code>T54516</code>  <id>54516</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Ventricular Repolarization</name>
  <code>T54540</code>  <id>54540</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter 2 Inhibitor</name>
  <code>T54622</code>  <id>54622</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter 2 Inhibitors</name>
  <code>T54623</code>  <id>54623</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter Antagonists</name>
  <code>T54625</code>  <id>54625</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter Interactions</name>
  <code>T54627</code>  <id>54627</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vinca Alkaloid</name>
  <code>T54694</code>  <id>54694</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Viral Envelope Interactions</name>
  <code>T54730</code>  <id>54730</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Viral Envelope Wrapping Protein Inhibitors</name>
  <code>T58463</code>  <id>58463</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Viral Envelope Wrapping Protein Interactions</name>
  <code>T58462</code>  <id>58462</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Viral Therapy</name>
  <code>T58884</code>  <id>58884</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Virus Neutralization</name>
  <code>T54774</code>  <id>54774</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Virus-specific Hyperimmune Globulins</name>
  <code>T54775</code>  <id>54775</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Viruses, Genetically-modified</name>
  <code>T54777</code>  <id>54777</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin A</name>
  <code>T54798</code>  <id>54798</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin A-class Agent</name>
  <code>T54797</code>  <id>54797</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B 12 Analog</name>
  <code>T54819</code>  <id>54819</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B 12 Analogue</name>
  <code>T54818</code>  <id>54818</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B 6 Analog</name>
  <code>T54824</code>  <id>54824</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B 6 Analogue</name>
  <code>T54823</code>  <id>54823</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B Complex Member</name>
  <code>T54814</code>  <id>54814</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B12</name>
  <code>T54822</code>  <id>54822</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B12 Analog</name>
  <code>T54820</code>  <id>54820</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B12 Analogue</name>
  <code>T54817</code>  <id>54817</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B12-class Agent</name>
  <code>T54821</code>  <id>54821</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B6 Analog</name>
  <code>T54826</code>  <id>54826</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin B6 Analogue</name>
  <code>T54825</code>  <id>54825</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin C</name>
  <code>T54828</code>  <id>54828</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin C-class Agent</name>
  <code>T54827</code>  <id>54827</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D</name>
  <code>T54835</code>  <id>54835</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D Analog</name>
  <code>T54829</code>  <id>54829</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D Analogue</name>
  <code>T54830</code>  <id>54830</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D-class Agent</name>
  <code>T54834</code>  <id>54834</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D2 Analog</name>
  <code>T54846</code>  <id>54846</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D2 Analogue</name>
  <code>T54845</code>  <id>54845</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D3 Analog</name>
  <code>T54857</code>  <id>54857</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin D3 Analogue</name>
  <code>T54856</code>  <id>54856</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin K</name>
  <code>T54888</code>  <id>54888</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin K Antagonist</name>
  <code>T54878</code>  <id>54878</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin K Epoxide Reductase Inhibitors</name>
  <code>T54882</code>  <id>54882</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin K Inhibitors</name>
  <code>T54885</code>  <id>54885</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin K-class Agent</name>
  <code>T54887</code>  <id>54887</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin Uptake and Modification Alteration</name>
  <code>T54894</code>  <id>54894</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Vitamin or Mineral</name>
  <code>T58507</code>  <id>58507</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Voltage-gated Calcium Channel Receptor Antagonists</name>
  <code>T54945</code>  <id>54945</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Volume of distribution</name>
  <code>T54946</code>  <id>54946</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>W [Preparations]</name>
  <code>T54967</code>  <id>54967</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Warfarin Reversal Agent</name>
  <code>T55028</code>  <id>55028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>X [Preparations]</name>
  <code>T55235</code>  <id>55235</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>X-Ray Contrast Activity</name>
  <code>T55264</code>  <id>55264</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Xanthine Oxidase Inhibitor</name>
  <code>T55281</code>  <id>55281</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Xanthine Oxidase Inhibitors</name>
  <code>T55282</code>  <id>55282</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Y [Preparations]</name>
  <code>T55359</code>  <id>55359</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Z [Preparations]</name>
  <code>T55412</code>  <id>55412</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Zaire EBOV GP-directed Antibody</name>
  <code>T58770</code>  <id>58770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Zaire EBOV GP-directed Antibody Interactions</name>
  <code>T58772</code>  <id>58772</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Zaire Ebolavirus Glycoprotein-directed Antibody</name>
  <code>T58769</code>  <id>58769</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions</name>
  <code>T58771</code>  <id>58771</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>Zero Order</name>
  <code>T55512</code>  <id>55512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha Adrenergic and beta Adrenergic Agonist</name>
  <code>T55710</code>  <id>55710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha Adrenergic and beta Adrenergic Receptor Agonist</name>
  <code>T55719</code>  <id>55719</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha Glucosidase Inhibitors</name>
  <code>T55681</code>  <id>55681</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha Particle-Emitting Radioactive Therapeutic Agent</name>
  <code>T44078</code>  <id>44078</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha and beta Adrenergic Agonist</name>
  <code>T55718</code>  <id>55718</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha and beta Adrenergic Receptor Agonist</name>
  <code>T55711</code>  <id>55711</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-1 Adrenergic Agonist</name>
  <code>T55691</code>  <id>55691</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-1 Adrenergic Agonists</name>
  <code>T2500</code>  <id>2500</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-1 Adrenergic Antagonists</name>
  <code>T2503</code>  <id>2503</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-1 Adrenergic Receptor Agonist</name>
  <code>T55690</code>  <id>55690</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-2 Adrenergic Agonist</name>
  <code>T9892</code>  <id>9892</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-2 Adrenergic Agonists</name>
  <code>T2506</code>  <id>2506</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-2 Adrenergic Antagonists</name>
  <code>T2510</code>  <id>2510</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Agonist</name>
  <code>T55705</code>  <id>55705</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Agonists</name>
  <code>T2495</code>  <id>2495</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Antagonist</name>
  <code>T55706</code>  <id>55706</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Antagonists</name>
  <code>T2497</code>  <id>2497</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Blocker</name>
  <code>T55708</code>  <id>55708</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Decongestant</name>
  <code>T55709</code>  <id>55709</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Receptor Agonist</name>
  <code>T55704</code>  <id>55704</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Receptor Inhibitor</name>
  <code>T55707</code>  <id>55707</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic and beta-Adrenergic Agonist</name>
  <code>T55720</code>  <id>55720</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic and beta-Adrenergic Blocker</name>
  <code>T55722</code>  <id>55722</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic and beta-Adrenergic Receptor Agonist</name>
  <code>T55716</code>  <id>55716</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Gal A Pharmacological Chaperone</name>
  <code>T58449</code>  <id>58449</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Galactosidase A Pharmacological Chaperone</name>
  <code>T58448</code>  <id>58448</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Glucosidase Inhibitor</name>
  <code>T55764</code>  <id>55764</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Glucosidase Inhibitors</name>
  <code>T55680</code>  <id>55680</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Hydroxy Acid</name>
  <code>T55770</code>  <id>55770</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha-Particle Emitting Activity</name>
  <code>T55812</code>  <id>55812</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha/beta Adrenergic Agonist</name>
  <code>T55717</code>  <id>55717</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>alpha/beta-Adrenergic Blocking Agent</name>
  <code>T55721</code>  <id>55721</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta Glucuronidase</name>
  <code>T58399</code>  <id>58399</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta Lactamase Inhibitor</name>
  <code>T56027</code>  <id>56027</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta Lactamase Inhibitors</name>
  <code>T56029</code>  <id>56029</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta Tubulin Interactions</name>
  <code>T56030</code>  <id>56030</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-1 Adrenergic Agonists</name>
  <code>T2520</code>  <id>2520</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-1 Adrenergic Antagonists</name>
  <code>T2524</code>  <id>2524</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-2 Adrenergic Agonist</name>
  <code>T56169</code>  <id>56169</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-2 Adrenergic Agonists</name>
  <code>T2526</code>  <id>2526</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-2 Adrenergic Antagonists</name>
  <code>T2529</code>  <id>2529</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-2 Adrenergic Receptor Agonist</name>
  <code>T56170</code>  <id>56170</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-3 Adrenergic Agonist</name>
  <code>T56175</code>  <id>56175</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-3 Adrenergic Agonists</name>
  <code>T2533</code>  <id>2533</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-3 Adrenergic Receptor Agonist</name>
  <code>T56173</code>  <id>56173</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Agonist</name>
  <code>T56032</code>  <id>56032</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Agonists</name>
  <code>T2512</code>  <id>2512</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Antagonists</name>
  <code>T2514</code>  <id>2514</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Blocker</name>
  <code>T56034</code>  <id>56034</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Blocker</name>
  <code>T2515</code>  <id>2515</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Receptor Agonist</name>
  <code>T56031</code>  <id>56031</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Receptor Inhibitor</name>
  <code>T56033</code>  <id>56033</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Receptor Inhibitor</name>
  <code>T2518</code>  <id>2518</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Lactamase Inhibitor</name>
  <code>T56026</code>  <id>56026</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta-Lactamase Inhibitors</name>
  <code>T56028</code>  <id>56028</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta2-Adrenergic Agonist</name>
  <code>T56172</code>  <id>56172</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta2-Adrenergic Receptor Agonist</name>
  <code>T56171</code>  <id>56171</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta3-Adrenergic Agonist</name>
  <code>T56176</code>  <id>56176</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>beta3-Adrenergic Receptor Agonist</name>
  <code>T56174</code>  <id>56174</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>cPMP</name>
  <code>T58543</code>  <id>58543</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>fms-Like Tyrosine Kinase 3 Inhibitors</name>
  <code>T58918</code>  <id>58918</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid (GABA)-ergic Agonist</name>
  <code>T57014</code>  <id>57014</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid A Agonist</name>
  <code>T56997</code>  <id>56997</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid A Receptor Agonist</name>
  <code>T57004</code>  <id>57004</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid A Receptor Positive Modulator</name>
  <code>T58903</code>  <id>58903</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid-A Agonist</name>
  <code>T56999</code>  <id>56999</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid-A Receptor Agonist</name>
  <code>T57003</code>  <id>57003</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid-ergic Agonist</name>
  <code>T57015</code>  <id>57015</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gamma-Ray Emitting Activity</name>
  <code>T57065</code>  <id>57065</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gp100 Peptide-HLA-directed Antibody Interactions</name>
  <code>T58698</code>  <id>58698</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>gp100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</name>
  <code>T58699</code>  <id>58699</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>l-Thyroxine</name>
  <code>T57295</code>  <id>57295</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>l-Thyroxine (T4)</name>
  <code>T57293</code>  <id>57293</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>l-Thyroxine-containing Agent</name>
  <code>T57294</code>  <id>57294</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>l-Triiodothyronine</name>
  <code>T57299</code>  <id>57299</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>l-Triiodothyronine (T3)</name>
  <code>T57298</code>  <id>57298</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>l-Triiodothyronine-containing Agent</name>
  <code>T57297</code>  <id>57297</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>mAb</name>
  <code>T58474</code>  <id>58474</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>mTOR Inhibitor Immunosuppressant</name>
  <code>T57375</code>  <id>57375</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>mTOR Inhibitors</name>
  <code>T57377</code>  <id>57377</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>moAb</name>
  <code>T58475</code>  <id>58475</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>mu-Opioid Receptor Agonist</name>
  <code>T57544</code>  <id>57544</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>mu-Opioid Receptor Agonists</name>
  <code>T37327</code>  <id>37327</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>penicillin binding protein Inhibitors</name>
  <code>T52710</code>  <id>52710</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>rhDNase 1</name>
  <code>T46392</code>  <id>46392</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>rhDNase I</name>
  <code>T46398</code>  <id>46398</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>siRNA</name>
  <code>T58454</code>  <id>58454</id>
  <status>ACTIVE</status>
 </term>
 <term>
  <namespace>MED-RT</namespace>
  <name>β-globin Gene Transfer</name>
  <code>T58654</code>  <id>58654</id>
  <status>ACTIVE</status>
 </term>
 <concept>
  <namespace>MED-RT</namespace>
  <name>1-Compartment [PK]</name>
  <code>C298</code>  <id>299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>1-Compartment</to_name>
    <to_code>T82</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000060</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>11-beta Hydroxysteroid Dehydrogenase Inhibitors [MoA]</name>
  <code>C654285</code>  <id>654285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11beta-HSD Inhibitors</to_name>
    <to_code>T58878</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11beta-Hydroxysteroid Dehydrogenase Inhibitors</to_name>
    <to_code>T58879</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>11-beta Hydroxysteroid Dehydrogenase Inhibitors</to_name>
    <to_code>T58875</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11β Hydroxysteroid Dehydrogenase Inhibitors</to_name>
    <to_code>T58880</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11-beta-Hydroxysteroid Dehydrogenase Inhibitors</to_name>
    <to_code>T58877</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11 beta-Hydroxysteroid Dehydrogenase Inhibitors</to_name>
    <to_code>T58876</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11βHSD Inhibitors</to_name>
    <to_code>T58881</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194061</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>11-beta Hydroxysteroid Dehydrogenase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA]</name>
  <code>C654284</code>  <id>654284</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
    <to_code>T58868</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
    <to_code>T58869</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
    <to_code>T58872</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11β Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
    <to_code>T58873</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11βHSD-1 Inhibitors</to_name>
    <to_code>T58874</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors</to_name>
    <to_code>T58870</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>11beta-HSD1 Inhibitors</to_name>
    <to_code>T58871</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194062</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>14-alpha Demethylase Inhibitors [MoA]</name>
  <code>C300411</code>  <id>300411</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors</to_name>
    <to_code>T162</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020025</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terconazole [37806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioconazole [38298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole nitrate [236601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oteseconazole [2602577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>2-Compartment [PK]</name>
  <code>C300</code>  <id>301</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>2-Compartment</to_name>
    <to_code>T309</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000061</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>3-Compartment [PK]</name>
  <code>C302</code>  <id>303</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>3-Compartment</to_name>
    <to_code>T438</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000062</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</name>
  <code>C635228</code>  <id>635228</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</to_name>
    <to_code>T618</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitor</to_name>
    <to_code>T617</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor</to_name>
    <to_code>T615</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>4-Hydroxyphenylpyruvate Dioxygenase Inhibitor</to_name>
    <to_code>T616</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175809</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with 4-hydroxyphenylpyruvate dioxygenase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitisinone [61805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with oxidoreductase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>5-Lipoxygenase Inhibitor [EPC]</name>
  <code>C635394</code>  <id>635394</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitor</to_name>
    <to_code>T720</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175956</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zileuton [40575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing 5-lipoxygenase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-Lipoxygenase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with 5-lipoxygenase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>5-Lipoxygenase Inhibitors [MoA]</name>
  <code>C635393</code>  <id>635393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitors</to_name>
    <to_code>T721</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175955</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>5-alpha Reductase Inhibitor [EPC]</name>
  <code>C635255</code>  <id>635255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitor</to_name>
    <to_code>T739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175836</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing 5-alpha reductase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with 5-alpha reductase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dutasteride [228790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>5-alpha Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>finasteride [25025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>5-alpha Reductase Inhibitors [MoA]</name>
  <code>C430</code>  <id>431</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors</to_name>
    <to_code>T740</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000126</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto extract [236344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>A [Preparations]</name>
  <code>C288627</code>  <id>288627</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>A [Preparations]</to_name>
    <to_code>T827</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010583</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anifrolumab [2565265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atorvastatin calcium [83366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctostaphylos tomentosa whole extract [2591795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica biserrata whole extract [2360136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus americanus whole extract [2592616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin human-kjda [2054166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus nidulans allergenic extract [1368357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>angiotensin II [1999003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus hybridus pollen extract [1363561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia zerumbet leaf extract [1309392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus hippocastanum bark extract [1309398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acai berry extract [848929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acriflavine hydrochloride [1664337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adansonia digitata seed oil [1421429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amyloglucosidase (Aspergillus niger) [2593716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-atto [2103479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amlexanox [46307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ambrosia artemisiifolia extract [1347557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydroxide gel [613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Althaea officinalis flower extract [1435101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer pseudoplatanus pollen extract [1801702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot kernel oil [1318515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American eel preparation [2375518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aldioxa [23161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer campestre leaf bud extract [2054071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amyl acetate [1370452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-isomethionyl acetate, (2R)-(+) [1664336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine, DL- [1729154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acesulfame [1310546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambenonium chloride [624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum virginicum whole extract [2667258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminacrine hydrochloride [81949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azelastine hydrochloride [235824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apis cerana worker secretion preparation [1373205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloysia citrodora leaf oil [2531386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ampicillin trihydrate [203115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amantadine [620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl acrylate [1788869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica anomala root extract [2590914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amantadine hydrochloride [282415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atovaquone [60212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein [2631084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous tacrolimus [235991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus ruber [1324086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple wood extract [2479556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha 1-antitrypsin [535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetamidopropyl trimonium chloride [1483777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aethusa cynapium extract [1351000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl cyclohexaneacetate [2557380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-(((2-(2-amino-3-hydroxy-2-(hydroxymethyl)propoxy)-1-hydroxypropyl)hydroxyphosphoryl)oxy)-1-hydroxypropyl)phosphonate [2380376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopropanediol [2050415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atomoxetine hydrochloride [353103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Althaea officinalis root extract [1306165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia annua leaf extract [1656306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-amino-2-ethyl-1,3-propanediol [1539638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>artemisia pallens whole extract [1603472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus manihot whole extract [2637343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia maritima flower extract [1309672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asiatic acid [1551574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almasilate anhydrous [1944248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aralia cordata root extract [1420958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-aminophenol [1435279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atractylodes macrocephala root extract [1372633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Azadirachta indica whole extract [1722379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-amino-2-hydroxytoluene [1740236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arbutamine [61609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anaplasma phagocytophilum [2168766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amorphophallus konjac root extract [1537210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetophenazine [16735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anthoxanthum odoratum extract [1319268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium methacrylate [1988680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alectinib [1727455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica dahurica whole extract [1490679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia cina flower extract [1309510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidyl alcohol [1368131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aristolochia clematitis whole extract [1552036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alstonia constricta bark extract [1441544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus chinensis seed extract [1868198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonia spirit, aromatic [317201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies balsamea leaf oil [1356479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum napellus extract [1310220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica gigas root extract [1307664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ascophyllum nodosum extract [1311127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine [1091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloysia citrodora flower oil [2391535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almagate [2475181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-amylcinnamaldehyde, (E)- [2265846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-amino-1,3-propanediol [2467839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amantadine sulfate [621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allethrin [513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetamine aspartate monohydrate [405812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum heterotropoides var. mandshuricum root extract [1365709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adipate ion [2109241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetamine sulfate [81952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anemone pratensis flowering top extract [1811457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia decurrens flower wax [1607326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus allochrous whole extract [2375707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amino methacrylate copolymer [1311153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actinidia polygama fruit extract [1307674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisindione [17941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alisma plantago-aquatica subsp. orientale whole extract [2263060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alisma plantago-aquatica root [2118534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alphaprodine hydrochloride [7433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apraclonidine [14845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum silicate [1362917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anacardium occidentale whole extract [2180254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acyclovir [281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asperagenin [1866040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylamide [1368125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anthrax immune globulin [1722336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic [1111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albuterol sulfate [142153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argania spinosa leaf extract [1593611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azelate [618278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoproxan [1440271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arroyo willow pollen extract [852170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ajmaline [423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-dihydroartemisinin [2584841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia nigra root extract [2560105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica dahurica var. formosana whole extract [1539965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium thioglycolate [1482632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aristotelia chilensis fruit extract [1655978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus esculentus whole extract [2119173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl octapeptide-3 [1313046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alcuronium chloride [66852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argentine canola pollen extract [1484975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfatradiol [1926478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiloride [644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arabica coffee bean allergenic extract [891502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acremonium strictum allergenic extract [905070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave polianthes flower wax [2180547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acemetacin [16695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aphanizomenon flos-aquae [1310848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyltryptophanate [1366817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxicillin [723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium laureth-5 sulfate [1306944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl sulfide [17376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albendazole [430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agathosma betulina leaf extract [1309499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminomethylpropanol (perfluoro-C6-C12 ethyl)phosphate [1491008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopropyl dimethicone (1000 MPA.S) [2463336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acellular tissue engineered vessel-tyod [2700340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atomoxetine [38400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylose, tapioca [2171590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydroxide, dried (USP) [81948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arformoterol [304962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic trioxide [18330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus propinquus root extract [1309814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arbekacin [26397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, human [203083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ardeparin sodium [87865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum magnesium hydroxide carbonate [2468436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Azadirachta indica bark extract [1307661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus glutinosa leaf extract [1992670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>advantame [1591894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-amino-5,6-dichloroquinazolin-3(4h )-yl)acetic acid [2634407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alizapride [17311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus viridis subsp. crispa leaf extract [2054070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspartame [1311524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus hypochondriacus seed extract [2541498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer negundo root bark extract [1925204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium phosphate, dibasic [1427061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amitriptyline [704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl tetrapeptide-15 [1733675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adenophora stricta root extract [1305553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.,.beta.&apos;-diglycerin [1648687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia nilotica bark extract [1987639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-isopropyl-phenethyl alcohol [2458326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allergenic extract, pigweed, spiny, pollen [314428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anastrozole [84857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Andrographis paniculata top extract [1998719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Absidia capillata allergenic extract [1306881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Australian pine pollen extract [852229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antirabies serum,equine [485234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen [2626471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atipamezole [18475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atipamezole hydrochloride [390043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American lobster allergenic extract [1997187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ardisia crenata root extract [2610397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avilamycin [1661561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha glucosidase [2475361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allantoin, (+)- [1739978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>African Pygeum extract [580117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica archangelica leaf extract [1309286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony trisulfide [1316091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum chloride hexahydrate [17611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amprolium [1006654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aconitic acid, (Z)- [1313275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous lactose [1307662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum napellus root extract [1330284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abetimus [1311600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum [1311504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin sodium dihydrogen phosphate [2679612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adipic acid [17050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alverine [17627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actaea dahurica whole extract [2678311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-terpineol, (+)- [2398338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus hippocastanum seed oil [1535452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium phosphate,monobasic [314493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agkistrodon contortrix venom [1310455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alarelin acetate [2641624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia oxyphylla fruit extract [2592957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl farnesylcysteine [1868830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha bisabolene [2675320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arabidopsis thaliana extract [1314265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adansonia digiata whole extract [1539421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine, D- [1742746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-amylase [560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arisaema consanguineum root extract [1724419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia princeps leaf oil [1547467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminosalicylate [113374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adonis vernalis flowering top extract [1546862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aquaporin-1 [2463337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflatoxin B1 [2282017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avacincaptad pegol [2645108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies sachalinensis var. sachalinensis oil [1309280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambergris [1311494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrivastine [19959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acenocoumarol [154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot kernal oil PEG-6 esters [1305536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>7-aminodesacetoxycephalosporanic acid [1990418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anileridine [17933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anguilla rostrata blood serum [1313312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopheryloxyacetate [1995482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium acryloyldimethyltaurate - beheneth-25 methacrylate crosspolymer (52000 MPA.S) [1541234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus moschatus seed extract [1352512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-acetonaphthone [2378835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus canadensis root extract [2532930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atazanavir [343047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminobenzoate [143980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia dealbata pollen extract [2202946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony sulfate [2564026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American chestnut allergenic extract [891752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcarnitine, DL- [1310540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azintamide [402580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfaxalone [1544577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atropa belladona whole extract [1361461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia decurrens extract [1362813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adenium obesum whole extract [2599920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminium triglycinate [1659193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aquilaria malaccensis stem extract [1307715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid violet 43 [1426422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atorvastatin [83367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica angustifolia flower extract [1309943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aviscumine [2591797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonio methacrylate copolymer type A [1424665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic salmon allergenic extract [900031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica dahurica var. formosana root extract [1923500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium iodide [1720161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apium graveolens whole extract [2102723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antithrombin III, human [221062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-aminobenzoate [618974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum starch octenylsuccinate [1426415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aromadendrin [1601985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminohippurate sodium [203194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparaginase Erwinia chrysanthemi [1431738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aqua regia [1537801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave atrovirens top extract [2591600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies alba leafy twig extract [1545037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alaria esculenta extract [1358846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arizona ash pollen extract [852496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abrocitinib [2591476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avocado oil [1311611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminolevulinate [155002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum zirconium pentachlorohydrate [1306097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acepromazine maleate [1114057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl tetrapeptide-2 [2476004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atezolizumab-tqjs [2693883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-pinene [2362183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia catechu wood extract [1811251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agastache foeniculum whole extract [2470030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl tetraisopalmitate [1356761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer saccharinum whole extract [1597887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus flavus var. oryzae [1329940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspartic acid [1169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfacalcidol [12062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abutilon theophrasti seed extract [2592956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amprolium ion [1546165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnebia euchroma root extract [2047171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-amylcinnamyl acetate [2395800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony triiodide [1423913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus rhombifolia bark extract [2590595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-amino-5-nitrothiazole [1665683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allopurinol sodium [80566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amisulpride [46303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprazolam [596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl dipeptide-1 cetyl ester [1374852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenosine phosphate disodium [1306123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aztreonam [1272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Avena sativa flowering top extract [1309702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium polyacryloyldimethyl taurate (55000 MPA.S) [2105930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anise oil [90926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum carmichaelii root extract [1310071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argon [1368133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus glabra nut extract [1357998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer saccharum whole extract [1597886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl glutamic acid [2001205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha, alpha-dimethylbenzyl alcohol [1306124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer pensylvanicum whole extract [2590593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer negundo inner bark extract [1727167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylated lanolin alcohols [1364294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acorus calamus var. angustatus whole extract [2539292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acryloyldimethyltaurate [1370664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrovitamin A [2669473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>artesunate [18346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium valerate [1441545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amentoflavone [2643210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achillea millefolium root oil [2467730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl arginine [2469242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>altrenogest [1314612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ansuvimab [2472152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anthrax Vaccine Adsorbed [404774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aloe vera leaf extract [1306128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl triethylhexyl citrate [1313223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Antiaris toxicara resin [1370298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>artemether [18343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot fruit oil [1428854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonia N-13 [1305558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adefovir dipivoxil [141400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprolium [1546166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amikacin sulfate, liposomal [2059179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alogliptin [1368001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alcea rosea flower extract [1307576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anamu preparation [283537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ardisia japonica stem extract [1309405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin,aggregated [317176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actinidia chinensis whole extract [1356482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopterin sodium [1440263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anti-interleukin-1.alpha. immunoglobulin G rabbit [1426469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium stearate [1312975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonia [1299884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apraclonidine hydrochloride [91350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almotriptan malate [283792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amodimethicone (240 CST) [2471080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avacincaptad pegol sodium [2645107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia vulgaris top oil [1360630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcarnitine [193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anamirta cocculus fruit extract [2591794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin B lipid complex [2001759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus nuttallii leaf extract [1309768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica chamissonis flower extract [1309288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl glucoside [1306933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-aminophenol [1740241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-aminobutyric acid, L- [2464936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia concinna fruit extract [1928182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atropa belladonna root extract [1353220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab [327361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprobarbital [17381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer saccharum leaf extract [2471077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actaea racemosa whole extract [1651691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aloglutamol [17392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abetimus sodium [1311599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>algal fungi allergenic extract [966692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asplenium scolopendrium whole extract [1543293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Armoracia rusticana whole extract [1946395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alkali blite pollen extract [852106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfentanil [480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Avena sativa leaf extract [1307606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acidulated phosphate fluoride [236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aronia arbutifolia whole extract [2001614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amodimethicone (3500 CST) [1483728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>annual bluegrass pollen extract [898404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adansonia digitata fruit pulp extract [2391137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica archangelica root extract [1309828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrimonia eupatoria leaf extract [1994294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apremilast [1492727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium hookeri whole extract [2630720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylic acid/ethylene copolymer (600 mPa.s) [1792115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aquaporin-4 [2370867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Araneus diadematus preparation [1353218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amorolfine hydrochloride [293865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminophylline [689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies sibirica leaf oil [1306158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopentamide, sulfate [1006396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia officinarum whole extract [2055272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arisaema triphyllum root extract [1309954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astacus astacus extract [1370790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aquilegia canadensis whole extract [2103291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agatolimod sodium [2665621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetamidoethoxyethanol [2370868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amodimethicone (1300 CST) [1535932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apomorphine hydrochloride [71225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Areca catechu fruit rind extract [2477851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium hydroxide [1362884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum kusnezoffii whole extract [2375524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arabica coffee oil [1362134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amprenavir [228656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adrenal cortex extract [91413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apaflurane [1368129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asplenium scolopendrium top extract [1482547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>6-aminocaproic acid [99]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albuterol [435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum sieboldii root extract [1307817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arimoclomol [2694283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid red 35 [2274098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alectinib hydrochloride [1727454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anthralin [873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amodiaquine hydrochloride [314495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic trichloride [2533832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidyl glucoside [1368132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl hexapeptide-49 [1798383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arformoterol tartrate [668284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium glycyrrhizinate trihydrate [2640215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum zirconium pentachlorohydrex gly [1305899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-aminohippuric acid [7832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anacardium occidentale bark extract [2591602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer nigrum whole extract [2539930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alchemilla vulgaris flowering top extract [2711887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anacardium occidentale fruit extract [1358956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies koreana leaf extract [2178060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony tartrate ion [2384445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin monohydrate [1298839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arisaema erubescens whole extract [2199293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amber [1311393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylsalicylsalicylic acid [1858285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alyssoides utriculata extract [1925581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium fistulosum bulb extract [1599142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia catechu whole extract [1650239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axicabtagene ciloleucel [1987398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia dealbata flower wax [2180546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfentanil hydrochloride [203203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin anhydrous [1299904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia galanga whole extract [1733796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antilymphocyte immunoglobulin [973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin,iodinated I-125 serum [317177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha ionone [1859172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium lauroyl sarcosinate [1489759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum dicetyl phosphate [2045337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aloe extract [91263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple extract [1424865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alisma plantago-aquatica subsp. orientale root extract [1372632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylocaine hydrochloride [235793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica acutiloba root extract [1309200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amitriptyline oxide [236734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminocaproate [113373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-bisabolol, (+-)- [1306126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidic acid [1716331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrisorcin [89729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amorolfine [17804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azilsartan medoxomil [1091642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia catechu bark extract [1547465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylmandelic acid, (+)- [1430397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amoeba proteus [1313311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspartate [42543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica flowers extract [283674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acorus calamus extract [1310280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aconitine [1441664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum stearate [46243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid red 337 [2621122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alanine, DL- [1546161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anigozanthos flavidus flowering top extract [2621642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetoin [2683094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus hybridus leaf extract [2590597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl hexanoate [1807113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfuzosin [17300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin [18631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe vera preparation [318340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica sinensis preparation [328141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alloin [17354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammoniac [1314236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arum maculatum root extract [1309789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anthemis arvensis flowering top extract [1995251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambroxol hydrochloride [438399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alginic acid [17305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asparagus adscendens root extract [1483729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alatrofloxacin mesylate [221054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprotinin [1056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albiglutide [1534763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisyl acetate [2605801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-asarone [2375532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl carboxymethyl cocoyl glycine [1313222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiloride hydrochloride, anhydrous [1298837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous zinc acetate [1299637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpine strawberry extract [1328308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allogenic bone-marrow-derived mesenchymal stem cells [2700761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcholine [194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azlocillin sodium [203836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple pectin [283540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afatinib dimaleate [1430441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amsacrine [739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-allyl-2,6-dimethoxyphenol [1423781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia capillaris whole extract [2570731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia tridentata top oil [1546863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arundinaria gigantea whole extract [2632731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ado-trastuzumab emtansine [1371041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aliskiren [325646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminolevulinic acid hydrochloride [261715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argania spinosa seed extract [1435100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>air [411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ADAMTS13, recombinant [2670285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acefylline methylsilanol mannuronate [2560400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asclepias incarnata root extract [2102724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine hydrochloride [89918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amivantamab-vmjw [2549198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alstonia scholaris bark extract [1673122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amodiaquine [720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-damascone [2398332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctostaphylos uva-ursi leaf extract [1306212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anastatica hierochuntica whole extract [2583869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aconitate [1721299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine amide [1591923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arnatto leaf extract [1659194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceglutamide aluminum [1426378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asimina triloba whole extract [2534453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amlodipine besylate [104416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetazolamide [167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antazoline hydrochloride [81954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>activated charcoal [272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atractylodes macrocephala whole extract [2263062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica montana extract [285208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ageratina herbacea whole extract [2630719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>andexanet alfa [2045114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine ferulate [2107305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argeratina aromatica root extract [1315107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aronia melanocarpa fruit extract [1311541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amaranth dye [1433189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alogliptin benzoate [1368000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-adaz [2641642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atoltivimab-ebgn [2461430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus flavus allergenic extract [999384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony potassium tartrate [981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alternaria alternata allergenic extract [901845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrostemma githago seed extract [1428414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl hexapeptide-8 [1314329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer negundo wood extract [2121052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia senegal whole extract [1989248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium laureth-7 sulfate [2059294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adrenalone [17073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum sodium silicate [1427203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>altretamine [5296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angostura bark extract [1322552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetic acid C-11 [2550706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acorus gramineus root extract [1306197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus manihot flower extract [1739231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(3-aminopropyl)diethanolamine [2371035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allergenic extract, false ragweed pollen [314365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aframomum angustifolium seed extract [1309401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alosetron [85248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asterias rubens preparation [1192621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum ferox root extract [1348454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia abrotanum whole extract [1313225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyldigoxins [199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atractylodes japonica root oil [1305643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica sinensis root oil [1990417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum dimyristate [1305555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylocaine [40660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anethum graveolens whole extract [1600751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple cider vinegar [360262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidyl behenate [1314266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arimoclomol citrate [2694282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abarelix [301739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azficel-T [1114112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopropazine fumarate [1440268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abobotulinumtoxinA [860168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alchemilla xanthochlora flowering top extract [1309722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetaminophen [161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium xylenesulfonate [1423272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Antirrhinum majus leaf extract [2590598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arizona cypress pollen extract [852814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argan oil [1305642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Althaea officinalis leaf extract [1307864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-bisabolol, (+)- [1487162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid green 50 [2532534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Austrian pine pollen extract [900750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica montana flower water [1486086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argentina anserina flowering top extract [1309729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allopurinol [519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe vera leaf polysaccharides [1739980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argipressin [1098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia seyal whole extract [2398145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>archangelenone [2667257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin B [732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ammopiptanthus mongolicus stem extract [2668551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atenolol [1202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alanylglutamine [1359422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Androctonus australis venom [1486798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica dahurica root extract [1306167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetoxolone [16784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ash pollen extract [1484982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctostaphylos uva-ursi whole extract [1658432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum heterotropoides extract [1372478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anamirta cocculus seed extract [1310018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple juice [1358965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol linoleate, D- [1427235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-aaty [2639649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ardeparin [87866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus mongholicus whole extract [2360134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydromethylenecitric acid [2286804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaryllis belladonna whole extract [2591601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Averrhoa carambola leaf extract [1307642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetaldehyde [1311137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyldigitoxin [132871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-chlorohydrin, (+/-)- [2396781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept-ayyh [2696256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydroxyphosphate [1423457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine aminobenzoate [1010241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ampelopsis japonica root extract [1309394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anifrolumab-fnia [2565276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acai fruit pulp [1482538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agathosma crenulata whole extract [2001811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum oxide [615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asunaprevir [1652103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anti-inhibitor coagulant complex [314504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl .alpha.-ionone [2396431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acoramidis hydrochloride [2698313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia umbelliformis whole extract [1539423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ancrod [772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-citronellal [2472775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic rock crab preparation [1599642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anacystis nidulans [2200639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctium lappa root oil [1866039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ailanthus altissima bark extract [2200073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adrafinil [45938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acmella oleracea flowering top extract [1547712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony arsenate [1313314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetone [178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avanafil [1291301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum sulfate tetradecahydrate [1306098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aripiprazole lauroxil [1673265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl tocopheryl phosphate [1427200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambroxol acefyllinate [236595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amyris balsamifera oil [1305639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alarelin [2641623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetiamine hydrochloride [236301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum sulfate anhydrous [1593147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abatacept [614391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ambrosia psilostachya top extract [1368328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(2-aminoethoxy)ethanol [1737111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aldesleukin [70223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave americana whole extract [1996979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alglucosidase alfa [629565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceglutamide [1426379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actinidia chinensis seed extract [1307842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aji pepper extract [1311143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic triiodide [1309691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctium minus root extract [1996103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica montana root extract [1309947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alclometasone [108088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica cordifolia flower extract [1307964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium ferrous sulfate [17784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aducanumab-avwa [2557218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>attapulgite [18516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adrenalone hydrochloride [236364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amyl salicylate [236149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopheryloxyacetic acid [1995481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctium lappa fruit oil [1541708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achyranthes japonica whole extract [1314262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ahnfeltiopsis concinna extract [1328285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3A,4,5,6,7,7A-hexahydro-1H-4,7-methanoinden-6-yl acetate [2467276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia tridentata whole extract [2533833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambroxol [625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid black 52 [1435106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopyrine [695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acmella oleracea flower extract [1307610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminolevulinic acid [683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atriplex polycarpa whole extract [2590599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allantoin glycyrrhetinic acid [1862870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenovirus type 7 vaccine live [1099937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achillea ptarmica whole extract [2375523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica anomala whole extract [1991256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American elm pollen extract [852054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azilsartan [1091643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azathioprine [1256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>androstenedione [784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium molybdate [17789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avobenzone [45045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abciximab [83929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atazanavir sulfate [358299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus exscapus whole flowering-fruiting extract [1605083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrimonia pilosa whole extract [1547466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atipamezole hydrochloridde [2123357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspidosperma quebracho-blanco root extract [2591796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus caudatus seed extract [1307690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acemannan [1426875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amifampridine [2106338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alibendol [236219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum zirconium octachlorohydrex gly [1306096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afoxolaner [1442093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amomum subulatum fruit extract [2687236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica sinensis whole extract [1370729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amikacin [641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminophylline dihydrate [1298965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argemone mexicana extract [1537756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Azadirachta indica seed oil [1305648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous liquid lanolin [1305544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amomum villosum var. xanthioides whole extract [1535473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apalutamide [1999574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ambrosia peruviana leaf extract [1307757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylic acid-sodium acrylate copolymer (1:1; 600 MPA.S at 0.2%) [1429914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic mackerel allergenic extract [2198984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium benzoate [1312540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>armodafinil [641465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acorus calamus root extract [1309395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum chlorohydrate anhydrous [2102410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, human recombinant [1300486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alphaprodine [594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia angustissima bark extract [1370191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminoglutethimide [677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia galanga leaf extract [1309959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agaricus subrufescens extract [1655977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopropyl ascorbyl phosphate [1307558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allogeneic processed thymus tissue [2626460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alcaftadine [1000082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adansonia digitata leaf extract [1428848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspartame acesulfame [1371304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol succinate [39626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amitriptyline hydrochloride [203168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-eleostearic acid [2630219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum cation [1546162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcholine chloride [20814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetamidopropyl trimonium [1483778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspartate magnesium hydrochloride [1167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-azetidinecarboxylic acid, (+)- [2397715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5.alpha.-hydroxy laxogenin [1801703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(all-Z)-4,7,10,13,16-docosapentaenoic acid [1360626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium laureth-2 sulfate [1307565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abaloparatide [1921069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfalfa pollen extract [852634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albutrepenonacog alfa [1743992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetone sodium bisulfite [1364858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alglucerase [46049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-acetoxy-3-pentyltetrahydropyran [2589802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus repens allergenic extract [1006310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctium lappa whole extract [1312542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acesulfame potassium [1310545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alseroxylon [599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axatilimab-csfr [2691528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aralia chinensis whole extract [1746485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylopectin [1368128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetic monoethanolamide [1311639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acebutolol [149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alcuronium [460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-aminomethylbenzoic acid [14852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Androctonus australis whole extract [2002063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus hippocastanum flower extract [1309497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anazolene acid [1440972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ansuvimab-zykl [2472151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acmella oleracea whole extract [1546861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aducanumab [2557217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agaric acid [1441428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azlocillin [1266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acalypha indica extract [1441294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminosalicylic acid [7833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axitinib [1242999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprenolol hydrochloride [81947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ardisia gigantifolia root extract [2634530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-lactose [2359362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetohydroxamic acid [16728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-aacf [2640849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium picrate [1859364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia vulgaris root extract [1341384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparagus cochinchinesis tuber extract [1307675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amitriptyline pamoate [235737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-D-galactosidase enzyme [259351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avutometinib [2714515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American aloe stem extract [1601988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylamidopropyltrimonium chloride/acrylamide copolymer (400 MPA.S) [1735030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony [1311407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apomorphine [1043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopromazine [2462496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allo-2-hydroxycitric acid [2369353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abametapir [2475532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amlodipine benzoate [2184116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium thiocyanate [2109607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-acetylanisole [2612428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-ethyl-3,4-methylenedioxybenzylamine [2698077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atractylodes lancea root extract [1307719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allylthiourea [1318494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-anisic acid [1426595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer saccharum bark-sap extract [1309406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acyclovir sodium [81944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asiaticoside [18405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus glutinosa bark extract [1441543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia pollen extract [851732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidonate [1368625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agathosma crenulata leaf extract [2048881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-terpinyl acetate, (-)- [2398336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus niger allergenic extract [1742530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl pentaerythritol [2003177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alendronic acid [236083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe emodin [2561527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin,iodinated I-131 serum [314301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica biserrata root extract [1366320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies alba leaf oil [1549633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia baileyana pollen extract [895223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adiantum capillus-veneris leaf extract [1649017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adefovir [16521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acamprosate calcium [152761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrimonia eupatoria flowering top extract [1309504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aronia melanocarpa fruit juice [1311549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>all-trans-retinol [1367187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopentamide [1006397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple cider [2593711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl lactoside [2268052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amilomer [259399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amifampridine phosphate [2106337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic cation [1485046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid red 1 [1863219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antazoline phosphate [866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atrasentan hydrochloride [2710448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adansonia digitata fruit extract [1424863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetamine saccharate [540810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisacril [1311637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acepromazine [155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia absinthium whole extract [2166649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aconite [242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-acetoxy-1, 8-cineole, (+)-endo- [2386028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspergillopepsin I (Aspergillus phoenicis) [2593717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asenapine maleate [860647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apixaban [1364430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica archangelica whole extract [2533831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydrate [1305556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apigenin [1368130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-methylbenzyl acetate [2374917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(-)-ambroxide [2557381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alverine citrate [71767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminosalicylic sodium [89753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afatinib [1430438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica root oil [1305640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>angiotensin II acetate, human [2204740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Annickia chlorantha bark extract [1307648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha hydroxy acids [236797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ampicillin (anhydrous) [221058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspen pollen extract [852339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminoethylphosphinic acid [1540525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argatroban [15202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antazoline sulfate [2680384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arbutin [1367175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alcohol, x-ray exposed (1000 rad) [1368126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylglucosamine [1362871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>angelicin [2690789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha 1-proteinase inhibitor, human [991743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avibactam sodium [1603833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium hypophosphite [2360135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>astemizole [42328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asclepias quadrifolia whole extract [1314267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aletris farinosa root extract [1309950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetate [164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ananas comosus whole extract [2284291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acexamic acid [15978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia capillaris flower extract [1307554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amyl cinnamal [1311606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argemone mexicana whole extract [1442191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anaerococcus tetradius [1592903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica pubescens root extract [1307573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica gigas whole extract [2287730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actaea dahurica root extract [1657850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe arborescens leaf extract [1422928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetophenone [2467143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atracurium besylate [1219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asclepias tuberosa flowering top extract [1309805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>astaxanthin [18451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus hypochondriacus whole extract [1539422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ABCB4 protein, human [2117853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apis cerana whole preparation [1545170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ampelopsis delavayana root extract [2665623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminaphthone [46276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony cation (3+) [1546167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aloe vera flower extract [1309199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abacavir [190521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica polymorpha root extract [1648927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Albizia julibrissin bark extract [1307572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anemone americana extract [1311411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-amino-2-methyl-1-propanol [1310544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylic acid/2-ethylhexyl acrylate/styrene copolymer (500000 MW) [2361309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceclofenac [16689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylated sucrose distearate [1427064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia abrotanum flowering top extract [1336267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine pyroglutamate [1482633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl sulfisoxazole [40595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achillea millefolium seed extract [2592615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium lauryl sulfate [1424667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparagine monohydrate [1666924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic halibut preparation [2174524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alcloxa [1305554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisotropine [89780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus moschatus flower extract [2263153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine aspartate [18254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-isomethylionone [1368186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amanita phalloides whole extract [1441299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achyrocline satureioides extract [1318236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ardisia gigantifolia whole extract [2610398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acebutolol hydrochloride [142130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus viridis leaf extract [1357999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avalglucosidase alfa [2565814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe africana leaf extract [2675984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atropa belladonna whole extract [1363430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alum, potassium anhydrous [1363564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ancylostoma caninum [2469251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acacia decurrens flower extract [1791834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyltriethyl citrate [1311603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisum extract [1320407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Azadirachta indica flower extract [1307952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl heptanoate [2383533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amcinonide [17652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum sulfate [17621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alclometasone dipropionate [17268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminacrine [645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus mongholicus root extract [2001494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrimonia eupatoria flower extract [1309501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atorvastatin calcium propylene glycol solvate [1483793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydroxyide-glycine (2:1) [1371308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anise seed extract [1309292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetophenazine maleate [91127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adipic acid-diglycol crosspolymer (20000 MPA.S) [1605702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alum, potassium [221456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium sulfate [1362695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Albuca bracteata whole extract [2002576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum sulfate octadecahydrate [2178309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium cocoyl isethionate [1426647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apis mellifera ven protein [259525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alexitol [644634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonio methacrylate copolymer type B [1306198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alvimopan [480639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica acutiloba root oil [1371908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acellular pertussis vaccine, inactivated [798302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus niger preparation [350312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American plum fruit extract [1737115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylase [743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almond allergenic extract [892507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-(.alpha.-aminopropyl)benzyl alcohol [1654972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ajuga turkestanica top extract [1307592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-fkjp [2640402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenite ion [1546382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aliskiren hemifumarate [732498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine zinc [1490795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfuzosin hydrochloride [46043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amidoline [17684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia capillaris leaf extract [2390758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica gigas root oil [1541881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aleurites moluccanus whole extract [2287547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adrenocorticotropin (ACTH 1-18),I-125 (TYR) [314298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopropyl dihydrogen phosphate [1367492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ABT-925 [1661017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arisaema dracontium root extract [1313734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium ion [1313310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid yellow 1 [2465831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept-boav [2725885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Armadillidium vulgare whole extract [2531930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminopterin [1440264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avibactam [1603834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>auranofin [1227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylate/butylaminoethyl methacrylate/methyl acrylate/methyl methacrylate/octylacrylamide copolymer (40000 WAMW) [2695992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alteplase [8410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-aqvh [2640387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aquilegia vulgaris extract [1320411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe andongensis leaf extract [1420957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allobarbital [516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum sesquichlorohydrate [543375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-(.alpha.-aminopropyl)benzyl alcohol hydrochloride, erythro-(+/-)- [1812466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alternanthera sessilis extract [1788870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alchemilla xanthochlora whole extract [2107417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminobutyric acid [70582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-(((2-(2-amino-3-hydroxy-2-(hydroxymethyl)propoxy)-1-hydroxypropyl)hydroxyphosphoryl)oxy)-1-hydroxypropyl)phosphonic acid [2380375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acoltremon [2716801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ainsliaea fragrans top extract [1552574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1.alpha.,24S-dihydroxyvitamin D2 [1536458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha,alpha-dibromo-d-camphor [1858362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium acryloyldimethyltaurate [1305559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisate [1370666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprostadil isopropyl ester [1813427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atropine sulfate [153971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparaginase [1156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azacitidine [1251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl methacrylate-glycol dimethacrylate crosspolymer [1747570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anthraquinone glycoside [283538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atractylodes lancea whole extract [2263061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbate manganese [1144960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atrasentan [2710449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amanita muscaria extract [1311039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.N-(methoxycarbonyl)-L-arginine [2272971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Azadirachta indica seed extract [1442504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ancestim [140502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl cyclohexanebutyrate [2584843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl hexamethyl tetralin [2289007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aniba rosaeodora whole extract [2539792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arbekacin sulfate [237044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcholinesterase [195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abrus precatorius whole extract [2180253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum pendulum root extract [2683196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum potassium sulfate [54989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antioxidant 119 [1489543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aquilaria sinensis wood extract [2106559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus niger var. niger extract [854082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl isostearate [2106325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-lactalbumin (bovine) [2621574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyltributyl citrate [1362881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALV-001 [2540430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-aminobenzoic acid [74]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylopectin (4,5-dihydroxy-1,3-dimethylimdazolidin-2-one cross linked) [2634494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atropa belladonna flowering top extract [1811764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anacaulase [2626723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum carmichaeli whole extract [2695417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avatrombopag [2045726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetamide [2475952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-amylase A type 1-2 [1306125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiloride hydrochloride [142424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astacus crayfish whole extract [2180412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl hexapeptide-1 [2588845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agropyron fragile whole extract [1492182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidonic acid [1368624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin B colloidal dispersion [101299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anacyclus pyrethrum root extract [1309397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydroxide [612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple peel extract [2625124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azidocillin [18609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat [2626470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ailanthus altissima whole extract [1809829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avapritinib [2272107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alteromonas macleodii [1551569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylene [200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha tocopherol [237099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum tristearate [1363698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl methacrylate-glycol dimethacrylate crosspolymer (low allyl methacrylate) [1790180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avacopan [2572100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous calcium iodide [214236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfalfa seed extract [1306199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum acetotartrate [46239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-ionene [2572112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atropine [1223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Althaea officinalis whole extract [1428412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminometradine [1440266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asclepias tuberosa root extract [1309413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambroxol-theophylline-7-acetate [186010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus terreus allergenic extract [314324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe ferox leaf preparation [1309503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave tequilana inulin [2714500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus propinquus root polysaccharides [2532931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allura red AC dye [1310600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept [1232150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aphloia theiformis leaf extract [1425901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid blue 25 [2178278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azathioprine sodium [267476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin [42527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid orange 20 [2375722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actinidia chinensis root extract [1363985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agathosma betulina leaf oil [2108820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agar [397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum lycoctonum extract [1441295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acecarbromal [16688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum zirconium trichlorohydrex gly [1370425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amanita phalloides [1858554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus terreus extract [999408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenine [290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abiraterone acetate [1100071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl coenzyme A [1490796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amezinium [17665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Argania spinosa whole extract [1482541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer saccharum sap extract [1372011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anileridine hydrochloride [235413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>9,10-anthraquinone [1482551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminobutyrate [618257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ailanthus altissima flowering twig extract [1348450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum fluoride [2273602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adina rubella root extract [1746483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylated lanolin [1789515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atosiban acetate [2680385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alitretinoin [81864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum dilinoleate [2121673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ampelopsis glandulosa var. brevipedunculata fruit extract [1746484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple seed extract [1369395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpelisib [2169285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparagus allergenic extract [891796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azosemide [18651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrostis gigantea top extract [1310102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-amylcinnamyl alcohol [1312537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylate [1364500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anagallis arvensis extract [1336266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfalfa top extract [1668214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aclidinium [1303098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atropa belladonna fruiting top extract [1312380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alloxan [2466730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica pubescens whole extract [1490681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amitraz [17763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>artichoke allergenic extract [891776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum chloride [46241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple fruit oil [1485785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic halibut allergenic extract [2261370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astrocaryum vulgare kernel oil [2465235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angophora costata whole extract [2121070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azeloyl diglycinate [1370630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-cyclodextrin [1362882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agarum clathratum extract [1331688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alanine [426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic cod allergenic extract [900025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acitretin [16818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus chinensis whole extract [2621641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus hippocastanum leaf extract [1309498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aclarubicin [239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apiospora montagnei allergenic extract [1006258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anethole trithione [820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcarnitine hydrochloride, DL- [1593400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avelumab [1875534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia annua whole extract [2001172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agaricus blazei whole extract [2360132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anidulafungin [341018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia montana leaf extract [1942696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atracurium [1218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azatadine [18600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid red 337 free acid [2619779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylsalicylate sodium [314293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artocarpus styracifolius root extract [2610399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antithrombin alfa [1427179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine cocoate [2386216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allantoin ascorbate [2559842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-aminobutan-2-ol [2375706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-hexylcinnamaldehyde, (2E)- [1747473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agalsidase alfa [2691830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisyl alcohol [1424668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-glucan oligosaccharide [1424647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus serrulata pollen extract [2043275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave tequilana juice [2122086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcellulose [1425216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atoltivimab [2461338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum magnesium silicate [17614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia princeps leaf extract [1309411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alcea rosea root extract [1799146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-terpinyl acetate, (+/-)- [2261734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>17-alpha-hydroxyprogesterone [5542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum chlorohydrex propylene glycol [1313224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azaperone [2601502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave tequilana top extract [1441296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allspice oil [2373647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic salmon oil [2644110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherylquinone [1376149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aloxiprin [17393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbic acid [1151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arbutus andrachne leafy shoot extract [1859365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-phellandrene [2530131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adiastatic barley malt extract [221053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept-mrbb [2706479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allantoin calcium pantothenate [2045944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenosine triphosphate disodium [1306127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidate [1716332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afamitresgene autoleucel [2690256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica sinensis root extract [1307866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>12-(9-anthroyloxy)stearic acid [1922739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-amylcinnamaldehyde dimethyl acetal [2384440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcarnitine hydrochloride [476316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl cyclohexanepropionate [2383931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus carnea whole extract [1801064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus amstelodami extract [2101007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony pentasulfide [1337969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiloxate [1426854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atorvastatin calcium trihydrate [1297766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetanilide [162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-bisabolol, (-)-EPI- [2118535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atidarsagene autotemcel [2677916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amniotic fluid (bovine) [1368127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxapine [722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adzuki bean extract [1735031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alcaligenes faecalis [1316425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin,microsphere human serum [314302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.,.beta.-methylene adenosine 5&apos;-diphosphate [2552302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almitrine [528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afamelanotide acetate [2278002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agastache rugosa whole extract [2539293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprindine hydrochloride [236158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achyranthes bidentata whole extract [2569976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amikacin sulfate [643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ampicillin sodium [81953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alendronate [46041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic tribromide [1313315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid blue 80 [2563676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ampicillin [733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amifostine anhydrous [1545987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arginine glutamate [114464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium fistulosum whoe extract [1812762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspidosperma quebracho-blanco bark extract [1309812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylic acid/isophorone diisocyanate/PEG-27 copolymer [1649132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl decapeptide-3 [1992055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>articaine [592464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Azadirachta indica leaf extract [1307640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl amyl glycolate [2566287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-aminophenol [1435285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alefacept [299635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agastache urticifolia whole extract [2533830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anthoxanthum odoratum antigen [465168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>althiazide [17599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-ryvk [2677776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic halibut preparation [1424920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anagrelide hydrochloride [236612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium salicylate [236220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparagine [1157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atezolizumab [1792776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acipimox [16817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alum, ammonium anhydrous [2101716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azilsartan kamedoxomil [1294597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin B liposomal [236594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous dextrose [349730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Areca catechu seed extract [2591405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asparagus cochinchinensis whole extract [2001179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia senegal flower extract [1484143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aniline [1441546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Avena sativa whole extract [1314244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alginate [1370451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus gummifer root extract [2256948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acamprosate [82819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl trifluoromethylphenyl valylglycine, DL- [1922906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aclidinium bromide [1303097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Albatrellus confluens fruiting body extract [2603280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-bwwd [2612153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acriflavine [249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alendronate sodium [203152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum chasmanthum whole extract [2667737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceprometazine [161203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum chlorohydrate [17610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amanita pantherina whole extract [1441298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum subacetate [235461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alosetron hydrochloride [85247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylate/isobutyl methacrylate/N-tert-octylacrylamide copolymer (75000 MW) [1918245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid violet 9 [2367763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apocarotenal [1376342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amyl nitrite [742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylarginyltryptophyl diphenylglycine [2586022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anethum graveolens leaf extract [2390284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amdinocillin [626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agkistrodon piscivorus antivenin [885183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alkanna tinctoria root extract [1799373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avotermin [1427086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ATLANTIC SALMON TRANSGENIC WHOLE (OPAFP-GHC2 RDNA CONSTRUCT INSERTED INTO .ALPHA.-LOCUS IN THE EO-1.ALPHA. LINEAGE) [1728305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actaea cimicifuga root extract [1309284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiodarone hydrochloride [203114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aculyn excel (polymer dispersion) [2390961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum chloride anhydrous [1608145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl tocopheryl maleate [1362140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amineptin [17698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenosine monophosphate [309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic trisulfide [1667210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acacia decurrens whole extract [1723136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apocynum cannabinum root extract [1309506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-glycerophosphorylethanolamine, (R)- [1876508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argatroban anhydrous [1546207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium cepa bulb extract [2695867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ADAMTS13, recombinant-krhn [2670286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acarbose [16681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antithrombin III [1009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ajmalicine [17205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-ketoglutaric acid [17511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asian ginseng extract [1370774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave tequilana leaf extract [1307543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin,chromated Cr-51 serum [314299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspalathus linearis whole extract [1653340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acorus gramineus whole extract [2693986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Andrographis paniculata whole extract [1534766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alisma plantago-aquatica whole extract [1549554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus fumigatus [1182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American ginseng root [259473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ajuga reptans whole extract [1649347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia absinthium flowering top extract [2168436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum carbonate [89858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbic acid 2-sulfate [1370459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aurothiomalate [42547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amnonium acryloyldimethyltaurate - vp copolymer [1307094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asciminib [2584304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetohexamide [173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfalfa oil [323994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-pinene, (+)- [2371700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Actaea spicata root extract [1309496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alemtuzumab [117055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anacamptis morio flower extract [2101419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>angoumois grain moth allergenic extract [892360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin dihydrate [253155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetamine [725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alpinia officinarum leaf extract [1307832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avatrombopag maleate [2045727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avutometinib potassium [2714514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe andongensis whole extract [2359255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amlodipine [17767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin human, USP [828529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia vulgaris whole extract [1541882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple allergenic extract [891771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus niger var. niger allergenic extract [1006297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum heterotropoides root extract [1922732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aldosterone [1312358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxicillin sodium [267360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anthrax immune globulin, human [1722335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American elderberry extract [1310213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anisole [2594597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe succotrina whole extract [2374552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alisma plantago-aquatica top extract [1428214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acellular tissue engineered vessel [2700338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alkyl (C12-15) benzoate [1310548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alirocumab [1659152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alum, ammonium [2101717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium carbonate [1310190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agaricus campestris var. campestris whole extract [1441297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminoquinuride [17747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adansonia digitata seed extract [1428849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum flufenamate [17612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony cation (5+) [1546283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atogepant [2571813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor (recombinant) pegylated [1741397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abacavir sulfate [221052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adonis vernalis extract [1342649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceclidine [2721766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agaricus bisporus whole extract [2180257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl methylsilanol pectinate [1314268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amygdalin [1371051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ajowan oil [1855063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>annatto extract [1313764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol calcium succinate, DL- [2598017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenovirus type 4 vaccine live [1099933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achyranthes japonica root extract [2585447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium cepa whole extract [1313308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acai extract [824547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aphanamixis polystachya whole extract [2711882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antipyrine [1001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia dracunculus whole extract [1797516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asenapine [784649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arched swimming crab, cooked preparation [1315108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-arbutin [1363429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave americana leaf extract [1307838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenosine [296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anistreplase [40028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apiole [314506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anacaulase-bcdb [2626722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylate/isobutyl methacrylate/N-tert-octylacrylamide copolymer (40000 MW) [2642867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica seed extract [1606330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprindine [1054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avens extract [1313319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium chloride [712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amanita muscaria var. muscaria fruiting body extract [1310111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Adina rubella whole extract [1747176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum europaeum extract [1012890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenate [1375924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abronia frangrans flower extract [2000574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum iodide [2280603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydroxylitol [1307762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminomethyl propanediol [1307680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceclidine hydrochloride [2721767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-terpineol [1371307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum aspirin [611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl salicylate [91101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aristolochia cymbifera flower extract [1858973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfalfa preparation [285243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceneuramate [2613559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arachidyl propionate [1306211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminohydroxybutyric acid [236512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Avicularia avicularia preparation [1426667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol succinate, DL- [2370134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus serrulata bark extract [1428415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia absinthium extract [1428850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amaranth acid [1546381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine [197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amonafide [1440270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium phosphate [17792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambrein [2584842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atorvastatin calcium anhydrous [2569977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allscale pollen extract [897304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axatilimab [2691526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alatrofloxacin [141440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium sativum whole extract [1441536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl phosphate [1370605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amosulalol hydrochloride [2667255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anamirta cocculus whole extract [1545038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica keiskei top extract [1311538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica cordifolia whole extract [2047350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus glutinosa whole extract [1999662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amobarbital [719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aniracetam [17939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, porcine [221060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium laurate [1442516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aesculus carnea flower extract [1309770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adagrasib [2625882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetamine aspartate [221057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ascaris lumbricoides preparation [1351898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceneuramic acid [2613558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylopectin, corn [2590757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia argyi whole extract [2385106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achillea millefolium oil [1740240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum bromide [2272620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adiphenine [333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-aminobutyrate [2464937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azidocillin sodium [236787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alexitol sodium [236340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acai oil [1309282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-glucoheptonic acid, magnesium salt (2:1) [289497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>activated attapulgite [133050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arbutamine hydrochloride [236829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acrothecium robustum allergenic extract [905088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hexafluorosilicate nonahydrate [2592958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminophylline hydrate [388049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anchovy preparation [1310517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astrocaryum aculeatum seed oil [1655568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia annua flowering top extract [2103290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>artemisinin [2367409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol, L- [2378842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allantoin [508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amikacin liposomal [2059180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azatadine maleate [58275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arum palaestinum whole extract [2122983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum nitrate [2360133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argan shell extract [2634309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica dahurica leaf extract [1606210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin microspheres, human [1370439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-isobutylphenethyl alcohol [1720936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asfotase alfa [1720259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azurite [2539938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acoramidis [2698312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aloe polysaccharide [476786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetoxolone aluminum [268907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe arborescens flower extract [2288156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achyranthes bidentata root extract [1307854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetiamine [236300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxicillin anhydrous [1297882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anemarrhena asphodeloides whole extract [1544272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-glycerophosphorylethanolamine monohydrate, (R)- [1876507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambrisentan [358274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Akebia stem extract [2166038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atosiban [59639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe arborescens whole extract [2055101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anredera cordifolia leaf extract [2669315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia mongolica leaf extract [2043274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>algestone [595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achillea millefolium extract [1372250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astrocaryum murumuru seed butter extract [1307542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amivantamab [2549199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiodarone [703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrimonia eupatoria extract [1314595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-acrylamido-2-methyl-1-propanesulfonic acid [2109231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apazone [1029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achillea millefolium flowering top extract [1747299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allspice allergenic extract [895552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbyl dipalmitate [1608545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous lanolin [1363703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetazolamide sodium [91406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium silicofluoride [314494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium laureth-3 sulfate [1307773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abies sibirica whole extract [1856267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetaminil [17813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprostadil [598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amifostine [4126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amanita pantherina fruiting body extract [2360891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American house dust mite allergenic extract [1116977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amomum testaceum seed extract [2058909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-alpha-vitamin D [350465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aniba rosaeodora wood extract [1312541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica atropurpurea root extract [1435861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apocynum androsaemifolium root extract [1309830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aconitic acid [1721298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium [709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amomum villosum seed extract [1872379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylated glycol stearate [1859171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia princeps whole extract [1600435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum sieboldii extract [1793894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus moschatus whole extract [2048130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alvimopan anhydrous [1516803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amdinocillin pivoxil [627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl tetrapeptide-5 [2052918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agatolimod [2665622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arsenic acid [1375923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asclepias curassavica extract [1348451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica montana flower extract [1306166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum kusnezoffi root extract [1364986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnica extract [144377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avalglucosidase alfa-ngpt [2565813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allogeneic processed thymus tissue-agdc [2626459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amobarbital sodium [1314242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antazoline [865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus fumigatus allergenic extract [466192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium acetate [1362883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American basswood pollen extract [995754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anagrelide [596724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antimony trioxide [2477431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aralia racemosa root extract [1309833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azelaic acid [18602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adapalene [60223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>androsterone [1312359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum distearate [1307778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxicillin trihydrate [133008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amosulalol [2667256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium lactate [215247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine sodium [237163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American cockroach allergenic extract [905258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(3-amino-4-hydroxyphenyl)-2-((2-(4-methoxyphenyl)-1-methylethyl)amino)ethanol [2283758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acid blue 9 ammonium [2101006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-amino-1-butanol [2588247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amylmetacresol [236248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apis mellifera preparation [285219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-terpinene [2542349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>articaine hydrochloride [2117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspirin [1191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anemarrhena asphodeloides root extract [1735152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amodimethicone (800 CST) [1427215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl cedrene [2289006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-chlorohydrin [2699583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe vera whole extract [1312539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha, alpha&apos;-diglycerol [2473375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine magnesium [1809634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aconitum carmichaelii lateral root extract [1875523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aristolochia serpentaria root extract [1442192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-hexylcinnamaldehyde [1311811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almotriptan [279645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol succinate, D- [1426447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adiphenine hydrochloride [235433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asarum canadense root extract [1428416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ailanthus altissima fruit extract [2590594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arnebia guttata root extract [2586023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aurothioglucose [4980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-succinimidyloxy carbonyl-omega-methoxy, polyoxyethylene MW 5000 [2399028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept-yszy [2715399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprocitentan [2679059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almitrine dimesylate [529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot juice [1307043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl tetrapeptide-11 [2371701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afamelanotide [2262250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avocado allergenic extract [895582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-aminocyclopropanol [2645303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azulene [2675343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprenolol [597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl alcohol [2385331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anogeissus leiocarpus bark extract [1309403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl tetrapeptide-3 [2000919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus flavus var. oryzae protease [1307040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abemaciclib [1946825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl sucrose [1307102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor (recombinant), PEGylated-aucl [2055654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia umbelliformis flower extract [1307806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus caudatus whole extract [1655564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenosine triphosphate [318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abrus precatorius seed extract [1309951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azelamide monoethanolamine [1428860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acalabrutinib [1986808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium nonoxynol-9 sulfate [2584966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot allergenic extract [895574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arundo pliniana root extract [1309800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Achlys triphylla whole extract [2367761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agave tequilana stem extract [2644446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alminoprofen [17387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-d-glucopyranose [1800492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ACV tripeptide [1551571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl [2631083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agrimonia pilosa leaf extract [2697821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acryloyldimethyltaurate-acrylamide copolymer [1370665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arachis hypogaea whole extract [1792311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Asparagopsis armata extract [1363627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anethole [17881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.alpha.-cubebene, (-)- [2530130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus root extract [479542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcholinesterase human [1372465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almond oil [1305638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ammi visnaga fruit extract [1353222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Angelica seed oil [1305641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Anemone nemorosa extract [1310266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprepitant [358255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrylic acid [1368626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus niger immunoserum rabbit [1313283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apis cerana whole extract [2590180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspalathus linearis leaf extract [1307645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum phosphate [17618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia dealbata flower extract [1488998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allyl methacrylate [2203551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azelastine [18603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl tetrapeptide-9 [1307099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anakinra [72435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arisaema erubescens root extract [1307669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot extract [1353891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum acetate [17609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetic anhydride [1370450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha-tocopherol acetate [1046243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Abelmoschus esculentus seed extract [1437307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum zirconium tetrachlorohydrex gly [1305896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aralia hispida root extract [1310007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ambrosia confertiflora whole extract [2121053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aratinga erythrogenys feather extract [2481134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbate [1370460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aripiprazole [89013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium bromide [1313309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-adbm [2103477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asciminib hydrochloride [2584303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abiraterone [1100072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aloe spicata whole extract [2590596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arabic gum allergenic extract [905301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprinocarsen [2634355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ABT-925 anhydrous free base [1661016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetyl aspartic acid [1872378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arthrospira platensis [1321355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium alginate [1926208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium laureth-12 sulfate [1744402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asafetida extract [319779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-afzb [2619155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambenonium [623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allylestrenol [525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aluminum hydride [1540524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aristolochia clematitis root extract [1309735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus chinensis whole extract [2106824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Artemisia argyi leaf extract [1307649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple seed oil [1799009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arctium lappa fruit extract [1307677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Astragalus preparation [319818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agalsidase beta [338817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>A [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetic acid [168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>AMPA Receptor Antagonists [MoA]</name>
  <code>C300401</code>  <id>300401</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>AMPA Receptor Antagonists</to_name>
    <to_code>T1283</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020016</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>AMPA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>APOC-III RNA Antisense Inhibitor [MoA]</name>
  <code>C654365</code>  <id>654365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC3 RNA Antisense Inhibitor</to_name>
    <to_code>T59042</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III RNA Antisense Inhibitor</to_name>
    <to_code>T59043</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194143</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>APOC-III-directed RNA Interaction [EPC]</name>
  <code>C654366</code>  <id>654366</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III-directed RNA Interaction</to_name>
    <to_code>T59044</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194144</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>APOC-III-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III RNA Antisense Inhibitor [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>APOC-III-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>APOC-III-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olezarsen [2701418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antilipemic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antisense oligonucleotide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antisense oligonucleotide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</name>
  <code>C608</code>  <id>609</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions</to_name>
    <to_code>T1451</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000215</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug Resistance-Associated Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag maleate [2045727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Absorption Half-Life [PK]</name>
  <code>C212</code>  <id>213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorption Half-Life</to_name>
    <to_code>T1564</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000017</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Absorption [PK]</name>
  <code>C194</code>  <id>195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorption</to_name>
    <to_code>T1565</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Absorption [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by intestinal surface area [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Absorption [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by concomitant drug administration [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Absorption [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorption Half-Life [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Absorption [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by gastric pH [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Absorption [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by food/other nutrients [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acellular Tissue Engineered Vessel [EPC]</name>
  <code>C654386</code>  <id>654386</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acellular Tissue Engineered Vessel</to_name>
    <to_code>T59075</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194163</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acellular Tissue Engineered Vessel [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Tissue engineered blood vessel (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetaminophen [EPC]</name>
  <code>C637370</code>  <id>637370</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetaminophen-containing Agent</to_name>
    <to_code>T1653</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetaminophen</to_name>
    <to_code>T1654</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177915</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetaminophen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetaminophen [M0000115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetaminophen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Paracetamol (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetaminophen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing paracetamol (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]</name>
  <code>C544</code>  <id>545</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetyl Aldehyde Dehydrogenase Inhibitors</to_name>
    <to_code>T1708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000183</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disulfiram [3554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Activity Alteration [PE]</name>
  <code>C26946</code>  <id>26947</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Activity Alteration</to_name>
    <to_code>T1742</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008290</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Release Inhibitor [EPC]</name>
  <code>C635190</code>  <id>635190</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitor</to_name>
    <to_code>T1745</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175771</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum toxin type A [1712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letibotulinumtoxinA [2689280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimabotulinumtoxinB [860178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with acetylcholinesterase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing acetylcholinesterase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abobotulinumtoxinA [860168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Release Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Neuromuscular blocking agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing neuromuscular blocker (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Release Inhibitors [MoA]</name>
  <code>C635189</code>  <id>635189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors</to_name>
    <to_code>T1746</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175770</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type B [2167673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Releasing Agent [EPC]</name>
  <code>C635191</code>  <id>635191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Releasing Agent</to_name>
    <to_code>T1747</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175772</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Releasing Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with acetylcholine receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Releasing Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing acetylcholine receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acetylcholine Releasing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acetylcholine Transporter Interactions [MoA]</name>
  <code>C30278</code>  <id>30279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ACh Transporter Interactions</to_name>
    <to_code>T1748</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions</to_name>
    <to_code>T1749</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009955</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acid-Base Activity [MoA]</name>
  <code>C630</code>  <id>631</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity</to_name>
    <to_code>T1829</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000226</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acid-Base Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acid-Base Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate [56443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium amino acid chelate [486895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate, heptahydrate [1311282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride hexahydrate [221118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium stearate [1310567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate anhydrous [1310549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate [39954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloride ion [153974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc acetate [58295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrate [114200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate, anhydrous [267453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride anhydrous [1311539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate [58300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium,chelated [259277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lactate [56489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium acetate tetrahydrate [317246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate monohydrate [1309410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride tetrahydrate [2003593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate anhydrous [1792467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc chloride [39937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate anhydrous [1299928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate trihydrate [1440975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium chloride [712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acidifying Activity [MoA]</name>
  <code>C635252</code>  <id>635252</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrogen Ion Donor Activity</to_name>
    <to_code>T1832</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity</to_name>
    <to_code>T1834</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrogen Ion Donors</to_name>
    <to_code>T1833</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175833</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluconolactone [25842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium zirconium cyclosilicate [2047628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Acquired Immunity [PE]</name>
  <code>C642966</code>  <id>642966</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity</to_name>
    <to_code>T1903</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183363</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acquired Immunity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Acquired Immunity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 [2606073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus [1365969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) [2691168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 [2688626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine [2686924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein [2606074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine [2686926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) [2691192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) [2610326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) [2610243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 [2666309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Actinomycin [EPC]</name>
  <code>C640341</code>  <id>640341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Actinomycin</to_name>
    <to_code>T2001</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Actinomycin-class Agent</to_name>
    <to_code>T2000</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180850</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Actinomycin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing dactinomycin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Actinomycin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dactinomycin [M0005644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Actinomycin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Dactinomycin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Actinomycin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dactinomycin [3100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Actively Acquired Immunity [PE]</name>
  <code>C642967</code>  <id>642967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Active Immunity</to_name>
    <to_code>T2034</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity</to_name>
    <to_code>T2035</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183364</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Actively Acquired Immunity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Actively Acquired Immunity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hepatitis A Vaccine, Inactivated [253174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen [1804259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen [1657224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus [1491862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen [2694005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Phuket/3073/2013 antigen [1657228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform S), recombinant [2588219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen [1664339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 capsid protein [2707119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Michigan/01/2021 antigen [2593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group Y [314725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen [2177290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Darwin/7/2019 antigen [2380838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus envelope glycoprotein [2624742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mumps Vaccine [763656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/122/2022 (H3N2) antigen [2675569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) [2664825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen [1666425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen [2688113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen [1593127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen [1601231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [798279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group C polysaccharide [29503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain [1005929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen [2379531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized [2642139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen [2719300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen [2687714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen [1664171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Austria/1359417/2021 antigen [2605039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen [2380836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen [1801767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein [2636589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 X-181 (H1N1), Inactivated [1303850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen [2720359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen [2280296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen [2645084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H1N1) antigen [1657128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen [2562554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vaccinia virus strain New York City Board of Health live antigen [1492300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen [2641877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain [1006250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group B vaccine [1593128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E1 [2707121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 2 [2197291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen [2717943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 4 vaccine live [1099933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 3 [2197292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anthrax Vaccine Adsorbed [404774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED [235574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen [2641622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Washington/02/2019 antigen [2280293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus B serotype 7 strain 55142 [1802483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 11 vaccine [798262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated [1300182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 1 [2197290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen [1657130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live, New York City Board of Health vaccinia strain [798467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen [2708995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group W-135 [314724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, recombinant [2636588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen [2686166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, live attenuated LR2006 OPY1 strain [2673238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen [1601233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen [1593130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen [2056525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Utah/9/2014 antigen [1657133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 4 [2197293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen [1663632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen [1946964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen [1601232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rubella virus vaccine [9486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen [1928528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen [2479040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Victoria/705/2018 antigen [2380575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine [798444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis pertactin vaccine, inactivated [1300184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Maryland/15/2016 antigen [2048563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Colorado/06/2017 antigen [2054177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen [2380835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ROTAVIRUS VACCINE, LIVE [253199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, attenuated Schwarz strain [2603499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) [2664725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Panama/45/90 antigen [2262062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen [2562555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/7/2009 (H1N1) antigen [1657331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live vaccinia virus [833079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen [2048564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Yellow Fever Vaccine [89890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen [2380834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen [2380837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen [2561244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella typhi Ty21a live antigen [762595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized [2642138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen [1928290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Iowa/06/2017 antigen [2056523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen [2642276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen [1794331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated [1300180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow fever virus strain 17D-204 live antigen [804187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H3N2) antigen [1657131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen [1427171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/46/2015 antigen [1942125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen vaccine [797752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, RIT-4385 strain [2603501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen [1664172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Montreal strain [314513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/9/2014 antigen [1723997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle [1601236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/WUH4618/2021 antigen [2605725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diptheria toxoid absorbed [1657601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen [2180337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis toxoid vaccine, inactivated [1300186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen [2388136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus [1427020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hong Kong/259/2010 antigen [1801603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen [2562553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 [2707120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen [2607735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid adsorbed [235600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen [1657127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen [2379530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform M), recombinant [2588218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen [2056521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cholera Vaccine [2427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Smallpox Vaccine [9835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen [2630221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 7 vaccine live [1099937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E2 [2707122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen [1663630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360571]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen [1657222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein [2624741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform L), recombinant [2588217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen [1928289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen [2177291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen [2380574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen [2180338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen [1666421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine flury-lep strain [830457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen [2564395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group A polysaccharide [29501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Varicella Virus Vaccine Live (Oka-Merck) strain [805486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vibrio cholerae CVD 103-HGR strain live antigen [1812935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus antigen [1657134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Activin Signaling Inhibitor [EPC]</name>
  <code>C654325</code>  <id>654325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Activin Signaling Inhibitor</to_name>
    <to_code>T58944</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194100</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Activin Signaling Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Activin Signaling Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Activin Signaling Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotatercept [2678930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Activin Signaling Inhibitors [MoA]</name>
  <code>C654324</code>  <id>654324</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Activin Signaling Inhibitors</to_name>
    <to_code>T58943</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194101</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Activin Signaling Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adeno-associated Virus Vector [EPC]</name>
  <code>C654020</code>  <id>654020</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adeno-associated Virus Vector</to_name>
    <to_code>T58378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193790</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adeno-associated Virus Vector [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voretigene neparvovec [1995537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adeno-associated Virus Vector [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viruses, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adeno-associated Virus Vector [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adeno-Associated Virus [M0478942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</name>
  <code>C654293</code>  <id>654293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adeno-associated Virus Vector-based Gene Therapy</to_name>
    <to_code>T58888</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194065</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Recombinant adeno-associated virus gene (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing genetically modified virus (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Deaminase Inhibitors [MoA]</name>
  <code>C552</code>  <id>553</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Deaminase Inhibitors</to_name>
    <to_code>T2303</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000187</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Deaminase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Diphosphate Receptor Inhibitors [MoA]</name>
  <code>C32026</code>  <id>32027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Diphosphate Receptor Inhibitors</to_name>
    <to_code>T2314</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ADP Receptor Inhibitors</to_name>
    <to_code>T2313</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010334</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Agonist [EPC]</name>
  <code>C637829</code>  <id>637829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonist</to_name>
    <to_code>T2339</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178375</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing adenosine A2 receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regadenoson [640062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with adenosine A2 receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adenosine [296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cardiovascular agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Agonists [MoA]</name>
  <code>C635207</code>  <id>635207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists</to_name>
    <to_code>T2340</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175788</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson anhydrous [1546015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Antagonists [MoA]</name>
  <code>C635208</code>  <id>635208</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists</to_name>
    <to_code>T2341</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175789</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>istradefylline [2199015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib [2044896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib disodium [2055929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Receptor Interactions [MoA]</name>
  <code>C635206</code>  <id>635206</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Interactions</to_name>
    <to_code>T2342</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175787</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</name>
  <code>C654134</code>  <id>654134</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP Citrate Lyase Inhibitor</to_name>
    <to_code>T58538</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor</to_name>
    <to_code>T58536</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ACL Inhibitor</to_name>
    <to_code>T58537</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193913</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bempedoic acid [2282403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</name>
  <code>C654135</code>  <id>654135</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP Citrate Lyase Inhibitors</to_name>
    <to_code>T58541</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors</to_name>
    <to_code>T58539</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ACL Inhibitors</to_name>
    <to_code>T58540</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193914</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adenovirus Vector-Based Gene Therapy [EPC]</name>
  <code>C654288</code>  <id>654288</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenovirus Vector-Based Gene Therapy</to_name>
    <to_code>T58883</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194066</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing genetically modified virus (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenovirus Vector-Based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Recombinant adeno-associated virus gene (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenovirus Vector-Based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenal Cortical Activity Alteration [PE]</name>
  <code>C26948</code>  <id>26949</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Cortical Activity Alteration</to_name>
    <to_code>T2474</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008291</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Cortical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Cortical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Clearance [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Cortical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Clearance [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Cortical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Cortical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Cortical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Cortical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrapone [6923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Cortical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat phosphate [2286253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Cortical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenal Medullary Activity Alteration [PE]</name>
  <code>C26950</code>  <id>26951</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Medullary Activity Alteration</to_name>
    <to_code>T2485</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008292</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Medullary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenal Epinephrine Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Medullary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenal Norepinephrine Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Medullary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenal Epinephrine Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Medullary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenal Norepinephrine Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Medullary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Medullary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenal Steroid Synthesis Inhibitor [EPC]</name>
  <code>C635366</code>  <id>635366</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitor</to_name>
    <to_code>T2488</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175928</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Steroid Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Steroid Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metyrapone [6923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hormone receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenal Steroid Synthesis Inhibitors [MoA]</name>
  <code>C635359</code>  <id>635359</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors</to_name>
    <to_code>T2489</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175921</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Steroid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenal Steroid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrapone [6923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat phosphate [2286253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Agonists [MoA]</name>
  <code>C422</code>  <id>423</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists</to_name>
    <to_code>T2490</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000122</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-hydroxyamphetamine [7839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine [156240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine hydrochloride [236481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine [6756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyamphetamine hydrobromide [82066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine sulfate [82042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Antagonists [MoA]</name>
  <code>C362</code>  <id>363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Antagonists</to_name>
    <to_code>T2491</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000092</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Decongestant [EPC]</name>
  <code>C635210</code>  <id>635210</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Decongestant</to_name>
    <to_code>T2492</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175791</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing adrenergic receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Decongestant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Receptor Agonist [EPC]</name>
  <code>C635321</code>  <id>635321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Agonist</to_name>
    <to_code>T2493</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175883</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with adrenergic receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinastine [39684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-hydroxyamphetamine [7839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing adrenergic receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic Receptor Interactions [MoA]</name>
  <code>C484</code>  <id>485</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Interactions</to_name>
    <to_code>T2494</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000153</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-Agonists [MoA]</name>
  <code>C596</code>  <id>597</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Agonists</to_name>
    <to_code>T2495</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists</to_name>
    <to_code>T2496</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000209</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic alpha-Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic alpha-Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine hydrochloride [1744461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergot preparation [91405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine hydrochloride [236961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine tartrate [39171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine [134615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate hydrochloride [91241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha-Antagonists [MoA]</name>
  <code>C376</code>  <id>377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Antagonists</to_name>
    <to_code>T2497</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alpha-adrenergic Blocker</to_name>
    <to_code>T2498</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists</to_name>
    <to_code>T2499</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000099</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic alpha-Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic alpha-Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacetazine [8338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole hydrochloride [235757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole [22298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine [220982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine hydrochloride [133041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha1-Agonists [MoA]</name>
  <code>C30200</code>  <id>30201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-1 Agonists</to_name>
    <to_code>T2501</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists</to_name>
    <to_code>T2502</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Agonists</to_name>
    <to_code>T2500</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009917</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha1-Antagonists [MoA]</name>
  <code>C30204</code>  <id>30205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-1 Antagonists</to_name>
    <to_code>T2504</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists</to_name>
    <to_code>T2505</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Antagonists</to_name>
    <to_code>T2503</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009919</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urapidil [39230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol hydrochloride [2667255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol [2667256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha2-Agonists [MoA]</name>
  <code>C30202</code>  <id>30203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-2 Agonists</to_name>
    <to_code>T2507</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists</to_name>
    <to_code>T2508</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-2 Adrenergic Agonists</to_name>
    <to_code>T2506</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009918</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate hydrochloride [91241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine [134615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine tartrate [39171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic alpha2-Antagonists [MoA]</name>
  <code>C30206</code>  <id>30207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists</to_name>
    <to_code>T2511</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-2 Adrenergic Antagonists</to_name>
    <to_code>T2510</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-2 Antagonists</to_name>
    <to_code>T2509</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009920</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atipamezole [18475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atipamezole hydrochloride [390043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-Agonists [MoA]</name>
  <code>C668</code>  <id>669</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Agonists</to_name>
    <to_code>T2512</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists</to_name>
    <to_code>T2513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000245</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic beta-Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic beta-Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta3-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic beta-Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta-Antagonists [MoA]</name>
  <code>C500</code>  <id>501</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Receptor Inhibitor</to_name>
    <to_code>T2518</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-adrenergic Receptor Inhibitor</to_name>
    <to_code>T2517</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Antagonists</to_name>
    <to_code>T2514</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists</to_name>
    <to_code>T2519</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-adrenergic Blocker</to_name>
    <to_code>T2516</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Blocker</to_name>
    <to_code>T2515</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000161</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic beta-Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenergic beta-Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talinolol [37546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine [155080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol sulfate [236904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine chloride [40165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol [2667256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol hydrochloride [2667255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol [29518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol [31462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol [37840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol [31555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol hydrochloride [236883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol hydrochloride [236178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol hydrochloride [227212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol hydrochloride [236374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol [1813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta1-Agonists [MoA]</name>
  <code>C30208</code>  <id>30209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists</to_name>
    <to_code>T2522</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-1 Agonists</to_name>
    <to_code>T2521</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-1 Adrenergic Agonists</to_name>
    <to_code>T2520</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009921</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta1-Antagonists [MoA]</name>
  <code>C30212</code>  <id>30213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-1 Adrenergic Antagonists</to_name>
    <to_code>T2524</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists</to_name>
    <to_code>T2525</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-1 Antagonists</to_name>
    <to_code>T2523</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009923</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>practolol [8620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol hydrochloride [2712069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta1-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta2-Agonists [MoA]</name>
  <code>C30210</code>  <id>30211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists</to_name>
    <to_code>T2528</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-2 Adrenergic Agonists</to_name>
    <to_code>T2526</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-2 Agonists</to_name>
    <to_code>T2527</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009922</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol HCl [235447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol [237159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol [4333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol hydrochloride [1546396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol hydrochloride [237160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine hydrochloride [105470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine hydrochloride [102397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol [19499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate dihydrate [998038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol mesylate [47187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol [1114326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol tartrate [487066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol hydrobromide [203124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol [1424884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine [6023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline [10368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol maleate [1114325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline sulfate [10369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol [1546059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine mesylate [6024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol tartrate [668284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine [9392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol acetate [221142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol trifenatate [1424883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol [33767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta2-Antagonists [MoA]</name>
  <code>C30214</code>  <id>30215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-2 Antagonists</to_name>
    <to_code>T2530</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists</to_name>
    <to_code>T2531</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-2 Adrenergic Antagonists</to_name>
    <to_code>T2529</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009924</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenergic beta3-Agonists [MoA]</name>
  <code>C644809</code>  <id>644809</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta3-Agonists</to_name>
    <to_code>T2534</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-3 Adrenergic Agonists</to_name>
    <to_code>T2533</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-3 Agonists</to_name>
    <to_code>T2532</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vibegron [2472254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta3-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta3-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Adrenocorticotropic Hormone [EPC]</name>
  <code>C635379</code>  <id>635379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenocorticotropic Hormone</to_name>
    <to_code>T2558</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175941</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenocorticotropic Hormone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenocorticotropic Hormone [M0000499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenocorticotropic Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticotropin [376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenocorticotropic Hormone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Adrenocorticotropic hormone (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Adrenocorticotropic Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cosyntropin [2890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing anterior pituitary hormone (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenocorticotropic Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Affected by concomitant drug administration [PK]</name>
  <code>C210</code>  <id>211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by concomitant drug administration</to_name>
    <to_code>T2596</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000016</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Affected by food/other nutrients [PK]</name>
  <code>C196</code>  <id>197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by food/other nutrients</to_name>
    <to_code>T2597</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Affected by food/other nutrients [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased by food [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Affected by food/other nutrients [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased by food [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Affected by gastric pH [PK]</name>
  <code>C202</code>  <id>203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by gastric pH</to_name>
    <to_code>T2598</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000012</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Affected by gastric pH [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased by acidity [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Affected by gastric pH [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhanced by acidity [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Affected by intestinal surface area [PK]</name>
  <code>C208</code>  <id>209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Affected by intestinal surface area</to_name>
    <to_code>T2599</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000015</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alcohol Dehydrogenase Inhibitors [MoA]</name>
  <code>C536</code>  <id>537</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alcohol Dehydrogenase Inhibitors</to_name>
    <to_code>T2759</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000179</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomepizole [15226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alcohol Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aldehyde Dehydrogenase Inhibitor [EPC]</name>
  <code>C635085</code>  <id>635085</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldehyde Dehydrogenase Inhibitor</to_name>
    <to_code>T2804</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175679</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aldehyde Dehydrogenase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disulfiram [3554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldehyde Dehydrogenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldehyde Dehydrogenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aldosterone Antagonist [EPC]</name>
  <code>C634950</code>  <id>634950</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonist</to_name>
    <to_code>T2825</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175557</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aldosterone Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eplerenone [298869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aldosterone Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with aldosterone receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aldosterone Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing aldosterone receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aldosterone Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spironolactone [9997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aldosterone Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aldosterone Antagonists [MoA]</name>
  <code>C634449</code>  <id>634449</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonist</to_name>
    <to_code>T2826</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonists</to_name>
    <to_code>T2827</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000011310</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alkalinizing Activity [MoA]</name>
  <code>C30340</code>  <id>30341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity</to_name>
    <to_code>T2920</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrogen Ion Scavengers</to_name>
    <to_code>T2918</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrogen Ion Scavenging Activity</to_name>
    <to_code>T2919</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009986</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine hydrochloride [1311534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicarbonate ion [1546277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine [10865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate anhydrous [1374802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alkaloid [EPC]</name>
  <code>C654171</code>  <id>654171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkaloid</to_name>
    <to_code>T58613</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193949</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkaloid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Alkaloid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkaloid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing alkaloid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkaloid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vinca Alkaloid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkaloid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkaloids [M0000713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkaloid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colchicine [2683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alkylating Activity [MoA]</name>
  <code>C650</code>  <id>651</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity</to_name>
    <to_code>T2936</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000236</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine hydrochloride [1114693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid [21183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, 1-stearyl ester [1435636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium citrate sesquihydrate [2049608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid monohydrate [221079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine [134547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate [105556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine [4089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate sodium [4090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine [2540964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide hydrochloride [2531370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uracil mustard [10996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide [2531369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trabectedin [1716278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine-lpyl [2540965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alkylating Drug [EPC]</name>
  <code>C634951</code>  <id>634951</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Drug</to_name>
    <to_code>T2937</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175558</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorambucil [2346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trabectedin [1716278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomustine [6466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclophosphamide anhydrous [1545988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>busulfan [1828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mechlorethamine [6674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ifosfamide [5657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lurbinectedin [2374729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procarbazine [8702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melphalan [6718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dacarbazine [3098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carmustine [2105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temozolomide [37776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing alkylating agent (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiotepa [10473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptozocin [10114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Alkylating agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitomycin [632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alkylating Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bendamustine [134547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allergen [APC]</name>
  <code>C654110</code>  <id>654110</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allergen</to_name>
    <to_code>T58515</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193889</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergen [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Chemical Allergen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergen [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Chemical Allergen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergen [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allergenic Extract [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allergenic Extract [APC]</name>
  <code>C654111</code>  <id>654111</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allergenic Extract</to_name>
    <to_code>T58516</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193890</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Food Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal and Animal Specific Allergenic Extract [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Pollen Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Fungal Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized House Dust Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Bacterial Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Pollen Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy [EPC]</name>
  <code>C654384</code>  <id>654384</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy</to_name>
    <to_code>T59072</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell (MSC) Therapy</to_name>
    <to_code>T59073</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194164</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cellularized Scaffold Cell Therapy [EPC]</name>
  <code>C654297</code>  <id>654297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cellularized Scaffold Cell Therapy</to_name>
    <to_code>T58895</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194074</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</name>
  <code>C644089</code>  <id>644089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy</to_name>
    <to_code>T2954</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184318</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematopoietic Stem Cells [M0010055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human cord blood hematopoietic progenitor cell [1307732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hematopoietic factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Cultured Cell Scaffold [EPC]</name>
  <code>C644090</code>  <id>644090</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cultured Cell Scaffold</to_name>
    <to_code>T2955</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184319</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foreskin keratinocyte, neonatal [1427138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foreskin fibroblast, neonatal [1427137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen type I, bovine [1426855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allogeneic Cultured Cell Scaffold [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tissue Scaffolds [M0505082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Biological surgical material (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Graft (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Replacement agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Dermal Fibroblast Cell Therapy [EPC]</name>
  <code>C654375</code>  <id>654375</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Dermal Fibroblast Cell Therapy</to_name>
    <to_code>T59063</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194145</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Epidermal Keratinocyte Cell Therapy [EPC]</name>
  <code>C654374</code>  <id>654374</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Epidermal Keratinocyte Cell Therapy</to_name>
    <to_code>T59062</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194146</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Pancreatic Islet Cellular Therapy [EPC]</name>
  <code>C654295</code>  <id>654295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Pancreatic Islet Cellular Therapy</to_name>
    <to_code>T58893</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194075</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allogeneic Processed Thymus Tissue-based Immunotherapy [EPC]</name>
  <code>C654298</code>  <id>654298</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Processed Thymus Tissue-based Immunotherapy</to_name>
    <to_code>T58896</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194076</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Allylamine Antifungal [EPC]</name>
  <code>C635312</code>  <id>635312</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allylamine Antifungal</to_name>
    <to_code>T2968</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175874</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allylamine Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terbinafine [37801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allylamine Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allylamine [M0000751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allylamine Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naftifine [31476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allylamine Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allylamine Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Allylamine Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allylamine Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alternative Complement Pathway Inhibitors [MoA]</name>
  <code>C654321</code>  <id>654321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alternative Complement Pathway Inhibitors</to_name>
    <to_code>T58940</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194102</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alternative Complement Pathway Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aluminum Complex [EPC]</name>
  <code>C635220</code>  <id>635220</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aluminum Complex</to_name>
    <to_code>T3028</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175801</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aluminum Complex [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucralfate [10156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aluminum Complex [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Organometallic Compounds [M0015420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing aluminium and/or aluminium compound (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aluminum Complex [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Aluminium compound (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aluminum Complex [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alveolar Surface Tension Alteration [PE]</name>
  <code>C26952</code>  <id>26953</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Alteration</to_name>
    <to_code>T3046</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008293</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Alveolar Surface Tension Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Alveolar Surface Tension Reduction [PE]</name>
  <code>C26954</code>  <id>26955</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction</to_name>
    <to_code>T3047</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008294</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril palmitate [69782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calfactant [232539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril [107784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beractant [46967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poractant alfa [236381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amide Local Anesthetic [EPC]</name>
  <code>C635088</code>  <id>635088</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amide Local Anesthetic</to_name>
    <to_code>T3103</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175682</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupivacaine [1815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropivacaine [35780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidocaine [6387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amides [M0000897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>articaine [592464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prilocaine [8686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Amide and/or amide derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amide Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepivacaine [6759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amino Acid Hypertonic Solution [EPC]</name>
  <code>C635216</code>  <id>635216</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid Hypertonic Solution</to_name>
    <to_code>T3149</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175797</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid Hypertonic Solution [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amino Acids [M0000922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid Hypertonic Solution [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amino Acids [658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Total parenteral nutrition agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Amino acid (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing amino acid (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amino Acid [EPC]</name>
  <code>C635199</code>  <id>635199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid</to_name>
    <to_code>T3212</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175780</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid Hypertonic Solution [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Amino acid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amino Acids [M0000922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing amino acid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutamine [4885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amino Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alanine [426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside Antibacterial [EPC]</name>
  <code>C634858</code>  <id>634858</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside Antibacterial</to_name>
    <to_code>T3282</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175477</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amikacin [641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tobramycin [10627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptomycin [10109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kanamycin [6099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with aminoglycoside structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neomycin [7299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentamicin [1596450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminoglycosides [M0000946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing aminoglycoside (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside Antimicrobial [EPC]</name>
  <code>C634859</code>  <id>634859</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside Antimicrobial</to_name>
    <to_code>T3283</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175478</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with aminoglycoside structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminoglycosides [M0000946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing aminoglycoside (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aminoglycoside [EPC]</name>
  <code>C635367</code>  <id>635367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside-class Agent</to_name>
    <to_code>T3284</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside</to_name>
    <to_code>T3285</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175929</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminoglycosides [M0000946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing aminoglycoside (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoglycoside [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Aminoglycoside (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aminoketone [EPC]</name>
  <code>C640363</code>  <id>640363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoketone</to_name>
    <to_code>T3294</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180855</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoketone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Aminoketone phenylethylamine derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminoketone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupropion [42347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</name>
  <code>C654250</code>  <id>654250</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ALAS1-directed RNA Interaction</to_name>
    <to_code>T58776</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminolevulinate Synthase 1-directed RNA Interaction</to_name>
    <to_code>T58775</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194024</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>givosiran [2265712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Transacylase (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aminosalicylate [EPC]</name>
  <code>C635200</code>  <id>635200</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminosalicylate-containing Agent</to_name>
    <to_code>T3342</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminosalicylate</to_name>
    <to_code>T3343</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175781</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminosalicylate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesalamine [52582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminosalicylate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsalazide [18747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminosalicylate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olsalazine [32385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminosalicylate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminosalicylic Acids [M0000971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aminosalicylate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfasalazine [9524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Salicylate (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminosalicylate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing salicylate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminosalicylate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ammonium Ion Binding Activity [MoA]</name>
  <code>C635225</code>  <id>635225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity</to_name>
    <to_code>T3378</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonia Binding Activity</to_name>
    <to_code>T3377</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175806</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoic acid [18989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylacetic acid [33332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylbutyric acid [1546447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amphenicol-class Antibacterial [EPC]</name>
  <code>C634861</code>  <id>634861</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicol-class Antibacterial</to_name>
    <to_code>T3421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175480</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicol-class Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicol-class Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Amphenicol (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicol-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicol-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramphenicol [2348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicol-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicol-class Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amphenicols [EXT]</name>
  <code>C634860</code>  <id>634860</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols</to_name>
    <to_code>T3422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175479</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphenicols [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chloramphenicol [M0004121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Benzyl Alcohols [M0002386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amphetamine Anorectic [EPC]</name>
  <code>C634807</code>  <id>634807</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphetamine Anorectic</to_name>
    <to_code>T3423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175425</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphetamine Anorectic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphetamine Anorectic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amphetamines [M0001015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphetamine Anorectic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Amfetamine (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphetamine Anorectic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing amfetamine (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amphetamine Anorectic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methamphetamine [6816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amylase Inhibitors [MoA]</name>
  <code>C31906</code>  <id>31907</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylase Inhibitors</to_name>
    <to_code>T3472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010274</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acarbose [16681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amylin Agonists [MoA]</name>
  <code>C300454</code>  <id>300454</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Agonists</to_name>
    <to_code>T3476</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020064</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amylin Analog [EPC]</name>
  <code>C637365</code>  <id>637365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Analogue</to_name>
    <to_code>T3477</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Analog</to_name>
    <to_code>T3478</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177910</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amylin Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Amylin analog (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amylin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramlintide [139953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amylin Analog [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing amylin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amyloid Beta-directed Antibody Interactions [MoA]</name>
  <code>C654188</code>  <id>654188</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions</to_name>
    <to_code>T58645</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193950</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab-irmb [2626142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab [2626143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab-azbt [2687965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab [2687966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Amyloid Beta-directed Antibody [EPC]</name>
  <code>C654187</code>  <id>654187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody</to_name>
    <to_code>T58644</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193951</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amyloid Beta-directed Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amyloid Beta-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lecanemab [2626143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Amyloid Beta-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lecanemab-irmb [2626142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Analgesia [PE]</name>
  <code>C634821</code>  <id>634821</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia</to_name>
    <to_code>T3536</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175439</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil [480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine polistirex [236792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil hydrochloride [203203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil hydrochloride [236540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone piperazine [236354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl hydrochloride [1652097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine [23744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl citrate [142436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine fumarate [2392633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine hydrochloride [91188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl [4337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone sodium [236529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil [56795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine [2392230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine resin complex [314786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil [73032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine citrate [221141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone [2001352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil citrate [58964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone hydrochloride [2122776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Analgesics [TC]</name>
  <code>C654030</code>  <id>654030</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics</to_name>
    <to_code>T58408</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193809</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine [24484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide acetate [486126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl hydrochloride [1652097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol, (+)- [1648123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine polistirex [236792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil hydrochloride [236540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine [2392230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine hydriodide [1942478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meloxicam [41493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol glucuronide [2704947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine sulfate [1655913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine citrate [235416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate [18889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dezocine [22713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl [4337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefopam hydrochloride [4324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine citrate [221141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil [73032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide [68503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone hydrochloride [2122776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine hydrochloride [7433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone piperazine [236354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin acetate [2569090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trolamine salicylate [38866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine oleate [1788982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine dioleate [1813434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine phosphate [2287550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine resin complex [314786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine [594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine fumarate [2392633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl citrate [142436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone sodium [236529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefopam [7285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac [35827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate hydrochloride [235398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine stearate [38625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine [38623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine acetate [2360432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine isostearate [1789185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol [6750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica extract [144377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine hydrochloride [1368178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine laurylaminopropionate [1996998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone [2001352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anaplastic Lymphoma Kinase Inhibitors [MoA]</name>
  <code>C654367</code>  <id>654367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anaplastic Lymphoma Kinase Inhibitors</to_name>
    <to_code>T59045</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194147</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Agonists [MoA]</name>
  <code>C470</code>  <id>471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists</to_name>
    <to_code>T3569</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000146</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone (micronized) [221168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stanozolol [10032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandriol [6817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandriol dipropionate [235381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandrostenolone [6818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Antagonists [MoA]</name>
  <code>C664</code>  <id>665</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists</to_name>
    <to_code>T3571</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Inhibitor</to_name>
    <to_code>T3570</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000243</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clascoterone [2474340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilutamide [31805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutamide [4508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicalutamide [83008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Androgen Receptor Inhibitor [EPC]</name>
  <code>C634953</code>  <id>634953</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Inhibitor</to_name>
    <to_code>T3572</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175560</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flutamide [4508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bicalutamide [83008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilutamide [31805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enzalutamide [1307298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clascoterone [2474340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with androgen receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Receptor Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing androgen receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Androgen Synthesis Inhibitors [MoA]</name>
  <code>C635363</code>  <id>635363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Synthesis Inhibitors</to_name>
    <to_code>T3573</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175925</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Androgen [EPC]</name>
  <code>C635243</code>  <id>635243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen-class Agent</to_name>
    <to_code>T3574</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen</to_name>
    <to_code>T3575</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175824</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testosterone Congeners [M0447347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoxymesterone [4494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyltestosterone [6904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with androgen receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Androstanes [M0001109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing androgen receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nandrolone [7244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danazol [3102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Androgen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone [10379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anesthetic [APC]</name>
  <code>C654109</code>  <id>654109</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetic</to_name>
    <to_code>T58514</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193878</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anesthetic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anesthetic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anesthetics [TC]</name>
  <code>C654031</code>  <id>654031</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics</to_name>
    <to_code>T58409</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193810</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor oil [1297880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liquefied phenol [239351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride [236539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha,alpha-dibromo-d-camphor [1858362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine [4171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine [20859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine hydrochloride [259454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine hydrochloride [2557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine hydrochloride [2117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil [56795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halothane [5095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor [1952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride monohydrate [1298851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine hydrochloride [91188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenol [33290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine [23744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine [592464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride anhydrous [1375412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine [259453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine [35780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride anhydrous [2198974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine [8686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine hydrochloride [53616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine hydrochloride [203185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil citrate [58964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine [6759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine hydrochloride [227221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor (natural) [1298738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiopoietin-like 3 Inhibitor [EPC]</name>
  <code>C654147</code>  <id>654147</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitor</to_name>
    <to_code>T58565</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ANGPTL3 Inhibitor</to_name>
    <to_code>T58566</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193915</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiopoietin-like 3 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiopoietin-like 3 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evinacumab [2478335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing lipase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with lipase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiopoietin-like 3 Inhibitors [MoA]</name>
  <code>C654146</code>  <id>654146</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ANGPTL3 Inhibitors</to_name>
    <to_code>T58564</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitors</to_name>
    <to_code>T58563</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193916</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evinacumab [2478335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Receptor Antagonists [MoA]</name>
  <code>C318</code>  <id>319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin II Receptor Antagonists</to_name>
    <to_code>T3765</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin II Receptor Blockers</to_name>
    <to_code>T3766</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists</to_name>
    <to_code>T3764</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000070</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan kamedoxomil [1294597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Receptor Blocker [EPC]</name>
  <code>C634954</code>  <id>634954</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Blocker</to_name>
    <to_code>T3768</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin II Receptor Blocker</to_name>
    <to_code>T3767</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175561</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>losartan [52175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing angiotensin II receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azilsartan [1091643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irbesartan [83818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valsartan [69749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>candesartan [214354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telmisartan [73494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olmesartan [321064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprosartan [83515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sparsentan [2630535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin 2 Receptor Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with angiotensin II receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</name>
  <code>C640507</code>  <id>640507</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin II Type I Receptor Blockers</to_name>
    <to_code>T3769</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists</to_name>
    <to_code>T3773</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin II Type I Receptor Antagonists</to_name>
    <to_code>T3770</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin II Type 1 Receptor Antagonists</to_name>
    <to_code>T3772</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Blockers</to_name>
    <to_code>T3771</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180999</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiotensin Converting Enzyme Inhibitor [EPC]</name>
  <code>C634955</code>  <id>634955</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin Converting Enzyme Inhibitor</to_name>
    <to_code>T3779</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175562</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing angiotensin-converting enzyme inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramipril [35296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>captopril [1998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosinoprilat [1546393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trandolaprilat [1546379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalapril [3827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinaprilat [1546359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perindopril [54552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramiprilat [1546377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalaprilat anhydrous [1545989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benazepril [18867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosinopril [50166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perindoprilat [1546400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trandolapril [38454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinapril [35208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benazeprilat [1546196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moexiprilat [1546358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Angiotensin Converting Enzyme Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisinopril anhydrous [1546022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Angiotensin-converting Enzyme Inhibitors [MoA]</name>
  <code>C540</code>  <id>541</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin Converting Enzyme Inhibitor</to_name>
    <to_code>T3788</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors</to_name>
    <to_code>T3789</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000181</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rescinnamine [9259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anion Transporter Interactions [MoA]</name>
  <code>C648272</code>  <id>648272</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anion Transporter Interactions</to_name>
    <to_code>T3836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188371</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antacid [PE]</name>
  <code>C26956</code>  <id>26957</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid</to_name>
    <to_code>T3931</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008295</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anthelmintic [EPC]</name>
  <code>C634862</code>  <id>634862</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthelmintic</to_name>
    <to_code>T4672</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic</to_name>
    <to_code>T4673</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175481</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebendazole [6672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>praziquantel [8628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiabendazole [10450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthelmintics [M0001301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triclabendazole [2118525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with anthelmintic mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthelmintic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albendazole [430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anthracycline Topoisomerase Inhibitor [EPC]</name>
  <code>C634796</code>  <id>634796</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthracycline Topoisomerase Inhibitor</to_name>
    <to_code>T3964</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175414</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epirubicin [3995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daunorubicin [3109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxorubicin [3639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthracyclines [M0028312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idarubicin [5650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthracycline Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing topoisomerase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with topoisomerase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anthracycline (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</name>
  <code>C652948</code>  <id>652948</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions</to_name>
    <to_code>T3987</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192702</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin [1722336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin, human [1722335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raxibacumab [1366567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obiltoxaximab [1746906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anthrax Protective Antigen-directed Antibody [EPC]</name>
  <code>C652949</code>  <id>652949</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody</to_name>
    <to_code>T3988</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192703</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthrax Protective Antigen-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obiltoxaximab [1746906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthrax Protective Antigen-directed Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anthrax Protective Antigen-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raxibacumab [1366567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-IgE [EPC]</name>
  <code>C635213</code>  <id>635213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IgE</to_name>
    <to_code>T3998</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IgE Antibody</to_name>
    <to_code>T3997</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175794</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-IgE [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Anti-immunoglobulin E antibody (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-IgE [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omalizumab [302379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-IgE [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased IgE Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-IgE [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>IgE-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IgE [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-anginal Agent [TC]</name>
  <code>C637764</code>  <id>637764</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antianginal</to_name>
    <to_code>T4016</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent</to_name>
    <to_code>T4018</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal</to_name>
    <to_code>T4017</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178310</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-anginal [EPC]</name>
  <code>C634809</code>  <id>634809</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal</to_name>
    <to_code>T4019</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175427</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-anginal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranolazine [35829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-anginal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-anginal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-anginal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cardiovascular agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-arrhythmic Agent [TC]</name>
  <code>C637765</code>  <id>637765</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent</to_name>
    <to_code>T4022</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiarrhythmic</to_name>
    <to_code>T4020</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic</to_name>
    <to_code>T4021</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178311</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dofetilide [49247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil hydrochloride [439837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone [233698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil [4648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>practolol [8620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-coagulant [EPC]</name>
  <code>C635434</code>  <id>635434</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-coagulant</to_name>
    <to_code>T4024</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticoagulant</to_name>
    <to_code>T4023</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175980</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argatroban [15202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein C, human [723868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desirudin [114934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argatroban anhydrous [1546207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalteparin [67109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bivalirudin [60819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetic acid [3755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Anticoagulant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid, anhydrous [221946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-coagulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin, porcine [235473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-emetic Agent [TC]</name>
  <code>C637825</code>  <id>637825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiemetic</to_name>
    <to_code>T4025</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiemetic Agent</to_name>
    <to_code>T4026</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent</to_name>
    <to_code>T4028</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic</to_name>
    <to_code>T4027</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178371</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron [26237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide [38685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosnetupitant [2044417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant [1731071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron hydrochloride [397405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone maleate [236099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide hydrochloride [57227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosnetupitant chloride hydrochloride [2044416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron hydrochloride [142149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride anhydrous [2119176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone [3626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant dimeglumine [754763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic Agent [EPC]</name>
  <code>C635161</code>  <id>635161</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent</to_name>
    <to_code>T4031</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Drug</to_name>
    <to_code>T4029</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic</to_name>
    <to_code>T4030</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175753</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valproic acid [11118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>felbamate [24812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethosuximide [4135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamotrigine [28439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxcarbazepine [32624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>primidone [8691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methsuximide [47858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Anticonvulsant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vigabatrin [14851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zonisamide [39998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiagabine [31914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-epileptic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenytoin [8183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-epileptic Agent [TC]</name>
  <code>C637767</code>  <id>637767</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiepileptic</to_name>
    <to_code>T4032</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent</to_name>
    <to_code>T4034</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic</to_name>
    <to_code>T4033</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178313</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproate [40254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vigabatrin [14851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium valproate [134422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium valproate [1927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethadione [10827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-infective Agent [TC]</name>
  <code>C637749</code>  <id>637749</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective</to_name>
    <to_code>T4036</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent</to_name>
    <to_code>T4037</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiinfective</to_name>
    <to_code>T4035</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178295</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etesevimab [2477854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zidovudine [11413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoquinol [3435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrated alcohol [1310469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate glucuronate [38725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymol [10553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine isethionate [34634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanol [448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domiphen bromide [49255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin, human [91603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cefa (obsolete) [801150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zalcitabine [3363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcohol, x-ray exposed (1000 rad) [1368126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docosanol [594680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niclosamide [7402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir sodium [2475076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domiphen [23623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine [34633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate [42333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin [1727875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-infective [APC]</name>
  <code>C654102</code>  <id>654102</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective</to_name>
    <to_code>T4036</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193879</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-infective [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-inflammatory Agent [TC]</name>
  <code>C637760</code>  <id>637760</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiinflammatory</to_name>
    <to_code>T4038</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory</to_name>
    <to_code>T4039</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent</to_name>
    <to_code>T4040</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178306</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone caproate [4464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resveratrol [1000492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate A sodium [476847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (shark) [1358172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rofecoxib [232158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcaftadine [1000082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone sodium [236529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone piperazine [236354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine tannate [221075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab-gxii [2717168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, bovine [1306129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nargenicin [2668421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisabolol [19461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone [4463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirfenidone [1592254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carprofen [20343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ichthammol [5645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine hydrochloride [203150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab-lbkz [2693778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone pivalate [4465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab [2693758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab-mrkz [2668385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine hydrochloride [236474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluprednisolone [4497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegloticase [1011650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valdecoxib [278567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine maleate [142429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belatacept [1112973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine [2400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.-bisabolol, (-)-EPI- [2118535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (bovine) [1299929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab [2691526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brensocatib [2721880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitexin [2684982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab [2717169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (porcine) [1366974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab-csfr [2691528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine polistirex [221074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine [20610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin potassium [660767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentoquatam [134568]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suprofen [10255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine [87636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-bisabolol, (+-)- [1306126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate (shark) [1789516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, porcine [1306202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anti-inhibitor Coagulant Complex [EPC]</name>
  <code>C643901</code>  <id>643901</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inhibitor Coagulant Complex</to_name>
    <to_code>T4041</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184166</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Anti-inhibitor coagulant complex (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anti-inhibitor coagulant complex [314504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing anti-inhibitor coagulant complex (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anti-inhibitor Coagulant Complex [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blood Coagulation Factors [M0002684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiarrhythmic [EPC]</name>
  <code>C634808</code>  <id>634808</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic</to_name>
    <to_code>T4042</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiarrhythmic</to_name>
    <to_code>T4043</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175426</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dronedarone [233698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propafenone [8754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dofetilide [49247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine [9068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiodarone [703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disopyramide [3541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotalol [9947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flecainide [4441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Antiarrhythmic agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidocaine [6387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibutilide [41289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mexiletine [6926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiarrhythmic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procainamide [8700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibacterial Agent [TC]</name>
  <code>C637750</code>  <id>637750</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent</to_name>
    <to_code>T4045</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial</to_name>
    <to_code>T4044</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178296</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phenethicillin [132907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate, liposomal [2059179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin mesylate [2709213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin [1266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroxoline [31901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclosan [10795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol calcium [1424675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin hydrochloride [66955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin napsylate [235836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefodizime [20485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium monohydrate [1309402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin sodium [1812261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin [6398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gramicidin [5011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin [1311566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazobactam [37617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methampicillin [29629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin [4448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan fumarate [2604576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin [1591901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate [2640868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miocamycin [6985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pristinamycin [66958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin sodium [236787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbenicillin [10168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver [2606543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome sulfate [236104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin [18609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzalkonium chloride (in water) [124073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citronella oil [1309376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam [2188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methampicillin sodium [273443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome [27130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin [10322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic acid [168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin hydrochloride [82036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin liposomal [2059180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin magnesium [235825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur [1311521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem [2717833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam hydrochloride [236202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-D-glucouronic acid [2569975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfanilamide [10184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline [2055906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefatrizine [2179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfabenzamide [37320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vaborbactam [1945213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troleandomycin [10864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzalkonium [1378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temocillin [37775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium [235750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline tosylate [2059268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telithromycin [274786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin mesylate [221177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin sodium [1591924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin sodium [203836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secnidazole [36314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidaxomicin [1111103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanic acid [21216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxalactam [7069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin [26797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin [2190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem etzadroxil [2717834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim sulfate [221176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin [270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline hydrochloride [2059038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur hydrochloride [1311520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium latamoxef [258330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin acetate [2198943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxithromycin [9478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline dihydrochloride [2055907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin propionate [28069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin hydrochloride [267342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate tetrahydrate [1306069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin [6084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefetamet [20482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin [2181306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin [11124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin [115552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxylenol [20877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzalkonium bromide [1425981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazolidinylurea [1310602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur sodium [1370372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazobactam sodium [221167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan [2604577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin sodium [267417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol [1424676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retapamulin [642274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzalkonium chloride [1379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethicillin [33277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nargenicin [2668421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibacterial [APC]</name>
  <code>C654104</code>  <id>654104</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial</to_name>
    <to_code>T4044</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193880</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxazolidinone Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lincosamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pleuromutilin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penem Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicol-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrofuran Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cephalosporin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ketolide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymyxin-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monobactam Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penicillin-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluoroquinolone Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibacterial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody Interactions [MoA]</name>
  <code>C31810</code>  <id>31811</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions</to_name>
    <to_code>T4119</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010226</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen [2177291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab [2697133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 4 [2197293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen [1663632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen [2380574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen [1946964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen [2180338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen [1666421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine flury-lep strain [830457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen [1928528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen [2479040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Victoria/705/2018 antigen [2380575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Maryland/15/2016 antigen [2048563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen [2564395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vibrio cholerae CVD 103-HGR strain live antigen [1812935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus antigen [1657134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Colorado/06/2017 antigen [2054177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 7 vaccine live [1099937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen [1663630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 1 [2197290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen [1657130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evinacumab [2478335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen [2708995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tick-borne encephalitis purified antigen [2583637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen [2686166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen [1657222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etesevimab [2477854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab [2610417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen [2056525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen [1928289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Utah/9/2014 antigen [1657133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab [2262279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 2 [2197291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen [2717943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab [2472152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 4 vaccine live [1099933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casirivimab [2465242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen [2056521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 3 [2197292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab [2391541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen [2641622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Washington/02/2019 antigen [2280293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cholera Vaccine [2427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus B serotype 7 strain 55142 [1802483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen [2630221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen [2388136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptinezumab-jjmr [2283045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen [2720359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab-zykl [2472151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab [2708333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen [2280296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hong Kong/259/2010 antigen [1801603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen [2645084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen [2562553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H1N1) antigen [1657128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen [2562554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen [2607735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen [1657127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen [2641877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain [1006250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab-mtci [2708340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen [2379530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen [2379531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen [2687714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen [2719300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen [1664171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Austria/1359417/2021 antigen [2605039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab-hncq [2697132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/WUH4618/2021 antigen [2605725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen [2380836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab [2387844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen [2180337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen [1801767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab-tmca [2262421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen [1794331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin-blmf [2387833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen [1666425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H3N2) antigen [1657131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen [1427171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/46/2015 antigen [1942125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen [2688113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, RIT-4385 strain [2603501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab-bbfg [2663939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptinezumab [2282660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen [1664172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain [1005929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/9/2014 antigen [1723997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen [2380834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen [2380837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen [2561244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin antibodies Fab fragments [203223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen [2177290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Darwin/7/2019 antigen [2380838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evinacumab-dgnb [2478646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imdevimab [2465249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen [1928290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Iowa/06/2017 antigen [2056523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/122/2022 (H3N2) antigen [2675569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab-sbzo [2610418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen [2642276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen [2380835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ROTAVIRUS VACCINE, LIVE [253199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen [1657224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, attenuated Schwarz strain [2603499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus [1491862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab-mwge [2391551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen [2694005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Phuket/3073/2013 antigen [1657228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarucizumab [1716191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Panama/45/90 antigen [2262062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen [1664339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab [2663938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen [2562555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/7/2009 (H1N1) antigen [1657331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Michigan/01/2021 antigen [2593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen [2048564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody or Antibody Fragment [APC]</name>
  <code>C654096</code>  <id>654096</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody or Antibody Fragment</to_name>
    <to_code>T58506</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193872</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amyloid Beta-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IgE [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antivenin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Radiotherapeutic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody or Antibody Fragment [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Antibody Interactions [MoA]</name>
  <code>C635439</code>  <id>635439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Antibody Interactions</to_name>
    <to_code>T4120</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175985</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Antibody Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>IgE-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Receptor Interactions [MoA]</name>
  <code>C30266</code>  <id>30267</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions</to_name>
    <to_code>T4121</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009949</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Cell Maturation Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemivibart [2677789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin-tftv [2571093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab-aqqg [2123180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histoplasmin [5363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin [2571094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>North American coral snake antivenin [979384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab-vfrm [2056690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyvalent Crotalidae antivenin [91596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab-cqyv [2619425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylpenicilloyl polylysine [19079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab-xiiy [2626348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab [2274803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab-aahu [2712692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efalizumab [356988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E, recombinant [1986820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster immune globulin [39385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab-lzsg [2104603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Varicella Virus Vaccine Live (Oka-Merck) strain [805486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps skin test antigen [89854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab [2571095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin-tllv [2714236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin, human [91603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab [2587789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa [2587717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>equine diphtheria antitoxin [91602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab-trbw [2274802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin [2721996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab-ekko [2587790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab-gnlm [2058868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies immune globulin, human [89886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab-gxly [2539968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin [1727875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab [2626349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rubella virus vaccine [9486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotrovimab [2550731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab [2619426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria antitoxin [3510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus [1426911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab-yhdp [2110604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab [2056691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Latrodectus mactans antivenin [89887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>purified protein derivative of tuberculin [8948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tositumomab [263010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PERTUSSIS VACCINE,ADSORBED [402543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-qvfc [2639944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-131-tositumomab [234449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab-mrkz [2668385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab-rmbw [2596772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E [1986821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab [2714237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine-gynx [2621549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab-hrii [2698200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guselkumab [1928588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab [2549199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab [2110605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilobelimab [2639620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster immune globulin (human) [485576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alemtuzumab [117055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab [2058846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Smallpox Vaccine [9835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-fcab [2587719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab [2698198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mumps Vaccine [763656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab-vmjw [2549198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertussis vaccine [8080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED [235574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab [2712693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab [2123126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab [2104604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Yellow Fever Vaccine [89890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab [2539967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Soluble Antigen Interactions [MoA]</name>
  <code>C651549</code>  <id>651549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Antigen Interactions</to_name>
    <to_code>T4122</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191501</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Soluble Antigen Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Soluble Protein Interactions [MoA]</name>
  <code>C650983</code>  <id>650983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Protein Interactions</to_name>
    <to_code>T4123</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191002</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Soluble Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin [2277607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin-ejfv [2268306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamlanivimab [2463114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab [2268307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Soluble Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Surface Antigen Interactions [MoA]</name>
  <code>C651550</code>  <id>651550</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions</to_name>
    <to_code>T4124</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191502</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Antigen Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Antigen Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab [2619426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab [2360231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idecabtagene vicleucel [2536430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus [1427211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan [2360232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab-mzwv [2621881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan-hziy [2360530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab [2621880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab-cqyv [2619425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Antigen Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Surface Glycolipid Interactions [MoA]</name>
  <code>C651546</code>  <id>651546</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Glycolipid Interactions</to_name>
    <to_code>T4125</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191498</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Glycolipid Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp-tebn [2590744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naxitamab [2474039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Glycolipid Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antibody-Surface Protein Interactions [MoA]</name>
  <code>C300409</code>  <id>300409</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions</to_name>
    <to_code>T4126</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020023</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD86-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selectin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD80-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antibody-Surface Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [798279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen [1593130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen [1601233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen [1593127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen [1601231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin-piiq [2174091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360571]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab [2682954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab-dlle [2682955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen [1601232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle [1601236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin [2174090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group B vaccine [1593128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab-clzb [2695870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit anti-human T-lymphocyte globulin [107044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymocyte immunoglobulin, equine [1427177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab [2695869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lymphocyte immune globulin, anti-thymocyte globulin, equine [91601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Surface Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anticholinergic [EPC]</name>
  <code>C634967</code>  <id>634967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticholinergic</to_name>
    <to_code>T4130</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticholinergic Agent</to_name>
    <to_code>T4128</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonist</to_name>
    <to_code>T4129</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175574</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scopolamine [9601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycopyrronium [1546438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropicamide [10869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with acetylcholine receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revefenacin [2102775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium cation [1546373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aclidinium [1303098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicyclomine [3361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiotropium [69120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clidinium [21232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing acetylcholine receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atropine [1223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benztropine [1424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>umeclidinium [1487514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methscopolamine [89785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Anticholinergic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium [7213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anticonvulsants [TC]</name>
  <code>C654032</code>  <id>654032</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants</to_name>
    <to_code>T58410</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193811</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rufinamide [69036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stiripentol [2054968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital sodium [235404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metharbital [6825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phensuximide [33309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganaxolone [2604689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacemide [33253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezogabine [1112990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidementia Agents [TC]</name>
  <code>C654033</code>  <id>654033</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents</to_name>
    <to_code>T58411</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193812</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil [135447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine gluconate [2690626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil hydrochloride [236559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>huperzine A [2267703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab-azbt [2687965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab [2687966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricaprylin [1314420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine [2690627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidepressive Agent [TC]</name>
  <code>C637768</code>  <id>637768</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressant</to_name>
    <to_code>T4135</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent</to_name>
    <to_code>T4136</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive</to_name>
    <to_code>T4134</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178314</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone hydrochloride [2672254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone hydrochloride [1086768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine hydrobromide [1439834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine [1455099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuranolone [2669905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram [321988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin [3332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine hydrochloride [142143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone [2672253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone [1086769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin hydrochloride [236807]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate [2607741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine hydrochloride [2119366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexanolone [2121777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tryptophan [10898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine [2119365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate monohydrate [2605948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram oxalate [353108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidiarrheal Agent [TC]</name>
  <code>C637827</code>  <id>637827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal</to_name>
    <to_code>T4137</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent</to_name>
    <to_code>T4138</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178373</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat etiprate [1872448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat ethyl [1872441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat [1872382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kaolin light [104100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kaolin [6102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidiarrheal [EPC]</name>
  <code>C637828</code>  <id>637828</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal</to_name>
    <to_code>T4139</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178374</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crofelemer [1364449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenoxylate [3500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difenoxin [23024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidiarrheal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Gastrointestinal agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidote [EPC]</name>
  <code>C634811</code>  <id>634811</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidote</to_name>
    <to_code>T4140</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175429</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antivenin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine [197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fomepizole [15226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Antidote (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decorporation Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carnitine Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxocobalamin [5514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B6 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Medicinal product acting as antidote agent (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidote for Acetaminophen Overdose [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidote for Acetaminophen Overdose [EPC]</name>
  <code>C635399</code>  <id>635399</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidote for Acetaminophen Overdose</to_name>
    <to_code>T4142</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175961</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine [197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reduction Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antidote for Acetaminophen Overdose [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antidote (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidote for Acetaminophen Overdose [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antidotes, Deterrents, and Toxicologic Agents [TC]</name>
  <code>C637748</code>  <id>637748</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents</to_name>
    <to_code>T4141</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178294</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamines [8826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate [618371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomepizole [15226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Agkistrodon piscivorus antivenin [885183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>andexanet alfa [2045114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium [1903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime cation [1546365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiosulfate [9876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium monohydrate [2001422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 [2101271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus atrox antivenin [885187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus adamanteus antivenin [885185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine hydrochloride [82015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetic acid [3690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prussian blue insoluble [24902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium anhydrous [1371967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor Xa (recombinant), inactivated-zhzo [2045125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine hydrochloride [236471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium [1368950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetate disodium [259268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Centruroides (scorpion) immune F(ab&apos;)2 (equine) [1119986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 (equine) [2101270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>North American coral snake antivenin [979384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin [877015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus scutulatus antivenin [885189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succimer [3446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine [3820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Latrodectus mactans antivenin [89887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate [36726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin disodium [2107308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate anhydrous [1807514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiemetic [EPC]</name>
  <code>C637826</code>  <id>637826</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic</to_name>
    <to_code>T4143</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiemetic</to_name>
    <to_code>T4144</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178372</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiemetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclizine [6676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiemetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiemetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiemetic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiemetic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiemetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethobenzamide [38685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Gastrointestinal agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiemetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antifibrinolytic Agent [EPC]</name>
  <code>C635027</code>  <id>635027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifibrinolytic Agent</to_name>
    <to_code>T4145</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175634</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifibrinolytic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tranexamic acid [10691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifibrinolytic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>6-aminocaproic acid [99]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifibrinolytic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifibrinolytic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprotinin [1056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hemostatic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifibrinolytic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Plasmin inhibitor agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifibrinolytic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antifungal Agent [TC]</name>
  <code>C637751</code>  <id>637751</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal</to_name>
    <to_code>T4157</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent</to_name>
    <to_code>T4158</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178297</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole mononitrate [134933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp [2560213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin [2639155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolnaftate [10637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium undecylenate [89746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium undecylenate [1744166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic acid [168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin acetate [2639156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloprogin [26422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oteseconazole [2602577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole [27901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine [31476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin [325887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp citrate [2560215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc pyrithione [39952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutrimazole [61773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole nitrate [203157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terconazole [37806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbendazole [4325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole [32411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioconazole [38298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenate [314881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc undecylenate [89748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine hydrochloride [91293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tavaborole [1543173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenic acid [10989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antifungal [APC]</name>
  <code>C654105</code>  <id>654105</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal</to_name>
    <to_code>T4157</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193881</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzylamine Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allylamine Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triterpenoid Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Azole Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid-based Polyene Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antifungal [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Echinocandin Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antigen Neutralization [MoA]</name>
  <code>C643673</code>  <id>643673</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization</to_name>
    <to_code>T4159</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antigen Neutralization [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endogenous Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antigen Neutralization [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Toxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antigen Neutralization [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antigen Neutralization [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) [617615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - klhw [2196290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G, human [1426680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - stwk [2672094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - kthm [2726012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G [5666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - slra [2123035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin, human [91603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies immune globulin, human [89886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin [1727875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - ifas [2102433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - hipp [2167145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - dira [2706382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antigout Agents [TC]</name>
  <code>C654034</code>  <id>654034</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents</to_name>
    <to_code>T58412</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193813</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lesinurad [1731031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febuxostat [73689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antihelminthic Agent [TC]</name>
  <code>C637752</code>  <id>637752</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic</to_name>
    <to_code>T4670</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent</to_name>
    <to_code>T4671</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178298</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flubendazole [25096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hygromycin B [1426887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxamniquine [7778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihelminthic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antihistamine [EPC]</name>
  <code>C635158</code>  <id>635158</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihistaminic</to_name>
    <to_code>T4674</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihistamine</to_name>
    <to_code>T4675</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175750</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihistamine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benztropine [1424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihistamine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxylamine [3642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihistamine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing histamine receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihistamine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyzine [5553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihistamine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihistamine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with histamine receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antihypoglycemic Agent [EPC]</name>
  <code>C650826</code>  <id>650826</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihypoglycemic Agent</to_name>
    <to_code>T4676</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190852</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihypoglycemic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihypoglycemic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucagon [4832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihypoglycemic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antihypoglycemic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasiglucagon [2535233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antileishmanial [EPC]</name>
  <code>C650825</code>  <id>650825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antileishmanial</to_name>
    <to_code>T4677</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190851</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antileishmanial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis [M0012333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antileishmanial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miltefosine [1494066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antileishmanial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis [M0012333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antileishmanial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiprotozoal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antileishmanial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimalarial Agent [TC]</name>
  <code>C637753</code>  <id>637753</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent</to_name>
    <to_code>T4680</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial</to_name>
    <to_code>T4679</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178299</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemether [18343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine [6694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine hydrochloride [82130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine succinate [2054091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine [2054023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine hydrochloride [58130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine [50749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil [2382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimalarial [EPC]</name>
  <code>C634863</code>  <id>634863</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial</to_name>
    <to_code>T4681</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175482</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroquine [2393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with antimalarial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>primaquine [8687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefloquine [6694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumefantrine [847728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>artemether [18343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxychloroquine [5521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine [9071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proguanil [2382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atovaquone [60212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimalarial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimanic Agent [TC]</name>
  <code>C637769</code>  <id>637769</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic</to_name>
    <to_code>T4682</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent</to_name>
    <to_code>T4683</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178315</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimetabolite Immunosuppressant [EPC]</name>
  <code>C635006</code>  <id>635006</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite Immunosuppressant</to_name>
    <to_code>T4684</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175613</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite Immunosuppressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycophenolic acid [7145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite Immunosuppressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antimetabolite (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antimetabolite (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimetabolite [EPC]</name>
  <code>C640361</code>  <id>640361</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite</to_name>
    <to_code>T4685</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180853</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing antimetabolite (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyurea [5552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Purine Antimetabolite [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioguanine anhydrous [1546005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floxuridine [4488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Antimetabolite (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimetabolite [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimicrobial Agent [TC]</name>
  <code>C637754</code>  <id>637754</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial</to_name>
    <to_code>T4686</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent</to_name>
    <to_code>T4687</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178300</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota, live [2626724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfabenzamide [37320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.-bisabolol, (-)-EPI- [2118535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypochlorite [1483317]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota, live-jslm [2626728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisabolol [19461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin mesylate [2709213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleandomycin [7629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifamycin sodium [236475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laurylpyridinium [2381133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-bisabolol, (+-)- [1306126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurolidine [2670453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laurylpyridinium chloride [2381132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifamycins [9385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypochlorous acid [1483316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimicrobial [APC]</name>
  <code>C654103</code>  <id>654103</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial</to_name>
    <to_code>T4686</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193882</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitroimidazole Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antiviral [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza A M2 Protein Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus NS5A Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimicrobial [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimigraine Agents [TC]</name>
  <code>C654035</code>  <id>654035</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents</to_name>
    <to_code>T58413</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193814</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zavegepant [2637955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atogepant [2571813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lasmiditan [2256930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erenumab [2045613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab-vfrm [2056690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erenumab-aooe [2045614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubrogepant [2268216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zavegepant hydrochloride [2637956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab-gnlm [2058868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab [2056691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan succinate [322249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab [2058846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimyasthenic Agents [TC]</name>
  <code>C654036</code>  <id>654036</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents</to_name>
    <to_code>T58414</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193815</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab [2712693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan [2672489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-qvfc [2639944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium [623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium chloride [624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab-aahu [2712692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-fcab [2587719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab-noli [2642273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan sodium [2672492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab [2642274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa [2587717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimycobacterial Agent [TC]</name>
  <code>C637755</code>  <id>637755</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial</to_name>
    <to_code>T4703</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent</to_name>
    <to_code>T4704</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178301</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazinamide [8987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol hydrochloride [142435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoniazid [6038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin sulfate [1987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin [78903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pretomanid [2198359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline [1364504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethionamide [4127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol [4110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antimycobacterial [EPC]</name>
  <code>C634864</code>  <id>634864</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial</to_name>
    <to_code>T4705</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175483</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrazinamide [8987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pretomanid [2198359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethionamide [4127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diarylquinoline Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptomycin [10109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoniazid [6038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with antimycobacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethambutol [4110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antineoplastic Agent [TC]</name>
  <code>C637761</code>  <id>637761</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic</to_name>
    <to_code>T4706</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent</to_name>
    <to_code>T4707</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178307</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab-bysp [2637395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab [2632981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin acetate [236538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunvozertinib [2719226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine hydrochloride [1114693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib mesylate [1425222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab [2539967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sipuleucel-T [997261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp-erzs [2109054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib mesylate [1940331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-anns [2174802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine-gynx [2621549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab-clzb [2695870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elotuzumab [1726104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib phosphate [1659192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab [2682954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obinutuzumab [974779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziftomenib [2725985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib hydrochloride [1364953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab-gxly [2539968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panitumumab [263034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib citrate [2690648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin microsphere [221175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-oysk [2375543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carfilzomib [1302966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab-vmjw [2549198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat sodium [2685237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alemtuzumab [117055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temsirolimus [657797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib [2584304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valrubicin [31435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab [2699588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorinostat [194337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine [11202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab [2268307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept [2682678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vipivotide tetraxetan [2597054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib dihydrochloride [2643049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotuzumab ozogamicin [1942950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine [134547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat [1603350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib potassium [2714514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab-hrii [2698200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine [4089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testolactone [10378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab-tgvs [2644448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-131-tositumomab [234449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab-cxix [2387334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib [2570736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib dihydrochloride [2479691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib hydrochloride [2714501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venetoclax [1747556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec [2644436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encorafenib [2049106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umbralisib [2478439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib sulfate [2361596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib [1722365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralsetinib [2394936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uracil mustard [10996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-boav [2725885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab [2714237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvestrant [282357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicalutamide [83008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab [2644447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abarelix [301739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexucabtagene autoleucel [2387277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>necitumumab [1723738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutamide [4508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix acetate [835863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib sulfate [2104548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanubrutinib [2262435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib monohydrate [1314319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab-dlle [2682955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab [2625122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib [1425099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-zzxf [2382599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib [2714502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib [2099704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib [1723735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib dimethyl sulfoxide [1425098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib [2534233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone hydrochloride [2721193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siltuximab [1535218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib ditosylate [481474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifileucel [2675860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vismodegib [1242987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infigratinib [2550729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil hydrochloride [1670303]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab [2698198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib tosylate [2099703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidubicel-onlv [2637354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exemestane [258494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisocabtagene maraleucel [2479136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trioxide [18330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide [2531369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umbralisib tosylate [2478438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciltacabtagene autoleucel [2594775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone [2721194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adagrasib [2625882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib hydrochloride [2362259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib maleate [2105844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine [2540964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-ayyh [2696256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab [2387844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib [475342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib hydrochloride [2477104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant dihydrochloride [2628473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib [480167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anastrozole [84857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib [1363268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capivasertib [2669967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine-lpyl [2540965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan [2360232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib fumarate [2105823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trabectedin [1716278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib anhydrous [2058848]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab-axgb [2625125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab-zbco [2699587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotorasib [2550714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab [2360231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib [2665204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat lactate [1603349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib s-malate [1363267]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zongertinib [2721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone acetate [1100071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp-tebn [2590744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab-rmbw [2596772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab [2549199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat hydrobromide [2670632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-pkrb [2107051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib citrate [1723734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab [2387211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin [2721996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib citrate [2595242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin [2571094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpelisib [2169285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine sulfate [11203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec-vncg [2644435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib hydrochloride [2183103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidubicel [2637355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib [2712546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>binimetinib [2049122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dictamnine [2685302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetuximab [318341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2-bis(4-hydroxy-3-tert-butylphenyl)propane [2267021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fam-trastuzumab deruxtecan-nxki [2267574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib mesylate [1604346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil [1670304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofatumumab [712566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin-ejfv [2268306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix [475230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib succinate [2570737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine sulfate [11199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab [2695869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab-zzxf [2382597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib fumarate [1722380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copanlisib [1945077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib maleate [1940642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib dihydrochloride monohydrate [2665205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib succinate [1873978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib citrate [2698326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox [2099295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dkst [2103478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib [2058849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib [1940332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin [2174090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denileukin diftitox-cxdl [2700746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin [2277607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirdametinib [2705551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin-tftv [2571093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin-blmf [2387833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat hydrobromide [2274379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olutasidenib [2623641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab-cmkb [2473850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-yszy [2715399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib [2105845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide [2664896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept-pmln [2682677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilutamide [31805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naxitamab [2474039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dttb [2289225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib hydrochloride [2534245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant [2725912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate [105556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine [11198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abemaciclib [1946825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide hydrochloride [2531370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib [2105806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin-tllv [2714236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab-fihj [2375130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib mesylate [2691151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine [1546446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab [2571095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tositumomab [263010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib hydrochloride [2712547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axitinib [1242999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acalabrutinib [1986808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamitresgene autoleucel [2690256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-mrbb [2706479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trelstar pamoate [905060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib [2714515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib [2643048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab [1721947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromic phosphate P32 [121070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab [2473851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blinatumomab [1597258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib hydrochloride [2584303]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib camsylate [1862578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone [1100072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin [50610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox-tdfk [2099305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab-irfc [2282019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib hydrochloride [1727454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab-dlwr [2632980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat [2685236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant tosylate [2725911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entrectinib [2197862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab-rwlc [2058825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan-hziy [2360530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obecabtagene autoleucel [2698195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab [2282018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin-piiq [2174091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib [1659191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide acetate [2664897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium nitrate [25544]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plerixafor [733003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib [2690647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab [1298944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipilimumab [1094833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate sodium [4090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiparasitic Agent [TC]</name>
  <code>C637756</code>  <id>637756</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent</to_name>
    <to_code>T4711</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic</to_name>
    <to_code>T4710</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178302</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonyl butoxide [8345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinosad [299081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrethrins [8991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine [3820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine hydrochloride [82015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malathion [6606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl alcohol [1426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxidectin [1047072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiparasitic [EPC]</name>
  <code>C634865</code>  <id>634865</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic</to_name>
    <to_code>T4712</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175484</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ectoparasiticide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parasitic Diseases [M0015919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antileishmanial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthelmintic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivermectin [6069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pediculicide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiparasitic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parasitic Diseases [M0015919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anti-infective agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiparkinson Agents [TC]</name>
  <code>C654037</code>  <id>654037</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents</to_name>
    <to_code>T58415</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193816</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>profenamine [4134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine hydrochloride [236190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole [72302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine [38876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethopropazine hydrochloride [6541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl hydrochloride [1115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl [10811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil mesylate [236380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolcapone [72937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnolol [2562549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil [8353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entacapone [60307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levodopa [6375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine hydrochloride [236892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>istradefylline [2199015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foslevodopa [2695775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhynchophylline [2562552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opicapone [2362167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole hydrochloride [236553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine [1043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine [19832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole dihydrochloride [236747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine hydrochloride [71225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiperspirant Activity [PE]</name>
  <code>C26958</code>  <id>26959</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity</to_name>
    <to_code>T4713</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008296</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium [2689322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chlorohydrate [17610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium bromide [2689321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiporter Interactions [MoA]</name>
  <code>C648275</code>  <id>648275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiporter Interactions</to_name>
    <to_code>T4719</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188374</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor hydrochloride [2199673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiprotozoal Agent [TC]</name>
  <code>C637757</code>  <id>637757</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent</to_name>
    <to_code>T4722</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal</to_name>
    <to_code>T4721</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178303</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miltefosine [1494066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimorazole [7427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine [2054023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornidazole [7701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine succinate [2054091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diloxanide furoate [23203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diloxanide [67182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiprotozoal [EPC]</name>
  <code>C634866</code>  <id>634866</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal</to_name>
    <to_code>T4723</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175485</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atovaquone [60212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflornithine [569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentamidine [7994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitazoxanide [31819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paromomycin [7934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with antiprotozoal mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiprotozoal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antipruritic Activity [PE]</name>
  <code>C26960</code>  <id>26961</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity</to_name>
    <to_code>T4724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008297</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcaftadine [1000082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonyl butoxide [8345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bampine hydrochloride [236519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar extract [90735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boric acid [1700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat [2571074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine lactate [236530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine [18753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat chloride [2571073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar pitch volatiles [90732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antipsychotic Agent [TC]</name>
  <code>C637770</code>  <id>637770</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent</to_name>
    <to_code>T4726</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic</to_name>
    <to_code>T4725</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178316</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine hydrochloride [1721073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol decanoate [186024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine dimalonate [236771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan L-malate [2570387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penfluridol [7974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol hydrochloride [236140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine [784649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine [8042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone tosylate [2275731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluspirilene [4507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline tartrate [2694829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone [2275602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol [10804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin [1791685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline [2694828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol [19777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloperidone [73178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antirheumatic Agent [EPC]</name>
  <code>C635119</code>  <id>635119</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent</to_name>
    <to_code>T4730</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175713</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antirheumatic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxychloroquine [5521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antirheumatic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillamine [7975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antirheumatic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leflunomide [27169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antirheumatic Agent [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antirheumatic Agent [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antirheumatic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antirheumatic Agent [TC]</name>
  <code>C637762</code>  <id>637762</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic</to_name>
    <to_code>T4731</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent</to_name>
    <to_code>T4732</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178308</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>upadacitinib [2196092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib citrate [1358492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baricitinib [2047232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol sodium [80566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leflunomide [27169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib [1357536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol [519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antisense Oligonucleotide [EPC]</name>
  <code>C651710</code>  <id>651710</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-sense Oligonucleotide</to_name>
    <to_code>T4735</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antisense Oligonucleotide</to_name>
    <to_code>T4736</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191626</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inotersen [2099289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oligonucleotides, Antisense [M0025055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eplontersen [2671939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mipomersen [1367839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nusinersen [1863556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golodirsen [2267207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casimersen [2480096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eteplirsen [1810569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olezarsen [2701418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antisense Oligonucleotide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tofersen [2634995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Oligonucleotide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antisense Oligonucleotide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiseptic Agent [TC]</name>
  <code>C637759</code>  <id>637759</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic</to_name>
    <to_code>T4737</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent</to_name>
    <to_code>T4738</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178305</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liquefied phenol [239351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen peroxide [5499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-D-glucouronic acid [2569975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexachlorophene [5293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenol [33290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiseptic [EPC]</name>
  <code>C634867</code>  <id>634867</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic</to_name>
    <to_code>T4739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175486</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiseptic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone-iodine [8611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiseptic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexachlorophene [5293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiseptic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Anti-infective agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiseptic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Communicable Diseases [M0004868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiseptic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiseptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiseptic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Communicable Diseases [M0004868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antispasticity Agents [TC]</name>
  <code>C654038</code>  <id>654038</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents</to_name>
    <to_code>T58416</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193817</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vibegron [2472254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate [59064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate hydrochloride [102170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverin [23684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverine hydrochloride [236960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antithrombin 3 Activators [MoA]</name>
  <code>C635029</code>  <id>635029</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin 3 Activators</to_name>
    <to_code>T4747</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin III Activators</to_name>
    <to_code>T4746</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175636</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antithrombin Activators [MoA]</name>
  <code>C30288</code>  <id>30289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators</to_name>
    <to_code>T4748</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009960</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antithrombin Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin 3 Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antithrombin-directed RNA Interaction [EPC]</name>
  <code>C654377</code>  <id>654377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin-directed RNA Interaction</to_name>
    <to_code>T59065</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194148</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antithrombin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antithrombin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fitusiran [2709439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Coagulant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antithrombins [MoA]</name>
  <code>C392</code>  <id>393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins</to_name>
    <to_code>T4757</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000107</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin sodium [152612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux sodium [322154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin [152610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antitussive Agent [TC]</name>
  <code>C637773</code>  <id>637773</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive</to_name>
    <to_code>T4759</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent</to_name>
    <to_code>T4760</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178319</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine hydrobromide [235428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloperastine [2104180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloperastine hydrochloride [2104181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noscapine [7533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzonatate [18993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antivenin [EPC]</name>
  <code>C643897</code>  <id>643897</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antivenin</to_name>
    <to_code>T4761</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184162</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus atrox antivenin [885187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus scutulatus antivenin [885189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Latrodectus mactans antivenin [89887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing antivenom (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centruroides (scorpion) immune F(ab&apos;)2 (equine) [1119986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antivenins [M0001517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Agkistrodon piscivorus antivenin [885183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Antivenom (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus adamanteus antivenin [885185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antivenin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiviral Agent [TC]</name>
  <code>C637758</code>  <id>637758</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral</to_name>
    <to_code>T4766</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent</to_name>
    <to_code>T4767</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178304</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilobelimab [2639620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil [300195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir [114289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer sodium [2710445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-lactoglobulin (bovine) [2722644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine anhydrous [2108659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer [2710434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emtricitabine [276237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir [1433868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir [73645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir [260101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir marboxil [2099995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticovirimat monohydrate [2055103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen [85763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imdevimab [2465249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir anhydrous [1546017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir calcium [402365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir potassium [1235585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide [1721603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir [619693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipranavir [190548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofosbuvir [1484911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir anhydrous [1546024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirsevimab [2642401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brincidofovir [2599518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir sodium [1433867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab [2716802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine [11194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilgavimab [2587306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir sodium [2625652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir hydrochloride [236081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil succinate [1928942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine [9386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab-zykl [2472151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirsevimab-alip [2642402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirmatrelvir [2587892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamlanivimab [2463114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir ethanolate [644682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir phosphate [259275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat monohydrate [2055677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir tromethamine [2380374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir [719872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir sodium [1999661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab [2472152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maribavir [2586068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casirivimab [2465242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bebtelovimab [2592360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir anhydrous [1546027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer free acid [2710444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine hydrochloride [82093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir [306266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir [1999660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixagevimab [2587300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir hydrate [2637854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maraviroc [620216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir mesylate [266565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemivibart [2677789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab-cfor [2716803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molnupiravir [2587901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir [2380373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotrovimab [2550731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab [2043283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir anhydrous [1598096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir [358262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab-uiyk [2043313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir sulfate [203153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen sodium [314633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanamivir [69722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elvitegravir [1306286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remdesivir [2284718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir propylene glycolate [2670599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir [2197842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Antiviral [EPC]</name>
  <code>C654106</code>  <id>654106</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral</to_name>
    <to_code>T4766</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193883</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Anxiolytics [TC]</name>
  <code>C654039</code>  <id>654039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics</to_name>
    <to_code>T58417</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193818</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrazepam [37985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nordazepam [3155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofisopam [38365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halazepam [26412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam [1535252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam hydrochloride [1999183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</name>
  <code>C651711</code>  <id>651711</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Apolipoprotein B-100 Synthesis Inhibitor</to_name>
    <to_code>T4931</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191627</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mipomersen [1367839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antilipemic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Appetite Alteration [PE]</name>
  <code>C634754</code>  <id>634754</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Alteration</to_name>
    <to_code>T5030</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175371</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Appetite Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Appetite Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Appetite Stimulation [PE]</name>
  <code>C634756</code>  <id>634756</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Stimulation</to_name>
    <to_code>T5031</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175373</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginseng preparation [325526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Appetite Suppression [PE]</name>
  <code>C634755</code>  <id>634755</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression</to_name>
    <to_code>T5033</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anorectic Activity</to_name>
    <to_code>T5032</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175372</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride anhydrous [1808546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride [1300700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride hemihydrate [1597623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin [1300701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aromatase Inhibitor [EPC]</name>
  <code>C634956</code>  <id>634956</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitor</to_name>
    <to_code>T5249</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175563</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letrozole [72965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anastrozole [84857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with aromatase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>exemestane [258494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing aromatase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aromatase Inhibitors [MoA]</name>
  <code>C634442</code>  <id>634442</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitor</to_name>
    <to_code>T5250</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors</to_name>
    <to_code>T5251</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175080</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anastrozole [84857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letrozole [72965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exemestane [258494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testolactone [10378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</name>
  <code>C635162</code>  <id>635162</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid Decarboxylation Inhibitors</to_name>
    <to_code>T5263</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid Decarboxylation Inhibitor</to_name>
    <to_code>T5264</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175754</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbidopa [2019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aromatic Amino Acid [EPC]</name>
  <code>C653574</code>  <id>653574</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid</to_name>
    <to_code>T5265</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193220</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatic Amino Acid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amino Acids, Aromatic [M0370111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aromatic Amino Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levodopa [6375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aromatic hydroxylation [PK]</name>
  <code>C26944</code>  <id>26945</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic hydroxylation</to_name>
    <to_code>T5266</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008289</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic hydroxylation [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Arterial Vasoconstriction [PE]</name>
  <code>C26962</code>  <id>26963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction</to_name>
    <to_code>T5327</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008298</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Arterial Vasodilation [PE]</name>
  <code>C26964</code>  <id>26965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation</to_name>
    <to_code>T5328</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008299</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetranitrate [7992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sul hemipenthy [259379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan kamedoxomil [1294597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine [2376944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine maleate [2377031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Arteriolar Vasoconstriction [PE]</name>
  <code>C634778</code>  <id>634778</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasoconstriction</to_name>
    <to_code>T5330</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175395</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Arteriolar Vasodilation [PE]</name>
  <code>C634762</code>  <id>634762</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation</to_name>
    <to_code>T5331</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175379</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sul hemipenthy [259379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinacidil [33717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Arteriolar Vasodilator [EPC]</name>
  <code>C634957</code>  <id>634957</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilator</to_name>
    <to_code>T5332</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175564</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minoxidil [6984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydralazine [5470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Arteriolar Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vasodilator (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aryl Hydrocarbon Receptor Agonist [EPC]</name>
  <code>C654240</code>  <id>654240</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonist</to_name>
    <to_code>T58754</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>AhR agonist</to_name>
    <to_code>T58755</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194018</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aryl Hydrocarbon Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aryl Hydrocarbon Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tapinarof [2602286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aryl Hydrocarbon Receptor Agonists [MoA]</name>
  <code>C654239</code>  <id>654239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>AhR agonists</to_name>
    <to_code>T58753</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonists</to_name>
    <to_code>T58752</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194019</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapinarof [2602286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Asparagine-specific Enzyme [EPC]</name>
  <code>C635062</code>  <id>635062</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Asparagine-specific Enzyme</to_name>
    <to_code>T5506</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175669</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Asparagine-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asparaginase [M0001815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Asparagine-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparaginase [1156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Asparagine-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calaspargase pegol [2121416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Asparagine-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing asparaginase (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Asparagine-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Asparaginase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Asparagine-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegaspargase [34132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Aspartate Activity Alteration [PE]</name>
  <code>C26966</code>  <id>26967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Aspartate Activity Alteration</to_name>
    <to_code>T5511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008300</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aspartate Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Aspartate Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Astringent Activity [PE]</name>
  <code>C26968</code>  <id>26969</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity</to_name>
    <to_code>T5619</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008301</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate, heptahydrate [1311282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum acetate [17609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate [39954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calamine [106212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate anhydrous [1299928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium chloride [1796444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc chloride [39937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>witch hazel [89821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate monohydrate [1309410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Atrial Depolarization [PE]</name>
  <code>C26970</code>  <id>26971</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Depolarization</to_name>
    <to_code>T5710</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008302</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Atrial Repolarization [PE]</name>
  <code>C26972</code>  <id>26973</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization</to_name>
    <to_code>T5739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008303</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Atypical Antipsychotic [EPC]</name>
  <code>C634812</code>  <id>634812</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Atypical Antipsychotic</to_name>
    <to_code>T5758</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175430</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimavanserin [1791685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olanzapine [61381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brexpiprazole [1658314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quetiapine [51272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risperidone [35636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clozapine [2626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lurasidone [1040028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cariprazine [1667655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziprasidone [115698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paliperidone [679314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aripiprazole [89013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asenapine [784649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumateperone [2275602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Atypical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iloperidone [73178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anti-psychotic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atypical Antipsychotic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autologous Cellular Immunotherapy [EPC]</name>
  <code>C644771</code>  <id>644771</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cellular Immunotherapy</to_name>
    <to_code>T5851</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184997</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Autologous T Cells [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor-derived Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Cellular Immunotherapy [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sipuleucel-T [997261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immune enhancement agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cellular Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autologous Chondrocyte Cell Therapy [EPC]</name>
  <code>C654376</code>  <id>654376</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Chondrocyte Cell Therapy</to_name>
    <to_code>T59064</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194149</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Chondrocyte Cell Therapy [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Autologous cultured chondrocyte (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autologous Cultured Cell [EPC]</name>
  <code>C644088</code>  <id>644088</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cultured Cell</to_name>
    <to_code>T5852</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184317</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Cultured Cell [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cultured cells (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cultured Cell [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autologous Fibroblast Cell Therapy [EPC]</name>
  <code>C654370</code>  <id>654370</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Fibroblast Cell Therapy</to_name>
    <to_code>T59056</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194150</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</name>
  <code>C654354</code>  <id>654354</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy</to_name>
    <to_code>T59031</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194103</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</name>
  <code>C654192</code>  <id>654192</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous HSC Gene Therapy</to_name>
    <to_code>T58652</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy</to_name>
    <to_code>T58651</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous HSC-Based Gene Therapy</to_name>
    <to_code>T58939</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193971</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-globin Gene Transfer [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin Function Restoration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Genome-Edited Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hematopoietic factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autonomic Ganglionic Activity Alteration [PE]</name>
  <code>C635036</code>  <id>635036</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Ganglionic Activity Alteration</to_name>
    <to_code>T5859</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175643</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autonomic Ganglionic Blocker [EPC]</name>
  <code>C635034</code>  <id>635034</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Ganglionic Blocker</to_name>
    <to_code>T5860</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175641</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with ganglion blocking mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecamylamine [6673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing ganglion blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Ganglionic Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Autonomic Nervous System Activity Alteration [PE]</name>
  <code>C635035</code>  <id>635035</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Nervous System Activity Alteration</to_name>
    <to_code>T5861</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175642</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parasympathetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Ganglionic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Autonomic Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Azole Antifungal [EPC]</name>
  <code>C634868</code>  <id>634868</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Azole Antifungal</to_name>
    <to_code>T5966</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175487</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terconazole [37806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>itraconazole [28031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>posaconazole [282446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isavuconazole [1720882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butoconazole [19884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clotrimazole [2623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tioconazole [38298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxiconazole [32638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luliconazole [1482680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miconazole [6932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketoconazole [6135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efinaconazole [1539753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oteseconazole [2602577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with azole structure and antifungal mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluconazole [4450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voriconazole [121243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertaconazole [36435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing azole (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>econazole [3743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azoles [M0002083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Azole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulconazole [37319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>B Cell Maturation Antigen-directed Antibody Interactions [MoA]</name>
  <code>C654392</code>  <id>654392</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>B Cell Maturation Antigen-directed Antibody Interactions</to_name>
    <to_code>T59088</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCMA-directed Antibody Interactions</to_name>
    <to_code>T59089</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194165</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</name>
  <code>C642217</code>  <id>642217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Lymphocyte Stimulator-directed Antibody Interactions</to_name>
    <to_code>T5981</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions</to_name>
    <to_code>T5982</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BLyS-directed Antibody Interactions</to_name>
    <to_code>T5980</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182636</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab [2626349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella typhi Ty21a live antigen [762595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus [1427020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow fever virus strain 17D-204 live antigen [804187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab-xiiy [2626348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 11 vaccine [798262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belimumab [1092437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</name>
  <code>C642218</code>  <id>642218</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Lymphocyte Stimulator-specific Inhibitor</to_name>
    <to_code>T5985</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BLyS-specific Inhibitor</to_name>
    <to_code>T5984</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator (BLyS)-specific Inhibitor</to_name>
    <to_code>T5983</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-specific Inhibitor</to_name>
    <to_code>T5987</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Lymphocyte Stimulator (BLyS)-specific Inhibitor</to_name>
    <to_code>T5986</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182637</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belimumab [1092437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>B [Preparations]</name>
  <code>C288628</code>  <id>288628</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>B [Preparations]</to_name>
    <to_code>T5988</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010584</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boron citrate [324014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus cerebelum preparation [1313218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brinzolamide [194881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belumosudil mesylate [2565692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzopyrene [2534454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black mustard seed extract [1486677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef heart preparation [1313322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brown rice allergenic extract [2103236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl methacrylate/methyl methacrylate/methacrylic acid/styrene crosspolymer [1599819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-((4,6-bis(octylthio)-1,3,5-triazin-2-yl)amino)-2,6-bis(1,1-dimethylethyl)-phenol [1312719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter dock pollen extract [1014739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brivaracetam [1739745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bakuchiol [1368134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bexagliflozin [2627044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromfenac sodium [47364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black imported fire ant allergenic extract [995738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beheneth-30 [1998446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-caryophyllene oxide [2395801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzquinamide hydrochloride [91272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzalkonium [1378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black walnut pollen extract [852569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beech pollen extract [852419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bezlotoxumab [1855048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bilberry extract [125929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus adrenal gland preparation [1310244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisulfite ion [2058420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baloxavir [2197842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus prostate gland preparation [1421149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brazil nut oil [1306156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzylidene dimethoxydimethylindanone [1427142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1-bis(tert-butylperoxy)cyclohexane [2393522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisdequalinium [19464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black mustard whole extract [1657726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium animalis [1550045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biosaccharide gum-4 [1541734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone [1514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beryllium sulfate tetrahydrate [2603751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butidrine [2390760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis vulgaris fruit extract [1310248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus ligament preparation [1552449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl nicotinamide [1440257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus nasal mucosa preparation [1370465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bumetanide [1808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benactyzine [1361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl salicylate [1362907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brucea javanica whole extract [1547470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-pinene, (-)- [2396437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burosumab-twza [2043854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bazedoxifene [1441386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blueberry allergenic extract [899382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromotheophylline [1546386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa vulgaris sap extract [1306170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bottlebrush pollen extract [852233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-butylene glycol monococoate [2637734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barbital [1325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus colon preparation [1545039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulism antitoxin E [236660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone dipropionate [19254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef kidney preparation [1311170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzylamine [2374339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic blue 1 [2263063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boric acid (H3BO3), cmpd. with 2,2&apos;,2&apos;&apos;-nitrilotris(ethanol) (1:3) [1923613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bluefish allergenic extract [892181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bulbine frutescens whole extract [1992056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-bromo-5-nitro-1,3-dioxane [1364947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica oleracea whole extract [2624887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromopride [19768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupivacaine liposome [1191504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beheneth-25 [1313735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-citronellol, (+-)- [1424650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica oleracea var. italica whole extract [1541727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus ovary preparation [1310273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bicarbonate ion [1546277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berdazimer [2710434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium bromide [2561243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromelains [1752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bay leaf extract [1606480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitolterol mesylate [47187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica rapa var. rapa extract [1311665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bryonia alba root extract [1309676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basil oil [1362135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subnitrate [19477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG-18 methyl ether dimethyl silane [1314269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromine [1311476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bay oil (Pimenta racemosa) [1426919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus parasympathetic nerve preparation [1552276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brivudine [59161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus lymph preparation [1310264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzaldehyde [1314334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brompheniramine [1767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bimekizumab [2668041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium chloride [1311065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue beech pollen extract [899611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black walnut shell extract [2630718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buprenorphine hydrochloride [203841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bovine type II collagen (tracheal cartilage) [2471082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borage extract [259460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl behenate [1312543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus sympathetic nerve preparation [1310296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamethan sulfate [102345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Benincasa hispida fruit extract [1311557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzotriazolyl dodecyl p-cresol [1368372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buclizine hydrochloride [91070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buserelin acetate [42569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belantamab mafodotin-blmf [2387833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-bisabolol [1359424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beremagene geperpavec-svdt [2637757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus knee joint preparation [1310262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bornyl acetate, (-)- [2395802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacampicillin [18687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boldenone [2289408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzhydrocodone hydrochloride [2122776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burrobrush pollen extract [852526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisoctrizole [1310510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-butanoyloxybenzoic acid [1373215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl PCA [1487116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berdazimer free acid [2710444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broadleaf cattail pollen extract [1232637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barnidipine hydrochloride [283819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambara groundnut extract [2621647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis lycium whole extract [2048129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bermuda grass smut allergenic extract [1014385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butedronate tetrasodium [1307583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behentrimonium chloride [1311160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berberine [1437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzphetamine hydrochloride [142425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bethanechol chloride [47088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bopindolol hydrogen malonate [236903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beeswax [1356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brussels sprout allergenic extract [899390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef tongue preparation [1543742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-sitosteryl sulfate [1487927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bryonia alba whole extract [1356126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzbromarone [1385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brompheniramine maleate [142427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blackberry allergenic extract [899378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus intestinal mucosa preparation [1364849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boswellia serrata resin oil [1305652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berotralstat hydrochloride [2467541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzenesulfonate [1313278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bifenthrin [2475177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buckminsterfullerene [1435890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula platyphylla var japonica resin [1307567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella washoensis [1544936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BOTULISM ANTITOXIN TRIV A,B&amp;E [408134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bedinvetmab [2642275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bethanidine sulfate [81966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benznidazole [18994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bile salts [1540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamifylline hydrochloride [236152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pendula wood extract [1667261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pendula bark extract [1309815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl acetate [1487188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belatacept [1112973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl alcohol [1426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benfluorex hydrochloride [235953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boswellia serrata whole extract [1486391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupropion hydrobromide [993548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis aristata fruit extract [2599310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boswellia preparation [485858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black cottonwood pollen extract [852376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BCG Vaccine [1344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bur oak pollen extract [900991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bidens pilosa leaf extract [1947407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzquercin [117896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus clausii [2600050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl betaine [2470531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine, anhydrous [350374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium sulfate [1331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black pepper preparation [259314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-ethylhexyl hydroxydimethoxy benzylmalonate [1313226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-beta-glucan synthase component FKS1 [2590729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus diencephalon preparation [2257294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barbexaclone [46795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG/PPG-20/20 dimethicone [1739981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus amyloliquefaciens [2359256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl benzoate [1487511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>binetrakin [1426682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica oleracea var. gemmifera whole extract [2001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brexpiprazole [1658314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl chloride [1311516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baloxavir marboxil [2099995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylparaben [1306937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boletus luridus fruiting body extract [1492943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium lactis [1150094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bimekizumab-bkzx [2668080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buflomedil [19836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyrospermol acetate [1995483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butabarbital sodium [91109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus mesencephalon preparation [1657851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-oleamido isopropyl alcohol [2286805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-bromo-2-acetylsalicylic acid [1803004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine hydrochloride [81965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basiliximab [196102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth [1599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black locust pollen extract [867325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacopa monniera whole extract [1807125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa vulgaris top extract [1314332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boscalid [1735163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brovanexine hydrochloride [402579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>becaplermin [115238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baclofen [1292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter apple preparation [285265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Barleria prionitis whole extract [1421432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus red blood cell preparation [1310292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butcher&apos;s broom preparation [236614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baptisia tinctoria extract [992917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brincidofovir [2599518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter almond extract [1421644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bleomycin sulfate [1621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beclomethasone 17-monopropionate [1546384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium chromate [1307797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brilliant blue FCF [1310605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brussels sprout extract [2099275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butamben [19861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>busulfan [1828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bougainvillea glabra flower extract [2687464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus gallstone preparation [1737793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Botryoglossum platycarpum extract [1331705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenate [1368204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzophenone [18997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bornaprine hydrochloride [235767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butalbital [19860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus large intestine preparation [2591799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromperidol [19777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blackberry flavor [1372002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brazilian pepper tree pollen extract [2632068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl cinnamate [1649557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bupleurum chinense root extract [1307736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-benzisothiazoline-3-one [1368198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamboo extract [1372003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bedaquiline fumarate [1364503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bepotastine [863035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoic anhydride [1998050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,4-butanediol monostearate [1735503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-bromo-2-nitroethanol [1648134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula lenta bark extract [2168266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus subtilis [1311119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica oleracea var. botrytis whole extract [1921874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butalamine [180806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus urinary bladder preparation [1658433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus cereus [1311112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bepridil [1436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoxonium chloride [46949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG-12 dimethicone (70 MPA.S) [1858282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-carotene, (9Z)- [2373651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth hydroxide [235954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl maleurate [1603854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biosaccharide gum-1 [1424360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef liver allergenic extract [972689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bictegravir sodium [1999661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth oxychloride [1311517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-pinene, (+)- [2393778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benazepril [18867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzethonium [1390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl avocadate [2168398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black carpenter ant allergenic extract [2057909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone dipropionate, augmented [215664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bendamustine hydrochloride [1114693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betahistine mesylate [71468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-endorphin human [2176246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butriptyline [19895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzenesulfonic acid [993243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brompheniramine tannate [405414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biperiden [1589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berahyaluronidase alfa-pmph [2723755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brucella abortus [1540822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylphenyl methylpropional, (+)- [1664338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bermuda grass pollen extract [851906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bryonia preparation [319815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-butanol, 4-(ethenyloxy)- [2289429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium iodide [1311072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Burkholderia mallei [1648417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyloctanol [2602284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butoconazole nitrate [47464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bergamot oil [1305651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brown mixture [308814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromazepam [1749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belladonna leaf extract [314517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin B immune FAB2, equine [1722683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buzepide metiodide [19943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biotinoyl tripeptide-1 [1368137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl alcohol [1310579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium carbonate [1305530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-butylresorcinol [1600929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bilberry juice extract [2266499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benfluorex [18880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boswellia frereana whole extract [2378030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsam poplar pollen extract [1014762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamifylline [18752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-glucogallin [2595941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benorilate [1372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black willow pollen extract [852162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butamben picrate [221067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-bis(benzothiazol-2-ylthiomethyl)urea [1742748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl salicylate [1859244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bassia scoparia fruit extract [1609188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-benzenedisulfonic acid [2391135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bovine cartilage extract [47295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bornyl acetate [1491978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pendula tar oil [1310070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beclomethasone dipropionate [1348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bivalirudin trifluoroacetate [2380556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bemiparin sodium [436195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benserazide [1374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>budesonide [19831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyldidecylmethylammonium chloride [2371037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>button mushroom extract [259260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betahistine [1511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buflomedil hydrochloride [235934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula lenta allergenic extract [1922750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(3-bromopropyl)benzene [2391134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black currant oil [73891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenamidopropyltrimonium methosulfate [1438114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brovanexine [19791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bidens bipinnata whole extract [1312544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyloctyl palmitate [1721960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pubescens leaf extract [1309819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus thuringiensis [1800077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis(1,10-phenanthroline)copper(2+) ion [1797117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bambuterol hydrochloride [235862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bivalirudin [60819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzarone [18923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus solar plexus preparation [1310293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica rapa subsp. oleifera whole extract [2670320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosentan monohydrate [498193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bortezomib [358258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bremelanotide [2176312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-d-galactopyranose [1424651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzhydrocodone [2001352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzilic acid [1430394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brown rice preparation [1311040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyrate [596718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>box elder maple pollen extract [851740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus bile preparation [1310249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth oxide [19472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic yellow 87 [2669798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butorphanol tartrate [203170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black sea bass allergenic extract [2102474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-hydroxyethoxypropyl dimethicone (37 CST) [1429043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-alanine [61]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulism antitoxin A [236658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-hydroxyethoxypropyl dimethicone (50 CST) [1359084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus mammary gland preparation [1546868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buthiazide [19882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ballota foetida extract [1342491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica juncea seed oil [1547569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus colostrum preparation [1310253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bifemelane [47111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broomweed pollen extract [1094193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Beta vulgaris extract [1368205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butterbur extract [2266501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-benzylheptanol [1489294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta sitosterol [47070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-phenyl-DL-phenylalanine [2604633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bidens pilosa whole extract [1372634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley (whole grain) allergenic extract [904859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butane [1310550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bletilla striata whole extract [1490682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley allergenic extract [862453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-thujaplicin [1312538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-awwb [2046138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brucine sulfate heptahydrate [1311058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzgalantamine gluconate [2690626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bishydroxyethyl dihydroxypropyl stearammonium [1494975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boroglycerin [1674201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula papyrifera whole extract [1742507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biclotymol [236268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus spleen preparation [1310295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef tallow preparation [1368135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl acrylate - C16-C20 alkyl methacrylate - methacrylic acid - methyl methacrylate copolymer [1485121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoxiquine [314521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacitracin methylene disalicylate [1363718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biperiden hydrochloride [91154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boswellia sacra whole extract [1440224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-bvzr [2268037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium animalis lactis B420 [2667739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG-PPG-14-14 dimethicone [1609071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buspirone [1827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium bifidum R0071 [2613771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamethan [1321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa textilis stem extract [1366321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone sodium phosphate [203220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl acrylate - methylacrylate acid copolymer (2 % methacrylic acid) [2199031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic red 51 [1812082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenamidopropyl dimethylamine behenate [1486029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brensocatib [2721880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine salicylate [1489196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baccharis pilularis whole extract [2590600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-D-ribose [1592263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa bambos whole extract [1485064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-tnjn [2700660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brotizolam [19790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef liver preparation [1330085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-eudesmol [2562544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brosimum acutifolium bark extract [1374398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bush mango extract [1724420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barberry extract [259404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromhexine hydrochloride [1601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupivacaine hydrochloride anhydrous [1375412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-maly [2599041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsalazide [18747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pubescens whole extract [2591798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella elizabethae [1544932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Breea segeta whole extract [2590602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subcarbonate [19475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzonatate [18993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butylene glycol 1-stearate [2048726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamipine [18753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beclamide [18846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl levulinate [1487835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beractant [46967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus ureter preparation [2176447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belimumab [1092437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin C immune FAB2 [1722699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoyl peroxide [1418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brunfelsia uniflora root extract [1923614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brazil nut whole allergenic extract [2102473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus anthracis [1595882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus pituitary gland preparation [1310291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>banana extract [285149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belladonna alkaloids [1359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borage oil [68905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoate [70589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Broussonetia papyrifera whole extract [1535475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosentan anhydrous [1468845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brodimoprim [19727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bruceantin [2693987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benproperine pamoate [236750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisphenol A [1433347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bentonite [1375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin G immune FAB2 [1722707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blackback founder extract [2387830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus mesenchyme preparation [1310265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black walnut allergenic extract [891695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl hexanoate [2467278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis pertactin vaccine, inactivated [1300184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzquinamide [19041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus gingiva preparation [2045728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bicyclohexylammonium fumagillin [1926481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa vulgaris stem extract [1306171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl glycolate [2392134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-diglyceryl polyacyladipate-1 [2532536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betrixaban [1927851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzydamine [1425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bone meal [19596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine [1512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bemiparin [280611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bay leaf allergenic extract [1010879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>budipine hydrochloride [236892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisabolol oxide A [2043281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black oak pollen extract [852260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bassia scoparia whole extract [2632777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab [253337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus tendon preparation [1310297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bay leaf oil [1305650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baptisia tinctoria whole extract [2548899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium chloride, dihydrate [1311064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burning bush pollen extract [852593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Buxus sempervirens leafy twig extract [1876509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Butea monosperma flower extract [1648691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black truffle extract [1860421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulism immune globulin IV human [544488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bezafibrate [1525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzocaine hydrochloride [1049105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoic acid 2-(2,4,6-trichlorophenyl)hydrazide [2286251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-ethoxydiglycol cyclohexane 1,4-dicarboxylate [2283759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broadleaf plantain pollen extract [1484983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus nerve preparation [1310267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2-bis(4-glycidyloxyphenyl)propane [1368138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bufo bufo whole extract [2002064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyltrimethylsilane [2557374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl ether [1594416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-pinene [1923811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium infantis [100213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisabolol oxide B, (-)- [1732120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bromus ramosus whole extract [1799290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium longum [1150096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis repens root extract [2593373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue crab preparation [1315126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subsalicylate [19478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzethonium chloride [40036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bretylium [19685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beach strawberry extract [1306191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butylene glycol dioleate [2118441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus gallbladder preparation [1310256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butedronate [1370573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brolucizumab-dbll [2204916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupranolol hydrochloride [236806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisacodyl [1596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>babassu seed extract [1539195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Blatta orientalis preparation [1346617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bifonazole [19295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus esophagus preparation [1552448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus hippocampus preparation [1310260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subcitrate potassium [1294617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-citronellol, (R)- [1310495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borneol, (+)- [2530132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-amyloid protein-(1-6)-peptidylglycylglycyl-L-cysteine-3-(2,5-dioxo-2,5-dihydro-1H-pyrrole-1-yl)-n-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)propanamide-alanine [2471302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broccoli sprout extract [1668220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brexanolone [2121777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyrospermol [1995484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brazillian pepper extract [1306935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzalkonium chloride (in water) [124073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butamirate citrate [382677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Backhousia citriodora whole extract [1591895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boerhavia diffusa root extract [1488999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella quintana [1544934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boron [1705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacitracin A [1986366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bicisate [1306100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyloctyl salicylate [1306948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betasizofiran [1368136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boswellia sacra bark extract [1371444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brazil nut allergenic extract [891514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Buddleja davidii whole extract [1314323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromfenac [19737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Briza maxima whole extract [2533834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth aluminate [40762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisabolol [19461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenic acid [1368203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylbenzene [2107612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black catechu extract [1541735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bean extract [1370773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brain-derived neurotrophic factor [47324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benazepril hydrochloride [235758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis vulgaris whole extract [1358474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-D-glucouronic acid [2569975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broccoli extract [2099294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biguanide [1918319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-ionone [2371702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>batilol [1306190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bethanidine [1523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benactyzine hydrochloride [314518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brentuximab vedotin [1147320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Borrelia burgdorferi [1426882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl erucate [1540826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoxonium [236962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bictegravir [1999660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus brainstem preparation [1482549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brillant blue [1722233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella clarridgeiae [1544931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzydamine hydrochloride [81963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-eleostearic acid [2469352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black currant juice [1488814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belinostat [1543543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borneol [1368202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-resorcylic acid [1368632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-octyldodecyl dimer dilinoleate - propanediol copolymer [2167166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betrixaban maleate [1927955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butanamide [1653515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,4-benzoquinone [319868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black cohosh extract [236665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biotin [1588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacopa monniera leaf extract [1310126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bethanechol [19257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bald cypress pollen extract [995747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzaldehyde propylene glycol acetal [2694728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl palmitate [2118125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broccoli seed oil [1659203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betahistine hydrochloride [81964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black walnut leaves extract [1319885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Buddleja davidii leaf extract [1600595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus parotid gland preparation [2001812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bromus ramosus flower extract [1310006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black carrot anthocyanins extract [1438057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis vulgaris root extract [1310120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth cation [1546284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica napus subsp. napus extract [1873590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupropion hydrochloride [203204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth dipropylacetate [324003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosentan [75207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pubescens flower bud extract [1437220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzgalantamine [2690627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beremagene geperpavec [2637758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>binimetinib [2049122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buclizine [59636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butalamine hydrochloride [236155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus joint capsule preparation [1311192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzophenone-9 [1366883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupivacaine [1815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl chloride [19900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzophenone-5 [1428833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzenesulfinic acid [2637735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-ocimene, (3Z)- [2542350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black widow spider preparation [1310216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus firmus [1316426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butylene glycol 1-propionate [1739232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bee pollen [253157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butylene glycol [1310542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brolucizumab [2204915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaxolol [1520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bixa orellana seed extract [1309203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus ankle joint preparation [1310246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bidens tripartita flowering top extract [1361491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol behenate [1607327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Biancaea decapetala root bark extract [2539931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2-bis(4-hydroxy-3-tert-butylphenyl)propane [2267021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biosaccharide gum-2 [1541235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brimonidine tartrate [39171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belladonna extract, USP [89781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benoxinate hydrochloride [235398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bexarotene [233272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-bromo-4-chloro-3-indolyl phosphate [2665337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone valerate [227897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenoyl hydroxyproline [1596136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromocriptine mesylate [142426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium [1311067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone benzoate [1517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium citrate [1546208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromperidol decanoate [186024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta carotene [19143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-butyloctyl methacrylate [1544967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basil allergenic extract [899355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benproperine [236749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brugia malayi preparation [1368139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bepridil hydrochloride [235752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boron nitride [1363426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium acetate [1486501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Borago officinalis seed extract [1307641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzododecinium bromide [1311594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth carbonate [19469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta tocopherol [1792723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boldenone undecylenate [2289409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitternut hickory pollen extract [899645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzalkonium bromide [1425981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus parathyroid gland preparation [1310289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bimatoprost [283810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue cohosh extract [287513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic aluminum carbonate gel [18789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzalkonium chloride [1379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsalazide disodium [153718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bryonia dioica root extract [1336265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupivacaine hydrochloride [267396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BCG, live, Montreal strain [314513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzylthiouracil [19084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef allergenic extract [892599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brodalumab [1872251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Babesia microti preparation [1435869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzophenone-4-isothiocyanate [2672340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butethamate citrate [156762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>7-behenoylstearate [1435518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behentrimonium methosulfate [1314333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl butyryllactate [2394439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-bromobutane, (S)- [1922902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BCG, live, Tice strain [221050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belantamab mafodotin [2387834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium oxalosuccinate [1311090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus uterus preparation [1493084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus lymph vessel preparation [1544137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bebtelovimab [2592360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bilberry seed oil [1484494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus adrenal cortex preparation [2050747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisdisulizole [1811860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bothrops atrox venom [1656912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisoprolol [19484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bromus secalinus top extract [1993211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bretylium tosylate [1737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butacaine [1829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bird pepper extract [1370777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-butoxyethanol [2385885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-nwgd [2712044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Borago officinalis flower extract [1309207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bushmaster venom [283545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus duodenum preparation [1421148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bentoquatam [134568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus eye preparation [1442193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus pancreas preparation [1310275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bendroflumethiazide [1369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butacaine sulfate [133044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupranolol [1817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-citronellol, (S)- [2050062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brucea javanica fruit extract [2619328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barbital sodium [235404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>budipine [19832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bornaprine [19610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baptisia australis root extract [2470031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin D immune FAB2 [1722701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl phosphate [1306192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butibufen [19880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Blitum bonus-henricus pollen extract [1484978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth-formic-iodide [237148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buckthorn preparation [319828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butanediol (mixed isomers) [2287731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,4-butanedithiol [2603741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-butyl oleate [1368213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine citrate [160460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bulbous buttercup pollen extract [1484985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butorphanol [1841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-butanoyloxybenzoate [1373216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black cohosh root extract [259511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brevibacterium stationis [1310908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl oxoacetate [2618830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin F immune FAB2, equine [1722704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl cyanoacetate [2283402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buserelin [1825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromodiphenhydramine hydrochloride [91065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzotriazolyl butylphenol sulfonate [1358700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromocriptine [1760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bazedoxifene acetate [1442171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated [1300182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benztropine [1424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth tribromophenate [47180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-bromo-2-methylpropane [2387544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaxolol hydrochloride [142144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl stearate [1363628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benztropine mesylate [18927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-isobutylene PPG-20 [1664650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bufo bufo cutaneous gland preparation [1324596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bemotrizinol [1306115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl acrylate - methyl acrylate - methylacrylic acid copolymer (18000 MW) [1990884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth camphocarbonate [237087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black pepper allergenic extract [899363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol dicaprylate [1427411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus hypothalamus preparation [1310261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyldimethyloctylammonium chloride [2399551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Botrytis cinerea allergenic extract [466195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black pepper oil [1309201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsam peru oil [1998858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bilirubin preparation [2285328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(bis(2-methylpropyl)phenoxy)-ethanol [1606492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus catalase preparation [2265847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buprenorphine [1819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bunazosin hydrochloride [236888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzododecinium chloride [1311592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-bromobutane [1922903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bemisiose [1734014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baicalin [1440261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus cartilage preparation [1310251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black widow spider venom [1310459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylphenyl methylpropional [1307156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylated hydroxyanisole [1362900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bulnesia sarmientoi wood oil [1307850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bepotastine besilate [658552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium iodate [1549555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baicalein [1592893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brucine sulfate [1311059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-bis((1-methylethyl)amino)propan-2-ol [2385341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bidens bipinnata top extract [1311562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bentiromide [18896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burosumab [2043855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bremelanotide acetate [2176311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boric acid [1700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baricitinib [2047232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blinatumomab [1597258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>besifloxacin [819911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>birch triterpenes [2675583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beheneth-5 [1747870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bampine hydrochloride [236519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buckwheat allergenic extract [899394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buteth-3 [1424669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol dicaprylate-dicaprate [1368141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus polyfermenticus [1372568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Broussonetia kazinoki whole extract [1535474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus brain preparation [1358698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subgallate [19476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylated hydroxytoluene [1848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula platyphylla var. japonica bark extract [1309407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacitracin A methylenedisalicylate [2286577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brigatinib [1921217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buspirone hydrochloride [203116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beryllium cation [2603752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella vinsonii [1544935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzene [1311295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beet top extract [2588215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butoxycaine [236881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bletilla striata bulb extract [1307544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica rapa var. rapa oil [1306155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BCG, live, Connaught strain [76469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bunazosin [19850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-diglyceryl polyacyladipate-2 [1721708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamipine lactate [236530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylscopolamine [1085787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blueberry extract [1549329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brilliant green cation [1546367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium cation [1334548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behentrimonium [1370579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beclomethasone dipropionate monohydrate [253156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Backhousia citriodora leaf extract [1367123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black carrot extract [2121707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pubescens bark extract [1307943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl octyl phthalate [2174794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzophenone-2 [1315125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black alder pollen extract [1484973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacitracin zinc [11417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berchemia lineata root extract [1733668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berahyaluronidase alfa [2723752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Berberis vulgaris root bark extract [1309766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bellis perennis flower extract [1306193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betadex [1362685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus pineal gland preparation [1310290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bleomycin [1622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus anthracis immunoserum rabbit [1322549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boron gluconate [259357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica rapa subsp. rapa seed extract [1540238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butamirate [19862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butethamate [392938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue spruce pollen extract [900704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa vulgaris leaf extract [1309681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-cyclodextrin sulfobutyl ether [2565264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bran [104125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica napus oil [1306159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzylparaben [19075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blancophor R [1597888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus somatic nerve preparation [1544245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamlanivimab [2463114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-ethoxydiglycol succinate [1363915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bittersweet extract [285163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butriptyline hydrochloride [324004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benperidol [1373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis(cysteinyl maleimide) PEG 20000 [2689929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus placenta preparation [1371903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl carbamate [1606852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brassica napus whole extract [2612150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromhexine [1753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beryllium [1310252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella bacilliformis [1544930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl benzoate [19044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butetamate citrate [235943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium oxide [1307801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley bran [1306942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butenafine hydrochloride [236558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>biperiden lactate [19377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benoxinate [18889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisdisulizole disodium [1811859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoresorcinol [1437984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis(1,3-dimethylbutyl) sulfosuccinate [2465234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Balanites roxburghii seed oil [1310114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benazeprilat [1546196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boesenbergia rotunda root extract [2553100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betulonate [2375520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Backhousia myrtifolia whole extract [2665344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus artery preparation [1549102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin E immune FAB2 [1722703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bioallethrin [19338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borneol, (-)- [2398335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus frontal lobe preparation [1310255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Benincasa hispida seed extract [1655979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bempedoic acid [2282403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisdequalinium diacetate [236889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium bifidum BGN4 [2607767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bopindolol [19605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Buddleja officinalis flower extract [1999472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyldidecylmethylammonium [2371038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baker&apos;s yeast allergenic extract [892674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black currant preparation [236154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benserazide hydrochloride [235765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borate ion [1424875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Beckwithia glacialis whole extract [2539174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylparaben sodium [1306936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromide ion [1546274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brine shrimp extract [1370373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brimonidine [134615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoin acetate [2693284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pubescens resin [1307770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum toxin type A [1712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsam fir leefy twig extract [1306168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl olivate [1374847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa arundinacea leaf extract [1307631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley malt allergenic extract [1006510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.beta.-carophyllene alcohol [2590728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bupleurum falcatum root extract [1309412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berdazimer sodium [2710445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beheneth-10 [1307569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus spinal cord preparation [1310294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bendamustine [134547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-lactoglobulin (bovine) [2722644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bedaquiline [1364504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium bifidum [285148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-bromocamphor, (+-)- [1373218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buchu [236531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin G immune FAB2, equine [1722706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black olive allergenic extract [974650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic yellow 57 [1428861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin E immune FAB2, equine [1722702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacitracin [1291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus intervertebral disc preparation [1442791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth biskalcitrate [687227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bellis perennis extract [1326077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis toxoid vaccine, inactivated [1300186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bencyclane [1367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bergamot orange extract [1543082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butylene glycol cocoate [2612672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus coagulans [1310844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benphothiamine [18891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylscopolamine bromide [1851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-D-glucopyranose [1442190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betulonic acid [2375519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium breve [2110011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus bone preparation [1421147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosutinib [1307619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated [1300180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol 2-laurate [1729312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus testicle preparation [1310298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzylpenicilloyl polylysine [19079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butabarbital [477631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beheneth-25 methacrylate [1793895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin A immune FAB2 [1722697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzphetamine [1422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bishydroxyethyl dihydroxypropyl stearammonium chloride [1494974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beryllium fluoride [2599581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bombyx mori whole preparation [2043282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG-12 dimethicone (500 MPA.S) [1663736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter almond oil [1370302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone acetate [1516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzimidazole [1362885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl ester of methyl vinyl ether-maleic anhydride copolymer (125 kD) [1368140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium oxalate [1603297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-butanediol [1307758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter orange oil [1314580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blackfoot abalone extract [1306119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin F immune FAB2 [1722705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>borogluconate [1370421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bupropion [42347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzotriazole [2385339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baccharis sarothroides whole allergenic extract [2104198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus hip joint preparation [1310258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-phenylpropyl dimethicone (15 CST) [1595581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>babassu oil [1305649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burdock root extract [236238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyloctyl oleate [1603855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brexucabtagene autoleucel [2387277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>banana peel extract [2542744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum toxin type B [2167673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betibeglogene autotemcel [2610349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bahia grass pollen extract [852673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus peyer&apos;s patch preparation [1314581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitolterol [19499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyric acid [1362696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brewer&apos;s yeast allergenic extract [892679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brucine [2181419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bicalutamide [83008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butobarbital [19874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol dicaprate [1428862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bowfin preparation [1347559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broccoli allergenic extract [899386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth phosphate [2600775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Broussonetia kazinoki root extract [1655980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa vulgaris whole extract [1307678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bencyclane fumarate [258328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin D immune FAB2, equine [1722700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley malt syrup [1306883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>banana fruit allergenic extract [2102480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis(1-methylamyl) sodium sulfosuccinate [1364856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brucella melitensis [1318470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beta-escin [1476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus bone marrow preparation [1314237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus thymus preparation [1322428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter fennel extract [1372008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bald-faced hornet venom protein [1297525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bambusa arundinacea stem extract [1306169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bambermycins [1367176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subcitrate [47181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosutinib monohydrate [1314319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4,6-bis(1-methylpentyl)resorcinol [2719298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus achilles tendon preparation [1310238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylvinal [19928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Borago officinialis whole extract [1547568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bambuterol [18751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butanedithiol [2639715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black-eyed pea allergenic extract [899490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bancha tea, leaf, twig preparation [1307787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-adcd [2627648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belumosudil [2564025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus umbilical cord preparation [2177097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(3,5-bis(trifluoromethyl)phenyl)ethanol [2053486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butetamate [235942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus vein preparation [1371904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belzutifan [2567226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butyleneglycol dimethacrylate [2286802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brilliant blue G [1998867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bifidobacterium lactis Bi-07 [2374919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bean sprout extract [1668219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoic acid [18989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barbasco extract [1370992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Boletus satanas fruiting body extract [1438056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoin resin [1406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(2-(2-bornyloxy)ethoxy)triethylamine [2049451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Blastocystis hominis [1599565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butoconazole [19884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-butadiene [2548035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef lung preparation [1370464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis [1608803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>7-behenoylstearic acid [1435517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley extract [1370766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth chloride oxide [236964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>banana allergenic extract [891830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bursera graveolens fruit oil [2606311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis(1-methylamyl) sulfosuccinate [1370615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Butea superba root extract [2001235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus conjunctiva preparation [1544136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus limbic system preparation [1310263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burweed marshelder pollen extract [852551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bartonella henselae [1544933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broccoli preparation [319808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beheneth-20 [1314842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bos taurus tonsil preparation [1310299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic red 46 [2669797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl isovalerate [2548036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bombyx mori larva preparation [1648690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butenafine [47461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bearberry preparation [266364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-butylaminoethanol [2373963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-butene [1362691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bronopol [1114345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brilliant green [19698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pedula whole extract [1993214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin C immune FAB2, equine [1722698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin A immune FAB2, equine [1722696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bilberry seed extract [1370991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bourgeonal [2584844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl arachidate [2695380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beclomethasone [1347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bumadizone [19847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bacampicillin hydrochloride [327584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benralizumab [1989100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum neurotoxin B immune FAB2 [1722684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzthiazide [19008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Betula pendula leaf extract [1351786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bamethan succinate [235933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brown iron oxide [1306946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bicisate dihydrochloride [1306099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belantamab [2387844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bean pod extract [283805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-bromo-3-chloro-5,5-dimethyl-2,4-imidazolidinedione [2374349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol monolaurate [1856503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromodiphenhydramine [19759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisoprolol fumarate [142146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley grain [283541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betulin [2467840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beets preparation [319826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>boceprevir [1102129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berotralstat [2467540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylene glycol 1-caprate 3-caprylate [1798299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basic fuchsin [1535513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyloctyl benzoate [1486796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzocaine [1399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broad leaved paperbark pollen extract [903913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bufexamac [1796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG-10 dimethicone dimer dilinoleate copolymer [1544483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bis-PEG PPG-16-16 PEG-PPG-16-16 dimethicone [1495477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butafosfan [819929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brain-derived neurotrophic factor, human [1313328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>behenyl acrylate polymer [2593852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butyl acetate [1362908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Baptisia tinctoria root extract [1309779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>B [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bixa orellana seed oil [1539998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</name>
  <code>C654294</code>  <id>654294</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCMA-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
    <to_code>T58891</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B Cell Maturation Antigen-directed Genetically Modified Autologous T-cell Immunotherapy</to_name>
    <to_code>T58890</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCMA-directed Genetically Modified Autologous T-cell Immunotherapy</to_name>
    <to_code>T58892</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
    <to_code>T58889</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194067</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Genetically modified T-cell (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing genetically modified T-cell (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>BCL-2 Inhibitor [EPC]</name>
  <code>C652705</code>  <id>652705</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCL 2 Inhibitor</to_name>
    <to_code>T6049</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcl 2 Inhibitor</to_name>
    <to_code>T6050</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Cell Lymphoma 2 Protein Inhibitor</to_name>
    <to_code>T6045</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Cell Lymphoma-2 Protein Inhibitor</to_name>
    <to_code>T6047</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCL-2 Inhibitor</to_name>
    <to_code>T6052</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Cell Lymphoma 2 Inhibitor</to_name>
    <to_code>T6046</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcl-2 Inhibitor</to_name>
    <to_code>T6048</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>B-Cell Lymphoma-2 Inhibitor</to_name>
    <to_code>T6051</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192515</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>BCL-2 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>BCL-2 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>BCL-2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venetoclax [1747556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BCL-2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</name>
  <code>C300435</code>  <id>300435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors</to_name>
    <to_code>T6179</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175411</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encorafenib [2049106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib mesylate [1425222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bacterial Neurotoxin Neutralization [MoA]</name>
  <code>C643837</code>  <id>643837</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization</to_name>
    <to_code>T6276</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184141</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diptheria toxoid absorbed [1657601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulism immune globulin IV human [544488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2, equine [1722700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2, equine [1722696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2, equine [1722706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2, equine [1722702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2 [1722684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2 [1722697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2, equine [1722683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2 [1722705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2 [1722703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2 [1722707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2 [1722701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2 [1722699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid adsorbed [235600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2, equine [1722704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2, equine [1722698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bacterial Toxin Neutralization [MoA]</name>
  <code>C643676</code>  <id>643676</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Toxin Neutralization</to_name>
    <to_code>T6296</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184011</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bacterial Toxin Neutralization [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Neurotoxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bacterial Toxin Neutralization [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthrax Protective Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anthrax Vaccine Adsorbed [404774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Toxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Toxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Toxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bezlotoxumab [1855048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bacterial Toxin Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Barbiturate [EPC]</name>
  <code>C635099</code>  <id>635099</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Barbiturate-class Agent</to_name>
    <to_code>T6341</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Barbiturate</to_name>
    <to_code>T6342</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175693</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Barbiturate [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing barbiturate (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Barbiturate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butalbital [19860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Barbiturate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Barbiturates [M0002177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Barbiturate [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Barbiturate (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Barbiturate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methohexital [6847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</name>
  <code>C300394</code>  <id>300394</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitor</to_name>
    <to_code>T6420</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors</to_name>
    <to_code>T6421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib [2584304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib hydrochloride [2584303]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine Antagonist [EPC]</name>
  <code>C635086</code>  <id>635086</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine Antagonist</to_name>
    <to_code>T6543</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175680</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flumazenil [4457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing benzodiazepine receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with benzodiazepine receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Benzodiazepine [EPC]</name>
  <code>C635100</code>  <id>635100</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine</to_name>
    <to_code>T6545</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine-class Agent</to_name>
    <to_code>T6544</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175694</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorazepam [6470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quazepam [35185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midazolam [6960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diazepam [3322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triazolam [10767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Benzodiazepine (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobazam [21241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clorazepic acid [235408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonazepam [2598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurazepam [4501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temazepam [10355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprazolam [596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlordiazepoxide [2356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzodiazepines [M0002356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estazolam [4077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxazepam [7781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzodiazepine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing benzodiazepine (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Benzothiazole [EPC]</name>
  <code>C635146</code>  <id>635146</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzothiazole</to_name>
    <to_code>T6582</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzothiazole-class Agent</to_name>
    <to_code>T6581</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175740</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzothiazole [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riluzole [35623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzothiazole [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Benzothiazole (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzothiazole [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzothiazoles [M0483511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing thiazole (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzothiazole [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Benzylamine Antifungal [EPC]</name>
  <code>C635313</code>  <id>635313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzylamine Antifungal</to_name>
    <to_code>T6621</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175875</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzylamine Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzylamine Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butenafine [47461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzylamine Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzylamine Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Benzylamine Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzylamines [M0002392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzylamine Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Beta-globin Gene Transfer [MoA]</name>
  <code>C654193</code>  <id>654193</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-globin Gene Transfer</to_name>
    <to_code>T58653</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>β-globin Gene Transfer</to_name>
    <to_code>T58654</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193972</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betibeglogene autotemcel [2610349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-globin Gene Transfer [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovotibeglogene autotemcel [2671958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-globin Gene Transfer [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Biguanide [EPC]</name>
  <code>C634958</code>  <id>634958</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Biguanide</to_name>
    <to_code>T6712</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Biguanide-class Agent</to_name>
    <to_code>T6711</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175565</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biguanide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing biguanide (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biguanide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metformin [6809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biguanide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biguanides [M0002471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biguanide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Biguanide (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Acid Binding Resin [EPC]</name>
  <code>C634804</code>  <id>634804</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Binding Resin</to_name>
    <to_code>T6720</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Resin</to_name>
    <to_code>T6719</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175422</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing bile acid (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Binding Resin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Bile acid sequestrant antilipemic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Binding Resin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Acid Sequestrant [EPC]</name>
  <code>C639784</code>  <id>639784</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Sequestrant</to_name>
    <to_code>T6721</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180292</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid Sequestrant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Bile acid sequestrant antilipemic agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid Sequestrant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colestipol [2685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid Sequestrant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholestyramine resin [2447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid Sequestrant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colesevelam [141626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid Sequestrant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Acid [EPC]</name>
  <code>C635221</code>  <id>635221</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid-class Agent</to_name>
    <to_code>T6722</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid</to_name>
    <to_code>T6723</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175802</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ursodiol [11065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholic acid [1440856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chenodeoxycholic acid [2323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Bile acid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bile Acids and Salts [M0002475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing bile acid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Salt Export Pump Inhibitors [MoA]</name>
  <code>C654066</code>  <id>654066</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BSEP Inhibitors</to_name>
    <to_code>T58447</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors</to_name>
    <to_code>T58446</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193845</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Salt Export Pump Interactions [MoA]</name>
  <code>C654067</code>  <id>654067</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Interactions</to_name>
    <to_code>T58444</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BSEP Interactions</to_name>
    <to_code>T58445</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193846</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Salt Export Pump Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Salt Export Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Secretion Alteration [PE]</name>
  <code>C26974</code>  <id>26975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Alteration</to_name>
    <to_code>T6732</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008304</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Composition Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat sesquihydrate [2563978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar [2690869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar lysine [2690868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat [2563966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Secretion Composition Alteration [PE]</name>
  <code>C300445</code>  <id>300445</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Composition Alteration</to_name>
    <to_code>T6733</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020055</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Secretion Composition Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bile Iron Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile Secretion Volume Alteration [PE]</name>
  <code>C300444</code>  <id>300444</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration</to_name>
    <to_code>T6734</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020054</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Secretion Volume Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholagogue Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bile Secretion Volume Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Choleretic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bile-acid Binding Activity [MoA]</name>
  <code>C634748</code>  <id>634748</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity</to_name>
    <to_code>T6735</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175365</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Binding Activity [MoA]</name>
  <code>C634738</code>  <id>634738</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity</to_name>
    <to_code>T6756</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175355</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin S Polymerization Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin Stabilizers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digoxin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Binding Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile-acid Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-lactoglobulin (bovine) [2722644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>attapulgite [18516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric sulfate [24913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated attapulgite [133050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesna [44]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentoquatam [134568]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bezlotoxumab [1855048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Biological Macromolecular Activity [MoA]</name>
  <code>C462</code>  <id>463</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity</to_name>
    <to_code>T6779</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000142</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Macromolecular Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Macromolecular Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hylan G-F 20 [284637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine [42955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine hydrochloride [89918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine chloride [1311519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (porcine) [1366974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine monohydrate [1314248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesterol [2438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine acetate [6537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine [4919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aspartate [18254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine [2106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine hydrochloride [1311532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, D- [1742746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine hydrochloride [1426681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-alanine [61]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine hydrochloride, (+)- [1539210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate (shark) [1789516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine [6536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aminobenzoate [1010241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, porcine [1306202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine tartrate [1364375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyrosine [10962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenine [290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, DL- [1729154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartic acid [1169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine, DL- [1546161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine [193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine [426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate A sodium [476847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (shark) [1358172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride, DL- [1593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine hydrochloride [6538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamine [4885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fiber [70727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine, DL- [1310540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride [476316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine fumarate [360300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, bovine [1306129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamic acid [25916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine [1091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (bovine) [1299929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline [2449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Biological Response Modifiers [MoA]</name>
  <code>C672</code>  <id>673</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers</to_name>
    <to_code>T6784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000247</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Biological Response Modifiers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n3 [612937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciltacabtagene autoleucel [2594775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil sodium [266663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L [2700765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil [31563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L-rknd [2700764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab-ilto [2691309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-txid [2700365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bipolar Agents [TC]</name>
  <code>C654040</code>  <id>654040</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bipolar Agents</to_name>
    <to_code>T58418</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193819</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan L-malate [2570387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bipolar Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bipolar Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bipolar Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bipolar Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bismuth [EPC]</name>
  <code>C639675</code>  <id>639675</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bismuth-containing Agent</to_name>
    <to_code>T6884</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bismuth</to_name>
    <to_code>T6885</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180183</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bismuth [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth cation [1546284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bismuth [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bismuth subsalicylate [19478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bismuth [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bismuth [M0002611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bismuth [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing bismuth (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bismuth [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Bismuth (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</name>
  <code>C654393</code>  <id>654393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager</to_name>
    <to_code>T59090</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific BCMA-directed CD3 T Cell Engager</to_name>
    <to_code>T59091</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194166</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Cell Maturation Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</name>
  <code>C651451</code>  <id>651451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed CD3-directed BiTE</to_name>
    <to_code>T6889</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD19-directed CD3-directed T Cell Engager</to_name>
    <to_code>T6890</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191421</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blinatumomab [1597258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoconjugates [M0028142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Fusion Proteins [M0018640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</name>
  <code>C654282</code>  <id>654282</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3 T Cell Engager</to_name>
    <to_code>T58859</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3 T-Cell Engager</to_name>
    <to_code>T58860</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3-directed T-Cell Engager</to_name>
    <to_code>T58862</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3-directed T Cell Engager</to_name>
    <to_code>T58861</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194063</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glofitamab [2639782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epcoritamab [2637392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bispecific HER2-directed Antibody [EPC]</name>
  <code>C654359</code>  <id>654359</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific HER2-directed Antibody</to_name>
    <to_code>T59036</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194137</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific HER2-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanidatamab [2698198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific HER2-directed Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific HER2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</name>
  <code>C654210</code>  <id>654210</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific gp100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</to_name>
    <to_code>T58695</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager</to_name>
    <to_code>T58692</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific Glycoprotein 100 Peptide-HLA-directed CD3 T Cell Engager</to_name>
    <to_code>T58693</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed CD3 T Cell Engager</to_name>
    <to_code>T58694</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193989</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tebentafusp [2590743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bisphosphonate [EPC]</name>
  <code>C634972</code>  <id>634972</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bisphosphonate-class Agent</to_name>
    <to_code>T6902</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bisphosphonate</to_name>
    <to_code>T6903</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175579</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alendronic acid [236083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pamidronic acid [1546406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronic acid [55685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphosphonates [M0006519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zoledronic acid anhydrous [1546014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing bisphosphonate (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibandronic acid [115265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidronic acid [1356715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bisphosphonate [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Bisphosphonate (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bladder Contractility Alteration [PE]</name>
  <code>C26976</code>  <id>26977</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bladder Contractility Alteration</to_name>
    <to_code>T6928</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008305</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bladder Contractility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bladder Contractility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bladder Sphincter Tone Alteration [PE]</name>
  <code>C26978</code>  <id>26979</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bladder Sphincter Tone Alteration</to_name>
    <to_code>T6934</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008306</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bladder Sphincter Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bladder Sphincter Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blocking Agent for Diagnostic Imaging [EPC]</name>
  <code>C635299</code>  <id>635299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blocking Agent for Diagnostic Imaging</to_name>
    <to_code>T6965</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175861</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blocking Agent for Diagnostic Imaging [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</name>
  <code>C26980</code>  <id>26981</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood &amp; Lymphatic Fluid Function Alteration</to_name>
    <to_code>T6966</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008307</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oncotic Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxygen Carrying Capacity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intravascular Volume Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood Coagulation Factor [EPC]</name>
  <code>C643903</code>  <id>643903</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Coagulation Factor</to_name>
    <to_code>T6984</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184168</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium ion [1316581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Coagulation related substance (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothrombin, human [1441689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing coagulation protein (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blood Coagulation Factors [M0002684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin alfa [1367075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin [10528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood Glucose Regulator [APC]</name>
  <code>C654113</code>  <id>654113</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulator</to_name>
    <to_code>T58518</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193891</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biguanide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihypoglycemic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Glucosidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazolidinedione [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-1 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Glucose Regulator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonylurea [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood Glucose Regulators [TC]</name>
  <code>C654041</code>  <id>654041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators</to_name>
    <to_code>T58419</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193820</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglitol [30009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linagliptin [1100699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel [2642217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semaglutide [1991302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride [1043560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride dihydrate [2643444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertugliflozin [1992672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertugliflozin pidolate [1992674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasiglucagon [2535233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acarbose [16681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin [857974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin [593411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel-jujn [2642260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab [2621880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albiglutide [1534763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin [1373458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide sodium [221173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin propanediol [1486966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab-mzwv [2621881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirzepatide [2601723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin hydrochloride [2716481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin [1488564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin anhydrous [1546030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin phosphate [621590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood Pressure Alteration [PE]</name>
  <code>C637932</code>  <id>637932</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration</to_name>
    <to_code>T7004</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178476</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine sulfate [82042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine [6756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine hydrochloride [236481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood Products/Modifiers/Volume Expanders [TC]</name>
  <code>C654042</code>  <id>654042</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders</to_name>
    <to_code>T58420</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193821</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human [1426166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-aafi [2057198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid monohydrate [221079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K [11258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide sodium [1746523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albutrepenonacog alfa [1743992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim-xnst [2612537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human-lans [2643194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib [2044896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag choline [2675185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor, human [826072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine hydrochloride [1311534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban maleate [1927955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), PEGylated-aucl [2055654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab-flyo [2055640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab-mtci [2708340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa [105694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor VIIa (recombinant)-jncw [2386863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl starch 130-0.4 [1363352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-ayow [2595942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptinezumab-jjmr [2283045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betibeglogene autotemcel [2610349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab [2110605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasburicase [283821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab [2708333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human-lans [2643196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor XIII a-subunit (recombinant) [1488293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab [1989794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turoctocog alfa [1737557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy polyethylene glycol-epoetin beta [729596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprotinin [1056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fitusiran [2709439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim [338036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel bisulfate [236991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein [2631084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran [2265712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab [2697133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-txid [2700365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, 1-stearyl ester [1435636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX, human [221099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K1 [8308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticagrelor [1116632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-fpgk [2613761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine [10865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX (recombinant), glycopegylated [1990855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b [2587059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec-rvox [2641609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib disodium [2055929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab [2262279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exagamglogene autotemcel [2671667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIIa [4256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran sodium [2265859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl [2631083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b-njft [2587060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide, bovine lung [1788946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban [1927851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivaroxaban [1114195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, human [825006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim [68442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide [1311089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-apgf [2469333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxelotor [2265678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII [4271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa-epbx [2047589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, bovine [2264114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovotibeglogene autotemcel [2671958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine [10594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarucizumab [1716191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec [2641610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa (activated), lyophilized [353106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urokinase [11055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium zirconium cyclosilicate [2047628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim [2612526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-pbbk [2602779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin alfa [1367075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX, human-lans [2643192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasma protein fraction [33835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferiprone [11645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric derisomaltose [2274394]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protein C, human-lans [2643198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag maleate [2045727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranexamic acid [10691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenecteplase [259280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron-dextran complex [5992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel [32968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothrombin, human-lans [2643202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate [1037042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-jmdb [2048018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab-tmca [2262421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-bmez [2260702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab-kxwh [1989795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine hydrochloride [97]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab-hncq [2697132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid [21183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX complex [1670383]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab-yhdp [2110604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX [4249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human [1426164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>6-aminocaproic acid [99]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium citrate sesquihydrate [2049608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desirudin [114934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor [11274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptinezumab [2282660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin [10528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab [2055641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romiplostim [805452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darbepoetin alfa [283838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>damoctocog alfa pegol [2055655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-cbqv [2102692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate mesylate [1037041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-sndz [1605064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Blood Viscosity Reducer [EPC]</name>
  <code>C635333</code>  <id>635333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Viscosity Reducer</to_name>
    <to_code>T7008</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175895</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Viscosity Reducer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentoxifylline [8013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Blood Viscosity Reducer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Viscosity modifier (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Viscosity Reducer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Alteration [PE]</name>
  <code>C26982</code>  <id>26983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration</to_name>
    <to_code>T7026</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008308</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride [10030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acidulated phosphate fluoride [236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride dihydrate [1311371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Formation Alteration [PE]</name>
  <code>C26984</code>  <id>26985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Alteration</to_name>
    <to_code>T7048</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008309</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bone Formation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bone Formation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Formation Inhibition [PE]</name>
  <code>C26986</code>  <id>26987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Inhibition</to_name>
    <to_code>T7049</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008310</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Formation Stimulation [PE]</name>
  <code>C26988</code>  <id>26989</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation</to_name>
    <to_code>T7050</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008311</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride f-18 [1311495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride [9873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stanozolol [10032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorine [1310123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab [2123126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asfotase alfa [1720259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab-aqqg [2123180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abaloparatide [1921069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Formation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Resorption Alteration [PE]</name>
  <code>C26990</code>  <id>26991</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration</to_name>
    <to_code>T7098</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008312</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bone Resorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bone Resorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dihydrogen phosphate [236560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Resorption Inhibition [PE]</name>
  <code>C26992</code>  <id>26993</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition</to_name>
    <to_code>T7099</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008313</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene hydrochloride [166551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate [57230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium nitrate [25544]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronic acid [115265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene acetate [1442171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid [77655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab-aqqg [2123180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium monohydrate [1356128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bnht [2717527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium hemi-pentahydrate [1356127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab [993449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid anhydrous [1546014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medronate disodium [317599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate disodium [83153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate sodium [236916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate [115264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate tetrasodium [1364894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bmwo [2717851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-kyqq [2725924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronic acid [236083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab [2123126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-nxxp [2723334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-dssb [2725498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene [1441386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate sodium [203152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium anhydrous [1926958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-qbde [2725562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bbdz [2715382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene [72143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate [46041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Resorption Stimulation [PE]</name>
  <code>C26994</code>  <id>26995</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Stimulation</to_name>
    <to_code>T7100</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008314</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abaloparatide [1921069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Resorption Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bone Surface Interactions [MoA]</name>
  <code>C30284</code>  <id>30285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions</to_name>
    <to_code>T7113</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009958</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medronate disodium [317599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate disodium [83153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate sodium [236916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate sodium [203152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium anhydrous [1926958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate [115264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate [46041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate tetrasodium [1364894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate [57230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronic acid [115265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid [77655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronic acid [236083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium monohydrate [1356128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium hemi-pentahydrate [1356127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid anhydrous [1546014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bovine Intestinal Adenosine Deaminase [EPC]</name>
  <code>C634852</code>  <id>634852</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bovine Intestinal Adenosine Deaminase</to_name>
    <to_code>T7155</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175471</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bovine Intestinal Adenosine Deaminase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenosine Deaminase [M0000379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bovine Intestinal Adenosine Deaminase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Adenosine deaminase (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bovine Intestinal Adenosine Deaminase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Bovine derived substance (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bovine Intestinal Adenosine Deaminase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bradykinin B2 Receptor Antagonist [EPC]</name>
  <code>C642560</code>  <id>642560</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonist</to_name>
    <to_code>T7179</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182965</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bradykinin B2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>icatibant [1148138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bradykinin B2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bradykinin B2 Receptor Antagonists [MoA]</name>
  <code>C642559</code>  <id>642559</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonists</to_name>
    <to_code>T7180</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182964</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant acetate [1294605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant [1148138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bradykinin Receptor Antagonists [MoA]</name>
  <code>C642558</code>  <id>642558</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin Receptor Antagonists</to_name>
    <to_code>T7181</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182963</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bradykinin Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bradykinin Receptor Interactions [MoA]</name>
  <code>C642557</code>  <id>642557</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin Receptor Interactions</to_name>
    <to_code>T7182</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182962</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bradykinin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Brain Derived Neurotropic Factor Activity Alteration [PE]</name>
  <code>C26996</code>  <id>26997</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Brain Derived Neurotropic Factor Activity Alteration</to_name>
    <to_code>T7197</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008315</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Brain Derived Neurotropic Factor Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Brain Derived Neurotropic Factor Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Cancer Resistance Protein Inhibitors [MoA]</name>
  <code>C650044</code>  <id>650044</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors</to_name>
    <to_code>T7291</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCRP Inhibitors</to_name>
    <to_code>T7290</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190113</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zongertinib [2721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutivacaftor [2701430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maribavir [2586068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oteseconazole [2602577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Cancer Resistance Protein Interactions [MoA]</name>
  <code>C650043</code>  <id>650043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Interactions</to_name>
    <to_code>T7293</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BCRP Interactions</to_name>
    <to_code>T7292</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190112</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Cancer Resistance Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Cancer Resistance Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Function Alteration [PE]</name>
  <code>C26998</code>  <id>26999</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Function Alteration</to_name>
    <to_code>T7298</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008316</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Glandular Development Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Ejection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Glandular Development Alteration [PE]</name>
  <code>C27000</code>  <id>27001</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Glandular Development Alteration</to_name>
    <to_code>T7299</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008317</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Glandular Development Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Glandular Development Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Glandular Development Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Milk Ejection [PE]</name>
  <code>C27002</code>  <id>27003</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Ejection</to_name>
    <to_code>T7300</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008318</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Milk Ejection [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Milk Ejection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Milk Ejection [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Breast Milk Ejection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Milk Excretion [PK]</name>
  <code>C270</code>  <id>271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Excretion</to_name>
    <to_code>T7301</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000046</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Breast Milk Secretion [PE]</name>
  <code>C27004</code>  <id>27005</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion</to_name>
    <to_code>T7302</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008319</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Milk Secretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Breast Milk Secretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bronchial Smooth Muscle Tone Alteration [PE]</name>
  <code>C27006</code>  <id>27007</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchial Smooth Muscle Tone Alteration</to_name>
    <to_code>T7432</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008320</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bronchial Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Bronchial Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bronchoconstriction [PE]</name>
  <code>C27008</code>  <id>27009</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction</to_name>
    <to_code>T7442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008321</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bronchodilation [PE]</name>
  <code>C27010</code>  <id>27011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation</to_name>
    <to_code>T7443</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008322</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine hydrochloride [105470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zafirlukast [114970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol mesylate [47187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol HCl [235447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol [4333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol hydrochloride [1546396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium [1303098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide mono [1552007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol tartrate [668284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine mesylate [6024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol [1546059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol acetate [221142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol trifenatate [1424883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium bromide [1487512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol tartrate [487066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol hydrobromide [203124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofylline [24611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol [1424884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revefenacin [2102775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline [10368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine hydrochloride [102397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol [19499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate dihydrate [998038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol [237159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol hydrochloride [237160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium [1487514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine [9392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol [33767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide monohydrate [1298831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol [1114326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine [6023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline sulfate [10369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol maleate [1114325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Bruton&apos;s Tyrosine Kinase Inhibitors [MoA]</name>
  <code>C654169</code>  <id>654169</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Agammaglobulinaemia Tyrosine Kinase Inhibitors</to_name>
    <to_code>T58610</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Bruton&apos;s Tyrosine Kinase Inhibitors</to_name>
    <to_code>T58609</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>BTK Inhibitors</to_name>
    <to_code>T58611</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193934</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bruton&apos;s Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bruton&apos;s Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bruton&apos;s Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanubrutinib [2262435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bruton&apos;s Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Butyrophenone [EPC]</name>
  <code>C635147</code>  <id>635147</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Butyrophenone</to_name>
    <to_code>T7682</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Butyrophenone-class Agent</to_name>
    <to_code>T7681</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175741</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Butyrophenone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butyrophenones [M0003113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Butyrophenone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Butyrophenone (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>C [Preparations]</name>
  <code>C288629</code>  <id>288629</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>C [Preparations]</to_name>
    <to_code>T7697</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010585</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloromethyl methyl ether [1312362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-22 alkyl phosphate [1424674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylhydroxamic acid [1307145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorobutanol hemihydrate [1309399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa whole extract [2048033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamedrine hydrochloride [314557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucurbita pepo whole extract [1541717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cystoseira tamariscifolia [2607150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clotrimazole [2623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthemum indicum whole extract [2531556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cardiospermum halicacabum leaf extract [2697963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl octacosanoate [1992516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-40 alcohols (MP 79C) [1650427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Croton eluteria bark extract [1673376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbetapentane citrate [283547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesterol [2438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic-capric-linoleic triglyceride [1376147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefpirome sulfate [236104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon schoenanthus oil [1306146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cortisol succinate [21651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium seed extract [2665348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium pangamate [1917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis turtschaninovii whole extract [2001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cephaelis ipecacuanha preparation [317824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cytisus scoparius whole extract [2046115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colletotrichum coccodes allergenic extract [1192729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaelirium luteum whole extract [2712545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-10 phosphate [1314342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus sinensis flower extract [1373722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citraconate [1435288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobenzorex [21244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Commiphora madagascariensis resin [1368331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coffea arabica fruit extract [1311529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat flea allergenic extract [886638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citral propylene glycol acetal [1812465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedrene [2632411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>candelilla wax powder [1424679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronella oil [1309376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefazolin sodium [203171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefditoren [83682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(4-chlorophenyl)-1-phenylethanol [1740931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium malate [1421150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis sativus leaf extract [1600137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coriander oil [1309241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crovalimab [2686619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon nardus whole extract [1797517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulose, oxidized [2481135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cystine dihydrochloride [2642207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorhexidine acetate [2359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chelidonium majus flowering top extract [1435388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carya laciniosa pollen extract [1305551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cicloxilic acid [21095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus maxima fruit rind oil [1306154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cydonia oblonga seed extract [1307560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlormezanone [2373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clorophene [21290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-10 [1314341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corymbia citriodora leaf oil [1306137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia chekiangoleosa seed oil [2590603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coffea arabica whole extract [2534457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 alcohols [1371310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clothiapine [2620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate (chicken) [1370983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorothiazide [2396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobetasol propionate [21245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclamate [2969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium saccharate anhydrous [2636533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>campesterol [20129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colistimethate sodium [48305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cissus quadrangularis whole extract [1988387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceresin [1425217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedryl acetate [2557382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chiro-inositol, (+)- [2267019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centella asiatica leaf extract [1307961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carapa procera whole extract [2362002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbenicillin indanyl sodium [56461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus sinensis fruit oil [1310064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthemum zawadskii whole extract [2398514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Castanea sative leaf extract [1310025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrimonium chloride [1311525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid monohydrate [221079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium trioxide [1539810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium leafy twig oil [1306153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phosphate, dihydrate [1310463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl alcohol [20615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-3 sulfate [1370606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colesevelam hydrochloride [141625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnitine hydrochloride, (+)- [1539210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cariprazine hydrochloride [1721073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropyl betaine [1311576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calophyllum inophyllum leaf extract [2550707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefadroxil monohydrate [204175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper sulfate anhydrous [1999541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Combretum micranthum whole extract [2001173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colistin sulfate [2710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlortetracycline hydrochloride [42545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chenodeoxycholic acid [2323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladonia cristatella whole extract [2690254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl dimethicone 45 [1491002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clocinizine [402583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>causticum preparation [1311056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crinecerfont [2701386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric glycinate [1428217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsicum frutescens whole extract [1995615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnarizine [2549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cirsium japonicum extract [2570729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colfosceril [107784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopentolate hydrochloride [106029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis melo extract [1428847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin 6-sulfate [2268212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroform [1362698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefixime [25033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopentamine [59094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium stearoyl lactylate [1927023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefodizime [20485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamic acid preparation [1368649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric sulfate, basic copper sulfate dibasic [2267037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerliponase [1922437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclobenzaprine hydrochloride [52101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C15-19 alkane [2560236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloric acid [1546391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor Xa (recombinant), inactivated-zhzo [2045125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casimersen [2480096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrot extract [1428866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chymosin [9248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon flexuosus leaf extract [2375828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clindamycin palmitate hydrochloride [91075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoa bean allergenic extract [891721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphor oil, white [1735333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C10-18 triglycerides [1312360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caladium bicolor whole extract [2533030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caesalpinia bonduc whole extract [2001813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clesrovimab-cfor [2716803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cuscuta japonica seed extract [1307742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>croton oil [1309665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coenochloris signiensis extract [1947410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyamemazine [21877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium iodide [1311081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt sulfate [1362742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cullen corylifolium whole extract [1808601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedramber [2584846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-2 phosphate [1545168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric arsenite [1311628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpropamide [2404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropyl dimethylamine propionate [1812567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordia boissieri whole extract [2562680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canis lupus familiaris hair extract [854025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cystine [3036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caramiphen [20191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum camphora resin [1541730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbon dioxide [2034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis vitalba top extract [1309748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus atlantica bark extract [1307594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chelidonium majus root extract [1368151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefuroxime [2194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cannabigerolate [2279519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynanchum stauntonii root extract [1595583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomethiazole edisylate [20802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclobarbital [2978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crested dogstail pollen extract [1484980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropyl propylene glycol-dimonium chloride [1595298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>condoliase [1546420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cipaglucosidase alfa [2667433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 pareth-12 [1313736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclizine tartrate [235771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa pollen extract [2002575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefsulodin sodium [267417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellene lactone [2281672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chrysanthemin extract [1547623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia oil [1306162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chaetomium globosum allergenic extract [466197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clenbuterol [2580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium bicarbonate [1373352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma aromatica root extract [2534440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftolozane [1597609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat skin extract [851949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopentamine hydrochloride [1300303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceruletide diethylamine [20024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosoprium cladosporioides allergenic extract [995720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>captopril [1998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celiprolol hydrochloride [203145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecyparis lawsoniana fruiting twig extract [1923304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco monoisopropanolamide [1435283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon oil, bark [1305634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous chloride hexahydrate [1426883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese cinnamon oil [1309337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium maculatum fruit extract [2053438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpheniramine tannate [221075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus monogyna leaf extract [1745931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clostebol acetate [236522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric chloride [21833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium oxalate [1485048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common hazel pollen extract [1484979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalothin sodium [9860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated rye grass pollen extract [1014774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crospovidone [1310706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-30 [1311623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cycloadiphenine hydrochloride [289372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cryptocarya agathophylla leaf oil [1309329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum verum whole extract [1946396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cochlearia officinalis flowering top extract [1309738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>captan [1368147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium lactate anhydrous [2697131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco-betaine [1367422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromous chloride [21032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic sulfate decahydrate [2603481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cannabinol [1976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clotiazepam [2622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium palmitate [2637681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>careless weed pollen extract [851926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cathine polistirex [236861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor X, human [1426166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caspofungin acetate [282363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-22 [1365710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona pubescens bark extract [1309667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-2 [1545169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyperus prolifer whole extract [2695984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cryptenamine [42618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper Cu-64 [2200143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocaine esterase [2463110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium maculatum whole extract [2001757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coniine [1313334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crospovidone (12 MPA.S at 5%) [1667764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centella asiatica leaf homeopathic preparation [1307965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceanothus integerrimus whole extract [2533845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>costus root oil [1309387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium [1895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrimides [2284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsicum annuum whole extract [1314843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorphenesin [2399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalamin concentrate [317216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chysanthellum indicum top extract [1306203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cairina moshcata heart-liver preparation [1311073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorhexidine hydrochloride [2361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorite ion [1546392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpromazine hydrochloride [104728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefpodoxime [20489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclizine lactate [91071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium chloride, dihydration [221069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen hemostat [253161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-20 alkyl glucoside [1424672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysonilia sitophila allergenic extract [314411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C18-38 alkyl hydroxystearoyl stearate [2586024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crithmum maritimum extract [1372010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer [235535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crospovidone (15 mpa.s at 5%) [2109746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloperastine hydrochloride [2104181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>candelilla wax [1311564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cricket allergenic extract [973447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cytisus scoparius flower extract [1547555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl glyceryl ether [2539030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurea benedicta flowering top extract [1435387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry seed oil [1306144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefaclor [2176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorophyllin copper complex [82242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl glyceryl ether [2382431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclosporine [3008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon bark [477053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium citrate malate [73409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetostearyl alcohol [1307840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetylpyridinium chloride anhydrous [1311527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cardiospermum halicacabum flowering top extract [1309968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12 olefin sulfonate [1370652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbimazole [2020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramphenicol stearate [20768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylarsonate [1744168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon schoenanthus leaf extract [1309422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpromazine [2403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calamine [106212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-33 [1307783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut oil glycereth-8 esters [1719252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrelopsis grevei bark extract [1309997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon oil, leaf [1309227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl myristoleate [1314343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-17 alkane [1541236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbobenzoxycarbonyl-phenylalanyl-alaninyldiazomethane [2376939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyprodenate maleate [236532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl ethylhexanoate [1306178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl betaine [1306175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide 3 [1362741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloconazole hydrochloride [236864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon schoenanthus top extract [1311584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceratostigma willmottianum flower extract [1309794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetylpyridinium acetate [1307588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C30-50 alcohols [1423780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium, chelated [253160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopyralid [1995248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus medica whole extract [2541166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbidopa [2019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canary grass pollen extract [852697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capmatinib hydrochloride [2362259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clocinizine hydrochloride [402584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticorelin ovine [74671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl dimethicone 25 [1373353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Collinsonia canadensis whole extract [2123124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobetasol [2590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia kissii seed oil [1307800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chrysarobin [1860418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus nobilis whole extract [1805272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chikungunya virus antigen, recombinant Senegal strain 37997 capsid protein [2707119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynanchum paniculatum root extract [1546864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cuttle fish ink [283555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium arsenate [1333425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clary sage oil [1309232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilazapril [21102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clorazepate dipotassium [2607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinacalcet hydrochloride [384379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrullus colocynthis whole extract [1663393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis yanhusuo whole extract [2665624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-chloro-2-methyl-1-propene [2469243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyamopsis tetragonoloba whole extract [2480112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid [21183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalexin monohydrate [215948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cannabichromene [2585216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnuba wax [1311568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl oleyl carbonate [1721620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casanthranol [66870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon preparation [285245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium fructoborate [2600351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canyon ragweed pollen extract [851942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloprostenol [2606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloropyramine hydrochloride [236457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropyl dimethylamine [1942697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choleth-20 [1306201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphor oil [1297880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclofenil [2983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calenduloside E [1428039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-6 [1311624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoa butter [21389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis recta whole extract [1999995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chimonanthus praecox flower oil [2289025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus limon fruit oil [1306152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyanomethylacetate [2264720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caesalpinia sappan wood extract [1806891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curculigo orchioides root extract [2001237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centruroides (scorpion) immune F(ab&apos;)2 (equine) [1119986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry seed extract [2596443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftizoxime sodium [82126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium album flower extract [1307574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium glycerophosphate [1909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorphenoxamine hydrochloride [235422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis recta flowering top extract [1309774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caulophyllum thalictroides root extract [1342487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic cation [1546418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphor, (-)- [1648124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalidae immune F(ab&apos;)2 [2101271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopenthiazide [3000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut extract [1372248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabotegravir sodium [2475076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cullen corylifolium fruit extract [1311580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cryptosporidium parvum [1322778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium [2496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl hydroxyethylcellulose (550000 MW) [1488054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chaenomeles speciosa fruit [1310288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coriaria ruscifolia fruit extract [1925877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytarabine [3041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoyl glycinate [1424461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl phosphate [1306184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium vulvaria extract [1428216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calaspargase pegol-mknl [2121417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clorsulon [28303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper oxodotreotide CU-64 [2396442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chionanthus virginicus bark extract [1309759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-((3-chlorophenyl)(4-(methylsulfonyl)phenyl)methylene)dihydro-2(3H)-furanone, (3Z)- [2099767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerium oxalate [314546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomipramine [2597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefamandole [2178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cola extract [283553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-16 [1306172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>concizumab-mtci [2708340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia japonica leaf extract [1307826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colestipol [2685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefadroxil hydrate [407888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clemastine [2578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cycrimine hydrochloride [235421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cuscuta chinensis seed extract [1310072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefoxitin sodium [203118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carpesium abrotanoides fruit extract [1875597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California scrub oak pollen extract [852802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia oleifera whole extract [1650609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-12 isoparaffin [1609072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous nitrate hexahydrate [1423922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclosporine, modified [236077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cumin allergenic extract [901365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcifediol anhydrous [1855064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl palmitoleate [1306183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoamphodiacetate [1364462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Commiphora africana resin [1537758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colchicum autumnale whole extract [1545682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl oleate [1368200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthemum x morifolium flower extract [1306204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cervus elaphus horn preparation [1875527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>curcumin [2955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer homopolymer type c [1305738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calophyllum tacamahaca whole extract [1486507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn dextrin [2691826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C18-36 acid triglyceride [1426385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cromolyn sodium [3538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capric diethanolamide [1432975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein, Lactococcus lactis cultured, Penicillium camemberti cultured, aged [1315112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer-974P [1363568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Copernicia prunifera whole extract [2587732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove preparation [1364295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide 2 [1426448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crovalimab-akkz [2686620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>conivaptan hydrochloride [1294548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum cassia twig extract [2055273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclophosphamide anhydrous [1545988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 alkyl lactate [1356133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Callicarpa japonica fruit extract [1809243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbon tetrachloride [2383337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chikungunya virus antigen, live attenuated LR2006 OPY1 strain [2673238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caulerpa lentillifera extract [1655981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladonia rangiferina whole extract [2619241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C.I. acid blue 324 [1649505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerivastatin [596723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilantro extract [325527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephradine [2239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken cartilage preparation [2359254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcifediol [1889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coltsfoot leaf extract [1372564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-cresyl acetate [14997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber seed oil [1483422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefsulodin [2190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloxacillin benzathine [1043213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftobiprole medocaril sodium [2691334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chrysanthemic acid, (+/-)- [2289244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis bungeana flowering-fruiting top extract [1307802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorophyll [2388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carfilzomib [1302966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caesalpinia spinosa whole extract [2045943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecyparis obtusa wood oil [1305633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus maxima seed extract [1306209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-13 pareth-9 [1991867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamine [1598329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-7 [1428865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Campsis radicans flower extract [2534455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcipotriene hydrate [1299898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cotton fiber allergenic extract [966925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calluna vulgaris flowering top extract [1309749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl glucoside [1307766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobicistat [1306284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl alcohol [1425218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium oxalate monohydrate [1485047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coffea arabica seed extract [2695791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphor [1952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilastatin sodium [82128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coriandrum sativum whole extract [1541716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coenzyme Q10, (2Z)- [1673704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper naphthenate [1373349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry allergenic extract [899734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl nonanoate [1362887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyproterone acetate [22054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus libani whole extract [2054069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftazidime [2191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellal [1424876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin 4-sulfate [1314214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbinoxamine maleate [91066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobenzorex hydrochloride [236205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-19 alkane [2050064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chocolate hind preparation [1994297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromonar [2508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftibuten [20492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynara preparation [235940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium ipodate [1911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalidae immune F(ab&apos;)2 (equine) [2101270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Copaifera officinalis resin [1307772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphoric acid, (+)- [2264361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamic acid [2621720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sulfate, dihydrate [1310465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cavia porcellus whole extract [2590606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-chlorophenyl)methyl 4-hydroxybenzoate [2104168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlamydomonas reinhardtii [2637877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide 4 [2389637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chelidonium majus extract [285220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corallina officinalis extract [1314844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crocus sativus flower extract [1740936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedazuridine [2384449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coccidioides immitis spherule [1549330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbazochrome sodium sulfonate [20209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove leaf oil [1309233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cevimeline hydrochloride [260036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-cyclohexadiene [2691092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caldiamide [1364944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn smut allergenic extract [314488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen type V, human [2667827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn starch [1039062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium behenate [1312385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate sodium [1605114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona officinalis preparation [350262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabazitaxel [996051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisatracurium besylate [136561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium chlorate dihydrate [1542454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canola oil [1309202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chymotrypsin [2530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcitonin [1311287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Celosia cristata flower extract [1547471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese elm pollen extract [852844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus medica fruit extract [1435099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate (shark) [1789516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteine, DL- [1313188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celery seed oil [2118637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chondrus crispus carrageenan [1540877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinacalcet [407990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-23 [1427231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor IX, human [221099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium galactogluconate bromide [47617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorphenindione [402527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefdinir [25037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium polystyrene sulfonate product [47630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorhexidine diacetate [133054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus alba whole extract [1922524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvedilol phosphate [668310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer copolymer type A [1310599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl stearate [1425221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canadian bluegrass pollen extract [1014731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen type I, bovine [1426855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium fluoride [2600776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carisoprodol [2101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canavalia ensiformis whole extract [2624893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftaroline fosamil [1040004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cosibelimab-ipdl [2717512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carica papaya whole extract [1364987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus pinnatifida whole extract [2570730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus deodara wood oil [1307686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsicum extract [319780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyamemazine tartrate [236251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlophedianol hydrochloride [1014329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Costus spicatus root extract [2665287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl trimethicone [1428864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticorelin ovine triflutate [74670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cydonia oblonga leaf extract [2479551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia japonica seed oil [1306161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cherry allergenic extract [862461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnosine hydrochloride [1370593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbamazepine [2002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 alkyl ethylhexanoate [1547713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose [2062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorine [1310122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorogenic acid [1311387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common carp allergenic extract [901390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordia sebestena flower extract [1482789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium gluconate monohydrate [1298846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl glucoside [1306179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens leaf extract [1358960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chamomile extract [1309226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber extract [1305719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crofelemer [1364449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyclopia intermedia leaf extract [1435859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colchicum autumnale bulb extract [1355184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisapride [35255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken allergenic extract [892653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cardiospermum halicacabum seed extract [1923770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciprofloxacin hydrochloride [81981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California black oak pollen extract [1014721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric triethanolamine [1867699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Commiphora wightii resin [2601098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sulfate, anhydrous [1328529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen,activated [751543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamide [1739005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camylofin hydrochloride [236175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capreomycin sulfate [1987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat&apos;s claw preparation [285223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnitine [2106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calophyllum inophyllum whole extract [2634918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chaste tree fruit oil [2716983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic/capric/palmitic/stearic triglyceride [1719259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl PEG-PPG-10-1 dimethicone (HLB 5) [1306941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco diisopropanolamide [1421434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl-behenyl-octyldodecyl lauroyl glutamate [1424868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlorella pyrenoidosa extract [1591911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorhexidine [2358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorzoxazone [2410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus monogyna flower extract [1310021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrorelix acetate [259338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C10-30 cholesterol-lanosterol esters [1368142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryloyl salicylic acid [1492035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrus junos fruit rind extract [1727719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-15 pareth-40 [1927867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cortisone [2878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carlina vulgaris whole extract [1800489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coccidioidin [2660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus reticulata leaf oil [1306132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cryptenamine tannates [235226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium oxide [28728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canakinumab [853491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramphenicol sodium succinate [47998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cytisus scoparius flowering top extract [2168418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium chloride [1901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefoperazone [2184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceritinib [1535457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crizanlizumab-tmca [2262421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corkwood tree leaf extract [1923402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cuminum cyminum whole extract [2055274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium ascorbate anhydrous [1307765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clarithromycin [21212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cicletanine [21914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclohexyl cinnamate [1601992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilgavimab [2587306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carica papaya leaf extract [1309415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopidogrel [32968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisplatin [2555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium dobesilate [1904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium ion [1316581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefixime anhydrous [1546021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium cyclamate [155015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 600 MPA.S at 2 %) [2099296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus horridus horridus whole extract [1745412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamyl alcohol [1362889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrorelix [68147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecyparis lawsoniana wood oil [2374340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftiofur [1311521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopidol [1367179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C10-36 olefin [1428863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry preparation [125933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium album whole extract [1421885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbon black [2032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-carbethoxyethyl)triethoxysilane [2475947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calaspargase pegol [2121416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colloidal oatmeal [221082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosporium cladosporioides extract [867198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centella asiatica extract [1310164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-carene [2395760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carnegiea gigantea flower extract [2534456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurea benedicta extract [1320410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coenzyme A [1314344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Combretum indicum whole extract [2592962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetylhydroxyproline palmitamide [1306185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crab allergenic extract [892610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cuminyl acetaldehyde [2378840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine camsyl [236236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium glucarate [1907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl sulfate [1366920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crassostrea gigas shell extract [2369380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftaroline fosamil acetate [1743286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C1 esterase inhibitor (human) [809864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorprothixene hydrochloride [91133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonseed acid [2697172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl lactate [1368150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefiderocol [2265702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus maxima fruit rind extract [1306207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium alginate [47610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetiedil [20609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium peroxide [1426443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocaine hydrochloride [81985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium valproate [1927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium hexafluorosilicate [1311304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon citratus whole extract [1596767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coccinia grandis leaf extract [2461142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coptis teeta root extract [2665346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrot juice [1366027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citraconic acid [1435287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cirsium japonicum flowering top extract [2375521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlortetracycline [2408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlortetracycline calcium [1306093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropyl PG-dimonium chloride phosphate [1311528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefdinir monohydrate [1306064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colestipol hydrochloride [104485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic chloride Cr-51 [1536069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cicada periostracum extract [2390762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl methicone (15000 MW) [2056454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorquinaldol [2407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvone, (+)- [1747726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 120 MPA.S at 1%) [2584311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis ambigua whole extract [2585441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisatracurium [319864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl palmitate [1311485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrot seed oil [1309293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbazochrome [2011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclandelate [2970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cibotium barometz root extract [1793899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coptis chinensis root extract [1376211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calocedrus decurrens pollen extract [2670160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia sinensis seed oil [1364131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbadox [1314339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber juice [1307563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonseed allergenic extract [852440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftiofur hydrochloride [1311520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine polistirex [235412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer interpolymer type B (allyl pentaerythritol crosslinked) [1366223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cherry juice [1307717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove leaf extract [1923502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coumaran [1855075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorproethazine [59860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove stem oil [1307803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chimaphila umbellata extract [1318231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clemastine fumarate [142430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cuminaldehyde [2177095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco-caprylate [1364293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordyceps gunnii fruiting body extract [1595582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramphenicol palmitate [20767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline fenofibrate [1433887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus limon flowering top oil [2054075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cestrum latifolium leaf extract [1376087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbazochrome sodium sulfonate hydrate [2469330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetirizine hydrochloride [203150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus paradisi fruit oil [1310127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium iodide [235273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cochineal [1425501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyberlindnera jadinii RNA [1432976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis viorna whole extract [2682734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capparis spinosa whole extract [2056925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creosol [1362910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobimetinib fumarate [1722380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefadroxil anhydrous [1545975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capsaicin [1992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis bungeana whole extract [1547472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon flexuosus whole extract [1442506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-20 [1310709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common cocklebur pollen extract [902215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroquine [2393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetostearyl sulfate [1370628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumaria frondosa preparation [1424877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulose [2221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbenoxolone [2017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa seed oil [1305550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloropropylate [1435282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen type II [2471083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefprozil anhydrous [1546020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cathine hydrochloride [236860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canrenoate [618970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clindamycin hydrochloride [81982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoyl glutamate [1370631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C30-38 olefin [2392135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyproheptadine [3013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 sec-pareth-12 sulfosuccinate [1370644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-13 pareth-3 [1368907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium maculatum leaf extract [1994298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcobutrol sodium [2634451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cetraria islandica subsp. islandica extract [1306351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cuscuta reflexa extract [2048126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephaloridine [2233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium quinoa whole extract [2683194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-12 [1311620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloride ion [153974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia japonica flower extract [1307547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorozotocin [1362886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorphenoxamine [20881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus atrox antivenin [885187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carthamus tinctorius flower oil [1495154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomocycline [21272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum aromaticum whole extract [1489545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut water [1799143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coccinia grandis fruit extract [1307768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crambe maritima leaf extract [1371034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Convallaria majalis bulb extract [1312085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceric oxide [1673068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calenduladiol [2282905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cholera Vaccine [2427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crambe hispanica subsp. abyssinica whole extract [2667327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropylamine oxide [1363576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creatine [2907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl-capryl oligoglucoside [1368146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper chloride [150596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-cymene [15002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coniferyl alcohol [1309334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaemelum nobile extract [1311376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloprostenol sodium [204179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-carboxyethyl acrylate [2286249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor VIIa (recombinant)-jncw [2386863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crospovidone (19 MPA.S at 5%) [1661326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-22 alcohols [1307780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>castor oil fish whole [1371316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcitriol [1894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coxsackievirus A [1668272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabozantinib s-malate [1363267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clevidipine butyrate [977863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula officinalis flower extract [1309289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Callicarpa nudiflora leaf extract [2268813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphene [2395761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellyl nitrile, (+/-) [2388134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula officinalis flowering top extract [1309775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl myristate [1306180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalothin [2236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona officinalis whole extract [1591950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coxsackievirus A21 [2591813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftazidime anhydrous [1545984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis armandii stem extract [1724423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpheniramine [2400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coal tar pitch volatiles [90732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlorella vulgaris extract [1370784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon allergenic extract [899673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorcyclizine [2354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosiphon okamuranus preparation [1313229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carbopol 981 [1311164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicory root extract [1371300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carminate [1368644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurium erythraea preparation [1368149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine phosphate anhydrous [1652891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor IX (recombinant), glycopegylated [1990855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coix lacryma-jobi seed oil [1366325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate sodium (bovine) [1299929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomipramine hydrochloride [81984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carglumic acid [401713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-2 [1425220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerium [1367178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coffee fruit preparation [1009451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cirsium arvense flowering top [2359931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-10 [1600142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorotheophylline [236872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine anhydrous [1545976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C14-22 alcohols [1307779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coptis japonica whole extract [2050978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline C-11 [1425419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline hydroxide [1311084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common chickweed leaf extract [1661436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorthalidone [2409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Croton tiglium seed extract [1309714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula officinalis whole extract [1428027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthemum indicum top extract [1992280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrageenan [1368862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida tropicalis allergenic extract [967033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium ascorbate [142407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholestyramine resin [2447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C14 olefin sulfonate [1370655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefepime hydrochloride [236058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cycloastragenol [2398144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caseinate [1370656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus bergamia leaf oil [2264903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium pidolate [87393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciltacabtagene autoleucel [2594775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonidine [2599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic sulfate pentadecahydrate [1875238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-15 [1311621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove allergenic extract [899724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorine dioxide [20799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium bromide [1874551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprooyl tetrapeptide-3 [1427143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium polynicotinate [700888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocklebur extract [880341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma kwangsiensis root extract [2106558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclomethicone 7 [1862729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytarabine liposome [968804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clevidipine [233603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephapirin [2238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus deodara wood extract [1486881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetylpyridinium chloride [2287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colistin [2709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboprost [2051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomiphene citrate [142431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorothen [59695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous phosphate [2624688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cimetidine hydrochloride [91251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia sinensis flower extract [1309958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chinquapin oak pollen extract [2167695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroxine [20875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis hexapetala whole extract [1594579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline [2449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftobiprole [2691333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C8-10/propylene glycol/peg-22/decylene glycol ether [2392630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capivasertib [2669967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus mexicana whole extract [1998612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvacrol [1998840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canna indica root extract [1307727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco monoethanolamide [1426393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (1.3 carboxymethyl substitution per saccharide; 600 MPA.S at 2%) [2565686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cicletanine hydrochloride [235874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cleome gynandra whole extract [2477853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate sodium (porcine) [1366974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium flower oil [1306150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloride hexahydrate [314553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cangrelor [1656052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codonopsis lanceolata root extract [1432472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefditoren pivoxil [72611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cootamundra wattle pollen extract [895353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cesium cation [1546368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common wasp venom protein [1297527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>croscarmellose [1310574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric acetate [1311216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlordiazepoxide [2356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cypermethrin [2590266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-chloro-4,5-dimethylphenol [2286250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cardiospermum halicacbum whole extract [1540827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciprofloxacin [2551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitutions per saccharide; 600 MPA.S at 2 %) [1812763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caplacizumab [2110605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-16 pareth-7 [2566275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chamomile flowers [221916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry juice [1358977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cotton allergenic extract [889548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon citratus leaf extract [1307549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyproheptadine hydrochloride [104592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus sinensis flower wax [1663734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytomegalovirus immune globulin [22178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Celosia cristata whole extract [2289215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorotrianisene [2397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cervus nippon velvet preparation [1442882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnauba wax [1307833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calluna vulgaris whole extract [2003323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium aluminum borosilicate [1358171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California blackberry extract [2590181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Codonopsis pilosula whole extract [2119694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclobutyrol [21954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corynoxeine [2562545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coceth-7 carboxylic acid [1424644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cherry birch pollen extract [852144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous carbonate [2606481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clidinium bromide [48212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysops vittatus whole allergenic extract [2627247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorophyllin [20852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cycloadiphenine [21945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cod liver oil [2669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carpipramine dihydrochloride [289326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantiifolia seed oil [1306149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaelirium luteum root extract [1322548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C1 esterase inhibitor [1599832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopyralid triethanolamine [1995247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordyceps sinensis preparation [283554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 pareth-9 [1857735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloticasone [2719926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvone [1427075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>compound benzoin tincture (USP) [215648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chelone glabra extract [1333265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caffeine monohydrate [236112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma xanthorrhiza oil [1306094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyclamen purpurascens tuber extract [1310339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caulophyllum robustum root extract [1314321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinoxacin [2550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotetan [2187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cannabigerol [2464938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroprocaine [20859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colfosceril palmitate [69782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobetasone [108074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona pubescens preparation [283551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma amada whole extract [1547578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus nobilis extract [1372007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocodimonium hydroxypropyl hydrolyzed keratin (1000 MW) [2101718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coix lacryma-jobi whole extract [2699765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulose acetate phthalate [1425215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Commiphora myrrha stem bark [2560107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sulfate [1925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnosine [1362697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl ethylhexanoate [1314340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chaenomeles japonica seed extract [2592959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlorella minutissima extract [1735032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cassia fistula fruit extract [1307589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagenase clostridium histolyticum-aaes [2475861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl macadamiate [2361301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caviar preparation [1425214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan succinamide (1300 MPA.S) [2399031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt oxide [2606479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>captodiamine [89812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistanche salsa stem extract [2698552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium picrate [1442999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium disodium pyrophosphate [1865167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carthamus tinctorius flower bud extract [1376213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclothiazide [22033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclacillin [2968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroprocaine hydrochloride [53616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabotegravir [2475077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chenodeoxycholate [42588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma longa root powder [2705361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclic AMP [1314330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclomethicone 5 [1305744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>castor fiber scent gland secretion [1375415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>catfish allergenic extract [2198979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cow milk allergenic extract [892665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine sulfate [91104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Castor canadensis scent gland secretion preparation [1371053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium undecylenate [89746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chimaphila maculata extract [1336264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbamoylcholine [1546387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftaroline [1040005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl isononanoate [1312361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phosphate dibasic [47627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetalkonium chloride [47907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholecystokinin [2420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryloyl/caproyl methyl glucamide [2205481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl olivate [1435858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cymene [2584847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cherimoya extract [1808538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium fruit extract [1311573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyldimethylethylammonium bromide [1427238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated mushroom allergenic extract [901369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclamen aldehyde [1376343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>channel catfish allergenic extract [2102475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cashew oil [1310044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citalopram hydrobromide [221078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crocus sativus whole extract [2632775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl stearate [1306200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canagliflozin [1373458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-7 [1372309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coenzyme A trilithium dihydrate [2642206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrate [114200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cuscuta australis seed extract [1791062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloxazolam [21311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopamide [2603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>charcoal [2296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carmoisine [1363916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis alpigena whole extract [1653327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-15 pareth-7 [1483735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco glucoside [1425503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus bergamia leaf extract [1310105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysopogon zizanioides whole extract [2048128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerous cation [1546388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cantharis vesicatoria preparation [265758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus limon whole extract [1733667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cervus elaphus whole preparation [1545680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese rhubarb root exract [1489544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber allergenic extract [899738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut alcohol [1426863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cassia javanica whole extract [2536137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated oat pollen extract [852114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium aspartate [287637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium maculatum root extract [1545040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroquine hydrochloride [451796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creatine monohydrate [1310467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl PEG-PPG-10-1 dimethicone (HLB 1.5) [1306940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cidofovir [83171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroacetate [48008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clemizolpenicillin [21226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedrol [1670019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California mugwort pollen extract [892734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetirizine [20610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpheniramine polistirex [221074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordia dichotoma fruit extract [2121054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotiam hydrochloride [236202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic/capric/myristic/stearic triglyceride [2669697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis vitalba whole extract [1801695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capecitabine [194000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cambendazole [1951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-15 pareth-20 [1790285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-60 myristyl glycol [2049987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn pollen extract [852015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clavulanate [48203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clocortolone pivalate [21250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma longa whole extract [1428853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefaclor anhydrous [1450910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>concizumab [2708333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>candesartan [214354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthellum indicum subsp. afroamericanum extract [1310162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Collinsonia canadensis root extract [1309782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cochlearia officinalis leaf extract [2053437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynanchum otophyllum whole extract [2598015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus sinensis leaf extract [1856269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colchiceine [2174385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clonostachys rosea f. rosea allergenic extract [1426481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens leaf oil [1309331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate, porcine [1306202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantiifolia leaf oil [1309295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Codium fragile extract [1735033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen alpha-1(I) chain (bovine) [2396784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonmouth venom [1595881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-coumaric acid [1485787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium gluconate [1908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceratonia siliqua whole extract [1366322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut oil [1309239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caffeic acid [1311397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chiococca alba root extract [1655561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia reticulata whole extract [1997243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-6 olivate [1733818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonidine hydrochloride [142432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona bark extract [1309666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon martini whole extract [1535477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clavulanic acid [21216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen type V [2667828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic fluoride [2603282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramine-T trihydrate [1592902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium silicate [1311526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Castanea sativa whole extract [1801151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftriaxone [2193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium flower extract [1306205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamic aldehyde [1368153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus sinensis seed oil [1872040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cresol [62130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carpinus betulus flower bud extract [2054074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coffea arabica seed, roasted, extract [1310128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clostridioides difficile [1534764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfates [2473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl trisiloxane [1363431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxyethyl siliconate [1486524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium saccharate [236693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium lactobionate [235784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen [2714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis melo var. cantalupensis whole extract [1356700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefmetazole [2182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carduus marianus preparation [350520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulase (Trichoderma longibrachiatum) [2475185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carprofen [20343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein, emmental cultured [1315109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosporium cladosporioides allergenic extract [995768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroquine phosphate [20863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carthamus tinctorius (safflower) oleosomes extract [1307784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coleus forskohlii root oil [1306135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carteolol hydrochloride [142132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsella bursa-pastoris extract [236641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma phaeocaulis root extract [2106822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crizotinib [1148495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chaenomeles lagenaria whole extract [2533847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellol acetate, (S)- [1313269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic-capric-succinic triglyercide [1356134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>certoparin sodium [152612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticotropin-releasing factor, human [1927940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cananga odorata flower wax [1541726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoamphodipropionate [1370641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan PCA [1858809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium seed extract [1309361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl palmitate [1655565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinoxate [288262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cemiplimab-rwlc [2058825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Croton lechleri resin [1371038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium monofluorophosphate [2463340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>californium Cf-249 [1794164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>climbazole [191566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl ricinoleate [1364381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida albicans [1963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-chloronaphthalene [2673865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn leaf extract [2664059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coal tar [2635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C18-C21 alkane [1435991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-chloro-2-hydroxypropylcocoalkyldimethylammonium chloride [2396890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citicoline [997602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cleome gynandra leaf extract [2197995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlormethiazole [2372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cervus elaphus horn oil [1309747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium citrate [407906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens leafy twig extract [1442505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cantharidin [1984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbarson [20206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclobenzaprine [21949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cananga odorata flower extract [1309966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese chestnut extract [1372271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clebopride maleate [236701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cotton seed extract [1309369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbidopa anhydrous [1545982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cherry plum extract [1358476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cystamine [1426401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon martini top extract [1442507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopropanemethanol, 1-methyl-2-((1,2,2-trimethylbicyclo(3.1.0)hex-3-yl)methyl)- [2557375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa seed extract [1429926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurium erythraea flowering top extract [1544246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-chloro-2-methyl-3-isothiazolone 1-oxide [1862282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalexin [2231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canary feather extract [894961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cerebral Phospholipids [578635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis virginiana top [1309776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper sulfate [21579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl chloride [1606197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calfactant [232539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cosyntropin hexahydrate [1653802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis chinensis root extract [1358482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum camphora whole extract [1487829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cryptolepis sanguinolenta whole extract [2539793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Culex pipiens preparation [1345679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefoxitin [2189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cochliobolus sativus allergenic extract [852398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chesnut oak pollen extract [900995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt [1310300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamate [1368650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coast live oak pollen extract [852302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteamine [3022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan [59038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cimicifuga simplex root extract [1541714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clodronate disodium [1546871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecostus cuspidatus whole extract [2711883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciprofloxacin lactate [235851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynoglossum lanceolatum whole extract [2045731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cotinus coggygria leaf extract [2533851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-16 pareth-5 [1734016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese cinnamon extract [1305720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus junos fruit extract [1366324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cider vinegar [283829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caffeine citrate [20033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cangrelor tetrasodium [1656051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Castanea sativa flower extract [1309936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric citrate [2394040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C13-14 isoparaffin [1311575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-20 acid PEG-8 ester [1485541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Concord grape juice [1747706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous chloride [1426884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canagliflozin anhydrous [1546031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorcyclizine hydrochloride [235725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium chloride anhydrous [1667640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cycloserine [3007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cariprazine [1667655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorocitric acid [2462207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn allergenic extract [892547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C8-10 alcohols [2462794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagenase Clostridium histolyticum [898492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crataegus extract [21716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crizanlizumab [2262279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium hydroxide [1910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cardamom oil [2462493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cycrimine [22037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobutinol hydrochloride [235956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carthamus tinctorius seedcake extract [1314586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>constant albicans extract [242874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide 5 [2596172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyproheptadine pyrid phos [236525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcipotriene [29365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carica papaya preparation [324031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline stearate [236669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Claviceps purpurea sclerotium [1311077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa subsp. sativa whole extract [2177094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper pidolate [1306939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cuprous chloride [1423796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrageenan calcium [2001679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus nuttallii whole extract [2533849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonitrate [2372697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Concord grape allergenic extract [901191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clospirazine hydrochloride [1648692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrimide [288088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlormadinone acetate [2369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper EDTA [1366888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caryocar brasiliense fruit oil [1495454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefpodoxime proxetil [47835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creeping bentgrass pollen extract [1094116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium threonate [273888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus adamanteus antivenin [885185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefonicid [2183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilastatin [2540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber seed extract [1307733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-13 alkyl lactate [1992563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cephalanthus occidentalis bark extract [1673701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cuprous oxide [21842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium quinoa seed extract [1306195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn silk preparation [283677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor IX, human-lans [2643192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copanlisib [1945077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carpinus betulus flower extract [1309994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capreomycin [78903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticorelin human triflutate [236900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisapride monohydrate [221077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbetapentane tannate [221070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramides [2243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrulline [2567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate A sodium [476847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis sativus whole extract [1484279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteamine hydrochloride [1426886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia oleifera seed extract [1307849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens seed extract [1309420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phosphate, dibasic, dihydrate [1311201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium fluoride [1905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chilipepper rockfish, cooked [2687239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn grain extract [1423924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C14-16 olefin sulfonate [1370596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon oil [1309229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyathea medullaris leaf extract [1866528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftiofur sodium [1370372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cortivazol [21660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroxylenol [20877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium carbimide [1902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cuttlefish preparation [1354524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Convolvulus arvensis extract [1876510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(C14-C18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine [1591920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia japonica seed extract [1309414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofarabine [44151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer homopolymer type B (allyl pentaerythritol or allyl sucrose crosslinked) [1732380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>castorbean seed extract [1351789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chymopapain [2525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colocasia esculenta root extract [1305762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corallium rubrum whole extract [1999793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clam allergenic extract [892539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat dander allergenic extract [465953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondrodendron tomentosum root extract [1340183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium carbonate [1897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chalcone [2592960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloprednol [21285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefmetazole sodium [203140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum camphora leafy twig extract [2589369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phosphate [1919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine [2670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus maxima leaf extract [1306208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma longa leaf extract [1307655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Callitris columellaris wood oil [2471084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvone, (+-)- [1427074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>CJC-1295 [1805005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric nitrate [2371954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper [2837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonazepam [2598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus reticulata whole extract [1724422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein, Streptococcus thermophilus cultured, Propionibacterium freudenreichii subsp. shermanii cultured, aged preparation [1421445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cryptomeria japonica whole extract [2606482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chikungunya virus antigen, recombinant Senegal strain 37997 [2707120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clary sage extract [1370470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium sulfide [1368199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canarium luzonicum whole extract [1487827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma aromatica root oil [1482794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(C10-C30)alkyl methacrylate ester [1312357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-20 phosphate [1492340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa susp. indica top extract [2168435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canarium indicum seed oil [2398513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber fruit oil [1306145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-10 [1659204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedar elm pollen extract [1014191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteine hydrochloride [221086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlordiazepoxide hydrochloride [203173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid, 1-stearyl ester [1435636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetiedil citrate [236204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celecoxib [140587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>curdlan [1313047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C13-16 isoparaffin [1314337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth 8 [1438111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclosporine microemulsion [484788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centella asiatica flowering top extract [1810985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cresatin [21732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan medium molecular weight (200-800 MPA.S) [1368152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 pareth-3 [1426678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer copolymer type C (allyl pentaerythritol crosslinked) [2285329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia japonica flower oil [1739223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Combretum micranthum leaf extract [1597186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus reticulata fruit oil [1306131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer-940 [1362909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistus incanus flowering top extract [1482788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephapirin benzathine [1294563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cauliflower allergenic extract [899661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Croton lechleri whole extract [1727168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorfenethazine [20785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefamandole nafate [20473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyperus rotundus whole extract [2263064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Convallaria majalis flower top extract [1648694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carya tomentosa bark extract [2697732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cichorium intybus whole extract [1545681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canis lupus familiaris extract [852244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cemiplimab [2058826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetuximab [318341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Copernicia alba whole extract [1992522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 1200 MPA.S at 1%) [1997244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creatinine [2913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbocysteine lysine monohydrate [1793898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Commiphora myrrha whole extract [1442701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cascara sagrada [66869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistanche tinctoria stem extract [2362245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefovecin sodium [1591924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus japonica fruit extract [2166039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbetapentane [20217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated mushroom extract [1311817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus paradisi whole extract [1432296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium quinoa seedcake extract [2699307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamine oxide [1306947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copiba oil [1306136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlophedianol [21254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein (cow milk) allergenic extract [892604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramphenicol succinate [20769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceratostigma willmottianum whole extract [1800659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan high molecular weight (400-800 MPA.S) [2053487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Croton tiglium whole extract [1546206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadexomer iodine [20012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calomel [1311098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus laevigata whole extract [2198972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C14-18 olefin sulfonate [2123367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinitapride [21125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen alpha-1(III) (human) [1593745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopentolate [3001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine anhyd [236131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken feather extract [894934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>catechin [1367177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryloamphopropionate [1368620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clebopride [21224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carazolol [20192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholecalciferol [2418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl diglyceryl tris(trimethylsiloxy)silylethyl dimethicone (3500 MM2/S) [2624693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoyl methyl monoethanolamine [2173915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phenoxide [2585538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium citrate [47613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canada balsam extract [1372000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chaenomeles lagenaria fruit extract [2107059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen type I [1426856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-carbethoxyethyl)diethoxy(methyl)silane [1314258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrageenan sodium [1593445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crambe maritima whole extract [1487085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer interpolymer type A (allyl sucrose crosslinked) [1305601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen, hydrolyzed [477454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloropyramine [20861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chocolate cacao bean allergenic extract [2102821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl laurate [2261376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cichorium intybus flower extract [1309822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabozantinib [1363268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>certeareth-100 [1543081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate sodium (shark) [1358172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 38 MPA.S at 2%) [2257286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynanchum vincetoxicum leaf extract [1310023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellaburate (MW 20000, 46 % butyryl, 2 % acetyl) [2268053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calophyllum tacamahaca seed oil [1306160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium formate [1362747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynomorium songaricum whole extract [2709295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsella bursa-pastoris top extract [1812326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium glubionate [25806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choriogonadotropin alfa [283550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbutamide [2068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus atlantica wood oil [1876808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline salicylate [20974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefuroxime sodium [204144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoyl proline [1806680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C.I. direct red 28 parent [2391143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corydine [2593178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula officinalis extract [285222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 2300 mpa.s at 1%) [2475182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus junos fruit oil [2288423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chrysosplenetin [1545792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistus monspeliensis whole extract [1745252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordia dichotoma whole extract [2670080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clocortolone [21249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 olefin sulfonate [1370653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cochliobolus spicifer allergenic extract [995699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chimonanthus praecox whole extract [1733676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carnitine chloride [1311519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrus pectin extract [581550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cirsium arvense stem extract [2592961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clindamycin [2582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium chloride dihydrate [221068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium preparation [350344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium acetate monohydrate [1306884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut juice [1420960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Celosia argentea seed extract [1482542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrulline malate [2707558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calvatia gigantea extract [1311041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona pubescens whole extract [2104343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciclesonide [274964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn oil [2854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coptis japonica root extract [1307577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl sulfate [1366924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>certoparin [152610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chaya leaf extract [1659210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco diethanolamide [1305724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium pantothenate, (-)- [1792121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carob allergenic extract [904498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoamphoacetate [1426830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calochortus tolmiei whole extract [2533836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaemelum nobile flower extract [1306194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E1 [2707121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceiba pentandra seed extract [2044340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caldiamide sodium [1364943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum camphora leaf extract [1307754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 400 MPA.S at 1%) [1653793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt gluconate [235987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerivastatin sodium [221072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium hypophosphite [1424671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C30-45 alkyl cetearyl dimethicone crosspolymer [2609244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus sinensis flower oil [1306133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camelus bactrianus hair extract [2590604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric cation [1427198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C32-36 isoalkyl stearate [2665126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium oxide [1363045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caesalpinia spinosa fruit pod extract [2057801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caltha palustris extract [1346616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C15-23 alkane [2103200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbon monoxide [2037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose calcium [1307734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloperastine [2104180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus limon seed oil [1425615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt disodium edetate [1722037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cortisone acetate [21655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulase [2219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-40 pareth-95 [2109240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl tallowate [2001987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corylus americana nut oil [1603849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus officinalis whole extract [1795582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer-934 [1307830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoa extract [1373895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecyparis obtusa whole extract [1429927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(3-chloropropyl)trimethoxysilane [2368125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clostridium perfringens [1318475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcobutrol [2634452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorocresol [20823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus deodara seed oil [2359253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cenobamate [2265690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinidon-ethyl [2472310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clioquinol [5942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl dimethicone [388458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat hair extract [248123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(C10-C16)alkyldimethylamine oxide [1872987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium nicotinic acid complex [137732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorphenesin carbamate [20880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carex humilis root extract [1309417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis vitalba flower extract [1355831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coptis deltoidea root extract [2634585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula arvensis leaf extract [1729161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn cob extract [1440225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofoctol [21264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phosphate, monobasic, anhydrous [1426444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyanide [1923817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoa shell extract [2171268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clinoptilolite [2624891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofexamide [21255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clidinium [21232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbromal [2067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbachol [1999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium maculatum preparation [285151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cosibelimab [2717511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomiphene [2596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellic acid [2693285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofexamide hydrochloride [236177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytomegalovirus immune globulin, human [1997443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclizine hydrochloride [155017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclodextrins [1426609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coffee bean allergenic extract [891727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium gluceptate [47618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous cation [1546419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cedrus atlantica bark oil [1306157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus durissus terrificus venom extract [1440287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethyl fragment [1874892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus laevigata fruit [1310259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clesrovimab [2716802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium chloride [1863268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cassia fistula whole extract [2589608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clorazepic acid [235408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoyl sarcosinate [1370598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid isopropyl ether [2560106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedar leaf oil [1309217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C24-28 olefin [1537318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium officinale root oil [1541883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromocarb diethylamine [48064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carpinus betulus whole extract [2003227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caramiphen edisylate [133053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crypthecodinium cohnii DHA oil [1307710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis ambigua tuber extract [1376214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cimex lectularius preparation [1330092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma zedoaria leaf extract [1650237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chickpea allergenic extract [1011049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crocin [2262278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl octanoate [1306181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>californium [2571855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxypolymethylene [20298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>croscarmellose sodium [1310573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium dihydrogen phosphate [236560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryloyl sarcosine [2109745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calteridol [1424676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cocos nucifera whole extract [1367493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorothymol [1363702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclohexanol [2099711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynanchum vincetoxicum root extract [1309807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capramidopropyl betaine [1541737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cesium chloride [20599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocklebur pollen extract [852025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crotamiton [21766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefadroxil hemihydrate [1297878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlorella emersonii extract [2382810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coix lacryma-jobi var. ma-yuen seed extract [1307827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefazolin [2180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crinum asiaticum whole extract [1421435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellol acetate, (R)- [1432295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium levulinate [47624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefadroxil [2177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese cinnamon leaf oil [1306148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casirivimab [2465242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrus pectin [581398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbocysteine [2023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyanocobalamin Co57 [91516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus rugosa whole extract [2049718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefonicid monosodium [266801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclotetrapeptide-24 aminocyclohexane carboxylate [1792312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cryptenamine acetates [235225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilostazol [21107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camylofine [20136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclododecane [2557361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurium erythraea flower extract [1309739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cladosporium sphaerospermum allergenic extract [867202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium Cr-51 [1306065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium lactate [47622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carpipramine [20342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotaxime sodium [203117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cevimeline [44281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline citrate [2453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celery allergenic extract [892372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum loureiroi whole extract [2553102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic sulfate [90402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline bitartrate [2451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor XIII a-subunit (recombinant) [1488293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordyceps militaris fruiting body extract [2593690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curculigo orchioides whole extract [2570477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-40 acid [1425982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California black walnut pollen extract [852561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceanothus thyrsiflorus whole extract [2709116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cosyntropin [2890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurea solstitialis whole extract [2533846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobutinol [21247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capromorelin [1986787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium quinoa flowering top extract [1649133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cantaloupe allergenic extract [892517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerliponase alfa [1922436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula arvensis whole extract [1992862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia sinensis whole extract [1356680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper gluconate [2839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon winterianus whole extract [2360889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylaldehyde [2396755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cypripedium parvifolum root extract [1343597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caryophyllene [1368148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caesalpinia sappan bark extract [1791061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynomorium songaricum stem extract [2592964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carthamus tinctorius whole extract [1724421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthellum indicum whole extract [2106260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt acetate [1369404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceforanide [20486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cumenesulfonate [1370634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbidium hookerianum flower extract [1737791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryloyl glycerin/sebacic acid copolymer (2000 MPA.S) [1869798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide eos [1603794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefepime [20481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canada goldenrod pollen extract [995743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotaxime [2186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caper berry extract [1307590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coxsackieviruses B [1668274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloxacillin sodium [9864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chenopodium ambrosioides extract [1342490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine hydrochloride [1115966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>catalase (Micrococcus luteus) [1648142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capmatinib [2362165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E2 [2707122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-9 [1362144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-16 alcohols [1368143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cheat grass pollen extract [852225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorambucil [2346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens whole extract [1483424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%) [1371909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cervus elaphus velvet preparation [1441655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl-octyldodecyl lauroyl glutamate [1435107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlamydia trachomatis [1318474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic-capric diglycerol succinate [1425909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chondrus preparation [1426885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cayenne pepper allergenic extract [1006340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-3 [1485184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteamine bitartrate [81990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl glucoside [1425219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coast sage pollen extract [852011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citicoline sodium [1099914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium orotate [235786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl dimethicone 150 [1442998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic phosphate P32 [121070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium phosphate, dibasic, dihyate [1310464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocaine [2653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomocycline sodium [102758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefprozil [19552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caryodendron orinocense whole extract [2167552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common wormwood pollen extract [896213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium fruit oil [1306151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma zedoria root extract [1335893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cardiotoxin III, Naja naja atra [2043924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-20 alkyl benzoate [1426384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centella asiatica root extract [2386333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coix lacryma-jobi var. ma-yuen seed oil [1541732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celiprolol [20498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cirsium japonicum root extract [2639345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonseed extract [853406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cardamom extract [1314587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrullus lanatus var. citroides whole extract [2118440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C9-11 pareth-8 [1424458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis vitalba leaf extract [1307839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>catalase [2133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocamidopropyl hydroxysultaine [1363593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curvularia inequalis allergenic extract [999438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbinoxamine [20220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chorionic gonadotropin [4986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryl methicone [1311638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclomethicone [1307080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-3 [1987473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboplatin [40048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefpirome [27130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia sinensis var. assamica whole extract [1442198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crateva magna bark extract [2592963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caplacizumab-yhdp [2110604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>castoryl maleate [1490683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canrenoic acid [81971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytosine [1372540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotiam [2188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium creosotate [317206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladanthus mixtus whole extract [1655982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco-caprylate-caprate [1369702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chondrus crispus extract [1311477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis yanhusuo tuber extract [1313230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cola nut extract [1307946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroquine diphosphate, (R)- [2593903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline magnesium trisalicylate [215799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caraway oil [1309373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticotropin, human [1535213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-16 pareth-9 [1484852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clorazepate [2353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-13 pareth-23 [1368905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>croconazole [21753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-15 sulfonate [1370654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crataegus monogyna fruit extract [1311577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cimetidine [2541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftolozane sulfate [1597608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 50-100 MPA.S at 1% ) [1597390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium flower wax [2540334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyperus rotundus root extract [1307777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sulfaloxate [102792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbocysteine-lysine [1427149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coix lacryma-jobi seed extract [1307831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor IX recombinant immunoglobulin G1 fusion protein [1535944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clindamycin phosphate [797272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper arsenate [1552051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crack willow pollen extract [2257289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 pareth-7 [1734015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caspofungin [140108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C10-16 pareth-1 [1437550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclopentanone [2557363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorothiazide sodium [91217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclodrine [1855092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canavalia gladiata seed pod extract [2563144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium cation [1546276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canrenoate potassium [1981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis melo root extract [2465231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium pyrophosphate [1362901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide 1 [1364385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinnamomum culilaban leaf oil [2553101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclomethycaine [21990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer 1342 [1311163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistus ladanifer resin [1540880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroacetic acid [2374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan low molecular weight (20-200 MPA.S) [1306196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefoperazone sodium [227214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalexin anhydrous [1299782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium polysulfide [2256949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camelina sativa whole extract [1744401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caseins [1440974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida albicans allergenic extract [214355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamedrine [21130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium oxoglurate [2667740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium propionate [1426453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calteridol calcium [1424675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coachwhip stem extract [1601989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorthenoxazin [20891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cryptomeria japonica leaf extract [1918451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colchicum autumnale seed extract [1485065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium monnieri fruit extract [2697463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crambe hispanica subsp. abyssinica seed oil [1306138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crisaborole [1865953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-5 [2397687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium bromate [2601447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium picolinate [59308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium hydroxide green [1312363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Consolida regalis flower extract [2533848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorokojic acid [2199653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caraway seed allergenic extract [899637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cotton fiber extract [1315113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefiderocol sulfate tosylate [2265863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopidogrel bisulfate [236991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cananga oil [1309214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cenegermin-bkbj [2104331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistus incanus whole extract [1358477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftazidime pentahydrate [235552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth 20 [1311619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamido benzylpiperidinyl ethoxypropylbenzamide [2046111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken fat preparation [2002584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colloid sulfur [89767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken liver preparation [1313217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-10 phosphate [1546870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbomer interpolymer type C (allyl sucrose crosslinked) [2392136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carya ovata bark extract [1739881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Codonopsis pilosula root extract [2103292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobetasone butyrate [21246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbamide peroxide [47686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-5 [1987474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucurbita pepo flower extract [1544634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-13 pareth-6 [1484500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium pyruvate [884629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>castor oil [2129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium officinale whole extract [1420959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida parapsilosis [1310914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloral betaine [89808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium borogluconate [1370420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chlorophytum borivilianum whole extract [2531557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caffeine [1886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellaburate (MW 12000, 32 &amp; butyryl, 18 % acetyl) [2054996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>captodiamine hydrochloride [236176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprooyl phytosphingosine [2621643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creatine ethyl ester [2058850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl esters wax [1311570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphoric acid 1-methyl ester [30193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonseed oil [1309243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cured fat, pork side bacon [1357997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine phosphate [2672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco-sulfate [1370657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>certolizumab pegol [709271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus sanguinea whole extract [2054073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium lactate pentahydrate [215834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphor (natural) [1298738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyproterone [3014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caesalpinia spinosa resin [1307087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camphor leaf oil [1306163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium hydride [1428413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium citrate anhydrous [2106283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cathine [32022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthemum x morifolium whole extract [2539791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciprofibrate [21149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creosote [2915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclohexanone [2362166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut acid [1307562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium monnieri fruit oil [2637853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clodronic acid [3350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytisine [1723152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciclopirox olamine [52172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-15 pareth-12 [2289008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California sheephead preparation [1324595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clozapine [2626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken breast preparation [1746905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocotrimonium chloride [2391550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chilean hazelnut oil [1307679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colistimethate [2708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Castanea crenata shell extract [1735509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl nonanoate [1539809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellyl methylcrotonate [2046112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium sulfate [1368145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chrysin [1362888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conyza canadensis extract [1331704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco/oleamidopopyl betaine [2262005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloral hydrate [2344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysanthellum indicum flower oil [1312365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorate ion [1546390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecyparis obtusa leaf extract [1305745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefetamet [20482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cullen corylifolium seed extract [2048127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Commiphora myrrha top extract [1489546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia sinensis root extract [1307818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cidofovir anhydrous [1546007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl behenate [1312545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese yam extract [1372641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cosmos sulphureus flowering top extract [2378839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium 12 [2625171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvone, (-)- [2048712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramine-T anhydrous [1593148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium amino acid chelate [994438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis solida whole extract [2699580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Conium maculatum flowering top extract [1328312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens bark extract [2479554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoyl isethionate [1366840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C11-15 pareth-5 [2103288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium iodized [317207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centipeda minima flowering top extract [2359930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefuroxime axetil [20493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-13 alcohols [1862973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclophosphamide lyophilized [221085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cashew nut allergenic extract [892526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholic acid [1440856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryl oligoglucoside [2372917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camelina sativa seed oil [1305631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Campylobacter jejuni [1435992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curcuma involucrata root extract [2619674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrullus lanatus var. lanatus whole extract [1747709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistanche deserticola stem extract [1603853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephapirin sodium [42562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium aspartate [253159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C18 olefin sulfonate [1370196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbinoxamine tannate [405970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clematis hexapetala root extract [1809897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centaurea cyanus flower extract [1309418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citalopram [2556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium acetate [214342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofibrate [2594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan medium molecular weight (200-400 MPA.S) [1650610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyperus esculentus leaf extract [1433191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefatrizine [2179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C.I. food yellow 3 (free acid) [1371306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California juniper pollen extract [852585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cayenne extract [259342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>conivaptan [302285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrullus colocynthis fruit extract [1358958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellaburate (MW 65000, 17 % butyryl, 30 % acetyl) [2199290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco-glycerides [1426455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclomethicone 4 [1363578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlormadinone [78904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>comfrey leaf extract [1318235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabbage allergenic extract [899398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium dioxide [1312546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capromorelin tartrate [1986788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide NS dilaurate [1655557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clavulanate potassium [831418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorproethazine hydrochloride [236297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corydalis decumbens root extract [1435102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl hydroxystearate [1370461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clerodendranthus spicatus leaf extract [1309780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chaste berry extract [259261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clospirazine [1648693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chaste tree preparation [236664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyprodenate [22051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cifostodine [2477852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen, soluble, fish skin [1368163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coccinella septempunctata preparation [1605082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus junos seed extract [1310041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynara scolymus whole extract [1809830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl PEG- PPG-10- 1 dimethicone (HLB 3) [1376098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistus monspeliensis leaf extract [1431225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carmustine [2105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coccinia grandis whole extract [2606066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cannabigerolic acid [2279518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sulfate, hemihydrate [1310466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen alpha-1(II) chain (human) [2671625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobaltous nitrate [1423923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobamamide [21373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cryptomeria japonica bark extract [2479553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camylofin bis(noramid-mes) [236534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronitrile [2383338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteine [3024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sulfide [90521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cercis siliquastrum whole extract [2054072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clinopodium chinense whole extract [2046113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carya laciniosa bark extract [2590605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>comfrey root extract [1343346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cochliobolus lunatus allergenic extract [852264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefovecin [1591901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftizoxime [2192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cyathula officinalis root extract [1307735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corallium rubrum exoskeleton preparation [1311193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric carbonate basic [1313321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorhexidine gluconate [20791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colchicine [2683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Callistemon citrinus pollen extract [2171260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carminic acid [1368643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colchicum autumnale flower extract [1492385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citiolone [21171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cistanche deserticola whole extract [2633003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbonate ion [1544139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clothianidin [2665345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagen alpha-1(VII) chain [2716574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cephalosporium roseum extract [1925834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carapa guianensis seed oil [1306164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cina artemisia preparation [283675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capromab pendetide [136300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camellia sinensis seed extract [1742506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common sagebrush pollen extract [852020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryloyl glycine [1305600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid, anhydrous [221946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(C14-C18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine [1591921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium [491498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canthaxanthin [42348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn oil PEG-6 esters [1790130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carteolol [2116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceanothus americanus leaf extract [1309757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsosiphon fulvescens extract [1426908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus maxima seed oil [1856268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium 2-ketogluconate [1869046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cipaglucosidase alfa-atga [2667434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl hydroxyethylcellulose (350000 MW) [1313703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium-sodium maleate methyl vinyl ether copolymer (1000000 MW, 1900 MPA.S at 11%) [1492944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrot allergenic extract [892368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynodon dactylon extract [1428417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboprost tromethamine [20259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonixin [2601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chamomile flower oil [1309221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citharacanthus spinicrus preparation [1311128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramphenicol [2348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium bromide [195983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftazidime sodium [221071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carzenide [20355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid acetate [1312366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotetan disodium [203141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coco-oleamidopropyl betaine [2263872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium aluminosilicate [1313228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabbage preparation [319810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic(capric mono)diglcyerides [1307310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clindamycin palmitate [21235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein allergenic extract [862460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-18 [2602282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calophyllum membranaceum whole extract [2634531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chocolate allergenic extract [1010915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chitosan oligosaccharide [1306943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticotropin [376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caproamphodipropionate [1370602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(cyclohexylamino)ethanesulfonic acid [2049985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclohexanepropanol, 2,2,6-trimethyl-.alpha.-propyl- [2557362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantiifolia whole extract [1541715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium oxybate [2387307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calophyllum membranaceum root extract [2610400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagenase [58939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corchorus olitorius leaf extract [1799293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-15 pareth-12 [1374804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium fruit rind extract [1306206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclophosphamide [3002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cifenline [21099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynanchum paniculatum whole extract [2107306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chia seed oil [968631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobimetinib [1722365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calamus oil [1431992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftibuten dihydrate [1297879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor X, human-lans [2643194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrimonium bromide [288999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coxiella burnetii [1432987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus horridus horridus venom [1310456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantiifolia flower extract [1310117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cornsilk [579893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvedilol [20352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(1-cyanocyclohexyl)acetic acid [2058838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobazam [21241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroquine sulfate [203119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calendula officinalis seed oil [1307790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbenicillin [2015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colesevelam [141626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannabis sativa subsp. flowering top extract [1484855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canrenone [1982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corticotropin-releasing hormone [214461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carpinus betulus flowering top extract [1309818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofezone [183877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common cockleburr pollen extract [867369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cola acuminata seed extract [1307595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis sativus fruit extract [2700058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cayaponia tayuya root extract [1945470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C13-15 alkane [1314336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celery seed extract [1309989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus officinalis fruit extract [1307556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholate [1426483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbaryl [9724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium officinale root extract [1307974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cordycepin [1989289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulose sulfate [2642135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clostridium botulinum [1811178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cod, unspecified preparation [1426437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprolactone [1998122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl caprylate [1654387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coal tar extract [90735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlortheophylline [1546416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceratostigma willmottianum flowering top extract [2591800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citronellyl acetate [2056062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cevimeline hydrochloride anhydrous [2698548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium versetamide sodium [1366881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn syrup [1310576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetromonium methosulfate [2056289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclophosphamide monohydrate [2679071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicory leaf extract [2001615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cinchona officinalis bark extract [1309771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove oil [7624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cananga odorata leaf oil [1793896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C9-12 alkane [2664491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerous oxalate nonahydrate [1427054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cicuta virosa whole extract [1484856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clascoterone [2474340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide eop [1537211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl stearate [1747867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cladribine [44157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Codium tomentosum extract [1311605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpheniramine maleate [142429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cupric oxide [21837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-25 [1306174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftriaxone sodium [203172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic bromide [2603281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium sodium phosphate [2288215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceramide 6 II [1314307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Collinsonia extract [1339883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium polycarbophil [20063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoate [1370658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coumarin [2898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylyl caprylate-caprate [1541116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cylindrotheca fusiformis extract [2531137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codfish allergenic extract [892543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosporium bruhnei extract [2043449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus bergamia whole extract [2372087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetromonium [2056290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantiifolia fruit oil [1607310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carbo animalis preparation [1326501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cloxacillin [2625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coceth-7 [1742990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalexin hydrochloride [281942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbenicillin disodium [258332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calotropis procera whole extract [2362001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladanthus mixtus flower volatile oil [1306134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cannavis sativa susp. indica top extract [1484854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida torresii [1343912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clenbuterol hydrochloride [235955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclizine [2977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chamaecyparis obtusa wood extract [2376940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-27 [2695381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium chloride monohydrate [2678349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C9-11 pareth-3 [1437551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteth-24 [1306173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calochortus gunnisonii whole extract [2533835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrus juice [2383932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common paper wasp venom protein [1294628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-40 pareth-10 [1307154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>camellia reticulata seed oil [2383303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorprothixene [2406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cymbopogon schoenanthus whole extract [1992057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl dimethicone/bis-vinyldimethicone crosspolymer [2275627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylamidopropyl betaine [2584845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsicum oleoresin [235787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-1,2-propanediol [2058840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholesteryl isostearate [1541744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coast maple pollen extract [851736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Centipeda minima whole extract [1540874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper carbonate [1427055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceteareth-25 [1311622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromic chloride [21009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C9-11 pareth-6 [1376451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Convallaria majalis extract [1344641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynara scolymus leaf extract [1322547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated barley pollen extract [1098118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciclopirox [21090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrobacter koseri [1544937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl oleate [1306182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofazimine [2592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chondroitin sulfate, bovine [1306129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cromoglycate [2921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinametic acid [21113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulose sodium phosphate [342965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C9-11 alkane/cycloalkane [2396018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Caolotropis gigantea root extract [1673374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cordyceps militaris whole extract [2170280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cromolyn [42612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cafedrine [47589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C12-14 isoparaffin [1314335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canis lupus familiaris milk preparation [1311102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline chloride [1425426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cesium [1310121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cenegermin [2104332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colonial bent grass pollen extract [1484937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cicuta virosa root extract [1310043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carapichea ipecacuanha whole extract [1740935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chocolate brown HT free acid [2000576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cadmium [1362694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cupressus sempervirens fruiting leafy twig extract [1438116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(4-(4-chlorophenyl)-3-phenyl-2-butenyl)-pyrrolidine 1,5-naphthalenedisulfonate [1307555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl behenate [1487529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalamins [42604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclobutyrol sodium [236180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium stearate [47633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus maxima fruit oil [1549224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cnidium monnieri whole extract [2632776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>croscarmellose sodium type A [1311609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caproyl lactate [1491980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C30-45 alkyl methicone [1313227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrullus colocynthis fruit pulp extract [1309772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cajanius cajan leaf extract [1421433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclomethicone 6 [1307081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camellia oleifera leaf extract [1305549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cereus hildmannianus whole extract [2588216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloramine-T [20762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cluster fig extract [1372249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C1 esterase inhibitor (recombinant) [1599831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium carbonate, precipitated [349908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>candesartan cilexetil [135481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cannabidiol [2045371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capryl-capramidopropyl betaine [1367173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbenicillin phenyl sodium [42580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorobutanol [2378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbenoxolone sodium [2018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citral [1362890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetylpyridinium [2286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citrus sinensis whole extract [1437985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut allergenic extract [891611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucurbitacin B [2688460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cajuput oil [1309211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ceanothus americanus whole extract [1358475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium pantothenate [1918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cornus florida bark extract [1860605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl glycol [1592894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrimonium [20614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Citrus aurantium leafy twig extract [2287154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corylus avellana flower bud extract [2054215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt titanium oxide [2391144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C30-45 olefin [1368144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Catalina preparation [1372930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclohexane [1367180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabergoline [47579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C20-40 pareth-3 [1375414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosporium herbarum allergenic extract [466198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Comocladia dentata bark-leaf extract [1310024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbon disulfide [1311478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canavalia gladiata whole extract [2606483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetyl acetate [1364378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclonium [21993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein, Lactococcus lactis cultured, aged [1315111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium gluconate [1311292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cauloside D [1542900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromonar hydrochloride [81980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorous acid [1543755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 130 MPA.S at 4%) [2632123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetearyl phosphate [1728295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caprylic-capric-lauric triglyceride [1313043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumaria sea cucumber extract [1307561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Crotalus scutulatus antivenin [885189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein, Lactococcus lactis cultured [1315110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clostebol [61686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>C-type Natriuretic Peptide Analog [EPC]</name>
  <code>C654201</code>  <id>654201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>C-type Natriuretic Peptide Analog</to_name>
    <to_code>T58667</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193980</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>C-type Natriuretic Peptide Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vosoritide [2586354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>C-type Natriuretic Peptide Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>C-type Natriuretic Peptide Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Natriuretic Peptide, C-Type [M0029831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>C-type natriuretic peptide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>C-type Natriuretic Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CCK Activity Alteration [PE]</name>
  <code>C27012</code>  <id>27013</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCK Activity Alteration</to_name>
    <to_code>T7888</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008323</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CCK Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CCK Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CCR5 Co-receptor Antagonist [EPC]</name>
  <code>C634965</code>  <id>634965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonist</to_name>
    <to_code>T7894</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Antagonist</to_name>
    <to_code>T7893</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175572</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CCR5 Co-receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CCR5 Co-receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maraviroc [620216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chemokine receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with chemokine receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD11a-directed Antibody Interactions [MoA]</name>
  <code>C635294</code>  <id>635294</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Antibody Interactions</to_name>
    <to_code>T7895</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175856</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efalizumab [356988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD11a-directed Humanized IgG1 Antibody [EPC]</name>
  <code>C635296</code>  <id>635296</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Humanized IgG1 Antibody</to_name>
    <to_code>T7897</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD-11a Directed Humanized IgG1 Antibody</to_name>
    <to_code>T7896</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175858</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD11a-directed Humanized IgG1 Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Humanized IgG1 Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Humanized IgG1 Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD123 Interaction [EPC]</name>
  <code>C654086</code>  <id>654086</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD123 Interaction</to_name>
    <to_code>T58477</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-3 Receptor alpha-chain Interaction</to_name>
    <to_code>T58478</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-3RA Interaction</to_name>
    <to_code>T58479</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193864</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD123 Interaction [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytotoxins [M0005633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD123 Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tagraxofusp [2109055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD123 Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD123 Interactions [MoA]</name>
  <code>C654085</code>  <id>654085</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD123 Interactions</to_name>
    <to_code>T58476</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193865</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD123 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD19 Receptor Interactions [MoA]</name>
  <code>C653915</code>  <id>653915</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19 Receptor Interactions</to_name>
    <to_code>T7898</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193544</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axicabtagene ciloleucel [1987398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisagenlecleucel [1986438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Antibody Interactions [MoA]</name>
  <code>C651452</code>  <id>651452</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions</to_name>
    <to_code>T7899</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191422</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab [2373951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisocabtagene maraleucel [2479136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab-cxix [2387334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine [2540964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obecabtagene autoleucel [2698195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexucabtagene autoleucel [2387277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab-cdon [2373950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blinatumomab [1597258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab [2387211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine-lpyl [2540965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Chimeric Antigen Receptor [EPC]</name>
  <code>C653917</code>  <id>653917</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Chimeric Antigen Receptor</to_name>
    <to_code>T7900</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193546</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Chimeric Antigen Receptor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axicabtagene ciloleucel [1987398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Chimeric Antigen Receptor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisagenlecleucel [1986438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Chimeric Antigen Receptor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>CD19-specific chimeric antigen receptor [M000615883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Chimeric antigen receptor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Chimeric Antigen Receptor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Cytolytic Antibody [EPC]</name>
  <code>C654236</code>  <id>654236</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19 directed Cytolytic Antibody</to_name>
    <to_code>T58748</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Cytolytic Antibody</to_name>
    <to_code>T58747</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194013</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inebilizumab [2373951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing inebilizumab (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Inebilizumab (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD19-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</name>
  <code>C654292</code>  <id>654292</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
    <to_code>T58887</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194068</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Genetically modified T-cell (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing genetically modified T-cell (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD2-directed Antibody Interactions [MoA]</name>
  <code>C635295</code>  <id>635295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed Antibody Interactions</to_name>
    <to_code>T7903</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175857</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</name>
  <code>C635297</code>  <id>635297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed LFA-3/Fc Fusion Protein</to_name>
    <to_code>T7905</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2 Directed LFA-3/Fc Fusion Protein</to_name>
    <to_code>T7904</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175859</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Fusion Proteins [M0018640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoconjugates [M0028142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing fusion protein (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Fusion protein (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Antibody Interactions [MoA]</name>
  <code>C634440</code>  <id>634440</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions</to_name>
    <to_code>T7906</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175078</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab [2626349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab-ocsq [2693449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofatumumab [712566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tositumomab [263010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab [2625122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-131-tositumomab [234449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab-xiiy [2626348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab-axgb [2625125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obinutuzumab [974779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab [1876366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab-bysp [2637395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Cytolytic Antibody [EPC]</name>
  <code>C635050</code>  <id>635050</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Cytolytic Antibody</to_name>
    <to_code>T7909</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Cytotoxin</to_name>
    <to_code>T7907</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed, Cytolytic Antibody</to_name>
    <to_code>T7908</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175657</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rituximab [121191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obinutuzumab [974779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ublituximab [2626349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocrelizumab [1876366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ofatumumab [712566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD20-directed Radiotherapeutic Antibody [EPC]</name>
  <code>C635051</code>  <id>635051</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed, Radiotherapeutic Antibody</to_name>
    <to_code>T7910</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Radiotherapeutic Antibody</to_name>
    <to_code>T7911</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175658</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Radiotherapeutic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibritumomab tiuxetan [262323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD20-directed Radiotherapeutic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Radiotherapeutic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD22-directed Antibody Interactions [MoA]</name>
  <code>C653987</code>  <id>653987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody Interactions</to_name>
    <to_code>T7912</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193616</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotuzumab ozogamicin [1942950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox-tdfk [2099305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox [2099295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD22-directed Immunoconjugate [EPC]</name>
  <code>C653988</code>  <id>653988</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Immunoconjugate</to_name>
    <to_code>T7914</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody-Drug Conjugate</to_name>
    <to_code>T7913</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193617</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD22-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD22-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoconjugates [M0028142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD22-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inotuzumab ozogamicin [1942950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD25-directed Cytotoxin [EPC]</name>
  <code>C637367</code>  <id>637367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD25-directed Cytotoxin</to_name>
    <to_code>T7915</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177912</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD25-directed Cytotoxin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denileukin diftitox [214470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD25-directed Cytotoxin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD25-directed Receptor Interactions [MoA]</name>
  <code>C637366</code>  <id>637366</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD25-directed Receptor Interactions</to_name>
    <to_code>T7916</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177911</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD3 Blocker Immunosuppressant [EPC]</name>
  <code>C635013</code>  <id>635013</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD-3 Blocker Immunosuppressant</to_name>
    <to_code>T7917</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Blocker Immunosuppressant</to_name>
    <to_code>T7918</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175620</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Blocker Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Agonists [MoA]</name>
  <code>C635011</code>  <id>635011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists</to_name>
    <to_code>T7919</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175618</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blinatumomab [1597258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Antagonists [MoA]</name>
  <code>C635012</code>  <id>635012</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Blockers</to_name>
    <to_code>T7920</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Antagonists</to_name>
    <to_code>T7922</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Inhibitors</to_name>
    <to_code>T7921</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175619</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD3 Receptor Interactions [MoA]</name>
  <code>C31920</code>  <id>31921</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Interactions</to_name>
    <to_code>T7923</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010281</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD3 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD3 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD3-directed Antibody Interactions [MoA]</name>
  <code>C635010</code>  <id>635010</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions</to_name>
    <to_code>T7924</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175617</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab-cqyv [2619425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab-axgb [2625125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab [2644447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab-mzwv [2621881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blinatumomab [1597258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab [2644880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab [2619426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab [2625122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab [2682954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab-tgvs [2644448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab-dlle [2682955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab-bysp [2637395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab [2621880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab-bcmm [2644881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD3-directed Antibody [EPC]</name>
  <code>C654308</code>  <id>654308</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody</to_name>
    <to_code>T58911</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Directed Antibody</to_name>
    <to_code>T58912</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194084</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD3-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teplizumab [2621880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunologic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD30-directed Antibody Interactions [MoA]</name>
  <code>C642561</code>  <id>642561</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Antibody Interactions</to_name>
    <to_code>T7931</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182966</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD30-directed Immunoconjugate [EPC]</name>
  <code>C642562</code>  <id>642562</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Immunoconjugate</to_name>
    <to_code>T7933</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Antibody-drug Conjugate</to_name>
    <to_code>T7932</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182967</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD30-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoconjugates [M0028142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD30-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD30-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brentuximab vedotin [1147320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD33-directed Antibody Interactions [MoA]</name>
  <code>C634439</code>  <id>634439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Antibody Interactions</to_name>
    <to_code>T7934</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175077</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD33-directed Immunoconjugate [EPC]</name>
  <code>C634964</code>  <id>634964</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Immunoconjugate</to_name>
    <to_code>T7937</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Cytolytic Antibody</to_name>
    <to_code>T7935</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Cytotoxin</to_name>
    <to_code>T7936</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175571</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD33-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD33-directed Immunoconjugate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemtuzumab ozogamicin [1294580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD38-directed Antibody Interactions [MoA]</name>
  <code>C652471</code>  <id>652471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions</to_name>
    <to_code>T7938</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192335</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab-irfc [2282019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab [2282018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab-fihj [2375130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab [1721947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD38-directed Cytolytic Antibody [EPC]</name>
  <code>C652472</code>  <id>652472</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Cytolytic Antibody</to_name>
    <to_code>T7939</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192336</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daratumumab [1721947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isatuximab [2282018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD38-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD38-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD4-directed Antibody Interactions [MoA]</name>
  <code>C654027</code>  <id>654027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Antibody Interactions</to_name>
    <to_code>T58402</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193805</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab [2043283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab-uiyk [2043313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD4-directed Blocking Antibody [EPC]</name>
  <code>C654026</code>  <id>654026</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Blocking Antibody</to_name>
    <to_code>T58400</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193806</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibalizumab [2043283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD52-directed Antibody Interactions [MoA]</name>
  <code>C634441</code>  <id>634441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Antibody Interactions</to_name>
    <to_code>T7964</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175079</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alemtuzumab [117055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD52-directed Cytolytic Antibody [EPC]</name>
  <code>C635052</code>  <id>635052</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed, Cytolytic Antibody</to_name>
    <to_code>T7965</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Cytotoxin</to_name>
    <to_code>T7966</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Cytolytic Antibody</to_name>
    <to_code>T7967</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175659</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD52-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CD52-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alemtuzumab [117055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD52-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD80-directed Antibody Interactions [MoA]</name>
  <code>C641726</code>  <id>641726</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD80-directed Antibody Interactions</to_name>
    <to_code>T7968</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182150</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD80-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belatacept [1112973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD80-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CD86-directed Antibody Interactions [MoA]</name>
  <code>C641727</code>  <id>641727</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD86-directed Antibody Interactions</to_name>
    <to_code>T7969</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182151</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD86-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belatacept [1112973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD86-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>COVID-19 mRNA Vaccine [EPC]</name>
  <code>C654319</code>  <id>654319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>COVID-19 messenger RNA Vaccine</to_name>
    <to_code>T58937</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>COVID-19 mRNA Vaccine</to_name>
    <to_code>T58936</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194097</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>COVID-19 mRNA Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 mRNA [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>COVID-19 mRNA Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CRH Activity Alteration [PE]</name>
  <code>C27014</code>  <id>27015</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRH Activity Alteration</to_name>
    <to_code>T8367</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008324</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased CRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased CRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CRH Secretion Alteration [PE]</name>
  <code>C27018</code>  <id>27019</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRH Secretion Alteration</to_name>
    <to_code>T8368</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008326</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased CRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased CRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CTLA-4-directed Antibody Interactions [MoA]</name>
  <code>C642215</code>  <id>642215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Antibody Interactions</to_name>
    <to_code>T8392</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA 4-directed Antibody Interactions</to_name>
    <to_code>T8388</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA4-directed Antibody Interactions</to_name>
    <to_code>T8391</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T Lymphocyte Antigen 4-directed Antibody Interactions</to_name>
    <to_code>T8390</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T Lymphocyte Antigen-4-directed Antibody Interactions</to_name>
    <to_code>T8386</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T-Lymphocyte Antigen-4-directed Antibody Interactions</to_name>
    <to_code>T8387</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T-Lymphocyte Antigen 4-directed Antibody Interactions</to_name>
    <to_code>T8389</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182634</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipilimumab [1094833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab-actl [2619312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab [2619313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CTLA-4-directed Blocking Antibody [EPC]</name>
  <code>C642216</code>  <id>642216</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T-Lymphocyte Antigen 4-directed Blocking Antibody</to_name>
    <to_code>T8400</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</to_name>
    <to_code>T8395</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</to_name>
    <to_code>T8399</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T Lymphocyte Antigen 4-directed Blocking Antibody</to_name>
    <to_code>T8394</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T-Lymphocyte Antigen-4-directed Blocking Antibody</to_name>
    <to_code>T8393</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA4-directed Blocking Antibody</to_name>
    <to_code>T8397</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Blocking Antibody</to_name>
    <to_code>T8402</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Cytotoxic T Lymphocyte Antigen 4 (CTLA-4)-Blocking Antibody</to_name>
    <to_code>T8398</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Blocking Antibody</to_name>
    <to_code>T8403</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA 4-directed Blocking Antibody</to_name>
    <to_code>T8396</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxic T Lymphocyte Antigen-4-directed Blocking Antibody</to_name>
    <to_code>T8401</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182635</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tremelimumab [2619313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipilimumab [1094833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>CTLA-4-directed Blocking Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CTLA-4-directed Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CXC Chemokine Receptor 4 Antagonist [EPC]</name>
  <code>C654339</code>  <id>654339</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CXCR4 Antagonist</to_name>
    <to_code>T58971</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CXCR-4 Antagonist</to_name>
    <to_code>T58970</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonist</to_name>
    <to_code>T58974</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194104</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>CXC Chemokine Receptor 4 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mavorixafor [2684021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>CXC Chemokine Receptor 4 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chemokine receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with chemokine receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>CXC Chemokine Receptor 4 Antagonists [MoA]</name>
  <code>C654338</code>  <id>654338</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CXCR4 Antagonists</to_name>
    <to_code>T58973</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonists</to_name>
    <to_code>T58969</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CXCR-4 Antagonists</to_name>
    <to_code>T58972</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194105</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcineurin Inhibitor Immunosuppressant [EPC]</name>
  <code>C634837</code>  <id>634837</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitor Immunosuppressant</to_name>
    <to_code>T8510</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175457</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclosporine [3008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anhydrous tacrolimus [235991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voclosporin [2475166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcineurin inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimecrolimus [321952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcineurin Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with calcineurin inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcineurin Inhibitors [MoA]</name>
  <code>C634838</code>  <id>634838</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors</to_name>
    <to_code>T8511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175458</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voclosporin [2475166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Antagonist [EPC]</name>
  <code>C654173</code>  <id>654173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonist</to_name>
    <to_code>T58615</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193952</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcitonin gene-related peptide receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptinezumab [2282660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Antagonists [MoA]</name>
  <code>C654174</code>  <id>654174</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonists</to_name>
    <to_code>T58616</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193953</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptinezumab [2282660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atogepant [2571813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</name>
  <code>C654151</code>  <id>654151</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonist</to_name>
    <to_code>T58571</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CGPR Antagonist</to_name>
    <to_code>T58572</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193917</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcitonin gene-related peptide receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atogepant [2571813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zavegepant [2637955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ubrogepant [2268216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimegepant [2282307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</name>
  <code>C654152</code>  <id>654152</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists</to_name>
    <to_code>T58573</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CGPR Antagonists</to_name>
    <to_code>T58574</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193918</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atogepant [2571813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zavegepant hydrochloride [2637956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubrogepant [2268216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zavegepant [2637955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcitonin [EPC]</name>
  <code>C635380</code>  <id>635380</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin-class Agent</to_name>
    <to_code>T8528</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin</to_name>
    <to_code>T8529</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175942</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcitonin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon calcitonin [36118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Calcitonin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcitonin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcitonin [M0003145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Binder [EPC]</name>
  <code>C634960</code>  <id>634960</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Binder</to_name>
    <to_code>T8536</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175567</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cellulose sodium phosphate [342965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Binder [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Binder [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Calcium exchange resin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Binder [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcium exchange resin (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Agent [APC]</name>
  <code>C654115</code>  <id>654115</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Agent</to_name>
    <to_code>T58519</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193892</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydropyridine Calcium Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Agonists [MoA]</name>
  <code>C696</code>  <id>697</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Agonists</to_name>
    <to_code>T8539</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000259</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Antagonists [MoA]</name>
  <code>C316</code>  <id>317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Blockers</to_name>
    <to_code>T8540</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists</to_name>
    <to_code>T8541</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000069</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Voltage-gated Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline hydrochloride [236767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline [4327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine [2376944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol, (+)- [1648123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline [37815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine maleate [2377031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol glucuronide [2704947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline hydrochloride [235839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol [6750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Blocker [EPC]</name>
  <code>C634959</code>  <id>634959</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Blocker</to_name>
    <to_code>T8542</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175566</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with calcium channel blocker mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amlodipine [17767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcium channel blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>verapamil [11170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diltiazem [3443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Channel Interactions [MoA]</name>
  <code>C458</code>  <id>459</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions</to_name>
    <to_code>T8543</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000140</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Chelating Activity [MoA]</name>
  <code>C634450</code>  <id>634450</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelator</to_name>
    <to_code>T8592</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Binding Activity</to_name>
    <to_code>T8591</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity</to_name>
    <to_code>T8593</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175089</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulose sodium phosphate [342965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium edetate [105745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium Resorption Inhibitor [EPC]</name>
  <code>C640364</code>  <id>640364</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Resorption Inhibitor</to_name>
    <to_code>T8625</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180856</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Resorption Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing bone resorption inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium Resorption Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Bone resorption inhibitor (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium [EPC]</name>
  <code>C635339</code>  <id>635339</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium-containing Agent</to_name>
    <to_code>T8633</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium</to_name>
    <to_code>T8634</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175901</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcium (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Calcium (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Compounds [M0026683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium [1895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium-Sensing Receptor Interactions [MoA]</name>
  <code>C300470</code>  <id>300470</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium-Sensing Receptor Interactions</to_name>
    <to_code>T8671</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020080</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-Sensing Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-Sensing Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calcium-sensing Receptor Agonist [EPC]</name>
  <code>C635340</code>  <id>635340</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium-sensing Receptor Agonist</to_name>
    <to_code>T8683</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Sensing Receptor Agonist</to_name>
    <to_code>T8682</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175902</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinacalcet [407990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing calcium-sensing receptor activator (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with calcium-sensing receptor activator mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calcium-sensing Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etelcalcetide [1876119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Calculi Dissolution Agent [EPC]</name>
  <code>C635254</code>  <id>635254</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Calculi Dissolution Agent</to_name>
    <to_code>T8685</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Calculi Dissolution Agent</to_name>
    <to_code>T8684</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175835</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calculi Dissolution Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gluconolactone [25842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calculi Dissolution Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Irrigation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calculi Dissolution Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calculi Dissolution Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acidifying Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calculi Dissolution Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citric acid, anhydrous [221946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Calculi Dissolution Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium cation [1426853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid Receptor Agonists [MoA]</name>
  <code>C640568</code>  <id>640568</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Agonists</to_name>
    <to_code>T8824</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid Receptor Antagonists [MoA]</name>
  <code>C640569</code>  <id>640569</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Antagonists</to_name>
    <to_code>T8825</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid Receptor Interactions [MoA]</name>
  <code>C640567</code>  <id>640567</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Interactions</to_name>
    <to_code>T8826</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cannabinoid [EPC]</name>
  <code>C635201</code>  <id>635201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid</to_name>
    <to_code>T8828</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid-class Agent</to_name>
    <to_code>T8827</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175782</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with cannabinoid receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cannabinoids [M0003267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing cannabinoid receptor agonist mechanism of action (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dronabinol [10402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cannabinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nabilone [31447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</name>
  <code>C643859</code>  <id>643859</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activator</to_name>
    <to_code>T8900</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthase 1 (CPS1) Activator</to_name>
    <to_code>T8899</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthase 1 Activator</to_name>
    <to_code>T8892</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activator</to_name>
    <to_code>T8893</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CPS1 Activator</to_name>
    <to_code>T8895</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoylphosphate Synthetase 1 Activator</to_name>
    <to_code>T8896</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl-Phosphate Synthetase 1 Activator</to_name>
    <to_code>T8897</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl-Phosphate Synthase 1 Activator</to_name>
    <to_code>T8898</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoylphosphate Synthase 1 Activator</to_name>
    <to_code>T8894</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184144</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carglumic acid [401713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme activator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</name>
  <code>C643858</code>  <id>643858</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthase 1 Activators</to_name>
    <to_code>T8903</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CPS1 Activators</to_name>
    <to_code>T8908</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl-Phosphate Synthase 1 Activators</to_name>
    <to_code>T8906</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 (CPS1) Activators</to_name>
    <to_code>T8901</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoylphosphate Synthetase 1 Activators</to_name>
    <to_code>T8905</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activators</to_name>
    <to_code>T8909</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthase 1 (CPS1) Activators</to_name>
    <to_code>T8904</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl-Phosphate Synthetase 1 Activators</to_name>
    <to_code>T8902</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoylphosphate Synthase 1 Activators</to_name>
    <to_code>T8907</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184143</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carglumic acid [401713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carbohydrate Metabolism Alteration [PE]</name>
  <code>C27020</code>  <id>27021</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration</to_name>
    <to_code>T8982</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008327</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbohydrate Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbohydrate Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polysaccharide Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbohydrate Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Glucose Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carbonic Anhydrase Inhibitor [EPC]</name>
  <code>C634910</code>  <id>634910</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitor</to_name>
    <to_code>T9041</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175517</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetazolamide [167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorphenamide [3353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing carbonic anhydrase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dorzolamide [60207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with carbonic anhydrase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carbonic Anhydrase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brinzolamide [194881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carbonic Anhydrase Inhibitors [MoA]</name>
  <code>C648</code>  <id>649</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors</to_name>
    <to_code>T9042</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000235</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide [60207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide hydrochloride [236065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brinzolamide [194881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carboxypeptidase [EPC]</name>
  <code>C643693</code>  <id>643693</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carboxypeptidase</to_name>
    <to_code>T9115</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184013</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carboxypeptidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucarpidase [1242127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carboxypeptidase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboxypeptidases [M0003411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carboxypeptidase [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Carboxypeptidase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protease (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carboxypeptidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiac Contractility Alteration [PE]</name>
  <code>C27022</code>  <id>27023</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Contractility Alteration</to_name>
    <to_code>T9249</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008328</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Contractility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Contractility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Contractility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Contractility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiac Glycoside [EPC]</name>
  <code>C634961</code>  <id>634961</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Glycoside</to_name>
    <to_code>T9250</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175568</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Glycoside [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing glycoside (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Glycoside [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Digitalis glycoside (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Glycoside [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>digoxin [3407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Glycoside [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Glycosides [M0003451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiac Myosin Inhibitor [EPC]</name>
  <code>C654269</code>  <id>654269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitor</to_name>
    <to_code>T58813</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194047</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Myosin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mavacamten [2600867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Myosin Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cardiovascular agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiac Myosin Inhibitors [MoA]</name>
  <code>C654268</code>  <id>654268</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitors</to_name>
    <to_code>T58812</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194048</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiac Rate Alteration [PE]</name>
  <code>C27024</code>  <id>27025</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration</to_name>
    <to_code>T9261</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008329</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rate Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rate Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiac Rhythm Alteration [PE]</name>
  <code>C27026</code>  <id>27027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration</to_name>
    <to_code>T9262</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008330</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiac Rhythm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atrial Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide hydrochloride [281189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide [42368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiovascular Activity Alteration [PE]</name>
  <code>C27028</code>  <id>27029</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration</to_name>
    <to_code>T9296</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008331</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rhythm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Contractility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Alterations [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiovascular Agent [APC]</name>
  <code>C654114</code>  <id>654114</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent</to_name>
    <to_code>T9297</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193893</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HMG-CoA Reductase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Volume Expander [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmacologic Cardiac Stress Test Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Glycoside [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin Converting Enzyme Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Sequestrant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine-depleting Sympatholytic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiarrhythmic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstrictor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Apolipoprotein B-100 Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dietary Cholesterol Absorption Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cardiovascular Agent [TC]</name>
  <code>C637763</code>  <id>637763</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent</to_name>
    <to_code>T9297</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178309</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-arrhythmic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cardiovascular Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-anginal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol [31462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol [37840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline hydrochloride [236767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riociguat [1439816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine hydrochloride [284157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol hydrochloride [236374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin calcium [861640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor [1656052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin magnesium [2001252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin [152610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine [2376944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis hydrochloride [2698313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel [613391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine hydrochloride [235229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis [2698312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine hydrochloride [1649479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept-csrk [2678931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol hydrochloride [2667255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine tetrahydrochloride [2611541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine sulfate [82042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 phosphate [2373964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine maleate [2377031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinacidil [33717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen [2637345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamabrom [54365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil hydrochloride [235934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine [10798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacidipine [28382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II acetate, human [2204740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotagliflozin [2638675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flosequinan [25089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine [24464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II [1999003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin sodium [1944734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macitentan [1442132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol hydrochloride [236883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline [4327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alirocumab [1659152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine hydrochloride [235370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rescinnamine [9259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan monohydrate [498193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrendipine [7441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane [42736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine [51253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol [29518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane hydrochloride [1294534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xipamide [11371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol [31555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacubitril [1656328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor tetrasodium [1656051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evolocumab [1665684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythritol [1369563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson anhydrous [1546015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil tartrate [289912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprocitentan [2679059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barnidipine hydrochloride [283819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetiedil [20609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol hydrochloride [236178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux sodium [322154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen sodium [2637346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine [6756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>unoprostone [1546408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloprost [40138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin sodium [152612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban tosylate [1599564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan kamedoxomil [1294597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sul hemipenthy [259379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen sodium [1367838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine hydrochloride [1311530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talinolol [37546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine hydrochloride [1744461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide hydrochloride [281189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin potassium [82118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil [19836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol hydrochloride [2712069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urapidil [39230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetiedil citrate [236204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin sodium [114194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar [1537034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrisentan [358274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil [27403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine hydrochloride [236481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban [1599538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide [42368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen [1367839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel hydrochloride [847020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine thenoate [236213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar sulfate [1537050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abciximab [83929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine [24457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol sulfate [236904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol [2667256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cariostatic Activity [PE]</name>
  <code>C27030</code>  <id>27031</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cariostatic Activity</to_name>
    <to_code>T9307</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008332</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Carnitine Analog [EPC]</name>
  <code>C635341</code>  <id>635341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carnitine Analog</to_name>
    <to_code>T9339</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Carnitine Analogue</to_name>
    <to_code>T9338</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175903</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carnitine Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carnitine [M0003493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carnitine Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Levocarnitine (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carnitine Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carnitine Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocarnitine [42955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Carnitine Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing levocarnitine (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Catechol O-Methyltransferase Inhibitors [MoA]</name>
  <code>C635164</code>  <id>635164</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol-O-Methyltransferase Inhibitors</to_name>
    <to_code>T9525</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitors</to_name>
    <to_code>T9527</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>COMT Inhibitors</to_name>
    <to_code>T9526</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol-O-Methyl Transferase Inhibitors</to_name>
    <to_code>T9523</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyl Transferase Inhibitors</to_name>
    <to_code>T9524</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175756</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opicapone [2362167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolcapone [72937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entacapone [60307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Catechol-O-Methyltransferase Inhibitor [EPC]</name>
  <code>C635165</code>  <id>635165</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol-O-Methyl Transferase (COMT) Inhibitor</to_name>
    <to_code>T9540</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol-O-Methyltransferase Inhibitor</to_name>
    <to_code>T9543</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyl Transferase Inhibitor</to_name>
    <to_code>T9538</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitor</to_name>
    <to_code>T9539</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>COMT Inhibitor</to_name>
    <to_code>T9541</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol-O-Methyltransferase (COMT) Inhibitor</to_name>
    <to_code>T9542</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175757</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing catechol-O-methyltransferase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with catechol-O-methyltransferase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolcapone [72937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entacapone [60307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catechol-O-Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opicapone [2362167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Catecholamine Synthesis Inhibitor [EPC]</name>
  <code>C634962</code>  <id>634962</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitor</to_name>
    <to_code>T9551</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175569</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metyrosine [266604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hypotensive agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Catecholamine Synthesis Inhibitors [MoA]</name>
  <code>C634744</code>  <id>634744</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitor</to_name>
    <to_code>T9552</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitors</to_name>
    <to_code>T9553</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175361</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Catecholamine [EPC]</name>
  <code>C634963</code>  <id>634963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine-class Agent</to_name>
    <to_code>T9554</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine</to_name>
    <to_code>T9555</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175570</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Catecholamine (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norepinephrine [7512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine [3992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing catecholamine (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dopamine [3628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Catecholamines [M0003647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Catecholamine-depleting Sympatholytic [EPC]</name>
  <code>C635033</code>  <id>635033</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine-depleting Sympatholytic</to_name>
    <to_code>T9556</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175640</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine-depleting Sympatholytic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reserpine [9260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine-depleting Sympatholytic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Catecholamine-depleting Sympatholytic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Centrally acting hypotensive agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine-depleting Sympatholytic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cation Transporter Interactions [MoA]</name>
  <code>C648273</code>  <id>648273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cation Transporter Interactions</to_name>
    <to_code>T9600</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188372</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Death Inducer [EPC]</name>
  <code>C643695</code>  <id>643695</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Death Inducer</to_name>
    <to_code>T9743</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184015</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Death Inducer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Death Inducer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Glucose Transport Alteration [PE]</name>
  <code>C27032</code>  <id>27033</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Glucose Transport Alteration</to_name>
    <to_code>T9745</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008333</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Glucose Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Glucose Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Membrane Alteration [PE]</name>
  <code>C27034</code>  <id>27035</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration</to_name>
    <to_code>T9746</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008334</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Membrane Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Membrane Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Membrane Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Membrane Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Membrane Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcohol, x-ray exposed (1000 rad) [1368126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanol [448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oil (containing omega-3 acids) [2053495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrated alcohol [1310469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Membrane Fusion Complex Interactions [MoA]</name>
  <code>C30276</code>  <id>30277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Fusion Complex Interactions</to_name>
    <to_code>T9747</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009954</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Membrane Fusion Complex Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Synaptic Fusion Complex Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Organelle Alteration [PE]</name>
  <code>C27036</code>  <id>27037</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Organelle Alteration</to_name>
    <to_code>T9748</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008335</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Therapy [APC]</name>
  <code>C654291</code>  <id>654291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Therapy</to_name>
    <to_code>T58886</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194069</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Dermal Fibroblast Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cellularized Scaffold Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Fibroblast Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Pancreatic Islet Cellular Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Epidermal Keratinocyte Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Chondrocyte Cell Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell Wall Alteration [PE]</name>
  <code>C27038</code>  <id>27039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Wall Alteration</to_name>
    <to_code>T9757</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008336</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Wall Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Wall Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Wall Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cell Wall Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Wall Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cell-mediated Immunity [PE]</name>
  <code>C644066</code>  <id>644066</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunity, Cellular</to_name>
    <to_code>T9761</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity</to_name>
    <to_code>T9762</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184306</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat flea allergenic extract [886638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixocortol pivalate [38336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buckwheat allergenic extract [899394]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow pine pollen extract [852716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley seed oil [1309236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian pepper tree pollen extract [2632070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radish allergenic extract [974687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Russian olive pollen extract [852367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>largemouth bass allergenic extract [1098183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shad scale pollen extract [852087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kapok tree fiber allergenic extract [852315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loose wheat smut allergenic extract [968437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sea scallop preparation [1426396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red bell pepper allergenic extract [901329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>winterfat pollen extract [852613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lime (citrus) extract [1305725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red pepper extract [1313692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hypomyces perniciosus allergenic extract [1192968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Carya laciniosa pollen extract [1305551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow hair extract [895488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red pine pollen extract [900754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trifolium pratense pollen extract [2102052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white willow pollen extract [1484986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black pepper allergenic extract [899363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oregano allergenic extract [1010965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pisum sativum (pea) extract [1426912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium camemberti allergenic extract [966943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme preparation [319823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit skin extract [895195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Humulus lupulus pollen extract [1740937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ustilago maydis extract [1427134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia pollen extract [851732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alnus glutinosa bark extract [1441543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salix repens pollen extract [2533912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Indian wormwood sage pollen extract [1006495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Colletotrichum coccodes allergenic extract [1192729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern yellow jacket venom protein [1297529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium sarciniforme allergenic extract [968130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trifolium pratense pollen extract [1340182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS [350081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bulbous buttercup pollen extract [1484985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS [350125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western waterhemp pollen extract [851934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium roquefortii allergenic extract [972365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sudan grass pollen extract [1098455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quackgrass pollen extract [852343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European aspen pollen extract [2166596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa bean allergenic extract [891721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ditiocarb, zinc salt [1427192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dill allergenic extract [975763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP [350160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower seed extract [1309391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog dander extract [2167551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disperse blue 106 [1368171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fivehorn smotherweed pollen extract [852124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saltbush pollen extract [897316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Puccinia graminis allergenic extract [999487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus repens allergenic extract [1006310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cotton seed extract [1309369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safflower seed extract [1440241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit allergenic extract [899424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avocado allergenic extract [895582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thimerosal [10472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg white (chicken) allergenic extract [892616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canary feather extract [894961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanolin alcohols [1426478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme allergenic extract [974527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula mucilaginosa allergenic extract [967529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dogfennel pollen extract [867218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syncephalastrum racemosum allergenic extract [968506]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus flavus var. oryzae protease [1307040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast live oak pollen extract [852302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quaternium-15 [283678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red snapper allergenic extract [889646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon preparation [1421430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valley oak pollen extract [1111024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodgepole pine pollen extract [898324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>greasewood pollen extract [852152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat pollen extract [867361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jack pine pollen extract [1014690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basil allergenic extract [899355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grama grass pollen extract [852197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grape extract [253172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn grain extract [1423924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sisal fiber allergenic extract [851882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil [1309229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamb allergenic extract [971849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Epicoccum nigrum allergenic extract [852466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat gluten extract [1370781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitternut hickory pollen extract [899645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver ragweed pollen extract [852306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben sodium [1311574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Malus domestica pollen extract [2593689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gliocladium viride extract [2101008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Douglas fir pollen extract [1098257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raspberry extract [1370769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated rye grass pollen extract [1014774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower pollen extract [852509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef allergenic extract [892599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common hazel pollen extract [1484979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfalfa pollen extract [852634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silk allergenic extract [314455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clam allergenic extract [892539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poppy seed allergenic extract [1011017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Whey Proteins [1723989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Strychnos nux-vomica seed extract [1309678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Concord grape allergenic extract [901191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herring allergenic extract [899434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creeping bentgrass pollen extract [1094116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canis lupus familiaris hair extract [854025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rattus norvegicus hair preparation [2471704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poverty weed pollen extract [852539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American basswood pollen extract [995754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Passalora fulva allergenic extract [883442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Apis mellifera preparation [285219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylparaben [29903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean allergenic extract [891668]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tuna allergenic extract [892503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic mackerel allergenic extract [2198984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American cockroach allergenic extract [905258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zucchini extract [1649134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig hair extract [895507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint allergenic extract [901313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crested dogstail pollen extract [1484980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sydney golden wattle pollen extract [895365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bald cypress pollen extract [995747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldibromo glutaronitrile [1307044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>littleseed canary grass pollen extract [1098232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine allergenic extract [1011412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat bran [253190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nettle pollen extract [852046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western yellow jacket venom protein [1297535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Oregon ash pollen extract [900045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Helminthosporium solani allergenic extract [867232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lentil allergenic extract [899444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American house dust mite allergenic extract [1116977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cauliflower allergenic extract [899661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cricket allergenic extract [973447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American elm pollen extract [852054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mountain cedar pollen extract [852581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl-p-hydroxybenzoate [1362892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salix lutea pollen extract [2590686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pale dock pollen extract [1232604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lime allergenic extract [1011060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phoma exigua var. exigua allergenic extract [867284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocean perch preparation [2471431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horseradish allergenic extract [1011043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lawsonia inermis leaf extract [1307699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Schinus terebinthifolius pollen extract [2590688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>careless weed pollen extract [851926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goat milk allergenic extract [862475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fremont cottonwood pollen extract [852355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse hair extract [1993210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower seed allergenic extract [901203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mulberry pollen extract [899593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM [317581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fig allergenic extract [973880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green bell pepper allergenic extract [862478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allspice allergenic extract [895552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Puccinia striiformis allergenic extract [852311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red mulberry pollen extract [852680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango allergenic extract [1011404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedar elm pollen extract [1014191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potato allergenic extract [892632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sour cherry allergenic extract [1012134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canyon ragweed pollen extract [851942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylguanidine [1368170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acrothecium robustum allergenic extract [905088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP [349980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western larch pollen extract [2166614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Humicola grisea allergenic extract [1014391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western white pine pollen extract [900743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Utah juniper pollen extract [852597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broad leaved paperbark pollen extract [903913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English walnut pollen extract [852577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion extract [1370469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces cerevisiae [9511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pacific halibut allergenic extract [882469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow hornet venom protein [1297537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cochliobolus spicifer allergenic extract [995699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat hair extract [895503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linden pollen extract [852070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chicken feather extract [894934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pinus cembroides pollen extract [2590679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kidney bean allergenic extract [891637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben calcium [1867698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>okra extract [1370787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley extract [1370766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylenediamine [1362740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>banana allergenic extract [891830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hazelnut allergenic extract [891633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burweed marshelder pollen extract [852551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dark leaved mugwort pollen extract [896246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lens scale pollen extract [852096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>longleaf pine pollen extract [1014360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canary grass pollen extract [852697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Iris germanica var. florentina root extract [1993233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bronopol [1114345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pineapple extract [1492174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hackberry pollen extract [852324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango extract [1426332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lombardy poplar pollen extract [852348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Austrian pine pollen extract [900750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lichtheimia corymbifera allergenic extract [995727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley malt syrup [1306883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sheep sorrel pollen extract [852213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosquito allergenic extract [974741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-isopropyl-N-phenyl-4-phenylenediamine [1363710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arizona cypress pollen extract [852814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Camelus bactrianus hair extract [2590604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California scrub oak pollen extract [852802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoamphodiacetate [1364462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern ragweed pollen extract [885750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit hair extract [895527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cumin allergenic extract [901365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white oak pollen extract [852294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bald-faced hornet venom protein [1297525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-oxydiethylene-2-benzothiazole sulfenamide [1363711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Verticillium albo-atrum allergenic extract [968467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel [1311629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black-eyed pea allergenic extract [899490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whey protein hydrolysate [2266754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>live oak pollen extract [867311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shagbark hickory pollen extract [852221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hard maple pollen extract [851874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Corylus americana nut oil [1603849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ash pollen extract [1484982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salt grass pollen extract [852329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy protein isolate [196238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allscale pollen extract [897304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza glabra extract [1370435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sardine allergenic extract [974129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard greens allergenic extract [899452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>northern pike allergenic extract [889602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-cyclohexyl-2-benzothiazosulfenamide [1306886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit extract [124323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium glaucum allergenic extract [1986792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Garrys oak pollen extract [900987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange pollen extract [897403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perennial rye grass pollen extract [852819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pepper tree pollen extract [852140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green olive allergenic extract [971379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lambs quarters pollen extract [852237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA [350060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut extract [1372248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor circinelloides f. circinelloides allergenic extract [2101422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western juniper pollen extract [852589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bahia grass pollen extract [852673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salt cedar pollen extract [852806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broccoli allergenic extract [899386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Italian rye grass pollen extract [1014340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellowfin tuna allergenic extract [2102488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oyster, unspecified preparation [1315121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carob allergenic extract [904498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phanerodontia chrysosporium allergenic extract [968114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coffee bean allergenic extract [891727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black olive allergenic extract [974650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow dander extract [2166591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paprika allergenic extract [899873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Coffea arabica seed extract [2695791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redroot pigweed pollen extract [851930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry allergenic extract [899734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peach allergenic extract [892575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus flavus allergenic extract [999384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chickpea allergenic extract [1011049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver maple pollen extract [851866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>post oak pollen extract [901011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig dander [2166593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton schoenleinii allergenic extract [968422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gray birch pollen extract [852178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cynara preparation [235940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocklebur pollen extract [852025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus arrhizus allergenic extract [314443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat germ oil [72385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>date allergenic extract [899742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sandbur ragweed pollen extract [851955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat hair extract [248123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quince extract [1370761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetracoccosporium paxianum allergenic extract [968502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichothecium roseum allergenic extract [968426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scallop allergenic extract [899916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red oak pollen extract [852268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg (chicken) allergenic extract [904507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water birch pollen extract [852166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neurospora intermedia allergenic extract [867274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Evernia prunastri extract [1311644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red currant allergenic extract [972480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley malt allergenic extract [1006510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat skin extract [852252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pussy willow pollen extract [852174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shortleaf pine pollen extract [852709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white poplar pollen extract [852382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern bayberry pollen extract [867260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cotton fiber allergenic extract [966925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English sole allergenic extract [974140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house fly allergenic extract [350173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white catfish allergenic extract [971166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>narrowleaf marshelder pollen extract [1098130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nux vomica extract [314743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canadian bluegrass pollen extract [1014731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Allium cepa bulb extract [2695867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog hair extract [895542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paper birch pollen extract [899576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canada goldenrod pollen extract [995743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rye allergenic extract [892638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesquite pollen extract [852320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon allergenic extract [901382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cheat grass pollen extract [852225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European beech pollen extract [1484981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean lecithin [579598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common carp allergenic extract [901390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palo verde pollen extract [852359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet vernal grass pollen extract [851898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange allergenic extract [892565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris root allergenic extract [1098353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cucumber extract [1305719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>privet pollen extract [852622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sipuleucel-T [997261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum allergenic extract [2101722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Coccidioides immitis spherule [1549330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadow foxtail pollen extract [1484974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wormwood sage pollen extract [852007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white fish allergenic extract [901265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tag alder pollen extract [851902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladosporium sphaerospermum allergenic extract [867202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tall oat grass pollen extract [1006506]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger root [125921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celery allergenic extract [892372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haddock allergenic extract [899428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue spruce pollen extract [900704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>european olive pollen extract [852653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California black walnut pollen extract [852561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylparaben [19075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantaloupe allergenic extract [892517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chinese elm pollen extract [852844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redberry juniper pollen extract [900113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cytisus scoparius flowering top extract [2168418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-mercaptobenzothiazole [1358845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>squash allergenic extract [975509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard pollen extract [852205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium chrysogenum var. chrysogenum allergenic extract [854130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosin [1362931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pistachio nut allergenic extract [904606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red maple pollen extract [851744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Koelers grass pollen extract [852605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk (chicken) allergenic extract [892620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>string bean allergenic extract [891676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brazilian pepper tree pollen extract [2632068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green ash pollen extract [852491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia longifolia pollen extract [853983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lettuce allergenic extract [899448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamyl alcohol [1362889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>northern quahog preparation [1925437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetramethylthiuram monosulfide [1363713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Russian thistle pollen extract [852158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velvet grass pollen extract [852514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flounder allergenic extract [899746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium cladosporioides extract [867198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California black oak pollen extract [1014721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast sage pollen extract [852011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osage orange pollen extract [1098189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>okra allergenic extract [1011021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium italicum allergenic extract [967960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine extract [1426364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chicken allergenic extract [892653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Solidago virgaurea pollen extract [1309242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium compactum allergenic extract [999457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pork allergenic extract [892628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipentamethylenethiuram disulfide [1426773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Paecilomyces variotii allergenic extract [966979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lentil seed extract [1426921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>queen palm pollen extract [867353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white sweet clover pollen extract [1014735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig skin extract [852298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black locust pollen extract [867325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed extract [853406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic halibut preparation [1424920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parakeet feather allergenic extract [1192987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turnip allergenic extract [883414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver birch pollen allergenic extract [1306108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton rubrum allergenic extract [968413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strawberry allergenic extract [892484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watermelon preparation [260014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine carbamate [2375923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS [350075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway seed allergenic extract [899637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus amstelodami extract [2101007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jute fiber allergenic extract [852412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet gum pollen extract [852627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Scotch pine pollen extract [900764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>slender ragweed pollen extract [851990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse skin extract [852479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorquinaldol [2407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>algal fungi allergenic extract [966692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goose feather extract [894783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Leucanthemum vulgare pollen [2102006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage leaf allergenic extract [1011627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cottonwood pollen extract [852376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bur oak pollen extract [900991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>German cockroach allergenic extract [905276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black pepper preparation [259314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English plantain pollen extract [852742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>annual bluegrass pollen extract [898404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Calocedrus decurrens pollen extract [2670160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alkali blite pollen extract [852106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vitis vinifera pollen extract [2669695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut allergenic extract [891658]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanilla bean extract [2275721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crab allergenic extract [892610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velvetleaf huckleberry allergenic extract [2102487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet pollen extract [852132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burrobrush pollen extract [852526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust allergenic extract [852519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse skin extract [852693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pear preparation [1367125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grain sorghum pollen extract [1098438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broadleaf cattail pollen extract [1232637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western black willow pollen extract [1014755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern white pine pollen extract [852738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salsola tragus pollen extract [1314927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiram [10517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duck allergenic extract [972037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheasant feather extract [1594964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans allergenic extract [214355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT, CAMEL [314336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass smut allergenic extract [1014385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobacco leaf allergenic extract [852062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mongolian gerbil skin allergenic extract [895070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nutmeg extract [1353217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinach allergenic extract [901317]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Soy Proteins [36853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-cyclohexyl-N&apos;-phenyl-1,4-phenylenediamine [1427136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brussels sprout allergenic extract [899390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English walnut allergenic extract [891687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hazelnut pollen extract [852281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common cocklebur pollen extract [902215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum extract [852617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic cod allergenic extract [900025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit peel extract [1358897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Periplaneta australasiae extract [2590183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc dibutyldithiocarbamate [1426942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxycitronellal [1362893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venison allergenic extract [882488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watermelon allergenic extract [901258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Apiospora montagnei allergenic extract [1006258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptomyces griseus allergenic extract [1314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watercress allergenic extract [1011418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue beech pollen extract [899611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Siberian elm pollen extract [1299981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora betae allergenic extract [852756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white alder pollen extract [851910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape extract [1307718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Jerusalem artichoke extract [1648701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben [34706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry juice [1307717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arizona ash pollen extract [852496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bluefish allergenic extract [892181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Grindelia ciliata pollen extract [2043451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat bran extract [1427046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic halibut allergenic extract [2261370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora herbarum allergenic extract [971198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perch allergenic extract [976711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avocado oil [1311611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat dextrin [637366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orchard grass pollen extract [851878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bay leaf extract [1606480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dendryphiella vinosa allergenic extract [995703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet wormwood pollen extract [2167819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharomyces cerevisiae allergenic extract [350141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Geotrichum candidum allergenic extract [999463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black walnut pollen extract [852569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium solani allergenic extract [867349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>London planetree [2166616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American chestnut allergenic extract [891752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia dealbata pollen extract [2202946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raspberry allergenic extract [899906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow dock pollen extract [852209]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>giant wild rye pollen extract [900148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white mulberry pollen extract [852669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loblolly pine pollen extract [900770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon allergenic extract [899673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loose barley smut allergenic extract [968492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparagus allergenic extract [891796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic salmon allergenic extract [900031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gibberella zeae allergenic extract [1922751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cashew nut allergenic extract [892526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plum allergenic extract [899470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern cottonwood pollen extract [852363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange pekoe tea allergenic extract [966696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape allergenic extract [892317]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gibberella fujikuroi extract [2043450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Khuskia oryzae allergenic extract [892338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N,N&apos;-diphenyl-4-phenylenediamine [1363709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California juniper pollen extract [852585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stachybotrys chartarum allergenic extract [968123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mung bean allergenic extract [891647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red imported fire ant allergenic extract [867341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western sycamore pollen extract [852750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitter dock pollen extract [1014739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabbage allergenic extract [899398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>river birch pollen extract [852148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black imported fire ant allergenic extract [995738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prairie sagebrush pollen extract [867142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse dander extract [2167548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian balsam [33219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove allergenic extract [899724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>veal allergenic extract [1012026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Evernia prunastri extract [1352501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carrot allergenic extract [892368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger allergenic extract [899420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oyster allergenic extract [973274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat allergenic extract [971932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Australian pine pollen extract [852229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American lobster allergenic extract [1997187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Microsporum audouinii allergenic extract [1014395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium expansum allergenic extract [967111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geraniol [1368875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine bush pollen extract [851894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duck feather extract [892851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein allergenic extract [862460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass smut allergenic extract [852128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese black pine pollen extract [900777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk phospholipids [314605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chinquapin oak pollen extract [2167695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rough marshelder pollen extract [852532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chocolate allergenic extract [1010915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brazil nut allergenic extract [891514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eggplant extract [1315116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trout allergenic extract [882482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton tonsurans allergenic extract [1098619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit bush pollen extract [851969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2&apos;-dithiobisbenzothiazole [1306112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bean extract [1370773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus lunatus allergenic extract [852264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion allergenic extract [899466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>weakleaf bur ragweed pollen extract [1117083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Callistemon citrinus pollen extract [2171260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza glabra root powder extract [2711885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Platycladus orientalis pollen extract [1360623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haematonectria haematococca allergenic extract [852503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broadleaf plantain pollen extract [1484983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turkey feather extract [1594963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2-bis(4-glycidyloxyphenyl)propane [1368138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida tropicalis allergenic extract [967033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turkey allergenic extract [975119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger var. niger extract [854082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor racemosus allergenic extract [852687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue crab preparation [1315126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-tert-butylphenol-formaldehyde resin (low molecular weight) [1427189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulmus rubra pollen allergenic extract [1426632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitch pine pollen extract [900758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciltacabtagene autoleucel [2594775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidurea [1368885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster skin extract [852663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoeugenol [1363706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Blatta orientalis preparation [1346617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rocky Mountain juniper pollen extract [852601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>banana extract [285149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radish extract [1314656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsnip allergenic extract [1011027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine [4158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry birch pollen extract [852144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog flea allergenic extract [886637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epidermophyton floccosum allergenic extract [995707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European house dust mite allergenic extract [1116979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red alder pollen extract [851914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white (mexican) dock pollen extract [1014743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black walnut allergenic extract [891695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora tarda allergenic extract [852404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parthenolide [32941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pyrethrum cinerariifolium allergenic extract [967970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acremonium strictum allergenic extract [905070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black oak pollen extract [852260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nutmeg allergenic extract [891652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burning bush pollen extract [852593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codfish allergenic extract [892543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rat skin extract [895279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mexican tea pollen extract [897391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eucalyptus globulus pollen extract [852386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gliocladium allergenic extract [1192997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef liver preparation [1330085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard seed allergenic extract [899456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common wasp venom protein [1297527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desert ragweed pollen extract [851981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cootamundra wattle pollen extract [895353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phoma destructiva allergenic extract [966995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lima bean allergenic extract [891641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cola acuminata seed extract [1307595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma harzianum allergenic extract [968197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>swordfish allergenic extract [901283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>licorice root extract [235524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cucumis sativus fruit extract [2700058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod, unspecified preparation [1426437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Jerusalem oak pollen extract [1014766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leek allergenic extract [1010932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arroyo willow pollen extract [852170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English oak pollen extract [1484984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tomato allergenic extract [892499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anise seed extract [1309292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulmus glabra pollen extract [2369372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley allergenic extract [862453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oneseed juniper pollen extract [900108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water oak pollen extract [1013944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast maple pollen extract [851736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley allergenic extract [899877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster hair extract [1594965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn extract [1323308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazolidinylurea [1310602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-MERCAPTOBENZOTHIAZOLE [1306880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garlic allergenic extract [899414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golden chain pollen extract [1996102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>honeydew melon allergenic extract [899476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eggplant allergenic extract [972601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red cedar pollen extract [852609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western wheatgrass pollen extract [852659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated barley pollen extract [1098118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Quercus marilandica pollen extract [1437222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated mushroom allergenic extract [901369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium digitatum allergenic extract [1427044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garlic preparation [265647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colonial bent grass pollen extract [1484937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit allergenic extract [813859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cucumber allergenic extract [899738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated oat pollen extract [852114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern sycamore pollen extract [852746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust mite extract, Dermatophagoides farinae [852810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redwood pollen extract [1014707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tabanus nigrovittatus extract [2590185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust mite extract, Dermatophagoides pteronyssinus [852826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shrimp allergenic extract [892592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sesame seed extract [1310046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brown rice preparation [1311040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>box elder maple pollen extract [851740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sesame seed allergenic extract [901199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black sea bass allergenic extract [2102474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>giant ragweed pollen extract [851998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor circinelloides f. lusitanicus allergenic extract [2101473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>date palm pollen extract [852704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint flowering top extract [2168421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pin oak pollen extract [900999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>para grass pollen extract [894750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syringa vulgaris pollen extract [2634236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cow milk allergenic extract [892665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broomweed pollen extract [1094193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lobster allergenic extract [892561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gambels oak pollen extract [852276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plains cottonwood pollen extract [867297]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse hair extract [895515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsam poplar pollen extract [1014762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sorghum bicolor pollen extract [1311406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black willow pollen extract [852162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>purified protein derivative of tuberculin [8948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neurospora sitophila allergenic extract [1098200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya allergenic extract [1011426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>microsporum canis allergenic extract [1014399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pignut hickory pollen extract [899650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint preparation [33093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamic aldehyde [1368153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>slash pine pollen extract [900731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Microascus brevicaulis allergenic extract [1192992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>groundsel pollen extract [897332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow sweet clover pollen extract [1014447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white hickory pollen extract [852193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadow fescue grass pollen extract [851918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef liver allergenic extract [972689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pumpkin allergenic extract [883459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet potato allergenic extract [901307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white ash pollen extract [852450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black carpenter ant allergenic extract [2057909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wing scale pollen extract [852074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California mugwort pollen extract [892734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanilla bean allergenic extract [901291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Amaranthus hybridus pollen extract [1363561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus nidulans allergenic extract [1368357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspen pollen extract [852339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scrub pine pollen extract [1013913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>German wasp venom protein [1297531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow birch pollen extract [899550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES [350004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog skin extract [852839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern yellow jacket venom protein [1297533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tree of heaven pollen extract [851890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut allergenic extract [891611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl cinnamal [1311606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clonostachys rosea f. rosea allergenic extract [1426481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acer pseudoplatanus pollen extract [1801702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cells, Allogeneic [EXT]</name>
  <code>C644830</code>  <id>644830</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Allogeneic</to_name>
    <to_code>T9769</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cells</to_name>
    <to_code>T9768</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185022</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human cord blood hematopoietic progenitor cell [1307732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cells, Cultured, Allogeneic [EXT]</name>
  <code>C644069</code>  <id>644069</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cultured Cells, Allogeneic</to_name>
    <to_code>T9773</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Allogeneic</to_name>
    <to_code>T9774</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cultured Cells</to_name>
    <to_code>T9772</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184309</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foreskin fibroblast, neonatal [1427137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foreskin keratinocyte, neonatal [1427138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cells, Cultured, Autologous [EXT]</name>
  <code>C644070</code>  <id>644070</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cultured Cells</to_name>
    <to_code>T9776</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cultured Cells, Autologous</to_name>
    <to_code>T9775</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous</to_name>
    <to_code>T9777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184310</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cells, Cultured, Autologous [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sipuleucel-T [997261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cells, Cultured, Autologous, Genetically-modified [EXT]</name>
  <code>C653918</code>  <id>653918</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous, Genetically-modified</to_name>
    <to_code>T9780</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Cultured Cells, Autologous</to_name>
    <to_code>T9778</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Autologous Cultured Cells</to_name>
    <to_code>T9779</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193547</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cells, Cultured, Autologous, Genetically-modified [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cells, Epidermal [EXT]</name>
  <code>C645191</code>  <id>645191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal</to_name>
    <to_code>T9783</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Cells</to_name>
    <to_code>T9781</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermis</to_name>
    <to_code>T9782</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185377</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit skin extract [895195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster skin extract [852663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog dander extract [2167551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse skin extract [852693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog skin extract [852839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP [350160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig dander [2166593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat skin extract [852252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow dander extract [2166591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mongolian gerbil skin allergenic extract [895070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig skin extract [852298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse dander extract [2167548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse skin extract [852479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rat skin extract [895279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Activity Alteration [PE]</name>
  <code>C27040</code>  <id>27041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration</to_name>
    <to_code>T9784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008337</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Motion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Cycle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir anhydrous [1598096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanamivir [69722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride hexahydrate [221118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine [193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine, DL- [1310540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium amino acid chelate [486895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, monohydrate [1311357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride [476316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric oxide [21837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic sodium phosphate heptahydrate [221090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tribasic sodium phosphate [36710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate magnesium [1549106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molybdenum [7024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate dibasic trihydrate [2475957]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine fumarate [360300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride anhydrous [1311539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium molybdate [17789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium folate [1300473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, dodecahydrate [1311345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium dihydrate [2611697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic anhydrous [1307158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride tetrahydrate [2003593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A [11246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casirivimab [2465242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolic acid [1025342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin sodium [2109051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium,chelated [259277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine sulfosalicylate [235562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal phosphate [9004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A palmitate [35406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat hydrobromide [2670632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine hydrochloride [1426681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid [7891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uracil mustard [10996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biotin [1588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper gluconate [2839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine tartrate [1364375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin tetrabutyrate [2106328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese sulfate [29268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride, DL- [1593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate [1592257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium anhydrous [2279515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric chloride [21833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid, (+-)- [2394646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc nicotinate [236834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemin [5175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline [2449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium stearate [1310567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir [619693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloride ion [153974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B12 [11248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese dioxide [29263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate glucosamine [1592256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese [6623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine [42955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium acetate tetrahydrate [317246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine phosphoserinate [236803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folic acid [4511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imdevimab [2465249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A myristate [1813433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium [1925820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate anhydrous [1792467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin [9346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilobelimab [2639620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B6 [42954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic potassium phosphate [55018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Communication Alteration [PE]</name>
  <code>C27042</code>  <id>27043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration</to_name>
    <to_code>T9791</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008338</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Communication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Communication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Extracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib dihydrochloride [2479691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Communication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Cycle Alteration [PE]</name>
  <code>C27044</code>  <id>27045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Cycle Alteration</to_name>
    <to_code>T9792</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008339</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Cycle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Division Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Cycle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Cycle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Death Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Cycle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Cycle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Cycle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat hydrobromide [2274379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Cycle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Cycle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Cycle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Death Alteration [PE]</name>
  <code>C27046</code>  <id>27047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Death Alteration</to_name>
    <to_code>T9793</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008340</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Death Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Death Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Degradation/Digestion Alteration [PE]</name>
  <code>C27048</code>  <id>27049</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration</to_name>
    <to_code>T9794</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008341</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Degradation/Digestion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Degradation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Degradation/Digestion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium [9641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium chloride [2200142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenate [36717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenious acid [36344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Degradation/Digestion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Division Phase Alteration [PE]</name>
  <code>C27050</code>  <id>27051</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Division Phase Alteration</to_name>
    <to_code>T9795</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008342</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Division Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitosis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Division Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meiosis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Division Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Division Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Division Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Division Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Growth Phase Alteration [PE]</name>
  <code>C27052</code>  <id>27053</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Alteration</to_name>
    <to_code>T9796</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008343</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Growth Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Growth Phase Arrest [PE]</name>
  <code>C27054</code>  <id>27055</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest</to_name>
    <to_code>T9797</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008344</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolnaftate [10637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib succinate [1873978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine sulfate [11199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine [11202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine sulfate [11203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n3 [612937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine [11198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Growth Phase Reduction [PE]</name>
  <code>C300398</code>  <id>300398</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction</to_name>
    <to_code>T9798</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020013</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Growth Phase Reduction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab-hrii [2698200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib camsylate [1862578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab [2698198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Growth Phase Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Motion Alteration [PE]</name>
  <code>C27056</code>  <id>27057</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Motion Alteration</to_name>
    <to_code>T9799</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008345</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Motion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Motion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Locomotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Motion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Locomotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Motion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Proliferation Alteration [PE]</name>
  <code>C635078</code>  <id>635078</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration</to_name>
    <to_code>T9800</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175672</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Proliferation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelial Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Proliferation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epithelial Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab [2632981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunvozertinib [2719226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encorafenib [2049106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib [2105845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab [2360231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib mesylate [1425222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib sulfate [2361596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib [1722365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim-xnst [2612537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant [2725912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zongertinib [2721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib s-malate [1363267]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib [2105806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abemaciclib [1946825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziftomenib [2725985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib sulfate [2104548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib monohydrate [1314319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanubrutinib [2262435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamitresgene autoleucel [2690256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib [2714502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib hydrochloride [2712547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib [1425099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acalabrutinib [1986808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axitinib [1242999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib hydrochloride [1364953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-txid [2700365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib [2712546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpelisib [2169285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib dimethyl sulfoxide [1425098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib hydrochloride [2183103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib ditosylate [481474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib [2714515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib [2643048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab-actl [2619312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>binimetinib [2049122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temsirolimus [657797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab [2473851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept-csrk [2678931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib dihydrochloride [2643049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copanlisib [1945077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib maleate [1940642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim [2612526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib fumarate [1722380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib potassium [2714514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab [2619313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib hydrochloride [2362259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib maleate [2105844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib [475342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant tosylate [2725911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib phosphate [2633006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entrectinib [2197862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab-dlwr [2632980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib hydrochloride [1727454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib succinate [1873978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib citrate [2698326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib [1363268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant dihydrochloride [2628473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan-hziy [2360530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin [2174090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib [480167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan [2360232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib fumarate [2105823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirdametinib [2705551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib hydrochloride [2714501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab-cmkb [2473850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olutasidenib [2623641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin-piiq [2174091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Proliferation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Structure Alteration [PE]</name>
  <code>C27058</code>  <id>27059</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration</to_name>
    <to_code>T9801</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008346</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytoskeleton Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Organelle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Wall Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-fihj [2375132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase [5464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-oysk [2119708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-nvhy [2700789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-tqjs [2693885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, ovine [486164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exagamglogene autotemcel [2671667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-zzxf [2382595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-ocsq [2693451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, human recombinant [1300478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-qvfc [2639946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, bovine [578350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Structure Molecule Interactions [MoA]</name>
  <code>C31868</code>  <id>31869</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Molecule Interactions</to_name>
    <to_code>T9802</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010255</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Structure Molecule Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Synthetic Activity Alteration [PE]</name>
  <code>C27060</code>  <id>27061</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration</to_name>
    <to_code>T9803</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008347</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Synthetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Translation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Synthetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Post Translation Protein Modification Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Synthetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Transcription Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Synthetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine [9386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tavaborole [1543173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>masoprocol [227239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfabenzamide [37320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine hydrochloride [82093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib hydrochloride [1364953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Synthetic Phase Alteration [PE]</name>
  <code>C27062</code>  <id>27063</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Phase Alteration</to_name>
    <to_code>T9804</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008348</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Synthetic Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Synthetic Phase Arrest [PE]</name>
  <code>C27064</code>  <id>27065</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Phase Arrest</to_name>
    <to_code>T9805</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008349</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Synthetic Phase Arrest [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cellular Transport Alteration [PE]</name>
  <code>C27066</code>  <id>27067</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Transport Alteration</to_name>
    <to_code>T9806</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008350</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pinocytosis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phagocytosis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Exocytosis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endocytosis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept root="true" >
  <namespace>MED-RT</namespace>
  <name>Cellular or Molecular Interactions [MoA]</name>
  <code>C624</code>  <id>625</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions</to_name>
    <to_code>T9807</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000223</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Macromolecular Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Membrane Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cellular or Molecular Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kelp preparation [285155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase beta [338817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol [35382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular or Molecular Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Activity Alteration [PE]</name>
  <code>C635130</code>  <id>635130</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Activity Alteration</to_name>
    <to_code>T9837</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175724</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Agent [TC]</name>
  <code>C637766</code>  <id>637766</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CNS Agent</to_name>
    <to_code>T9838</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent</to_name>
    <to_code>T9839</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178312</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine phosphate [2106337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod [1012892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine tosylate [1923002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate [82819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxybate [2387307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil hydrochloride [203203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givinostat [2678889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurursodiol [2613950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theobromine sod salicylate [236926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine [50675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate calcium [152761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline [2694828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol [2694283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine fumarate [2392633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec [2170226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab-mwge [2391551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl [237005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liraglutide [475968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golodirsen [2267207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital [9624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen [2099289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triazolam [10767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine [183379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod hydrochloride [1012891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine dimesylate [673579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxybate [2387308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole hydrochloride [236553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline tartrate [2694829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil [480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride anhydrous [1808546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine [38400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine [2392230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine [193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfampridine [897018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline tartrate [636674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine [6719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen sodium [2099290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran [2053490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride [476316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate chloride [2562177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riluzole [35623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine hydrochloride [235972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol citrate [2694282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital sodium [91110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod lauryl sulfate [2610292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab-irmb [2626142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen sodium [2671940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurursodiol dihydrate [2665620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edaravone [1921877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theobromine [10437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium lipid complex [2284710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium [2053491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxybate [9899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin [1300701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>armodafinil [641465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride, DL- [1593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant hydrochloride [2197879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foslevodopa [2695775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droxidopa [1489913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofinetide [2632852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbachol [1999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethchlorvynol [4118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl acetate hydrochloride [82043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omaveloxolone [2631931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofersen [2634995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole [72302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium oxybate [2387309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine hydrochloride [353103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide [6911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide maleate [203190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flibanserin [1665509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine [2106338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride [1300700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fezolinetant [2637134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate [2562176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine [700810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine [10318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diroximel fumarate [2261783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran lipid complex [2284711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orlistat [37925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine, DL- [1310540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine [156240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine tartrate [994808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline [591622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec-xioi [2170225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallamine triethiodide [4639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab [2626143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brivaracetam [1739745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerliponase alfa [1922436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceprometazine [161203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine hydrochloride [50676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab [2391541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disulfiram [3554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride monohydrate [221160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine hydrochloride [236685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemborexant [2272403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nusinersen [1863556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride hemihydrate [1597623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Depressant [EPC]</name>
  <code>C635166</code>  <id>635166</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depressant</to_name>
    <to_code>T9845</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175758</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxybutyric acid [1546380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxybate [2387302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depressant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Central depressant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Depression [PE]</name>
  <code>C635134</code>  <id>635134</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression</to_name>
    <to_code>T9846</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175728</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depression [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depression [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depression [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Depression [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine [2119365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine [24484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine hydrochloride [2119366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-hydroxybutyric acid [1546380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine citrate [235416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brivaracetam [1739745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Stimulant [EPC]</name>
  <code>C635145</code>  <id>635145</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulant</to_name>
    <to_code>T9872</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulant</to_name>
    <to_code>T9874</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CNS Stimulant</to_name>
    <to_code>T9873</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175739</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexmethylphenidate [352372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caffeine [1886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Central stimulant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisdexamfetamine [700810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylphenidate [6901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphetamine [725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methamphetamine [6816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextroamphetamine [3288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central Nervous System Stimulation [PE]</name>
  <code>C635135</code>  <id>635135</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation</to_name>
    <to_code>T9875</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175729</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central Nervous System Stimulation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine [156240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine dimesylate [673579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine [700810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate [2562176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate chloride [2562177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Central alpha-2 Adrenergic Agonist [EPC]</name>
  <code>C634947</code>  <id>634947</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central a-2 Adrenergic Agonist</to_name>
    <to_code>T9893</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective alpha2-Agonist</to_name>
    <to_code>T9891</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central alpha-2 Adrenergic Agonist</to_name>
    <to_code>T9894</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-2 Adrenergic Agonist</to_name>
    <to_code>T9892</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175554</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexmedetomidine [48937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldopa anhydrous [1545996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clonidine [2599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanabenz [5033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanfacine [40114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing central alpha-2 adrenergic receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Central alpha-2 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tizanidine [57258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Centrally-mediated Muscle Relaxation [PE]</name>
  <code>C635136</code>  <id>635136</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation</to_name>
    <to_code>T9895</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175730</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cephalosporin Antibacterial [EPC]</name>
  <code>C634869</code>  <id>634869</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cephalosporin Antibacterial</to_name>
    <to_code>T9918</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175488</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefepime [20481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cephalexin anhydrous [1299782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftazidime anhydrous [1545984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefprozil [19552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftolozane [1597609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefpodoxime [20489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefditoren [83682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftaroline [1040005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftizoxime [2192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefazolin [2180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefdinir [25037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefadroxil anhydrous [1545975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Cephalosporin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftibuten [20492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefuroxime [2194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftriaxone [2193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotetan [2187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceftobiprole [2691333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephalosporins [M0003827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefiderocol [2265702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefixime anhydrous [1546021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefaclor anhydrous [1450910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefoxitin [2189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephalosporin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cefotaxime [2186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cephamycin Antibacterial [EPC]</name>
  <code>C635369</code>  <id>635369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cephamycin Antibacterial</to_name>
    <to_code>T9928</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175931</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephamycin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephamycin Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Cephamycin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephamycin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephamycin Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephamycin Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing cephamycin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cephamycin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephamycins [M0003831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arterial Vasoconstriction [PE]</name>
  <code>C27068</code>  <id>27069</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction</to_name>
    <to_code>T9966</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008351</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cerebral Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan succinate [322249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergot preparation [91405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arterial Vasodilation [PE]</name>
  <code>C27070</code>  <id>27071</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasodilation</to_name>
    <to_code>T9967</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008352</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cerebral Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arteriolar Vasoconstriction [PE]</name>
  <code>C634779</code>  <id>634779</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arteriolar Vasoconstriction</to_name>
    <to_code>T9968</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175396</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cerebral Arteriolar Vasodilation [PE]</name>
  <code>C634763</code>  <id>634763</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cerebral Arteriolar Vasodilation</to_name>
    <to_code>T9969</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175380</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cervical Dilation Alteration [PE]</name>
  <code>C27072</code>  <id>27073</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Dilation Alteration</to_name>
    <to_code>T10052</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008353</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cervical Dilation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cervical Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cervical Dilation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cervical Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cervical Function Alteration [PE]</name>
  <code>C27074</code>  <id>27075</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Function Alteration</to_name>
    <to_code>T10053</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008354</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cervical Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cervical Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Dilation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cervical Smooth Muscle Tone Alteration [PE]</name>
  <code>C27076</code>  <id>27077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Smooth Muscle Tone Alteration</to_name>
    <to_code>T10060</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008355</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cervical Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cervical Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cervical Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cervical Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chelating Activity [MoA]</name>
  <code>C352</code>  <id>353</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity</to_name>
    <to_code>T10162</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelator</to_name>
    <to_code>T10161</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000087</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiosulfate [9876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium monohydrate [2001422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium anhydrous [1371967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium edetate [105745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline [110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane hydrochloride [1294534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium [1368950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline sulfate [42836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir [2197842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate [36726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prussian blue insoluble [24902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane [42736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate anhydrous [1807514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium [1903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chemical Structure [APC]</name>
  <code>C654126</code>  <id>654126</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemical Structure</to_name>
    <to_code>T58528</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193894</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Barbiturate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cephalosporin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diarylquinoline Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allylamine Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenocorticotropic Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penicillin-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoketone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Low Molecular Weight Heparin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Omega-3 Fatty Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin-class Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alpha [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actinomycin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Echinocandin Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Glycoside [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphetamine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkaloid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergotamine Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylxanthine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Serum Albumin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lincosamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tricyclic Antidepressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitroimidazole Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyridone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Psoralen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aluminum Complex [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrethroid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parenteral Iron Replacement [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medium-chain Triglyceride [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biguanide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ester Local Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thalidomide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxaborole Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenothiazine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Porphyrin Precursor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Growth Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazolidinedione [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicol-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrofuran Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxazolidinone Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid-based Polyene Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Hydroxy Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinic Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ketolide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon beta [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bismuth [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrate Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>C-type Natriuretic Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bisphosphonate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reducing and Complexing Thiol [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Thyroxine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminosalicylate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leptin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antisense Oligonucleotide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Retinoid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzylamine Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Stimulating Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penem Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymyxin-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pleuromutilin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amide Local Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzothiazole [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monobactam Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-based Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluoroquinolone Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Triiodothyronine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonylurea [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unfractionated Heparin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amino Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemical Structure [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Azole Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chemokine Co-receptor 5 Antagonists [MoA]</name>
  <code>C634827</code>  <id>634827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Antagonists</to_name>
    <to_code>T10324</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonists</to_name>
    <to_code>T10322</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonist</to_name>
    <to_code>T10323</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175445</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maraviroc [620216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chemokine Co-receptor 5 Interactions [MoA]</name>
  <code>C634826</code>  <id>634826</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Interactions</to_name>
    <to_code>T10326</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Interactions</to_name>
    <to_code>T10325</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175444</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemokine Co-receptor 5 Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chemokine Receptor Type 4 Interaction [EPC]</name>
  <code>C654088</code>  <id>654088</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interaction</to_name>
    <to_code>T58481</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR4 Interaction</to_name>
    <to_code>T58482</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193866</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemokine Receptor Type 4 Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mogamulizumab [2054068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemokine Receptor Type 4 Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chemokine Receptor Type 4 Interactions [MoA]</name>
  <code>C654087</code>  <id>654087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interactions</to_name>
    <to_code>T58480</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193867</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chemokine Receptor Type 4 Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CXC Chemokine Receptor 4 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide [2664896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide acetate [2664897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activation Potentiators [MoA]</name>
  <code>C643860</code>  <id>643860</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators</to_name>
    <to_code>T10475</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184145</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanzacaftor [2701431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutivacaftor [2701430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activator [EPC]</name>
  <code>C634966</code>  <id>634966</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activator</to_name>
    <to_code>T10476</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175573</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Activator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lubiprostone [623033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Activators [MoA]</name>
  <code>C634836</code>  <id>634836</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activator</to_name>
    <to_code>T10477</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators</to_name>
    <to_code>T10478</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175456</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lubiprostone [623033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Agonists [MoA]</name>
  <code>C334</code>  <id>335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Agonists</to_name>
    <to_code>T10479</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000078</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Antagonists [MoA]</name>
  <code>C626</code>  <id>627</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Antagonists</to_name>
    <to_code>T10481</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Blockers</to_name>
    <to_code>T10480</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000224</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Chloride Channel Interactions [MoA]</name>
  <code>C490</code>  <id>491</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Interactions</to_name>
    <to_code>T10482</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000156</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Chloride Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxidectin [1047072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholagogue Activity [PE]</name>
  <code>C27078</code>  <id>27079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholagogue Activity</to_name>
    <to_code>T10627</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008356</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholagogue Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholecystokinin Analog [EPC]</name>
  <code>C635217</code>  <id>635217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin Analog</to_name>
    <to_code>T10650</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCK Analog</to_name>
    <to_code>T10649</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin (CCK) Analog</to_name>
    <to_code>T10646</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin (CCK) Analogue</to_name>
    <to_code>T10647</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CCK Analogue</to_name>
    <to_code>T10648</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175798</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholecystokinin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sincalide [9800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholecystokinin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholecystokinin [M0004235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cholecystokinin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing cholecystokinin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Choleretic Activity [PE]</name>
  <code>C27080</code>  <id>27081</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Choleretic Activity</to_name>
    <to_code>T10671</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008357</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Absorption Alteration [PE]</name>
  <code>C27082</code>  <id>27083</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Absorption Alteration</to_name>
    <to_code>T10728</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008358</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Elimination Alteration [PE]</name>
  <code>C27084</code>  <id>27085</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Elimination Alteration</to_name>
    <to_code>T10729</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008359</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Elimination Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Elimination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Elimination Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Elimination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Metabolism Alteration [PE]</name>
  <code>C27086</code>  <id>27087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Metabolism Alteration</to_name>
    <to_code>T10738</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008360</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Elimination Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene [72143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene hydrochloride [166551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Secretion Alteration [PE]</name>
  <code>C31830</code>  <id>31831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Secretion Alteration</to_name>
    <to_code>T10741</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010236</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Synthesis Alteration [PE]</name>
  <code>C27088</code>  <id>27089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Synthesis Alteration</to_name>
    <to_code>T10753</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008361</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholesterol Synthesis Inhibitors [MoA]</name>
  <code>C635357</code>  <id>635357</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Synthesis Inhibitors</to_name>
    <to_code>T10754</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175919</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholesterol Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursadiol [2045735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Agonists [MoA]</name>
  <code>C634752</code>  <id>634752</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists</to_name>
    <to_code>T10803</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175369</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine [155080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamoylcholine [1546387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline [591622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine chloride [40165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride anhydrous [2698548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Antagonists [MoA]</name>
  <code>C634753</code>  <id>634753</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists</to_name>
    <to_code>T10804</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175370</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium [1487514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium [1546438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropicamide [10869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium bromide [1487512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital sodium [235404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethopropazine hydrochloride [6541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate [107770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>profenamine [4134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate bromide [52560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium tosylate [2052857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revefenacin [2102775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium [1303098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Ganglionic Nicotinic Agonists [MoA]</name>
  <code>C635045</code>  <id>635045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Agonists</to_name>
    <to_code>T10805</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175652</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</name>
  <code>C635046</code>  <id>635046</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Antagonists</to_name>
    <to_code>T10806</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175653</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Interactions [MoA]</name>
  <code>C634751</code>  <id>634751</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Interactions</to_name>
    <to_code>T10807</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175368</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Agonist [EPC]</name>
  <code>C635259</code>  <id>635259</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscarinic Agonist</to_name>
    <to_code>T10808</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonist</to_name>
    <to_code>T10809</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175840</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bethanechol [19257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanomeline [2694828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with acetylcholine receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing acetylcholine receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Agonists [MoA]</name>
  <code>C386</code>  <id>387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists</to_name>
    <to_code>T10810</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000104</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline [2694828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine hydrobromide [235428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine [2721766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDART</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine hydrochloride [2721767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride [260036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbachol [1999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride anhydrous [2698548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline tartrate [2694829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Antagonist [EPC]</name>
  <code>C635106</code>  <id>635106</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscarinic Antagonist</to_name>
    <to_code>T10813</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscarinic Anticholinesterase Antagonist</to_name>
    <to_code>T10812</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonist</to_name>
    <to_code>T10814</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscarinic Anticholinergic Antagonist</to_name>
    <to_code>T10811</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175700</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing muscarinic receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homatropine [27084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trospium [236778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solifenacin [322167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with muscarinic receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darifenacin [136198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atropine [1223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycopyrronium [1546438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxybutynin [32675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolterodine [119565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavoxate [4440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Antagonists [MoA]</name>
  <code>C428</code>  <id>429</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists</to_name>
    <to_code>T10815</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000125</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropicamide [10869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium bromide [1487512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide monohydrate [1298831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin [136198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium bromide [2689321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium [1487514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide mono [1552007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine fumarate [797196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revefenacin [2102775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin hydrobromide [485417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin succinate [476588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium chloride [38891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine [38876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate hydrochloride [106029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium [236778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine hydrochloride [236190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine hydrochloride [235775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium [1546438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate [59064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin [322167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium [2689322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine [119565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium [1303098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate hydrochloride [102170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine tartrate [221174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate [3001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine [797195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Muscarinic Receptor Interactions [MoA]</name>
  <code>C372</code>  <id>373</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Receptor Interactions</to_name>
    <to_code>T10816</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000097</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Muscarinic Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</name>
  <code>C635123</code>  <id>635123</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists</to_name>
    <to_code>T10817</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175717</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride [3565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suxamethonium bromide [121039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine iodide [262295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride dihydrate [2397714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine [10154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</name>
  <code>C635124</code>  <id>635124</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists</to_name>
    <to_code>T10818</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175718</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium [23651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium [319864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium besylate [136561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium cation [1546399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium [30077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium [1218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium bromide [228530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine chloride [82115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium [7883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium bromide [11153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallamine triethiodide [4639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium chloride [52796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium bromide [7884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine [10917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium besylate [1219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium bromide [66983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium [262100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium [33742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium bromide [32521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium [71535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium chloride [49275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Agonist [EPC]</name>
  <code>C635112</code>  <id>635112</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonist</to_name>
    <to_code>T10822</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotine Agonist</to_name>
    <to_code>T10820</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinic Cholinergic Agonist</to_name>
    <to_code>T10819</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinic Agonist</to_name>
    <to_code>T10821</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175706</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with nicotinic receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotine [7407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing nicotinic receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Agonists [MoA]</name>
  <code>C464</code>  <id>465</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonists</to_name>
    <to_code>T10823</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000143</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine iodide [203206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Antagonists [MoA]</name>
  <code>C632</code>  <id>633</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists</to_name>
    <to_code>T10824</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000227</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Ganglionic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Nicotinic Receptor Interactions [MoA]</name>
  <code>C576</code>  <id>577</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Receptor Interactions</to_name>
    <to_code>T10825</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000199</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Nicotinic Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Receptor Agonist [EPC]</name>
  <code>C635322</code>  <id>635322</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Receptor Agonist</to_name>
    <to_code>T10827</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonist</to_name>
    <to_code>T10826</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175884</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varenicline [591622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with acetylcholine receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pilocarpine [8328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcholine [194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacholine [155080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbamoylcholine [1546387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aceclidine [2721766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing acetylcholine receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cevimeline [44281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinergic Receptor Inhibitor [EPC]</name>
  <code>C635370</code>  <id>635370</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Receptor Inhibitor</to_name>
    <to_code>T10828</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175932</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with acetylcholine receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinergic Receptor Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing acetylcholine receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Inhibitor [EPC]</name>
  <code>C635129</code>  <id>635129</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitor</to_name>
    <to_code>T10830</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholinesterase Inhibitor</to_name>
    <to_code>T10829</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175723</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edrophonium cation [1546421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neostigmine [7315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ecothiopate [89778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galantamine [4637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with acetylcholinesterase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing acetylcholinesterase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malathion [6606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridostigmine [9000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donepezil [135447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rivastigmine [183379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Inhibitors [MoA]</name>
  <code>C532</code>  <id>533</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors</to_name>
    <to_code>T10831</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000177</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malathion [6606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>huperzine A [2267703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine [10318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil hydrochloride [236559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium [623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine [2690627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine hydrochloride [235972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine [183379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine gluconate [2690626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine tartrate [994808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil [135447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium chloride [624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurophate [6027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Reactivator [EPC]</name>
  <code>C635148</code>  <id>635148</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivator</to_name>
    <to_code>T10832</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175742</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Reactivator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing cholinesterase reactivator (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Reactivator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with cholinesterase reactivator mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Reactivator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cholinesterase Reactivator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralidoxime [34345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cholinesterase Reactivators [MoA]</name>
  <code>C338</code>  <id>339</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators</to_name>
    <to_code>T10833</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000080</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime cation [1546365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Classical Complement Pathway Inhibitor [EPC]</name>
  <code>C654214</code>  <id>654214</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Inhibitor</to_name>
    <to_code>T58691</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitor</to_name>
    <to_code>T58690</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193991</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sutimlimab [2591404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Classical Complement Pathway Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Classical Complement Pathway Inhibitors [MoA]</name>
  <code>C654215</code>  <id>654215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitors</to_name>
    <to_code>T58706</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Inhibitors</to_name>
    <to_code>T58707</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193990</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Classical Complement Pathway Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Classical Complement Pathway Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab [2591404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Claudin 18.2-directed Antibody Interactions [MoA]</name>
  <code>C654352</code>  <id>654352</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin18.2-directed Cytolytic Antibody Interactions</to_name>
    <to_code>T59023</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CLDN18.2-directed Cytolytic Antibody Interactions</to_name>
    <to_code>T59025</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Antibody Interactions</to_name>
    <to_code>T59021</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CLDN 18.2-directed Cytolytic Antibody Interactions</to_name>
    <to_code>T59024</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin-18.2-directed Cytolytic Antibody Interactions</to_name>
    <to_code>T59022</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194106</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab [2695869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Claudin 18.2-directed Cytolytic Antibody [EPC]</name>
  <code>C654353</code>  <id>654353</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin-18.2-directed Cytolytic Antibody</to_name>
    <to_code>T59027</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CLDN18.2-directed Cytolytic Antibody</to_name>
    <to_code>T59030</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin18.2-directed Cytolytic Antibody</to_name>
    <to_code>T59028</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Cytolytic Antibody</to_name>
    <to_code>T59026</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CLDN 18.2-directed Cytolytic Antibody</to_name>
    <to_code>T59029</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194107</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolbetuximab [2695869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Clearance [PK]</name>
  <code>C304</code>  <id>305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Clearance</to_name>
    <to_code>T11197</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000063</value>
  </property>
 </concept>
 <concept root="true" >
  <namespace>MED-RT</namespace>
  <name>Clinical Kinetics [PK]</name>
  <code>C180</code>  <id>181</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Clinical Kinetics</to_name>
    <to_code>T11226</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000003</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinical Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Distribution [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinical Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorption [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinical Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Elimination [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinical Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinetics [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Clinically Unimportant Route of Excretion [PK]</name>
  <code>C272</code>  <id>273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Clinically Unimportant Route of Excretion</to_name>
    <to_code>T11227</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000047</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nail Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Saliva Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sweat Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hair Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tear Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Clinically Unimportant Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Umbilical Lint Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Co-methyltransferase [PK]</name>
  <code>C258</code>  <id>259</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Co-methyltransferase</to_name>
    <to_code>T11360</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000040</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coagulation Activity Alteration [PE]</name>
  <code>C635431</code>  <id>635431</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Activity Alteration</to_name>
    <to_code>T11362</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175977</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coagulation Factor Activity Alteration [PE]</name>
  <code>C27090</code>  <id>27091</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Activity Alteration</to_name>
    <to_code>T11363</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008362</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Factor Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Factor Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coagulation Factor Alteration [PE]</name>
  <code>C27092</code>  <id>27093</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Alteration</to_name>
    <to_code>T11364</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008363</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Factor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Factor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Concentration Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab [2717169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab-gxii [2717168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coagulation Factor Concentration Alteration [PE]</name>
  <code>C27094</code>  <id>27095</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Concentration Alteration</to_name>
    <to_code>T11365</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008364</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Factor Concentration Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coagulation Factor Concentration Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Collagen Formation Alteration [PE]</name>
  <code>C27096</code>  <id>27097</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Alteration</to_name>
    <to_code>T11521</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008365</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen Formation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen Formation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Collagen Formation Inhibition [PE]</name>
  <code>C27098</code>  <id>27099</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Inhibition</to_name>
    <to_code>T11522</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008366</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Collagen Formation Promotion [PE]</name>
  <code>C27100</code>  <id>27101</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion</to_name>
    <to_code>T11523</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008367</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec-svdt [2637757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (porcine) [1366974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (shark) [1358172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate A sodium [476847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, bovine [1306129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec [2637758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (bovine) [1299929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, porcine [1306202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate (shark) [1789516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Promotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Collagen-specific Enzyme [EPC]</name>
  <code>C635281</code>  <id>635281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen-specific Enzyme</to_name>
    <to_code>T11560</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175843</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagenases [M0026363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagenase Clostridium histolyticum [898492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Collagenase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing collagenase (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collagen-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>collagenase [58939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Collecting Duct Water Permeability Alteration [PE]</name>
  <code>C27102</code>  <id>27103</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Collecting Duct Water Permeability Alteration</to_name>
    <to_code>T11566</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008368</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collecting Duct Water Permeability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Collecting Duct Water Permeability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</name>
  <code>C300426</code>  <id>300426</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors</to_name>
    <to_code>T11590</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020036</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab [2691526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab-csfr [2691528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</name>
  <code>C654331</code>  <id>654331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CSF-1R Blocker</to_name>
    <to_code>T58959</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor-1 Receptor Blocker</to_name>
    <to_code>T58957</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor 1 Receptor Blocker</to_name>
    <to_code>T58958</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CSF1R Blocker</to_name>
    <to_code>T58960</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194108</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axatilimab [2691526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Compartments [PK]</name>
  <code>C296</code>  <id>297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Compartments</to_name>
    <to_code>T11635</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000059</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Compartments [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>3-Compartment [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Compartments [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>1-Compartment [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Compartments [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>2-Compartment [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Competitive Cholinergic Nicotinic Antagonists [MoA]</name>
  <code>C635109</code>  <id>635109</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists</to_name>
    <to_code>T11642</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175703</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium chloride [49275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium [71535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium bromide [32521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium [33742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium [262100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium bromide [66983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium besylate [1219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine [10917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium bromide [7884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium chloride [52796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium bromide [11153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallamine triethiodide [4639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium [7883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine chloride [82115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium [1218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium [30077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium bromide [228530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium cation [1546399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium [319864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium [23651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium besylate [136561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Competitive NMDA Receptor Antagonists [MoA]</name>
  <code>C641383</code>  <id>641383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive N-methyl-D-aspartate Receptor Antagonists</to_name>
    <to_code>T11643</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive NMDA Receptor Antagonists</to_name>
    <to_code>T11644</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181817</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Competitive Opioid Antagonists [MoA]</name>
  <code>C635092</code>  <id>635092</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists</to_name>
    <to_code>T11645</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175686</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan anhydrous [1516803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan [480639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement 1 Inactivators [MoA]</name>
  <code>C350</code>  <id>351</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 1 Inactivators</to_name>
    <to_code>T11646</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000086</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab-jome [2591415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 1 Inactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab [2591404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 1 Inactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement 5 Inactivators [MoA]</name>
  <code>C634823</code>  <id>634823</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5 Inactivators</to_name>
    <to_code>T11647</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175441</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacopan [2572100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5 Inactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement 5a Receptor Antagonist [EPC]</name>
  <code>C654200</code>  <id>654200</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>C5aR Antagonist</to_name>
    <to_code>T58666</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonist</to_name>
    <to_code>T58665</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193973</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement 5a Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement 5a Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avacopan [2572100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement 5a Receptor Antagonists [MoA]</name>
  <code>C654199</code>  <id>654199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonists</to_name>
    <to_code>T58663</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>C5aR Antagonists</to_name>
    <to_code>T58664</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193974</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacopan [2572100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement 5a Receptor Interactions [MoA]</name>
  <code>C654198</code>  <id>654198</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Interactions</to_name>
    <to_code>T58661</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>C5aR Interactions</to_name>
    <to_code>T58662</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193975</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement 5a Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement C5 Inhibitor [EPC]</name>
  <code>C654333</code>  <id>654333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitor</to_name>
    <to_code>T58962</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194109</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement C5 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crovalimab [2686619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement C5 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement C5 Inhibitors [MoA]</name>
  <code>C654332</code>  <id>654332</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitors</to_name>
    <to_code>T58961</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194110</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab [2686619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement C5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Factor B Inhibitor [EPC]</name>
  <code>C654345</code>  <id>654345</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitor</to_name>
    <to_code>T58994</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194111</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Factor B Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iptacopan [2671061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Factor B Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Factor B Inhibitors [MoA]</name>
  <code>C654344</code>  <id>654344</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitors</to_name>
    <to_code>T58993</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194112</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan [2671061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Factor D Inhibitor [EPC]</name>
  <code>C654323</code>  <id>654323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitor</to_name>
    <to_code>T58942</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194113</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Factor D Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danicopan [2678952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Factor D Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with complement inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Factor D Inhibitors [MoA]</name>
  <code>C654322</code>  <id>654322</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitors</to_name>
    <to_code>T58941</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194114</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Inactivators [MoA]</name>
  <code>C562</code>  <id>563</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inactivators</to_name>
    <to_code>T11845</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000192</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inactivators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5 Inactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inactivators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 1 Inactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inactivators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Inhibitor [EPC]</name>
  <code>C634968</code>  <id>634968</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitor</to_name>
    <to_code>T11846</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175575</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zilucoplan [2672489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pozelimab [2663938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eculizumab [591781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ravulizumab [2107301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with complement inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Factor D Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegcetacoplan [2557372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avacincaptad pegol [2645108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Complement Inhibitors [MoA]</name>
  <code>C635428</code>  <id>635428</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors</to_name>
    <to_code>T11847</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175974</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Classical Complement Pathway Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Complement Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alternative Complement Pathway Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan [2672489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab-cwvz [2107316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab [591781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab [2107301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan hydrochloride [2671062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab-akkz [2686620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol sodium [2645107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab [2663938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan [2671061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab-bbfg [2663939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aeeb [2706347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab-jome [2591415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aagh [2706334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab [2686619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab [2591404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol [2645108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan sodium [2672492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegcetacoplan [2557372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Conduction System Depolarization [PE]</name>
  <code>C27104</code>  <id>27105</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization</to_name>
    <to_code>T11883</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008369</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conduction System Depolarization [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lengthen Conduction System Depolarization Time [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conduction System Depolarization [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shorten Conduction System Depolarization Time [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Conduction System Repolarization [PE]</name>
  <code>C27106</code>  <id>27107</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Conduction System Repolarization</to_name>
    <to_code>T11884</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008370</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conduction System Repolarization [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lengthen Conduction System Repolarization Time [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conduction System Repolarization [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shorten Conduction System Repolarization Time [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conduction System Repolarization [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Delay Conduction System Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arterial Vasoconstriction [PE]</name>
  <code>C27108</code>  <id>27109</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction</to_name>
    <to_code>T11927</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008371</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conjunctival Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arterial Vasodilation [PE]</name>
  <code>C27110</code>  <id>27111</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasodilation</to_name>
    <to_code>T11928</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008372</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Conjunctival Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arteriolar Vasoconstriction [PE]</name>
  <code>C634783</code>  <id>634783</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arteriolar Vasoconstriction</to_name>
    <to_code>T11929</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175400</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Conjunctival Arteriolar Vasodilation [PE]</name>
  <code>C634767</code>  <id>634767</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arteriolar Vasodilation</to_name>
    <to_code>T11930</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175384</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Alteration [PE]</name>
  <code>C27112</code>  <id>27113</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Alteration</to_name>
    <to_code>T11949</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008373</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Connective Tissue Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen Formation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Connective Tissue Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Permeability Alteration Decrease [PE]</name>
  <code>C300443</code>  <id>300443</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration Decrease</to_name>
    <to_code>T11958</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020053</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Permeability Alteration Increase [PE]</name>
  <code>C300442</code>  <id>300442</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration Increase</to_name>
    <to_code>T11959</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020052</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Connective Tissue Permeability Alteration [PE]</name>
  <code>C300441</code>  <id>300441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration</to_name>
    <to_code>T11960</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020051</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Connective Tissue Permeability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Connective Tissue Permeability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Permeability Alteration Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Contrast Agent for Ultrasound Imaging [EPC]</name>
  <code>C635302</code>  <id>635302</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Contrast Agent for Ultrasound Imaging</to_name>
    <to_code>T11992</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175864</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Ultrasound contrast media (product) [356442006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfur hexafluoride [1599276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perflutren [283753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin microspheres, human [1370439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perflexane [1540828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Contrast Agent for Ultrasound Imaging [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Contrast media (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Contrast Agent for Ultrasound Imaging [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Copper Absorption Inhibitor [EPC]</name>
  <code>C634923</code>  <id>634923</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Absorption Inhibitor</to_name>
    <to_code>T12003</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175530</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper Absorption Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc cation [1546264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper Absorption Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Copper Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Copper Chelating Activity [MoA]</name>
  <code>C300465</code>  <id>300465</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelator</to_name>
    <to_code>T12004</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelating Activity</to_name>
    <to_code>T12005</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020075</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine [10798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Copper Chelator [EPC]</name>
  <code>C654237</code>  <id>654237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelator</to_name>
    <to_code>T12004</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194014</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trientine [10798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chelating agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with chelating agent mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Copper-containing Intrauterine Device [EPC]</name>
  <code>C635250</code>  <id>635250</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper-containing Intrauterine Device (IUD)</to_name>
    <to_code>T12013</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper-containing Intrauterine Device</to_name>
    <to_code>T12014</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper-containing IUD</to_name>
    <to_code>T12012</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175831</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper-containing Intrauterine Device [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper [2837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper-containing Intrauterine Device [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Copper [M0005152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper-containing Intrauterine Device [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Copper-containing intrauterine device (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Copper-containing Intrauterine Device [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Copper (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper-containing Intrauterine Device [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coronary Arterial Vasoconstriction [PE]</name>
  <code>C27114</code>  <id>27115</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasoconstriction</to_name>
    <to_code>T12107</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008374</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coronary Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coronary Arterial Vasodilation [PE]</name>
  <code>C27116</code>  <id>27117</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation</to_name>
    <to_code>T12108</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008375</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Coronary Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barnidipine hydrochloride [283819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacidipine [28382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrendipine [7441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline [4327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson anhydrous [1546015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline hydrochloride [236767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coronary Arteriolar Vasoconstriction [PE]</name>
  <code>C634780</code>  <id>634780</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arteriolar Vasoconstriction</to_name>
    <to_code>T12109</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175397</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Coronary Arteriolar Vasodilation [PE]</name>
  <code>C634764</code>  <id>634764</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Coronary Arteriolar Vasodilation</to_name>
    <to_code>T12110</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175381</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Corticosteroid Hormone Receptor Agonists [MoA]</name>
  <code>C634830</code>  <id>634830</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists</to_name>
    <to_code>T12134</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175450</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone acetonide [103447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone [108091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Corticosteroid [EPC]</name>
  <code>C634969</code>  <id>634969</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid</to_name>
    <to_code>T12135</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175576</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisone [8640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone acetonide [10761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone [3264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone [10759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cortisone [2878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone [5492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clocortolone [21249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clobetasol [2590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deflazacort [22396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medrysone [29439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylprednisolone [6902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loteprednol [237027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocinonide [4462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflorasone [91311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>budesonide [19831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alclometasone [108088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betamethasone [1514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorometholone [4491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desoximetasone [3255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desonide [3254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluticasone [41126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurandrenolide [4500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halcinonide [5084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vamorolone [2669799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing corticosteroid and/or corticosteroid derivative (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halobetasol [41208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amcinonide [17652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunisolide anhydrous [1546428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beclomethasone [1347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Corticosteroid and/or corticosteroid derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone [8638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mometasone [108118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticosteroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocinolone acetonide [4461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Corticotropin Releasing Hormone Alteration [PE]</name>
  <code>C27016</code>  <id>27017</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin Releasing Hormone Alteration</to_name>
    <to_code>T12139</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRH Alteration</to_name>
    <to_code>T12138</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008325</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticotropin Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CRH Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticotropin Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CRH Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</name>
  <code>C654369</code>  <id>654369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRF 1 Receptor Antagonist</to_name>
    <to_code>T59053</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist</to_name>
    <to_code>T59051</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRF Type 1 Receptor Antagonist</to_name>
    <to_code>T59054</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin Releasing Factor Type 1 Receptor Antagonist</to_name>
    <to_code>T59052</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRF1 Receptor Antagonist</to_name>
    <to_code>T59055</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194151</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crinecerfont [2701386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with corticotropin releasing hormone antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hormone receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</name>
  <code>C654368</code>  <id>654368</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRF Type 1 Receptor Antagonists</to_name>
    <to_code>T59049</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRF1 Receptor Antagonists</to_name>
    <to_code>T59050</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CRF 1 Receptor Antagonists</to_name>
    <to_code>T59048</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists</to_name>
    <to_code>T59046</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin Releasing Factor Type 1 Receptor Antagonists</to_name>
    <to_code>T59047</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194152</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cortisol Synthesis Inhibitor [EPC]</name>
  <code>C654157</code>  <id>654157</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cortisol Synthesis Inhibitor</to_name>
    <to_code>T58586</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193935</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cortisol Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osilodrostat [2286252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cortisol Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoketoconazole [2588846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cortisol Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cortisol Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with steroid 11-beta-monooxygenase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cortisol Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Current Non-smoker [EXT]</name>
  <code>C31974</code>  <id>31975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Current Non-smoker</to_name>
    <to_code>T12416</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010308</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_with</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Current Non-smoker [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_with</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Current Non-smoker [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arterial Vasoconstriction [PE]</name>
  <code>C27118</code>  <id>27119</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction</to_name>
    <to_code>T12420</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008376</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cutaneous Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergot preparation [91405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arterial Vasodilation [PE]</name>
  <code>C27120</code>  <id>27121</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation</to_name>
    <to_code>T12421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008377</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cutaneous Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arteriolar Vasoconstriction [PE]</name>
  <code>C634781</code>  <id>634781</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arteriolar Vasoconstriction</to_name>
    <to_code>T12422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175398</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cutaneous Arteriolar Vasodilation [PE]</name>
  <code>C634765</code>  <id>634765</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cutaneous Arteriolar Vasodilation</to_name>
    <to_code>T12423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175382</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclic Pyranopterin Monophosphate [EPC]</name>
  <code>C654136</code>  <id>654136</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>cPMP</to_name>
    <to_code>T58543</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate</to_name>
    <to_code>T58542</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin phosphoric acid</to_name>
    <to_code>T58547</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin phosphate</to_name>
    <to_code>T58546</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin monophosphoric acid</to_name>
    <to_code>T58545</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin monophoshic acid</to_name>
    <to_code>T58544</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193919</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclic Pyranopterin Monophosphate [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosdenopterin [2531288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclic Pyranopterin Monophosphate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pterins [M0018073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclic Pyranopterin Monophosphate [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing pteridine (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Pterins (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclic Pyranopterin Monophosphate [EXT]</name>
  <code>C654137</code>  <id>654137</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin monophoshic acid</to_name>
    <to_code>T58544</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin monophosphoric acid</to_name>
    <to_code>T58545</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin phosphate</to_name>
    <to_code>T58546</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic pyranopterin phosphoric acid</to_name>
    <to_code>T58547</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate</to_name>
    <to_code>T58542</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>cPMP</to_name>
    <to_code>T58543</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193920</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosdenopterin [2531288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclin-dependent Kinase 4 Inhibitors [MoA]</name>
  <code>C654141</code>  <id>654141</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Division Protein Kinase 4 Inhibitors</to_name>
    <to_code>T58553</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CDK 4 Inhibitors</to_name>
    <to_code>T58552</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name> Cyclin-dependent Kinase 4 Inhibitors</to_name>
    <to_code>T58551</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193921</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclin-dependent Kinase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclin-dependent Kinase 6 Inhibitors [MoA]</name>
  <code>C654142</code>  <id>654142</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CDK 6 Inhibitors</to_name>
    <to_code>T58555</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Division Protein Kinase 6 Inhibitors</to_name>
    <to_code>T58556</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name> Cyclin-dependent Kinase 6 Inhibitors</to_name>
    <to_code>T58554</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193922</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclin-dependent Kinase 6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase 2 Inhibitors [MoA]</name>
  <code>C26942</code>  <id>26943</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase II Inhibitors</to_name>
    <to_code>T12818</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>COX-2 Inhibitors</to_name>
    <to_code>T12817</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase 2 Inhibitors</to_name>
    <to_code>T12819</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008288</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valdecoxib [278567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rofecoxib [232158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase Inhibitor [EPC]</name>
  <code>C635377</code>  <id>635377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitor</to_name>
    <to_code>T12827</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175939</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketorolac [35827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclooxygenase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Non-steroidal anti-inflammatory agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cyclooxygenase Inhibitors [MoA]</name>
  <code>C498</code>  <id>499</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors</to_name>
    <to_code>T12828</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000160</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cyclooxygenase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carprofen [20343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nepafenac [298665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suprofen [10255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin potassium [660767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac [35827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meloxicam [41493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trolamine salicylate [38866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cysteine Proteinase Inhibitors [MoA]</name>
  <code>C380</code>  <id>381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cysteine Proteinase Inhibitors</to_name>
    <to_code>T12967</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000101</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</name>
  <code>C643861</code>  <id>643861</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator</to_name>
    <to_code>T12990</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CFTR Potentiator</to_name>
    <to_code>T12989</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator</to_name>
    <to_code>T12988</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184146</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing cystic fibrosis transmembrane conductance regulator potentiator (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deutivacaftor [2701430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activation Potentiators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivacaftor [1243041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Respiratory system agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cystine Depleting Agent [EPC]</name>
  <code>C646937</code>  <id>646937</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Depleting Agent</to_name>
    <to_code>T12997</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187051</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystine Depleting Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cystine Depleting Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cysteamine [3022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cystine Disulfide Reduction [MoA]</name>
  <code>C634942</code>  <id>634942</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction</to_name>
    <to_code>T12998</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175549</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiopronin [6765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine bitartrate [81990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine hydrochloride [1426886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine [3022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytidine Deaminase Inhibitor [EPC]</name>
  <code>C654212</code>  <id>654212</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Deaminase Inhibitor</to_name>
    <to_code>T58700</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Analog Deaminase Inhibitor</to_name>
    <to_code>T58701</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193992</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytidine Deaminase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Deaminase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytidine Deaminase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with cytidine deaminase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytidine Deaminase Inhibitors [MoA]</name>
  <code>C654213</code>  <id>654213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Analog Deaminase Inhibitors</to_name>
    <to_code>T58703</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Deaminase Inhibitors</to_name>
    <to_code>T58702</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193993</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 11A1 Inhibitors [MoA]</name>
  <code>C654205</code>  <id>654205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11A1 Inhibitors</to_name>
    <to_code>T58673</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 11A1 Inhibitors</to_name>
    <to_code>T58675</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP11A1 Inhibitors</to_name>
    <to_code>T58674</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193984</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 11B1 Inhibitors [MoA]</name>
  <code>C654156</code>  <id>654156</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11B1 Inhibitors</to_name>
    <to_code>T58583</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP11B1 Inhibitors</to_name>
    <to_code>T58584</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 11B1 Inhibitors</to_name>
    <to_code>T58585</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193936</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 17A1 Inhibitor [EPC]</name>
  <code>C642214</code>  <id>642214</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitor</to_name>
    <to_code>T13208</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 17A1 Inhibitor</to_name>
    <to_code>T13206</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP17A1 Inhibitor</to_name>
    <to_code>T13205</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP17 Inhibitor</to_name>
    <to_code>T13207</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182633</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abiraterone [1100072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing cytochrome P450 17A1 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with cytochrome P450 17A1 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 17A1 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 17A1 Inhibitors [MoA]</name>
  <code>C642213</code>  <id>642213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 17A1 Inhibitors</to_name>
    <to_code>T13210</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP17A1 Inhibitors</to_name>
    <to_code>T13209</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitors</to_name>
    <to_code>T13211</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182632</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone acetate [1100071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone [1100072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A Inducers [MoA]</name>
  <code>C651689</code>  <id>651689</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A Inducers</to_name>
    <to_code>T13213</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 1A Inducers</to_name>
    <to_code>T13212</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191624</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 1A Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A1 Inhibitors [MoA]</name>
  <code>C654189</code>  <id>654189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A1 Inhibitors</to_name>
    <to_code>T58646</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 1A1 Inhibitors</to_name>
    <to_code>T58648</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP1A1 Inhibitors</to_name>
    <to_code>T58647</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193954</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A2 Inducers [MoA]</name>
  <code>C651272</code>  <id>651272</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers</to_name>
    <to_code>T13215</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 1A2 Inducers</to_name>
    <to_code>T13214</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191266</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 1A2 Inhibitors [MoA]</name>
  <code>C641704</code>  <id>641704</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 1A2 Inhibitors</to_name>
    <to_code>T13216</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors</to_name>
    <to_code>T13217</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182138</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fezolinetant [2637134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2A6 Inhibitors [MoA]</name>
  <code>C654155</code>  <id>654155</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2A6 Inhibitors</to_name>
    <to_code>T58582</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193937</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2A6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2B6 Inducers [MoA]</name>
  <code>C646965</code>  <id>646965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers</to_name>
    <to_code>T13219</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2B6 Inducers</to_name>
    <to_code>T13218</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187064</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemborexant [2272403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2B6 Inhibitors [MoA]</name>
  <code>C641705</code>  <id>641705</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2B6 Inhibitors</to_name>
    <to_code>T13220</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors</to_name>
    <to_code>T13221</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182139</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C19 Inducers [MoA]</name>
  <code>C645451</code>  <id>645451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2C19 Inducers</to_name>
    <to_code>T13222</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers</to_name>
    <to_code>T13223</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185607</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C19 Inhibitors [MoA]</name>
  <code>C641706</code>  <id>641706</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2C19 Inhibitors</to_name>
    <to_code>T13224</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors</to_name>
    <to_code>T13225</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182140</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C8 Inducers [MoA]</name>
  <code>C646964</code>  <id>646964</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers</to_name>
    <to_code>T13227</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2C8 Inducers</to_name>
    <to_code>T13226</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187063</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omaveloxolone [2631931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir sodium monohydrate [1600438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C8 Inhibitors [MoA]</name>
  <code>C646963</code>  <id>646963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2C8 Inhibitors</to_name>
    <to_code>T13228</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors</to_name>
    <to_code>T13229</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187062</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir sodium monohydrate [1600438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel [32968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone [1100072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C9 Inducers [MoA]</name>
  <code>C645336</code>  <id>645336</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers</to_name>
    <to_code>T13231</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2C9 Inducers</to_name>
    <to_code>T13230</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185507</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elvitegravir [1306286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2C9 Inhibitors [MoA]</name>
  <code>C645333</code>  <id>645333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2C9 Inhibitors</to_name>
    <to_code>T13232</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors</to_name>
    <to_code>T13233</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185504</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis [2698312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib phosphate [2716557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutivacaftor [2701430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zafirlukast [114970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2D6 Inducers [MoA]</name>
  <code>C651273</code>  <id>651273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2D6 Inducers</to_name>
    <to_code>T13234</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inducers</to_name>
    <to_code>T13235</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191267</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2D6 Inhibitor [EPC]</name>
  <code>C641701</code>  <id>641701</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitor</to_name>
    <to_code>T13237</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2D6 Inhibitor</to_name>
    <to_code>T13236</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182135</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 2D6 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine [9068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 2D6 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2D6 Inhibitors [MoA]</name>
  <code>C641703</code>  <id>641703</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors</to_name>
    <to_code>T13239</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 2D6 Inhibitors</to_name>
    <to_code>T13238</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182137</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat [1603350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berotralstat [2467540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone [1100072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 2E1 Inducers [MoA]</name>
  <code>C654172</code>  <id>654172</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2E1 Inducers</to_name>
    <to_code>T58614</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193955</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2E1 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A Inducers [MoA]</name>
  <code>C650058</code>  <id>650058</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers</to_name>
    <to_code>T13241</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A Inducers</to_name>
    <to_code>T13240</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190118</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib [2690647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipranavir [190548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir [2380373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir tromethamine [2380374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir heminonahydrate [1600437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir sodium monohydrate [1600438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maraviroc [620216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir sodium [2625652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A Inhibitor [EPC]</name>
  <code>C650975</code>  <id>650975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitor</to_name>
    <to_code>T13243</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A Inhibitor</to_name>
    <to_code>T13242</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191001</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobicistat [1306284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritonavir [85762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A Inhibitors [MoA]</name>
  <code>C650045</code>  <id>650045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors</to_name>
    <to_code>T13245</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A Inhibitors</to_name>
    <to_code>T13244</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190114</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 3A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolvaptan [358257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venetoclax [1747556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maraviroc [620216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone [233698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone hydrochloride [736680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A4 Inducers [MoA]</name>
  <code>C645335</code>  <id>645335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers</to_name>
    <to_code>T13247</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A4 Inducers</to_name>
    <to_code>T13246</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185506</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flibanserin [1665509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belzutifan [2567226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omaveloxolone [2631931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A4 Inhibitors [MoA]</name>
  <code>C641707</code>  <id>641707</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A4 Inhibitors</to_name>
    <to_code>T13248</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors</to_name>
    <to_code>T13249</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182141</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givinostat [2678889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol oxalate [1593586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacopan [2572100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol [1551777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berotralstat [2467540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticagrelor [1116632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline [2694828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir anhydrous [1546024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant [1731071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine hydrochloride [1649479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubrogepant [2268216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finerenone [2562811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofinetide [2632852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant dimeglumine [754763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxelotor [2265678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maribavir [2586068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A5 Inducers [MoA]</name>
  <code>C651274</code>  <id>651274</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A5 Inducers</to_name>
    <to_code>T13250</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inducers</to_name>
    <to_code>T13251</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191268</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 3A5 Inhibitors [MoA]</name>
  <code>C650046</code>  <id>650046</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 3A5 Inhibitors</to_name>
    <to_code>T13252</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors</to_name>
    <to_code>T13253</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190115</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 Inducers [MoA]</name>
  <code>C645334</code>  <id>645334</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 Inducers</to_name>
    <to_code>T13309</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inducers</to_name>
    <to_code>T13310</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185505</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2E1 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochrome P450 Inhibitors [MoA]</name>
  <code>C641702</code>  <id>641702</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors</to_name>
    <to_code>T13312</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CYP450 Inhibitors</to_name>
    <to_code>T13311</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182136</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2B6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2A6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C8 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 11B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2C19 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytochrome P450 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat phosphate [2286253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytochromes [PK]</name>
  <code>C240</code>  <id>241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochromes</to_name>
    <to_code>T13344</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000031</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytokine Receptor Superfamily Interactions [MoA]</name>
  <code>C528</code>  <id>529</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions</to_name>
    <to_code>T13398</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000175</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD123 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Co-receptor 5 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytokine Receptor Superfamily Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metreleptin [1491625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept [2682678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept-csrk [2678931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept-pmln [2682677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytolytic Agent [EPC]</name>
  <code>C651596</code>  <id>651596</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytolytic Agent</to_name>
    <to_code>T13413</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191548</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytolytic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytolytic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxycholic acid [3194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytolytic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</name>
  <code>C654024</code>  <id>654024</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV DNA Terminase Complex Inhibitor</to_name>
    <to_code>T58383</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus DNA Terminase Complex Inhibitor</to_name>
    <to_code>T58384</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193800</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing Cytomegalovirus terminase complex inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with Cytomegalovirus terminase complex inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letermovir [1988648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Terminase Complex Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C634841</code>  <id>634841</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T13421</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T13419</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T13420</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T13422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175461</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cidofovir anhydrous [1546007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valganciclovir [275891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganciclovir [4678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C639782</code>  <id>639782</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T13426</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T13423</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T13425</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T13424</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180290</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</name>
  <code>C654196</code>  <id>654196</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitor</to_name>
    <to_code>T58657</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV pUL97 Kinase Inhibitor</to_name>
    <to_code>T58658</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193976</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maribavir [2586068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</name>
  <code>C654197</code>  <id>654197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitors</to_name>
    <to_code>T58659</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CMV pUL97 Kinase Inhibitors</to_name>
    <to_code>T58660</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193977</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maribavir [2586068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytoprotective Agent [EPC]</name>
  <code>C640362</code>  <id>640362</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytoprotective Agent</to_name>
    <to_code>T13434</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180854</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytoprotective Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexrazoxane [42736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytoprotective Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bleomycin [1622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytoprotective Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-mercaptoethanesulfonic acid [1546354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Gastrointestinal agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytoprotective Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytoskeleton Alteration [PE]</name>
  <code>C27122</code>  <id>27123</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytoskeleton Alteration</to_name>
    <to_code>T13442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008378</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytoskeleton Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytoskeleton Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytoskeleton Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytoskeleton Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Cytotoxin [EPC]</name>
  <code>C654083</code>  <id>654083</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxin</to_name>
    <to_code>T58472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193862</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytotoxin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD25-directed Cytotoxin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytotoxin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Cytotoxic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytotoxin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytotoxins [M0005633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Cytotoxin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tagraxofusp [2109055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>D [Preparations]</name>
  <code>C288630</code>  <id>288630</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>D [Preparations]</to_name>
    <to_code>T13465</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010586</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium (ethoxycarbonyl)phosphonate [1483690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dienestrol [3368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dacarbazine [3098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxyribonucleases [3210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflubenzuron [1665336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxycytidine hydrochloride [2642209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decylamine oxide [1494854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dipteryx odorata seed extract [1307709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donislecel [2642217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipivefrin [23410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2-dichloro-1-(2-chlorophenyl)ethanol [1995245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dronabinol [10402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl isosorbide [1426599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dipalmitoyl-sn-glycero-3-phospho-(1&apos;-rac-glycerol), sodium salt [1599274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicumarol [1598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D-transallethrin [324005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextranomer [22708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ditch stonecroft extract [1869801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docusate calcium [82001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxylamine succinate, (R)- [2622915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicapryl adipate [2566192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium phthalate [2274243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihematoporphyrin ether [23066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium [2461333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demeton-S-methylsulfone [2683415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethoxanate hydrochloride [235424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone acetate [22690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydro-alpha-ergocryptine [91170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>DL-lactic acid [1314409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diltiazem hydrochloride [203211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethoxanate [121069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl isostearate [1858074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dryobalanops aromatica whole extract [2602776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,3&apos;-diindolylmethane [1603521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxycholic acid, monosodium salt [1367220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasiglucagon [2535233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethindene [3449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropylene glycol caprylate [1651692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan hydrochloride [267251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C orange no. 10 [1307045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclofenac potassium [81997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-diamino-5-methylphenoxyethanol [1737336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diltiazem malate [81999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dorzolamide hydrochloride [236065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dyclonine hydrochloride [91188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexfenfluramine hydrochloride [155142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl succinate [2393581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimyristoylphosphatidylcholine [1362902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darifenacin hydrobromide [485417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darunavir hydrate [2637854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dobesilic acid [235935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doconexent [1006469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>d-alpha-tocopheryl acetate [1441649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dictamnine [2685302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflorasone [91311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drospirenone [11636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dianthus superbus flowering top extract [2590640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihexyverine hydrochloride [236210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dipalmitoylphosphatidylcholine, DL- [1926947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroemetine hydrochloride [236465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deflazacort [22396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium ethylene dimyristamide PEG-15 disulfate [1855528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domperidone maleate [236099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipalmitoyl hydroxyproline [1363580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium chloride [1426625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dryopteris filix-mas root extract [1355832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexmethylphenidate [352372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>defibrotide [1311089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydralazine sulfate [235959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline monohydrate [203122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>degarelix [475230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,5-di-tert-pentylhydroquinone [1593448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol monobutyl ether [1552575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyl (6-chloro-2-carbazoyl)methylmalonate [1648699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol triethoxycaprylylsilane tetraethyl silicate crosspolymer (4000000 MW) [1747727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demecarium bromide [22482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone-diene dimethicone crosspolymer [1312387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxybenzoate [1370674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium [1549116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domperidone [3626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.delta.-tocopherol [2109747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexmethylphenidate hydrochloride [353105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenylpyraline [23386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deracoxib [356834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergocornine mesylate [42644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decanoic acid, 1-methylbutyl ester [2693286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenylsiloxy phenyl trimethicone [1312558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>davana oil [1489000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dilinoleic acid/propanediol copolymer [1803670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dydrogesterone [3706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dibromo-3-chloropropane [1367191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dianthus caryophyllus whole extract [2590639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drotrecogin alfa (activated), lyophilized [353106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dendryphiella vinosa allergenic extract [995703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylcarbamazine [3384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dipalmitoylphosphatidylcholine [1926948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dipalmitoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [1424658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibasic calcium phosphate, dihydrate [2632248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denatonium [1546417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 200 [1426664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone acetate anhydrous [2378841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dendrobium moniliforme whole extract [2570280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Diplacus aurantiacus whole extract [2533854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-dichlorobenzoic acid [2045940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexpanthenol [22701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicocoyl pentaerythrityl distearyl citrate [2374915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl myristamine [2360890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demeclocycline [3154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diacetyl boldine [1312548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium n-ethyl-n-4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene-2,5-cyclohexadien-1-ylidene)-3-sulfobenzenemethanaminium [1807340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl hexastearate [1541745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denatonium benzoate [1313232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deacetylbisacodyl [1872905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxypropyltrimonium chloride [1314851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>direct yellow 6 [2562883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darolutamide [2180325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabigatran etexilate mesylate [1037041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diacetylrhein [22759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>direct blue 2 [2054103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphtherial respiratory pseudomembrane preparation, human [1648415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxacurium [23651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisostearoyl polyglyceryl-3 dimer dilinoleate [1484496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalteparin sodium [82137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodoxynol-5 [2043436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Diospyros kaki leaf extract [1309423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dornase alfa [337623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylpropion hydrochloride [81998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyl azelate [2464291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desirudin [114934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docosahexaenoate [73]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 6 [1311178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl jojobate [1431147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duvelisib [2058509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>durlobactam sodium [2639090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl 2,6-naphthalate [1363596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,5-dimethylbenzene-1-sulfonate [1370663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-dihydroxybenzoic acid [1727169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyl lauroyl glutamide [1370108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,3&apos;-dihydroxydipropyl ether [2374914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daphne odora bark extract [1309932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisostearyl fumarate [2106560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextroamphetamine saccharate [221088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium zinc edetate [2537433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deucravacitinib [2612087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4,4&apos;-dinitrocarbanilide [1546355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl sebacate [1426781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenoxylate [3500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duck allergenic extract [972037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylamine [1745413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 12500 [2109855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyl sulfate [1428869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 6 barium lake [1539907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disilver oxide [1368701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylaminoethyl PEG-5 cocoate [2466991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylenetriamine pentamethylene phosphonic acid [1312549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl ethyleneglycol monoether [2643152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-8 laurate [1313264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-desoxypyridoxine hydrochloride [2463935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrofolic acid [2267573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium HEDTA [1428868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl sulfoxide [3455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichloralphenazone [22892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(dibutylamino)methanol [2058839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-distearoyllecithin [1426933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-dimethylaminopropylamine [1661327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipotassium glycyrrhizinate [1367264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicetyldimonium chloride [1376095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimyristyldimonium chloride [2380870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan [3289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyltin [2183101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dilinoleoyl-3-oleoyl-SN-glycerol [2700154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drometrizole trisiloxane [1992874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desert sand verbena leaf extract [1601987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenoxylate hydrochloride [82005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delta 9-tetrahydrocannabinol acetate [2621718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl lauramine oleate [1993216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-C12-15 alkyl fumarate [1368179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibenzylidene sorbitol [1307141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrostreptomycin [1549540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydro-alpha-ergocryptine mesylate [1426902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydrocholic acid [3141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromoramide [3290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl carbonate [1307048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimecrotic acid magnesium [236347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distigmine [3551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daratumumab-fihj [2375130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dieffenbachia seguine extract [1353887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropylamine dichloroacetate [1727556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dittrichia viscosa whole extract [1940150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyltoluamide [3129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decitabine [15657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daphne mezereum bark extract [1350999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(4-(diethylamino)-2-hydroxybenzoyl)benzoic acid [1307085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea alata whole extract [2709114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dry biocellulose (MW 2000000) [2372436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dilinoleic acid [2044276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasiglucagon hydrochloride [2535234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipyrone [3523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipipanone [23405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dipsacus asper root extract [1310075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dobutamine hydrochloride [203121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,7-dimethyl-1-octanol [1601994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(1,1-dimethylethyl)urea [2262004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexmedetomidine [48937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dopexamine [23638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxepin [3638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-dimethylacrylic acid, (E)- [1860614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 40 [3272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisostearyl dimer dilinoleate [1648136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dofetilide [49247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dichapetalum madagascariense bark/leaf extract [1923625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol distearate [1486708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docetaxel [72962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone crosspolymer (450000 MPA.S at 12% in cyclopentasiloxane) [1607313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone/PEG-10/15 crosspolymer [2372919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl palmitamine [1312987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deanol pidolate [236195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>durvalumab [1919503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenidol [23370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dried sodium phosphate [1366977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deanol acetamidobenzoate [22361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>digitalin [1923401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deuruxolitinib phosphate [2716557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dalbergia pinnata root extract [1310013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 500 [2118578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrostreptomycin sulfate [1549556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimetridazole [1600136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deslorelin [1311744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C green no. 8 [1426464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorophen [3351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Datura metel flower extract [2592965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dimyristoyl-sn-glycero-3-carboxaminopropylpolyethylene glycol 2000 methyl ether [2053485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenyl dimethicone (400 CST) [1606479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di(4-tert-butylcyclohexyl) peroxydicarbonate [1310539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daridorexant [2591497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentamethylenethiuram disulfide [1426773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl hexa C5-9 acid esters [1435109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dyphylline [3714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexbrompheniramine [22696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyethyl stearamine oxide [1739230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difetarsone [402587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolasetron mesylate [29398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drometrizole [1426903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyldodecyl dodecanedioate [1421634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drynaria fortunei whole extract [1733669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delafloxacin [1927663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daemonodrops draco resin [1420961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog skin extract [894987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl-2-N,N-dimethylaminopropionate [1427197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dill seed oil [1309204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropyl adipate [1363600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium distyrylbiphenyl disulfonate [1735036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daphne mezereum whole extract [1545790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyl phthalate [1362873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropylene glycol caprate-caprylate diester [1312559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decahydro-2,2,6,6,7,8,8-heptamethyl-2H-indeno(4,5-b)furan [2557364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenhydramine hydrochloride [1362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicresulene polymer [324007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibromopropamidine isethionate [22862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorotetrafluoroethane [124848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difemerine [163406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicloxacillin [3356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearyldimonium chloride [1311552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl palmitate [1363565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergocornine [3415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolomite [23622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dopamine [3628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinitolmide [1487907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl olivate [1536455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dierucoylphosphatidylcholine, dl- [1855891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didanosine [3364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>DIGITALIS,POWDERED [484908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (50000 CST) [1862283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone-vinyl dimethicone crosspolymer (hard particle) [1368471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylimidazolidinone rice starch [2264725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinoprostone [3478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone/polyglycerin-3 crosspolymer [2604557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dioleoyl-sn-glycero-3-phosphocholine [1424656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,7-dimethyloctane-1,7-diol [1313707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,9-decadiene [1729153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-dimethylaminophenol [15027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,6-dimethyloctan-2-ol [2700155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydrocholate [42625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diglycol stearate [1363597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daunorubicin citrate [1364321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-7 phosphate [1424173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dendrobium nobile stem extract [1420962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab [993449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxorubicin liposome [214525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimercaprol [3445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deudextromethorphan hydrobromide [2569465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyltetradeceth-30 [2386215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duloxetine hydrochloride [476250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-nxxp [2723334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl glutarate [2393529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diaminohydroxypropanetetraacetic acid [1659205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-dehydro-7.alpha.-methyltestosterone [2610241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-dichloro-5,6-dicyanobenzoquinone [2288812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dilinoleic acid/butanediol copolymer [2612151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabrafenib mesylate [1425222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphemanil [89782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline calcium [82012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroacetic acid [1312367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyldodecyl lauroyl glutamate [2560703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disteareth-100 isophorone diisocyanate [2201563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrocodeine bitartrate [104966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didecyldimethylammonium bromide [2469250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 75 [3275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecylamine [1648137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran sulfate [40068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodicin [1362744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dunaliella salina extract [1426466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium EDTA-copper CU-64 [2368536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dilsea carnosa extract [1363603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desoximetasone [3255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 110 [358871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorobenzene [89548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearyl ether [1307263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denatonium benzoate anhydrous [1313231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyacetone [3430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dilinoleoyl-sn-glycero-3-phosphocholine [2119816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demecarium [107771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone isonicotinate [3265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disteardimonium hectorite [1372929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diglycerin [1313741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl benzoate [1313705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-isopropylammonium [236452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroabietate [1432978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioxolane [2383339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphtheria antitoxin [3510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyldodecyl adipate [2682953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drosera rotundifolia extract [283557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium nicotinamide adenine dinucleotide [1716102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropylene glycol monocaprate monocaprylate [2373942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didesmethyltocotrienol [253165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desogestrel [22656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 70 [3274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dillweed oil [2118124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl disulfide [1999573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daclatasvir dihydrochloride [1606217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-C12-13 alkyl tartrate [1535215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donislecel-jujn [2642260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Diacronema lutheri preparation [2531135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicloxacillin sodium [267257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desmopressin [3251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium pamoate monohydrate [2386241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisocetyl adipate [2665415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diamond turbot extract [1424878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-n-octyl sodium sulfosuccinate [1534779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl tetrahydroxystearate/tetraisostearate [1925781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium rutinyl disulfate [1723153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropyl paraoxon [1804569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-diaminophenoxyethanol [1740235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daclizumab [190353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Datura stramonium flowering top extract [1809835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxylamine [3642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-diarachidoyl-sn-glycero-3-phosphocholine [1307781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C orange no. 5 [1312547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darutoside [1859167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didodecyldimethylammonium bromide [2373436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol diethyl ether [1435108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>datopotamab deruxtecan [2703033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium myristoyl glutamate [1364791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drotrecogin alfa [352374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimercaptosuccinate [1370569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>devil&apos;s claw preparation [236279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deutetrabenazine [1876905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 1000 [1426417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Datura stramonium whole extract [1999794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxercalciferol [11516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,6-di-tert-butyl-4-methoxyphenol [1648689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopromine [236206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darunavir [460132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dictamnus dasycarpus root bark extract [1603850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,6-dimethyl-5-heptenal [1552361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl 4-phthalate [1736744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diglyceryl monosebacate [2619242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimer dilinoleyl diisostearate [2532353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-dimethylnonan-4-ol [2557377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclofenac [3355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(dipropylamino)ethanol [1995246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-diethylaminoethanol [1433902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delandistrogene moxeparvovec-rokl [2641674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>DLin-MC3-DMA [2053488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>date palm pollen extract [852704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 1 [214485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatrizoate meglumine [3320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl capramide [1314304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (100000 CST) [1314246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexchlorpheniramine [22697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibasic potassium phosphate [55018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium latamoxef [258330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diptheria toxoid absorbed [1657601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diazoxide [3327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diazoxide choline [2711542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecylbenzenesulfonic acid [1094060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(2-dodecen-1-yl)dihydro-2,5-furandione, (2E)- [2359261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyl adipate [2684993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danofloxacin mesylate [1358487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diazolidinylurea [1310602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasatinib anhydrous [1546019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexetimide hydrochloride [259361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium stearyl sulfosuccinate [2634297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D-glucuronic acid [314584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-dimethylurea [1358483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 27 aluminum lake [1310559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylmethoxy chromanol [1539811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Davidsonia pruriens fruit extract [2621644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-diamino-5-methylphenoxyethanol hydrochloride [1737335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapagliflozin propanediol [1486966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium acetyl glucosamine phosphate [1990421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darbepoetin alfa [283838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>debrisoquin [3118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D-biotin [314583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2-dinitropropyl acrylate [2359258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropizine, (S)-isomer [52014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dopexamine hydrochloride [235768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decanoyl N-methylglucamide [2045461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxypropyltrimonium [1370590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-D morpholine [2370888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>defactinib hydrochloride [2714501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dysprosium [1311482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexketoprofen [237162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroacetate [1370635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl adipate [1306945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desert date extract [1428855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dengue virus live antigen, CYD serotype 3 [2197292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-10 phosphate [1371447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diltiazem maleate [314592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecamethylpentasiloxane [1371445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dryopteris crassirhizoma whole extract [1314582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2&apos;,3&apos;-dihydroxyacetophenone [2268051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl succinate [1313740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D.C. red no. 33 [1310601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicobalt edetate [288331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disofenin [314599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desert ragweed pollen extract [851981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyaluminum aminoacetate anhydrous [1543414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D-glutamic acid [1428878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Datura stramonium extract [1310350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 20 [1366227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibenzepin [3332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl gallate [1596928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol adipate [1313739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxepin hydrochloride [203179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylamino hydroxybenzoyl hexyl benzoate [1426392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimyristyldimonium [2380871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolasetron [68091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinoprost [3477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone [324072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (2000 CST) [1366232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium caproamphodipropionate [1364442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioxybenzone [23350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichloroacetic acid [155021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibunate [402565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl benzyl carbinyl butyrate [2385330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desmeninol calcium [1738094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dengue virus live antigen, CYD serotype 4 [2197293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenyl dimethicone (100 CST) [1535514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>divinylbenzene [1788842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drimia indica bulb extract [1988404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,5-diaminotoluene [1482535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium lauroamphodiacetate [1366895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 100 [1310496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dipsacus fullonum whole extract [1921158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog flea allergenic extract [886637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (14000 CST) [1747702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dactylopius coccus whole extract [1482791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropyl sebacate [1363601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyl oxalacetate [1370607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibasic sodium phosphate heptahydrate [221090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan hydroiodide [539765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-diaminophenoxyethanol hydrochloride [1740234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dipsacus chinensis whole extract [2055275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearoylphosphatidylglycerol [1942752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan polistirex [236146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimer dilinoleyl dimer dilinoleate [1492036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>datopotamab deruxtecan-dlnk [2703034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diperodon [59247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropylene glycol [1368869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergocryptine [3417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium carboxymethylarsonate [1744167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dordaviprone hydrochloride [2721193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darifenacin [136198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daunorubicin [3109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-D diethylethanolamine [2569561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropizine [23419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dianthus chinensis whole extract [1358895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextrose hydrous [1297771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicetylphosphate [1314346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>direct black 19 [2289222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dictamnus albus whole extract [2680132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylaminoethyl-dextran [1426613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dendropanax dentiger root with stem extract [2569978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donepezil [135447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domiphen [23623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyl malonate [2395765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatomaceous earth [1362874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Draba nemorosa whole extract [2585442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2&apos;-deoxyadenosine [2642189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicloran [22895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C brown no. 1 [1313737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didecyl ether [1552451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol gum [1650426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-bbdz [2715382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecylphosphocholine [2567015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dothiepin [3634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-decene [1307761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dactylis glomerata top extract [1310152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Duboisia leichhardtii leaf extract [1307617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D &amp; C red no. 27 [1311172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desflurane [27340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearoylphosphatidylcholine, DL- [1426932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibasic calcium phosphate, anhydrous [2632249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disteareth-75 isophorone diisocyanate [1546708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.delta.-dodecalactone [2371704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclofenac epolamine [40968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipalmitoylethyl hydroxyethylmonium methosulfate [1312557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difetarsone sodium [402588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (70 CST) [1656307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deuruxolitinib [2716558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethoxydiphenylsilane [2199635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasabuvir sodium monohydrate [1600438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyl phthalate [1362921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea communis top extract [2266500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatrizoate sodium [3321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dutasteride [228790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropylamine [1362925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibucaine [3339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea japonica root extract [1307611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demeclocycline hydrochloride [81993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Delphinium staphisagria preparation [283556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-deoxyglucose [1733674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dierucoylphosphatidylcholine [1855892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyaluminum sodium carbonate [23163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium cocoyl glutamate [1366830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxypropyl PEG-5 linoleammonium chloride [1307792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline [3640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(2,4-dichlorophenyl)ethanol [1807445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalteparin [67109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>droxicam [23687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doramectin [73455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium glycyrrhizate [1313716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donanemab-azbt [2687965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapiprazole hydrochloride [235757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deanol bisorcate [236194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didodecyl phosphate [1593447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-dichloro-2-propanol [1305516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium C12-14 sec-pareth-12 sulfosuccinate [1366885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexketoprofen trometamol [233386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabigatran etexilate [1037042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipotassium [2397120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duck feather extract [892851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danofloxacin [1358488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea cayenensis tuber extract [2720179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>debrisoquine sulfate [203120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferasirox [614373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docusate [82003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daxibotulinumtoxinA-lanm [2612452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daemonorops draco whole extract [1433641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Datura ferox whole extract [2106261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan tannate [259262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyldimonium [2382593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dacomitinib anhydrous [2058848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difelikefalin acetate [2569090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diacetyl benzoyl lathyrol [1426391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (sodium salt) [1546351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecahydroxycyclohexane dihydrate [1313337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deudextromethorphan [2569466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desipramine dibudinate [1099738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delmopinol [60451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioxane [2383534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2&apos;-dithiobisbenzothiazole [1306112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,10-decanediol [1309235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisobutyl adipate [1363599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C yellow no. 10, aluminum lake [1305567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone sodium phosphate [48933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 28 [1310707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diosmin [3489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium carboxyethyl siliconate [1486523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextrothyroxine sodium [40070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C blue no. 4 [1426460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyldithiocarbamate [1426943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dendrobium bigibbum flower extract [1799142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium EDTA-copper [1366887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>droperidol [3648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Davallia divaricata whole extract [2698550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisodecyl adipate [1655566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxyphytantriyl (2-hydroxyethyl)palmitamide [1728291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergocryptine mesylate [42646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delavirdine mesylate [142152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium hydrogen citrate [1366889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3 di-o-methyl-d-glucose [2372920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl glucoside, alpha- [2633004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinutuximab [1606274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>durlobactam [2639089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichloroacetate [3347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deutivacaftor [2701430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>direct red 81 [2686947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docetaxel anhydrous [1299922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demegestone [22483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dromostanolone propionate [23683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium 1-(laureth-2) sulfosuccinate [2168001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delgocitinib [2721163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphtheria toxoid adsorbed [235600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyltin oxide [2391139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-dichlorophenoxyacetic acid, sodium salt [1371448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisooctyl adipate [1794890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desvenlafaxine succinate [683693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deslorelin acetate [1311743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dendrobium nobile whole extract [2634353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasabuvir [1597381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dendranthema indicum flower extract [1307609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>durapatite [49334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyl adipate [1367137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decanal [1484495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decamethrin [22374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dicrateria rotunda oil [2281671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecene [1595034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan hydrobromide [102490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D &amp; C red # 30 aluminum lake [1310563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deanol [3116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethoxytolyl propylresorcinol [1988686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxazosin [49276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dyclonine [23744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diroximel fumarate [2261783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxapram [3637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 21 [1310541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docosanoic acid, 1-(((1-oxodecyl)oxy)methyl)-2-((oxooctyl)oxy)ethyl ester, (+-)- [2106429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danaparoid sodium [103843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyldimonium chloride [1539967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dequalinium chloride [3120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipyrone magnesium [236464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>detajmium [82665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium oleamido MEA-sulfosuccinate [1366900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didecyldimethylammonium [1425983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium ricinoleic monoethanolamide sulfosuccinate [1363992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipivefrin hydrochloride [203156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipotassium 4&apos;,5&apos;-dibromofluorescein [2266809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapagliflozin [1488564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicyclomine hydrochloride [152021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimyristoylphosphatidylglycerol [1427048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxacurium chloride [49275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deceth-6 [1729162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl hexahydroxystearate [1313746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diglycerin monostearate [1995486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disperse blue 3 [1812081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>damiana extract [236802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabigatran [1546356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropylacetamide [23420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibrompropamidine [22865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl benzyl carbinol [2289010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dirithromycin [23437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-distearoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [2621546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dantrolene [3105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone phosphate [235486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium decyl phenyl ether disulfonate [2637752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergocristine monomesylate [42645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipotassium aspartate [2397119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difenoxin [23024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distarch phosphate, corn [2604631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>droxidopa [1489913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desoxycorticosterone pivalate [22537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daunorubicin hydrochloride [81992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diacetylated monoglycerides [1426474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran [42635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decamethyltetrasiloxane [1366739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denileukin diftitox-cxdl [2700746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Danio rerio egg preparation [1311291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxorubicin hydrochloride liposome [466523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dichrostachys cinerea whole extract [2370148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium citrate sesquihydrate [2049608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydro-beta-ergocryptine [91171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delandistrogene moxeparvovec [2641675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2&apos;-dihydroxy-4,4&apos;-dimethoxy-5,5&apos;-disulfobenzophenone [1370643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea collettii var. hypoglauca root extract [1309419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicalcium silicate [2586586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Delphinium staphisagria whole extract [2117332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextrose monohydrate [1299920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium 2-sulfolaurate [1313195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethanolamine oleth-10 phosphate [1856757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 350 [1363569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dictamnus dasycarpus whole extract [1442702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyltetradecyl(3-(trimethoxysilyl)propyl)ammonium chloride [2473841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dacomitinib [2058849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyaluminum aminoacetate [23162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl ether [1313349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxapram hydrochloride [82011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxorubicin [3639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol monoethyl ether [1311147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D.C. red no. 36 [1426926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disopyramide [3541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexbrompheniramine tannate [686390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Douglas fir pollen extract [1098257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol monophenyl ether [1719253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextrin palmitate (corn; 20000 MW) [1859922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecylhexadecyltrimonium chloride [2698346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-dihydroxyacetophenone [1999190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium lauriminodipropionate tocopheryl phosphate [1997179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docusate potassium [82002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danicopan [2678952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-dssb [2725498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipotassium adipate [237123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium hydrogen phosphate dehydrate [1311230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorobenzyl alcohol [22906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dengue virus live antigen, CYD serotype 2 [2197291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diperodon hydrochloride [133043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dactinomycin [3100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyldodecyl (1-naphthylmethyl) ammonium chloride [2634300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dicentra canadensis root extract [1534777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline hydrochloride [236647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donidalorsen sodium [2724362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethanolamine [1362911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>detajmium bitartrate [236784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docosaenoic acid [1291425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-qbde [2725562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromoramide tartrate [104959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibekacin [3328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-7 isostearate [1313742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroeugenol [2571991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium edetate hydrate [1310470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium ascorbyl sitostanol phosphate [2469332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dogfennel pollen extract [867218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diamond [1362686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desloratadine [275635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextrothyroxine [3292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextranase Penicillium [1312708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desoxycorticosterone acetate [258333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difenoxin hydrochloride [235373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-kyqq [2725924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatrizoic acid [1546223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergotamine [3418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darunavir ethanolate [644682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dothiepin hydrochloride [142133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium sulfosalicylate [1364465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-8 meadowfoamate [2622906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisocetyl dodecanedioate [1427125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl maleate [1312551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daunorubicin liposomal [214468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-PPG-3 myristyl ether adipate [1307157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>divalproex sodium [266856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>digoxin [3407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 30 [1311176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl adipate [2393526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioleylamidoethyl(diethoxylated-hydroxyethyl)monium methosulfate [2375307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docosahexaenoic acid [144450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dungeness crab, cooked preparation [1315114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darunavir propylene glycolate [2670599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxycholic acid [3194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimercaptosuccinic acid [2475951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalfampridine [897018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dipsacus fullonum root extract [1866519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxycetyl phosphate [1370670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergotamine mesylate [203176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dequalinium salicylate [236549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylcyclohexylethoxy isobutylpropanoate [2557366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diloxanide [67182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C yellow no.11 [1305581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol [1429928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danthron [22293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>detomidine hydrochloride [48928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drotaverine hydrochloride [236960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drosera intermedia extract [1371948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>defibrotide, bovine lung [1788946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ditiocarb, zinc salt [1427192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecylbenzenesulfonate [1370659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dengue virus live antigen, CYD serotype 1 [2197290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dill allergenic extract [975763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disperse blue 106 [1368171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog dander extract [2167551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroquercetin glucoside [2644502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyltin dilaurate [2183100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Diptheria protein [221091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyltin bis(propylene glycol maleate) [2593179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diosmetin [1314347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-8 isostearate [2287732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-bnht [2717527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipropylene glycol dibenzoate [1314348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daunorubicin citrate liposome [221087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difebarbamate [23020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexmedetomidine hydrochloride [228054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylcarbamazine citrate [203175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenyltrichloroethane [1367423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxorubicin hydrochloride [142433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (250000 MW) [1314290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea oppositifolia whole extract [1606220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dopa, DL [1657852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropanolamine [1362922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Descurainia sophia seed extract [2592967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethyldithiocarbamate [1427193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium stearoyl glutamate [1366832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difluprednate [23043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergotamine tartrate [236680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipyrithione [1362743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deslanoside [3248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dipalmitoyl-sn-glycero-3-phospho-(1&apos;-rac-glycerol) [1599275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl diallyl ammonium chloride [2398835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichromate ion [1313336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-D-trolamine [2047869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daratumumab [1721947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphtheria toxoid vaccine, inactivated [798304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dotatate gallium ga-68 [676679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Digitalis leaf extract [235219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dicentra formosa whole extract [2533852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-8 benzoate [2104182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrocodeine [23088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deanol bitartrate [236124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dandelion extract [124150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donepezil hydrochloride [236559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 33 free acid [2672351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demelverin [236795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denaverine [22503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphemanil methylsulfate [23364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl gallate [2463333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroemetine [3142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipeptide diaminobutyroyl benzylamide diacetate [1735328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl sebacate [1433642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroxanthan gum [1596137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(3,4-dimethoxyphenyl)propane-1,2-diol [2374549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,7-dimethyloct-6-en-3-ol [2671293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydroabietic acid [1432977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxycytidine [2642208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclofenac diethylammonium [236125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denatured ethanol [216449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-dibromo-5,5-dimethylhydantoin [2368732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl-2-N,N-dimethylaminopropionate hydrochloride [1427196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecanedioate [2635088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium ethylenediaminediacetate [1651598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipotassium glucose-6-phosphate [1541245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl sulfate [2205404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydralazine sul hemipenthy [259379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>detomidine [22672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disperse red 15 [2395759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drosera anglica extract [1338934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimyristoylphosphatidylglycerol, DL [1427047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicaprylyl carbonate [1372926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium.alpha.-tocopheryl phosphate, D- [2683416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyethyl cocamine oxide [1363598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-PPG-2 myreth-10 adipate [1426159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxazosin mesylate [39173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflucortolone [3392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C violet no. 2 [1426924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphtherial respiratory pseudomembrane preparation [1648416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexfenfluramine [3268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium 2-sulfopalmitate [1486521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalbavancin [1539239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone trimethyl acetate [22694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic cow hair extract [895488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ditiocarb silver [2393532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxylamine succinate [23665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydralazine [3409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl hexacaprylate [1426607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol monomethyl ether [1538383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol (41 MPA.S) [1363579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desmopressin acetate [42634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenhydramine [3498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl salicylate [1923237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodatate [2396443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disulfiram [3554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disopyramide phosphate [203178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4,4-dimethyloxazolidine [1658442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenyl ether [2391140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dostarlimab [2539967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dulacia inopiflora wood extract [1370986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflucortolone valerate [23035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylamphetamine [1362926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C orange no. 4 [1426468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylaminoethyl-dextran hydrochloride [1426612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorofluoromethane [1426470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethiconol/trimethylsiloxysilicate crosspolymer (40/60 W/W; 1000000 PA.S) [1800493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea japonica whole extract [2665625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipyridamole [3521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenylpyraline hydrochloride [203155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl glucoside [1311572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 34 [1437986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylamine salicylate [162592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-dimethylol-5,5-dimethylhydantoin [1310543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylpropion [3389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dronedarone hydrochloride [736680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrotachysterol [3429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-7 panthenyl phosphate (12 panthenol) [2374553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexetimide [3267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisopropyl dilinoleate [1426909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatrizoate [3319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diheptyl succinate [1488055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dill extract [2108821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl sulfate [1362927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium glutamate [2601595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delavirdine [83816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-dimethyl-3-cyclohexene carboxaldehyde [2376941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dronedarone [233698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diazepam [3322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone/peg-10/15 crosspolymer in dimethicone 6 (130000 cps) [2470538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibenzyl ether [1747705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docosahexaenoic acid algal oil [2723562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethoxy di-p-cresol [1312556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibromocyanoacetamide [2637530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>digitoxin [3403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C orange no. 11 [1544393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denaverine hydrochloride [236794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dostarlimab-gxly [2539968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dilauryl citrate [1592895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl hexa C5-10 acid esters [1427412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium aspartate [2619780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [1424655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol monoethyl ether acetate [1737113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylacetamide [1368874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic cow skin extract [852256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenhydramine citrate [82004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone-phenyl vinyl dimethicone crosspolymer [2594594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doravirine [2055755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decoquinate [1314345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethoxyethyl succinate [1432479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dilauryldimonium chloride [1544575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicyclomine [3361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dithionate [1443002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deoxycholate [42627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>di-C12-13 alkyl malate [1735035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demelverine hydrochloride [236796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deanol aceglutamate [48780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desoxycorticosterone [3256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylmethoxy chromanyl palmitate [1435519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doravine [2055767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyl sebacate [1363700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-15 acetate [1426828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>detosu/triethylene glycol/triethylene glycol polyglycolide copolymer [2370141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylaminomethylcoumarin [1737792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflorasone diacetate [23033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl oleate [1307038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dl-alpha tocopheryl acetate [317841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium laureth sulfosuccinate [1366891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daptomycin [22299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doripenem [119771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearoylphosphatidylglycerol, DL- [1942751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-docosahexanoyl-sn-glycero-3-phosphoserine [1549115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalbavancin hydrochloride [1541465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-((dimethylamino)methyl)-1,3-diphenyl-1-propanol, erythro- [2289003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>date allergenic extract [899742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>digoxin antibodies Fab fragments [203223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium laureth-12 sulfosuccinate [1871182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1-diphenylurea [2471079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydro-beta-ergocryptine mesylate [1426905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dandelion pollen extract [852079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethanolamine fusidate [22971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dryobalanops aromitica resin [2106561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donidalorsen [2724361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docosanol [594680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethanolamine cetyl phosphate [1363595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-desoxypyridoxine [2463936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexrazoxane [42736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4,5-dichloro-2-octyl-3-isothiazolone [1486818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorphenamide [3353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daridorexant hydrochloride [2591496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1-difluoroethane [1305515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyl maleate [1491007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextroamphetamine [3288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dienogest [22968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dulse extract [1312722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(dibutylamino)ethyl methacrylate [2550705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexlansoprazole sesquihydrate [2673463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab-bmwo [2717851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexrazoxane hydrochloride [1294534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic goat skin extract [852252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergocristine [3416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2&apos;-deoxyguanosine [2642210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibenzepin hydrochloride [236807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-dimethylbutyl salicylate [1424661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Digitalis preparation [91235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>donanemab [2687966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone 410 [1299921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dichlorodifluoromethane [50110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol 2000 [2473374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desvenlafaxine fumarate monohydrate [1487366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.delta.-damascone [2396782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea villosa whole extract [2627280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dromostanolone [23678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolutegravir [1433868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenylamine [1363044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium oleamido mipa-sulfosuccinate [1366902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexamethasone [3264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicaprylyl ether [1367138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinoprost tromethamine [23321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone/bis-isobutyl PPG-20 crosspolymer [1606214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dirlotapide [1592684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergotoxine [3419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4,7,10,13,16,19-docosahexaenoic acid, (4E,7E,10E,13E,16E,19E)- [2261373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearyldimonium [1311550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexchlorpheniramine maleate [54828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearyl pentaerythritol diphosphite [2054997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic cow dander extract [2166591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>direct blue 1 [2563143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dymanthine [2274100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflunisal [3393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-dimethylaminophenol hydrochloride [236930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolutegravir sodium [1433867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-dodecylperhydroazepine-1-oxide [2695988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimecrotic acid [236346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deserpidine [62174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desonide [3254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daucus carota subsp. carota whole extract [1600138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deceth-8 [1735034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol ethyl methyl ether [2398515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyloxazolidinone [1313738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenhydramine diacefyllinate [236260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium lauroyl glutamate [1928076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyl acetate [2391549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium ethylene dicocamide PEG-15 disulfate [1364463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextroamphetamine sulfate [3287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dotatate [1797118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioscorine [1716101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D&amp;C red no. 7 [1310564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapsone [3108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydromyrcenol [1659907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethylsilanol hyaluronate [1424864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearoylethyl hydroxyethylmonium methosulfate [1363827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dactylis glomerata allergenic extract [1922738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,6-di-tert-butyl-4-((methylthio)methyl)phenol [1648688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difemerine hydrochloride [236208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylhexyl syringylidenemalonate [1368195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,5-diaminotoluene sulfate [1482534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline hyclate [23663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dulaglutide [1551291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desmeninol [1738095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diltiazem [3443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>defibrotide sodium [1746523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diloxanide furoate [23203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dilauryl thiodipropionate [2046116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihexyl sodium sulfosuccinate [2637736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decyltetradeceth-25 [2001620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicapryl succinate [2585745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diisostearyl malate [1363602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyldodecylbenzylammonium [1311593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclazuril [1368201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl benzyl carbinyl acetate [1314315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>degarelix acetate [835863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daclatasvir [1606218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicalcium phosphate anhydrous [1314331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-8 adipate [2359249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihexyverine [236209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disintegrin and metalloproteinase domain-containing protein 11 [2467551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl lauramine [1313743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dictamnus dasycarpus root extract [1923818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dantrolene sodium [3106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium cocoamphodipropionate [1366877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,7-dimethyloctanal [1311602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimyristoylphosphatidylcholine, DL- [1427050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,4-diphenyl-1,3-butadiene [1739233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrodehydro-.beta.-ionone [2557365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicalcium phosphate [253163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone-vinyl dimethicone crosspolymer [1361659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrogenated tallow phthalic acid amide [1313184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dorzolamide [60207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferoxamine [3131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drimia maritima whole extract [1998613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethadione [1428867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drotaverin [23684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-dierucoyl-sn-glycero-3(phospho-rac-(1-glycerol)) [2397985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dirofilaria immitis [1597621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desvenlafaxine [734064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>defactinib [2714502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decanoic acid [22380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenhydramine tannate [360283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-diaminophenoxyethanol sulfate [2394500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone propyl PG-betaine [2606775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferoxamine mesylate [3132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexbrompheniramine maleate [48936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dezocine [22713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium cocoamphodiacetate [1364461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxybutyl ether [14699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl fumarate [1373478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duloxetine [72625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dianthus caryophyllus flower extract [1428844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domiphen bromide [49255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium azelate [2117384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone PEG-8 succinate [2044265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl methylglutarate [2393527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline anhydrous [1545992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylstilbestrol [3390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecanol [1362875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydro pentamethylindanone [2372918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>distearyl phthalamic acid [1312560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dopamine hydrochloride [82010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethanolamine oleth-3 phosphate [1495478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delafloxacin meglumine [1927662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Delphinium staphisagria seed extract [1309677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4-dichlorophenoxyacetate [1371449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diheptyl adipate [2684977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimenhydrinate [3444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclofenac sodium [203214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Delphinium ajacis seed extract [2590638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecyl propionate [1603857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decylene glycol [1426901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dioctyl maleate [1356765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexlansoprazole [816346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dobutamine [3616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium oxaloacetate [2697039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>damiana leaf extract [282470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrocapsaicin [2166037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog hair extract [895495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalotuzumab [1432293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dioscorea villosa tuber extract [1309690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium pyrophosphate [267798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydrosanol [22427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferiprone [11645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dark leaved mugwort pollen extract [896246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dandelion honey [1535698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danazol [3102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docusate sodium [71722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dordaviprone [2721194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denileukin diftitox [214470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dehydrated alcohol [1310469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibutyl ethylhexanoyl glutamide [1370107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decan-4-olide [1424652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decarboxy carnosine hydrochloride [1363432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>7-dehydrocholesterol [1362616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexchlorpheniramine tannate [353104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daprodustat [2628210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylene glycol abietate [2665347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecanedioic acid [2635087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Digitalis purpurea whole extract [1314850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difelikefalin [2569089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>D &amp; C green 5 [1311171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drosera rotundifolia flowering top extract [2280908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dandelion root extract [259436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextrates [1426816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenidol hydrochloride [47877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>danaparoid [78484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drimia maritima bulb extract [1311399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenylguanidine [1368170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Diospyros mespiliformis leaf extract [1667687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Diisononyl adipate [2533838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasatinib [475342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabrafenib [1424911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desipramine [3247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Dictyopteris polypodioides extract [1442997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dragon&apos;s blood extract [1372005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dodecahydroxycyclohexane [1370583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dupilumab [1876376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ditetracycline tetrasodium edetate [1739006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibucaine hydrochloride [235402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.delta.-decalactone [2371703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethicone methacrylate (3000 MW) [2198358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>damoctocog alfa pegol [2055655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentaerythrityl tri-polyhydroxystearate [1733677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalfopristin [229369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium lauryl sulfosuccinate [1366898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatrizoate lysine [236477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desipramine hydrochloride [203174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-dimercapto-1-propanesulfonic acid [1546352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroxyethyl lauramine oxide [2669405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethyl anthranilate [2359250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicalcium citrate [2585217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disodium dihydrogen hypophosphate [2370175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapiprazole [22298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Daucus carota subsp. sativus seed extract [1442508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Drynaria fortunei root extract [1309421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didecyldimethylammonium chloride [1011450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethanolamine bis(C8-C18 perfluoroalkylethyl)phosphate [1363594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimethindene maleate [258334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic goat hair extract [895503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>D [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dequalinium [3226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Alteration [PE]</name>
  <code>C300381</code>  <id>300381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Alteration</to_name>
    <to_code>T13767</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019996</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Gyrase Inhibitors [MoA]</name>
  <code>C300476</code>  <id>300476</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors</to_name>
    <to_code>T13773</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020086</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin mesylate [221177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin [115552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Integrity Alteration [PE]</name>
  <code>C27124</code>  <id>27125</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration</to_name>
    <to_code>T13778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008379</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Integrity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Integrity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Methylation Decrease [PE]</name>
  <code>C300384</code>  <id>300384</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation Decrease</to_name>
    <to_code>T13784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019999</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Methylation Increase [PE]</name>
  <code>C300383</code>  <id>300383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation Increase</to_name>
    <to_code>T13785</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019998</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Methylation [PE]</name>
  <code>C300382</code>  <id>300382</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation</to_name>
    <to_code>T13786</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019997</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Methylation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Methylation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methylation Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Methyltransferase Inhibitors [MoA]</name>
  <code>C300380</code>  <id>300380</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methytransferase Inhibitors</to_name>
    <to_code>T13787</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methyltransferase Inhibitors</to_name>
    <to_code>T13788</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019995</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Polymerase Inhibitors [MoA]</name>
  <code>C300450</code>  <id>300450</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors</to_name>
    <to_code>T13816</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020060</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir hydrochloride [236081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine anhydrous [2108659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir [73645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brincidofovir [2599518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine [11194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Replication Alteration [PE]</name>
  <code>C27126</code>  <id>27127</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Replication Alteration</to_name>
    <to_code>T13836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008380</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>DNA Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloprogin [26422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver [2606543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DNA Terminase Complex Inhibitors [MoA]</name>
  <code>C654025</code>  <id>654025</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Terminase Complex Inhibitors</to_name>
    <to_code>T58385</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193801</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Terminase Complex Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>DOPA Decarboxylase Inhibitors [MoA]</name>
  <code>C635163</code>  <id>635163</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydroxyphenylalanine Decarboxylase Inhibitors</to_name>
    <to_code>T14004</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>DOPA Decarboxylase Inhibitors</to_name>
    <to_code>T14005</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175755</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DOPA Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decarboxylase Inhibitor [EPC]</name>
  <code>C635283</code>  <id>635283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitor</to_name>
    <to_code>T14168</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175845</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decarboxylase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decarboxylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflornithine [569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decarboxylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decarboxylase Inhibitors [MoA]</name>
  <code>C635282</code>  <id>635282</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitors</to_name>
    <to_code>T14169</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175844</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decorporation Agent [EPC]</name>
  <code>C653116</code>  <id>653116</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decorporation Agent</to_name>
    <to_code>T14181</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192801</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decorporation Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prussian blue insoluble [24902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antidote (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decorporation Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decrease Spermatogenesis [PE]</name>
  <code>C27128</code>  <id>27129</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decrease Spermatogenesis</to_name>
    <to_code>T14182</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008381</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Acetylcholine Activity [PE]</name>
  <code>C27132</code>  <id>27133</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity</to_name>
    <to_code>T14183</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008383</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium [1546438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine [38876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine hydrochloride [236190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime cation [1546365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium tosylate [2052857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Adhesion Factor Activity [PE]</name>
  <code>C27134</code>  <id>27135</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity</to_name>
    <to_code>T14184</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008384</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa (activated), lyophilized [353106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efalizumab [356988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vedolizumab [1538097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab-sztn [2725169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Adhesion Factor Degradation [PE]</name>
  <code>C27136</code>  <id>27137</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Degradation</to_name>
    <to_code>T14185</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008385</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Adhesion Factor Production [PE]</name>
  <code>C27138</code>  <id>27139</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Production</to_name>
    <to_code>T14186</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008386</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Adrenal Epinephrine Secretion [PE]</name>
  <code>C27140</code>  <id>27141</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenal Epinephrine Secretion</to_name>
    <to_code>T14187</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008387</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Adrenal Norepinephrine Secretion [PE]</name>
  <code>C27142</code>  <id>27143</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenal Norepinephrine Secretion</to_name>
    <to_code>T14188</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008388</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Adrenocorticotropic Hormone Secretion [PE]</name>
  <code>C27130</code>  <id>27131</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased ACTH Sectretion</to_name>
    <to_code>T14189</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion</to_name>
    <to_code>T14190</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008382</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide diaspartate [1364104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide [1364105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide pamoate [1597818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Amino Acid Synthesis [PE]</name>
  <code>C31828</code>  <id>31829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Amino Acid Synthesis</to_name>
    <to_code>T14191</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010235</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Amino Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Anal Sphincter Tone [PE]</name>
  <code>C27144</code>  <id>27145</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Anal Sphincter Tone</to_name>
    <to_code>T14192</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008389</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Antibody Activity [PE]</name>
  <code>C27146</code>  <id>27147</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Activity</to_name>
    <to_code>T14193</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008390</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Antibody Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased IgE Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Antibody Degradation [PE]</name>
  <code>C27148</code>  <id>27149</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Degradation</to_name>
    <to_code>T14194</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008391</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Antibody Production [PE]</name>
  <code>C27150</code>  <id>27151</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Production</to_name>
    <to_code>T14195</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008392</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Aspartate Activity [PE]</name>
  <code>C27152</code>  <id>27153</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Aspartate Activity</to_name>
    <to_code>T14196</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008393</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Ganglionic Activity [PE]</name>
  <code>C635037</code>  <id>635037</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity</to_name>
    <to_code>T14197</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175644</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Ganglionic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</name>
  <code>C27154</code>  <id>27155</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Acetylcholine Activity</to_name>
    <to_code>T14198</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008394</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Aspartate Activity [PE]</name>
  <code>C27156</code>  <id>27157</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Aspartate Activity</to_name>
    <to_code>T14199</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008395</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C27158</code>  <id>27159</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T14200</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008396</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System CCK Activity [PE]</name>
  <code>C27160</code>  <id>27161</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System CCK Activity</to_name>
    <to_code>T14201</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008397</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C27162</code>  <id>27163</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T14202</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008398</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Dopamine Activity [PE]</name>
  <code>C27164</code>  <id>27165</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Dopamine Activity</to_name>
    <to_code>T14203</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008399</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Dynorphin Activity [PE]</name>
  <code>C27166</code>  <id>27167</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Dynorphin Activity</to_name>
    <to_code>T14204</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008400</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Endorphin Activity [PE]</name>
  <code>C27168</code>  <id>27169</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Endorphin Activity</to_name>
    <to_code>T14205</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008401</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Enkephalin Activity [PE]</name>
  <code>C27170</code>  <id>27171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Enkephalin Activity</to_name>
    <to_code>T14206</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008402</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Epinephrine Activity [PE]</name>
  <code>C27172</code>  <id>27173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Epinephrine Activity</to_name>
    <to_code>T14207</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008403</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System GABA Activity [PE]</name>
  <code>C27174</code>  <id>27175</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System GABA Activity</to_name>
    <to_code>T14208</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008404</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Gastrin Activity [PE]</name>
  <code>C27176</code>  <id>27177</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Gastrin Activity</to_name>
    <to_code>T14209</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008405</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Glutamate Activity [PE]</name>
  <code>C27178</code>  <id>27179</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Glutamate Activity</to_name>
    <to_code>T14210</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008406</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Glycine Activity [PE]</name>
  <code>C27180</code>  <id>27181</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Glycine Activity</to_name>
    <to_code>T14211</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008407</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Histamine Activity [PE]</name>
  <code>C27182</code>  <id>27183</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Histamine Activity</to_name>
    <to_code>T14212</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008408</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C27184</code>  <id>27185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T14213</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008409</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Neurotensin Activity [PE]</name>
  <code>C27186</code>  <id>27187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Neurotensin Activity</to_name>
    <to_code>T14214</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008410</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Nitric Oxide Activity [PE]</name>
  <code>C27188</code>  <id>27189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Nitric Oxide Activity</to_name>
    <to_code>T14215</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008411</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Norepinephrine Activity [PE]</name>
  <code>C27190</code>  <id>27191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Norepinephrine Activity</to_name>
    <to_code>T14216</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008412</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Organized Electrical Activity [PE]</name>
  <code>C27192</code>  <id>27193</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Organized Electrical Activity</to_name>
    <to_code>T14217</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008413</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Serotonin Activity [PE]</name>
  <code>C27194</code>  <id>27195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Serotonin Activity</to_name>
    <to_code>T14218</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008414</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System Substance P Activity [PE]</name>
  <code>C27196</code>  <id>27197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Substance P Activity</to_name>
    <to_code>T14219</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008415</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Autonomic Nervous System VIP Activity [PE]</name>
  <code>C27198</code>  <id>27199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System VIP Activity</to_name>
    <to_code>T14220</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008416</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Autonomic Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased B Lymphocyte Activation [PE]</name>
  <code>C641732</code>  <id>641732</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Activation</to_name>
    <to_code>T14221</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182156</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib phosphate [2633006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belimumab [1092437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased B Lymphocyte Destruction [PE]</name>
  <code>C27200</code>  <id>27201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Destruction</to_name>
    <to_code>T14222</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008417</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased B Lymphocyte Production [PE]</name>
  <code>C27202</code>  <id>27203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Production</to_name>
    <to_code>T14223</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008418</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Biliary Motility [PE]</name>
  <code>C27204</code>  <id>27205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Biliary Motility</to_name>
    <to_code>T14224</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008419</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Bladder Contractility [PE]</name>
  <code>C27206</code>  <id>27207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility</to_name>
    <to_code>T14225</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008420</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine [119565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine fumarate [797196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine [797195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine tartrate [221174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium chloride [38891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium [236778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vibegron [2472254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Bladder Sphincter Tone [PE]</name>
  <code>C27208</code>  <id>27209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone</to_name>
    <to_code>T14226</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008421</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vibegron [2472254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Blood Pressure [PE]</name>
  <code>C637933</code>  <id>637933</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure</to_name>
    <to_code>T14227</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178477</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson anhydrous [1546015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol [31462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol [37840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol [31555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol hydrochloride [236178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol hydrochloride [236374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barnidipine hydrochloride [283819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprocitentan [2679059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sul hemipenthy [259379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan kamedoxomil [1294597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate hydrochloride [91241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan [75207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinacidil [33717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol hydrochloride [236883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macitentan [1442132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil [4648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrisentan [358274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacidipine [28382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>practolol [8620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil hydrochloride [439837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rescinnamine [9259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol sulfate [236904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol [29518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrendipine [7441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Blood Viscosity [PE]</name>
  <code>C635331</code>  <id>635331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity</to_name>
    <to_code>T14228</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175893</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxelotor [2265678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Bradykinin Activity [PE]</name>
  <code>C27210</code>  <id>27211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Activity</to_name>
    <to_code>T14229</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008422</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen sodium [2724362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen [2724361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Bradykinin Degradation [PE]</name>
  <code>C27212</code>  <id>27213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation</to_name>
    <to_code>T14230</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008423</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Bradykinin Production [PE]</name>
  <code>C27214</code>  <id>27215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Production</to_name>
    <to_code>T14231</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008424</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab-gxii [2717168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebetralstat [2717944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab [2717169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Derived Neurotropic Activity [PE]</name>
  <code>C27216</code>  <id>27217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Derived Neurotropic Activity</to_name>
    <to_code>T14232</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008425</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Acetylcholine Activity [PE]</name>
  <code>C27218</code>  <id>27219</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Acetylcholine Activity</to_name>
    <to_code>T14233</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008426</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Aspartate Activity [PE]</name>
  <code>C27220</code>  <id>27221</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Aspartate Activity</to_name>
    <to_code>T14234</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008427</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Brain Derived Neurotropic Activity [PE]</name>
  <code>C27222</code>  <id>27223</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Brain Derived Neurotropic Activity</to_name>
    <to_code>T14235</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008428</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem CCK Activity [PE]</name>
  <code>C27224</code>  <id>27225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem CCK Activity</to_name>
    <to_code>T14236</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008429</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Disorganized Electrical Activity [PE]</name>
  <code>C27226</code>  <id>27227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Disorganized Electrical Activity</to_name>
    <to_code>T14237</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008430</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Dopamine Activity [PE]</name>
  <code>C27228</code>  <id>27229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity</to_name>
    <to_code>T14238</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008431</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Dynorphin Activity [PE]</name>
  <code>C27230</code>  <id>27231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dynorphin Activity</to_name>
    <to_code>T14239</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008432</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Endorphin Activity [PE]</name>
  <code>C27232</code>  <id>27233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Endorphin Activity</to_name>
    <to_code>T14240</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008433</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Enkephalin Activity [PE]</name>
  <code>C27234</code>  <id>27235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Enkephalin Activity</to_name>
    <to_code>T14241</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008434</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Epinephrine Activity [PE]</name>
  <code>C27236</code>  <id>27237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Epinephrine Activity</to_name>
    <to_code>T14242</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008435</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem GABA Activity [PE]</name>
  <code>C27238</code>  <id>27239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem GABA Activity</to_name>
    <to_code>T14243</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008436</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Gastrin Activity [PE]</name>
  <code>C27240</code>  <id>27241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Gastrin Activity</to_name>
    <to_code>T14244</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008437</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Glutamate Activity [PE]</name>
  <code>C27242</code>  <id>27243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Glutamate Activity</to_name>
    <to_code>T14245</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008438</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Glycine Activity [PE]</name>
  <code>C27244</code>  <id>27245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Glycine Activity</to_name>
    <to_code>T14246</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008439</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Histamine Activity [PE]</name>
  <code>C27246</code>  <id>27247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Histamine Activity</to_name>
    <to_code>T14247</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008440</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Nerve Growth Factor Activity [PE]</name>
  <code>C27248</code>  <id>27249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Nerve Growth Factor Activity</to_name>
    <to_code>T14248</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008441</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Neurotensin Activity [PE]</name>
  <code>C27250</code>  <id>27251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Neurotensin Activity</to_name>
    <to_code>T14249</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008442</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Nitric Oxide Activity [PE]</name>
  <code>C27252</code>  <id>27253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Nitric Oxide Activity</to_name>
    <to_code>T14250</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008443</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Norepinephrine Activity [PE]</name>
  <code>C27254</code>  <id>27255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Norepinephrine Activity</to_name>
    <to_code>T14251</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008444</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Organized Electrical Activity [PE]</name>
  <code>C27256</code>  <id>27257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity</to_name>
    <to_code>T14252</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008445</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Serotonin Activity [PE]</name>
  <code>C27258</code>  <id>27259</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Serotonin Activity</to_name>
    <to_code>T14253</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008446</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem Substance P Activity [PE]</name>
  <code>C27260</code>  <id>27261</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Substance P Activity</to_name>
    <to_code>T14254</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008447</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Brain Stem VIP Activity [PE]</name>
  <code>C27262</code>  <id>27263</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem VIP Activity</to_name>
    <to_code>T14255</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008448</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased CCK Activity [PE]</name>
  <code>C27264</code>  <id>27265</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased CCK Activity</to_name>
    <to_code>T14256</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008449</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased CRH Activity [PE]</name>
  <code>C27266</code>  <id>27267</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased CRH Activity</to_name>
    <to_code>T14257</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008450</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased CRH Secretion [PE]</name>
  <code>C27268</code>  <id>27269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased CRH Secretion</to_name>
    <to_code>T14258</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008451</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Calcitonin Secretion [PE]</name>
  <code>C27270</code>  <id>27271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcitonin Secretion</to_name>
    <to_code>T14259</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008452</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erenumab [2045613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcitonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab-vfrm [2056690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcitonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erenumab-aooe [2045614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcitonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab [2056691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcitonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Calcium-sensing Receptor Sensitivity [MoA]</name>
  <code>C300472</code>  <id>300472</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcium-sensing Receptor Sensitivity</to_name>
    <to_code>T14260</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020082</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Capillary Permeability [PE]</name>
  <code>C31864</code>  <id>31865</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability</to_name>
    <to_code>T14261</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010253</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</name>
  <code>C27272</code>  <id>27273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Acetylcholine Activity</to_name>
    <to_code>T14262</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008453</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Aspartate Activity [PE]</name>
  <code>C27274</code>  <id>27275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Aspartate Activity</to_name>
    <to_code>T14263</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008454</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity [PE]</name>
  <code>C27276</code>  <id>27277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity</to_name>
    <to_code>T14264</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008455</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle CCK Activity [PE]</name>
  <code>C27278</code>  <id>27279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle CCK Activity</to_name>
    <to_code>T14265</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008456</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Disorganized Electrical Activity [PE]</name>
  <code>C27280</code>  <id>27281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Disorganized Electrical Activity</to_name>
    <to_code>T14266</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008457</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Dopamine Activity [PE]</name>
  <code>C27282</code>  <id>27283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Dopamine Activity</to_name>
    <to_code>T14267</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008458</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Dynorphin Activity [PE]</name>
  <code>C27284</code>  <id>27285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Dynorphin Activity</to_name>
    <to_code>T14268</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008459</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Endorphin Activity [PE]</name>
  <code>C27286</code>  <id>27287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Endorphin Activity</to_name>
    <to_code>T14269</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008460</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Enkephalin Activity [PE]</name>
  <code>C27288</code>  <id>27289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Enkephalin Activity</to_name>
    <to_code>T14270</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008461</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Epinephrine Activity [PE]</name>
  <code>C27290</code>  <id>27291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Epinephrine Activity</to_name>
    <to_code>T14271</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008462</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle GABA Activity [PE]</name>
  <code>C27292</code>  <id>27293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle GABA Activity</to_name>
    <to_code>T14272</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008463</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Gastrin Activity [PE]</name>
  <code>C27294</code>  <id>27295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Gastrin Activity</to_name>
    <to_code>T14273</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008464</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Glutamate Activity [PE]</name>
  <code>C27296</code>  <id>27297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Glutamate Activity</to_name>
    <to_code>T14274</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008465</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Glycine Activity [PE]</name>
  <code>C27298</code>  <id>27299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Glycine Activity</to_name>
    <to_code>T14275</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008466</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Histamine Activity [PE]</name>
  <code>C27300</code>  <id>27301</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Histamine Activity</to_name>
    <to_code>T14276</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008467</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Nerve Growth Factor Activity [PE]</name>
  <code>C27302</code>  <id>27303</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Nerve Growth Factor Activity</to_name>
    <to_code>T14277</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008468</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Neurotensin Activity [PE]</name>
  <code>C27304</code>  <id>27305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Neurotensin Activity</to_name>
    <to_code>T14278</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008469</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Nitric Oxide Activity [PE]</name>
  <code>C27306</code>  <id>27307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Nitric Oxide Activity</to_name>
    <to_code>T14279</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008470</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Norepinephrine Activity [PE]</name>
  <code>C27308</code>  <id>27309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Norepinephrine Activity</to_name>
    <to_code>T14280</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008471</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</name>
  <code>C27310</code>  <id>27311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity</to_name>
    <to_code>T14281</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008472</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Serotonin Activity [PE]</name>
  <code>C27312</code>  <id>27313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Serotonin Activity</to_name>
    <to_code>T14282</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008473</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle Substance P Activity [PE]</name>
  <code>C27314</code>  <id>27315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Substance P Activity</to_name>
    <to_code>T14283</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008474</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cardiac Muscle VIP Activity [PE]</name>
  <code>C27316</code>  <id>27317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle VIP Activity</to_name>
    <to_code>T14284</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008475</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Membrane Integrity [PE]</name>
  <code>C27318</code>  <id>27319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity</to_name>
    <to_code>T14285</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008476</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc pyrithione [39952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxidectin [1047072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deoxycholic acid [3194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexachlorophene [5293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terconazole [37806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole nitrate [236601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioconazole [38298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Membrane Synthesis &amp; Repair [PE]</name>
  <code>C27320</code>  <id>27321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Synthesis &amp; Repair</to_name>
    <to_code>T14286</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008477</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Membrane Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Wall Integrity [PE]</name>
  <code>C27322</code>  <id>27323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity</to_name>
    <to_code>T14287</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008478</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbenicillin [10168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin napsylate [235836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine hydrochloride [91293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin sodium [236787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin sodium [487070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbendazole [4325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole nitrate [203157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phenethicillin [132907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin [4448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin [26797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate, liposomal [2059179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutrimazole [61773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin liposomal [2059180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin magnesium [235825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin [325887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethicillin [33277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine [31476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole [27901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin acetate [2639156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloprogin [26422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole nitrate [236601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin [10322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temocillin [37775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium [235750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxylenol [20877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin [2639155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefetamet [20482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium monohydrate [1309402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin [18609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cell Wall Synthesis &amp; Repair [PE]</name>
  <code>C27324</code>  <id>27325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair</to_name>
    <to_code>T14288</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008479</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxalactam [7069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin hydrochloride [1541465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin sodium [1591924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temocillin [37775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium [235750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium monohydrate [1309402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin phenyl sodium [42580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefatrizine [2179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin hydrochloride [66955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin napsylate [235836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol calcium [1424675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phenethicillin [132907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam hydrochloride [236202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pretomanid [2198359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur [1311521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem [2717833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin magnesium [235825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethicillin [33277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol [1424676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam [2188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin [10322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome [27130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin [2181306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin [11124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin [6084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur sodium [1370372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin [18609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin propionate [28069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbenicillin [10168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome sulfate [236104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium latamoxef [258330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin sodium [236787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin [1591901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur hydrochloride [1311520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin [4448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin [26797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem etzadroxil [2717834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cell Wall Synthesis &amp; Repair [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cellular Death [PE]</name>
  <code>C27326</code>  <id>27327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Death</to_name>
    <to_code>T14289</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008480</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triacetate [1665222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triphosphate sodium [236509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine [11017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine 5-mo-phos disod [236785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cellular Locomotion [PE]</name>
  <code>C27328</code>  <id>27329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Locomotion</to_name>
    <to_code>T14290</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008481</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Locomotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Locomotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cellular Migration [PE]</name>
  <code>C30224</code>  <id>30225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration</to_name>
    <to_code>T14291</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009928</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Cellular Migration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Cellular Migration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod arginine [2668046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod [2668045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Acetylcholine Activity [PE]</name>
  <code>C27330</code>  <id>27331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity</to_name>
    <to_code>T14292</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008482</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide hydrochloride [57227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide [38685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Aspartate Activity [PE]</name>
  <code>C27332</code>  <id>27333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Aspartate Activity</to_name>
    <to_code>T14293</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008483</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C27334</code>  <id>27335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T14294</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008484</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System CCK Activity [PE]</name>
  <code>C27336</code>  <id>27337</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System CCK Activity</to_name>
    <to_code>T14295</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008485</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C27338</code>  <id>27339</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T14296</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008486</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethadione [10827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vigabatrin [14851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Dopamine Activity [PE]</name>
  <code>C27340</code>  <id>27341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dopamine Activity</to_name>
    <to_code>T14297</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008487</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline tartrate [636674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline [591622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Dynorphin Activity [PE]</name>
  <code>C27342</code>  <id>27343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dynorphin Activity</to_name>
    <to_code>T14298</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008488</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Endorphin Activity [PE]</name>
  <code>C27344</code>  <id>27345</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Endorphin Activity</to_name>
    <to_code>T14299</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008489</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Enkephalin Activity [PE]</name>
  <code>C27346</code>  <id>27347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Enkephalin Activity</to_name>
    <to_code>T14300</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008490</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Epinephrine Activity [PE]</name>
  <code>C27348</code>  <id>27349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Epinephrine Activity</to_name>
    <to_code>T14301</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008491</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System GABA Activity [PE]</name>
  <code>C27350</code>  <id>27351</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System GABA Activity</to_name>
    <to_code>T14302</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008492</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam [2383941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam besylate [2383942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Gastrin Activity [PE]</name>
  <code>C27352</code>  <id>27353</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Gastrin Activity</to_name>
    <to_code>T14303</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008493</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Glutamate Activity [PE]</name>
  <code>C27354</code>  <id>27355</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glutamate Activity</to_name>
    <to_code>T14304</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008494</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine hydrochloride [236685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine [6719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riluzole [35623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Glycine Activity [PE]</name>
  <code>C27356</code>  <id>27357</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glycine Activity</to_name>
    <to_code>T14305</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008495</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Histamine Activity [PE]</name>
  <code>C27358</code>  <id>27359</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity</to_name>
    <to_code>T14306</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008496</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant hydrochloride [2197879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceprometazine [161203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C27360</code>  <id>27361</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T14307</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008497</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Neurotensin Activity [PE]</name>
  <code>C27362</code>  <id>27363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Neurotensin Activity</to_name>
    <to_code>T14308</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008498</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Nitric Oxide Activity [PE]</name>
  <code>C27364</code>  <id>27365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Nitric Oxide Activity</to_name>
    <to_code>T14309</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008499</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nargenicin [2668421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Norepinephrine Activity [PE]</name>
  <code>C27366</code>  <id>27367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity</to_name>
    <to_code>T14310</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008500</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate hydrochloride [91241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Organized Electrical Activity [PE]</name>
  <code>C27368</code>  <id>27369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity</to_name>
    <to_code>T14311</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008501</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethopropazine hydrochloride [6541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>profenamine [4134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine tartrate [164308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital sodium [91109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-hydroxybutyric acid [1546380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine [10825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halothane [5095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine hydrochloride [2119366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem tartrate [221183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital [477631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine [2119365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Serotonin Activity [PE]</name>
  <code>C27370</code>  <id>27371</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity</to_name>
    <to_code>T14312</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008502</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride anhydrous [2119176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron hydrochloride [397405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System Substance P Activity [PE]</name>
  <code>C27372</code>  <id>27373</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Substance P Activity</to_name>
    <to_code>T14313</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008503</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Central Nervous System VIP Activity [PE]</name>
  <code>C27374</code>  <id>27375</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System VIP Activity</to_name>
    <to_code>T14314</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008504</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Brain Stem VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Acetylcholine Activity [PE]</name>
  <code>C27376</code>  <id>27377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Acetylcholine Activity</to_name>
    <to_code>T14315</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008505</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Aspartate Activity [PE]</name>
  <code>C27378</code>  <id>27379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Aspartate Activity</to_name>
    <to_code>T14316</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008506</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Brain Derived Neurotropic Activity [PE]</name>
  <code>C27380</code>  <id>27381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Brain Derived Neurotropic Activity</to_name>
    <to_code>T14317</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008507</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum CCK Activity [PE]</name>
  <code>C27382</code>  <id>27383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum CCK Activity</to_name>
    <to_code>T14318</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008508</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Disorganized Electrical Activity [PE]</name>
  <code>C27384</code>  <id>27385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Disorganized Electrical Activity</to_name>
    <to_code>T14319</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008509</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Dopamine Activity [PE]</name>
  <code>C27386</code>  <id>27387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Dopamine Activity</to_name>
    <to_code>T14320</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008510</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Dynorphin Activity [PE]</name>
  <code>C27388</code>  <id>27389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Dynorphin Activity</to_name>
    <to_code>T14321</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008511</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Endorphin Activity [PE]</name>
  <code>C27390</code>  <id>27391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Endorphin Activity</to_name>
    <to_code>T14322</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008512</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Enkephalin Activity [PE]</name>
  <code>C27392</code>  <id>27393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Enkephalin Activity</to_name>
    <to_code>T14323</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008513</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Epinephrine Activity [PE]</name>
  <code>C27394</code>  <id>27395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Epinephrine Activity</to_name>
    <to_code>T14324</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008514</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum GABA Activity [PE]</name>
  <code>C27396</code>  <id>27397</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum GABA Activity</to_name>
    <to_code>T14325</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008515</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Gastrin Activity [PE]</name>
  <code>C27398</code>  <id>27399</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Gastrin Activity</to_name>
    <to_code>T14326</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008516</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Glutamate Activity [PE]</name>
  <code>C27400</code>  <id>27401</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Glutamate Activity</to_name>
    <to_code>T14327</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008517</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Glycine Activity [PE]</name>
  <code>C27402</code>  <id>27403</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Glycine Activity</to_name>
    <to_code>T14328</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008518</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Histamine Activity [PE]</name>
  <code>C27404</code>  <id>27405</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Histamine Activity</to_name>
    <to_code>T14329</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008519</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Nerve Growth Factor Activity [PE]</name>
  <code>C27406</code>  <id>27407</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Nerve Growth Factor Activity</to_name>
    <to_code>T14330</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008520</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Neurotensin Activity [PE]</name>
  <code>C27408</code>  <id>27409</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Neurotensin Activity</to_name>
    <to_code>T14331</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008521</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Nitric Oxide Activity [PE]</name>
  <code>C27410</code>  <id>27411</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Nitric Oxide Activity</to_name>
    <to_code>T14332</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008522</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Norepinephrine Activity [PE]</name>
  <code>C27412</code>  <id>27413</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Norepinephrine Activity</to_name>
    <to_code>T14333</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008523</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Organized Electrical Activity [PE]</name>
  <code>C27414</code>  <id>27415</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Organized Electrical Activity</to_name>
    <to_code>T14334</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008524</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Serotonin Activity [PE]</name>
  <code>C27416</code>  <id>27417</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Serotonin Activity</to_name>
    <to_code>T14335</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008525</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum Substance P Activity [PE]</name>
  <code>C27418</code>  <id>27419</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum Substance P Activity</to_name>
    <to_code>T14336</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008526</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebellum VIP Activity [PE]</name>
  <code>C27420</code>  <id>27421</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebellum VIP Activity</to_name>
    <to_code>T14337</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008527</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Acetylcholine Activity [PE]</name>
  <code>C27422</code>  <id>27423</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Acetylcholine Activity</to_name>
    <to_code>T14338</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008528</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Aspartate Activity [PE]</name>
  <code>C27424</code>  <id>27425</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Aspartate Activity</to_name>
    <to_code>T14339</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008529</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity [PE]</name>
  <code>C27426</code>  <id>27427</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Brain Derived Neurotropic Activity</to_name>
    <to_code>T14340</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008530</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex CCK Activity [PE]</name>
  <code>C27428</code>  <id>27429</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex CCK Activity</to_name>
    <to_code>T14341</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008531</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Disorganized Electrical Activity [PE]</name>
  <code>C27430</code>  <id>27431</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Disorganized Electrical Activity</to_name>
    <to_code>T14342</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008532</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Dopamine Activity [PE]</name>
  <code>C27432</code>  <id>27433</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Dopamine Activity</to_name>
    <to_code>T14343</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008533</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Dynorphin Activity [PE]</name>
  <code>C27434</code>  <id>27435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Dynorphin Activity</to_name>
    <to_code>T14344</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008534</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Endorphin Activity [PE]</name>
  <code>C27436</code>  <id>27437</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Endorphin Activity</to_name>
    <to_code>T14345</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008535</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Enkephalin Activity [PE]</name>
  <code>C27438</code>  <id>27439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Enkephalin Activity</to_name>
    <to_code>T14346</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008536</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Epinephrine Activity [PE]</name>
  <code>C27440</code>  <id>27441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Epinephrine Activity</to_name>
    <to_code>T14347</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008537</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex GABA Activity [PE]</name>
  <code>C27442</code>  <id>27443</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex GABA Activity</to_name>
    <to_code>T14348</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008538</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Gastrin Activity [PE]</name>
  <code>C27444</code>  <id>27445</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Gastrin Activity</to_name>
    <to_code>T14349</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008539</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Glutamate Activity [PE]</name>
  <code>C27446</code>  <id>27447</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Glutamate Activity</to_name>
    <to_code>T14350</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008540</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Glycine Activity [PE]</name>
  <code>C27448</code>  <id>27449</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Glycine Activity</to_name>
    <to_code>T14351</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008541</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Histamine Activity [PE]</name>
  <code>C27450</code>  <id>27451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Histamine Activity</to_name>
    <to_code>T14352</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008542</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Nerve Growth Factor Activity [PE]</name>
  <code>C27452</code>  <id>27453</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Nerve Growth Factor Activity</to_name>
    <to_code>T14353</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008543</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Neurotensin Activity [PE]</name>
  <code>C27454</code>  <id>27455</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Neurotensin Activity</to_name>
    <to_code>T14354</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008544</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Nitric Oxide Activity [PE]</name>
  <code>C27456</code>  <id>27457</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Nitric Oxide Activity</to_name>
    <to_code>T14355</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008545</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Norepinephrine Activity [PE]</name>
  <code>C27458</code>  <id>27459</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Norepinephrine Activity</to_name>
    <to_code>T14356</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008546</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</name>
  <code>C27460</code>  <id>27461</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Organized Electrical Activity</to_name>
    <to_code>T14357</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008547</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Serotonin Activity [PE]</name>
  <code>C27462</code>  <id>27463</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Serotonin Activity</to_name>
    <to_code>T14358</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008548</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex Substance P Activity [PE]</name>
  <code>C27464</code>  <id>27465</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex Substance P Activity</to_name>
    <to_code>T14359</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008549</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cerebral Cortex VIP Activity [PE]</name>
  <code>C27466</code>  <id>27467</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cerebral Cortex VIP Activity</to_name>
    <to_code>T14360</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008550</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cervical Dilation [PE]</name>
  <code>C27468</code>  <id>27469</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cervical Dilation</to_name>
    <to_code>T14361</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008551</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cervical Smooth Muscle Tone [PE]</name>
  <code>C27470</code>  <id>27471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cervical Smooth Muscle Tone</to_name>
    <to_code>T14362</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008552</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Absorption [PE]</name>
  <code>C27472</code>  <id>27473</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption</to_name>
    <to_code>T14363</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008553</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursadiol [2045735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursodiol [11065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Elimination [PE]</name>
  <code>C27474</code>  <id>27475</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Elimination</to_name>
    <to_code>T14364</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008554</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Secretion [PE]</name>
  <code>C31832</code>  <id>31833</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Secretion</to_name>
    <to_code>T14365</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010237</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursadiol [2045735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cholesterol Synthesis [PE]</name>
  <code>C27476</code>  <id>27477</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis</to_name>
    <to_code>T14366</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008555</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc nicotinate [236834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Coagulation Activity [PE]</name>
  <code>C635432</code>  <id>635432</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticoagulation Activity</to_name>
    <to_code>T14367</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity</to_name>
    <to_code>T14371</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-coagulation Activity</to_name>
    <to_code>T14370</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-coagulation</to_name>
    <to_code>T14368</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticoagulation</to_name>
    <to_code>T14369</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175978</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate mesylate [1037041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate [1037042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Coagulation Factor Activity [PE]</name>
  <code>C27478</code>  <id>27479</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity</to_name>
    <to_code>T14372</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008556</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Coagulation Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prothrombin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban [1927851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protein C, human [723868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desirudin [114934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin potassium [82118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin sodium [152612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban tosylate [1599564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin sodium [114194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protein C, human-lans [2643198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin [152610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban maleate [1927955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban [1599538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa (activated), lyophilized [353106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux sodium [322154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antithrombin III, human [221062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivaroxaban [1114195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Coagulation Factor Concentration [PE]</name>
  <code>C27480</code>  <id>27481</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration</to_name>
    <to_code>T14373</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008557</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin sodium [114194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa (activated), lyophilized [353106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin potassium [82118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Ca++ Excretion [PE]</name>
  <code>C27482</code>  <id>27483</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Ca++ Excretion</to_name>
    <to_code>T14374</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008558</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Cl- Excretion [PE]</name>
  <code>C27484</code>  <id>27485</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Cl- Excretion</to_name>
    <to_code>T14375</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008559</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct H+ Excretion [PE]</name>
  <code>C27486</code>  <id>27487</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct H+ Excretion</to_name>
    <to_code>T14376</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008560</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct HCO3- Excretion [PE]</name>
  <code>C27488</code>  <id>27489</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct HCO3- Excretion</to_name>
    <to_code>T14377</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008561</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct K+ Excretion [PE]</name>
  <code>C27490</code>  <id>27491</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct K+ Excretion</to_name>
    <to_code>T14378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008562</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Mg++ Excretion [PE]</name>
  <code>C27492</code>  <id>27493</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Mg++ Excretion</to_name>
    <to_code>T14379</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008563</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Na+ Excretion [PE]</name>
  <code>C27494</code>  <id>27495</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Na+ Excretion</to_name>
    <to_code>T14380</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008564</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct PO4-- Excretion [PE]</name>
  <code>C27496</code>  <id>27497</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct PO4-- Excretion</to_name>
    <to_code>T14381</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008565</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct SO4-- Excretion [PE]</name>
  <code>C27498</code>  <id>27499</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct SO4-- Excretion</to_name>
    <to_code>T14382</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008566</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Collecting Duct Water Permeability [PE]</name>
  <code>C27500</code>  <id>27501</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Water Permeability</to_name>
    <to_code>T14383</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008567</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Complement Activity [PE]</name>
  <code>C27502</code>  <id>27503</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity</to_name>
    <to_code>T14384</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008568</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacopan [2572100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab-akkz [2686620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab [2686619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilobelimab [2639620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Complement Degradation [PE]</name>
  <code>C27504</code>  <id>27505</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Degradation</to_name>
    <to_code>T14385</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008569</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan [2672489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan sodium [2672492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Complement Production [PE]</name>
  <code>C27506</code>  <id>27507</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production</to_name>
    <to_code>T14386</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008570</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan [2671061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan hydrochloride [2671062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Copper Ion Absorption [PE]</name>
  <code>C634922</code>  <id>634922</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Copper Ion Absorption</to_name>
    <to_code>T14387</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175529</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc cation [1546264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Copper Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytokine Activity [PE]</name>
  <code>C27508</code>  <id>27509</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity</to_name>
    <to_code>T14388</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008571</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basiliximab [196102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib dihydrochloride monohydrate [2665205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab-lbkz [2693778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab [2693758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab-asmn [2053449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerandomilast [2725523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab-mrkz [2668385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab [2053436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab [2166040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib [2665204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab-bkzx [2668080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab-rzaa [2166132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab [2668041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarilumab [1923319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab-ilto [2691309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytokine Degradation [PE]</name>
  <code>C27510</code>  <id>27511</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Degradation</to_name>
    <to_code>T14389</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008572</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytokine Production [PE]</name>
  <code>C27512</code>  <id>27513</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production</to_name>
    <to_code>T14390</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008573</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L [2700765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L-rknd [2700764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab-dlwr [2632980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab-ilto [2691309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab [2632981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytoskeleton Integrity [PE]</name>
  <code>C27514</code>  <id>27515</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytoskeleton Integrity</to_name>
    <to_code>T14391</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008574</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytoskeleton Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Cytoskeleton Synthesis &amp; Repair [PE]</name>
  <code>C27516</code>  <id>27517</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytoskeleton Synthesis &amp; Repair</to_name>
    <to_code>T14392</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008575</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased DNA Integrity [PE]</name>
  <code>C27518</code>  <id>27519</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity</to_name>
    <to_code>T14393</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008576</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotuzumab ozogamicin [1942950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil [2382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib camsylate [1862578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir [1433868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib tosylate [2099703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valrubicin [31435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trioxide [18330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trioxsalen [10844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir potassium [1235585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trabectedin [1716278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir sodium [1433867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic [1111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir [719872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib [2099704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil hydrochloride [142428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elvitegravir [1306286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased DNA Replication [PE]</name>
  <code>C27520</code>  <id>27521</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication</to_name>
    <to_code>T14394</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008577</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin mesylate [221177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate glucuronate [38725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secnidazole [36314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetyldithranol [38536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir hydrochloride [236081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine [11194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin [115552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate [42333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine anhydrous [2108659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valrubicin [31435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir [73645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Dihydrotestosterone Secretion [PE]</name>
  <code>C30240</code>  <id>30241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dihydrotestosterone Secretion</to_name>
    <to_code>T14396</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DHT Secretion</to_name>
    <to_code>T14395</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009936</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dihydrotestosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dihydrotestosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto extract [236344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dihydrotestosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Disorganized Electrical Activity [PE]</name>
  <code>C27522</code>  <id>27523</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity</to_name>
    <to_code>T14397</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008578</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine tartrate [164308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine [10825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Ca++ Excretion [PE]</name>
  <code>C27524</code>  <id>27525</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Ca++ Excretion</to_name>
    <to_code>T14398</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008579</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Cl- Excretion [PE]</name>
  <code>C27526</code>  <id>27527</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Cl- Excretion</to_name>
    <to_code>T14399</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008580</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule H+ Excretion [PE]</name>
  <code>C27528</code>  <id>27529</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule H+ Excretion</to_name>
    <to_code>T14400</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008581</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule HCO3- Excretion [PE]</name>
  <code>C27530</code>  <id>27531</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule HCO3- Excretion</to_name>
    <to_code>T14401</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008582</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule K+ Excretion [PE]</name>
  <code>C27532</code>  <id>27533</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion</to_name>
    <to_code>T14402</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008583</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Mg++ Excretion [PE]</name>
  <code>C27534</code>  <id>27535</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Mg++ Excretion</to_name>
    <to_code>T14403</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008584</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule Na+ Excretion [PE]</name>
  <code>C27536</code>  <id>27537</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Na+ Excretion</to_name>
    <to_code>T14404</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008585</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule PO4-- Excretion [PE]</name>
  <code>C27538</code>  <id>27539</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion</to_name>
    <to_code>T14405</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008586</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Distal Tubule SO4-- Excretion [PE]</name>
  <code>C27540</code>  <id>27541</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule SO4-- Excretion</to_name>
    <to_code>T14406</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008587</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Diuresis [PE]</name>
  <code>C634743</code>  <id>634743</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiuretic Activity</to_name>
    <to_code>T14407</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Diuresis</to_name>
    <to_code>T14408</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175360</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argipressin [1098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Diuresis at Loop of Henle [PE]</name>
  <code>C634750</code>  <id>634750</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Diuresis at Loop of Henle</to_name>
    <to_code>T14409</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175367</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Dopamine Activity [PE]</name>
  <code>C27542</code>  <id>27543</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity</to_name>
    <to_code>T14410</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008588</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol [10804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacetazine [8338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine tosylate [1923002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol hydrochloride [236140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penfluridol [7974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine [8042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine dimalonate [236771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Dynorphin Activity [PE]</name>
  <code>C27544</code>  <id>27545</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dynorphin Activity</to_name>
    <to_code>T14411</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008589</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Eicosanoid Activity [PE]</name>
  <code>C27546</code>  <id>27547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Eicosanoid Activity</to_name>
    <to_code>T14412</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008590</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Eicosanoid Degradation [PE]</name>
  <code>C27548</code>  <id>27549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Eicosanoid Degradation</to_name>
    <to_code>T14413</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008591</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Eicosanoid Production [PE]</name>
  <code>C27550</code>  <id>27551</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Eicosanoid Production</to_name>
    <to_code>T14414</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008592</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Eicosanoid Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Embryonic &amp; Fetal Growth [PE]</name>
  <code>C27552</code>  <id>27553</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic &amp; Fetal Growth</to_name>
    <to_code>T14415</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008593</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Embryonic &amp; Fetal Viability [PE]</name>
  <code>C27554</code>  <id>27555</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic &amp; Fetal Viability</to_name>
    <to_code>T14416</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008594</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Embryonic Implantation [PE]</name>
  <code>C27556</code>  <id>27557</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation</to_name>
    <to_code>T14417</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008595</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal acetate [1005920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper Cu-64 [2200143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drospirenone [11636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal [1005921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etonogestrel [14584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper [2837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Endocytosis [PE]</name>
  <code>C27558</code>  <id>27559</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endocytosis</to_name>
    <to_code>T14418</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008596</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Endorphin Activity [PE]</name>
  <code>C27560</code>  <id>27561</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endorphin Activity</to_name>
    <to_code>T14419</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008597</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Endothelial Coagulation Activity [PE]</name>
  <code>C27562</code>  <id>27563</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Coagulation Activity</to_name>
    <to_code>T14420</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008598</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Endothelial Proliferation [PE]</name>
  <code>C635084</code>  <id>635084</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation</to_name>
    <to_code>T14421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175678</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab-svoa [2591584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib esylate [1592736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capivasertib [2669967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab [2591519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab [2204915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib mesylate [1604346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab-dbll [2204916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enkephalin Activity [PE]</name>
  <code>C27564</code>  <id>27565</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enkephalin Activity</to_name>
    <to_code>T14422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008599</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Acetylcholine Activity [PE]</name>
  <code>C27566</code>  <id>27567</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Acetylcholine Activity</to_name>
    <to_code>T14423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008600</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Aspartate Activity [PE]</name>
  <code>C27568</code>  <id>27569</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Aspartate Activity</to_name>
    <to_code>T14424</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008601</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C27570</code>  <id>27571</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T14425</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008602</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System CCK Activity [PE]</name>
  <code>C27572</code>  <id>27573</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System CCK Activity</to_name>
    <to_code>T14426</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008603</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C27574</code>  <id>27575</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T14427</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008604</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Dopamine Activity [PE]</name>
  <code>C27576</code>  <id>27577</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Dopamine Activity</to_name>
    <to_code>T14428</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008605</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Dynorphin Activity [PE]</name>
  <code>C27578</code>  <id>27579</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Dynorphin Activity</to_name>
    <to_code>T14429</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008606</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Endorphin Activity [PE]</name>
  <code>C27580</code>  <id>27581</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Endorphin Activity</to_name>
    <to_code>T14430</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008607</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Enkephalin Activity [PE]</name>
  <code>C27582</code>  <id>27583</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Enkephalin Activity</to_name>
    <to_code>T14431</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008608</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Epinephrine Activity [PE]</name>
  <code>C27584</code>  <id>27585</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Epinephrine Activity</to_name>
    <to_code>T14432</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008609</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System GABA Activity [PE]</name>
  <code>C27586</code>  <id>27587</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System GABA Activity</to_name>
    <to_code>T14433</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008610</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Gastrin Activity [PE]</name>
  <code>C27588</code>  <id>27589</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Gastrin Activity</to_name>
    <to_code>T14434</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008611</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Glutamate Activity [PE]</name>
  <code>C27590</code>  <id>27591</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Glutamate Activity</to_name>
    <to_code>T14435</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008612</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Glycine Activity [PE]</name>
  <code>C27592</code>  <id>27593</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Glycine Activity</to_name>
    <to_code>T14436</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008613</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Histamine Activity [PE]</name>
  <code>C27594</code>  <id>27595</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Histamine Activity</to_name>
    <to_code>T14437</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008614</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C27596</code>  <id>27597</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T14438</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008615</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Neurotensin Activity [PE]</name>
  <code>C27598</code>  <id>27599</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Neurotensin Activity</to_name>
    <to_code>T14439</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008616</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Nitric Oxide Activity [PE]</name>
  <code>C27600</code>  <id>27601</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Nitric Oxide Activity</to_name>
    <to_code>T14440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008617</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Norepinephrine Activity [PE]</name>
  <code>C27602</code>  <id>27603</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Norepinephrine Activity</to_name>
    <to_code>T14441</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008618</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Organized Electrical Activity [PE]</name>
  <code>C27604</code>  <id>27605</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Organized Electrical Activity</to_name>
    <to_code>T14442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008619</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Serotonin Activity [PE]</name>
  <code>C27606</code>  <id>27607</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Serotonin Activity</to_name>
    <to_code>T14443</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008620</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System Substance P Activity [PE]</name>
  <code>C27608</code>  <id>27609</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Substance P Activity</to_name>
    <to_code>T14444</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008621</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Enteric Nervous System VIP Activity [PE]</name>
  <code>C27610</code>  <id>27611</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System VIP Activity</to_name>
    <to_code>T14445</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008622</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Epinephrine Activity [PE]</name>
  <code>C27612</code>  <id>27613</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epinephrine Activity</to_name>
    <to_code>T14446</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008623</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Epithelial Proliferation [PE]</name>
  <code>C635082</code>  <id>635082</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation</to_name>
    <to_code>T14447</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175676</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab-zbco [2699587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dictamnine [2685302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin microsphere [221175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab [2699588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Erythroid Cell Destruction [PE]</name>
  <code>C27614</code>  <id>27615</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythroid Cell Destruction</to_name>
    <to_code>T14448</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008624</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Erythroid Cell Production [PE]</name>
  <code>C27616</code>  <id>27617</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythroid Cell Production</to_name>
    <to_code>T14449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008625</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Erythropoetin Secretion [PE]</name>
  <code>C27618</code>  <id>27619</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythropoetin Secretion</to_name>
    <to_code>T14450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008626</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Esophageal Motility [PE]</name>
  <code>C27620</code>  <id>27621</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Esophageal Motility</to_name>
    <to_code>T14451</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008627</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Esophageal Muscle Tone [PE]</name>
  <code>C27622</code>  <id>27623</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Esophageal Muscle Tone</to_name>
    <to_code>T14452</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008628</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Esophageal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Exocytosis [PE]</name>
  <code>C27624</code>  <id>27625</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Exocytosis</to_name>
    <to_code>T14453</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008629</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Exocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Exocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Extracellular Communication [PE]</name>
  <code>C31814</code>  <id>31815</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Extracellular Communication</to_name>
    <to_code>T14454</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010228</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Extracellular Communication [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Fibrinolysis [PE]</name>
  <code>C635025</code>  <id>635025</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis</to_name>
    <to_code>T14456</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifibrinolysis</to_name>
    <to_code>T14455</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175632</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranexamic acid [10691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>6-aminocaproic acid [99]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprotinin [1056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Fibroblast Migration [PE]</name>
  <code>C31854</code>  <id>31855</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration</to_name>
    <to_code>T14457</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010248</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vosoritide [2586354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Folic Acid Modification [PE]</name>
  <code>C30238</code>  <id>30239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folate Modification</to_name>
    <to_code>T14458</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification</to_name>
    <to_code>T14459</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009935</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfanilamide [10184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Follicle Stimulating Hormone Secretion [PE]</name>
  <code>C27626</code>  <id>27627</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased FSH Secretion</to_name>
    <to_code>T14460</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion</to_name>
    <to_code>T14461</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008630</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrienone [7519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trelstar pamoate [905060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin acetate [236538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix choline [2621020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GABA Activity [PE]</name>
  <code>C27628</code>  <id>27629</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GABA Activity</to_name>
    <to_code>T14462</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008631</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GHRH Activity [PE]</name>
  <code>C27632</code>  <id>27633</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GHRH Activity</to_name>
    <to_code>T14463</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008633</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GHRH Secretion [PE]</name>
  <code>C27634</code>  <id>27635</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GHRH Secretion</to_name>
    <to_code>T14464</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008634</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GI Motility [PE]</name>
  <code>C27636</code>  <id>27637</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility</to_name>
    <to_code>T14465</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008635</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Small Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Esophageal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Biliary Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>attapulgite [18516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated attapulgite [133050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GI Smooth Muscle Tone [PE]</name>
  <code>C27638</code>  <id>27639</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone</to_name>
    <to_code>T14466</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008636</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Small Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gallbladder Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Anal Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pyloric Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased LES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased UES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Esophageal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sphincter of Odi Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine hydrochloride [235229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine [24464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate [59064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate hydrochloride [102170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Gallbladder Tone [PE]</name>
  <code>C27644</code>  <id>27645</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gallbladder Tone</to_name>
    <to_code>T14467</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008639</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Gastric Motility [PE]</name>
  <code>C27646</code>  <id>27647</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility</to_name>
    <to_code>T14468</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008640</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semaglutide [1991302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liraglutide [475968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albiglutide [1534763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dulaglutide [1551291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Gastric Muscle Tone [PE]</name>
  <code>C27648</code>  <id>27649</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastric Muscle Tone</to_name>
    <to_code>T14469</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008641</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Gastrin Activity [PE]</name>
  <code>C27650</code>  <id>27651</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastrin Activity</to_name>
    <to_code>T14470</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008642</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glomerular Filtration Pressure [PE]</name>
  <code>C27652</code>  <id>27653</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glomerular Filtration Pressure</to_name>
    <to_code>T14471</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008643</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucagon Secretion [PE]</name>
  <code>C27654</code>  <id>27655</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion</to_name>
    <to_code>T14472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008644</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin phosphate [621590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semaglutide [1991302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin hydrochloride [2716481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linagliptin [1100699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin anhydrous [1546030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dulaglutide [1551291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin [593411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride dihydrate [2643444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin [857974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride [1043560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucocorticoid Clearance [PE]</name>
  <code>C30246</code>  <id>30247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Clearance</to_name>
    <to_code>T14473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009939</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troleandomycin [10864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Clearance [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucocorticoid Secretion [PE]</name>
  <code>C27656</code>  <id>27657</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion</to_name>
    <to_code>T14474</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008645</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide [1364105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide pamoate [1597818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide diaspartate [1364104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Gluconeogenesis [PE]</name>
  <code>C27658</code>  <id>27659</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis</to_name>
    <to_code>T14475</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008646</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glucose Transport into Cells [PE]</name>
  <code>C27660</code>  <id>27661</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucose Transport into Cells</to_name>
    <to_code>T14476</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008647</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glutamate Activity [PE]</name>
  <code>C27662</code>  <id>27663</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glutamate Activity</to_name>
    <to_code>T14477</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008648</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycine Activity [PE]</name>
  <code>C27664</code>  <id>27665</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycine Activity</to_name>
    <to_code>T14478</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008649</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycogenesis [PE]</name>
  <code>C27666</code>  <id>27667</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenesis</to_name>
    <to_code>T14479</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008650</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycogenolysis [PE]</name>
  <code>C27668</code>  <id>27669</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis</to_name>
    <to_code>T14480</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008651</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Glycolysis [PE]</name>
  <code>C27670</code>  <id>27671</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis</to_name>
    <to_code>T14481</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008652</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide sodium [221173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GnRH Activity [PE]</name>
  <code>C27640</code>  <id>27641</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Activity</to_name>
    <to_code>T14482</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008637</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased GnRH Secretion [PE]</name>
  <code>C27642</code>  <id>27643</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion</to_name>
    <to_code>T14483</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008638</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix acetate [835863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix [475230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Granulocytic Cell Destruction [PE]</name>
  <code>C27672</code>  <id>27673</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Granulocytic Cell Destruction</to_name>
    <to_code>T14484</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008653</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Granulocytic Cell Production [PE]</name>
  <code>C27674</code>  <id>27675</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Granulocytic Cell Production</to_name>
    <to_code>T14485</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008654</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Growth Factor Activity [PE]</name>
  <code>C31822</code>  <id>31823</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity</to_name>
    <to_code>T14486</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010232</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirfenidone [1592254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab [2043855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine [2724363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine hydrochloride [2724364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab-twza [2043854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Growth Hormone Secretion [PE]</name>
  <code>C27630</code>  <id>27631</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GH Secretion</to_name>
    <to_code>T14487</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion</to_name>
    <to_code>T14488</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008632</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide acetate [236167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide [68092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine hydrochloride [2724364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine [2724363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Hair Growth [PE]</name>
  <code>C637776</code>  <id>637776</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hair Growth</to_name>
    <to_code>T14489</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178322</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Hematological Cell Destruction [PE]</name>
  <code>C27676</code>  <id>27677</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematological Cell Destruction</to_name>
    <to_code>T14490</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008655</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythroid Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Hematopoiesis [PE]</name>
  <code>C27678</code>  <id>27679</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis</to_name>
    <to_code>T14491</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008656</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib citrate [1358492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib [1357536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Hematopoietic Stem Cell Mobilization [PE]</name>
  <code>C637779</code>  <id>637779</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoietic Stem Cell Mobilization</to_name>
    <to_code>T14492</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178325</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Activity [PE]</name>
  <code>C27680</code>  <id>27681</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity</to_name>
    <to_code>T14493</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008657</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine hydrochloride [1294532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine hydrochloride [91063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine [10849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine resin complex [314786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine tosylate [1923002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine [135391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine citrate [71533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine [863035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine tannate [221075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine difumarate [221094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine hydrochloride [236961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine [356887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine tartrate [164308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine hydrochloride [71534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen [6146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene [6822]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loratadine [28889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine hydrochloride [236599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine hydrochloride [203150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine besilate [658552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine maleate [142429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine tannate [1099727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine hydrochloride [236474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene hydrochloride [235721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine polistirex [236792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine [10825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine [10847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine [2400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine [20610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine polistirex [221074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline sulfate [2680384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine [28144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine dihydrochloride [402349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine [28627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astemizole [42328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine [87636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen fumarate [11404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine citrate [221141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Degradation [PE]</name>
  <code>C27682</code>  <id>27683</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Degradation</to_name>
    <to_code>T14494</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008658</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Production [PE]</name>
  <code>C27684</code>  <id>27685</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Production</to_name>
    <to_code>T14495</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008659</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Histamine Release [PE]</name>
  <code>C635021</code>  <id>635021</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release</to_name>
    <to_code>T14496</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175628</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol [1424884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil [31563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine [135391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol trifenatate [1424883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil sodium [266663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased IgE Activity [PE]</name>
  <code>C635212</code>  <id>635212</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased IgE Activity</to_name>
    <to_code>T14497</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175793</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab-igec [2725997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased IgE Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab [302379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased IgE Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologic Activity [PE]</name>
  <code>C634943</code>  <id>634943</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immune Suppression</to_name>
    <to_code>T14499</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Suppression</to_name>
    <to_code>T14498</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunosuppression</to_name>
    <to_code>T14500</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity</to_name>
    <to_code>T14502</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immune System Suppression</to_name>
    <to_code>T14501</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175550</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siltuximab [1535218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogenic bone-marrow-derived mesenchymal stem cells [2700761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belimumab [1092437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib [2641595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib citrate [1358492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L [2700765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab [2691526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate [265323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifitegrast [1801820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab-ocsq [2693449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib tosylate [2641596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib phosphate [2716557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L-rknd [2700764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dupilumab [1876376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab-csfr [2691528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib [1357536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Biogenic Amine Activity [PE]</name>
  <code>C27686</code>  <id>27687</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Biogenic Amine Activity</to_name>
    <to_code>T14503</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008660</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Biogenic Amine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Biogenic Amine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</name>
  <code>C27688</code>  <id>27689</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Biogenic Amine Degradation</to_name>
    <to_code>T14504</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008661</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Biogenic Amine Production [PE]</name>
  <code>C27690</code>  <id>27691</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Biogenic Amine Production</to_name>
    <to_code>T14505</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008662</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Biogenic Amine Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Biogenic Amine Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Molecule Activity [PE]</name>
  <code>C27692</code>  <id>27693</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity</to_name>
    <to_code>T14506</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008663</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kallidin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Biogenic Amine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate [265323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus preparation [1312384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer acetate [84375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED [235574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Molecule Degradation [PE]</name>
  <code>C27694</code>  <id>27695</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Degradation</to_name>
    <to_code>T14507</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008664</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kallidin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Biogenic Amine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Immunologically Active Molecule Production [PE]</name>
  <code>C27696</code>  <id>27697</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Production</to_name>
    <to_code>T14508</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008665</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Biogenic Amine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kallidin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 1 [214485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Inorganic Ion Absorption [PE]</name>
  <code>C634921</code>  <id>634921</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption</to_name>
    <to_code>T14509</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175528</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Inorganic Ion Absorption [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Copper Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor hydrochloride [2199673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Insulin Secretion [PE]</name>
  <code>C27698</code>  <id>27699</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Insulin Secretion</to_name>
    <to_code>T14510</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008666</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Intercellular Communication [PE]</name>
  <code>C27700</code>  <id>27701</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intercellular Communication</to_name>
    <to_code>T14511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008667</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intercellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Intraocular Aqueous Secretion [PE]</name>
  <code>C30256</code>  <id>30257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion</to_name>
    <to_code>T14512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009944</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol [1813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol hydrochloride [227212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Intraocular Fluid Pressure [PE]</name>
  <code>C30254</code>  <id>30255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure</to_name>
    <to_code>T14513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009943</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Intraocular Fluid Pressure [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Aqueous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide [60207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>travoprost [283809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbachol [1999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost [43611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafluprost [1244607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine [134615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil mesylate [1992863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag [2612691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimatoprost [283810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine tartrate [39171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag isopropyl [2612690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide hydrochloride [236065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brinzolamide [194881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>unoprostone [1546408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost acid [2675687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl unoprostone [135313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Intravascular Volume [PE]</name>
  <code>C27704</code>  <id>27705</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume</to_name>
    <to_code>T14514</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008669</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Iodine Organification [PE]</name>
  <code>C27706</code>  <id>27707</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Iodine Organification</to_name>
    <to_code>T14515</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008670</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Iodine Organification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Iodine Organification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Iodine Uptake [PE]</name>
  <code>C27708</code>  <id>27709</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Iodine Uptake</to_name>
    <to_code>T14516</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008671</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Kallidin Activity [PE]</name>
  <code>C27710</code>  <id>27711</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kallidin Activity</to_name>
    <to_code>T14517</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008672</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Kallidin Degradation [PE]</name>
  <code>C27712</code>  <id>27713</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kallidin Degradation</to_name>
    <to_code>T14518</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008673</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Kallidin Production [PE]</name>
  <code>C27714</code>  <id>27715</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kallidin Production</to_name>
    <to_code>T14519</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008674</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Kinin Activity [PE]</name>
  <code>C27716</code>  <id>27717</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity</to_name>
    <to_code>T14520</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008675</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Kinin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Kinin Degradation [PE]</name>
  <code>C27718</code>  <id>27719</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Degradation</to_name>
    <to_code>T14521</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008676</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Kinin Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Kinin Production [PE]</name>
  <code>C27720</code>  <id>27721</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Kinin Production</to_name>
    <to_code>T14522</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008677</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Kinin Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bradykinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased LES Tone [PE]</name>
  <code>C27722</code>  <id>27723</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased LES Tone</to_name>
    <to_code>T14523</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008678</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Large Intestinal Motility [PE]</name>
  <code>C27724</code>  <id>27725</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility</to_name>
    <to_code>T14524</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008679</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eluxadoline [1653781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Large Intestinal Muscle Tone [PE]</name>
  <code>C27726</code>  <id>27727</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Muscle Tone</to_name>
    <to_code>T14525</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008680</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Leukotriene Activity [PE]</name>
  <code>C27728</code>  <id>27729</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity</to_name>
    <to_code>T14526</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008681</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Leukotriene Degradation [PE]</name>
  <code>C27730</code>  <id>27731</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Degradation</to_name>
    <to_code>T14527</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008682</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Leukotriene Production [PE]</name>
  <code>C27732</code>  <id>27733</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Production</to_name>
    <to_code>T14528</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008683</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apremilast [1492727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Leukotriene Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</name>
  <code>C27734</code>  <id>27735</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipid Derived Immunologically Active Molecule Activity</to_name>
    <to_code>T14529</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008684</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Eicosanoid Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</name>
  <code>C27736</code>  <id>27737</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipid Derived Immunologically Active Molecule Degradation</to_name>
    <to_code>T14530</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008685</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Eicosanoid Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</name>
  <code>C27738</code>  <id>27739</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipid Derived Immunologically Active Molecule Production</to_name>
    <to_code>T14531</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008686</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Eicosanoid Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipogenesis [PE]</name>
  <code>C27740</code>  <id>27741</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipogenesis</to_name>
    <to_code>T14532</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008687</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lipolysis [PE]</name>
  <code>C27742</code>  <id>27743</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis</to_name>
    <to_code>T14533</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008688</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Ca++ Excretion [PE]</name>
  <code>C27744</code>  <id>27745</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Ca++ Excretion</to_name>
    <to_code>T14534</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008689</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Cl- Excretion [PE]</name>
  <code>C27746</code>  <id>27747</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Cl- Excretion</to_name>
    <to_code>T14535</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008690</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle H+ Excretion [PE]</name>
  <code>C27748</code>  <id>27749</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle H+ Excretion</to_name>
    <to_code>T14536</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008691</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle HCO3- Excretion [PE]</name>
  <code>C27750</code>  <id>27751</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle HCO3- Excretion</to_name>
    <to_code>T14537</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008692</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle K+ Excretion [PE]</name>
  <code>C27752</code>  <id>27753</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle K+ Excretion</to_name>
    <to_code>T14538</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008693</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Mg++ Excretion [PE]</name>
  <code>C27754</code>  <id>27755</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Mg++ Excretion</to_name>
    <to_code>T14539</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008694</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle Na+ Excretion [PE]</name>
  <code>C27756</code>  <id>27757</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Na+ Excretion</to_name>
    <to_code>T14540</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008695</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle PO4-- Excretion [PE]</name>
  <code>C27758</code>  <id>27759</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle PO4-- Excretion</to_name>
    <to_code>T14541</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008696</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Loop of Henle SO4-- Excretion [PE]</name>
  <code>C27760</code>  <id>27761</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle SO4-- Excretion</to_name>
    <to_code>T14542</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008697</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Luteinizing Hormone Secretion [PE]</name>
  <code>C30228</code>  <id>30229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion</to_name>
    <to_code>T14544</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased LH Secretion</to_name>
    <to_code>T14543</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009930</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrienone [7519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin acetate [236538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix choline [2621020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trelstar pamoate [905060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lymphocyte Activation [PE]</name>
  <code>C637783</code>  <id>637783</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation</to_name>
    <to_code>T14545</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178329</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lymphocyte Activation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lymphocyte Activation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod lauryl sulfate [2610292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod [1012892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod hydrochloride [1012891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lymphocyte Cell Destruction [PE]</name>
  <code>C27762</code>  <id>27763</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Destruction</to_name>
    <to_code>T14546</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008698</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lymphocyte Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lymphocyte Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lymphocyte Cell Production [PE]</name>
  <code>C27764</code>  <id>27765</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production</to_name>
    <to_code>T14547</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008699</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lymphocyte Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Lymphocyte Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased B Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basiliximab [196102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate [265323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Lysosomal Function [PE]</name>
  <code>C27766</code>  <id>27767</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function</to_name>
    <to_code>T14548</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008700</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerliponase alfa [1922436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Medullary Respiratory Drive [PE]</name>
  <code>C27768</code>  <id>27769</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive</to_name>
    <to_code>T14549</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008701</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine iodide [203206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Megakaryocte Cell Destruction [PE]</name>
  <code>C27770</code>  <id>27771</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocte Cell Destruction</to_name>
    <to_code>T14550</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008702</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Megakaryocte Cell Production [PE]</name>
  <code>C27772</code>  <id>27773</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocte Cell Production</to_name>
    <to_code>T14551</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008703</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Megakaryocte Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Megakaryocyte Maturation [PE]</name>
  <code>C635425</code>  <id>635425</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocyte Maturation</to_name>
    <to_code>T14552</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175971</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Meiosis [PE]</name>
  <code>C27774</code>  <id>27775</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Meiosis</to_name>
    <to_code>T14553</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008704</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Meiosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Meiosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Meiosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Melatonin Activity [PE]</name>
  <code>C27776</code>  <id>27777</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Melatonin Activity</to_name>
    <to_code>T14554</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008705</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Melatonin Secretion [PE]</name>
  <code>C27778</code>  <id>27779</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Melatonin Secretion</to_name>
    <to_code>T14555</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008706</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Metabolic Rate [PE]</name>
  <code>C27780</code>  <id>27781</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate</to_name>
    <to_code>T14556</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008707</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niclosamide [7402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>helium [5140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine [6704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Acetylcholine Activity [PE]</name>
  <code>C27782</code>  <id>27783</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Acetylcholine Activity</to_name>
    <to_code>T14557</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008708</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Aspartate Activity [PE]</name>
  <code>C27784</code>  <id>27785</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Aspartate Activity</to_name>
    <to_code>T14558</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008709</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Brain Derived Neurotropic Activity [PE]</name>
  <code>C27786</code>  <id>27787</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Brain Derived Neurotropic Activity</to_name>
    <to_code>T14559</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008710</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain CCK Activity [PE]</name>
  <code>C27788</code>  <id>27789</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain CCK Activity</to_name>
    <to_code>T14560</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008711</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Disorganized Electrical Activity [PE]</name>
  <code>C27790</code>  <id>27791</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Disorganized Electrical Activity</to_name>
    <to_code>T14561</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008712</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Dopamine Activity [PE]</name>
  <code>C27792</code>  <id>27793</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Dopamine Activity</to_name>
    <to_code>T14562</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008713</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Dynorphin Activity [PE]</name>
  <code>C27794</code>  <id>27795</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Dynorphin Activity</to_name>
    <to_code>T14563</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008714</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Endorphin Activity [PE]</name>
  <code>C27796</code>  <id>27797</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Endorphin Activity</to_name>
    <to_code>T14564</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008715</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Enkephalin Activity [PE]</name>
  <code>C27798</code>  <id>27799</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Enkephalin Activity</to_name>
    <to_code>T14565</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008716</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Epinephrine Activity [PE]</name>
  <code>C27800</code>  <id>27801</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Epinephrine Activity</to_name>
    <to_code>T14566</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008717</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain GABA Activity [PE]</name>
  <code>C27802</code>  <id>27803</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain GABA Activity</to_name>
    <to_code>T14567</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008718</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Gastrin Activity [PE]</name>
  <code>C27804</code>  <id>27805</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Gastrin Activity</to_name>
    <to_code>T14568</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008719</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Glutamate Activity [PE]</name>
  <code>C27806</code>  <id>27807</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Glutamate Activity</to_name>
    <to_code>T14569</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008720</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Glycine Activity [PE]</name>
  <code>C27808</code>  <id>27809</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Glycine Activity</to_name>
    <to_code>T14570</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008721</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Histamine Activity [PE]</name>
  <code>C27810</code>  <id>27811</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Histamine Activity</to_name>
    <to_code>T14571</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008722</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Nerve Growth Factor Activity [PE]</name>
  <code>C27812</code>  <id>27813</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Nerve Growth Factor Activity</to_name>
    <to_code>T14572</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008723</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Neurotensin Activity [PE]</name>
  <code>C27814</code>  <id>27815</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Neurotensin Activity</to_name>
    <to_code>T14573</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008724</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Nitric Oxide Activity [PE]</name>
  <code>C27816</code>  <id>27817</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Nitric Oxide Activity</to_name>
    <to_code>T14574</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008725</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Norepinephrine Activity [PE]</name>
  <code>C27818</code>  <id>27819</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Norepinephrine Activity</to_name>
    <to_code>T14575</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008726</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Organized Electrical Activity [PE]</name>
  <code>C27820</code>  <id>27821</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Organized Electrical Activity</to_name>
    <to_code>T14576</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008727</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Serotonin Activity [PE]</name>
  <code>C27822</code>  <id>27823</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Serotonin Activity</to_name>
    <to_code>T14577</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008728</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain Substance P Activity [PE]</name>
  <code>C27824</code>  <id>27825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain Substance P Activity</to_name>
    <to_code>T14578</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008729</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Midbrain VIP Activity [PE]</name>
  <code>C27826</code>  <id>27827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Midbrain VIP Activity</to_name>
    <to_code>T14579</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008730</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Mineralocorticoid Secretion [PE]</name>
  <code>C27828</code>  <id>27829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion</to_name>
    <to_code>T14580</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008731</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Mitosis [PE]</name>
  <code>C27830</code>  <id>27831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis</to_name>
    <to_code>T14581</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008732</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetyldithranol [38536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine sulfate [11203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podophyllin [8462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantharidin [1984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine sulfate [11199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc pyrithione [39952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine [11198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine [11202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podofilox [8463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Monocytic Cell Destruction [PE]</name>
  <code>C27832</code>  <id>27833</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Monocytic Cell Destruction</to_name>
    <to_code>T14582</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008733</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Monocytic Cell Production [PE]</name>
  <code>C27834</code>  <id>27835</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Monocytic Cell Production</to_name>
    <to_code>T14583</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008734</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Acetylcholine Activity [PE]</name>
  <code>C27836</code>  <id>27837</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity</to_name>
    <to_code>T14584</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008735</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type B [2167673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Aspartate Activity [PE]</name>
  <code>C27838</code>  <id>27839</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Aspartate Activity</to_name>
    <to_code>T14585</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008736</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Brain Derived Neurotropic Activity [PE]</name>
  <code>C27840</code>  <id>27841</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Brain Derived Neurotropic Activity</to_name>
    <to_code>T14586</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008737</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System CCK Activity [PE]</name>
  <code>C27842</code>  <id>27843</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System CCK Activity</to_name>
    <to_code>T14587</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008738</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Disorganized Electrical Activity [PE]</name>
  <code>C27844</code>  <id>27845</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Disorganized Electrical Activity</to_name>
    <to_code>T14588</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008739</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Dopamine Activity [PE]</name>
  <code>C27846</code>  <id>27847</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Dopamine Activity</to_name>
    <to_code>T14589</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008740</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Dynorphin Activity [PE]</name>
  <code>C27848</code>  <id>27849</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Dynorphin Activity</to_name>
    <to_code>T14590</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008741</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Endorphin Activity [PE]</name>
  <code>C27850</code>  <id>27851</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Endorphin Activity</to_name>
    <to_code>T14591</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008742</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Enkephalin Activity [PE]</name>
  <code>C27852</code>  <id>27853</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Enkephalin Activity</to_name>
    <to_code>T14592</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008743</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Epinephrine Activity [PE]</name>
  <code>C27854</code>  <id>27855</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Epinephrine Activity</to_name>
    <to_code>T14593</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008744</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System GABA Activity [PE]</name>
  <code>C27856</code>  <id>27857</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System GABA Activity</to_name>
    <to_code>T14594</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008745</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Gastrin Activity [PE]</name>
  <code>C27858</code>  <id>27859</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Gastrin Activity</to_name>
    <to_code>T14595</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008746</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Glutamate Activity [PE]</name>
  <code>C27860</code>  <id>27861</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Glutamate Activity</to_name>
    <to_code>T14596</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008747</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Glycine Activity [PE]</name>
  <code>C27862</code>  <id>27863</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Glycine Activity</to_name>
    <to_code>T14597</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008748</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Histamine Activity [PE]</name>
  <code>C27864</code>  <id>27865</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Histamine Activity</to_name>
    <to_code>T14598</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008749</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Nerve Growth Factor Activity [PE]</name>
  <code>C27866</code>  <id>27867</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Nerve Growth Factor Activity</to_name>
    <to_code>T14599</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008750</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Neurotensin Activity [PE]</name>
  <code>C27868</code>  <id>27869</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Neurotensin Activity</to_name>
    <to_code>T14600</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008751</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Nitric Oxide Activity [PE]</name>
  <code>C27870</code>  <id>27871</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Nitric Oxide Activity</to_name>
    <to_code>T14601</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008752</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Norepinephrine Activity [PE]</name>
  <code>C27872</code>  <id>27873</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Norepinephrine Activity</to_name>
    <to_code>T14602</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008753</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Organized Electrical Activity [PE]</name>
  <code>C27874</code>  <id>27875</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Organized Electrical Activity</to_name>
    <to_code>T14603</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008754</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Serotonin Activity [PE]</name>
  <code>C27876</code>  <id>27877</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Serotonin Activity</to_name>
    <to_code>T14604</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008755</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System Substance P Activity [PE]</name>
  <code>C27878</code>  <id>27879</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Substance P Activity</to_name>
    <to_code>T14605</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008756</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Muscular System VIP Activity [PE]</name>
  <code>C27880</code>  <id>27881</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System VIP Activity</to_name>
    <to_code>T14606</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008757</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cardiac Muscle VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Muscular System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Myeloid Cell Destruction [PE]</name>
  <code>C27882</code>  <id>27883</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Destruction</to_name>
    <to_code>T14607</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008758</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Myeloid Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Monocytic Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Myeloid Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Granulocytic Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Myeloid Cell Production [PE]</name>
  <code>C27884</code>  <id>27885</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production</to_name>
    <to_code>T14608</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008759</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Myeloid Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Monocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Myeloid Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Nasal and Sinus Mucosal Edema [PE]</name>
  <code>C30312</code>  <id>30313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Mucosal Edema</to_name>
    <to_code>T14609</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009972</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Nasal and Sinus Secretions [PE]</name>
  <code>C28158</code>  <id>28159</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions</to_name>
    <to_code>T14610</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008896</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Nerve Growth Factor Activity [PE]</name>
  <code>C27888</code>  <id>27889</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nerve Growth Factor Activity</to_name>
    <to_code>T14611</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008761</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Neurotensin Activity [PE]</name>
  <code>C27890</code>  <id>27891</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Neurotensin Activity</to_name>
    <to_code>T14612</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008762</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Nitric Oxide Activity [PE]</name>
  <code>C27892</code>  <id>27893</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nitric Oxide Activity</to_name>
    <to_code>T14613</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008763</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Norepinephrine Activity [PE]</name>
  <code>C27894</code>  <id>27895</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity</to_name>
    <to_code>T14614</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008764</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine tosylate [1923002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacetazine [8338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine hydrochloride [142143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Oncotic Pressure [PE]</name>
  <code>C27896</code>  <id>27897</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Oncotic Pressure</to_name>
    <to_code>T14615</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008765</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Organic Ion Degradation [PE]</name>
  <code>C27898</code>  <id>27899</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organic Ion Degradation</to_name>
    <to_code>T14616</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008766</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Organic Ion Synthesis [PE]</name>
  <code>C27900</code>  <id>27901</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organic Ion Synthesis</to_name>
    <to_code>T14617</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008767</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Organic Ion Synthesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uric Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Organic Ion Synthesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Amino Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomepizole [15226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organic Ion Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Organized Electrical Activity [PE]</name>
  <code>C27902</code>  <id>27903</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity</to_name>
    <to_code>T14618</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008768</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium oxybate [2387309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine hydrochloride [203185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutethimide [4903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxybate [2387308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine hydrochloride [227221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine [35780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride anhydrous [2198974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine [259453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl [237005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethchlorvynol [4118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl acetate hydrochloride [82043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine hydrochloride [53616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxybate [9899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyprylon [6910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine [594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl citrate [142436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon [11363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalbital [19860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloral hydrate [2344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride monohydrate [1298851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine [4171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine hydrochloride [2557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129 [2626219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil hydrochloride [203203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxybate [2387307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine hydrochloride [259454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil citrate [58964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129, hyperpolarized [2626220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemborexant [2272403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine hydrochloride [7433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine [6759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride anhydrous [1375412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil [73032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine [8686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil [56795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinamate [24474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl [4337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dezocine [22713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride [236539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl hydrochloride [1652097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil [480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil hydrochloride [236540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine [20859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Ovarian Estrogen Secretion [PE]</name>
  <code>C27904</code>  <id>27905</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion</to_name>
    <to_code>T14619</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008769</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvestrant [282357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letrozole [72965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anastrozole [84857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exemestane [258494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Ovarian Progesterone Secretion [PE]</name>
  <code>C27906</code>  <id>27907</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Progesterone Secretion</to_name>
    <to_code>T14620</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008770</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Progesterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Oxygen Carrying Capacity [PE]</name>
  <code>C27908</code>  <id>27909</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Oxygen Carrying Capacity</to_name>
    <to_code>T14621</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008771</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Oxytocin Secretion [PE]</name>
  <code>C27910</code>  <id>27911</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Oxytocin Secretion</to_name>
    <to_code>T14622</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008772</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased PIF Activity [PE]</name>
  <code>C27912</code>  <id>27913</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PIF Activity</to_name>
    <to_code>T14623</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008773</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased PIF Secretion [PE]</name>
  <code>C27914</code>  <id>27915</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PIF Secretion</to_name>
    <to_code>T14624</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008774</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased PRF Activity [PE]</name>
  <code>C27916</code>  <id>27917</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PRF Activity</to_name>
    <to_code>T14625</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008775</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased PRF Secretion [PE]</name>
  <code>C27918</code>  <id>27919</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PRF Secretion</to_name>
    <to_code>T14626</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008776</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased PTH Secretion [PE]</name>
  <code>C27920</code>  <id>27921</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion</to_name>
    <to_code>T14627</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008777</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide [1876119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide hydrochloride [1876122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paricalcitol [73710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Pancreatic Somatostatin Secretion [PE]</name>
  <code>C27922</code>  <id>27923</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pancreatic Somatostatin Secretion</to_name>
    <to_code>T14628</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008778</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Acetylcholine Activity [PE]</name>
  <code>C27924</code>  <id>27925</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity</to_name>
    <to_code>T14629</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008779</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine hydrobromide [235428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate hydrochloride [106029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate [3001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl hydrochloride [1115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl [10811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide monohydrate [1298831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropicamide [10869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide mono [1552007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Activity [PE]</name>
  <code>C635041</code>  <id>635041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parasympatholytic Activity</to_name>
    <to_code>T14630</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity</to_name>
    <to_code>T14631</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175648</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline [37815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline hydrochloride [235839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Aspartate Activity [PE]</name>
  <code>C27926</code>  <id>27927</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Aspartate Activity</to_name>
    <to_code>T14632</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008780</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Brain Derived Neurotropic Activity [PE]</name>
  <code>C27928</code>  <id>27929</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Brain Derived Neurotropic Activity</to_name>
    <to_code>T14633</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008781</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic CCK Activity [PE]</name>
  <code>C27930</code>  <id>27931</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic CCK Activity</to_name>
    <to_code>T14634</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008782</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Disorganized Electrical Activity [PE]</name>
  <code>C27932</code>  <id>27933</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Disorganized Electrical Activity</to_name>
    <to_code>T14635</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008783</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Dopamine Activity [PE]</name>
  <code>C27934</code>  <id>27935</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Dopamine Activity</to_name>
    <to_code>T14636</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008784</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Dynorphin Activity [PE]</name>
  <code>C27936</code>  <id>27937</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Dynorphin Activity</to_name>
    <to_code>T14637</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008785</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Endorphin Activity [PE]</name>
  <code>C27938</code>  <id>27939</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Endorphin Activity</to_name>
    <to_code>T14638</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008786</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Enkephalin Activity [PE]</name>
  <code>C27940</code>  <id>27941</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Enkephalin Activity</to_name>
    <to_code>T14639</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008787</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Epinephrine Activity [PE]</name>
  <code>C27942</code>  <id>27943</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Epinephrine Activity</to_name>
    <to_code>T14640</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008788</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic GABA Activity [PE]</name>
  <code>C27944</code>  <id>27945</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic GABA Activity</to_name>
    <to_code>T14641</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008789</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Gastrin Activity [PE]</name>
  <code>C27946</code>  <id>27947</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Gastrin Activity</to_name>
    <to_code>T14642</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008790</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Glutamate Activity [PE]</name>
  <code>C27948</code>  <id>27949</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Glutamate Activity</to_name>
    <to_code>T14643</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008791</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Glycine Activity [PE]</name>
  <code>C27950</code>  <id>27951</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Glycine Activity</to_name>
    <to_code>T14644</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008792</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Histamine Activity [PE]</name>
  <code>C27952</code>  <id>27953</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Histamine Activity</to_name>
    <to_code>T14645</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008793</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Nerve Growth Factor Activity [PE]</name>
  <code>C27954</code>  <id>27955</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Nerve Growth Factor Activity</to_name>
    <to_code>T14646</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008794</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Neurotensin Activity [PE]</name>
  <code>C27956</code>  <id>27957</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Neurotensin Activity</to_name>
    <to_code>T14647</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008795</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Nitric Oxide Activity [PE]</name>
  <code>C27958</code>  <id>27959</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Nitric Oxide Activity</to_name>
    <to_code>T14648</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008796</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Norepinephrine Activity [PE]</name>
  <code>C27960</code>  <id>27961</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Norepinephrine Activity</to_name>
    <to_code>T14649</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008797</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Organized Electrical Activity [PE]</name>
  <code>C27962</code>  <id>27963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Organized Electrical Activity</to_name>
    <to_code>T14650</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008798</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Serotonin Activity [PE]</name>
  <code>C27964</code>  <id>27965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Serotonin Activity</to_name>
    <to_code>T14651</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008799</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic Substance P Activity [PE]</name>
  <code>C27966</code>  <id>27967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Substance P Activity</to_name>
    <to_code>T14652</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008800</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Parasympathetic VIP Activity [PE]</name>
  <code>C27968</code>  <id>27969</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic VIP Activity</to_name>
    <to_code>T14653</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008801</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Acetylcholine Activity [PE]</name>
  <code>C27970</code>  <id>27971</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Acetylcholine Activity</to_name>
    <to_code>T14654</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008802</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Aspartate Activity [PE]</name>
  <code>C27972</code>  <id>27973</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Aspartate Activity</to_name>
    <to_code>T14655</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008803</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C27974</code>  <id>27975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T14656</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008804</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System CCK Activity [PE]</name>
  <code>C27976</code>  <id>27977</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System CCK Activity</to_name>
    <to_code>T14657</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008805</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C27978</code>  <id>27979</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T14658</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008806</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Dopamine Activity [PE]</name>
  <code>C27980</code>  <id>27981</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Dopamine Activity</to_name>
    <to_code>T14659</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008807</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</name>
  <code>C27982</code>  <id>27983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Dynorphin Activity</to_name>
    <to_code>T14660</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008808</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Endorphin Activity [PE]</name>
  <code>C27984</code>  <id>27985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Endorphin Activity</to_name>
    <to_code>T14661</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008809</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</name>
  <code>C27986</code>  <id>27987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Enkephalin Activity</to_name>
    <to_code>T14662</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008810</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Epinephrine Activity [PE]</name>
  <code>C27988</code>  <id>27989</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Epinephrine Activity</to_name>
    <to_code>T14663</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008811</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System GABA Activity [PE]</name>
  <code>C27990</code>  <id>27991</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System GABA Activity</to_name>
    <to_code>T14664</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008812</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Gastrin Activity [PE]</name>
  <code>C27992</code>  <id>27993</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Gastrin Activity</to_name>
    <to_code>T14665</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008813</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Glutamate Activity [PE]</name>
  <code>C27994</code>  <id>27995</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Glutamate Activity</to_name>
    <to_code>T14666</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008814</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Glycine Activity [PE]</name>
  <code>C27996</code>  <id>27997</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Glycine Activity</to_name>
    <to_code>T14667</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008815</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Histamine Activity [PE]</name>
  <code>C27998</code>  <id>27999</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Histamine Activity</to_name>
    <to_code>T14668</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008816</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C28000</code>  <id>28001</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T14669</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008817</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Neurotensin Activity [PE]</name>
  <code>C28002</code>  <id>28003</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Neurotensin Activity</to_name>
    <to_code>T14670</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008818</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Nitric Oxide Activity [PE]</name>
  <code>C28004</code>  <id>28005</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Nitric Oxide Activity</to_name>
    <to_code>T14671</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008819</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Norepinephrine Activity [PE]</name>
  <code>C28006</code>  <id>28007</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Norepinephrine Activity</to_name>
    <to_code>T14672</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008820</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</name>
  <code>C28008</code>  <id>28009</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Organized Electrical Activity</to_name>
    <to_code>T14673</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008821</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Serotonin Activity [PE]</name>
  <code>C28010</code>  <id>28011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity</to_name>
    <to_code>T14674</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008822</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron hydrochloride [397405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride anhydrous [2119176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System Substance P Activity [PE]</name>
  <code>C28012</code>  <id>28013</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Substance P Activity</to_name>
    <to_code>T14675</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008823</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Nervous System VIP Activity [PE]</name>
  <code>C28014</code>  <id>28015</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System VIP Activity</to_name>
    <to_code>T14676</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008824</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Autonomic Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enteric Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Peripheral Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Peripheral Respiratory Drive [PE]</name>
  <code>C28016</code>  <id>28017</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Respiratory Drive</to_name>
    <to_code>T14677</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008825</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Phagocytosis [PE]</name>
  <code>C28018</code>  <id>28019</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Phagocytosis</to_name>
    <to_code>T14678</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008826</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Pharyngeal Mucosal Edema [PE]</name>
  <code>C30310</code>  <id>30311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pharyngeal Mucosal Edema</to_name>
    <to_code>T14679</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009971</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Pharyngeal Secretions [PE]</name>
  <code>C27886</code>  <id>27887</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pharyngeal Secretions</to_name>
    <to_code>T14680</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008760</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Pinocytosis [PE]</name>
  <code>C28020</code>  <id>28021</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pinocytosis</to_name>
    <to_code>T14681</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008827</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Placental Human Chorionic Gonadotropin Secretion [PE]</name>
  <code>C28022</code>  <id>28023</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Placental HCG Secretion</to_name>
    <to_code>T14682</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Placental Human Chorionic Gonadotropin Secretion</to_name>
    <to_code>T14683</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008828</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol [24591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Placental Human Chorionic Gonadotropin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Placental Human Chorionic Gonadotropin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Activating Factor Activity [PE]</name>
  <code>C28024</code>  <id>28025</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Activity</to_name>
    <to_code>T14684</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008829</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil [27403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil tartrate [289912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Activating Factor Degradation [PE]</name>
  <code>C28026</code>  <id>28027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Degradation</to_name>
    <to_code>T14685</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008830</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Activating Factor Production [PE]</name>
  <code>C28028</code>  <id>28029</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production</to_name>
    <to_code>T14686</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008831</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Aggregation [PE]</name>
  <code>C28030</code>  <id>28031</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation</to_name>
    <to_code>T14687</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008832</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab-yhdp [2110604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel hydrochloride [847020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticagrelor [1116632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel [613391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine hydrochloride [97]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel bisulfate [236991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor tetrasodium [1656051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oil of garlic [1309210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel [32968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar [1537034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar sulfate [1537050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abciximab [83929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine [10594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor [1656052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab [2110605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Platelet Production [PE]</name>
  <code>C635426</code>  <id>635426</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production</to_name>
    <to_code>T14688</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175972</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen [2099289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen sodium [2099290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Polymorphonuclear Leukocyte Migration [PE]</name>
  <code>C31850</code>  <id>31851</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration</to_name>
    <to_code>T14689</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010246</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prolactin Secretion [PE]</name>
  <code>C28032</code>  <id>28033</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion</to_name>
    <to_code>T14690</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008833</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostaglandin Activity [PE]</name>
  <code>C28034</code>  <id>28035</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity</to_name>
    <to_code>T14691</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008834</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostaglandin Degradation [PE]</name>
  <code>C28036</code>  <id>28037</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Degradation</to_name>
    <to_code>T14692</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008835</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostaglandin Production [PE]</name>
  <code>C28038</code>  <id>28039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production</to_name>
    <to_code>T14693</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008836</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, porcine [1306202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate (shark) [1789516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nepafenac [298665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suprofen [10255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin potassium [660767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac [35827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carprofen [20343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (porcine) [1366974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (bovine) [1299929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone piperazine [236354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacetin [8113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trolamine salicylate [38866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, bovine [1306129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone sodium [236529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rofecoxib [232158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valdecoxib [278567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (shark) [1358172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate A sodium [476847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meloxicam [41493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostatic Secretion [PE]</name>
  <code>C28040</code>  <id>28041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostatic Secretion</to_name>
    <to_code>T14694</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008837</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prostatic Size [PE]</name>
  <code>C28042</code>  <id>28043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostatic Size</to_name>
    <to_code>T14695</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008838</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostatic Size [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Protein Breakdown [PE]</name>
  <code>C28044</code>  <id>28045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Breakdown</to_name>
    <to_code>T14696</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008839</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Protein Modification [PE]</name>
  <code>C28046</code>  <id>28047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification</to_name>
    <to_code>T14697</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008840</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab [2107301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab-cwvz [2107316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Protein Synthesis [PE]</name>
  <code>C28048</code>  <id>28049</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis</to_name>
    <to_code>T14698</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008841</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran [2053490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine [1546446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gramicidin [5011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir [358262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen sodium [2637346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir ethanolate [644682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate, liposomal [2059179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen sodium [2724362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin liposomal [2059180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen sodium [1367838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine [11194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipranavir [190548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine anhydrous [2108659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethionamide [4127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox-tdfk [2099305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir [114289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate [2640868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin mesylate [221177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telithromycin [274786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir hydrate [2637854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen [2637345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate glucuronate [38725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir mesylate [266565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fitusiran [2709439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran lipid complex [2284711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troleandomycin [10864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetyldithranol [38536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline tosylate [2059268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir sulfate [203153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen sodium [314633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline [2055906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp-erzs [2109054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleandomycin [7629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir calcium [402365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium [2053491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium lipid complex [2284710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retapamulin [642274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox [2099295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin [115552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen [1367839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir anhydrous [1546024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate [42333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxithromycin [9478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin acetate [2198943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate tetrahydrate [1306069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin hydrochloride [267342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline dihydrochloride [2055907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen [2724361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen [85763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline hydrochloride [2059038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin [270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofersen [2634995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Prothrombin Activity [PE]</name>
  <code>C654232</code>  <id>654232</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prothrombin Activity</to_name>
    <to_code>T58743</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193995</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prothrombin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Ca++ Excretion [PE]</name>
  <code>C28050</code>  <id>28051</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Ca++ Excretion</to_name>
    <to_code>T14699</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008842</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Cl- Excretion [PE]</name>
  <code>C28052</code>  <id>28053</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Cl- Excretion</to_name>
    <to_code>T14700</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008843</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule H+ Excretion [PE]</name>
  <code>C28054</code>  <id>28055</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule H+ Excretion</to_name>
    <to_code>T14701</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008844</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule HCO3- Excretion [PE]</name>
  <code>C28056</code>  <id>28057</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule HCO3- Excretion</to_name>
    <to_code>T14702</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008845</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule K+ Excretion [PE]</name>
  <code>C28058</code>  <id>28059</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule K+ Excretion</to_name>
    <to_code>T14703</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008846</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Mg++ Excretion [PE]</name>
  <code>C28060</code>  <id>28061</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Mg++ Excretion</to_name>
    <to_code>T14704</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008847</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule Na+ Excretion [PE]</name>
  <code>C28062</code>  <id>28063</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Na+ Excretion</to_name>
    <to_code>T14705</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008848</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule PO4-- Excretion [PE]</name>
  <code>C28064</code>  <id>28065</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion</to_name>
    <to_code>T14706</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008849</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Proximal Tubule SO4-- Excretion [PE]</name>
  <code>C28066</code>  <id>28067</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule SO4-- Excretion</to_name>
    <to_code>T14707</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008850</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Pyloric Sphincter Tone [PE]</name>
  <code>C28068</code>  <id>28069</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pyloric Sphincter Tone</to_name>
    <to_code>T14708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008851</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased RNA Integrity [PE]</name>
  <code>C28070</code>  <id>28071</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity</to_name>
    <to_code>T14709</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008852</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eteplirsen [1810569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen sodium [2637346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofersen [2634995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen [2099289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran [2604578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium lipid complex [2284710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran sodium [2265859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium [2053491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen [2637345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran [2265712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen [1367839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fitusiran [2709439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen sodium [2099290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran [2053490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran lipid complex [2284711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen sodium [1367838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased RNA Replication [PE]</name>
  <code>C28072</code>  <id>28073</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication</to_name>
    <to_code>T14710</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008853</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate [42333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir marboxil [2099995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remdesivir [2284718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir [2197842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidaxomicin [1111103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate glucuronate [38725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Ca++ Excretion [PE]</name>
  <code>C28074</code>  <id>28075</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion</to_name>
    <to_code>T14711</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008854</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Cl- Excretion [PE]</name>
  <code>C28076</code>  <id>28077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Cl- Excretion</to_name>
    <to_code>T14712</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008855</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal H+ Excretion [PE]</name>
  <code>C28078</code>  <id>28079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal H+ Excretion</to_name>
    <to_code>T14713</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008856</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal HCO3- Excretion [PE]</name>
  <code>C28080</code>  <id>28081</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal HCO3- Excretion</to_name>
    <to_code>T14714</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008857</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Ion Excretion [PE]</name>
  <code>C28082</code>  <id>28083</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ion Excretion</to_name>
    <to_code>T14715</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008858</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Urea Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal K+ Excretion [PE]</name>
  <code>C28084</code>  <id>28085</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion</to_name>
    <to_code>T14716</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008859</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Mg++ Excretion [PE]</name>
  <code>C28086</code>  <id>28087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Mg++ Excretion</to_name>
    <to_code>T14717</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008860</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Na+ Excretion [PE]</name>
  <code>C28088</code>  <id>28089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Na+ Excretion</to_name>
    <to_code>T14718</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008861</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone pivalate [22537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Organic Anion Excretion [PE]</name>
  <code>C28090</code>  <id>28091</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Anion Excretion</to_name>
    <to_code>T14719</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008862</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Organic Cation Excretion [PE]</name>
  <code>C28092</code>  <id>28093</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Cation Excretion</to_name>
    <to_code>T14720</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008863</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Organic Ion Excretion [PE]</name>
  <code>C28094</code>  <id>28095</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Ion Excretion</to_name>
    <to_code>T14721</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008864</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Organic Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Anion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal Organic Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Cation Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal PO4-- Excretion [PE]</name>
  <code>C28096</code>  <id>28097</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal PO4-- Excretion</to_name>
    <to_code>T14722</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008865</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal SO4-- Excretion [PE]</name>
  <code>C28098</code>  <id>28099</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal SO4-- Excretion</to_name>
    <to_code>T14723</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008866</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Distal Tubule SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Proximal Tubule SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Collecting Duct SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Loop of Henle SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Renal Urea Excretion [PE]</name>
  <code>C31836</code>  <id>31837</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Urea Excretion</to_name>
    <to_code>T14724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010239</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Respiratory Mucosal Edema [PE]</name>
  <code>C30298</code>  <id>30299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Mucosal Edema</to_name>
    <to_code>T14725</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009965</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Respiratory Mucosal Edema [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pharyngeal Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Respiratory Mucosal Edema [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Respiratory Mucosal Edema [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Respiratory Secretion Viscosity [PE]</name>
  <code>C28100</code>  <id>28101</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity</to_name>
    <to_code>T14726</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008867</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide I123 [91531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Respiratory Secretions [PE]</name>
  <code>C28102</code>  <id>28103</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions</to_name>
    <to_code>T14727</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008868</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Respiratory Secretions [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Respiratory Secretions [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Respiratory Secretions [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pharyngeal Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Reverse Transcription to DNA [PE]</name>
  <code>C28104</code>  <id>28105</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA</to_name>
    <to_code>T14728</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008869</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib camsylate [1862578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emtricitabine [276237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat lactate [1603349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zidovudine [11413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide [1721603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil succinate [1928942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat [1603350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil [300195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zalcitabine [3363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir anhydrous [1546017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir [1999660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir sodium [1999661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sebaceous Gland Activity [PE]</name>
  <code>C30332</code>  <id>30333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity</to_name>
    <to_code>T14729</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009982</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol [35382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoyl peroxide [1418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin microsphere [221175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sebaceous Gland Quantity [PE]</name>
  <code>C30326</code>  <id>30327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Quantity</to_name>
    <to_code>T14730</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009979</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Quantity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin microsphere [221175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Quantity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity [PE]</name>
  <code>C28106</code>  <id>28107</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Acetylcholine Activity</to_name>
    <to_code>T14731</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008870</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Aspartate Activity [PE]</name>
  <code>C28108</code>  <id>28109</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Aspartate Activity</to_name>
    <to_code>T14732</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008871</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C28110</code>  <id>28111</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T14733</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008872</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System CCK Activity [PE]</name>
  <code>C28112</code>  <id>28113</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System CCK Activity</to_name>
    <to_code>T14734</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008873</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C28114</code>  <id>28115</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T14735</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008874</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Dopamine Activity [PE]</name>
  <code>C28116</code>  <id>28117</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Dopamine Activity</to_name>
    <to_code>T14736</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008875</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Dynorphin Activity [PE]</name>
  <code>C28118</code>  <id>28119</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Dynorphin Activity</to_name>
    <to_code>T14737</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008876</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Endorphin Activity [PE]</name>
  <code>C28120</code>  <id>28121</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Endorphin Activity</to_name>
    <to_code>T14738</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008877</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Enkephalin Activity [PE]</name>
  <code>C28122</code>  <id>28123</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Enkephalin Activity</to_name>
    <to_code>T14739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008878</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Epinephrine Activity [PE]</name>
  <code>C28124</code>  <id>28125</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Epinephrine Activity</to_name>
    <to_code>T14740</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008879</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System GABA Activity [PE]</name>
  <code>C28126</code>  <id>28127</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System GABA Activity</to_name>
    <to_code>T14741</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008880</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Gastrin Activity [PE]</name>
  <code>C28128</code>  <id>28129</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Gastrin Activity</to_name>
    <to_code>T14742</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008881</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Glutamate Activity [PE]</name>
  <code>C28130</code>  <id>28131</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Glutamate Activity</to_name>
    <to_code>T14743</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008882</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Glycine Activity [PE]</name>
  <code>C28132</code>  <id>28133</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Glycine Activity</to_name>
    <to_code>T14744</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008883</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Histamine Activity [PE]</name>
  <code>C28134</code>  <id>28135</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Histamine Activity</to_name>
    <to_code>T14745</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008884</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C28136</code>  <id>28137</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T14746</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008885</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Neurotensin Activity [PE]</name>
  <code>C28138</code>  <id>28139</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Neurotensin Activity</to_name>
    <to_code>T14747</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008886</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</name>
  <code>C28140</code>  <id>28141</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Nitric Oxide Activity</to_name>
    <to_code>T14748</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008887</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</name>
  <code>C28142</code>  <id>28143</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Norepinephrine Activity</to_name>
    <to_code>T14749</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008888</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</name>
  <code>C28144</code>  <id>28145</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity</to_name>
    <to_code>T14750</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008889</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor [1952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine [34905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine hydrochloride [2117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine [10391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol glucuronide [2704947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenol [33290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate [18889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine [23744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butacaine [1829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor (natural) [1298738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol [6750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine hydrochloride [91188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl chloride [4141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liquefied phenol [239351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha,alpha-dibromo-d-camphor [1858362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine hydrochloride [227778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine [592464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor oil [1297880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate hydrochloride [235398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine hydrochloride [91189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol, (+)- [1648123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Serotonin Activity [PE]</name>
  <code>C28146</code>  <id>28147</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Serotonin Activity</to_name>
    <to_code>T14751</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008890</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System Substance P Activity [PE]</name>
  <code>C28148</code>  <id>28149</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System Substance P Activity</to_name>
    <to_code>T14752</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008891</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sensory-Somatic Nervous System VIP Activity [PE]</name>
  <code>C28150</code>  <id>28151</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sensory-Somatic Nervous System VIP Activity</to_name>
    <to_code>T14753</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008892</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Serotonin Activity [PE]</name>
  <code>C28152</code>  <id>28153</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity</to_name>
    <to_code>T14754</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008893</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron [26237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flibanserin [1665509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron hydrochloride [142149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine tosylate [1923002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Serotonin Degradation [PE]</name>
  <code>C28154</code>  <id>28155</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation</to_name>
    <to_code>T14755</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008894</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine mesylate [236189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Serotonin Production [PE]</name>
  <code>C28156</code>  <id>28157</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Production</to_name>
    <to_code>T14756</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008895</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat [1872382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat ethyl [1872441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat etiprate [1872448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Skin Keratinization [PE]</name>
  <code>C29836</code>  <id>29837</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratolytic Activity</to_name>
    <to_code>T14757</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Exfoliant Acitivity</to_name>
    <to_code>T14758</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization</to_name>
    <to_code>T14759</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009735</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin [508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etretinate [4182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin, (+)- [1739978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lactate [215247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Small Intestinal Motility [PE]</name>
  <code>C28160</code>  <id>28161</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Small Intestinal Motility</to_name>
    <to_code>T14760</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008897</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Small Intestinal Muscle Tone [PE]</name>
  <code>C28162</code>  <id>28163</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Small Intestinal Muscle Tone</to_name>
    <to_code>T14761</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008898</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Small Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Small Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Acetylcholine Activity [PE]</name>
  <code>C28164</code>  <id>28165</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Acetylcholine Activity</to_name>
    <to_code>T14762</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008899</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Aspartate Activity [PE]</name>
  <code>C28166</code>  <id>28167</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Aspartate Activity</to_name>
    <to_code>T14763</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008900</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Brain Derived Neurotropic Activity [PE]</name>
  <code>C28168</code>  <id>28169</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Brain Derived Neurotropic Activity</to_name>
    <to_code>T14764</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008901</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle CCK Activity [PE]</name>
  <code>C28170</code>  <id>28171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle CCK Activity</to_name>
    <to_code>T14765</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008902</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Disorganized Electrical Activity [PE]</name>
  <code>C28172</code>  <id>28173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Disorganized Electrical Activity</to_name>
    <to_code>T14766</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008903</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Dopamine Activity [PE]</name>
  <code>C28174</code>  <id>28175</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Dopamine Activity</to_name>
    <to_code>T14767</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008904</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Dynorphin Activity [PE]</name>
  <code>C28176</code>  <id>28177</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Dynorphin Activity</to_name>
    <to_code>T14768</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008905</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Endorphin Activity [PE]</name>
  <code>C28178</code>  <id>28179</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Endorphin Activity</to_name>
    <to_code>T14769</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008906</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Enkephalin Activity [PE]</name>
  <code>C28180</code>  <id>28181</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Enkephalin Activity</to_name>
    <to_code>T14770</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008907</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Epinephrine Activity [PE]</name>
  <code>C28182</code>  <id>28183</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Epinephrine Activity</to_name>
    <to_code>T14771</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008908</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle GABA Activity [PE]</name>
  <code>C28184</code>  <id>28185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle GABA Activity</to_name>
    <to_code>T14772</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008909</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Gastrin Activity [PE]</name>
  <code>C28186</code>  <id>28187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Gastrin Activity</to_name>
    <to_code>T14773</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008910</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Glutamate Activity [PE]</name>
  <code>C28188</code>  <id>28189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Glutamate Activity</to_name>
    <to_code>T14774</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008911</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Glycine Activity [PE]</name>
  <code>C28190</code>  <id>28191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Glycine Activity</to_name>
    <to_code>T14775</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008912</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Histamine Activity [PE]</name>
  <code>C28192</code>  <id>28193</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Histamine Activity</to_name>
    <to_code>T14776</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008913</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Nerve Growth Factor Activity [PE]</name>
  <code>C28194</code>  <id>28195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Nerve Growth Factor Activity</to_name>
    <to_code>T14777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008914</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Neurotensin Activity [PE]</name>
  <code>C28196</code>  <id>28197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Neurotensin Activity</to_name>
    <to_code>T14778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008915</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Nitric Oxide Activity [PE]</name>
  <code>C28198</code>  <id>28199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Nitric Oxide Activity</to_name>
    <to_code>T14779</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008916</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Norepinephrine Activity [PE]</name>
  <code>C28200</code>  <id>28201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Norepinephrine Activity</to_name>
    <to_code>T14780</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008917</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Organized Electrical Activity [PE]</name>
  <code>C28202</code>  <id>28203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Organized Electrical Activity</to_name>
    <to_code>T14781</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008918</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Serotonin Activity [PE]</name>
  <code>C28204</code>  <id>28205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Serotonin Activity</to_name>
    <to_code>T14782</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008919</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle Substance P Activity [PE]</name>
  <code>C28206</code>  <id>28207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle Substance P Activity</to_name>
    <to_code>T14783</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008920</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Smooth Muscle VIP Activity [PE]</name>
  <code>C28208</code>  <id>28209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Smooth Muscle VIP Activity</to_name>
    <to_code>T14784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008921</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Somatostatin (SRIF) Activity [PE]</name>
  <code>C28210</code>  <id>28211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Somatostatin (SRIF) Activity</to_name>
    <to_code>T14785</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008922</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Somatostatin (SRIF) Secretion [PE]</name>
  <code>C28212</code>  <id>28213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Somatostatin (SRIF) Secretion</to_name>
    <to_code>T14786</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008923</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sperm Motility [PE]</name>
  <code>C28214</code>  <id>28215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sperm Motility</to_name>
    <to_code>T14787</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008924</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper [2837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sperm Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper Cu-64 [2200143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sperm Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sphincter of Odi Tone [PE]</name>
  <code>C28216</code>  <id>28217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sphincter of Odi Tone</to_name>
    <to_code>T14788</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008925</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sphincter of Odi Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sphincter of Odi Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Acetylcholine Activity [PE]</name>
  <code>C28218</code>  <id>28219</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Acetylcholine Activity</to_name>
    <to_code>T14789</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008926</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Aspartate Activity [PE]</name>
  <code>C28220</code>  <id>28221</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Aspartate Activity</to_name>
    <to_code>T14790</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008927</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Brain Derived Neurotropic Activity [PE]</name>
  <code>C28222</code>  <id>28223</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Brain Derived Neurotropic Activity</to_name>
    <to_code>T14791</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008928</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord CCK Activity [PE]</name>
  <code>C28224</code>  <id>28225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord CCK Activity</to_name>
    <to_code>T14792</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008929</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Disorganized Electrical Activity [PE]</name>
  <code>C28226</code>  <id>28227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Disorganized Electrical Activity</to_name>
    <to_code>T14793</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008930</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Dopamine Activity [PE]</name>
  <code>C28228</code>  <id>28229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Dopamine Activity</to_name>
    <to_code>T14794</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008931</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Dynorphin Activity [PE]</name>
  <code>C28230</code>  <id>28231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Dynorphin Activity</to_name>
    <to_code>T14795</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008932</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Endorphin Activity [PE]</name>
  <code>C28232</code>  <id>28233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Endorphin Activity</to_name>
    <to_code>T14796</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008933</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Enkephalin Activity [PE]</name>
  <code>C28234</code>  <id>28235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Enkephalin Activity</to_name>
    <to_code>T14797</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008934</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Epinephrine Activity [PE]</name>
  <code>C28236</code>  <id>28237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Epinephrine Activity</to_name>
    <to_code>T14798</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008935</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord GABA Activity [PE]</name>
  <code>C28238</code>  <id>28239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord GABA Activity</to_name>
    <to_code>T14799</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008936</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Gastrin Activity [PE]</name>
  <code>C28240</code>  <id>28241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Gastrin Activity</to_name>
    <to_code>T14800</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008937</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Glutamate Activity [PE]</name>
  <code>C28242</code>  <id>28243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Glutamate Activity</to_name>
    <to_code>T14801</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008938</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Glycine Activity [PE]</name>
  <code>C28244</code>  <id>28245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Glycine Activity</to_name>
    <to_code>T14802</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008939</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Histamine Activity [PE]</name>
  <code>C28246</code>  <id>28247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Histamine Activity</to_name>
    <to_code>T14803</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008940</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Nerve Growth Factor Activity [PE]</name>
  <code>C28248</code>  <id>28249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Nerve Growth Factor Activity</to_name>
    <to_code>T14804</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008941</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Neurotensin Activity [PE]</name>
  <code>C28250</code>  <id>28251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Neurotensin Activity</to_name>
    <to_code>T14805</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008942</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Nitric Oxide Activity [PE]</name>
  <code>C28252</code>  <id>28253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Nitric Oxide Activity</to_name>
    <to_code>T14806</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008943</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Norepinephrine Activity [PE]</name>
  <code>C28254</code>  <id>28255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Norepinephrine Activity</to_name>
    <to_code>T14807</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008944</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Organized Electrical Activity [PE]</name>
  <code>C28256</code>  <id>28257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Organized Electrical Activity</to_name>
    <to_code>T14808</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008945</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Serotonin Activity [PE]</name>
  <code>C28258</code>  <id>28259</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Serotonin Activity</to_name>
    <to_code>T14809</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008946</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord Substance P Activity [PE]</name>
  <code>C28260</code>  <id>28261</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord Substance P Activity</to_name>
    <to_code>T14810</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008947</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Spinal Cord VIP Activity [PE]</name>
  <code>C28262</code>  <id>28263</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Spinal Cord VIP Activity</to_name>
    <to_code>T14811</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008948</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sterol Synthesis [PE]</name>
  <code>C31806</code>  <id>31807</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sterol Synthesis</to_name>
    <to_code>T14812</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010224</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Acetylcholine Activity [PE]</name>
  <code>C28264</code>  <id>28265</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity</to_name>
    <to_code>T14813</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008949</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Aspartate Activity [PE]</name>
  <code>C28266</code>  <id>28267</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Aspartate Activity</to_name>
    <to_code>T14814</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008950</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Brain Derived Neurotropic Activity [PE]</name>
  <code>C28268</code>  <id>28269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Brain Derived Neurotropic Activity</to_name>
    <to_code>T14815</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008951</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle CCK Activity [PE]</name>
  <code>C28270</code>  <id>28271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle CCK Activity</to_name>
    <to_code>T14816</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008952</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Contraction [PE]</name>
  <code>C28272</code>  <id>28273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction</to_name>
    <to_code>T14817</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008953</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium bromide [66983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine iodide [262295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium besylate [1219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium chloride [52796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl hydrochloride [1115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium [33742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium [262100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium chloride [49275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine [10917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride [3565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suxamethonium bromide [121039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium cation [1546399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium [319864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium [23651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine chloride [82115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium [1218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium bromide [32521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium bromide [11153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine [10154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl [10811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium bromide [228530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine iodide [203206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium [71535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallamine triethiodide [4639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium [7883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium bromide [7884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride dihydrate [2397714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium besylate [136561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium [30077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Disorganized Electrical Activity [PE]</name>
  <code>C28274</code>  <id>28275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Disorganized Electrical Activity</to_name>
    <to_code>T14818</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008954</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Dopamine Activity [PE]</name>
  <code>C28276</code>  <id>28277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Dopamine Activity</to_name>
    <to_code>T14819</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008955</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Dynorphin Activity [PE]</name>
  <code>C28278</code>  <id>28279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Dynorphin Activity</to_name>
    <to_code>T14820</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008956</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Endorphin Activity [PE]</name>
  <code>C28280</code>  <id>28281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Endorphin Activity</to_name>
    <to_code>T14821</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008957</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Enkephalin Activity [PE]</name>
  <code>C28282</code>  <id>28283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Enkephalin Activity</to_name>
    <to_code>T14822</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008958</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Epinephrine Activity [PE]</name>
  <code>C28284</code>  <id>28285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Epinephrine Activity</to_name>
    <to_code>T14823</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008959</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle GABA Activity [PE]</name>
  <code>C28286</code>  <id>28287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle GABA Activity</to_name>
    <to_code>T14824</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008960</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Gastrin Activity [PE]</name>
  <code>C28288</code>  <id>28289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Gastrin Activity</to_name>
    <to_code>T14825</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008961</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Glutamate Activity [PE]</name>
  <code>C28290</code>  <id>28291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Glutamate Activity</to_name>
    <to_code>T14826</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008962</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Glycine Activity [PE]</name>
  <code>C28292</code>  <id>28293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Glycine Activity</to_name>
    <to_code>T14827</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008963</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Histamine Activity [PE]</name>
  <code>C28294</code>  <id>28295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Histamine Activity</to_name>
    <to_code>T14828</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008964</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Nerve Growth Factor Activity [PE]</name>
  <code>C28296</code>  <id>28297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Nerve Growth Factor Activity</to_name>
    <to_code>T14829</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008965</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Neurotensin Activity [PE]</name>
  <code>C28298</code>  <id>28299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Neurotensin Activity</to_name>
    <to_code>T14830</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008966</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Nitric Oxide Activity [PE]</name>
  <code>C28300</code>  <id>28301</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Nitric Oxide Activity</to_name>
    <to_code>T14831</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008967</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Norepinephrine Activity [PE]</name>
  <code>C28302</code>  <id>28303</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Norepinephrine Activity</to_name>
    <to_code>T14832</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008968</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Organized Electrical Activity [PE]</name>
  <code>C28304</code>  <id>28305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity</to_name>
    <to_code>T14833</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008969</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrethrins [8991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Serotonin Activity [PE]</name>
  <code>C28306</code>  <id>28307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Serotonin Activity</to_name>
    <to_code>T14834</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008970</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Substance P Activity [PE]</name>
  <code>C28308</code>  <id>28309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Substance P Activity</to_name>
    <to_code>T14835</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008971</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle Tone [PE]</name>
  <code>C635141</code>  <id>635141</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone</to_name>
    <to_code>T14836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175735</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Striated Muscle VIP Activity [PE]</name>
  <code>C28310</code>  <id>28311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle VIP Activity</to_name>
    <to_code>T14837</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008972</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Substance P Activity [PE]</name>
  <code>C28312</code>  <id>28313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Substance P Activity</to_name>
    <to_code>T14838</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008973</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Acetylcholine Activity [PE]</name>
  <code>C28314</code>  <id>28315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Acetylcholine Activity</to_name>
    <to_code>T14839</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008974</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Activity [PE]</name>
  <code>C635043</code>  <id>635043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Activity</to_name>
    <to_code>T14841</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympatholytic Activity</to_name>
    <to_code>T14840</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175650</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Aspartate Activity [PE]</name>
  <code>C28316</code>  <id>28317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Aspartate Activity</to_name>
    <to_code>T14842</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008975</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Brain Derived Neurotropic Activity [PE]</name>
  <code>C28318</code>  <id>28319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Brain Derived Neurotropic Activity</to_name>
    <to_code>T14843</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008976</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic CCK Activity [PE]</name>
  <code>C28320</code>  <id>28321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic CCK Activity</to_name>
    <to_code>T14844</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008977</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Disorganized Electrical Activity [PE]</name>
  <code>C28322</code>  <id>28323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Disorganized Electrical Activity</to_name>
    <to_code>T14845</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008978</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Dopamine Activity [PE]</name>
  <code>C28324</code>  <id>28325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Dopamine Activity</to_name>
    <to_code>T14846</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008979</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Dynorphin Activity [PE]</name>
  <code>C28326</code>  <id>28327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Dynorphin Activity</to_name>
    <to_code>T14847</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008980</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Endorphin Activity [PE]</name>
  <code>C28328</code>  <id>28329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Endorphin Activity</to_name>
    <to_code>T14848</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008981</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Enkephalin Activity [PE]</name>
  <code>C28330</code>  <id>28331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Enkephalin Activity</to_name>
    <to_code>T14849</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008982</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Epinephrine Activity [PE]</name>
  <code>C28332</code>  <id>28333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Epinephrine Activity</to_name>
    <to_code>T14850</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008983</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic GABA Activity [PE]</name>
  <code>C28334</code>  <id>28335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic GABA Activity</to_name>
    <to_code>T14851</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008984</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Gastrin Activity [PE]</name>
  <code>C28336</code>  <id>28337</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Gastrin Activity</to_name>
    <to_code>T14852</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008985</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Glutamate Activity [PE]</name>
  <code>C28338</code>  <id>28339</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Glutamate Activity</to_name>
    <to_code>T14853</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008986</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Glycine Activity [PE]</name>
  <code>C28340</code>  <id>28341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Glycine Activity</to_name>
    <to_code>T14854</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008987</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Histamine Activity [PE]</name>
  <code>C28342</code>  <id>28343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Histamine Activity</to_name>
    <to_code>T14855</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008988</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Nerve Growth Factor Activity [PE]</name>
  <code>C28344</code>  <id>28345</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Nerve Growth Factor Activity</to_name>
    <to_code>T14856</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008989</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Neurotensin Activity [PE]</name>
  <code>C28346</code>  <id>28347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Neurotensin Activity</to_name>
    <to_code>T14857</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008990</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Nitric Oxide Activity [PE]</name>
  <code>C28348</code>  <id>28349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Nitric Oxide Activity</to_name>
    <to_code>T14858</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008991</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Norepinephrine Activity [PE]</name>
  <code>C28350</code>  <id>28351</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity</to_name>
    <to_code>T14859</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008992</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine hydrochloride [133041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine [220982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Organized Electrical Activity [PE]</name>
  <code>C28352</code>  <id>28353</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Organized Electrical Activity</to_name>
    <to_code>T14860</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008993</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Serotonin Activity [PE]</name>
  <code>C28354</code>  <id>28355</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Serotonin Activity</to_name>
    <to_code>T14861</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008994</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic Substance P Activity [PE]</name>
  <code>C28356</code>  <id>28357</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Substance P Activity</to_name>
    <to_code>T14862</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008995</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Sympathetic VIP Activity [PE]</name>
  <code>C28358</code>  <id>28359</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic VIP Activity</to_name>
    <to_code>T14863</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008996</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased T Lymphocyte Activation [PE]</name>
  <code>C641731</code>  <id>641731</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation</to_name>
    <to_code>T14864</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182155</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased T Lymphocyte Activation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab [2632981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib phosphate [2633006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab-dlwr [2632980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifitegrast [1801820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased T Lymphocyte Destruction [PE]</name>
  <code>C28360</code>  <id>28361</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Destruction</to_name>
    <to_code>T14865</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008997</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased T Lymphocyte Production [PE]</name>
  <code>C28362</code>  <id>28363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production</to_name>
    <to_code>T14866</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008998</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased TRH Activity [PE]</name>
  <code>C28364</code>  <id>28365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased TRH Activity</to_name>
    <to_code>T14867</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008999</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased TRH Secretion [PE]</name>
  <code>C28366</code>  <id>28367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased TRH Secretion</to_name>
    <to_code>T14868</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009000</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Testosterone Secretion [PE]</name>
  <code>C28370</code>  <id>28371</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion</to_name>
    <to_code>T14869</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009002</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicalutamide [83008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin acetate [236538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix [475230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate [105556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine [4089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix acetate [835863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate sodium [4090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trelstar pamoate [905060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abarelix [301739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Thromboxane Activity [PE]</name>
  <code>C28374</code>  <id>28375</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity</to_name>
    <to_code>T14870</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009004</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Thromboxane Degradation [PE]</name>
  <code>C28376</code>  <id>28377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Degradation</to_name>
    <to_code>T14871</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009005</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Thromboxane Production [PE]</name>
  <code>C28378</code>  <id>28379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production</to_name>
    <to_code>T14872</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009006</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Thyroid Hormone Iodination [PE]</name>
  <code>C28380</code>  <id>28381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Iodination</to_name>
    <to_code>T14873</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Thyroid Hormone Secretion [PE]</name>
  <code>C28382</code>  <id>28383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Secretion</to_name>
    <to_code>T14874</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Thyroid Stimulating Hormone Secretion [PE]</name>
  <code>C28368</code>  <id>28369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Stimulating Hormone Secretion</to_name>
    <to_code>T14876</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased TSH Secretion</to_name>
    <to_code>T14875</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009001</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Tracheo-Bronchial Mucosal Edema [PE]</name>
  <code>C30308</code>  <id>30309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Mucosal Edema</to_name>
    <to_code>T14877</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009970</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zafirlukast [114970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Tracheo-Bronchial Secretions [PE]</name>
  <code>C28384</code>  <id>28385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Secretions</to_name>
    <to_code>T14878</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roflumilast [1091836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheo-Bronchial Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</name>
  <code>C28386</code>  <id>28387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheobronchial Stretch Receptor Activity</to_name>
    <to_code>T14879</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009010</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzonatate [18993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Transcription to RNA [PE]</name>
  <code>C28388</code>  <id>28389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA</to_name>
    <to_code>T14880</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009011</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran sodium [2605574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alitretinoin [81864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran sodium [2265859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant [2725912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran [2265712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant tosylate [2725911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran [2604578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased UES Tone [PE]</name>
  <code>C28390</code>  <id>28391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased UES Tone</to_name>
    <to_code>T14881</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009012</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Urethra Smooth Muscle Tone [PE]</name>
  <code>C30320</code>  <id>30321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone</to_name>
    <to_code>T14882</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009976</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine hydrochloride [235229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine [24464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Uric Acid Synthesis [PE]</name>
  <code>C28392</code>  <id>28393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uric Acid Synthesis</to_name>
    <to_code>T14883</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009013</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol sodium [80566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uric Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febuxostat [73689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uric Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol [519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uric Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasburicase [283821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uric Acid Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</name>
  <code>C28394</code>  <id>28395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone</to_name>
    <to_code>T14884</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009014</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine hydrochloride [105470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol [4333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol hydrobromide [203124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine [9392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline sulfate [10369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline [10368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased VIP Activity [PE]</name>
  <code>C28396</code>  <id>28397</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased VIP Activity</to_name>
    <to_code>T14885</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009015</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Central Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Muscular System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Vaginal Muscle Tone [PE]</name>
  <code>C28398</code>  <id>28399</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vaginal Muscle Tone</to_name>
    <to_code>T14886</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009016</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Vaginal Secretion [PE]</name>
  <code>C28400</code>  <id>28401</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vaginal Secretion</to_name>
    <to_code>T14887</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009017</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Vascular Permeability [PE]</name>
  <code>C31862</code>  <id>31863</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability</to_name>
    <to_code>T14888</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010252</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Vascular Permeability [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen sodium [2724362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-mrbb [2706479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-ayyh [2696256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-yszy [2715399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-boav [2725885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziv-aflibercept [1304475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen [2724361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebetralstat [2717944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Vascular Smooth Muscle Tone [PE]</name>
  <code>C31900</code>  <id>31901</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone</to_name>
    <to_code>T14889</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010271</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine [24464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine hydrochloride [235229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Vasopressin Secretion [PE]</name>
  <code>C28402</code>  <id>28403</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vasopressin Secretion</to_name>
    <to_code>T14890</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009018</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Ventilatory Gas Flow [PE]</name>
  <code>C28404</code>  <id>28405</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ventilatory Gas Flow</to_name>
    <to_code>T14891</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009019</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ventilatory Gas Flow [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased Vitamin Uptake and Modification [PE]</name>
  <code>C30236</code>  <id>30237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification</to_name>
    <to_code>T14892</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009934</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Decreased Vitamin Uptake and Modification [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Folic Acid Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol calcium succinate, DL- [2598017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E [11256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E acetate [2531274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E d-alpha [220892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E DL-alpha [220893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha tocopherol [237099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased by acidity [PK]</name>
  <code>C206</code>  <id>207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased by acidity</to_name>
    <to_code>T14893</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000014</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Decreased by food [PK]</name>
  <code>C198</code>  <id>199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased by food</to_name>
    <to_code>T14894</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000010</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Delay Conduction System Repolarization [PE]</name>
  <code>C31932</code>  <id>31933</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Delay Conduction System Repolarization</to_name>
    <to_code>T14942</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010287</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Delay Conduction System Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Delay Conduction System Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Demulcent Activity [MoA]</name>
  <code>C634925</code>  <id>634925</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity</to_name>
    <to_code>T14992</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175532</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2910 [1363586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (15000 MPA.S) [1300445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 38 MPA.S at 2%) [2257286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (4000 CPS) [1300447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 400 MPA.S at 1%) [1653793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (50 MPA.S) [1297881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose [27334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (3 MPA.S) [1300446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100 MPA.S) [1300444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (6 cps) [1300454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 300 [8513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 600 MPA.S at 2 %) [2099296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (5 MPA.S) [1300452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100000 MPA.S) [1300448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (1600000 WAMW) [2048727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitutions per saccharide; 600 MPA.S at 2 %) [1812763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (4000 MPA.S) [1300455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15 MPA.S) [1300450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropylcellulose [27291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 50-100 MPA.S at 1% ) [1597390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15000 MPA.S) [1300451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (type H) [1811461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 400 [8514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (50 MPA.S) [1300453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium [491498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2208 [1363585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose [2062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (4000 mpa.s) [1299222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%) [1371909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (3 MPA.S) [1300449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Demulcent [EPC]</name>
  <code>C634928</code>  <id>634928</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent</to_name>
    <to_code>T14993</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175535</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Demulcent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (1600000 WAMW) [2048727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Demulcent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type H) [1811461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Demulcent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropylcellulose [27291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Demulcent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dental and Oral Agents [TC]</name>
  <code>C654043</code>  <id>654043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents</to_name>
    <to_code>T58421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193822</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride [260036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride f-18 [1311495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride [9873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaflur [2712235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium chloride [2287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride dihydrate [1311371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride [10030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium chloride anhydrous [1311527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride anhydrous [2698548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium acetate [1307588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, dihydrate [2632248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palifermin [196319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium [2286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dodecyl sulfate [9871]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dephosphorylation Inhibitors [MoA]</name>
  <code>C30286</code>  <id>30287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dephosphorylation Inhibitors</to_name>
    <to_code>T15284</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009959</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Depigmenting Activity [PE]</name>
  <code>C635289</code>  <id>635289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Activity</to_name>
    <to_code>T15285</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175851</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depigmenting Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequinol [15080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobenzone [17145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Depigmenting Agent [EPC]</name>
  <code>C635291</code>  <id>635291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Agent</to_name>
    <to_code>T15286</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175853</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Depolarizing Neuromuscular Blocker [EPC]</name>
  <code>C635125</code>  <id>635125</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Depolarizing Neuromuscular Blocker</to_name>
    <to_code>T15287</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175719</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Depolarizing agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylcholine [10154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Depolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing depolarizing neuromuscular blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dermal Regeneration Activity [PE]</name>
  <code>C300463</code>  <id>300463</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermal Regeneration Activity</to_name>
    <to_code>T15305</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020073</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dermatologic Activity Alteration [PE]</name>
  <code>C28406</code>  <id>28407</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration</to_name>
    <to_code>T15358</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009020</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sebaceous Gland Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermal Regeneration Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiperspirant Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratin Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hair Follicle Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipruritic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dermatologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Astringent Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abametapir [2475532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyacetone [3430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase [58939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypsin [10890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dermatological Agents [TC]</name>
  <code>C654044</code>  <id>654044</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents</to_name>
    <to_code>T58422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193823</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetyldithranol [38536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab-rzaa [2166132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto extract [236344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>padimate-O [32786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib tosylate [2641596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloprogin [26422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea hydrochloride [1862866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixekizumab [1745099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib [2641595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kelp preparation [285155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin hydrochloride [1541465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar pitch volatiles [90732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alitretinoin [81864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinosad [299081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol, (S)- [1663407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec [2637758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine [10847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homosalate [91326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper [2837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloe extract [91263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-phenylpropanal propylene glycol acetal [1947505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycolic acid [587318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crotamiton [21766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab [2053436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A [11246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyproline [1311548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peg-75 lanolin [1363619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc oxide [11423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone [108091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podofilox [8463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper Cu-64 [2200143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-bisabolol, (+-)- [1306126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 5-aminolevulinate [337068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobenzone [17145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A palmitate [35406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyacetone [3430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol propyl ether [1947500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine hydrochloride [91063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexpanthenol [22701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octisalate [91327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben sodium [1311574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum sulfate octadecahydrate [2178309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secukinumab [1599788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium edetate [105745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum sulfate [17621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octinoxate [13369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone caproate [4464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine citrate [71533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec-svdt [2637757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wild yam extract [237020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trioxsalen [10844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brodalumab [1872251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab-asmn [2053449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint oil [33094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab [2589225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica extract [144377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ingenol mebutate [1242806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goldenseal extract [1372255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben [34706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline hydrochloride [2059038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene [29365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol [34693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone [4463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avobenzone [45045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 410 [1299921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer [2710434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium [1546438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-120 methyl glucose dioleate [1309363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene hydrate [1299898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A myristate [1813433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lactate [215247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abrocitinib [2591476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone pivalate [4465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle extract [283579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer sodium [2710445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 100 [1310496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 sorbitan diisostearate [1363615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4,6-bis(1-methylpentyl)resorcinol [2719298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronate [62372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl alcohol [1426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioxolone [2059173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluprednisolone [4497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol 2-(2-methylbutyrate) [1947503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.-bisabolol, (-)-EPI- [2118535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propolis [8783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate tetrahydrate [2104324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium bromide [2689321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide [2262250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer free acid [2710444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium tosylate [2052857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanolin alcohols [1426478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybenzone [32673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-4 dilaurate [1363613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine [10391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoctrizole [1310510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifarotene [2205637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate [36702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-100 stearate [1367120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crisaborole [1865953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine [18753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone [324072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoyl peroxide [1418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simethicone [9796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar extract [90735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anacaulase-bcdb [2626722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxate [288262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat [2626470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-6 lauramide [1363617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen [2626471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dupilumab [1876376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>birch triterpenes [2675583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bampine hydrochloride [236519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 stearate [1314849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab [2166040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantharidin [1984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl aminolevulinate hydrochloride [1300479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prademagene zamikeracel [2713314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc acetate [58295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine lactate [236530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine hydrochloride [91189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisabolol [19461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase [58939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone acetonide [103447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin [508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin, (+)- [1739978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ichthammol [5645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum acetate [17609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapinarof [2602286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetylated hyaluronate [2198976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-8 dioleate [1363621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib phosphate [2716557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab-ldrm [2589374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apremilast [1492727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben calcium [1867698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abametapir [2475532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide acetate [2278002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypsin [10890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequinol [15080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidurea [1368885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>becaplermin [115238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anacaulase [2626723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab [2693758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etretinate [4182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol [35382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guselkumab [1928588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium [2689322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole [1426903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SIMETHICONE-CELLULOSE [283585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea [11002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminobenzoic acid [74]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab-lbkz [2693778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diagnostic Agent [APC]</name>
  <code>C654116</code>  <id>654116</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent</to_name>
    <to_code>T15655</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193895</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Helicobacter pylori Diagnostic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhalation Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Dye [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Test Antigen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diagnostic Agent [TC]</name>
  <code>C637771</code>  <id>637771</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent</to_name>
    <to_code>T15655</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic</to_name>
    <to_code>T15654</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178317</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopiclenol [2618720]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine [10917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioflupane [2571854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129 [2626219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histoplasmin [5363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate lysine [236477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat F-18 [2556616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indocyanine green acid form [2199577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flotufolastat [2637947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicisate [1306100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxilan [27793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodipamide [5936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicisate dihydrochloride [1306099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium [1310124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate sodium [3321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotide gallium ga-68 [2199391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobutrol [84990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglic acid [1426458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pertechnetate Tc 99m [10349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iothalamate [9886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxides [72901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin acetate [1999419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium GA-68 gozetotide [2586016]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium pyrophosphate [267798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine chloride [40165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pyrophosphate decahydrate [1944687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate [5973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine iodipamide [29456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat [2556617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iocetamic acid [183830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetapir F-18 [1427224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium 67 citrate [272758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-131 [1546415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson anhydrous [1546015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein sodium [57789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium sulfate [1331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pyrophosphate [1364532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>empagliflozin [1545653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-hydroxyamphetamine [7839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine [4158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadofosveset trisodium [1364289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadodiamide [41144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine carbamate [2375923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium-111 [90540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iso-sulfan blue [27863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflexane [1540828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate meglumine [5971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoic acid [1546223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenomethionine Se 75 [9133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodopa F-18 [2571853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodopa [2571852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129, hyperpolarized [2626220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin hexahydrate [1653802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin [1368001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate sodium [66896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium 99m [90650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dulaglutide [1551291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamic acid [1546451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m sestamibi [1482913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypan blue free acid [1726081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicilloyl polylysine [2667743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobenate dimeglumine [68173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gozetotide [2588949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium ipodate [1911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobenate [692620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodeoxyglucose F18 [1362737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m disofenin [37665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetate disodium [259268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioflupane I-123 [1426874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoxetate [802624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur hexafluoride [1599276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafolacianine [2586857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotride [2199392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fanolesomab [1314371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine [155080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-133 [259282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurpiridaz F-18 [2700762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium pyrophosphate [1426658]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoterate meglumine [1421151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate meglumine [66895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin benzoate [1368000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>82 rubidium [1546434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangafodipir trisodium, anhydrous [221119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrophosphate [1364533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate sodium I125 [91537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetaben [2571857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese cation (2+) [1546272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate meglumine [3320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indocyanine green [5775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopromide [27781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iohexol [5956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoxetate disodium [637320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafolacianine sodium [2586858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobitridol [87639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal [9471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flortaucipir [2571858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopamidol [5966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurpiridaz [2700763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyamphetamine hydrobromide [82066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoteridol [25483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetaben f-18 [1492940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flotufolastat F-18 [2637946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangafodipir [236987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallous chloride Tl201 [91588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid hydrochloride [261715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate sodium [9887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrapone [6923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine chloride [82115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflutren [283753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate [5970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,chromated Cr-51 serum [314299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid [683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate [5976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>purified protein derivative of tuberculin [8948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iophendylate [5968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodixanol [27729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopanoic acid [5967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyproline [1311548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-123 [1361657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioversol [27792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin [2890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate [3319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodohippurate I131 sodium [91540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein [25138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopentetate dimeglumine [25486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetreotide [1724429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrophosphoric acid [1546425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium [1362690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluciclovine [2571859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyanocobalamin Co57 [91516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethiodized oil [4125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoversetamide [228833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin [1999420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 oxyquinoline [1314372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,iodinated I-125 serum [317177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diagnostic Dye [EPC]</name>
  <code>C634929</code>  <id>634929</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Dye</to_name>
    <to_code>T15656</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175536</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indigotindisulfonic acid [1546441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Diagnostic dye (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indocyanine green [5775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trypan blue free acid [1726081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diagnostic Dye [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorescein [25138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diarylquinoline Antimycobacterial [EPC]</name>
  <code>C646643</code>  <id>646643</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diarylquinoline Antimycobacterial</to_name>
    <to_code>T15693</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000186775</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bedaquiline [1364504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarylquinolines [M0582947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diarylquinoline Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antimycobacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diarylquinoline Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dietary Cholesterol Absorption Inhibitor [EPC]</name>
  <code>C635349</code>  <id>635349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dietary Cholesterol Absorption Inhibitor</to_name>
    <to_code>T15871</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175911</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dietary Cholesterol Absorption Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ezetimibe [341248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dietary Cholesterol Absorption Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Cholesterol Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antilipemic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dietary Cholesterol Absorption Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Digestive Alteration [PE]</name>
  <code>C28408</code>  <id>28409</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration</to_name>
    <to_code>T15938</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009021</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Enzymatic Replacement [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Fat Digestion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Carbohydrate Digestion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simethicone [9796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SIMETHICONE-CELLULOSE [283585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase alfa [2691830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 410 [1299921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Digestive/GI System Activity Alteration [PE]</name>
  <code>C28410</code>  <id>28411</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration</to_name>
    <to_code>T15945</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009022</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Saliva Production Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cariostatic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Mucous Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Digestive/GI System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor hydrochloride [2199673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium zirconium cyclosilicate [2047628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Digoxin Binding Activity [MoA]</name>
  <code>C643877</code>  <id>643877</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Digoxin Binding Activity</to_name>
    <to_code>T15962</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184150</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digoxin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</name>
  <code>C634870</code>  <id>634870</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antibacterial</to_name>
    <to_code>T16002</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175489</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoprim [10829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antifolate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</name>
  <code>C635372</code>  <id>635372</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimalarial</to_name>
    <to_code>T16003</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175934</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrimethamine [9010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimalarial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antifolate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antimalarial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimalarial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</name>
  <code>C635392</code>  <id>635392</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimicrobial</to_name>
    <to_code>T16004</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175954</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antifolate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Medicinal product acting as antiinfective agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anti-infective agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</name>
  <code>C634871</code>  <id>634871</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antiprotozoal</to_name>
    <to_code>T16005</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175490</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiprotozoal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antifolate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiprotozoal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitor [EPC]</name>
  <code>C635371</code>  <id>635371</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor</to_name>
    <to_code>T16006</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175933</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydrofolate Reductase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dihydrofolate reductase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antifolate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydrofolate Reductase Inhibitors [MoA]</name>
  <code>C560</code>  <id>561</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors</to_name>
    <to_code>T16007</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000191</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate glucuronate [38725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim sulfate [221176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate [42333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil [2382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil hydrochloride [142428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</name>
  <code>C645315</code>  <id>645315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydroorotate Dehydrogenase Inhibitors</to_name>
    <to_code>T16036</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185501</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriflunomide [1310520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dihydropyridine Calcium Channel Blocker [EPC]</name>
  <code>C634803</code>  <id>634803</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydropyridine Calcium Channel Blocker</to_name>
    <to_code>T16047</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175421</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydropyridines [M0006414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amlodipine [17767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nisoldipine [7435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicardipine [7396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>felodipine [4316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dihydropyridine derivative structure and calcium channel blocker mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clevidipine [233603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifedipine [7417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isradipine [33910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dihydropyridine Calcium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nimodipine [7426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing calcium channel blocker (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydropyridine Calcium Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diminish Penile Erection [PE]</name>
  <code>C28412</code>  <id>28413</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diminish Penile Erection</to_name>
    <to_code>T16194</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009023</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dipeptidase Inhibitors [MoA]</name>
  <code>C634906</code>  <id>634906</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dehydropeptidase Inhibitors</to_name>
    <to_code>T16255</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidase Inhibitors</to_name>
    <to_code>T16256</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydropeptidase Inhibitors</to_name>
    <to_code>T16254</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175513</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</name>
  <code>C635351</code>  <id>635351</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitor</to_name>
    <to_code>T16264</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase IV Inhibitor</to_name>
    <to_code>T16261</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase-4 Inhibitor</to_name>
    <to_code>T16260</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl-Peptidase IV Inhibitor</to_name>
    <to_code>T16262</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>DPP-4 Inhibitor</to_name>
    <to_code>T16259</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase-4 (DPP-4) Inhibitor</to_name>
    <to_code>T16263</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175913</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sitagliptin [593411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linagliptin [1100699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing dipeptidyl peptidase IV inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alogliptin [1368001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saxagliptin anhydrous [1546030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</name>
  <code>C635350</code>  <id>635350</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gliptins</to_name>
    <to_code>T16269</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors</to_name>
    <to_code>T16270</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase IV Inhibitors</to_name>
    <to_code>T16267</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>DPP-4 Inhibitors</to_name>
    <to_code>T16266</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase-4 Inhibitors</to_name>
    <to_code>T16268</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl-Peptidase IV Inhibitors</to_name>
    <to_code>T16265</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175912</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin [1368001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linagliptin [1100699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin hydrochloride [2716481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin benzoate [1368000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin anhydrous [1546030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride [1043560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin [593411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride dihydrate [2643444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin phosphate [621590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin [857974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Direct Thrombin Inhibitor [EPC]</name>
  <code>C634911</code>  <id>634911</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Direct Thrombin Inhibitor</to_name>
    <to_code>T16352</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175518</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing direct thrombin inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabigatran [1546356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argatroban anhydrous [1546207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with direct thrombin inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bivalirudin [60819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>argatroban [15202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Direct Thrombin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desirudin [114934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Disclosing Agent [EPC]</name>
  <code>C654243</code>  <id>654243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Disclosing Agent</to_name>
    <to_code>T58758</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194020</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Disclosing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brilliant blue G [1998867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Disclosing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Dye (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Disclosing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Disorganized Electrical Activity Alteration [PE]</name>
  <code>C28414</code>  <id>28415</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Disorganized Electrical Activity Alteration</to_name>
    <to_code>T16407</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009024</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Disorganized Electrical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Disorganized Electrical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Distribution [PK]</name>
  <code>C214</code>  <id>215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Distribution</to_name>
    <to_code>T16425</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000018</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Distribution [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Volume of distribution [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Distribution [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Site of concentration [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Distribution [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Site of relative exclusion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Disulfide Reduction [MoA]</name>
  <code>C634941</code>  <id>634941</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Disulfide Reduction</to_name>
    <to_code>T16426</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175548</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Disulfide Reduction [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diuresis Alteration [PE]</name>
  <code>C634741</code>  <id>634741</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diuresis Alteration</to_name>
    <to_code>T16471</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175358</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuresis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuresis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Diuretic [APC]</name>
  <code>C654094</code>  <id>654094</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diuretic</to_name>
    <to_code>T58504</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193873</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuretic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Loop Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuretic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuretic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuretic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium-sparing Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Diuretic [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide-like Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Activity Alteration [PE]</name>
  <code>C28416</code>  <id>28417</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Activity Alteration</to_name>
    <to_code>T16566</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009025</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone tosylate [2275731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone [2275602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Agonists [MoA]</name>
  <code>C412</code>  <id>413</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopaminergic Agonist</to_name>
    <to_code>T16567</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists</to_name>
    <to_code>T16568</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000117</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine hydrochloride [284157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine hydrochloride [71225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole dihydrochloride [236747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine [1043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine hydrochloride [1721073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole hydrochloride [236553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil [8353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil mesylate [236380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine [51253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>armodafinil [641465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole [72302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Antagonists [MoA]</name>
  <code>C638</code>  <id>639</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists</to_name>
    <to_code>T16569</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000230</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine [8042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penfluridol [7974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol hydrochloride [236140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine dimalonate [236771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine maleate [84158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacetazine [8338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol [10804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine [6883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine D2 Antagonists [MoA]</name>
  <code>C635218</code>  <id>635218</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists</to_name>
    <to_code>T16570</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175799</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amisulpride [46303]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone [3626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluspirilene [4507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone [2721194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone hydrochloride [2721193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone maleate [236099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Receptor Interactions [MoA]</name>
  <code>C584</code>  <id>585</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions</to_name>
    <to_code>T16583</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000203</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levodopa [6375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foslevodopa [2695775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Reuptake Inhibitor Anorectic [EPC]</name>
  <code>C635381</code>  <id>635381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Reuptake Inhibitor Anorectic</to_name>
    <to_code>T16584</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175943</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Reuptake Inhibitor Anorectic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing dopamine reuptake inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Reuptake Inhibitor Anorectic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dopamine reuptake inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Transporter Interactions [MoA]</name>
  <code>C616</code>  <id>617</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Transporter Interactions</to_name>
    <to_code>T16585</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000219</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine Uptake Inhibitors [MoA]</name>
  <code>C406</code>  <id>407</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors</to_name>
    <to_code>T16586</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000114</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</name>
  <code>C654270</code>  <id>654270</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NDRI</to_name>
    <to_code>T58817</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine and Norepinephrine Reuptake Inhibitor</to_name>
    <to_code>T58814</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine-Norepinephrine Reuptake Inhibitor</to_name>
    <to_code>T58816</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine-Dopamine Reuptake Inhibitor</to_name>
    <to_code>T58818</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNRI</to_name>
    <to_code>T58815</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194049</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solriamfetol [2121751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dopamine reuptake inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing dopamine reuptake inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing norepinephrine reuptake inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with norepinephrine reuptake inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopamine-2 Receptor Antagonist [EPC]</name>
  <code>C635219</code>  <id>635219</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine-2 (D2) Receptor Antagonist</to_name>
    <to_code>T16601</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>D2 Receptor Antagonist</to_name>
    <to_code>T16600</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine-2 Receptor Antagonist</to_name>
    <to_code>T16602</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175800</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine D2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dopamine receptor D2 antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing dopamine receptor D2 antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amisulpride [46303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>droperidol [3648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoclopramide [6915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dopaminergic Agonist [EPC]</name>
  <code>C634973</code>  <id>634973</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonist</to_name>
    <to_code>T16603</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopaminergic Agonist</to_name>
    <to_code>T16604</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175580</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopaminergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopaminergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with dopamine receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopaminergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apomorphine [1043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dopaminergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing dopamine receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dyes [MoA]</name>
  <code>C634926</code>  <id>634926</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes</to_name>
    <to_code>T16785</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stains</to_name>
    <to_code>T58762</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175533</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein sodium [57789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indigotindisulfonic acid [1546441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium [1362690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypan blue free acid [1726081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein [25138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium I 131 [82097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indocyanine green acid form [2199577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brilliant blue G [1998867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal [9471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indocyanine green [5775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Dynorphin Activity Alteration [PE]</name>
  <code>C28418</code>  <id>28419</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Dynorphin Activity Alteration</to_name>
    <to_code>T16813</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009026</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dynorphin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Dynorphin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dynorphin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>E [Preparations]</name>
  <code>C288631</code>  <id>288631</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>E [Preparations]</to_name>
    <to_code>T16924</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010587</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoetin alfa-epbx [2047589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl stearate [1368181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprazinone HCl [236310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etifoxine [24441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eryngium yuccifolium root extract [1861941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum fluviatile whole extract [2287548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl hydroxystearate benzoate [1732119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus radiata flower top oil [1540872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia neriifolia leaf extract [2673586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eutrochium purpureum root [1309791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethyl-1,6-hexanediol [1428859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etofenamate [24608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>econazole [3743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl menthane carboxamide [1358486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus alba leaf extract [2122439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg (chicken) allergenic extract [904507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprozinol [24274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate disodium, anhydrous [1299924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl perfluorobutyl ether [1540871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eclipta prostrata leaf extract [1307644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enobosarm [2168587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estramustine [4089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estrogens, esterified (USP) [214549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidronate tetrasodium [1364894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erysimum preparation [319799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl stearate [1369682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia fischeriana root extract [2631985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eravacycline dihydrochloride [2055907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esafoxolaner [2636785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etifoxine hydrochloride [236215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl lactate [1427072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethchlorvynol [4118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflapegrastim [2612526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etelcalcetide [1876119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elagolix sodium [2049847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enfortumab [2268307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Escherichia coli [350202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acetoacetate ethylene glycol ketal [2388133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl palmate [1440254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euonymus atropurpureus branch bark-root bark extract [1428219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl ether [1363043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acrylate [1859382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (20 MPA.S) [1313697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estriol [4094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephryl borate [24255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea angustifolia root extract [259415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexyl benzoate [1313732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English sole allergenic extract [974140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estrogens, conjugated (USP) [4099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estetrol [2539031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene-vinyl acetate copolymer (40% vinyl acetate) [1312577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Engraulis japonica extract [2611454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eliglustat tartrate [1547219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene-vinyl acetate copolymer (50% vinyl acetate) [1736747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eta-tocopherol [2721765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enoxolone dipotassium [2043284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esketamine hydrochloride [2119366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esmolol [49737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efalizumab [356988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl cocoate [1484498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eggplant allergenic extract [972601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea purpurea root extract [259513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylmercurithiosalicylic acid [1546427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanethioic acid, S-(1-((1E)-2-hydroxyethenyl)butyl) ester [2473844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efgartigimod alfa [2587717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprinomectin [1006619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl menthane carboxamide, 1R,3R,4S [1869726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etrasimod [2668045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eschscholzia californica flowering top extract [1423921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eleutherococcus senticosus whole extract [2001988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethambutol [4110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egtazic acid [1742992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine dihydriodide [1593852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine hydrochloride [362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl palmitate [1426380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexyl 4-phenylbenzophenone-2&apos;-carboxylate [1546353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Evodia rutaecarpa fruit extract, immature [2635086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl linoleate [24522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl chloride [4141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etrasimod arginine [2668046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate dipotassium anhydrous [1540526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edotreotride [2199392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl 2,2-dimethylhydrocinnamal [1649018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethoxyethanol [1314365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylmorphine [4166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanolamine oleate [24460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eutrochium purpureum whole extract [1986786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etelcalcetide hydrochloride [1876122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupatorium perfoliatum flowering top extract [1309783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elymus violaceus whole extract [2668416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate calcium [1368950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eliglustat [1547220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate [42662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethynodiol diacetate [4170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus polybractea leaf oil [1307684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythrityl tetranitrate [4040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus smithii oil [2399546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole strontium [1435522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern sycamore pollen extract [852746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epilobium angustifolium leaf extract [1309425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eruca vesicaria subsp. sativa leaf extract [1541728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (4 MPA.S) [1313698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethacrynate sodium [4108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enasidenib mesylate [1940331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enoximone [49626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>exametazime [62153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (50 MPA.S) [1739984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epirubicin [3995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elettaria ensal whole extract [2592621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia amygdaloides extract [1547608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enoxacin [3925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elaeis guineensis fruit butter [1307144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoprostenol sodium [104463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus globulus whole extract [1363729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethiodized oil [4125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eremocitrus glauca fruit extract [1541718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entecavir anhydrous [1546027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole [283742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Enterococcus faecalis [10098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erwinia asparaginase [235996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edrophonium [3752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum arvense top extract [1306235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium grandiflorum flowering top extract [1310141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (10 MPA.S) [1313704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl hexyl salicylate [236880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethaverine [24464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin stearate [24351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl isononanoate [1367139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entecavir [306266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epcoritamab-bysp [2637395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ehrendorferia chrysantha whole extract [2533856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emodepside [354606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg yolk phosphatides [349762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>EGTA disodium [1742991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efbemalenograstim alfa-vuxw [2670656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium grandiflorum whole extract [1358889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-ethyl citrate [2587731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edible oyster preparation [1426438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidronate [42682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elettaria cardamomum whole extract [1314853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole magnesium dihydrate [1601995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethynodiol [24591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptinezumab-jjmr [2283045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>european olive pollen extract [852653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoetin alfa [105694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eravacycline [2055906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia sieboldiana root extract [2695027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl methicone (8 MPA.S) [1540870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl pyrrolidone [1551421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emu oil [1309389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elastin [1730435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexanol [2394645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl isovalerate [1314357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acetate [1314355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Entamoeba histolytica [1316053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Enterobius vermicularis preparation [1333420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European flounder preparation [1426439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl nitrite [1921585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergocalciferol [4018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoxyquin [1314354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanol, 2-(2-((4-((2-bromo-4,6-dinitrophenyl)azo)-1-naphthalenyl)amino)ethoxy)-, acetate (ester) [2376930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emetine [3820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epigallocatechin gallatyl glucoside [2549747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl lauroyl arginate [1426163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enmetazobactam [2675985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoxydiglycol oleate [2624694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole magnesium [283562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol cypionate [1000146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Enterococcus faecium [1943794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl trisiloxane [1607328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine disuccinate [1370612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinastine [39684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoheptazine citrate [235416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epilobium fleischeri whole extract [1788980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>equine diphtheria antitoxin [91602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epicriptine [1546422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ericameria nauseosa whole extract [2533857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin [4053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elotuzumab [1726104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl oleate [1426862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European honey bee venom protein [854163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elymus repens root extract [1310134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine sulfate [91166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>econazole nitrate [142434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol hemihydrate [236859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl glycolate [2602133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinococcus granulosus preparation [1426375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl linolenate [1483807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethybenztropine [1358000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elderberry preparation [319834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoheptazine [24484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl 10-undecenoate [1543079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evinacumab [2478335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European beech pollen extract [1484981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eriobotrya japonica leaf extract [1310088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl jojobate [1435390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European elderberry extract [1311531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ersofermin [1311285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acrylate-methacrylic acid-steareth-20 methacrylate copolymer [1433495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esmolol hydrochloride [203222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eurycoma longifolia whole extract [2585253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexyl glycidyl ether [2369827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium brevicornu whole extract [2585537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echium plantagineum seed oil [1305635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(ethylenedinitrilo)tetraacetonitrile [2286574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>exemestane [258494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum hyemale extract [1332872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus gunnii leaf oil [1600139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eculizumab [591781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etilevodopa [1421444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>escargot shell, cooked [1540823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalaprilat anhydrous [1545989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethenyl [2565266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl butylacetylaminopropionate [2397705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediaminetetraacetate [1370600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupatorium japonicum whole extract [1313690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflornithine [569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ertapenem [325642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epstein-Barr virus [1316054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine sulfate [1249590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erlotinib hydrochloride [477320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoxiconazole [2593180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etilefrine [4169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elderberry fruit [260053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ephedra sinica stem extract [1551454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emedastine difumarate [221094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl glycerin acetal levulinate [2370889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg shell membrane [1428044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evening primrose extract [260040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elexacaftor [2256951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erechtites hieraciifolius extract [1428218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etofamide [24607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl salicylate [1546423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethacrynate [62349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ebastine [23796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern white pine extract [1372264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elemi extract [1426441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptifibatide [75635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elastin, human [1876396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanethiol [1314352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epicatechin [2641822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European hazelnut oil [1307809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eribulin [1045453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>exenatide [60548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethinyl estradiol [4124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eslicarbazepine [1482502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eryngium maritimum root extract [2467552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethionamide [4127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equus caballus collagen [1306187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edotreotide gallium ga-68 [2199391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalaprilat [3829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etretinate [4182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl valerate [1312574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl sulfate [1665664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erenumab [2045613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emtricitabine [276237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elsholtzia ciliata whole extract [1868197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ephedra nevadensis whole extract [2590644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl lauroyl arginate hydrochloride [1426162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl palmitate [1306938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethenzamide [24468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ecklonia cava extract [1435389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elamipretide [2725600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Empetrum nigrum fruit juice [1311589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus radiata leaf oil [1483423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine hydrate [283561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergot alkaloids [4023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose aqueous dispersion type B [2610401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esculin [1314351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine tetraethanol [1361654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Evernia prunastri extract [1352501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elacestrant dihydrochloride [2628473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edible rock crab preparation [2199490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflornithine hydrochloride [81945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose aqueous dispersion type A [2609844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Enterobacter cloacae [1491010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etofylline [24611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl maltol [1314359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergotamine [4025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethaverine hydrochloride [235229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enfuvirtide [139896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl levulinate [1313748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esketamine [2119365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eryngium maritimum extract [1482536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg yolk phospholipids [314605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eszopiclone [461016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eichhornia crassipes whole extract [1544484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl methoxycinnamate [2468050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene glycol monobenzyl ether [1860420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epigallocatechin gallate palmitates [1536067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>europium [1311484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elapegademase [2059219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elaeis oleifera seed oil [1491737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English walnut pollen extract [852577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eggplant extract [1315116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eculizumab-aeeb [2706347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etanercept-szzs [2103480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergonovine maleate [24313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elaeis guineensis whole extract [1425413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg shell preparation [2541497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ecklonia radiata extract [2691104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucommia ulmoides bark extract [1309788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene glycol [1314364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edoxudine [49428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eplontersen sodium [2671940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus globulus pollen extract [852386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ezetimibe [341248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erythranthe cardinalis whole extract [2534458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ectoine [1426644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol 3-benzoate [60661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erythrina variegata bark extract [2106823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine tannate [221096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efetozole [2691105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupatorium perfoliatum whole extract [1649446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanol [448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>europium oxide [1311116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eletriptan hydrobromide monohydrate [2198973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>endothelial growth factor A, vascular [2642870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoetin beta [105695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylmorphine hydrochloride [235782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethisterone [4129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>encorafenib [2049106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl anthranilate [2396756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg extract [1315115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl oleate [1314361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin phosphate [4058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edodekin alfa [1371906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estrogenic substances [259263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl 2-methylbutyrate [1312568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epilobium angustifolium whole extract [1539424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus camaldulensis leaf oil [1540025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl butyrate [1314356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eutanol G [1363715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexylglycerin [1367134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etilefrine hydrochloride [235960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equus caballus whole preparation [1552632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eutrema japonicum whole extract [1606332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English oak pollen extract [1484984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efloxate [23852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergotamine tartrate [42676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoxazene [41078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eosine yellowish [1310593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl caproate [2476631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ephedra distachya flowering twig extract [1309669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupolyphaga sinensis preparation [1541237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-ethyl-2-pyrrolecarboxaldehyde [1368194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enilconazole [1442172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enrofloxacin [24192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (7 MPA.S) [1312575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine hydrochloride [91165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine [4158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eleutherococcus nodiflorus root bark extract [1310083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European rabbit hair extract [895527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European house dust mite allergenic extract [1116979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ecballium elaterium fruit extract [1310229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epidermophyton floccosum allergenic extract [995707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eurycoma longifolia root extract [2001239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entacapone [60307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus globulus leaf extract [1305545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ehrlichia canis [1608966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylbenzene [1540523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia pekinensis root extract [1729316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eurotium herbariorum allergenic extract [999450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elosulfase alfa [1489914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eribulin mesylate [1045452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erbium [1311483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epcoritamab [2637392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethotoin [4136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl macadamiate [1314358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European elderberry juice [1438112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eremophila scoparia whole extract [2395440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptacog alfa activated [253149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(ethyltrisulfanyl)propane [2603742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea purpurea extract [260025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elaeis guineensis fruit extract [1432292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eschscholzia californica extract [265576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethamsylate [4112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ecamsule ditriethanolamine [2359252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eyebright preparation [259366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalaprilat dihydrate [2672730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etesevimab [2477854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>embutramide [2464539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol [4083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidronate disodium [9872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euonymus europaeus seed extract [2386842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine [3966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin stinoprate [236847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enfortumab vedotin-ejfv [2268306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elbasvir [1734628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethopropazine hydrochloride [6541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eicosapentaenoate [618597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium pubescens whole extract [2716393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinastine hydrochloride [236961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elranatamab-bcmm [2644881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emetine hydrochloride [82015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea angustifolia leaf extract [1307673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>equol, (+) [1648566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethacridine lactate [4107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylestrenol [4162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efbemalenograstim alfa [2670630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl cysteine hydrochloride [236634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus dives leafy twig oil [1747865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanolamine [24457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ecklonia kurome extract [2261002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Enterobacter aerogenes [1544929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etomidate [4177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene-vinyl acetate copolymer (15% vinyl acetate) [1313710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erdafitinib [2123125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethohexadiol [1362891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetic acid [3755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea, aerial parts [283560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estrogens [4100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoxydiglycol behenate [1794165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ertugliflozin [1992672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eteplirsen [1810569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elacestrant [2628469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethosuximide [4135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate calcium disodium [1903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythrosine sodium anhydrous [1736634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum arvense whole extract [1535478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>encainide [42368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus piperita leaf oil [2593181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etoposide phosphate [24614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elagolix [2049846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl vanillate [2588043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elafibranor [2684941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexyl stearate [1368886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etoposide [4179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl hydroxystearate [1368707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea root extract [477379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus oil [59087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin estolate [4055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emicizumab-kxwh [1989795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin ethylsuccinate [4056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epicoccum nigrum allergenic extract [852466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enasidenib [1940332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erdosteine [24305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine [3992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg shell, cooked [1427195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol valerate [24395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea pallida root extract [969119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eicosapentaenoic acid [90]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate disodium [3539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ecallantide [658708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoprostenol [8814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidocaine [4171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elymus repens top extract [1344644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl cellulose [1310565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanolamine thenoate [236213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalapril maleate [203123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptinezumab [2282660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium wushanense whole extract [2107307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-ethoxyundecane [2671359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enfortumab vedotin [2277607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium sagittatum top extract [1673375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eplontersen [2671939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eltrombopag [711942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethacridine [4106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl gallate [1596929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eltrombopag choline [2675185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl cysteine [24513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erycibe obtusifolia stem extract [1788843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethambutol hydrochloride [142435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl p-hydroxyhydrocinnamate [2642871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate calcium disodium monohydrate [2001422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetol [1314349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elamipretide hydrochloride [2725599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emepronium carrageenate [23944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia lathyris extract [1337633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eslicarbazepine acetate [1482501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eicosenoic acid [1374399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflapegrastim-xnst [2612537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythrosine [4061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erbium sulfate octahydrate [2049335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl perfluoroisobutyl ether [1541247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene-vinyl acetate copolymer (9% vinyl acetate) [1427045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene dicocamide peg-15 disulfate [1370603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ESCHERICHIA COLI ANTIGEN [237121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern cottonwood pollen extract [852363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eleutherococcus senticosus root oil [2591606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl benzoate [1921584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene [1314362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etravirine [475969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epomediol [24263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexanoic acid [1305517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>equol, (-)- [1803717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene-vinyl acetate copolymer (28% vinyl acetate) [1426456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl pelargonate [2587718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emicizumab [1989794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum arvense stem oil [1864322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucommia ulmoides whole extract [1535479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ezogabine [1112990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eletriptan [231049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl methylphenylglycidate [1546209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl olivate [2665656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erysimum cheiri seed extract [2711783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl methacrylate [2373437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erysimum cheiri extract [1810298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elemi oil [2588242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enoxaparin sodium [221095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoglucid [4132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efavirenz [195085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylnicotinate [236122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprazinone [24272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene-vinyl acetate copolymer (19% vinylacetate) [1312576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol acetate [405416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edoxaban [1599538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia hirta leaf extract [2641890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etanercept-ykro [2462511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergonovine [4021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eltrombopag olamine [735651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene brassylate [1314363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethinamate [24474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estrone [4103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etofibrate [24609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acrylate and methyl methacrylate copolymer (2:1; 750000 MW) [1426457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprosartan [83515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erythroxylum catuaba bark extract [1609189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus extract [319781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enflurane [3920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elranatamab [2644880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl methoxycrylene [1311616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estetrol monohydrate [2539035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucommia ulmoides leaf extract [1866521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl cyanoacrylate [1608793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elvitegravir [1306286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emapalumab-lzsg [2104603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efinaconazole [1539753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea preparation [228041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enzalutamide [1307298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylnorepinephrine [156240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene distearamide [1655222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>equol, (+-)- [1492341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eclipta prostrata whole extract [1360622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea pallida preparation [1364288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ecamsule [1544124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ephedra sinica root extract [1724424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylhexyl acrylate [1432294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate sodium tetrahydrate [1356152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erlotinib [337525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eplerenone [298869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethopabate [1314353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elivaldogene autotemcel [2612527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea angustifolia extract [236121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylbisiminomethylguaiacol manganese chloride [1373152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epsiprantel [24285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetate calcium disodium anhydrous [1371967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>exagamglogene autotemcel [2671667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethamivan [24453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl-p-hydroxybenzoate [1362892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eugenia uniflora whole extract [1535488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ensartinib [2712546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English lavender oil [2168411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ecothiopate [89778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enzacamene [1311507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl vanillin [1311571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emepronium [3816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epidermal growth factor [1427158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etoricoxib [307296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eriodictyon californicum flowering top extract [1371949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etranacogene dezaparvovec-drlb [2626768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enoxaparin [67108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (100 MPA S) [1305739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergot preparation [91405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elapegademase-lvlr [2059218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia thymifolia whole extract [1371301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene oxide [1368154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-eicosene [1313731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene dodecanedioate [2604565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>everolimus [141704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>everlasting extract [1337279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphrasia stricta extract [1353885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl sebacate [1426475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethylaminoethanol [1313220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea purpurea flowering top water [2602283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eculizumab-aagh [2706334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etranacogene dezaparvovec [2626727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl glutamate [1544275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Evans blue [4191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eperua falcata bark extract [1487909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidocaine hydrochloride [227221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum arvense branch extract [1307596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equus caballus leg callous preparation [1488227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evinacumab-dgnb [2478646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European rabbit skin extract [895195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epigallocatechin gallate [24246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl ferulate [1420983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetic acid dihydrate [2465735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprosartan mesylate [236878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylparaben potassium [2686158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythorbate [1356146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea purpurea aerial parts extract [477531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>East Indian lemongrass oil [1309338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Elymus repens whole extract [1661742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etanercept [214555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eschscholzia californica flower extract [2593941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Embelia ribes whole extract [2707700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern yellow jacket venom protein [1297529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia hirta flowering top extract [1543077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etodolac [24605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin lactobionate [24347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergoloid mesylates, USP [4024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylcellulose (45 MPA.S) [1649449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eriodictyon californicum leaf extract [1342455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epilobium angustifolium flowering top extract [1307564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euterpe oleracea whole extract [1358888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia corollata root extract [1921561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epifagus virginiana extract [1353221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eucalyptol [21116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edoxaban tosylate [1599564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ertugliflozin pidolate [1992674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ehrlichia chaffeensis extract [1492326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia resinifera resin [1310367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl laurate [1314306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entrectinib [2197862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Entada phaseoloides whole extract [1546867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elastin, bovine [1730434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanolamine hydrochloride [1311530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl dihydroxypropyl PABA [314611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg yolk (chicken) allergenic extract [892620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estramustine phosphate sodium [4090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eriobotrya japonica whole extract [2533858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia antisyphilitica whole extract [2587596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estazolam [4077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ebanol [2383933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erodium stephanianum top extract [1485538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythrosine sodium [1366961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eleuthero preparation [1368902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epigallocatechin gallate stearates [1536068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epigaea repens extract [1544392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eugenol [4186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euonymus alatus whole extract [1358887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole magnesium trihydrate [2688630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl pyruvate [1539968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Etlingera elatior whole extract [2180258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eriastrum filifolium whole extract [2289221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl olivate [2266752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus gum extract [1541731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eucalyptus piperita leaf extract [1495155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>escitalopram oxalate [353108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl thioglycolate [2533859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efmoroctocog alfa [1543095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>encainide hydrochloride [281189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupatorium perfoliatum preparation [285152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupatorium cannabinum extract [1309987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ericerus pela polycosanol [1313747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ensulizole [13714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl linalool [1376096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>8-epi-cyanocobalamin [1722234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eupatorium cannabinum whole extract [1995487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl ethylhexanoate [1313265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphrasia officinalis preparation [283679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emapalumab [2104604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Entada phaseoloides leaf extract [1310085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entsufon sodium [1366956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ellagic acid [1043181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus cinerea whole extract [2059231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erigeron strigosus whole extract [2118077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efgartigimod alfa-fcab [2587719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ertapenem sodium [353107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine tetra (methylene phosphonic acid) monohydrate [1311236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elm extract [1372006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emedastine [28144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acetoacetate [1603474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylparaben sodium [1364859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ensifentrine [2687215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg white (chicken) allergenic extract [892616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eletriptan hydrobromide [360288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edaravone [1921877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern white pine pollen extract [852738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylnorepinephrine hydrochloride [289080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-ethyl-3-oxetanemethanol [2285402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eluxadoline [1653781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl 2-methylpentanoate [2557367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>echothiophate iodide [3740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estramustine phosphate [105556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epirubicin hydrochloride [203213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Equisetum hyemale top extract [1724425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>escitalopram [321988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>escin [4065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Echinacea purpurea flowering top extract [1307637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elinzanetant [2725511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythrulose, D- [1862681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erenumab-aooe [2045614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English walnut allergenic extract [891687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emepronium bromide [71481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evodiamine [2199291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole sodium [1294569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eleutherococcus sessilflorus whole extract [1313687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estriol succinate [24416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium sagittatum leaf extract [2540132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Embelia ribes fruit extract [2679611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl nitrate [1314360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol [2589801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eladocagene exuparvovec-tneq [2698765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl loflazepate [24524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia hirta extract [1347564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eprozinol hydrochloride [402567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl 2,4-decadienoate, (2E,4Z)- [1869048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eladocagene exuparvovec [2698762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergothioneine [1314350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(2-ethylhexyloxy)ethanol [2288811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethoxazene hydrochloride [402538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine carbamate [2375923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efgartigimod alfa-qvfc [2639944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphorbia kansui whole extract [2699581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ensartinib hydrochloride [2712547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estropipate [33747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edrophonium cation [1546421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl acrylate and methyl methacrylate copolymer (2:1; 600000 MW) [1312573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evening primrose oil [203219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>endothelial growth factor A, human vascular [2642869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etidronic acid [1356715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin gluceptate [24346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edrophonium chloride [3754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Erodium cicutarium extract [1433760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eutrochium purpureum flowering top extract [1813290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eicosyl povidone (2 eicosyl branches-repeat) [1489921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Euphrasia officinalis leaf extract [2274241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine bitartrate [203180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexylglyceryl behenate [1592896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entsufon [1366957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European aspen pollen extract [2166596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>empagliflozin [1545653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elder extract [317808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eurotium amstelodami allergenic extract [2101329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylene glycol allyl ether [2389636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English plantain pollen extract [852742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern oyster allergenic extract [2103250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eryngium maritimum whole extract [2563920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edrecolomab [80726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epimedium grandiflorum top extract [1311044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etonogestrel [14584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethacrynic acid [4109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evolocumab [1665684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythritol [1369563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enalapril [3827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>E [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylhexyl acetate [1313749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>E3 Ubiquitin Ligase Inhibitors [MoA]</name>
  <code>C300475</code>  <id>300475</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>E3 Ubiquitin Ligase Inhibitors</to_name>
    <to_code>T16969</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020085</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>E3 Ubiquitin Ligase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>E3 Ubiquitin Ligase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Echinocandin Antifungal [EPC]</name>
  <code>C634900</code>  <id>634900</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Echinocandin Antifungal</to_name>
    <to_code>T17227</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175507</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinocandins [M0507131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Echinocandin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lipopeptides [M0519359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>micafungin [325887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anidulafungin [341018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caspofungin [140108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Echinocandin Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rezafungin [2639155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ectoparasiticide [EPC]</name>
  <code>C654281</code>  <id>654281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ectoparasiticide</to_name>
    <to_code>T58858</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194050</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ectoparasiticide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lotilaner [1998841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Electrical Activity Alteration [PE]</name>
  <code>C28420</code>  <id>28421</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration</to_name>
    <to_code>T17414</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009027</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Electrical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Electrical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Disorganized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprobarbital [17381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital sodium [235404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Electrolyte Activity [MoA]</name>
  <code>C618</code>  <id>619</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity</to_name>
    <to_code>T17415</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000220</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate monohydrate [1309410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxytol [473387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium acetate tetrahydrate [317246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lactate [56489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate anhydrous [1792467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron-dextran complex [5992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric ammonium citrate [24897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate trihydrate [1440975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium zirconium cyclosilicate [2047628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic potassium phosphate [55018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric citrate [1594675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate [56443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate, heptahydrate [1311282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous fumarate [24941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dihydrogen phosphate [236560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric chloride [21833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate [58300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium stearate [1310567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate anhydrous [1310549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate [24947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloride ion [153974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc acetate [58295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron [90176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic anhydrous [1307158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride tetrahydrate [2003593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium,chelated [259277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysaccharide iron complex [105669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc chloride [39937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate anhydrous [1299928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ferric gluconate complex [261435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous gluconate [24942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate,dried [259346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper gluconate [2839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron,peptonized [235272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide [1310572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride hexahydrate [221118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, monohydrate [1311357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium amino acid chelate [486895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tribasic sodium phosphate [36710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric oxide [21837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic sodium phosphate heptahydrate [221090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate, anhydrous [267453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride anhydrous [1311539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide yellow [1305582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate dibasic trihydrate [2475957]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate [39954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, dodecahydrate [1311345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Electrolyte [EPC]</name>
  <code>C635222</code>  <id>635222</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolytes</to_name>
    <to_code>T17416</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte</to_name>
    <to_code>T17417</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175803</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Electrolyte [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing electrolyte (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Electrolyte [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Electrolytes [M0007189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Electrolyte [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Electrolyte (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Elimination [PK]</name>
  <code>C222</code>  <id>223</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Elimination</to_name>
    <to_code>T17466</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000022</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Elimination [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Route of Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Elimination [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Alteration [PE]</name>
  <code>C28422</code>  <id>28423</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Alteration</to_name>
    <to_code>T17508</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009028</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic Implantation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Growth Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Viability Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovum Fertilization Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Development Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Development Alteration [PE]</name>
  <code>C28424</code>  <id>28425</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Development Alteration</to_name>
    <to_code>T17509</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009029</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Development Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Embryonic &amp; Fetal Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Development Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Embryonic &amp; Fetal Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Growth Alteration [PE]</name>
  <code>C28426</code>  <id>28427</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Growth Alteration</to_name>
    <to_code>T17510</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009030</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Growth Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Embryonic &amp; Fetal Growth [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Growth Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic &amp; Fetal Growth [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Embryonic &amp; Fetal Viability Alteration [PE]</name>
  <code>C28428</code>  <id>28429</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Viability Alteration</to_name>
    <to_code>T17511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009031</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Viability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic &amp; Fetal Viability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic &amp; Fetal Viability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Embryonic &amp; Fetal Viability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Embryonic Implantation Alteration [PE]</name>
  <code>C28430</code>  <id>28431</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic Implantation Alteration</to_name>
    <to_code>T17512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009032</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic Implantation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Embryonic Implantation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Embryonic Implantation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Emesis Suppression [PE]</name>
  <code>C28434</code>  <id>28435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression</to_name>
    <to_code>T17522</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009034</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymol [10553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant dimeglumine [754763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone [3626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron hydrochloride [142149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosnetupitant chloride hydrochloride [2044416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride anhydrous [2119176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron hydrochloride [397405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant [1731071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide hydrochloride [57227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone maleate [236099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide [38685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron [26237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosnetupitant [2044417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Emesis [PE]</name>
  <code>C28432</code>  <id>28433</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis</to_name>
    <to_code>T17523</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009033</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disulfiram [3554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Emollient Activity [PE]</name>
  <code>C28436</code>  <id>28437</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity</to_name>
    <to_code>T17536</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009035</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea hydrochloride [1862866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-100 stearate [1367120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peg-75 lanolin [1363619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-6 lauramide [1363617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 sorbitan diisostearate [1363615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine stearate [38625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-4 dilaurate [1363613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-120 methyl glucose dioleate [1309363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-8 dioleate [1363621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium chloride [1796444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea [11002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lactate [215247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 stearate [1314849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emollient Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endocrine Activity Alteration [PE]</name>
  <code>C28438</code>  <id>28439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endocrine Activity Alteration</to_name>
    <to_code>T17724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009036</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Islet Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Placental Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Cortical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pineal Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Medullary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endocytosis Alteration [PE]</name>
  <code>C28440</code>  <id>28441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endocytosis Alteration</to_name>
    <to_code>T17730</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009037</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endogenous Antigen Neutralization [MoA]</name>
  <code>C643677</code>  <id>643677</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endogenous Antigen Neutralization</to_name>
    <to_code>T17734</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184012</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endogenous Antigen Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endoglycosidase [EPC]</name>
  <code>C634924</code>  <id>634924</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endoglycosidase</to_name>
    <to_code>T17738</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175531</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endoglycosidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase, ovine [486164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endoglycosidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase, bovine [578350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endoglycosidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berahyaluronidase alfa [2723752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endoglycosidase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycoside Hydrolases [M0009499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endoglycosidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase, human recombinant [1300478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endoglycosidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endoglycosidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endonuclease Inhibitors [MoA]</name>
  <code>C654073</code>  <id>654073</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endonuclease Inhibitors</to_name>
    <to_code>T58458</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193851</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endonuclease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endorphin Activity Alteration [PE]</name>
  <code>C28442</code>  <id>28443</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endorphin Activity Alteration</to_name>
    <to_code>T17764</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009038</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endorphin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endorphin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endothelial Coagulation Activity Alteration [PE]</name>
  <code>C28444</code>  <id>28445</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelial Coagulation Activity Alteration</to_name>
    <to_code>T17778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009039</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelial Coagulation Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endothelial Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelial Coagulation Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endothelial Proliferation Alteration [PE]</name>
  <code>C635080</code>  <id>635080</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelial Proliferation Alteration</to_name>
    <to_code>T17785</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175674</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelial Proliferation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelial Proliferation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Endothelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Agonists [MoA]</name>
  <code>C634746</code>  <id>634746</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Agonists</to_name>
    <to_code>T17786</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175363</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Antagonist [EPC]</name>
  <code>C634974</code>  <id>634974</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonist</to_name>
    <to_code>T17787</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175581</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing endothelin receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atrasentan [2710449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with endothelin receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sparsentan [2630535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macitentan [1442132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosentan anhydrous [1468845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ambrisentan [358274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprocitentan [2679059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Antagonists [MoA]</name>
  <code>C634747</code>  <id>634747</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonist</to_name>
    <to_code>T17788</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists</to_name>
    <to_code>T17789</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175364</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrisentan [358274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprocitentan [2679059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan monohydrate [498193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macitentan [1442132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atrasentan [2710449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan [75207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Endothelin Receptor Interactions [MoA]</name>
  <code>C634745</code>  <id>634745</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Interactions</to_name>
    <to_code>T17790</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175362</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Endothelin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enhance Penile Erection [PE]</name>
  <code>C28446</code>  <id>28447</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhance Penile Erection</to_name>
    <to_code>T17809</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009040</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhance Penile Erection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhance Penile Erection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhance Penile Erection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enhanced by acidity [PK]</name>
  <code>C204</code>  <id>205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhanced by acidity</to_name>
    <to_code>T17810</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000013</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enkephalin Activity Alteration [PE]</name>
  <code>C28448</code>  <id>28449</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enkephalin Activity Alteration</to_name>
    <to_code>T17815</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009041</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enkephalin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enkephalin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enkephalinase Inhibitors [MoA]</name>
  <code>C568</code>  <id>569</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enkephalinase Inhibitors</to_name>
    <to_code>T17856</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000195</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzymatic Activity [MoA]</name>
  <code>C534</code>  <id>535</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity</to_name>
    <to_code>T17945</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000178</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacrosidase [214817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-nvhy [2700789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase [2059219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velaglucerase alfa [901805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase-lvlr [2059218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa [2565814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa-atga [2667434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa [2667433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asfotase alfa [1720259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylase / lipase / protease [392491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taliglucerase alfa [1291609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa-ngpt [2565813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegademase bovine [59768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase alfa [2691830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzymatic Pathway of Metabolism [PK]</name>
  <code>C238</code>  <id>239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Pathway of Metabolism</to_name>
    <to_code>T17946</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000030</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epoxide hydrolases [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine oxidase [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-acetyl transferases [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Esterases [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfotransferases [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochromes [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glutathione s-transferases [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucuronosyl transferases [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Co-methyltransferase [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiopurine methyltransferase [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzymatic Pathway of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic hydroxylation [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Activator [APC]</name>
  <code>C654118</code>  <id>654118</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activator</to_name>
    <to_code>T58521</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193896</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activator [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Activators [MoA]</name>
  <code>C640</code>  <id>641</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators</to_name>
    <to_code>T17947</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000231</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GTP Phosphohydrolase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lyase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ligase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxylase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase [58939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIIa [4256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor Xa (recombinant), inactivated-zhzo [2045125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen,I-125 [314623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegloticase [1011650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa (activated), lyophilized [353106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor VIIa (recombinant)-jncw [2386863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>andexanet alfa [2045114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasburicase [283821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor XIII a-subunit (recombinant) [1488293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turoctocog alfa [1737557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vericiguat [2475830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human [1426166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human-lans [2643194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII [4271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Inducers [MoA]</name>
  <code>C650047</code>  <id>650047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inducers</to_name>
    <to_code>T17948</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190116</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Inhibitor [APC]</name>
  <code>C654119</code>  <id>654119</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitor</to_name>
    <to_code>T58522</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193897</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxaborole Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Anti-inflammatory Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cortisol Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylxanthine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Dehydropeptidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitor Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 17A1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol-O-Methyltransferase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitor [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 3A Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatic Amino Acid Decarboxylation Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selectin Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldehyde Dehydrogenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-alpha Reductase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HMG-CoA Reductase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Glucosidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 2D6 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intestinal Lipase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Inhibitors [MoA]</name>
  <code>C444</code>  <id>445</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors</to_name>
    <to_code>T17949</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000133</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endonuclease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Deaminase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dephosphorylation Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Phosphorylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>14-alpha Demethylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Squalene Monooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epoxide Hydrolase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Diphosphate Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fatty Acid Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncouplers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Activating Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catechol O-Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosyl Transferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbonic Anhydrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>11-beta Hydroxysteroid Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiac Myosin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decarboxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ubiquitin Ligase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alcohol Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin phenyl sodium [42580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine [6704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin hydrochloride [66955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonyl butoxide [8345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niclosamide [7402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letrozole [72965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin propionate [28069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline [1364504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vigabatrin [14851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exemestane [258494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin [2190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat sodium [2685237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline fumarate [1364503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat hydrobromide [2274379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemin [5175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantharidin [1984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resveratrol [1000492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>6-aminocaproic acid [99]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin sodium [267417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anastrozole [84857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin [11124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin [6084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat [2685236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testolactone [10378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Interaction [APC]</name>
  <code>C654117</code>  <id>654117</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interaction</to_name>
    <to_code>T58520</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193898</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitor [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Stabilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activator [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Interactions [MoA]</name>
  <code>C504</code>  <id>505</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions</to_name>
    <to_code>T17950</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000163</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Stabilizers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B12 [11248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc acetate [58295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid, (+-)- [2394646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc nicotinate [236834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl aminolevulinate hydrochloride [1300479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium stearate [1310567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone piperazine [236354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate [58300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium anhydrous [2279515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-fihj [2375132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate, heptahydrate [1311282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase-pqpz [2046361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate [1592257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-ocsq [2693451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone sodium [236529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-nvhy [2700789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin tetrabutyrate [2106328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium chloride [1796444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene hydrate [1299898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium latamoxef [258330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B6 [42954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentiromide [18896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin [9346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-oysk [2119708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-zzxf [2382595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate trihydrate [1440975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium [1925820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A myristate [1813433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate anhydrous [1792467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folic acid [4511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, bovine [578350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium acetate tetrahydrate [317246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine phosphoserinate [236803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat hydrochloride [2054264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate glucosamine [1592256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene [29365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate monohydrate [1309410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paricalcitol [73710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythritol [1369563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium molybdate [17789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate [39954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid hydrochloride [261715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium folate [1300473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubidecarenone [21406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride anhydrous [1311539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxalactam [7069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molybdenum [7024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate magnesium [1549106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid [683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase [2046360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium amino acid chelate [486895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride hexahydrate [221118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biotin [1588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-qvfc [2639946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid [7891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucarpidase [1242127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerliponase alfa [1922436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A palmitate [35406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-tqjs [2693885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate anhydrous [1299928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, ovine [486164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 5-aminolevulinate [337068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc chloride [39937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat [2054252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal phosphate [9004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolic acid [1025342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin sodium [2109051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, human recombinant [1300478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A [11246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium dihydrate [2611697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride tetrahydrate [2003593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase [5464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Reactivators [MoA]</name>
  <code>C594</code>  <id>595</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Reactivators</to_name>
    <to_code>T17954</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000208</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Reactivators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Replacements/Modifiers [TC]</name>
  <code>C654045</code>  <id>654045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers</to_name>
    <to_code>T58423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193824</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-oysk [2119708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-tqjs [2693885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam [2184137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, ovine [486164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>misoprostol [42331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegunigalsidase alfa-iwxj [2637445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebelipase alfa [1726975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-zzxf [2382595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha 1-proteinase inhibitor, human [991743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa [2565814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine hydrochloride [81965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-qvfc [2639946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa [2667433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucarpidase [1242127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasminogen [2557200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerliponase alfa [1922436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegademase bovine [59768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velmanase alfa-tycv [2630724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ADAMTS13, recombinant [2670285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carglumic acid [401713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase-lvlr [2059218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab [2717169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idursulfase [644101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase [5464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat hydrochloride [2054264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laronidase [392509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat [2054252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam monohydrate [2184136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat sulfate [2595574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant [1148138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, bovine [578350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat sodium [2685237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa-ngpt [2565813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, human recombinant [1300478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase [2059219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine [1512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elosulfase alfa [1489914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab-gxii [2717168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-fihj [2375132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase beta [338817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taliglucerase alfa [1291609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galsulfase [578033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant acetate [1294605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegunigalsidase alfa [2637446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemin [5175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase alfa [2691830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olipudase alfa-rpcp [2610406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-nvhy [2700789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam anhydrous [2268500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglustat [402316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacrosidase [214817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velaglucerase alfa [901805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasminogen, human-tvmh [2557201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa-atga [2667434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ADAMTS13, recombinant-krhn [2670286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velmanase alfa [2630725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase-pqpz [2046361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat [2685236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olipudase alfa [2610407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase [2046360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-ocsq [2693451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letrozole [72965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine citrate [160460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Stabilizer [EPC]</name>
  <code>C654302</code>  <id>654302</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Stabilizer</to_name>
    <to_code>T58902</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194077</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miglustat [402316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme Stabilizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Stabilizers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme Stabilizers [MoA]</name>
  <code>C654301</code>  <id>654301</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Stabilizers</to_name>
    <to_code>T58901</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194078</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglustat [402316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Stabilizers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Enzyme [APC]</name>
  <code>C654108</code>  <id>654108</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme</to_name>
    <to_code>T58513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193884</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Asparagine-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carboxypeptidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Metabolizing Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endoglycosidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sucrose-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal beta Glucuronidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collagen-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease 1 [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Enzyme [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Epidermal Growth Factor Receptor Antagonist [EPC]</name>
  <code>C635057</code>  <id>635057</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Antagonist</to_name>
    <to_code>T18070</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EGFR Antagonist</to_name>
    <to_code>T18068</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor (EGFR) Antagonist</to_name>
    <to_code>T18069</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonist</to_name>
    <to_code>T18067</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175664</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with epidermal growth factor receptor inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>necitumumab [1723738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panitumumab [263034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal Growth Factor Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetuximab [318341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protein kinase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with protein kinase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Epidermal and Animal Specific Allergenic Extract [APC]</name>
  <code>C654112</code>  <id>654112</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal and Animal Specific Allergenic Extract</to_name>
    <to_code>T58517</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193899</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Feather Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Animal Hair Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Animal Skin Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Plant Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Insect Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epidermal and Animal Specific Allergenic Extract [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Insect Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Epinephrine Activity Alteration [PE]</name>
  <code>C28450</code>  <id>28451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epinephrine Activity Alteration</to_name>
    <to_code>T18202</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009042</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epinephrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epinephrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Epithelial Proliferation Alteration [PE]</name>
  <code>C635079</code>  <id>635079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epithelial Proliferation Alteration</to_name>
    <to_code>T18249</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175673</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epithelial Proliferation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Epithelial Proliferation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Epoxide Hydrolase Inhibitors [MoA]</name>
  <code>C652511</code>  <id>652511</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epoxide Hydrolase Inhibitors</to_name>
    <to_code>T18283</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192345</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brivaracetam [1739745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epoxide Hydrolase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Epoxide hydrolases [PK]</name>
  <code>C244</code>  <id>245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epoxide hydrolases</to_name>
    <to_code>T18288</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000033</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype A [EPC]</name>
  <code>C648888</code>  <id>648888</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype A</to_name>
    <to_code>T18320</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188980</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype A [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Equine botulinum neurotoxin a immune fab2 (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype A [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype A [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype B [EPC]</name>
  <code>C648889</code>  <id>648889</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype B</to_name>
    <to_code>T18321</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188981</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype B [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype B [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Equine botulinum neurotoxin b immune fab2 (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype B [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype C [EPC]</name>
  <code>C648890</code>  <id>648890</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype C</to_name>
    <to_code>T18322</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188982</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype C [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype C [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Botulinum antitoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype C [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype D [EPC]</name>
  <code>C648891</code>  <id>648891</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype D</to_name>
    <to_code>T18323</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188983</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype D [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Botulinum antitoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype D [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype D [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype E [EPC]</name>
  <code>C648892</code>  <id>648892</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype E</to_name>
    <to_code>T18324</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188984</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype E [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Equine botulinum neurotoxin e immune fab2 (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype E [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype E [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Botulinum antitoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype E [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype F [EPC]</name>
  <code>C648893</code>  <id>648893</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype F</to_name>
    <to_code>T18325</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188985</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype F [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype F [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Botulinum antitoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype F [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Equine Botulinum Antitoxin, Serotype G [EPC]</name>
  <code>C648894</code>  <id>648894</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype G</to_name>
    <to_code>T18326</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188986</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Equine Botulinum Antitoxin, Serotype G [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Antitoxin [M0002842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing botulinum antitoxin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Botulinum antitoxin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ergosterol Synthesis Inhibitors [MoA]</name>
  <code>C30282</code>  <id>30283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors</to_name>
    <to_code>T18367</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009957</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine hydrochloride [91293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine [31476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole nitrate [236601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutrimazole [61773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ergot Derivative [EPC]</name>
  <code>C635246</code>  <id>635246</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot Derivative</to_name>
    <to_code>T18375</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175827</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot Derivative [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing ergot alkaloid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot Derivative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabergoline [47579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot Derivative [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Ergot alkaloid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot Derivative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylergonovine [6883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot Derivative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromocriptine [1760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot Derivative [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergot Alkaloids [M0007656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ergot-derived Dopamine Receptor Agonist [EPC]</name>
  <code>C635186</code>  <id>635186</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot-derived Dopamine Receptor Agonist</to_name>
    <to_code>T18376</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175767</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot-derived Dopamine Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pergolide [8047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot-derived Dopamine Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergot-derived Dopamine Receptor Agonist [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergot Alkaloids [M0007656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dopamine receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing dopamine receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ergotamine Derivative [EPC]</name>
  <code>C635185</code>  <id>635185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergotamine Derivative</to_name>
    <to_code>T18377</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175766</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergotamine Derivative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydroergotamine [3418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergotamine Derivative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergotamine [4025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ergotamine Derivative [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergotamines [M0007665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing ergotamine (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergotamine Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Ergotamine (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergotamine Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Erythrocyte Function Alteration [PE]</name>
  <code>C654194</code>  <id>654194</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythrocyte Function Alteration</to_name>
    <to_code>T58655</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193978</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythrocyte Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin Function Restoration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Erythroid Maturation Agent [EPC]</name>
  <code>C654259</code>  <id>654259</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythroid Maturation Agent</to_name>
    <to_code>T58789</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194025</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythroid Maturation Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythroid Maturation Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luspatercept [2262544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hematologic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythroid Maturation Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Erythropoiesis-stimulating Agent [EPC]</name>
  <code>C635058</code>  <id>635058</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythropoiesis-stimulating Agent</to_name>
    <to_code>T18447</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythropoiesis-stimulating Agent (ESA)</to_name>
    <to_code>T18445</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ESA</to_name>
    <to_code>T18446</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175665</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darbepoetin alfa [283838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Erythropoietin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxy polyethylene glycol-epoetin beta [729596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythropoietin [M0007726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing erythropoietin receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Erythropoiesis-stimulating Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoetin alfa [105694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ester Local Anesthetic [EPC]</name>
  <code>C635089</code>  <id>635089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ester Local Anesthetic</to_name>
    <to_code>T18514</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175683</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ester Local Anesthetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ester Local Anesthetic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esters [M0007766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ester Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chloroprocaine [20859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ester Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracaine [10391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Local anesthetic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ester Local Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Esterases [PK]</name>
  <code>C242</code>  <id>243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Esterases</to_name>
    <to_code>T18516</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000032</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estradiol Antagonists [MoA]</name>
  <code>C634718</code>  <id>634718</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estradiol Antagonists</to_name>
    <to_code>T18529</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000011319</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen Agonist/Antagonist [EPC]</name>
  <code>C635245</code>  <id>635245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SERM</to_name>
    <to_code>T18557</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulator</to_name>
    <to_code>T18555</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Estrogen Agonist and Antagonist</to_name>
    <to_code>T18556</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Agonist/Antagonist</to_name>
    <to_code>T18558</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175826</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomiphene [2596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toremifene [38409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamoxifen [10324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ospemifene [1370971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Selective estrogen receptor modulator (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bazedoxifene [1441386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing selective estrogen receptor modulator (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raloxifene [72143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Agonists [MoA]</name>
  <code>C378</code>  <id>379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists</to_name>
    <to_code>T18559</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000100</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estetrol [2539031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienestrol [3368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Antagonist [EPC]</name>
  <code>C634975</code>  <id>634975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Inhibitor</to_name>
    <to_code>T18560</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonist</to_name>
    <to_code>T18561</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175582</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elacestrant [2628469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fulvestrant [282357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing estrogen receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with estrogen receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Antagonists [MoA]</name>
  <code>C468</code>  <id>469</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists</to_name>
    <to_code>T18563</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Inhibitor</to_name>
    <to_code>T18562</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000145</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estradiol Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant [2725912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant tosylate [2725911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant dihydrochloride [2628473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvestrant [282357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen Receptor Modulators [MoA]</name>
  <code>C550</code>  <id>551</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Modulators</to_name>
    <to_code>T18564</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000186</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen Synthesis Inhibitors [MoA]</name>
  <code>C635364</code>  <id>635364</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Synthesis Inhibitors</to_name>
    <to_code>T18574</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175926</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aromatase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Estrogen [EPC]</name>
  <code>C635244</code>  <id>635244</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen-class Agent</to_name>
    <to_code>T18575</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen</to_name>
    <to_code>T18576</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175825</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estranes [M0007786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estradiol [4083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estetrol [2539031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>estrogens, conjugated (USP) [4099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing estrogen receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethinyl estradiol [4124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with estrogen receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Estrogen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estradiol Congeners [M0447348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Exocytosis Alteration [PE]</name>
  <code>C28452</code>  <id>28453</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Exocytosis Alteration</to_name>
    <to_code>T18942</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009043</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Exocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Exocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Exocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Exocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Expectorant [EPC]</name>
  <code>C654183</code>  <id>654183</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Expectorant</to_name>
    <to_code>T58638</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193956</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Expectorant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Expectorant agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Expectorant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Expectorant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaifenesin [5032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Expectorant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Extracellular Communication [PE]</name>
  <code>C31818</code>  <id>31819</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Extracellular Communication</to_name>
    <to_code>T18999</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010230</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Extracellular Communication [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Extracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Extracellular Communication [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Extracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>F [Preparations]</name>
  <code>C288632</code>  <id>288632</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>F [Preparations]</to_name>
    <to_code>T19070</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010588</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenproporex [24867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C yellow no. 6 [1305574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosfomycin [4550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C blue #2 lake [1307695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferriclate calcium sodium [2619162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fingolimod hydrochloride [1012891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosdenopterin [2531288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurandrenolide [4500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fennel seed preparation [125918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fulvic acid [1314310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C red no. 4 [1310575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinogen, human [2264108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flumequine [25112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium compactum allergenic extract [999457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorometholone acetate [221101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flutrimazole [61773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluphenazine [4496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fumaria officials whole extract [1809828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ferula sumbul root extract [1309808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibroblast growth factor 7 [1789471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluralaner [1538098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fludrocortisone [4452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fecal microbiota spores, live [2636537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferumoxides [72901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fucus spiralis extract [2636730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formoterol [25255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagopyrum esculentum extract [1352033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorapatite [1313343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrosoferric oxide [1310708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Frangula purshiana bark extract [1350209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>feclobuzone [2391141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluconazole [4450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fidanacogene elaparvovec-dzkt [2681020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flopropione [25082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florbetapir [1427225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C yellow no. 5 free acid [1926832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fragaria vesca leaf extract [1793892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flumethiazide [89911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fucus vesiculosus extract [1334747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorouracil [4492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Francisella tularensis [1432988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formate [1362748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor IX [4249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluticasone propionate [50121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous bisglycinate hydrochloride [1306114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenspiride hydrochloride [236281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flupentixol hydrochloride [235742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric ammonium ferrocyanide [1426442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluindione [50097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavin adenine dinucleotide disodium [2642191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>farnesol [1362903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fesoterodine fumarate [797196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floctafenine [4444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurbiprofen sodium [91351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flumethasone pivalate [25113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foscarbidopa [2695774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floxacillin magnesium [235825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fallopia multiflora root extract [1309940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric pyrophosphate [1607976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flotufolastat [2637947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Freesia alba flower extract [1370104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Foeniculum vulgare leaf extract [1606478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fumaryl diketopiperazine [1544485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C blue #2 aluminum lake [2119470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fecal microbiota, live-jslm [2626728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluspirilene [4507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fingolimod [1012892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florfenicol [25086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foscolic acid [1368645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flounder allergenic extract [899746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>febuxostat [73689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ficus carica leaf extract [1440226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunisolide anhydrous [1546428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrosoferric phosphate [1311293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosfestrol tetrasodium [281876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferulic acid [1368647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosfructose [2119172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoride ion [196213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fe heme polypeptide [284110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoride ion F-18 [1546273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous arsenate [1370299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenugreek seed oil [2361302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>faricimab-svoa [2591584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorexon stain [25161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorodopa [2571852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C yellow #5 aluminum lake [1425915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fomepizole [15226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fondaparinux sodium [322154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Forsythia suspensa whole extract [1358896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous sulfate,dried [259346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluphenazine hydrochloride [203207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fecal microbiota spores, live-brpk [2636536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flufenamate [618272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flutemetamol [1486026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fecal microbiota, live [2626724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>filgrastim-txid [2700365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>frunevetmab [2601304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>finafloxacin [1598641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinogen,I-125 [314623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fremanezumab [2056691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fludarabine [24698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formic acid [4537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunitrazepam [4460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluprednisolone [4497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosamprenavir [358262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Filipendula ulmaria flower extract [1307553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>febuprol [24809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fonazine mesylate [50139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>felypressin [4319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous iodide [1311296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous phosphate [107056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ferula assa-foetida whole extract [1420963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric oxide yellow [1305582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C red no. 4 free acid [1999761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric picrate preparation [1311314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fragaria vesca fruit juice [2397114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fritillaria delavayi whole extract [2592968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fivehorn smotherweed pollen extract [852124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosaprepitant [1731071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenfluramine [4328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous asparto glycinate [644718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrocyanide [2383540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>febantel [24805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoroestradiol F-18 [2372221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurpiridaz [2700763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoxazoline hydrochloride [236387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous oxalate [236196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric phosphate [24910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Frasera caroliniensis root extract [1435393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fam-trastuzumab deruxtecan-nxki [2267574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosphenytoin [72236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flupirtine gluconate [259480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurbiprofen [4502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosnetupitant [2044417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floxuridine [4488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoldopam [24853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluphenazine decanoate [25190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>filgrastim [68442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flibanserin [1665509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>feverfew extract [114203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunisolide [25120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formoterol fumarate [236216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fructose [4570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>follitropin beta [25357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fusafungin [25437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>furcelleran [1858559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ficus carica whole extract [1364988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosnetupitant chloride hydrochloride [2044416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formalin [314636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosveset [1312592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurazepam hydrochloride [71484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Filipendula ulmaria root extract [1307967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florbetaben [2571857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fuzapladib [2632642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Flickingeria fimbriata stem extract [1307707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocortolone caproate [4464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavoxate [4440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunarizine hydrochloride [82019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fumagillin [1926480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluvoxamine maleate [203143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fu ling [1314424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>frovatriptan [228783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor X [4262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fragaria vesca whole extract [1541239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluvoxamine [42355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floralozone [2557368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenofibrate [8703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoprop triisopropanolamine [2359251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous disulfide [1544140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocinolone [25126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagus sylvatica flower bud extract [1309464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavoxate hydrochloride [142437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Frangula californica bark extract [1309934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosamprenavir calcium [402365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fanolesomab [1314371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferulate [1368648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fonazine [50138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous fumarate [24941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>field mushroom allergenic extract [2102477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Furcellaria lumbricalis extract [1667781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flupirtine maleate [236774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fructose, DL- [2374739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fragaria chiloensis whole extract [2001193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous cation [1541238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorexon disodium [579979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>finerenone [2562811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fennel extract [1370467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fumaria officinalis flowering top extract [1309992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluciclovine [2571859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flubendazole [25096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fedratinib hydrochloride [2197594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous carbonate [1440290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flaxseed allergenic extract [901351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fuzapladib sodium [2632644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoprofen [4331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VIII, human [826070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>follicle stimulating hormone [227518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foscarnet sodium [57529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VIII [4257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fremont cottonwood pollen extract [852355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fexofenadine [87636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>futibatinib [2628190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flufenamic acid [4453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluclorolone [108091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric oxide [1310572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fig allergenic extract [973880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric ferricyanide [2604034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fleroxacin [42322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>framycetin sulfate [235749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous picrate [1552631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoxymesterone [4494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fusel oil [2287733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fludarabine phosphate [25102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenfluramine hydrochloride [82018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunixin [25121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Flemingia macrophylla root extract [2045730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foscarnet [33562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>folate [62356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fludrocortisone acetate [165516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibroblast growth factor-1 [1591916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorbenside [2467550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous aspartate [236617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>forsythiaside [2670319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fucose [2466731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fitusiran [2709439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fentanyl [4337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>febarbamate [24807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferumoxsil [77754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenozolone [24860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VIIa [4256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flecainide [4441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric chloride [24898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluphenazine enanthate [30129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluprednidene acetate [25194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fish oil (containing omega-3 acids) [2053495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fraxinus excelsior bark extract [1309996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Foeniculum vulgare whole extract [1597889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fremanezumab-vfrm [2056690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosfomycin tromethamine [142135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flortaucipir F-18 [2372689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenugreek seed preparation [360375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>faricimab [2591519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fusidate sodium [9874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>furterene [2643212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formic acid, sodium salt [2376943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavin-adenine dinucleotide [1314412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoterol [4333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fisetin [2667741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenethylline [24840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fesoterodine [797195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor XIII [4271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foscolate [1368646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>firocoxib [473298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florbetapir F-18 [1427224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fraxinus latifolia whole extract [2571090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flutemetamol F-18 [1486025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fidanacogene elaparvovec [2681011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fumitory extract [236156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>folic acid [4511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C blue #2 HT aluminum lake [1425505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floxacillin [4448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoverine [24855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Felis catus milk prepration [1661546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferumoxytol [473387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fumaric acid [25389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous succinate [24946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocinonide [4462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ficus religiosa leafy twig extract [1719256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flupenthixol [4495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ficus benghalensis bark extract [2268213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagraea berteroana flower extract [2123311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluprednidene [236650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fusidic acid [4608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric ammonium citrate [24897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>felbamate [24812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>furosemide [4603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoprop triethanolamine [1721297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunarizine [4459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric nitrate [1363046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorosilicate [1431152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Filipendula ulmaria leaf extract [1307668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C blue #1 aluminum lake [1307694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluciclovine F-18 [1796118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoprofen calcium [267171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fructooligosaccharide [259372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor IX complex [1670383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric chloride hexahydrate [1323279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric citrate [1594675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoxazoline [24856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Frangula preparation [324039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorine [1310123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ferula assa-foetida root extract [1307720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenofibrate micronized [221100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosinoprilat [1546393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurazepam [4501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fatty acids, omega-6 [1495153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagonia arabica whole extract [2102922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric cacodylate [317229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>famotidine [4278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flupirtine [25193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric pyrophosphate citrate [1607975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fritillaria przewalskii bulb extract [1311591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosphenytoin sodium [82806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor XIII, human [1091605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluclorolone acetonide [103447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>farnesane [2268050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flaxseed extract [318224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous sulfate [24947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosinopril sodium [227278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fostamatinib [2044896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C blue #10 aluminum lake [1425504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flucloronide [190410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric subsulfate solution [24912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous chloride [24940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenbendazole [4325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous oxide [1363047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ferula communis subsp. glauca extract [1594763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>farnesol, (2E,6Z)- [2200390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>false ragweed pollen extract [851938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flecainide acetate [42686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fursultiamin [4604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fondaparinux [321208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fipronil [1433761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>furazolidone [4601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>follicle stimulating hormone, porcine [1594665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flupenthixol decanoate [25188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fibraurea tinctoria whole extract [2711691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fritillaria delavayi bulb extract [1543411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fast green FCF stain [1310705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenofibric acid [24852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>finasteride [25025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavodic acid [25060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fraxinus americana bark extract [1428418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flutamide [4508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Festuca pratensis top extract [1421886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fucus serratus extract [1342489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2&apos;-fucosyllactose [1733688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>farnesyl acetate [1487114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fulvestrant [282357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocortin butyl ester [25127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formoterol fumarate dihydrate [998038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ficus carica flower extract [1428845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fingolimod lauryl sulfate [2610292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fuchsia magellanica whole extract [2534459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fomitopsis pinicola fruiting body extract [1355185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorodopa F-18 [2571853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenbufen [24830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Forsythia suspensa fruit extract [1311590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Freesia alba whole extract [2374913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foreskin keratinocyte, neonatal [1427138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fexofenadine hydrochloride [236474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric citrate anhydrous [2539966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenamiphos [1869713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fostemsavir [2380373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocinolone acetonide [4461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous cysteine glycinate [1490797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Frangula alnus bark extract [1310063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>frovatriptan succinate [322249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoxetine [4493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floxacillin sodium monohydrate [1309402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>frankincense extract [1311479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous lactate [136034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagraea berteroana flower oil [2123310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric carboxymaltose [1433693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosinopril [50166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenugreek leaf extract [1307769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>framycetin [4556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flumazenil [4457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluvastatin [41127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Filipendula rubra whole extract [2376931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fendiline hydrochloride [236767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Forsythia suspensa root extract [2359932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formestane [15070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C red 40 lake [1305560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fennel oil [1305608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Filipendula ulmaria whole extract [1312579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorescein sodium [57789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fostamatinib disodium [2055929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fedrilate [235961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocortolone [4463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoxetine hydrochloride [227224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flortaucipir [2571858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoldopam mesylate [203151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunixin meglumine [25122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fospropofol disodium [813021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>felbinac [262307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenethylline hydrochloride [236651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenproporex hydrochloride [236528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Festuca pratensis allergenic extract [1922741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florbetaben f-18 [1492940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fomivirsen [85763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous cacodylate [235271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fominoben [183875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinolysis inhibitor [353110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagus sylvatica whole extract [1805150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric cation [1546357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>follitropin alfa [386938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinogen [4385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluocortolone pivalate [4465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foslevodopa [2695775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric derisomaltose [2274394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fruquintinib [2670179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosdenopterin hydrobromide [2531287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavone [1536070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous glycine sulfate [105655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ficusin [2103294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fragarin [1739229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagus sylvatica nut extract [1313342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fritillaria cirrhosa bulb extract [1535489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluke, unspecified preparation [1370468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fructosylnystose [2590645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD &amp; C red no. 40 aluminum lake [1310558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoterol hydrobromide [203124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fexinidazole [2564146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VII, human [1426164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium moniliforme antigen [2101340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinogen concentrate (human) [831503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Flemingia prostrata whole extract [2669316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric hydroxide [1428835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fentanyl citrate [142436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurpiridaz F-18 [2700762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous ascorbate [4356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>felodipine [4316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluvastatin sodium [72875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorescein dilaurate [25142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fusidate [113608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenticonazole [24876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>filgrastim-sndz [1605064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenbutrazate [158507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric acetate, basic [1656308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fraxinus excelsior leaf extract [1309986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD&amp;C red #40 HT aluminum lake [1425913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous bromide [1719260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorodeoxyglucose F18 [1362737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium oxysporum allergenic extract [2101722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formaldehyde sulfoxylate [1592295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>farnesal [1484497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fumarate [70598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>famciclovir [68099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fomocain [25231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous sulfide [1724430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluticasone furoate [705022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorescein [25138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>filgrastim-aafi [2057198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>feprazone [8673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluticasone [41126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flosequinan [25089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric maltol [2539932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fospropofol [828682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric sulfate [24913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous bisglycinate [1102188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferrous gluconate [24942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VII, human-lans [2643196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formaldehyde [4530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosaprepitant dimeglumine [754763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenugreek seed meal [282436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foreskin fibroblast, neonatal [1427137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fostemsavir tromethamine [2380374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flathead sole preparation [1536616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flumethasone [4458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fendiline [4327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fagus sylvatica flowering top [1309466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>filgrastim-ayow [2595942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fomivirsen sodium [314633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenipentol [24846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>floxacillin sodium [235750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formaldehyde-sodium naphthalenesulfonate copolymer (3000 MW) [1551458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flunisolide hemihydrate [1298840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric hexacyanoferrate [539399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fiber [70727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fish oils [4419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>frankincense oil [1309424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorometholone [4491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fosfestrol [25284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fezolinetant [2637134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fentanyl hydrochloride [1652097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VII [4254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fidaxomicin [1111103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>FD &amp;C yellow #6 aluminum lake [1310562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenticonazole nitrate [236229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Foeniculum vulgare var. vulgare whole extract [1991499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flotufolastat F-18 [2637946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenspiride [4335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flucytosine [4451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flavodic acid, disodium salt [288862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>F [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fedratinib [2197490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]</name>
  <code>C654310</code>  <id>654310</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Feline McDonough Sarcoma-like Receptor Tyrosine Kinase 3 Inhibitors</to_name>
    <to_code>T58915</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FLT3 Inhibitors</to_name>
    <to_code>T58916</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>fms-Like Tyrosine Kinase 3 Inhibitors</to_name>
    <to_code>T58918</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors</to_name>
    <to_code>T58914</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FMS-related Receptor Tyrosine Kinase 3 Inhibitors</to_name>
    <to_code>T58919</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FMS-like Receptor Tyrosine Kinase 3 Inhibitors</to_name>
    <to_code>T58917</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194085</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib [2643048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Factor VIII Activator [EPC]</name>
  <code>C635354</code>  <id>635354</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor VIII Activator</to_name>
    <to_code>T19356</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175916</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor VIII Activator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desmopressin [3251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor VIII Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor VIII Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hemostatic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor VIII Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Factor Xa Inhibitor [EPC]</name>
  <code>C635030</code>  <id>635030</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Activated Factor 10 Inhibitor</to_name>
    <to_code>T19439</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Activated Factor X Inhibitor</to_name>
    <to_code>T19440</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitor</to_name>
    <to_code>T19442</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor 10a Inhibitor</to_name>
    <to_code>T19441</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175637</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing coagulation factor Xa inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apixaban [1364430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with coagulation factor Xa inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edoxaban [1599538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fondaparinux [321208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Factor Xa Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rivaroxaban [1114195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Factor Xa Inhibitors [MoA]</name>
  <code>C635028</code>  <id>635028</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors</to_name>
    <to_code>T19446</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Activated Factor 10 Inhibitors</to_name>
    <to_code>T19444</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Activated Factor X Inhibitors</to_name>
    <to_code>T19443</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor 10a Inhibitors</to_name>
    <to_code>T19445</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175635</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin [152610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivaroxaban [1114195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban maleate [1927955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban [1599538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin sodium [152612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban [1927851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Farnesoid X Receptor Agonist [EPC]</name>
  <code>C652789</code>  <id>652789</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonist</to_name>
    <to_code>T19538</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192561</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing farnesoid X receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obeticholic acid [1798288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Farnesoid X Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with farnesoid X receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hormone (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cholelitholytic AND/OR choleretic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Farnesoid X Receptor Agonists [MoA]</name>
  <code>C652788</code>  <id>652788</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonists</to_name>
    <to_code>T19539</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192560</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obeticholic acid [1798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Farnesyltransferase Inhibitor [EPC]</name>
  <code>C654165</code>  <id>654165</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitor</to_name>
    <to_code>T58603</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193938</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Farnesyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Farnesyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonafarnib [2467553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing transferase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with transferase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Farnesyltransferase Inhibitors [MoA]</name>
  <code>C654164</code>  <id>654164</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FTIs</to_name>
    <to_code>T58602</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitors</to_name>
    <to_code>T58601</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193939</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fatty Acid Synthetase Inhibitors [MoA]</name>
  <code>C640527</code>  <id>640527</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fatty Acid Synthetase Inhibitors</to_name>
    <to_code>T19621</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181000</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fatty Acid Transporter Interactions [MoA]</name>
  <code>C648269</code>  <id>648269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fatty Acid Transporter Interactions</to_name>
    <to_code>T19624</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188368</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fatty Acid Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fc Receptor Interactions [MoA]</name>
  <code>C654222</code>  <id>654222</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fc Receptor Interactions</to_name>
    <to_code>T58722</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FcRn Blockers</to_name>
    <to_code>T58723</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193996</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fc Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fecal Excretion [PK]</name>
  <code>C268</code>  <id>269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion</to_name>
    <to_code>T19664</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000045</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Female Reproductive System Activity Alteration [PE]</name>
  <code>C28454</code>  <id>28455</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Female Reproductive System Activity Alteration</to_name>
    <to_code>T19704</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009044</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Female Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Female Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Female Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Female Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Female Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Female Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Embryonic &amp; Fetal Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Female Reproductive System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fibrinolysis Alteration [PE]</name>
  <code>C635024</code>  <id>635024</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fibrinolysis Alteration</to_name>
    <to_code>T19901</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175631</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fibrinolysis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fibrinolysis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</name>
  <code>C654249</code>  <id>654249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fibroblast Growth Factor Receptor Inhibitors</to_name>
    <to_code>T58773</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FGFR Inhibitors</to_name>
    <to_code>T58774</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194026</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>First Order [PK]</name>
  <code>C292</code>  <id>293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>First Order</to_name>
    <to_code>T20035</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000057</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fish Proteins, Dietary [EXT]</name>
  <code>C644816</code>  <id>644816</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary</to_name>
    <to_code>T20040</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185014</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>largemouth bass allergenic extract [1098183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white fish allergenic extract [901265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bluefish allergenic extract [892181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocean perch preparation [2471431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic cod allergenic extract [900025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herring allergenic extract [899434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common carp allergenic extract [901390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellowfin tuna allergenic extract [2102488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic mackerel allergenic extract [2198984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic salmon allergenic extract [900031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pacific halibut allergenic extract [882469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tuna allergenic extract [892503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon preparation [1421430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trout allergenic extract [882482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red snapper allergenic extract [889646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic halibut preparation [1424920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod, unspecified preparation [1426437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>northern pike allergenic extract [889602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white catfish allergenic extract [971166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sardine allergenic extract [974129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English sole allergenic extract [974140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flounder allergenic extract [899746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codfish allergenic extract [892543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>swordfish allergenic extract [901283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic halibut allergenic extract [2261370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haddock allergenic extract [899428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black sea bass allergenic extract [2102474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perch allergenic extract [976711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fluorescence Contrast Activity [MoA]</name>
  <code>C654203</code>  <id>654203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluorescence Contrast Activity</to_name>
    <to_code>T58671</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193981</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafolacianine [2586857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluorescence Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid [683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluorescence Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fluoroquinolone Antibacterial [EPC]</name>
  <code>C653594</code>  <id>653594</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluoroquinolone Antibacterial</to_name>
    <to_code>T20192</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193223</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluoroquinolones [M0372253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ciprofloxacin [2551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxifloxacin [139462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delafloxacin [1927663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levofloxacin [82122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fluoroquinolone Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Focal Adhesion Kinase Inhibitors [MoA]</name>
  <code>C654390</code>  <id>654390</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FAK Inhibitors</to_name>
    <to_code>T59082</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PTK2 Inhibitors</to_name>
    <to_code>T59083</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Focal Adhesion Kinase Inhibitors</to_name>
    <to_code>T59081</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194167</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Folate Analog Metabolic Inhibitor [EPC]</name>
  <code>C634977</code>  <id>634977</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analogue Metabolic Inhibitor</to_name>
    <to_code>T20308</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog Metabolic Inhibitor</to_name>
    <to_code>T20309</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175584</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed [68446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid [M0008658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralatrexate [662019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methotrexate [6851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antifolate (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antifolate (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Folate Analog [EPC]</name>
  <code>C637823</code>  <id>637823</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog</to_name>
    <to_code>T20311</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analogue</to_name>
    <to_code>T20310</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178369</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Folate and/or folate derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoleucovorin [877015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leucovorin [6313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomefolic acid [1025342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folate Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid [M0008658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing folic acid (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Folic Acid Metabolism Inhibitors [MoA]</name>
  <code>C400</code>  <id>401</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolic Inhibitors</to_name>
    <to_code>T20327</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors</to_name>
    <to_code>T20328</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Antagonists</to_name>
    <to_code>T20326</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000111</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Folic Acid Metabolism Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim sulfate [221176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim hydrochloride [259281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim lactate [235855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Free Radical Scavenging Activity [MoA]</name>
  <code>C518</code>  <id>519</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging</to_name>
    <to_code>T20524</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity</to_name>
    <to_code>T20525</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000170</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E acetate [2531274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine [4126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine anhydrous [1545987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A [11246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitexin [2684982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoyl peroxide [1418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E d-alpha [220892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol calcium succinate, DL- [2598017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E [11256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A palmitate [35406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E DL-alpha [220893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha tocopherol [237099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A myristate [1813433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fruit Proteins [EXT]</name>
  <code>C644817</code>  <id>644817</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins</to_name>
    <to_code>T20626</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185015</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon allergenic extract [901382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raspberry extract [1370769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avocado oil [1311611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lime (citrus) extract [1305725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango allergenic extract [1011404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apple allergenic extract [891771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango extract [1426332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lime allergenic extract [1011060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange allergenic extract [892565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut allergenic extract [891611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape extract [1307718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fig allergenic extract [973880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantaloupe allergenic extract [892517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pineapple extract [1492174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green olive allergenic extract [971379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watermelon preparation [260014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine allergenic extract [1011412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit allergenic extract [899424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quince extract [1370761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit peel extract [1358897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strawberry allergenic extract [892484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Concord grape allergenic extract [901191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plum allergenic extract [899470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine extract [1426364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grape extract [253172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black olive allergenic extract [974650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apricot allergenic extract [895574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velvetleaf huckleberry allergenic extract [2102487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>date allergenic extract [899742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit extract [124323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>banana extract [285149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya allergenic extract [1011426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raspberry allergenic extract [899906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peach allergenic extract [892575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>banana allergenic extract [891830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut extract [1372248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>honeydew melon allergenic extract [899476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avocado allergenic extract [895582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pear preparation [1367125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry allergenic extract [899734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apple extract [1424865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape allergenic extract [892317]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watermelon allergenic extract [901258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Full Cholinergic Nicotinic Agonists [MoA]</name>
  <code>C635107</code>  <id>635107</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Cholinergic Nicotinic Agonists</to_name>
    <to_code>T20650</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175701</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Full Opioid Agonists [MoA]</name>
  <code>C635090</code>  <id>635090</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists</to_name>
    <to_code>T20651</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175684</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Full Opioid Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Full Opioid Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid kappa Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil citrate [58964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil [73032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl citrate [142436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl [4337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil [56795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil hydrochloride [203203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil [480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil [480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil hydrochloride [236540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil hydrochloride [203203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl hydrochloride [1652097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fusion Protein Inhibitors [MoA]</name>
  <code>C635008</code>  <id>635008</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors</to_name>
    <to_code>T20725</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175615</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fusion Protein Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fusion Protein Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab-cfor [2716803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirsevimab-alip [2642402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib citrate [2698326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab [2716802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirsevimab [2642401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Fusion Protein Interactions [MoA]</name>
  <code>C635007</code>  <id>635007</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions</to_name>
    <to_code>T20726</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175614</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Fusion Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept-csrk [2678931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl [2631083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept [2262544]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp-erzs [2109054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept-aamt [2262543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein [2631084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>G [Preparations]</name>
  <code>C288633</code>  <id>288633</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>G [Preparations]</to_name>
    <to_code>T20745</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010589</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycine hydrochloride [1311532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green peppercorn extract [1372272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold monoiodide [1486799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gryllus bimaculatus extract [2611453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glasdegib [2105845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grindelia squarrosa whole extract [1606334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycopyrronium tosylate [2052857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4&apos;-galactosyllactose [2607019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guaiacum sanctum resin [1311271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold cation (1+) [2045117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycoprotein hormones, alpha subunit [1427201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golden seal root [253171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucose pentaacetate [1792129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glechoma hederacea extract [1310140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaietolin, (S)- [2643153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl triacetyl ricinoleate [2635083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit allergenic extract [899424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit juice [1431224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranium oil, Algerian type [1309347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl stearate SE [1364379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma linoleic acid [283563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl linoleate [1368193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucarpidase [1242127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gotu kola extract [319837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>greasewood pollen extract [852152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golimumab [819300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glofitamab [2639782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galphimia glauca whole extract [1368327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-nonalactone [1659905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium maculatum root oil [1487505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>.gamma.-tocopherol [2368126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gastric mucins [4698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemeprost [12449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadolinium oxide [1311118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gilteritinib [2105806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gatifloxacin hemihydrate [1999763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucosamine sulfate potassium chloride [1789517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ginkgo biloba root extract [1918243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycidyl acrylate [1735329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galbanum oil [1307685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold tribromide [1433888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol distearate [1367188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol formal [1311689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl caprate [1366664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranial [2119367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycolide [1540882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-terpinene [2393523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl monooleate citrate [1991257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galactoarabinan [1425353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadofosveset [1364290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl dioleate [2387831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guaiacum officinale wood extract [2637098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gramicidin [5011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanadrel [26296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>griseofulvin microsize [91077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold trichloride [1311297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glaucine [1368876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold cation (3+) [1546374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium 67 citrate [272758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl isostearate [1311695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>German cockroach allergenic extract [905276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gestonorone caproate [4791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl laurate [1311693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gelsemium sempervirens preparation [285153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger extract [285241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grevillea speciosa flower extract [1648700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl abietate [1426927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guizotia abyssinica seed oil [1552172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>germanium dioxide [1309238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra whole extract [1535490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goose feather extract [894783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>givosiran sodium [2265859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1,3-dibehenate [2535257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl myristate [1311692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin type a porcine (160 bloom) [2380371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranial propylene glycol acetal [2373649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grape seed proanthocyanidins [283566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guarea guidonia bark extract [1862097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold sodium thiomalate [4981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gelidium sesquipedale extract [1735037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-7 [1371311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>griseofulvin, ultramicrocrystalline [217398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glabridin [1603522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium herbaceum whole extract [1373723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gardenia cornuta whole extract [2001130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl stearate [1311155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentian violet [4778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol (1-(12-hydroxystearate)) [1944766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goserelin [50610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol salicylate [26051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-undecalactone [1376148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentamicin sulfate [1870193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadobutrol [84990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia mangostana bark extract [1874548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentianella quinquefolia extract [1719251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyrrhizin, ammoniated [1311505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-diacetyltartarate 2,3-stearate [1372310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guinea pig skin extract [852298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium GA-68 gozetotide [2586016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanethidine [5036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyoxal [4967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golotimod [2367440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gastrodia elata tuber extract [2462454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl palmitate [1426928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanine [1372539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadolinium cation (3+) [1546429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gardenia taitensis flower extract [1309426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma linolenic oil [283564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana manshurica root extract [2680317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit seed extract [259449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycine max whole extract [1366326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grepafloxacin hydrochloride [236862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyrrhizate [1370586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gestodene [25734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerin methyl ether [2099713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol dilaurate [2204571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glechoma hederacea flowering top extract [1431284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium [1310124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-31 [2634161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grindelia hirsutula whole extract [1492939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ginkgo biloba whole extract [2475187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanidine [50675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepotidacin [2709212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucuronate [1426907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gitalin [89791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl linolenate [1307262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-18 ethylhexanoate [1426944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyoxyloyl carbocysteine [2668156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadopiclenol [2618720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamithromycin [1113697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-6 [1492338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1,2-dioleate [1426915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana cruciata root extract [1862096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-aminobutyric acid [4617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>griseofulvin [5021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green ash pollen extract [852491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gastric mucin,pork [237040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium hirsutum whole extract [2283031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium nitrate [25544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl caprylate [1307152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garden snail mucin preparation [1428846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gestronol [4793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol 1,2-didocosanoate [1427150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerylphosphorylcholine [4918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin type B bovine (200 bloom) [1866344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanosine [1591890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gibberella fujikuroi extract [2043450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadopentetate dimeglumine [25486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentianella amarella flower extract [1309428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grape seed [237115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycolic acid [587318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grain mill dust allergenic extract [894795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana manshurica whole extract [1547559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycorine [2360433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gibberella zeae allergenic extract [1922751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadolinium [1310171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>greater celandine [236982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanylcystamine [1658444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galbanum [1796918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gastrodia elata whole extract [2359266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadoversetamide [228833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gluconolactone [25842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanidine hydrochloride [50676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green bell pepper allergenic extract [862478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gluconic acid [2475956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol monolactate [2101719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycofurol [1427078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gliotoxin [1661743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gabapentin enacarbil [1101333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glibornuride [102846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol dimethacrylate [1427079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>greater galangal extract [1372251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goat milk allergenic extract [862475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guaiacum officinale resin [1352520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Griffonia preparation [259412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galium boreale whole extract [2375720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1,3-distearate [2048118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycolate [70603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucosyl hesperidin [1433192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallopamil [4648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium cation Ga-67 [1546371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glimepiride [25789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gardenia yellow extract [2632124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyl-isolysine [1813047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gum talha extract [1370785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>giant wild rye pollen extract [900148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol oleate [1314312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiacolsulfonate [636827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl caprylate-caprate [1312392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin hydrolysate (porcine skin, MW 3000) [1366990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucose 1,6-bisphosphate [2565267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucomannan [11454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geotrichum candidum allergenic extract [999463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garlic powder [325524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glechoma longituba top extract [1429391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium robertianum leaf extract [2670081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranyl acetate [1807120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonadotropin releasing factor analog-diphtheria toxoid conjugate [1191668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin type B bovine (230 bloom) [1998844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-oryzanol [25608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glicofosfopeptical [236463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganciclovir sodium [82131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Griffonia simplicifolia seed extract [2274242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gymnadenia conopsea whole extract [2386029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia mangostana fruit rind extract [1356679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia indica seed butter extract [1309811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guazuma ulmifolia leaf extract [1307837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutamate [70602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl hydroxystearate [2531033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucosyl steviol [1307153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl arachidonate [1427076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-linolenate [1987476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gelidium cartilagineum extract [1435391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutathione [4890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gigartina skottsbergii [2628326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamboge [89698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grindelia ciliata pollen extract [2043451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadoxetate disodium [637320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>granisetron [26237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gardenoside [2585534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goldenseal extract [1372255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol 1,3-dimethacrylate [1860613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold sodium thiosulfate [9876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guggul lipids [283568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycylglycine [1362904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guafacine hydrochloride [862004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucagon [4832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadoteridol [25483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gardenia jasminoides fruit extract [1311374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepirone hydrochloride [2672254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentisic acid [1368641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza uralensis extract [1342493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemifloxacin mesylate [402429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>germanium [4784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium hirsutum leaf extract [2669812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana macrophylla root extract [1309427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl monostearate [1311165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl dilaurate [1311691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guava juice [1731014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green tea extract [659476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentamicin [1596450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gambir leaf extract [1609190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Genipa americana fruit extract [1492037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycopyrronium [1546438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guinea pig hair extract [895507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glymidine [102848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gatifloxacin anhydrous [1546025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucuronic acid [1426906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol stearate SE [1735330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol stearate [1426255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gymnema sylvestre leaf extract [1493693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemifloxacin [138099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza uralensis root extract [2266490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanylcystamine hydrobromide [1658443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gluceptate [50470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyrrhetinic acid [1311506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>giant puffball extract [1311063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gleditsia sinensis whole extract [1442703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gardenia resinifera resin [1541725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaifenesin [5032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gelsemium sempervirens root extract [1309695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemcitabine [12574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-2 cocoate [1305748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galectin-3 [2688018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gellan gum (high acyl) [2001326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutathione disulfide [25953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiacol ethylglycolate [236314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gardenian blue [1659909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonadorelin diacetate tetrahydrate [1298838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grama grass pollen extract [852197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grape extract [253172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepefrine [41157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaraprolose (1300 MPA.S at 1%) [1940005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapiprant [1862951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit peel extract [1358897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin type A porcine (195 bloom) [2679778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanadrel sulfate [91239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyburide [4815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucose [4850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentisic acid ethanolamide [1427180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit seed oil [1306130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadobenate dimeglumine [68173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-octalactone [2043769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadopentetate [1546432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin type B bovine (150 bloom) [2463112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gozetotide [2588949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium robertianum extract [1313750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grazoprevir anhydrous [1871173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium cation [1546282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-arachidonate [1987475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>granisetron hydrochloride [142149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goose allergenic extract [882485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucosamine sulfate [4847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galphimia glauca flowering top extract [1346618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadoxetate [802624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonadorelin acetate [204193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gliocladium viride extract [2101008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ginko biloba leaf oil [1356135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ganoderma lucidum whole extract [2287734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl stearate - PEG-100 stearate [2167167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galangal oil [1307682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green english pea allergenic extract [2102798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonadotropin releasing hormone, D-Arg(6) ethyl amide acetate [1306117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit extract [124323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceran polyricinoleic acid ester [1541750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garrys oak pollen extract [900987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl rosinate [1928891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepotidacin mesylate [2709213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Giardia lamblia [1439028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit oil [1309212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green olive allergenic extract [971379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentian violet cation [1546369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gliocladium allergenic extract [1192997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentian preparation [319824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-methacryloxypropyltrimethoxysilane [2386843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold monosulfide [1546210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiacolsulfonic acid [26288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium thunbergii flowering top extract [2119796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golden seal extract [408114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-glyceryl monooleate [1426374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepirone [2672253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galantamine [4637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl behenate-eicosadioate [1371968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gefitinib [328134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galium aparine extract [1345678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepefrine tartrate [236858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana urnula flower extract [1358176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanfacine [40114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glebionis coronaria whole extract [1800486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycogen [1426910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallic acid [1311389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>germanium citrate lactate [1427153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galactose [4626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadodiamide [41144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadofosveset trisodium [1364289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerin [4910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goserelin acetate [203146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl tribehenate- isostearate- eicosandioate [1376099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gluceptate sodium [317595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galium boreale leaf extract [1488226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-aminobutyrate [618771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galcanezumab-gnlm [2058868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganirelix acetate [259264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gugulu extract [26346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium barbadense leaf extract [2200139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza uralensis whole extract [1535491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-linolenic acid [25605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl triacetyl 12-hydroxystearate [2696552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerophosphoinositol lysine [2461971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glofitamab-gxbm [2639781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra extract [1370435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-cyclodextrin [1366989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutaric acid [1943799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycine zinc chelate [806626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiacol [5031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-17 stearate [1314241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana lutea root extract [1307945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Guaiacum officinale wood oil [2637099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gatifloxacin [228476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyrrhizin, ammoniated pentahydrate [1371367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grindelia squarrosa flowering top extract [1426158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ginkgo biloba leaf extract [259265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucan endo-1,3-.alpha.-glucosidase AGN1 [2118531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycosine [2359267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1,3-dioleate [1424662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutethimide [4903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra root powder extract [2711885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl palmitostearate [1423683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gaultheria procumbens whole extract [2601099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanethidine sulfate [203181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucose oxidase [1427073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl monobehenate [1655567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gluconate [70599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-26 caprylate [2058982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerophosphoinositol choline [2123309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>genistein [25696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiac [1373150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gynostemma pentaphyllum leaf extract [1855195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-linolenate [618453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza inflata root extract [1307598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>giant scallop preparation [1869802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gratiola officinalis extract [1336269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl [2531034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geum urbanum root extract [1541240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gladiolus communis whole extract [2590646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranium wilfordii whole extract [1733805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guarana preparation [236953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gellan gum (low acyl) [1420964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold keratinate [50598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin type B bovine (160 bloom) [1800668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grepafloxacin [83719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gardenia jasminoides whole extract [1541884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-laurate [1990422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golodirsen [2267207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grindelia hirsutula flowering top extract [1309683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guselkumab [1928588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guava extract [1426645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-17 cocoate [1312391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guar hydroxypropyltrimonium (1.7 substituents per saccharide) [1368618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glasdegib maleate [2105844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyoxal trimer, dihydrate [1426857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganirelix [35825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guar gum [26344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-adipate [1426925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia mangostana fruit extract [1654961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gaultheria procumbens top extract [1310285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium herbaceum flower extract [2593942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl distearate [1311690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranylgeranylacetone [1362746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gelsemium sempervirens whole extract [1493692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl stearate citrate [1426411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium maculatum root extract [1346619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gliclazide [4816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium maculatum whole extract [1487830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia indica fruit extract [1376212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger allergenic extract [899420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza echinata root extract [1652101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galega officinalis extract [1862095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol ester of hydrogenated rosin [1999410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>givinostat [2678889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gilteritinib fumarate [2105823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gelidiella acerosa extract [1372013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutarate [1943800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ganoderma lucidum stem extract [1309999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ginkgo biloba extract [236809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geraniol [1368875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-8 [2396433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl phosphate [1423803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucagon (rDNA) [261716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garadacimab-gxii [2717168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol palmitate [1307155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 2-caprylate [2680301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia cambogia preparation [253168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginsenoside [349656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gardenia jasminoides flower extract [1800485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucose-6-phosphate [1541246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra leaf extract [1313045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallamine [4638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glipizide [4821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galcanezumab [2058846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gelatin [4716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanabenz [5033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galanthus nivalis seed extract [1358173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl dipalmitate [2383341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grape seed oil [1309208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glechoma longituba whole extract [1537757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-stearate [1427173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginseng root [259385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green tea leaf extract [283567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gila monster venom [1595880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garadacimab [2717169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyrrhizinate [1359426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganciclovir [4678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gracilaria gracilis whole extract [2463738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ginkgo biloba seed extract [1673560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonorrheal urethral secretion human [1311177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glecaprevir [1940635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>GLY-GLN-PRO-ARG-OH [2613778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycidyl methacrylate [1869700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaietolin [236315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-7 trimethyl ether [1371446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallamine triethiodide [4639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycopyrrolate [4955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger root [125921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>German wasp venom protein [1297531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutamic acid hydrochloride [91269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gleditsia sinensis fruit extract [1311596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallic acid monohydrate [1426746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycine propionyl-L-carnitine [2669317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium wilfordii top extract [1489547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl diisostearate [1735038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gleditsia sinensis seed extract [2686032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grape seed extract [237116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galactose monohydrate [1492336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gaultheria procumbens leaf extract [1358001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gabapentin [25480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium herbaceum seed resin [1601996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gleptoferron [1855078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gossypium herbaceum root bark extract [1309785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garcinia cambogia fruit extract [1311595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutamine [4885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiol [2542348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemcitabine hydrochloride [236234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucamine [1313187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>givosiran [2265712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemfibrozil [4719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gekko gecko preparation [2627246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerin 2-methyl ether [2604173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemtuzumab ozogamicin [1294580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-glyceryl capryl ether [2665085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol phenylbutyrate [1368451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentian, stemless, whole extract [1657728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-2 [2537434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl monolaurate [314647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>groundsel pollen extract [897332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerin 1,3-dimethyl ether [2471705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guar hydroxypropyltrimonium chloride (1.7 substituents per saccharide) [1368617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geranium thunbergii whole extract [2583870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gynostemma pentaphyllum top extract [1372927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentiana crassicaulis whole extract [2106825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyoxal trimer [1426858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycylhydroxyprolylproline [1860610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycine [4919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-7 triacetate [1535631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl behenate [1305749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-18 [1311613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garden lady&apos;s mantle extract [1314299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium-67 [1546372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gliquidone [25793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucose glutamate [2468430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerol formal, .alpha.,.alpha&apos; [2679989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gliocladium viride allergenic extract [2101353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucosamine [4845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycyrrhizic acid [26143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galanthus nivalis extract [1719258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grifola frondosa whole extract [1371312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grazoprevir [1734630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golden seal root extract [283680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Globularia cordifolia whole extract [1994299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium chloride,Ga-67 [314639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gamma-interferon [1421648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gallus gallus gizzard lining preparation [2106428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Genista tinctoria extract [1650835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-20 [1608320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucagon hydrochloride [253170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gleditsia sinensis thorn extract [2375525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gambels oak pollen extract [852276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold [1311190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gestrinone [4792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginseng preparation [325526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>giant ragweed pollen extract [851998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galantamine hydrobromide [860693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl monoundecylenate [1658440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garlic allergenic extract [899414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutaral [4888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gymnema sylvestre preparation [283569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadoterate meglumine [1421151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golden chain pollen extract [1996102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanabenz acetate [227225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gentianella amarella whole extract [1800661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>germanium sesquioxide [1314410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Graptophyllum pictum whole extract [2048125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green bell pepper extract [1315118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucametacin [25834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucosamine hydrochloride [236608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycocholic acid [1426482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganaxolone [2604689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gypsophila paniculata root extract [1655986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-26 [1426630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl acrylate - acrylic acid copolymer (300000 CP AT 2%) [2612496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyphosate [1800093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl cocoate [1311694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1-undecylenate [1607316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyburide, micronized [217364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanfacine hydrochloride [203142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guanethidine monosulfate [82023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gray birch pollen extract [852178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonadorelin hydrochloride [204194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-25 PCA isostearate [2383340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geranium extract [1372247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gonadorelin [6384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl lactopalmitate/stearate [2002787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glehnia littoralis root extract [1309431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glatiramer acetate [84375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grevillea buxifolia flower extract [1807126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallopamil hydrochloride [439837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galsulfase [578033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadobenate [692620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glatiramer [214582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl citrate [1432297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucuronolactone [1535222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-20 cocoate [2285323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycosmis citrifolia whole extract [2535258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycol cetearate [1428870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Galium odoratum extract [1351003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerin 1-methyl ether [2604172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glutamic acid [25916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garden cress sprout extract [1312593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaifenesin.beta.-isomer [2569484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gentisate [1368642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl 1,2-dioleate, (S)- [2673193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>germanium cation (4+) [1546439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gynostemma pentaphyllum whole extract [2705690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guaiazulene [26290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyceryl ricinoleate [1427077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycereth-5 lactate [1483736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garlic preparation [265647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guinea pig dander [2166593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>G-Protein-linked Receptor Interactions [MoA]</name>
  <code>C482</code>  <id>483</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor-Effector Interactions</to_name>
    <to_code>T20777</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions</to_name>
    <to_code>T20778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000152</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalmic Hormone Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormones Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysophospholipid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium-Sensing Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>G-Protein-linked Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp-tebn [2590744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirzepatide [2601723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin [7824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II acetate, human [2204740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab-tgvs [2644448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II [1999003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin acetate [1733680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab [2644447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA A Agonists [MoA]</name>
  <code>C570</code>  <id>571</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists</to_name>
    <to_code>T20785</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Agonists</to_name>
    <to_code>T20784</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000196</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam [4501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem tartrate [221183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunitrazepam [4460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quazepam [35185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopamide [2603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stiripentol [2054968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triazolam [10767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanol [448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcohol, x-ray exposed (1000 rad) [1368126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nordazepam [3155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam hydrochloride [1999183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam hydrochloride [71484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrated alcohol [1310469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexobarbital [5302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam [1535252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA A Antagonists [MoA]</name>
  <code>C326</code>  <id>327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine Antagonist</to_name>
    <to_code>T20786</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine Receptor Antagonist</to_name>
    <to_code>T20787</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Antagonists</to_name>
    <to_code>T20788</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists</to_name>
    <to_code>T20789</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000074</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentylenetetrazole [8015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA A Modulators [MoA]</name>
  <code>C414</code>  <id>415</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Modulators</to_name>
    <to_code>T20790</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators</to_name>
    <to_code>T20791</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000118</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA A Modulators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halazepam [26412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quazepam [35185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate [82819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate calcium [152761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunitrazepam [4460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyprylon [6910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methaqualone [6823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem tartrate [221183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexanolone [2121777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam [4501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam [1535252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam [2383941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexobarbital [5302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam besylate [2383942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethchlorvynol [4118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metharbital [6825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital sodium [91110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam hydrochloride [71484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam hydrochloride [1999183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital [9624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nordazepam [3155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triazolam [10767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Interactions [MoA]</name>
  <code>C454</code>  <id>455</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions</to_name>
    <to_code>T20792</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000138</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA A Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA A Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA A Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA A Receptor Positive Modulators [MoA]</name>
  <code>C654231</code>  <id>654231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators</to_name>
    <to_code>T58742</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193997</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuranolone [2669905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganaxolone [2604689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA B Agonists [MoA]</name>
  <code>C410</code>  <id>411</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Agonists</to_name>
    <to_code>T20793</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists</to_name>
    <to_code>T20794</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000116</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopamide [2603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium oxybate [2387309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem tartrate [221183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxybate [9899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxybate [2387307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxybate [2387308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA B Antagonists [MoA]</name>
  <code>C636</code>  <id>637</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Antagonists</to_name>
    <to_code>T20796</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Antagonists</to_name>
    <to_code>T20795</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000229</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentylenetetrazole [8015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA B Modulators [MoA]</name>
  <code>C680</code>  <id>681</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Modulators</to_name>
    <to_code>T20798</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Modulators</to_name>
    <to_code>T20797</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000251</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital [9624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital sodium [91110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GABA B Receptor Interactions [MoA]</name>
  <code>C586</code>  <id>587</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Interactions</to_name>
    <to_code>T20799</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000204</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA B Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA B Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GABA B Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kava preparation [285228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GHRH Activity Alteration [PE]</name>
  <code>C28456</code>  <id>28457</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Activity Alteration</to_name>
    <to_code>T20889</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009045</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GHRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GHRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GHRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GHRH Secretion Alteration [PE]</name>
  <code>C28460</code>  <id>28461</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Secretion Alteration</to_name>
    <to_code>T20890</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009047</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GHRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GHRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GHRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GI Motility Alteration [PE]</name>
  <code>C28462</code>  <id>28463</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Motility Alteration</to_name>
    <to_code>T20891</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009048</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GI Motility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GI Motility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GI Smooth Muscle Tone Alteration [PE]</name>
  <code>C28464</code>  <id>28465</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Smooth Muscle Tone Alteration</to_name>
    <to_code>T20892</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009049</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GI Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GI Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GLP-1 Receptor Agonist [EPC]</name>
  <code>C637953</code>  <id>637953</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 Receptor Agonist</to_name>
    <to_code>T20907</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-1 Receptor Agonist</to_name>
    <to_code>T20908</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide 1 Receptor Agonist</to_name>
    <to_code>T20906</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178480</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dulaglutide [1551291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>semaglutide [1991302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liraglutide [475968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing glucagon-like peptide 1 receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucagon-Like Peptide 1 [M0160181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirzepatide [2601723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lixisenatide [1440051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-1 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>exenatide [60548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GLP-2 Analog [EPC]</name>
  <code>C650966</code>  <id>650966</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide 2 Analog</to_name>
    <to_code>T20909</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 Analog</to_name>
    <to_code>T20910</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Analog</to_name>
    <to_code>T20911</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190992</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-2 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucagon-Like Peptide 2 [M0358087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-2 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teduglutide [1364468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-2 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>GLP-2 Analog [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing peptide hormone (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Glucagon-like peptide 2 (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GTP Phosphohydrolase Activators [MoA]</name>
  <code>C682</code>  <id>683</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GTP Phosphohydrolase Activators</to_name>
    <to_code>T20992</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000252</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gadolinium-based Contrast Agent [EPC]</name>
  <code>C642965</code>  <id>642965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent</to_name>
    <to_code>T21085</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183362</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadobutrol [84990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadolinium cation (3+) [1546429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadobutrol [M0239381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gadolinium-based Contrast Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Magnetic resonance imaging contrast media (product) [349360003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Magnetic resonance imaging contrast media (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Gadolinium and/or gadolinium compound (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing gadolinium and/or gadolinium compound (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</name>
  <code>C28472</code>  <id>28473</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration</to_name>
    <to_code>T21215</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009053</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eszopiclone [461016]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuranolone [2669905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gamma Secretase Inhibitor [EPC]</name>
  <code>C654347</code>  <id>654347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitor</to_name>
    <to_code>T58996</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194115</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gamma Secretase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gamma Secretase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirogacestat [2670631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gamma Secretase Inhibitors [MoA]</name>
  <code>C654346</code>  <id>654346</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitors</to_name>
    <to_code>T58995</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194116</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Secretase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gastric Acid Alteration [PE]</name>
  <code>C28474</code>  <id>28475</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration</to_name>
    <to_code>T21265</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009054</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastric Acid Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antacid [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastric Acid Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastric Acid Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Acid Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gastric Mucous Secretion Alteration [PE]</name>
  <code>C28476</code>  <id>28477</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Mucous Secretion Alteration</to_name>
    <to_code>T21282</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009055</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastric Mucous Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastric Mucous Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Mucous Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastric Mucous Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gastrin Activity Alteration [PE]</name>
  <code>C28478</code>  <id>28479</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrin Activity Alteration</to_name>
    <to_code>T21284</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009056</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gastrointestinal Agent [APC]</name>
  <code>C654121</code>  <id>654121</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent</to_name>
    <to_code>T21314</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193900</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminosalicylate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-2 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulant Laxative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytoprotective Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medium-chain Triglyceride [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Motility Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiemetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Laxative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticholinergic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gastrointestinal Agent [TC]</name>
  <code>C637824</code>  <id>637824</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent</to_name>
    <to_code>T21314</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178370</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-emetic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidiarrheal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lubiprostone [623033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eluxadoline [1653781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate calcium [82001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine [1876597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine tosylate [1876598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus crispatus [2054188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate [59064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota spores, live-brpk [2636536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholic acid [1440856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri [285156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri subsp. reuteri F275 [2668424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teduglutide [1364468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (4000 CPS) [1297402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin dihydrochloride [753341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum [1673942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate hydrochloride [102170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus helveticus [1310845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus GG [602811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylase / lipase / protease [392491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus [6205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobacillic acid [2002583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol, L- [1742749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine hydrochloride [235775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SENOKOT-S [219866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycols [8516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol oxalate [1593586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride succinate [2107309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol [9945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus delbrueckii subsp. bulgaricus [100272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide / magnesium hydroxide [1009149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar [2690869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>di-n-octyl sodium sulfosuccinate [1534779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus bifidus [236855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota spores, live [2636537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>misoprostol [42331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate sodium [71722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursodiol [11065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisacodyl [1596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus BCMC 12130 [2639942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor hydrochloride [2199673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum 299 [2706643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>standardized enzyme lactase [221165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obeticholic acid [1798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan anhydrous [1516803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone bromide [979111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat [2563966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate [82003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus casei [1592255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar lysine [2690868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat sesquihydrate [2563978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus [100278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase alfa [2691830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone [29899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate potassium [82002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan [480639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin acetate [408108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancreatin [7880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate bromide [52560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (100 CPS) [1310583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate [107770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin [9627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactase [41397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol [1551777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ligilactobacillus salivarius [2110033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus [6204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gastrointestinal Motility Inhibitor [EPC]</name>
  <code>C650827</code>  <id>650827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Motility Inhibitor</to_name>
    <to_code>T21319</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190853</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Motility Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glucagon [4832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Motility Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gastrointestinal Motility Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Gastrointestinal agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Motility Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Alterations [MoA]</name>
  <code>C654012</code>  <id>654012</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Alterations</to_name>
    <to_code>T58363</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193791</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Alterations [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Alterations [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec [2641675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Alterations [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viltolarsen [2389840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Alterations [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec-rokl [2641674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Alterations [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casimersen [2480096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Alterations [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Editing or Modification [MoA]</name>
  <code>C654015</code>  <id>654015</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing</to_name>
    <to_code>T58368</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Modification</to_name>
    <to_code>T58369</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification</to_name>
    <to_code>T58366</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193792</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec-rokl [2641674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etranacogene dezaparvovec-drlb [2626768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidanacogene elaparvovec [2681011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidanacogene elaparvovec-dzkt [2681020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etranacogene dezaparvovec [2626727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vosoritide [2586354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exagamglogene autotemcel [2671667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revakinagene taroretcel-lwey [2708831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revakinagene taroretcel [2708830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec [2641675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Expression Interactions [MoA]</name>
  <code>C654011</code>  <id>654011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions</to_name>
    <to_code>T58362</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193793</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Expression Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Translation Modulation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Expression Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transcription Modulation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Expression Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Alterations [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen sodium [2724362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran [2604578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen sodium [2671940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran sodium [2605574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donidalorsen [2724361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Expression Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Therapy [APC]</name>
  <code>C654233</code>  <id>654233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Therapy</to_name>
    <to_code>T58744</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194012</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Hematopoietic Stem-Cell-Based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Transcription Modulation [MoA]</name>
  <code>C654013</code>  <id>654013</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transcription Modulation</to_name>
    <to_code>T58364</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193794</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Transcription Modulation [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viltolarsen [2389840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transcription Modulation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belzutifan [2567226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transcription Modulation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec-vncg [2644435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transcription Modulation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec [2644436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transcription Modulation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Transduction or Replacement [MoA]</name>
  <code>C654016</code>  <id>654016</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction</to_name>
    <to_code>T58370</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement</to_name>
    <to_code>T58367</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Replacement</to_name>
    <to_code>T58371</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193795</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gene Transduction or Replacement [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Beta-globin Gene Transfer [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec-svdt [2637757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voretigene neparvovec [1995537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec-rvox [2641609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopapogene imadenovec-drba [2723360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec [2641610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elivaldogene autotemcel [2612527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eladocagene exuparvovec-tneq [2698765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atidarsagene autotemcel [2677916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopapogene imadenovec [2723361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eladocagene exuparvovec [2698762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec [2170226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec [2637758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec-xioi [2170225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Transduction or Replacement [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gene Translation Modulation [MoA]</name>
  <code>C654014</code>  <id>654014</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Translation Modulation</to_name>
    <to_code>T58365</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193796</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>General Anesthesia [PE]</name>
  <code>C635429</code>  <id>635429</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia</to_name>
    <to_code>T21433</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175975</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halothane [5095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>General Anesthetic [EPC]</name>
  <code>C635087</code>  <id>635087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthetic</to_name>
    <to_code>T21434</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175681</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etomidate [4177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>General Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>General anesthetic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketamine [6130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propofol [8782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desflurane [27340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sevoflurane [36453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>General Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoflurane [6026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Generalized Systemic Effects [PE]</name>
  <code>C28480</code>  <id>28481</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Generalized Systemic Effects</to_name>
    <to_code>T21435</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009057</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Generalized Systemic Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Generalized Systemic Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Generalized Systemic Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Generalized Systemic Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Generalized Systemic Effects [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Generalized Systemic Effects [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Generalized Systemic Effects [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium chloride [712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Generalized Systemic Effects [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Autologous T Cells [EPC]</name>
  <code>C653920</code>  <id>653920</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Autologous T Cells</to_name>
    <to_code>T21453</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193549</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axicabtagene ciloleucel [1987398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Genetically modified T-cell (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing genetically modified T-cell (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B-cell Maturation Antigen-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Autologous T Cells [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisagenlecleucel [1986438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Oncolytic Viral Therapy [EPC]</name>
  <code>C651808</code>  <id>651808</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Oncolytic Viral Therapy</to_name>
    <to_code>T21454</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191724</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Oncolytic Viral Therapy [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oncolytic Viruses [M0022762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Oncolytic Viral Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genetically-modified Virus Vector [EPC]</name>
  <code>C654019</code>  <id>654019</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Virus Vector</to_name>
    <to_code>T58377</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193797</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Virus Vector [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Editing or Modification [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genetically-modified Virus Vector [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viruses, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Genetic material (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Virus Vector [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Agents [TC]</name>
  <code>C654046</code>  <id>654046</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents</to_name>
    <to_code>T58424</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193825</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine fumarate [797196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohydroxamic acid [16728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin hydrobromide [485417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentosan polysulphate sodium [134413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin succinate [476588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiopronin [6765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolvaptan [358257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium chloride [38891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonoxynol-9 [53750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesna [44]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline hydrochloride [235839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine hydrochloride [1426886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium [236778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paricalcitol [73710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline [37815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin [136198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil [306674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine [6883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursadiol [2045735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride [307306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine sulfosalicylate [235562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine [220982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine hydrochloride [133041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine [119565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine tartrate [221174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine bitartrate [81990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine [797195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride trihydrate [1309396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine [3022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine maleate [84158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin [322167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arterial Vasoconstriction [PE]</name>
  <code>C28482</code>  <id>28483</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction</to_name>
    <to_code>T21470</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009058</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genitourinary Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arterial Vasodilation [PE]</name>
  <code>C28484</code>  <id>28485</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasodilation</to_name>
    <to_code>T21471</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009059</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Genitourinary Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arteriolar Vasoconstriction [PE]</name>
  <code>C634784</code>  <id>634784</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arteriolar Vasoconstriction</to_name>
    <to_code>T21472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175401</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Genitourinary Arteriolar Vasodilation [PE]</name>
  <code>C634768</code>  <id>634768</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arteriolar Vasodilation</to_name>
    <to_code>T21473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175385</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glinide [EPC]</name>
  <code>C634810</code>  <id>634810</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinide-class Agent</to_name>
    <to_code>T21672</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinide</to_name>
    <to_code>T21673</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175428</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Meglitinide (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nateglinide [274332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing meglitinide (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>repaglinide [73044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glinides [EXT]</name>
  <code>C637362</code>  <id>637362</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinides</to_name>
    <to_code>T21674</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177907</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinides [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nateglinide [M0353981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinides [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meglitinide [M0096461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glinides [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>repaglinide [M0196126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glomerular Filtration Pressure Alteration [PE]</name>
  <code>C28486</code>  <id>28487</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glomerular Filtration Pressure Alteration</to_name>
    <to_code>T21700</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009060</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glomerular Filtration Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glomerular Filtration Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glomerular Filtration Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glomerular Filtration Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon Receptor Agonists [MoA]</name>
  <code>C654138</code>  <id>654138</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Agonists</to_name>
    <to_code>T58548</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193923</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Glucagon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasiglucagon [2535233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon Receptor Interactions [MoA]</name>
  <code>C31908</code>  <id>31909</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Interactions</to_name>
    <to_code>T21754</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010275</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</name>
  <code>C300448</code>  <id>300448</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-1 Agonists</to_name>
    <to_code>T21783</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 Agonists</to_name>
    <to_code>T21782</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists</to_name>
    <to_code>T21784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020058</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirzepatide [2601723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dulaglutide [1551291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albiglutide [1534763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liraglutide [475968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semaglutide [1991302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 (GLP-1) Antagonists [MoA]</name>
  <code>C300449</code>  <id>300449</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-1 Antagonists</to_name>
    <to_code>T21786</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Antagonists</to_name>
    <to_code>T21787</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 Antagonists</to_name>
    <to_code>T21785</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020059</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</name>
  <code>C300447</code>  <id>300447</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-1 Receptor Interactions</to_name>
    <to_code>T21789</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 Receptor Interactions</to_name>
    <to_code>T21788</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions</to_name>
    <to_code>T21790</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020057</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirzepatide [2601723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-1 (GLP-1) Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</name>
  <code>C650964</code>  <id>650964</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 Agonists</to_name>
    <to_code>T21791</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Agonists</to_name>
    <to_code>T21793</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Agonists</to_name>
    <to_code>T21792</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190990</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teduglutide [1364468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 (GLP-2) Antagonists [MoA]</name>
  <code>C650965</code>  <id>650965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Antagonists</to_name>
    <to_code>T21795</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 Antagonists</to_name>
    <to_code>T21794</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Antagonists</to_name>
    <to_code>T21796</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190991</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</name>
  <code>C650963</code>  <id>650963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 Receptor Interactions</to_name>
    <to_code>T21798</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions</to_name>
    <to_code>T21799</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Receptor Interactions</to_name>
    <to_code>T21797</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190989</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucagon-like Peptide-2 (GLP-2) Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucan Synthase Inhibitors [MoA]</name>
  <code>C300417</code>  <id>300417</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors</to_name>
    <to_code>T21825</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020027</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp [2560213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin acetate [2639156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin [325887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp citrate [2560215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin sodium [487070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin [2639155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucocorticoid Receptor Agonists [MoA]</name>
  <code>C496</code>  <id>497</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists</to_name>
    <to_code>T21836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000159</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloprednol [21285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucocorticoid Receptor Antagonists [MoA]</name>
  <code>C398</code>  <id>399</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Antagonists</to_name>
    <to_code>T21837</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000110</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucocorticoid Synthesis Inhibitors [MoA]</name>
  <code>C635361</code>  <id>635361</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Synthesis Inhibitors</to_name>
    <to_code>T21838</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175923</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucose Metabolism Alteration [PE]</name>
  <code>C28488</code>  <id>28489</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration</to_name>
    <to_code>T21862</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009061</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucose Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucose Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucose Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucose Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc nicotinate [236834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</name>
  <code>C654238</code>  <id>654238</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GIPR Agonist</to_name>
    <to_code>T58751</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GIP Receptor Agonist</to_name>
    <to_code>T58750</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist</to_name>
    <to_code>T58749</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194015</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirzepatide [2601723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucosyl Transferase Inhibitors [MoA]</name>
  <code>C300403</code>  <id>300403</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosyl Transferase Inhibitors</to_name>
    <to_code>T21943</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020018</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucosyl Transferase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucosylceramide Synthase Inhibitor [EPC]</name>
  <code>C635202</code>  <id>635202</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitor</to_name>
    <to_code>T21953</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175783</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucosylceramide Synthase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eliglustat [1547220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucosylceramide Synthase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miglustat [402316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glucosylceramide Synthase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing glycosidase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with glycosidase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucosylceramide Synthase Inhibitors [MoA]</name>
  <code>C300404</code>  <id>300404</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitors</to_name>
    <to_code>T21954</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020019</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglustat [402316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucosylceramide Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glucuronosyl transferases [PK]</name>
  <code>C246</code>  <id>247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucuronosyl transferases</to_name>
    <to_code>T21966</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000034</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glutamate Activity Alteration [PE]</name>
  <code>C28490</code>  <id>28491</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glutamate Activity Alteration</to_name>
    <to_code>T21976</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009062</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glutamate Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glutamate Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glutathione s-transferases [PK]</name>
  <code>C248</code>  <id>249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glutathione s-transferases</to_name>
    <to_code>T22101</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000035</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycine Activity Alteration [PE]</name>
  <code>C28492</code>  <id>28493</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Activity Alteration</to_name>
    <to_code>T22180</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009063</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine [4919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine hydrochloride [1311532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycine Agonists [MoA]</name>
  <code>C324</code>  <id>325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Agonists</to_name>
    <to_code>T22181</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000073</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycine Antagonists [MoA]</name>
  <code>C416</code>  <id>417</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Antagonists</to_name>
    <to_code>T22182</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000119</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycine Receptor Interactions [MoA]</name>
  <code>C666</code>  <id>667</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Receptor Interactions</to_name>
    <to_code>T22212</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000244</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycogen Metabolism Alteration [PE]</name>
  <code>C28494</code>  <id>28495</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycogen Metabolism Alteration</to_name>
    <to_code>T22239</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009064</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycogen Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycogen Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycogen Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycogen Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</name>
  <code>C651547</code>  <id>651547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody Interactions</to_name>
    <to_code>T22372</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside (GD2)-directed Antibody Interactions</to_name>
    <to_code>T22371</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GD2-directed Antibody Interactions</to_name>
    <to_code>T22370</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191499</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naxitamab [2474039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycolipid Disialoganglioside-directed Antibody [EPC]</name>
  <code>C651548</code>  <id>651548</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GD2-directed Antibody</to_name>
    <to_code>T22374</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside (GD2)-directed Antibody</to_name>
    <to_code>T22373</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody</to_name>
    <to_code>T22375</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191500</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naxitamab [2474039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinutuximab [1606274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycolipid Disialoganglioside-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycopeptide Antibacterial [EPC]</name>
  <code>C634872</code>  <id>634872</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycopeptide Antibacterial</to_name>
    <to_code>T22378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175491</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycopeptides [M0009481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vancomycin [11124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing glycopeptide (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with glycopeptide structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</name>
  <code>C654211</code>  <id>654211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycoprotein 100 Peptide-HLA-directed Antibody Interactions</to_name>
    <to_code>T58697</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>gp100 Peptide-HLA-directed Antibody Interactions</to_name>
    <to_code>T58698</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>gp100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</to_name>
    <to_code>T58699</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions</to_name>
    <to_code>T58696</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193994</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan Metabolism Alteration [PE]</name>
  <code>C300431</code>  <id>300431</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Alteration</to_name>
    <to_code>T22412</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucopolysaccharide</to_name>
    <to_code>T22411</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020041</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosaminoglycan Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosaminoglycan Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan Metabolism Decrease [PE]</name>
  <code>C300433</code>  <id>300433</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Decrease</to_name>
    <to_code>T22413</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020043</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan Metabolism Increase [PE]</name>
  <code>C300432</code>  <id>300432</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Increase</to_name>
    <to_code>T22414</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020042</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laronidase [392509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elosulfase alfa [1489914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idursulfase [644101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosaminoglycan [EPC]</name>
  <code>C635256</code>  <id>635256</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan</to_name>
    <to_code>T22415</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175837</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosaminoglycan [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentosan polysulfate [155046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosaminoglycan [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycosaminoglycans [M0009496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosaminoglycan [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Mucopolysaccharide (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosphingolipid Synthesis Alteration [PE]</name>
  <code>C300405</code>  <id>300405</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Alteration</to_name>
    <to_code>T22422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020020</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosphingolipid Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Glycosphingolipid Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosphingolipid Synthesis Decrease [PE]</name>
  <code>C300407</code>  <id>300407</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Decrease</to_name>
    <to_code>T22423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020022</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglustat [402316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Glycosphingolipid Synthesis Increase [PE]</name>
  <code>C300406</code>  <id>300406</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Increase</to_name>
    <to_code>T22424</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020021</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegunigalsidase alfa-iwxj [2637445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegunigalsidase alfa [2637446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GnRH Activity Alteration [PE]</name>
  <code>C28466</code>  <id>28467</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Activity Alteration</to_name>
    <to_code>T22472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009050</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GnRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GnRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>GnRH Secretion Alteration [PE]</name>
  <code>C28470</code>  <id>28471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Secretion Alteration</to_name>
    <to_code>T22473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009052</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GnRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>GnRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Alteration [PE]</name>
  <code>C28468</code>  <id>28469</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration</to_name>
    <to_code>T22540</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GNRH Alteration</to_name>
    <to_code>T22539</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009051</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</name>
  <code>C635048</code>  <id>635048</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone (GnRH) Agonist</to_name>
    <to_code>T22544</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Receptor Agonist</to_name>
    <to_code>T22545</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonist</to_name>
    <to_code>T22546</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175655</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Gonadotropin releasing factor (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafarelin [28656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goserelin [50610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing gonadotropin releasing factor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leuprolide [42375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triptorelin [38782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histrelin [50975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</name>
  <code>C635047</code>  <id>635047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Receptor Agonists</to_name>
    <to_code>T22547</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists</to_name>
    <to_code>T22548</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175654</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trelstar pamoate [905060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin acetate [236538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin [50610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</name>
  <code>C635258</code>  <id>635258</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Antagonist</to_name>
    <to_code>T22541</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonist</to_name>
    <to_code>T22543</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone (GnRH) Antagonist</to_name>
    <to_code>T22542</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175839</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with gonadotropin releasing hormone receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elagolix [2049846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing gonadotropin releasing hormone receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>degarelix [475230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relugolix [2472778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetrorelix [68147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganirelix [35825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</name>
  <code>C634445</code>  <id>634445</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists</to_name>
    <to_code>T22550</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Receptor Antagonists</to_name>
    <to_code>T22549</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175084</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix choline [2621020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abarelix [301739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix acetate [835863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix [475230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin Releasing Hormone Secretion Inhibitor [EPC]</name>
  <code>C634978</code>  <id>634978</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GnRH Secretion Inhibitor</to_name>
    <to_code>T22551</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Secretion Inhibitor</to_name>
    <to_code>T22552</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175585</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Secretion Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with gonadotropin releasing hormone receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin Releasing Hormone Secretion Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing gonadotropin releasing hormone receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Gonadotropin [EPC]</name>
  <code>C635257</code>  <id>635257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin</to_name>
    <to_code>T22553</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175838</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutropin alfa [388084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonadotropins [M0009540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>follicle stimulating hormone [227518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with gonadotropin mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing gonad regulating hormone (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Gonadotropin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choriogonadotropin alfa [283550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Grain Proteins [EXT]</name>
  <code>C644818</code>  <id>644818</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins</to_name>
    <to_code>T22594</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185016</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat allergenic extract [971932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brown rice preparation [1311040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn extract [1323308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley extract [1370766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat gluten extract [1370781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley malt allergenic extract [1006510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley allergenic extract [862453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn grain extract [1423924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rye allergenic extract [892638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buckwheat allergenic extract [899394]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley malt syrup [1306883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Factor [APC]</name>
  <code>C654107</code>  <id>654107</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Factor</to_name>
    <to_code>T58512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193885</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Factor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Platelet-derived Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Factor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Nerve Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Factor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Factor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Factor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Agonists [MoA]</name>
  <code>C31890</code>  <id>31891</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Agonists</to_name>
    <to_code>T22758</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010266</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Antagonist [EPC]</name>
  <code>C650078</code>  <id>650078</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Inhibitor</to_name>
    <to_code>T22759</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Antagonist</to_name>
    <to_code>T22760</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190119</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing growth hormone receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with growth hormone receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegvisomant [278739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Receptor Antagonists [MoA]</name>
  <code>C31892</code>  <id>31893</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Antagonists</to_name>
    <to_code>T22761</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010267</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Factor Analog [EPC]</name>
  <code>C641710</code>  <id>641710</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRF Analog</to_name>
    <to_code>T22769</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Hormone Analogue</to_name>
    <to_code>T22766</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor Analog</to_name>
    <to_code>T22773</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Analogue</to_name>
    <to_code>T22764</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Analog</to_name>
    <to_code>T22770</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRF Analogue</to_name>
    <to_code>T22767</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Hormone Analog</to_name>
    <to_code>T22762</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Hormone (GHRH) Analogue</to_name>
    <to_code>T22772</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor (GHRF) Analogue</to_name>
    <to_code>T22763</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor (GHRF) Analog</to_name>
    <to_code>T22765</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor Analogue</to_name>
    <to_code>T22768</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Hormone (GHRH) Analog</to_name>
    <to_code>T22771</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182144</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Growth Hormone-Releasing Hormone [M0020158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tesamorelin [1044584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Releasing Factor Analog [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Somatotropin releasing factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing somatotropin releasing factor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Releasing Hormone Alteration [PE]</name>
  <code>C28458</code>  <id>28459</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Hormone Alteration</to_name>
    <to_code>T22775</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Alteration</to_name>
    <to_code>T22774</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009046</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GHRH Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Secretagogue Receptor Agonist [EPC]</name>
  <code>C654010</code>  <id>654010</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonist</to_name>
    <to_code>T58358</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ghrelin Receptor Agonist</to_name>
    <to_code>T58361</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193785</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Secretagogue Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Secretagogue Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macimorelin [1999420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Secretagogue Receptor Agonists [MoA]</name>
  <code>C654008</code>  <id>654008</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists</to_name>
    <to_code>T58354</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ghrelin Receptor Agonists</to_name>
    <to_code>T58355</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193786</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin [1999420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon [2644503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon-ghla [2644513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin acetate [1999419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Growth Hormone Secretagogue Receptor Interactions [MoA]</name>
  <code>C654009</code>  <id>654009</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ghrelin Receptor Interactions</to_name>
    <to_code>T58357</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Interactions </to_name>
    <to_code>T58356</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193787</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Growth Hormone Secretagogue Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Guanylate Cyclase Activators [MoA]</name>
  <code>C645313</code>  <id>645313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators</to_name>
    <to_code>T22916</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185499</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Guanylate Cyclase Stimulators [MoA]</name>
  <code>C650443</code>  <id>650443</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators</to_name>
    <to_code>T22917</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190484</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riociguat [1439816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil [306674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vericiguat [2475830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride [307306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vericiguat [2475830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride trihydrate [1309396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Guanylate Cyclase-C Agonist [EPC]</name>
  <code>C645314</code>  <id>645314</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase-C Agonist</to_name>
    <to_code>T22927</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185500</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Guanylate Cyclase-C Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plecanatide [1873752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Guanylate Cyclase-C Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Guanylate Cyclase-C Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linaclotide [1307404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme activator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase-C Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>H [Preparations]</name>
  <code>C288634</code>  <id>288634</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>H [Preparations]</to_name>
    <to_code>T22980</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010590</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (100000 MPA.S) [1300448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hog skin extract [852839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (1600000 WAMW) [2048727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase, ovine [486164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hymetellose (50 MPA.S) [1939372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (4000 MPA.S) [1300455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haddock allergenic extract [899428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydrastis preparation [314666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Houttuynia cordata flowering top extract [1309469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-qvfc [2639946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hafnium [1534767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed glycosaminoglycans (bovine; 50000 MW) [1313712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexapeptide-9 [2399027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyzine hydrochloride [154987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthemum canadense extract [1320405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hottonia palustris flower extract [1309467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyproline [1311548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hederagenin [2045115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthus annuus sprout extract [1368332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hovenia dulcis fruit extract [1311608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2,6-hexanetriol [1362577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B surface antigen (isoform M), recombinant [2588218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hesperetin [1314255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated polybutene (1300 MW) [1314287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (4000 CPS) [1300447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyphenyl propamidobenzoic acid [1427188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyzine [5553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxide ion [1314279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hexenal, (2e)- [2281309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexahydro-4,7-methanoinden-6-yl propionate [2395762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (40 MPA.S at 2%) [1376150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydantoin [1721294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexapeptide-49 [2584309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human milk preparation [1661547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyoscyamine hydrobromide [1047802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human epidermal growth factor [1427157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyectoin [2119368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthemum nummularium flower extract [1352521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl laurdimonium chloride [1648218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexacosanoate [1997246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxylated lanolin [1356701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (15 MPA.S) [1300450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin, porcine [235473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human coxsackievirus A7 [1435395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexobendine hydrochloride [439431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hexenyl salicylate, cis- [2359262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydrangea arborescens whole extract [1658431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroquinone [5509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type H) [1811461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,6-hexamethylene diisocyanate [1428547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedera helix flowering twig extract [1330087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B surface antigen (isoform L), recombinant [2588217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human enterovirus A [1668271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hemp [1788846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone probutate [27196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (90000 WAMW) [2055269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyoscyamine sulfate anhydrous [1742407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Horse antihuman thymocyte gamma globulin [107051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type EL) [1653098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house fly extract [967921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Houttuynia cordata whole extract [1358899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose acetate succinate 06081224 (3 MM2-S) [1376345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hura crepitans sap extract [1366113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen cation [2557600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human coxsackievirus B4 [1427210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated menhaden oil [1309481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse chestnut whole extract [1661336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helicobacter pylori [1318501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated polybutene (370 MW) [1306210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrochlorothiazide [5487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated macadamia seed oil [1868613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse hair extract [895515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl chitosan [866459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyacinth bean extract [2637948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydralazine hydrochloride [82027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (4000 CPS at 1%) [1307036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyestrones [5530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hog hair extract [895542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed wheat protein (enzymatic, 3000 MW) [1426424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptanoic acid [991260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxymethylglycinate [1370672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hexyloxypropylene glycol [2059295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (5 MPA.S) [1300452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyldecyl laurate [1312598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparan sulfate (porcine 5500 MW) [2603493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type e) [1356136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroiodic acid [27208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum italicum flower extract [1310048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexobarbital [5302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen dimethicone (30 CST) [2613886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HETERZYGOUS YUCATAN MINIATURE PIG SCN5A MUTATED GENE DISRUPTED BY A SCN5A-NEO RDNA CONSTRUCT IN EXON 11 [2204572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypophosphite ion [1546440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HLAL RDNA construct in SBC LAL-C chicken [1796975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hemicellulase [26514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrobromic acid [1426869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (160000 WAMW) [2166043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house fly allergenic extract [350173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (280 MPA.S at 2%) [1492183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl methacrylate [2468433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypalmitoyl sphinganine [1747474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus rosa-sinensis flowering top extract [1310008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (200000 MPA.S) [2631986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human hair preparation [1442514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl salicylate [1421892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxychloroquine sulfate [153972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type J) [1485045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hylocereus undatus fruit extract [2181533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed sheep wool keratin (200 MW) [2539169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexenyl acetate, (2Z)- [2274706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptanes [1367182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Holodiscus discolor whole extract [2387538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2&apos;,2&apos;&apos;,2&apos;&apos;&apos;-((4-((2-hydroxyethyl)amino)-8-(piperidin-1-yl)pyrimido(5,4-D)pyrimidine-2,6-diyl)dinitrilo)tetraethanol [2548676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>highbush blueberry extract [1945027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B virus [1427211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed jojoba esters (potassium salts) [1789206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hirudin [1546205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose acetate succinate [2645263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse chestnut preparation [317825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydralazine [5470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hagenia abyssinica flower extract [1862479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (100 MPA.S) [1300444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedychium coronarium root extract [1307804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hetacillin [26797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1H,5H-cyclopenta(3,4)(1)benzopyrano(6,7,8-IJ)quinolizin-12(9H)-one, 2,3,6,7,10,11-hexahydro- [2378833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone valerate [27199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>holy basil leaf extract [1860076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histidine [5340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptyl glucoside [2462498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HEPATITIS A IMMUNE GLOBULIN,HU [237062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl hexanoate [2000994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolysed bovine collagen (enzymatic; 2000-5000 MW) [1312600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human coxsackievirus B [1668273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyriopsis cumingii whole extract [1495456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone hydrochloride [236931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedera helix leaf extract [1309795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxy-1-(5-isocamphyl)cyclohexane [2557378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyacinthus orientalis flower extract [1796919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Heterotheca inuloides flower extract [1372928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthus annuus whole extract [1425412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexacosyl glycol [2367762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halazepam [26412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hawthorn flowering top extract [1653024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen sulfite [1366859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histidinal, L- [2621896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypericum oil [1352522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroflumethiazide [5495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hawthorn flower extract [969139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Huperzia serrata extract [1376501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin sodium [9877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen [1427171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypochlorite [1483317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Pterocladiella tenuis polysaccharides (enzymatic; 750 MW) [2044917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hawthorn preparation [155097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human vaccinia immune globulin [597392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-fihj [2375132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxycyclophosphamide [2675983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone [5489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroquinine [2468435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxybenzyl alcohol [2045942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexafluorenium bromide [53017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hemin [5175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HC red no. 3 [2469246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus rosa-sinensis leaf extract [1307747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxocobalamin [5514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human parvovirus B19 virus [1368364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana leaf extract [1307887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydracrylic acid [2673464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl methylcellulose 2910 [1363586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hordeum vulgare top extract [1311547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen peroxide [5499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated polydecene (3100 CST) [2606776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hexenal propylene glycol acetal, (1E)- [1673572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippeastrum puniceum whole extract [1942330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Homalomena occulta root extract [2610748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypophosphorous acid [1423684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated poly(C6-20 olefin; 100 CST) [2383934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-hydroxymethyl(methyleneoxy)-1-aza-3,7-dioxabicyclo(3,3,0)octane [1732117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed elastin, bovine, alkaline (1000 MW) [1312601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heroin hydrochloride [81994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus mutabilis flower extract [1724426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer [1729151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bisstearyldimonium chloride [1368486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>17-hydroxystearic acid [2185790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexafluorenium [26826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honeydew melon allergenic extract [899476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human chorionic gonadotropin [340705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamidine [26849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexapeptide-11 [1996982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyacinthoides non-scripta extract [1428043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homatropine methylbromide [27085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus rosa-sinensis flower extract [1923771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human plasma preparation [2539171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hesperidin complex [314661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis nosodes [350255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexadecane [2167851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana top extract [1307756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (4 MPA.S) [2675619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Heracleum hemsleyanum whole extract [2610747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>harpagoside [2048124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl palmityl oxyhydroxypropyl palmitamide [2471867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hottonia palustris whole extract [2003474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptaminol hydrochloride [236294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum italicum flower oil [1309354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexadecene (mixed isomers) [2173916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl starch 130-0.4 [1363352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl methylcellulose 2208 [1363585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxocobalamin hydrochloride [1947247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hexenyl hexanoate, (3Z)- [2000995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human adipose preparation [1368621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated coconut oil [1307683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydnocarpus kurzii seed oil [1420965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haemophilus influenzae immunoserum rabbit [1367192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hylan [27306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone cypionate [163524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hylotelephium telephium whole extract [2539933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydrastis canadensis whole preparation [1314583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horehound extract [1426436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypoxis hemerocallidea root extract [1310069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halometasone [26416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexaminolevulinate hydrochloride [1426871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose [27334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedeoma pulegioides leaf oil [2639088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptaminol adenosine phosphate [236293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone bitartrate [142439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-hexadecyl-5-ethyl-2-methylpyridinium bromide [2394501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hoodia gordonii extract [578315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyldecanol [1363575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) [2599921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herpesvirus 1, human [1316105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose phthalate (31% phthalate, 40 CST) [1368892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated palm oil [1307676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl laurate [1367126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>12-hydroxystearate [1368629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyoscyamus niger extract [1311152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heme iron polypeptide [978673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(2-(2-hydroxypropoxy)propoxy)-1-propanol [2359259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herpesvirus 3, human [11131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (2000 CPS at 1%) [1299925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histamine hydrochloride [350466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydromorphone hydrochloride [203177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hericium americanum fruiting body extract [2631131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>10-hydroxystearic acid [2476630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>12-hydroxyeicosapentaenoic acid, (12R)- [2261372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helleborus niger whole extract [1999674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Humulus lupulus stem extract [1309472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone butyrate [103468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hard maple pollen extract [851874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated polydecene (550 MW) [1314588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin, bovine [1856273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyoscyamus extract [314674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human skin preparation [1593853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae [1364467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated jojoba oil [1745008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honokiol [2562546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histidine monohydrochloride [1309689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histrelin acetate [1294622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypinacolone retinoate [1795946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyacinthus orientalis whole extract [1549103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hordenine [27120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyssop oil [1362137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamethyldisiloxane [1311540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2906 (4000 mpa.s) [1299222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human mammary gland preparation [1372308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrotalcite [27221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human placental tissue preparation [2176248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halofantrine [50749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halothane [5095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heme arginate [26506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone polistirex [221107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl 5-aminolevulinate [1426872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl laurdimonium [1648219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronic acid [5463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus B Conjugate Vaccine [214606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3&apos;-hydroxyacetophenone [2560214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrofluoric acid [5496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (1500 MPA.S at 1%) [1312606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2,4,4,6,8,8-heptamethylnonane [1362933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B immune globulin [26744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptanal [2360434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine [798444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroquinine sulfate [2468434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyisohexyl 3-cyclohexene carboxaldehyde [1426621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (3000 CPS at 1%) [1363604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Gelidium lingulatum polysaccharides (enzymatic; 750 MW) [2044904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl guar (2500-4500 MPA.S at 1%) [1361655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed sericin (enzymatic; 2500 MW) [1544274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum gymnocephalum whole extract [2099292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypericum extract [1309228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose [27244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hepatitis A Vaccine, Inactivated [253174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus rosa-sinensis whole extract [2048123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histidine monohydrochloride monohydrate [1305609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen dimethicone (20 CST) [1866044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human coxsackievirus B3 [1435396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human coxsackievirus A2 [1435394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana flower water extract [1307636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexadecyl povidone (4 hexadecyl branches-repeat) [1366991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippophae rhamnoides seed extract [2104183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (1500 MPA.S) [2395758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexadecanal [2049630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone sodium succinate [235483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (50 MPA.S) [1300453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>helium [5140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (60000 MPA.S) [1986432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyurea [5552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 3cP [1363589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexasodium phytate [1730445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyestrone diacetate [236161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hackberry pollen extract [852324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus capsular oligosaccharide [221105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthus annuus seed wax extract [1307740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana bark extract [1307752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyldecyl stearate [1312599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexadecanolactone [1438492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexylresorcinol [5321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hydroxyethyl methacrylate [1362692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthus annuus seedcake extract [1307763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (280 MPA.S at 5%) [1487367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyaluronan [258347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippophae rhamnoides fruit juice [1311604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus sabdariffa seed oil [2118526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyoscyamus niger whole extract [1442993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthus annuus flowering top extract [1309686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated palm/palm kernel oil peg-6 esters [2002788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone acetate [27197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamidine diisethionate [1939371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydrangea extract [1372001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Holarrhena pubescens bark extract [1307856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helleborus extract [1351001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (6500 MPA.S at 2%) [1376344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type M) [1433886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hazelnut allergenic extract [891633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolysed marine collagen (enzymatic; 2000 MW) [1427229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated starch hydrolysate [1651693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haematonectria haematococca allergenic extract [852503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae type b [50937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropylbetadex (0.58-0.68 MS) [1363608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Lupinus albus seed protein (enzymatic; 3500 mw) [2371705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-hexadecene [1313219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hops oil [1735039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histamine [5333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroquinidine hydrochloride [236160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Himanthalia elongata extract [1426383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Humicola grisea allergenic extract [1014391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910-5cP [1363583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>12-hydroxystearic acid [1368628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropylcellulose [27291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedychium spicatum whole extract [2629781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Halimeda opuntia extract [1314311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hekla lava [1426873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herpesvirus 5, human [1316104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2906 (4 mpa.s) [1426846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl trimonium chloride [2104987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Gracilaria chilensis polysaccharides (enzymatic; 750 MW) [2044913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypotaurine [2597523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [798279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Himatanthus lancifolius bark extract [1374400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hawthorn berry [283570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>high fructose corn syrup [1310511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hieracium pilosella flowering top [1310001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(1,2,6,7-3H)-testosterone [1989005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxy-2,5-dimethylfuran-2(3H)-one [1313733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum litoreum whole extract [2180548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (100 MPA.S at 2%) [1362147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse dander extract [2167548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bispalmitamide monoethanolamide [1942708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated polydecene (1500 CST) [2389632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hydroxydecanoic acid [1486027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated soybean phosphatidylcholine [2392131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated jojoba oil-jojoba oil, randomized (iodine value 57-61) [1483230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (3 MPA.S) [1300446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin calcium [20044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexylnicotinate [235812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human dander preparation [1484853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histamine dihydrochloride [142136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homarine hydrochloride [1426929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl decanoate [1313706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippophae rhamnoides seed oil [1309359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (5000 CPS at 1%) [1307084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexoprenaline [5307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hydroxydecanoate [1486028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum italicum flowering top extract [1309358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated soybean oil [1309222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyldecyl myristoyl methylaminopropionate [1427017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bisstearyldimonium [1368487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-tqjs [2693885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Harrisia pomanensis stem extract [1431718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptaminol acefyllinate [236292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hexaplex trunculus hypobranchial gland juice [1312379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hippurate [1923620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house mouse hair extract [1993210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone aceponate [41277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedera helix top extract [1311601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose phthalate (24% phthalate, 55 CST) [1368890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated soybean lecithin [1426418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hieracium pilosella whole extract [1649349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hericium erinaceus fruiting body extract [2631132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed placental protein (bovine) [1311655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hygromycin B [1426887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen [5497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl urea [1363605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>helicin [236999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hovenia dulcis whole extract [2204928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippophae rhamnoides whole extract [1356686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hydroxyacetophenone [1919492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hexenyl acetate, (3Z)- [1426376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (10000 MPA.S) [1437983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated tallow acid [1425354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana leaf water extract [1307819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexapeptide-10 [1739993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type G) [1596141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Heloderma horridum venom [1310457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (15000 MPA.S) [1300445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (140 CPSat 5%) [1305727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horseradish allergenic extract [1011043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyoscyamus niger leaf extract [1487831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hoodia gordonii sap extract [2669318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexanoyl dipeptide-3 norleucine acetate [1426471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexachlorophene [5293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxydecyl ubiquinoyl dipalmitoyl glycerate [1943485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse chestnut seed [260020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hydroxy-4-methoxybenzenesulfonic acid [1307551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halobetasol [41208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homarine [1426930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>high-density polyethylene [1424910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heather pollen extract [1484977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxybenzoic acid [1649527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homosalate [91326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxystearate [1370462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyzine pamoate [203182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed sheep wool keratin (2000 MW) [2056288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heroin [3304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halobetasol propionate [45318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honey preparation [285279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose, unspecified [2204929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyprogesterone caproate (USP) [12488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hesperidin [5281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus syriacus bark extract [1608319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hordeum vulgare whole extract [1858363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated didecene [1440250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 0.45% stearoxy ether [2601503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroquinidine [27220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>humulene [2266811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honey mushroom extract [2592969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haloprogin [26422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Humulus lupulus whole extract [1535492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated poly(C6-14 olefin; 4 CST) [2639343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrochloric acid [5486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hard fat [1368196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexylcaine hydrochloride [1546032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparinoids [5228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexane [1999411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypericum perforatum flower extract [1309362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2&apos;-hydroxyacetophenone [1664428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2906 (50 MPA.S) [1297881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human adrenal gland preparation [2277352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypericum perforatum leaf extract [1307704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana root bark-stem bark extract [1309697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptylundecyl hydroxystearate [1364948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (type L) [1356137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Gelidium sesquipedale polysaccharides (enzymatic; 750 MW) [2044910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxytyrosol [1314227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamethylindanopyran [1314281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyldecyl isostearate [1812580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (20000 WAMW) [2535502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helminthosporium solani allergenic extract [867232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 (750 MPA.S) [2361308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated castor oil [1309218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hydroxypropyl methacrylate [2204914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-hydroxyethyl acrylate [1314328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-zzxf [2382595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropylcocoate PEG-8 dimethicone [1482914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl gamma-cyclodextrin [1601114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen dimethicone (13 CST) [1793893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus sabdariffa calyx extract [1311543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Houttuynia cordata top extract [2001175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Holothuria sea cucumber preparation [2166042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus laevis flower extract [2123308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (15000 MPA.S) [1300451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose (70000 WAMW) [2099291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human coxsackievirus B1 [1427209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl methylcellulose phthalate [1363587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedeoma pulegioides extract [1353881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated avocado oil [1440252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>helicidine [233562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>10-hydroxydecanoate [1368623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone [5492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heliotropine butane-2,3-diol acetal [2467279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bisstearamide monoethanolamide [1541741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hylan G-F 20 [284637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herring allergenic extract [899434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated palm kernel glycerides [1313709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated methyl abietate [1440228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homatropine hydrobromide [235428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyamphetamine hydrobromide [82066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana whole extract [1314854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus lunariifolius whole extract [2480116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus sabdariffa whole extract [2568104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human cord blood hematopoietic progenitor cell [1307732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexasodium hexametaphosphate [1487530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hymetellose (4150 MPA.S) [2118527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase, bovine [578350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (6 cps) [1300454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolysed Lepidium meyenii root extract (enzymatic) [1742993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helleborus extract [2047647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated rapeseed oil [1440247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed oryzanol [2585254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haberlea rhodopensis leaf extract [1310093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypnea musciformis extract [1363609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexametaphosphate [1487531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hymenoptera allergenic extract [235614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogen cyanide [1367183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halofantrine hydrochloride [58130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyoctacosanyl hydroxystearate [1367169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Human skin proteins, partially hydrolyzed [1657854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HYDROLYZED JOJOBA ESTERS (ACID FORM) [1307311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hemophilus B polysaccharide [314656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B surface antigen vaccine [797752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose, low substituted [1363584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated olive oil cetyl esters [1855890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Gelidium rex polysaccharides (enzymatic; 750 MW) [2044906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>10-hydroxycapric acid [1368622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-hydroxytryptophan, DL- [1313305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated palm kernel oil [1309360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl acetate [1807127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haloperidol decanoate [26420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptaminol [5254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-nvhy [2700789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heavy mineral oil [258439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippomane mancinella fruiting leafy twig extract [1310002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hemidesmus indicus root extract [1309969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human parathyroid preparation [1597627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydrangea arborescens root extract [1309475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hazelnut pollen extract [852281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hippuric acid [1923619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl corn starch (5% substitution by weight) [1363607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxymethoxyphenyl propylmethylmethoxybenzofuran [2043287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bis-hydroxyethyldimonium chloride [1492301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(4-hydroxy-3-methoxyphenyl)-decan-3-one [1928181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus sabdariffa flower extract [1309215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human colostrum [1605775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippophae rhamnoides fruit extract [1311546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-hexanediol [1362584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexocyclium methylsulfate [235430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxycitronellal [1362893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>habanero extract [1337637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honey locust whole extract [2263066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed soy protein (enzymatic; 2000 MW) [1721695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparan sulfate [2603494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed oryzanol oleates [2044916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyssopus officinalis whole extract [1482787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-hydroxytryptophan [94]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedychium spicatum root extract [1928184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hordeum vulgare root extract [1306189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum arenarium whole extract [1809898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-hydroxyethyl)(hydroxymethyl)amine [2375705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hesperidin methylchalcone [72086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hexenyl butyrate, (3Z)- [2000996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated poly(C6-14 olefin; 2 CST) [1722671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hesperadin [1552358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexanediol [1307037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated poly(C6-14 olefin; 6 CST) [1812572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis C virus [1491863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human sputum, Bordetella pertussis infected [1312370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 50cP [1363590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house dust allergenic extract [852519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HC yellow no. 2 [2386335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamethylene diisocyanate-trimethylol hexyllactone crosspolymer [1608039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxycitric acid [1312602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated palm glycerides [1310582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house mouse skin extract [852693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamethylcyclotrisiloxane [1994321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated vegetable oil [1309225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hops allergenic extract [899480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptane [2472186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase [5464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helianthemum nummularium whole extract [1801065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethylpiperazine ethane sulfonic acid [1312611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexobendine [5303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halcinonide [5084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human adenovirus B serotype 7 strain 55142 [1802483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halazone [59838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haslea ostrearia whole extract [2179290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexafluorosilicate [1862869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyoscyamine sulfate [1225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hops extract [259266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase, human recombinant [1300478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hamster skin extract [895062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxymethyl cellulose [1363606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxy acetophenone [1541733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypericin [1546455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hydnocarpus castaneus whole extract [2709113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HC yellow no. 5 [1428873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone tannate [597355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-hydroxytryptophan, D- [2462458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydromorphone [3423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse skin extract [852479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>huperzine A [2267703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hyssopus officinalis extract [1309237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Gracilaria vermiculophylla polysaccharides (enzymatic; 750 MW) [2044914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human ligament preparation [1657853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hawthorn leaf with flower extract [1309793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl-alpha-cyclodextrin [1442707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hymecromone [5556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexylcaine [26879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose acetate succinate 12070923 (3 MM2-S) [1426290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyprogesterone acetate [1101886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hog epithelia extract [852091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl guar hydroxypropyltrimonium chloride [2683200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated olive oil unsaponifiables [1799145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herpesvirus 6, human [2167553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cetyldimonium phosphate [1549632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated jojoba oil, randomized [1540881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bis-hydroxyethyldimonium [1492302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herring sperm DNA [1314256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl cellulose, unspecified [1804020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helleborus niger root extract [1309990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hydroxy-4-methoxybenzenesulfonate [1370572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-hydroxybutyric acid [1546380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronate [62372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human papillomavirus [1311095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heptyl undecylenate [1307091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexacosanoic acid [1997245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose acetate succinate 16070722 (3 Mm2-S) [1313185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (1800 MPA.S at 2%) [1376452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-hexen-1-ol, (3Z)- [1807112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxycaprylic acid [1486023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-oysk [2119708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halometasone monohydrate [237025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated olive oil [1658762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl distarch phosphate, high amylose corn [1312394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis A virus [1491862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocortisone sodium phosphate [235482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Humulus lupulus pollen extract [1740937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>homatropine [27084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helichrysum arenarium flower extract [1656322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl acrylate [2619243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B surface antigen (isoform S), recombinant [2588219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hippophae rhamnoides fruit oil [1310092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hectorite [1367162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human breast tumor cell [1345682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HC yellow no. 4 [2179013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated polyisobutene 8 [2642872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin sodium, bovine [236025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypochlorous acid [1483316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hetastarch [5531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haloperidol lactate [217483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated cottonseed oil [1309478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hesperetin laurate [1366665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexoprenaline sulfate [258331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human placenta hydrolysate [1329960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hedychium flavescens whole extract [2590647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honey bee venom [124427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexylene glycol [1305548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl ethylcellulose [1722035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2208 [1363588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexetidine [5301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hordenine sulfate [236237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histamine phosphate [26925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone resin complex [314667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histrelin [50975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haloperidol [5093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxocobalamin acetate [236302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl corn amylopectin, phosphate crosslinked (4000 MPA.S at 5%) [1596138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hematoporphyrin [5164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyoscyamine [153970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hericium americanum whole extract [2359933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypomyces perniciosus allergenic extract [1192968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haberlea rhodopensis whole extract [2723017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus syriacus seed extract [1372466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-hydroxylysine [1368166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexamethyldisilazane [1986434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypochlorite ion [1800664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl betadex (0.6 hydroxypropyl residues per glucose) [2105627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hetacillin potassium [1299048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horseradish tree whole extract [1661015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herpesvirus 2, human [1318479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hibiscus bifurcatus whole extract [2463334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin sodium, porcine [314659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 [1363567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose phthalate (31% phthalate, 170 CST) [1368891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>halibut liver oil [91473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated coco-glycerides [1364377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated jojoba oil/jojoba oil, randomized (iodine value 40-44) [1722036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexocyclium [26867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hypromellose 2910 (3 MPA.S) [1300449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>histoplasmin [5363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human calcitonin [235481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human embryo tissue preparation [2539170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hamamelis virginiana top water extract [1311598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin [5224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2H-tricosafluoro-5,8,11,14-tetrakis(trifluoromethyl)-3,6,9,12,15-pentaoxaoctadecane [1872907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxychloroquine [5521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>HC blue no. 2 [2386334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl behenamidopropyl dimonium chloride [1373153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrolyzed Gelidium elegans polysaccharides (enzymatic; 750 MW) [2044900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hawthorn berry extract [283571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl cellulose (5500 MPA.S at 2%) [1430439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>holmium [1311388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexadecanamide [159085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hexyl cinnamate [2604566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl bispalmitamide [1942709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Harpagophytum procumbens whole extract [2043285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haematococcus pluvialis extract [1426382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrogenated jojoba oil/jojoba oil, randomized (iodine value 64-70) [1940147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxypropyl tetrahydropyrantriol [1747475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxycaprylate [1486024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>H [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hyaluronidase-ocsq [2693451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HCV NS3/4A Protease Inhibitors [MoA]</name>
  <code>C642233</code>  <id>642233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus NS3/4A Protease Inhibitors</to_name>
    <to_code>T23012</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors</to_name>
    <to_code>T23013</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182638</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER Receptor Family Antagonists [MoA]</name>
  <code>C300391</code>  <id>300391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Family Inhibitors</to_name>
    <to_code>T23036</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Family Antagonists</to_name>
    <to_code>T23044</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Receptor Family Inhibitors</to_name>
    <to_code>T23038</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Antagonists</to_name>
    <to_code>T23042</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Epidermal Growth Factor Receptor Family Antagonists</to_name>
    <to_code>T23041</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Family Inhibitors</to_name>
    <to_code>T23039</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Epidermal Growth Factor Receptor Family Inhibitors</to_name>
    <to_code>T23043</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EGFR Family Antagonists</to_name>
    <to_code>T23035</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Receptor Family Antagonists</to_name>
    <to_code>T23046</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EGFR Family Inhibitors</to_name>
    <to_code>T23045</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Inhibitors</to_name>
    <to_code>T23037</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Family Antagonists</to_name>
    <to_code>T23040</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020006</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER Receptor Family Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER Receptor Family Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER Receptor Family Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER Receptor Family Interactions [MoA]</name>
  <code>C312</code>  <id>313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Family Interactions</to_name>
    <to_code>T23050</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EGFR Family Interactions</to_name>
    <to_code>T23047</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Epidermal Growth Factor Receptor Family Interactions</to_name>
    <to_code>T23048</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Family Interactions</to_name>
    <to_code>T23049</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Receptor Family Interactions</to_name>
    <to_code>T23051</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000067</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER Receptor Family Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Receptor Family Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER1 Antagonists [MoA]</name>
  <code>C300395</code>  <id>300395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-1 Antagonists</to_name>
    <to_code>T23057</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Inhibitors</to_name>
    <to_code>T23055</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EGFR Antagonists</to_name>
    <to_code>T23058</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Antagonists</to_name>
    <to_code>T23053</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Inhibitors</to_name>
    <to_code>T23052</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EGFR Inhibitors</to_name>
    <to_code>T23056</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists</to_name>
    <to_code>T23059</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-1 Inhibitors</to_name>
    <to_code>T23054</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020010</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>necitumumab [1723738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panitumumab [263034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetuximab [318341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER2-directed Antibody Interactions [MoA]</name>
  <code>C654358</code>  <id>654358</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2-directed Antibody Interactions</to_name>
    <to_code>T59035</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194138</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab [2698198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER2/Neu/cerbB2 Antagonists [MoA]</name>
  <code>C300393</code>  <id>300393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2 Inhibitors</to_name>
    <to_code>T23067</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-2 Antagonists</to_name>
    <to_code>T23063</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-2 Inhibitors</to_name>
    <to_code>T23066</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-2/Neu/cerbB2 Inhibitors</to_name>
    <to_code>T23065</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-2/Neu/cerbB2 Antagonists</to_name>
    <to_code>T23062</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists</to_name>
    <to_code>T23068</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2 Antagonists</to_name>
    <to_code>T23061</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Inhibitors</to_name>
    <to_code>T23064</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fam-trastuzumab deruxtecan-nxki [2267574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zongertinib [2721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dttb [2289225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dkst [2103478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab-zbco [2699587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab-zzxf [2382597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-oysk [2375543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-anns [2174802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab [1298944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab [2699588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-zzxf [2382599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab-cmkb [2473850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib ditosylate [481474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-pkrb [2107051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib [480167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab [2473851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER2/neu Receptor Antagonist [EPC]</name>
  <code>C635054</code>  <id>635054</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/neu Receptor Antagonist</to_name>
    <to_code>T23060</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ErbB2 Receptor Antagonist</to_name>
    <to_code>T58360</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2 Receptor Antagonist</to_name>
    <to_code>T58359</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175661</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>margetuximab [2473851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/Neu/cerbB2 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pertuzumab [1298944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HER2/neu Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab [224905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HER3 Antagonists [MoA]</name>
  <code>C300397</code>  <id>300397</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER3 Inhibitors</to_name>
    <to_code>T23070</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-3 Inhibitors</to_name>
    <to_code>T23069</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER3 Antagonists</to_name>
    <to_code>T23072</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HER-3 Antagonists</to_name>
    <to_code>T23071</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020012</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab [2699588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab-zbco [2699587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</name>
  <code>C654029</code>  <id>654029</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV 1 Post-attachment Fusion Inhibitors</to_name>
    <to_code>T58406</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitors</to_name>
    <to_code>T58407</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193807</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir tromethamine [2380374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab-uiyk [2043313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab [2043283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir [2380373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HIV Capsid Inhibitors [MoA]</name>
  <code>C654316</code>  <id>654316</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Capsid Inhibitors</to_name>
    <to_code>T58933</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194086</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Capsid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HIV Fusion Protein Inhibitors [MoA]</name>
  <code>C640529</code>  <id>640529</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Fusion Protein Inhibitors</to_name>
    <to_code>T23157</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Fusion Protein Inhibitors</to_name>
    <to_code>T23158</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181002</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HIV Fusion Protein Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV 1 Post-attachment Fusion Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HIV Integrase Inhibitors [MoA]</name>
  <code>C432</code>  <id>433</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Inhibitors</to_name>
    <to_code>T23163</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors</to_name>
    <to_code>T23164</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000127</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir [1433868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elvitegravir [1306286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir [719872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir sodium [2475076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir potassium [1235585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir sodium [1433867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HIV Protease Inhibitors [MoA]</name>
  <code>C670</code>  <id>671</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Protease Inhibitors</to_name>
    <to_code>T23171</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors</to_name>
    <to_code>T23172</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000246</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir [358262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir anhydrous [1546024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipranavir [190548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir sulfate [203153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir propylene glycolate [2670599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine [6883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine maleate [84158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide [6911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir hydrate [2637854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide maleate [203190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir calcium [402365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir [114289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir mesylate [266565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir ethanolate [644682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>HMG-CoA Reductase Inhibitor [EPC]</name>
  <code>C634982</code>  <id>634982</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitor</to_name>
    <to_code>T23352</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>HMG-CoA Reductase Inhibitor</to_name>
    <to_code>T23353</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175589</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pravastatin [42463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluvastatin [41127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosuvastatin [301542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lovastatin [6472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atorvastatin [83367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitavastatin [861634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simvastatin [36567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>HMG-CoA Reductase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hair Excretion [PK]</name>
  <code>C282</code>  <id>283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hair Excretion</to_name>
    <to_code>T23589</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000052</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hair Follicle Alteration [PE]</name>
  <code>C637774</code>  <id>637774</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hair Follicle Alteration</to_name>
    <to_code>T23590</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178320</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hair Follicle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hair Growth [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hair Follicle Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hair Growth [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Half-Life [PK]</name>
  <code>C306</code>  <id>307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Half-Life</to_name>
    <to_code>T23599</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000064</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hedgehog Pathway Inhibitor [EPC]</name>
  <code>C643864</code>  <id>643864</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hedgehog Pathway Inhibitor</to_name>
    <to_code>T23802</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184149</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glasdegib [2105845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vismodegib [1242987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hedgehog Pathway Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sonidegib [1659191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hedgehog Pathway Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Helicobacter pylori Diagnostic [EPC]</name>
  <code>C635324</code>  <id>635324</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Helicobacter pylori Diagnostic</to_name>
    <to_code>T23811</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Helicobacter Pylori Diagnostic</to_name>
    <to_code>T23810</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H. Pylori Diagnostic</to_name>
    <to_code>T23808</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H. pylori Diagnostic</to_name>
    <to_code>T23809</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175886</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Helicobacter pylori Diagnostic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urea c-13 [226724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_diagnose</name>
   <from_namespace>MED-RT</from_namespace><from_name>Helicobacter pylori Diagnostic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Helicobacter pylori Diagnostic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematologic Activity Alteration [PE]</name>
  <code>C28496</code>  <id>28497</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration</to_name>
    <to_code>T23840</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009065</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemorrheologic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematological Cell Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood &amp; Lymphatic Fluid Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematological Cell Quantity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine citrate [160460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine hydrochloride [81965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin antibodies Fab fragments [203223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine [1512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematological Cell Destruction Alteration [PE]</name>
  <code>C28498</code>  <id>28499</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematological Cell Destruction Alteration</to_name>
    <to_code>T23852</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009066</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Destruction Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematological Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Destruction Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematological Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematological Cell Function Alteration [PE]</name>
  <code>C635019</code>  <id>635019</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematological Cell Function Alteration</to_name>
    <to_code>T23853</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175626</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythrocyte Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monocyte Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mast Cell Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematological Cell Quantity Alteration [PE]</name>
  <code>C28500</code>  <id>28501</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematological Cell Quantity Alteration</to_name>
    <to_code>T23854</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009067</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Quantity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoiesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematological Cell Quantity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematological Cell Destruction Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematology Agent [APC]</name>
  <code>C654131</code>  <id>654131</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematology Agent</to_name>
    <to_code>T58533</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193901</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin S Polymerization Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Warfarin Reversal Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Direct Thrombin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Antihemophilic Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unfractionated Heparin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombolytic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Volume Expander [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-reducing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythroid Maturation Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Erythropoiesis-stimulating Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Aggregation Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antithrombin-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Coagulation Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Serum Albumin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Mobilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifibrinolytic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Reversal Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Low Molecular Weight Heparin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor VIII Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-coagulant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Blood Coagulation Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Viscosity Reducer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematology Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inhibitor Coagulant Complex [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematopoiesis Alteration [PE]</name>
  <code>C28502</code>  <id>28503</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoiesis Alteration</to_name>
    <to_code>T23882</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009068</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematopoiesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematopoiesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematopoietic Stem Cell Function Alteration [PE]</name>
  <code>C637777</code>  <id>637777</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Function Alteration</to_name>
    <to_code>T23887</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178323</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematopoietic Stem Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Hematopoietic Stem Cell Mobilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematopoietic Stem Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide acetate [2664897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide [2664896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hematopoietic Stem Cell Mobilizer [EPC]</name>
  <code>C637780</code>  <id>637780</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Mobilizer</to_name>
    <to_code>T23888</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178326</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematopoietic Stem Cell Mobilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plerixafor [733003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hematopoietic Stem Cell Mobilizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immune enhancement agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Mobilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hemic/Lymphatic Activity Alteration [PE]</name>
  <code>C28504</code>  <id>28505</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemic/Lymphatic Activity Alteration</to_name>
    <to_code>T23924</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009069</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemic/Lymphatic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemic/Lymphatic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemic/Lymphatic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b-njft [2587060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemic/Lymphatic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b [2587059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemic/Lymphatic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hemoglobin Function Restoration [PE]</name>
  <code>C654195</code>  <id>654195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin Function Restoration</to_name>
    <to_code>T58656</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193979</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betibeglogene autotemcel [2610349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin Function Restoration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovotibeglogene autotemcel [2671958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin Function Restoration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin Function Restoration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hemoglobin S Polymerization Inhibitor [EPC]</name>
  <code>C654252</code>  <id>654252</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin S Polymerization Inhibitor</to_name>
    <to_code>T58779</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HbS Polymerization Inhibitor</to_name>
    <to_code>T58780</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194027</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voxelotor [2265678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with hemoglobin S polymerization inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing hemoglobin S polymerization inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemoglobin S Polymerization Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin S Polymerization Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hemoglobin S Polymerization Inhibitors [MoA]</name>
  <code>C654251</code>  <id>654251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HbS Polymerization Inhibitors</to_name>
    <to_code>T58778</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin S Polymerization Inhibitors</to_name>
    <to_code>T58777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194028</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxelotor [2265678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemoglobin S Polymerization Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hemorrheologic Alteration [PE]</name>
  <code>C635330</code>  <id>635330</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemorrheologic Alteration</to_name>
    <to_code>T24048</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175892</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemorrheologic Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemorrheologic Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Blood Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel [32968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemorrheologic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemorrheologic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel bisulfate [236991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemorrheologic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemorrheologic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hemostasis Alteration [PE]</name>
  <code>C28506</code>  <id>28507</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration</to_name>
    <to_code>T24055</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009070</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemostasis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Aggregation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemostasis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelial Coagulation Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemostasis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fibrinolysis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemostasis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Factor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hemostasis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Coagulation Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban [1927851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 phosphate [2373964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric subsulfate solution [24912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban maleate [1927955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprotinin [1056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemostasis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Heparin Binding Activity [MoA]</name>
  <code>C635435</code>  <id>635435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Binding Activity</to_name>
    <to_code>T24073</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175981</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine hydrochloride [236471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamines [8826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Heparin Derivative [EPC]</name>
  <code>C635298</code>  <id>635298</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Derivative</to_name>
    <to_code>T24081</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175860</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Heparin Derivative [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heparinoids [M0010193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Heparin Derivative [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing heparin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Heparin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Heparin Reversal Agent [EPC]</name>
  <code>C635437</code>  <id>635437</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Reversal Agent</to_name>
    <to_code>T24088</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175983</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Heparin Reversal Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Heparin Reversal Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protamines [8826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Heparin Reversal Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anticoagulant antagonist (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Reversal Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatic Excretion [PK]</name>
  <code>C264</code>  <id>265</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion</to_name>
    <to_code>T24112</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000043</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatic Glucagon Receptor Agonists [MoA]</name>
  <code>C654139</code>  <id>654139</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Glucagon Receptor Agonists</to_name>
    <to_code>T58549</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193924</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatic Metabolism [PK]</name>
  <code>C230</code>  <id>231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism</to_name>
    <to_code>T24115</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000026</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin sodium [114194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
  <code>C635049</code>  <id>635049</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HBV Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24163</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI)</to_name>
    <to_code>T24165</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HBV NRTI</to_name>
    <to_code>T24167</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HBV Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24164</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatits B Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24166</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24168</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175656</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir anhydrous [1546017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamivudine [68244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>entecavir anhydrous [1546027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adefovir [16521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</name>
  <code>C642234</code>  <id>642234</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitor</to_name>
    <to_code>T24183</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor</to_name>
    <to_code>T24184</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus NS3/4A Protease Inhibitor</to_name>
    <to_code>T24185</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182639</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glecaprevir [1940635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grazoprevir anhydrous [1871173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing Hepatitis C virus NS3/4A protease inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voxilaprevir [1939323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus NS5A Inhibitor [EPC]</name>
  <code>C651250</code>  <id>651250</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS5A Inhibitor</to_name>
    <to_code>T24186</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus NS5A Inhibitor</to_name>
    <to_code>T24187</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191256</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing Hepatitis C virus protein NS5A inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ledipasvir [1591922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elbasvir [1734628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velpatasvir [1799206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus NS5A Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pibrentasvir [1940636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</name>
  <code>C651251</code>  <id>651251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV Non-Nucleoside NS5B Palm Polymerase Inhibitor</to_name>
    <to_code>T24188</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor</to_name>
    <to_code>T24189</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191257</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</name>
  <code>C651541</code>  <id>651541</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor</to_name>
    <to_code>T24192</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus (HCV) Nucleotide Analog NS5B Polymerase Inhibitor</to_name>
    <to_code>T24190</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV Nucleotide Analog NS5B Polymerase Inhibitor</to_name>
    <to_code>T24191</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191493</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing Hepatitis C virus protein NS5B inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sofosbuvir [1484911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C639679</code>  <id>639679</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue HSV DNA Polymerase Inhibitor</to_name>
    <to_code>T24413</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24408</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HSV Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24410</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog HSV DNA Polymerase Inhibitor</to_name>
    <to_code>T24411</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24412</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24409</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24415</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HSV Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24414</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180187</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acyclovir [281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valacyclovir [73645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>famciclovir [68099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C639783</code>  <id>639783</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24436</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analogue HSV DNA Polymerase Inhibitor</to_name>
    <to_code>T24430</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24431</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog HSV DNA Polymerase Inhibitor</to_name>
    <to_code>T24435</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24432</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analogue Herpes Simplex Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24434</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HSV Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24433</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HSV Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24429</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180291</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</name>
  <code>C654317</code>  <id>654317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy</to_name>
    <to_code>T58934</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194087</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Genetically modified virus (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing genetically modified virus (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Type 1 Vector-based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C639680</code>  <id>639680</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Varicella Zoster Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24455</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Varicella Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24459</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Herpes Zoster Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24457</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VZV Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24463</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Zoster Virus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24464</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog VZV DNA Polymerase Inhibitor</to_name>
    <to_code>T24462</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Varicella Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24460</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue Varicella Zoster Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24465</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue VZV DNA Polymerase Inhibitor</to_name>
    <to_code>T24456</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VZV Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24458</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue Herpes Zoster Virus DNA Polymerase Inhibitor</to_name>
    <to_code>T24461</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24466</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180188</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acyclovir [281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valacyclovir [73645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C634848</code>  <id>634848</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Herpesvirus DNA Polymerase Inhibitor</to_name>
    <to_code>T24475</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T24478</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue Herpesvirus DNA Polymerase Inhibitor</to_name>
    <to_code>T24476</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpesvirus Nucleoside Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T24477</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175468</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesviridae Infections [M0010285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acyclovir [281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesviridae Infections [M0010285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penciclovir [59839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valacyclovir [73645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine Activity Alteration [PE]</name>
  <code>C28508</code>  <id>28509</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Activity Alteration</to_name>
    <to_code>T24653</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009071</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine Agonists [MoA]</name>
  <code>C402</code>  <id>403</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Agonists</to_name>
    <to_code>T24654</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000112</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine H1 Receptor Antagonists [MoA]</name>
  <code>C558</code>  <id>559</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists</to_name>
    <to_code>T24659</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Blockers</to_name>
    <to_code>T24657</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H1 Receptor Antagonists</to_name>
    <to_code>T24655</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Antagonists</to_name>
    <to_code>T24656</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H1 Receptor Blockers</to_name>
    <to_code>T24658</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000190</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine hydrochloride [236961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine [356887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine difumarate [221094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen [6146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine tartrate [164308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine hydrochloride [71534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene [6822]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine besilate [658552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loratadine [28889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine hydrochloride [236599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine hydrochloride [203150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine hydrochloride [91063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcaftadine [1000082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine [10849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine hydrochloride [1294532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bampine hydrochloride [236519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine resin complex [314786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine citrate [71533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine lactate [236530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine [135391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine [863035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine tannate [221075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine [28144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine [20610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine polistirex [221074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline sulfate [2680384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylpyraline hydrochloride [203155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceprometazine [161203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine [18753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine dihydrochloride [402349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine [28627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astemizole [42328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine [87636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen fumarate [11404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine citrate [221141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine maleate [142429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene hydrochloride [235721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine tannate [1099727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine hydrochloride [236474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine polistirex [236792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine [10825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine [2400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine [10847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine H2 Receptor Antagonists [MoA]</name>
  <code>C480</code>  <id>481</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Blockers</to_name>
    <to_code>T24662</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists</to_name>
    <to_code>T24664</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H2 Receptor Antagonists</to_name>
    <to_code>T24661</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H2 Receptor Blockers</to_name>
    <to_code>T24663</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Antagonists</to_name>
    <to_code>T24660</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000151</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Receptor Antagonists [MoA]</name>
  <code>C640530</code>  <id>640530</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H3 Receptor Blockers</to_name>
    <to_code>T24667</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Antagonists</to_name>
    <to_code>T24668</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Blockers</to_name>
    <to_code>T24665</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H3 Receptor Antagonists</to_name>
    <to_code>T24666</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Antagonists</to_name>
    <to_code>T24669</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181003</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant hydrochloride [2197879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine H3 Receptor Inverse Agonists [MoA]</name>
  <code>C654275</code>  <id>654275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-3 Receptor Inverse Agonists</to_name>
    <to_code>T58839</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H3 Receptor Inverse Agonists</to_name>
    <to_code>T58838</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Inverse Agonists</to_name>
    <to_code>T58837</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194051</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Inverse Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine Receptor Antagonists [MoA]</name>
  <code>C592</code>  <id>593</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Antagonists</to_name>
    <to_code>T24673</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists</to_name>
    <to_code>T24674</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000207</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine Receptor Interactions [MoA]</name>
  <code>C610</code>  <id>611</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Interactions</to_name>
    <to_code>T24675</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000216</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Inverse Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine Receptor Inverse Agonists [MoA]</name>
  <code>C654274</code>  <id>654274</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Receptor Inverse Agonists</to_name>
    <to_code>T58836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194052</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine Receptor Inverse Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Inverse Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine-1 Receptor Antagonist [EPC]</name>
  <code>C634980</code>  <id>634980</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-1 Receptor Antagonist</to_name>
    <to_code>T24680</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H1 Receptor Antagonist</to_name>
    <to_code>T24679</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H1 Receptor Inhibitor</to_name>
    <to_code>T24678</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175587</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbinoxamine [20220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olopatadine [135391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cetirizine [20610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing histamine H1 receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocetirizine [356887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alcaftadine [1000082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bepotastine [863035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acrivastine [19959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with histamine H1 receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azelastine [18603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fexofenadine [87636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpheniramine [2400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenhydramine [3498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desloratadine [275635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine-1 Receptor Inhibitor [EPC]</name>
  <code>C634912</code>  <id>634912</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H1 Receptor Antagonist</to_name>
    <to_code>T24681</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H1 Receptor Inhibitor</to_name>
    <to_code>T24682</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-1 Receptor Inhibitor</to_name>
    <to_code>T24683</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175519</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketotifen [6146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinastine [39684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-1 Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olopatadine [135391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with histamine H1 receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-1 Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing histamine H1 receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-1 Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine-2 Receptor Antagonist [EPC]</name>
  <code>C635203</code>  <id>635203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-2 (H2) Receptor Antagonist</to_name>
    <to_code>T24685</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H2 Receptor Antagonist</to_name>
    <to_code>T24684</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-2 Receptor Antagonist</to_name>
    <to_code>T24686</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175784</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing histamine H2 receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cimetidine [2541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with histamine H2 receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranitidine [9143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nizatidine [42319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>famotidine [4278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</name>
  <code>C654276</code>  <id>654276</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>H3 Receptor Antagonist/Inverse Agonist</to_name>
    <to_code>T58841</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Antagonist/Inverse Agonist</to_name>
    <to_code>T58842</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-3 Receptor Antagonist/Inverse Agonist</to_name>
    <to_code>T58840</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194053</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitolisant [2197878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing histamine H3 receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine H3 Receptor Inverse Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with histamine H3 receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histone Deacetylase Inhibitor [EPC]</name>
  <code>C634981</code>  <id>634981</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HDAC Inhibitor</to_name>
    <to_code>T24789</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitor</to_name>
    <to_code>T24791</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase (HDAC) Inhibitor</to_name>
    <to_code>T24790</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175588</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorinostat [194337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panobinostat [1603350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with histone deacetylase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>givinostat [2678889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing histone deacetylase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belinostat [1543543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Histone Deacetylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romidepsin [877510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Histone Deacetylase Inhibitors [MoA]</name>
  <code>C634434</code>  <id>634434</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors</to_name>
    <to_code>T24793</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitor</to_name>
    <to_code>T24792</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175071</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givinostat [2678889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belinostat [1543543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorinostat [194337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat lactate [1603349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat [1603350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant [TC]</name>
  <code>C654047</code>  <id>654047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant</to_name>
    <to_code>T58425</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193826</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Stimulant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Stimulant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Stimulant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Stimulant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Stimulant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>becaplermin [115238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metreleptin [1491625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin [2890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palopegteriparatide [2693635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin hexahydrate [1653802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy polyethylene glycol-epoetin beta [729596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somapacitan [2557373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somapacitan-beco [2557394]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</name>
  <code>C654048</code>  <id>654048</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)</to_name>
    <to_code>T58426</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193827</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finerenone [2562811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloprednol [21285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone acetate [258333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone pivalate [22537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dydrogesterone [3706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</name>
  <code>C654049</code>  <id>654049</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)</to_name>
    <to_code>T58427</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193828</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin acetate [58932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin-tcgd [2569592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon [2644503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon-ghla [2644513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide [2176312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin [7824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide acetate [2176311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin acetate [1733680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin [56188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin-releasing hormone [10580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin acetate [1044583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin [2569562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins) [TC]</name>
  <code>C654050</code>  <id>654050</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)</to_name>
    <to_code>T58428</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193829</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</name>
  <code>C654051</code>  <id>654051</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)</to_name>
    <to_code>T58429</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193830</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandrostenolone [6818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>segesterone acetate [2055977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urofollitropin [134404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drospirenone [11636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene acetate [1442171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrel [7518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrienone [7519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandriol dipropionate [235381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandriol [6817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estetrol monohydrate [2539035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estetrol [2539031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutropin alfa [388084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol [24591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal [1005921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>segesterone [2055978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylestrenol [4162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stanozolol [10032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene [1441386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal acetate [1005920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone (micronized) [221168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienestrol [3368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</name>
  <code>C654052</code>  <id>654052</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)</to_name>
    <to_code>T58430</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193831</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin alfa [4952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Parathyroid) [TC]</name>
  <code>C654054</code>  <id>654054</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid)</to_name>
    <to_code>T58432</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193832</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide [1876119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide hydrochloride [1876122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Pituitary) [TC]</name>
  <code>C654055</code>  <id>654055</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary)</to_name>
    <to_code>T58433</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193833</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide [1364105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide pamoate [1597818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atosiban [59639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine [2724363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide diaspartate [1364104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atosiban acetate [2680385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine hydrochloride [2724364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</name>
  <code>C654056</code>  <id>654056</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers)</to_name>
    <to_code>T58434</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193834</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicalutamide [83008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant (Thyroid) [TC]</name>
  <code>C654057</code>  <id>654057</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Thyroid)</to_name>
    <to_code>T58435</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193835</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormonal Agents, Suppressant [TC]</name>
  <code>C654053</code>  <id>654053</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant</to_name>
    <to_code>T58431</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193836</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Suppressant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Sex Hormones/Modifiers) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Suppressant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Pituitary) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Suppressant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Parathyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormonal Agents, Suppressant [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant (Thyroid) [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide [68092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darbepoetin alfa [283838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat phosphate [2286253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix choline [2621020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide acetate [236167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Agonists [MoA]</name>
  <code>C476</code>  <id>477</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists</to_name>
    <to_code>T24893</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000149</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucagon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin acetate [58932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide [2262250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutropin alfa [388084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melatonin [6711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin [56188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide acetate [2278002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin-releasing hormone [10580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Antagonists [MoA]</name>
  <code>C620</code>  <id>621</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Antagonists</to_name>
    <to_code>T24894</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000221</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Interactions [MoA]</name>
  <code>C692</code>  <id>693</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Interactions</to_name>
    <to_code>T24895</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000257</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormone Receptor Modulators [MoA]</name>
  <code>C688</code>  <id>689</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators</to_name>
    <to_code>T24896</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000255</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone Receptor Modulators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod arginine [2668046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod [2668045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hormone [APC]</name>
  <code>C654098</code>  <id>654098</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone</to_name>
    <to_code>T58508</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193874</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenocorticotropic Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Factor Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Stimulating Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin-class Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>C-type Natriuretic Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxytocic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Thyroxine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Growth Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Triiodothyronine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leptin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholecystokinin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hormone [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Anticoagulant Protein [EPC]</name>
  <code>C648887</code>  <id>648887</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Anticoagulant Protein</to_name>
    <to_code>T24922</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188979</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anticoagulant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Anticoagulant Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Antihemophilic Factor [EPC]</name>
  <code>C643902</code>  <id>643902</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Antihemophilic Factor</to_name>
    <to_code>T24923</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184167</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blood Coagulation Factors [M0002684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing antihemophilic factor agent (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, human [203083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>antihemophilic factor, human recombinant [1300486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Antihemophilic Factor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Antihemophilic factor agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Blood Coagulation Factor [EPC]</name>
  <code>C643904</code>  <id>643904</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Blood Coagulation Factor</to_name>
    <to_code>T24924</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184169</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonacog alfa [1300488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coagulation Factor IX (Human) [617148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>von Willebrand factor, human [826072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinogen concentrate (human) [831503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor VII, human [1426164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor IX, human [221099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coagulation factor X, human [1426166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>factor XIII, human [1091605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blood Coagulation Factors [M0002684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptacog alfa activated [253149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fibrinogen, human [2264108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Blood Coagulation Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin, human [825006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing coagulation protein (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Blood Coagulation Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Coagulation related substance (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Blood Coagulation Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human C1 Esterase Inhibitor [EPC]</name>
  <code>C643907</code>  <id>643907</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human C1 Esterase Inhibitor</to_name>
    <to_code>T24925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184172</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>C1 esterase inhibitor (human) [809864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing C1 esterase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with C1 esterase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human C1 Esterase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</name>
  <code>C635117</code>  <id>635117</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein</to_name>
    <to_code>T24927</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human CTLA-4/Fc-IgG1 Recombinant Fusion Protein</to_name>
    <to_code>T24926</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175711</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoconjugates [M0028142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Fusion Proteins [M0018640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Fusion protein (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</name>
  <code>C654315</code>  <id>654315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Capsid Inhibitor</to_name>
    <to_code>T58931</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Capsid Inhibitor</to_name>
    <to_code>T58932</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194088</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Capsid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenacapavir [2625651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</name>
  <code>C635009</code>  <id>635009</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor</to_name>
    <to_code>T24938</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Fusion Inhibitor (HIV-1 FI)</to_name>
    <to_code>T24936</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Entry Inhibitor</to_name>
    <to_code>T24934</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Fusion Inhibitor</to_name>
    <to_code>T24937</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 FI</to_name>
    <to_code>T24935</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175616</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enfuvirtide [139896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with human immunodeficiency virus fusion inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing fusion inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
  <code>C634843</code>  <id>634843</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24945</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24939</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24941</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24947</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24948</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24944</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor (HIV-1 NNRTI)</to_name>
    <to_code>T24940</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Nonnucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24946</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Non-Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24942</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 NNRTI</to_name>
    <to_code>T24943</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175463</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilpivirine [1102270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nevirapine [53654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efavirenz [195085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doravirine [2055755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etravirine [475969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
  <code>C634844</code>  <id>634844</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 NNRTI and NRTI</to_name>
    <to_code>T24953</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24955</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24949</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24956</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24951</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24952</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24957</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24950</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Nonnucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24954</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175464</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]</name>
  <code>C654028</code>  <id>654028</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Post-attachment Fusion Inhibitor</to_name>
    <to_code>T58404</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Post-attachment Entry Inhibitor</to_name>
    <to_code>T58405</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor</to_name>
    <to_code>T58403</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193808</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibalizumab [2043283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</name>
  <code>C635325</code>  <id>635325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor</to_name>
    <to_code>T24963</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (HIV-1 INSTI)</to_name>
    <to_code>T24958</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV INSTI</to_name>
    <to_code>T24962</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 INSTI</to_name>
    <to_code>T24961</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Strand Transfer Inhibitor</to_name>
    <to_code>T24959</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV-1 Integrase Strand Transfer Inhibitor</to_name>
    <to_code>T24960</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175887</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raltegravir [719872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolutegravir [1433868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elvitegravir [1306286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabotegravir [2475077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with integrase strand transfer inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing integrase strand transfer inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</name>
  <code>C634842</code>  <id>634842</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24964</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24965</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24969</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV NRTI</to_name>
    <to_code>T24966</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Nucleoside Analog Reverse Transcriptase Inhibitor (HIV NRTI)</to_name>
    <to_code>T24967</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Nucleoside Analogue Reverse Transcriptase Inhibitor</to_name>
    <to_code>T24968</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175462</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamivudine [68244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abacavir [190521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emtricitabine [276237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>didanosine [3364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zidovudine [11413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir anhydrous [1546017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stavudine [59763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with reverse transcriptase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing reverse transcriptase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</name>
  <code>C634913</code>  <id>634913</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Protease Inhibitor</to_name>
    <to_code>T24973</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitor</to_name>
    <to_code>T24971</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV PI</to_name>
    <to_code>T24970</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitor (HIV PI)</to_name>
    <to_code>T24972</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175520</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing human protease inhibitor protein (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Human protease inhibitor protein (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunoglobulin G [EPC]</name>
  <code>C643900</code>  <id>643900</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin G</to_name>
    <to_code>T24978</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184165</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulism immune globulin IV human [544488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human vaccinia immune globulin [597392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rho(D) immune globulin, human [1789837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulin G, human [1426680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytomegalovirus immune globulin, human [1997443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin G [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoglobulins [M0011122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Human immunoglobulin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing human immunoglobulin (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Immunoglobulin [EPC]</name>
  <code>C643899</code>  <id>643899</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin</to_name>
    <to_code>T24979</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184164</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing human immunoglobulin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Human immunoglobulin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B immune globulin [26744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Immunoglobulin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoglobulins [M0011122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Platelet-derived Growth Factor [EPC]</name>
  <code>C635323</code>  <id>635323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Platelet-derived Growth Factor</to_name>
    <to_code>T24981</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175885</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>becaplermin [115238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Platelet-Derived Growth Factor [M0017024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Human platelet-derived growth factor (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Platelet-derived Growth Factor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing human platelet-derived growth factor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human Serum Albumin [EPC]</name>
  <code>C643909</code>  <id>643909</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Serum Albumin</to_name>
    <to_code>T24982</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184174</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albumin human, USP [828529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Human serum albumin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing human serum albumin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human Serum Albumin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Albumin [M0019692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Human alpha-1 Proteinase Inhibitor [EPC]</name>
  <code>C643906</code>  <id>643906</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Human alpha-1 Proteinase Inhibitor</to_name>
    <to_code>T24983</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184171</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Trypsin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Human alpha1 proteinase inhibitor (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing human alpha1 proteinase inhibitor (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Human alpha-1 Proteinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alpha 1-proteinase inhibitor, human [991743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Humanized Monoclonal Antibody Fragment [EPC]</name>
  <code>C652003</code>  <id>652003</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Humanized Monoclonal Antibody Fragment</to_name>
    <to_code>T24984</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191873</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Humanized Monoclonal Antibody Fragment [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal, Humanized [M0556300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Humanized Monoclonal Antibody Fragment [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idarucizumab [1716191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunoglobulin fragment (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humanized Monoclonal Antibody Fragment [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Humoral Immunity [PE]</name>
  <code>C644793</code>  <id>644793</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity</to_name>
    <to_code>T24987</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185002</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 11 vaccine [798262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopapogene imadenovec-drba [2723360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow fever virus strain 17D-204 live antigen [804187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopapogene imadenovec [2723361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella typhi Ty21a live antigen [762595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Humoral and Cellular Immune Response Activators [MoA]</name>
  <code>C654381</code>  <id>654381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral and Cellular Immune Response Activators</to_name>
    <to_code>T59069</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194153</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</name>
  <code>C652491</code>  <id>652491</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal Cholesteryl Ester-specific Enzyme</to_name>
    <to_code>T25141</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme</to_name>
    <to_code>T25142</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192342</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysosomal Acid Cholesterol Esterase [M0507876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebelipase alfa [1726975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Lysosomal enzyme (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</name>
  <code>C635239</code>  <id>635239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal Glucocerebroside-specific Enzyme</to_name>
    <to_code>T25143</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme</to_name>
    <to_code>T25144</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175820</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velaglucerase alfa [901805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucosylceramidase [M0009360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imiglucerase [84959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Glucosylceramidase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taliglucerase alfa [1291609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</name>
  <code>C635240</code>  <id>635240</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal Glycogen-specific Enzyme</to_name>
    <to_code>T25145</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycogen-specific Enzyme</to_name>
    <to_code>T25146</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175821</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alglucosidase alfa [629565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Alpha-glucosidase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Glucosidases [M0000794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avalglucosidase alfa [2565814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing alpha-glucosidase (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</name>
  <code>C635242</code>  <id>635242</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal GAG-specific Enzyme</to_name>
    <to_code>T25147</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycosaminoglycan (GAG)-specific Enzyme</to_name>
    <to_code>T25150</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal GAG-specific Enzyme</to_name>
    <to_code>T25148</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal Glycosaminoglycan (GAG)-specific Enzyme</to_name>
    <to_code>T25149</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme</to_name>
    <to_code>T25151</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175823</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfatases [M0020759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>galsulfase [578033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elosulfase alfa [1489914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laronidase [392509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idursulfase [644101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Lysosomal enzyme (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</name>
  <code>C653785</code>  <id>653785</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal N-terminal Tripeptidyl Peptidase</to_name>
    <to_code>T25153</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tripeptidyl Peptidase I</to_name>
    <to_code>T25152</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase</to_name>
    <to_code>T25155</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tripeptidyl Peptidase-1</to_name>
    <to_code>T25154</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193414</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cerliponase alfa [1922436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Tripeptidyl-peptidase I (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tripeptidyl-Peptidase 1 [M000748625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</name>
  <code>C635241</code>  <id>635241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal Neutral Glycosphingolipid-specific Enzyme</to_name>
    <to_code>T25156</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme</to_name>
    <to_code>T25157</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175822</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>agalsidase beta [338817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Galactosidase [M0000793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegunigalsidase alfa [2637446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Lysosomal enzyme (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</name>
  <code>C652492</code>  <id>652492</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysozomal Triacylglycerol-specific Enzyme</to_name>
    <to_code>T25158</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme</to_name>
    <to_code>T25159</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192343</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebelipase alfa [1726975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Lysosomal enzyme (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydroxylase Activators [MoA]</name>
  <code>C650440</code>  <id>650440</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxylase Activators</to_name>
    <to_code>T25233</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190481</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hydroxylase Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</name>
  <code>C420</code>  <id>421</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HMG-CoA Reductase Inhibitors</to_name>
    <to_code>T25255</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors</to_name>
    <to_code>T25257</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HMG-CoA Reductase Inhibitor</to_name>
    <to_code>T25256</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000121</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin magnesium [2001252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin calcium [861640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin sodium [1944734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</name>
  <code>C635227</code>  <id>635227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors</to_name>
    <to_code>T25274</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175808</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists [MoA]</name>
  <code>C651595</code>  <id>651595</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Agonists</to_name>
    <to_code>T25522</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Cation Channel Agonists</to_name>
    <to_code>T25524</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cation Channel Agonists</to_name>
    <to_code>T25523</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists</to_name>
    <to_code>T25525</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Channel Agonists</to_name>
    <to_code>T25520</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCN Channel Agonists</to_name>
    <to_code>T25521</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191547</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</name>
  <code>C651594</code>  <id>651594</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cation Channel Antagonists</to_name>
    <to_code>T25529</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Channel Antagonists</to_name>
    <to_code>T25530</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists</to_name>
    <to_code>T25531</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCN Channel Antagonists</to_name>
    <to_code>T25526</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Cation Channel Antagonists</to_name>
    <to_code>T25528</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Antagonists</to_name>
    <to_code>T25527</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191546</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine hydrochloride [1649479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</name>
  <code>C651592</code>  <id>651592</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Channel Blocker</to_name>
    <to_code>T25535</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker</to_name>
    <to_code>T25537</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Blocker</to_name>
    <to_code>T25533</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cation Channel Blocker</to_name>
    <to_code>T25532</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCN Channel Blocker</to_name>
    <to_code>T25536</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Cation Channel Blocker</to_name>
    <to_code>T25534</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191544</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivabradine [1649480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with calcium channel blocker mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</name>
  <code>C651593</code>  <id>651593</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cation Channel Interactions</to_name>
    <to_code>T25539</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization Cyclic-Nucleotide Gated Ion Channel Interactions</to_name>
    <to_code>T25540</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions</to_name>
    <to_code>T25543</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HCN Channel Interactions</to_name>
    <to_code>T25538</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Cation Channel Interactions</to_name>
    <to_code>T25542</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>I(h) Channel Interactions</to_name>
    <to_code>T25541</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191545</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hyperpolarized Contrast Agent [EPC]</name>
  <code>C654309</code>  <id>654309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarized Contrast Agent</to_name>
    <to_code>T58913</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194089</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hyperpolarized Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xenon-129, hyperpolarized [2626220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hyperpolarized Contrast Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Magnetic resonance imaging contrast media (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarized Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypothalamic Endocrine Activity Alteration [PE]</name>
  <code>C28510</code>  <id>28511</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration</to_name>
    <to_code>T25706</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009072</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prolactin Inhibiting Factor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prolactin Releasing Factor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalamic Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyrotropin Releasing Hormone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypothalamic Hormone Receptor Agonists [MoA]</name>
  <code>C300378</code>  <id>300378</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Agonists</to_name>
    <to_code>T25707</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019993</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin acetate [236538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trelstar pamoate [905060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypothalamic Hormone Receptor Antagonists [MoA]</name>
  <code>C300379</code>  <id>300379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Antagonists</to_name>
    <to_code>T25708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019994</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abarelix [301739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypothalmic Hormone Interactions [MoA]</name>
  <code>C300377</code>  <id>300377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalmic Hormone Interactions</to_name>
    <to_code>T25718</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000019992</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalmic Hormone Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypothalmic Hormone Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypothalamic Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</name>
  <code>C654299</code>  <id>654299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors</to_name>
    <to_code>T58897</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIF PH Inhibitors</to_name>
    <to_code>T58898</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194079</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]</name>
  <code>C654220</code>  <id>654220</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia Inducible Factor- 2 alpha Inhibitors</to_name>
    <to_code>T58719</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIF-2α Inhibitors</to_name>
    <to_code>T58718</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor 2 alpha Inhibitors</to_name>
    <to_code>T58716</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIF-2 alpha Inhibitors</to_name>
    <to_code>T58717</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193998</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belzutifan [2567226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor Inhibitor [EPC]</name>
  <code>C654218</code>  <id>654218</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIF Inhibitor</to_name>
    <to_code>T58711</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Inhibitor</to_name>
    <to_code>T58710</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia Inducible Factor Inhibitor</to_name>
    <to_code>T58712</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193999</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belzutifan [2567226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor Inhibitors [MoA]</name>
  <code>C654219</code>  <id>654219</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIF Inhibitors</to_name>
    <to_code>T58714</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Inhibitors</to_name>
    <to_code>T58713</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia Inducible Factor Inhibitors</to_name>
    <to_code>T58715</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194000</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</name>
  <code>C654300</code>  <id>654300</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor</to_name>
    <to_code>T58899</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIF PH Inhibitor</to_name>
    <to_code>T58900</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194080</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vadadustat [2679296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daprodustat [2628210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>I [Preparations]</name>
  <code>C288635</code>  <id>288635</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>I [Preparations]</to_name>
    <to_code>T25763</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010591</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-6, human [1427163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon beta-1b [72257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idrocilamide [19729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-2b [5880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron succinyl milk protein complex [27825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated, A-H3N2 (A-Uruguay-716-2007) strain [805469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosorbide mononitrate [28004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imiquimod [59943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-Brisbane-10-2007 (H3N2)-like virus (A-Uruguay-716-2007 NYMC X-175C) strain [805520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iproniazid [5981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isothiazolinone [1811252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearate [1424880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixekizumab [1745099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipecac [5975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipodate sodium [9887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inula helenium root extract [1309723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipodate [5976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopulegol [1314235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl myristate [1809635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen [2380574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab-axxq [2266523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen [2180338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibutilide [41289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex aquifolium fruiting top extract [1486502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inositol [5833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iophendylate [5968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-1, beta [2176735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Isodon rubescens whole extract [1600738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin-like growth factor 2, human [1728769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamate [5970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixazomib citrate [1723734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indacaterol maleate [1114325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus antigen, Panama 2007-99 (H3N2) [1366997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ictasol [236850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inclisiran sodium [2588259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin lispro [86009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen [2564395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Imperatoria ostruthia root extract [1544247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immature Juglans regia fruit rind extract [1311047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomerized safflower acid [1596768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibrexafungerp [2560213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ifenprodil [27403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Indigofera tinctoria leaf extract [1607314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>incobotulinumtoxinA [1000104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indigotindisulfonate [325514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Hong Kong/259/2010 antigen [1801603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-2a [5879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen [2607735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inositol niacinate [27604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-8 [1426866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron,peptonized [235272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodoquinol [3435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin human, rDNA origin [631657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomalt [1363717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutane [1363040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamic acid I-125 [1546452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inclisiran [2588243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iotrolan [51474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoceteth-25 [1735325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 oxyquinoline [1314372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen [2056521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immature Citrus aurantium fruit extract [1372635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isododecane [1362913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inebilizumab-cdon [2373950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irinotecan hydrochloride [153329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron carbonyl [262150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea nil seed extract [1307600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isolan [1807442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iobenguane I-123 [1426748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl stearate [2118123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomyrtol [236265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin subcutaneous (human) - klhw [2196290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen [2630221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen [1794331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, regular, beef-pork [235275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inga alba bark extract [2480117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inosine [1483575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivermectin [6069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Isatis tinctoria whole extract [2282323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab-qbtx [2103476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl isobutyrate [1664340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007 (H1N1) strain [805549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iomeprol [2606484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Brisbane/46/2015 antigen [1942125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Issatchenkia orientalis whole extract [1804171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine I-131 [1546394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Illicium anisatum whole extract [1918046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>icatibant acetate [1294605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl isostearate [1363996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea batatas whole extract [2472777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium [1362699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Singapore/WUH4618/2021 antigen [2605725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris versicolor whole extract [1875234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, pork [1309342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium [7213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007, NYMC X-175C (H3N2) strain [857919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex aquifolium whole extract [2003324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indigo [1426889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris versicolor root extract [1333213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoamyl cinnamate [2046779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea purpurea top extract [1311612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulin G, human [1426680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosorbide [6057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosorbide dicaprylate [2002720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, prompt zinc, human [235285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus [1312375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopromide [27781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea mauritiana tuber extract [1312614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iohexol [5956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isodecyl salicylate [1872041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inert ingredients [748794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated B-Florida-4-2006 strain [805553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irinotecan liposomal [1719768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain [1005909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isotridecyl isononanoate [1307088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Panama/45/90 antigen [2262062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoniacinamide [1312616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indole [1311224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium bromide anhydrous [1445143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus, B Panama-45-90 hemmagglutinin antigen, inactivated [1313274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isometheptene [27946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/California/7/2009 (H1N1) antigen [1657331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoxaflutole [1371313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl ethylhexanoate [1368159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens balsamina flowering top extract [2594595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine-125 [253341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearamidopropyl morpholine lactate [1426452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen [2380834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indanazoline hydrochloride [292036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen [2561244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indeloxazine hydrochloride [1311672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoflurophate [6027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl palmitate [1939383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>icatibant [1148138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isotridecyl alcohol [2587641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron fumarate [486120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoaminile [27866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indomethacin [5781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen [1928290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Iowa/06/2017 antigen [2056523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, protamine zinc, beef-pork [314685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A-California-7-2009-(H1N1)v-like virus vaccine [864701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>invert sugar [27712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Imperata cylindrica root extract [1309433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iobitridol [87639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin degludec [1670007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>istradefylline [2199015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isothiazole [1495075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isavuconazonium [1608322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropamide [89784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iprindole [5979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoamyl cocoate [1607311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium bromide monohydrate [1309404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex aquifolium leaf extract [1307755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen [2686166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocorynoxeine [2562547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated, Influenza B (B-Florida-4-2006) strain [805471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indoramin [5784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodophors [596712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopanoate [637485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens glandulifera flower extract [1348452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodohippurate [314691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoproterenol sulfate [82031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodide ion I-131 [1546415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl behenate [1862103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, protamine zinc, human [236646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoambrettolide [2589803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibalizumab [2043283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin glulisine, human [400008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioxapine [1364410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen [1928528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropylphenylbutanal [2383935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoetharine [6023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoflupredone acetate [1364586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inamrinone [738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated, B-Florida-4-2006-like virus (B-Florida-4-2006) strain [805524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isodeceth-6 [1312615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iobenguane sulfate I-123 [1427223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>impacarzine [2367441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Perth/722/2024 (H3N2) antigen [2720359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex paraguariensis leaf extract [1305743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inosinic acid [5832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen [2280296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen [2645084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoamyl laurate [1313238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoflurane [6026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropylphthalimide [1484281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin intravenous (human) - kthm [2726012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irinotecan hydrochloride liposome [1719767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Washington/19/2020 (H1N1) antigen [2562554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobornyl methacrylate [1491001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex pedunculosa whole extract [1372636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidazole-2-hydroxybenzoate [27438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipramine pamoate [91118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen [2641877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imlunestrant [2725912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imdazole [2465734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-12 [1309680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin intravenous (human) - stwk [2672094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodoxamid [51471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin glargine [274783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen [2717943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin subcutaneous (human) - hipp [2167145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulin M, human [1314195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon gamma-1a [1314240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamic acid [1546451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropylbenzyl salicylate [1366670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron [90176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isorhynchophylline [2562548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ifenprodil tartrate [289912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Switzerland/3330/2017 (H1N1) antigen [2198896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulin A, human [1426842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Washington/02/2019 antigen [2280293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosulfan blue inner salt [1546453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl acetate [1599636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isotretinoin [6064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopanoate sodium [340398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoeugenyl benzyl ether, (Z)- [2467141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearamidopropyl ethyldimonium ethosulfate [1803005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indocyanine green acid form [2199577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixabepilone [337523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoceteth 20 [1368878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipilimumab [1094833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl myristate [27985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen [1666425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioxilan [27793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl isobutyrate [1429933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen [2688113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isatuximab [2282018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Irvingia gabonensis seed butter extract [1364403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl alcohol [1368191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearamidopropyl dimethylamine [2697439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain [1005929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoascorbic acid [1356145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen [2687714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen [2719300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Austria/1359417/2021 antigen [2605039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indomethacin sodium trihydrate [258329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iloprost [40138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isotachysterol 3 [2673866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idecabtagene vicleucel [2536430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodohippurate I123 sodium [91551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris missouriensis whole extract [2539934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea pes-caprae flowering top extract [1421627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin isophane, pork [221108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imetelstat [2685236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearoyl lactylate [1370616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl alcohol [797541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivosidenib [2049873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imlunestrant tosylate [2725911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin argine [1740938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imiglucerase [84959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen [1801767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isatuximab-irfc [2282019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Indian wormwood sage pollen extract [1006495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens capensis leaf extract [2678350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Live Attenuated, A-Uruguay -716-2007 (H3N2) (A-Brisbane-10-2007-like) strain [805539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Phuket/3073/2013 antigen [1657228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isodecyl isononanoate [1495073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idarucizumab [1716191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated [1427019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen [1664339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indeloxazine [1311673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioxaglic acid [1426458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 chloride [42987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indobufen [27518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idarubicin [5650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isethionic acid [1364896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Michigan/01/2021 antigen [2593400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-1 alpha [2176733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isodecyl alcohol [2361827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isometheptene mucate (1:1) [317238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl laurate [1363434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin aspart-szjj [2705729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ilomastat [1368877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-iodo-2-propynol [2465830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iocetamic acid [183830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Indonesia/05/2005 (H5N1) antigen [1869634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-12, human [1318050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>intramuscular immunoglobulin [108067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutyramide [1653517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulin G [5666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioxaglate [5973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ichthammol [5645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium [1549118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/California/122/2022 (H3N2) antigen [2675569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Texas/50/2012 (H3N2) antigen [1663630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Irvingia gabonensis seed extract [1307570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus (H5N1) antigen [1804260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-icosapentoyl-sn-glycero-3-phosphoserine [1549117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin intravenous (human) - dira [2706382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ispaghula extract [82089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoeicosane [1313241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon gamma-1b [5882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea digitata root extract [2590649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indomethacin sodium [1294612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus vaccine, B-Massachusetts-2-2012-like virus, recombinant [1442194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen [1657222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron sucrose [24909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Isodon rubescens top extract [1488815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoflupredone [1546449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iprazochrome [51486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea purpurea seed extract [1371910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen [1928289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibuprofen [5640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indanazoline [27492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indapamide [5764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodide ion [1546275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iminodisuccinate [1366938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indinavir sulfate [203153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iobenguane I-131 [2053281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibalizumab-uiyk [2043313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen [2177291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoniazid [6038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iberis amara seed extract [1309960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodixanol [27729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens walleriana whole extract [2684980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen [1666421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indacaterol [1114326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopanoic acid [5967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inonotus obliquus whole extract [2001814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibutamoren [1805438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin intravenous (human) - slra [2123035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidapril hydrochloride [259335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin lispro protamine, human [314684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>icariin [1788871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isradipine [33910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropamide iodide [6051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-3 [1311225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibandronate [115264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin isophane, human [253181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-11 [1311380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus antigen [1657134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoxsuprine [6066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen [2388136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indol-3-yl sodium phosphate [2469249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioversol [27792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, prompt zinc, beef-pork [235283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007 (H3N2) (A-Brisbane-10-2007-like) strain [805551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoproterenol [6054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus [1427020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inebilizumab [2373951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ilunocitinib [2693414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens balsamina leaf extract [1358478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isodecyl laurate [1441186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inula helnium whole extract [2471870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, regular, beef [314686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab-dyyb [1790539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>itraconazole [28031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen [2562553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Live Attenuated, A-South Dakota-6-2007 (H1N1) (A-Brisbane-59-2007-like) strain [805537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodohippurate I131 sodium [91540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris germanica root extract [1309752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosteareth-5 [2048888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodate ion [1546442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indican [2463933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen [1657127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-n3 [612937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-3n,human leukocyte derived [314687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodide ion I-123 [1361657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen [2379530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocarboxazid [6011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutylparaben [1364296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, regular, human [253182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropanolamine lauryl sulfate [1731735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodide I-125 [1546266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidacloprid [1251576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidocarb dipropionate [1740238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl linoleate [1605701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipriflavone [51487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon gamma, porcine recombinant [1421647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 pentetreotide [1724429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoconazole nitrate [203157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, protamine zinc, pork [235279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium cation [1546373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin glargine-aglr [2589006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indigo carmine [227312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopentane [1368703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfacon-1 [59744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inavolisib [2695422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl lauroyl sarcosinate [1427226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoamyl acetate [1368172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin aspart-xjhz [2720519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioflupane I-123 [1426874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibutilide fumarate [51256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoetharine mesylate [6024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007, IVR-148 (H1N1) strain [857917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain [1005931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl myristate [1313239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus (H3N2) antigen [1657131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, regular, pork [221109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron protein succinylate [27823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropanolamine [1736006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron polysaccharide [219315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidazolidinone [2565925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidapril [60245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inamrinone lactate [91236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens glandulifera whole extract [1801505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutyl stearate [1489927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain [1116738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulin A [1426454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus antigen, Hong Kong 330-2001 [1366998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Hubei Wujigang/158/2009/antigen [1664172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl stearoyl stearate [1366671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens balsamina flower extract [1549225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin isophane, beef-pork [317598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 pentetate disodium [259268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Brisbane/9/2014 antigen [1723997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearamidopropyl epoxypropyl dimonium chloride [2380831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine-131-tositumomab [234449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inga edulis seed extract [1420970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibandronate sodium [236916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-isobutyl-4-methyltetrahydropyran-4-ol [1725033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus vaccine, B-Massachusetts-2-2012-like virus [1427022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopentyldiol [1314276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idelalisib [1544460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indinavir anhydrous [1546024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin isophane, beef [317235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isodecyl neopentanoate [1307092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron sorbitex [27824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iloperidone [73178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen [2180337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoproterenol hydrochloride [82030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioxaglate meglumine [66895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irbesartan [83818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoamyl butyrate [1314272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indocyanine green [5775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens balsamina whole extract [1875610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-10 [1311299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen [2380835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearic diethanolamide [1436959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium cation In-111 [1546281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl palmitate [1311179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidocarb [1740237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomaltulose anhydrous [2607147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocyclocitral [2467134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl ethylimidazolinium ethosulfate [2056455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, prompt zinc, beef [235284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibuprofen, sodium salt [1429044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-1, beta, human [2176734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibuprofen lysine [36761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl hydroxystearate [1373445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamate sodium I125 [91537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin-like growth factor 2 [1728770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen [2562555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Live Attenuated, B-Brisbane-60-2008 strain [857953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated, A-H1N1 (A-Brisbane-59-2007) strain [805467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inotuzumab ozogamicin [1942950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen [2048564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin intravenous (human) - ifas [2102433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopamidol [5966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipramine hydrochloride [150816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen [2380837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isavuconazole [1720882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-iodo-2-propynylbutylcarbamate [1426467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipramine [5691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imdevimab [2465249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inonotus obliquus fruiting body extract [1311610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoceteth-10 [1369683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ingenol mebutate [1242806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imatinib [282388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobornyl acetate [2398330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomethyleugenol [1423782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon type II [5885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibopamine [51253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl alcohol [1362928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imetelstat sodium [2685237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus vaccine, B-Texas-6-2011, inactivated [1304278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-n1 [202912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indigotindisulfonic acid [1546441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen [2642276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoprene [1364275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immature Citrus sinensis fruit extract [1539815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex pubescens root extract [1309432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen [1657130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen [2708995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris domestica root extract [1722034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isavuconazonium sulfate [1608321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine I-120 [1492441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isospaglumic acid [236303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixazomib [1723735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl maleate [1426623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex paraguariensis whole extract [1368377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoxsuprine hydrochloride [82033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodoform [27748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>intrinsic factor concentrate [91500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl sebacate [2606777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibopamine hydrochloride [284157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoconazole [27901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen [2056525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl ferulate [2105548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, protamine zinc, beef [235278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imatinib mesylate [284924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isothipendyl [28012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Indigofera tinctoria whole extract [1735324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immune globulin subcutaneous (human) [617615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Utah/9/2014 antigen [1657133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon-beta [4381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris pallida root extract [1309832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain [1005911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin glargine-yfgn [2563969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inula racemosa root extract [2688454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-12, human recombinant [1328172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon beta-1a [75917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen [1663632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Isatis tinctoria root extract [1307808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen [1946964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibritumomab tiuxetan [262323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl unoprostone [135313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus [1541617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iso-sulfan blue [27863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium-111 [90540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen [2479040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iscotrizinol [2602134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Victoria/705/2018 antigen [2380575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Maryland/15/2016 antigen [2048563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inotersen sodium [2099290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetane [1987477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl linoleate [1484858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomaltitol [2600777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Colorado/06/2017 antigen [2054177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoetharine hydrochloride [102397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-5 [1367184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodamide [5928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Live Attenuated, B-Florida-4-2006 strain [805541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inosine pranobex [6048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus (H1N1) antigen [1657128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-9 [1309465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutylene [2099712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ifosfamide [5657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3&apos;-iminodi-benzoic acid [2588486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ipratropium bromide [203212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamate meglumine [5971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain [1006250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isolaureth-10 [1869585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Italian rye grass pollen extract [1014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibrutinib [1442981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irinotecan [51499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioxaglate sodium [66896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin aspart, human [51428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipenem monohydrate [2184135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosorbide dinitrate [6058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidazole [2472898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin lispro-aabc [2376838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibutamoren mesylate [1805437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idebenone [51296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex cornuta whole extract [2684979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus vaccine, B-Massachusetts-2-2012 BX-51B, inactivated [1428984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobornyl acrylate [1603858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-iodobenzylguanidine [14448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen [2641622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus [1312376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl isostearate [1314415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indole-3-carbinol [2598119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl behenate [1356483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-4 [5891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin isophane [1605101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>intrinsic factor [5920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodinated glycerol [27723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl neopentanoate [1314848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl stearate [1312620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibandronic acid [115265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl stearate [1313240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iva angustifolia whole extract [2590650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isothipendyl hydrochloride [235726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibrexafungerp citrate [2560215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine bush pollen extract [851894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocetyl isostearate [2623403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indoramin hydrochloride [235773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ilex aquifolium flowering top extract [1309961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodipamide [5936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopentol [27779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioflupane [2571854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutyl acetate [1603476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, prompt zinc, pork [235286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus vaccine B/Brisbane/60/2008 antigen [857921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine povacrylex [692863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iptacopan [2671061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus [1304122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>icosapent ethyl [1304974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivabradine hydrochloride [1649479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoamyl salicylate [1940006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosteareth-20 [1652251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris tenax extract [1666105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen [2379531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropyl titanium triisostearate [1356144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ispaghula husk [104129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab [191831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen [1664171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-iodo-1-propanol [1435281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idarubicin hydrochloride [82124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoeugenyl acetate [2393779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab-abda [1927283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ipomoea purga root extract [1309706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl lactate [1657014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron bile salts [235376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-6 [1367185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearyl palmitate [1368901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isophorone diisocyanate [2626882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iota-carrageenan [2565488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen [2380836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iresine calea extract [1441322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isomaltulose [2607148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris germanica extract [1428843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipenem anhydrous [1545986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inulin lauryl carbamate [2611696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isometheptene mucate [104994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>IR-3535 [1737733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris germanica var. florentina root extract [1993233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indinavir [114289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivacaftor [1243041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen [1657224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen [1804259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idoxuridine [5653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin aspart protamine, human [352385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Illicium difengpi bark extract [2370870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isostearic acid [1424879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron-dextran complex [5992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen [2694005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imepitoin [2600779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inulin [5924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoeugenol [1363706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iridium [1311131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isononyl isononanoate [1367167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoleucine [6033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-n1 lymphoblastoid [261717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ilodecakin [2604685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidurea [1368885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris domestica whole extract [1492938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iptacopan hydrochloride [2671062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isopropylparaben [1368879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idursulfase [644101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivabradine [1649480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen [2177290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isobutyl alcohol [1363048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Impatiens irvingii whole extract [2675297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A-B virus immunoserum rabbit [1344642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin detemir [139825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Darwin/7/2019 antigen [2380838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inotersen [2099289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imperialine [1860087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interleukin-7 [1367202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>icodextrin [140480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infigratinib [2550729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>immunoglobulins, intravenous [42386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Inula helenium extract [2174793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus vaccine, B-Wisconsin-1-2010-like virus [1303855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine [5933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>I [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipenem [5690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>IgE-directed Antibody Interactions [MoA]</name>
  <code>C635211</code>  <id>635211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>IgE-directed Antibody Interactions</to_name>
    <to_code>T26054</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175792</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab-igec [2725997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>IgE-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab [302379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>IgE-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicilloyl polylysine [2667743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>IgE-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ileal Bile Acid Transporter Inhibitor [EPC]</name>
  <code>C654181</code>  <id>654181</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Apical Sodium Bile Acid Transporter Inhibitor</to_name>
    <to_code>T58629</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IBAT Inhibitor</to_name>
    <to_code>T58631</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ASBT Inhibitor</to_name>
    <to_code>T58630</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitor</to_name>
    <to_code>T58628</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Sodium Bile Acid Cotransporter Inhibitor</to_name>
    <to_code>T58632</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193957</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ileal Bile Acid Transporter Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ileal Bile Acid Transporter Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maralixibat [2571074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ileal Bile Acid Transporter Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>odevixibat [2563966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ileal Bile Acid Transporter Inhibitors [MoA]</name>
  <code>C654182</code>  <id>654182</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Sodium Bile Acid Cotransporter Inhibitors</to_name>
    <to_code>T58637</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors</to_name>
    <to_code>T58633</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ASBT Inhibitors</to_name>
    <to_code>T58635</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Apical Sodium Bile Acid Transporter Inhibitors</to_name>
    <to_code>T58634</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IBAT Inhibitors</to_name>
    <to_code>T58636</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193958</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat [2563966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat chloride [2571073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat [2571074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat sesquihydrate [2563978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Imaging Agent [APC]</name>
  <code>C654095</code>  <id>654095</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Agent</to_name>
    <to_code>T58505</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193875</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Dye [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Paramagnetic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiographic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarized Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Contrast Agent for Ultrasound Imaging [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhalation Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Imaging Contrast Activity [MoA]</name>
  <code>C31872</code>  <id>31873</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity</to_name>
    <to_code>T26070</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010257</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Contrast Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluorescence Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Contrast Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Contrast Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Imaging Contrast Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopamidol [5966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate sodium [66896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurpiridaz [2700763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodixanol [27729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafolacianine sodium [2586858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate [5973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurpiridaz F-18 [2700762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate [5970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein [25138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129, hyperpolarized [2626220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethiodized oil [4125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat [2556617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine iodipamide [29456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate meglumine [66895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafolacianine [2586857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iothalamate [9886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate [3319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopromide [27781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat F-18 [2556616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate meglumine [3320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioversol [27792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate lysine [236477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodipamide [5936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxilan [27793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iohexol [5956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate sodium I125 [91537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopiclenol [2618720]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate sodium [3321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium sulfate [1331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein sodium [57789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglic acid [1426458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate meglumine [5971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129 [2626219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunoglobulin G [EPC]</name>
  <code>C643898</code>  <id>643898</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunoglobulin G</to_name>
    <to_code>T26181</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184163</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymocyte immunoglobulin, equine [1427177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lymphocyte immune globulin, anti-thymocyte globulin, equine [91601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ovine digoxin immune fab [1745257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Immunoglobulin G (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit anti-human T-lymphocyte globulin [107044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoglobulins [M0011122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunoglobulin G [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunoglobulin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologic Activity Alteration [PE]</name>
  <code>C28512</code>  <id>28513</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration</to_name>
    <to_code>T26298</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009073</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Degradation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Production Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat&apos;s claw preparation [285223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir sodium [2475076]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leflunomide [27169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilonacept [763450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idecabtagene vicleucel [2536430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamlanivimab [2463114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexucabtagene autoleucel [2387277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilobelimab [2639620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologic Adjuvants [MoA]</name>
  <code>C448</code>  <id>449</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Adjuvants, Immunologic</to_name>
    <to_code>T26299</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants</to_name>
    <to_code>T26300</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000135</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 1 [214485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Montreal strain [314513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer acetate [84375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein [2624741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diptheria toxoid absorbed [1657601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid adsorbed [235600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies immune globulin, human [89886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole phosphate [1535214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acemannan [1426875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antirabies serum,equine [485234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus envelope glycoprotein [2624742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole [6371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole hydrochloride [227227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Adjuvants [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologic Agent [APC]</name>
  <code>C654127</code>  <id>654127</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Agent</to_name>
    <to_code>T58529</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193902</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IgE [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B Lymphocyte Stimulator-specific Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematopoietic Stem Cell Mobilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcineurin Inhibitor Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunoglobulin G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Chimeric Antigen Receptor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD33-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD30-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Claudin 18.2-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cellular Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD20-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoclonal Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon beta [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD4-directed Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BCL-2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Autologous T Cells [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD22-directed Immunoconjugate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunoglobulin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alpha [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologic Factor Interactions [MoA]</name>
  <code>C342</code>  <id>343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions</to_name>
    <to_code>T26306</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000082</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Biological Response Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral and Cellular Immune Response Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement Inactivators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion extract [1370469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lyme Disease Vaccine [214177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat germ oil [72385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen vaccine [797752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus arrhizus allergenic extract [314443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hemophilus B polysaccharide [314656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk phospholipids [314605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazolidinylurea [1310602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus preparation [1312384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben sodium [1311574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley seed oil [1309236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil [1309229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bronopol [1114345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus [1365969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidurea [1368885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat bran extract [1427046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hepatitis A Vaccine, Inactivated [253174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat dextrin [637366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichothecium roseum allergenic extract [968426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b [50937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben [34706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben calcium [1867698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry juice [1307717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme preparation [319823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean lecithin [579598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy protein isolate [196238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform L), recombinant [2588217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 3, human [11131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoamphodiacetate [1364462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat bran [253190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans allergenic extract [214355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Soy Proteins [36853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanolin alcohols [1426478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet pollen extract [852132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform M), recombinant [2588218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust allergenic extract [852519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologic and Biological Factor Interactions [MoA]</name>
  <code>C686</code>  <id>687</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic and Biological Factor Interactions</to_name>
    <to_code>T26307</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000254</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Capsid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Surface Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologic and Biological Factor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cellular Structure Molecule Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic and Biological Factor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunological Agents [TC]</name>
  <code>C654058</code>  <id>654058</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents</to_name>
    <to_code>T58436</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193837</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab-bcmm [2644881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efbemalenograstim alfa [2670630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Iowa/06/2017 antigen [2056523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab [2204915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen [1928290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic processed thymus tissue-agdc [2626459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Yellow Fever Vaccine [89890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate [265323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofatumumab [712566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen [2380834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen [2561244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain [1005909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Panama/45/90 antigen [2262062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab [2663938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live vaccinia virus [833079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/7/2009 (H1N1) antigen [1657331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab [2619313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, attenuated Schwarz strain [2603499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated B-Florida-4-2006 strain [805553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab [2668041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007, NYMC X-175C (H3N2) strain [857919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic processed thymus tissue [2626460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G, human [1426680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle [1601236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/WUH4618/2021 antigen [2605725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec [2641675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies immune globulin, human [89886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/46/2015 antigen [1942125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegcetacoplan [2557372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen vaccine [797752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec-svdt [2637757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab-bbfg [2663939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Montreal strain [314513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab [302379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen [1794331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow fever virus strain 17D-204 live antigen [804187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hemophilus B polysaccharide [314656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007 (H1N1) strain [805549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cholera Vaccine [2427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Smallpox Vaccine [9835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - klhw [2196290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen [2630221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Measles Vaccine [6669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil mesylate [2565692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen [2056521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab-cdon [2373950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aducanumab-avwa [2557218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid adsorbed [235600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen [2607735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belinostat [1543543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerandomilast [2725523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hong Kong/259/2010 antigen [1801603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 [2707120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab-lzsg [2104603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab-igec [2725997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen [2564395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E, recombinant [1986820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen [2380574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen [2180338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib tosylate [2641596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine [2686926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab [2644880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab [2107301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec-vncg [2644435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein [2624741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etranacogene dezaparvovec-drlb [2626768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-Brisbane-10-2007 (H3N2)-like virus (A-Uruguay-716-2007 NYMC X-175C) strain [805520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib [2641595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixekizumab [1745099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec [2637758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 7 vaccine live [1099937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab-actl [2619312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360571]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elivaldogene autotemcel [2612527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated, A-H3N2 (A-Uruguay-716-2007) strain [805469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) [2691192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G [5666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab-bkzx [2668080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod hydrochloride [1012891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aagh [2706334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etranacogene dezaparvovec [2626727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/122/2022 (H3N2) antigen [2675569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group Y [314725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib phosphate [2716557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Phuket/3073/2013 antigen [1657228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen [1664339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform S), recombinant [2588219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Michigan/01/2021 antigen [2593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basiliximab [196102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon beta-1a [1546168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus [1491862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Live Attenuated, A-Uruguay -716-2007 (H3N2) (A-Brisbane-10-2007-like) strain [805539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab [2686619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster immune globulin [39385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab-rwlc [2058825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarilumab [1923319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriflunomide [1310520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen [1801767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab-tmca [2262421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen [2687714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen [2719300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized [2642139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Austria/1359417/2021 antigen [2605039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obecabtagene autoleucel [2698195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idecabtagene vicleucel [2536430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quercetin [9060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen [1601231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod [1012892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen [2688113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voclosporin [2475166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab-jome [2591415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept [2262544]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain [1005929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab-cqyv [2619425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen [1666425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Washington/02/2019 antigen [2280293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertussis vaccine [8080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine, inactivated [845525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus B serotype 7 strain 55142 [1802483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - hipp [2167145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab [2104604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen [2717943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 2 [2197291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anthrax Vaccine Adsorbed [404774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - kthm [2726012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2 [1722701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen [2641877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen [2562554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group B vaccine [1593128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - stwk [2672094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein [2636589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen [2720359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen [2280296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen [2645084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aducanumab [2557217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belatacept [1112973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L-rknd [2700764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen [1928528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2, equine [1722704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab [2591404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated, B-Florida-4-2006-like virus (B-Florida-4-2006) strain [805524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab [1876366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab-ilto [2691309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rubella virus vaccine [9486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen [1601232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab-cfor [2716803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated, Influenza B (B-Florida-4-2006) strain [805471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen [1593130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab [2262279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemivibart [2677789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated [1300182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 1 [2197290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, recombinant [2636588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab-cwvz [2107316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group W-135 [314724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen [2686166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carfilzomib [1302966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec-rokl [2641674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen [2642276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab-sbzo [2610418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - ifas [2102433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen [2380837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized [2642138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella typhi Ty21a live antigen [762595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus [1427211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponesimod [2532300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen [2562555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated, A-H1N1 (A-Brisbane-59-2007) strain [805467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Live Attenuated, B-Brisbane-60-2008 strain [857953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin, human [1722335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen [2048564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L [2700765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raxibacumab [1366567]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster immune globulin (human) [485576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen [2380835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ROTAVIRUS VACCINE, LIVE [253199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) [2664725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab-trbw [2274802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2, equine [1722702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen [2180337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efalizumab [356988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis toxoid vaccine, inactivated [1300186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab [2716802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secukinumab [1599788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PERTUSSIS VACCINE,ADSORBED [402543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab [2626349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diptheria toxoid absorbed [1657601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab [2619426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2, equine [1722706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin, human [1997443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer acetate [84375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepolizumab [1720597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab-asmn [2053449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain [1116738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, RIT-4385 strain [2603501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen [1664172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acellular pertussis vaccine, inactivated [798302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2 [1722697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/9/2014 antigen [1723997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated [1300180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec [2644436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007, IVR-148 (H1N1) strain [857917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen [1427171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopapogene imadenovec [2723361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H3N2) antigen [1657131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab [2053436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab [2565265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform M), recombinant [2588218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan [2672489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen [1657127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine [2686924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2, equine [1722683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n3 [612937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen [2379530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007 (H3N2) (A-Brisbane-10-2007-like) strain [805551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen [2388136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab [2373951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus [1427020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efbemalenograstim alfa-vuxw [2670656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Live Attenuated, A-South Dakota-6-2007 (H1N1) (A-Brisbane-59-2007-like) strain [805537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen [2562553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - slra [2123035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilonacept [763450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group A polysaccharide [29501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vibrio cholerae CVD 103-HGR strain live antigen [1812935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus antigen [1657134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen [2177291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen [1666421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine flury-lep strain [830457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform L), recombinant [2588217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab [2610417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen [1928289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2 [1722703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 [2606073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab-xiiy [2626348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen [1663630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) [2610243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E2 [2707122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - dira [2706382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogenic bone-marrow-derived mesenchymal stem cells [2700761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen [1657222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus envelope glycoprotein [2624742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 [2688626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mumps Vaccine [763656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b [50937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan hydrochloride [2671062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) [2610326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen [2177290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulism immune globulin IV human [544488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Darwin/7/2019 antigen [2380838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab [591781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein [2606074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab-fnia [2565276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2, equine [1722698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 capsid protein [2707119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus [1365969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciltacabtagene autoleucel [2594775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E [1986821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab-dbll [2204916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopapogene imadenovec-drba [2723360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit anti-human T-lymphocyte globulin [107044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hepatitis A Vaccine, Inactivated [253174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen [1657224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen [2694005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen [2380836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib phosphate [2633006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2 [1722684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen [1664171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen [2379531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab-sztn [2725169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2, equine [1722696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen [1593127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lyme Disease Vaccine [214177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) [2691168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan [2671061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aeeb [2706347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group C polysaccharide [29503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept-aamt [2262543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [798279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin acetate [2569090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) [2664825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obiltoxaximab [1746906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen [2641622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2 [1722705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 11 vaccine [798262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 4 vaccine live [1099933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 [2666309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab-ocsq [2693449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 3 [2197292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED [235574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin [22178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belimumab [1092437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2 [1722699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, recombinant Senegal strain 37997 envelope protein E1 [2707121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod lauryl sulfate [2610292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain [1006250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Live Attenuated, B-Florida-4-2006 strain [805541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin [1722336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H1N1) antigen [1657128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2 [1722707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Victoria/705/2018 antigen [2380575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen [2479040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan sodium [2672492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Maryland/15/2016 antigen [2048563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis pertactin vaccine, inactivated [1300184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Colorado/06/2017 antigen [2054177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 4 [2197293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen [1946964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen [1663632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B immune globulin [26744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2, equine [1722700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chikungunya virus antigen, live attenuated LR2006 OPY1 strain [2673238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Utah/9/2014 antigen [1657133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) [617615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen [1601233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vedolizumab [1538097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen [2056525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen [1657130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belzutifan [2567226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab [2274803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siltuximab [1535218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab-akkz [2686620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live, New York City Board of Health vaccinia strain [798467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen [2708995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 3, human [11131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tick-borne encephalitis purified antigen [2583637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil [2564025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologically Active Molecule Activity Alteration [PE]</name>
  <code>C28514</code>  <id>28515</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration</to_name>
    <to_code>T26308</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009074</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologically Active Molecule Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologically Active Molecule Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n3 [612937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologically Active Molecule Degradation Alteration [PE]</name>
  <code>C28516</code>  <id>28517</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Degradation Alteration</to_name>
    <to_code>T26309</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009075</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologically Active Molecule Degradation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologically Active Molecule Degradation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunologically Active Molecule Production Alteration [PE]</name>
  <code>C28518</code>  <id>28519</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologically Active Molecule Production Alteration</to_name>
    <to_code>T26310</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009076</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologically Active Molecule Production Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunologically Active Molecule Production Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Immunotherapy [APC]</name>
  <code>C654290</code>  <id>654290</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunotherapy</to_name>
    <to_code>T58885</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194070</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunotherapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cellular Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunotherapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Processed Thymus Tissue-based Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Immunotherapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Bordetella Pertussis Vaccine [EPC]</name>
  <code>C643528</code>  <id>643528</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Bordetella Pertussis Vaccine</to_name>
    <to_code>T26333</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183896</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis toxoid vaccine, inactivated [1300186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis fimbriae 2/3 vaccine, inactivated [1300182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis filamentous hemagglutinin vaccine, inactivated [1300180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bordetella pertussis pertactin vaccine, inactivated [1300184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Bordetella Pertussis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pertussis Vaccine [M0016424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Bordetella pertussis antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Bordetella Pertussis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Clostridium Tetani Vaccine [EPC]</name>
  <code>C643532</code>  <id>643532</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Clostridium Tetani Vaccine</to_name>
    <to_code>T26334</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183900</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus Toxoid [M0021204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Clostridium Tetani Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetanus toxoid vaccine, inactivated [798306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Clostridium tetani antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Clostridium Tetani Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</name>
  <code>C643519</code>  <id>643519</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Corynebacterium Diphtheriae Vaccine</to_name>
    <to_code>T26335</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183887</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria Toxoid [M0006523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphtheria toxoid vaccine, inactivated [798304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Corynebacterium diphtheriae antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</name>
  <code>C643520</code>  <id>643520</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Haemophilus Influenzae B Vaccine</to_name>
    <to_code>T26336</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183888</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Vaccines [M0027264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine [798444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Haemophilus influenzae type b antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Hepatitis A Virus Vaccine [EPC]</name>
  <code>C643521</code>  <id>643521</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Hepatitis A Virus Vaccine</to_name>
    <to_code>T26337</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183889</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis A Vaccines [M0357587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis A Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Hepatitis A virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Hepatitis A Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Hepatitis B Virus Vaccine [EPC]</name>
  <code>C643522</code>  <id>643522</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Hepatitis B Virus Vaccine</to_name>
    <to_code>T26338</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183890</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B surface antigen vaccine [797752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen [1427171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B Vaccines [M0026310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Hepatitis B Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Hepatitis B virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Hepatitis B Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Human Papillomavirus Vaccine [EPC]</name>
  <code>C643523</code>  <id>643523</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Human Papillomavirus Vaccine</to_name>
    <to_code>T26339</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183891</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Papillomavirus Vaccines [M0498157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 16 vaccine [798264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 6 vaccine [798268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 11 vaccine [798262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Human Papillomavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 18 vaccine [798266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing human papillomavirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Human Papillomavirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Influenza A Virus Vaccine [EPC]</name>
  <code>C643524</code>  <id>643524</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Influenza A Virus Vaccine</to_name>
    <to_code>T26340</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183892</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza A virus A/Vietnam/1203/2004 (H5N1) antigen [1804259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza Vaccines [M0011310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Influenza A virus vaccine, A-California-7-2009 X-181 (H1N1), Inactivated [1303850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing influenza virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Influenza A Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Influenza B Virus Vaccine [EPC]</name>
  <code>C643525</code>  <id>643525</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Influenza B Virus Vaccine</to_name>
    <to_code>T26341</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183893</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Influenza B Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza Vaccines [M0011310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing influenza virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Influenza B Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</name>
  <code>C643526</code>  <id>643526</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Japanese Encephalitis Virus Vaccine</to_name>
    <to_code>T26342</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183894</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Japanese Encephalitis Vaccines [M0357284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Japanese encephalitis virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Meningococcal Vaccine [EPC]</name>
  <code>C643527</code>  <id>643527</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Meningococcal Vaccine</to_name>
    <to_code>T26343</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183895</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meningococcal group A polysaccharide [29501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Vaccines [M0357647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Meningococcal Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meningococcal group A polysaccharide [M0127318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Neisseria meningitidis antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Meningococcal Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Pneumococcal Vaccine [EPC]</name>
  <code>C643529</code>  <id>643529</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Pneumococcal Vaccine</to_name>
    <to_code>T26344</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183897</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Vaccines [M0357124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Pneumococcal Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Streptococcus pneumoniae antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Pneumococcal Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Poliovirus Vaccine [EPC]</name>
  <code>C643530</code>  <id>643530</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Poliovirus Vaccine</to_name>
    <to_code>T26345</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183898</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poliovirus Vaccines [M0361653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Poliovirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Human poliovirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Poliovirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Rabies Virus Vaccine [EPC]</name>
  <code>C643531</code>  <id>643531</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Rabies Virus Vaccine</to_name>
    <to_code>T26346</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183899</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rabies Vaccines [M0018367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Rabies Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabies virus vaccine flury-lep strain [830457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Rabies lyssavirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Rabies Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Salmonella Typhi Vaccine [EPC]</name>
  <code>C643533</code>  <id>643533</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Salmonella Typhi Vaccine</to_name>
    <to_code>T26347</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183901</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Typhoid [M0022188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vi polysaccharide vaccine, typhoid [M0161214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Salmonella Typhi Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactivated Yersinia Pestis Vaccine [EPC]</name>
  <code>C643534</code>  <id>643534</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Yersinia Pestis Vaccine</to_name>
    <to_code>T26348</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183902</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Yersinia Pestis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague Vaccine [M0016950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactivated Yersinia Pestis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Yersinia pestis antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Yersinia Pestis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inactive Preparations by FDA Established Pharmacologic Class</name>
  <code>C654093</code>  <id>654093</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactive Preparations by FDA Established Pharmacologic Class</to_name>
    <to_code>T58503</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193876</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Releasing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein-Trypsin Inactivator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autologous Cultured Cell [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Antithrombin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleotide Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Galactosidase A Pharmacological Chaperone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Activated Protein C [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Interferon beta [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype G [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Butyrophenone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteolytic Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor-directed Cytotoxin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thioxanthene [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoglycoside [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bovine Intestinal Adenosine Deaminase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intraocular Irrigating Solution [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodinated Contrast Agent for Radiographic Imaging [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype E [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Secretion Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Oncolytic Viral Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Protease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-4 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Exchange Resin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Opener [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitroimidazole [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cephamycin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multivitamin Preparation [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype B [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Streptogramin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoiesis Stimulating Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype F [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lincosamide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Resorption Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD2-directed LFA-3/Fc Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Yersinia Pestis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Mumps Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Locally-acting Aminosalicylate [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blocking Agent for Diagnostic Imaging [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD3 Blocker Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype C [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Death Inducer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza Neuraminidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human CTLA-4 and Fc-IgG1 Recombinant Fusion Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD11a-directed Humanized IgG1 Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Lightening Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Anticoagulant Protein [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Analgesic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Natriuretic Peptide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Supplement [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Narcotic Antitussive [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype D [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Binding Resin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Virus Vector [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Equine Botulinum Antitoxin, Serotype A [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Influenza A Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytidine Deaminase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Megakaryocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inactive Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetaminophen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increase Spermatogenesis [PE]</name>
  <code>C28520</code>  <id>28521</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increase Spermatogenesis</to_name>
    <to_code>T26361</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009077</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increase Spermatogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increase Spermatogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increase Spermatogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increase Spermatogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Acetylcholine Activity [PE]</name>
  <code>C28524</code>  <id>28525</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity</to_name>
    <to_code>T26362</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009079</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine hydrochloride [50676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine [50675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium [623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium chloride [624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine [2690627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malathion [6606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine gluconate [2690626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Adhesion Factor Activity [PE]</name>
  <code>C28526</code>  <id>28527</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Activity</to_name>
    <to_code>T26363</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009080</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Adhesion Factor Degradation [PE]</name>
  <code>C28528</code>  <id>28529</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Degradation</to_name>
    <to_code>T26364</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009081</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Adhesion Factor Production [PE]</name>
  <code>C28530</code>  <id>28531</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production</to_name>
    <to_code>T26365</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009082</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Adrenal Epinephrine Secretion [PE]</name>
  <code>C28532</code>  <id>28533</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenal Epinephrine Secretion</to_name>
    <to_code>T26366</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009083</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Adrenal Norepinephrine Secretion [PE]</name>
  <code>C28534</code>  <id>28535</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenal Norepinephrine Secretion</to_name>
    <to_code>T26367</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009084</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenal Norepinephrine Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenal Norepinephrine Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Adrenocorticotropic Hormone Secretion [PE]</name>
  <code>C28522</code>  <id>28523</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased ACTH Secretion</to_name>
    <to_code>T26368</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenocorticotropic Hormone Secretion</to_name>
    <to_code>T26369</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009078</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticorelin ovine [74671]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticorelin ovine triflutate [74670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Anal Sphincter Tone [PE]</name>
  <code>C28536</code>  <id>28537</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Anal Sphincter Tone</to_name>
    <to_code>T26370</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009085</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Antibody Activity [PE]</name>
  <code>C28538</code>  <id>28539</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity</to_name>
    <to_code>T26371</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009086</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Colorado/06/2017 antigen [2054177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Maryland/15/2016 antigen [2048563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen [2479040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen [1928528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Victoria/705/2018 antigen [2380575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen [1601232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen [1946964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen [1663632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 4 [2197293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen [1601233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen [1593130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen [2056525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Utah/9/2014 antigen [1657133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyvalent Crotalidae antivenin [91596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen [2686166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group W-135 [314724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live, New York City Board of Health vaccinia strain [798467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen [2708995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 1 [2197290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen [1657130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus B serotype 7 strain 55142 [1802483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 11 vaccine [798262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine, inactivated [845525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertussis vaccine [8080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Washington/02/2019 antigen [2280293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen [2641622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 3 [2197292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anthrax Vaccine Adsorbed [404774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen [2717943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 2 [2197291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 4 vaccine live [1099933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain [1006250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group B vaccine [1593128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen [2562554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen [2641877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H1N1) antigen [1657128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen [2645084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen [2280296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen [2720359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen [1801767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen [2380836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Austria/1359417/2021 antigen [2605039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen [2379531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen [1664171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen [2687714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen [2719300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [798279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group C polysaccharide [29503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain [1005929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen [2688113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen [1601231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen [1593127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen [1666425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) [2664825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/122/2022 (H3N2) antigen [2675569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Darwin/7/2019 antigen [2380838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group Y [314725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen [2177290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Michigan/01/2021 antigen [2593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E [1986821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen [1664339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform S), recombinant [2588219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Phuket/3073/2013 antigen [1657228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus [1491862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen [2694005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen [1657224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hepatitis A Vaccine, Inactivated [253174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E, recombinant [1986820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus antigen [1657134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group A polysaccharide [29501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vibrio cholerae CVD 103-HGR strain live antigen [1812935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>equine diphtheria antitoxin [91602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine flury-lep strain [830457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria antitoxin [3510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen [1666421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen [2380574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen [2180338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen [2177291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen [1928289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform L), recombinant [2588217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen [1657222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360571]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen [1663630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 7 vaccine live [1099937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen [2630221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Smallpox Vaccine [9835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cholera Vaccine [2427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen [2056521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform M), recombinant [2588218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen [2379530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen [2607735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid adsorbed [235600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen [1657127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen [2562553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hong Kong/259/2010 antigen [1801603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus [1427020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen [2180337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diptheria toxoid absorbed [1657601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/WUH4618/2021 antigen [2605725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PERTUSSIS VACCINE,ADSORBED [402543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle [1601236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/9/2014 antigen [1723997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Montreal strain [314513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen [1664172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen vaccine [797752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, RIT-4385 strain [2603501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/46/2015 antigen [1942125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H3N2) antigen [1657131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus subtype ADW2 HBsAg surface protein antigen [1427171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow fever virus strain 17D-204 live antigen [804187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen [1794331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen [2642276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen [1928290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Iowa/06/2017 antigen [2056523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen [2561244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella typhi Ty21a live antigen [762595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen [2380837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen [2380834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/7/2009 (H1N1) antigen [1657331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live vaccinia virus [833079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen [2048564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen [2562555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Panama/45/90 antigen [2262062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) [2664725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, attenuated Schwarz strain [2603499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen [2380835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ROTAVIRUS VACCINE, LIVE [253199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Antibody Degradation [PE]</name>
  <code>C28540</code>  <id>28541</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Degradation</to_name>
    <to_code>T26372</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009087</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Antibody Production [PE]</name>
  <code>C28542</code>  <id>28543</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production</to_name>
    <to_code>T26373</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009088</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Antibody Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Maryland/15/2016 antigen [2048563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2570/2019 (H1N1) antigen [2479040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen [1928528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Victoria/705/2018 antigen [2380575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Colorado/06/2017 antigen [2054177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus strain CR 326F antigen, inactivated [2274413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Slovenia/2903/2015 (H1N1) antigen [1946964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/361/2011 (H3N2) antigen [1663632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 4 [2197293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rubella virus vaccine [9486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen [1601232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyvalent Crotalidae antivenin [91596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen [1593130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen [1601233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/INFTT-16-0610/2016 antigen [2056525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Utah/9/2014 antigen [1657133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 3, human [11131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live, New York City Board of Health vaccinia strain [798467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen [2708995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 1 [2197290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/55/2014 (H3N2) antigen [1657130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Thailand/8/2022 (H3N2) antigen [2686166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, recombinant [2636588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group W-135 [314724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertussis vaccine [8080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Washington/02/2019 antigen [2280293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/4897/2022 (H1N1) antigen [2641622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus B serotype 7 strain 55142 [1802483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 11 vaccine [798262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine, inactivated [845525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/800/2024 (H3N2) antigen [2717943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 2 [2197291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 4 vaccine live [1099933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED [235574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dengue virus live antigen, CYD serotype 3 [2197292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anthrax Vaccine Adsorbed [404774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Washington/19/2020 (H1N1) antigen [2562554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Georgia/12/2022 (H1N1) antigen [2641877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain [1006250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group B vaccine [1593128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/South Australia/34/2019 (H3N2) antigen [2280296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein [2636589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Perth/722/2024 (H3N2) antigen [2720359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H1N1) antigen [1657128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/31694/2022 (H1N1) antigen [2645084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Minnesota/41/2019 (H3N2) antigen [2380836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/71/2014 (H3N2) antigen [1801767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Austria/1359417/2021 antigen [2605039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen [2379531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized [2642139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Beijing/32/1992 (H3N2) antigen [1664171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Massachusetts/18/2022 (H3N2) antigen [2687714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/District of Columbia/27/2023 (H3N2) antigen [2719300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus [1426911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>North American coral snake antivenin [979384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lyme Disease Vaccine [214177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/1304/2022 (H3N2) antigen [2688113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen [1593127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen [1601231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [798279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group C polysaccharide [29503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain [1005929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histoplasmin [5363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/New Caledonia/20/1999 (H1N1) antigen [1666425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mumps Vaccine [763656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b [50937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/122/2022 (H3N2) antigen [2675569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Darwin/7/2019 antigen [2380838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal polysaccharide vaccine group Y [314725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/02/2018 (H1N1) antigen [2177290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Bolivia/559/2013 (H1N1) antigen [1664339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform S), recombinant [2588219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Phuket/3073/2013 antigen [1657228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Michigan/01/2021 antigen [2593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus [1365969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E [1986821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hepatitis A Vaccine, Inactivated [253174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus [1491862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen [2694005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen [1657224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>equine diphtheria antitoxin [91602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E, recombinant [1986820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus antigen [1657134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/1/2020 (H1N1) antigen [2564395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Varicella Virus Vaccine Live (Oka-Merck) strain [805486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/60/2008 antigen [1657226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group A polysaccharide [29501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vibrio cholerae CVD 103-HGR strain live antigen [1812935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Latrodectus mactans antivenin [89887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>purified protein derivative of tuberculin [8948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Victoria/2454/2019 (H1N1) antigen [2380574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Indiana/08/2018 (H3N2) antigen [2180338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Kansas/14/2017 (H3N2) antigen [2177291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus vaccine flury-lep strain [830457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria antitoxin [3510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/6/1986 (H1N1) antigen [1666421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform L), recombinant [2588217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Michigan/45/2015 (H1N1) antigen [1928289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360571]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Texas/50/2012 (H3N2) antigen [1663630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine [1301887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenovirus type 7 vaccine live [1099937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Christchurch/16/2010 (H1N1) antigen [1657222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cholera Vaccine [2427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Sydney/5/2021 (H1N1) antigen [2630221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Smallpox Vaccine [9835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen (isoform M), recombinant [2588218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/North Carolina/04/2016 (H3N2) antigen [2056521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Norway/16606/2021 (H3N2) antigen [2607735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid adsorbed [235600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Brisbane/10/2010 (H1N1) antigen [1657127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen [2379530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza B virus vaccine, B-Brisbane-60-2008-like virus [1427020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus [1303851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/66/2019 (H1N1) antigen [2388136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine [1301885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine [1300464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen [2562553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hong Kong/259/2010 antigen [1801603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus preparation [1312384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Idaho/07/2018 (H1N1) antigen [2180337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PERTUSSIS VACCINE,ADSORBED [402543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle [1601236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diptheria toxoid absorbed [1657601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Singapore/WUH4618/2021 antigen [2605725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B surface antigen vaccine [797752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus vaccine live, RIT-4385 strain [2603501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/46/2015 antigen [1942125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Brisbane/9/2014 antigen [1723997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Montreal strain [314513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Hubei Wujigang/158/2009/antigen [1664172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylpenicilloyl polylysine [19079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow fever virus strain 17D-204 live antigen [804187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen [1794331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus (H3N2) antigen [1657131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hemophilus B polysaccharide [314656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/West Virginia/30/2022 (H1N1) antigen [2642276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen [1928290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Iowa/06/2017 antigen [2056523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Nebraska/14/2019 (H1N1) antigen [2380837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/39/2019 (H3N2) antigen [2380834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Yellow Fever Vaccine [89890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Tasmania/503/2020 (H3N2) antigen [2561244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized [2642138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella typhi Ty21a live antigen [762595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus B/Panama/45/90 antigen [2262062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/California/7/2009 (H1N1) antigen [1657331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smallpox vaccine live vaccinia virus [833079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen [2048564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Wisconsin/588/2019 (H1N1) antigen [2562555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Hawaii/70/2019 (H1N1) antigen [2380835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ROTAVIRUS VACCINE, LIVE [253199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A vaccine (inactivated) strain HM175 [798361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>measles virus vaccine live, attenuated Schwarz strain [2603499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Aspartate Activity [PE]</name>
  <code>C28544</code>  <id>28545</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Aspartate Activity</to_name>
    <to_code>T26374</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009089</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Ganglionic Activity [PE]</name>
  <code>C635038</code>  <id>635038</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Ganglionic Activity</to_name>
    <to_code>T26375</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175645</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Acetylcholine Activity [PE]</name>
  <code>C28546</code>  <id>28547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Acetylcholine Activity</to_name>
    <to_code>T26376</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009090</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Aspartate Activity [PE]</name>
  <code>C28548</code>  <id>28549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Aspartate Activity</to_name>
    <to_code>T26377</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009091</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C28550</code>  <id>28551</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T26378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009092</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System CCK Activity [PE]</name>
  <code>C28552</code>  <id>28553</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System CCK Activity</to_name>
    <to_code>T26379</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009093</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C28554</code>  <id>28555</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T26380</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009094</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Dopamine Activity [PE]</name>
  <code>C28556</code>  <id>28557</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Dopamine Activity</to_name>
    <to_code>T26381</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009095</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Dynorphin Activity [PE]</name>
  <code>C28558</code>  <id>28559</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Dynorphin Activity</to_name>
    <to_code>T26382</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009096</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Endorphin Activity [PE]</name>
  <code>C28560</code>  <id>28561</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Endorphin Activity</to_name>
    <to_code>T26383</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009097</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Enkephalin Activity [PE]</name>
  <code>C28562</code>  <id>28563</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Enkephalin Activity</to_name>
    <to_code>T26384</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009098</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Epinephrine Activity [PE]</name>
  <code>C28564</code>  <id>28565</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Epinephrine Activity</to_name>
    <to_code>T26385</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009099</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System GABA Activity [PE]</name>
  <code>C28566</code>  <id>28567</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System GABA Activity</to_name>
    <to_code>T26386</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009100</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Gastrin Activity [PE]</name>
  <code>C28568</code>  <id>28569</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Gastrin Activity</to_name>
    <to_code>T26387</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009101</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Glutamate Activity [PE]</name>
  <code>C28570</code>  <id>28571</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Glutamate Activity</to_name>
    <to_code>T26388</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009102</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Glycine Activity [PE]</name>
  <code>C28572</code>  <id>28573</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Glycine Activity</to_name>
    <to_code>T26389</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009103</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Histamine Activity [PE]</name>
  <code>C28574</code>  <id>28575</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Histamine Activity</to_name>
    <to_code>T26390</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009104</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C28576</code>  <id>28577</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T26391</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009105</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Neurotensin Activity [PE]</name>
  <code>C28578</code>  <id>28579</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Neurotensin Activity</to_name>
    <to_code>T26392</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009106</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</name>
  <code>C28580</code>  <id>28581</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Nitric Oxide Activity</to_name>
    <to_code>T26393</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009107</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</name>
  <code>C28582</code>  <id>28583</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Norepinephrine Activity</to_name>
    <to_code>T26394</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009108</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Organized Electrical Activity [PE]</name>
  <code>C28584</code>  <id>28585</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Organized Electrical Activity</to_name>
    <to_code>T26395</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009109</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Serotonin Activity [PE]</name>
  <code>C28586</code>  <id>28587</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Serotonin Activity</to_name>
    <to_code>T26396</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009110</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System Substance P Activity [PE]</name>
  <code>C28588</code>  <id>28589</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Substance P Activity</to_name>
    <to_code>T26397</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009111</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Autonomic Nervous System VIP Activity [PE]</name>
  <code>C28590</code>  <id>28591</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System VIP Activity</to_name>
    <to_code>T26398</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009112</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Autonomic Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased B Lymphocyte Activation [PE]</name>
  <code>C641734</code>  <id>641734</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Activation</to_name>
    <to_code>T26399</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182158</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased B Lymphocyte Destruction [PE]</name>
  <code>C28592</code>  <id>28593</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction</to_name>
    <to_code>T26400</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009113</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-131-tositumomab [234449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tositumomab [263010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased B Lymphocyte Production [PE]</name>
  <code>C28594</code>  <id>28595</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Production</to_name>
    <to_code>T26401</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009114</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Bile Iron Secretion [PE]</name>
  <code>C300446</code>  <id>300446</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bile Iron Secretion</to_name>
    <to_code>T26402</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020056</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Biliary Motility [PE]</name>
  <code>C28596</code>  <id>28597</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Biliary Motility</to_name>
    <to_code>T26403</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009115</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Bladder Contractility [PE]</name>
  <code>C28598</code>  <id>28599</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bladder Contractility</to_name>
    <to_code>T26404</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009116</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Bladder Sphincter Tone [PE]</name>
  <code>C28600</code>  <id>28601</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bladder Sphincter Tone</to_name>
    <to_code>T26405</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009117</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Blood Pressure [PE]</name>
  <code>C637934</code>  <id>637934</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure</to_name>
    <to_code>T26406</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178478</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droxidopa [1489913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa-epbx [2047589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II acetate, human [2204740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrel [7518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II [1999003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa [105694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Blood Viscosity [PE]</name>
  <code>C635332</code>  <id>635332</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Blood Viscosity</to_name>
    <to_code>T26407</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175894</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Bradykinin Activity [PE]</name>
  <code>C28602</code>  <id>28603</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bradykinin Activity</to_name>
    <to_code>T26408</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009118</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Bradykinin Degradation [PE]</name>
  <code>C28604</code>  <id>28605</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bradykinin Degradation</to_name>
    <to_code>T26409</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009119</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Bradykinin Production [PE]</name>
  <code>C28606</code>  <id>28607</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bradykinin Production</to_name>
    <to_code>T26410</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009120</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Derived Neurotropic Activity [PE]</name>
  <code>C28608</code>  <id>28609</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Derived Neurotropic Activity</to_name>
    <to_code>T26411</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009121</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Acetylcholine Activity [PE]</name>
  <code>C28610</code>  <id>28611</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Acetylcholine Activity</to_name>
    <to_code>T26412</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009122</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Aspartate Activity [PE]</name>
  <code>C28612</code>  <id>28613</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Aspartate Activity</to_name>
    <to_code>T26413</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009123</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Brain Derived Neurotropic Activity [PE]</name>
  <code>C28614</code>  <id>28615</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Brain Derived Neurotropic Activity</to_name>
    <to_code>T26414</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009124</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem CCK Activity [PE]</name>
  <code>C28616</code>  <id>28617</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem CCK Activity</to_name>
    <to_code>T26415</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009125</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Disorganized Electrical Activity [PE]</name>
  <code>C28618</code>  <id>28619</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Disorganized Electrical Activity</to_name>
    <to_code>T26416</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009126</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Dopamine Activity [PE]</name>
  <code>C28620</code>  <id>28621</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Dopamine Activity</to_name>
    <to_code>T26417</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009127</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Dynorphin Activity [PE]</name>
  <code>C28622</code>  <id>28623</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Dynorphin Activity</to_name>
    <to_code>T26418</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009128</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Endorphin Activity [PE]</name>
  <code>C28624</code>  <id>28625</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Endorphin Activity</to_name>
    <to_code>T26419</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009129</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Enkephalin Activity [PE]</name>
  <code>C28626</code>  <id>28627</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Enkephalin Activity</to_name>
    <to_code>T26420</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009130</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Epinephrine Activity [PE]</name>
  <code>C28628</code>  <id>28629</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Epinephrine Activity</to_name>
    <to_code>T26421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009131</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem GABA Activity [PE]</name>
  <code>C28630</code>  <id>28631</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem GABA Activity</to_name>
    <to_code>T26422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009132</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Gastrin Activity [PE]</name>
  <code>C28632</code>  <id>28633</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Gastrin Activity</to_name>
    <to_code>T26423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009133</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Glutamate Activity [PE]</name>
  <code>C28634</code>  <id>28635</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Glutamate Activity</to_name>
    <to_code>T26424</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009134</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Glycine Activity [PE]</name>
  <code>C28636</code>  <id>28637</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Glycine Activity</to_name>
    <to_code>T26425</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009135</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Histamine Activity [PE]</name>
  <code>C28638</code>  <id>28639</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Histamine Activity</to_name>
    <to_code>T26426</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009136</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Nerve Growth Factor Activity [PE]</name>
  <code>C28640</code>  <id>28641</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Nerve Growth Factor Activity</to_name>
    <to_code>T26427</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009137</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Neurotensin Activity [PE]</name>
  <code>C28642</code>  <id>28643</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Neurotensin Activity</to_name>
    <to_code>T26428</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009138</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Nitric Oxide Activity [PE]</name>
  <code>C28644</code>  <id>28645</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Nitric Oxide Activity</to_name>
    <to_code>T26429</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009139</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Norepinephrine Activity [PE]</name>
  <code>C28646</code>  <id>28647</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Norepinephrine Activity</to_name>
    <to_code>T26430</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009140</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Organized Electrical Activity [PE]</name>
  <code>C28648</code>  <id>28649</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Organized Electrical Activity</to_name>
    <to_code>T26431</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009141</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Serotonin Activity [PE]</name>
  <code>C28650</code>  <id>28651</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity</to_name>
    <to_code>T26432</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009142</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem Substance P Activity [PE]</name>
  <code>C28652</code>  <id>28653</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Substance P Activity</to_name>
    <to_code>T26433</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009143</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Brain Stem VIP Activity [PE]</name>
  <code>C28654</code>  <id>28655</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem VIP Activity</to_name>
    <to_code>T26434</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009144</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased CCK Activity [PE]</name>
  <code>C28656</code>  <id>28657</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased CCK Activity</to_name>
    <to_code>T26435</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009145</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased CRH Activity [PE]</name>
  <code>C28658</code>  <id>28659</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased CRH Activity</to_name>
    <to_code>T26436</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009146</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased CRH Secretion [PE]</name>
  <code>C28660</code>  <id>28661</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased CRH Secretion</to_name>
    <to_code>T26437</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009147</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Calcitonin Secretion [PE]</name>
  <code>C28662</code>  <id>28663</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcitonin Secretion</to_name>
    <to_code>T26438</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009148</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Calcium-sensing Receptor Sensitivity [MoA]</name>
  <code>C300471</code>  <id>300471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity</to_name>
    <to_code>T26439</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020081</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide [1876119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide hydrochloride [1876122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcium-sensing Receptor Sensitivity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Capillary Permeability [PE]</name>
  <code>C31866</code>  <id>31867</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Capillary Permeability</to_name>
    <to_code>T26440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010254</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Acetylcholine Activity [PE]</name>
  <code>C28664</code>  <id>28665</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Acetylcholine Activity</to_name>
    <to_code>T26441</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009149</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Aspartate Activity [PE]</name>
  <code>C28666</code>  <id>28667</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Aspartate Activity</to_name>
    <to_code>T26442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009150</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Brain Derived Neurotropic Activity [PE]</name>
  <code>C28668</code>  <id>28669</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Brain Derived Neurotropic Activity</to_name>
    <to_code>T26443</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009151</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle CCK Activity [PE]</name>
  <code>C28670</code>  <id>28671</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle CCK Activity</to_name>
    <to_code>T26444</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009152</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Disorganized Electrical Activity [PE]</name>
  <code>C28672</code>  <id>28673</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Disorganized Electrical Activity</to_name>
    <to_code>T26445</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009153</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Dopamine Activity [PE]</name>
  <code>C28674</code>  <id>28675</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Dopamine Activity</to_name>
    <to_code>T26446</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009154</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Dynorphin Activity [PE]</name>
  <code>C28676</code>  <id>28677</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Dynorphin Activity</to_name>
    <to_code>T26447</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009155</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Endorphin Activity [PE]</name>
  <code>C28678</code>  <id>28679</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Endorphin Activity</to_name>
    <to_code>T26448</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009156</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Enkephalin Activity [PE]</name>
  <code>C28680</code>  <id>28681</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Enkephalin Activity</to_name>
    <to_code>T26449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009157</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Epinephrine Activity [PE]</name>
  <code>C28682</code>  <id>28683</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Epinephrine Activity</to_name>
    <to_code>T26450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009158</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle GABA Activity [PE]</name>
  <code>C28684</code>  <id>28685</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle GABA Activity</to_name>
    <to_code>T26451</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009159</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Gastrin Activity [PE]</name>
  <code>C28686</code>  <id>28687</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Gastrin Activity</to_name>
    <to_code>T26452</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009160</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Glutamate Activity [PE]</name>
  <code>C28688</code>  <id>28689</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Glutamate Activity</to_name>
    <to_code>T26453</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009161</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Glycine Activity [PE]</name>
  <code>C28690</code>  <id>28691</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Glycine Activity</to_name>
    <to_code>T26454</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009162</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Histamine Activity [PE]</name>
  <code>C28692</code>  <id>28693</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Histamine Activity</to_name>
    <to_code>T26455</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009163</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Nerve Growth Factor Activity [PE]</name>
  <code>C28694</code>  <id>28695</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Nerve Growth Factor Activity</to_name>
    <to_code>T26456</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009164</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Neurotensin Activity [PE]</name>
  <code>C28696</code>  <id>28697</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Neurotensin Activity</to_name>
    <to_code>T26457</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009165</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Nitric Oxide Activity [PE]</name>
  <code>C28698</code>  <id>28699</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Nitric Oxide Activity</to_name>
    <to_code>T26458</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009166</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Norepinephrine Activity [PE]</name>
  <code>C28700</code>  <id>28701</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Norepinephrine Activity</to_name>
    <to_code>T26459</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009167</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Organized Electrical Activity [PE]</name>
  <code>C28702</code>  <id>28703</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity</to_name>
    <to_code>T26460</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009168</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride monohydrate [2678349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Serotonin Activity [PE]</name>
  <code>C28704</code>  <id>28705</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Serotonin Activity</to_name>
    <to_code>T26461</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009169</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle Substance P Activity [PE]</name>
  <code>C28706</code>  <id>28707</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Substance P Activity</to_name>
    <to_code>T26462</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009170</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cardiac Muscle VIP Activity [PE]</name>
  <code>C28708</code>  <id>28709</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle VIP Activity</to_name>
    <to_code>T26463</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009171</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Membrane Integrity [PE]</name>
  <code>C28710</code>  <id>28711</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Membrane Integrity</to_name>
    <to_code>T26464</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009172</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Membrane Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Membrane Synthesis &amp; Repair [PE]</name>
  <code>C28712</code>  <id>28713</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Membrane Synthesis &amp; Repair</to_name>
    <to_code>T26465</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009173</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Wall Integrity [PE]</name>
  <code>C28714</code>  <id>28715</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Wall Integrity</to_name>
    <to_code>T26466</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009174</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cell Wall Synthesis &amp; Repair [PE]</name>
  <code>C28716</code>  <id>28717</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Wall Synthesis &amp; Repair</to_name>
    <to_code>T26467</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009175</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cellular Death [PE]</name>
  <code>C28718</code>  <id>28719</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death</to_name>
    <to_code>T26468</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009176</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab-rwlc [2058825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib [2058849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dkst [2103478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab [2387844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox [2099295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab [2626349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denileukin diftitox-cxdl [2700746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin [2174090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venetoclax [1747556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim hydrochloride [259281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib fumarate [2105823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab [2282018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin [2277607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab [1298944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib anhydrous [2058848]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin-piiq [2174091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin-blmf [2387833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab [2698198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib tosylate [2099703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fam-trastuzumab deruxtecan-nxki [2267574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carfilzomib [1302966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ingenol mebutate [1242806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab [2695869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine sulfate [11199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim sulfate [221176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin-ejfv [2268306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone [2721194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab [2268307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotuzumab ozogamicin [1942950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine [11202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorinostat [194337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab-zzxf [2382597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim lactate [235855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab-hrii [2698200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox-tdfk [2099305]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziftomenib [2725985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin [2721996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin-tllv [2714236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib sulfate [2104548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib citrate [1723734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-zzxf [2382599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone hydrochloride [2721193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-131 [1546415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib [1723735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine sulfate [11203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib [2099704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-oysk [2375543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab-xiiy [2626348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-anns [2174802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp-erzs [2109054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belinostat [1543543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab-clzb [2695870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dttb [2289225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab [2714237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine [11198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib [2105806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-pkrb [2107051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cellular Locomotion [PE]</name>
  <code>C28720</code>  <id>28721</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Locomotion</to_name>
    <to_code>T26469</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009177</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Locomotion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cellular Migration [PE]</name>
  <code>C30226</code>  <id>30227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration</to_name>
    <to_code>T26470</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009929</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Cellular Migration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Polymorphonuclear Leukocyte Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Cellular Migration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibroblast Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus [1426911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histoplasmin [5363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylpenicilloyl polylysine [19079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mumps Vaccine [763656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>purified protein derivative of tuberculin [8948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cellular Migration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Acetylcholine Activity [PE]</name>
  <code>C28722</code>  <id>28723</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity</to_name>
    <to_code>T26471</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009178</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>huperzine A [2267703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine [183379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine [10318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine [2106338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine tartrate [994808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine phosphate [2106337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil hydrochloride [236559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil [135447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine hydrochloride [235972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Aspartate Activity [PE]</name>
  <code>C28724</code>  <id>28725</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Aspartate Activity</to_name>
    <to_code>T26472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009179</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C28726</code>  <id>28727</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T26473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009180</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System CCK Activity [PE]</name>
  <code>C28728</code>  <id>28729</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System CCK Activity</to_name>
    <to_code>T26474</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009181</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C28730</code>  <id>28731</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T26475</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009182</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Dopamine Activity [PE]</name>
  <code>C28732</code>  <id>28733</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity</to_name>
    <to_code>T26476</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009183</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole [72302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levodopa [6375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foslevodopa [2695775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole hydrochloride [236553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opicapone [2362167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entacapone [60307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole dihydrochloride [236747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolcapone [72937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Dynorphin Activity [PE]</name>
  <code>C28734</code>  <id>28735</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dynorphin Activity</to_name>
    <to_code>T26477</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009184</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Endorphin Activity [PE]</name>
  <code>C28736</code>  <id>28737</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Endorphin Activity</to_name>
    <to_code>T26478</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009185</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Enkephalin Activity [PE]</name>
  <code>C28738</code>  <id>28739</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Enkephalin Activity</to_name>
    <to_code>T26479</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009186</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Epinephrine Activity [PE]</name>
  <code>C28740</code>  <id>28741</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Epinephrine Activity</to_name>
    <to_code>T26480</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009187</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System GABA Activity [PE]</name>
  <code>C28742</code>  <id>28743</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity</to_name>
    <to_code>T26481</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009188</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam [1535252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halazepam [26412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopamide [2603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quazepam [35185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam hydrochloride [71484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam hydrochloride [1999183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexanolone [2121777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam [4501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stiripentol [2054968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triazolam [10767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Gastrin Activity [PE]</name>
  <code>C28744</code>  <id>28745</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Gastrin Activity</to_name>
    <to_code>T26482</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009189</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Glutamate Activity [PE]</name>
  <code>C28746</code>  <id>28747</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Glutamate Activity</to_name>
    <to_code>T26483</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009190</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Glycine Activity [PE]</name>
  <code>C28748</code>  <id>28749</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Glycine Activity</to_name>
    <to_code>T26484</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009191</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Histamine Activity [PE]</name>
  <code>C28750</code>  <id>28751</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Histamine Activity</to_name>
    <to_code>T26485</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009192</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C28752</code>  <id>28753</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T26486</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009193</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Neurotensin Activity [PE]</name>
  <code>C28754</code>  <id>28755</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Neurotensin Activity</to_name>
    <to_code>T26487</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009194</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Nitric Oxide Activity [PE]</name>
  <code>C28756</code>  <id>28757</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Nitric Oxide Activity</to_name>
    <to_code>T26488</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009195</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Norepinephrine Activity [PE]</name>
  <code>C28758</code>  <id>28759</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity</to_name>
    <to_code>T26489</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009196</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate [2607741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin hydrochloride [236807]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate monohydrate [2605948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin [3332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine mesylate [236189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Organized Electrical Activity [PE]</name>
  <code>C28760</code>  <id>28761</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity</to_name>
    <to_code>T26490</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009197</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfampridine [897018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Serotonin Activity [PE]</name>
  <code>C28762</code>  <id>28763</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity</to_name>
    <to_code>T26491</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009198</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine hydrobromide [1439834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone hydrochloride [1086768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine [1455099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide maleate [203190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide [6911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram [321988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate [2607741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone [1086769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan succinate [322249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram oxalate [353108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate monohydrate [2605948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System Substance P Activity [PE]</name>
  <code>C28764</code>  <id>28765</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Substance P Activity</to_name>
    <to_code>T26492</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009199</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Central Nervous System VIP Activity [PE]</name>
  <code>C28766</code>  <id>28767</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System VIP Activity</to_name>
    <to_code>T26493</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009200</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Central Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Brain Stem VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Acetylcholine Activity [PE]</name>
  <code>C28768</code>  <id>28769</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Acetylcholine Activity</to_name>
    <to_code>T26494</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009201</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Aspartate Activity [PE]</name>
  <code>C28770</code>  <id>28771</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Aspartate Activity</to_name>
    <to_code>T26495</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009202</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Brain Derived Neurotropic Activity [PE]</name>
  <code>C28772</code>  <id>28773</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Brain Derived Neurotropic Activity</to_name>
    <to_code>T26496</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009203</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum CCK Activity [PE]</name>
  <code>C28774</code>  <id>28775</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum CCK Activity</to_name>
    <to_code>T26497</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009204</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Disorganized Electrical Activity [PE]</name>
  <code>C28776</code>  <id>28777</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Disorganized Electrical Activity</to_name>
    <to_code>T26498</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009205</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Dopamine Activity [PE]</name>
  <code>C28778</code>  <id>28779</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Dopamine Activity</to_name>
    <to_code>T26499</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009206</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Dynorphin Activity [PE]</name>
  <code>C28780</code>  <id>28781</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Dynorphin Activity</to_name>
    <to_code>T26500</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009207</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Endorphin Activity [PE]</name>
  <code>C28782</code>  <id>28783</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Endorphin Activity</to_name>
    <to_code>T26501</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009208</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Enkephalin Activity [PE]</name>
  <code>C28784</code>  <id>28785</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Enkephalin Activity</to_name>
    <to_code>T26502</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009209</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Epinephrine Activity [PE]</name>
  <code>C28786</code>  <id>28787</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Epinephrine Activity</to_name>
    <to_code>T26503</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009210</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum GABA Activity [PE]</name>
  <code>C28788</code>  <id>28789</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum GABA Activity</to_name>
    <to_code>T26504</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009211</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Gastrin Activity [PE]</name>
  <code>C28790</code>  <id>28791</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Gastrin Activity</to_name>
    <to_code>T26505</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009212</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Glutamate Activity [PE]</name>
  <code>C28792</code>  <id>28793</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Glutamate Activity</to_name>
    <to_code>T26506</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009213</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Glycine Activity [PE]</name>
  <code>C28794</code>  <id>28795</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Glycine Activity</to_name>
    <to_code>T26507</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009214</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Histamine Activity [PE]</name>
  <code>C28796</code>  <id>28797</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Histamine Activity</to_name>
    <to_code>T26508</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009215</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Nerve Growth Factor Activity [PE]</name>
  <code>C28798</code>  <id>28799</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Nerve Growth Factor Activity</to_name>
    <to_code>T26509</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009216</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Neurotensin Activity [PE]</name>
  <code>C28800</code>  <id>28801</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Neurotensin Activity</to_name>
    <to_code>T26510</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009217</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Nitric Oxide Activity [PE]</name>
  <code>C28802</code>  <id>28803</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Nitric Oxide Activity</to_name>
    <to_code>T26511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009218</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Norepinephrine Activity [PE]</name>
  <code>C28804</code>  <id>28805</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Norepinephrine Activity</to_name>
    <to_code>T26512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009219</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Organized Electrical Activity [PE]</name>
  <code>C28806</code>  <id>28807</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Organized Electrical Activity</to_name>
    <to_code>T26513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009220</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Serotonin Activity [PE]</name>
  <code>C28808</code>  <id>28809</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Serotonin Activity</to_name>
    <to_code>T26514</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009221</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum Substance P Activity [PE]</name>
  <code>C28810</code>  <id>28811</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum Substance P Activity</to_name>
    <to_code>T26515</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009222</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebellum VIP Activity [PE]</name>
  <code>C28812</code>  <id>28813</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebellum VIP Activity</to_name>
    <to_code>T26516</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009223</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Acetylcholine Activity [PE]</name>
  <code>C28814</code>  <id>28815</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Acetylcholine Activity</to_name>
    <to_code>T26517</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009224</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Aspartate Activity [PE]</name>
  <code>C28816</code>  <id>28817</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Aspartate Activity</to_name>
    <to_code>T26518</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009225</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Brain Derived Neurotropic Activity [PE]</name>
  <code>C28818</code>  <id>28819</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Brain Derived Neurotropic Activity</to_name>
    <to_code>T26519</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009226</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex CCK Activity [PE]</name>
  <code>C28820</code>  <id>28821</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex CCK Activity</to_name>
    <to_code>T26520</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009227</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Disorganized Electrical Activity [PE]</name>
  <code>C28822</code>  <id>28823</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Disorganized Electrical Activity</to_name>
    <to_code>T26521</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009228</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Dopamine Activity [PE]</name>
  <code>C28824</code>  <id>28825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity</to_name>
    <to_code>T26522</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009229</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Dynorphin Activity [PE]</name>
  <code>C28826</code>  <id>28827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Dynorphin Activity</to_name>
    <to_code>T26523</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009230</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Endorphin Activity [PE]</name>
  <code>C28828</code>  <id>28829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Endorphin Activity</to_name>
    <to_code>T26524</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009231</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Enkephalin Activity [PE]</name>
  <code>C28830</code>  <id>28831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Enkephalin Activity</to_name>
    <to_code>T26525</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009232</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Epinephrine Activity [PE]</name>
  <code>C28832</code>  <id>28833</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Epinephrine Activity</to_name>
    <to_code>T26526</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009233</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex GABA Activity [PE]</name>
  <code>C28834</code>  <id>28835</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex GABA Activity</to_name>
    <to_code>T26527</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009234</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine hydrochloride [142143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Gastrin Activity [PE]</name>
  <code>C28836</code>  <id>28837</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Gastrin Activity</to_name>
    <to_code>T26528</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009235</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Glutamate Activity [PE]</name>
  <code>C28838</code>  <id>28839</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Glutamate Activity</to_name>
    <to_code>T26529</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009236</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Glycine Activity [PE]</name>
  <code>C28840</code>  <id>28841</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Glycine Activity</to_name>
    <to_code>T26530</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009237</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Histamine Activity [PE]</name>
  <code>C28842</code>  <id>28843</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Histamine Activity</to_name>
    <to_code>T26531</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009238</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Nerve Growth Factor Activity [PE]</name>
  <code>C28844</code>  <id>28845</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Nerve Growth Factor Activity</to_name>
    <to_code>T26532</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009239</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Neurotensin Activity [PE]</name>
  <code>C28846</code>  <id>28847</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Neurotensin Activity</to_name>
    <to_code>T26533</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009240</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Nitric Oxide Activity [PE]</name>
  <code>C28848</code>  <id>28849</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Nitric Oxide Activity</to_name>
    <to_code>T26534</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009241</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Norepinephrine Activity [PE]</name>
  <code>C28850</code>  <id>28851</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity</to_name>
    <to_code>T26535</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009242</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine hydrochloride [353103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride monohydrate [221160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine [38400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Organized Electrical Activity [PE]</name>
  <code>C28852</code>  <id>28853</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Organized Electrical Activity</to_name>
    <to_code>T26536</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009243</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Serotonin Activity [PE]</name>
  <code>C28854</code>  <id>28855</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Serotonin Activity</to_name>
    <to_code>T26537</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009244</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex Substance P Activity [PE]</name>
  <code>C28856</code>  <id>28857</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex Substance P Activity</to_name>
    <to_code>T26538</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009245</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cerebral Cortex VIP Activity [PE]</name>
  <code>C28858</code>  <id>28859</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cerebral Cortex VIP Activity</to_name>
    <to_code>T26539</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009246</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cervical Dilation [PE]</name>
  <code>C28860</code>  <id>28861</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cervical Dilation</to_name>
    <to_code>T26540</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009247</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cervical Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>misoprostol [42331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cervical Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cervical Smooth Muscle Tone [PE]</name>
  <code>C28862</code>  <id>28863</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cervical Smooth Muscle Tone</to_name>
    <to_code>T26541</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009248</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Absorption [PE]</name>
  <code>C28864</code>  <id>28865</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Absorption</to_name>
    <to_code>T26542</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009249</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Elimination [PE]</name>
  <code>C28866</code>  <id>28867</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Elimination</to_name>
    <to_code>T26543</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009250</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Elimination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen [2701418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Elimination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Elimination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen sodium [2701417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Elimination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Secretion [PE]</name>
  <code>C31834</code>  <id>31835</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Secretion</to_name>
    <to_code>T26544</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010238</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cholesterol Synthesis [PE]</name>
  <code>C28868</code>  <id>28869</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis</to_name>
    <to_code>T26545</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009251</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese dioxide [29263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebelipase alfa [1726975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese [6623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese sulfate [29268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cholesterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Activity [PE]</name>
  <code>C635433</code>  <id>635433</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Procoagulation Activity</to_name>
    <to_code>T26547</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pro-coagulation Activity</to_name>
    <to_code>T26549</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Procoagulation</to_name>
    <to_code>T26548</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity</to_name>
    <to_code>T26550</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pro-coagulation</to_name>
    <to_code>T26546</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175979</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endothelial Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothrombin, human-lans [2643202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human [1426166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrel [7518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothrombin, human [1441689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen,I-125 [314623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Coagulation Factor IX (Human) [617148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human-lans [2643194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albutrepenonacog alfa [1743992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX, human [221099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen concentrate (human) [831503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human [1426164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX [4249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor, human [826072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX (recombinant), glycopegylated [1990855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX, human-lans [2643192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>andexanet alfa [2045114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human-lans [2643196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor Xa (recombinant), inactivated-zhzo [2045125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor Activity [PE]</name>
  <code>C28870</code>  <id>28871</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity</to_name>
    <to_code>T26551</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009252</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrin Polymerization Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, human [825006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human [1426166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium ion [1316581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothrombin, human-lans [2643202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen,I-125 [314623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol sodium phosphate [52549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab-hncq [2697132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab [2697133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol [29491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human-lans [2643194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin [10528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant FVIIa [314620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin alfa [1367075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor [11274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K3 [6728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor Concentration [PE]</name>
  <code>C28872</code>  <id>28873</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration</to_name>
    <to_code>T26552</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009253</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinogen Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrin Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Coagulation Factor Concentration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIIa [4256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turoctocog alfa [1737557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor XIII a-subunit (recombinant) [1488293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor VIIa (recombinant)-jncw [2386863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin [10528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin alfa [1367075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen,I-125 [314623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human-lans [2643194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, bovine [2264114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII [4271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human [1426166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothrombin, human-lans [2643202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, human [825006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor IX Activity [PE]</name>
  <code>C643880</code>  <id>643880</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Activity</to_name>
    <to_code>T26553</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184153</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidanacogene elaparvovec-dzkt [2681020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidanacogene elaparvovec [2681011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor IX Concentration [PE]</name>
  <code>C643884</code>  <id>643884</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Concentration</to_name>
    <to_code>T26554</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184157</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX complex [1670383]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor IX Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor VII Concentration [PE]</name>
  <code>C643883</code>  <id>643883</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VII Concentration</to_name>
    <to_code>T26555</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184156</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor VIII Activity [PE]</name>
  <code>C635352</code>  <id>635352</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity</to_name>
    <to_code>T26556</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175914</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab-kxwh [1989795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec [2641610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), PEGylated-aucl [2055654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec-rvox [2641609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>damoctocog alfa pegol [2055655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab [1989794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor VIII Concentration [PE]</name>
  <code>C635353</code>  <id>635353</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration</to_name>
    <to_code>T26557</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175915</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec [2641610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), PEGylated-aucl [2055654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec-rvox [2641609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>damoctocog alfa pegol [2055655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor VIII Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor X Activity [PE]</name>
  <code>C643881</code>  <id>643881</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Activity</to_name>
    <to_code>T26558</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184154</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab-mtci [2708340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab [2708333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Coagulation Factor X Concentration [PE]</name>
  <code>C643885</code>  <id>643885</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Concentration</to_name>
    <to_code>T26559</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184158</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab [2708333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX complex [1670383]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab-mtci [2708340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Coagulation Factor X Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Ca++ Excretion [PE]</name>
  <code>C28874</code>  <id>28875</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Ca++ Excretion</to_name>
    <to_code>T26560</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009254</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Cl- Excretion [PE]</name>
  <code>C28876</code>  <id>28877</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Cl- Excretion</to_name>
    <to_code>T26561</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009255</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct H+ Excretion [PE]</name>
  <code>C28878</code>  <id>28879</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct H+ Excretion</to_name>
    <to_code>T26562</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009256</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct HCO3- Excretion [PE]</name>
  <code>C28880</code>  <id>28881</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct HCO3- Excretion</to_name>
    <to_code>T26563</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009257</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct K+ Excretion [PE]</name>
  <code>C28882</code>  <id>28883</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct K+ Excretion</to_name>
    <to_code>T26564</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009258</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Mg++ Excretion [PE]</name>
  <code>C28884</code>  <id>28885</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Mg++ Excretion</to_name>
    <to_code>T26565</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009259</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Na+ Excretion [PE]</name>
  <code>C28886</code>  <id>28887</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Na+ Excretion</to_name>
    <to_code>T26566</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009260</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct PO4-- Excretion [PE]</name>
  <code>C28888</code>  <id>28889</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct PO4-- Excretion</to_name>
    <to_code>T26567</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009261</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct SO4-- Excretion [PE]</name>
  <code>C28890</code>  <id>28891</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct SO4-- Excretion</to_name>
    <to_code>T26568</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009262</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Collecting Duct Water Permeability [PE]</name>
  <code>C28892</code>  <id>28893</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability</to_name>
    <to_code>T26569</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009263</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamabrom [54365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Water Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Complement Activity [PE]</name>
  <code>C28894</code>  <id>28895</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Complement Activity</to_name>
    <to_code>T26570</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009264</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Complement Degradation [PE]</name>
  <code>C28896</code>  <id>28897</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Complement Degradation</to_name>
    <to_code>T26571</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009265</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Complement Production [PE]</name>
  <code>C28898</code>  <id>28899</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Complement Production</to_name>
    <to_code>T26572</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009266</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cytokine Activity [PE]</name>
  <code>C28900</code>  <id>28901</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity</to_name>
    <to_code>T26573</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009267</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab [2644447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab [2644880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab-bcmm [2644881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab-tgvs [2644448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp-tebn [2590744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cytokine Degradation [PE]</name>
  <code>C28902</code>  <id>28903</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Degradation</to_name>
    <to_code>T26574</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009268</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Cytokine Production [PE]</name>
  <code>C28904</code>  <id>28905</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production</to_name>
    <to_code>T26575</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009269</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab-dlle [2682955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab-rmbw [2596772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab [2682954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab-axgb [2625125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab [2625122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased DNA Integrity [PE]</name>
  <code>C28906</code>  <id>28907</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity</to_name>
    <to_code>T26576</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009270</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegademase bovine [59768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine [11017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine 5-mo-phos disod [236785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triacetate [1665222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triphosphate sodium [236509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased DNA Replication [PE]</name>
  <code>C28908</code>  <id>28909</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication</to_name>
    <to_code>T26577</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009271</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegademase bovine [59768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine [11017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine 5-mo-phos disod [236785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triacetate [1665222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triphosphate sodium [236509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Dihydrotestosterone Secretion [PE]</name>
  <code>C30242</code>  <id>30243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dihydrotestosterone Secretion</to_name>
    <to_code>T26579</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased DHT Secretion</to_name>
    <to_code>T26578</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009937</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Disorganized Electrical Activity [PE]</name>
  <code>C28910</code>  <id>28911</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Disorganized Electrical Activity</to_name>
    <to_code>T26580</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009272</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentylenetetrazole [8015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Ca++ Excretion [PE]</name>
  <code>C28912</code>  <id>28913</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Ca++ Excretion</to_name>
    <to_code>T26581</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009273</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Cl- Excretion [PE]</name>
  <code>C28914</code>  <id>28915</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion</to_name>
    <to_code>T26582</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009274</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule H+ Excretion [PE]</name>
  <code>C28916</code>  <id>28917</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion</to_name>
    <to_code>T26583</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009275</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule HCO3- Excretion [PE]</name>
  <code>C28918</code>  <id>28919</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule HCO3- Excretion</to_name>
    <to_code>T26584</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009276</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule K+ Excretion [PE]</name>
  <code>C28920</code>  <id>28921</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion</to_name>
    <to_code>T26585</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009277</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Mg++ Excretion [PE]</name>
  <code>C28922</code>  <id>28923</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Mg++ Excretion</to_name>
    <to_code>T26586</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009278</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule Na+ Excretion [PE]</name>
  <code>C28924</code>  <id>28925</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion</to_name>
    <to_code>T26587</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009279</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule PO4-- Excretion [PE]</name>
  <code>C28926</code>  <id>28927</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule PO4-- Excretion</to_name>
    <to_code>T26588</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009280</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Distal Tubule SO4-- Excretion [PE]</name>
  <code>C28928</code>  <id>28929</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule SO4-- Excretion</to_name>
    <to_code>T26589</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009281</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Diuresis [PE]</name>
  <code>C634742</code>  <id>634742</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Diuretic Activity</to_name>
    <to_code>T26590</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis</to_name>
    <to_code>T26591</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175359</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xipamide [11371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamabrom [54365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolvaptan [358257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Diuresis at Loop of Henle [PE]</name>
  <code>C634749</code>  <id>634749</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle</to_name>
    <to_code>T26592</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175366</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Diuresis at Loop of Henle [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Dopamine Activity [PE]</name>
  <code>C28930</code>  <id>28931</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity</to_name>
    <to_code>T26593</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009282</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil [8353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine [51253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil mesylate [236380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide [2176312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eladocagene exuparvovec [2698762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eladocagene exuparvovec-tneq [2698765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine [19832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide acetate [2176311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine hydrochloride [284157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine hydrochloride [236892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Dynorphin Activity [PE]</name>
  <code>C28932</code>  <id>28933</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dynorphin Activity</to_name>
    <to_code>T26594</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009283</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Eicosanoid Activity [PE]</name>
  <code>C28934</code>  <id>28935</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Eicosanoid Activity</to_name>
    <to_code>T26595</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009284</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Leukotriene Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Eicosanoid Degradation [PE]</name>
  <code>C28936</code>  <id>28937</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Eicosanoid Degradation</to_name>
    <to_code>T26596</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009285</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Leukotriene Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Eicosanoid Production [PE]</name>
  <code>C28938</code>  <id>28939</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Eicosanoid Production</to_name>
    <to_code>T26597</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009286</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Eicosanoid Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Leukotriene Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Embryonic &amp; Fetal Growth [PE]</name>
  <code>C28940</code>  <id>28941</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Embryonic &amp; Fetal Growth</to_name>
    <to_code>T26598</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009287</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Embryonic &amp; Fetal Viability [PE]</name>
  <code>C28942</code>  <id>28943</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Embryonic &amp; Fetal Viability</to_name>
    <to_code>T26599</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009288</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Embryonic Implantation [PE]</name>
  <code>C28944</code>  <id>28945</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Embryonic Implantation</to_name>
    <to_code>T26600</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009289</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Endocytosis [PE]</name>
  <code>C28946</code>  <id>28947</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endocytosis</to_name>
    <to_code>T26601</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009290</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Endorphin Activity [PE]</name>
  <code>C28948</code>  <id>28949</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endorphin Activity</to_name>
    <to_code>T26602</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009291</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Endothelial Coagulation Activity [PE]</name>
  <code>C28950</code>  <id>28951</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endothelial Coagulation Activity</to_name>
    <to_code>T26603</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009292</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endothelial Coagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Endothelial Proliferation [PE]</name>
  <code>C635083</code>  <id>635083</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Endothelial Proliferation</to_name>
    <to_code>T26604</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175677</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enkephalin Activity [PE]</name>
  <code>C28952</code>  <id>28953</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enkephalin Activity</to_name>
    <to_code>T26605</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009293</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Acetylcholine Activity [PE]</name>
  <code>C28954</code>  <id>28955</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Acetylcholine Activity</to_name>
    <to_code>T26606</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009294</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Aspartate Activity [PE]</name>
  <code>C28956</code>  <id>28957</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Aspartate Activity</to_name>
    <to_code>T26607</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009295</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C28958</code>  <id>28959</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T26608</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009296</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System CCK Activity [PE]</name>
  <code>C28960</code>  <id>28961</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System CCK Activity</to_name>
    <to_code>T26609</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009297</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C28962</code>  <id>28963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T26610</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009298</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Dopamine Activity [PE]</name>
  <code>C28964</code>  <id>28965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Dopamine Activity</to_name>
    <to_code>T26611</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009299</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Dynorphin Activity [PE]</name>
  <code>C28966</code>  <id>28967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Dynorphin Activity</to_name>
    <to_code>T26612</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009300</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Endorphin Activity [PE]</name>
  <code>C28968</code>  <id>28969</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Endorphin Activity</to_name>
    <to_code>T26613</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009301</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Enkephalin Activity [PE]</name>
  <code>C28970</code>  <id>28971</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Enkephalin Activity</to_name>
    <to_code>T26614</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009302</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Epinephrine Activity [PE]</name>
  <code>C28972</code>  <id>28973</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Epinephrine Activity</to_name>
    <to_code>T26615</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009303</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System GABA Activity [PE]</name>
  <code>C28974</code>  <id>28975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System GABA Activity</to_name>
    <to_code>T26616</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009304</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Gastrin Activity [PE]</name>
  <code>C28976</code>  <id>28977</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Gastrin Activity</to_name>
    <to_code>T26617</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009305</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Glutamate Activity [PE]</name>
  <code>C28978</code>  <id>28979</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Glutamate Activity</to_name>
    <to_code>T26618</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009306</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Glycine Activity [PE]</name>
  <code>C28980</code>  <id>28981</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Glycine Activity</to_name>
    <to_code>T26619</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009307</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Histamine Activity [PE]</name>
  <code>C28982</code>  <id>28983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Histamine Activity</to_name>
    <to_code>T26620</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009308</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C28984</code>  <id>28985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T26621</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009309</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Neurotensin Activity [PE]</name>
  <code>C28986</code>  <id>28987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Neurotensin Activity</to_name>
    <to_code>T26622</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009310</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Nitric Oxide Activity [PE]</name>
  <code>C28988</code>  <id>28989</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Nitric Oxide Activity</to_name>
    <to_code>T26623</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009311</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Norepinephrine Activity [PE]</name>
  <code>C28990</code>  <id>28991</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Norepinephrine Activity</to_name>
    <to_code>T26624</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009312</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Organized Electrical Activity [PE]</name>
  <code>C28992</code>  <id>28993</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Organized Electrical Activity</to_name>
    <to_code>T26625</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009313</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Serotonin Activity [PE]</name>
  <code>C28994</code>  <id>28995</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Serotonin Activity</to_name>
    <to_code>T26626</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009314</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System Substance P Activity [PE]</name>
  <code>C28996</code>  <id>28997</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Substance P Activity</to_name>
    <to_code>T26627</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009315</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Enteric Nervous System VIP Activity [PE]</name>
  <code>C28998</code>  <id>28999</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System VIP Activity</to_name>
    <to_code>T26628</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009316</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Epinephrine Activity [PE]</name>
  <code>C29000</code>  <id>29001</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epinephrine Activity</to_name>
    <to_code>T26629</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009317</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Epithelial Proliferation [PE]</name>
  <code>C635081</code>  <id>635081</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epithelial Proliferation</to_name>
    <to_code>T26630</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175675</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palifermin [196319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>becaplermin [115238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Erythroid Cell Destruction [PE]</name>
  <code>C29002</code>  <id>29003</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Destruction</to_name>
    <to_code>T26631</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009318</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Erythroid Cell Production [PE]</name>
  <code>C29004</code>  <id>29005</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production</to_name>
    <to_code>T26632</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009319</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxsil [77754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy polyethylene glycol-epoetin beta [729596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysaccharide iron complex [105669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric citrate [1594675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa-epbx [2047589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron [90176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa [105694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept [2262544]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate,dried [259346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate [24947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept-aamt [2262543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron,peptonized [235272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide [1310572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginesatide [1248798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric ammonium citrate [24897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron-dextran complex [5992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous fumarate [24941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ferric gluconate complex [261435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darbepoetin alfa [283838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide yellow [1305582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous gluconate [24942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Erythropoetin Secretion [PE]</name>
  <code>C29006</code>  <id>29007</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion</to_name>
    <to_code>T26633</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009320</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darbepoetin alfa [283838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Esophageal Motility [PE]</name>
  <code>C29008</code>  <id>29009</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Motility</to_name>
    <to_code>T26634</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009321</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Esophageal Muscle Tone [PE]</name>
  <code>C29010</code>  <id>29011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Muscle Tone</to_name>
    <to_code>T26635</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009322</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Exocytosis [PE]</name>
  <code>C29012</code>  <id>29013</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Exocytosis</to_name>
    <to_code>T26636</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009323</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Exocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Extracellular Communication [PE]</name>
  <code>C31816</code>  <id>31817</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Extracellular Communication</to_name>
    <to_code>T26638</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cell Signaling</to_name>
    <to_code>T26637</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010229</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Extracellular Communication [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>upadacitinib [2196092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Extracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baricitinib [2047232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Extracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrin Concentration [PE]</name>
  <code>C643887</code>  <id>643887</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrin Concentration</to_name>
    <to_code>T26639</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184160</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrin Polymerization Activity [PE]</name>
  <code>C643882</code>  <id>643882</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrin Polymerization Activity</to_name>
    <to_code>T26640</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184155</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrin Polymerization Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrinogen Concentration [PE]</name>
  <code>C643886</code>  <id>643886</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinogen Concentration</to_name>
    <to_code>T26641</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184159</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Fibrinolysis [PE]</name>
  <code>C635026</code>  <id>635026</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis</to_name>
    <to_code>T26642</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175633</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Fibrinolysis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide [1311089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide, bovine lung [1788946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide sodium [1746523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibrinolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Fibroblast Migration [PE]</name>
  <code>C31856</code>  <id>31857</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Fibroblast Migration</to_name>
    <to_code>T26643</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010249</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Follicle Stimulating Hormone Secretion [PE]</name>
  <code>C29014</code>  <id>29015</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased FSH Secretion</to_name>
    <to_code>T26644</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion</to_name>
    <to_code>T26645</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009324</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urofollitropin [134404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urofollitropin [134404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GABA Activity [PE]</name>
  <code>C29016</code>  <id>29017</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity</to_name>
    <to_code>T26646</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009325</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kava preparation [285228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproate [40254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital [9624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate calcium [152761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunitrazepam [4460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nordazepam [3155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium valproate [134422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vigabatrin [14851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium valproate [1927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate [82819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital sodium [91110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexobarbital [5302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GHRH Activity [PE]</name>
  <code>C29020</code>  <id>29021</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Activity</to_name>
    <to_code>T26647</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009327</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin acetate [1044583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GHRH Secretion [PE]</name>
  <code>C29022</code>  <id>29023</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GHRH Secretion</to_name>
    <to_code>T26648</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009328</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GI Motility [PE]</name>
  <code>C29024</code>  <id>29025</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility</to_name>
    <to_code>T26649</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009329</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Biliary Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Small Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Emesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Motility [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed preparation [360375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GI Smooth Muscle Tone [PE]</name>
  <code>C29026</code>  <id>29027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone</to_name>
    <to_code>T26650</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009330</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Small Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gallbladder Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased LES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Anal Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sphincter of Odi Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pyloric Sphincter Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased UES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased GI Smooth Muscle Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Esophageal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GI Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Gallbladder Tone [PE]</name>
  <code>C29032</code>  <id>29033</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gallbladder Tone</to_name>
    <to_code>T26651</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009333</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gallbladder Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Gastric Motility [PE]</name>
  <code>C29034</code>  <id>29035</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility</to_name>
    <to_code>T26652</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009334</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan anhydrous [1516803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan [480639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol oxalate [1593586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone [29899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol [1551777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone bromide [979111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Gastric Muscle Tone [PE]</name>
  <code>C29036</code>  <id>29037</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastric Muscle Tone</to_name>
    <to_code>T26653</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009335</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Gastrin Activity [PE]</name>
  <code>C29038</code>  <id>29039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastrin Activity</to_name>
    <to_code>T26654</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009336</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glomerular Filtration Pressure [PE]</name>
  <code>C29040</code>  <id>29041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glomerular Filtration Pressure</to_name>
    <to_code>T26655</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009337</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glomerular Filtration Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glomerular Filtration Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glucagon Secretion [PE]</name>
  <code>C29042</code>  <id>29043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucagon Secretion</to_name>
    <to_code>T26656</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009338</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasiglucagon [2535233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glucocorticoid Clearance [PE]</name>
  <code>C30244</code>  <id>30245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Clearance</to_name>
    <to_code>T26657</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009938</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glucocorticoid Secretion [PE]</name>
  <code>C29044</code>  <id>29045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion</to_name>
    <to_code>T26658</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009339</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin hexahydrate [1653802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin [2890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Gluconeogenesis [PE]</name>
  <code>C29046</code>  <id>29047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis</to_name>
    <to_code>T26659</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009340</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese [6623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese sulfate [29268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese dioxide [29263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Gluconeogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glucose Transport into Cells [PE]</name>
  <code>C29048</code>  <id>29049</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells</to_name>
    <to_code>T26660</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009341</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacrosidase [214817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide sodium [221173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucose Transport into Cells [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glutamate Activity [PE]</name>
  <code>C29050</code>  <id>29051</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutamate Activity</to_name>
    <to_code>T26661</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009342</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glutathione Concentration [PE]</name>
  <code>C635398</code>  <id>635398</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration</to_name>
    <to_code>T26662</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175960</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium [9641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium chloride [2200142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenate [36717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenious acid [36344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glycine Activity [PE]</name>
  <code>C29052</code>  <id>29053</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycine Activity</to_name>
    <to_code>T26663</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009343</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glycogenesis [PE]</name>
  <code>C29054</code>  <id>29055</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis</to_name>
    <to_code>T26664</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009344</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glycogenolysis [PE]</name>
  <code>C29056</code>  <id>29057</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis</to_name>
    <to_code>T26665</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009345</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucosidase alfa [629565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasiglucagon [2535233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycogenolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Glycolysis [PE]</name>
  <code>C29058</code>  <id>29059</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis</to_name>
    <to_code>T26666</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009346</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glycolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GnRH Activity [PE]</name>
  <code>C29028</code>  <id>29029</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Activity</to_name>
    <to_code>T26667</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009331</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased GnRH Secretion [PE]</name>
  <code>C29030</code>  <id>29031</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion</to_name>
    <to_code>T26668</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009332</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GnRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Granulocytic Cell Destruction [PE]</name>
  <code>C29060</code>  <id>29061</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Destruction</to_name>
    <to_code>T26669</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009347</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Granulocytic Cell Production [PE]</name>
  <code>C29062</code>  <id>29063</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production</to_name>
    <to_code>T26670</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009348</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-txid [2700365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-bmez [2260702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-apgf [2469333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-cbqv [2102692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-sndz [1605064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-fpgk [2613761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-aafi [2057198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim [338036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-pbbk [2602779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim [68442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-ayow [2595942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-jmdb [2048018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Growth Factor Activity [PE]</name>
  <code>C31824</code>  <id>31825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Factor Activity</to_name>
    <to_code>T26671</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010233</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Growth Hormone Secretion [PE]</name>
  <code>C29018</code>  <id>29019</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion</to_name>
    <to_code>T26673</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased GH Secretion</to_name>
    <to_code>T26672</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009326</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin acetate [1999419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon [2644503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon-ghla [2644513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin acetate [1044583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin [1999420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin acetate [58932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin [56188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Hair Growth [PE]</name>
  <code>C637775</code>  <id>637775</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hair Growth</to_name>
    <to_code>T26674</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178321</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Hemagglutinin Inhibition Antibody Production [PE]</name>
  <code>C645975</code>  <id>645975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hemagglutinin Inhibition Antibody Production</to_name>
    <to_code>T26675</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000186107</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Hematological Cell Destruction [PE]</name>
  <code>C29064</code>  <id>29065</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematological Cell Destruction</to_name>
    <to_code>T26676</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009349</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematological Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Hematopoiesis [PE]</name>
  <code>C29066</code>  <id>29067</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoiesis</to_name>
    <to_code>T26677</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009350</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythroid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Hematopoiesis [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxytol [473387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atidarsagene autotemcel [2677916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoiesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Hematopoietic Stem Cell Mobilization [PE]</name>
  <code>C637778</code>  <id>637778</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoietic Stem Cell Mobilization</to_name>
    <to_code>T26678</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178324</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plerixafor [733003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide [2664896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide acetate [2664897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hematopoietic Stem Cell Mobilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Activity [PE]</name>
  <code>C29068</code>  <id>29069</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Activity</to_name>
    <to_code>T26679</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009351</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Degradation [PE]</name>
  <code>C29070</code>  <id>29071</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Degradation</to_name>
    <to_code>T26680</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009352</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Production [PE]</name>
  <code>C29072</code>  <id>29073</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production</to_name>
    <to_code>T26681</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009353</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylpenicilloyl polylysine [19079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Histamine Release [PE]</name>
  <code>C635022</code>  <id>635022</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release</to_name>
    <to_code>T26682</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175629</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burning bush pollen extract [852593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codfish allergenic extract [892543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nutmeg allergenic extract [891652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parthenolide [32941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pyrethrum cinerariifolium allergenic extract [967970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acremonium strictum allergenic extract [905070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black oak pollen extract [852260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora tarda allergenic extract [852404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog flea allergenic extract [886637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epidermophyton floccosum allergenic extract [995707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European house dust mite allergenic extract [1116979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red alder pollen extract [851914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black walnut allergenic extract [891695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white (mexican) dock pollen extract [1014743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine [4158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsnip allergenic extract [1011027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry birch pollen extract [852144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radish extract [1314656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>banana extract [285149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English oak pollen extract [1484984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tomato allergenic extract [892499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod, unspecified preparation [1426437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Jerusalem oak pollen extract [1014766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leek allergenic extract [1010932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arroyo willow pollen extract [852170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>licorice root extract [235524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cucumis sativus fruit extract [2700058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lima bean allergenic extract [891641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cola acuminata seed extract [1307595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>swordfish allergenic extract [901283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma harzianum allergenic extract [968197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common wasp venom protein [1297527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desert ragweed pollen extract [851981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cootamundra wattle pollen extract [895353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phoma destructiva allergenic extract [966995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef liver preparation [1330085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard seed allergenic extract [899456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eucalyptus globulus pollen extract [852386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gliocladium allergenic extract [1192997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rat skin extract [895279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mexican tea pollen extract [897391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2&apos;-dithiobisbenzothiazole [1306112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit bush pollen extract [851969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bean extract [1370773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brazil nut allergenic extract [891514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eggplant extract [1315116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton tonsurans allergenic extract [1098619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trout allergenic extract [882482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rough marshelder pollen extract [852532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chinquapin oak pollen extract [2167695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chocolate allergenic extract [1010915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium expansum allergenic extract [967111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geraniol [1368875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duck feather extract [892851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine bush pollen extract [851894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein allergenic extract [862460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass smut allergenic extract [852128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese black pine pollen extract [900777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk phospholipids [314605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Australian pine pollen extract [852229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat allergenic extract [971932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American lobster allergenic extract [1997187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Microsporum audouinii allergenic extract [1014395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oyster allergenic extract [973274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>veal allergenic extract [1012026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carrot allergenic extract [892368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Evernia prunastri extract [1352501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger allergenic extract [899420]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prairie sagebrush pollen extract [867142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse dander extract [2167548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove allergenic extract [899724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian balsam [33219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Blatta orientalis preparation [1346617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoeugenol [1363706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rocky Mountain juniper pollen extract [852601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulmus rubra pollen allergenic extract [1426632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitch pine pollen extract [900758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidurea [1368885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster skin extract [852663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue crab preparation [1315126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor racemosus allergenic extract [852687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger var. niger extract [854082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-tert-butylphenol-formaldehyde resin (low molecular weight) [1427189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turkey allergenic extract [975119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida tropicalis allergenic extract [967033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2-bis(4-glycidyloxyphenyl)propane [1368138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turkey feather extract [1594963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza glabra root powder extract [2711885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Platycladus orientalis pollen extract [1360623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Callistemon citrinus pollen extract [2171260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haematonectria haematococca allergenic extract [852503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broadleaf plantain pollen extract [1484983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus lunatus allergenic extract [852264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion allergenic extract [899466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>weakleaf bur ragweed pollen extract [1117083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>slash pine pollen extract [900731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Microascus brevicaulis allergenic extract [1192992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow sweet clover pollen extract [1014447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>groundsel pollen extract [897332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white hickory pollen extract [852193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint preparation [33093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pignut hickory pollen extract [899650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamic aldehyde [1368153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya allergenic extract [1011426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neurospora sitophila allergenic extract [1098200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>microsporum canis allergenic extract [1014399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sorghum bicolor pollen extract [1311406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black willow pollen extract [852162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse hair extract [895515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsam poplar pollen extract [1014762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clonostachys rosea f. rosea allergenic extract [1426481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acer pseudoplatanus pollen extract [1801702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tree of heaven pollen extract [851890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern yellow jacket venom protein [1297533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut allergenic extract [891611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl cinnamal [1311606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow birch pollen extract [899550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog skin extract [852839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES [350004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>German wasp venom protein [1297531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus nidulans allergenic extract [1368357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspen pollen extract [852339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scrub pine pollen extract [1013913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California mugwort pollen extract [892734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanilla bean allergenic extract [901291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Amaranthus hybridus pollen extract [1363561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef liver allergenic extract [972689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pumpkin allergenic extract [883459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet potato allergenic extract [901307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white ash pollen extract [852450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black carpenter ant allergenic extract [2057909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wing scale pollen extract [852074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadow fescue grass pollen extract [851918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit allergenic extract [813859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cucumber allergenic extract [899738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated oat pollen extract [852114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern sycamore pollen extract [852746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust mite extract, Dermatophagoides farinae [852810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colonial bent grass pollen extract [1484937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium digitatum allergenic extract [1427044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garlic preparation [265647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red cedar pollen extract [852609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western wheatgrass pollen extract [852659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated barley pollen extract [1098118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Quercus marilandica pollen extract [1437222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated mushroom allergenic extract [901369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster hair extract [1594965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn extract [1323308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley allergenic extract [899877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garlic allergenic extract [899414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazolidinylurea [1310602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-MERCAPTOBENZOTHIAZOLE [1306880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>honeydew melon allergenic extract [899476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golden chain pollen extract [1996102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eggplant allergenic extract [972601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oneseed juniper pollen extract [900108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water oak pollen extract [1013944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley allergenic extract [862453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast maple pollen extract [851736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anise seed extract [1309292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulmus glabra pollen extract [2369372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cow milk allergenic extract [892665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lobster allergenic extract [892561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broomweed pollen extract [1094193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plains cottonwood pollen extract [867297]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gambels oak pollen extract [852276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syringa vulgaris pollen extract [2634236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint flowering top extract [2168421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pin oak pollen extract [900999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>para grass pollen extract [894750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor circinelloides f. lusitanicus allergenic extract [2101473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sesame seed allergenic extract [901199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black sea bass allergenic extract [2102474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>giant ragweed pollen extract [851998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>date palm pollen extract [852704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sesame seed extract [1310046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brown rice preparation [1311040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>box elder maple pollen extract [851740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shrimp allergenic extract [892592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust mite extract, Dermatophagoides pteronyssinus [852826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redwood pollen extract [1014707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tabanus nigrovittatus extract [2590185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alkali blite pollen extract [852106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Calocedrus decurrens pollen extract [2670160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut allergenic extract [891658]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vitis vinifera pollen extract [2669695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bur oak pollen extract [900991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>German cockroach allergenic extract [905276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>annual bluegrass pollen extract [898404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English plantain pollen extract [852742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black pepper preparation [259314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Leucanthemum vulgare pollen [2102006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goose feather extract [894783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage leaf allergenic extract [1011627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cottonwood pollen extract [852376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse skin extract [852479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>algal fungi allergenic extract [966692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorquinaldol [2407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet gum pollen extract [852627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Scotch pine pollen extract [900764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>slender ragweed pollen extract [851990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus amstelodami extract [2101007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway seed allergenic extract [899637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jute fiber allergenic extract [852412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton rubrum allergenic extract [968413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strawberry allergenic extract [892484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watermelon preparation [260014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine carbamate [2375923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS [350075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English walnut allergenic extract [891687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brussels sprout allergenic extract [899390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nutmeg extract [1353217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mongolian gerbil skin allergenic extract [895070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Soy Proteins [36853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinach allergenic extract [901317]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-cyclohexyl-N&apos;-phenyl-1,4-phenylenediamine [1427136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans allergenic extract [214355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass smut allergenic extract [1014385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT, CAMEL [314336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobacco leaf allergenic extract [852062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western black willow pollen extract [1014755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern white pine pollen extract [852738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salsola tragus pollen extract [1314927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duck allergenic extract [972037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiram [10517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheasant feather extract [1594964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pear preparation [1367125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grain sorghum pollen extract [1098438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broadleaf cattail pollen extract [1232637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burrobrush pollen extract [852526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust allergenic extract [852519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse skin extract [852693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanilla bean extract [2275721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velvetleaf huckleberry allergenic extract [2102487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crab allergenic extract [892610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet pollen extract [852132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flounder allergenic extract [899746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium cladosporioides extract [867198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velvet grass pollen extract [852514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>northern quahog preparation [1925437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetramethylthiuram monosulfide [1363713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamyl alcohol [1362889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Russian thistle pollen extract [852158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brazilian pepper tree pollen extract [2632068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green ash pollen extract [852491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia longifolia pollen extract [853983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lettuce allergenic extract [899448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk (chicken) allergenic extract [892620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Koelers grass pollen extract [852605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>string bean allergenic extract [891676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red maple pollen extract [851744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium chrysogenum var. chrysogenum allergenic extract [854130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosin [1362931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pistachio nut allergenic extract [904606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cytisus scoparius flowering top extract [2168418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-mercaptobenzothiazole [1358845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>squash allergenic extract [975509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard pollen extract [852205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turnip allergenic extract [883414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver birch pollen allergenic extract [1306108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic halibut preparation [1424920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parakeet feather allergenic extract [1192987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed extract [853406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black locust pollen extract [867325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig skin extract [852298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Paecilomyces variotii allergenic extract [966979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>queen palm pollen extract [867353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lentil seed extract [1426921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white sweet clover pollen extract [1014735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pork allergenic extract [892628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium compactum allergenic extract [999457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipentamethylenethiuram disulfide [1426773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Solidago virgaurea pollen extract [1309242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California black oak pollen extract [1014721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osage orange pollen extract [1098189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast sage pollen extract [852011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium italicum allergenic extract [967960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine extract [1426364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>okra allergenic extract [1011021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chicken allergenic extract [892653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparagus allergenic extract [891796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic salmon allergenic extract [900031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon allergenic extract [899673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loose barley smut allergenic extract [968492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white mulberry pollen extract [852669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loblolly pine pollen extract [900770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia dealbata pollen extract [2202946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raspberry allergenic extract [899906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>giant wild rye pollen extract [900148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow dock pollen extract [852209]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American chestnut allergenic extract [891752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>London planetree [2166616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet wormwood pollen extract [2167819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharomyces cerevisiae allergenic extract [350141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Geotrichum candidum allergenic extract [999463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium solani allergenic extract [867349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black walnut pollen extract [852569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabbage allergenic extract [899398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>river birch pollen extract [852148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black imported fire ant allergenic extract [995738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western sycamore pollen extract [852750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitter dock pollen extract [1014739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stachybotrys chartarum allergenic extract [968123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California juniper pollen extract [852585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mung bean allergenic extract [891647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red imported fire ant allergenic extract [867341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N,N&apos;-diphenyl-4-phenylenediamine [1363709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gibberella fujikuroi extract [2043450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Khuskia oryzae allergenic extract [892338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern cottonwood pollen extract [852363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange pekoe tea allergenic extract [966696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape allergenic extract [892317]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plum allergenic extract [899470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cashew nut allergenic extract [892526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gibberella zeae allergenic extract [1922751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape extract [1307718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora betae allergenic extract [852756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white alder pollen extract [851910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptomyces griseus allergenic extract [1314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Apiospora montagnei allergenic extract [1006258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watercress allergenic extract [1011418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue beech pollen extract [899611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Siberian elm pollen extract [1299981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venison allergenic extract [882488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxycitronellal [1362893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc dibutyldithiocarbamate [1426942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>watermelon allergenic extract [901258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum extract [852617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic cod allergenic extract [900025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Periplaneta australasiae extract [2590183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit peel extract [1358897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hazelnut pollen extract [852281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common cocklebur pollen extract [902215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bay leaf extract [1606480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dendryphiella vinosa allergenic extract [995703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orchard grass pollen extract [851878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avocado oil [1311611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perch allergenic extract [976711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat dextrin [637366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat bran extract [1427046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic halibut allergenic extract [2261370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora herbarum allergenic extract [971198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bluefish allergenic extract [892181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Grindelia ciliata pollen extract [2043451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arizona ash pollen extract [852496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry juice [1307717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Jerusalem artichoke extract [1648701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben [34706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza glabra extract [1370435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>northern pike allergenic extract [889602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard greens allergenic extract [899452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sardine allergenic extract [974129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ash pollen extract [1484982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salt grass pollen extract [852329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy protein isolate [196238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allscale pollen extract [897304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shagbark hickory pollen extract [852221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hard maple pollen extract [851874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Corylus americana nut oil [1603849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black-eyed pea allergenic extract [899490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whey protein hydrolysate [2266754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel [1311629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>live oak pollen extract [867311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-oxydiethylene-2-benzothiazole sulfenamide [1363711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Verticillium albo-atrum allergenic extract [968467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern ragweed pollen extract [885750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoamphodiacetate [1364462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit hair extract [895527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cumin allergenic extract [901365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white oak pollen extract [852294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bald-faced hornet venom protein [1297525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arizona cypress pollen extract [852814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Camelus bactrianus hair extract [2590604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California scrub oak pollen extract [852802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Austrian pine pollen extract [900750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lichtheimia corymbifera allergenic extract [995727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley malt syrup [1306883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-isopropyl-N-phenyl-4-phenylenediamine [1363710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sheep sorrel pollen extract [852213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosquito allergenic extract [974741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phanerodontia chrysosporium allergenic extract [968114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broccoli allergenic extract [899386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salt cedar pollen extract [852806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellowfin tuna allergenic extract [2102488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oyster, unspecified preparation [1315121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carob allergenic extract [904498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Italian rye grass pollen extract [1014340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bahia grass pollen extract [852673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western juniper pollen extract [852589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lambs quarters pollen extract [852237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA [350060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut extract [1372248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor circinelloides f. circinelloides allergenic extract [2101422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange pollen extract [897403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perennial rye grass pollen extract [852819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pepper tree pollen extract [852140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green olive allergenic extract [971379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-cyclohexyl-2-benzothiazosulfenamide [1306886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium glaucum allergenic extract [1986792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit extract [124323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Garrys oak pollen extract [900987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cochliobolus spicifer allergenic extract [995699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow hornet venom protein [1297537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat hair extract [895503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English walnut pollen extract [852577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion extract [1370469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces cerevisiae [9511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pacific halibut allergenic extract [882469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Utah juniper pollen extract [852597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broad leaved paperbark pollen extract [903913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Humicola grisea allergenic extract [1014391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western white pine pollen extract [900743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acrothecium robustum allergenic extract [905088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP [349980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western larch pollen extract [2166614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canyon ragweed pollen extract [851942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylguanidine [1368170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potato allergenic extract [892632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sour cherry allergenic extract [1012134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango extract [1426332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lombardy poplar pollen extract [852348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pineapple extract [1492174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bronopol [1114345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hackberry pollen extract [852324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>longleaf pine pollen extract [1014360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lens scale pollen extract [852096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dark leaved mugwort pollen extract [896246]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canary grass pollen extract [852697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Iris germanica var. florentina root extract [1993233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burweed marshelder pollen extract [852551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>banana allergenic extract [891830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylenediamine [1362740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hazelnut allergenic extract [891633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>okra extract [1370787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley extract [1370766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chicken feather extract [894934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pinus cembroides pollen extract [2590679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kidney bean allergenic extract [891637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben calcium [1867698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linden pollen extract [852070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange allergenic extract [892565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris root allergenic extract [1098353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cucumber extract [1305719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cheat grass pollen extract [852225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European beech pollen extract [1484981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean lecithin [579598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common carp allergenic extract [901390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palo verde pollen extract [852359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet vernal grass pollen extract [851898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon allergenic extract [901382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rye allergenic extract [892638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesquite pollen extract [852320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paper birch pollen extract [899576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canada goldenrod pollen extract [995743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog hair extract [895542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canadian bluegrass pollen extract [1014731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nux vomica extract [314743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Allium cepa bulb extract [2695867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>narrowleaf marshelder pollen extract [1098130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylparaben [19075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantaloupe allergenic extract [892517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chinese elm pollen extract [852844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redberry juniper pollen extract [900113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue spruce pollen extract [900704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California black walnut pollen extract [852561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>european olive pollen extract [852653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger root [125921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tall oat grass pollen extract [1006506]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celery allergenic extract [892372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haddock allergenic extract [899428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladosporium sphaerospermum allergenic extract [867202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wormwood sage pollen extract [852007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white fish allergenic extract [901265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tag alder pollen extract [851902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apple extract [1424865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum allergenic extract [2101722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadow foxtail pollen extract [1484974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>privet pollen extract [852622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocklebur pollen extract [852025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus arrhizus allergenic extract [314443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat germ oil [72385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gray birch pollen extract [852178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton schoenleinii allergenic extract [968422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cynara preparation [235940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>post oak pollen extract [901011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig dander [2166593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chickpea allergenic extract [1011049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver maple pollen extract [851866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peach allergenic extract [892575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus flavus allergenic extract [999384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redroot pigweed pollen extract [851930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry allergenic extract [899734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow dander extract [2166591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paprika allergenic extract [899873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Coffea arabica seed extract [2695791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coffee bean allergenic extract [891727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black olive allergenic extract [974650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cotton fiber allergenic extract [966925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English sole allergenic extract [974140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white catfish allergenic extract [971166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house fly allergenic extract [350173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apple allergenic extract [891771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shortleaf pine pollen extract [852709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pussy willow pollen extract [852174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern bayberry pollen extract [867260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white poplar pollen extract [852382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red currant allergenic extract [972480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barley malt allergenic extract [1006510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat skin extract [852252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water birch pollen extract [852166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neurospora intermedia allergenic extract [867274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Evernia prunastri extract [1311644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scallop allergenic extract [899916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red oak pollen extract [852268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg (chicken) allergenic extract [904507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetracoccosporium paxianum allergenic extract [968502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichothecium roseum allergenic extract [968426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat hair extract [248123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quince extract [1370761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>date allergenic extract [899742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sandbur ragweed pollen extract [851955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fivehorn smotherweed pollen extract [852124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saltbush pollen extract [897316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower seed extract [1309391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disperse blue 106 [1368171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog dander extract [2167551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quackgrass pollen extract [852343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European aspen pollen extract [2166596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa bean allergenic extract [891721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ditiocarb, zinc salt [1427192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dill allergenic extract [975763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP [350160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sudan grass pollen extract [1098455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western waterhemp pollen extract [851934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium roquefortii allergenic extract [972365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bulbous buttercup pollen extract [1484985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS [350125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS [350081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apricot allergenic extract [895574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>greasewood pollen extract [852152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat pollen extract [867361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red snapper allergenic extract [889646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodgepole pine pollen extract [898324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valley oak pollen extract [1111024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon preparation [1421430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast live oak pollen extract [852302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quaternium-15 [283678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dogfennel pollen extract [867218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus flavus var. oryzae protease [1307040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syncephalastrum racemosum allergenic extract [968506]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanolin alcohols [1426478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme allergenic extract [974527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula mucilaginosa allergenic extract [967529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avocado allergenic extract [895582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canary feather extract [894961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg white (chicken) allergenic extract [892616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thimerosal [10472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit allergenic extract [899424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safflower seed extract [1440241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Puccinia graminis allergenic extract [999487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus repens allergenic extract [1006310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cotton seed extract [1309369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trifolium pratense pollen extract [2102052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red pine pollen extract [900754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white willow pollen extract [1484986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow hair extract [895488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hypomyces perniciosus allergenic extract [1192968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Carya laciniosa pollen extract [1305551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>winterfat pollen extract [852613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lime (citrus) extract [1305725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red pepper extract [1313692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shad scale pollen extract [852087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kapok tree fiber allergenic extract [852315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loose wheat smut allergenic extract [968437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red bell pepper allergenic extract [901329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sea scallop preparation [1426396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Russian olive pollen extract [852367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>largemouth bass allergenic extract [1098183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian pepper tree pollen extract [2632070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radish allergenic extract [974687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat flea allergenic extract [886638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixocortol pivalate [38336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow pine pollen extract [852716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley seed oil [1309236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buckwheat allergenic extract [899394]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trifolium pratense pollen extract [1340182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Colletotrichum coccodes allergenic extract [1192729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium sarciniforme allergenic extract [968130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern yellow jacket venom protein [1297529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salix repens pollen extract [2533912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Indian wormwood sage pollen extract [1006495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Humulus lupulus pollen extract [1740937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ustilago maydis extract [1427134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia pollen extract [851732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alnus glutinosa bark extract [1441543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit skin extract [895195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium camemberti allergenic extract [966943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme preparation [319823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oregano allergenic extract [1010965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black pepper allergenic extract [899363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pisum sativum (pea) extract [1426912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lime allergenic extract [1011060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phoma exigua var. exigua allergenic extract [867284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salix lutea pollen extract [2590686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl-p-hydroxybenzoate [1362892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pale dock pollen extract [1232604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mountain cedar pollen extract [852581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cricket allergenic extract [973447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American elm pollen extract [852054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cauliflower allergenic extract [899661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Oregon ash pollen extract [900045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Helminthosporium solani allergenic extract [867232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American house dust mite allergenic extract [1116977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lentil allergenic extract [899444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>littleseed canary grass pollen extract [1098232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat bran [253190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine allergenic extract [1011412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nettle pollen extract [852046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western yellow jacket venom protein [1297535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bald cypress pollen extract [995747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sydney golden wattle pollen extract [895365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldibromo glutaronitrile [1307044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Puccinia striiformis allergenic extract [852311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red mulberry pollen extract [852680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedar elm pollen extract [1014191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango allergenic extract [1011404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fig allergenic extract [973880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green bell pepper allergenic extract [862478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allspice allergenic extract [895552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mulberry pollen extract [899593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM [317581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goat milk allergenic extract [862475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fremont cottonwood pollen extract [852355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse hair extract [1993210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower seed allergenic extract [901203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>careless weed pollen extract [851926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Schinus terebinthifolius pollen extract [2590688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horseradish allergenic extract [1011043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lawsonia inermis leaf extract [1307699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocean perch preparation [2471431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silk allergenic extract [314455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clam allergenic extract [892539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated rye grass pollen extract [1014774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower pollen extract [852509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef allergenic extract [892599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common hazel pollen extract [1484979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfalfa pollen extract [852634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Douglas fir pollen extract [1098257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gliocladium viride extract [2101008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raspberry extract [1370769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver ragweed pollen extract [852306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben sodium [1311574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Malus domestica pollen extract [2593689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamb allergenic extract [971849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Epicoccum nigrum allergenic extract [852466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat gluten extract [1370781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitternut hickory pollen extract [899645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn grain extract [1423924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sisal fiber allergenic extract [851882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil [1309229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jack pine pollen extract [1014690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basil allergenic extract [899355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grama grass pollen extract [852197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grape extract [253172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zucchini extract [1649134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig hair extract [895507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American cockroach allergenic extract [905258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint allergenic extract [901313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crested dogstail pollen extract [1484980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Apis mellifera preparation [285219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylparaben [29903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean allergenic extract [891668]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Atlantic mackerel allergenic extract [2198984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tuna allergenic extract [892503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American basswood pollen extract [995754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Passalora fulva allergenic extract [883442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poverty weed pollen extract [852539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canis lupus familiaris hair extract [854025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rattus norvegicus hair preparation [2471704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creeping bentgrass pollen extract [1094116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Strychnos nux-vomica seed extract [1309678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herring allergenic extract [899434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Concord grape allergenic extract [901191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poppy seed allergenic extract [1011017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Whey Proteins [1723989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased IgG Production [PE]</name>
  <code>C644792</code>  <id>644792</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunoglobulin G Production</to_name>
    <to_code>T26683</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production</to_name>
    <to_code>T26684</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185001</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased IgG Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Hemagglutinin Inhibition Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Douglas fir pollen extract [1098257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gliocladium viride extract [2101008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora betae allergenic extract [852756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white alder pollen extract [851910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silk allergenic extract [314455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common hazel pollen extract [1484979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfalfa pollen extract [852634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated rye grass pollen extract [1014774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower pollen extract [852509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Periplaneta australasiae extract [2590183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sisal fiber allergenic extract [851882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum extract [852617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil [1309229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grama grass pollen extract [852197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jack pine pollen extract [1014690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hazelnut pollen extract [852281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common cocklebur pollen extract [902215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue beech pollen extract [899611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Siberian elm pollen extract [1299981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Malus domestica pollen extract [2593689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptomyces griseus allergenic extract [1314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver ragweed pollen extract [852306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitternut hickory pollen extract [899645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Epicoccum nigrum allergenic extract [852466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat dextrin [637366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Passalora fulva allergenic extract [883442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American basswood pollen extract [995754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poverty weed pollen extract [852539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora herbarum allergenic extract [971198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat bran extract [1427046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crested dogstail pollen extract [1484980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dendryphiella vinosa allergenic extract [995703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American cockroach allergenic extract [905258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig hair extract [895507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Apis mellifera preparation [285219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orchard grass pollen extract [851878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylparaben [29903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Strychnos nux-vomica seed extract [1309678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry juice [1307717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Whey Proteins [1723989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben [34706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rattus norvegicus hair preparation [2471704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Grindelia ciliata pollen extract [2043451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canis lupus familiaris hair extract [854025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arizona ash pollen extract [852496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creeping bentgrass pollen extract [1094116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loose barley smut allergenic extract [968492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mountain cedar pollen extract [852581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American elm pollen extract [852054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white mulberry pollen extract [852669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cricket allergenic extract [973447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loblolly pine pollen extract [900770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phoma exigua var. exigua allergenic extract [867284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pale dock pollen extract [1232604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salix lutea pollen extract [2590686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat bran [253190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>London planetree [2166616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nettle pollen extract [852046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western yellow jacket venom protein [1297535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>littleseed canary grass pollen extract [1098232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Geotrichum candidum allergenic extract [999463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black walnut pollen extract [852569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium solani allergenic extract [867349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sydney golden wattle pollen extract [895365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bald cypress pollen extract [995747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharomyces cerevisiae allergenic extract [350141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow dock pollen extract [852209]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>giant wild rye pollen extract [900148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia dealbata pollen extract [2202946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American house dust mite allergenic extract [1116977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Oregon ash pollen extract [900045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Helminthosporium solani allergenic extract [867232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM [317581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red imported fire ant allergenic extract [867341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California juniper pollen extract [852585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mulberry pollen extract [899593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stachybotrys chartarum allergenic extract [968123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse hair extract [1993210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fremont cottonwood pollen extract [852355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black imported fire ant allergenic extract [995738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red mulberry pollen extract [852680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedar elm pollen extract [1014191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>river birch pollen extract [852148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Puccinia striiformis allergenic extract [852311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western sycamore pollen extract [852750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitter dock pollen extract [1014739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lawsonia inermis leaf extract [1307699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gibberella zeae allergenic extract [1922751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gibberella fujikuroi extract [2043450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Khuskia oryzae allergenic extract [892338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Schinus terebinthifolius pollen extract [2590688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern cottonwood pollen extract [852363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Russian thistle pollen extract [852158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Hypomyces perniciosus allergenic extract [1192968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Carya laciniosa pollen extract [1305551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia longifolia pollen extract [853983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brazilian pepper tree pollen extract [2632068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>green ash pollen extract [852491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>winterfat pollen extract [852613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium cladosporioides extract [867198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trifolium pratense pollen extract [2102052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red pine pollen extract [900754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white willow pollen extract [1484986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velvet grass pollen extract [852514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow hair extract [895488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium chrysogenum var. chrysogenum allergenic extract [854130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosin [1362931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian pepper tree pollen extract [2632070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard pollen extract [852205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow pine pollen extract [852716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley seed oil [1309236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cytisus scoparius flowering top extract [2168418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat flea allergenic extract [886638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixocortol pivalate [38336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loose wheat smut allergenic extract [968437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shad scale pollen extract [852087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kapok tree fiber allergenic extract [852315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Koelers grass pollen extract [852605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red maple pollen extract [851744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Russian olive pollen extract [852367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black locust pollen extract [867325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed extract [853406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salix repens pollen extract [2533912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Indian wormwood sage pollen extract [1006495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ustilago maydis extract [1427134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig skin extract [852298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acacia pollen extract [851732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alnus glutinosa bark extract [1441543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Humulus lupulus pollen extract [1740937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver birch pollen allergenic extract [1306108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trifolium pratense pollen extract [1340182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Colletotrichum coccodes allergenic extract [1192729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium sarciniforme allergenic extract [968130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parakeet feather allergenic extract [1192987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern yellow jacket venom protein [1297529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Solidago virgaurea pollen extract [1309242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium camemberti allergenic extract [966943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme preparation [319823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium italicum allergenic extract [967960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California black oak pollen extract [1014721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osage orange pollen extract [1098189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white sweet clover pollen extract [1014735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit skin extract [895195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Paecilomyces variotii allergenic extract [966979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>queen palm pollen extract [867353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium compactum allergenic extract [999457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cottonwood pollen extract [852376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP [350160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goose feather extract [894783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quackgrass pollen extract [852343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Leucanthemum vulgare pollen [2102006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European aspen pollen extract [2166596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>algal fungi allergenic extract [966692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sudan grass pollen extract [1098455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse skin extract [852479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Calocedrus decurrens pollen extract [2670160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alkali blite pollen extract [852106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vitis vinifera pollen extract [2669695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fivehorn smotherweed pollen extract [852124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saltbush pollen extract [897316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>German cockroach allergenic extract [905276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English plantain pollen extract [852742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>annual bluegrass pollen extract [898404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog dander extract [2167551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bur oak pollen extract [900991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS [350075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS [350081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton rubrum allergenic extract [968413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium roquefortii allergenic extract [972365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet gum pollen extract [852627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western waterhemp pollen extract [851934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Scotch pine pollen extract [900764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus amstelodami extract [2101007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jute fiber allergenic extract [852412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bulbous buttercup pollen extract [1484985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS [350125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quaternium-15 [283678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mongolian gerbil skin allergenic extract [895070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast live oak pollen extract [852302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Soy Proteins [36853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT, CAMEL [314336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass smut allergenic extract [1014385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syncephalastrum racemosum allergenic extract [968506]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus flavus var. oryzae protease [1307040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobacco leaf allergenic extract [852062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans allergenic extract [214355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dogfennel pollen extract [867218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>greasewood pollen extract [852152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat pollen extract [867361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valley oak pollen extract [1111024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodgepole pine pollen extract [898324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust allergenic extract [852519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house mouse skin extract [852693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cotton seed extract [1309369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet pollen extract [852132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Puccinia graminis allergenic extract [999487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus repens allergenic extract [1006310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula mucilaginosa allergenic extract [967529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheasant feather extract [1594964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western black willow pollen extract [1014755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanolin alcohols [1426478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme allergenic extract [974527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern white pine pollen extract [852738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salsola tragus pollen extract [1314927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thimerosal [10472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grain sorghum pollen extract [1098438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broadleaf cattail pollen extract [1232637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canary feather extract [894961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guinea pig dander [2166593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium digitatum allergenic extract [1427044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>post oak pollen extract [901011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver maple pollen extract [851866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus arrhizus allergenic extract [314443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eastern sycamore pollen extract [852746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust mite extract, Dermatophagoides farinae [852810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat germ oil [72385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated oat pollen extract [852114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocklebur pollen extract [852025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colonial bent grass pollen extract [1484937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton schoenleinii allergenic extract [968422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gray birch pollen extract [852178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coast maple pollen extract [851736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oneseed juniper pollen extract [900108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow dander extract [2166591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water oak pollen extract [1013944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulmus glabra pollen extract [2369372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cultivated barley pollen extract [1098118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Quercus marilandica pollen extract [1437222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red cedar pollen extract [852609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western wheatgrass pollen extract [852659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golden chain pollen extract [1996102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster hair extract [1594965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazolidinylurea [1310602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat skin extract [852252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>para grass pollen extract [894750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pin oak pollen extract [900999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor circinelloides f. lusitanicus allergenic extract [2101473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>date palm pollen extract [852704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water birch pollen extract [852166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neurospora intermedia allergenic extract [867274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plains cottonwood pollen extract [867297]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gambels oak pollen extract [852276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house fly allergenic extract [350173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cotton fiber allergenic extract [966925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broomweed pollen extract [1094193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pussy willow pollen extract [852174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syringa vulgaris pollen extract [2634236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shortleaf pine pollen extract [852709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white poplar pollen extract [852382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern bayberry pollen extract [867260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat hair extract [248123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust mite extract, Dermatophagoides pteronyssinus [852826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tabanus nigrovittatus extract [2590185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redwood pollen extract [1014707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>box elder maple pollen extract [851740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red oak pollen extract [852268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichothecium roseum allergenic extract [968426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetracoccosporium paxianum allergenic extract [968502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesquite pollen extract [852320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow sweet clover pollen extract [1014447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>groundsel pollen extract [897332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris root allergenic extract [1098353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white hickory pollen extract [852193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>slash pine pollen extract [900731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Microascus brevicaulis allergenic extract [1192992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palo verde pollen extract [852359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet vernal grass pollen extract [851898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pignut hickory pollen extract [899650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cheat grass pollen extract [852225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European beech pollen extract [1484981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean lecithin [579598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black willow pollen extract [852162]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nux vomica extract [314743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canadian bluegrass pollen extract [1014731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sorghum bicolor pollen extract [1311406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsam poplar pollen extract [1014762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse hair extract [895515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>narrowleaf marshelder pollen extract [1098130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neurospora sitophila allergenic extract [1098200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>microsporum canis allergenic extract [1014399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paper birch pollen extract [899576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Canada goldenrod pollen extract [995743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog hair extract [895542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>european olive pollen extract [852653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES [350004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hog skin extract [852839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California black walnut pollen extract [852561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue spruce pollen extract [900704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow birch pollen extract [899550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>German wasp venom protein [1297531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clonostachys rosea f. rosea allergenic extract [1426481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acer pseudoplatanus pollen extract [1801702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redberry juniper pollen extract [900113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>southern yellow jacket venom protein [1297533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chinese elm pollen extract [852844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tree of heaven pollen extract [851890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadow foxtail pollen extract [1484974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white ash pollen extract [852450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black carpenter ant allergenic extract [2057909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wing scale pollen extract [852074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum allergenic extract [2101722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>privet pollen extract [852622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadow fescue grass pollen extract [851918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scrub pine pollen extract [1013913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladosporium sphaerospermum allergenic extract [867202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus nidulans allergenic extract [1368357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspen pollen extract [852339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Amaranthus hybridus pollen extract [1363561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California mugwort pollen extract [892734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tag alder pollen extract [851902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broad leaved paperbark pollen extract [903913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chinquapin oak pollen extract [2167695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rough marshelder pollen extract [852532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Utah juniper pollen extract [852597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Humicola grisea allergenic extract [1014391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western white pine pollen extract [900743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass smut allergenic extract [852128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese black pine pollen extract [900777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk phospholipids [314605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium expansum allergenic extract [967111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duck feather extract [892851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine bush pollen extract [851894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow hornet venom protein [1297537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cochliobolus spicifer allergenic extract [995699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic goat hair extract [895503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces cerevisiae [9511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English walnut pollen extract [852577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton tonsurans allergenic extract [1098619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion extract [1370469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse dander extract [2167548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian balsam [33219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western larch pollen extract [2166614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Microsporum audouinii allergenic extract [1014395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acrothecium robustum allergenic extract [905088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Australian pine pollen extract [852229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP [349980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canary grass pollen extract [852697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Iris germanica var. florentina root extract [1993233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>longleaf pine pollen extract [1014360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lens scale pollen extract [852096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor racemosus allergenic extract [852687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger var. niger extract [854082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida tropicalis allergenic extract [967033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burweed marshelder pollen extract [852551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Blatta orientalis preparation [1346617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rocky Mountain juniper pollen extract [852601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lombardy poplar pollen extract [852348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidurea [1368885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hackberry pollen extract [852324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Syrian hamster skin extract [852663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulmus rubra pollen allergenic extract [1426632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitch pine pollen extract [900758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bronopol [1114345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chicken feather extract [894934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pinus cembroides pollen extract [2590679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linden pollen extract [852070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>weakleaf bur ragweed pollen extract [1117083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus lunatus allergenic extract [852264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylenediamine [1362740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turkey feather extract [1594963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haematonectria haematococca allergenic extract [852503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>broadleaf plantain pollen extract [1484983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Callistemon citrinus pollen extract [2171260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Platycladus orientalis pollen extract [1360623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pyrethrum cinerariifolium allergenic extract [967970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Acremonium strictum allergenic extract [905070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black oak pollen extract [852260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shagbark hickory pollen extract [852221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hard maple pollen extract [851874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora tarda allergenic extract [852404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel [1311629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whey protein hydrolysate [2266754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>live oak pollen extract [867311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burning bush pollen extract [852593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy protein isolate [196238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allscale pollen extract [897304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ash pollen extract [1484982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salt grass pollen extract [852329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>California scrub oak pollen extract [852802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arizona cypress pollen extract [852814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Camelus bactrianus hair extract [2590604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sheep sorrel pollen extract [852213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosquito allergenic extract [974741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Austrian pine pollen extract [900750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lichtheimia corymbifera allergenic extract [995727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red alder pollen extract [851914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white (mexican) dock pollen extract [1014743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Verticillium albo-atrum allergenic extract [968467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog flea allergenic extract [886637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epidermophyton floccosum allergenic extract [995707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European house dust mite allergenic extract [1116979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European rabbit hair extract [895527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>white oak pollen extract [852294]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bald-faced hornet venom protein [1297525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry birch pollen extract [852144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoamphodiacetate [1364462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bahia grass pollen extract [852673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western juniper pollen extract [852589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma harzianum allergenic extract [968197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phanerodontia chrysosporium allergenic extract [968114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English oak pollen extract [1484984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salt cedar pollen extract [852806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Italian rye grass pollen extract [1014340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arroyo willow pollen extract [852170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Jerusalem oak pollen extract [1014766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gliocladium allergenic extract [1192997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange pollen extract [897403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eucalyptus globulus pollen extract [852386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perennial rye grass pollen extract [852819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pepper tree pollen extract [852140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Garrys oak pollen extract [900987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mexican tea pollen extract [897391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rat skin extract [895279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit extract [124323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium glaucum allergenic extract [1986792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cootamundra wattle pollen extract [895353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phoma destructiva allergenic extract [966995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common wasp venom protein [1297527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor circinelloides f. circinelloides allergenic extract [2101422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard seed allergenic extract [899456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lambs quarters pollen extract [852237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA [350060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologic Activity [PE]</name>
  <code>C634944</code>  <id>634944</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immune System Stimulation</to_name>
    <to_code>T26688</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immune Stimulation</to_name>
    <to_code>T26685</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Stimulation</to_name>
    <to_code>T26686</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunostimulation</to_name>
    <to_code>T26687</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity</to_name>
    <to_code>T26689</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175551</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept-pmln [2682677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized [2642139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-txid [2700365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sipuleucel-T [997261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized [2642138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elotuzumab [1726104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efbemalenograstim alfa [2670630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus envelope glycoprotein [2624742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapinarof [2602286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab [2716802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab-rwlc [2058825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein [2636589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipilimumab [1094833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efbemalenograstim alfa-vuxw [2670656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F protein, recombinant [2636588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein [2624741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab-cfor [2716803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept [2682678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Biogenic Amine Activity [PE]</name>
  <code>C29074</code>  <id>29075</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Biogenic Amine Activity</to_name>
    <to_code>T26690</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009354</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Biogenic Amine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Biogenic Amine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Biogenic Amine Degradation [PE]</name>
  <code>C29076</code>  <id>29077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Biogenic Amine Degradation</to_name>
    <to_code>T26691</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009355</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Biogenic Amine Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Biogenic Amine Production [PE]</name>
  <code>C29078</code>  <id>29079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Biogenic Amine Production</to_name>
    <to_code>T26692</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009356</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Biogenic Amine Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Biogenic Amine Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Molecule Activity [PE]</name>
  <code>C29080</code>  <id>29081</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity</to_name>
    <to_code>T26693</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009357</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Biogenic Amine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kallidin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Complement Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir calcium [402365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir mesylate [266565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir [114289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies immune globulin, human [89886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir [358262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir anhydrous [1546024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir sulfate [203153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zalcitabine [3363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole phosphate [1535214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea preparation [228041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps skin test antigen [89854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole [6371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole hydrochloride [227227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir anhydrous [1546017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antirabies serum,equine [485234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Molecule Degradation [PE]</name>
  <code>C29082</code>  <id>29083</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Degradation</to_name>
    <to_code>T26694</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009358</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kallidin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Biogenic Amine Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Complement Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Immunologically Active Molecule Production [PE]</name>
  <code>C29084</code>  <id>29085</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Production</to_name>
    <to_code>T26695</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009359</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cytokine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Complement Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adhesion Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kallidin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Biogenic Amine Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acemannan [1426875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Insulin Secretion [PE]</name>
  <code>C29086</code>  <id>29087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion</to_name>
    <to_code>T26696</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009360</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin [593411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin [857974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semaglutide [1991302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linagliptin [1100699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel [2642217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium,chelated [259277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel-jujn [2642260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride dihydrate [2643444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide sodium [221173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride [1043560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin phosphate [621590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin hydrochloride [2716481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin anhydrous [1546030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Intracellular Communication [PE]</name>
  <code>C27702</code>  <id>27703</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intracellular Communication</to_name>
    <to_code>T26697</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000008668</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Intravascular Volume [PE]</name>
  <code>C29088</code>  <id>29089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume</to_name>
    <to_code>T26698</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009361</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasma protein fraction [33835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 1 [214485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate anhydrous [1310549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl starch 130-0.4 [1363352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran [42635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Iodine Organification [PE]</name>
  <code>C29090</code>  <id>29091</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Iodine Organification</to_name>
    <to_code>T26699</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009362</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Iodine Uptake [PE]</name>
  <code>C29092</code>  <id>29093</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Iodine Uptake</to_name>
    <to_code>T26700</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009363</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Kallidin Activity [PE]</name>
  <code>C29094</code>  <id>29095</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kallidin Activity</to_name>
    <to_code>T26701</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009364</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Kallidin Degradation [PE]</name>
  <code>C29096</code>  <id>29097</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kallidin Degradation</to_name>
    <to_code>T26702</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009365</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Kallidin Production [PE]</name>
  <code>C29098</code>  <id>29099</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kallidin Production</to_name>
    <to_code>T26703</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009366</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Kinin Activity [PE]</name>
  <code>C29100</code>  <id>29101</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kinin Activity</to_name>
    <to_code>T26704</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009367</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Kinin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bradykinin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Kinin Degradation [PE]</name>
  <code>C29102</code>  <id>29103</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kinin Degradation</to_name>
    <to_code>T26705</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009368</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Kinin Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bradykinin Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Kinin Production [PE]</name>
  <code>C29104</code>  <id>29105</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Kinin Production</to_name>
    <to_code>T26706</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009369</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Kinin Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Bradykinin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased LES Tone [PE]</name>
  <code>C29106</code>  <id>29107</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased LES Tone</to_name>
    <to_code>T26707</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009370</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased LES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased LES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased LES Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Large Intestinal Motility [PE]</name>
  <code>C29108</code>  <id>29109</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility</to_name>
    <to_code>T26708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009371</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picosulfate sodium [33688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisacodyl [1596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium cation [1311382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate sodium [71722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine [1876597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfate ion [1426598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium cation [1364429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine tosylate [1876598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate calcium [82001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil [6972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloe extract [91263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (4000 CPS) [1297402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate potassium [82002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil, light [577312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deacetylbisacodyl [1872905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate [82003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>di-n-octyl sodium sulfosuccinate [1534779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malt soup extract [91264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride succinate [2107309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heavy mineral oil [258439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casanthranol [66870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (100 CPS) [1310583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Large Intestinal Muscle Tone [PE]</name>
  <code>C29110</code>  <id>29111</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Muscle Tone</to_name>
    <to_code>T26709</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009372</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Leukotriene Activity [PE]</name>
  <code>C29112</code>  <id>29113</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Leukotriene Activity</to_name>
    <to_code>T26710</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009373</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Leukotriene Degradation [PE]</name>
  <code>C29114</code>  <id>29115</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Leukotriene Degradation</to_name>
    <to_code>T26711</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009374</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Leukotriene Production [PE]</name>
  <code>C29116</code>  <id>29117</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Leukotriene Production</to_name>
    <to_code>T26712</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009375</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</name>
  <code>C29118</code>  <id>29119</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipid Derived Immunologically Active Molecule Activity</to_name>
    <to_code>T26713</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009376</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Eicosanoid Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lipid Derived Immunologically Active Molecule Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</name>
  <code>C29120</code>  <id>29121</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipid Derived Immunologically Active Molecule Degradation</to_name>
    <to_code>T26714</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009377</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Eicosanoid Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lipid Derived Immunologically Active Molecule Degradation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</name>
  <code>C29122</code>  <id>29123</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipid Derived Immunologically Active Molecule Production</to_name>
    <to_code>T26715</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009378</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Eicosanoid Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lipid Derived Immunologically Active Molecule Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lipogenesis [PE]</name>
  <code>C29124</code>  <id>29125</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis</to_name>
    <to_code>T26716</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009379</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lipolysis [PE]</name>
  <code>C29126</code>  <id>29127</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis</to_name>
    <to_code>T26717</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009380</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evolocumab [1665684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alirocumab [1659152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Ca++ Excretion [PE]</name>
  <code>C29128</code>  <id>29129</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion</to_name>
    <to_code>T26718</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009381</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Cl- Excretion [PE]</name>
  <code>C29130</code>  <id>29131</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion</to_name>
    <to_code>T26719</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009382</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle H+ Excretion [PE]</name>
  <code>C29132</code>  <id>29133</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle H+ Excretion</to_name>
    <to_code>T26720</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009383</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle HCO3- Excretion [PE]</name>
  <code>C29134</code>  <id>29135</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle HCO3- Excretion</to_name>
    <to_code>T26721</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009384</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle K+ Excretion [PE]</name>
  <code>C29136</code>  <id>29137</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion</to_name>
    <to_code>T26722</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009385</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Mg++ Excretion [PE]</name>
  <code>C29138</code>  <id>29139</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion</to_name>
    <to_code>T26723</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009386</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle Na+ Excretion [PE]</name>
  <code>C29140</code>  <id>29141</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion</to_name>
    <to_code>T26724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009387</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle PO4-- Excretion [PE]</name>
  <code>C29142</code>  <id>29143</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle PO4-- Excretion</to_name>
    <to_code>T26725</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009388</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Loop of Henle SO4-- Excretion [PE]</name>
  <code>C29144</code>  <id>29145</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle SO4-- Excretion</to_name>
    <to_code>T26726</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009389</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Luteinizing Hormone Secretion [PE]</name>
  <code>C30230</code>  <id>30231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion</to_name>
    <to_code>T26728</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased LH Secretion</to_name>
    <to_code>T26727</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009931</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutropin alfa [388084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lymphocyte Activation [PE]</name>
  <code>C637782</code>  <id>637782</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation</to_name>
    <to_code>T26729</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178328</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lymphocyte Activation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lymphocyte Activation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elotuzumab [1726104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lymphocyte Cell Destruction [PE]</name>
  <code>C29146</code>  <id>29147</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Destruction</to_name>
    <to_code>T26730</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009390</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lymphocyte Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lymphocyte Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab-cdon [2373950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alemtuzumab [117055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab [2373951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lymphocyte Cell Production [PE]</name>
  <code>C29148</code>  <id>29149</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production</to_name>
    <to_code>T26731</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009391</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lymphocyte Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Lymphocyte Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased B Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase [2059219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase-lvlr [2059218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Lysosomal Function [PE]</name>
  <code>C29150</code>  <id>29151</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function</to_name>
    <to_code>T26732</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009392</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idursulfase [644101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa-atga [2667434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elosulfase alfa [1489914]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa [2667433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galsulfase [578033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laronidase [392509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Macrophage Proliferation [PE]</name>
  <code>C643500</code>  <id>643500</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Macrophage Proliferation</to_name>
    <to_code>T26733</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183884</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Macrophage Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Medullary Respiratory Drive [PE]</name>
  <code>C29152</code>  <id>29153</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive</to_name>
    <to_code>T26734</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009393</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonia spirit, aromatic [317201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Megakaryocte Cell Destruction [PE]</name>
  <code>C29154</code>  <id>29155</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Destruction</to_name>
    <to_code>T26735</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009394</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Megakaryocte Cell Production [PE]</name>
  <code>C29156</code>  <id>29157</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Production</to_name>
    <to_code>T26736</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009395</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Megakaryocte Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag maleate [2045727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Megakaryocyte Maturation [PE]</name>
  <code>C635423</code>  <id>635423</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation</to_name>
    <to_code>T26737</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175969</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag choline [2675185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romiplostim [805452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Meiosis [PE]</name>
  <code>C29158</code>  <id>29159</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Meiosis</to_name>
    <to_code>T26738</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009396</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Melatonin Activity [PE]</name>
  <code>C29160</code>  <id>29161</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Activity</to_name>
    <to_code>T26739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009397</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melatonin [6711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramelteon [596205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tasimelteon [1490468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Melatonin Secretion [PE]</name>
  <code>C29162</code>  <id>29163</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Secretion</to_name>
    <to_code>T26740</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009398</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Metabolic Rate [PE]</name>
  <code>C29164</code>  <id>29165</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate</to_name>
    <to_code>T26741</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009399</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elamipretide [2725600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elamipretide hydrochloride [2725599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Acetylcholine Activity [PE]</name>
  <code>C29166</code>  <id>29167</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Acetylcholine Activity</to_name>
    <to_code>T26742</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009400</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Aspartate Activity [PE]</name>
  <code>C29168</code>  <id>29169</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Aspartate Activity</to_name>
    <to_code>T26743</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009401</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Brain Derived Neurotropic Activity [PE]</name>
  <code>C29170</code>  <id>29171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Brain Derived Neurotropic Activity</to_name>
    <to_code>T26744</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009402</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain CCK Activity [PE]</name>
  <code>C29172</code>  <id>29173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain CCK Activity</to_name>
    <to_code>T26745</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009403</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Disorganized Electrical Activity [PE]</name>
  <code>C29174</code>  <id>29175</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Disorganized Electrical Activity</to_name>
    <to_code>T26746</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009404</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Dopamine Activity [PE]</name>
  <code>C29176</code>  <id>29177</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Dopamine Activity</to_name>
    <to_code>T26747</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009405</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Dynorphin Activity [PE]</name>
  <code>C29178</code>  <id>29179</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Dynorphin Activity</to_name>
    <to_code>T26748</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009406</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Endorphin Activity [PE]</name>
  <code>C29180</code>  <id>29181</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Endorphin Activity</to_name>
    <to_code>T26749</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009407</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Enkephalin Activity [PE]</name>
  <code>C29182</code>  <id>29183</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Enkephalin Activity</to_name>
    <to_code>T26750</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009408</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Epinephrine Activity [PE]</name>
  <code>C29184</code>  <id>29185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Epinephrine Activity</to_name>
    <to_code>T26751</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009409</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain GABA Activity [PE]</name>
  <code>C29186</code>  <id>29187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain GABA Activity</to_name>
    <to_code>T26752</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009410</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Gastrin Activity [PE]</name>
  <code>C29188</code>  <id>29189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Gastrin Activity</to_name>
    <to_code>T26753</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009411</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Glutamate Activity [PE]</name>
  <code>C29190</code>  <id>29191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Glutamate Activity</to_name>
    <to_code>T26754</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009412</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Glycine Activity [PE]</name>
  <code>C29192</code>  <id>29193</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Glycine Activity</to_name>
    <to_code>T26755</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009413</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Histamine Activity [PE]</name>
  <code>C29194</code>  <id>29195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Histamine Activity</to_name>
    <to_code>T26756</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009414</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Nerve Growth Factor Activity [PE]</name>
  <code>C29196</code>  <id>29197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Nerve Growth Factor Activity</to_name>
    <to_code>T26757</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009415</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Neurotensin Activity [PE]</name>
  <code>C29198</code>  <id>29199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Neurotensin Activity</to_name>
    <to_code>T26758</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009416</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Nitric Oxide Activity [PE]</name>
  <code>C29200</code>  <id>29201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Nitric Oxide Activity</to_name>
    <to_code>T26759</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009417</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Norepinephrine Activity [PE]</name>
  <code>C29202</code>  <id>29203</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Norepinephrine Activity</to_name>
    <to_code>T26760</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009418</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Organized Electrical Activity [PE]</name>
  <code>C29204</code>  <id>29205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Organized Electrical Activity</to_name>
    <to_code>T26761</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009419</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Serotonin Activity [PE]</name>
  <code>C29206</code>  <id>29207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Serotonin Activity</to_name>
    <to_code>T26762</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009420</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain Substance P Activity [PE]</name>
  <code>C29208</code>  <id>29209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain Substance P Activity</to_name>
    <to_code>T26763</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009421</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Midbrain VIP Activity [PE]</name>
  <code>C29210</code>  <id>29211</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Midbrain VIP Activity</to_name>
    <to_code>T26764</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009422</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Mineralocorticoid Secretion [PE]</name>
  <code>C29212</code>  <id>29213</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mineralocorticoid Secretion</to_name>
    <to_code>T26765</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009423</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin hexahydrate [1653802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin [2890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mineralocorticoid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Mitosis [PE]</name>
  <code>C29214</code>  <id>29215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mitosis</to_name>
    <to_code>T26766</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009424</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Monocyte Activation [PE]</name>
  <code>C643499</code>  <id>643499</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Monocyte Activation</to_name>
    <to_code>T26767</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183883</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Monocyte Activation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Macrophage Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Monocytic Cell Destruction [PE]</name>
  <code>C29216</code>  <id>29217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Monocytic Cell Destruction</to_name>
    <to_code>T26768</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009425</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Monocytic Cell Production [PE]</name>
  <code>C29218</code>  <id>29219</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Monocytic Cell Production</to_name>
    <to_code>T26769</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009426</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Acetylcholine Activity [PE]</name>
  <code>C29220</code>  <id>29221</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Acetylcholine Activity</to_name>
    <to_code>T26770</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009427</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Aspartate Activity [PE]</name>
  <code>C29222</code>  <id>29223</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Aspartate Activity</to_name>
    <to_code>T26771</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009428</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Brain Derived Neurotropic Activity [PE]</name>
  <code>C29224</code>  <id>29225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Brain Derived Neurotropic Activity</to_name>
    <to_code>T26772</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009429</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System CCK Activity [PE]</name>
  <code>C29226</code>  <id>29227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System CCK Activity</to_name>
    <to_code>T26773</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009430</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Disorganized Electrical Activity [PE]</name>
  <code>C29228</code>  <id>29229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Disorganized Electrical Activity</to_name>
    <to_code>T26774</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009431</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Dopamine Activity [PE]</name>
  <code>C29230</code>  <id>29231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Dopamine Activity</to_name>
    <to_code>T26775</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009432</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Dynorphin Activity [PE]</name>
  <code>C29232</code>  <id>29233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Dynorphin Activity</to_name>
    <to_code>T26776</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009433</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Endorphin Activity [PE]</name>
  <code>C29234</code>  <id>29235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Endorphin Activity</to_name>
    <to_code>T26777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009434</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Enkephalin Activity [PE]</name>
  <code>C29236</code>  <id>29237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Enkephalin Activity</to_name>
    <to_code>T26778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009435</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Epinephrine Activity [PE]</name>
  <code>C29238</code>  <id>29239</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Epinephrine Activity</to_name>
    <to_code>T26779</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009436</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System GABA Activity [PE]</name>
  <code>C29240</code>  <id>29241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity</to_name>
    <to_code>T26780</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009437</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Gastrin Activity [PE]</name>
  <code>C29242</code>  <id>29243</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Gastrin Activity</to_name>
    <to_code>T26781</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009438</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Glutamate Activity [PE]</name>
  <code>C29244</code>  <id>29245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Glutamate Activity</to_name>
    <to_code>T26782</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009439</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Glycine Activity [PE]</name>
  <code>C29246</code>  <id>29247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Glycine Activity</to_name>
    <to_code>T26783</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009440</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Histamine Activity [PE]</name>
  <code>C29248</code>  <id>29249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Histamine Activity</to_name>
    <to_code>T26784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009441</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Nerve Growth Factor Activity [PE]</name>
  <code>C29250</code>  <id>29251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Nerve Growth Factor Activity</to_name>
    <to_code>T26785</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009442</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Neurotensin Activity [PE]</name>
  <code>C29252</code>  <id>29253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Neurotensin Activity</to_name>
    <to_code>T26786</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009443</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Nitric Oxide Activity [PE]</name>
  <code>C29254</code>  <id>29255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Nitric Oxide Activity</to_name>
    <to_code>T26787</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009444</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Norepinephrine Activity [PE]</name>
  <code>C29256</code>  <id>29257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Norepinephrine Activity</to_name>
    <to_code>T26788</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009445</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Organized Electrical Activity [PE]</name>
  <code>C29258</code>  <id>29259</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Organized Electrical Activity</to_name>
    <to_code>T26789</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009446</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Serotonin Activity [PE]</name>
  <code>C29260</code>  <id>29261</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Serotonin Activity</to_name>
    <to_code>T26790</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009447</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System Substance P Activity [PE]</name>
  <code>C29262</code>  <id>29263</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Substance P Activity</to_name>
    <to_code>T26791</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009448</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Muscular System VIP Activity [PE]</name>
  <code>C29264</code>  <id>29265</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System VIP Activity</to_name>
    <to_code>T26792</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009449</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Cardiac Muscle VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Muscular System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Myeloid Cell Destruction [PE]</name>
  <code>C29266</code>  <id>29267</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Destruction</to_name>
    <to_code>T26793</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009450</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Myeloid Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Monocytic Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Myeloid Cell Destruction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Myeloid Cell Production [PE]</name>
  <code>C29268</code>  <id>29269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production</to_name>
    <to_code>T26794</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009451</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Myeloid Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Granulocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Myeloid Cell Production [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Monocytic Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-ayow [2595942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim [68442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim [338036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim [2612526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-pbbk [2602779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib [1940332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-aafi [2057198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-fpgk [2613761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-sndz [1605064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-cbqv [2102692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib mesylate [1940331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-apgf [2469333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim-xnst [2612537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-bmez [2260702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Nasal and Sinus Mucosal Edema [PE]</name>
  <code>C30302</code>  <id>30303</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nasal and Sinus Mucosal Edema</to_name>
    <to_code>T26795</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009967</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Nasal and Sinus Secretions [PE]</name>
  <code>C29542</code>  <id>29543</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nasal and Sinus Secretions</to_name>
    <to_code>T26796</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009588</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Nerve Growth Factor Activity [PE]</name>
  <code>C29272</code>  <id>29273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nerve Growth Factor Activity</to_name>
    <to_code>T26797</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009453</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Neurotensin Activity [PE]</name>
  <code>C29274</code>  <id>29275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Neurotensin Activity</to_name>
    <to_code>T26798</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009454</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Nitric Oxide Activity [PE]</name>
  <code>C29276</code>  <id>29277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity</to_name>
    <to_code>T26799</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009455</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer sodium [2710445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer [2710434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer free acid [2710444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetranitrate [7992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Norepinephrine Activity [PE]</name>
  <code>C29278</code>  <id>29279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity</to_name>
    <to_code>T26800</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009456</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Oncotic Pressure [PE]</name>
  <code>C29280</code>  <id>29281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure</to_name>
    <to_code>T26801</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009457</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Organic Ion Degradation [PE]</name>
  <code>C29282</code>  <id>29283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organic Ion Degradation</to_name>
    <to_code>T26802</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009458</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiopronin [6765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organic Ion Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organic Ion Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Organic Ion Synthesis [PE]</name>
  <code>C29284</code>  <id>29285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organic Ion Synthesis</to_name>
    <to_code>T26803</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009459</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Organized Electrical Activity [PE]</name>
  <code>C29286</code>  <id>29287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organized Electrical Activity</to_name>
    <to_code>T26804</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009460</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Ovarian Estrogen Secretion [PE]</name>
  <code>C29288</code>  <id>29289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion</to_name>
    <to_code>T26805</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009461</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate [105556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate sodium [4090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine [4089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Ovarian Progesterone Secretion [PE]</name>
  <code>C29290</code>  <id>29291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Progesterone Secretion</to_name>
    <to_code>T26806</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009462</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Oxygen Carrying Capacity [PE]</name>
  <code>C29292</code>  <id>29293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oxygen Carrying Capacity</to_name>
    <to_code>T26807</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009463</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxelotor [2265678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oxygen Carrying Capacity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Oxytocin Secretion [PE]</name>
  <code>C29294</code>  <id>29295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oxytocin Secretion</to_name>
    <to_code>T26808</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009464</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased PIF Activity [PE]</name>
  <code>C29296</code>  <id>29297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PIF Activity</to_name>
    <to_code>T26809</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009465</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased PIF Secretion [PE]</name>
  <code>C29298</code>  <id>29299</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PIF Secretion</to_name>
    <to_code>T26810</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009466</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased PRF Activity [PE]</name>
  <code>C29300</code>  <id>29301</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PRF Activity</to_name>
    <to_code>T26811</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009467</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased PRF Secretion [PE]</name>
  <code>C29302</code>  <id>29303</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PRF Secretion</to_name>
    <to_code>T26812</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009468</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased PTH Secretion [PE]</name>
  <code>C29304</code>  <id>29305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PTH Secretion</to_name>
    <to_code>T26813</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009469</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palopegteriparatide [2693635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Pancreatic Somatostatin Secretion [PE]</name>
  <code>C29306</code>  <id>29307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pancreatic Somatostatin Secretion</to_name>
    <to_code>T26814</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009470</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Acetylcholine Activity [PE]</name>
  <code>C29308</code>  <id>29309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Acetylcholine Activity</to_name>
    <to_code>T26815</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009471</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine hydrochloride [133041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine [220982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Activity [PE]</name>
  <code>C635042</code>  <id>635042</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Activity</to_name>
    <to_code>T26817</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parasympathomimetic Activity</to_name>
    <to_code>T26816</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175649</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Parasympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Aspartate Activity [PE]</name>
  <code>C29310</code>  <id>29311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Aspartate Activity</to_name>
    <to_code>T26818</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009472</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Brain Derived Neurotropic Activity [PE]</name>
  <code>C29312</code>  <id>29313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Brain Derived Neurotropic Activity</to_name>
    <to_code>T26819</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009473</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic CCK Activity [PE]</name>
  <code>C29314</code>  <id>29315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic CCK Activity</to_name>
    <to_code>T26820</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009474</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Disorganized Electrical Activity [PE]</name>
  <code>C29316</code>  <id>29317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Disorganized Electrical Activity</to_name>
    <to_code>T26821</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009475</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Dopamine Activity [PE]</name>
  <code>C29318</code>  <id>29319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Dopamine Activity</to_name>
    <to_code>T26822</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009476</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Dynorphin Activity [PE]</name>
  <code>C29320</code>  <id>29321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Dynorphin Activity</to_name>
    <to_code>T26823</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009477</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Endorphin Activity [PE]</name>
  <code>C29322</code>  <id>29323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Endorphin Activity</to_name>
    <to_code>T26824</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009478</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Enkephalin Activity [PE]</name>
  <code>C29324</code>  <id>29325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Enkephalin Activity</to_name>
    <to_code>T26825</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009479</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Epinephrine Activity [PE]</name>
  <code>C29326</code>  <id>29327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Epinephrine Activity</to_name>
    <to_code>T26826</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009480</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic GABA Activity [PE]</name>
  <code>C29328</code>  <id>29329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic GABA Activity</to_name>
    <to_code>T26827</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009481</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Gastrin Activity [PE]</name>
  <code>C29330</code>  <id>29331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Gastrin Activity</to_name>
    <to_code>T26828</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009482</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Glutamate Activity [PE]</name>
  <code>C29332</code>  <id>29333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Glutamate Activity</to_name>
    <to_code>T26829</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009483</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Glycine Activity [PE]</name>
  <code>C29334</code>  <id>29335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Glycine Activity</to_name>
    <to_code>T26830</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009484</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Histamine Activity [PE]</name>
  <code>C29336</code>  <id>29337</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Histamine Activity</to_name>
    <to_code>T26831</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009485</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Nerve Growth Factor Activity [PE]</name>
  <code>C29338</code>  <id>29339</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Nerve Growth Factor Activity</to_name>
    <to_code>T26832</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009486</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Neurotensin Activity [PE]</name>
  <code>C29340</code>  <id>29341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Neurotensin Activity</to_name>
    <to_code>T26833</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009487</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Nitric Oxide Activity [PE]</name>
  <code>C29342</code>  <id>29343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Nitric Oxide Activity</to_name>
    <to_code>T26834</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009488</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Norepinephrine Activity [PE]</name>
  <code>C29344</code>  <id>29345</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Norepinephrine Activity</to_name>
    <to_code>T26835</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009489</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Organized Electrical Activity [PE]</name>
  <code>C29346</code>  <id>29347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Organized Electrical Activity</to_name>
    <to_code>T26836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009490</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Serotonin Activity [PE]</name>
  <code>C29348</code>  <id>29349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Serotonin Activity</to_name>
    <to_code>T26837</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009491</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic Substance P Activity [PE]</name>
  <code>C29350</code>  <id>29351</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Substance P Activity</to_name>
    <to_code>T26838</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009492</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Parasympathetic VIP Activity [PE]</name>
  <code>C29352</code>  <id>29353</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic VIP Activity</to_name>
    <to_code>T26839</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009493</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</name>
  <code>C29354</code>  <id>29355</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Acetylcholine Activity</to_name>
    <to_code>T26840</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009494</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Aspartate Activity [PE]</name>
  <code>C29356</code>  <id>29357</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Aspartate Activity</to_name>
    <to_code>T26841</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009495</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Aspartate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C29358</code>  <id>29359</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T26842</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009496</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Brain Derived Neurotropic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System CCK Activity [PE]</name>
  <code>C29360</code>  <id>29361</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System CCK Activity</to_name>
    <to_code>T26843</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009497</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System CCK Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C29362</code>  <id>29363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T26844</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009498</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Disorganized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Disorganized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Dopamine Activity [PE]</name>
  <code>C29364</code>  <id>29365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Dopamine Activity</to_name>
    <to_code>T26845</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009499</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dopamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Dynorphin Activity [PE]</name>
  <code>C29366</code>  <id>29367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Dynorphin Activity</to_name>
    <to_code>T26846</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009500</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Dynorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Endorphin Activity [PE]</name>
  <code>C29368</code>  <id>29369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Endorphin Activity</to_name>
    <to_code>T26847</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009501</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Endorphin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Enkephalin Activity [PE]</name>
  <code>C29370</code>  <id>29371</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Enkephalin Activity</to_name>
    <to_code>T26848</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009502</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Enkephalin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Epinephrine Activity [PE]</name>
  <code>C29372</code>  <id>29373</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Epinephrine Activity</to_name>
    <to_code>T26849</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009503</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Epinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System GABA Activity [PE]</name>
  <code>C29374</code>  <id>29375</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System GABA Activity</to_name>
    <to_code>T26850</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009504</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System GABA Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Gastrin Activity [PE]</name>
  <code>C29376</code>  <id>29377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Gastrin Activity</to_name>
    <to_code>T26851</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009505</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Gastrin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Glutamate Activity [PE]</name>
  <code>C29378</code>  <id>29379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Glutamate Activity</to_name>
    <to_code>T26852</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009506</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Glutamate Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Glycine Activity [PE]</name>
  <code>C29380</code>  <id>29381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Glycine Activity</to_name>
    <to_code>T26853</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009507</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Glycine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Histamine Activity [PE]</name>
  <code>C29382</code>  <id>29383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Histamine Activity</to_name>
    <to_code>T26854</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009508</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Histamine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C29384</code>  <id>29385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T26855</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009509</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Nerve Growth Factor Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Neurotensin Activity [PE]</name>
  <code>C29386</code>  <id>29387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Neurotensin Activity</to_name>
    <to_code>T26856</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009510</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Neurotensin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</name>
  <code>C29388</code>  <id>29389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Nitric Oxide Activity</to_name>
    <to_code>T26857</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009511</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Nitric Oxide Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</name>
  <code>C29390</code>  <id>29391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Norepinephrine Activity</to_name>
    <to_code>T26858</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009512</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Norepinephrine Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</name>
  <code>C29392</code>  <id>29393</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Organized Electrical Activity</to_name>
    <to_code>T26859</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009513</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Serotonin Activity [PE]</name>
  <code>C29394</code>  <id>29395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Serotonin Activity</to_name>
    <to_code>T26860</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009514</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System Substance P Activity [PE]</name>
  <code>C29396</code>  <id>29397</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Substance P Activity</to_name>
    <to_code>T26861</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009515</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Nervous System VIP Activity [PE]</name>
  <code>C29398</code>  <id>29399</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System VIP Activity</to_name>
    <to_code>T26862</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009516</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Autonomic Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Peripheral Nervous System VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Enteric Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Peripheral Respiratory Drive [PE]</name>
  <code>C29400</code>  <id>29401</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Respiratory Drive</to_name>
    <to_code>T26863</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009517</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Phagocytosis [PE]</name>
  <code>C29402</code>  <id>29403</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis</to_name>
    <to_code>T26864</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009518</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea preparation [228041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Pharyngeal Mucosal Edema [PE]</name>
  <code>C30304</code>  <id>30305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pharyngeal Mucosal Edema</to_name>
    <to_code>T26865</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009968</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Pharyngeal Secretions [PE]</name>
  <code>C29270</code>  <id>29271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pharyngeal Secretions</to_name>
    <to_code>T26866</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009452</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Pinocytosis [PE]</name>
  <code>C29404</code>  <id>29405</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pinocytosis</to_name>
    <to_code>T26867</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009519</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Placental Human Chorionic Gonadotropin Secretion [PE]</name>
  <code>C29406</code>  <id>29407</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Placental HCG Secretion</to_name>
    <to_code>T26868</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Placental Human Chorionic Gonadotropin Secretion</to_name>
    <to_code>T26869</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009520</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Activating Factor Activity [PE]</name>
  <code>C29408</code>  <id>29409</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Activity</to_name>
    <to_code>T26870</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009521</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium morrhuate [9892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Activating Factor Degradation [PE]</name>
  <code>C29410</code>  <id>29411</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Degradation</to_name>
    <to_code>T26871</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009522</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Activating Factor Production [PE]</name>
  <code>C29412</code>  <id>29413</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Activating Factor Production</to_name>
    <to_code>T26872</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009523</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Aggregation [PE]</name>
  <code>C29414</code>  <id>29415</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Aggregation</to_name>
    <to_code>T26873</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009524</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor [11274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor, human [826072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Platelet Production [PE]</name>
  <code>C635424</code>  <id>635424</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombopoiesis</to_name>
    <to_code>T26874</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production</to_name>
    <to_code>T26875</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175970</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag maleate [2045727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag choline [2675185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romiplostim [805452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Polymorphonuclear Leukocyte Migration [PE]</name>
  <code>C31852</code>  <id>31853</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Polymorphonuclear Leukocyte Migration</to_name>
    <to_code>T26876</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010247</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prolactin Secretion [PE]</name>
  <code>C29416</code>  <id>29417</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prolactin Secretion</to_name>
    <to_code>T26877</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009525</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone [3626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone maleate [236099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prostaglandin Activity [PE]</name>
  <code>C29418</code>  <id>29419</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity</to_name>
    <to_code>T26878</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009526</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>misoprostol [42331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimatoprost [283810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafluprost [1244607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prostaglandin Degradation [PE]</name>
  <code>C29420</code>  <id>29421</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Degradation</to_name>
    <to_code>T26879</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009527</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prostaglandin Production [PE]</name>
  <code>C29422</code>  <id>29423</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Production</to_name>
    <to_code>T26880</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009528</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>borage oil [68905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prostatic Secretion [PE]</name>
  <code>C29424</code>  <id>29425</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostatic Secretion</to_name>
    <to_code>T26881</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009529</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prostatic Size [PE]</name>
  <code>C29426</code>  <id>29427</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostatic Size</to_name>
    <to_code>T26882</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009530</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Protein Breakdown [PE]</name>
  <code>C29428</code>  <id>29429</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown</to_name>
    <to_code>T26883</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009531</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen [2099289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-zzxf [2382599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-anns [2174802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant dihydrochloride [2628473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen sodium [2099290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran [2053490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran [2604578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dkst [2103478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocriplasmin [29998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fam-trastuzumab deruxtecan-nxki [2267574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-oysk [2375543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-pkrb [2107051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dttb [2289225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Protein Modification [PE]</name>
  <code>C29430</code>  <id>29431</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Modification</to_name>
    <to_code>T26884</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009532</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Protein Synthesis [PE]</name>
  <code>C29432</code>  <id>29433</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis</to_name>
    <to_code>T26885</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009533</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nusinersen [1863556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stanozolol [10032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golodirsen [2267207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec [2170226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec-xioi [2170225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casimersen [2480096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prothrombin Activity [PE]</name>
  <code>C635419</code>  <id>635419</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Activity</to_name>
    <to_code>T26886</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175965</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K1 [8308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K [11258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Prothrombin Concentration [PE]</name>
  <code>C643888</code>  <id>643888</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Concentration</to_name>
    <to_code>T26887</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184161</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Ca++ Excretion [PE]</name>
  <code>C29434</code>  <id>29435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Ca++ Excretion</to_name>
    <to_code>T26888</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009534</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Cl- Excretion [PE]</name>
  <code>C29436</code>  <id>29437</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Cl- Excretion</to_name>
    <to_code>T26889</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009535</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule H+ Excretion [PE]</name>
  <code>C29438</code>  <id>29439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule H+ Excretion</to_name>
    <to_code>T26890</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009536</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule HCO3- Excretion [PE]</name>
  <code>C29440</code>  <id>29441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule HCO3- Excretion</to_name>
    <to_code>T26891</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009537</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule K+ Excretion [PE]</name>
  <code>C29442</code>  <id>29443</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule K+ Excretion</to_name>
    <to_code>T26892</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009538</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Mg++ Excretion [PE]</name>
  <code>C29444</code>  <id>29445</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Mg++ Excretion</to_name>
    <to_code>T26893</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009539</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule Na+ Excretion [PE]</name>
  <code>C29446</code>  <id>29447</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Na+ Excretion</to_name>
    <to_code>T26894</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009540</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule PO4-- Excretion [PE]</name>
  <code>C29448</code>  <id>29449</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule PO4-- Excretion</to_name>
    <to_code>T26895</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009541</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Proximal Tubule SO4-- Excretion [PE]</name>
  <code>C29450</code>  <id>29451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule SO4-- Excretion</to_name>
    <to_code>T26896</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009542</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Pyloric Sphincter Tone [PE]</name>
  <code>C29452</code>  <id>29453</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pyloric Sphincter Tone</to_name>
    <to_code>T26897</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009543</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased RNA Degradation [PE]</name>
  <code>C654364</code>  <id>654364</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Degradation</to_name>
    <to_code>T59041</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194154</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fitusiran [2709439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen [2701418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased RNA Integrity [PE]</name>
  <code>C29454</code>  <id>29455</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity</to_name>
    <to_code>T26898</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009544</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triacetate [1665222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triphosphate sodium [236509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine [11017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine 5-mo-phos disod [236785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nusinersen [1863556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased RNA Replication [PE]</name>
  <code>C29456</code>  <id>29457</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Replication</to_name>
    <to_code>T26899</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009545</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Ca++ Excretion [PE]</name>
  <code>C29458</code>  <id>29459</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ca++ Excretion</to_name>
    <to_code>T26900</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009546</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ca++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Cl- Excretion [PE]</name>
  <code>C29460</code>  <id>29461</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Cl- Excretion</to_name>
    <to_code>T26901</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009547</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Cl- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal H+ Excretion [PE]</name>
  <code>C29462</code>  <id>29463</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal H+ Excretion</to_name>
    <to_code>T26902</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009548</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal H+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal HCO3- Excretion [PE]</name>
  <code>C29464</code>  <id>29465</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion</to_name>
    <to_code>T26903</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009549</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal HCO3- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium citrate sesquihydrate [2049608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, 1-stearyl ester [1435636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrate [114200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine hydrochloride [1311534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid [21183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lactate [56489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate anhydrous [1310549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid monohydrate [221079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine [10865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Ion Excretion [PE]</name>
  <code>C29466</code>  <id>29467</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion</to_name>
    <to_code>T26904</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009550</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Cl- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal HCO3- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ca++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Urea Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal H+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminohippurate sodium [203194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine hydrochloride [235370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium [1903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate calcium trisodium [132879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium [1368950]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine tetrahydrochloride [2611541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium anhydrous [1371967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine [10798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium monohydrate [2001422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal K+ Excretion [PE]</name>
  <code>C29468</code>  <id>29469</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion</to_name>
    <to_code>T26905</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009551</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal K+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone pivalate [22537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Mg++ Excretion [PE]</name>
  <code>C29470</code>  <id>29471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Mg++ Excretion</to_name>
    <to_code>T26906</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009552</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Mg++ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Mg++ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Na+ Excretion [PE]</name>
  <code>C29472</code>  <id>29473</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion</to_name>
    <to_code>T26907</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009553</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Na+ Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Na+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Organic Anion Excretion [PE]</name>
  <code>C29474</code>  <id>29475</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Anion Excretion</to_name>
    <to_code>T26908</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009554</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Organic Anion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uricosuric Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Organic Cation Excretion [PE]</name>
  <code>C29476</code>  <id>29477</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Cation Excretion</to_name>
    <to_code>T26909</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009555</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Organic Ion Excretion [PE]</name>
  <code>C29478</code>  <id>29479</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion</to_name>
    <to_code>T26910</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009556</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Organic Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Cation Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal Organic Ion Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Anion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesna [44]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin propanediol [1486966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>empagliflozin [1545653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin [1488564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin [1373458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal PO4-- Excretion [PE]</name>
  <code>C29480</code>  <id>29481</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion</to_name>
    <to_code>T26911</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009557</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal PO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dihydrogen phosphate [236560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal PO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal SO4-- Excretion [PE]</name>
  <code>C29482</code>  <id>29483</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal SO4-- Excretion</to_name>
    <to_code>T26912</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009558</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Distal Tubule SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Collecting Duct SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Loop of Henle SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Renal SO4-- Excretion [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Proximal Tubule SO4-- Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Renal Urea Excretion [PE]</name>
  <code>C31838</code>  <id>31839</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Urea Excretion</to_name>
    <to_code>T26913</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010240</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea hydrochloride [1862866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Urea Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea [11002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Urea Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Respiratory Mucosal Edema [PE]</name>
  <code>C30300</code>  <id>30301</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Mucosal Edema</to_name>
    <to_code>T26914</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009966</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Respiratory Mucosal Edema [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nasal and Sinus Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Respiratory Mucosal Edema [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pharyngeal Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Respiratory Mucosal Edema [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheo-Bronchial Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Respiratory Secretion Viscosity [PE]</name>
  <code>C29484</code>  <id>29485</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretion Viscosity</to_name>
    <to_code>T26915</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009559</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Respiratory Secretions [PE]</name>
  <code>C29486</code>  <id>29487</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions</to_name>
    <to_code>T26916</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009560</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Respiratory Secretions [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pharyngeal Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Respiratory Secretions [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nasal and Sinus Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Respiratory Secretions [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheo-Bronchial Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine iodide [203206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium guaiacolsulfonate [91275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Retinal Pigment Epithelium Function [PE]</name>
  <code>C654018</code>  <id>654018</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Retinal Pigment Epithelium Function</to_name>
    <to_code>T58374</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RPE Function</to_name>
    <to_code>T58376</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193798</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voretigene neparvovec [1995537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Retinal Pigment Epithelium Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Reverse Transcription to DNA [PE]</name>
  <code>C29488</code>  <id>29489</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Reverse Transcription to DNA</to_name>
    <to_code>T26917</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009561</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sebaceous Gland Activity [PE]</name>
  <code>C30330</code>  <id>30331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sebaceous Gland Activity</to_name>
    <to_code>T26918</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009981</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sebaceous Gland Quantity [PE]</name>
  <code>C30328</code>  <id>30329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sebaceous Gland Quantity</to_name>
    <to_code>T26919</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009980</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Acetylcholine Activity [PE]</name>
  <code>C29492</code>  <id>29493</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Acetylcholine Activity</to_name>
    <to_code>T26920</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009563</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Aspartate Activity [PE]</name>
  <code>C29494</code>  <id>29495</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Aspartate Activity</to_name>
    <to_code>T26921</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009564</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity [PE]</name>
  <code>C29496</code>  <id>29497</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Brain Derived Neurotropic Activity</to_name>
    <to_code>T26922</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009565</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System CCK Activity [PE]</name>
  <code>C29498</code>  <id>29499</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System CCK Activity</to_name>
    <to_code>T26923</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009566</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity [PE]</name>
  <code>C29500</code>  <id>29501</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Disorganized Electrical Activity</to_name>
    <to_code>T26924</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009567</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Dopamine Activity [PE]</name>
  <code>C29502</code>  <id>29503</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Dopamine Activity</to_name>
    <to_code>T26925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009568</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Dynorphin Activity [PE]</name>
  <code>C29504</code>  <id>29505</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Dynorphin Activity</to_name>
    <to_code>T26926</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009569</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Endorphin Activity [PE]</name>
  <code>C29506</code>  <id>29507</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Endorphin Activity</to_name>
    <to_code>T26927</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009570</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Enkephalin Activity [PE]</name>
  <code>C29508</code>  <id>29509</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Enkephalin Activity</to_name>
    <to_code>T26928</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009571</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Epinephrine Activity [PE]</name>
  <code>C29510</code>  <id>29511</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Epinephrine Activity</to_name>
    <to_code>T26929</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009572</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System GABA Activity [PE]</name>
  <code>C29512</code>  <id>29513</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System GABA Activity</to_name>
    <to_code>T26930</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009573</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Gastrin Activity [PE]</name>
  <code>C29514</code>  <id>29515</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Gastrin Activity</to_name>
    <to_code>T26931</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009574</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Glutamate Activity [PE]</name>
  <code>C29516</code>  <id>29517</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Glutamate Activity</to_name>
    <to_code>T26932</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009575</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Glycine Activity [PE]</name>
  <code>C29518</code>  <id>29519</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Glycine Activity</to_name>
    <to_code>T26933</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009576</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Histamine Activity [PE]</name>
  <code>C29520</code>  <id>29521</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Histamine Activity</to_name>
    <to_code>T26934</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009577</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</name>
  <code>C29522</code>  <id>29523</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity</to_name>
    <to_code>T26935</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009578</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin-bkbj [2104331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin [2104332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity [PE]</name>
  <code>C29524</code>  <id>29525</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Nitric Oxide Activity</to_name>
    <to_code>T26936</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009579</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Norepinephrine Activity [PE]</name>
  <code>C29526</code>  <id>29527</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Norepinephrine Activity</to_name>
    <to_code>T26937</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009580</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Organized Electrical Activity [PE]</name>
  <code>C29528</code>  <id>29529</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Organized Electrical Activity</to_name>
    <to_code>T26938</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009581</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Serotonin Activity [PE]</name>
  <code>C29530</code>  <id>29531</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Serotonin Activity</to_name>
    <to_code>T26939</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009582</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System Substance P Activity [PE]</name>
  <code>C29532</code>  <id>29533</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Substance P Activity</to_name>
    <to_code>T26940</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009583</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System VIP Activity [PE]</name>
  <code>C29534</code>  <id>29535</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System VIP Activity</to_name>
    <to_code>T26941</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009584</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sensory-Somatic Nervous System [PE]</name>
  <code>C29490</code>  <id>29491</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sensory-Somatic Nervous System</to_name>
    <to_code>T26942</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009562</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Serotonin Activity [PE]</name>
  <code>C29536</code>  <id>29537</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity</to_name>
    <to_code>T26943</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009585</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Serotonin Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone [2672253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone hydrochloride [2672254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Serotonin Degradation [PE]</name>
  <code>C29538</code>  <id>29539</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Degradation</to_name>
    <to_code>T26944</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009586</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Serotonin Production [PE]</name>
  <code>C29540</code>  <id>29541</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Production</to_name>
    <to_code>T26945</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009587</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tryptophan [10898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Skin Keratinization [PE]</name>
  <code>C30316</code>  <id>30317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization</to_name>
    <to_code>T26946</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009974</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Small Intestinal Motility [PE]</name>
  <code>C29544</code>  <id>29545</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Small Intestinal Motility</to_name>
    <to_code>T26947</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009589</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Small Intestinal Muscle Tone [PE]</name>
  <code>C29546</code>  <id>29547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Small Intestinal Muscle Tone</to_name>
    <to_code>T26948</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009590</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Acetylcholine Activity [PE]</name>
  <code>C29548</code>  <id>29549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Acetylcholine Activity</to_name>
    <to_code>T26949</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009591</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride succinate [2107309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Aspartate Activity [PE]</name>
  <code>C29550</code>  <id>29551</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Aspartate Activity</to_name>
    <to_code>T26950</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009592</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Brain Derived Neurotropic Activity [PE]</name>
  <code>C29552</code>  <id>29553</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Brain Derived Neurotropic Activity</to_name>
    <to_code>T26951</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009593</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle CCK Activity [PE]</name>
  <code>C29554</code>  <id>29555</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle CCK Activity</to_name>
    <to_code>T26952</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009594</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Disorganized Electrical Activity [PE]</name>
  <code>C29556</code>  <id>29557</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Disorganized Electrical Activity</to_name>
    <to_code>T26953</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009595</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Dopamine Activity [PE]</name>
  <code>C29558</code>  <id>29559</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Dopamine Activity</to_name>
    <to_code>T26954</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009596</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Dynorphin Activity [PE]</name>
  <code>C29560</code>  <id>29561</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Dynorphin Activity</to_name>
    <to_code>T26955</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009597</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Endorphin Activity [PE]</name>
  <code>C29562</code>  <id>29563</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Endorphin Activity</to_name>
    <to_code>T26956</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009598</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Enkephalin Activity [PE]</name>
  <code>C29564</code>  <id>29565</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Enkephalin Activity</to_name>
    <to_code>T26957</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009599</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Epinephrine Activity [PE]</name>
  <code>C29566</code>  <id>29567</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Epinephrine Activity</to_name>
    <to_code>T26958</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009600</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle GABA Activity [PE]</name>
  <code>C29568</code>  <id>29569</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle GABA Activity</to_name>
    <to_code>T26959</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009601</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Gastrin Activity [PE]</name>
  <code>C29570</code>  <id>29571</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Gastrin Activity</to_name>
    <to_code>T26960</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009602</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Glutamate Activity [PE]</name>
  <code>C29572</code>  <id>29573</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Glutamate Activity</to_name>
    <to_code>T26961</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009603</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Glycine Activity [PE]</name>
  <code>C29574</code>  <id>29575</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Glycine Activity</to_name>
    <to_code>T26962</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009604</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Histamine Activity [PE]</name>
  <code>C29576</code>  <id>29577</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Histamine Activity</to_name>
    <to_code>T26963</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009605</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Nerve Growth Factor Activity [PE]</name>
  <code>C29578</code>  <id>29579</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Nerve Growth Factor Activity</to_name>
    <to_code>T26964</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009606</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Neurotensin Activity [PE]</name>
  <code>C29580</code>  <id>29581</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Neurotensin Activity</to_name>
    <to_code>T26965</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009607</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Nitric Oxide Activity [PE]</name>
  <code>C29582</code>  <id>29583</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Nitric Oxide Activity</to_name>
    <to_code>T26966</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009608</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Norepinephrine Activity [PE]</name>
  <code>C29584</code>  <id>29585</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Norepinephrine Activity</to_name>
    <to_code>T26967</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009609</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Organized Electrical Activity [PE]</name>
  <code>C29586</code>  <id>29587</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Organized Electrical Activity</to_name>
    <to_code>T26968</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009610</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Serotonin Activity [PE]</name>
  <code>C29588</code>  <id>29589</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Serotonin Activity</to_name>
    <to_code>T26969</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009611</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle Substance P Activity [PE]</name>
  <code>C29590</code>  <id>29591</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle Substance P Activity</to_name>
    <to_code>T26970</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009612</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Smooth Muscle VIP Activity [PE]</name>
  <code>C29592</code>  <id>29593</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Smooth Muscle VIP Activity</to_name>
    <to_code>T26971</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009613</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Somatostatin (SRIF) Activity [PE]</name>
  <code>C29594</code>  <id>29595</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Somatostatin (SRIF) Activity</to_name>
    <to_code>T26972</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009614</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Somatostatin (SRIF) Secretion [PE]</name>
  <code>C29596</code>  <id>29597</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Somatostatin (SRIF) Secretion</to_name>
    <to_code>T26973</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009615</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sperm Death [PE]</name>
  <code>C30348</code>  <id>30349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sperm Death</to_name>
    <to_code>T26974</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009990</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sperm Motility [PE]</name>
  <code>C29598</code>  <id>29599</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sperm Motility</to_name>
    <to_code>T26975</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009616</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sphincter of Odi Tone [PE]</name>
  <code>C29600</code>  <id>29601</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sphincter of Odi Tone</to_name>
    <to_code>T26976</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009617</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sphincter of Odi Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sphincter of Odi Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Acetylcholine Activity [PE]</name>
  <code>C29602</code>  <id>29603</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Acetylcholine Activity</to_name>
    <to_code>T26977</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009618</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Aspartate Activity [PE]</name>
  <code>C29604</code>  <id>29605</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Aspartate Activity</to_name>
    <to_code>T26978</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009619</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Brain Derived Neurotropic Activity [PE]</name>
  <code>C29606</code>  <id>29607</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Brain Derived Neurotropic Activity</to_name>
    <to_code>T26979</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009620</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord CCK Activity [PE]</name>
  <code>C29608</code>  <id>29609</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord CCK Activity</to_name>
    <to_code>T26980</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009621</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Disorganized Electrical Activity [PE]</name>
  <code>C29610</code>  <id>29611</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Disorganized Electrical Activity</to_name>
    <to_code>T26981</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009622</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Dopamine Activity [PE]</name>
  <code>C29612</code>  <id>29613</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Dopamine Activity</to_name>
    <to_code>T26982</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009623</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Dynorphin Activity [PE]</name>
  <code>C29614</code>  <id>29615</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Dynorphin Activity</to_name>
    <to_code>T26983</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009624</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Endorphin Activity [PE]</name>
  <code>C29616</code>  <id>29617</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Endorphin Activity</to_name>
    <to_code>T26984</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009625</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Enkephalin Activity [PE]</name>
  <code>C29618</code>  <id>29619</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Enkephalin Activity</to_name>
    <to_code>T26985</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009626</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Epinephrine Activity [PE]</name>
  <code>C29620</code>  <id>29621</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Epinephrine Activity</to_name>
    <to_code>T26986</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009627</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord GABA Activity [PE]</name>
  <code>C29622</code>  <id>29623</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord GABA Activity</to_name>
    <to_code>T26987</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009628</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Gastrin Activity [PE]</name>
  <code>C29624</code>  <id>29625</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Gastrin Activity</to_name>
    <to_code>T26988</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009629</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Glutamate Activity [PE]</name>
  <code>C29626</code>  <id>29627</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Glutamate Activity</to_name>
    <to_code>T26989</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009630</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Glycine Activity [PE]</name>
  <code>C29628</code>  <id>29629</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Glycine Activity</to_name>
    <to_code>T26990</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009631</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Histamine Activity [PE]</name>
  <code>C29630</code>  <id>29631</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Histamine Activity</to_name>
    <to_code>T26991</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009632</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Nerve Growth Factor Activity [PE]</name>
  <code>C29632</code>  <id>29633</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Nerve Growth Factor Activity</to_name>
    <to_code>T26992</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009633</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Neurotensin Activity [PE]</name>
  <code>C29634</code>  <id>29635</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Neurotensin Activity</to_name>
    <to_code>T26993</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009634</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Nitric Oxide Activity [PE]</name>
  <code>C29636</code>  <id>29637</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Nitric Oxide Activity</to_name>
    <to_code>T26994</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009635</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Norepinephrine Activity [PE]</name>
  <code>C29638</code>  <id>29639</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Norepinephrine Activity</to_name>
    <to_code>T26995</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009636</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Organized Electrical Activity [PE]</name>
  <code>C29640</code>  <id>29641</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Organized Electrical Activity</to_name>
    <to_code>T26996</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009637</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Serotonin Activity [PE]</name>
  <code>C29642</code>  <id>29643</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Serotonin Activity</to_name>
    <to_code>T26997</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009638</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord Substance P Activity [PE]</name>
  <code>C29644</code>  <id>29645</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord Substance P Activity</to_name>
    <to_code>T26998</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009639</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Spinal Cord VIP Activity [PE]</name>
  <code>C29646</code>  <id>29647</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Spinal Cord VIP Activity</to_name>
    <to_code>T26999</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009640</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sterol Synthesis [PE]</name>
  <code>C31808</code>  <id>31809</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sterol Synthesis</to_name>
    <to_code>T27000</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010225</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Acetylcholine Activity [PE]</name>
  <code>C29648</code>  <id>29649</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Acetylcholine Activity</to_name>
    <to_code>T27001</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009641</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Aspartate Activity [PE]</name>
  <code>C29650</code>  <id>29651</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Aspartate Activity</to_name>
    <to_code>T27002</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009642</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Brain Derived Neurotropic Activity [PE]</name>
  <code>C29652</code>  <id>29653</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Brain Derived Neurotropic Activity</to_name>
    <to_code>T27003</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009643</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle CCK Activity [PE]</name>
  <code>C29654</code>  <id>29655</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle CCK Activity</to_name>
    <to_code>T27004</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009644</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Contraction [PE]</name>
  <code>C29656</code>  <id>29657</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction</to_name>
    <to_code>T27005</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009645</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Disorganized Electrical Activity [PE]</name>
  <code>C29658</code>  <id>29659</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Disorganized Electrical Activity</to_name>
    <to_code>T27006</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009646</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Dopamine Activity [PE]</name>
  <code>C29660</code>  <id>29661</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Dopamine Activity</to_name>
    <to_code>T27007</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009647</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Dynorphin Activity [PE]</name>
  <code>C29662</code>  <id>29663</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Dynorphin Activity</to_name>
    <to_code>T27008</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009648</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Endorphin Activity [PE]</name>
  <code>C29664</code>  <id>29665</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Endorphin Activity</to_name>
    <to_code>T27009</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009649</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Enkephalin Activity [PE]</name>
  <code>C29666</code>  <id>29667</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Enkephalin Activity</to_name>
    <to_code>T27010</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009650</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Epinephrine Activity [PE]</name>
  <code>C29668</code>  <id>29669</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Epinephrine Activity</to_name>
    <to_code>T27011</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009651</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle GABA Activity [PE]</name>
  <code>C29670</code>  <id>29671</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle GABA Activity</to_name>
    <to_code>T27012</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009652</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Gastrin Activity [PE]</name>
  <code>C29672</code>  <id>29673</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Gastrin Activity</to_name>
    <to_code>T27013</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009653</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Glutamate Activity [PE]</name>
  <code>C29674</code>  <id>29675</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Glutamate Activity</to_name>
    <to_code>T27014</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009654</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Glycine Activity [PE]</name>
  <code>C29676</code>  <id>29677</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Glycine Activity</to_name>
    <to_code>T27015</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009655</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Histamine Activity [PE]</name>
  <code>C29678</code>  <id>29679</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Histamine Activity</to_name>
    <to_code>T27016</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009656</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Nerve Growth Factor Activity [PE]</name>
  <code>C29680</code>  <id>29681</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Nerve Growth Factor Activity</to_name>
    <to_code>T27017</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009657</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Neurotensin Activity [PE]</name>
  <code>C29682</code>  <id>29683</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Neurotensin Activity</to_name>
    <to_code>T27018</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009658</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Nitric Oxide Activity [PE]</name>
  <code>C29684</code>  <id>29685</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Nitric Oxide Activity</to_name>
    <to_code>T27019</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009659</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Norepinephrine Activity [PE]</name>
  <code>C29686</code>  <id>29687</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Norepinephrine Activity</to_name>
    <to_code>T27020</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009660</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Organized Electrical Activity [PE]</name>
  <code>C29688</code>  <id>29689</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Organized Electrical Activity</to_name>
    <to_code>T27021</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009661</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Serotonin Activity [PE]</name>
  <code>C29690</code>  <id>29691</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Serotonin Activity</to_name>
    <to_code>T27022</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009662</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Substance P Activity [PE]</name>
  <code>C29692</code>  <id>29693</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Substance P Activity</to_name>
    <to_code>T27023</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009663</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle Tone [PE]</name>
  <code>C635142</code>  <id>635142</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Tone</to_name>
    <to_code>T27024</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175736</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Striated Muscle VIP Activity [PE]</name>
  <code>C29694</code>  <id>29695</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle VIP Activity</to_name>
    <to_code>T27025</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009664</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Substance P Activity [PE]</name>
  <code>C29696</code>  <id>29697</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Substance P Activity</to_name>
    <to_code>T27026</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009665</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Substance P Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Acetylcholine Activity [PE]</name>
  <code>C29698</code>  <id>29699</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Acetylcholine Activity</to_name>
    <to_code>T27027</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009666</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Activity [PE]</name>
  <code>C635044</code>  <id>635044</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity</to_name>
    <to_code>T27029</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Activity</to_name>
    <to_code>T27028</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175651</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Epinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Brain Derived Neurotropic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Enkephalin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Aspartate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Dynorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic CCK Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Acetylcholine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Histamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Glycine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Gastrin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic GABA Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Endorphin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Dopamine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Sympathetic Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Glutamate Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>armodafinil [641465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Aspartate Activity [PE]</name>
  <code>C29700</code>  <id>29701</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Aspartate Activity</to_name>
    <to_code>T27030</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009667</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Brain Derived Neurotropic Activity [PE]</name>
  <code>C29702</code>  <id>29703</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Brain Derived Neurotropic Activity</to_name>
    <to_code>T27031</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009668</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic CCK Activity [PE]</name>
  <code>C29704</code>  <id>29705</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic CCK Activity</to_name>
    <to_code>T27032</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009669</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Disorganized Electrical Activity [PE]</name>
  <code>C29706</code>  <id>29707</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Disorganized Electrical Activity</to_name>
    <to_code>T27033</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009670</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Dopamine Activity [PE]</name>
  <code>C29708</code>  <id>29709</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Dopamine Activity</to_name>
    <to_code>T27034</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009671</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Dynorphin Activity [PE]</name>
  <code>C29710</code>  <id>29711</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Dynorphin Activity</to_name>
    <to_code>T27035</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009672</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Endorphin Activity [PE]</name>
  <code>C29712</code>  <id>29713</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Endorphin Activity</to_name>
    <to_code>T27036</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009673</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Enkephalin Activity [PE]</name>
  <code>C29714</code>  <id>29715</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Enkephalin Activity</to_name>
    <to_code>T27037</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009674</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Epinephrine Activity [PE]</name>
  <code>C29716</code>  <id>29717</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Epinephrine Activity</to_name>
    <to_code>T27038</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009675</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic GABA Activity [PE]</name>
  <code>C29718</code>  <id>29719</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic GABA Activity</to_name>
    <to_code>T27039</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009676</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Gastrin Activity [PE]</name>
  <code>C29720</code>  <id>29721</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Gastrin Activity</to_name>
    <to_code>T27040</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009677</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Glutamate Activity [PE]</name>
  <code>C29722</code>  <id>29723</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Glutamate Activity</to_name>
    <to_code>T27041</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009678</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Glycine Activity [PE]</name>
  <code>C29724</code>  <id>29725</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Glycine Activity</to_name>
    <to_code>T27042</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009679</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Histamine Activity [PE]</name>
  <code>C29726</code>  <id>29727</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Histamine Activity</to_name>
    <to_code>T27043</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009680</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Nerve Growth Factor Activity [PE]</name>
  <code>C29728</code>  <id>29729</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Nerve Growth Factor Activity</to_name>
    <to_code>T27044</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009681</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Neurotensin Activity [PE]</name>
  <code>C29730</code>  <id>29731</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Neurotensin Activity</to_name>
    <to_code>T27045</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009682</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Nitric Oxide Activity [PE]</name>
  <code>C29732</code>  <id>29733</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Nitric Oxide Activity</to_name>
    <to_code>T27046</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009683</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Norepinephrine Activity [PE]</name>
  <code>C29734</code>  <id>29735</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Norepinephrine Activity</to_name>
    <to_code>T27047</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009684</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Organized Electrical Activity [PE]</name>
  <code>C29736</code>  <id>29737</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Organized Electrical Activity</to_name>
    <to_code>T27048</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009685</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Serotonin Activity [PE]</name>
  <code>C29738</code>  <id>29739</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Serotonin Activity</to_name>
    <to_code>T27049</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009686</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic Substance P Activity [PE]</name>
  <code>C29740</code>  <id>29741</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Substance P Activity</to_name>
    <to_code>T27050</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009687</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Sympathetic VIP Activity [PE]</name>
  <code>C29742</code>  <id>29743</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic VIP Activity</to_name>
    <to_code>T27051</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009688</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased T Lymphocyte Activation [PE]</name>
  <code>C641733</code>  <id>641733</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation</to_name>
    <to_code>T27052</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182157</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichothecium roseum allergenic extract [968426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme preparation [319823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry juice [1307717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat bran extract [1427046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat dextrin [637366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab [2619313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat preparation [1441652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley seed oil [1309236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisagenlecleucel [1986438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil [1309229]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion extract [1370469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axicabtagene ciloleucel [1987398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat germ oil [72385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus arrhizus allergenic extract [314443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipilimumab [1094833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk phospholipids [314605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>walnut allergenic extract [314470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet pollen extract [852132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust allergenic extract [852519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab-rmbw [2596772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans allergenic extract [214355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Soy Proteins [36853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoamphodiacetate [1364462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat smut allergenic extract [852797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat bran [253190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean lecithin [579598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy protein isolate [196238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>western ragweed pollen extract [851985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased T Lymphocyte Destruction [PE]</name>
  <code>C29744</code>  <id>29745</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction</to_name>
    <to_code>T27053</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009689</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit anti-human T-lymphocyte globulin [107044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lymphocyte immune globulin, anti-thymocyte globulin, equine [91601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymocyte immunoglobulin, equine [1427177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Destruction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased T Lymphocyte Production [PE]</name>
  <code>C29746</code>  <id>29747</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Production</to_name>
    <to_code>T27054</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009690</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased T Lymphocyte Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased TRH Activity [PE]</name>
  <code>C29748</code>  <id>29749</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased TRH Activity</to_name>
    <to_code>T27055</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009691</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased TRH Secretion [PE]</name>
  <code>C29750</code>  <id>29751</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased TRH Secretion</to_name>
    <to_code>T27056</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009692</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Testosterone Secretion [PE]</name>
  <code>C29754</code>  <id>29755</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Testosterone Secretion</to_name>
    <to_code>T27057</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009694</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thrombolysis [PE]</name>
  <code>C29756</code>  <id>29757</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis</to_name>
    <to_code>T27058</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009695</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urokinase [11055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenecteplase [259280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thromboxane Activity [PE]</name>
  <code>C29758</code>  <id>29759</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Activity</to_name>
    <to_code>T27059</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009696</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thromboxane Degradation [PE]</name>
  <code>C29760</code>  <id>29761</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Degradation</to_name>
    <to_code>T27060</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009697</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thromboxane Production [PE]</name>
  <code>C29762</code>  <id>29763</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Production</to_name>
    <to_code>T27061</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009698</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thromboxane Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thyroid Hormone Iodination [PE]</name>
  <code>C29764</code>  <id>29765</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Iodination</to_name>
    <to_code>T27062</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009699</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin alfa [4952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kelp preparation [285155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thyroid Hormone Secretion [PE]</name>
  <code>C29766</code>  <id>29767</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion</to_name>
    <to_code>T27063</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009700</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Thyroid Stimulating Hormone Secretion [PE]</name>
  <code>C29752</code>  <id>29753</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Stimulating Hormone Secretion</to_name>
    <to_code>T27065</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased TSH Secretion</to_name>
    <to_code>T27064</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009693</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin-releasing hormone [10580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin alfa [4952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Tracheo-Bronchial Mucosal Edema [PE]</name>
  <code>C30306</code>  <id>30307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheo-Bronchial Mucosal Edema</to_name>
    <to_code>T27066</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009969</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Tracheo-Bronchial Secretions [PE]</name>
  <code>C29768</code>  <id>29769</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheo-Bronchial Secretions</to_name>
    <to_code>T27067</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009701</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheo-Bronchial Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Tracheobronchial Stretch Receptor Activity [PE]</name>
  <code>C29770</code>  <id>29771</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheobronchial Stretch Receptor Activity</to_name>
    <to_code>T27068</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009702</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Transcription to RNA [PE]</name>
  <code>C29772</code>  <id>29773</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Transcription to RNA</to_name>
    <to_code>T27069</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009703</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased UES Tone [PE]</name>
  <code>C29774</code>  <id>29775</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased UES Tone</to_name>
    <to_code>T27070</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009704</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Urethra Smooth Muscle Tone [PE]</name>
  <code>C30322</code>  <id>30323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Urethra Smooth Muscle Tone</to_name>
    <to_code>T27071</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009977</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</name>
  <code>C29776</code>  <id>29777</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone</to_name>
    <to_code>T27072</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009705</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine maleate [84158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin acetate [1733680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin acetate [1733680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine [6883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin [7824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin [7824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased VIP Activity [PE]</name>
  <code>C29778</code>  <id>29779</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased VIP Activity</to_name>
    <to_code>T27073</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009706</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Muscular System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased VIP Activity [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Central Nervous System VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Vaginal Muscle Tone [PE]</name>
  <code>C29780</code>  <id>29781</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vaginal Muscle Tone</to_name>
    <to_code>T27074</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009707</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vaginal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Vaginal Secretion [PE]</name>
  <code>C29782</code>  <id>29783</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vaginal Secretion</to_name>
    <to_code>T27075</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009708</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vaginal Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Vascular Permeability [PE]</name>
  <code>C31860</code>  <id>31861</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vascular Permeability</to_name>
    <to_code>T27076</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010251</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Increased Vascular Permeability [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Capillary Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Vascular Smooth Muscle Tone [PE]</name>
  <code>C31898</code>  <id>31899</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vascular Smooth Muscle Tone</to_name>
    <to_code>T27077</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010270</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Vasopressin Secretion [PE]</name>
  <code>C29784</code>  <id>29785</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vasopressin Secretion</to_name>
    <to_code>T27078</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009709</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Ventilatory Gas Flow [PE]</name>
  <code>C29786</code>  <id>29787</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ventilatory Gas Flow</to_name>
    <to_code>T27079</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009710</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha 1-proteinase inhibitor, human [991743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ventilatory Gas Flow [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased Vitamin Uptake and Modification [PE]</name>
  <code>C30234</code>  <id>30235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification</to_name>
    <to_code>T27080</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009933</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene [29365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene hydrate [1299898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Increased by food [PK]</name>
  <code>C200</code>  <id>201</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased by food</to_name>
    <to_code>T27081</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000011</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Indirect Lipase Activators [MoA]</name>
  <code>C654145</code>  <id>654145</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Indirect Lipase Activators</to_name>
    <to_code>T58562</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193925</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Indirect Lipase Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiopoietin-like 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inflammatory Bowel Disease Agents [TC]</name>
  <code>C654059</code>  <id>654059</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents</to_name>
    <to_code>T58437</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193838</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vedolizumab [1538097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab-mrkz [2668385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod arginine [2668046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod [2668045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab-sztn [2725169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Influenza A M2 Protein Inhibitor [EPC]</name>
  <code>C634936</code>  <id>634936</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Proton Pump Inhibitor</to_name>
    <to_code>T27210</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza A M2 Protein Inhibitor</to_name>
    <to_code>T27211</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175543</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Influenza A M2 Protein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimantadine [9386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Influenza A M2 Protein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amantadine [620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Influenza A M2 Protein Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza A M2 Protein Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Influenza Neuraminidase Inhibitor [EPC]</name>
  <code>C634851</code>  <id>634851</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza Neuraminidase Inhibitor</to_name>
    <to_code>T27212</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175437</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Influenza Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Influenza Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with neuraminidase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza Neuraminidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing neuraminidase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Influenza Neuraminidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhalation Diagnostic Agent [EPC]</name>
  <code>C635304</code>  <id>635304</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhalation Diagnostic Agent</to_name>
    <to_code>T27236</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175866</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inhalation Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xenon-133 [259282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inhalation Diagnostic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inhalation Diagnostic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic substance (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhalation Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Breast Glandular Development [PE]</name>
  <code>C29788</code>  <id>29789</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Breast Glandular Development</to_name>
    <to_code>T27245</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009711</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Breast Milk Ejection [PE]</name>
  <code>C29790</code>  <id>29791</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Breast Milk Ejection</to_name>
    <to_code>T27246</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009712</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Breast Milk Secretion [PE]</name>
  <code>C29792</code>  <id>29793</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Breast Milk Secretion</to_name>
    <to_code>T27247</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009713</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Embryonic &amp; Fetal Development [PE]</name>
  <code>C29794</code>  <id>29795</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Embryonic &amp; Fetal Development</to_name>
    <to_code>T27248</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009714</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovarian Follicular Phase [PE]</name>
  <code>C29796</code>  <id>29797</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase</to_name>
    <to_code>T27249</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009715</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovarian Luteal Phase [PE]</name>
  <code>C29798</code>  <id>29799</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Luteal Phase</to_name>
    <to_code>T27250</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009716</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovulation [PE]</name>
  <code>C29800</code>  <id>29801</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation</to_name>
    <to_code>T27251</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009717</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal acetate [1005920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>segesterone [2055978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal [1005921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drospirenone [11636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>segesterone acetate [2055977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etonogestrel [14584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Ovum Fertilization [PE]</name>
  <code>C635249</code>  <id>635249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization</to_name>
    <to_code>T27252</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175830</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper chloride [150596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper [2837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper Cu-64 [2200143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper sulfate [21579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric oxide [21837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric chloride [21833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper gluconate [2839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Penile Development [PE]</name>
  <code>C29802</code>  <id>29803</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Penile Development</to_name>
    <to_code>T27253</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009718</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Uterine Menstrual Phase [PE]</name>
  <code>C29804</code>  <id>29805</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Uterine Menstrual Phase</to_name>
    <to_code>T27254</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009719</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Uterine Proliferative Phase [PE]</name>
  <code>C29806</code>  <id>29807</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Uterine Proliferative Phase</to_name>
    <to_code>T27255</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009720</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibit Uterine Secretory Phase [PE]</name>
  <code>C29808</code>  <id>29809</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Uterine Secretory Phase</to_name>
    <to_code>T27256</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009721</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Carbohydrate Digestion [PE]</name>
  <code>C29810</code>  <id>29811</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Carbohydrate Digestion</to_name>
    <to_code>T27257</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009722</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglitol [30009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Carbohydrate Digestion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acarbose [16681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Carbohydrate Digestion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Fat Digestion [PE]</name>
  <code>C29812</code>  <id>29813</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Fat Digestion</to_name>
    <to_code>T27258</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009723</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orlistat [37925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Fat Digestion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Gastric Acid Secretion [PE]</name>
  <code>C29814</code>  <id>29815</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion</to_name>
    <to_code>T27259</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009724</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan fumarate [2604576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate bromide [52560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan [2604577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate [107770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Gastric Mucous Secretion [PE]</name>
  <code>C29816</code>  <id>29817</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Mucous Secretion</to_name>
    <to_code>T27260</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009725</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine hydrochloride [235775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</name>
  <code>C29818</code>  <id>29819</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption</to_name>
    <to_code>T27261</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009726</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium cation [1311382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium cation [1364429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil, light [577312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfate ion [1426598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil [6972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malt soup extract [91264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heavy mineral oil [258439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (4000 CPS) [1297402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycols [8516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (100 CPS) [1310583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</name>
  <code>C29820</code>  <id>29821</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion</to_name>
    <to_code>T27262</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009727</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Pancreatic Enzymatic Secretion [PE]</name>
  <code>C29822</code>  <id>29823</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Pancreatic Enzymatic Secretion</to_name>
    <to_code>T27263</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009728</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Pancreatic Fluid/Electrolyte Secretion [PE]</name>
  <code>C29824</code>  <id>29825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Pancreatic Fluid/Electrolyte Secretion</to_name>
    <to_code>T27264</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009729</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</name>
  <code>C29826</code>  <id>29827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption</to_name>
    <to_code>T27265</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009730</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inhibition Small Intestine Fluid/Electrolyte Secretion [PE]</name>
  <code>C29828</code>  <id>29829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Secretion</to_name>
    <to_code>T27266</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009731</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Inorganic Ion Absorption Alteration [PE]</name>
  <code>C634920</code>  <id>634920</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Inorganic Ion Absorption Alteration</to_name>
    <to_code>T27284</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175527</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Inorganic Ion Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Inorganic Ion Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inorganic Ion Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin Analog [EPC]</name>
  <code>C634833</code>  <id>634833</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog</to_name>
    <to_code>T27349</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analogue</to_name>
    <to_code>T27348</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175453</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin glulisine, human [400008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin detemir [139825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin glargine [274783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin [M0011417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin lispro [86009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin aspart, human [51428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin degludec [1670007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing insulin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Insulin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin Receptor Agonists [MoA]</name>
  <code>C628</code>  <id>629</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists</to_name>
    <to_code>T27376</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000225</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide sodium [221173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef-pork [235281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin Receptor Antagonists [MoA]</name>
  <code>C320</code>  <id>321</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Antagonists</to_name>
    <to_code>T27377</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000071</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin Receptor Interactions [MoA]</name>
  <code>C658</code>  <id>659</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Interactions</to_name>
    <to_code>T27378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000240</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin [EPC]</name>
  <code>C635382</code>  <id>635382</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-class Agent</to_name>
    <to_code>T27385</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin</to_name>
    <to_code>T27386</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175944</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin [M0011417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Insulin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing insulin (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>insulin, regular, human [253182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</name>
  <code>C654153</code>  <id>654153</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IGF-1R Inhibitor</to_name>
    <to_code>T58576</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitor</to_name>
    <to_code>T58575</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193926</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teprotumumab [2274803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protein kinase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with protein kinase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</name>
  <code>C654154</code>  <id>654154</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IGF-1R Inhibitors</to_name>
    <to_code>T58578</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitors</to_name>
    <to_code>T58577</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193927</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab [2274803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</name>
  <code>C452</code>  <id>453</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Interactions</to_name>
    <to_code>T58579</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IGF-1R Interactions</to_name>
    <to_code>T58581</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IGF Type 1 Receptor Interactions</to_name>
    <to_code>T25790</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IGF-1 Receptor Interactions</to_name>
    <to_code>T58580</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000137</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin acetate [1044583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Integrase Inhibitors [MoA]</name>
  <code>C694</code>  <id>695</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrase Inhibitors</to_name>
    <to_code>T27455</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000258</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Integrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Integrin Receptor Antagonist [EPC]</name>
  <code>C635194</code>  <id>635194</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonist</to_name>
    <to_code>T27461</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175775</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vedolizumab [1538097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrin Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natalizumab [354770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrin Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing selective adhesion molecule inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with selective adhesion molecule inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Integrin Receptor Antagonists [MoA]</name>
  <code>C635193</code>  <id>635193</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonists</to_name>
    <to_code>T27462</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175774</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrin Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab-sztn [2725169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vedolizumab [1538097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Integrin Receptor Interactions [MoA]</name>
  <code>C635192</code>  <id>635192</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Interactions</to_name>
    <to_code>T27463</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175773</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Integrin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon Inducers [MoA]</name>
  <code>C492</code>  <id>493</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Inducers</to_name>
    <to_code>T27622</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000157</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon Receptor Interactions [MoA]</name>
  <code>C654185</code>  <id>654185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Receptor Interactions</to_name>
    <to_code>T58641</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193959</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b-njft [2587060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b [2587059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon alfa-2b [EPC]</name>
  <code>C654202</code>  <id>654202</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alfa-2b</to_name>
    <to_code>T58668</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alfa-2B</to_name>
    <to_code>T58670</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IFN alpha-2B</to_name>
    <to_code>T58669</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193982</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alfa-2b [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropeginterferon alfa-2b [2587059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alfa-2b [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interferon alfa-2b (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alfa-2b [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon alfa-2b [M0023695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alfa-2b [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Interferon alfa-2b (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon alpha [EPC]</name>
  <code>C634914</code>  <id>634914</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alpha-class Agent</to_name>
    <to_code>T27646</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alfa</to_name>
    <to_code>T27647</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alpha</to_name>
    <to_code>T27648</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175521</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peginterferon alfa-2b [M0374956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Interferon alfa (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon alfa-2b [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interferon alfa (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peginterferon alfa-2a [M0263641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon alfa-n3 [612937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon alpha [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginterferon alfa-2a [120608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon beta [EPC]</name>
  <code>C651709</code>  <id>651709</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon beta-class Agent</to_name>
    <to_code>T27649</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon beta</to_name>
    <to_code>T27650</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191625</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon beta [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon beta-1b [72257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon beta [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginterferon beta-1a [1546168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon beta [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Interferon beta (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon beta [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon beta-1a [75917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon beta [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interferon beta (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon beta [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon-beta [M0025715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma Antagonists [MoA]</name>
  <code>C654079</code>  <id>654079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IFNγ Antagonists</to_name>
    <to_code>T58466</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma Antagonists</to_name>
    <to_code>T58465</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193855</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab [2104604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma Blocker [EPC]</name>
  <code>C654080</code>  <id>654080</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma Blocker</to_name>
    <to_code>T58467</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IFNγ Blocker</to_name>
    <to_code>T58468</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193856</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interferon gamma inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>emapalumab [2104604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interferon gamma inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interferon gamma [EPC]</name>
  <code>C634934</code>  <id>634934</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma</to_name>
    <to_code>T27662</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon gamma-class Agent</to_name>
    <to_code>T27661</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175541</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon-gamma [M0011490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interferon gamma (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Interferon gamma (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interferon gamma [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>interferon gamma-1b [5882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Agonists [MoA]</name>
  <code>C635114</code>  <id>635114</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Activators</to_name>
    <to_code>T27708</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL1 Receptor Activators</to_name>
    <to_code>T27707</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL1 Receptor Agonists</to_name>
    <to_code>T27705</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Agonists</to_name>
    <to_code>T27706</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175708</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Antagonists [MoA]</name>
  <code>C635115</code>  <id>635115</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonists</to_name>
    <to_code>T27720</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Inhibitors</to_name>
    <to_code>T27717</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL1 Receptor Blockers</to_name>
    <to_code>T27715</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL1 Receptor Antagonists</to_name>
    <to_code>T27716</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL1 Receptor Inhibitors</to_name>
    <to_code>T27718</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Blockers</to_name>
    <to_code>T27719</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175709</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 1 Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilonacept [763450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 1 Receptor Interactions [MoA]</name>
  <code>C635113</code>  <id>635113</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL1 Receptor Interactions</to_name>
    <to_code>T27721</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Interactions</to_name>
    <to_code>T27722</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175707</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 1 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 1 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor A Antagonists [MoA]</name>
  <code>C653650</code>  <id>653650</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Antagonists</to_name>
    <to_code>T27730</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17RA Antagonists</to_name>
    <to_code>T27723</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17 RA Antagonists</to_name>
    <to_code>T27727</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17RA Antagonists</to_name>
    <to_code>T27725</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17RA Antagonists</to_name>
    <to_code>T27726</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17 RA Antagonists</to_name>
    <to_code>T27729</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Antagonists</to_name>
    <to_code>T27724</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17RA Antagonists</to_name>
    <to_code>T27728</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193279</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brodalumab [1872251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor A Interactions [MoA]</name>
  <code>C653649</code>  <id>653649</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17RA Interactions</to_name>
    <to_code>T27734</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17 RA Interactions</to_name>
    <to_code>T27733</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Interactions</to_name>
    <to_code>T27736</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17RA Interactions</to_name>
    <to_code>T27731</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Interactions</to_name>
    <to_code>T27738</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17RA Interactions</to_name>
    <to_code>T27732</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17RA Interactions</to_name>
    <to_code>T27735</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17 RA Interactions</to_name>
    <to_code>T27737</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193278</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 17 Receptor A Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brodalumab [1872251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 17 Receptor Interactions [MoA]</name>
  <code>C653648</code>  <id>653648</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor Interactions</to_name>
    <to_code>T27740</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17 Receptor Interactions</to_name>
    <to_code>T27739</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor Interactions</to_name>
    <to_code>T27742</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17 Receptor Interactions</to_name>
    <to_code>T27741</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193277</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 17 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Agonists [MoA]</name>
  <code>C31918</code>  <id>31919</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Activators</to_name>
    <to_code>T27743</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Activators</to_name>
    <to_code>T27745</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Agonists</to_name>
    <to_code>T27744</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Agonists</to_name>
    <to_code>T27746</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010280</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Antagonists [MoA]</name>
  <code>C31916</code>  <id>31917</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Blockers</to_name>
    <to_code>T27750</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Antagonists</to_name>
    <to_code>T27752</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Inhibitors</to_name>
    <to_code>T27751</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Inhibitors</to_name>
    <to_code>T27748</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Antagonists</to_name>
    <to_code>T27749</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Blockers</to_name>
    <to_code>T27747</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010279</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basiliximab [196102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor Interactions [MoA]</name>
  <code>C31914</code>  <id>31915</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Interactions</to_name>
    <to_code>T27753</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Interactions</to_name>
    <to_code>T27754</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010278</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 2 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 2 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 2 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD25-directed Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</name>
  <code>C635014</code>  <id>635014</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor-directed Antibody Interactions</to_name>
    <to_code>T27756</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor-directed Antibody Interactions</to_name>
    <to_code>T27755</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175621</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basiliximab [196102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 31 Receptor Interactions [MoA]</name>
  <code>C654329</code>  <id>654329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 31 Receptor Interactions</to_name>
    <to_code>T58955</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194117</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 31 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor Interactions [MoA]</name>
  <code>C653711</code>  <id>653711</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4 Receptor Interactions</to_name>
    <to_code>T27758</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor Interactions</to_name>
    <to_code>T27762</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4R Interactions</to_name>
    <to_code>T27761</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4R Interactions</to_name>
    <to_code>T27757</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4 Receptor Interactions</to_name>
    <to_code>T27759</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-4 Receptor Interactions</to_name>
    <to_code>T27760</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193340</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 4 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor alpha Antagonists [MoA]</name>
  <code>C653712</code>  <id>653712</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-4 Receptor alpha Antagonists</to_name>
    <to_code>T27763</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4 Receptor alpha Antagonists</to_name>
    <to_code>T27765</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4R alpha Antagonists</to_name>
    <to_code>T27766</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4 Receptor alpha Antagonists</to_name>
    <to_code>T27764</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha Antagonists</to_name>
    <to_code>T27768</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4R alpha Antagonists</to_name>
    <to_code>T27767</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193341</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dupilumab [1876376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 4 Receptor alpha-directed Antibody Interactions [MoA]</name>
  <code>C653710</code>  <id>653710</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4R alpha-directed Antibody Interactions</to_name>
    <to_code>T27771</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4R alpha-directed Antibody Interactions</to_name>
    <to_code>T27770</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T27772</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4 Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T27769</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193339</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</name>
  <code>C654022</code>  <id>654022</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-5 Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T58387</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T58398</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T58391</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IL-5 Receptor alpha mAb Interactions</to_name>
    <to_code>T58389</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T58386</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL5 Receptor alpha-directed Antibody Interactions</to_name>
    <to_code>T58388</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193802</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benralizumab [1989100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Agonists [MoA]</name>
  <code>C650438</code>  <id>650438</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Agonists</to_name>
    <to_code>T27774</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Activators</to_name>
    <to_code>T27775</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Activators</to_name>
    <to_code>T27773</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Agonists</to_name>
    <to_code>T27776</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190479</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Antagonists [MoA]</name>
  <code>C650437</code>  <id>650437</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Inhibitors</to_name>
    <to_code>T27777</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Antagonists</to_name>
    <to_code>T27778</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Inhibitors</to_name>
    <to_code>T27779</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists</to_name>
    <to_code>T27782</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Blockers</to_name>
    <to_code>T27781</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Blockers</to_name>
    <to_code>T27780</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190478</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab [2391541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab-mwge [2391551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarilumab [1923319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin 6 Receptor Interactions [MoA]</name>
  <code>C650436</code>  <id>650436</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Interactions</to_name>
    <to_code>T27784</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Interactions</to_name>
    <to_code>T27783</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190477</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 6 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin 6 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin Agent [APC]</name>
  <code>C654128</code>  <id>654128</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin Agent</to_name>
    <to_code>T58530</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193903</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-4 Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-1 Receptor Antagonist [EPC]</name>
  <code>C635116</code>  <id>635116</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-1 (IL-1) Receptor Antagonist</to_name>
    <to_code>T27808</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonist</to_name>
    <to_code>T27806</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-1 Receptor Antagonist</to_name>
    <to_code>T27809</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 (IL1) Receptor Antagonist</to_name>
    <to_code>T27807</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175710</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interleukin 1 receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interleukin 1 receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anakinra [72435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-12 Antagonist [EPC]</name>
  <code>C653077</code>  <id>653077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-12 Antagonist</to_name>
    <to_code>T27850</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL12 Antagonist</to_name>
    <to_code>T27849</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonist</to_name>
    <to_code>T27852</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 12 Antagonist</to_name>
    <to_code>T27851</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192797</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-12 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-aekn [2705377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-12 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab [847083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-12 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-12 Antagonists [MoA]</name>
  <code>C653076</code>  <id>653076</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 12 Antagonists</to_name>
    <to_code>T27855</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL12 Antagonists</to_name>
    <to_code>T27853</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-12 Antagonists</to_name>
    <to_code>T27854</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists</to_name>
    <to_code>T27856</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192796</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-13 Antagonist [EPC]</name>
  <code>C654207</code>  <id>654207</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 13 Antagonist</to_name>
    <to_code>T58681</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-13 Antagonist</to_name>
    <to_code>T58682</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonist</to_name>
    <to_code>T58680</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 13 Antagonist</to_name>
    <to_code>T58683</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193985</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-13 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tralokinumab [2589225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-13 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lebrikizumab [2693758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-13 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-13 Antagonists [MoA]</name>
  <code>C654206</code>  <id>654206</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-13 Antagonists</to_name>
    <to_code>T58678</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 13 Antagonists</to_name>
    <to_code>T58679</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists</to_name>
    <to_code>T58676</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 13 Antagonists</to_name>
    <to_code>T58677</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193986</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab-ldrm [2589374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab [2693758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab [2589225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab-lbkz [2693778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-15 Receptor Agonist [EPC]</name>
  <code>C654343</code>  <id>654343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-15 Receptor Agonist</to_name>
    <to_code>T58990</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonist</to_name>
    <to_code>T58988</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 15 Receptor Agonist</to_name>
    <to_code>T58989</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 15 Receptor Agonist</to_name>
    <to_code>T58992</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL15 Receptor Agonist</to_name>
    <to_code>T58991</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194118</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-15 Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-15 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nogapendekin alfa inbakicept-pmln [2682677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-15 Receptor Agonists [MoA]</name>
  <code>C654342</code>  <id>654342</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 15 Receptor Agonists</to_name>
    <to_code>T58987</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 15 Receptor Agonists</to_name>
    <to_code>T58984</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-15 Receptor Agonists</to_name>
    <to_code>T58985</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonists</to_name>
    <to_code>T58983</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL15 Receptor Agonists</to_name>
    <to_code>T58986</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194119</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept-pmln [2682677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-15 Receptor Interactions [MoA]</name>
  <code>C654341</code>  <id>654341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Interactions</to_name>
    <to_code>T58976</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL15R Interactions</to_name>
    <to_code>T58981</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 15 Receptor Interactions</to_name>
    <to_code>T58977</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 15 Receptor Interactions</to_name>
    <to_code>T58982</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 15R Interactions </to_name>
    <to_code>T58978</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-15 Receptor Interactions</to_name>
    <to_code>T58979</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL15 Receptor Interactions</to_name>
    <to_code>T58980</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194120</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-15 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17 Receptor A Antagonist [EPC]</name>
  <code>C653647</code>  <id>653647</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17 RA Antagonist</to_name>
    <to_code>T27920</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17RA Antagonist</to_name>
    <to_code>T27923</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Antagonist</to_name>
    <to_code>T27925</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17RA Antagonist</to_name>
    <to_code>T27922</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17RA Antagonist</to_name>
    <to_code>T27919</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Antagonist</to_name>
    <to_code>T27921</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17 RA Antagonist</to_name>
    <to_code>T27924</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17RA Antagonist</to_name>
    <to_code>T27918</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193276</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-17 Receptor A Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brodalumab [1872251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-17 Receptor A Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17 Receptor A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A Antagonist [EPC]</name>
  <code>C651543</code>  <id>651543</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17A (IL17A) Antagonist</to_name>
    <to_code>T27931</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonist</to_name>
    <to_code>T27935</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17A Antagonist</to_name>
    <to_code>T27932</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A (IL-17A) Antagonist</to_name>
    <to_code>T27934</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17A Antagonist</to_name>
    <to_code>T27933</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17A Antagonist</to_name>
    <to_code>T27930</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191495</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-17A Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixekizumab [1745099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-17A Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-17A Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secukinumab [1599788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A Antagonists [MoA]</name>
  <code>C651542</code>  <id>651542</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17A Antagonists</to_name>
    <to_code>T27936</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17A Antagonists</to_name>
    <to_code>T27937</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonists</to_name>
    <to_code>T27938</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191494</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secukinumab [1599788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixekizumab [1745099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A-directed Antibody Interactions [MoA]</name>
  <code>C651544</code>  <id>651544</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17A-directed Antibody Interactions</to_name>
    <to_code>T27939</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody Interactions</to_name>
    <to_code>T27941</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17A-directed Antibody Interactions</to_name>
    <to_code>T27940</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191496</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab [2668041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab-bkzx [2668080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-17A-directed Antibody [EPC]</name>
  <code>C651545</code>  <id>651545</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17A-directed Antibody</to_name>
    <to_code>T27943</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 17A (IL17A)-directed Antibody</to_name>
    <to_code>T27947</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL17A-directed Antibody</to_name>
    <to_code>T27944</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody</to_name>
    <to_code>T27948</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 17A-directed Antibody</to_name>
    <to_code>T27942</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-17A-directed Antibody</to_name>
    <to_code>T27945</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A (IL-17A)-directed Antibody</to_name>
    <to_code>T27946</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191497</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-17A-directed Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Receptor Blocking Antibody [EPC]</name>
  <code>C635015</code>  <id>635015</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody</to_name>
    <to_code>T27976</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Blocker (Antibody)</to_name>
    <to_code>T27978</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody</to_name>
    <to_code>T27980</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor Blocking Antibody</to_name>
    <to_code>T27977</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Blocking Antibody</to_name>
    <to_code>T27979</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175622</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-2 Receptor Blocking Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-2 Receptor Blocking Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-2 Receptor Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basiliximab [196102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-2 Receptor-directed Cytotoxin [EPC]</name>
  <code>C635053</code>  <id>635053</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL2 Receptor-directed Cytotoxin</to_name>
    <to_code>T28007</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor-directed Cytotoxin</to_name>
    <to_code>T28006</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor-directed Cytotoxin</to_name>
    <to_code>T28010</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 2 Receptor-directed Cytotoxin</to_name>
    <to_code>T28008</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-2 Receptor-directed Cytotoxin</to_name>
    <to_code>T28009</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175660</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor-directed Cytotoxin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-23 Antagonist [EPC]</name>
  <code>C653079</code>  <id>653079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonist</to_name>
    <to_code>T28027</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 23 Antagonist</to_name>
    <to_code>T28025</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-23 Antagonist</to_name>
    <to_code>T28026</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL23 Antagonist</to_name>
    <to_code>T28024</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192799</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tildrakizumab [2053436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risankizumab [2166040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guselkumab [1928588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab [847083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interleukin 23 receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-aekn [2705377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interleukin 23 receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirikizumab [2668384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-23 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-23 Antagonists [MoA]</name>
  <code>C653078</code>  <id>653078</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-23 Antagonists</to_name>
    <to_code>T28030</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 23 Antagonists</to_name>
    <to_code>T28028</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists</to_name>
    <to_code>T28031</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL23 Antagonists</to_name>
    <to_code>T28029</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192798</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab [2166040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab [2053436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-stba [2700389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aekn [2705377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guselkumab [1928588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-aauz [2702602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab-asmn [2053449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-ttwe [2705553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab-rzaa [2166132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-auub [2700665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab-mrkz [2668385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-hmny [2725083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-kfce [2705577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab-srlf [2717063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-31 Receptor alpha Antagonist [EPC]</name>
  <code>C654330</code>  <id>654330</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonist</to_name>
    <to_code>T58956</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194121</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-31 Receptor alpha Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nemolizumab [2691310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-31 Receptor alpha Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-31 Receptor alpha Antagonists [MoA]</name>
  <code>C654328</code>  <id>654328</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 31 Receptor alpha Antagonists</to_name>
    <to_code>T58954</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-31 Receptor alpha Antagonists</to_name>
    <to_code>T58950</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL31 Receptor alpha Antagonists</to_name>
    <to_code>T58952</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonists</to_name>
    <to_code>T58949</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-31R alpha Antagonists</to_name>
    <to_code>T58951</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL31R alpha Antagonists</to_name>
    <to_code>T58953</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194122</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-36 Receptor Antagonist [EPC]</name>
  <code>C654267</code>  <id>654267</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL36 Receptor Antagonist</to_name>
    <to_code>T58811</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonist</to_name>
    <to_code>T58807</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-36 Receptor Antagonist</to_name>
    <to_code>T58809</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 36 Receptor Antagonist</to_name>
    <to_code>T58808</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-36RA</to_name>
    <to_code>T58810</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194039</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-36 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spesolimab [2610417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-36 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing interleukin receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with interleukin receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-36 Receptor Antagonists [MoA]</name>
  <code>C654266</code>  <id>654266</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 36 Receptor Antagonists</to_name>
    <to_code>T58803</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonists</to_name>
    <to_code>T58802</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-36 Receptor Antagonists</to_name>
    <to_code>T58804</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-36RAs</to_name>
    <to_code>T58805</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL36 Receptor Antagonists</to_name>
    <to_code>T58806</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194040</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab [2610417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-36 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-4 Receptor alpha Antagonist [EPC]</name>
  <code>C653713</code>  <id>653713</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4 Receptor alpha Antagonist</to_name>
    <to_code>T28064</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha Antagonist</to_name>
    <to_code>T28066</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4R alpha Antagonist</to_name>
    <to_code>T28067</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL4R alpha Antagonist</to_name>
    <to_code>T28068</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-4 Receptor alpha Antagonist</to_name>
    <to_code>T28069</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-4 Receptor alpha Antagonist</to_name>
    <to_code>T28065</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193342</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dupilumab [1876376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interleukin-4 receptor alpha antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interleukin-4 receptor alpha antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-4 Receptor alpha Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 4 Receptor alpha Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Antagonist [EPC]</name>
  <code>C652002</code>  <id>652002</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL5 Antagonist</to_name>
    <to_code>T28093</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 Antagonist</to_name>
    <to_code>T28094</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonist</to_name>
    <to_code>T28096</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-5 Antagonist</to_name>
    <to_code>T28095</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191872</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interleukin 5 receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interleukin 5 receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepolizumab [1720597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reslizumab [1746889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Antagonists [MoA]</name>
  <code>C652001</code>  <id>652001</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonists</to_name>
    <to_code>T28097</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191871</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepolizumab [1720597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reslizumab [1746889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</name>
  <code>C654021</code>  <id>654021</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 (IL-5) Receptor alpha-directed Antibody</to_name>
    <to_code>T58395</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody</to_name>
    <to_code>T58379</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-IL-5 Receptor alpha mAb</to_name>
    <to_code>T58392</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-5 Receptor alpha-directed Antibody</to_name>
    <to_code>T58393</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 Receptor alpha-directed Antibody</to_name>
    <to_code>T58396</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL5 Receptor alpha-directed Antibody</to_name>
    <to_code>T58394</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193803</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benralizumab [1989100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal, Humanized [M0556300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 Antagonist [EPC]</name>
  <code>C650987</code>  <id>650987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-6 Antagonist</to_name>
    <to_code>T28114</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 (IL-6) Antagonist</to_name>
    <to_code>T28116</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 (IL6) Antagonist</to_name>
    <to_code>T28118</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Antagonist</to_name>
    <to_code>T28117</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonist</to_name>
    <to_code>T28119</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Antagonist</to_name>
    <to_code>T28115</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191006</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interleukin receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interleukin receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>siltuximab [1535218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 Antagonists [MoA]</name>
  <code>C650985</code>  <id>650985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Antagonists</to_name>
    <to_code>T28121</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonists</to_name>
    <to_code>T28122</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-6 Antagonists</to_name>
    <to_code>T28120</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191004</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siltuximab [1535218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6 Receptor Antagonist [EPC]</name>
  <code>C650439</code>  <id>650439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonist</to_name>
    <to_code>T28125</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6 Receptor Antagonist</to_name>
    <to_code>T28123</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 (IL6) Receptor Antagonist</to_name>
    <to_code>T28124</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 (IL-6) Receptor Antagonist</to_name>
    <to_code>T28127</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Receptor Antagonist</to_name>
    <to_code>T28128</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-6 Receptor Antagonist</to_name>
    <to_code>T28126</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190480</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with interleukin receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interleukin receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocilizumab [612865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarilumab [1923319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6-directed Antibody Interactions [MoA]</name>
  <code>C650984</code>  <id>650984</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-6-directed Antibody Interactions</to_name>
    <to_code>T28152</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6-directed Antibody Interactions</to_name>
    <to_code>T28151</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6-directed Antibody Interactions</to_name>
    <to_code>T28153</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191003</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Interleukin-6-directed Antibody [EPC]</name>
  <code>C650988</code>  <id>650988</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 (IL-6)-directed Antibody</to_name>
    <to_code>T28157</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6-directed Antibody</to_name>
    <to_code>T28160</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL6-directed Antibody</to_name>
    <to_code>T28156</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL-6-directed Antibody</to_name>
    <to_code>T28159</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6 (IL6)-directed Antibody</to_name>
    <to_code>T28155</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IL 6-directed Antibody</to_name>
    <to_code>T28154</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 6-directed Antibody</to_name>
    <to_code>T28158</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Interleukin-6-directed Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Intestinal Lipase Inhibitor [EPC]</name>
  <code>C634984</code>  <id>634984</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Intestinal Lipase Inhibitor</to_name>
    <to_code>T28228</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175591</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with lipase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orlistat [37925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intestinal Lipase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing lipase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Intestinal Metabolism [PK]</name>
  <code>C228</code>  <id>229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Intestinal Metabolism</to_name>
    <to_code>T28229</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000025</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intestinal Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>site_of_metabolism</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intestinal Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Intracellular Communication [PE]</name>
  <code>C31820</code>  <id>31821</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Intracellular Communication</to_name>
    <to_code>T28257</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010231</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intracellular Communication [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intercellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intracellular Communication [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensifentrine [2687215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intracellular Communication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Intraocular Fluid Pressure Alteration [PE]</name>
  <code>C30252</code>  <id>30253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Intraocular Fluid Pressure Alteration</to_name>
    <to_code>T28293</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009942</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intraocular Fluid Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intraocular Fluid Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Intraocular Irrigating Solution [EPC]</name>
  <code>C634930</code>  <id>634930</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Intraocular Irrigating Solution</to_name>
    <to_code>T28294</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175537</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Irrigating solution (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intraocular Irrigating Solution [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Intravascular Volume Alteration [PE]</name>
  <code>C29830</code>  <id>29831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Intravascular Volume Alteration</to_name>
    <to_code>T28305</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009732</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intravascular Volume Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Intravascular Volume Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iodide Peroxidase Inhibitors [MoA]</name>
  <code>C31910</code>  <id>31911</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodide Peroxidase Inhibitors</to_name>
    <to_code>T28324</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Peroxidase Inhibitors</to_name>
    <to_code>T28323</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010276</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iodinated Contrast Agent for Radiographic Imaging [EPC]</name>
  <code>C635305</code>  <id>635305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodinated Contrast Agent for Radiographic Imaging</to_name>
    <to_code>T28335</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175867</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iodinated Contrast Agent for Radiographic Imaging [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Iodinated contrast media (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing iodine and/or iodine compound (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodinated Contrast Agent for Radiographic Imaging [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iodine Organification Alteration [PE]</name>
  <code>C29832</code>  <id>29833</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodine Organification Alteration</to_name>
    <to_code>T28338</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009733</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iodine Organification Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Iodine Organification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iodine Organification Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Iodine Organification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iodine Uptake Alteration [PE]</name>
  <code>C29834</code>  <id>29835</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodine Uptake Alteration</to_name>
    <to_code>T28340</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009734</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iodine Uptake Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Iodine Uptake [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iodine Uptake Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Iodine Uptake [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ion Channel Interactions [MoA]</name>
  <code>C564</code>  <id>565</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions</to_name>
    <to_code>T28391</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000193</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ligand-Gated Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine hydrochloride [82093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoltremon [2716801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine [34905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine hydrochloride [227778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine [9386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ion Channel or Pump Agent [APC]</name>
  <code>C654133</code>  <id>654133</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel or Pump Agent</to_name>
    <to_code>T58535</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193904</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Ganglionic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chloride Channel Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>TRPM8 Thermoreceptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Channel Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Channel or Pump Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium-sparing Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ion Exchange Activity [MoA]</name>
  <code>C634739</code>  <id>634739</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Exchange Activity</to_name>
    <to_code>T28398</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175356</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Exchange Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Exchange Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prussian blue insoluble [24902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ion Transporter Interactions [MoA]</name>
  <code>C648271</code>  <id>648271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Transporter Interactions</to_name>
    <to_code>T28401</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188370</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cation Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Symporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ionophoric Activity [MoA]</name>
  <code>C640570</code>  <id>640570</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionophoric Activity</to_name>
    <to_code>T28403</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181010</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ionotropic Glutamate Receptor Antagonists [MoA]</name>
  <code>C300399</code>  <id>300399</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists</to_name>
    <to_code>T28404</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020014</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ionotropic Glutamate Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ionotropic Glutamate Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kainate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ionotropic Glutamate Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>AMPA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil [27403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil tartrate [289912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ionotropic Glutamate Receptor Interactions [MoA]</name>
  <code>C648290</code>  <id>648290</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Interactions</to_name>
    <to_code>T28405</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188381</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ionotropic Glutamate Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iron Chelating Activity [MoA]</name>
  <code>C466</code>  <id>467</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelator</to_name>
    <to_code>T28477</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity</to_name>
    <to_code>T28478</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000144</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Siderophore Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferiprone [11645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetic acid [3690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iron Chelator [EPC]</name>
  <code>C634915</code>  <id>634915</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelator</to_name>
    <to_code>T28479</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175522</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferiprone [11645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferoxamine [3131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deferasirox [614373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chelating agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with chelating agent mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Iron Supplement [EPC]</name>
  <code>C634916</code>  <id>634916</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron-containing Supplement</to_name>
    <to_code>T28498</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Supplement</to_name>
    <to_code>T28499</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175523</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Supplement [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Iron supplement (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Iron Supplement [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron Compounds [M0540735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing iron (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Supplement [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Irrigation [MoA]</name>
  <code>C634927</code>  <id>634927</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Irrigation</to_name>
    <to_code>T28513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175534</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Irrigation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluconolactone [25842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Irrigation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</name>
  <code>C654208</code>  <id>654208</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitor</to_name>
    <to_code>T58684</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IDH1 Inhibitor</to_name>
    <to_code>T58685</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase-1 Inhibitor</to_name>
    <to_code>T58686</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193987</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivosidenib [2049873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with isocitrate dehydrogenase-1 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorasidenib [2690647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 1 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing isocitrate dehydrogenase-1 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</name>
  <code>C654209</code>  <id>654209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors</to_name>
    <to_code>T58687</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IDH1 Inhibitors</to_name>
    <to_code>T58688</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase-1 Inhibitors</to_name>
    <to_code>T58689</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193988</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib [2690647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olutasidenib [2623641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib citrate [2690648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</name>
  <code>C653986</code>  <id>653986</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase-2 Inhibitor</to_name>
    <to_code>T28564</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IDH2 Inhibitor</to_name>
    <to_code>T28565</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitor</to_name>
    <to_code>T28566</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193615</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorasidenib [2690647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enasidenib [1940332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing isocitrate dehydrogenase-2 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Isocitrate Dehydrogenase 2 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</name>
  <code>C653985</code>  <id>653985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitors</to_name>
    <to_code>T28569</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase-2 Inhibitors</to_name>
    <to_code>T28567</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>IDH2 Inhibitors</to_name>
    <to_code>T28568</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193614</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib [2690647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib [1940332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib citrate [2690648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Isocitrate Dehydrogenase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>J [Preparations]</name>
  <code>C288636</code>  <id>288636</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>J [Preparations]</to_name>
    <to_code>T28676</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010592</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis var. saxatilis whole extract [2591814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jojoba butter [1362138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>josamycin propionate [28069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>juniper tar [6086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jujube fruit extract [1424897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jatropha curcas whole extract [1663394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Justicia spicigera leaf extract [2593848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus virginiana allergenic extract [1314591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juglans regia flowering top extract [1310159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juglans cinerea branch bark-root bark extract [1309750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jateorhiza calumba root extract [1310157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis var. saxatilis fruit extract [1992861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jerusalem oak pollen extract [1014766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jammu lemongrass oil [2374551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Johnson grass pollen extract [852136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese encephalitis virus [1439114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>June grass pollen extract [851965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Joshua tree root extract [1601986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jasminum officinale leaf extract [1651595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jacobaea vulgaris extract [1428420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jasmone [2557370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jasminum officinale flower extract [1307879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juglans regia leaf extract [1324597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jerusalem artichoke extract [1648701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>javanicin [2693988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus deppeana wood oil [1307759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis stem extract [2054265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese pagoda tree flower bud extract [1660771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>juniper berry oil [1309245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jojoba oil, randomized [1491858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jacaranda caroba flower extract [1310056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese encephalitis virus vaccine, inactivated [845525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juglans nigra bark extract [1307711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jasminum sambac flower extract [1540869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jewel weed whole extract [1657791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jasminum grandiflorum flower extract [1654012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jasmine oil [1309240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juglans nigra whole extract [1370466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus sabina leaf [1310161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jujube seed extract [2106744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese black pine pollen extract [900777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Johnson grass smut allergenic extract [852128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Justicia adhatoda leaf extract [1309704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jojoba acid [1742509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus oxycedrus leaf oil [1600140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>juglans regia shell extract [1424881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jasminum officinale fruit extract [2564382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jojoba wax [1309258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jacobaea maritima extract [1345681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis whole extract [6085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis fruit extract [1310189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Johnson grass smut pollen extract [852118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jatropha curcas seed extract [1309701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jarcaranda caroba leaf extract [1651694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus virginiana oil [1307948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Justicia adhatoda flower extract [1860077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jasminum officinale whole extract [1541719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jack pine pollen extract [1014690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>josamycin [6084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus phoenicea resin [1811260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jasminum sambac whole extract [1603478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus virginiana twig extract [1314257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Justicia gendarussa leaf extract [1310078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Java citronella oil [1747704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jute fiber allergenic extract [852412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jasmine lactone [1426261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juglans regia whole extract [1435862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus sabina leafy twig extract [1309719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>J [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jacobaea maritima leaf extract [2592623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Janus Kinase 3 Inhibitors [MoA]</name>
  <code>C654283</code>  <id>654283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>JAK-3 Inhibitors</to_name>
    <to_code>T58864</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>JAK3 Inhibitors</to_name>
    <to_code>T58866</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>JAK-3 Protein Tyrosine Kinase Inhibitors</to_name>
    <to_code>T58865</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase 3 Inhibitors</to_name>
    <to_code>T58863</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>JAK3 Protein Tyrosine Kinase Inhibitors</to_name>
    <to_code>T58867</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194064</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Janus Kinase Inhibitor [EPC]</name>
  <code>C650832</code>  <id>650832</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitor</to_name>
    <to_code>T28715</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190858</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abrocitinib [2591476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruxolitinib [1193326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>delgocitinib [2721163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing Janus kinase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baricitinib [2047232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deuruxolitinib [2716558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>upadacitinib [2196092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with Janus kinase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tofacitinib [1357536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Janus Kinase Inhibitors [MoA]</name>
  <code>C650831</code>  <id>650831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors</to_name>
    <to_code>T28716</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190857</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Janus Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib [2665204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib tosylate [2641596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib phosphate [2716557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib dihydrochloride monohydrate [2665205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abrocitinib [2591476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>upadacitinib [2196092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib citrate [1358492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib [2641595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib [1357536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baricitinib [2047232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>K [Preparations]</name>
  <code>C288637</code>  <id>288637</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>K [Preparations]</to_name>
    <to_code>T28799</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010593</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kininogenase [6095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketamine [6130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kaolin [6102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kojic dipalmitate [1314207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kluyveromyces marxianus [1804172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kerosene [1311375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kiwi fruit allergenic extract [1010926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Klebsiella pneumoniae [1311061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>karum seed oil [1483231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>keracyanin chloride [236274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kunzea pomifera fruit extract [1812670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kalmia latifolia leaf [1307972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kanamycin A sulfate [1300476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kiwi fruit oil [1745929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kelp preparation [285155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Korean ginseng root extract [259471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Khaya senegalensis bark extract [1307601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kava root [259421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kalanchoe pinnata leaf extract [1539425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>krill oil [880350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>khellin [6147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>karaya gum extract [852617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Karwinskia humboldtiana seed extract [1923812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Krameria lappacea whole extract [1545683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kinetin [16054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kanamycin A [1727573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kapok tree fiber allergenic extract [852315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Koelers grass pollen extract [852605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketoprofen [6142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Krameria lappacea root extract [1309764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketoconazole [6135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Knoxia roxburghii subsp. brunonis root extract [2542283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>karaya gum allergenic extract [904554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kukui nut extract [1307863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketorolac [35827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kiwi fruit extract [1358901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketotifen fumarate [11404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>karaya gum [6111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kiwi seed oil [1486759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-ketogluconate [1869045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kalanchoe daigremontiana leaf extract [1535221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kaolin light [104100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kjellmaniella gyrata preparation [1314322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketoprofen lysine [28199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kamala extract [28116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketazolam [28181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kalopanax septemlobus bark extract [1307713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kiwi juice [1747711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kunzea ambigua whole extract [2168267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketorolac tromethamine [28200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kojic acid [1426451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kebuzone [28198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kakadu plum extract [1598581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketamine hydrochloride [203184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>keratin, type I cytoskeletal 40 [2606493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kaempferia galanga root extract [1310098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Korean ginseng preparation [259470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kidney bean allergenic extract [891637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kanamycin [6099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kaempferia galanga whole extract [1606221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kappaphycus alvarezii extract [1661014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketanserin [6131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketotifen [6146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kalmia latifolia whole extract [1998614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kalmia angustifolia leaf extract [1310163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kale extract [1592296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>keracyanin [28165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kentucky bluegrass pollen extract [852834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kadsura coccinea whole extract [2610402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kigelia africana fruit extract [1311615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kanamycin sulfate [203183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Khuskia oryzae allergenic extract [892338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-kestose [2590592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kukui nut oil [1309364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kalimeris indica whole extract [2590653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kava preparation [285228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>K [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Korean ginseng root [260038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kainate Receptor Antagonists [MoA]</name>
  <code>C300402</code>  <id>300402</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kainate Receptor Antagonists</to_name>
    <to_code>T28835</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020017</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kallikrein Inhibitors [MoA]</name>
  <code>C643878</code>  <id>643878</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors</to_name>
    <to_code>T28845</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184151</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab [2717169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebetralstat [2717944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab-flyo [2055640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berotralstat [2467540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab [2055641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>garadacimab-gxii [2717168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kallikrein-Trypsin Inactivator [EPC]</name>
  <code>C643908</code>  <id>643908</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein-Trypsin Inactivator</to_name>
    <to_code>T28846</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184173</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kappa Opioid Receptor Agonist [EPC]</name>
  <code>C654226</code>  <id>654226</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>KOR Agonist</to_name>
    <to_code>T58731</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kappa Opioid Receptor Agonist</to_name>
    <to_code>T58730</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194001</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kappa Opioid Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>difelikefalin [2569089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kappa Opioid Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid kappa Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing opioid receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Analgesic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Keratin Alteration [PE]</name>
  <code>C30314</code>  <id>30315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratin Alteration</to_name>
    <to_code>T28925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009973</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Keratin Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Keratin Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Skin Keratinization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratin Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratin Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Keratinocyte Growth Factor Receptor Agonists [MoA]</name>
  <code>C300461</code>  <id>300461</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Agonists</to_name>
    <to_code>T28986</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020071</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palifermin [196319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Keratinocyte Growth Factor Receptor Antagonists [MoA]</name>
  <code>C300462</code>  <id>300462</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Antagonists</to_name>
    <to_code>T28987</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020072</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Keratinocyte Growth Factor Receptor Interactions [MoA]</name>
  <code>C300460</code>  <id>300460</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Interactions</to_name>
    <to_code>T28988</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020070</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Keratinocyte Growth Factor Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Keratinocyte Growth Factor Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ketolide Antibacterial [EPC]</name>
  <code>C634873</code>  <id>634873</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ketolide Antibacterial</to_name>
    <to_code>T29082</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175492</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketolides [M0462018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Ketolide (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telithromycin [274786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing ketolide (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ketolide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kinase Inhibitor [EPC]</name>
  <code>C634998</code>  <id>634998</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitor</to_name>
    <to_code>T29157</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175605</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>futibatinib [2628190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palbociclib [1601374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gefitinib [328134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abemaciclib [1946825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilaciclib [2479690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribociclib [1873916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vemurafenib [1147220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leniolisib [2633005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erdafitinib [2123125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selumetinib [2289380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osimertinib [1721560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nintedanib [1592737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crizotinib [1148495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zongertinib [2721604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemigatinib [2359268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taletrectinib [2716919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sirolimus [35302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remibrutinib [2724365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pazopanib [714438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pexidartinib [2183102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>afatinib [1430438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tovorafenib [2682434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilotinib [662281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralsetinib [2394936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ponatinib [1364347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>everolimus [141704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobimetinib [1722365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibrutinib [1442981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>repotrectinib [2670644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temsirolimus [657797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inavolisib [2695422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ripretinib [2369389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regorafenib [1312397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imatinib [282388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selpercatinib [2370147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tepotinib [2477103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quizartinib [2643048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lazertinib [2691150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with protein kinase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bosutinib [1307619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing protein kinase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avutometinib [2714515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vandetanib [1098413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pacritinib [2595243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capmatinib [2362165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avapritinib [2272107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorafenib [495881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/neu Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirdametinib [2705551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tucatinib [2361285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tivozanib [2534233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neratinib [1940643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruxolitinib [1193326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenvatinib [1603296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilzabrutinib [2722398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midostaurin [1919083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabozantinib [1363268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idelalisib [1544460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vimseltinib [2705378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acalabrutinib [1986808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trametinib [1425099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alectinib [1727455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lapatinib [480167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>axitinib [1242999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunitinib [357977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorlatinib [2103164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dasatinib anhydrous [1546019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirtobrutinib [2629338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dabrafenib [1424911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ceritinib [1535457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>larotrectinib [2105628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brigatinib [1921217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanubrutinib [2262435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erlotinib [337525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kinase Inhibitors [MoA]</name>
  <code>C634444</code>  <id>634444</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors</to_name>
    <to_code>T29158</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175082</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anaplastic Lymphoma Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib maleate [1940642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib [2712546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umbralisib tosylate [2478438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib dihydrochloride [2643049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpelisib [2169285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib [2643048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abemaciclib [1946825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib hydrochloride [2362259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib phosphate [2633006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib mesylate [2691151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umbralisib [2478439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infigratinib [2550729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib succinate [1873978]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib dihydrochloride [2479691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralsetinib [2394936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib succinate [2570737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib [2570736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib [1722365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib hydrochloride [2477104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib hydrochloride [2712547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib citrate [2595242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Kinetics [PK]</name>
  <code>C288</code>  <id>289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Kinetics</to_name>
    <to_code>T29160</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000055</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Half-Life [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Clearance [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Order [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Kinetics [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Compartments [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>L [Preparations]</name>
  <code>C288638</code>  <id>288638</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>L [Preparations]</to_name>
    <to_code>T29272</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010594</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>low-density polyethylene [1426403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lotilaner [1998841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium candidum flower oil [2464312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levacetylleucine [2375522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liquidambar formosana resin [1429392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lente insulin, beef-pork [314682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleic acids, conjugated [382272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl glycol hydroxypropyl ether [1428874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocabastine [28627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine [6536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl sulfosuccinate [1370649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleic acid [6400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumacaftor [1655922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lymphocyte immune globulin, anti-thymocyte globulin, equine [91601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lawsonia inermis leaf extract [1307699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 33 vaccine [1596931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactoferrin, bovine [1600928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liver derivative complex [253185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-23 [1367165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus helveticus [1310845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurdimoniumhydroxypropyl decylglucoside chloride [1788865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loxapine succinate [6476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum lucidum fruit extract [1803904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lysosomal alpha-Glucosidase [2475360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead acetate [1423667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia citriodora flower extract [1307746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium gluconate [52106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime allergenic extract [1011060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisuride [6446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactoferrin [1425933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenvatinib [1603296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanthanum carbonate [234416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liquidambar orientalis fruit extract [2199292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutrelin [1426636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl betaine [1314211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Litchi chinensis whole extract [1989331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>littleseed canary grass pollen extract [1098232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobetaxolol [353497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larix sibirica wood extract [1314302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactic acid, D- [1742994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonapegsomatropin-tcgd [2569592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia citriodora leaf extract [1371037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lavandin oil [1309385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil allergenic extract [899444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lexidronam [1926935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lophatherum gracile top extract [1872059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula dentata whole extract [1483425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene, (+/-)- [1426477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera canadensis whole extract [2590658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomethadone HCl [236914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lingonberry extract [1427413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Levant cottonseed extract [1307846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lefamulin acetate [2198943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liquidambar formosana fruit extract [1724427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liatris spicata root extract [1924454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leniolisib [2633005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon oil, terpeneless [1437502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lansoprazole [17128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroamphoacetate [1370571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactic acid, L- [2462499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon peel extract [1314594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycoperdon utriforme fruiting body extract [1314926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lingonberry seed oil [1376151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lygodium japonicum spore extract [2592973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera caprifolium whole extract [1800820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loxapine hydrochloride [91138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lacticaseibacillus casei [1592255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leucanthemum vulgare extract [1800488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalyl acetate, (+)- [2048708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleamidopropyl PG-dimonium chloride [1369684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leuzea rhapontica root extract [2592970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Loxosceles reclusa preparation [1426420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorcaserin [1300701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lepidium didymum leaf extract [1862598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lurasidone hydrochloride [1040027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligilactobacillus salivarius [2110033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisinopril [29046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoleucovorin disodium [2107308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamb allergenic extract [971849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laricifomes officinalis fruiting body extract [1311197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 18 vaccine [798266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linzagolix [2621019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>LP-20 [2048034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luffa aegyptiaca seed oil [1314270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium lancifolium bulb extract [1345680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenacapavir sodium [2625652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lithospermum erythrorhizon root extract [1307791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanadelumab-flyo [2055640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lodoxamide tromethamine [28859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Litsea cubeba fruit extract [1442509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalyl acetate [1735331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>losartan potassium [203160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lodgepole pine pollen extract [898324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levalbuterol [237159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactoferrin (synthetic human) [2286238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl acetate [2175690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium orotate [28815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum sinense subsp. chuanxiong root extract [1309803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lachesis muta whole extract [1488819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl sarcosinate [1370639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanolin alcohols [1426478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula stoechas whole extract [1540239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium benzoate [1363722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium hydroxide [1546376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ligustrazine [2676952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl aminopropylglycine [1426937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Listeria monocytogenes [1491871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loxoprofen [28908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lyapolate [29006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalool, (+)- [1430254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levopropoxyphene napsylate [402519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, Human papillomavirus type 6 [85982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysophosphatidic acid [1793921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laminaria ochroleuca extract [1426559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limonia acidissima wood extract [1310519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leontopodium alpinum extract [1539684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>latanoprost acid [2675687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera dasystyla flower bud extract [1307591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauralkonium [2533923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lyral [1420141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium chinense root bark extract [1307660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>larotrectinib [2105628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-11 [1925780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lente insulin, beef [235280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium chloride [1311533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine hydrochloride [6538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>large white petunia whole extract [1996986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limulus polyphemus extract [1421478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera japonica top extract [1369686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomilnacipran hydrochloride [1433211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomifylline [164423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanthanum oxide [1311114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-((L-menthyl)oxy)propane-1,2-diol [1314260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lagerstroemia indica extract [1370984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lens culinaris fruit extract [1307035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactococcus lactis [2466983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liraglutide [475968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoglucose [1788981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomethadyl [237005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonen-10-ol, (+)- [1534778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lamium album flower extract [1309434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum tenuissimum root extract [1307659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomepromazine maleate [160372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-7 [1363566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon peel wax [1311618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine pidolate [2588245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera caprifolium flowering top extract [1429969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl aspartate [1370580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laneth-75 [2389303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine monohydrate [1314248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Luffa acutangula fruit extract [1310287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linden leaf extract [1596680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Luviset 360 [2588489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula angustifolia flower wax [2180549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linvoseltamab-gcpt [2719477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopodium clavatum preparation [283577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lawsonia inermis flowering top extract [1488997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>landiolol hydrochloride [2712069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limonium gerberi flowering top extract [1366737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lobeline [6464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>long-(ARG3)insulin-like growth factor-I [1809244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoleucovorin calcium pentahydrate [1648126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl aldehyde [1312621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime (citrus) extract [1305725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leontopodium alpinum flower extract [1309438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>LICORICE EXTRACT [314711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levorotatory alkaloids of belladonna [221113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lesinurad [1731031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopodium complanatum whole extract [1438109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl sarcosinate [1370618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligustrum lucidum seed extract [2590657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laidlomycin [1546426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-10 [1363573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Loeselia mexicana whole extract [2055102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lophophora williamsii flower extract [1648125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactarius rubidus whole extract [2372915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laponite [1314219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loose wheat smut allergenic extract [968437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime oil [1309377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera hypoglauca whole extract [2393525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactose [6211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactase [41397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>largemouth bass allergenic extract [1098183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loose oat smut allergenic extract [968475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leucovorin calcium [225852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Loeselia mexicana top extract [2289216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurylpyridinium [2381133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera xylosteum fruit extract [1311318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lexidronam pentasodium [1926934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leucoagaricus leucothites whole extract [1600740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lecanemab [2626143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-2 sulfate [1370617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lapyrium [28456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liver,desiccated [91498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil extract [2117970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutropin alfa [388084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonazolac calcium salt [52162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutetium [1534772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl methacrylate - glycol dimethacrylate crosspolymer [1358485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumbrokinase [2665339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauramidopropylamine oxide [1356138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomitapide mesylate [1364478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lophatherum gracile whole extract [1599143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauramidopropyl dimethylamine [1485539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lupinus elegans whole extract [2590659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lindera aggregata whole extract [1490684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levamisole hydrochloride [227227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lawsonia inermis whole extract [1541722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>licorice allergenic extract [1010954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lente insulin, pork [93108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl pyrrolidone [1368363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon allergenic extract [901382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanreotide [68092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorcaserin hydrochloride [1300700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lazertinib [2691150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lentinula edodes mycelium extract [1368206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon juice [1358955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium hydrogen aspartate [236573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobetaxolol hydrochloride [261718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lormetazepam [28894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleamidopropyl PG-dimonium [1369685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisdexamfetamine [700810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl lactylate [1370592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liquidambar orientalis whole extract [1733804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium longiflorium [314712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levo-methamphetamine [1314416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanthanum [1311070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liquidambar styraciflua resin [1313242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Locasia macrorrhizos whole extract [2610396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>legume preparation [319829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linzagolix choline [2621020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene diepoxide [2166618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactuca virosa leaf extract [1309699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laminaria digitata hydrolized alginic acid [1372565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysyllysllysine [2108023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactide, DL- [2550708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lesser galangal root extract [1307953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lithospermum erythrorhizon whole extract [2637751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liprotamase amylase [1868614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobupivacaine [259453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomitapide [1364479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalool, ()- [1362146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lovage oil [1310097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lobelia spicata leaf extract [1311398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum lucidum whole extract [1868202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-15 [2639626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl glucoside [1364382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoisomethadone [2286994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lavender jobfish whole extract [2373648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera japonica whole extract [1923813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lespedeza capitata flowering top extract [1310079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lepidium meyenii root extract [1307638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomefloxacin [28872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactiplantibacillus plantarum 299 [2706643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon balm oil [1309492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linolenate [595958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lopinavir [195088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liquefied phenol [239351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-12 [1363577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lichtheimia ramosa extract [1014749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leptospermum scoparium leaf extract [1991125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutetium Lu 177 dotatate [1999335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laminaria digitata preparation [1310584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lepidium meyenii whole extract [1595584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium citrate [52105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>latanoprostene bunod [1988390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Luffa aegyptiaca fruit extract [1735043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leptinotarsa decemlineata preparation [2711784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laidlomycin propionate potassium [1306103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl PCA [1427202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>latex [1314891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>latanoprost [43611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl fumarate [2700067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levulinate [1358175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera confusa whole extract [1358959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-7 carboxylic acid [2667639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula angustifolia subsp. angustifolia leaf extract [2671358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leptin [1441651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocabastine hydrochloride [1294532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysozyme [1426865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus [6204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead monosilicate [1552046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene, ()- [1363991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium oxide [2629641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liothyronine [10814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levorphanol tartrate [153973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-2 [1367145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lubabegron [2360331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisuride maleate [6553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon myrtle leaf oil [1661434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laminaria japonica extract [1426558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum wallichii root extract [1365706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lurasidone [1040028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurocapram [1603852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysophosphatidylcholine, soybean [2055271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lachesis muta venom [1310458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleate [70611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamotrigine [28439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanolin oil [1309249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula angustifolia flower extract [1307886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lithospermum officinale seed oil [2003374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobunolol hydrochloride [227212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycosa tarantula preparation [1342488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lecanemab-irmb [2626142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, Human papillomavirus type 18 [458451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth sulfosuccinate [1370646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lepidium sativum leaf extract [1606211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>landiolol [2712070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levofloxacin anhydrous [1546009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>LYMPHOCYTE IMMUNE GLOBULIN, RABBIT [325523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium barbarum fruit extract [1311632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 58 vaccine [1596934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 16 vaccine [798264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium acetate [52103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium lancifolium flowering top extract [1344798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobunolol [1813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lambs quarters pollen extract [852237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leflunomide [27169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lofexidine [28863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larrea divaricata leaf extract [1307618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luliconazole [1482680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula x intermedia flower extract [2001196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luteinizing hormone [6383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl/myristoyl methyl glucamide [2055270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomenthol [236388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactobacillic acid [2002583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>live oak pollen extract [867311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Luffa operculata whole extract [1356480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium succinate [28817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lifileucel [2675860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl lactate [2044274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroamphodiacetate [1370648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limosilactobacillus fermentum [2471430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorcaserin hydrochloride anhydrous [1808546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanreotide acetate [236167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene oxide, cis-(+)- [2556900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead iodide [1311159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium chinense fruit extract [1311635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lichtheimia corymbifera allergenic extract [995727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopodium complanatum spore extract [1551456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leucocyanidin [28574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lofepramine [6465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus delbrueckii subsp. bulgaricus [100272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithopone [2640031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lasalocid [1364397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leucine [6308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levothyroxine [10582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lens scale pollen extract [852096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>longleaf pine pollen extract [1014360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loratadine [28889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>low-substituted hydroxypropyl cellulose (11% hydroxypropyl; 120000 MW) [1918320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laminaria hyperborea extract [1736004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leuprolide mesylate [2595041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl palmitate [2200071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liriope spicata tuber extract [2705186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larrea tridentata whole extract [1484860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loracarbef [28981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lombardy poplar pollen extract [852348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium chinense leaf extract [2375721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larix decidua whole extract [1657786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauralkonium chloride [2533922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauramidopropyl hydroxysultaine [1667211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauramine oxide [1364388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lipegfilgrastim [1440046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopodium clavatum spore extract [1311057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisocabtagene maraleucel [2479136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopus lucidus flowering top extract [1724428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysozyme hydrochloride [1311597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linden pollen extract [852070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lobaria pulmonaria extract [1353888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamb preparation [1315120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonazolac [28876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactuca indica whole extract [2585443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limonia acidissima bark extract [1928529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lowbush blueberry juice [1486793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Litchi chinensis seed extract [1307805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lasiobema championii stem extract [2634555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larrea divaricata whole extract [1999191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luesinum [350532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithospermum officinale root extract [1600742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levallorphan tartrate [235419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauramidopropyl betaine [1311186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loncastuximab tesirine-lpyl [2540965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia citriodora flowering top oil [1307847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lapsana communis whole extract [1314245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lavender oil [28486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidamidine [28701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopus virginicus extract [1311148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurate [1370594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Litsea glutinosa bark extract [2385107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumasiran sodium [2467161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Litsea oil [1307939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lachesine [28381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leniolisib phosphate [2633006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lindera aggregata root extract [1420971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Linum usitatissimum whole extract [1947406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonafarnib [2467553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidocaine hydrochloride anhydrous [1299236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula latifolia whole extract [2384439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine aspartate [2548236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium lancifolium whole flowering extract [1340185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lefamulin [2198944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luprostiol [2583725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lynestrenol [6529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limosilactobacillus fermentum ME-3 [2637531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl PEG-32 glycerides [1597625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-5 [2634317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera dasystyla whole extract [2376933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime peel extract [1363437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Levisticum officinale root extract [1482543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lemna minor extract [1333267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limosilactobacillus reuteri subsp. reuteri F275 [2668424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lathyrus odoratus flower extract [1309436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-5 carboxylic acid [2634316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium silicate [2691100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonapegsomatropin [2569562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ling preparation [1427168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula x intermedia whole extract [2167554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lacticaseibacillus rhamnosus GG [602811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemborexant [2272403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levalbuterol hydrochloride [237160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laricifomes officinalis whole extract [1432473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lente insulin, human [314683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium [6448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lavender extract [1307767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lepirudin [237057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorcaserin hydrochloride hemihydrate [1597623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium chinense whole extract [1868204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lamprocapnos spectabilis flower extract [1648702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocarnitine fumarate [360300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loose barley smut allergenic extract [968492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larix decidua flowering top extract [1310045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loblolly pine pollen extract [900770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>licorice [42769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia citrodora flower extract [1874549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leonurus japonicus stem extract [2565687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loperamide hydrochloride [82038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L-methionine-S,R-sulfoximine [1722382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liriope muscari root extract [1600741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leontopodium nivale subsp. alpinum root extract [1606854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Levilactobacillus brevis [2377030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene, (-)- [1426777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Latrodectus mactans antivenin [89887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>London planetree [2166616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurtrimonium [1427083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lufenuron [83586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letibotulinumtoxinA-wlbg [2689282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lacosamide [623400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime juice [1358957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl trisiloxane [1600441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligustrum vulgare whole extract [2054998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lotus corniculatus flower volatile oil [1535494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lobelia inflata leaf extract [1994302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead [6260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levodopa [6375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanosteryl stearate [1487189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larrea tridenta top extract [1311133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon extract [1364291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lettuce whole allergenic extract [2102479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene [28730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-3 [1310570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium aspartate [746070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanolin acid [2110036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limonia acidissima whole extract [2605085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ledum palustre twig extract [1310203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum sinense root extract [1309353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium cation [1546265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia sidoides leaf oil [2622905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lercanidipine hydrochloride [153679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligustrum lucidum fruit extract [2597249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenvatinib mesylate [1604346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limonium gerberi whole extract [1654638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine thiazolidine carboxylate [1356709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera caprifolium flower extract [1307960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levonorgestrel [6373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ledismase [1742510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia alba whole extract [1986435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl-myristyl benzoate [1369898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lindane [1388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lupinus albus seed extract [1344626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoleucovorin [877015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene, (+)- [1426476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorazepam [6470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letermovir [1988648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl lactyl lactate, DL- [2594598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactic acid lactate, L- [2640216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>low-substituted hydroxypropyl cellulose (8% hydroxypropyl: 140000 MW) [1872043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limnanthes alba whole extract [1429934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactitol [28395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loureirin B [2469244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levalbuterol tartrate [487066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-11 carboxylic acid [1925779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomefolate [1592257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lobelia erinus extract [2709115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula stoechas flowering top extract [1309437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leptospermum scoparium whole extract [1988678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laurus nobilis whole extract [1541720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene oxide [1992035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levallorphan [6370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levorphanol [6378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl hydroxysultaine [1813432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liquidambar orientalis resin [1420972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loperamide [6468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamivudine [68244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocarnitine hydrochloride [1426681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauric acid [1363435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lornoxicam [20890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-8 [1993212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linvoseltamab [2719416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lipase [6406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutein esters [259462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leonurus cardiaca flowering top extract [1549105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Legionella pneumophila [1491870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lytta vesicatoria preparation [1311265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liothyronine sodium [142448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead tetroxide [1593125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus acidophilus [6205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Levant cottonseed oil [1307951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levamisole phosphate [1535214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lathyrus odoratus seed extract [2388132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalool oxide [1941462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomefolic acid [1025342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leucanthemum vulgare pollen [2102006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lamium album flowering top extract [1811841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lentinula edodes whole extract [1674198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl peg-9 polydimethylsiloxyethyl dimethicone [1373154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomustine [6466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene oxide, trans-(+)- [2372698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lincomycin [6398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lymecycline [6513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linseed oil [6404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lazertinib mesylate [2691151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>losartan [52175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Larix decidua resin [1311404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letrozole [72965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera confusa flower extract [1492937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-20 [2003592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopodium japonicum top extract [2640285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ledipasvir [1591922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lebrikizumab-lbkz [2693778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L-erythrulose [1486718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>low-substituted hydroxypropyl cellulose (11% hydroxypropyl; 130000 MW) [1872042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomilnacipran [1433212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lowbush blueberry extract [1311630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-30 [1538052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead cation Pb4 [1858364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linezolid [190376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalool, (-)- [1800669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liprotamase protease [1999473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lecithin [8214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocarnitine [42955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanatoside C [27929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 31 vaccine [1596930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lachnanthes caroliniana extract [1427206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 52 vaccine [1596933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lagerstroemia speciosa leaf extract [2288179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil seed extract [1426921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Levisticum officinale [1862596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linaclotide [1307404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead acetate anhydrous [1544391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauric isopropanolamide [2262541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>low-substituted hydroxypropyl cellulose (11% hydroxypropyl; 100000 MW) [2121055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactulose [6218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutein [11359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loteprednol [237027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lobelia cardinalis extract [1424266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lincomycin hydrochloride [82036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactate [114202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leucojum aestivum bulb extract [1356708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lettuce allergenic extract [899448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liver stomach concentrate [802755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl lactyl lactate, L- [2596955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanthanum chloride [1596140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luspatercept [2262544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>labdanum oil [2059144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laburnum anagyroides flowering top extract [1791063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leonurus japonicus flowering top extract [2369358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loxoprofen sodium dihydrate [259486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lolium perenne top extract [2535259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Linaria vulgaris extract [1648698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl glutamate [1370614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum porteri root extract [1309799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanthanum cation (3+) [1546443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>labetalol [6185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Luffa operculata fruit extract [1328309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-4 [393540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidocaine hydrochloride [142440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lentilactobacillus kefiri [2626886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lathyrus sativas seed extract [1309937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levetiracetam [114477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lophatherum gracile leaf extract [1310094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lofepramine hydrochloride [6294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lasmiditan [2256930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauric acid diethanolamide [1363705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligustrum lucidum whole extract [1868203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lupinus albus seed oil [1792120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactic acid [28393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomefolate calcium [1028454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lurbinectedin [2374729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loxapine [6475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lucinactant [1293254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levosimendan [73107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lacticaseibacillus paracasei [2375526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula angustifolia subsp. pyrenaica whole extract [2619577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lacidipine [28382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalool, (+-)- [1368896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levamisole [6371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactiplantibacillus plantarum [1673942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium longiflorum bulb extract [1657855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactose, x-ray exposed (1000 rad) [1310038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ledum palustre whole extract [1608379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leucovorin [6313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl isethionate [1370608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine acetate [6537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoketoconazole [2588846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linolenic acid [52071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lovastatin [6472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead carbonate [1545043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liquid petroleum [1426663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letibotulinumtoxinA [2689280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine clonixinate [78127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lippia graveolens leaf extract [2604032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lifitegrast [1801820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumasiran [2467140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>labetalol hydrochloride [202693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidocaine [6387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lixisenatide [1440051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lycopene [29008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-4 carboxylic acid [1803718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomefolate magnesium [1549106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liquefied petroleum gas [1426480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus bifidus [236855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lathyrus sativus whole extract [1999795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauromacrogols [386055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lasalocid sodium [1364396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leptin human [1441650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurylpyridinium chloride [2381132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus acidophilus BCMC 12130 [2639942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lobster allergenic extract [892561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Levisticum officinale leaf extract [704942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomethadyl acetate hydrochloride [82043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leonurus cardiaca extract [1351002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 6 vaccine [798268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl methylaminoproprionate [2182891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomefolate glucosamine [1592256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleamidopropyl dimethylamine [1364949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(L-menthoxy)ethanol [1428832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lacto-N-neotetraose [1733678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumefantrine [847728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lovotibeglogene autotemcel [2671958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lofexidine hydrochloride [235853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laminaria angustata extract [1371995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L-lactate [1427172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum wallichii whole extract [1312622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-25 [1999675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lythrum salicaria whole extract [2565947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocetirizine [356887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactose monohydrate [1305527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lacticaseibacillus rhamnosus [100278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linerixibat [2665338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lipotropic Agents [6436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera hypoglauca flower extract [2592972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lagerstroemia speciosa whole extract [2267020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levothyroxine sodium [40144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>light green SF yellowish [1305579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumateperone tosylate [2275731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levofloxacin [82122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leucas cephalotes whole extract [1600739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysine hydrochloride, DL- [2556901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levulinic acid [6379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limonium vulgare flowering top extract [1311627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lercanidipine [135056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium brownii var. viridulum bulb extract [2637950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead diphosphate [1598348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobupivacaine hydrochloride [259454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lumateperone [2275602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Liriodendron tulipifera whole extract [2369360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leuprolide acetate [203217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lysozyme, chicken egg white [1426864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon oil [1309253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead sulfide [1549104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl laurate [1426922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lidoflazine [6390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lolium temulentum top extract [1492299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium lancifolium whole extract [1358954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lard [1857906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl phosphate [2270815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lobelia inflata preparation [1364292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lypressin [6531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>licorice root extract [235524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loprazolam mesylate [235846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus crispatus [2054188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lima bean allergenic extract [891641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauric monoethanolamide [1855084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium bromide [1310187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleamidopropyl PG-dimonium chloride phosphate [1426459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lubiprostone [623033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauric diethanolamine [1811261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocarnitine tartrate [1364375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenograstim [70167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levocetirizine dihydrochloride [402349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauric acid methyl ester [1362932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactobacillus gasseri [2462497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leek allergenic extract [1010932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-6 carboxylate [2471091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl methacrylate [2586067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomefloxacin hydrochloride [235762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lophophytum leandrii extract [1655987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levamlodipine [2376944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lead chloride [2534460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lamium album extract [1426419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Limosilactobacillus reuteri [285156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactococcus lactis immunoserum rabbit [1367193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laronidase [392509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactobionate [1426414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium barbarum root bark extract [2058908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactitol monohydrate [1305520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leptospermum petersonii leaf oil extract [1309357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 11 vaccine [798262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonoctocog alfa [1796377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium candidum bulb extract [1311551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lachesine chloride [103231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letosteine [28554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lapatinib ditosylate [481474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lodoxamide [52151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactobionic acid [1426413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leptospermum scoparium top extract [2639344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum sinense susp. chuaxiong whole extract [1650611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomethadone [236913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lysimachia nummularia extract [1549107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanolin [6227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopodium clavatum whole extract [1485066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium hydroxide anhydrous [1546375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ligusticum tenuissimum leaf extract [1309806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalyl acetate, (-)- [2398334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl lysine [1426404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>L1 protein, human papillomavirus type 45 vaccine [1596932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leontopodium alpinum flowering top extract [1309439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lepidium sativum seed extract [1535493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(l-menthoxy)-2-methylpropane-1,2-diol [1944955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium sulfate [28818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>larotrectinib sulfate [2104548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linoleamidopropyl propylene glycol-dimonium chloride [2360330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactic acid lactate, DL- [1745458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Linum catharticum extract [1735042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>locust bean gum extract [1424898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ledikite [1661716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenacapavir [2625651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levonordefrin [132889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-6 [2642339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactarius indigo whole extract [1547577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lomatium dissectum root extract [1337634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levoleucovorin calcium [979509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lilium candidum flower extract [1307714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linalool oxide pyranoid, (+/-)- [2359263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loncastuximab tesirine [2540964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-9 phosphate [2373964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levamlodipine maleate [2377031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lebrikizumab [2693758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>long pepper extract [1364404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lantana camara leaf extract [1745414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>limonene oxide, (+)- [1992034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium hydroxide monohydrate [1298832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laurtrimonium chloride [1427082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera periclymenum flowering twig extract [1716091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liver extract [6459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime extract [1426473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisinopril anhydrous [1546022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lisdexamfetamine dimesylate [673579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactoperoxidase [1310514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lusutrombopag [2054984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenalidomide [342369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lomatium dissectum whole extract [1661744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linagliptin [1100699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lactuca virosa extract [1311289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levopropoxyphene [6377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium phosphate [1863143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanadelumab [2055641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium carbonate [42351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lantana camara leaf volatile oil [2049221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Litchi fruit extract [1307049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laidlomycin propionate [1370570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycium barbarum whole extract [1747712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lepidium sativum whole extract [1739224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lyme Disease Vaccine [214177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>luspatercept-aamt [2262543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauryl PEG-PPG-18-18 methicone [1427186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lolium perenne allergenic extract [1427059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lapatinib [480167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leuprolide [42375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lavandula angustifolia whole extract [1376346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lorlatinib [2103164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lymphocyte immune globulin, anti-thymocyte globulin [1011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lapsana communis flowering top extract [1309435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanosterol [1442199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loteprednol etabonate [52177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lycopus europaeus whole extract [2099359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levothyroxine sodium anhydrous [1372638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauroyl - myristoyl amidopropyl amine oxide [2590759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lacticaseibacillus casei KE-99 [1604558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lauramide [1427070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lonicera japonica flower extract [1307753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>L [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Laccocephalum mylittae whole extract [2477850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>L-Calcium Channel Receptor Antagonists [MoA]</name>
  <code>C300455</code>  <id>300455</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists</to_name>
    <to_code>T29286</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020065</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil hydrochloride [439837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil [4648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barnidipine hydrochloride [283819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrendipine [7441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacidipine [28382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</name>
  <code>C29838</code>  <id>29839</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Absorption Alteration</to_name>
    <to_code>T29662</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009736</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Large Intestine Fluid/Electrolyte Alteration [PE]</name>
  <code>C29840</code>  <id>29841</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Alteration</to_name>
    <to_code>T29663</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009737</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Large Intestine Fluid/Electrolyte Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Large Intestine Fluid/Electrolyte Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</name>
  <code>C29842</code>  <id>29843</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Secretion Alteration</to_name>
    <to_code>T29664</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009738</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casanthranol [66870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Large Intestine Fluid/Electrolyte Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lead Chelating Activity [MoA]</name>
  <code>C635416</code>  <id>635416</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelator</to_name>
    <to_code>T29764</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity</to_name>
    <to_code>T29765</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175962</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate calcium trisodium [132879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetate disodium [259268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetic acid [3690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succimer [3446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate [618371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium edetate [105745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate pentasodium [314774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate zinc trisodium [408077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lead Chelator [EPC]</name>
  <code>C635417</code>  <id>635417</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelator</to_name>
    <to_code>T29766</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175963</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lead Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lead Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetic acid [3690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lead Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succimer [3446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lead Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>edetic acid [3755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chelating agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with chelating agent mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lengthen Conduction System Depolarization Time [PE]</name>
  <code>C31924</code>  <id>31925</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lengthen Conduction System Depolarization Time</to_name>
    <to_code>T29877</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010283</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lengthen Conduction System Depolarization Time [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lengthen Conduction System Depolarization Time [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lengthen Conduction System Repolarization Time [PE]</name>
  <code>C31928</code>  <id>31929</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lengthen Conduction System Repolarization Time</to_name>
    <to_code>T29878</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010285</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Leptin Analog [EPC]</name>
  <code>C650828</code>  <id>650828</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leptin Analog</to_name>
    <to_code>T29906</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leptin Analogue</to_name>
    <to_code>T29905</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190854</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leptin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metreleptin [1491625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leptin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leptin [M0328567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leptin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Leptin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leptin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing peptide hormone (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leptin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Leukocyte Growth Factor [EPC]</name>
  <code>C635059</code>  <id>635059</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukocyte Growth Factor</to_name>
    <to_code>T30265</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175666</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>filgrastim [68442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sargramostim [69634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulocyte Colony-Stimulating Factor [M0024696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim [338036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eflapegrastim [2612526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Myeloid Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efbemalenograstim alfa [2670630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukocyte Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulocyte-Macrophage Colony-Stimulating Factor [M0024695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Colony stimulating factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing colony stimulating factor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Antagonist [EPC]</name>
  <code>C635196</code>  <id>635196</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>LTRA</to_name>
    <to_code>T30362</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonist</to_name>
    <to_code>T30363</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonist (LTRA)</to_name>
    <to_code>T30361</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175777</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zafirlukast [114970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with leukotriene receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>montelukast [88249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing leukotriene receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Antagonists [MoA]</name>
  <code>C344</code>  <id>345</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonists</to_name>
    <to_code>T30364</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000083</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zafirlukast [114970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Receptor Interactions [MoA]</name>
  <code>C426</code>  <id>427</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Interactions</to_name>
    <to_code>T30365</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000124</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Leukotriene Synthesis Inhibitor [EPC]</name>
  <code>C634970</code>  <id>634970</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Synthesis Inhibitor</to_name>
    <to_code>T30366</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175577</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing leukotriene receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Leukotriene Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with leukotriene receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ligand-Gated Ion Channel Interactions [MoA]</name>
  <code>C648289</code>  <id>648289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ligand-Gated Ion Channel Interactions</to_name>
    <to_code>T30456</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188380</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thermoreceptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionotropic Glutamate Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligand-Gated Ion Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ligase Activators [MoA]</name>
  <code>C643857</code>  <id>643857</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ligase Activators</to_name>
    <to_code>T30459</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184142</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ligase Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbamoyl Phosphate Synthetase 1 Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lincosamide Antibacterial [EPC]</name>
  <code>C634825</code>  <id>634825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lincosamide Antibacterial</to_name>
    <to_code>T30492</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175443</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clindamycin [2582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Lincomycin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lincosamides [M0515779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing lincomycin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lincosamide [EPC]</name>
  <code>C635314</code>  <id>635314</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lincosamide-class Agent</to_name>
    <to_code>T30493</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lincosamide</to_name>
    <to_code>T30494</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175876</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lincosamides [M0515779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing lincomycin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lincosamide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Lincomycin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipase Activators [MoA]</name>
  <code>C654144</code>  <id>654144</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipase Activators</to_name>
    <to_code>T58561</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193928</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipase Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Indirect Lipase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipase Inhibitors [MoA]</name>
  <code>C30198</code>  <id>30199</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipase Inhibitors</to_name>
    <to_code>T30535</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009916</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orlistat [37925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipid Emulsion [EPC]</name>
  <code>C651255</code>  <id>651255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Emulsion</to_name>
    <to_code>T30551</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191261</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Emulsion [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olive oil [1309250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Emulsion [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean oil [9949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Emulsion [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lipids [M0012553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Emulsion [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Fat emulsion (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Emulsion [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Intravenous nutrition - fats (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipid Metabolism Alteration [PE]</name>
  <code>C29844</code>  <id>29845</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration</to_name>
    <to_code>T30552</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009739</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosphingolipid Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipotropic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triglyceride Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velaglucerase alfa [901805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taliglucerase alfa [1291609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase beta [338817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat [2054252]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat hydrochloride [2054264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipid-based Polyene Antifungal [EPC]</name>
  <code>C634903</code>  <id>634903</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid-based Polyene Antifungal</to_name>
    <to_code>T30564</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175510</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin B [732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyenes [M0017172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipid-based Polyene Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid-based Polyene Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipoglycopeptide Antibacterial [EPC]</name>
  <code>C651311</code>  <id>651311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptide Antibacterial</to_name>
    <to_code>T30596</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191281</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oritavancin [1547611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telavancin [473837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoglycopeptide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalbavancin [1539239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing glycopeptide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with glycopeptide structure and antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipoglycopeptides [EXT]</name>
  <code>C651310</code>  <id>651310</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides</to_name>
    <to_code>T30597</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191280</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Glycopeptides [M0009481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipopeptide Antibacterial [EPC]</name>
  <code>C634902</code>  <id>634902</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipopeptide Antibacterial</to_name>
    <to_code>T30613</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175509</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipopeptide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with cyclic lipopeptide structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipopeptide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daptomycin [22299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lipopeptides [M0519359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipopeptide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipotropic Activity Alteration [PE]</name>
  <code>C29846</code>  <id>29847</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipotropic Activity Alteration</to_name>
    <to_code>T30667</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009740</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lipoxygenase Inhibitors [MoA]</name>
  <code>C446</code>  <id>447</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors</to_name>
    <to_code>T30670</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000134</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lipoxygenase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>5-Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</name>
  <code>C643535</code>  <id>643535</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Anthracis Vaccine</to_name>
    <to_code>T30708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183903</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax Vaccines [M0356664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bacillus anthracis strain V770-NP1-R antigens [1368371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Bacillus anthracis antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</name>
  <code>C643539</code>  <id>643539</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy</to_name>
    <to_code>T30711</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin (BCG) Immunotherapy</to_name>
    <to_code>T30709</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated BCG Immunotherapy</to_name>
    <to_code>T30710</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183906</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing antigen of live attenuated Mycobacterium bovis (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BCG, live, Tice strain [221050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>BCG Vaccine [M0002239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Macrophage Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Antigen of live attenuated Mycobacterium bovis (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Immunologically Active Molecule Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</name>
  <code>C643536</code>  <id>643536</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated BCG Vaccine</to_name>
    <to_code>T30713</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin (BCG) Vaccine</to_name>
    <to_code>T30712</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin Vaccine</to_name>
    <to_code>T30714</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183904</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>BCG, live, Tice strain [221050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>BCG Vaccine [M0002239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Mycobacterium bovis antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</name>
  <code>C643537</code>  <id>643537</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Herpes Zoster Virus Vaccine</to_name>
    <to_code>T30715</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183905</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster Vaccine [M0491099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Varicella Virus Vaccine Live (Oka-Merck) strain [805486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Influenza A Virus Vaccine [EPC]</name>
  <code>C643672</code>  <id>643672</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Influenza A Virus Vaccine</to_name>
    <to_code>T30716</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Influenza A Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza Vaccines [M0011310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing influenza virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Influenza A Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Measles Virus Vaccine [EPC]</name>
  <code>C643540</code>  <id>643540</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Measles Virus Vaccine</to_name>
    <to_code>T30717</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183907</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Measles morbillivirus antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Measles Vaccine [M0013153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Measles Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Mumps Virus Vaccine [EPC]</name>
  <code>C643551</code>  <id>643551</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Mumps Virus Vaccine</to_name>
    <to_code>T30718</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183918</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Measles morbillivirus antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mumps Vaccine [M0014203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Rotavirus Vaccine [EPC]</name>
  <code>C643541</code>  <id>643541</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Rotavirus Vaccine</to_name>
    <to_code>T30719</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183908</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rotavirus Vaccines [M0357125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Rubella Virus Vaccine [EPC]</name>
  <code>C643542</code>  <id>643542</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Rubella Virus Vaccine</to_name>
    <to_code>T30720</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183909</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rubella Vaccine [M0019294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Rubella Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Rubella virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Rubella Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Salmonella Typhi Vaccine [EPC]</name>
  <code>C643543</code>  <id>643543</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Salmonella Typhi Vaccine</to_name>
    <to_code>T30721</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183910</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Typhoid [M0022188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salmonella typhi Ty21a live antigen [762595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</name>
  <code>C643544</code>  <id>643544</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Varicella Zoster Virus Vaccine</to_name>
    <to_code>T30723</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Chickenpox Virus Vaccine</to_name>
    <to_code>T30722</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183911</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chickenpox Vaccine [M0028909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Varicella Virus Vaccine Live (Oka-Merck) strain [805486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</name>
  <code>C643545</code>  <id>643545</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Yellow Fever Virus Vaccine</to_name>
    <to_code>T30724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183912</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Yellow Fever Vaccine [M0357360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow fever virus strain 17D-204 live antigen [804187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Human Adenovirus Type 4 Vaccine [EPC]</name>
  <code>C643546</code>  <id>643546</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Human Adenovirus Type 4 Vaccine</to_name>
    <to_code>T30725</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183913</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human adenovirus E serotype 4 strain CL-68578 [1299785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenovirus Vaccines [M0569028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Live, Unattenuated [M0569003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 4 Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Adenovirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Human Adenovirus Type 4 Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Human Adenovirus Type 7 Vaccine [EPC]</name>
  <code>C643547</code>  <id>643547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Human Adenovirus Type 7 Vaccine</to_name>
    <to_code>T30726</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183914</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenovirus Vaccines [M0569028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human adenovirus B serotype 7 strain 55142 [1802483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Live, Unattenuated [M0569003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Human Adenovirus Type 7 Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Adenovirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Human Adenovirus Type 7 Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Mumps Virus Vaccine [EPC]</name>
  <code>C643548</code>  <id>643548</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Mumps Virus Vaccine</to_name>
    <to_code>T30727</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183915</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Attenuated [M0022454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Mumps Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mumps Vaccine [M0014203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Mumps orthorubulavirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Mumps Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Rotavirus Vaccine [EPC]</name>
  <code>C643549</code>  <id>643549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Rotavirus Vaccine</to_name>
    <to_code>T30728</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183916</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G1 vaccine [798286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rotavirus Vaccines [M0357125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G4 vaccine [798292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Live, Unattenuated [M0569003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G2 vaccine [798288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain P1A[8] vaccine [798294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Rotavirus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>human-bovine reassortant rotavirus strain G3 vaccine [798290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Rotavirus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Rotavirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Live Vaccinia Virus Vaccine [EPC]</name>
  <code>C643550</code>  <id>643550</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Vaccinia Virus Vaccine</to_name>
    <to_code>T30729</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183917</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Actively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Live, Unattenuated [M0569003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Smallpox Vaccine [M0019978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Live Vaccinia Virus Vaccine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vaccinia virus strain New York City Board of Health live antigen [1492300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing Vaccinia virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Vaccinia Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Local Anesthesia [PE]</name>
  <code>C635430</code>  <id>635430</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia</to_name>
    <to_code>T30795</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175976</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine [8686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine [20859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine hydrochloride [53616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine hydrochloride [259454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine hydrochloride [91189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine hydrochloride [2557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine hydrochloride [227778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride anhydrous [1375412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine [592464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine [259453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride [236539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine [35780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride anhydrous [2198974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine [6759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine [34905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine hydrochloride [203185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine [10391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Local Anesthetic [EPC]</name>
  <code>C634932</code>  <id>634932</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthetic</to_name>
    <to_code>T30796</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175539</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Local Anesthetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ester Local Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Local Anesthetic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proparacaine [34905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Local Anesthetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amide Local Anesthetic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Local Anesthetic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Local Anesthetic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Local anesthetic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Locally-acting Aminosalicylate [EPC]</name>
  <code>C634835</code>  <id>634835</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Locally-acting Aminosalicylate</to_name>
    <to_code>T30798</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Locally Acting Aminosalicylate</to_name>
    <to_code>T30797</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175455</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Locally-acting Aminosalicylate [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminosalicylic Acids [M0000971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Loop Diuretic [EPC]</name>
  <code>C634983</code>  <id>634983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Loop Diuretic</to_name>
    <to_code>T30817</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175590</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis at Loop of Henle [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bumetanide [1808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>furosemide [4603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Loop diuretic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethacrynic acid [4109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Loop Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>torsemide [38413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Low Molecular Weight Heparin [EPC]</name>
  <code>C634979</code>  <id>634979</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>LMWH</to_name>
    <to_code>T30882</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Low Molecular Weight Heparin (LMWH)</to_name>
    <to_code>T30883</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Low Molecular Weight Heparin</to_name>
    <to_code>T30884</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175586</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Low Molecular Weight Heparin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>enoxaparin [67108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Low Molecular Weight Heparin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalteparin [67109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Low Molecular Weight Heparin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing low molecular weight heparin (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Low Molecular Weight Heparin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Low molecular weight heparin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Low Molecular Weight Heparin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heparin, Low-Molecular-Weight [M0010191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lyase Activators [MoA]</name>
  <code>C645312</code>  <id>645312</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lyase Activators</to_name>
    <to_code>T31009</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185498</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lyase Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lyase Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activation Gene-3 Antagonists [MoA]</name>
  <code>C654229</code>  <id>654229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>LAG-3 Antagonists</to_name>
    <to_code>T58738</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Antagonists</to_name>
    <to_code>T58737</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene 3 Antagonists</to_name>
    <to_code>T58739</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194002</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activation Gene-3 Blocker [EPC]</name>
  <code>C654228</code>  <id>654228</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene 3 Blocker</to_name>
    <to_code>T58736</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Blocker</to_name>
    <to_code>T58734</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>LAG-3 Blocker</to_name>
    <to_code>T58735</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194003</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Activation Gene-3 Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Activation Gene-3 Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relatlimab [2596773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activation Gene-3 Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Activity Modulation [PE]</name>
  <code>C641728</code>  <id>641728</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activity Modulation</to_name>
    <to_code>T31055</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182152</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Activity Modulation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Activity Modulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activity Modulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Function Alteration [PE]</name>
  <code>C637781</code>  <id>637781</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function Alteration</to_name>
    <to_code>T31059</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178327</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Activity Modulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit anti-human T-lymphocyte globulin [107044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymocyte immunoglobulin, equine [1427177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lymphocyte immune globulin, anti-thymocyte globulin, equine [91601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</name>
  <code>C652929</code>  <id>652929</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>LFA-1 Antagonist</to_name>
    <to_code>T31060</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function-Associated Antigen-1 Antagonist</to_name>
    <to_code>T31061</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192701</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lifitegrast [1801820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</name>
  <code>C652928</code>  <id>652928</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>LFA-1 Antagonists</to_name>
    <to_code>T31062</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function-Associated Antigen-1 Antagonists</to_name>
    <to_code>T31063</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192700</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifitegrast [1801820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lymphocyte Growth Factor [EPC]</name>
  <code>C635060</code>  <id>635060</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Growth Factor</to_name>
    <to_code>T31068</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175667</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Growth Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Cell Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Growth Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lymphocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aldesleukin [70223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lymphocyte Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-2 [M0011506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immune enhancement agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytokine agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing cytokine (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lymphocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lysophospholipid Receptor Interactions [MoA]</name>
  <code>C641378</code>  <id>641378</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysophospholipid Receptor Interactions</to_name>
    <to_code>T31266</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181812</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysophospholipid Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosphingolipid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miltefosine [1494066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysophospholipid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lysosomal Function Alteration [PE]</name>
  <code>C29848</code>  <id>29849</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration</to_name>
    <to_code>T31272</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009741</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosomal Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosomal Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lysosomal Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lysosomal beta Glucuronidase [EPC]</name>
  <code>C654023</code>  <id>654023</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Glucuronidase</to_name>
    <to_code>T58399</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal beta Glucuronidase</to_name>
    <to_code>T58382</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193804</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vestronidase alfa [1989819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Beta-glucuronidase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucuronidase [M0009366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosomal beta Glucuronidase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Proteins [M0018641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosomal beta Glucuronidase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Lysosphingolipid Receptor Interactions [MoA]</name>
  <code>C641379</code>  <id>641379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Lysosphingolipid Receptor Interactions</to_name>
    <to_code>T31300</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181813</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Lysosphingolipid Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>M [Preparations]</name>
  <code>C288639</code>  <id>288639</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>M [Preparations]</to_name>
    <to_code>T31302</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010595</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine tartrate [235774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Microcitrus australis fruit extract [1370987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate [29164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl acrylate [1367155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maytenus krukovii bark extract [2123365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moricizine [40169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus alba root bark extract [1310055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha aquatica leaf extract [1307852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maleic acid [1426330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monensin sodium [2719468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese sulfate anhydrous [1746493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methohexital sodium [91185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl-4-isothiazolin-3-one hydrochloride [1804258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Microascus brevicaulis allergenic extract [1192992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium palmitoyl glutamate [1735044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menfegol [31575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium oxide [6582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mechlorethamine hydrochloride [155036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miglustat [402316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk thistle leaf extract [1661435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium tartrate [1314220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metipranolol hydrochloride [314731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia whole extract [1795583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>millet seed allergenic extract [899770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucuna pruriens seed extract [1485786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefloquine [6694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metformin [6809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mesembryanthemum crystallinum whole extract [1860419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium carbonate [29155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium sulfate heptahydrate [236741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microsporum canis allergenic extract [1014399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylic acid - methyl methacrylate copolymer (1:2) [1309724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methscopolamine bromide [56092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca alternifolia whole extract [1487832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methandriol dipropionate [235381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclizine [6676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metronidazole [6922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maclura cochinchinensis whole extract [2281308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 2-furoate [2384442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Murraya paniculata fruit extract [2632263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meningococcal group A polysaccharide [29501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl acetate, (-)- [2048710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium sulfate [6585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melissa officinalis flower extract [2637737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monobenzone [17145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium laureth sulfate [2175691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine hydrochloride [235751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese violet [1313243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylprednisolone sodium succinate [203189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl glucose [2174505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylephedrine hydrochloride, DL- [1311544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia acuminata bark extract [2173990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mercurialis perennis whole extract [2591815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methanol [1310568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenamine mandelate [161623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midazolam hydrochloride [203128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milnacipran hydrochloride [30003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxy PEG-10 [1805769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Meningitis vaccine [108542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca alternifolia leaf extract [1309330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myrtle leaf oil [1307835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minoxidil sulfate ester [1926479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melengestrol acetate [1537798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl perfluoroisobutyl ether [1431149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadow fescue grass pollen extract [851918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium chloride tetrahydrate [2003593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl salicylate 2-ethylbutyrate [1921110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristalkonium chloride [1314217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mangifera indica seed extract [1486517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecobalamin [29421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Michelia alba leaf oil [2043326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morazone [30218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylsilanol PCA [2264358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monopotassium phosphite [1793923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maleate [1426331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malarial plasmodium group immunoserum rabbit [1367199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl undecenoyl leucinate [1427065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mikania parviflora leaf extract [1719250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl oleate [1734017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malvin [1309703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morniflumate [30225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl-4-isothiazolin-3-one [1367166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacholine [155080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor racemosus preparation [350310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meyer lemon extract [2270943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metyrosine [266604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepolizumab [1720597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melissa officinalis leaf extract [1307836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mibefradil dihydrochloride [83214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malachite green cation [1547770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methandriol [6817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minoxidil [6984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>marstacimab-hncq [2697132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl orange [1551460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>momordicae [853112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methsuximide [47858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium silicate [1310566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metomidate [1311585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylbenzethonium chloride [1796444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maleic anhydride [1362876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mangifera indica whole extract [1731021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>measles virus preparation [1312384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 200 [2277806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maprotiline hydrochloride [203126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Monascus purpureus West [261713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Millettia pulchra root extract [2634551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl butetisalicylate [236908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercury, ammoniated [29542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitoxantrone hydrochloride [203129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methimazole [6835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric sulfide [1311278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morganella morganii [1311228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylprednisolone [6902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>misoprostol [42331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl nicotinate [1425406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor circinelloides f. lusitanicus allergenic extract [2101473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methanolamine [1430389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>madecassic acid [1551573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milnacipran [588250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miristalkonium [236393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl-palmitoyl oxostearamide-arachamide mea [1313186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca viridiflora flowering top extract [2673194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-methyl-1,3,5-triphenyl-2-pyrazoline [2593853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>matrine [2049547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molindone [7019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirikizumab-mrkz [2668385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monosodium glutamate anhydrous [1313974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mirabilis jalapa top extract [1441657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mesophyllum lichenoides extract [1426450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mu-conotoxin G IIIC [2399555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methotrexate [6851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miltefosine [1494066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxyphenamine [29704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Micrurus corallinus venom [1310460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mirabilis jalapa flowering top extract [1373032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaclazepam hydrochloride [29590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>millet extract [1310040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methysergide maleate [203190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1&apos;-((1-methyl-1,2-ethanediyl)2-propenoic acid, bis(oxy(1-methyl-2,1-ethanediyl))) ester [1807444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthol [6750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>masoprocol [227239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda officianalis root extract [1546412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myrrh oil [1309206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia virginiana flower extract [1307541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menhaden oil [2467841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>muskmelon extract [1363443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medronic acid [1314368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metopimazine [29954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menadione sodium bisulfite [52551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malondialdehyde [1657018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenamic acid [6693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meperidine hydrochloride [103755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylephedrine [1739004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>modified corn starch (1-octenyl succinic anhydride) [1425926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moth bean extract [1313183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesna [44]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(MPEG 2000)-N,N-ditetradecylacetamide [2599922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthol glucuronide [2704947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melissa officinalis leaf oil [1309328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maclura tricuspidata bark extract [2000993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese chloride [29261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine ioxithalamate [29459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methanesulfonic acid [1426387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl lactate [1363720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monomethyl fumarate [1546433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus australis leaf extract [1420974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltobionic acid [2605590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl dihydrojasmonate (synthetic) [1427217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>musk ketone [1438530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-methoxypsoralen [15842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese aspartate [253187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>memantine [6719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mold extract [235618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium sulfate dihydrate [2107060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl-2-propylpropane-1,3-diol [1648135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirtazapine [15996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia liliiflora flower extract [1310034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 301 [2632412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylbenzyl acetate [1427219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Macadamia ternifolia whole extract [2287549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molsidomine [7023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl-1,2-benzoisothiazolin-3-one [2362185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesylate [1426388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium nitrite [2637344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mevalonolactone [1442202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metharbital [6825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirtazapine hemihydrate [1992054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mephenesin [6755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maprotiline mesylate [236328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaproterenol [7688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mitchella repens extract [2532533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mint extract [1372004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia biondii bark extract [1307607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenorex hydrochloride [236179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maribavir [2586068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl pyrrolidone carboxylate, (-),DL- [1356713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macadamia nut allergenic extract [1011066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>m-phenylenediamine [1435286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mexican tea pollen extract [897391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melilotus officinalis whole extract [2176245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moraxella catarrhalis subsp. catarrhalis [1592901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese iodide [2627379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>migalastat [2054252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclofenoxate [2228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylprednisolone sodium phosphate [29917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monoolein [1311678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl trimethicone [1311614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Madia elegans whole extract [2533898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maropitant citrate [818233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclofenamic acid [6678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard seed allergenic extract [899456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristamidopropylamine oxide [1485540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mizolastine [61455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyltestosterone [6904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitotane [7004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mavorixafor [2684021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltose [1311261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia grandiflora leaf extract [1539418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mosunetuzumab-axgb [2625125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoclopramide [6915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese acetate tetrahydrate [1366224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-methyltetrahydrofolic acid [1313966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium glutamate [236324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl-4-phenyl-2-butanol [2289004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium orotate [139233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midazolam maleate [142441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese dioxide [29263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclocycline [29418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meningococcal group C polysaccharide [29503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Musa basjoo whole extract [1314228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Machilus thunbergii branch extract [2637532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnesium salt [90120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl aminolevulinate hydrochloride [1300479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecysteine hydrochloride [235828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl d-lactate, (-)- [1866625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methantheline bromide [91163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia officinalis whole extract [2053489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitomycin [632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl dihydrojasmonate [1307050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moringa oleifera leaf extract [1307834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyprylon [6910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl anthranilate [29742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldopa [6876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>muramidase hydrochloride [236329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magaldrate anhydrous [1872036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha x rotundifolia leaf extract [1307557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepenzolate [107770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl hydroxyurea [1665338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morella pubescens fruit wax [2102920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Microsporum audouinii allergenic extract [1014395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Menyanthes trifoliata leaf extract [1667212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morpholine salicylate [236348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefloquine hydrochloride [82130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnolol [2562549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malt soup extract [91264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylinositol [1435864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine antimoniate [319866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxaverine hydrochloride [236673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium laureth-8 sulfate [2198971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midamaline hydrochloride [2369639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric sulfate [1311475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor racemosus allergenic extract [852687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl abietate [2465733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aspartate [142131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate, dibasic [1482795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mimosa tenuiflora bark extract [1307957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Manilkara obovata leaf extract [1987640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 112 [2107304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methyl anisole [1313261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia grandiflora flower extract [1309352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl 5-cyclohexylpentanol [2266744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macimorelin acetate [1999419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene blue anhydrous [2198975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melothria heterophylla root extract [2118847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mangiferin [1362895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl stearate [1363574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melphalan flufenamide [2531369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylephedrine, DL- [1546444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monosulfiram [30206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mequinol [15080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mimulus ringens whole extract [2533899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoserpidine [235829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxifloxacin [139462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(((1-methyl-2-(5-methyl-3-oxazolidinyl)ethoxy)methoxy)methoxy)methanol [1801150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus sylvestris whole extract [1798357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium valproate [134422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metolazone [6916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malic acid, L- [1427053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>montelukast [88249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentan-1-one [2395764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitapivat sulfate [2595574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mumps Vaccine [763656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>muramidase [7094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malva sylvestris flowering top extract [1309488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine iodipamide [29456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadowfoam oil [1309256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia seed extract [1992036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium chlorate [1605084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miconazole [6932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midodrine [6963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristic diisopropanolamide [1549874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium lauryl sulfate [1489922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melilotus extract [1372253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mauritia flexuosa whole extract [1431705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldiethanolamine [1371054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 3-hydroxybenzoate [1373724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate anhydrous [1657484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxalactam [7069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monomenthyl glutarate [1489548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylchloroisothiazolinone/methylisothiazolinone mixture [1862287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monomethyl adipate [2287551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha arvensis flowering top extract [1309327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl lactate [1310581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltose monohydrate [1311260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metahomomenthol, (+/-)- [2673512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moroxydine hydrochloride [1291996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mangafodipir [236987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium chloride hexahydrate [221118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldopa anhydrous [1545996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl blue [2176448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebrofenin [1311500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aluminometasilicate type I-A [1426329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malva sylvestris seed extract [1655988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltitol [1363049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menadiol [29491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miranol 2MHT modified [259350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium ascorbate [1311396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Micrococcus luteus preparation [1426449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moringa oleifera fruit extract [2257293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mephobarbital [6758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrciaria edulis fruit juice [1747724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristic acid [1356758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk thistle fruit extract [284153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxidectin [1047072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus australis root extract [1307602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melia azederach leaf extract [1428839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moroxydine [30227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metricus paper wasp venom protein [1294630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl vinyl ether and maleic anhydride copolymer (1100000 WAMW) [2669013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mivacurium [30077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-methyldeoxycytidine [2642190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoprolol [6918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metergoline [6834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mung bean allergenic extract [891647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mevalonolactone, (+/-)- [1442201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menatetrenone [29495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mephitis mephitis anal gland fluid preparation [1311288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morella cerifera fruit wax [1994303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metreleptin [1491625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycobacterium bovis immunoserum rabbit [1367195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 5-aminolevulinate [337068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>musk xylene [1921875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molybdate ion [1546395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minaprine hydrochloride [236400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malathion [6606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molidustat sodium [2637534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monosodium dl-glutamate [2049260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malpighia emarginata seed extract [1307604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meprobamate [6760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Monascus purpureus [1442200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-methoxytryptamine [1426888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrciaria dubia fruit extract [1311645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mycoplasma pneumoniae [1360621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myreth-4 [1544486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesoridazine [6779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl diisopropyl propionamide [1312714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus alba leaf extract [1309988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molasses [1307820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mannuronate methylsilanol [1860184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia champaca flower oil [2670038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenamine hippurate [29652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melarsomine [1012534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maitake extract [1311410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macimorelin [1999420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>memantine hydrochloride [236685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxyflurane [6857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl benzoate [1314316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia grandiflora bark extract [1307581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>momelotinib [2665204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methadone hydrochloride [218337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medioresinol dimethyl ether [2643211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methdilazine [29648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methyl-1-pentanol [2465230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha arvensis top extract [1599157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>muscadine grape extract [1992540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mercurialis perennis extract [1322554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moexipril [30131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl stearic acid [1363442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclofenoxate hydrochloride [236572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midazolam [6960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minoxidil sulfate [1651695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepivacaine [6759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myosotis sylvatica flowering top extract [1310119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard oil [1360631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methacryloyloxyethyl phosphorylcholine [2584546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxifloxacin hydrochloride [228750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metacresol [1367170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylergonovine [6883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoclopramide dihydrochloride [267035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mansoa alliacea leaf extract [1374402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>margetuximab-cmkb [2473850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macelignan [1872381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycophenolic acid [7145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medifoxamine [29434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-methylcyclohexa-1,3-diene [2174382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxonidine [30257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malva sylvestris whole extract [1799008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melphalan hydrochloride [235857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirdametinib [2705551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha canadensis flowering top extract [2679054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malva sylvestris flower extract [1309350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mahonia aquifolium whole extract [1423797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medetomidine hydrochloride [29428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mangafodipir trisodium, anhydrous [221119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maropitant [715869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylethyl ketone [1363708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl lactate, DL- [2045725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucuna pruriens whole extract [2119175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristalkonium [1370587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methicillin [2181306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Musa x paradisiaca leaf extract [1307702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myristica fragrans whole extract [1544248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>madecassoside [87855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mandelic acid [29256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl sorbate [1314223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Millettia pinnata seed extract [1729164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methoxy-1-propanol [2380833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methane [2598120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese cation (2+) [1546272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl bromide [29746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium cation [1426853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl cocoyl taurate [1370610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milrinone lactate [155120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepindolol sulfate [236904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>merbromin [6762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl propionate [1313247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malachite green oxalate [1664341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mafenide acetate [6573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxychlor [2598123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moringa oleifera seed extract [1309442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl isethionate [1370619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melissa officinalis extract [1311497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maackia floribunda stem extract [1307841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium [6574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molidustat [2637535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercaptopurine anhydrous [1546028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl aminomethylcyclohexane carboxamide hydrochloride [1314856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methyl-1,4-pentanediyl dimethacrylate [2106324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methysergide [6911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(1-methylbutyl)phenol [2691520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium acetate [314718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium acetate tetrahydrate [317246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malic acid [29209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia obovata bark extract [1309440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia biondii flower bud extract [2531310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milrinone [52769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl cinnamate [1367156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango leaf extract [1737114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>muscone [1606471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methixene hydrochloride [258230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoclopramide hydrochloride [267036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maritime pine extract [1368708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenamine [6832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium peroxide [1666106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mansoa alliacea bark extract [1374401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylsilanol acetylmethionate [1427218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(methylamino)ethanol [2359260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 102 SCG [2678212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mandarin oil [1305716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylal [2385338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monobasic potassium phosphate [55019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mezlocillin [6927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methazolamide [6826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycophenolate mofetil hydrochloride [237112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcyclopentenolone [2699424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl methacrylate-glycol dimethacrylate crosspolymer [1312390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Matricaria recutita extract [285157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mucopolysaccharide polysulfate [30320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaraminol [6805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mica [1362896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medorrhinum [350533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclocycline sulfosalicylate [203162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca cajuputi leaf oil [1805768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium sulfate monohydrate [1311259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Michelia champaca flower extract [1992075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium malate [283578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meloxicam [41493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric oxide (purified) [221122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melilotus officinalis top extract [1347563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine iodamide [29455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesite [2475179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milbemycin oxime [68730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>modified Vaccinia Ankara-Bavarian Nordic [2464823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxy polyethylene glycol-epoetin beta [729596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mauritia flexuosa fruit oil [1307775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycophenolate mofetil [68149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium pidolate [116240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monophosphoryl lipid A [1363051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>16-methylheptadecanoic acid [1799140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>micronomicin sulfate [236199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Matricaria recutita leaf extract [1310066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclofenamate sodium [6677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>megestrol acetate [29451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia leaf extract [1307858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenidramium [236421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mongolian gerbil skin allergenic extract [895070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moricizine hydrochloride [221126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melphalan flufenamide hydrochloride [2531370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mammal bone, fossilized [1541729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium salicylate [52364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midamaline [2369640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metocurine [29950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Machilus thunbergii bark extract [1309487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mutanase Schizosaccharomyces pombe [1314198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moexipril hydrochloride [236066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magadi soda [1367411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meningococcal group B vaccine [1593128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morantel [1368900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl benzoin [1307079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mimosa tenuiflora leaf extract [1862478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylfolic acid [486456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>modified fluid gelatins [52853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maca preparation [319839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl sarcosinate [1370597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene blue [6878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>MIXED VESPID VENOM PROTEIN [324054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium citrate [52356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric cation [1368903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>modafinil [30125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medroxyprogesterone [6691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl undecylenate [1543078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>motixafortide acetate [2664897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric oxide [29545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maple leaf sycamore pollen extract [900788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methixene [29682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melon extract [1363610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycophenolate sodium [408142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myreth-3 myristate [2122754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthone, (+/-)- [2048709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium lactate dihydrate, L- [2003550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl chloride [1305751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mannitol [6628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene glycol [1797646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylnaltrexone [29899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methohexital [6847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltotetraose [2641823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methdilazine hydrochloride [91121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mephentermine [6756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mimosa pudica leaf extract [1435523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Murraya paniculata leafy twig extract [2641892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Momordica charantia whole extract [1594580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melitracen [446248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard pollen extract [852205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadowfoamamidopropyl betaine [1364950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltose anhydrous [2590661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl vinyl ether [1729163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-mercaptobenzothiazole [1358845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midecamycin [30005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mangostin [2619910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maranta arundinacea root extract [1600743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mechlorethamine [6674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha piperita extract [1334930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenolone acetate [29653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morazone hydrochloride [236679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aluminum silicate type Ia [1722910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methotrimeprazine hydrochloride [91124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mipomersen sodium [1367838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myristica fragrans fruit extract [1995252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maftivimab-ebgn [2461432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyltriethanolammonium methosulfate [2288209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucuna pruriens fruit trichome extract [1311060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxetumomab pasudotox-tdfk [2099305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercury [6769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maprotiline [6646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebendazole [6672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molindone hydrochloride [82051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylprednisolone aceponate [62136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylphenidate [6901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristamine oxide [1431153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercaptopurine [103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus alba stem extract [1307545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesoridazine besylate [203186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylphenidate hydrochloride [203188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium trisilicate [29170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirvetuximab soravtansine [2621548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meropenem [29561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mammal liver preparation [1311117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mahonia aquifolium fruiting top extract [1311636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mordant yellow 10 [2567331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylsulfonylmethane [23247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meningococcal polysaccharide vaccine group Y [314725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>migalastat hydrochloride [2054264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methyl-5-thiazoleethanol [2692023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl tetrapeptide-4 [1312389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia fruit extract [1311641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia seed oil [1307843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mosla cavaleriei whole extract [2641891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midodrine hydrochloride [993491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morantel tartrate [1368899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene diphosphonate [29844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mephenytoin [6757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Marsdenia cundurango whole extract [1740939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mafenide [6572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium fluoride [1435860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medroxyprogesterone acetate [1000112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meradimate [91324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metyrapone [6923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melia azedarach whole extract [1429939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebeverine hydrochloride [235827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyclothiazide [6860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myosotis arvensis extract [1348449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia kobus flowering top extract [1801506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Manihot esculenta whole extract [1946553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldopate [6877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesquite pollen extract [852320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molybdenum [7024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium sulfite [1990883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melia azedarach bark extract [1428837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methandrostenolone [6818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aluminometasilicate type i-b [1314291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl glucose dioleate [1421621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecysteine [29426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monoethanolamine thioglycolate [2475186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaxalone [59078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoprolol tartrate [203191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl glucoside [1313246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,4-methylenedioxybenzoyl methylsulfone [1995882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese difluoride [1921126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebhydrolin napadisylate [22822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methapyrilene hydrochloride [235721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moringa oleifera bark extract [1307603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mackerel allergenic extract [889591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Macrocystis pyrifera extract [1426431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>MPEG 6000 acetyl lysine [2620178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylic acid - ethyl acrylate copolymer (1:1) type A [1309718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morella cerifera root bark extract [1309827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl isobutyl ketone [1362929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha canadensis top extract [2585747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mycogone nigra allergenic extract [1306122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-myristylpicolinium [1425941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monobasic sodium phosphate, dihydrate [1311286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha spicata extract [1594933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moschus berezovskii musk sac resin [1494846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mangifera indica seed butter extract [1307828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(3-methyl-2-thienyl)acrylic acid [2475074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macitentan [1442132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric cyanide [1311110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia x alba whole extract [2590660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>marine non-gelling gelatin, high MW [1998465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenidramium methylsulfate [236422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>margaric acid [1987137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepirodipine [39879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylic acid copolymer [1309721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium salicylate tetrahydrate [253186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl laurate [1425923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirvetuximab soravtansine-gynx [2621549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mucor circinelloides f. lusitanicus preparation [1426705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malachite green [896038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl lactate [1310580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine [7052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese PCA [1608391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menadiol sodium phosphate [52549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadow foxtail pollen extract [1484974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mesembryanthemum tortuosum whole extract [2001195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morrhuic acid [1547609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthone 1,2-glycerol ketal, (+/-)- [2462151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mogamulizumab-kpkc [2054077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrica cerifera fruit extract [2623397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor racemosus immunoserum rabbit [1313972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylpropanediol [1367168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine sulfate [30236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia liliiflora whole extract [1991258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melengestrol [1537799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylbenzethonium [29829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercurous iodide preparation [1311283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese carbonate [1314366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>modified corn starch (3-E-docecenyl succinic anhydride) [1426611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium thiosulfate [236420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus nigra root extract [1307539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia officinalis flower extract [1309351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxamine hydrochloride [203187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mandragora officinarum root extract [1310014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mumps virus vaccine live, RIT-4385 strain [2603501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylic acid - ethyl acrylate copolymer (4500 MPA.S) [1494845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl heptine carbonate [1313237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myrtecaine [59082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myrtol [174965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mezlocillin sodium [82048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia sprengeri whole extract [2375528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl perfluorobutyl ether [1431148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenolone enanthate [29654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl cocoate [1871426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mobocertinib [2570736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus alba root extract [1307712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepenzolate bromide [52560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus alba extract [1370989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxypropylgluconamide [1862683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midostaurin [1919083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methscopolamine [89785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca viridiflora whole extract [2590662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium asparaginate [1313172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mumps virus vaccine live, Jeryl Lynn strain [798372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mupirocin calcium [221128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methicone (20 CST) [1313720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylparaben sodium [1310557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium, chelated [215976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manidipine hydrochloride [259487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol [1314261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia acuminata flower extract [1307816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melissa officinalis flowering top extract [1648697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium hydroxide [6581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk thistle extract [283579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxamine [6853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medrysone [29439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenolone [6833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maclura tricuspidata whole extract [1358962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha arvensis flower oil [1305636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphide [1942477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methotrexate sodium [287734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose (15 CPS) [1313699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrica esculenta fruit extract [2671785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium laureth [2175692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malate [70612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium disodium EDTA [1422486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl benzodioxepinone [2047870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium ascorbyl phosphate [1425918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylate-methoxy PEG-10 maleate-styrene copolymer [1429943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methoxybenzoyloxyacetic acid [2275628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 2-nonynoate [2384443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miglitol [30009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl ethylene glycol carbonate, (-)- [2046117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltose syrup [1310512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mometasone [108118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl diacetylcysteinate [236395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Momordica cochinchinensis seed extract [1420973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>m-aminobenzyl alcohol [2359264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Medicago sativa leaf extract [1309826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristamidopropyl PG-dimonium chloride phosphate [1440231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrtus communis whole extract [1597291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melatonin [6711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mite extract [236583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monobutyl maleate [2001495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepindolol [29518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl aminomethylcyclohexane carboxamide [1370591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrothamnus flabellifolia leaf extract [1373354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaflumizone [1489918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha suaveolens leaf extract [2474038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesyloxybenzyl methoxyethyl chlorobenzamide [2046118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maraviroc [620216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mirabilis jalapa whole extract [2667640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molgramostim [70161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 103 [2413032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate, monobasic [1731599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methampicillin [29629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>montelukast sodium [115713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mahonia aquifolium root extract [1309441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mountain pepper whole extract [2048036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium Mg-28 [2275622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 3-methylorsellinate [2396434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthol, (+)- [1648123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molnupiravir [2587901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard greens allergenic extract [899452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese phosphate [1313302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha arvensis leaf extract [1314855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca cajuputi whole extract [2535503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aluminum silicate type IIA [2106996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylbenzyl methylbenzimidazole piperidinylmethanone [1307039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mosunetuzumab [2625122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-methyl-8-hydroxyquinoline [15850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>marstacimab [2697133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mastocarpus stellatus extract [1424904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malpighia glabra fruit extract [1364406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mosquito allergenic extract [974741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mallotus japonicus bark extract [2570160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus domestica flower extract [1309809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyl-2-methylamino-1-propanol [2396758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxaverine [52918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl paraoxon [1793922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia denudata flower bud extract [2592974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 302 [2637132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene chloride [1311537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacycline hydrochloride [235554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebhydroline [29411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium amino acid chelate [486895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Momordica charantia fruit extract [1306885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia fruit juice [1311642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltobionate [2605591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylsilanol ascorbate [1314308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moschus moschiferus whole extract [1313688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maftivimab [2461339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecasermin [274403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda officinalis whole extract [1486392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melia azedarach leaf extract [2286575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mestranol [6782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methamphetamine hydrochloride [82044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monosodium methylarsonate [1596139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia sieboldii root extract [2621832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose (1500 CPS) [1313700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium orotate dihydrate [1926471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk fat, cow [1305763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl soyate [1802481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthone, (+)- [2282305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Momordica balsamina whole extract [1740940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macadamia acid [1991869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango bark extract [1925438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca quinquenervia leaf oil [1307888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morrhuate [1547610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose (4000 CPS) [1297402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl lactate, (+)- [1551572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mountain pepper fruit extract [1661437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>MEASLES VIRUS VACCINE,LIVE ATTENUATED [235574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine liposomal [477468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midecamycin diacetate [236200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>MENINGOCOCCAL VACCINE B [324050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morinda citrifolia extract [403712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercurius solubilis preparation [1310193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minaxolone [1495077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine benzoate [236401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor circinelloides f. circinelloides allergenic extract [2101422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metrizamide [6920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mavacamten [2600867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthol 1-propylene glycol carbonate, (-)- [1371320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadowfoam seed oil fatty acids [1540873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Millettia pinnata whole extract [2590663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylnaltrexone bromide [979111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium potassium aluminosilicate fluoride [2464931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myricetin [1368374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese citrate decahydrate [1791698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecamylamine [6673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Murraya koenigii whole extract [2048122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melilotus indicus whole extract [1442699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenamate [257844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl gluceth-10 [1367118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Matricaria recutita flowering top extract [1307730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>measles virus vaccine live, Enders&apos; attenuated Edmonston strain [804179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxsalen [6854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methylbutyric acid [2281310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylic acid - methyl methacrylate copolymer (1:1) [1309720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecamylamine hydrochloride [91240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium iodide [1992669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melicope pteleifolia leaf extract [1437851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Monarda didyma leaf oil [2563622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mucins [7076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose [6873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl malate phosphonic acid [1926939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monosodium ethylenediaminetetraacetate [1363994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mannitol hexanitrate [89792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mofezolac [11469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morpholine [1368870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mcpa triisopropanolamine [2379731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metavanadate [596548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus pumila whole extract [2002715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mupirocin [42372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium bromate [2629642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristate [1313976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moringa oleifera leaf oil [1865401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldopate hydrochloride [91241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirikizumab [2668384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Matricaria recutita root extract [1722232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medigoxin [6686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meperidine [6754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium oleth sulfate [2621831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 3-hydroxyhexanoate [2605086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadowfoam estolide [2640866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melia azedarach fruit extract [1428838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methapyrilene [6822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango extract [1426332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca alternifolia flowering top extract [1435096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methotrimeprazine [6852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miocamycin [6985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metylperon hydrochloride [289623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor plumbeus allergenic extract [314415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltol [1362894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylmethacrylate [29897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monensin [1368208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaclazepam [614654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrtus communis top extract [1311125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia biondii flower extract [1651700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl pentapeptide-4 [1313054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylesculetin acetate [1426628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese [6623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl-alpha-ionone [1999321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium chloride [6579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus nigra fruit extract [1311643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mephentermine sulfate [82042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medium chain triglycerides [1310578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl myristate [1425924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthone 1,2-glycerol ketal, (-)- [1426479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metyrapone tartrate [1313245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango seed oil [1307681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mexiletine hydrochloride [142138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molybdenum trichloride [2664834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha piperita leaf extract [1309326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium oxybate [2387308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mountain cedar pollen extract [852581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miristalkonium chloride [236394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>marine non-gelling gelatin [1998464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltooligosyl glucoside [2469245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moexiprilat [1546358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maclura cochinchinensis root extract [1746486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene blue cation [1546414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mometasone furoate [30145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>99 molybdenum [90574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methadone [6813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meropenem anhydrous [1546029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mecasermin rinfabate [616877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Murraya paniculata whole extract [2045729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Monardella odoratissima whole extract [2533901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Matricaria chamomilla flowering top oil [1309332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Marsdenia condurango bark extract [1310015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl lactate, L- [1431993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha pulegium extract [1426923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxisylyte [10561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl glucose sesquistearate [1592258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>micronomicin [29996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monoethanolamine lauryl sulfate [1370789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrothamnus flabellifolia whole extract [1872380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenorex [29444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldibromo glutaronitrile [1307044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl oleoyl taurate [1789473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus domestica leaf extract [2390285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medronate [1358207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medronate disodium [317599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malva neglecta whole extract [1998848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macadamia seed oil glycereth-8 esters [1429937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mycobacterium tuberculosis [1492936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl salicylate [1368207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus australis wood extract [1428841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mumps skin test antigen [89854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mahonia aquifolium root bark extract [1347560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Melaleuca ericifolia leaf oil [1422485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mephentermine hydrochloride [236481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mulberry pollen extract [899593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylprednisolone acetate [155323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl ricinoleate [1541746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango juice [1358964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine [6704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxy PEG-22/dodecyl glycol polymer [1940007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxyisopropanol [2462502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl hexapeptide-12, (VAL-GLY-VAL-ALA-PRO-GLY)- [2667329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesulfen [29584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mallotus japonicus flower oil [1541709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha canadensis whole extract [2619675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango allergenic extract [1011404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium L-threonate [1549113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melanotransferrin [2665288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>6-methyl citronellol [2046781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia kobus bark extract [1312377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metocurine iodide [203206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia liliiflora flower bud extract [2122671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirabegron [1300786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate, monobasic, dihydrate [1487155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia sprengeri flower bud extract [2390757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Musa x paradisiaca whole extract [1606331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methyl-3-decen-5-ol [2557379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meprednisone [29523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-methylpentadecane [2413031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycobacterium microti immunoserum rabbit [1367196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mineral oil [6972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-methylhydantoin [1729875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 2-octenoate, (E)- [2585678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylic acid [1424905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metabisulfite ion [2697173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Measles Vaccine [6669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk protein concentrate [2595236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxy PEG PPG-7-3 aminopropyl dimethicone [1543455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese bromide [2627378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus sylvestris flower extract [1309743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mexiletine [6926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha arvensis leaf oil [1307691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha arvensis whole extract [1490685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mycobacterium bovis [1320629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk thistle fruit [259389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl dihydroabietate [1600931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitoxantrone [7005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mannose, L- [2123307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mifepristone [6964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>montmorrillonite [1425919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline wax [1368704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese sulfate [29268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mycobacterium phlei [1310907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mianserin hydrochloride [203127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxifloxacin hydrochloride monohydrate [1926505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myrrh extract [67257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mofebutazone [30202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus domestica whole extract [1482537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mipomersen [1367839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mannose [6633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mibefradil [83213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moxetumomab pasudotox [2099295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mockernut extract [1872037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menadiol phosphate [360777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Madhuca longifolia var. latifolia seed butter extract [1808532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus domestica pollen extract [2593689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyleugenol [1368373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Momordica charantia stem extract [2696971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclizine hydrochloride [82041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium gluconate [52358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mugwort sage pollen extract [852029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metenkefalin [1349278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metamizole sodium [1537943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>momelotinib dihydrochloride monohydrate [2665205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methadyl acetate [6814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mometasone furoate monohydrate [153374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaraminol bitartrate [6806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl propionate [1435520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylergonovine maleate [84158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manuka oil [1355829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>measles virus vaccine live, attenuated Schwarz strain [2603499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aspartate anhydrous [1792467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melphalan [6718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Momordica balsamina immature fruit extract [1311092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese citrate [283767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metylperon [29961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medazepam [6680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miconazole nitrate [42790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium palmitostearate [1743153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxyphenamine hydrochloride [451944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylparaben [29903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medifoxamine fumarate [236781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate, tribasic, pentahydrate [1313280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium glycinate [476818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metronidazole hydrochloride [82047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monostearyl citrate [1368188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metanil yellow [1305576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mycophenolate [265323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mersalyl [6774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mobocertinib succinate [2570737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methantheline [6821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylserine [1313244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mepivacaine hydrochloride [203185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mebeverine [29410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mintlactone [1724822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango blossom pollen extract [1006371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese pyrophosphate [1721296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minocycline hydrochloride [6979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meprednisone disodium phosphate [1742508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha aquatica var. citrata leaf extract [1723158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk thistle seed extract [259274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mianserin [6929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mineral oil, light [577312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium chloride anhydrous [1311539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methyllactic acid [2685742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>malt extract [235375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metformin hydrochloride [235743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>micafungin [325887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myrcene [2166047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meningococcal polysaccharide vaccine group W-135 [314724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Musa x paradisiaca flower extract [1649015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monooctanoin [30198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrciaria dubia seed extract [1307724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magaldrate [29151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylenedioxycinnamic acid [324051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mandragora officinarum preparation [350386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mimulus guttatus whole extract [1799147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaproterenol sulfate [6804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric iodide [1426941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl dihydrojasmonate, (-)-trans- [2458323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mivacurium chloride [52796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moringa oleifera seed oil [1309443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl salicylate [29787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 2-sulfolaurate [1370609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Matricaria chamomilla whole extract [1307559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>muromonab-CD3 [42405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monofluorophosphate [52885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-methyl-2-pyrrolidinone [1305552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metipranolol [10824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium carbonate hydroxide [1363704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>moclobemide [30121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monophenylheptamethylcyclotetrasiloxane [2166046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mequitazine [29528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Manihot esculenta root extract [1309336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Millettia pulchra whole extract [2610403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milk thistle seed [283580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monoethyl fumarate [52882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese gluconate [52403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-mercaptoethanesulfonic acid [1546354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium myristate [1313980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium aluminum silicate type IC [1730436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myrtus communis leaf extract [1309445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl hydrogenated rosinate [1490691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl acetate [2372219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malabar plum juice [2170606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>megestrol [6703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha pulegium whole extract [2542745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Maranta arundiacea whole extract [2102921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melamine [1603851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Minquartia guianensis bark extract [1374403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoprolol succinate [221124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minocycline [6980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese monoxide [1728312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methenamine sulfosalicylate [235562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia officinalis bark extract [1307853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoprolol fumarate [102313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Moschus moschiferus musk sac resin [1426870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-methylundecanal [2378836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manitol [2475831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 105 [2274239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>motixafortide [2664896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 101 [2058847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mirabilis jalapa seed extract [1808533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>macadamia oil [1307956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methicillin sodium [267073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercuric chloride [1311634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malva sylvestris leaf extract [1307582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meglumine iotroxinate [52527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maralixibat [2571074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metronidazole benzoate [103866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Monarda didyma leaf extract [1428851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mimulus guttatus flowering top extract [1309946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucuna birdwoodiana stem extract [2594596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadow brome pollen extract [1484976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium stearate [1310567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Marrubium vulgare extract [1424909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meptazinol hydrochloride [11347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melanin synthetic (tyrosine, peroxide) [1312388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl isobutyrate [2460732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methionine [6837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methaqualone [6823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mogamulizumab [2054068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methampicillin sodium [273443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>melarsomine dihydrochloride [1012533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose (100 CPS) [1310583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Menyanthes trifoliata extract [1652100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl phenylacetate [2699422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mumps virus [1426911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mentha suaveolens whole extract [1800487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methylaminorex, cis-(+/-)- [2665286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mercurialis annua flowering top extract [1652098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mosapride [135091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>monofluorophosphate ion [1546445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine sulfate liposomal [477397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methocarbamol [6845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mild silver protein [30021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minaprine [30031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus alba bark extract [1309444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitapivat [2594468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose [1000577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylnicotinate [29900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maltodextrin [1363050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl acetate, (+/-)- [2282306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medrogestone [6690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>maralixibat chloride [2571073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristyl alcohol [1362897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacrylate [1424906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manidipine [29275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Magnolia x alba flower oil [1539426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacycline [6812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-methylphenethyl alcohol [2167998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mitracarpus hirtus whole extract [2467137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylheptyl isostearate [2548675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>menthyl ethylamido oxalate [2571661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meptazinol [6761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese acetate [1370629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose (25 CPS) [1313701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylcellulose (400 cps) [1313702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium lactate [214688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mazindol [6664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(3,4-methylenedioxyphenyl)-2-methylpropanal [1376341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl dehydroabietate [2637951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methamphetamine [6816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>margetuximab [2473851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl palmitate [1486520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylephedrine hydrochloride [1739003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methscopolamine nitrate [857649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>micafungin sodium [487070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myo-inositol trispyrophosphate [1791813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesterolone [6781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium gluconogluceptate [236564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>marbofloxacin [69256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitobronitol [6996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl L-arginine [1992539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesalamine [52582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl gluceth-20 [1363572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium palmitate [1424873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-methyl-5-heptanone oxime [2679168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malmea depressa bark extract [1923615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microcrystalline cellulose 102 [2056923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium phosphate dibasic trihydrate [237119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Michelia alba whole extract [2635084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium sulfate anhydrous [1311625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meclofenamate [588003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methacholine chloride [40165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium nitrate [1362814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylhomatropine [1546413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medetomidine [52016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefruside [6696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>myristoyl glutamate [1370584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxy PEG-40 [1747568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Morus nigra leaf extract [2468431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>M [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Myricaria paniculata stem extract [1725034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>M2 Protein Inhibitors [MoA]</name>
  <code>C634935</code>  <id>634935</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors</to_name>
    <to_code>T31303</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175542</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine [9386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine hydrochloride [82093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Macrolide Antibacterial [EPC]</name>
  <code>C634813</code>  <id>634813</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antibacterial</to_name>
    <to_code>T31790</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175431</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fidaxomicin [1111103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macrolides [M0028311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with macrolide structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing macrolide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Macrolide Antimicrobial [EPC]</name>
  <code>C635373</code>  <id>635373</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antimicrobial</to_name>
    <to_code>T31791</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175935</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clarithromycin [21212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macrolides [M0028311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin [18631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with macrolide structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azithromycin anhydrous [1299904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin [4053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing macrolide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Macrolide [EPC]</name>
  <code>C635315</code>  <id>635315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide</to_name>
    <to_code>T31793</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide-class Agent</to_name>
    <to_code>T31792</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175877</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing macrolide (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Macrolide (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macrolides [M0028311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrolide Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Macrolide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>erythromycin [4053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</name>
  <code>C340</code>  <id>341</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrophage Colony Stimulating Factor Receptor Interactions</to_name>
    <to_code>T31798</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000081</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efbemalenograstim alfa-vuxw [2670656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efbemalenograstim alfa [2670630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Magnesium Ion Exchange Activity [MoA]</name>
  <code>C635253</code>  <id>635253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnesium Ion Exchange Activity</to_name>
    <to_code>T31874</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175834</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluconolactone [25842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnesium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Magnetic Resonance Contrast Activity [MoA]</name>
  <code>C635300</code>  <id>635300</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity</to_name>
    <to_code>T31883</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175862</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129, hyperpolarized [2626220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopentetate dimeglumine [25486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobenate dimeglumine [68173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopiclenol [2618720]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoxetate disodium [637320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobutrol [84990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobenate [692620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoterate meglumine [1421151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadodiamide [41144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangafodipir [236987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadofosveset trisodium [1364289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadolinium cation (3+) [1546429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoversetamide [228833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese cation (2+) [1546272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoxetate [802624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxides [72901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoteridol [25483]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangafodipir trisodium, anhydrous [221119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadofosveset [1364290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Male Reproductive System Activity Alteration [PE]</name>
  <code>C29850</code>  <id>29851</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Male Reproductive System Activity Alteration</to_name>
    <to_code>T31923</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009742</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Male Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Male Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Male Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mast Cell Function Alteration [PE]</name>
  <code>C635020</code>  <id>635020</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mast Cell Function Alteration</to_name>
    <to_code>T32135</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175627</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mast Cell Stabilizer [EPC]</name>
  <code>C635023</code>  <id>635023</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mast Cell Stabilizer</to_name>
    <to_code>T32136</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175630</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nedocromil [31563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cromolyn [42612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Stabilizer [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing mast cell stabilizer (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Stabilizer [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with mast cell stabilizer mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olopatadine [135391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mast Cell Stabilizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Meat Proteins [EXT]</name>
  <code>C644819</code>  <id>644819</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins</to_name>
    <to_code>T32308</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185017</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef allergenic extract [892599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef liver preparation [1330085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamb allergenic extract [971849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venison allergenic extract [882488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pork allergenic extract [892628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit allergenic extract [813859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>veal allergenic extract [1012026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef liver allergenic extract [972689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Medium-chain Triglyceride [EPC]</name>
  <code>C654244</code>  <id>654244</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Medium-chain Triacylglycerol</to_name>
    <to_code>T58761</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Medium-chain Triglyceride</to_name>
    <to_code>T58759</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Medium-chain TG</to_name>
    <to_code>T58760</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194023</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Medium-chain Triglyceride [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triglycerides [M0021969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Medium-chain Triglyceride [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triheptanoin [1313234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Triacylglycerol (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medium-chain Triglyceride [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Medullary Respiratory Center Activity Alteration [PE]</name>
  <code>C29852</code>  <id>29853</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration</to_name>
    <to_code>T32399</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009743</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Medullary Respiratory Center Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Medullary Respiratory Center Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane citrate [283547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane tannate [221070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane [20217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen [20191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen edisylate [133053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Megakaryocyte Growth Factor [EPC]</name>
  <code>C635061</code>  <id>635061</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Megakaryocyte Growth Factor</to_name>
    <to_code>T32419</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175668</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Megakaryocyte Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombopoietin [M0021434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Megakaryocyte Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-11 [M0026381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Platelet-derived growth factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Megakaryocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing human platelet-derived growth factor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Megakaryocyte Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Meiosis Alteration [PE]</name>
  <code>C29854</code>  <id>29855</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Meiosis Alteration</to_name>
    <to_code>T32446</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009744</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Meiosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Meiosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Meiosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Meiosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanin Synthesis Inhibitor [EPC]</name>
  <code>C635292</code>  <id>635292</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocyte Pigment Inhibitor</to_name>
    <to_code>T32447</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitor</to_name>
    <to_code>T32448</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175854</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanin Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depigmenting Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanin Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroquinone [5509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanin Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanin Synthesis Inhibitors [MoA]</name>
  <code>C635288</code>  <id>635288</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitors</to_name>
    <to_code>T32449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175850</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobenzone [17145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequinol [15080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanin Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanocortin 4 Receptor Agonist [EPC]</name>
  <code>C654168</code>  <id>654168</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonist</to_name>
    <to_code>T58606</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MC4 Receptor Agonist</to_name>
    <to_code>T58607</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193940</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin 4 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>setmelanotide [2469247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin 4 Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing melanocortin receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Centrally acting appetite suppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanocortin 4 Receptor Agonists [MoA]</name>
  <code>C654167</code>  <id>654167</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonists</to_name>
    <to_code>T58605</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MC4 Receptor Agonists</to_name>
    <to_code>T58608</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193941</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>setmelanotide [2469247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanocortin Receptor Agonist [EPC]</name>
  <code>C654258</code>  <id>654258</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MCR Agonist</to_name>
    <to_code>T58788</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonist</to_name>
    <to_code>T58787</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194029</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with melanocortin receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing melanocortin receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bremelanotide [2176312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Melanocyte stimulating hormone analog (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanocortin Receptor Agonists [MoA]</name>
  <code>C654257</code>  <id>654257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonists</to_name>
    <to_code>T58785</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MCR Agonists</to_name>
    <to_code>T58786</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194030</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin 4 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide [2176312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanocortin Receptor Interactions [MoA]</name>
  <code>C654166</code>  <id>654166</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Interactions</to_name>
    <to_code>T58604</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193942</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melanocortin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanocyte Destruction [PE]</name>
  <code>C635290</code>  <id>635290</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocyte Destruction</to_name>
    <to_code>T32453</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175852</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</name>
  <code>C654351</code>  <id>654351</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAGE-A4-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
    <to_code>T59020</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy</to_name>
    <to_code>T59019</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194123</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Genetically modified T-cell (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing genetically modified T-cell (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanoma-associated Antigen A4-directed Genetically Modified Autologous T Cell Immunotherapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melatonin Activity Alteration [PE]</name>
  <code>C29856</code>  <id>29857</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Activity Alteration</to_name>
    <to_code>T32472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009745</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Melatonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melatonin Alteration [PE]</name>
  <code>C29858</code>  <id>29859</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Alteration</to_name>
    <to_code>T32473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009746</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melatonin Receptor Agonist [EPC]</name>
  <code>C635149</code>  <id>635149</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonist</to_name>
    <to_code>T32474</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175743</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing melatonin agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramelteon [596205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with melatonin agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tasimelteon [1490468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melatonin Receptor Agonists [MoA]</name>
  <code>C678</code>  <id>679</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonists</to_name>
    <to_code>T32475</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000250</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramelteon [596205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tasimelteon [1490468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melatonin Receptor Interactions [MoA]</name>
  <code>C424</code>  <id>425</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Interactions</to_name>
    <to_code>T32476</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000123</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Melatonin Secretion Alteration [PE]</name>
  <code>C29860</code>  <id>29861</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Secretion Alteration</to_name>
    <to_code>T32477</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009747</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Melatonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Melatonin Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Melatonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Membrane Transporter Interactions [MoA]</name>
  <code>C648268</code>  <id>648268</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Membrane Transporter Interactions</to_name>
    <to_code>T32532</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188367</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Membrane Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fatty Acid Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Membrane Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monosaccharide Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Membrane Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Membrane Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Membrane Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Membrane Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Membrane Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver [2606543]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Membrane Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxidectin [1047072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Membrane Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Menin Inhibitor [EPC]</name>
  <code>C654361</code>  <id>654361</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitor</to_name>
    <to_code>T59038</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194139</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Menin Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Menin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revumenib [2698325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Menin Inhibitors [MoA]</name>
  <code>C654360</code>  <id>654360</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitors</to_name>
    <to_code>T59037</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194140</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziftomenib [2725985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Menin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mesenchymal Epithelial Transition Inhibitors [MoA]</name>
  <code>C654148</code>  <id>654148</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MET Inhibitors</to_name>
    <to_code>T58568</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mesenchymal Epithelial Transition Inhibitors</to_name>
    <to_code>T58567</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193929</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mesenchymal Epithelial Transition Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mesenchymal Epithelial Transition Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metabolic Activity Alteration [PE]</name>
  <code>C29862</code>  <id>29863</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration</to_name>
    <to_code>T32755</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009748</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peptide Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin Uptake and Modification Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inorganic Ion Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Carbohydrate Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamic acid [25916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine [1091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, D- [1742746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-alanine [61]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartic acid [1169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kelp preparation [285155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenine [290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyrosine [10962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, DL- [1729154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine, DL- [1546161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine [6536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aminobenzoate [1010241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine hydrochloride [89918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine monohydrate [1314248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine [426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine acetate [6537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine [4919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aspartate [18254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fiber [70727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine hydrochloride [1311532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine hydrochloride [6538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamine [4885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesterol [2438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metabolic Alkalinizer [EPC]</name>
  <code>C635334</code>  <id>635334</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Alkalinizer</to_name>
    <to_code>T32756</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175896</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Alkalinizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkalinizing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Alkalinizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium citrate anhydrous [1374802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metabolic Bone Disease Agents [TC]</name>
  <code>C654060</code>  <id>654060</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents</to_name>
    <to_code>T58438</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193839</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abaloparatide [1921069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab-aqqg [2123180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid [77655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab [2043855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid anhydrous [1546014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab [993449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium hemi-pentahydrate [1356127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium monohydrate [1356128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bnht [2717527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene hydrochloride [166551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate tetrasodium [1364894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-kyqq [2725924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronic acid [115265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate [57230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bmwo [2717851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene [72143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate [115264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bbdz [2715382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-qbde [2725562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palovarotene [2663954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-dssb [2725498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-nxxp [2723334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab [2123126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium cation Sr-89 [2280602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium anhydrous [1926958]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab-twza [2043854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate disodium [83153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate sodium [236916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metabolic Rate Alteration [PE]</name>
  <code>C29864</code>  <id>29865</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Rate Alteration</to_name>
    <to_code>T32760</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009749</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Rate Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolic Rate Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Metabolic Rate [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Rate Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metabolism [PK]</name>
  <code>C224</code>  <id>225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolism</to_name>
    <to_code>T32770</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000023</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzymatic Pathway of Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Site of Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metal Chelating Activity [MoA]</name>
  <code>C634853</code>  <id>634853</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelator</to_name>
    <to_code>T32781</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity</to_name>
    <to_code>T32782</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175472</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelating Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine hydrochloride [235370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine tetrahydrochloride [2611541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine [10798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metal Chelator [EPC]</name>
  <code>C634854</code>  <id>634854</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelator</to_name>
    <to_code>T32783</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175473</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dimercaprol [3445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iron Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lead Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metal Chelator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium Binder [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chelating agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with chelating agent mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metalloendopeptidase Inhibitors [MoA]</name>
  <code>C651826</code>  <id>651826</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metalloendopeptidase Inhibitors</to_name>
    <to_code>T32788</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191726</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metalloendopeptidase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Metalloprotease Inhibitors [MoA]</name>
  <code>C651825</code>  <id>651825</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Metalloprotease Inhibitors</to_name>
    <to_code>T32800</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191725</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Metalloprotease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metalloendopeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abametapir [2475532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metalloprotease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methylated Sulfonamide Antibacterial [EPC]</name>
  <code>C634904</code>  <id>634904</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamide Antibacterial</to_name>
    <to_code>T33052</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175511</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mafenide [6572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylated Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sulfonamide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with sulfonamide structure and antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methylated Sulfonamides [EXT]</name>
  <code>C634905</code>  <id>634905</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamides</to_name>
    <to_code>T33053</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175512</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylated Sulfonamides [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mafenide [M0012880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Sulfonamides [M0020790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methylating Activity [MoA]</name>
  <code>C635223</code>  <id>635223</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyl Donors</to_name>
    <to_code>T33054</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Activity</to_name>
    <to_code>T33055</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175804</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine hydrochloride [81965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine, anhydrous [350374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine [1512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methylating Agent [EPC]</name>
  <code>C635224</code>  <id>635224</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Agent</to_name>
    <to_code>T33056</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175805</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylating Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine [1512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylating Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylating Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with methyltransferase mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylating Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaine, anhydrous [350374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methyltransferase Inhibitor [EPC]</name>
  <code>C654149</code>  <id>654149</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitor</to_name>
    <to_code>T58569</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193930</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazemetostat [2274378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing methyltransferase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methyltransferase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with methyltransferase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methyltransferase Inhibitors [MoA]</name>
  <code>C654150</code>  <id>654150</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitors</to_name>
    <to_code>T58570</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193931</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib citrate [2698326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methyltransferase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Methylxanthine [EPC]</name>
  <code>C635209</code>  <id>635209</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylxanthine</to_name>
    <to_code>T33195</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylxanthine-class Agent</to_name>
    <to_code>T33194</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175790</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylxanthine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xanthines [M0023046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylxanthine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theophylline anhydrous [91178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylxanthine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing methylated xanthine derivative (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylxanthine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Methylated xanthine derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Methylxanthine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caffeine [1886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</name>
  <code>C646665</code>  <id>646665</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitor</to_name>
    <to_code>T33318</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MTTP Inhibitor</to_name>
    <to_code>T33317</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000186779</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with microsomal triglyceride transfer protein inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lomitapide [1364479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing microsomal triglyceride transfer protein inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microsomal Triglyceride Transfer Protein Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</name>
  <code>C646664</code>  <id>646664</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MTTP Inhibitors</to_name>
    <to_code>T33319</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitors</to_name>
    <to_code>T33320</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000186778</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Microsomal Triglyceride Transfer Protein Interactions [MoA]</name>
  <code>C648270</code>  <id>648270</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Interactions</to_name>
    <to_code>T33321</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188369</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microsomal Triglyceride Transfer Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microsomal Triglyceride Transfer Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Microtubule Inhibition [PE]</name>
  <code>C634446</code>  <id>634446</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition</to_name>
    <to_code>T33328</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175085</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine-gynx [2621549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin [2277607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin [2571094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab [2714237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab [2268307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin-tftv [2571093]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin-blmf [2387833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin [2721996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin-tllv [2714236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab [2387844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab [2571095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirbanibulin [2471078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin-ejfv [2268306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Microtubule Inhibitor [EPC]</name>
  <code>C634985</code>  <id>634985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibitor</to_name>
    <to_code>T33329</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175592</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabazitaxel [996051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixabepilone [337523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirbanibulin [2471078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with microtubule inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>docetaxel anhydrous [1299922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing microtubule inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eribulin [1045453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Microtubule Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paclitaxel [56946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Receptor Agonists [MoA]</name>
  <code>C366</code>  <id>367</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists</to_name>
    <to_code>T33399</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000094</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone [3256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone acetate [258333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone pivalate [22537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Receptor Antagonist [EPC]</name>
  <code>C654190</code>  <id>654190</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonist</to_name>
    <to_code>T58649</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193969</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mineralocorticoid Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hormone receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Receptor Antagonists [MoA]</name>
  <code>C456</code>  <id>457</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonists</to_name>
    <to_code>T33400</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000139</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mineralocorticoid Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finerenone [2562811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mineralocorticoid Synthesis Inhibitors [MoA]</name>
  <code>C635362</code>  <id>635362</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Synthesis Inhibitors</to_name>
    <to_code>T33401</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175924</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</name>
  <code>C654159</code>  <id>654159</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MEK1 Protein Kinase Inhibitors</to_name>
    <to_code>T58592</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MEK-1 Protein Kinase Inhibitors</to_name>
    <to_code>T58591</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAP Kinase Kinase 1 Inhibitors</to_name>
    <to_code>T58590</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors</to_name>
    <to_code>T58589</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193943</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirdametinib [2705551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib [2714515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib potassium [2714514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</name>
  <code>C654160</code>  <id>654160</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MEK2 Protein Kinase Inhibitors</to_name>
    <to_code>T58596</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAP Kinase Kinase 2 Inhibitors</to_name>
    <to_code>T58594</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MEK-2 Protein Kinase Inhibitors</to_name>
    <to_code>T58595</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors</to_name>
    <to_code>T58593</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193944</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirdametinib [2705551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</name>
  <code>C654158</code>  <id>654158</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase Inhibitors</to_name>
    <to_code>T58587</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAP Kinase Kinase Inhibitors</to_name>
    <to_code>T58588</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193945</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mitosis Alteration [PE]</name>
  <code>C29866</code>  <id>29867</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitosis Alteration</to_name>
    <to_code>T33632</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009750</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mitosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mitosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Inhibitor [EPC]</name>
  <code>C635150</code>  <id>635150</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAOI</to_name>
    <to_code>T33731</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitor (MAOI)</to_name>
    <to_code>T33732</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitor</to_name>
    <to_code>T33733</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175744</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rasagiline [134748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tranylcypromine [10734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selegiline [9639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing monoamine oxidase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Type B Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenelzine [8123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isocarboxazid [6011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with monoamine oxidase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Inhibitors [MoA]</name>
  <code>C546</code>  <id>547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAOI</to_name>
    <to_code>T33734</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors</to_name>
    <to_code>T33735</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000184</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate [2562176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine [700810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine mesylate [236189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine [10847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine hydrobromide [1439834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride monohydrate [221160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate [2607741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opicapone [2362167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine hydrochloride [236481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine hydrochloride [91063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine citrate [71533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine [1455099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine hydrochloride [353103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine hydrochloride [71534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl acetate hydrochloride [82043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levodopa [6375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foslevodopa [2695775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine tannate [1099727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine [38400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate monohydrate [2605948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone hydrochloride [1086768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichloralphenazone [22892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate dihydrate [998038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate chloride [2562177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram [321988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine [10849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine [6756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram oxalate [353108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine dimesylate [673579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine sulfate [82042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isometheptene mucate (1:1) [317238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone [1086769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl [237005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isometheptene mucate [104994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate hydrochloride [91241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase Type B Inhibitor [EPC]</name>
  <code>C635170</code>  <id>635170</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Type B Inhibitor</to_name>
    <to_code>T33739</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Type B (MAO-B) Inhibitor</to_name>
    <to_code>T33736</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAO-B Inhibitor</to_name>
    <to_code>T33738</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAOI-B</to_name>
    <to_code>T33737</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175762</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with monoamine oxidase B inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing monoamine oxidase B inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safinamide [1922448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoamine Oxidase Type B Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selegiline [9639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase-A Inhibitors [MoA]</name>
  <code>C635168</code>  <id>635168</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAO-A Inhibitors</to_name>
    <to_code>T33745</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-A Inhibitors</to_name>
    <to_code>T33747</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAOI-A</to_name>
    <to_code>T33746</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175760</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoamine Oxidase-B Inhibitors [MoA]</name>
  <code>C635169</code>  <id>635169</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAOI-B</to_name>
    <to_code>T33749</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors</to_name>
    <to_code>T33750</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MAO-B Inhibitors</to_name>
    <to_code>T33748</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175761</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase-B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoamine oxidase [PK]</name>
  <code>C256</code>  <id>257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine oxidase</to_name>
    <to_code>T33751</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000039</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monobactam Antibacterial [EPC]</name>
  <code>C634874</code>  <id>634874</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monobactam Antibacterial</to_name>
    <to_code>T33752</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175493</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Monobactam (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing monobactam (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Monobactams [M0014030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monobactam Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aztreonam [1272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monobactam Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monoclonal Antibody [EPC]</name>
  <code>C654084</code>  <id>654084</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoclonal Antibody</to_name>
    <to_code>T58473</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>mAb</to_name>
    <to_code>T58474</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>moAb</to_name>
    <to_code>T58475</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193863</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD19-directed Cytolytic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoclonal Antibody [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing monoclonal antibody (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoclonal Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mogamulizumab [2054068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monoclonal Antibody [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Monoclonal antibody (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monocyte Function Alteration [PE]</name>
  <code>C643498</code>  <id>643498</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monocyte Function Alteration</to_name>
    <to_code>T33773</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183882</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monocyte Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Monocyte Activation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Monosaccharide Transporter Interactions [MoA]</name>
  <code>C648288</code>  <id>648288</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Monosaccharide Transporter Interactions</to_name>
    <to_code>T33803</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188379</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Monosaccharide Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mood Stabilizer [EPC]</name>
  <code>C635159</code>  <id>635159</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mood Stabilizer</to_name>
    <to_code>T33811</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175751</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valproic acid [11118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lithium cation [1546265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimanic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbamazepine [2002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamotrigine [28439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mood Stabilizer [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mood Disorders [M0029642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Psychotropic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mood Stabilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</name>
  <code>C635077</code>  <id>635077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucocutaneous Epithelial Cell Growth Factor</to_name>
    <to_code>T33919</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175671</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Epithelial Proliferation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palifermin [196319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibroblast Growth Factor 7 [M0168688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Keratinocyte growth factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing recombinant human keratinocyte growth factor (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucocutaneous Epithelial Cell Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mucolytic [EPC]</name>
  <code>C635195</code>  <id>635195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucolytic</to_name>
    <to_code>T33928</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175776</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucolytic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetylcysteine [197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucolytic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Respiratory system agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucolytic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arterial Vasoconstriction [PE]</name>
  <code>C29868</code>  <id>29869</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arterial Vasoconstriction</to_name>
    <to_code>T33976</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009751</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arterial Vasodilation [PE]</name>
  <code>C29870</code>  <id>29871</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arterial Vasodilation</to_name>
    <to_code>T33977</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009752</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arteriolar Vasoconstriction [PE]</name>
  <code>C634782</code>  <id>634782</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arteriolar Vasoconstriction</to_name>
    <to_code>T33978</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175399</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Mucosal Arteriolar Vasodilation [PE]</name>
  <code>C634766</code>  <id>634766</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucosal Arteriolar Vasodilation</to_name>
    <to_code>T33979</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175383</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Mucosal Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Conjunctival Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Multidrug Resistance-Associated Protein 2 Inhibitors [MoA]</name>
  <code>C654176</code>  <id>654176</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug Resistance-Associated Protein 2 Inhibitors</to_name>
    <to_code>T58618</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MRP2 Inhibitors</to_name>
    <to_code>T58620</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ABCC2 Inhibitors</to_name>
    <to_code>T58619</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193960</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Multidrug Resistance-Associated Protein Interactions [MoA]</name>
  <code>C654175</code>  <id>654175</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug Resistance-Associated Protein Interactions</to_name>
    <to_code>T58617</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193961</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Multidrug Resistance-Associated Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug Resistance-Associated Protein 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</name>
  <code>C651471</code>  <id>651471</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors</to_name>
    <to_code>T33998</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MATE1 Inhibitors</to_name>
    <to_code>T33997</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191423</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir [1433868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</name>
  <code>C654143</code>  <id>654143</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MATE-2K Inhibitors</to_name>
    <to_code>T58558</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MATE2 Inhibitors</to_name>
    <to_code>T58559</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>MATE2-K Inhibitiors</to_name>
    <to_code>T58560</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors</to_name>
    <to_code>T58557</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193932</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Multivitamin Preparation [EPC]</name>
  <code>C635348</code>  <id>635348</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Multivitamin Preparation</to_name>
    <to_code>T34131</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175910</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Multivitamin Preparation [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Multivitamin agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing vitamin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multivitamin Preparation [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Muscle Relaxant [EPC]</name>
  <code>C635143</code>  <id>635143</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Muscle Relaxant</to_name>
    <to_code>T34193</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscle Relaxant</to_name>
    <to_code>T34194</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175737</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metaxalone [59078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carisoprodol [2101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methocarbamol [6845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorzoxazone [2410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cyclobenzaprine [21949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orphenadrine [7715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscle Relaxant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Muscular Arterial Vasoconstriction [PE]</name>
  <code>C29872</code>  <id>29873</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasoconstriction</to_name>
    <to_code>T34200</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009753</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscular Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine hydrochloride [105470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine [9392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Muscular Arterial Vasodilation [PE]</name>
  <code>C29874</code>  <id>29875</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasodilation</to_name>
    <to_code>T34201</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009754</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Muscular Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Muscular Arteriolar Vasoconstriction [PE]</name>
  <code>C634787</code>  <id>634787</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arteriolar Vasoconstriction</to_name>
    <to_code>T34202</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175404</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Muscular Arteriolar Vasodilation [PE]</name>
  <code>C634771</code>  <id>634771</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscular Arteriolar Vasodilation</to_name>
    <to_code>T34203</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175388</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Musculoskeletal Activity Alteration [PE]</name>
  <code>C29876</code>  <id>29877</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Musculoskeletal Activity Alteration</to_name>
    <to_code>T34261</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009755</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Musculoskeletal Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Musculoskeletal Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Contraction Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Musculoskeletal Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Musculoskeletal Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Musculoskeletal Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Musculoskeletal Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Connective Tissue Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>N [Preparations]</name>
  <code>C288640</code>  <id>288640</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>N [Preparations]</to_name>
    <to_code>T34610</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010596</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>narasin [1314370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n-(carbonyl-methoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine [1370662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naxitamab-gqgk [2474235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natural red 26 [1442708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netarsudil [1992864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nymphaea alba flower extract [1307745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalmefene [31479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>noxythiolin [7543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-valyltryptophan [1425405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nogapendekin alfa inbakicept-pmln [2682677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifedipine [7417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilutamide [31805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl glycol diethylhexanoate [1307148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphthalenesulfonic acid (mixed isomers) [1799148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel acetate tetrahydrate [1313175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxone [7242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naxitamab [2474039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitroxoline [31901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norelgestromin [326374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-butylphthalimide [1600977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nigella sativa seed extract [1808612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonanal [1314253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1,1,2,2,3,3,4,4-nonafluorononane [2639943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadide phosphate monosodium [2642192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg extract [1353217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nerolidol [2371699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-dialkyl methyl benzyl ammonium chloride (C12-C18) [2461144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirsevimab-alip [2642402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-cyclohexyl-N&apos;-phenyl-1,4-phenylenediamine [1427136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nymphaea odorata root extract [1310052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus pseudonarcissus flower extract [1309446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirmatrelvir [2587892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nevirapine hemihydrate [2462459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-carboxymethylchitosan [2690867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadoxolol hydrochloride [236178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>8-(N-indolyl)-2,6-dimethyl-7-octen-2-ol [2384441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niacinamide [7405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetyl-glucosamine thiazoline [2597521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(3-aminopropyl)-N-dodecyl-1,3-propanediamine [2384783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel cation [1546280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nerium oleander flower [2109479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-dimethylglycine hydrochloride [1921876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrofurantoin [7454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norethandrolone [7513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotine bitartrate anhydrous [1306106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nemolizumab-ilto [2691309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nomifensine [7500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nomegestrol acetate [53744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-dimethyl-2-octadecanamine [1648140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nebivolol [31555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel gluconate [1368209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neatsfoot oil [1358967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neomycin sulfate [7300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen [1601232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifurpipone [1311582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nizatidine [42319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafcillin [7233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neo-homosalate [236816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus poeticus whole extract [2590664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nuciferine [2667817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen [1593130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netupitant [1552337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitroprusside [7476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neurotrophin 3 [1363714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neratinib [1940643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N,N&apos;-bis(hydroxymethyl)urea [1990423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel acetate [1313176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-bis(2-hydroxyethyl)-p-phenylenediamine sulfate [1427230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitisinone [61805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natamycin [7268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niaprazine [31722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalbuphine hydrochloride [154985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nectarine allergenic extract [1010999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera germ extract [1428852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norethindrone enanthate [31984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-alkyl ethylbenzyl dimethyl ammonium (C12-C14) [1422066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naratriptan [141366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphazoline nitrate [235810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel carbonate hydroxide tetrahydrate [1811768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nandrolone [7244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-naphthalenesulfonate [1366947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niobium [1426867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilotinib tartrate [2698561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norfenefrine hydrochloride [236468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nerium oleander whole extract [2590182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetylcaprolactam [2465232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicorandil [31748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norethindrone [7514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera root extract [1373155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>new coccine [1364276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n-decyl alcohol [1363052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinyl alcohol tartrate [235354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n1-hexadecyl-n1,n1,n2,n2-tetramethyl-n2-(3-(trihydroxysilyl)propyl)ethane-1,2-diaminium dichloride [2569471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norfenefrine [31988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naproxen sodium [142442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-8 [1313171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naringin sodium [236396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitric oxide synthase [2627243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxone hydrochloride dihydrate [1010598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nateglinide [274332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetylcarnosine [1796119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nefopam [7285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nivolumab [1597876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-nonylphenol [1788868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nystose [2590651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrate ion [1546271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirsevimab [2642401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-monoacetylcystine [2267406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neodymium [1311480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen [1601231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-naphthalenesulfonic acid [1442718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nomifensine maleate [262302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neurotensin [2590652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nordihydroguaiaretate [1860612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-2 [1601983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafronyloxalate [7237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitazoxanide [31819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nuphar lutea leaf extract [2588955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern quahog preparation [1925437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norgestrel [7518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotine [7407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-12 [1314216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nyctanthes arbor-tristis whole extract [2668422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrite ion [1546424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nymphaea caerulea flower extract [1307942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norepinephrine, DL- [1657875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(hydroxyethyl)ethylenediaminetriacetic acid [1364568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netarsudil mesylate [1992863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinamide ribotide [2262276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinuric acid [1994363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>noggin [1858663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine [901505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl gly dcapryl-dcaprate [1307101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotine polacrilex [31765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-3 [2630218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nerium oleander leaf extract [1310031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nimodipine [7426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neryl acetate [2395766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neostigmine [7315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nivolumab-rmbw [2596770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-naphthol [1740233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-vinylcaprolactam [2534441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera flower wax [1307151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natural graphite [90249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niacinamide ascorbate [1363721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera leaf extract [1307977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nintedanib [1592737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nerandomilast [2725523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxone hydrochloride [203192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-nonylphenol [2625123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nefazodone hydrochloride [236082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nerol [2274605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirogacestat hydrobromide [2670632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N&apos;-diphenyl-4-phenylenediamine [1363709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-dimethylacrylamide [1371317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetyl-.alpha.-D-glucosamine [2280292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitroglycerin [4917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-dodecyl .beta.-D-maltoside [2178066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel sulfate [31738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrogen [7456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2-naphthyloxy)acetic acid [2685740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nedocromil [31563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nordihydroguaiaretic acid, (+/-)- [1860611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinic acid benzyl ester [31767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonathymulin [1946823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netilmicin [7337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nephelium lappaceum fruit rind extract [1747700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nettle pollen extract [852046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-dimethyllauramide [2387542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neohesperidin dihydrochalcone [1312741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n-butyl lactate [1435572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine [901511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinate ethanolamine [2627646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2&apos;,3,3&apos;,4,4&apos;,5,5&apos;,6-nonachlorodiphenyl either [2056924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(3-(dimethylamino)propyl)octadecanamide [1364376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-dimethylglycine [1313173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadofaragene firadenovec-vncg [2644435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N.alpha.-methylhistamine dihydrochloride [2107611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-hydroxysuccinimide [1368884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nabumetone [31448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphtha, light [2619913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol, 4-sulfate, ammonium salt [1367076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nolinium [2257602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera stamen extract [1420975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nintedanib esylate [1592736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nelfinavir mesylate [266565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern bluefin tuna allergenic extract [2049894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetyl dipeptide-1 [1314273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nikethamide [7424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nelfinavir [134527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nasturtium officinale leaf extract [2592624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitric acid [1311391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotine bitartrate [1306107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(3,4-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N,N&apos;-bis (hydroxymethyl) urea [1792714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nuphar japonica root extract [1551422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonacog alfa [1300488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilvadipine [53692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilotinib hydrochloride monohydrate [2701416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-14 [2630163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nerve growth factor [7327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Naja naja venom [1310461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl glycol diheptanoate [1306188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>New Zealand green mussel extract [1306118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera root oil [2559958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-nitropropane [2372437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neratinib maleate [1940642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nomegestrol [31930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neurospora crassa allergenic extract [1193003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nedocromil sodium [266663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nigella sativa seed oil [1431150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicarbazin [1311583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicofuranose [104486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nivolumab-nvhy [2700791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naringenin [1368173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-9 sulfate [2584967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-lauroylproline [1728290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N,N&apos;,N&apos;-tetrakis(2-hydroxypropyl)adipamide [1855522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern brown shrimp allergenic extract [2102481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-norbornene-2-methylolacrylate [2288173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naltrexone [7243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neostigmine bromide [82055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle [1601236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neopicrorhiza scrophulariiflora root extract [1309710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinamide adenine dinucleotide (NAD) [1044975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(1,3,4-tris(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N,N&apos;-bis(hydroxymethyl)urea [1947502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>noradrenaline hydrochloride [2256931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifurzide [31786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>novobiocin sodium [82057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis [7288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nandina domestica whole extract [1996985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nimesulide [53694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niraparib [1918231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nylon 12 [1358484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nystatin [7597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n-butyl acrylate [1313770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel sulfate hexahydrate [1368214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>NADH [7222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-n-butylphthalide [1484499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphthoquine [1721293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nortriptyline hydrochloride [203130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinamide hydriodide [317251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-cyclohexyl-2-benzothiazosulfenamide [1306886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl glycol dicaprylate-dicaprate [1307100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Natal orange extract [1648141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadolol [7226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nimorazole [7427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norethynodrel [7515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norflurane [1311560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilotinib hydrochloride [1804015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafarelin [28656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrofurantoin, macrocrystals [235559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nefopam hydrochloride [4324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naldemedine tosylate [1876598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nereocystis luetkeana [1862483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg oil [1309209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naftazone [31475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>10-(N-methylpiperidyliden-4)-1-azathioxanthene malonate [2464290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetylmethionine [1426463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nandrolone decanoate [31494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>necitumumab [1723738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-10 [1311556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphthalene [1311149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-oxydiethylene-2-benzothiazole sulfenamide [1363711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern paper wasp venom protein [1294632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nattokinase [53553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxegol oxalate [1593586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadoxolol [31462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-isopropyl-N-phenyl-4-phenylenediamine [1363710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus pseudonarcissus extract [1719249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Naja naja whole extract [1745415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-4 [1368184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafcillin sodium monohydrate [485026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Notopterygium incisum whole extract [1490686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern pike allergenic extract [889602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen [1601233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-methylephedrine [1311545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonivamide [31945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera flower extract [1309447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg allergenic extract [891652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nylidrin hydrochloride [82060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonylphenol [1591892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-ethylhexedrone [2669696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel [1311629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera whole extract [1373156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n1,n1,n2,n2-tetramethyl-n1-octadecyl-n2-(3-(trihydroxysilyl)propyl)ethane-1,2-diaminium dichloride [2569470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netilmicin sulfate [203193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nymphaea alba root extract [2397984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>novobiocin [7538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nelarabine [274771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinyl alcohol [7414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalmefene hydrochloride [236069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetyl-methionine, DL- [1426462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nortriptyline [7531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitric oxide synthase type III [2627245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitric oxide [7442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphazoline [7247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nedosiran sodium [2675288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-nonylphenol [1591893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitroso-DL-citrulline [2275616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nipocalimab [2712693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafcillin sodium [9893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicoboxil [235788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetylvaline [2604632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nasturtium officienale whole extract [1313691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nicotiana tabacum whole extract [1430129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niraparib tosylate monohydrate [2640208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafarelin acetate [203147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-tert-octylacrylamide [1545167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus tazetta bulb extract [1311646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphtho(2,1-b)furan [2557371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphazoline hydrochloride [82054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-30 [1311559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n-dodecane [1314271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naringin [31538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neostigmine methylsulfate [7316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nialamide [7394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N5-((2E)-((2-(((2,3-bis(omega-methoxypoly(oxyethylene))propoxy)carbonyl)amino)ethoxy)imino)ethyl)glutamine (43000 MW) [2476006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nardostachys chinensis whole extract [1358963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrofurantoin, monohydrate [221129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitarsone [1311555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalbuphine [7238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-9 [53750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nesiritide [19666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(N-morpholino)ethanesulfonic acid [2360130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nardostachys chinensis root extract [2592975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifuroxazide [31782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naphtha [1923814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natalizumab-sztn [2725169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naftifine [31476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetyltyrosine [31005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen [1593127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>North American coral snake antivenin [979384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-4 sulfate [1367077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrofurazone [7455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-n-octyl-4-isothiazolin-3-one [1362738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera seed extract [1309448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neral [1484865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus jonquilla flower oil [2370879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neotame [1367111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nabilone [31447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-acetyltryptophan [1368212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>normethadone [32009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nylon 612 (MW14000) [1807892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nusinersen [1863556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalidixate [618425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine [901509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-ethylurea [2047170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nemolizumab [2691310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naltrexone hydrochloride [105069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilotinib [662281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadroparin [67031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nashipati extract [2558504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafronyl [7236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifuratel [7419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norfloxacin [7517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niraparib tosylate [2637447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Notopterygium franhetii root extract [1309325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neurotrophin 4 [1426704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-20 [1367189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl glycol dicaprate [1367144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-lactoylethanolamine [1424270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naftifine hydrochloride [91293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(N-(3-cholamidopropyl)-N-(3-lactobionamidopropyl))cholamide [2643432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-alkyl dimethyl benzyl ammonium chloride (C12-C18) [1539816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niacin [7393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-(carbonyl-methoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt [1366942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naldemedine [1876597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nifurtimox [7421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine [797631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nylidrin [7595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nebivolol hydrochloride [236883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neurospora sitophila allergenic extract [1098200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrocellulose [1425879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonapeptide-1 [2462494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nuphar luteum root extract [1309762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrazepam [7440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>n-tris((hydroxymethyl)methyl)-3-aminopropanesulfonic acid [2584542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natalizumab [354770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niclosamide [7402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nipocalimab-aahu [2712692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nisoldipine [7435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nux vomica extract [314743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>narrowleaf marshelder pollen extract [1098130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel carbonate hydroxide [1811769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niflumic acid [7418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nilotinib d-tartrate [2715454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicergoline [7398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norepinephrine [7512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-100 [1311558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicotinic acid propyl ester [236738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nedosiran [2675287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(nonyloxy)1,2-propanediol [2391136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nandrolone phenpropionate [31495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-caproylsphingosine [1603859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-alkyl ethylbenzyl dimethyl ammonium chloride (C12-C14) [1422065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nefazodone [31565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N-bis(2-hydroxyethyl)lactamide [1597295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-((ethoxycarbonyl)methyl)-p-menthane-3-carboxamide [2360430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nordazepam [3155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>navy kidney bean allergenic extract [1012190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrendipine [7441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitenpyram [341379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine [901507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nogapendekin alfa inbakicept [2682678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine [2360574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nepafenac [298665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-alkyl dimethyl benzyl ammonium ion (C12-C18) [2461143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalidixic acid [7240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-alkyl dimethyl benzyl ammonium (C12-C18) [1539817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neurospora intermedia allergenic extract [867274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirogacestat [2670631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,4-naphthoquinone [1602556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicardipine [7396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neomycin [7299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nicardipine hydrochloride [235230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N2-(4-fluorobenzoyl)-L-arginine [2120185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naproxen [7258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-N-octylphenol [2395436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxegol [1551777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norgestimate [31994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl glycol [1368162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nevirapine [53654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitromersol [89721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Norwalk virus [1747300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naratriptan hydrochloride [236690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus poeticus flower oil [2618666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norethindrone acetate [31983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Narcissus poeticus flower wax [2180550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Notopterygium incisum root extract [1307976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nymphaea caerulea flower volatile oil [2609900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern quahog allergenic extract [2103241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neon [7301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrous oxide [7486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>noggin, human [1858662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norepinephrine bitartrate [7508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nelumbo nucifera flower oil [1310047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-naphthoquinone [1661328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nonoxynol-5 [2281102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>noscapine [7533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadofaragene firadenovec [2644436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neodymium oxide [1311107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nargenicin [2668421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norgestrienone [7519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neopentyl glycol diisostearate [1367136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Nasturtium officinale extract [1352519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>N-Calcium Channel Receptor Antagonists [MoA]</name>
  <code>C300459</code>  <id>300459</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-Calcium Channel Receptor Antagonists</to_name>
    <to_code>T34653</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020069</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide [68503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide acetate [486126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>N-acetyl transferases [PK]</name>
  <code>C252</code>  <id>253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-acetyl transferases</to_name>
    <to_code>T34721</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000037</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>N-methyl-D-aspartate Receptor Antagonist [EPC]</name>
  <code>C635151</code>  <id>635151</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonist</to_name>
    <to_code>T34722</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-methyl-D-aspartate (NMDA) Receptor Antagonist</to_name>
    <to_code>T34723</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-methyl-D-aspartate Receptor Antagonist</to_name>
    <to_code>T34724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175745</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with N-methyl-D-aspartate receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>memantine [6719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>N-type Calcium Channel Antagonist [EPC]</name>
  <code>C635103</code>  <id>635103</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-type Calcium Channel Antagonist</to_name>
    <to_code>T34727</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175697</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>N-type Calcium Channel Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziconotide [68503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>N-type Calcium Channel Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with calcium channel blocker mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing calcium channel blocker (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>NMDA Receptor Antagonists [MoA]</name>
  <code>C300400</code>  <id>300400</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists</to_name>
    <to_code>T35020</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-methyl-D-aspartate Receptor Antagonists</to_name>
    <to_code>T35019</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020015</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>NMDA Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>NMDA Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>NMDA Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Glycine Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>NMDA Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine [6719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate [82819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate calcium [152761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine hydrochloride [236685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>NMDA Receptor Glycine Antagonists [MoA]</name>
  <code>C641386</code>  <id>641386</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>NMDA Receptor Glycine Antagonists</to_name>
    <to_code>T35022</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>N-methyl-D-aspartate Receptor Glycine Antagonists</to_name>
    <to_code>T35021</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181820</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nail Excretion [PK]</name>
  <code>C284</code>  <id>285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nail Excretion</to_name>
    <to_code>T35070</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000053</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Narcotic Antitussive [EPC]</name>
  <code>C635214</code>  <id>635214</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Narcotic Antitussive</to_name>
    <to_code>T35152</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175795</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Narcotic Antitussive [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morphinans [M0014063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Narcotic Antitussive [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Narcotic Antitussive [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Narcotic Antitussive [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antitussive agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Narcotic Antitussive [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing opioid receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Narcotic Antitussive [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Natriuretic Peptide [EPC]</name>
  <code>C634986</code>  <id>634986</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Natriuretic Peptide</to_name>
    <to_code>T35169</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175593</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Natriuretic Peptide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Natriuretic factor (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Natriuretic Peptide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Natriuretic Peptides [M0447624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Negative Chronotropy [PE]</name>
  <code>C29878</code>  <id>29879</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy</to_name>
    <to_code>T35238</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009756</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol hydrochloride [2712069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>practolol [8620]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil [4648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil hydrochloride [439837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine hydrochloride [1649479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Negative Inotropy [PE]</name>
  <code>C29880</code>  <id>29881</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy</to_name>
    <to_code>T35239</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009757</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Negative Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neonatal Fc Receptor Blocker [EPC]</name>
  <code>C654221</code>  <id>654221</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blocker</to_name>
    <to_code>T58720</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>FcRn Blocker</to_name>
    <to_code>T58721</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194004</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Immunoglobulin, Fc fragment (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rozanolixizumab [2642274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neonatal Fc Receptor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>efgartigimod alfa [2587717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neonatal Fc Receptor Blockers [MoA]</name>
  <code>C654223</code>  <id>654223</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal FcRn Blockers</to_name>
    <to_code>T58725</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers</to_name>
    <to_code>T58724</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194005</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab [2642274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-qvfc [2639944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab-noli [2642273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa [2587717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab-aahu [2712692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab [2712693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neprilysin Inhibitor [EPC]</name>
  <code>C651828</code>  <id>651828</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitor</to_name>
    <to_code>T35449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191728</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neprilysin Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neprilysin Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with neprilysin inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neprilysin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacubitrilat [1860608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Hypotensive agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protease inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neprilysin Inhibitors [MoA]</name>
  <code>C651827</code>  <id>651827</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors</to_name>
    <to_code>T35450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191727</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacubitril [1656328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacubitrilat [1860608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nerve Growth Factor Activity Alteration [PE]</name>
  <code>C29882</code>  <id>29883</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nerve Growth Factor Activity Alteration</to_name>
    <to_code>T35473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009758</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nerve Growth Factor Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nerve Growth Factor Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nerve Growth Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nervous System Activity Alteration [PE]</name>
  <code>C29884</code>  <id>29885</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nervous System Activity Alteration</to_name>
    <to_code>T35488</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009759</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinosad [299081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nervous System Agent [APC]</name>
  <code>C654129</code>  <id>654129</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nervous System Agent</to_name>
    <to_code>T58531</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193905</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Typical Antipsychotic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminoketone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonergot Dopamine Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Reactivator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopaminergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-type Calcium Channel Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticholinergic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monoamine Oxidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tricyclic Antidepressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mood Stabilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-epileptic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinesterase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Atypical Antipsychotic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergotamine Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-3 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Depressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Benzodiazepine Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot Derivative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine-2 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenothiazine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nervous System Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Stimulant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuraminidase Inhibitor [EPC]</name>
  <code>C634917</code>  <id>634917</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitor (NAI)</to_name>
    <to_code>T35557</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NAI</to_name>
    <to_code>T35558</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitor</to_name>
    <to_code>T35559</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175524</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oseltamivir [260101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with neuraminidase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing neuraminidase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peramivir [619693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanamivir [69722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oseltamivir carboxylate [1546279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuraminidase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuraminidase Inhibitors [MoA]</name>
  <code>C634818</code>  <id>634818</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors</to_name>
    <to_code>T35560</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175436</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir [619693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanamivir [69722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir [260101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir phosphate [259275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir carboxylate [1546279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir anhydrous [1598096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuraminidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</name>
  <code>C654230</code>  <id>654230</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuroactive Steroid GABA A Receptor Positive Modulator</to_name>
    <to_code>T58741</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator</to_name>
    <to_code>T58740</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194006</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zuranolone [2669905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganaxolone [2604689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing gamma-aminobutyric acid receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with gamma-aminobutyric acid receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 1 Antagonists [MoA]</name>
  <code>C31882</code>  <id>31883</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P Receptor Antagonists</to_name>
    <to_code>T35738</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NK 1 Receptor Antagonists</to_name>
    <to_code>T35739</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists</to_name>
    <to_code>T35740</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010262</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosnetupitant chloride hydrochloride [2044416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant dimeglumine [754763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosnetupitant [2044417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant [1731071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 1 Receptor Interactions [MoA]</name>
  <code>C31880</code>  <id>31881</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P Receptor Interactions</to_name>
    <to_code>T35741</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Receptor Interactions</to_name>
    <to_code>T35743</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NK 1 Receptor Interactions</to_name>
    <to_code>T35742</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010261</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurokinin 1 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 3 Receptor Antagonist [EPC]</name>
  <code>C654305</code>  <id>654305</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NK3 Receptor Antagonist</to_name>
    <to_code>T58907</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonist</to_name>
    <to_code>T58906</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194090</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurokinin 3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fezolinetant [2637134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurokinin 3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 3 Receptor Antagonists [MoA]</name>
  <code>C654306</code>  <id>654306</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NK3 Receptor Antagonists</to_name>
    <to_code>T58909</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonists</to_name>
    <to_code>T58908</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194091</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fezolinetant [2637134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurokinin 3 Receptor Interactions [MoA]</name>
  <code>C654307</code>  <id>654307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Interactions</to_name>
    <to_code>T58910</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194092</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurokinin 3 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Activity Alteration [PE]</name>
  <code>C635132</code>  <id>635132</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Activity Alteration</to_name>
    <to_code>T35772</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175726</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Centrally-mediated Muscle Relaxation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Blockade [PE]</name>
  <code>C635137</code>  <id>635137</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade</to_name>
    <to_code>T35773</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175731</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blockade [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blockade [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Blocker [EPC]</name>
  <code>C654170</code>  <id>654170</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blocker</to_name>
    <to_code>T58612</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193962</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>letibotulinumtoxinA [2689280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Neuromuscular blocking agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nondepolarizing Neuromuscular Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abobotulinumtoxinA [860168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing neuromuscular blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>botulinum toxin type A [1712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depolarizing Neuromuscular Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Depolarizing Blockade [PE]</name>
  <code>C635139</code>  <id>635139</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Depolarizing Blockade</to_name>
    <to_code>T35774</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175733</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride dihydrate [2397714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride [3565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine [10154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Depolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neuromuscular Nondepolarizing Blockade [PE]</name>
  <code>C635138</code>  <id>635138</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade</to_name>
    <to_code>T35782</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175732</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium cation [1546399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium besylate [136561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium [319864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium [1218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium [68139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium bromide [11153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium [7883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium bromide [7884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium besylate [1219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium [71535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium bromide [32521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurotensin Activity Alteration [PE]</name>
  <code>C29886</code>  <id>29887</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotensin Activity Alteration</to_name>
    <to_code>T35829</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009760</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotensin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotensin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Neurotensin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</name>
  <code>C29888</code>  <id>29889</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration</to_name>
    <to_code>T35844</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009761</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nerve Growth Factor Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glutamate Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aspartate Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enkephalin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endorphin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dynorphin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gamma Amino Butyric Acid (GABA) Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Brain Derived Neurotropic Factor Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CCK Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotensin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide acetate [486126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethadione [10827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide [68503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacemide [33253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paraldehyde [7909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium [33742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phensuximide [33309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium bromide [66983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter &amp; Neuromuscular Transmitter Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurotransmitter Transporter Interactions [MoA]</name>
  <code>C388</code>  <id>389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions</to_name>
    <to_code>T35848</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000105</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Neurotransmitter Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital sodium [235404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital [477631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrated alcohol [1310469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprobarbital [17381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethadione [10827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital sodium [91109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanol [448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalbital [19860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcohol, x-ray exposed (1000 rad) [1368126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutethimide [4903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Neurotrophic Factor Receptor (RET) Inhibitors [MoA]</name>
  <code>C300427</code>  <id>300427</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotrophic Factor Receptor (RET) Inhibitors</to_name>
    <to_code>T35849</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020037</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy [EPC]</name>
  <code>C654296</code>  <id>654296</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinamide Modified Allogeneic Hematopoietic Progenitor Cell Therapy</to_name>
    <to_code>T58894</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194081</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nicotinic Acid [EPC]</name>
  <code>C634987</code>  <id>634987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinic Acid-containing Agent</to_name>
    <to_code>T35967</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinic Acid</to_name>
    <to_code>T35968</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175594</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nicotinic Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Nicotinic acid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nicotinic Acid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicotinic Acids [M0014839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nicotinic Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing nicotinic acid (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nicotinic Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niacin [7393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitrate Vasodilator [EPC]</name>
  <code>C634797</code>  <id>634797</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrate-class Vasodilator</to_name>
    <to_code>T36086</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrate Vasodilator</to_name>
    <to_code>T36087</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175415</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrate Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosorbide dinitrate [6058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrate Vasodilator [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrates [M0014874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrate Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isosorbide mononitrate [28004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrate Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrate Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitroglycerin [4917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrate Vasodilator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Nitrate-based vasodilating agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Activity Alteration [PE]</name>
  <code>C29890</code>  <id>29891</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Activity Alteration</to_name>
    <to_code>T36096</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009762</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitric Oxide Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitric Oxide Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Donors [MoA]</name>
  <code>C418</code>  <id>419</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors</to_name>
    <to_code>T36097</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000120</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetranitrate [7992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrous oxide [7486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Releasing Agent [EPC]</name>
  <code>C654326</code>  <id>654326</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Releasing Agent</to_name>
    <to_code>T58945</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194124</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitric Oxide Releasing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berdazimer free acid [2710444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitric Oxide Releasing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Nitric Oxide Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitric Oxide Synthase Inhibitors [MoA]</name>
  <code>C524</code>  <id>525</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Synthase Inhibitors</to_name>
    <to_code>T36098</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000173</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitrofuran Antibacterial [EPC]</name>
  <code>C634875</code>  <id>634875</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrofuran Antibacterial</to_name>
    <to_code>T36163</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175494</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrofuran Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrofuran Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrofurantoin [7454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrofuran Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrofurans [M0014892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrofuran Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrofuran Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitrofurantoin, macrocrystals [235559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrofuran Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrofuran Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitrogen Binding Agent [EPC]</name>
  <code>C635226</code>  <id>635226</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrogen Binding Agent</to_name>
    <to_code>T36170</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175807</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrogen Binding Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylacetic acid [33332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrogen Binding Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzoic acid [18989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrogen Binding Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ammonium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitrogen Binding Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-phenylbutyric acid [1546447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitroimidazole Antimicrobial [EPC]</name>
  <code>C634817</code>  <id>634817</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitroimidazole Antimicrobial</to_name>
    <to_code>T36195</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175435</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing nitroimidazole (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Nitroimidazole (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tinidazole [10612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fexinidazole [2564146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metronidazole [6922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitroimidazoles [M0014907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secnidazole [36314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nitroimidazole [EPC]</name>
  <code>C635316</code>  <id>635316</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitroimidazole</to_name>
    <to_code>T36197</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitroimidazole-class Agent</to_name>
    <to_code>T36196</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175878</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Nitroimidazole (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing nitroimidazole (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nitroimidazole [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitroimidazoles [M0014907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nodal Depolarization [PE]</name>
  <code>C29892</code>  <id>29893</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization</to_name>
    <to_code>T36277</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009763</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Depolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nodal Repolarization [PE]</name>
  <code>C29894</code>  <id>29895</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Repolarization</to_name>
    <to_code>T36279</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009764</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nodal Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Nucleoside Analog [EXT]</name>
  <code>C634840</code>  <id>634840</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog</to_name>
    <to_code>T36315</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonnucleoside Analogue</to_name>
    <to_code>T36313</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonnucleoside Analog</to_name>
    <to_code>T36314</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analogue</to_name>
    <to_code>T36312</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175460</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</name>
  <code>C30264</code>  <id>30265</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors</to_name>
    <to_code>T36316</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009948</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Animal Dander Allergenic Extract [EPC]</name>
  <code>C645176</code>  <id>645176</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Dander Allergenic Extract</to_name>
    <to_code>T36320</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185368</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse dander extract [2167548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salivary Proteins and Peptides [M0515971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog dander extract [2167551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- GUINEA PIG DANDER CAVIA SP [350160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guinea pig dander [2166593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dander [M0576325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic cow dander extract [2166591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Animal material diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Dander Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Animal Hair Allergenic Extract [EPC]</name>
  <code>C645171</code>  <id>645171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Hair Allergenic Extract</to_name>
    <to_code>T36321</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185363</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rattus norvegicus hair preparation [2471704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic goat hair extract [895503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guinea pig hair extract [895507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canis lupus familiaris hair extract [854025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- GERBIL HAIR GERBILLUS SPP [349980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hog hair extract [895542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European rabbit hair extract [895527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Animal Fur [M0370530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syrian hamster hair extract [1594965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic cow hair extract [895488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Camelus bactrianus hair extract [2590604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT, CAMEL [314336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house mouse hair extract [1993210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse hair extract [895515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Animal material diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Hair Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Animal Skin Allergenic Extract [EPC]</name>
  <code>C645172</code>  <id>645172</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Skin Allergenic Extract</to_name>
    <to_code>T36322</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185364</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic cow skin extract [852256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syrian hamster skin extract [852663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European rabbit skin extract [895195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horse skin extract [852479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rat skin extract [895279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog skin extract [894987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>guinea pig skin extract [852298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mongolian gerbil skin allergenic extract [895070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house mouse skin extract [852693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hog skin extract [852839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>domestic goat skin extract [852252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Animal material diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Animal Skin Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Bacterial Allergenic Extract [EPC]</name>
  <code>C645178</code>  <id>645178</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Bacterial Allergenic Extract</to_name>
    <to_code>T36323</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185369</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptomyces griseus allergenic extract [1314592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Bacterial Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Proteins [M0002130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Bacterial Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Chemical Allergen [EPC]</name>
  <code>C645179</code>  <id>645179</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Chemical Allergen</to_name>
    <to_code>T36324</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185370</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glycerin [4910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Chemical Allergen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Feather Allergenic Extract [EPC]</name>
  <code>C645185</code>  <id>645185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Feather Allergenic Extract</to_name>
    <to_code>T36325</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185373</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pheasant feather extract [1594964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goose feather extract [894783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turkey feather extract [1594963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken feather extract [894934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canary feather extract [894961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parakeet feather allergenic extract [1192987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feathers [M0008280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Feather Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duck feather extract [892851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Animal material diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Feather Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Food Allergenic Extract [EPC]</name>
  <code>C645180</code>  <id>645180</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Food Allergenic Extract</to_name>
    <to_code>T36326</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185371</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyme preparation [319823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kidney bean allergenic extract [891637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pisum sativum (pea) extract [1426912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black pepper allergenic extract [899363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oregano allergenic extract [1010965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onion allergenic extract [899466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangerine extract [1426364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>okra allergenic extract [1011021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chicken allergenic extract [892653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>banana allergenic extract [891830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hazelnut allergenic extract [891633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil seed extract [1426921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra root powder extract [2711885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>okra extract [1370787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork allergenic extract [892628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley extract [1370766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot extract [1353891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue crab preparation [1315126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turkey allergenic extract [975119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>whole wheat allergenic extract [901299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango extract [1426332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turnip allergenic extract [883414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic halibut preparation [1424920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pineapple extract [1492174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pecan pollen extract [852272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>veal allergenic extract [1012026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carrot allergenic extract [892368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radish allergenic extract [974687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pistachio nut allergenic extract [904606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger allergenic extract [899420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhubarb preparation [91266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potato allergenic extract [892632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sour cherry allergenic extract [1012134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat preparation [1441652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>squash allergenic extract [975509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove allergenic extract [899724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buckwheat allergenic extract [899394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat allergenic extract [971932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg yolk (chicken) allergenic extract [892620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American lobster allergenic extract [1997187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>string bean allergenic extract [891676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sea scallop preparation [1426396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red bell pepper allergenic extract [901329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oyster allergenic extract [973274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brussels sprout extract [2099275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon preparation [285245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>largemouth bass allergenic extract [1098183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern quahog preparation [1925437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chocolate allergenic extract [1010915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime (citrus) extract [1305725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>casein allergenic extract [862460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lettuce allergenic extract [899448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red pepper extract [1313692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colloidal oatmeal [221082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flounder allergenic extract [899746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bean extract [1370773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eggplant extract [1315116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brazil nut allergenic extract [891514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onion extract [1370469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trout allergenic extract [882482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry preparation [125933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharomyces cerevisiae [9511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flaxseed extract [318224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pacific halibut allergenic extract [882469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almond allergenic extract [892507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green olive allergenic extract [971379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya extract [1992412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit allergenic extract [899424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower seed extract [1440241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanilla bean extract [2275721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velvetleaf huckleberry allergenic extract [2102487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium glaucum allergenic extract [1986792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crab allergenic extract [892610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit extract [124323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyme allergenic extract [974527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duck allergenic extract [972037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oats preparation [285251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut extract [1372248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avocado allergenic extract [895582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef liver preparation [1330085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pear preparation [1367125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hops extract [259266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard seed allergenic extract [899456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg white (chicken) allergenic extract [892616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg extract [1353217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>licorice root extract [235524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spinach allergenic extract [901317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cucumis sativus fruit extract [2700058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lima bean allergenic extract [891641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida albicans allergenic extract [214355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg extract [1315115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cola acuminata seed extract [1307595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>swordfish allergenic extract [901283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English walnut allergenic extract [891687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tomato allergenic extract [892499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cod, unspecified preparation [1426437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brussels sprout allergenic extract [899390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red snapper allergenic extract [889646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leek allergenic extract [1010932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broccoli allergenic extract [899386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon preparation [1421430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oyster, unspecified preparation [1315121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carob allergenic extract [904498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellowfin tuna allergenic extract [2102488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strawberry allergenic extract [892484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watermelon preparation [260014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radish extract [1314656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>banana extract [285149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley malt syrup [1306883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apricot allergenic extract [895574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black walnut allergenic extract [891695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsnip allergenic extract [1011027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cumin allergenic extract [901365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caraway seed allergenic extract [899637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoa extract [1373895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocoa bean allergenic extract [891721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage leaf allergenic extract [1011627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dill allergenic extract [975763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corylus americana nut oil [1603849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black-eyed pea allergenic extract [899490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugar beet allergenic extract [899359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove preparation [1364295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger extract [285241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra extract [1370435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codfish allergenic extract [892543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peanut allergenic extract [891658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard greens allergenic extract [899452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>northern pike allergenic extract [889602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sardine allergenic extract [974129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower seed extract [1309391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn allergenic extract [892547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg allergenic extract [891652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black pepper preparation [259314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>herring allergenic extract [899434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Concord grape allergenic extract [901191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quince extract [1370761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jerusalem artichoke extract [1648701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>date allergenic extract [899742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poppy seed allergenic extract [1011017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Whey Proteins [1723989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scallop allergenic extract [899916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame seed extract [1310046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brown rice preparation [1311040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bluefish allergenic extract [892181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>egg (chicken) allergenic extract [904507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shrimp allergenic extract [892592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avocado oil [1311611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red currant allergenic extract [972480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint flowering top extract [2168421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perch allergenic extract [976711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley malt allergenic extract [1006510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Food Additives [M0008672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon extract [1364291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame seed allergenic extract [901199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black sea bass allergenic extract [2102474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic halibut allergenic extract [2261370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bay leaf extract [1606480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zucchini extract [1649134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dietary Proteins [M0006342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cow milk allergenic extract [892665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lobster allergenic extract [892561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spearmint allergenic extract [901313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English sole allergenic extract [974140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white catfish allergenic extract [971166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple allergenic extract [891771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean allergenic extract [891668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage extract [1354504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic mackerel allergenic extract [2198984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tuna allergenic extract [892503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn grain extract [1423924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley allergenic extract [862453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paprika allergenic extract [899873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>karaya gum extract [852617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coffea arabica seed extract [2695791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic cod allergenic extract [900025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grapefruit peel extract [1358897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anise seed extract [1309292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coffee bean allergenic extract [891727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basil allergenic extract [899355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grape extract [253172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black olive allergenic extract [974650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peach allergenic extract [892575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watercress allergenic extract [1011418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated mushroom allergenic extract [901369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green bell pepper extract [1315118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lamb allergenic extract [971849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venison allergenic extract [882488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn extract [1323308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsley allergenic extract [899877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garlic allergenic extract [899414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watermelon allergenic extract [901258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>honeydew melon allergenic extract [899476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eggplant allergenic extract [972601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat gluten extract [1370781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry allergenic extract [899734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tragacanth [1368197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raspberry extract [1370769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>garlic preparation [265647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chickpea allergenic extract [1011049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber allergenic extract [899738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit allergenic extract [813859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clam allergenic extract [892539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynara preparation [235940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef allergenic extract [892599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape extract [1307718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis fruit extract [1310189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horseradish allergenic extract [1011043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beef liver allergenic extract [972689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plum allergenic extract [899470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pumpkin allergenic extract [883459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet potato allergenic extract [901307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spearmint extract [1372258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cashew nut allergenic extract [892526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocean perch preparation [2471431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white fish allergenic extract [901265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon allergenic extract [892584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange pekoe tea allergenic extract [966696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanilla bean allergenic extract [901291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apple extract [1424865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape allergenic extract [892317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dill extract [2108821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mung bean allergenic extract [891647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger root [125921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>goat milk allergenic extract [862475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celery allergenic extract [892372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haddock allergenic extract [899428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower seed allergenic extract [901203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cabbage allergenic extract [899398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mango allergenic extract [1011404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fig allergenic extract [973880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cantaloupe allergenic extract [892517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green bell pepper allergenic extract [862478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coconut allergenic extract [891611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allspice allergenic extract [895552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Allium cepa bulb extract [2695867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangerine allergenic extract [1011412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharomyces cerevisiae allergenic extract [350141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya allergenic extract [1011426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raspberry allergenic extract [899906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsicum extract [319780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cauliflower allergenic extract [899661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil allergenic extract [899444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American chestnut allergenic extract [891752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamon allergenic extract [899673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemon allergenic extract [901382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean preparation [287515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rye allergenic extract [892638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lime allergenic extract [1011060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange allergenic extract [892565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cucumber extract [1305719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint preparation [33093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asparagus allergenic extract [891796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Atlantic salmon allergenic extract [900031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Food Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common carp allergenic extract [901390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Food specific diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Food Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Fungal Allergenic Extract [EPC]</name>
  <code>C645184</code>  <id>645184</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Fungal Allergenic Extract</to_name>
    <to_code>T36327</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185372</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Microascus brevicaulis allergenic extract [1192992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoma exigua var. exigua allergenic extract [867284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>algal fungi allergenic extract [966692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleospora tarda allergenic extract [852404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eurotium herbariorum allergenic extract [999450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loose barley smut allergenic extract [968492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acremonium strictum allergenic extract [905070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosporium herbarum allergenic extract [466198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- CURVULARIA INAEQUALIS [350125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Helminthosporium solani allergenic extract [867232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus amstelodami extract [2101007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat smut allergenic extract [852797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epidermophyton floccosum allergenic extract [995707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chrysonilia sitophila allergenic extract [314411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium roquefortii allergenic extract [972365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Neurospora sitophila allergenic extract [1098200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>microsporum canis allergenic extract [1014399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verticillium albo-atrum allergenic extract [968467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lichtheimia corymbifera allergenic extract [995727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharomyces cerevisiae allergenic extract [350141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Geotrichum candidum allergenic extract [999463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemphylium solani allergenic extract [867349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton rubrum allergenic extract [968413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Puccinia striiformis allergenic extract [852311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Clonostachys rosea f. rosea allergenic extract [1426481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phanerodontia chrysosporium allergenic extract [968114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida albicans allergenic extract [214355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bermuda grass smut allergenic extract [1014385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus flavus var. oryzae protease [1307040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syncephalastrum racemosum allergenic extract [968506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichoderma harzianum allergenic extract [968197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stachybotrys chartarum allergenic extract [968123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cochliobolus sativus allergenic extract [852398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT, FUSARIUM ROSEUM [317581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- BROME GRASS, CHEAT USTILAGO BULLATA [350060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn smut allergenic extract [314488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fungal Proteins [M0008890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor circinelloides f. circinelloides allergenic extract [2101422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gibberella fujikuroi extract [2043450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus terreus allergenic extract [314324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus nidulans allergenic extract [1368357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Khuskia oryzae allergenic extract [892338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cladosporium sphaerospermum allergenic extract [867202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodotorula mucilaginosa allergenic extract [967529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoma destructiva allergenic extract [966995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Puccinia graminis allergenic extract [999487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus repens allergenic extract [1006310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gibberella zeae allergenic extract [1922751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium glaucum allergenic extract [1986792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium oxysporum allergenic extract [2101722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gliocladium allergenic extract [1192997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton schoenleinii allergenic extract [968422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton tonsurans allergenic extract [1098619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodotorula rubra allergenic extract [867321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharomyces cerevisiae [9511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cochliobolus spicifer allergenic extract [995699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhizopus arrhizus allergenic extract [314443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cladosporium cladosporioides extract [867198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium expansum allergenic extract [967111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleospora betae allergenic extract [852756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida albicans [1963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Humicola grisea allergenic extract [1014391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Johnson grass smut allergenic extract [852128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium digitatum allergenic extract [1427044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Hypomyces perniciosus allergenic extract [1192968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gliocladium viride extract [2101008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alternaria alternata allergenic extract [901845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Epicoccum nigrum allergenic extract [852466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acrothecium robustum allergenic extract [905088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apiospora montagnei allergenic extract [1006258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus flavus allergenic extract [999384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loose wheat smut allergenic extract [968437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Microsporum audouinii allergenic extract [1014395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhizopus stolonifer allergenic extract [967721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chaetomium globosum allergenic extract [466197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium chrysogenum var. chrysogenum allergenic extract [854130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Colletotrichum coccodes allergenic extract [1192729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton mentagrophytes allergenic extract [867357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemphylium sarciniforme allergenic extract [968130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor plumbeus allergenic extract [314415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Curvularia inequalis allergenic extract [999438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dendryphiella vinosa allergenic extract [995703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat smut allergenic extract [349978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Candida tropicalis allergenic extract [967033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cephalosporium roseum extract [1925834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>neurospora intermedia allergenic extract [867274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor circinelloides f. lusitanicus allergenic extract [2101473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ustilago maydis extract [1427134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleospora herbarum allergenic extract [971198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus fumigatus allergenic extract [466192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mucor racemosus allergenic extract [852687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Aspergillus niger var. niger extract [854082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passalora fulva allergenic extract [883442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichoderma viride allergenic extract [968401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tetracoccosporium paxianum allergenic extract [968502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fusarium compactum allergenic extract [999457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Haematonectria haematococca allergenic extract [852503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichothecium roseum allergenic extract [968426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paecilomyces variotii allergenic extract [966979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cochliobolus lunatus allergenic extract [852264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium italicum allergenic extract [967960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium camemberti allergenic extract [966943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Fungal Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Botrytis cinerea allergenic extract [466195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Fungal Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized House Dust Allergenic Extract [EPC]</name>
  <code>C645187</code>  <id>645187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized House Dust Allergenic Extract</to_name>
    <to_code>T36328</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185374</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>House Dust [M0006896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized House Dust Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house dust allergenic extract [852519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>House dust specific diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized House Dust Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Insect Allergenic Extract [EPC]</name>
  <code>C645173</code>  <id>645173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Insect Allergenic Extract</to_name>
    <to_code>T36329</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185365</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>German cockroach allergenic extract [905276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dog flea allergenic extract [886637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American cockroach allergenic extract [905258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk allergenic extract [314455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house fly allergenic extract [350173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Blatta orientalis preparation [1346617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cricket allergenic extract [973447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat flea allergenic extract [886638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Proteins [M0028968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mosquito allergenic extract [974741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tabanus nigrovittatus extract [2590185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Periplaneta australasiae extract [2590183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Insect specific diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Insect Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Insect Venom Allergenic Extract [EPC]</name>
  <code>C645174</code>  <id>645174</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Insect Venom Allergenic Extract</to_name>
    <to_code>T36330</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185366</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black imported fire ant allergenic extract [995738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red imported fire ant allergenic extract [867341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black carpenter ant allergenic extract [2057909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Proteins [M0028968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthropod Venoms [M0001758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Insect venom specific diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Insect Venom Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Plant Allergenic Extract [EPC]</name>
  <code>C645188</code>  <id>645188</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Plant Allergenic Extract</to_name>
    <to_code>T36331</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185375</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>okra allergenic extract [1011021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cotton seed extract [1309369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jerusalem artichoke extract [1648701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velvetleaf huckleberry allergenic extract [2102487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>date allergenic extract [899742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poppy seed allergenic extract [1011017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green olive allergenic extract [971379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lawsonia inermis leaf extract [1307699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower seed extract [1440241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos nux-vomica seed extract [1309678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>horseradish allergenic extract [1011043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Concord grape allergenic extract [901191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kidney bean allergenic extract [891637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange pekoe tea allergenic extract [966696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape allergenic extract [892317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hops extract [259266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard seed allergenic extract [899456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>okra extract [1370787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra root powder extract [2711885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil seed extract [1426921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plant Proteins [M0016962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Alnus glutinosa bark extract [1441543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tobacco leaf allergenic extract [852062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger root [125921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cola acuminata seed extract [1307595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Iris germanica var. florentina root extract [1993233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonseed extract [853406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mung bean allergenic extract [891647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red currant allergenic extract [972480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>licorice root extract [235524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint flowering top extract [2168421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg extract [1353217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley malt allergenic extract [1006510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage extract [1354504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allspice allergenic extract [895552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>leek allergenic extract [1010932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carob allergenic extract [904498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brussels sprout allergenic extract [899390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fig allergenic extract [973880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bay leaf extract [1606480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turnip allergenic extract [883414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barley malt syrup [1306883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove allergenic extract [899724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cytisus scoparius flowering top extract [2168418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhubarb preparation [91266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anise seed extract [1309292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>basil allergenic extract [899355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sour cherry allergenic extract [1012134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coffea arabica seed extract [2695791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger allergenic extract [899420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn grain extract [1423924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lentil allergenic extract [899444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>caraway seed allergenic extract [899637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cumin allergenic extract [901365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eggplant allergenic extract [972601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American chestnut allergenic extract [891752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry allergenic extract [899734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cauliflower allergenic extract [899661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Capsicum extract [319780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watercress allergenic extract [1011418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chickpea allergenic extract [1011049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clove preparation [1364295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugar beet allergenic extract [899359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dill allergenic extract [975763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage leaf allergenic extract [1011627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyrethrum cinerariifolium allergenic extract [967970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tragacanth [1368197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Corylus americana nut oil [1603849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cranberry preparation [125933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nutmeg allergenic extract [891652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape extract [1307718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Juniperus communis fruit extract [1310189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flaxseed extract [318224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint preparation [33093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eggplant extract [1315116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cynara preparation [235940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colloidal oatmeal [221082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orris root allergenic extract [1098353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard greens allergenic extract [899452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ginger extract [285241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Glycyrrhiza glabra extract [1370435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cottonseed allergenic extract [852440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Plant Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</name>
  <code>C645189</code>  <id>645189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Plant Fiber Allergenic Extract</to_name>
    <to_code>T36332</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185376</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cotton fiber allergenic extract [966925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sisal fiber allergenic extract [851882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plant Proteins [M0016962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>kapok tree fiber allergenic extract [852315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jute fiber allergenic extract [852412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Plant Fiber Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-Standardized Pollen Allergenic Extract [EPC]</name>
  <code>C645175</code>  <id>645175</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Pollen Allergenic Extract</to_name>
    <to_code>T36333</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185367</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitternut hickory pollen extract [899645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golden chain pollen extract [1996102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redroot pigweed pollen extract [851930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siberian elm pollen extract [1299981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus marilandica pollen extract [1437222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Malus domestica pollen extract [2593689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated barley pollen extract [1098118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue beech pollen extract [899611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver ragweed pollen extract [852306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western wheatgrass pollen extract [852659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red cedar pollen extract [852609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus glabra pollen extract [2369372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grama grass pollen extract [852197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common cocklebur pollen extract [902215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>jack pine pollen extract [1014690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hazelnut pollen extract [852281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coast maple pollen extract [851736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water oak pollen extract [1013944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oneseed juniper pollen extract [900108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfalfa pollen extract [852634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colonial bent grass pollen extract [1484937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common hazel pollen extract [1484979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower pollen extract [852509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gray birch pollen extract [852178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated rye grass pollen extract [1014774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern sycamore pollen extract [852746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cultivated oat pollen extract [852114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cocklebur pollen extract [852025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver maple pollen extract [851866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white alder pollen extract [851910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Douglas fir pollen extract [1098257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>post oak pollen extract [901011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arizona ash pollen extract [852496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spiny pigweed pollen extract [895919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>creeping bentgrass pollen extract [1094116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red oak pollen extract [852268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>box elder maple pollen extract [851740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Grindelia ciliata pollen extract [2043451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sandbur ragweed pollen extract [851955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>smooth brome pollen extract [852217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redwood pollen extract [1014707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dandelion pollen extract [852079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white poplar pollen extract [852382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern bayberry pollen extract [867260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syringa vulgaris pollen extract [2634236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pussy willow pollen extract [852174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shortleaf pine pollen extract [852709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crested dogstail pollen extract [1484980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plains cottonwood pollen extract [867297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Gambels oak pollen extract [852276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broomweed pollen extract [1094193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pollen [M0017130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>date palm pollen extract [852704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poverty weed pollen extract [852539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>giant ragweed pollen extract [851998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water birch pollen extract [852166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>para grass pollen extract [894750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mugwort sage pollen extract [852029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pin oak pollen extract [900999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American basswood pollen extract [995754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oregon ash pollen extract [900045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow dock pollen extract [852209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>giant wild rye pollen extract [900148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canada goldenrod pollen extract [995743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paper birch pollen extract [899576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia dealbata pollen extract [2202946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black walnut pollen extract [852569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>balsam poplar pollen extract [1014762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet wormwood pollen extract [2167819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>narrowleaf marshelder pollen extract [1098130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sydney golden wattle pollen extract [895365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bald cypress pollen extract [995747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>London planetree [2166616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redtop grass pollen extract [851870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nettle pollen extract [852046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black willow pollen extract [852162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beech pollen extract [852419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Canadian bluegrass pollen extract [1014731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>littleseed canary grass pollen extract [1098232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sorghum bicolor pollen extract [1311406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palo verde pollen extract [852359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pale dock pollen extract [1232604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European beech pollen extract [1484981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cheat grass pollen extract [852225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix lutea pollen extract [2590686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pignut hickory pollen extract [899650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white hickory pollen extract [852193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow sweet clover pollen extract [1014447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>groundsel pollen extract [897332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>slash pine pollen extract [900731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western ragweed pollen extract [851985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American elm pollen extract [852054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mesquite pollen extract [852320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loblolly pine pollen extract [900770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white mulberry pollen extract [852669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mountain cedar pollen extract [852581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Amaranthus hybridus pollen extract [1363561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinus terebinthifolius pollen extract [2590688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California mugwort pollen extract [892734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tag alder pollen extract [851902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern cottonwood pollen extract [852363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wormwood sage pollen extract [852007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scrub pine pollen extract [1013913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>careless weed pollen extract [851926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspen pollen extract [852339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>privet pollen extract [852622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white ash pollen extract [852450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wing scale pollen extract [852074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadow foxtail pollen extract [1484974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bitter dock pollen extract [1014739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redberry juniper pollen extract [900113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western sycamore pollen extract [852750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tree of heaven pollen extract [851890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Chinese elm pollen extract [852844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cedar elm pollen extract [1014191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red mulberry pollen extract [852680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>river birch pollen extract [852148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acer pseudoplatanus pollen extract [1801702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>corn pollen extract [852015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Fremont cottonwood pollen extract [852355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tall oat grass pollen extract [1006506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>european olive pollen extract [852653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- POPLAR POPULUS DELTOIDES [350004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California black walnut pollen extract [852561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>blue spruce pollen extract [900704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California juniper pollen extract [852585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow birch pollen extract [899550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mulberry pollen extract [899593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red maple pollen extract [851744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canyon ragweed pollen extract [851942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Russian olive pollen extract [852367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western larch pollen extract [2166614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Koelers grass pollen extract [852605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Australian pine pollen extract [852229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shad scale pollen extract [852087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mustard pollen extract [852205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow pine pollen extract [852716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prairie sagebrush pollen extract [867142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peruvian pepper tree pollen extract [2632070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velvet grass pollen extract [852514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English walnut pollen extract [852577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit bush pollen extract [851969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense pollen extract [2102052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white willow pollen extract [1484986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red pine pollen extract [900754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western white pine pollen extract [900743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Japanese black pine pollen extract [900777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia longifolia pollen extract [853983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodine bush pollen extract [851894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>winterfat pollen extract [852613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Brazilian pepper tree pollen extract [2632068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>green ash pollen extract [852491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Carya laciniosa pollen extract [1305551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Russian thistle pollen extract [852158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broad leaved paperbark pollen extract [903913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Utah juniper pollen extract [852597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chinquapin oak pollen extract [2167695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rough marshelder pollen extract [852532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broadleaf plantain pollen extract [1484983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Callistemon citrinus pollen extract [2171260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycladus orientalis pollen extract [1360623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white sweet clover pollen extract [1014735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>queen palm pollen extract [867353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linden pollen extract [852070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>weakleaf bur ragweed pollen extract [1117083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California black oak pollen extract [1014721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osage orange pollen extract [1098189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coast sage pollen extract [852011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago virgaurea pollen extract [1309242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus cembroides pollen extract [2590679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pecan pollen extract [852272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hackberry pollen extract [852324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Johnson grass pollen extract [852136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus rubra pollen allergenic extract [1426632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitch pine pollen extract [900758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rocky Mountain juniper pollen extract [852601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Lombardy poplar pollen extract [852348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver birch pollen allergenic extract [1306108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense pollen extract [1340182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Acacia pollen extract [851732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burweed marshelder pollen extract [852551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Humulus lupulus pollen extract [1740937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black locust pollen extract [867325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common sagebrush pollen extract [852020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canary grass pollen extract [852697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Indian wormwood sage pollen extract [1006495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dark leaved mugwort pollen extract [896246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lens scale pollen extract [852096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix repens pollen extract [2533912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>longleaf pine pollen extract [1014360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white oak pollen extract [852294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cherry birch pollen extract [852144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern ragweed pollen extract [885750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bulbous buttercup pollen extract [1484985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white (mexican) dock pollen extract [1014743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>slender ragweed pollen extract [851990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red alder pollen extract [851914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scotch pine pollen extract [900764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet gum pollen extract [852627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western waterhemp pollen extract [851934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sheep sorrel pollen extract [852213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Austrian pine pollen extract [900750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- RYEGRASS, WESTERN ELYMUS GLAUCUS [350075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>California scrub oak pollen extract [852802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Arizona cypress pollen extract [852814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ALLERGENIC EXTRACT- CEDAR, INCENSE LIBOCEDRUS DECURRENS [350081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English plantain pollen extract [852742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>annual bluegrass pollen extract [898404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allscale pollen extract [897304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salt grass pollen extract [852329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bur oak pollen extract [900991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ash pollen extract [1484982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera pollen extract [2669695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Calocedrus decurrens pollen extract [2670160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alkali blite pollen extract [852106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burning bush pollen extract [852593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saltbush pollen extract [897316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fivehorn smotherweed pollen extract [852124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sudan grass pollen extract [1098455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium repens pollen extract [1363563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>live oak pollen extract [867311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black cottonwood pollen extract [852376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>black oak pollen extract [852260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shagbark hickory pollen extract [852221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hard maple pollen extract [851874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European aspen pollen extract [2166596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Leucanthemum vulgare pollen [2102006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quackgrass pollen extract [852343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>grain sorghum pollen extract [1098438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>broadleaf cattail pollen extract [1232637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>false ragweed pollen extract [851938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lambs quarters pollen extract [852237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Cootamundra wattle pollen extract [895353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern white pine pollen extract [852738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salsola tragus pollen extract [1314927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desert ragweed pollen extract [851981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western black willow pollen extract [1014755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugar beet pollen extract [852132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Garrys oak pollen extract [900987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Mexican tea pollen extract [897391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>burrobrush pollen extract [852526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Eucalyptus globulus pollen extract [852386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pepper tree pollen extract [852140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange pollen extract [897403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Italian rye grass pollen extract [1014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arroyo willow pollen extract [852170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salt cedar pollen extract [852806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valley oak pollen extract [1111024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lodgepole pine pollen extract [898324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Jerusalem oak pollen extract [1014766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat pollen extract [867361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>English oak pollen extract [1484984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>greasewood pollen extract [852152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western juniper pollen extract [852589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dogfennel pollen extract [867218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bahia grass pollen extract [852673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>coast live oak pollen extract [852302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Standardized Pollen Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Non-narcotic Antitussive [EPC]</name>
  <code>C635215</code>  <id>635215</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonnarcotic Antitussive</to_name>
    <to_code>T36338</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-narcotic Antitussive</to_name>
    <to_code>T36339</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175796</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-narcotic Antitussive [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-narcotic Antitussive [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzonatate [18993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-narcotic Antitussive [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Non-narcotic Antitussive [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antitussive agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-narcotic Antitussive [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</name>
  <code>C645956</code>  <id>645956</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive AMPA Receptor Antagonist</to_name>
    <to_code>T36345</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-competitive AMPA Glutamate Receptor Antagonist</to_name>
    <to_code>T36346</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive AMPA Glutamate Receptor Antagonist</to_name>
    <to_code>T36348</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-competitive AMPA Receptor Antagonist</to_name>
    <to_code>T36347</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000186106</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>AMPA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perampanel [1356552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing glutamate receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive Cholinergic Nicotinic Antagonists [MoA]</name>
  <code>C635110</code>  <id>635110</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive Cholinergic Nicotinic Antagonists</to_name>
    <to_code>T36350</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-competitive Cholinergic Nicotinic Antagonists</to_name>
    <to_code>T36349</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175704</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive NMDA Receptor Antagonists [MoA]</name>
  <code>C641384</code>  <id>641384</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive N-methyl-D-aspartate Receptor Antagonists</to_name>
    <to_code>T36351</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive NMDA Receptor Antagonists</to_name>
    <to_code>T36352</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181818</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine hydrochloride [2119366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine [2119365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Noncompetitive Opioid Antagonists [MoA]</name>
  <code>C635093</code>  <id>635093</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive Opioid Antagonists</to_name>
    <to_code>T36354</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-competitive Opioid Antagonists</to_name>
    <to_code>T36353</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175687</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nondepolarizing Neuromuscular Blocker [EPC]</name>
  <code>C635126</code>  <id>635126</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nondepolarizing Neuromuscular Blocker</to_name>
    <to_code>T36355</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175720</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vecuronium [71535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Nondepolarizing agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Nondepolarizing Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing nondepolarizing neuromuscular blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rocuronium [68139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Neuromuscular Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atracurium [1218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Cholinergic Nicotinic Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisatracurium [319864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nondepolarizing Neuromuscular Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vecuronium cation [1546399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nonergot Dopamine Agonist [EPC]</name>
  <code>C635187</code>  <id>635187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonergot Dopamine Agonist</to_name>
    <to_code>T36360</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175768</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonergot Dopamine Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropinirole [72302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonergot Dopamine Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramipexole [746741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonergot Dopamine Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonergot Dopamine Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rotigotine [616739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing dopamine receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonergot Dopamine Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with dopamine receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonergot Dopamine Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Anti-inflammatory Drug [EPC]</name>
  <code>C635128</code>  <id>635128</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NSAID</to_name>
    <to_code>T36395</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Antiinflammatory Drug</to_name>
    <to_code>T36388</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-steroidal Antiinflammatory Drug</to_name>
    <to_code>T36393</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-steroidal Anti-inflammatory Drug</to_name>
    <to_code>T36390</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Antiinflammatory Agent</to_name>
    <to_code>T36389</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Anti-inflammatory Agent</to_name>
    <to_code>T36394</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-steroidal Antiinflammatory Agent</to_name>
    <to_code>T36391</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-steroidal Anti-inflammatory Agent</to_name>
    <to_code>T36392</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Anti-inflammatory Drug</to_name>
    <to_code>T36396</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175722</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anti-Inflammatory Agents, Non-Steroidal [M0001335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nepafenac [298665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenoprofen [4331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketorolac [35827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piroxicam [8356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaprozin [32613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etodolac [24605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolmetin [10636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibuprofen [5640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mefenamic acid [6693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nabumetone [31448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bromfenac [19737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Non-steroidal anti-inflammatory agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diflunisal [3393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>celecoxib [140587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostaglandin Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meloxicam [41493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspirin [1191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ketoprofen [6142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naproxen [7258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indomethacin [5781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurbiprofen [4502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulindac [10237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Anti-inflammatory Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diclofenac [3355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Anti-inflammatory Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</name>
  <code>C654191</code>  <id>654191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist</to_name>
    <to_code>T58650</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193970</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>finerenone [2562811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hormone receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Activity Alteration [PE]</name>
  <code>C29896</code>  <id>29897</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration</to_name>
    <to_code>T36429</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009765</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Releasing Agent [EPC]</name>
  <code>C652791</code>  <id>652791</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Releasing Agent</to_name>
    <to_code>T36445</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192563</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Releasing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine [3966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Releasing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Norepinephrine Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with adrenergic receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Releasing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing adrenergic receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Releasing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Reuptake Inhibitor Anorectic [EPC]</name>
  <code>C635385</code>  <id>635385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Reuptake Inhibitor Anorectic</to_name>
    <to_code>T36446</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175947</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with norepinephrine reuptake inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing norepinephrine reuptake inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Reuptake Inhibitor [EPC]</name>
  <code>C635101</code>  <id>635101</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Norepinephrine Reuptake Inhibitor</to_name>
    <to_code>T36447</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SNRI</to_name>
    <to_code>T36448</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Reuptake Inhibitor</to_name>
    <to_code>T36449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175695</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viloxazine [11196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with norepinephrine reuptake inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing norepinephrine reuptake inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atomoxetine [38400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Transporter Interactions [MoA]</name>
  <code>C646</code>  <id>647</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions</to_name>
    <to_code>T36450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000234</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Norepinephrine Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine Uptake Inhibitors [MoA]</name>
  <code>C382</code>  <id>383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors</to_name>
    <to_code>T36451</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000102</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil mesylate [1992863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine hydrochloride [353103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride monohydrate [221160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin hydrochloride [236807]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate [2607741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin [3332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine hydrochloride [142143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate monohydrate [2605948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine [38400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine mesylate [236189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic [EPC]</name>
  <code>C634806</code>  <id>634806</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic</to_name>
    <to_code>T36457</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175424</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with cellular transport inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nuclear Export Inhibitor [EPC]</name>
  <code>C654242</code>  <id>654242</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitor</to_name>
    <to_code>T58757</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194021</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nuclear Export Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selinexor [2178390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nuclear Export Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nuclear Export Inhibitors [MoA]</name>
  <code>C654241</code>  <id>654241</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitors</to_name>
    <to_code>T58756</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194022</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nuclear Export Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Related Agent [APC]</name>
  <code>C654122</code>  <id>654122</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Related Agent</to_name>
    <to_code>T58524</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193906</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-based Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitor [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antisense Oligonucleotide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histone Deacetylase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Related Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Interfering RNA [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Replication Alteration [PE]</name>
  <code>C29898</code>  <id>29899</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration</to_name>
    <to_code>T36647</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009766</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molnupiravir [2587901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Synthesis Inhibitor [APC]</name>
  <code>C654120</code>  <id>654120</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitor</to_name>
    <to_code>T58523</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193907</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folate Analog Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimetabolite [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Polymerase Inhibitor [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Synthesis Inhibitors [MoA]</name>
  <code>C644</code>  <id>645</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors</to_name>
    <to_code>T36648</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000233</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Folic Acid Metabolism Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ribonucleotide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Terminase Complex Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidaxomicin [1111103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol [4110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetyldithranol [38536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine [11194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eteplirsen [1810569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine anhydrous [2108659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran sodium [2605574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran [2604578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leflunomide [27169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate [265323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemether [18343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol hydrochloride [142435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleic Acid Transcription Alteration [PE]</name>
  <code>C29900</code>  <id>29901</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Transcription Alteration</to_name>
    <to_code>T36649</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009767</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Transcription Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reverse Transcription to DNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleic Acid Transcription Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription to RNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Antifungal [EPC]</name>
  <code>C634847</code>  <id>634847</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue Antifungal</to_name>
    <to_code>T36662</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Antifungal</to_name>
    <to_code>T36661</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antifungal</to_name>
    <to_code>T36663</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175467</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flucytosine [4451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Nucleoside analog (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing nucleoside analog (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog Antiviral [EPC]</name>
  <code>C634846</code>  <id>634846</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue Antiviral</to_name>
    <to_code>T36664</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antiviral</to_name>
    <to_code>T36665</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175466</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribavirin [9344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiviral Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluridine [10803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ganciclovir [4678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>idoxuridine [5653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog Antiviral [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing nucleoside analog (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antiviral [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Nucleoside analog (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antiviral [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog Antiviral [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog [EPC]</name>
  <code>C634845</code>  <id>634845</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue</to_name>
    <to_code>T36668</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog</to_name>
    <to_code>T36669</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175465</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Nucleoside analog (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing nucleoside analog (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Analog [EXT]</name>
  <code>C634839</code>  <id>634839</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog</to_name>
    <to_code>T36667</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analogue</to_name>
    <to_code>T36666</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175459</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Nucleosides [M0015066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zidovudine [11413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emtricitabine [276237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir hydrochloride [236081]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir anhydrous [1546027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir [306266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofosbuvir [1484911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir [73645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Metabolic Inhibitor [EPC]</name>
  <code>C634988</code>  <id>634988</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Metabolic Inhibitor</to_name>
    <to_code>T36675</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175595</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cytarabine [3041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>decitabine [15657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fludarabine [24698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clofarabine [44151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mercaptopurine anhydrous [1546028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorouracil [4492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentostatin [8011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemcitabine [12574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluridine [10803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>capecitabine [194000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azacitidine [1251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Metabolic Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nelarabine [274771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antimetabolite (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antimetabolite (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</name>
  <code>C30262</code>  <id>30263</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors</to_name>
    <to_code>T36681</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009947</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emtricitabine [276237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zidovudine [11413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide [1721603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil [300195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil succinate [1928942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir anhydrous [1546017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir [306266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir [1999660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zalcitabine [3363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir anhydrous [1546027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir sodium [1999661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleoside Synthesis Inhibitors [MoA]</name>
  <code>C634436</code>  <id>634436</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors</to_name>
    <to_code>T36682</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175074</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Deaminase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Nucleoside Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydrofolate Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nucleotide Metabolic Inhibitor [EPC]</name>
  <code>C635326</code>  <id>635326</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleotide Metabolic Inhibitor</to_name>
    <to_code>T36703</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175888</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antimetabolite (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleotide Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antimetabolite (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleotide Metabolic Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Nut Proteins [EXT]</name>
  <code>C644821</code>  <id>644821</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins</to_name>
    <to_code>T36715</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185019</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cashew nut allergenic extract [892526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Corylus americana nut oil [1603849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pistachio nut allergenic extract [904606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American chestnut allergenic extract [891752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brazil nut allergenic extract [891514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black walnut allergenic extract [891695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut allergenic extract [891658]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>English walnut allergenic extract [891687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hazelnut allergenic extract [891633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>O [Preparations]</name>
  <code>C288641</code>  <id>288641</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>O [Preparations]</to_name>
    <to_code>T36739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010597</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl erucate [2625645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oclacitinib maleate [1487005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olsalazine [32385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytetracycline hydrochloride [4780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia cochenillifera flower extract [1601991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octamethyltetrasiloxane [2536937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytetracycline dihydrate [266974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octanesulfonic acid [1592897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oligopeptide-74 [2700661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus lung preparation [1606469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyl triazone [1314657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleandomycin [7629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymetazoline [7812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyquinoline sulfate [42836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxandrolone [7779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleyl oleate [1426427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onasemnogene abeparvovec-xioi [2170225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oryctolagus cuniculus pituitary gland preparation [1723172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxothiazolidinecarboxylic acid [1926836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omoconazole mononitrate [134933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obinutuzumab [974779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyphencyclimine hydrochloride [91164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ophiocordyceps sinensis extract [1427139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omega-3 fatty acids [4301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyl dodecanol [1367124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ormetoprim [32533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olaparib [1597582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia ficus-indica seed oil [2055001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxycodone terephthalate [159821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth sulfate [2700069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxantel [1871175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omeprazole [7646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenanthe crocata root extract [1595580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>o-cymen-5-ol [1364387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxytropis chiliophylla whole extract [1725035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxogestone [2593371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orris root allergenic extract [1098353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange allergenic extract [892565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osthol [1547630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octreotide acetate [221130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxacycloheptadec-8-en-2-one, (8Z)- [1366226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opopanax resin [1805284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ozanimod [2288236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxypolygelatine [32699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ononis repens whole extract [1358961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osilodrostat phosphate [2286253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ovis aries placenta preparation [1795469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omidenepag [2612691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum basilicum whole extract [1314309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxytropis falcata whole extract [2665340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyphencyclimine [32698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orris allergenic extract [314753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornithylaspartate [32541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olanzapine pamoate [1294588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oseltamivir carboxylate [1546279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olmesartan [321064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Orchis mascula tuber extract [1492442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxolamine [32658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxybutynin chloride [54251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Origanum vulgare subsp. hirtum whole extract [1597293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octenylsuccinic acid [2368127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus thyroid preparation [1606477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olopatadine hydrochloride [236599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxazepam [7781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia ficus-indica flower extract [1307848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>odesivimab [2461340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxalate [1441660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyphenonium [7818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleamido mipa-sulfosuccinate [1370651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Orchis mascula whole extract [1366328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaliplatin [32592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecyl trimethyl ammonium chloride [1426372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>o-phenanthroline [1872047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxycodone [7804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytetracycline anhydrous [1545999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octotropine methylbromide [17945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ospemifene [1370971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octanol [1487826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornithine, (L)-isomer [314709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oneseed juniper pollen extract [900108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-octanol [1362615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>o-xylene [1313248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olipudase alfa-rpcp [2610406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxamniquine [7778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaprozin [32613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-oleamido-1,3,4-octadecatriyl prolinate [1993215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus knee joint preparation [1715938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octenidine hydrochloride [2119239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>odevixibat [2563966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oligopeptide 104 [2663955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecenedioate [1427185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octenidine [2119240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxidronate disodium [1306067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ornithogalum umbellatum extract [1328310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxybate [2387302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl xyloside [2479557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaceprol [28068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onion juice [2565948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxydendrum arboreum leaf extract [1655563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octreotide [7617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obiltoxaximab [1746906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oldenlandia diffusa extract [1426389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oreochromis aureus whole extract [2590601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-12 [1793742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orgotein [32526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocrelizumab-ocsq [2693449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus uterus preparation [2168597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymorphone hydrochloride [82064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oryctolagus cuniculus nerve preparation [2104628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecanoic acid, (octadecylimino)di-2,1-ethanediyl ester [2373439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia ficus-indica extract [1426950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange pollen extract [897403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus kidney preparation [1715937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldecanol [1426402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum gratissimum leaf oil [1366327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oyster, unspecified preparation [1315121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-o-(2-methoxy-4-hexadecenyl)glycerol [2370136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orthoclase [2593183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornithine [7704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryza sativa whole extract [1366329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea flower extract [1331706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyltriethoxysilane [1310586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxalis corniculata whole extract [1539417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orotic acid monohydrate [1311238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ouabain [7762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osmium [1311130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus ligament preparation [1669636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleic acid ozonide [2465834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-O-ethyl ascorbic acid [1313221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus thymus preparation [1715940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxygen [7806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-9 [54034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyphenonium bromide [42833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxtriphylline [20976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange oil [1309230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Orthosiphon aristatus whole extract [2057682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocriplasmin [29998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxetorone fumarate [54243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus ovary preparation [2106740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyl caprate [2200072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus diencephalon preparation [2106741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oliceridine [2392230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olezarsen sodium [2701417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum basilicum flowering top extract [1309489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oryctolagus cuniculus spleen preparation [1723175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omeprazole sodium [1792108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodeceth-16 [1742483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-1 [1368185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,6-octadienal, (2E,6E)- [1788867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxolinic acid [7798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>OspA protein [54214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum gratissimum whole extract [1429394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleyl alcohol [1310603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecenedioic acid [1427184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxibendazole [1009342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>12-oxooctadecanoic acid [1733689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxiconazole nitrate [56226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyquinoline [110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxidronic acid [1546448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-O-tetradecylglycerol [2287736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyfedrine hydrochloride [236758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxothiazolidine [1654970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia tuna stem extract [2673753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaloacetate [1661330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-11 [1731023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>okra extract [1370787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2&apos;-oxydipropanol [2373948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oregano leaf oil [1314320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>o-anisaldehyde [1992076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2,3,4,5,6,7,8-octahydro-8,8-dimethyl-2-naphthalenecarbonitrile [2105919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxypaeoniflora [2562550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ondansetron [26225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxacillin [7773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omidubicel-onlv [2637354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onion allergenic extract [899466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>otilonium bromide [54216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-7 [2397688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obeticholic acid [1798288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornidazole [7701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oseltamivir [260101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ovemotide [1427208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenothera biennis seed extract [1437503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ombitasvir heminonahydrate [1600437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ozone [2289011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Orchis mascula flower extract [1551309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenothera biennis flower extract [1309449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ovis aries testicle preparation [1545041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octylphenoxyethanol [2670600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ondansetron hydrochloride anhydrous [2119176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornithogalum umbellatum flowering top extract [1310115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymetazoline hydrochloride [106101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olive oil decyl esters [1863568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onasemnogene abeparvovec [2170226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocean pout preparation [2374741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus testicle preparation [1715939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecyl palmitate [1494196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octacosanol [12166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oyster allergenic extract [973274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ophiopogon japonicus root extract [1307807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omidenepag isopropyl [2612690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-10 [1426408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat allergenic extract [971932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ononis campestris root extract [1307692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia tuna fruit extract [2566277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omega-3 acid ethyl esters (USP) [484348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opium [7676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus parasympathetic nerve preparation [1856754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea fruit volatile oil [1307825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Orcytolagus cuniculus hypothalamus preparation [1606468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange peel wax [1311647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orphenadrine [7715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oryctolagus cuniculus adrenal gland preparation [1723170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytetracycline [7821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oritavancin [1547611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>9-octadecenamide, N-(2-hydroxy-1-(hydroxymethyl)heptadecyl)-, (9Z)- [1921548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleyl erucate [1432298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octocrylene [77674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxidronate [1306068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orotic acid [7712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orthosilicic acid [1650612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onion extract [1370469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olopatadine [135391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oteseconazole [2602577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opipramol hydrochloride [82062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>odesivimab-ebgn [2461434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxilofrine hydrochloride [236554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxcarbazepine [32624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum americanum leaf extract [1309831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olodaterol [1546059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl oleate [1483232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleate [70616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olive oil [1309250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>odevixibat sesquihydrate [2563978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-3-phosphate [1314374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia ficus-indica fruit juice [1432476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ostericum grosseserratum root extract [1600744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange pekoe tea allergenic extract [966696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ofloxacin [7623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange oil terpeneless [1371052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ombitasvir [1597371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Onosmodium virginianum whole extract [1310133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ovis aries skin preparation [2539794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omeprazole magnesium [236486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocean perch preparation [2471431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange peel extract [1370778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ononis repens root extract [1545684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-O-methyldopamine hydrochloride [1741053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ornithogalum umbellatum bulb extract [2701327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytocin acetate [1733680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxiconazole [32638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Osmanthus fragrans flower extract [1664342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxolamine citrate [59053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olaflur [2712235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oil of ginger [1309388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-4 phosphate [2599367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ononis campestris extract [1311302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxycodone hydrochloride [82063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oseltamivir phosphate [259275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecene [1367494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyphenbutazone [7816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opicapone [2362167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenothera biennis root extract [1309450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oprelvekin [139994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaprozin potassium [660767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ozanimod hydrochloride [2288235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea (olive oil) unsaponifiables [1742482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oil of niaouli [1309375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omalizumab-igec [2725997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opipramol [7674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orlistat [37925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oregon ash pollen extract [900045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-5 [1426398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-5 [1314375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxybutynin [32675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octanoic acid [20178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olmesartan medoxomil [118463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olaratumab [1855735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>OPIUM, POWDERED [221135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleylamide [1368883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omadacycline tosylate [2059268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleanolate [1370638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecyltrimethylammonium [1426373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange oil, distilled [1606472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat bran [253190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-octanediol [1363571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornipressin [7703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omidubicel [2637355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oolong tea leaf extract [1307150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Onosmodium virginianum root extract [1347561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleic acid [7631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oritavancin diphosphate [1549827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl lactate [1313260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia ficus indica leaf extract [2476632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>o-toluenesulfonamide [2049864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ovalbumin [1314593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>7-oxodehydroepiandrosterone 3-acetate [1747869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecane [1790648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenanthe crocata whole extract [2592625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxypertine [7815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxfendazole [32634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum tenuiflorum leaf oil [2048350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea flower bud extract [2053439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ondansetron hydrochloride [203148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olivine [1368210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olsalazine sodium [104123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxeladin citrate [54239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obidoxime chloride [7605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldimethylamine oxide [2707559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleanolic acid [1426254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oregano flowering top extract [1309310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opium tincture [221134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octadecanaminium, N,N-dimethyl-N-(3-(trihydroxysilyl)propyl) [1798702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl neopentanoate [1364386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaloacetic acid [1661329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olanzapine [61381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ofatumumab [712566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytropis lambertii top extract [1432794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxiracetam [32645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-3 [1359085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat kernel oil [1307722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omaveloxolone [2631931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orphenadrine citrate [7716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxalic acid [1427058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orchard grass pollen extract [851878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleamido mea-sulfosuccinate [1370650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldimethylammonium chloride [2399552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obidoxime [42826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oligopeptide-10 [1939310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ovine digoxin immune fab [1745257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornithine hydrochloride [1311542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxitropium [32649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl stearate [1314208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryza sativa hull extract [2709206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olealkonium chloride [1442883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octen-3-ol [2395763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-O-methyldpamine [1742513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenothera biennis leaf extract [1307578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osilodrostat [2286252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl myristate [1311617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenothera biennis flowering top extract [1307613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyquinoline potassium sulfate (2:1) [266832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ozenoxacin [1994739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octisalate [91327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyl sulfate [1438637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(3-oxazolidinyl)ethyl methacrylate [1356132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxilofrine [32639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Origanum majorana extract [1355405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octanediol [1600440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octinoxate [13369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxatomide [54236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxychlorosene sodium [221136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus spinal cord preparation [1606851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl citrate crosspolymer [2274240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omalizumab [302379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oftasceine [1367088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osimertinib mesylate [1721559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum basilicum root extract [2690979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orthocresol [2266810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxalis stricta whole extract [1928705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Okoubaka aubrevillei bark extract [1330089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olutasidenib [2623641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyfedrine [7805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Origanum vulgare subsp. hirtum flower extract [1311508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oregano oil [705279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octadecanaminium, N,N-dimethyl-N-(3-(trihydroxysilyl)propyl) chloride [1798701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleamide [2680311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-40 [1426395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxitropium bromide [54270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1&apos;-oxybis(2-propanol) [1798386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-25 [1601569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus eye preparation [2104327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia tuna flowering top extract [1431310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus bone preparation [1658650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oiticica oil [2665658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oats preparation [285251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxalic acid, dihydrate [1427057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxybenzone [32673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>O-ethylvanillin [2359265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-5-phosphate [2107303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ox bile extract [89870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxprenolol hydrochloride [203131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxychlorosene [32680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oryctolagus cuniculus heart preparation [1723171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxantel pamoate [1871176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxalis montana leaf extract [1337635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>opopanax chironium whole extract [1603481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocean quahog extract [2392631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea leaf extract [1307955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osimertinib [1721560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum tenuiflorum top extract [1311561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyl acetate [2048711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-O-ethyl ascorbate [1373721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olive oil polyglyceryl-6 esters [2392138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxerutins [67187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orange juice [1358966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ovis aries whole extract [2052262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus thalamus preparation [2256932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum africanum leaf extract [1544273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxeladin [32626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oxyuranus scutellatus canni venom extract [1440286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol [32301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octadecyl di-tert-butyl-4-hydroxyhydrocinnamate [2471304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytocin [7824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-8 [2396759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ocrelizumab [1876366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>7-oxo-prasterone [1427084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>o-phthalaldehyde [7602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea whole extract [1376347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl behenate [1540878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orphenadrine hydrochloride [202723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Olea europaea bark extract [1376088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omacetaxine [1546446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octenyl succinate [1442197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-20 [1314300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytetracycline calcium [82065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oyster shell calcium carbonate preparation [1311062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>onabotulinumtoxinA [860189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleuropein [2376830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olive leaf extract [435657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ornithine alpha-ketoglutarate [1482634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olanzapine pamoate monohydrate [885604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oncorhynchus masou sperm DNA [1432979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omega-3 carboxylic acids [1652071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oclacitinib [1487006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus pancreatin preparation [2462503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oldenlandia herbacea whole extract [2690980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octopamine [1311141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>origanum oil [1308067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olodaterol hydrochloride [1546396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-13 [2698019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia ficus-indica stem extract [1309451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ostrea edulis shell preparation [1438113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus liver preparation [1606194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>okra allergenic extract [1011021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl benzoate [2099357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oregano allergenic extract [1010965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-octyl cyanoacrylate [2533837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osage orange pollen extract [1098189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-O-ethylascorbic acid [1373720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omadacycline [2059269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omoconazole [32411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Onopordum extract [1371999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia cochenillifera fruit extract [1874076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-octen-3-yl acetate [2395768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia tuna whole extract [2369366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxetorone [32633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ocimum tenuiflorum whole extract [1722381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>osteum [32559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxprenolol [7801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodeceth-25 [2001617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orbifloxacin [995897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxacillin sodium [9898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxyphenisatin [8136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat smut allergenic extract [349978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omacetaxine mepesuccinate [27100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olezarsen [2701418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-2 [1426410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oil of garlic [1309210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olipudase alfa [2610407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleth-10 phosphate [1594932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oil of patchouli [1309372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octodrine [236867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Opuntia streptacantha stem extract [1486716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymetholone [7813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octenylsuccinic anhydride [2572113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenanthe aquatica fruit extract [1311050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oliceridine fumarate [2392633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-octyldodecyl 5-oxo-L-prolinate [2559600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus cartilage preparation [1715936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>obecabtagene autoleucel [2698195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyl acrylate [1654639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oryctolagus cuniculus duodenum preparation [1723481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octylonium [32311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octodrine camsylate [236868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octoxynol-2 ethane sulfonate [1370667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octyldodecyl stearoyl stearate [1356148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Oenocarpus bataua seed oil [2672539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleyl lactate [1922525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octanoic acid 1-C-13 [1723483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octopamine hydrochloride [1744461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymethurea [2673587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymorphone [7814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>6-O-palmitoylascorbic acid [1088438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oleoyl tyrosine [1372479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>O [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oat straw extract [1872988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ocular Smooth Muscle Activity Alteration [PE]</name>
  <code>C29902</code>  <id>29903</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ocular Smooth Muscle Activity Alteration</to_name>
    <to_code>T36974</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009768</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ocular Smooth Muscle Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ocular Smooth Muscle Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oligonucleotide Telomerase Inhibitor [EPC]</name>
  <code>C654337</code>  <id>654337</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitor</to_name>
    <to_code>T58968</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194125</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oligonucleotide Telomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imetelstat [2685236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oligonucleotide Telomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oligonucleotide Telomerase Inhibitors [MoA]</name>
  <code>C654336</code>  <id>654336</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitors</to_name>
    <to_code>T58967</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194126</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat [2685236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oligonucleotide Telomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Omega-3 Fatty Acid [EPC]</name>
  <code>C634976</code>  <id>634976</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Omega-3 Fatty Acid-class Agent</to_name>
    <to_code>T37119</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Omega-3 Fatty Acid</to_name>
    <to_code>T37120</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175583</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Omega-3 Fatty Acid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>N-3 fatty acid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Omega-3 Fatty Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omega-3 fatty acids [4301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Omega-3 Fatty Acid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatty Acids, Omega-3 [M0023885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oncotic Pressure Alteration [PE]</name>
  <code>C29904</code>  <id>29905</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oncotic Pressure Alteration</to_name>
    <to_code>T37267</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009769</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oncotic Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oncotic Pressure Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Oncotic Pressure [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ophthalmic Agents [TC]</name>
  <code>C654061</code>  <id>654061</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents</to_name>
    <to_code>T58439</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193840</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose [2062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 130 MPA.S at 4%) [2632123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol diacetate [1427008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%) [1371909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab [2591519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (type H) [1811461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 400 [8514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropicamide [10869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15 MPA.S) [1300450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol, (S)- [1663407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine hydrochloride [227778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide hydrochloride [236065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (4000 CPS at 1%) [1307036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil [31563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (50 MPA.S) [1297881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifitegrast [1801820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol [2645108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine [28627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (4000 MPA.S) [1300455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100000 MPA.S) [1300448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 300 [8513]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium [1362690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline sulfate [2680384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein [25138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil mesylate [1992863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-phenylpropanal propylene glycol acetal [1947505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (4000 CPS) [1300447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (15000 MPA.S) [1300445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brinzolamide [194881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin [2104332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost [43611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine [2721766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol propyl ether [1947500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimatoprost [283810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine hydrochloride [1294532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2910 [1363586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafluprost [1244607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil sodium [266663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15000 MPA.S) [1300451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine [134615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (5 MPA.S) [1300452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine hydrochloride [236599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nepafenac [298665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine hydrochloride [236961]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine tartrate [39171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100 MPA.S) [1300444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (6 cps) [1300454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag [2612691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurophate [6027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine hydrobromide [235428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol [34693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyamphetamine hydrobromide [82066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal [9471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein sodium [57789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (4000 mpa.s) [1299222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revakinagene taroretcel [2708830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (2000 CPS at 1%) [1299925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revakinagene taroretcel-lwey [2708831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoltremon [2716801]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin-bkbj [2104331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-hydroxyamphetamine [7839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocriplasmin [29998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine isethionate [34634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 400 MPA.S at 1%) [1653793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine [34905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (1500 MPA.S at 1%) [1312606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl unoprostone [135313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-mrbb [2706479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost acid [2675687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine hydrochloride [2721767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate hydrochloride [106029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol sodium [2645107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol 2-(2-methylbutyrate) [1947503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2208 [1363585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol hydrochloride [227212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-boav [2725885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide [60207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab-svoa [2591584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitutions per saccharide; 600 MPA.S at 2 %) [1812763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine [28144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol [1813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-yszy [2715399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziv-aflibercept [1304475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose [27334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole [22298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (3 MPA.S) [1300449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluorohexyloctane [2637547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine [135391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol monostearate [1314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 50-100 MPA.S at 1% ) [1597390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropylcellulose [27291]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 600 MPA.S at 2 %) [2099296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine [863035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (5000 CPS at 1%) [1307084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole hydrochloride [235757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag isopropyl [2612690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (3 MPA.S) [1300446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine [34633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 38 MPA.S at 2%) [2257286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium [491498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (50 MPA.S) [1300453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>travoprost [283809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine besilate [658552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-ayyh [2696256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose [27244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine difumarate [221094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate [3001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Agonist [EPC]</name>
  <code>C635096</code>  <id>635096</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Binder</to_name>
    <to_code>T37308</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist</to_name>
    <to_code>T37310</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Agonist</to_name>
    <to_code>T37309</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175690</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydromorphone [3423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing opioid receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tapentadol [787390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meperidine [6754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxycodone [7804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymorphone [7814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sufentanil [56795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propoxyphene [8785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihydrocodeine [23088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>morphine [7052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with opioid receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tramadol [10689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fentanyl [4337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levorphanol [6378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>loperamide [6468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>codeine anhydrous [1545976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remifentanil [73032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kappa Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methadone [6813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfentanil [480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrocodone [5489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Agonist/Antagonist [EPC]</name>
  <code>C635098</code>  <id>635098</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Antagonist</to_name>
    <to_code>T37311</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist/Antagonist</to_name>
    <to_code>T37312</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Antagonist</to_name>
    <to_code>T37314</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Opioid Antagonist</to_name>
    <to_code>T37313</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist</to_name>
    <to_code>T37317</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Opioid Antagonist</to_name>
    <to_code>T37315</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist/Antagonist</to_name>
    <to_code>T37316</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175692</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butorphanol [1841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalbuphine [7238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with opioid receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing opioid receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing opioid receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Agonists [MoA]</name>
  <code>C526</code>  <id>527</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists</to_name>
    <to_code>T37318</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000174</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Full Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin acetate [2569090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine [2392230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dezocine [22713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl acetate hydrochloride [82043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine fumarate [2392633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl [237005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Analgesic [EPC]</name>
  <code>C634822</code>  <id>634822</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Analgesic</to_name>
    <to_code>T37319</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175440</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Analgesic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing opioid receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Analgesic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with opioid receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Antagonist [EPC]</name>
  <code>C635097</code>  <id>635097</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Antagonist</to_name>
    <to_code>T37320</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonist</to_name>
    <to_code>T37321</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175691</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing opioid receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naldemedine [1876597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alvimopan anhydrous [1516803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxone [7242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samidorphan [2559612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naltrexone [7243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylnaltrexone [29899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naloxegol [1551777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with opioid receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nalmefene [31479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Antagonists [MoA]</name>
  <code>C486</code>  <id>487</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists</to_name>
    <to_code>T37322</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000154</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone bromide [979111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eluxadoline [1653781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine [1876597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine tosylate [1876598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan L-malate [2570387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone [29899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan [480639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol oxalate [1593586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan anhydrous [1516803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dezocine [22713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol [1551777]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid Receptor Interactions [MoA]</name>
  <code>C578</code>  <id>579</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Interactions</to_name>
    <to_code>T37326</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000200</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Opioid Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine [594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine hydrochloride [7433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid kappa Receptor Agonists [MoA]</name>
  <code>C654227</code>  <id>654227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>KOR Agonists</to_name>
    <to_code>T58733</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid kappa Receptor Agonists</to_name>
    <to_code>T58732</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid kappa Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Opioid mu-Receptor Agonists [MoA]</name>
  <code>C651982</code>  <id>651982</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists</to_name>
    <to_code>T37328</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>mu-Opioid Receptor Agonists</to_name>
    <to_code>T37327</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191866</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone [2001352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eluxadoline [1653781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone hydrochloride [2122776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine tosylate [1876598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine [1876597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Optical Imaging Agent [EPC]</name>
  <code>C654204</code>  <id>654204</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Optical Imaging Agent</to_name>
    <to_code>T58672</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193983</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Optical Imaging Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pafolacianine [2586857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Optical Imaging Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminolevulinic acid [683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Optical Imaging Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fluorescence Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Order [PK]</name>
  <code>C290</code>  <id>291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Order</to_name>
    <to_code>T37420</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000056</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Order [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zero Order [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Order [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>First Order [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Agonists [MoA]</name>
  <code>C650973</code>  <id>650973</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Agonists</to_name>
    <to_code>T37421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190999</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Antagonist [EPC]</name>
  <code>C650974</code>  <id>650974</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonist</to_name>
    <to_code>T37422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191000</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suvorexant [1547099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lemborexant [2272403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with orexin receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>daridorexant [2591497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing orexin receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Antagonists [MoA]</name>
  <code>C650972</code>  <id>650972</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists</to_name>
    <to_code>T37423</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190998</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemborexant [2272403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant [2591497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant hydrochloride [2591496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Orexin Receptor Interactions [MoA]</name>
  <code>C650971</code>  <id>650971</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Interactions</to_name>
    <to_code>T37424</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190997</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orexin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organ System Specific Effects [PE]</name>
  <code>C29906</code>  <id>29907</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organ System Specific Effects</to_name>
    <to_code>T37429</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009770</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reproductive System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Digestive/GI System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Special Sensory Systems Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatologic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Musculoskeletal Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hemic/Lymphatic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organ System Specific Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter 1 Inhibitors [MoA]</name>
  <code>C650041</code>  <id>650041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OAT1 Inhibitors</to_name>
    <to_code>T37437</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors</to_name>
    <to_code>T37438</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190110</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter 3 Inhibitors [MoA]</name>
  <code>C650042</code>  <id>650042</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OAT3 Inhibitors</to_name>
    <to_code>T37439</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors</to_name>
    <to_code>T37440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190111</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pretomanid [2198359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporter Interactions [MoA]</name>
  <code>C442</code>  <id>443</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter Interactions</to_name>
    <to_code>T37441</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000132</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Anion Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</name>
  <code>C650038</code>  <id>650038</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OATP1B1 Inhibitors</to_name>
    <to_code>T37449</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors</to_name>
    <to_code>T37450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190107</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofinetide [2632852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voclosporin [2475166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</name>
  <code>C650039</code>  <id>650039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OATP1B3 Inhibitors</to_name>
    <to_code>T37451</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors</to_name>
    <to_code>T37452</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190108</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofinetide [2632852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voclosporin [2475166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</name>
  <code>C650040</code>  <id>650040</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OATP2B1 Inhibitors</to_name>
    <to_code>T37453</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors</to_name>
    <to_code>T37454</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190109</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat [2571074]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Cation Transporter 1 Inhibitors [MoA]</name>
  <code>C651271</code>  <id>651271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 1 Inhibitors</to_name>
    <to_code>T37458</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OCT1 Inhibitors</to_name>
    <to_code>T37457</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191265</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Cation Transporter 2 Inhibitors [MoA]</name>
  <code>C646962</code>  <id>646962</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OCT2 Inhibitors</to_name>
    <to_code>T37464</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors</to_name>
    <to_code>T37465</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187061</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol [2694283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givinostat [2678889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir [1433868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Cation Transporter Interactions [MoA]</name>
  <code>C646961</code>  <id>646961</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter Interactions</to_name>
    <to_code>T37466</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187060</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Cation Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Cation Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Ion Degradation Alteration [PE]</name>
  <code>C29908</code>  <id>29909</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Degradation Alteration</to_name>
    <to_code>T37468</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009771</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Ion Degradation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organic Ion Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Ion Degradation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organic Ion Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Ion Metabolism Alteration [PE]</name>
  <code>C29910</code>  <id>29911</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Metabolism Alteration</to_name>
    <to_code>T37469</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009772</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Ion Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Degradation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Ion Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organic Ion Synthesis Alteration [PE]</name>
  <code>C29912</code>  <id>29913</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration</to_name>
    <to_code>T37470</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009773</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Ion Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organic Ion Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organic Ion Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organic Ion Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Ion Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Organized Electrical Activity Alteration [PE]</name>
  <code>C29914</code>  <id>29915</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration</to_name>
    <to_code>T37472</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009774</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organized Electrical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Organized Electrical Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Organized Electrical Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium,chelated [259277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organized Electrical Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arterial Vasoconstriction [PE]</name>
  <code>C29916</code>  <id>29917</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arterial Vasoconstriction</to_name>
    <to_code>T37537</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009775</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oropharyngeal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arterial Vasodilation [PE]</name>
  <code>C29918</code>  <id>29919</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arterial Vasodilation</to_name>
    <to_code>T37538</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009776</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oropharyngeal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arteriolar Vasoconstriction [PE]</name>
  <code>C634785</code>  <id>634785</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arteriolar Vasoconstriction</to_name>
    <to_code>T37539</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175402</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oropharyngeal Arteriolar Vasodilation [PE]</name>
  <code>C634769</code>  <id>634769</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oropharyngeal Arteriolar Vasodilation</to_name>
    <to_code>T37540</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175386</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</name>
  <code>C654078</code>  <id>654078</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor</to_name>
    <to_code>T58464</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193857</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tecovirimat [2055104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Osmotic Activity [MoA]</name>
  <code>C31934</code>  <id>31935</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity</to_name>
    <to_code>T37589</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010288</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icodextrin [140480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactitol [28395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycols [8516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl starch 130-0.4 [1363352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium cation [1311382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfate ion [1426598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium cation [1364429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Osmotic Diuretic [EPC]</name>
  <code>C635229</code>  <id>635229</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Diuretic</to_name>
    <to_code>T37590</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175810</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Diuretic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Osmotic diuretic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mannitol [6628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Osmotic Laxative [EPC]</name>
  <code>C635230</code>  <id>635230</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Laxative</to_name>
    <to_code>T37591</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175811</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactitol [28395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>magnesium cation [1426853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cation [1311382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lactulose [6218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfate ion [1426598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 3350 [221147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium ion [1318915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Osmotic Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cation [1364429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Laxative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Laxative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Otic Agents [TC]</name>
  <code>C654062</code>  <id>654062</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Otic Agents</to_name>
    <to_code>T58440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193841</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Otic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Otic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Otic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ovarian Endocrine Activity Alteration [PE]</name>
  <code>C29920</code>  <id>29921</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Endocrine Activity Alteration</to_name>
    <to_code>T37754</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009777</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Progesterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Progesterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ovarian Estrogen Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ovarian Follicular Phase Alteration [PE]</name>
  <code>C29922</code>  <id>29923</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Follicular Phase Alteration</to_name>
    <to_code>T37755</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009778</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Follicular Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Follicular Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ovarian Function Alteration [PE]</name>
  <code>C29924</code>  <id>29925</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Function Alteration</to_name>
    <to_code>T37756</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009779</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovulation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Follicular Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Luteal Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ovarian Luteal Phase Alteration [PE]</name>
  <code>C29926</code>  <id>29927</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Luteal Phase Alteration</to_name>
    <to_code>T37758</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009780</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Luteal Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovarian Luteal Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovarian Luteal Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Luteal Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Luteal Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovarian Luteal Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ovulation Alteration [PE]</name>
  <code>C29928</code>  <id>29929</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovulation Alteration</to_name>
    <to_code>T37777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009781</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovulation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovulation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estetrol monohydrate [2539035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovulation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estetrol [2539031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovulation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ovum Fertilization Alteration [PE]</name>
  <code>C635248</code>  <id>635248</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ovum Fertilization Alteration</to_name>
    <to_code>T37778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175829</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ovum Fertilization Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxaborole Antifungal [EPC]</name>
  <code>C651290</code>  <id>651290</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxaborole Antifungal</to_name>
    <to_code>T37779</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191279</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxaborole Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxaborole Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxaborole Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tavaborole [1543173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxaborole Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxaborole Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxaborole Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Boron Compounds [M0002832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxaborole Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxazolidinone Antibacterial [EPC]</name>
  <code>C634876</code>  <id>634876</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxazolidinone Antibacterial</to_name>
    <to_code>T37819</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175495</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with oxazolidinone structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxazolidinones [M0361132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tedizolid [1540825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>linezolid [190376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxazolidinone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxidation Activity [MoA]</name>
  <code>C634939</code>  <id>634939</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation Activity</to_name>
    <to_code>T37829</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175546</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oil (containing omega-3 acids) [2053495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxidation-Reduction Activity [MoA]</name>
  <code>C634938</code>  <id>634938</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reduction-Oxidation Activity</to_name>
    <to_code>T37830</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation-Reduction Activity</to_name>
    <to_code>T37832</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Redox Activity</to_name>
    <to_code>T37831</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175545</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxidation-Reduction Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxidation-Reduction Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reduction Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation-Reduction Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxidation-Reduction Agent [EPC]</name>
  <code>C652725</code>  <id>652725</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation-Reduction Agent</to_name>
    <to_code>T37833</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192516</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxidation-Reduction Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylene blue cation [1546414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxidation-Reduction Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation-Reduction Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxygen Carrying Capacity Alteration [PE]</name>
  <code>C29930</code>  <id>29931</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxygen Carrying Capacity Alteration</to_name>
    <to_code>T37892</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009782</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxygen Carrying Capacity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oxygen Carrying Capacity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxygen Carrying Capacity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Oxygen Carrying Capacity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxygen Carrying Capacity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxygen Carrying Capacity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxygen Carrying Capacity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Oxytocic [EPC]</name>
  <code>C635247</code>  <id>635247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxytocic</to_name>
    <to_code>T37952</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175828</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxytocic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytocin [M0015703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxytocic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytocin [7824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxytocic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Oxytocic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Oxytocic agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P [Preparations]</name>
  <code>C288642</code>  <id>288642</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P [Preparations]</to_name>
    <to_code>T37961</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010598</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene terephthalate (intrinsic viscosity 1.00-2.00) [2000034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 stearate [1648781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 234 [1651699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paliperidone [679314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pafolacianine sodium [2586858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenethyl octanoate [2632413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl sarcosinate [1726121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pichia jadinii extract [1427220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phragmites australis root extract [1307738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palm kernel glycerides [1592262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poppy seed allergenic extract [1011017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parachlorophenol [14982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 rapeseed sterol [1307700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dilaurate [1986789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimagedine [1311670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium thiocyanate [1427066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picrasma quassioides wood extract [1361660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol behenate [1859169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prenylamine lactate [34407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-(2-methylbutyrate) [1542901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polygeline [8521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Propionibacterium acnes [1310910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim-pbbk [2602779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium stearate [1368705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pozelimab [2663938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pacific ocean perch allergenic extract [2102486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein S, human-lans [2643200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30 glyceryl laurate [2002790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palonosetron hydrochloride [397405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata fruit extract [1311651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllostachys nigra leaf extract [2601715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaverine codecarboxylate [158387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl glycine [1359086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl dipeptide-7 [1368160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyamide-8 (4500 MW) [1802853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poverty weed pollen extract [852539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perampanel [1356552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palbociclib [1601374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patiromer sorbitex calcium [2204723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 900000 [1441534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 glyceryl stearate [1313177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulex irritans preparation [1311151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polarcrillin [1370669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passalora fulva allergenic extract [883442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (45000 MW) [2266494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plasma protein fraction [33835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipemidic acid [8337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycolate [2466982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palopegteriparatide [2693635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothrombin, human-lans [2643202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prolintane hydrochloride [235831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sorbate [8606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prasugrel hydrochloride [847020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peptones [8040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-80 glyceryl cocoate [1492189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-(p-hydroxyphenyl)-2-butanone [1860422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednicarbate [34369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>primaquine [8687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pea fiber extract [2630721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-4-30 copolymer [2694076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl trimethicone [1310585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palm oil [32809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(phosphonooxy)- 2-propenoic acid [2385888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>passion flower extract [285159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polystyrene sulfonate [1546437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllostachys reticulata resin [1312720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prosolv SMCC 50 [1426703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicilloyl polylysine [2667743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemirolast [19551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium hydroxycitrate [2671200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetate pentasodium [314774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork kidney preparation [1311167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentobarbital sodium [203085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylic acid (8000 MW) [1484857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-nitrobiphenyl [2571811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax ginseng root water extract [1309490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 300 [8513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus dulcis whole extract [1999192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmatine [1314367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-20-15 dimethicone [1426939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipoxolan hydrochloride [235861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propofol [8782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perazine [8042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenicarbazide [235808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petroselinum crispum extract [1353886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Periploca sepium root bark extract [1485537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polylactic acid-polyglycolic acid copolymer [1309726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenazopyridine hydrochloride [203197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 sorbitan stearate [1918052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sulfooleate [1426700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panobinostat lactate [1603349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl tetraisostearate [1358489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytonadiol tetrasodium diphosphate [1926458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Puccinia striiformis allergenic extract [852311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygala senega whole extract [1649447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>petroleum alkylate [1652847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed disodium heptahydrate [1666923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea abies wood extract [1372259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-10 caprylyl ether [2621119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper cubeba fruit extract [1310227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pasireotide [1364105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-26 [1541885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentifylline [33086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paromomycin [7934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-14 dimethicone [1535606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 2-stearate [2173390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piketoprofen [82910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>policresulen [54908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>progabide [34568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluoromethyldecalin [1986868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantolactone, (+-)- [1426783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-15 [2637755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pale dock pollen extract [1232604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 sorbitan stearate [1489549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium bitartrate [223779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoephedrine polistirex [407885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphorylcholine [2585444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoma exigua var. exigua allergenic extract [867284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penstemon davidsonii whole extract [2533902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisone [8640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polydatin [1364277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus sylvestris bark extract [1491859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pembrolizumab-pmph [2723753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenazocine hydrobromide [104979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-150 stearate [1368156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipazethate [33740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perindoprilat [1546400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pivmecillinam hydrochloride [102745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paclitaxel protein-bound [486610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 distearate [2199654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-aminohippurate [42837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla montana whole extract [2591603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pulegone [2393774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylethyl alcohol [8126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pancratium maritimum whole extract [1992541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paromomycin sulfate [66912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 distearate [2467842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plumeria rubra flower extract [1307812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pamidronate disodium [105443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica leaf extract [1310019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment yellow 1 [1872250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-30-160 copolymer [1426947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium carbonate 1 1/2 hydrate [1311294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proquazone [2669456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polacrillin [1370589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium camemberti allergenic extract [966943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-10 glyceryl stearate [1426935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paprika oil [1307689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pear allergenic extract [899883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(N-acetyl, N-arginyl)glucosamine (50000-80000 MW) [1372682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protriptyline [8886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-propoxy-1-propanol [1356481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentapeptide-18 [2684981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimobendan [1110783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potato starch [1427056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piellia ternata whole extract [1547571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus [1427212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxybenzamine hydrochloride [71512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium graveolens flowering top extract [1307599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment red 48 [1426161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paris polyphylla root extract [1307586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PROPINOX HCL [236776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panaxynol [2676953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginterferon beta-1a [1546168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K60 [2359275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-12/SMDI copolymer [1440239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prochlorperazine mesylate [235739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30 glyceryl linoleate [1862480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polypropylene (30000 MW) [2118848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pacific salmon allergenic extract [1098247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propafenone hydrochloride [203135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl hydroxypropyltrimonium amylopectin/glycerin crosspolymer [2637852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(perfluorohexyl)ethanol [1986349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 lauramide [1363617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylmercuric acetate [1426778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platostoma chinensis whole extract [1358479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 oleate [2285326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phytolacca americana whole extract [1661745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsley seed oil [1309236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrithioxin [9020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine bark extract [259276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-15-15 dimethicone [1494197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoephedrine [8896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus mume fruit oil [1735540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein C [8834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Papaya preparation [324030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>profluralin [2665290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudolarix amabilis bark extract [1547621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Portulaca pilosa whole extract [2178065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium arsenite [1426894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyethylene-24-cholesteryl ether [1362898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pholedrine [33432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 14000 [1368893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrrolidonecarboxylic acid [9036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pareptide [2619909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pawpaw extract [1650241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perindopril erbumine [72260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propionic acid [34658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium bromide [34299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propionate [121047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxyacetate [1426336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paeonia lactiflora root oil [2106562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium phenethicillin [132907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimethixene [33712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxal [9002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pertussis vaccine [8080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus thunbergii leaf extract [2665416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirenoxine [228080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phymatolithon calcareum preparation [1731724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus serotina bark extract [1307851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Puccinia graminis allergenic extract [999487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralidoxime cation [1546365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-15 cocamine [1366668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (75000 MW) [1312723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl stearate [2664062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pefloxacin mesylate [262299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirisudanol maleate [236172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polawax polysorbate [1425089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perflexane [1540828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polymetaphosphate [1364922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus strobus cone extract [2590680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemigatinib [2359268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-11 (1000000 MW) [1426654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pau d&apos;arco preparation [342940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proxyphylline [34906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phloroglucinol [8196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 450 [1363441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyrithione Disulfide [236295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parthenium hysterophorus extract [1432796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid), (50:50; 12000 MW) [1536460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus salicina fruit extract [2630164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata root extract [1745930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>punica granatum whole extract [1432478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperacetazine [8338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyestradiol phosphate [34120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phleum pratense top extract [1350211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 6000 [1314384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 dilaurate [2265844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>praseodymium [1311481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentolamine [8153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium roquefortii allergenic extract [972365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-60 glyceryl stearate [1652252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine [2593177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin V calcium [236517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol (40000 MW) [1855459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipecuronium [33742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 propylheptyl ether [2584305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pibrentasvir [1940636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parethoxycaine HCl [236250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sodium saccharate dihydrate [1801709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paricalcitol [73710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus tabuliformis pollen extract [1801708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinctada margaritifera shell extract [1874550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylisohexanol [1376152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 7000000 [1312731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitostearate [1743154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polacrillin potassium [1314377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plumeria rubra whole extract [1921563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pteridium aquilinum root extract [1309767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poldine methylsulfate [33927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium phosphate dibasic trihydrate [2475957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycodon grandiflorum root extract [1307614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus tremuloides bark extract [1310106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phaeodactylum tricornutum extract [1592735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxine phosphoserinate [236803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phellodendrine [2622304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoleic acid [2475955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrrole [1338938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrethrum extract [1232405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus sylvestris flowering top extract [1310084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physalis virginiana whole extract [2590678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum multiflorum root extract [1307696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-120 glyceryl stearate [1739983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propicillin potassium [236615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 methyl ether [1314193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenobarbital quinidine [54620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora edulis fruit extract [1655989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pasireotide diaspartate [1364104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphatidylserine [89959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-9 oleate [2534443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sodium saccharate [1788996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim-apgf [2469333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Psidium guajava leaf extract [1799150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus x yedoensis leaf extract [1539419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parecoxib sodium [279951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plasminogen [2557200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pussy willow pollen extract [852174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-12-PEG-50 lanolin [1495078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piscidia piscipula whole extract [1991790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propantheline bromide [8762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramipexole dihydrochloride [236747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3-pentanedione [2693283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancuronium [7883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-3 benzyl ether ethylhexanoate [1436961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palladium [1311279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-9 stearate [1307086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylephrine hydrochloride [8164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyester-10 [1314200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenobarbital [8134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piribedil mesylate [236380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylacetic acid [33332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-150 dilaurate [1857718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium hydroxide [34311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peach allergenic extract [892575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium palmitate [1674188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinellia ternata root extract [1307663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-70 lanolin [2374550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paulownia tomentosa leaf extract [1310113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-28 (1100000 MW) [1426914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K90 [1310497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine dihydrochloride [2562175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PERTUSSIS VACCINE,ADSORBED [402543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomegranate seed oil [1306095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Potentilla erecta root extract [1307737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petasites hybridus leaf extract [1369687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polybutene (1400 MW) [1313725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylate-13 [2637016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prabotulinumtoxinA-xvfs [2117869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudomonas aeruginosa [1310913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persea americana seed butter extract [1309494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol-hydroxyethylcellulose stearyldimonium chloride [1723159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propicillin [34649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirbuterol acetate [221142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphite [1793924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pea allergenic extract [892569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prezatide copper [1314233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(4-vinylpyridine-N-oxide) [2634299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parnaparin [69528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polymethylsilsesquioxane (4.5 microns) [1426430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipoxolan [33758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamine 1304 [2374352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitavastatin sodium [1944734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylephrine bitartrate [91167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycerin-6 [1313721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralmorelin dihydrochloride [1492038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol (100000 MW) [1796719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment blue 1 [1793744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procyclidine [8718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-47 (methacrylamidopropyltrimethylammonium chloride-co-methyl acrylate-co-acrylic acid 45:10:45; 1200000 MW) [1601597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylamide (crosslinked; 0.01-0.2 mole percent bisacrylamide) [1313270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>practolol [8620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plazomicin [2049549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-25-25 dimethicone [1541248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propyl acetate [1649519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluoroperhydrophenanthrene [1540875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prochlorperazine [8704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyracantha fortuneana fruit extract [1311666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol myristyl ether acetate [1356703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pholcodine [33431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium aspartate [8589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dicaprylate-dicaprate [1426622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-1 trideceth-6 [1427227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 80 [8560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylmercuric nitrate [89722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleione yunnanensis whole extract [2711362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus speciosa leaf extract [1309953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 2000 [1364383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentostatin [8011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid 7:3:1; 280000 MW) [1427228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-4 (1600 MPA.S at 2%) [2550710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago major leaf extract [1310005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 triisostearate [1649137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosphingosine hydrochloride [1534773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus lannesiana flower extract [2710465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosterols [8310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patisiran lipid complex [2284711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propyperone [1999765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantolactone, (R)- [1427236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed disodium hemipentahydrate [2056898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone k25-28 [1313718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycodon grandiflorus whole extract [2634295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Perilla frutescens leaf oil [1307672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoperidine hydrochloride [106508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(methyl methacrylate; 450000 MW) [1433496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl acetaldehyde dimethyl acetal [2467130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyester-5 (tg-38) [1865719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 40 castor oil [1309216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperocaine [33752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phaseolus lunatus whole extract [2708829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol diacetate [1427008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus densiflora leaf extract [1541723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipamperone dihydrochloride [289159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG:PPG-4-12:dimethicone [1366993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pamabrom [54365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-24-glycereth-24 [1653592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitamidopropyltrimonium chloride [1489928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium silicate [1311377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 cocamine [2395446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-14 1-((methylphenyl)ethyl)phenyl ether [2169287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proscillaridin [8795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 stearate [1312712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4 laurate [2640867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ptelea trifoliata bark extract [1309713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrantel pamoate [8985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-17 [1313179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 dimethicone [1314194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phellodendron amurense whole extract [1594581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphate ion [486961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pilocarpus jaborandii whole extract [2045372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 dioleate [1363621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pinaverium bromide [54743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 glyceryl laurate [2002789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 60 [1368867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-phenylenediamine [1362740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid) (50:50; 46000 MW) [1999996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>padimate A [1363712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>praziquantel [8628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirfenidone [1592254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethyloxazoline (500000 MW) [2182794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylparaben calcium [1867698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus cembroides pollen extract [2590679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylhydrazine [8167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl pentapeptide-4 [1426596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus dulcis flower extract [2053442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 21 [1992411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propiomazine hydrochloride [6232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycodon grandiflorum leaf extract [1309786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pelargonate [2054105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium graveolens flower oil [1307705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-propoxy-2-propanol [1358844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pilocarpine hydrochloride [235426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-7 (70/30 acrylamide/dadmac; 2600000 MW) [1738847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramiverine [190433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax notoginseng root extract [1365707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 methylglucose distearate [2476007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 beeswax [2399032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polymyxin B sulfate [388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paltusotine hydrochloride [2724364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pizotyline [8373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl tetraoleate [1314196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluoropolymethylisopropyl ether [1430131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium roseum oil [1813398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphatidylcholine, soybean [2109751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proflavine [8723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phryma leptostachya root extact [2001496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-14 palmeth-60 hexyl dicarbamate [1314317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pratia purpurascens exctract [2378838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium acetate [54987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone [8610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitate [1370621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora edulis seed oil [1363440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene [1314239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylenimine hydrochloride (20000 MW) [2469930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 stearate [1314849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phragmites australis whole extract [1368339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment yellow 3 [1491868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoisocytidine [34930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-10 (1000 MPA.S at 2%) [1486717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoleate [2475954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosteryl/isostearyl/cetyl/stearyl/behenyl dimer dilinoleate [2048257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythritol tetranitrate [7992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyruvic acid [35161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluorohexyloctane [2637547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parecoxib [279950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4-oleate [1540876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid), (85:15; 23000 MW) [2631025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pivampicillin [8372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propoxyphene napsylate [8786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothrombin [1441688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol ethyl ether [2385887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin V [7984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-20 methyl glucose ether distearate [1373204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica seed extract [1310004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago lanceolata whole extract [2587643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliglusam hydrochloride [2368131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus armeniaca whole extract [1373159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitavastatin calcium [861640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cocoyl glycinate [1655990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palovarotene [2663954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phragmites australis stem extract [1922526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylamide (10000 MW) [1313719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prifinium [236174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-palmitate [1726445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Porphyra umbilicalis extract [1368343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 stearate [1313257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perennial rye grass pollen extract [852819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pepper tree pollen extract [852140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirlimycin [1367292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperonal [33753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphoric acid [8259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitavastatin magnesium [2001252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paritaprevir dihydrate [1600436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoephedrine tannate [221151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-phenyl propionic acid [2627300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (65000 MW) [2644879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenazocine [8119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Proteus rettgeri [2002418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peptostreptococcus anaerobius [1311307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paramethasone acetate [32895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perlite [1858075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 335 [1313711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-15 glyceryl stearate [1363611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol (108000 MW) [2668414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl oligopeptide [1314373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus alba bark extract [1876511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl tetracaprylate-tetracaprate [1313199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30 stearate [1368155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>placebo [8375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 4500 [1358490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (1100000 MW) [1426412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proparacaine [34905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimavanserin [1791685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol monolaurate [1356149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentazocine hydrochloride [104973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 caprate [2569078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Poa pratensis allergenic extract [1922745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propiverine [55175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramoxine hydrochloride [57555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pfaffia paniculata root extract [1311512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica var. nucipersica whole extract [2533910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl proline [1370622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium perchlorate [34318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus nigra leaf bud extract [2055003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium orotate [8602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus sylvestris cone extract [1372561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picric acid [1320642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>primidone [8691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonum aviculare whole extract [1992543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrazon [1874547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomegranate extract [725206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prolactin [1426890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxyisopropanol [1313723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paliperidone palmitate [858045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomegranate fruit rind extract [1311658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pholedrine sulfate [236644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proteoglycan 4 [2619327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralatrexate [662019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentafluoropropane [1591891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polidronium chloride [1426891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago major extract [1311368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethyelene glycol 7000 [1309368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium capitatum leaf extract [2634294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylamide (1300000 MW) [1356764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethyloxazoline (200000 MW) [2118533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pargeverine hydrochloride [236455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednimustine [8637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K12 [1305759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piroxicam-beta-cyclodextrin [68115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-p-menthene-8-thiol [1940004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platanus x acerifolia whole extract [1428421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylparaben [34706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-phytase A (Aspergillus niger) [2700156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyester-7 [1368161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peptone,dried [314776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 dioleate [1552357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Potentilla discolor whole extract [2120566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-200 dilaurate [1314191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-32 dioleate [1747346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polypodium virginianum root extract [2636531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid), (75:25; 20000 MW) [2664061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-44 [1744029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum odoratum root extract [1307550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propanediol caprylate [2621210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-propanol, 1,1&apos;-oxybis(3-(1-naphthalenyloxy))- [2637686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla koreana root extract [1307667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-120 methyl glucose dioleate [1309363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 glyceryl triisostearate [1540273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegvisomant [278739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-propanol [1362872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium behenoyl hydroxyproline [1596135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-butyrate [2263157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tripeptide-1 [1722914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea abies leaf extract [1549108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(lactic-co-glycolic acid) (75/25, 0.23-0.26 dL/g inherent viscosity) [1309730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax pseudoginseng root extract [1376500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palivizumab [194279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylate-1 crosspolymer [2622907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poppy seed oil [1432299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 182 [1314380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine needle oil (pinus mugo) [1360627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica fruiting top extract [2387539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylhexedrine hydrochloride [236461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipecuronium bromide [66983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylpropanolamine bitartrate [221140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prazosin hydrochloride [203210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllostachys edulis stem extract [2413034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Portulaca grandiflora seed extract [1594931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax ginseng leaf extract [1918244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 350 [1368165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-14 1-((methylphenyl)ethyl)phenyl ether ammonium sulfate [2169286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentapeptide-59 [2698197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-55 propylene glycol oleate [2623642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax quinquefolius whole extract [1428042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxal phosphate anhydrous [1599827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Periplaneta australasiae extract [2590183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peoniflorin [2288155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunella vulgaris leaf extract [1800821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudognaphalium luteoalbum whole extract [1812325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>policapram [2668059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 sorbitan laurate [1859168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polynoxylin [34188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenmetrazine hydrochloride [203198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Perilla frutescens seed extract [1307814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pozelimab-bbfg [2663939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Perilla frutescens leaf extract [1309493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phyllostachys nigra sap extract [1430251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piroxicam [8356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol, (R)- [1314303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora caerulea fruit extract [2667742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 50 hydrogenated castor oil [1426435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygala tenuifolia root extract [1429948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleospora betae allergenic extract [852756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-30 [1482540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium aluminate [1922748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 40 [1367265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine-N-butyl methacrylate; 4:1) [1313968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrrolidinyl diaminopyrimidine oxide [1741137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrophyllite [2636602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl salicyate [895808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pilocarpus microphyllus leaf extract [1667354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrilamine [9009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pridinol [34479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus pinaster wood extract [2001194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegaptanib sodium [594119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pratia purpurascens extract [2380572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrantel tartrate [2197593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment yellow 109 [1999676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG/PPG-30/10 dimethicone [1734019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(phthalocyaninato(2-)) copper [1424646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment red 1 [1872248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrantel [8984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Punica granatum flower extract [1307706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 soy sterol [1314190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phellodendron amurense bark extract [1307947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propyl gallate [1311134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxine hydrochloride [203164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus radiata bark extract [2621118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-15 stearyl ether [1313178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-200 hydrogenated glyceryl palmate [1552360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 caprate [2169283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 20 cetostearyl ether [1307046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 hydrogenated castor oil [1356707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium aminobenzoate [142141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus cerasifera whole extract [1800076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propanediol dicaprylate [1436167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentermine hydrochloride [82078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim [338036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(dl-lactic-co-glycolic acid), (50:50; 63000 mw) [1309728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petiveria alliacea preparation [705701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-10 methyl glucose ether [1428877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyroligneous acid [1535931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxetine hydrochloride, hemihydrate [1298842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penbutolol [7973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus mugo subsp. mugo bark extract [1488821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>padimate-O [32786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Padang cassia oil [1489763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-36-41 dimethyl ether [1427043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paclitaxel [56946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 dimethicone (300 CST) [1367152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium metaphosphate [1426446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K29-32 [1305758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 400 [8514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 laurate [1490690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea mariana leaf oil [1362141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaverine hydrochloride [203132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentylamine [1367190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pterocarpus marsupium whole extract [2469236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus mume flower oil [2571812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax ginseng flower extract [1307726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol, (S)- [1663407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-propanediol, 1-benzoate [1797116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proparacaine hydrochloride [227778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine needle oil (pinus sylvestris) [1305670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polythiazide [8565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytol [2046119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, inner salt, (2S)- [1433756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pinene [2385340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pasteurella multocida [1437221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetate calcium trisodium [132879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-methylaminophenol sulfate [2625121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus lambertiana resin [1359088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piprozoline [33761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 sorbitan stearate [2101529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Perilla frutescens fruit extract [1311653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-200 glyceryl stearate [2396889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramlintide [139953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudopterogorgia elisabethae extract [1314386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>probucol [8699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-32 laurate [2588246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudostellaria heterophylla whole extract [1600746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-25 propylene glycol stearate [1314192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polypodium lepidopteris root extract [2275614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prucalopride [2107310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parakeet feather allergenic extract [1192987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium sidoides whole extract [2712656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (2300 MW) [1312736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylic acid (800000 MW) [1309736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phormium tenax seed oil [2001129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmidrol [2001986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persea americana whole extract [2533908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmarosa oil [1309374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pheretima aspergillum extract [1746488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-9 [1314210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peanut (Arachis hypogaea) allergen-dnfp [2279402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-120 stearate [1362145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 hydroxyethyl cocamide/isostearamide [1594765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl sh-tripeptide-4 amide [1868208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus speciosa flower extract [2359274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 laurate [1363614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 sorbitan peroleate [2570564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegvaliase-pqpz [2046361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 diheptanoate [1314230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-22 (4500 MPA.S) [1442517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenacemide [33253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 monoisostearate [1435110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 hydrogenated lanolin [1601993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pistachio nut allergenic extract [904606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-55 hydrogenated castor oil [1359087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>policosanol [69440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitic acid [1426390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pilocarpus jaborandi leaf extract [1310081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya seed oil [2637855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polidocanol [968170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4 caprate [1792715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Parthenocissus quinquefolia leaf extract [1859367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-phytase B (Aspergillus niger) [1313304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pheniramine maleate [266959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piroctone [2058907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus densiflora whole extract [2288428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 behenate [1998842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonum cuspidatum root extract [1309457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium ascorbate [1592259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phellodendron chinensis bark extract [1307612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-5 propylheptyl ether [2173920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium magnesium aspartate [1793925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipenzolate bromide [202840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polatuzumab vedotin-piiq [2174091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perphenazine enanthate [33212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment blue 16 [1999764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peucedanum praeruptorum root extract [1535495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pear preparation [1367125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus armeniaca leaf extract [1487507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluorooctyl triethoxysilane [1312743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phospholipids [8246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork intestine preparation [1311392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium,chelated [259277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pittosporum pentandrum whole extract [2045733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 1450 [1367110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysaccharide iron complex [105669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyritinol hydrochloride [236508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycladus orientalis seed extract [1306120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Primula veris flower extract [1487833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegaptanib [498509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potato peel extract [2465570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyurethane-34 (55 MPA) [2589707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 hydroxyethyl stearamide [1482786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pafuramidine [718967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantothenic acid [7891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Perilla frutescens seed oil [1307703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penpulimab-kcqx [2712646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein S, human [1426165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-100 stearate [1367120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (35000 MW) [1314206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phellinus linteus mycelium extract [1312717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus sylvestris whole extract [1800666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plumeria alba flower oil [2589085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyllysylvalyldiaminobutyric acid [1538143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-60 glyceryl isostearate [1356490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pogostemon cablin top extract [1307646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dicaprylate [1426619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 11000 [1314585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physalis alkekengi calyx extract [1369564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 85 [1368887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyamide-3 (12000 MW) [1788948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium dichromate [8595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panthenol triacetate, (+)- [1426597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>permethrin [33199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax ginseng fruit extract [1311648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG/PPG-10/2 dimethicone [1726094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegoterate [1607779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persicaria tinctoria leaf extract [1307670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phensuximide [33309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentosan polysulphate sodium [134413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-3 cocamine [1804257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosphingosine [1363444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pikea robusta extract [1421146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenindamine [33283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium salicylate [235418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancreatic lipase [1427018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 10000 [2200636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol/polyvinyl acetate copolymer (8:1; 50000MW) [1996999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>primaquine phosphate [8689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylephrine [8163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polystyrene sulfonic acid [1546436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentadecanoic acid [1987138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus laurocerasus whole extract [1998616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>purslane extract [1424645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-11 stearyl ether [1426946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperonyl butoxide [8345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglucose sorbitol carboxymethyl ether [1537909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>platinum [1311280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pangamate [646818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peach kernel oil glycereth-8 esters [1547570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridostigmine bromide [9001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ppg-26 oleate [2046780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginesatide acetate [1248797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paullinia cupana seed extract [1311509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein C, human [723868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4 palmitate [2699678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus tremuloides whole extract [1990853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prazosin [8629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propolis [8783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30 glyceryl cocoate [2386217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetate zinc trisodium [408077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxyethanol [89552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polistirex [1312709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 cocamide [1307041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palifermin [196319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peanut oil [18235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-3 [1796120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl salicylate [36122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propentofylline [34644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pradofloxacin [1367269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentane [1311563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomiferin [2593691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyamide-5 [2620843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone [8638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 hexaoleate [1541747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenethylamine [1309741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-20-6 dimethicone [1426780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirbuterol HCl [235447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pepsin A [8016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pediculus humanus var. capitis [1600442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxalene [1314414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperacillin sodium [203134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perillaldehyde [1426913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium oxybate [2387309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment yellow 138 [1438510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl fragment [1742481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polifeprosan 20 [1426339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 hydrogenated lanolin [2047758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phormidium persicinum [1425936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Parietaria officinalis leaf extract [1650423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothionamide [8871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polistes fuscatus whole extract [2590184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium lauroyl glutamate [1789747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 338 [1364384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pumice [1989334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-150 lanolin [2590668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picosulfate sodium [33688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium graveolens whole extract [1442512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 MPA.S) [1607777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago lanceolata leaf extract [1309370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sulfate [34323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2,3-propanetriol, 2-(4-aminobenzoate) [2362184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>para grass pollen extract [894750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procainamide hydrochloride [155056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenmetrazine [8133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla patens extract [1311154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(lactic-co-glycolic acid) (50/50, 0.45-0.6 dL/g inherent viscosity) [1309725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint flowering top extract [2168421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl tetraethylhexanoate [1426406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsley allergenic extract [899877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium pyrophosphate [1426658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 stearate [1309367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 40 stearate [1426432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia lactiflora whole extract [1490687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxal 5-phosphate glutamate [2374916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed disodium [282443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 40 hydrogenated castor oil [1305669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prasterone sodium sulfate [1366962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea abies flower bud extract [1310000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-80 sorbitan laurate [1440237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipothiazine [8348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyltoloxamine resin complex [314786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-propanedithiol [2281674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyester-8 (1400 MW, cyanodiphenylpropenoyl capped) [1314201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-90 diisostearate [1648139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phryma leptostachya whole extract [1945226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 400000 [1312738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pravastatin sodium [203144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plasmin [4388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycerin-10 [1314205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium olivate [2286254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pentadiplandra brazzeana root extract [2667744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Proteus vulgaris [1316073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-15 hydroxystearate [1807443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-oleate [2468052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physostigma venenosum whole extract [2001678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonum arenastrum whole extract [1535496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tripeptide-53 amide [1868209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramipexole [746741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 65 [1426405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pacritinib [2595243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-80 stearate [1484396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>petrolatum [8091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penoxsulam [1482792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>8-p-menthene-1,2-diol, (+)- [2050063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phlomoides rotata whole extract [1725036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pacific cod preparation [1421438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 dioleate [2588485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pheniramine [8132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-15 stearyl ether benzoate [1426945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2-propanediamine [1999575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-47 (methacrylamidopropyltrimethylammonium chloride-co-methyl acrylate-co-acrylic acid 46:8:46; 1300000 MW) [2641594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenformin hydrochloride [235288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-69 (350000 MW) [2268049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium methoxysalicylate [1551457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-10 (30000 MPA.S at 2%) [1428215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomegranate juice [1358975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pumpkin allergenic extract [883459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podophyllum hexandrum root extract [2630722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancreas extract [236439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>precyclemone B [2397689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylenes [8519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperine [1311146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penbutolol sulfate [82070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipamperone [33739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procaterol [34530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pangamic acid [7886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 9000 [1606853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetate [618371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1,2-distearate [1370193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenytoin [8183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-105-5 copolymer [1426949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 81 [1996988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-phenyldodecane-p-sulfonate [2571860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (400000 MW) [1664621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl-n-tert-butylnitrone [2694077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea mariana whole extract [2048035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya allergenic extract [1011426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peptide-T [2644766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 sorbitan isostearate [1372933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 35 castor oil [1309246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pridinol monomesylate [55092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirenzepine hydrochloride [235775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 3500 [1312707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper hancei top extract [2553103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancrelipase amylase [1427033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>purified protein derivative of tuberculin [8948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ponatinib hydrochloride [1364953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pazopanib hydrochloride [732187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytic acid [8302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promethazine dioxide [236815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylic acid (450000 MW) [1314282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus mume fruit extract [1311663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cyanide [1923819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panitumumab [263034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pignut hickory pollen extract [899650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>providone-Iodine [544983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia x suffruticosa seed extract [2590667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piroctone olamine [33783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>platinic chloride [1549109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment violet 23 [2397126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procyanidolic oligomer [236649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picaridin [1737729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia californica whole extract [2539935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium tartrate [55024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxyethyl caprylate [1361658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-4 myristyl ether [2387832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia anomala root extract [1923501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4 isostearate [1367130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia veitchii root extract [1420976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-7 (76-24 acrylamide-dadmac; 120 kD) [1314324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>progesterone [8727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus dulcis pollen extract [2631943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pueraria candollei var. mirifica root extract [1876118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium chlorate [59203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patent blue violet [32950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procyanidin A2 [2631026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosterol esters [637205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone tebutate [34376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycladus orientalis pollen extract [1360623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium nitrite [1365705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago asiatica extract [1367497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parathyroid hormone [1427222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoephedrine hydrochloride [91168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Papaver rhoeas flower extract [1310150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralmorelin [1492039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus dulcis bark extract [1307665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein S [34822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylalanine,DL- [236948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 distearate [1421890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea abies whole extract [2587642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petasites amplus whole extract [2564006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propionamide [1366667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polygalacturonic acid [1918053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygala senega root extract [1310087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-150 pentaerythrityl tetrastearate [1312646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propafenone [8754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantoprazole [40790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picosulfurate [1546458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus laurocerasus leaf extract [1310017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-60 almond glycerides [1363618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pimpinella anisum extract [1426421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol di(2-methylbutyrate) [1739982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 cocamine [2169288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine sulfate [1549138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phytolacca octandra leaf extract [2053440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polixetonium chloride [1736633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylethyl resorcinol [1313724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago seed [82088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pacific oyster preparation [2199491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium phosphate [34322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>primycin [2479689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 3350 [221147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrrolidone carboxylic acid ethyl cocoyl arginate [1741922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perhexiline [8050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleurotus eryngii whole extract [2360030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllanthus niruri whole extract [1374404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Portulaca grandiflora whole extract [1594930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment red 7 [1872249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>physostigmine [8299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 laurate [1363623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenethylamine hydrochloride [1364287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-8 distearate [1363622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol (18000 MW) [1809900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paraldehyde [7909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrimethamine [9010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-3 benzyl ether myristate [1314314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peruvian balsam [33219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine [8340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosteryl macadamiate [1866045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 pentaricinoleate [2376936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol t-butyl ether [2471085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 methyl ether [1367495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prairie sagebrush pollen extract [867142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxyacetic acid [1426335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phlebodium aureum root extract [1790089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper methysticum whole extract [1314199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plazomicin sulfate [2052872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Primula veris extract [1311310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prademagene zamikeracel [2713314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peramivir [619693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plectranthus barbatus whole extract [1544131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pivalic acid [1426868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 propylheptyl ether [1541886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ptychopetalum olacoides root extract [1432990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancrelipase protease [1427034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-125-30 copolymer [2386336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poractant alfa [236381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyrola asarifolia whole extract [2467132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,5-pentanediol [1362880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylic acid (300000 MW) [1719257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium expansum allergenic extract [967111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint oil terpeneless [2467554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyruvaldehyde [1373350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-16 (N-vinylpyrrolidinone:3-methyl-1-vinylimidazolium chloride (5:5)) [1371321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polydextrose [1363053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-caprylate [2668060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 oleate [1798371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoma destructiva allergenic extract [966995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene oxide 200000 [1809901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dibenzoate [1314212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-68 [1740239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-250 distearate [2376934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pueraria montana var. chinensis root extract [1307687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K25 [1367141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-9 polydimethylsiloxyethyl dimethicone [1371303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllanthus niruri top extract [1311656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tripeptide-8 [2583628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium permanganate [8604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-60 sorbitan stearate [1487142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyurethane-34 (40 MPA) [1673802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl acetate [1541597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PLUMERIA EXTRACT [1313235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 rapeseedamide [1307829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyepsilon-lysine (4000 MW) [1996987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propoxyphene hydrochloride [71517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Proteus mirabilis [1310903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyrus communis flower extract [2122083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peanut oil, hydrogenated [1540357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirtobrutinib [2629338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patisiran [2053490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(p-methoxyphenyl)propylene-1,2-oxide [2370138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Punica granatum leaf extract [1794166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 124 [1314379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol (MW 94000) [1790286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>platelet glycoprotein VI [2637677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pokeweed preparation [285160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum odoratum whole extract [1373158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pamidronate [11473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum biflorum root etxract [1373157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol monopalmitostearate [1427010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propoxyphene [8785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyurethane-39 [2690255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 2-(2-methylbutyrate) [1947503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphocellulose [33504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protease [8031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginterferon alfa-2b [253453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paramethasone [7910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 8 stearate [1367133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pteris ensiformis whole extract [2592977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenobarbital sodium [82077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pimpinella saxifraga whole extract [2592626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleospora tarda allergenic extract [852404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polacrilin [1314376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus mugo subsp. mugo leafy twig extract [1796979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyrethrum cinerariifolium allergenic extract [967970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parthenolide [32941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus pinaster whole extract [1855094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium brevicompactum [1426666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine hydrate [67518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 250 [1872039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyurethane-35 (not more than MPA.S at 40 %) [2557220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plum preparation [307387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 hydroxyethyl cocamide [1421437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-150 disetearate [1305728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 stearate [2286803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proglumetacin [34769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>psyllium hydrocolloid [314809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prenylamine [8674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsley extract [317857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium oxide [1599267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pidotimod [40450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentamidine isethionate [7995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pertuzumab-zzxf [2382597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrophosphate [1364533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium arsenite anhydrous [1426895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 2-myristate [2285327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>persimmon extract [1322526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 35000 [1368894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol [8570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procyclidine hydrochloride [142443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>8-pentadecanone [2691820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitolisant hydrochloride [2197879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyruvate [72031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persea americana leaf extract [1307844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 isostearate [2118918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim-jmdb [2048018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperacillin [8339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylparaben sodium [1311574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentobarbital [8004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propyliodone [8793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-10 (10000 MPA.S at 2%) [2049895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procaine [8701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylacetaldehyde [1367159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 2000000 [1438115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>posaconazole [282446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 soy sterol [1314288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus spinosa flower bud extract [1309816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-9 propylheptyl ether [2669404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 acrylate-perfluorohexylethyl acrylate copolymer [1986367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Portulaca oleracea whole extract [1358898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prosopis cineraria wood extract [2590684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata flower extract [1355833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>podophyllin [8462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegcetacoplan [2557372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 diisostearate [1738092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphatidylinositols [8217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phendimetrazine hydrochloride [297716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2-ceteth-9 [2369367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxine dipalmitate [1314231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint oil [33094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG &amp; PPG-17-6 copolymer [1359423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(2-(2-(2-phenoxyethoxy)ethoxy)ethoxy)ethanol [1655970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla vulgaris extract [1311188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramlintide acetate [356773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoma glomerata allergenic extract [975996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 12000 [1989912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid), (75:25; 140000 MW) [2639716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-phenylpropanal propylene glycol acetal [1947505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paramethadione [32894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus trichocarpa whole extract [2590683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-dodecylbenzenesulfonic acid [1495319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propantheline [8761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>porfimer sodium [333848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene terephthalate (intrinsic viscosity 0.40-0.70) [2047189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentosan polysulfate [155046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 61 [1923243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbates [8561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrithione [35100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polymyxin B [8536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone sodium phosphate [55062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium citrate monohydrate [221149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium nitrate [34316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Portulaca oleracea leaf extract [1429042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>podofilox [8463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perflunafene [2462501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylephrine tannate [221139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 myristate [2603288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tetrapeptide-7 [1314277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protamines [8826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proximadiol [2562551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenindamine tartrate [221137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (800000 MW) [1374805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(laurylglucoside)-7 [1927429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proguanil hydrochloride [142428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium oxyquinolone [325520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium estrone [325519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phospholipid,beef [236757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxetine mesylate [436212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata seed extract [1371911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegaspargase [34132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenol [33290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pistacia lentiscus seed oil [1363831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paltusotine [2724363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium tetrachloroaurate dihydrate [2120298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-3 myristyl ether [1427148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimagedine hydrochloride [1311669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone phosphate [34374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmate [1356711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycols [8516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>petroleum preparation [324028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylbutyrate [81647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin G potassium [203133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancreatic alpha-amylase [2475192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panicum miliaceum whole extract [2592976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pentaclethra macroloba seed oil [1997156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pearl (Hyriopsis cumingii) extract [1438509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 300000 [1426702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petasites japonicus root extract [1368337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylehrine [325517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus apetala whole extract [1607315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peumus boldus leaf extract [1310049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-14 PPG-7 ethylhexyl ether [2266812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pinaverium [33724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenacetin [8113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peracetic acid [2045732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>progesterone, micronized [259409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyester (adipic acid, 1,6-hexanediol, neopentyl glycol) [2289218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 dipalmitate [2480113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-behenate [2101072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium lauryl sulfate [1427140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>platinic chloride hexahydrate [1720938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin G [7980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycladus orientalis leaf extract [1309453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pumpkin whole allergenic extract [2102476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pepper extract [1427085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium iodide [8597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polypodium leucotomos [578377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenprocoumon [8150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment orange 2 [1491867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polignate sodium [1541249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrithione sodium [2464540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pelargonic acid [2054104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tetrapeptide-94 [2668590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 237 [1492190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phytolacca americana fruit extract [1314247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>profenamine [4134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ponazuril [298983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pisum sativum (pea) extract [1426912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physalis angulata extract [1338937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phaseolus vulgaris whole extract [1876358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-12 [1793745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium oleate [1426936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata whole extract [1732648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pristinamycin [66958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pecan pollen extract [852272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyaminopropyl biguanide hydrochloride [2370881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol ricinoleate [1944253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proguanil [2382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K15 [1314251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed tromethamine anhydrous [2604776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plicamycin [6995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physalia physalis preparation [1354527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycolic acid [2466981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prasterone [3143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peach juice [1651320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 tetraisostearate [2665127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propiolactone [1311565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procaterol hydrochloride [58918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudevernia furfuracea extract [1426918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podocarpus elatus fruit extract [2122672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphatidylcholine:ceramide cholinephosphotransferase 1 [2606778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperidinepropionic acid [1356491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-9 dimethicone [1312396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus cerasus flower extract [2643154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plasminogen, human-tvmh [2557201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancrelipase [235379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentagastrin [7993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promethazine [8745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podocarpus elatus whole extract [1803720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethyloxazoline (5000 MW) [2468051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 ricinoleate [1313258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyltoloxamine [33408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peruvian pepper tree pollen extract [2632070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper excelsum leaf extract [2690737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyhydroxystearic acid [1872909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus cerasus flower bud extract [1860609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pullulan [1425878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-25 stearate [2108126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol monostearate [1314411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tripeptide-5 [1314284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palm kernelate [1370620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-phenylethanol [2001176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Proteus inconstans [1310846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cetyl phosphate [1367140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pertuzumab [1298944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-37 (10000 MPA.S) [1370678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphocysteamine [8226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomegranate fruit extract [1246101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-175 distearate [2534442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piflufolastat F-18 [2556616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petasites fragrans extract [1428876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plukenetia volubilis seed oil [1307822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetic acid [3690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plantain preparation [285246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 dilaurate [1363613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-3 alpha-linolenamide [1312711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-5 [1862971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium laurate [1808535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prilocaine [8686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus pinaster seed oil [1864321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 100000 [1735332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-3 distearoylamidoethylmonium methosulfate [1427016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pectin [32987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyltoloxamine citrate [221141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenelzine [8123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleiogynium timoriense fruit extract [2376935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polygalacturonate [1918054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipazetate hydrochloride [236487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pregabalin [187832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-50 stearate [2118846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago ovata seed extract [1309942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-18-18-dimethicone [1426610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-53 [1601984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prajmaline [8622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-5-ceteth-20 [1424874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pueraria montana var. lobata root extract [1309751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment green 7 [1918055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus sylvestris leafy twig [1310095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegbovigrastim [1746487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG 12 buteth 16 [1314243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picrotoxin [2539172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petasites hybridus root extract [1541241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polihexanide hydrochloride [1790898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pembrolizumab [1547545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyethylene ether [235534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (2600000 MW) [2003713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pasireotide pamoate [1597818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus sylvestris sprout extract [1809827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine citrate [342992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyhydroxystearic acid stearate [1872908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 lanolin [2288210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol heptanoate [1427060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propamidine isethionate [34634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paritaprevir [1597373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(sodium vinyl sulfonate) [52259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine nut extract [1872038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyurethane-62 [2565487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothrombin, human [1441689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol (130000 MW) [2273236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pongamia pinnata fruit extract [2672261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin G benzathine [7982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemivibart [2677789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus serrulata flower extract [1310037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-39 (31-40-29 acrylic acid-acrylamide-dadmac; 1500000 MW) [1421900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantolactone [1427237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia suffruticosa root extract [1307975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus balsamifera leaf bud extract [1428422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone-iodine [8611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyltoloxamine polistirex [236792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piscidia piscipula root bark extract [1309296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvalent Crotalidae antivenin [91596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(vinylpyrrolidone-co-vinyl-acetate) [1311488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylacetate [70619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago major seed extract [1310080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxetine [32937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenelzine sulfate [8124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protamine hydrochloride [236471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonum bistorta root extract [1309456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Parietaria officinalis extract [1351897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palonosetron [70561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrodifenium bromide [9021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-allyl ether [1544276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 MW) [1798376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 60 castor oil [1309972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panthenol [1044977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ponatinib [1364347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proxigermanium [158660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol [34693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>physostigmine salicylate [33656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-menthane-3,8-diol [2385886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl methicone (500 CST) [1654388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phellinus linteus whole extract [1314197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 15 hydroxystearate [2472795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pargyline [7930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrilamine maleate [82091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythritol 3,5-di-tert-butyl-4-hydroxyhydrocinnamate [1926329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemirolast potassium [259318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudotsuga menziesii resin [2463335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllanthus emblica fruit extract [1311654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piridocaine hydrochloride [1947298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-39 (35-35-30 acrylic acid-acrylamide-dadmac; 1500000 MW) [1426649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pivampicillin hydrochloride [42553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium tellurite [1921888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium metabisulfite [1362899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 200 [1368864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata extract [253193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 oleate [1356767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 hydrogenated castor oil [1651596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panobinostat [1603350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid) (75:25; 140000 MW) [1947144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protriptyline hydrochloride [203199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-5 trioleate [2399029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitavastatin [861634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Porphyra tenera extract [1808534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pistacia lentiscus resin [1313236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone sodium succinate [55063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prolinal [2569079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenolsulfonate [1651702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tetrapeptide-95 [2668591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium citrate [54993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus tremula flowering top extract [1310100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 diisostearate [1431226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paprika allergenic extract [899873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prajmalium bitartrate [236896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 700 [1312721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycerol polyricinoleic acid [1541749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrilamine tannate [221152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procarbazine [8702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phendimetrazine tartrate [58157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentylenetetrazole [8015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylhexedrine [8792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paris quadrifolia extract [1492935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus cerasifera flower extract [1353883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus armeniaca seed extract [1309458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene oxide [1368175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pafolacianine [2586857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylpropanol [2475178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patisiran sodium lipid complex [2284710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyvinyl acetate phthalate [1367129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>post oak pollen extract [901011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol monocaprate [2099293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Punica granatum seed extract [1310067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium 37 (200 MPA.S) [1314234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platycladus orientalis whole extract [1923816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polacrilin potassium [1367128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrophosphoric acid [1546425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirlimycin hydrochloride [1367291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine hexahydrate [271743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 glyceryl cocoate [1307098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parasorbate [1998744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>privet pollen extract [852622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-51/SMDI copolymer [1721621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrazinamide [8987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pazopanib [714438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prazepam [8627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penfluridol [7974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>psyllium seed coatings,blond [314812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridostigmine [9000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetate calcium [1369590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-8-ceteth-20 [2534445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentamidine [7994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promazine hydrochloride [142444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pummelo extract [1363624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphate ion(2-) [2699657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>posterior pituitary hormones [8366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylamide (crosslinked; 2 mole percent bisacrylamide) [1993232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluorodimethylcyclohexane [1876640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentapeptide-34 trifluoroacetate [2610316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persicaria punctata extract [1482544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-pyrrolidone [1358473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(p-hydroxyphenyl)dimethylsulfonium chloride [1921086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phlebodium aureum leaf extract [2539431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginesatide [1248798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium gluconate [89903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>POLYQUATERNIUM-80 [2604571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine nut oil [2102725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid) (50:50; 15000 MW) [2257287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenformin [8129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-myristate [2282661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paper birch pollen extract [899576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysilicone-15 [1367142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia lactiflora flower extract [1594764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prucalopride succinate [2107309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propiomazine [8770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pergolide [8047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palo verde pollen extract [852359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl tetrastearate [1307090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 900 [1314204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium triiodide [1376155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 glyceryl stearate [2699125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>permanganate [1923815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralidoxime iodide [55052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patiromer [1716203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus palustris leaf extract [1366330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perflutren [283753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dicaprate [1427009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene oxide 5000000 [1944252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythritol [33055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piflufolastat [2556617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 8000000 [1370827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Primula hendersonii whole extract [2533896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-45 palm kernel glycerides [1489761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium citrate anhydrous [1374802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus x yedoensis flower extract [2388333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(lactic-co-glycolic acid) (85/15, 0.25-0.27 dL/g inherent viscosity) [1309732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium [8588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirenzepine [8352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 sorbitan stearate [2601100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prochlorperazine maleate [8706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piroxicam cinnamate [33787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol salicylate [236449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pineapple extract [1492174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Proteins [8859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>petroleum distillate [90737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 hydrogenated castor oil [1926952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycerin-20 [2396435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancuronium bromide [7884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Padina pavonica extract [1424357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-10 cetyl ether [1356702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentolamine mesylate [227240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-75 dilaurate [2562173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-6 (15000 MW) [1373446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl myristyl serinate [2667641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,4,9,10-perylenetetracarboxylic diimide [1491869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 ricinoleate [1373726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polarcrillin sodium [1366978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,5-piperazinedione [1313303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dipropionate [1806903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-20-20 dimethicone [1426672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylbutazone [8160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-32 distearate [2463530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl isoleucine [1733679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothipendyl [55244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 rapeseed sterol [1862481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piretanide [33770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proglumide [8730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 glyceryl dimyristate [1307096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenindione [8130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phendimetrazine [33272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phytolacca americana root extract [1309711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancreatic triacylglycerol lipase [2475193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potato allergenic extract [892632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium bicarbonate [34296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus domestica subsp. insititia seed oil [1422929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenolate sodium [1495317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pterocarpus soyauxii wood extract [2003231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K17 [1313249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium ion [1318915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-55 [2691821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pacific halibut allergenic extract [882469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 oleate [2383936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potash [1370422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllanthus emblica fruit juice [1356140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl glutamate [1370585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphonic acid [1427087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-25-laureth-25 [1371318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-propenoic acid, 2-cyano-3,3-diphenyl-2,2-bis(((2-cyano-1-oxo-3,3-diphenyl-2-propenyl)oxy)methyl)-1,3-propanediyl ester [2372916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (85000 MW) [1812933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>periciazine [8766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 331 [1486516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyoxyl 60 hydrogenated castor oil [1307688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pogostemon cablin whole extract [1487834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitolisant [2197878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) [1369405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-23 glyceryl distearate [1721435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium asparaginate [1313174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 188 [155152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl distearate [1312716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pefloxacin [7960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyhydroxystearic acid (2300 MW) [1307042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parethoxycaine [236249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitamidopropyltrimonium [1489929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentazocine [8001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol hydroxystearate [2003790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Potentilla anserina whole extract [1442994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya juice [1312645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-10 (400 CPS at 2%) [1367143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl lysyldioxymethionyllysine [1424459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium glaucum allergenic extract [1986792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 soy sterol [1433643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralsetinib [2394936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 polyricinoleate [2643065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper sarmentosum whole extract [2711692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus spinosa fruit extract [1482548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pexidartinib [2183102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelargonium sidoides root extract [1310166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya extract [1992412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pelvetia canaliculata extract [1426416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platanus occidentalis whole extract [1440278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 glyceryl isostearate [1435865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peptostreptococcus anaerobius DNA [2536938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 laurate [1313256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 ethylhexanoate [1726669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-90 stearate [1543741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago asiatica seed extract [2118532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 105 [2465732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Perilla frutescens whole extract [2590049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoenix dactylifera whole extract [1992542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 sesquiisostearate [1742941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-3 oleate [1648138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phanerodontia chrysosporium allergenic extract [968114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 184 [1368182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-6 (150000 MW) [1999412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>purslane oil [1367164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polytetrafluoroethylene [1358182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork collagen preparation [1311319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physalis pubescens fruit juice [2603287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 2500 [2119177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plasmodium malariae [1432989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cocoate [1426445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemoline [7966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 2-behenate [2383937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 decaoleate [1421889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoenix dactylifera seed extract [1368338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 dilaurate [1312710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenethyl benzoate [1426333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipobroman [8347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridinolcarbamate [8997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylthiouracil [8794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 2-oleate [1788995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dioleate [1369688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus massoniana resin [1311586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pioglitazone [33738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 soy sterol [1863569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 stearate [1363612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 500 [1313266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 isoceteth-20 acetate [1314209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantanus orientalis whole extract [2055002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-3 distearate [1489764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(DL-lactic-co-glycolic acid), (75:25; 9500 MW) [2671242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine tar [8333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin V benzathine [18926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus resinosa whole extract [2283757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment orange 34 [2000532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-14-4 dimethicone [1426673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-20 glyceryl stearate [1309365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantethine [32863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol alginate [1361656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proline, DL- [1426951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palm acid [1426624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimavanserin tartrate [1791686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2-stearate [1922746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promestriene [34625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 acrylate [1940009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirinitramide [8354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus spinosa whole extract [1442995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper wallichii leafy twig extract [2610404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper capense whole extract [2667251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG/PPG-18/12 dimethicone [2387543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus mume whole extract [1600745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perindopril [54552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pineapple allergenic extract [899895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Papaver orientale seed oil [2413033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 caprate [2467277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentermine resin [221138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylhydrazine hydrochloride [292726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persicaria filiformis flowering top extract [1990420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoperidine [8143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piribedil [8353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-14 butyl ether [1368192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylalanine [8156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-50 lanolin [2686033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora incarnata seed oil [1309491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus thunbergii whole extract [1600141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protamone [453012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus tremuloides leaf extract [1310108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-32 stearate [1309366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 glyceryl laurate [2540678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piridocaine [1947299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pheniramine aminosalicylate [159340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus densiflora root extract [1367496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium benzoate [54991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylate [1370575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poldine [33926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 caprylate [2559843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium ascorbyl tocopheryl phosphate [1427199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus massoniana pollen extract [1801707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirarubicin [33764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paregoric [32926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaveretum [7894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluoromethylcyclopentane [2048724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pennyroyal oil [1309213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonum cuspidatum whole extract [1420977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentapeptide-31 [1875949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pleospora herbarum allergenic extract [971198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly-L-lysine (30000-70000 MW) [2380370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylamide (1500 MW) [1312742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenazopyridine [8120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paulownia tomentosa whole extract [2479550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (1000 MW) [1368895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Protortonia cacti preparation [1355830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia suffruticosa flower oil [1739225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer [155156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perch allergenic extract [976711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora edulis whole extract [2049986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentastarch [816249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picrate [1443000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaya seed extract [1537752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylbutazone sodium [236529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol propyl ether [1947500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pandanus tectorius root extract [1546706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Padang cassia bark extract [2665289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax ginseng whole extract [1368530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 caprylic-capric glycerides [1543773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisoprene (34000 MW) [2118834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytase [1043631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 pentaoleate [2384444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pumpkin seed oil [466570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sodium tartrate [1311363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pilocarpine [8328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polatuzumab vedotin [2174090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dibutyrate [2370144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysulfated glycosaminoglycan [1085955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenolate [1495318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propranolol [8787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 20000 [1747569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipotiazine palmitate [235745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pradofloxacin trihydrate [2680581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphatidylethanolamines [8215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (55000 MW) [1925580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pilocarpine nitrate [103244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenothrin [33303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimozide [8331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polymethylsilsesquioxane (11 microns) [1426429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysorbate 20 [8559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prilocaine hydrochloride [2557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudolarix amabilis whole extract [1999322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 181 [1371947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 stearate [1312395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patisiran sodium [2053491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium sulfide [236907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxetine hydrochloride [235830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica flower extract [1310009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perflenapent [2474632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 800 [1307313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperidolate hydrochloride [102170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(perfluorohexyl)ethanethiol [2672488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-(phosphonooxy)- 2-propenoate [2385889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prezatide [1368533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Platanus occidentalis bark extract [2590682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 403 [1422193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prickly pear fruit extract [1368342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pterocarpus marsupium bark extract [2465836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaverine [7895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia suffruticosa root bark extract [1307729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promazine [8742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plum allergenic extract [899470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podophyllum preparation [324040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promegestone [8744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium bromate [34298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 1000000 [1314202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 3000 [1368866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propolis wax [1311659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plecanatide [1873752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>para-cresol [2467144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrethrins [8991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procaine hydrochloride [106558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-propanediol bis(4-aminobenzoate) [1923479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peginterferon alfa-2a [120608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-32 oleate [1428875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-phenylbutyric acid [1546447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl collagen acid [236410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunella vulgaris flowering top extract [1309294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papain [7892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 4000000 [1370192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pregna-4,17-diene-3,16-dione [1088591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pueraria montana var. lobata flowering top extract [1733670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petiveria alliacea root extract [1309495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procarbazine hydrochloride [66925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper betle leaf extract [1421446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene terephthalate (intrinsic visconsity 0.70-1.00) [1737846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllolobium chinense seed extract [2665341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudognaphalium luteoalbum leaf extract [1353219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-(p-hydroxyphenyl)-2-butanone acetate [1307548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 myristate [2188090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantothenate [62400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (1300 MW) [1426426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pacritinib citrate [2595242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenytoin sodium [71227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 myristyl ether propionate [1426407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenolsulfonphthalein [8141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium glabrum [1328760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phthalylsulfacetamide [89736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxine [684879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonum aviculare top extract [1310279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>physostigmine sulfate [106047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium methylparaben [1535699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piracetam [8351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium lactate, DL- [2571989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia lactiflora root extract [1307731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pexidartinib hydrochloride [2183103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30 glyceryl stearate [1747476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pear juice [1313233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus alba leaf extract [2053441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-37 (25000 MPA.S) [1372567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork allergenic extract [892628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prussian blue insoluble [24902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrethrum allergenic extract [2102029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pioglitazone hydrochloride [259319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paecilomyces variotii allergenic extract [966979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium glucoheptonate [236259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-propenoic acid, 3-hydroxypropyl ester [2689781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prezatide copper acetate [1314596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium italicum allergenic extract [967960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6-dioleate [1431309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsley oil [1482539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica twig extract [2570281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phospholipase D1 [2608530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium aluminum disilicate [2267407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perazine dimalonate [236771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone (K-30) simethicone emulsion [1305760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 distearate [1367498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus tabuliformis bark extract [1307671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proline [8737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picolinic acid [33684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 2-methylbutyrate [2059293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 distearate [2619244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylic acid (250000 MW) [1309733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pygeum africanum preparation [236466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-25 hydrogenated castor oil [1356139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30 castor oil [1485183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralidoxime mesylate [55053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panthenyl ethyl ether acetate [1657859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propionaldehyde [2359273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 ricinoleate [2534444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomalidomide [1369713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus strobus bark extract [1309309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-phenyl-1-propanol [2479688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyllysylvalyldiaminobutyroylthreonine [1486022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment red 5 [1372631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegunigalsidase alfa-iwxj [2637445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-16 macademia glycerides [2360894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol methyl ether [1367160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podophyllum peltatum root extract [1310099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium lauryl phosphate [1593446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>panthenyl ethyl ether [1356484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol butyl ether [1799007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 dimethicone (600 CST) [1368157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 beta-sitosteryl ether [2604569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pancreatin [7880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tripeptide-1 acetate [2109750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penciclovir [59839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phyllanthus emblica whole extract [2178752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Planatus occidentalis bark extract [1370990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium chrysogenum var. chrysogenum allergenic extract [854130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 glyceryl oleate [1726095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perindopril arginine [1600711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 1000 [1368863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paclitaxel poliglumex [2473230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimecrolimus [321952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus virginiana bark extract [1442700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantoprazole sodium [253191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picrorhiza kurroa whole extract [2557800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plerixafor [733003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim-cbqv [2102692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylheptyl caprylate [1427011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peptide Hydrolases [8028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phthalylsulfathiazole [33632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax japonicus root extract [1307794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylbutazone piperazine [236354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 glyceryl triisostearate [1545358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyisobutylene (200000 MW) [1366994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl hexapeptide-12 [1732116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plumeria alba flower extract [1999323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propanidid [8758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegoxol 7 stearate [1367127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-7 (70-30 acrylamide-DADMAC; 1600 kD) [1426394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pretomanid [2198359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propinox [76273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pheasant feather extract [1594964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxal phosphate [9004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-phenylazo-2-naphthylamine [1430252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pueraria montana var. lobata whole extract [1435397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper aduncum leaf extract [1374405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium tartrate hemihydrate [2054999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penconazole [2593184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-20 methyl glucose ether [1368183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pongamol [1426400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>probenecid [8698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petroselinum crispum root extract [1311510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrvinium [35163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium chloride [8591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla alpina whole extract [2583871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propranolol hydrochloride [82084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulmonaria officinalis whole extract [1809896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penpulimab [2712542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 sesquioleate [2261377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxybenzamine [8149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperidolate [59064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polygalic acid [1735162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pamidronic acid [1546406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunella vulgaris flower extract [2533909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 sorbitan oleate [1485119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyamide-3 (20000 MW) [2643443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 &amp; SMDI copolymer [1366992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propanediol 1-phosphate [2603037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [1440971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pisum sativum whole extract [1866393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-175 diisostearate [1426160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 stearate [1998843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipenzolate [33743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrrolidine [2585446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propofol lipid emulsion [2559907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 600 [1310598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>psyllium [8928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phospholipid phosphatase 1 [2562174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-60 lanolin [1603523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium bisulfite [1426433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,10,15,19,23-pentahydrosqualene [1862733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium hydroxyquinoline sulfate [235776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentaerythrityl tetrabehenate [1542375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 glyceryl isostearate [1440235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-40 sorbitan diisostearate [1363615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protocatechualdehyde [1362689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phanera variegata whole extract [2381134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyester-5 (TG-48) [2289012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Portulaca oreracea seed extract [1608546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus americana whole extract [1811765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peramivir anhydrous [1598096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>procainamide [8700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-30-dipolyhydroxystearate [1363570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol diethylhexanoate [1426620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 hydroxyethyl isostearamide [1940148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 dipolyhydroxystearate [1363445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillamine [7975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 caprylate [2533031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plutonium [1600135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peanut allergenic extract [891658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pipemidate [113831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-7 (70-30 acrylamide-DADMAC; 900 kD) [1314297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone sodium metasulphobenzoate [268872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 oleate [1363616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pravastatin [42463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium carbonate [34300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed monohydrate [2590669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pineapple juice [1799149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphoramidic acid [1312381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propane [1362877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palm kernel oil [1309252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralidoxime chloride [55322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-150-decyl alcohol-SMDI copolymer (1350 MPA.S at 3%) [1435521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycerin-4 [1486795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago indica seed coat extract [2120183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prolintane [34604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin V potassium [203195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrogallol [9022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proxibarbal [83885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-39 (22.5-51-26.5 acrylic acid-acrylamide-DADMAC; 1600000 MW) [1428041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>porcine heart preparation [1311301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia obovata root extract [1865702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentoxifylline [8013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pramoxine [34347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylmercury [1426779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus koraiensis seed oil [1488820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phlorhizin [1362735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-80 sorbitan palmitate [1430440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene oxide 2000000 [2044901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pistachio oil [1307870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosteryl/octyldodecyl lauroyl glutamate [1796718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed [68446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork liver preparation [1311071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plains cottonwood pollen extract [867297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper kadsura stem extract [1307855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>passiflora incarnata flowering top extract [1309979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ponesimod [2532300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>proflavine hemisulfate [8724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Picea mariana resin [1311051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 4000 [1310594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prolinamidoethyl imidazole [1362142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phellodendron chinense whole extract [1945225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prothipendyl hydrochloride [236710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-90 glyceryl isostearate [2387540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pin oak pollen extract [900999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prevotella intermedia [2591816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polihexanide [1373041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylephrine hydrochloride, DL- [2670532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol dinitrate [2370146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pridinol hydrochloride [236869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyroglutamate [155060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-20 methyl glucose sesquistearate [1430130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4 polyricinoleate [2677422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylisothiocyanate [1368174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphorus [8263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prune preparation [340262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polysaccharide-K [1804843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantothenic acid, (+-)- [2394646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyestradiol [34119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenmetrazine theoclate [236652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poly(lactide) [1424562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pregnenolone [114052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-anisaldehyde [1940008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prochlorperazine edisylate [8705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cocoyl glutamate [1425355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polaprezinc [2179843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Passiflora edulis fruit juice [1539635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenethicillin [33277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plectranthus amboinicus whole extract [2360893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxypropione [133070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillium digitatum allergenic extract [1427044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-7 trimethylolpropane coconut ether [2597522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Panax notoginseng whole extract [1606213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plasacryl T20 [2668190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plum juice [2604570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium mercuric iodide [1426940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pargyline hydrochloride [82069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla pratensis extract [283682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-5 cocamide [2630879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine phosphate [54749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physostigma venenosum seed extract [1310076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus massoniana leaf extract [1746489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ptychopetalum olacoides wood extract [1371302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pergolide mesylate [8048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plant stanol ester [259320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrroloquinolinedione tricarboxylic acid [2471086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-2 methyl ether [1312727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentadecalactone [1312715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-1-PEG-9 lauryl glycol ether [1489919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimeclone [2673756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 distearate [2621544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt [1440970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pseudognaphalium obtusifolium extract [1311121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium lactate [314797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>papaveretum hydrochloride [253192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyaminopropyl biguanide [1314381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peg-75 lanolin [1363619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium chromate(VI) [34303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentermine [8152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-32 hydrogenated palm glycerides [1547622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pork brain preparation [1311069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenyl butyrate [1545685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>picosulfuric acid [1546457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phloretin [1368167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Psidium guajava extract [1428840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Piper methysticum root extract [1309452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium azeloyl diglycinate [1366229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimeclone hydrochloride [2673755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus taeda bark extract [1593612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia officinalis whole extract [1489760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polybutester [2049679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>plum seed oil [1309455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podophyllum peltatum preparation [324036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegvaliase [2046360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 laurate [1426747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paeonia officinalis root extract [1310101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pinacidil [33717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegloticase [1011650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica flower bud extract [1945838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 8000 [1307312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol 1-stearate [2169962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pimpinella saxifraga root extract [1310033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pecan allergenic extract [892332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla koreana whole extract [1429953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Physalis alkekengi fruit extract [1435097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Porphyridium purpureum extract [1328315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pisum sativum whole allergenic extract [2261371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegunigalsidase alfa [2637446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phragmites karka whole extract [2261383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-4 caprylic-capric glycerides [2474631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint preparation [33093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 1500 [1314382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phthalimidoperoxycaproic acid [2665626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pigment brown 1 [2000531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim-fpgk [2613761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentazocine lactate [203196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine adipate [33746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyritidium [1420978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Paris polyphylla whole extract [1793743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paraffin [7906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin G procaine [7983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Petiveria alliacea whole extract [1373036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-phenylphenol [236677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine:N-butyl methacrylate; 3:7) [1359090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentigide [1362920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin G sodium [9900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum multiflorum whole extract [1435866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pitch pine pollen extract [900758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-chloro-m-cresol [1370582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoephedrine sulfate [91169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poloxamer 407 [155155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene carbonate [1363696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pine whole extract [2121056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propiverine hydrochloride [55176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 dimethicone (220 CST) [2621708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-17-18 dimethicone [1373725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum cyrtonema root extract [1592900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polygonum cuspidatum leaf extract [1492339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxetine hydrochloride anhydrous [1311626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Polygonatum sibiricum root extract [1372637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pothos repens root extract [2634552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peppermint allergenic extract [1010971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-tert-butylphenol-formaldehyde resin (low molecular weight) [1427189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Podophyllum hexandrum whole extract [2636601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protein C, human-lans [2643198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylpropanolamine [8175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Populus tremula whole extract [1545791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pizotyline malate [235747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-6 isostearate [1366669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-12 dimethicone/PPG-20 crosspolymer [1600596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 diisostearate [1364380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrisuccideanol [35097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-45/dodecyl glycol copolymer [1940010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plectranthus barbatus root extract [1309454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phosphorus 32 [258478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3-propanediol [1363030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Propionibacterium avidum [1310909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenolsulfonic acid [1651701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium iodate [34312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-9 diglycidyl ether and sodium hyaluronate cross polymer [1421547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-30 cetyl ether [2002065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protamine sulfate (USP) [8825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propamidine [34633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 stearate [2539173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-4 stearate [1873581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegfilgrastim-bmez [2260702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prasugrel [613391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promethazine hydrobromide [485608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-75 stearate [1363620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peucedanum ostruthium leaf extract [1311511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednazoline [168651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Poncirus trifoliata fruit extract [1358900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrrolidone carboxylate [1370623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG PPG116-66 copolymer [1366231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-PPG-14-7 dimethyl ether [1356766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-6 polyricinoleate [2465731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promethazine hydrochloride [142445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Penicillin [70618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pralidoxime [34345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylene glycol caprylate [1661194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phytosteryl isostearyl dimer dilinoleate [1735045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perhexiline maleate [33169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-8 isostearate [2199864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-11 avocado glycerides [1543415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenolphthalein [155122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pemetrexed dipotassium [2699334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propranolol glycol [2105554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus halepensis resin [2629718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-10 (20000 MPA.S at 2%) [2467131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-10 beta-sitosterol [1808613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednisolone acetate [34372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>povidone K30 [1297406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperazine, 1-(4&apos;-methoxy(1,1&apos;-biphenyl)-2-yl)- [1594338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunella vulgaris extract [2001198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus persica whole extract [2585445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus mume flower extract [1307653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>platinic iodide [1720940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polixetonium [1549143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium citrate trihydrate [2634820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglycerin-3 [1426428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tetrapeptide-10 [2387076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegademase bovine [59768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pyrus communis flower whole extract [2565688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perphenazine [8076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium guaiacolsulfonate [91275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperacillin anhydrous [1546000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Prunus serotina fruit extract [1311664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poison ivy extract [236106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-37 (3000 MPA.S) [1372481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Persicaria tinctoria top extract [1424359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylpropanolamine hydrochloride [3266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palm kernel acid [1426626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyethylene glycol 600000 [1314203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-5 polyricinoleate [2612152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parsnip allergenic extract [1011027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-16 soy sterol [1855888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prednylidene [12473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylsilanetriol [2637676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pindolol [8332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palmitoyl tripeptide-54 amide [1868210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-hydroxyamphetamine [7839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyacrylate crosspolymer-6 [2698020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyamide-3 (30000 MW) [1926330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-3 oleate [1370731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Porphyra yezoensis extract [1426917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PEG-50 shea butter [2462445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Packera aurea extract [1330093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-2 palmitate [2384782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium undecylenate [1744166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Punica granatum root bark extract [1354526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pSCN5A-Neo [2204567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Poa pratensis top extract [1326503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pulsatilla vulgaris top extract [2621829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>PPG-26-buteth-26 [1423273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parasorbic acid [1998743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentetreotide [69893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-10 (125 MPA.S at 2%) [1429395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirbuterol [33767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phleum pratense allergenic extract [1922743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pumpkin seed extract [126291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pteridium aquilinum whole extract [1482545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Pinus densiflora bark extract [1310107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polidronium [1426892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Plantago australis whole extract [2590681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propyphenazone [34710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyrvinium pamoate [55347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Phoenix reclinata fruit extract [1801066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyglyceryl-10 pentastearate [1876663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polyquaternium-32 (30000 MPA.S at 2%) [1655569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>peroxidase [1600930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pLDLR-Neo [2204566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P-Glycoprotein Inducers [MoA]</name>
  <code>C651270</code>  <id>651270</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inducers</to_name>
    <to_code>T37962</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191264</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P-Glycoprotein Inhibitors [MoA]</name>
  <code>C645332</code>  <id>645332</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors</to_name>
    <to_code>T37963</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185503</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berotralstat [2467540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voclosporin [2475166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venetoclax [1747556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline [2694828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticagrelor [1116632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vimseltinib [2705378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abrocitinib [2591476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutivacaftor [2701430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maribavir [2586068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abciximab [83929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline hydrochloride [2059038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotagliflozin [2638675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flibanserin [1665509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P-Glycoprotein Interactions [MoA]</name>
  <code>C656</code>  <id>657</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Interactions</to_name>
    <to_code>T37964</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000239</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P-Glycoprotein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P-Glycoprotein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Glycoprotein Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P-Selectin Blockers [MoA]</name>
  <code>C654254</code>  <id>654254</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Selectin Blockers</to_name>
    <to_code>T58782</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194031</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab [2262279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Selectin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P2Y12 Platelet Inhibitor [EPC]</name>
  <code>C641708</code>  <id>641708</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Platelet Inhibitor</to_name>
    <to_code>T37985</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Platelet Aggregation Inhibitor</to_name>
    <to_code>T37984</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182142</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prasugrel [613391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clopidogrel [32968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cangrelor [1656052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>P2Y12 Platelet Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticagrelor [1116632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with platelet aggregation inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Platelet Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing platelet aggregation inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Platelet Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>P2Y12 Receptor Antagonists [MoA]</name>
  <code>C641709</code>  <id>641709</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists</to_name>
    <to_code>T37986</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182143</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticagrelor [1116632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel hydrochloride [847020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel bisulfate [236991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor tetrasodium [1656051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor [1656052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel [613391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel [32968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>PCSK9 Inhibitor [EPC]</name>
  <code>C651847</code>  <id>651847</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor</to_name>
    <to_code>T38077</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitor</to_name>
    <to_code>T38078</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191731</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PCSK9 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PCSK9 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alirocumab [1659152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PCSK9 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing proprotein convertase subtilisin/kexin type 9 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PCSK9 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>evolocumab [1665684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>PCSK9 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>PCSK9 Inhibitors [MoA]</name>
  <code>C651846</code>  <id>651846</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitors</to_name>
    <to_code>T38080</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors</to_name>
    <to_code>T38079</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191730</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alirocumab [1659152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evolocumab [1665684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>PIF Activity Alteration [PE]</name>
  <code>C29932</code>  <id>29933</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>PIF Activity Alteration</to_name>
    <to_code>T38233</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009783</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PIF Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PIF Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PIF Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PIF Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>PIF Secretion Alteration [PE]</name>
  <code>C29936</code>  <id>29937</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>PIF Secretion Alteration</to_name>
    <to_code>T38234</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009785</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PIF Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PIF Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PIF Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PIF Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>PRF Activity Alteration [PE]</name>
  <code>C29938</code>  <id>29939</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>PRF Activity Alteration</to_name>
    <to_code>T38421</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009786</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PRF Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PRF Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PRF Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PRF Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>PRF Secretion Alteration [PE]</name>
  <code>C29942</code>  <id>29943</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>PRF Secretion Alteration</to_name>
    <to_code>T38422</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009788</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PRF Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PRF Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>PRF Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PRF Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Enzymatic Replacement [PE]</name>
  <code>C29944</code>  <id>29945</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Enzymatic Replacement</to_name>
    <to_code>T38618</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009789</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylase / lipase / protease [392491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Enzymatic Replacement [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Enzymatic Secretion Alteration [PE]</name>
  <code>C29946</code>  <id>29947</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Enzymatic Secretion Alteration</to_name>
    <to_code>T38619</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009790</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Enzymatic Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Pancreatic Enzymatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Enzymatic Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Enzymatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Fluid/Electrolyte Secretion Alteration [PE]</name>
  <code>C29948</code>  <id>29949</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Fluid/Electrolyte Secretion Alteration</to_name>
    <to_code>T38625</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009791</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Fluid/Electrolyte Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Fluid/Electrolyte Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Pancreatic Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Islet Activity Alteration [PE]</name>
  <code>C29950</code>  <id>29951</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Islet Activity Alteration</to_name>
    <to_code>T38627</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009792</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Islet Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pancreatic Somatostatin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Islet Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Islet Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Islet Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Insulin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Islet Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pancreatic Somatostatin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Islet Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glucagon Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel-jujn [2642260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Islet Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel [2642217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Islet Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pancreatic Secretion Alteration [PE]</name>
  <code>C29952</code>  <id>29953</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration</to_name>
    <to_code>T38635</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009793</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Enzymatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pancreatic Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Fluid/Electrolyte Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pancreatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Para-Aminobenzoic Acid Inhibitors [MoA]</name>
  <code>C30260</code>  <id>30261</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PABA Inhibitor</to_name>
    <to_code>T38707</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors</to_name>
    <to_code>T38708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009946</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfabenzamide [37320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfanilamide [10184]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Para-Aminobenzoic Acid Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Paramagnetic Contrast Agent [EPC]</name>
  <code>C639676</code>  <id>639676</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Paramagnetic Contrast Agent</to_name>
    <to_code>T38752</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180184</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Paramagnetic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferumoxides [72901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Paramagnetic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadodiamide [41144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Paramagnetic Contrast Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Magnetic Resonance Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Paramagnetic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadoteridol [25483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Paramagnetic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gadofosveset [1364290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Paramagnetic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>manganese cation (2+) [1546272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Magnetic resonance imaging contrast media (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Paramagnetic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Magnetic resonance imaging contrast media (product) [349360003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Paramagnetic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parasympathetic Activity Alteration [PE]</name>
  <code>C635039</code>  <id>635039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parasympathetic Activity Alteration</to_name>
    <to_code>T38828</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175646</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parasympathetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parasympathetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Parasympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathormone Receptor Agonists [MoA]</name>
  <code>C494</code>  <id>495</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Agonists</to_name>
    <to_code>T38834</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000158</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abaloparatide [1921069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathormone Receptor Antagonists [MoA]</name>
  <code>C450</code>  <id>451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Antagonists</to_name>
    <to_code>T38835</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000136</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathormone Receptor Interactions [MoA]</name>
  <code>C314</code>  <id>315</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Interactions</to_name>
    <to_code>T38836</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000068</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathormone Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathormone Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Gland Activity Alteration [PE]</name>
  <code>C29954</code>  <id>29955</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Gland Activity Alteration</to_name>
    <to_code>T38839</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009794</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Calcitonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased PTH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Calcitonin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine [4126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine anhydrous [1545987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone Analog [EPC]</name>
  <code>C640343</code>  <id>640343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone Analogue</to_name>
    <to_code>T38840</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone Analog</to_name>
    <to_code>T38841</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180852</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teriparatide [32915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parathyroid Hormone [M0015931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing parathyroid and/or parathyroid hormone derivative (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Parathyroid hormone and/or parathyroid hormone derivative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone [EPC]</name>
  <code>C640342</code>  <id>640342</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone</to_name>
    <to_code>T38848</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid-class Hormone</to_name>
    <to_code>T38847</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180851</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parathyroid hormone [1427222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parathyroid Hormone [M0015931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Parathyroid hormone and/or parathyroid hormone derivative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing parathyroid and/or parathyroid hormone derivative (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parathyroid Hormone-Related Peptide Analog [EPC]</name>
  <code>C653824</code>  <id>653824</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone-Related Peptide Analog</to_name>
    <to_code>T38850</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone-Related Peptide Analogue</to_name>
    <to_code>T38849</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193453</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone-Related Peptide Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone-Related Peptide Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abaloparatide [1921069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parathyroid Hormone-Related Peptide Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parathyroid Hormone-Related Protein [M0150746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Parathormone related peptide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing parathyroid and/or parathyroid hormone derivative (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parathyroid Hormone-Related Peptide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Parenteral Iron Replacement [EPC]</name>
  <code>C637368</code>  <id>637368</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parenteral Iron Replacement Agent</to_name>
    <to_code>T38868</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Parenteral Iron Replacement</to_name>
    <to_code>T38869</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177913</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron [M0011718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iron sucrose [24909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ferric gluconate complex [261435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing iron in parenteral dose form (medicinal product form)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferumoxytol [473387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron Compounds [M0540735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Parenteral Iron Replacement [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric cation [1546357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Iron supplement (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parenteral Iron Replacement [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Partial Cholinergic Nicotinic Agonist [EPC]</name>
  <code>C635111</code>  <id>635111</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Nicotinic Cholinergic Agonist</to_name>
    <to_code>T38936</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Nicotinic Agonist</to_name>
    <to_code>T38938</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Nicotine Agonist</to_name>
    <to_code>T38937</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonist</to_name>
    <to_code>T38939</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175705</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Cholinergic Nicotinic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varenicline [591622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Partial Cholinergic Nicotinic Agonists [MoA]</name>
  <code>C635108</code>  <id>635108</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonists</to_name>
    <to_code>T38940</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175702</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline tartrate [636674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline [591622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Cholinergic Nicotinic Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist [EPC]</name>
  <code>C635095</code>  <id>635095</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist/Antagonist</to_name>
    <to_code>T38944</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist</to_name>
    <to_code>T38947</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Antagonist</to_name>
    <to_code>T38943</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Opioid Antagonist</to_name>
    <to_code>T38942</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Antagonist</to_name>
    <to_code>T38945</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist/Antagonist</to_name>
    <to_code>T38941</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Opioid Antagonist</to_name>
    <to_code>T38946</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175689</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing opioid receptor partial agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>buprenorphine [1819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with opioid receptor partial agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonist/Antagonist [EPC]</name>
  <code>C635094</code>  <id>635094</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Antagonist</to_name>
    <to_code>T38948</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Opioid Antagonist</to_name>
    <to_code>T38949</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist/Antagonist</to_name>
    <to_code>T38953</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Opioid Antagonist</to_name>
    <to_code>T38950</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist/Antagonist</to_name>
    <to_code>T38951</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Antagonist</to_name>
    <to_code>T38952</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175688</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with opioid receptor partial agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with opioid receptor partial antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Competitive Opioid Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing opioid receptor partial agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Partial Opioid Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pentazocine [8001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Partial Opioid Agonists [MoA]</name>
  <code>C635091</code>  <id>635091</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonists and Opioid Antagonists</to_name>
    <to_code>T38955</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists</to_name>
    <to_code>T38960</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonist and Antagonist</to_name>
    <to_code>T38954</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists and Opioid Antagonists</to_name>
    <to_code>T38958</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist/Antagonist</to_name>
    <to_code>T38957</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists/Antagonists</to_name>
    <to_code>T38956</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Opioid Agonist and Antagonist</to_name>
    <to_code>T38959</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175685</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Partial Opioid Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Passively Acquired Immunity [PE]</name>
  <code>C642968</code>  <id>642968</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity</to_name>
    <to_code>T38971</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Acquired Passive Immunity</to_name>
    <to_code>T38970</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183365</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin-blmf [2387833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - dira [2706382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human vaccinia immune globulin [597392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Centruroides (scorpion) immune F(ab&apos;)2 (equine) [1119986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 (equine) [2101270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>North American coral snake antivenin [979384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus scutulatus antivenin [885189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2 [1722697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) [617615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2 [1722703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Latrodectus mactans antivenin [89887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2, equine [1722700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B immune globulin [26744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin, human [1997443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin [1727875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2, equine [1722696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2, equine [1722706]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies immune globulin, human [89886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - slra [2123035]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2 [1722707]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab [2387844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin, human [91603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2, equine [1722704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster immune globulin [39385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2, equine [1722702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2 [1722684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G, human [1426680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Agkistrodon piscivorus antivenin [885183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster immune globulin (human) [485576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin [1722336]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin [22178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2 [1722701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2 [1722699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - kthm [2726012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2, equine [1722698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2, equine [1722683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - stwk [2672094]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin, human [1722335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 [2101271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - hipp [2167145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - ifas [2102433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus atrox antivenin [885187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulism immune globulin IV human [544488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus [1427211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G [5666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus adamanteus antivenin [885185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2 [1722705]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - klhw [2196290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Passively Acquired Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pediculicide [EPC]</name>
  <code>C641377</code>  <id>641377</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pediculocide</to_name>
    <to_code>T39027</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pediculicide</to_name>
    <to_code>T39028</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181811</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pediculicide [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparasitic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pediculicide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pediculicide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spinosad [299081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pediculicide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pediculicide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzyl alcohol [1426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pediculicide [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ivermectin [6069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Insecticide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pediculicide [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Penem Antibacterial [EPC]</name>
  <code>C634877</code>  <id>634877</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penem Antibacterial</to_name>
    <to_code>T39090</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175496</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meropenem anhydrous [1546029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Carbapenem (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipenem anhydrous [1545986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbapenems [M0024174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ertapenem [325642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penem Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing carbapenem (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Penicillin-class Antibacterial [EPC]</name>
  <code>C634878</code>  <id>634878</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penicillin Class Antibacterial</to_name>
    <to_code>T39133</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penicillin-class Antibacterial</to_name>
    <to_code>T39134</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175497</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ampicillin [733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillins [M0016152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticarcillin [10591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dicloxacillin [3356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nafcillin [7233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piperacillin anhydrous [1546000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxacillin [7773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing penicillin (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxicillin anhydrous [1297882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin V [7984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with penicillin structure (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penicillin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>penicillin G [7980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Penile Alteration [PE]</name>
  <code>C29956</code>  <id>29957</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Alteration</to_name>
    <to_code>T39138</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009795</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penile Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Development Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penile Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Erectile Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Penile Development Alteration [PE]</name>
  <code>C29958</code>  <id>29959</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Development Alteration</to_name>
    <to_code>T39139</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009796</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penile Development Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penile Development Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Penile Erectile Alteration [PE]</name>
  <code>C29960</code>  <id>29961</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Erectile Alteration</to_name>
    <to_code>T39142</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009797</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penile Erectile Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enhance Penile Erection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Penile Erectile Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diminish Penile Erection [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Penile Venous Vasodilation [PE]</name>
  <code>C29962</code>  <id>29963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation</to_name>
    <to_code>T39153</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009798</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride trihydrate [1309396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil [306674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride [307306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peptide Metabolism Alteration [PE]</name>
  <code>C635397</code>  <id>635397</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peptide Metabolism Alteration</to_name>
    <to_code>T39289</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175959</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peptide Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Glutathione Concentration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin dihydrochloride [753341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peptide Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin [1368001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peptide Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peptide Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin benzoate [1368000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peptide Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peripheral Carotid Chemoreceptor Alteration [PE]</name>
  <code>C29964</code>  <id>29965</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Carotid Chemoreceptor Alteration</to_name>
    <to_code>T39482</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009799</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peripheral Carotid Chemoreceptor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Peripheral Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peripheral Carotid Chemoreceptor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Peripheral Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peripheral Nervous System Activity Alteration [PE]</name>
  <code>C635131</code>  <id>635131</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Nervous System Activity Alteration</to_name>
    <to_code>T39485</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175725</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peripheral Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peripheral Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sensory System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peripheral Nervous System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuromuscular Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin acetate [2569090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Nervous System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</name>
  <code>C634989</code>  <id>634989</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor alpha (PPAR-alpha) Agonist</to_name>
    <to_code>T39564</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-alpha Agonist</to_name>
    <to_code>T39563</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor alpha Agonist</to_name>
    <to_code>T39565</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175596</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with peroxisome proliferator-activated alpha receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenofibric acid [24852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pioglitazone [33738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing peroxisome proliferator-activated alpha receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemfibrozil [4719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fenofibrate [8703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor delta Agonist [EPC]</name>
  <code>C654327</code>  <id>654327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor delta Agonist</to_name>
    <to_code>T58946</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR delta Agonist</to_name>
    <to_code>T58947</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-delta Agonist</to_name>
    <to_code>T58948</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194127</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing peroxisome proliferator-activated receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with peroxisome proliferator-activated receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</name>
  <code>C639678</code>  <id>639678</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor gamma (PPAR-gamma) Agonist</to_name>
    <to_code>T39566</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor gamma Agonist</to_name>
    <to_code>T39568</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-gamma Agonist</to_name>
    <to_code>T39567</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180186</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with peroxisome proliferator-activated receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosiglitazone [84108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pioglitazone [33738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing peroxisome proliferator-activated gamma receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor Activity [MoA]</name>
  <code>C634757</code>  <id>634757</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Activity</to_name>
    <to_code>T39576</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR Activity</to_name>
    <to_code>T39575</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175374</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</name>
  <code>C654335</code>  <id>654335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Agonist</to_name>
    <to_code>T58964</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR Agonist</to_name>
    <to_code>T58966</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194128</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor delta Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor alpha Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator Receptor gamma Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing peroxisome proliferator-activated receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with peroxisome proliferator-activated receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elafibranor [2684941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</name>
  <code>C654334</code>  <id>654334</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR Agonists</to_name>
    <to_code>T58965</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Agonists</to_name>
    <to_code>T58963</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194129</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor beta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</name>
  <code>C634758</code>  <id>634758</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-alpha Agonists</to_name>
    <to_code>T39577</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR alpha Agonists</to_name>
    <to_code>T39579</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists</to_name>
    <to_code>T39580</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome-Proliferator Receptor alpha (PPAR-alpha) Agonists</to_name>
    <to_code>T39578</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175375</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor beta Agonists [MoA]</name>
  <code>C634759</code>  <id>634759</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-beta Agonists</to_name>
    <to_code>T39582</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor beta Agonists</to_name>
    <to_code>T39583</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR beta Agonists</to_name>
    <to_code>T39581</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175376</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</name>
  <code>C634761</code>  <id>634761</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-delta Agonists</to_name>
    <to_code>T39584</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR delta Agonists</to_name>
    <to_code>T39585</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor delta Agonists</to_name>
    <to_code>T39586</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175378</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar [2690869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar lysine [2690868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor delta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</name>
  <code>C634760</code>  <id>634760</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists</to_name>
    <to_code>T39589</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR-gamma Agonists</to_name>
    <to_code>T39588</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PPAR gamma Agonists</to_name>
    <to_code>T39587</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175377</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phagocytosis Alteration [PE]</name>
  <code>C29966</code>  <id>29967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phagocytosis Alteration</to_name>
    <to_code>T39652</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009800</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phagocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phagocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Phagocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept root="true" >
  <namespace>MED-RT</namespace>
  <name>Pharmaceutical and Biological Preparations</name>
  <code>C176</code>  <id>177</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmaceutical and Biological Preparations</to_name>
    <to_code>T39658</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000001</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pharmaceutical and Biological Preparations</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Preparations by FDA Established Pharmacologic Class</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pharmaceutical and Biological Preparations</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Preparations by Generic Ingredient</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pharmaceutical and Biological Preparations</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactive Preparations by FDA Established Pharmacologic Class</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pharmacologic Cardiac Stress Test Agent [EPC]</name>
  <code>C654179</code>  <id>654179</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmacologic Cardiac Stress Test Agent</to_name>
    <to_code>T58626</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193963</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pharmacologic Cardiac Stress Test Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regadenoson anhydrous [1546015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cardiovascular agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmacologic Cardiac Stress Test Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pharmacological Chaperone [EXT]</name>
  <code>C654069</code>  <id>654069</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmacological Chaperone</to_name>
    <to_code>T58450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193847</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phenothiazine [EPC]</name>
  <code>C635152</code>  <id>635152</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenothiazine-class Agent</to_name>
    <to_code>T39749</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenothiazine Derivative</to_name>
    <to_code>T39748</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenothiazine</to_name>
    <to_code>T39750</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175746</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing phenothiazine (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluphenazine [4496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenothiazines [M0016525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluoperazine [10800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Phenothiazine and/or phenothiazine derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioridazine [10502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perphenazine [8076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorpromazine [2403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prochlorperazine [8704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenothiazine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>promethazine [8745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phenylalanine Hydroxylase Activator [EPC]</name>
  <code>C650442</code>  <id>650442</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activator</to_name>
    <to_code>T39777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190483</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenylalanine Hydroxylase Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenylalanine Hydroxylase Activator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Phenylalanine 4-monooxygenase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenylalanine Hydroxylase Activator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sapropterin [753340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with hydrolase mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phenylalanine Hydroxylase Activators [MoA]</name>
  <code>C650441</code>  <id>650441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activators</to_name>
    <to_code>T39778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190482</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sepiapterin [2723056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin dihydrochloride [753341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Hydroxylase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phenylalanine Metabolizing Enzyme [EPC]</name>
  <code>C654082</code>  <id>654082</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Metabolizing Enzyme</to_name>
    <to_code>T58471</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193858</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phenylalanine Metabolizing Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegvaliase [2046360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Metabolizing Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phenylalanine Metabolizing Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphate Binder [EPC]</name>
  <code>C634990</code>  <id>634990</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Binder</to_name>
    <to_code>T39925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175597</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphate Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sevelamer [214824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphate Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ferric cation [1546357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphate Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanthanum cation (3+) [1546443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphate Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcium ion [1316581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphate Binder [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing chelating agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Binder [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with anion exchange resin mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Binder [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphate Chelating Activity [MoA]</name>
  <code>C300464</code>  <id>300464</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity</to_name>
    <to_code>T39928</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelator</to_name>
    <to_code>T39927</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Binding Activity</to_name>
    <to_code>T39926</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020074</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium hydroxide [1910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pangamate [1917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium amino acid chelate [994438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium [1895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium iodized [317207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfate [1925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate dibasic [47627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricalcium phosphate [47628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium creosotate [317206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric cation [1546357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanthanum cation (3+) [1546443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium ion [1316581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 3 Inhibitor [EPC]</name>
  <code>C634991</code>  <id>634991</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase III Inhibitor</to_name>
    <to_code>T40036</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitor</to_name>
    <to_code>T40037</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175598</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ensifentrine [2687215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilostazol [21107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milrinone [52769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 3 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with phosphodiesterase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing phosphodiesterase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 3 Inhibitors [MoA]</name>
  <code>C634447</code>  <id>634447</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase III Inhibitor</to_name>
    <to_code>T40039</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors</to_name>
    <to_code>T40040</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase III Inhibitors</to_name>
    <to_code>T40038</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175086</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensifentrine [2687215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 4 Inhibitor [EPC]</name>
  <code>C642556</code>  <id>642556</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase IV Inhibitor</to_name>
    <to_code>T40041</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitor</to_name>
    <to_code>T40042</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182961</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roflumilast [1091836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ensifentrine [2687215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crisaborole [1865953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 4 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apremilast [1492727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing phosphodiesterase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with phosphodiesterase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 4 Inhibitors [MoA]</name>
  <code>C642555</code>  <id>642555</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase IV Inhibitors</to_name>
    <to_code>T40043</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase IV Inhibitor</to_name>
    <to_code>T40044</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors</to_name>
    <to_code>T40045</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182960</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apremilast [1492727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roflumilast [1091836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverine hydrochloride [236960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensifentrine [2687215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crisaborole [1865953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerandomilast [2725523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverin [23684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 5 Inhibitor [EPC]</name>
  <code>C634992</code>  <id>634992</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase V Inhibitor</to_name>
    <to_code>T40046</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitor</to_name>
    <to_code>T40050</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PDE-5 Inhibitor</to_name>
    <to_code>T40048</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase-5 (PDE-5) Inhibitor</to_name>
    <to_code>T40047</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase-5 Inhibitor</to_name>
    <to_code>T40049</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175599</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tadalafil [358263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sildenafil [136411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avanafil [1291301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing phosphodiesterase 5 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vardenafil [306674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase 5 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with phosphodiesterase 5 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase 5 Inhibitors [MoA]</name>
  <code>C300412</code>  <id>300412</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase V Inhibitor</to_name>
    <to_code>T40051</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase V Inhibitors</to_name>
    <to_code>T40052</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors</to_name>
    <to_code>T40053</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020026</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riociguat [1439816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride [307306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride trihydrate [1309396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil [306674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphodiesterase Inhibitors [MoA]</name>
  <code>C434</code>  <id>435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors</to_name>
    <to_code>T40061</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000128</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphodiesterase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase 5 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofisopam [38365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphodiesterase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide 3-Kinase alpha Inhibitors [MoA]</name>
  <code>C654350</code>  <id>654350</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3Kα Inhibitors</to_name>
    <to_code>T59017</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PIK3CA Inhibitors</to_name>
    <to_code>T59018</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3K α Inhibitors</to_name>
    <to_code>T59014</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphatidylinositol 3-Kinase alpha Inhibitors</to_name>
    <to_code>T59012</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3K-alpha Inhibitors</to_name>
    <to_code>T59015</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3K-α Inhibitors</to_name>
    <to_code>T59016</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3K alpha Inhibitors</to_name>
    <to_code>T59013</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinase alpha Inhibitors</to_name>
    <to_code>T59011</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194130</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinase alpha Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide 3-Kinase delta Inhibitors [MoA]</name>
  <code>C654280</code>  <id>654280</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide-3-Kinase delta Inhibitors</to_name>
    <to_code>T58855</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinase delta Inhibitors</to_name>
    <to_code>T58853</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3K delta Inhibitors</to_name>
    <to_code>T58856</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3Kδ Inhibitors</to_name>
    <to_code>T58857</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphatidylinositol 3-Kinase delta Inhibitors</to_name>
    <to_code>T58854</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194054</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinase delta Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Phosphoinositide 3-Kinases Inhibitors [MoA]</name>
  <code>C654279</code>  <id>654279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide-3-Kinases Inhibitors</to_name>
    <to_code>T58851</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PI3Ks Inhibitors</to_name>
    <to_code>T58852</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphatidylinositol 3-Kinases Inhibitors</to_name>
    <to_code>T58850</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinases Inhibitors</to_name>
    <to_code>T58849</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194055</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinase delta Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinase alpha Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphoinositide 3-Kinases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Photoabsorption [MoA]</name>
  <code>C31792</code>  <id>31793</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption</to_name>
    <to_code>T40286</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorbtion</to_name>
    <to_code>T40285</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010217</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoabsorption [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet B Radiation Absorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoabsorption [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet A Radiation Absorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trioxsalen [10844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihematoporphyrin ether [23066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxate [288262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Flavin Mononucleotide [4509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Photoactivated Radical Generator [EPC]</name>
  <code>C635438</code>  <id>635438</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoactivated Radical Generator</to_name>
    <to_code>T40287</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175984</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoactivated Radical Generator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxsalen [6854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoactivated Radical Generator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dihematoporphyrin ether [23066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoactivated Radical Generator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoactivated Radical Generator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Photosensitizing agent (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoactivated Radical Generator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Photoenhancer [EPC]</name>
  <code>C634933</code>  <id>634933</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoenhancer</to_name>
    <to_code>T40288</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175540</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoenhancer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>verteporfin [118886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoenhancer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Flavin Mononucleotide [4509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoenhancer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin 5&apos;-phosphate [1925821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoenhancer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Photoenhancer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Photosensitizing Activity [PE]</name>
  <code>C29968</code>  <id>29969</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity</to_name>
    <to_code>T40299</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009801</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoctrizole [1310510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihematoporphyrin ether [23066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole [1426903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar pitch volatiles [90732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 5-aminolevulinate [337068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Flavin Mononucleotide [4509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar extract [90735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl aminolevulinate hydrochloride [1300479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid hydrochloride [261715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid [683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photosensitizing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Physical or Chemical Agent [APC]</name>
  <code>C654132</code>  <id>654132</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Physical or Chemical Agent</to_name>
    <to_code>T58534</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193908</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper-containing Intrauterine Device [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Alkalinizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Dye [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calculi Dissolution Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhalation Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Copper Absorption Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin Stabilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Heparin Reversal Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Binder [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiographic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoactivated Radical Generator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Disclosing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decorporation Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Laxative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human Serum Albumin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metal Chelator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucolytic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Paramagnetic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Releasing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Phosphate Binder [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Depleting Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrogen Binding Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Volume Expander [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reducing and Complexing Thiol [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Contrast Agent for Ultrasound Imaging [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid Sequestrant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation-Reduction Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoenhancer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gadolinium-based Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physical or Chemical Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Physiochemical Activity [MoA]</name>
  <code>C308</code>  <id>309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity</to_name>
    <to_code>T40323</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000065</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitric Oxide Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfate Donors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acid-Base Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dyes [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Photoabsorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alkylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Oxidation-Reduction Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Demulcent Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ionophoric Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Electrolyte Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Irrigation [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiochemical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>padimate-O [32786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium chloride [2200142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenious acid [36344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese [6623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octinoxate [13369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avobenzone [45045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chlorohydrate [17610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese sulfate [29268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium [9641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxate [288262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol [9945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide [38685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxylenol [20877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminohippurate sodium [203194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybenzone [32673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octisalate [91327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide I123 [91531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea [11002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminobenzoic acid [74]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenate [36717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol, L- [1742749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podophyllin [8462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide hydrochloride [57227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea hydrochloride [1862866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese dioxide [29263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc oxide [11423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiochemical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept root="true" >
  <namespace>MED-RT</namespace>
  <name>Physiological Effects [PE]</name>
  <code>C29970</code>  <id>29971</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Physiological Effects</to_name>
    <to_code>T40325</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009802</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiological Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organ System Specific Effects [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiological Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Generalized Systemic Effects [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Physiological Effects [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pineal Gland Activity Alteration [PE]</name>
  <code>C29972</code>  <id>29973</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pineal Gland Activity Alteration</to_name>
    <to_code>T40432</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009803</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pineal Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pinocytosis Alteration [PE]</name>
  <code>C29974</code>  <id>29975</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pinocytosis Alteration</to_name>
    <to_code>T40440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009804</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pinocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Pinocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pinocytosis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Pinocytosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pituitary Gland Activity Alteration [PE]</name>
  <code>C29976</code>  <id>29977</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration</to_name>
    <to_code>T40511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009805</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Growth Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Oxytocin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Follicle Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Stimulating Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Oxytocin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vasopressin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vasopressin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Luteinizing Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Adrenocorticotropic Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prolactin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin acetate [1044583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin [50610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pituitary Hormone Receptor Agonists [MoA]</name>
  <code>C508</code>  <id>509</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists</to_name>
    <to_code>T40512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000165</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin hexahydrate [1653802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticorelin ovine triflutate [74670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin [2890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticorelin ovine [74671]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pituitary Hormone Receptor Antagonists [MoA]</name>
  <code>C676</code>  <id>677</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Antagonists</to_name>
    <to_code>T40513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000249</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pituitary Hormones Receptor Interactions [MoA]</name>
  <code>C460</code>  <id>461</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormones Receptor Interactions</to_name>
    <to_code>T40519</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000141</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Hormones Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pituitary Hormones Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormones Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pituitary Hormones Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Placental Endocrine Activity Alteration [PE]</name>
  <code>C29978</code>  <id>29979</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Placental Endocrine Activity Alteration</to_name>
    <to_code>T40547</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009806</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Placental Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Placental Human Chorionic Gonadotropin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Placental Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Placental Human Chorionic Gonadotropin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Plasma Kallikrein Inhibitor [EPC]</name>
  <code>C653011</code>  <id>653011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Kallikrein Inhibitor</to_name>
    <to_code>T40623</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192750</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with kallikrein inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing kallikrein inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ecallantide [658708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>berotralstat [2467540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanadelumab [2055641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Kallikrein Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebetralstat [2717944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Plasma Metabolism [PK]</name>
  <code>C236</code>  <id>237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Metabolism</to_name>
    <to_code>T40638</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000029</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Plasma Volume Expander [EPC]</name>
  <code>C643910</code>  <id>643910</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Volume Expander</to_name>
    <to_code>T40639</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184175</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Intravascular Volume [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 70 [3274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Osmotic Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Plasma expander (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hetastarch [5531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 75 [3275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextran 40 [3272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasma Volume Expander [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxyethyl starch 130-0.4 [1363352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Plasmin Inhibitors [MoA]</name>
  <code>C31886</code>  <id>31887</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasmin Inhibitors</to_name>
    <to_code>T40647</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010264</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranexamic acid [10691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasmin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Plasminogen Activators [MoA]</name>
  <code>C356</code>  <id>357</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasminogen Activators</to_name>
    <to_code>T40659</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000089</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Plasminogen Activators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasminogen [2557200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasminogen, human-tvmh [2557201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet Activating Factor Inhibitors [MoA]</name>
  <code>C30290</code>  <id>30291</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Activating Factor Inhibitors</to_name>
    <to_code>T40674</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009961</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Activating Factor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine [10594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Activating Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine hydrochloride [97]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Activating Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet Aggregation Alteration [PE]</name>
  <code>C29980</code>  <id>29981</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Aggregation Alteration</to_name>
    <to_code>T40685</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009807</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet Aggregation Inhibitor [EPC]</name>
  <code>C634971</code>  <id>634971</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Aggregation Inhibitor</to_name>
    <to_code>T40686</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175578</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with platelet aggregation inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eptifibatide [75635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing platelet aggregation inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipyridamole [3521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aspirin [1191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirofiban [73137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticlopidine [10594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet Aggregation Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</name>
  <code>C30292</code>  <id>30293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein IIb/IIIA Inhibitors</to_name>
    <to_code>T40706</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein 2b/3A Inhibitors</to_name>
    <to_code>T40705</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009962</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Glycoprotein IIb/IIIA Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</name>
  <code>C300420</code>  <id>300420</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PDGFR Inhibitors</to_name>
    <to_code>T40731</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor Inhibitors</to_name>
    <to_code>T40732</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020030</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor Receptor alpha Antagonist [EPC]</name>
  <code>C653575</code>  <id>653575</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor alpha Antagonist</to_name>
    <to_code>T40736</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor alpha (PDGFR-alpha) Antagonist</to_name>
    <to_code>T40735</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PDGFR-alpha Antagonist</to_name>
    <to_code>T40734</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PDGFR alpha Antagonist</to_name>
    <to_code>T40733</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193221</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protein-tyrosine kinase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</name>
  <code>C300418</code>  <id>300418</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PDGFR alpha Inhibitors</to_name>
    <to_code>T40737</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors</to_name>
    <to_code>T40738</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020028</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor alpha Receptor Interactions [MoA]</name>
  <code>C364</code>  <id>365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Interactions</to_name>
    <to_code>T40739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000093</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-derived Growth Factor alpha Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</name>
  <code>C300419</code>  <id>300419</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PDGFR beta Inhibitors</to_name>
    <to_code>T40740</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor beta Receptor Inhibitors</to_name>
    <to_code>T40741</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020029</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-derived Growth Factor beta Receptor Interactions [MoA]</name>
  <code>C556</code>  <id>557</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor beta Receptor Interactions</to_name>
    <to_code>T40742</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000189</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-derived Growth Factor beta Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor beta Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platelet-reducing Agent [EPC]</name>
  <code>C635031</code>  <id>635031</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet Reducing Agent</to_name>
    <to_code>T40743</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-reducing Agent</to_name>
    <to_code>T40744</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175638</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-reducing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-reducing Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with platelet aggregation inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-reducing Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing platelet aggregation inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-reducing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anagrelide [596724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platelet-reducing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platinum-based Drug [EPC]</name>
  <code>C634795</code>  <id>634795</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Agent</to_name>
    <to_code>T40749</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-based Drug</to_name>
    <to_code>T40750</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175413</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-based Drug [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Platinum compound (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-based Drug [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Compounds [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-based Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboplatin [40048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-based Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cisplatin [2555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-based Drug [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing platinum and/or platinum compound (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-based Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxaliplatin [32592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antineoplastic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-based Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Platinum-containing Compounds [EXT]</name>
  <code>C634435</code>  <id>634435</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Compounds</to_name>
    <to_code>T40751</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175073</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-containing Compounds [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Platinum Compounds [M0026727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Platinum-containing Compounds [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Organoplatinum Compounds [M0015422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Compounds [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Compounds [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Compounds [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pleuromutilin Antibacterial [EPC]</name>
  <code>C634816</code>  <id>634816</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pleuromutilin Antibacterial</to_name>
    <to_code>T40767</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175434</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleuromutilin [M000764986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retapamulin [642274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Pleuromutilin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pleuromutilin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lefamulin [2198944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Plutonium Chelating Activity [MoA]</name>
  <code>C300466</code>  <id>300466</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelator</to_name>
    <to_code>T40780</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity</to_name>
    <to_code>T40781</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020076</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetic acid [3690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate pentasodium [314774]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate zinc trisodium [408077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetate disodium [259268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate calcium trisodium [132879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate [618371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plutonium Chelating Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</name>
  <code>C654385</code>  <id>654385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pneumococcal 21-valent Conjugate Vaccine</to_name>
    <to_code>T59074</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194168</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Conjugate [M0027265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Vaccines [M0357124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antigen of Streptococcus pneumoniae capsular polysaccharide conjugated (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</name>
  <code>C651671</code>  <id>651671</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PARP Inhibitor</to_name>
    <to_code>T40962</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitor</to_name>
    <to_code>T40965</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly (ADP Ribose) Polymerase Inhibitor</to_name>
    <to_code>T40958</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PARP Polymerase Inhibitor</to_name>
    <to_code>T40960</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitor</to_name>
    <to_code>T40964</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly ADP-Ribose Polymerase Inhibitor</to_name>
    <to_code>T40961</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly ADP Ribose Polymerase Inhibitor</to_name>
    <to_code>T40963</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitor</to_name>
    <to_code>T40966</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly (ADP-Ribose) Polymerase Inhibitor</to_name>
    <to_code>T40959</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191623</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talazoparib [2099704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rucaparib [1862579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>niraparib [1918231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olaparib [1597582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</name>
  <code>C651670</code>  <id>651670</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly (ADP Ribose) Polymerase Inhibitors</to_name>
    <to_code>T40969</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly Adenosine 5’-Diphosphoribose Polymerase Inhibitors</to_name>
    <to_code>T40967</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly ADP Ribose Polymerase Inhibitors</to_name>
    <to_code>T40971</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PARP Polymerase Inhibitors</to_name>
    <to_code>T40972</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly ADP-Ribose Polymerase Inhibitors</to_name>
    <to_code>T40973</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PARP Inhibitors</to_name>
    <to_code>T40974</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly (ADP-Ribose) Polymerase Inhibitors</to_name>
    <to_code>T40968</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyadenosine 5’-Diphosphoribose Polymerase Inhibitors</to_name>
    <to_code>T40970</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors</to_name>
    <to_code>T40975</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191622</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib [2099704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib tosylate [2099703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib camsylate [1862578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poly(ADP-Ribose) Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Polyene Antifungal [EPC]</name>
  <code>C634879</code>  <id>634879</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antifungal</to_name>
    <to_code>T41066</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175498</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antifungal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyenes [M0017172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nystatin [7597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amphotericin B [732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Polyene Antimicrobial [EPC]</name>
  <code>C635374</code>  <id>635374</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antimicrobial</to_name>
    <to_code>T41067</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175936</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyenes [M0017172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>natamycin [7268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polyene Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anti-infective agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polyene Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Polymerase Acidic Endonuclease Inhibitor [EPC]</name>
  <code>C654075</code>  <id>654075</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitor</to_name>
    <to_code>T58460</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PA Endonuclease Inhibitor</to_name>
    <to_code>T58461</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193852</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baloxavir [2197842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Polymerase Acidic Endonuclease Inhibitors [MoA]</name>
  <code>C654074</code>  <id>654074</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitors</to_name>
    <to_code>T58459</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193853</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir [2197842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir marboxil [2099995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymerase Acidic Endonuclease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Polymyxin-class Antibacterial [EPC]</name>
  <code>C634880</code>  <id>634880</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymyxin-class Antibacterial</to_name>
    <to_code>T41148</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polymyxin Class Antibacterial</to_name>
    <to_code>T41147</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175499</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polymyxins [M0017217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>colistimethate [2708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Polymyxin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polymyxin B [8536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polymyxin-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Polysaccharide Metabolism Alteration [PE]</name>
  <code>C300430</code>  <id>300430</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Polysaccharide Metabolism Alteration</to_name>
    <to_code>T41201</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020040</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polysaccharide Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycogen Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Polysaccharide Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glycosaminoglycan Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Porphyrin Precursor [EPC]</name>
  <code>C635284</code>  <id>635284</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Porphyrin Precursor</to_name>
    <to_code>T41301</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175846</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Porphyrin Precursor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing 5-aminolevulinic acid (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Porphyrin Precursor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminolevulinic Acid [M0000951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Porphyrin Precursor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aminolevulinic acid [683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Porphyrin Precursor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyl 5-aminolevulinate [337068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Porphyrin Precursor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>5-aminolevulinic acid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Positive Chronotropy [PE]</name>
  <code>C29982</code>  <id>29983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy</to_name>
    <to_code>T41306</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009808</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson anhydrous [1546015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disulfiram [3554]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Chronotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Positive Inotropy [PE]</name>
  <code>C29984</code>  <id>29985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy</to_name>
    <to_code>T41307</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009809</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positive Inotropy [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Positron Emitting Activity [MoA]</name>
  <code>C635307</code>  <id>635307</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity</to_name>
    <to_code>T41324</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175869</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetaben [2571857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flotufolastat F-18 [2637946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluciclovine [2571859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dotatate gallium GA-68 [1872044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicisate dihydrochloride [1306099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurpiridaz F-18 [2700762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium GA-68 gozetotide [2586016]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetaben f-18 [1492940]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dotatate gallium ga-68 [676679]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetapir F-18 [1427224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicisate [1306100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>82 rubidium [1546434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurpiridaz [2700763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat F-18 [2556616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flotufolastat [2637947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoroestradiol F-18 [2372221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluciclovine F-18 [1796118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper oxodotreotide CU-64 [2396442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flortaucipir [2571858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Post Translation Protein Modification Alteration [PE]</name>
  <code>C29986</code>  <id>29987</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Post Translation Protein Modification Alteration</to_name>
    <to_code>T41325</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009810</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Post Translation Protein Modification Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Post Translation Protein Modification Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Post Translation Protein Modification Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Post Translation Protein Modification Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Post-transcriptional RNA Interaction [PE]</name>
  <code>C654363</code>  <id>654363</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Post-transcriptional RNA Interaction</to_name>
    <to_code>T59040</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194155</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Post-transcriptional RNA Interaction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Degradation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Binder [EPC]</name>
  <code>C637832</code>  <id>637832</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Binder</to_name>
    <to_code>T41378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178378</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Binder [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Binder [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Potassium exchange resin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patiromer [1716203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Binder [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing potassium exchange resin (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Binder [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium polystyrene sulfonate [56512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Agonists [MoA]</name>
  <code>C634829</code>  <id>634829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Agonists</to_name>
    <to_code>T41379</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175449</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Antagonists [MoA]</name>
  <code>C634828</code>  <id>634828</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists</to_name>
    <to_code>T41381</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Blockers</to_name>
    <to_code>T41380</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175448</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine phosphate [2106337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfampridine [897018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine [2106338]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Blocker [EPC]</name>
  <code>C653056</code>  <id>653056</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Blocker</to_name>
    <to_code>T41382</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192795</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dalfampridine [897018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing potassium channel blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amifampridine [2106338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with potassium channel blocker mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Interactions [MoA]</name>
  <code>C600</code>  <id>601</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions</to_name>
    <to_code>T41383</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000211</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dofetilide [49247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Opener [EPC]</name>
  <code>C642324</code>  <id>642324</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Activator</to_name>
    <to_code>T41384</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Opener</to_name>
    <to_code>T41385</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182729</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Opener [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with potassium channel activator mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Channel Opener [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing potassium channel activator (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Channel Openers [MoA]</name>
  <code>C642323</code>  <id>642323</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Activators</to_name>
    <to_code>T41386</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers</to_name>
    <to_code>T41387</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182728</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezogabine [1112990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinacidil [33717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Channel Openers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Exchange Resin [EPC]</name>
  <code>C634799</code>  <id>634799</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Exchange Resin</to_name>
    <to_code>T41440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175417</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cation exchange resin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Exchange Resin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing cation exchange resin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Exchange Resin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Ion Binding Activity [MoA]</name>
  <code>C637831</code>  <id>637831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Binding Activity</to_name>
    <to_code>T41445</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Binding Activity</to_name>
    <to_code>T41444</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178377</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer [1716203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer sorbitex calcium [2204723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Binding Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Ion Exchange Activity [MoA]</name>
  <code>C634740</code>  <id>634740</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Exchange Activity</to_name>
    <to_code>T41446</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175357</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Ion Exchange Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium Salt [EPC]</name>
  <code>C634993</code>  <id>634993</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Salt</to_name>
    <to_code>T41454</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175600</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Salt [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium ion [1318915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Salt [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>potassium cation [1311382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium Salt [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Compounds [M0026737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing potassium (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Salt [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Potassium (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Salt [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium-competitive Acid Blocker [EPC]</name>
  <code>C654357</code>  <id>654357</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium-competitive Acid Blocker</to_name>
    <to_code>T59034</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194136</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-competitive Acid Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with hydrogen/potassium adenosine triphosphatase enzyme system inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-competitive Acid Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-competitive Acid Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Potassium-sparing Diuretic [EPC]</name>
  <code>C634800</code>  <id>634800</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium-sparing Diuretic</to_name>
    <to_code>T41463</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175418</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-sparing Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-sparing Diuretic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Potassium-sparing diuretic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-sparing Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-sparing Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamterene [10763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-sparing Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amiloride [644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Potassium-sparing Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal K+ Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Poultry Proteins [EXT]</name>
  <code>C644820</code>  <id>644820</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Poultry Proteins</to_name>
    <to_code>T41468</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185018</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poultry Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duck allergenic extract [972037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poultry Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turkey allergenic extract [975119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poultry Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chicken allergenic extract [892653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poultry Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Preparations by FDA Established Pharmacologic Class</name>
  <code>C634794</code>  <id>634794</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Preparations by FDA Established Pharmacologic Class</to_name>
    <to_code>T16676</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000189939</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytolytic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Therapy [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diuretic [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetic [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody or Antibody Fragment [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gene Therapy [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin or Mineral [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipid Emulsion [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Therapy [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaccine [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allergen [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acellular Tissue Engineered Vessel [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Factor [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hematology Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Interaction [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Physical or Chemical Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Tubular Transport Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Imaging Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunologic Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulator [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nervous System Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytotoxin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel or Pump Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Allogeneic Cultured Cell Scaffold [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Related Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemical Structure [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Muscle Relaxant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interaction [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunotherapy [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidote [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by FDA Established Pharmacologic Class</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Preparations by Generic Ingredient</name>
  <code>C288626</code>  <id>288626</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Preparations by Generic Ingredient</to_name>
    <to_code>T16677</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010582</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>K [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>J [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>H [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>W [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>L [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>I [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Z [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>A [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>F [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Q [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>R [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>C [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>E [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>B [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>D [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>S [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Y [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>N [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>O [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>U [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>V [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Preparations by Generic Ingredient</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X [Preparations]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progestational Hormone Receptor Agonists [MoA]</name>
  <code>C548</code>  <id>549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists</to_name>
    <to_code>T41906</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000185</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drospirenone [11636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrel [7518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etonogestrel [14584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progestational Hormone Receptor Antagonists [MoA]</name>
  <code>C408</code>  <id>409</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Antagonists</to_name>
    <to_code>T41907</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000115</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progesterone Agonist/Antagonist [EPC]</name>
  <code>C651257</code>  <id>651257</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone Agonist/Antagonist</to_name>
    <to_code>T41910</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Progesterone Agonist and Antagonist</to_name>
    <to_code>T41909</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Progesterone Receptor Modulator</to_name>
    <to_code>T41908</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191263</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with progesterone receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ulipristal [1005921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing progesterone receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with progesterone receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone Agonist/Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing progesterone receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Steroid hormone (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hormone (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progesterone [EPC]</name>
  <code>C634994</code>  <id>634994</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone-containing Agent</to_name>
    <to_code>T41920</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone</to_name>
    <to_code>T41921</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175601</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing progesterone (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Progesterone (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>progesterone [8727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progesterone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Progesterone [M0017672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progestin Antagonist [EPC]</name>
  <code>C635260</code>  <id>635260</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin Antagonist</to_name>
    <to_code>T41925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175841</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing progesterone receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mifepristone [6964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with hormone receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progestin Synthesis Inhibitors [MoA]</name>
  <code>C635365</code>  <id>635365</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin Synthesis Inhibitors</to_name>
    <to_code>T41926</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175927</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progestin [EPC]</name>
  <code>C634995</code>  <id>634995</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin</to_name>
    <to_code>T41927</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175602</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>megestrol [6703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>drospirenone [11636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levonorgestrel [6373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethynodiol [24591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dienogest [22968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desogestrel [22656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Progesterone Congeners [M0447349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>segesterone [2055978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norelgestromin [326374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norethindrone [7514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>norgestimate [31994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etonogestrel [14584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Synthetic progestogen (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin-containing Intrauterine System [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>17-alpha-hydroxyprogesterone [5542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>medroxyprogesterone [6691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing steroid (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Progestin-containing Intrauterine System [EPC]</name>
  <code>C635251</code>  <id>635251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin-containing Intrauterine System</to_name>
    <to_code>T41930</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin-containing IUS</to_name>
    <to_code>T41928</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin-containing Intrauterine System (IUS)</to_name>
    <to_code>T41929</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175832</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin-containing Intrauterine System [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Ovum Fertilization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin-containing Intrauterine System [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levonorgestrel [6373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Progestin-containing Intrauterine System [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Progesterone Congeners [M0447349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Progesterone (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin-containing Intrauterine System [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Drug-device combination product (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin-containing Intrauterine System [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Ligand-1 Antagonists [MoA]</name>
  <code>C653708</code>  <id>653708</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PD-L1 Antagonists</to_name>
    <to_code>T41950</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists</to_name>
    <to_code>T41951</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193337</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Ligand-1 Blocker [EPC]</name>
  <code>C653709</code>  <id>653709</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PD-L1 Blocker</to_name>
    <to_code>T41952</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Blocker</to_name>
    <to_code>T41953</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193338</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avelumab [1875534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cosibelimab [2717511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing programmed cell death protein 1 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>durvalumab [1919503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Ligand-1 Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</name>
  <code>C653707</code>  <id>653707</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions</to_name>
    <to_code>T41955</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PD-L1-directed Antibody Interactions</to_name>
    <to_code>T41954</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193336</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Ligand-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Receptor-1 Blocking Antibody [EPC]</name>
  <code>C651254</code>  <id>651254</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1 Blocking Antibody</to_name>
    <to_code>T41957</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PD-1 Blocking Antibody</to_name>
    <to_code>T41956</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191260</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dostarlimab [2539967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tislelizumab [2677426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nivolumab [1597876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retifanlimab [2632981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toripalimab [2669406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pembrolizumab [1547545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atezolizumab [1792776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1 Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</name>
  <code>C651253</code>  <id>651253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions</to_name>
    <to_code>T41959</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PD-1-directed Antibody Interactions</to_name>
    <to_code>T41958</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191259</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab-dlwr [2632980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab-rwlc [2058825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab [2632981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab [2539967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab-gxly [2539968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Programmed Death Receptor-1-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prolactin Inhibiting Factor Alteration [PE]</name>
  <code>C29934</code>  <id>29935</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PIF Alteration</to_name>
    <to_code>T41988</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prolactin Inhibiting hormone Alteration</to_name>
    <to_code>T41989</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prolactin Inhibiting Factor Alteration</to_name>
    <to_code>T41990</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009784</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prolactin Inhibiting Factor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PIF Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prolactin Inhibiting Factor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PIF Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prolactin Releasing Factor Alteration [PE]</name>
  <code>C29940</code>  <id>29941</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PRF Alteration</to_name>
    <to_code>T41995</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prolactin Releasing Factor Alteration</to_name>
    <to_code>T41996</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009787</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prolactin Releasing Factor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PRF Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prolactin Releasing Factor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PRF Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proline-rich Tyrosine Kinase 2 Inhibitors [MoA]</name>
  <code>C654391</code>  <id>654391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proline-rich Tyrosine Kinase 2 Inhibitors</to_name>
    <to_code>T59084</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PYK2 Inhibitors</to_name>
    <to_code>T59087</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyk2 Inhibitors</to_name>
    <to_code>T59086</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proline-rich Tyrosine Kinase-2 Inhibitors</to_name>
    <to_code>T59085</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194169</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proprotein Convertase Inhibitors [MoA]</name>
  <code>C651845</code>  <id>651845</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proprotein Convertase Inhibitors</to_name>
    <to_code>T42160</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191729</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proprotein Convertase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostacyclin Receptor Agonist [EPC]</name>
  <code>C652475</code>  <id>652475</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacyclin Receptor Agonist</to_name>
    <to_code>T42193</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192339</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacyclin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selexipag [1729002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacyclin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacyclin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with prostacyclin receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostacyclin Receptor Agonists [MoA]</name>
  <code>C300458</code>  <id>300458</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacyclin Receptor Agonists</to_name>
    <to_code>T42194</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020068</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloprost [40138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacyclin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacyclin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostacycline Vasodilator [EPC]</name>
  <code>C634798</code>  <id>634798</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline Vasodilator</to_name>
    <to_code>T42196</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline-class Vasodilator</to_name>
    <to_code>T42195</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175416</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epoprostenol [8814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline Vasodilator [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostaglandins I [M0017817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treprostinil [343048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing prostacyclin PGI2 (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Prostacyclin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostacycline [EPC]</name>
  <code>C634996</code>  <id>634996</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline-class Agent</to_name>
    <to_code>T42197</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline</to_name>
    <to_code>T42198</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175603</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing prostacyclin PGI2 (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Prostacyclin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostaglandins I [M0017817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostacycline [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iloprost [40138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Analog [EPC]</name>
  <code>C634834</code>  <id>634834</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Analog</to_name>
    <to_code>T42200</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Analogue</to_name>
    <to_code>T42199</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175454</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostaglandins [M0017805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Prostaglandin analog (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dinoprostone [3478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>travoprost [283809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bimatoprost [283810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carboprost [2051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprostadil [598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafluprost [1244607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>latanoprost [43611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing prostaglandin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E1 Agonist [EPC]</name>
  <code>C639681</code>  <id>639681</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PGE-1 Agonist</to_name>
    <to_code>T42207</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Agonist</to_name>
    <to_code>T42208</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PGE1 Agonist</to_name>
    <to_code>T42206</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180189</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin E1 Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin E1 Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alprostadil [598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Prostaglandin group E (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing E series prostaglandin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E1 Analog [EPC]</name>
  <code>C635204</code>  <id>635204</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PGE1 Analogue</to_name>
    <to_code>T42211</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Analog</to_name>
    <to_code>T42217</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin-1 (PGE1) Analog</to_name>
    <to_code>T42212</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PGE1 Analog</to_name>
    <to_code>T42215</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 (PGE1) Analog</to_name>
    <to_code>T42213</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin-1 (PGE1) Analogue</to_name>
    <to_code>T42216</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin-1 Analogue</to_name>
    <to_code>T42209</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 (PGE1) Analogue</to_name>
    <to_code>T42210</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin-1 Analog</to_name>
    <to_code>T42214</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175785</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin E1 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostaglandins E, Synthetic [M0017811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin E1 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>misoprostol [42331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing E series prostaglandin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Prostaglandin group E (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E2 Receptor Agonist [EPC]</name>
  <code>C654265</code>  <id>654265</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EP2 Receptor Agonist</to_name>
    <to_code>T58800</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin EP2 Receptor Agonist</to_name>
    <to_code>T58801</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonist</to_name>
    <to_code>T58799</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194041</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin E2 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omidenepag [2612691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin E2 Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing prostaglandin (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin E2 Receptor Agonists [MoA]</name>
  <code>C654264</code>  <id>654264</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonists</to_name>
    <to_code>T58796</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>EP2 Receptor Agonists</to_name>
    <to_code>T58797</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin EP2 Receptor Agonists</to_name>
    <to_code>T58798</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194042</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag [2612691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Receptor Agonists [MoA]</name>
  <code>C390</code>  <id>391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists</to_name>
    <to_code>T42227</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000106</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacyclin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>misoprostol [42331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>unoprostone [1546408]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost acid [2675687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl unoprostone [135313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag [2612691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimatoprost [283810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>travoprost [283809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag isopropyl [2612690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost [43611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafluprost [1244607]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Receptor Antagonists [MoA]</name>
  <code>C394</code>  <id>395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists</to_name>
    <to_code>T42228</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000108</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride anhydrous [1375412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacetin [8113]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostaglandin Receptor Interactions [MoA]</name>
  <code>C440</code>  <id>441</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Interactions</to_name>
    <to_code>T42229</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000131</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostaglandin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostatic Alteration [PE]</name>
  <code>C29988</code>  <id>29989</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Alteration</to_name>
    <to_code>T42299</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009811</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostatic Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Size Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostatic Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostatic Secretion Alteration [PE]</name>
  <code>C29990</code>  <id>29991</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Secretion Alteration</to_name>
    <to_code>T42320</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009812</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostatic Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostatic Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Prostatic Size Alteration [PE]</name>
  <code>C29992</code>  <id>29993</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostatic Size Alteration</to_name>
    <to_code>T42322</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009813</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostatic Size Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Prostatic Size [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Prostatic Size Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prostatic Size [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease Activator [EPC]</name>
  <code>C654395</code>  <id>654395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activator</to_name>
    <to_code>T59093</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194170</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme activator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease Activators [MoA]</name>
  <code>C654394</code>  <id>654394</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activators</to_name>
    <to_code>T59092</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194171</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone [2721194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone hydrochloride [2721193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease Inhibitor [EPC]</name>
  <code>C635327</code>  <id>635327</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitor</to_name>
    <to_code>T42335</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitor</to_name>
    <to_code>T42334</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175889</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neprilysin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nelfinavir [134527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritonavir [85762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saquinavir [83395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with protease inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lopinavir [195088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>darunavir [460132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human alpha-1 Proteinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amprenavir [228656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Direct Thrombin Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Human C1 Esterase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing protease inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tipranavir [190548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin Converting Enzyme Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atazanavir [343047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indinavir anhydrous [1546024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>PCSK9 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Kallikrein Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease Inhibitors [MoA]</name>
  <code>C330</code>  <id>331</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors</to_name>
    <to_code>T42336</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000076</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HIV Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidyl Peptidase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metalloprotease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enkephalinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin-converting Enzyme Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cysteine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proprotein Convertase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2208 [1363585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brensocatib [2721880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2910 [1363586]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat hydrobromide [2670632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirmatrelvir [2587892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor Interactions [MoA]</name>
  <code>C650967</code>  <id>650967</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PAR Receptor Interactions</to_name>
    <to_code>T42343</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor Interactions</to_name>
    <to_code>T42344</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190993</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease-activated Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 Antagonist [EPC]</name>
  <code>C650970</code>  <id>650970</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 (PAR-1) Antagonist</to_name>
    <to_code>T42345</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonist</to_name>
    <to_code>T42347</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PAR-1 Antagonist</to_name>
    <to_code>T42346</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190996</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease-activated Receptor-1 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorapaxar [1537034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease-activated Receptor-1 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Platelet Aggregation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease-activated Receptor-1 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 Antagonists [MoA]</name>
  <code>C650969</code>  <id>650969</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonists</to_name>
    <to_code>T42349</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PAR-1 Antagonists</to_name>
    <to_code>T42348</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190995</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar sulfate [1537050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar [1537034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protease-activated Receptor-1 Interactions [MoA]</name>
  <code>C650968</code>  <id>650968</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Interactions</to_name>
    <to_code>T42351</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PAR-1 Interactions</to_name>
    <to_code>T42350</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190994</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protease-activated Receptor-1 Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proteasome Inhibitor [EPC]</name>
  <code>C634997</code>  <id>634997</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitor</to_name>
    <to_code>T42360</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175604</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteasome Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteasome Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing proteasome inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteasome Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bortezomib [358258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteasome Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carfilzomib [1302966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteasome Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ixazomib [1723735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteasome Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with proteasome inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proteasome Inhibitors [MoA]</name>
  <code>C634437</code>  <id>634437</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors</to_name>
    <to_code>T42363</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteosome Inhibitors</to_name>
    <to_code>T42361</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitor</to_name>
    <to_code>T42362</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175075</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib [1723735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib citrate [1723734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carfilzomib [1302966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteasome Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protein Degradation Alteration [PE]</name>
  <code>C29994</code>  <id>29995</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Degradation Alteration</to_name>
    <to_code>T42402</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009814</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Degradation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Degradation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protein Kinase Inhibitors [MoA]</name>
  <code>C634438</code>  <id>634438</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors</to_name>
    <to_code>T42442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175076</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytomegalovirus pUL97 Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib [2058849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib [475342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entrectinib [2197862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib [1425099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axitinib [1242999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib [480167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib [1363268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib dimethyl sulfoxide [1425098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>binimetinib [2049122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib anhydrous [2058848]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temsirolimus [657797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib [1722365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib sulfate [2361596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib fumarate [1722380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copanlisib [1945077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abemaciclib [1946825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Protein Synthesis Inhibitors [MoA]</name>
  <code>C478</code>  <id>479</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors</to_name>
    <to_code>T42481</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000150</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Protein Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>APOC-III RNA Antisense Inhibitor [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleandomycin [7629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemether [18343]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate, liposomal [2059179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tavaborole [1543173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline [2055906]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen sodium [314633]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gramicidin [5011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline tosylate [2059268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine [1546446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troleandomycin [10864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telithromycin [274786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin hydrochloride [1541465]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate [2640868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin [270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline hydrochloride [2059038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen [85763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline dihydrochloride [2055907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin hydrochloride [267342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate tetrahydrate [1306069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxithromycin [9478]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin acetate [2198943]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethionamide [4127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eteplirsen [1810569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denileukin diftitox-cxdl [2700746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin liposomal [2059180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protein Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proteolytic Enzyme [EPC]</name>
  <code>C651669</code>  <id>651669</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteolytic Enzyme</to_name>
    <to_code>T42588</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191621</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteolytic Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Endopeptidase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proteolytic Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptide Hydrolases [M0016225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proteolytic Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</name>
  <code>C654311</code>  <id>654311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>ROS1 Inhibitors</to_name>
    <to_code>T58921</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors</to_name>
    <to_code>T58920</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194093</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proton Pump Inhibitor [EPC]</name>
  <code>C634918</code>  <id>634918</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitor</to_name>
    <to_code>T42870</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175525</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium-competitive Acid Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esomeprazole [283742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pantoprazole [40790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dexlansoprazole [816346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabeprazole [114979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with hydrogen/potassium adenosine triphosphatase enzyme system inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lansoprazole [17128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omeprazole [7646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proton Pump Inhibitors [MoA]</name>
  <code>C472</code>  <id>473</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors</to_name>
    <to_code>T42871</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000147</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>M2 Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan fumarate [2604576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc pyrithione [39952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan [2604577]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Proton Pump Interactions [MoA]</name>
  <code>C648274</code>  <id>648274</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Interactions</to_name>
    <to_code>T42872</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188373</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Proton Pump Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proton Pump Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Provitamin D2 Compound [EPC]</name>
  <code>C635347</code>  <id>635347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Provitamin D2 Compound</to_name>
    <to_code>T42925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175909</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Provitamin D2 Compound [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ergocalciferol [4018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Provitamin D2 Compound [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergocalciferols [M0007651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing ergocalciferol (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Provitamin D2 Compound [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Ergocalciferol (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Provitamin D2 Compound [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Psoralen [EPC]</name>
  <code>C635317</code>  <id>635317</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Psoralen-class Agent</to_name>
    <to_code>T42993</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Psoralen</to_name>
    <to_code>T42994</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175879</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Psoralen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methoxsalen [6854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Psoralen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoralens [M0017973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Psoralen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing psoralen (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Psoralen [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Psoralen (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arterial Vasoconstriction [PE]</name>
  <code>C29996</code>  <id>29997</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasoconstriction</to_name>
    <to_code>T43056</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009815</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pulmonary Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arterial Vasodilation [PE]</name>
  <code>C29998</code>  <id>29999</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation</to_name>
    <to_code>T43057</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009816</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pulmonary Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrisentan [358274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macitentan [1442132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloprost [40138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan [75207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arteriolar Vasoconstriction [PE]</name>
  <code>C634788</code>  <id>634788</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arteriolar Vasoconstriction</to_name>
    <to_code>T43058</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175405</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Arteriolar Vasodilation [PE]</name>
  <code>C634772</code>  <id>634772</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Arteriolar Vasodilation</to_name>
    <to_code>T43059</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175389</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Excretion [PK]</name>
  <code>C266</code>  <id>267</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Excretion</to_name>
    <to_code>T43100</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000044</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Metabolism [PK]</name>
  <code>C232</code>  <id>233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Metabolism</to_name>
    <to_code>T43114</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000027</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Venous Vasoconstriction [PE]</name>
  <code>C30000</code>  <id>30001</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasoconstriction</to_name>
    <to_code>T43183</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009817</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pulmonary Venous Vasodilation [PE]</name>
  <code>C30002</code>  <id>30003</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation</to_name>
    <to_code>T43184</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009818</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pupillary Constriction [PE]</name>
  <code>C30004</code>  <id>30005</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction</to_name>
    <to_code>T43190</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009819</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine [2721766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride [260036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbachol [1999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole [22298]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine hydrochloride [2721767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurophate [6027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole hydrochloride [235757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Constriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pupillary Dilation [PE]</name>
  <code>C30006</code>  <id>30007</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation</to_name>
    <to_code>T43191</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009820</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropicamide [10869]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate [3001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate hydrochloride [106029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyamphetamine hydrobromide [82066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine hydrobromide [235428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-hydroxyamphetamine [7839]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pupillary Dilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Purine Antimetabolite [EPC]</name>
  <code>C635118</code>  <id>635118</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Purine Antimetabolite</to_name>
    <to_code>T43198</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175712</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with purine antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>azathioprine [1256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cladribine [44157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing purine antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleic Acid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Purine Antimetabolite [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purines [M0018169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyrethroid [EPC]</name>
  <code>C635285</code>  <id>635285</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrethroid-class Agent</to_name>
    <to_code>T43304</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrethroid</to_name>
    <to_code>T43305</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175847</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrethroid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing pyrethroid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrethroid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrethrins [M0018228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrethroid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>permethrin [33199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrethroid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Pyrethroid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyridone [EPC]</name>
  <code>C651450</code>  <id>651450</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyridone</to_name>
    <to_code>T43313</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191420</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyridone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridones [M0018236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyridone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pirfenidone [1592254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Pyridine and/or pyridine derivative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyridone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Analog [EPC]</name>
  <code>C651925</code>  <id>651925</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Analog</to_name>
    <to_code>T43353</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Analogue</to_name>
    <to_code>T43352</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191809</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrimidines [M0018260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uridine [11017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Pyrimidine analog (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Phosphorylase Inhibitors [MoA]</name>
  <code>C651984</code>  <id>651984</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Phosphorylase Inhibitors</to_name>
    <to_code>T43358</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191868</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Phosphorylase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyrimidine Synthesis Inhibitor [EPC]</name>
  <code>C645316</code>  <id>645316</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Synthesis Inhibitor</to_name>
    <to_code>T43361</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185502</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teriflunomide [1310520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrimidine Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dihydroorotate Dehydrogenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrimidine Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</name>
  <code>C634850</code>  <id>634850</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog DNA Polymerase Inhibitor</to_name>
    <to_code>T43401</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analogue DNA Polymerase Inhibitor</to_name>
    <to_code>T43400</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175470</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>foscarnet [33562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Polymerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyrophosphate Analog [EXT]</name>
  <code>C634849</code>  <id>634849</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog</to_name>
    <to_code>T43403</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analogue</to_name>
    <to_code>T43402</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175469</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Diphosphates [M0018275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyruvate Kinase Activator [EPC]</name>
  <code>C654216</code>  <id>654216</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activator</to_name>
    <to_code>T58708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyruvate Kinase Activator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyruvate Kinase Activator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitapivat [2594468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Pyruvate Kinase Activator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Pyruvate kinase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Pyruvate Kinase Activators [MoA]</name>
  <code>C654217</code>  <id>654217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activators</to_name>
    <to_code>T58709</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat sulfate [2595574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyruvate Kinase Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Q [Preparations]</name>
  <code>C288643</code>  <id>288643</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Q [Preparations]</to_name>
    <to_code>T43482</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010599</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>QS-21 [2002417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus alba extract [1312383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine arsenite [1426898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinupramine [35242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quercetin caprylate [1599156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinapril [35208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quince extract [1370761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinic acid [1427232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus rubra whole extract [1863220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-90 bentonite [2560230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>queen palm pollen extract [867353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine [9071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine bisulfate [9073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus robur nut extract [1311052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-52 [1363626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quarternium-15 [1367171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinethazone [59743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinaprilat [1546359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus robur flower extract [1309753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine bisulfate [55377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus robur whole extract [1541242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinoline yellow [1305564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinapril hydrochloride [235759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-18 hectorite [1431997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinestrol [9066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinacrine [9061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinupristin [229367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-53 [2055747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinhydrone [1344799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-90 montmorillonite [2537435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-15 [283678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quassia amara whole extract [1369897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quillaja saponaria wood extract [1438110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine salicylate [1426899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinagolide hydrochloride [236233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus velutina whole extract [2043271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine gluconate [35220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinate [1427233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinagolide [76887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine sulfate [9069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quassia amara wood extract [1310168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine dihydrochloride [388472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-16 [2274099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-14 [1312730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-33 [1597389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus spp. whole extract [1993213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-18 [1363625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-27 [1732649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quizartinib dihydrochloride [2643049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-15 trans-form [2537630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-90 [2570732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quadrosilan [1313268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-91 [1368158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinacrine monohydrochloride [82092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quercetin [9060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-22 [1426897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quetiapine fumarate [221153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-24 [1539969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quillaja saponaria whole extract [2667938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinoa oil [1437504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinestradol [35215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus marilandica pollen extract [1437222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-90 sepiolite [2537436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quebracho bark extract [1309798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-15 cis-form [1314289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine [9068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quackgrass pollen extract [852343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus robur flower bud extract [2055000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus robur wood extract [2479549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quetiapine [51272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quillaja saponaria bark extract [1309948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinfamide [35216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinidine polygalacturonate [41875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quizartinib [2643048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine arsenate [1309255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus rubra bark extract [1312382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine hydrochloride [9074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus garryana whole extract [2043268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus kelloggii whole extract [2043270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-73 [2667745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus suber bark extract [1307810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus robur twig bark extract [1307647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus petraea whole extract [2264602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine ascorbate [236327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quazepam [35185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-82 [1541736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quinine sulfate [9075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Q [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Quercus agrifolia whole extract [2043272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Quinolone Antibacterial [EPC]</name>
  <code>C634814</code>  <id>634814</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antibacterial</to_name>
    <to_code>T43564</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175432</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with quinolone structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinolones [M0023650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Quinolone Antimicrobial [EPC]</name>
  <code>C635375</code>  <id>635375</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antimicrobial</to_name>
    <to_code>T43565</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175937</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gatifloxacin anhydrous [1546025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>besifloxacin [819911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ofloxacin [7623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinolones [M0023650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Quinolone Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gemifloxacin [138099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Quinolone (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing quinoline (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Quinolone Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>R [Preparations]</name>
  <code>C288644</code>  <id>288644</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>R [Preparations]</to_name>
    <to_code>T43583</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010600</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ricinus communis whole extract [1432797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raffinose [1362905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resmethrin [35380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruellia simplex whole extract [2590685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rat skin extract [895279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa moschata oil [1305662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina seed extract [1373728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhamnus cathartica bark extract [2714498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rocuronium bromide [32521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ripretinib [2369389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relebactam monohydrate [2184136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosoxacin [35797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riluzole [35623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rocuronium [68139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus ursinus whole extract [2118075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice oil [1307748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruscogenin [35890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhizobian gum [1869799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ronidazole [1535498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>robenacoxib [1250203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritonavir [85762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubidium fluoride [1872046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remibrutinib [2724365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reteplase [76895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radish extract [1314656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruta graveolens flowering top extract [1309685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranolazine [35829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabies virus [1648419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa x damascena flower wax [2180552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remdesivir [2284718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red alder pollen extract [851914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retinol acetate [35400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin 5&apos;-phosphate [1925821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus corchorifolius fruit extract [1654971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roflumilast [1091836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifampin [9384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropinirole hydrochloride [236553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rasagiline [134748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropivacaine hydrochloride [236539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rutin sodium propylsulfonate [236537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum officinale root extract [1310065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revakinagene taroretcel-lwey [2708831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red king crab preparation [1928707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhododendron ferrugineum whole extract [1922729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regrelor [1313722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex acetosella whole extract [1735326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riociguat [1439816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rutin sodium sulfate [236445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus spp whole extract [1663402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rinfabate [1426631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilpivirine [1102270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus chamaemorus fruit extract [1311671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus toxicodendron extract [283583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa centifolia flower oil [1305664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhaponticum carthamoides root extract [1996990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>repotrectinib [2670644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red mulberry whole extract [1996984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rivaroxaban [1114195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhododendron indicum flower extract [2588054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus chinensis root extract [1373160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rivastigmine [183379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabacfosadine [2003595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex acetosa whole extract [1363562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ranunculus sceleratus extract [1862682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red yeast rice [232540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa multiflora whole extract [2380571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritodrine hydrochloride [105470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Raphanus sativus var. Caudatus root extract [2480114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit anti-human T-lymphocyte globulin [107044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribociclib [1873916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remimazolam besylate [2383942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhamnose [1872246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retinyl linoleate [1370677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>racementhol [1430390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubella virus [1365969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa alba flower extract [2371036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhodamine B [1362930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rocky Mountain juniper pollen extract [852601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ribes nigrum seed oil [1305665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimegepant sulfate [2282322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosewood oil [1307693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhubarb preparation [91266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifapentine [35617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus chinensis gall extract [1802850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ribes nigrum leaf extract [1491860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ranunculus bulbosus extract [1328307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice bran oil [1309223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhubarb allergenic extract [1011033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosmarinyl glucoside [2123048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reishi mushroom preparation [1313180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabeprazole sodium [226868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribonucleic acid sodium [236790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhododendron aureum leaf extract [1309717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rofecoxib [232158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa multiflora root extract [2634354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruscus aculeatus root extract [1309509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimiterol [9388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina fruit extract [1311501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum tanguticum whole extract [1541243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum rhaponticum root extract [1996991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>robenidine [1311554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina seed oil [2567688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilmenidine [55679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rough marshelder pollen extract [852532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rolapitant [1665496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rebaudioside A [1667222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>racepinephrine [66887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodotorula rubra allergenic extract [867321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhododendron caucasicum whole extract [2711886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubidium [1311489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rizatriptan benzoate [237082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit bush pollen extract [851969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus corchorifolius whole extract [2399544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa X alba flower oil [2471868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ranunculus ficaria extract [1355818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice bean extract [1941992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raw sugar [1483267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodiola kirilowii root extract [1990882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radium bromide [1311076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radium [1546450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rizatriptan [88014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retifanlimab [2632981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rose bengal sodium [1362690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reductic acid [2593372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rehmannia elata root extract [1865700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramucirumab [1535922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regorafenib monohydrate [1371319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus fruticosus root extract [2669455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red clover preparation [285193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilmenidine phosphate [236379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimantadine [9386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa rugosa flower bud extract [1483620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimiterol hydrobromide [203161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rasburicase [283821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosemary extract [1314597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remimazolam [2383941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redberry juniper pollen extract [900113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranibizumab [595060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>royal jelly [35805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa centifolia whole extract [2621545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rolapitant hydrochloride [1673367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rituximab-pvvr [2273510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabies virus vaccine flury-lep strain [830457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rutin [9500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>racemethionine [9100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimegepant [2282307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus coreanus whole extract [2570733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rickettsia prowazekii [1744460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revumenib [2698325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosiglitazone [84108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roxarsone [1314413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relugolix [2472778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranitidine hydrochloride [203136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa multiflora flower wax [1489920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rickettsia rickettsii [1482546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubia cordifolia root extract [1547468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilonacept [763450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reproterol [35373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ranunculus bulbosus root extract [2533130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodiola crenulata whole extract [2627241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risankizumab-rzaa [2166132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosuvastatin [301542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rye allergenic extract [892638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus chamaemorus seed extract [1312378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reserpine [9260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifamycin SV [35616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus idaeus fruit volatile oil [1541710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rezafungin acetate [2639156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramelteon [596205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relatlimab [2596773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropeginterferon alfa-2b [2587059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remifentanil hydrochloride [236540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit skin extract [867315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranibizumab-nuna [2602351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rose bengal sodium I 131 [82097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radium chloride Ra-223 [1424174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosmarinus officinalis flowering top extract [1309727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redwood pollen extract [1014707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized [2642138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropinirole [72302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rose bengal [9471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raloxifene [72143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red oak pollen extract [852268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina flower oil [1425900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum acuminatum root extract [2665342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raspberry seed oil [1309291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>repaglinide [73044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ribes nigrum flower bud extract [1549697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rho(D) immune globulin, human [1789837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin [9346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhynchophylline [2562552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ROTAVIRUS VACCINE, LIVE [253199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red currant allergenic extract [972480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rapeseed sterol extract [1307741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropivacaine [35780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropivacaine hydrochloride anhydrous [2198974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rehmannia glutinosa whole extract [1490688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimabotulinumtoxinB [860178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>racepinephrine hydrochloride [314610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remestemcel-L [2700765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raxibacumab [1366567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruthenium tribromide [1989389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronic acid [55685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa roxburghii fruit extract [1311668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rituximab-abbs [2105824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roxithromycin [9478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosemary oil [90945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risdiplam [2390935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rufinamide [69036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa davurica flower bud extract [1799151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin tetrabutyrate [2106328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Robinia pseudoacacia flower extract [2050979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roxatidine [114817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhizopus stolonifer allergenic extract [967721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa damascena flowering top extract [1310016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosmarinus officinalis whole extract [1364990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>razoxane [9154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redroot pigweed pollen extract [851930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice germ oil [1307708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regadenoson [640062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleth-40 [1868829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rozanolixizumab [2642274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red cedar pollen extract [852609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruta graveolens flowering top oil [1367425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin 5&apos;-phosphate sodium anhydrous [2279515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resorcinol monoacetate [2106739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rescinnamine [9259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice bran, defatted [2531931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubia tinctorum whole extract [1370301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex crispus top extract [1310183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum pumilum whole extract [2683195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romiplostim [805452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa californica whole extract [2533911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa rubiginosa seed oil [1309290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rose petal extract [1322046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romosozumab-aqqg [2123180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rehmannia glutinosa root extract [1309220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhizopus arrhizus allergenic extract [314443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronate sodium hemi-pentahydrate [1356127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruta graveolens whole extract [1310215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabbit allergenic extract [813859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubidium chloride [1367087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>racecadotril [16738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>RESPIRATORY VACCINE [253196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rainbow trout allergenic extract [2102483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifaximin [35619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifamycin sodium [236475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa gallica flower oil [1307744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice allergenic extract [901337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodotorula mucilaginosa allergenic extract [967529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red kidney bean allergenic extract [1012183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red delicious apple allergenic extract [895588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus idaeus subsp. strigosus whole extract [2000544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboprine [1376156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus fruticosus seed extract [1600747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubidium nitrite [1658653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>respiratory syncytial virus pre-fusion F protein [2636589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redwood whole extract [1996993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romidepsin [877510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleic monoethanolamide sulfosuccinate [1370599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red snapper allergenic extract [889646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleate [618482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum palmatum whole extract [1442704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubella virus vaccine [9486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa gallica flower extract [1309502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ractopamine [1311677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramiprilat [1546377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex crispus whole extract [1360628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ribes rubrum whole extract [2394950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus fruticosus whole extract [2001178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranitidine bismuth citrate [55471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa centifolia flower wax [2180551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rituximab [121191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus fruticosus leaf extract [1309507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reslizumab [1746889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remestemcel-L-rknd [2700764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revakinagene taroretcel [2708830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropeginterferon alfa-2b-njft [2587060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>respiratory syncytial virus pre-fusion F protein, recombinant [2636588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ravulizumab-cwvz [2107316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosuvastatin calcium [323828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regadenoson anhydrous [1546015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>respiratory syncytial virus immune globulin intravenous [119246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rapacuronium [262100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reproterol hydrochloride [235833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosmarinus officinalis flower extract [1309505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rauwolfia preparation [78678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa multiflora fruit extract [1311667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romosozumab [2123126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina flower extract [1309745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>recombinant antihemophilic factor VIII [253151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruta graveolens preparation [285162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus aromatica root bark extract [1353884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus chingii whole extract [2370872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodomyrtus tomentosa fruit extract [1363468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhenium [1667763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>robusta coffee bean extract [1307314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regorafenib [1312397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodiola crenulata root extract [1372932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum palmatum root extract [1436168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum officinale whole extract [1435867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>recombinant interferon beta-1b [72258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin 5&apos;-phosphate sodium [1925820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reboxetine [60842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus glabra top extract [1310173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus chamaemorus whole extract [1875603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus idaeus leaf extract [1309981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relebactam [2184137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleamidopropyl ethyldimonium ethosulfate [1307142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retinyl propionate [1356759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rucaparib camsylate [1862578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retinaldehyde [2268087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resorcinol [35382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus laciniatus whole extract [2178088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rotenone [1366666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resveratrol [1000492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radish allergenic extract [974687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risankizumab [2166040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosin [1362931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized [2642139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus chingii var. suavissimus leaf extract [1806682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red maple pollen extract [851744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa damascena whole extract [1543294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Russian olive pollen extract [852367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raltitrexed [196239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reviparin sodium [75961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retifanlimab-dlwr [2632980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranibizumab-eqrn [2612673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribavirin [9344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red bell pepper allergenic extract [901329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>RNA [9394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rose oil [1309371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex acetosa whole leaf extract [1721436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red pepper extract [1313692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Reynoutria multiflora root oil [2669403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubia tinctorum root extract [1309973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Russian thistle pollen extract [852158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilpivirine hydrochloride [1102287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosa canina fruit oil [1305715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roxatidine acetate hydrochloride [236543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa alba flower oil extract [2002791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus glabra bark extract [1307857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronate sodium [60334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabies virus vaccine wistar strain PM-1503-3M (human), inactivated [830464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red paper wasp venom protein [1294634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubidium iodide [2634902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruxolitinib [1193326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red pine pollen extract [900754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retinyl retinoate [1373727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romifidine hydrochloride [1091913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhodinol [1986339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risperidone [35636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin 5&apos;-phosphate sodium dihydrate [2611697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhus chinensis whole extract [1372476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa damascena flower wax [1539420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rapacuronium bromide [228530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimexolone [55681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>regenerated cellulose [2000577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosmarinus officinalis flowering top oil [1376348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raltegravir [719872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riboflavin sodium [2109051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rimantadine hydrochloride [82093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retatrutide [2722410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribose [1314858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodiola sacra root extract [1943532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red imported fire ant allergenic extract [867341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosiglitazone maleate [253198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rucaparib [1862579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruthenium [1534768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reboxetine mesylate [60841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhododendron aureum whole extract [1999725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raspberry juice [1307723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rennet [35360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relatlimab-rmbw [2596772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rauwolfia alkaloids [9152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhopalurus princeps venom [1812093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remifentanil [73032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>red mulberry pollen extract [852680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabacfosadine succinate [2003594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>river birch pollen extract [852148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Raphanus sativus var. sativus seed [1652250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex obtusifolius root extract [1997155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ravulizumab [2107301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritlecitinib tosylate [2641596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redtop grass pollen extract [851870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resmetirom [2677894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rivastigmine tartrate [994808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranitidine [9143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhododendron ferrugineum leaf extract [1918048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raspberry allergenic extract [899906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronate [73056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rancid beef preparation [1311083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa moschata seed oil [1310011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raloxifene hydrochloride [166551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Raphanus sativa extract [1311246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifabutin [55672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rhodium [1311402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus idaeus seed extract [1431709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rheum officinale stem extract [1373039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleamidopropyltrimonium chloride [1591912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex japonicus root extract [1733671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa luciae flowering top extract [2539936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice (whole grain) allergenic extract [892661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritlecitinib [2641595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rose bengal AT [1546378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa chinensis flower extract [2565949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ritodrine [9392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronate sodium monohydrate [1356128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosmarinus officinalis preparation [317702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa damascena flower oil [1305663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus chamaemorus seed oil [1310096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina leaf extract [1438291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleic acid [35605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosin partially dimerized glycerol ester [1549331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risedronate sodium anhydrous [1926958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rituximab-arrx [2472325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rumex crispus root extract [1345677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retinamide [1367161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rotigotine [616739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubidium chloride Rb-82 [1367086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rattus norvegicus hair preparation [2471704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa canina whole extract [1739226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ractopamine hydrochloride [1311676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rolitetracycline [9462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remoxipride [35350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ricinus communis leaf extract [2682809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabeprazole [114979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rudbeckia hirta whole extract [2539795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubes nigrum seed extract [1307697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remoxipride hydrochloride [235832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rauwolfia serpentina (USP) [317836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa centifolia flower extract [1364989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rozanolixizumab-noli [2642273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhamnus cathartica fruit extract [1367391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramipril [35296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifamycins [9385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radium Ra-223 cation [1745075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhinacanthus nasutus leaf extract [2632264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhodiola kirilowii whole extract [1740941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rasagiline mesylate [577300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosaniline hydrochloride [1535512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rabies immune globulin, human [89886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice bran [1356151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rilzabrutinib [2722398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>82 rubidium [1546434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosmarinate [2531312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Robinia pseudoacacia bark extract [1309971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosmarinic acid [2531311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>reviparin [75960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relebactam anhydrous [2268500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubus coreanus fruit extract [1655991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ruttnera lamellosa oil [2281670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>redroot pigweed whole allergenic extract [1306882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resacetophenone [2685741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>robenidine hydrochloride [1311553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ropivacaine hydrochloride monohydrate [1298851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Russula emetica preparation [1441399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revefenacin [2102775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ribociclib succinate [1873978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>revumenib citrate [2698326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rho(D) immune globulin [35465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rubella virus vaccine live (Wistar RA 27-3 strain) [762817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rezafungin [2639155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa damascena flower extract [1307568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romifidine [1091919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rosa arkansana root extract [1592898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rhinacanthus nasutus whole extract [2565689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain [805573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radium cation [1546270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>retapamulin [642274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raspberry extract [1370769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>roxatidine acetate [35803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ricinoleamidopropyltrimonium [1591913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rorippa nasturtium-aquaticum flowering top extract [1309500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>raltegravir potassium [1235585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>recombinant FVIIa [314620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rough cocklebur pollen extract [995600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ruxolitinib phosphate [1193325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Rubia cordifolia whole extract [2045734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Reynoutria multiflora stem extract [2669694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>R [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rice germ preparation [1427015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RANK Ligand Blocking Activity [MoA]</name>
  <code>C646940</code>  <id>646940</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity</to_name>
    <to_code>T43602</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activator of Nuclear Factor-kappa B Ligand Blocking Activity</to_name>
    <to_code>T43600</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RANKL Blocking Activity</to_name>
    <to_code>T43601</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187054</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-qbde [2725562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bbdz [2715382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-nxxp [2723334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-dssb [2725498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bnht [2717527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bmwo [2717851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab [993449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-kyqq [2725924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RANK Ligand Inhibitor [EPC]</name>
  <code>C646941</code>  <id>646941</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand (RANKL) Inhibitor</to_name>
    <to_code>T43603</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RANKL Inhibitor</to_name>
    <to_code>T43604</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activator of Nuclear Factor-kappa B Ligand Inhibitor</to_name>
    <to_code>T43605</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Inhibitor</to_name>
    <to_code>T43606</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187055</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RANK Ligand Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RANK Ligand Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing receptor activator of nuclear factor kappa-B ligand inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>RANK Ligand Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RANK Ligand Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>denosumab [993449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RNA Integrity Alteration [PE]</name>
  <code>C30008</code>  <id>30009</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Integrity Alteration</to_name>
    <to_code>T43708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009821</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Integrity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Integrity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Integrity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RNA Polymerase Inhibitor [APC]</name>
  <code>C654162</code>  <id>654162</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Polymerase Inhibitor</to_name>
    <to_code>T58599</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193946</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Polymerase Inhibitor [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RNA Replicase Inhibitors [MoA]</name>
  <code>C651252</code>  <id>651252</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA-dependent RNA Polymerase Inhibitors</to_name>
    <to_code>T43733</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors</to_name>
    <to_code>T43734</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191258</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofosbuvir [1484911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remdesivir [2284718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir sodium monohydrate [1600438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replicase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RNA Replication Alteration [PE]</name>
  <code>C30010</code>  <id>30011</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replication Alteration</to_name>
    <to_code>T43739</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009822</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Replication Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Replication Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RNA Synthetase Inhibitor Antibacterial [EPC]</name>
  <code>C634908</code>  <id>634908</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitor Antibacterial</to_name>
    <to_code>T43743</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175515</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mupirocin [42372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>RNA Synthetase Inhibitor Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitor Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>RNA Synthetase Inhibitors [MoA]</name>
  <code>C634909</code>  <id>634909</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors</to_name>
    <to_code>T43744</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175516</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran [2604578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vutrisiran sodium [2605574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RNA Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Agent [EPC]</name>
  <code>C637369</code>  <id>637369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent</to_name>
    <to_code>T44072</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000177914</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioflupane I-123 [1426874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>copper oxodotreotide CU-64 [2396442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iobenguane sulfate I-123 [1427223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>piflufolastat F-18 [2556616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pertechnetate Tc 99m [10349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dotatate gallium ga-68 [676679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Radioactive isotope (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gallium GA-68 gozetotide [2586016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thallous cation Tl-201 [1546370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flotufolastat F-18 [2637946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 chloride [42987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 pentetate disodium [259268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodide ion I-123 [1361657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamic acid I-125 [1546452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluorodeoxyglucose F18 [1362737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluciclovine F-18 [1796118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 oxyquinoline [1314372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m exametazime [1431726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoroestradiol F-18 [2372221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m medronate [1488818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florbetapir F-18 [1427224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>82 rubidium [1546434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>florbetaben f-18 [1492940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flutemetamol F-18 [1486025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Diagnostic radioisotope (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m sestamibi [1482913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoride ion F-18 [1546273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m tilmanocept [1373391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>flurpiridaz F-18 [2700762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indium In-111 pentetreotide [1724429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc-99m sulfur colloid [1423270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonia N-13 [1305558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>choline C-11 [1425419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dotatate gallium GA-68 [1872044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc-99m pyrophosphate [1488368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</name>
  <code>C635309</code>  <id>635309</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for Positron Emission Tomography</to_name>
    <to_code>T44073</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175871</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Radioactive isotope (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing radioactive isotope (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for Positron Emission Tomography [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</name>
  <code>C635308</code>  <id>635308</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for gamma-Scintigraphy</to_name>
    <to_code>T44074</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175870</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Radioactive isotope (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing radioactive isotope (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Agent for gamma-Scintigraphy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioactive Diagnostic Antibody [EPC]</name>
  <code>C635311</code>  <id>635311</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Antibody</to_name>
    <to_code>T44075</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175873</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Diagnostic Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing radioactive isotope (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Radioactive isotope (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Diagnostic Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioactive Therapeutic Agent [EPC]</name>
  <code>C635310</code>  <id>635310</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Therapeutic Agent</to_name>
    <to_code>T44076</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175872</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Therapeutic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodide ion I-131 [1546415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Therapeutic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Therapeutic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Therapeutic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium cation Sr-89 [2280602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive Therapeutic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing radioactive isotope (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Radioactive isotope (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</name>
  <code>C646939</code>  <id>646939</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive alpha-Particle Emitting Therapeutic Agent</to_name>
    <to_code>T44079</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Particle-Emitting Radioactive Therapeutic Agent</to_name>
    <to_code>T44078</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187053</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>radium Ra-223 cation [1745075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Particle Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Radioactive isotope (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing radioactive isotope (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioactive alpha-Particle Emitting Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radiographic Contrast Agent [EPC]</name>
  <code>C639677</code>  <id>639677</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiographic Contrast Agent</to_name>
    <to_code>T44083</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180185</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Optical Imaging Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diatrizoic acid [1546223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>barium sulfate [1331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethiodized oil [4125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iohexol [5956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iothalamic acid [1546451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iodixanol [27729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iomeprol [2606484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ioversol [27792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carbon dioxide [2034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopamidol [5966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiographic Contrast Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>iopromide [27781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Contrast media (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiographic Contrast Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioligand Activity [MoA]</name>
  <code>C654234</code>  <id>654234</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Activity</to_name>
    <to_code>T58745</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194016</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radioligand Therapeutic Agent [EPC]</name>
  <code>C654235</code>  <id>654235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Therapeutic Agent</to_name>
    <to_code>T58746</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194017</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioligand Therapeutic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radioligand Therapeutic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Lutetium-177 (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Therapeutic Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Radiopharmaceutical Activity [MoA]</name>
  <code>C588</code>  <id>589</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity</to_name>
    <to_code>T44087</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000205</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiopharmaceutical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Ray Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiopharmaceutical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Particle Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiopharmaceutical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radioligand Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Radiopharmaceutical Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Positron Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetapir F-18 [1427224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,iodinated I-125 serum [317177]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iocetamic acid [183830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium I 131 [82097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutemetamol F-18 [1486025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m sestamibi [1482913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 oxyquinoline [1314372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m exametazime [1431726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium 99m [90650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium-89 chloride [281890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromic phosphate P32 [121070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc-99m pyrophosphate [1488368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene diphosphonate [29844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyanocobalamin Co57 [91516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine iodipamide [29456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoride ion F-18 [1546273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m tilmanocept [1373391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129, hyperpolarized [2626220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetreotide [1724429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc-99m sulfur colloid [1423270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonia N-13 [1305558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline C-11 [1425419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodohippurate I131 sodium [91540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane sulfate I-123 [1427223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pertechnetate Tc 99m [10349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenomethionine Se 75 [9133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 chloride [42987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,iodinated I-131 serum [314301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-123 [1361657]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamic acid I-125 [1546452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vipivotide tetraxetan [2597054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotide gallium ga-68 [2199391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallous cation Tl-201 [1546370]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>82 rubidium [1546434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iophendylate [5968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium cation Sr-89 [2280602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium-111 [90540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopanoic acid [5967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate [5976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m medronate [1488818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,chromated Cr-51 serum [314299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-133 [259282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fanolesomab [1314371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioflupane I-123 [1426874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotride [2199392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129 [2626219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium 67 citrate [272758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate sodium [9887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetate disodium [259268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m disofenin [37665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxidronate [1306068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodeoxyglucose F18 [1362737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-131 [1546415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallous chloride Tl201 [91588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioflupane [2571854]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium ipodate [1911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiopharmaceutical Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Rearranged during Transfection (RET) Inhibitors [MoA]</name>
  <code>C654161</code>  <id>654161</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Rearranged during Transfection (RET) Inhibitors</to_name>
    <to_code>T58597</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RET Inhibitors</to_name>
    <to_code>T58598</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193947</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rearranged during Transfection (RET) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralsetinib [2394936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rearranged during Transfection (RET) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Activity Modifying Protein Agonists [MoA]</name>
  <code>C300452</code>  <id>300452</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists</to_name>
    <to_code>T44153</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020062</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Activity Modifying Protein Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-fpgk [2613761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-aafi [2057198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-jmdb [2048018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim [68442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-ayow [2595942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim [338036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-pbbk [2602779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-apgf [2469333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-bmez [2260702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-cbqv [2102692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-sndz [1605064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Activity Modifying Protein Antagonists [MoA]</name>
  <code>C300453</code>  <id>300453</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Antagonists</to_name>
    <to_code>T44154</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020063</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Activity Modifying Proteins [MoA]</name>
  <code>C300451</code>  <id>300451</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Proteins</to_name>
    <to_code>T44155</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020061</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Activity Modifying Proteins [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Activity Modifying Proteins [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Activin Signaling Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Activity Modifying Proteins [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Protein Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Agonist [APC]</name>
  <code>C654100</code>  <id>654100</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Agonist</to_name>
    <to_code>T58510</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193886</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium-sensing Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-4 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenosine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-1 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E2 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostaglandin E1 Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacyclin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GLP-2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melanocortin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Nicotinic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cannabinoid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mu-Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-15 Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Secretagogue Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Melatonin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonergot Dopamine Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Depolarizing Neuromuscular Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amylin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergot-derived Dopamine Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>TRPM8 Thermoreceptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Agonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopaminergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Antagonist [APC]</name>
  <code>C654101</code>  <id>654101</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Antagonist</to_name>
    <to_code>T58511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193887</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gonadotropin Releasing Hormone Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nondepolarizing Neuromuscular Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-1 Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-3 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiotensin 2 Receptor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor-1 Receptor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-2 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aldosterone Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Protease-activated Receptor-1 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neonatal Fc Receptor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Muscarinic Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Histamine-1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticholinergic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Autonomic Ganglionic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Orexin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-4 Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 3 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Endothelin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine-2 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17 Receptor A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Complement 5a Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hedgehog Pathway Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Growth Hormone Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER2/neu Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Agonist/Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihistamine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-2 Receptor Blocking Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bradykinin B2 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Epidermal Growth Factor Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-31 Receptor alpha Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CCR5 Co-receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Antagonist [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P2Y12 Platelet Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Interaction [APC]</name>
  <code>C654099</code>  <id>654099</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interaction</to_name>
    <to_code>T58509</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193888</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Activin Signaling Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Antagonist [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD123 Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-6 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Chemokine Receptor Type 4 Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-23 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD20-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific CD19-directed CD3-directed T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Agonist [APC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-5 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-17A Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-13 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interaction [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin-12 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Interactions [MoA]</name>
  <code>C348</code>  <id>349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions</to_name>
    <to_code>T44165</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000085</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>G-Protein-linked Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcitonin Gene-related Peptide Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell Membrane Fusion Complex Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Protein Kinase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Activity Modifying Proteins [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fc Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Monosaccharide Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibody-Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>ATP-Binding Cassette (ABC) Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interleukin 31 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholinergic Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytokine Receptor Superfamily Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotransmitter Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Integrin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Interferon Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ion Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palovarotene [2663954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane citrate [283547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy polyethylene glycol-epoetin beta [729596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubrogepant [2268216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifarotene [2205637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane [20217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane tannate [221070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebelipase alfa [1726975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen edisylate [133053]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen [20191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alitretinoin [81864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin microsphere [221175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Protein Kinase Interactions [MoA]</name>
  <code>C604</code>  <id>605</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Protein Kinase Interactions</to_name>
    <to_code>T44166</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000213</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Macrophage Colony Stimulating Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor alpha Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Receptor Family Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatotropin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin-like Growth Factor-1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Insulin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Keratinocyte Growth Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Protein Kinase Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor beta Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Protein Kinase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Receptor Tyrosine Kinase Inhibitors [MoA]</name>
  <code>C300385</code>  <id>300385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors</to_name>
    <to_code>T44174</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020000</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HER Receptor Family Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fibroblast Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurotrophic Factor Receptor (RET) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mesenchymal Epithelial Transition Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platelet-derived Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bcr-Abl Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stem Cell Factor (KIT) Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Receptor Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rearranged during Transfection (RET) Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axitinib [1242999]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dictamnine [2685302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib esylate [1592736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib [2105806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zongertinib [2721604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib hydrochloride [2534245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entrectinib [2197862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib [2534233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib mesylate [1604346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib fumarate [2105823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Activated Protein C [EPC]</name>
  <code>C635032</code>  <id>635032</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Activated Protein C</to_name>
    <to_code>T46388</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175639</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Activated Protein C [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Recombinant human activated protein c (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Activated Protein C [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protein C [M0017852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Activated Protein C [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Proteins [M0018641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Antithrombin [EPC]</name>
  <code>C643905</code>  <id>643905</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Antithrombin</to_name>
    <to_code>T46389</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184170</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Antithrombin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing recombinant human antithrombin III (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Antithrombin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Factor Xa Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Antithrombin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Proteins [M0018641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Antithrombin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Coagulation Factor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Antithrombin [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Antithrombin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Recombinant human antithrombin III (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Deoxyribonuclease 1 [EPC]</name>
  <code>C635396</code>  <id>635396</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human DNase 1</to_name>
    <to_code>T46396</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>rhDNase I</to_name>
    <to_code>T46398</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease 1 Enzyme</to_name>
    <to_code>T46400</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease 1</to_name>
    <to_code>T46401</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease I (rhDNase) Enzyme</to_name>
    <to_code>T46395</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease I Enzyme</to_name>
    <to_code>T46397</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease I</to_name>
    <to_code>T46399</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease 1 (rhDNase) Enzyme</to_name>
    <to_code>T46393</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>rhDNase 1</to_name>
    <to_code>T46392</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human DNase I</to_name>
    <to_code>T46394</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175958</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Proteins [M0018641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dornase alfa [337623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Deoxyribonuclease 1 [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxyribonuclease I [M0006007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Deoxyribonuclease I (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease 1 [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing deoxyribonuclease (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Deoxyribonuclease 1 [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Growth Hormone [EPC]</name>
  <code>C634999</code>  <id>634999</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Growth Hormone</to_name>
    <to_code>T46402</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175606</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Growth Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatropin [61148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Growth Hormone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Human Growth Hormone (Mammalian) [M0397867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Growth Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lonapegsomatropin [2569562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with growth hormone receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Growth Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing anterior pituitary hormone (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Growth Hormone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Interferon beta [EPC]</name>
  <code>C635153</code>  <id>635153</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Interferon beta</to_name>
    <to_code>T46404</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175747</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Interferon beta [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon-beta [M0025715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Interferon beta [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Interferon beta (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Interferon beta [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing interferon beta (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Interferon beta [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Proteins [M0018641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </name>
  <code>C654304</code>  <id>654304</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Lysosomal alpha-Mannosidase</to_name>
    <to_code>T58905</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194082</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysosomal alpha-Mannosidase [M0446508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Alpha-mannosidase (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Lysosomal alpha-Mannosidase [EPC] </to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Recombinant Human Nerve Growth Factor [EPC]</name>
  <code>C654072</code>  <id>654072</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Nerve Growth Factor</to_name>
    <to_code>T58457</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193854</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Nerve Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Recombinant Proteins [M0018641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Nerve Growth Factor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cenegermin [2104332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Recombinant Human Nerve Growth Factor [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nerve Growth Factor [M0328210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Nerve growth factor (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Recombinant Human Nerve Growth Factor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Reducing and Complexing Thiol [EPC]</name>
  <code>C635336</code>  <id>635336</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reducing and Complexing Thiol</to_name>
    <to_code>T46438</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175898</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reducing and Complexing Thiol [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-substituted Glycines [M0289359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reducing and Complexing Thiol [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiopronin [6765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reducing and Complexing Thiol [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystine Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Organic sulfur compound (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reducing and Complexing Thiol [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sulfur and/or sulfur compound (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reducing and Complexing Thiol [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Reduction Activity [MoA]</name>
  <code>C634940</code>  <id>634940</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reduction Activity</to_name>
    <to_code>T46439</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175547</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reduction Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Disulfide Reduction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reduction Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Free Radical Scavenging Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reduction Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arterial Vasoconstriction [PE]</name>
  <code>C30012</code>  <id>30013</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arterial Vasoconstriction</to_name>
    <to_code>T46511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009823</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Afferent Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arterial Vasodilation [PE]</name>
  <code>C30014</code>  <id>30015</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arterial Vasodilation</to_name>
    <to_code>T46512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009824</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Afferent Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arteriolar Vasoconstriction [PE]</name>
  <code>C634790</code>  <id>634790</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arteriolar Vasoconstriction</to_name>
    <to_code>T46513</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175407</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Afferent Arteriolar Vasodilation [PE]</name>
  <code>C634774</code>  <id>634774</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arteriolar Vasodilation</to_name>
    <to_code>T46514</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175391</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Arterial Vasoconstriction [PE]</name>
  <code>C30016</code>  <id>30017</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction</to_name>
    <to_code>T46517</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009825</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Arterial Vasodilation [PE]</name>
  <code>C30018</code>  <id>30019</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation</to_name>
    <to_code>T46518</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009826</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril calcium [259493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Arteriolar Vasoconstriction [PE]</name>
  <code>C634789</code>  <id>634789</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arteriolar Vasoconstriction</to_name>
    <to_code>T46519</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175406</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arteriolar Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Arteriolar Vasodilation [PE]</name>
  <code>C634773</code>  <id>634773</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Arteriolar Vasodilation</to_name>
    <to_code>T46520</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175390</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Afferent Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Arteriolar Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Dehydropeptidase Inhibitor [EPC]</name>
  <code>C634907</code>  <id>634907</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Dehydropeptidase Inhibitor</to_name>
    <to_code>T46525</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175514</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Dehydropeptidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cilastatin [2540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Dehydropeptidase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dipeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing peptide hydrolase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Dehydropeptidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with peptide hydrolase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Dehydropeptidase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arterial Vasoconstriction [PE]</name>
  <code>C30020</code>  <id>30021</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arterial Vasoconstriction</to_name>
    <to_code>T46526</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009827</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Efferent Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arterial Vasodilation [PE]</name>
  <code>C30022</code>  <id>30023</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arterial Vasodilation</to_name>
    <to_code>T46527</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009828</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Efferent Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arteriolar Vasoconstriction [PE]</name>
  <code>C634791</code>  <id>634791</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arteriolar Vasoconstriction</to_name>
    <to_code>T46528</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175408</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Efferent Arteriolar Vasodilation [PE]</name>
  <code>C634775</code>  <id>634775</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Efferent Arteriolar Vasodilation</to_name>
    <to_code>T46529</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175392</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Endocrine Activity Alteration [PE]</name>
  <code>C30024</code>  <id>30025</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Endocrine Activity Alteration</to_name>
    <to_code>T46530</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009829</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Erythropoetin Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Excretion [PK]</name>
  <code>C262</code>  <id>263</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion</to_name>
    <to_code>T46531</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000042</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PK</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Ion Transport Alteration [PE]</name>
  <code>C30026</code>  <id>30027</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration</to_name>
    <to_code>T46538</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009830</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Ion Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Ion Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin [1373458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin [1488564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin propanediol [1486966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>empagliflozin [1545653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Metabolism [PK]</name>
  <code>C234</code>  <id>235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Metabolism</to_name>
    <to_code>T46539</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000028</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Organic Ion Transport Alteration [PE]</name>
  <code>C30028</code>  <id>30029</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Organic Ion Transport Alteration</to_name>
    <to_code>T46542</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009831</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Organic Ion Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Organic Ion Transport Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Renal Organic Ion Excretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal Tubular Transport Inhibitor [EPC]</name>
  <code>C654378</code>  <id>654378</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Tubular Transport Inhibitor</to_name>
    <to_code>T59066</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194156</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Tubular Transport Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Tubular Transport Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal Tubular Transport Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Organic Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renal/Urological Activity Alteration [PE]</name>
  <code>C30030</code>  <id>30031</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration</to_name>
    <to_code>T46548</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009832</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glomerular Filtration Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bladder Contractility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bladder Sphincter Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Organic Ion Transport Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urethra Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diuresis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renal/Urological Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Collecting Duct Water Permeability Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal/Urological Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renin Inhibitor [EPC]</name>
  <code>C635338</code>  <id>635338</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitor</to_name>
    <to_code>T46549</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175900</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renin Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with renin inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renin Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing renin inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renin Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aliskiren [325646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Renin Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Renin Inhibitors [MoA]</name>
  <code>C635337</code>  <id>635337</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors</to_name>
    <to_code>T46551</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Direct Renin Inhibitors</to_name>
    <to_code>T46550</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175899</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Reproductive System Activity Alteration [PE]</name>
  <code>C30032</code>  <id>30033</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reproductive System Activity Alteration</to_name>
    <to_code>T46572</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009833</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Male Reproductive System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reproductive System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Female Reproductive System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reproductive System Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Agent [APC]</name>
  <code>C654124</code>  <id>654124</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Agent</to_name>
    <to_code>T58526</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193909</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antihistamine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mast Cell Stabilizer [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Expectorant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-narcotic Antitussive [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mucolytic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Stimulant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Leukotriene Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arterial Vasoconstriction [PE]</name>
  <code>C30034</code>  <id>30035</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arterial Vasoconstriction</to_name>
    <to_code>T46589</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009834</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arterial Vasodilation [PE]</name>
  <code>C30036</code>  <id>30037</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arterial Vasodilation</to_name>
    <to_code>T46590</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009835</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arteriolar Vasoconstriction [PE]</name>
  <code>C634786</code>  <id>634786</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arteriolar Vasoconstriction</to_name>
    <to_code>T46591</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175403</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Arteriolar Vasodilation [PE]</name>
  <code>C634770</code>  <id>634770</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Arteriolar Vasodilation</to_name>
    <to_code>T46592</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175387</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Mucosal Edema Alteration [PE]</name>
  <code>C30296</code>  <id>30297</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Mucosal Edema Alteration</to_name>
    <to_code>T46610</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009964</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Mucosal Edema Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Mucosal Edema Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Mucosal Edema [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Secretion Alteration [PE]</name>
  <code>C30038</code>  <id>30039</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Secretion Alteration</to_name>
    <to_code>T46614</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009836</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Secretion Viscosity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretions [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Secretion Viscosity Alteration [PE]</name>
  <code>C30040</code>  <id>30041</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Secretion Viscosity Alteration</to_name>
    <to_code>T46615</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009837</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Secretion Viscosity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Secretion Viscosity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Respiratory Secretion Viscosity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Smooth Muscle Tone Alteration [PE]</name>
  <code>C30042</code>  <id>30043</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Smooth Muscle Tone Alteration</to_name>
    <to_code>T46616</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009838</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bronchial Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Stimulant [EPC]</name>
  <code>C635122</code>  <id>635122</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Stimulant</to_name>
    <to_code>T46620</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175716</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Stimulant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Respiratory stimulant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Stimulant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Medullary Respiratory Drive [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Stimulant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxapram [3637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</name>
  <code>C635016</code>  <id>635016</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody</to_name>
    <to_code>T46623</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RSV Anti-F Protein Monoclonal (mAb)</to_name>
    <to_code>T46622</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RSV Anti-F Protein Monoclonal Antibody</to_name>
    <to_code>T46621</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175623</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Syncytial Virus Infections [M0027589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Syncytial Virus Infections [M0027589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palivizumab [194279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clesrovimab [2716802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nirsevimab [2642401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antibody to Respiratory syncytial virus (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</name>
  <code>C654383</code>  <id>654383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus mRNA Vaccine</to_name>
    <to_code>T59071</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194157</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus mRNA [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Humoral and Cellular Immune Response Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vaccine product containing virus antigen (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory Syncytial Virus mRNA [EXT]</name>
  <code>C654382</code>  <id>654382</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus mRNA</to_name>
    <to_code>T59070</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194158</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory System Agent [TC]</name>
  <code>C637772</code>  <id>637772</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent</to_name>
    <to_code>T46630</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178318</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory System Agent [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antitussive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium bromide [1487512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine lactate [236530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol tartrate [668284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol [1546059]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poractant alfa [236381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab [2587789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol [1424884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benralizumab [1989100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofylline [24611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine [10849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bampine hydrochloride [236519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab-ekko [2587790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>helium [5140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene [6822]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loratadine [28889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zafirlukast [114970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol hydrochloride [1546396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol [4333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab-cfor [2716803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol [33767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide monohydrate [1298831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium [1487514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roflumilast [1091836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine [6023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reslizumab [1746889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine tannate [1099727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate dihydrate [998038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol [19499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine [18753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beractant [46967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine hydrochloride [102397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen fumarate [11404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calfactant [232539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensifentrine [2687215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol [237159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brensocatib [2721880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepolizumab [1720597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylhexedrine [8792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol trifenatate [1424883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol acetate [221142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wild yam extract [237020]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab [302379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine mesylate [6024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide mono [1552007]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revefenacin [2102775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline [10368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylhexedrine hydrochloride [236461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clesrovimab [2716802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol hydrobromide [203124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol tartrate [487066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol mesylate [47187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium [1303098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine hydrochloride [71534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen [6146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goldenseal extract [1372255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol HCl [235447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib esylate [1592736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan [75207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline sulfate [10369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol maleate [1114325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab-igec [2725997]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine [156240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol [1114326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene hydrochloride [235721]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerandomilast [2725523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol hydrochloride [237160]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline sulfate [2680384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Respiratory/Pulmonary Activity Alteration [PE]</name>
  <code>C30044</code>  <id>30045</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration</to_name>
    <to_code>T46638</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009839</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Medullary Respiratory Center Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tracheobronchial Stretch Receptor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peripheral Carotid Chemoreceptor Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventilatory Gas Flow Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Mucosal Edema Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Respiratory/Pulmonary Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab-ekko [2587790]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprobarbital [17381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab [2587789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory/Pulmonary Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Retinal Pigment Epithelium Alteration [PE]</name>
  <code>C654017</code>  <id>654017</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RPE Alteration</to_name>
    <to_code>T58373</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Retinal Pigment Epithelium Alteration</to_name>
    <to_code>T58372</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193799</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinal Pigment Epithelium Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Retinal Pigment Epithelium Function [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Retinoid [EPC]</name>
  <code>C635000</code>  <id>635000</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Retinoid</to_name>
    <to_code>T46761</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Retinoid-class Agent</to_name>
    <to_code>T46760</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175607</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazarotene [83947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bexarotene [233272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alitretinoin [81864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing retinoid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinoids [M0018962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adapalene [60223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tretinoin [10753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acitretin [16818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palovarotene [2663954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isotretinoin [6064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifarotene [2205637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Retinoid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Retinoid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Reverse Transcriptase Inhibitors [MoA]</name>
  <code>C384</code>  <id>385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reverse Transcriptase Inhibitors</to_name>
    <to_code>T46811</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000103</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reverse Transcriptase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reverse Transcriptase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reverse Transcriptase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Reverse Transcription to DNA Alteration [PE]</name>
  <code>C30046</code>  <id>30047</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reverse Transcription to DNA Alteration</to_name>
    <to_code>T46812</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009840</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reverse Transcription to DNA Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Reverse Transcription to DNA Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Reverse Transcription to DNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Reversed Anticoagulation Activity [PE]</name>
  <code>C635436</code>  <id>635436</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticoagulation Activity Reversal</to_name>
    <to_code>T46814</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anti-coagulation Activity</to_name>
    <to_code>T46816</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation</to_name>
    <to_code>T46813</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-coagulation Activity Reversal</to_name>
    <to_code>T46817</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-coagulation Reversal</to_name>
    <to_code>T46818</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticoagulation Reversal</to_name>
    <to_code>T46819</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anti-coagulation</to_name>
    <to_code>T46815</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity</to_name>
    <to_code>T46820</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175982</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>andexanet alfa [2045114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K1 [8308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamines [8826]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K [11258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor Xa (recombinant), inactivated-zhzo [2045125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine hydrochloride [236471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Rho Kinase Inhibitor [EPC]</name>
  <code>C654007</code>  <id>654007</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitor</to_name>
    <to_code>T58353</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193788</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rho Kinase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rho Kinase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with Rho-associated protein kinase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rho Kinase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netarsudil [1992864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protein kinase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Rho Kinase Inhibitors [MoA]</name>
  <code>C654006</code>  <id>654006</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors</to_name>
    <to_code>T58352</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193789</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil mesylate [2565692]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil mesylate [1992863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil [2564025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rho Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ribonucleotide Reductase Inhibitors [MoA]</name>
  <code>C602</code>  <id>603</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ribonucleotide Reductase Inhibitors</to_name>
    <to_code>T46988</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000212</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ribonucleotide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Rifamycin Antibacterial [EPC]</name>
  <code>C634881</code>  <id>634881</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antibacterial</to_name>
    <to_code>T47076</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175500</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifaximin [35619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifampin [9384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifamycins [M0019113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing rifamycin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with rifamycin structure (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Rifamycin Antimicrobial [EPC]</name>
  <code>C634899</code>  <id>634899</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimicrobial</to_name>
    <to_code>T47077</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175506</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifamycins [M0019113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Rifamycin (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Rifamycin Antimycobacterial [EPC]</name>
  <code>C634882</code>  <id>634882</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimycobacterial</to_name>
    <to_code>T47078</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175501</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimycobacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimycobacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifabutin [55672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimycobacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifamycins [M0019113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Rifamycin Antimycobacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rifapentine [35617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with rifamycin structure (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Rifamycin Antimycobacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Route of Excretion [PK]</name>
  <code>C260</code>  <id>261</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Route of Excretion</to_name>
    <to_code>T47175</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000041</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Clinically Unimportant Route of Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Breast Milk Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Route of Excretion [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fecal Excretion [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>S [Preparations]</name>
  <code>C288645</code>  <id>288645</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>S [Preparations]</to_name>
    <to_code>T47227</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010601</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sibutramine hydrochloride monohydrate [221160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schizonepeta tenuifolia whole extract [1489550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon allergenic extract [892584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hydroxymethylglycinate [1367223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium nitrate 15N [2393524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sparassis crispa whole extract [2001618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver sulfide [1549110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serine [9671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium iodide [9884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>semaglutide [1991302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saponaria officinalis leaf extract [1488816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugammadex [1726988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acetate trihydrate [237108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfadoxine [10173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 3 capsular polysaccharide antigen [854958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solanine [1745416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower seed allergenic extract [901203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic beeswax [2462009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium nitrate [1356142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ferric gluconate complex [261435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salsalate [36108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stypocaulon scoparium preparation [1426635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>snail preparation [1368534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium molybdate(VI) [36699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scrophularia nodosa leaf and stem extract [1796924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sparsentan [2630535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertraline [36437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl acetate [2200070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spike lavender oil [237023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium copper chlorophyllin [1366841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>styrene/isoprene/styrene block copolymer [2385109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower lecithin [1487532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sydney golden wattle pollen extract [895365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenocysteine [1549332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine [2686926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna alexandrina seed extract [1310029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose [10159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan monolaurate [1363055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium 1-naphthalenesulfonate [1442717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium molybdate dihydrate [1423799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatrem [56570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium oleyl sulfate [2621830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulbactam pivoxyl [166010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa stomach preparation [1311242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfabenzamide [37320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simeprevir sodium [1484518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scutellaria galericulata leaf extract [1651696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silanediol salicylate [1356706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulbactam sodium [82100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serotonin [1311214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methylesculetin acetate [1426627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sesamum indicum whole extract [1541721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver chloride [1314846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>squill extract [91613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samarium Sm153 [196342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa intestinal mucosa preparation [2285325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearalkonium chloride [1310555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solriamfetol hydrochloride [2121750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simetone [1658655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 15B capsular polysaccharide antigen [854940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>standardized enzyme lactase [221165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarecycline hydrochloride [2059038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenium chloride [2200142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium propionate anhydrous [1432980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SD alcohol 40 (20% w/w) [1305764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stephania sinica whole extract [2541939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatropin [61148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senecio scandens flowering top extract [2360032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos nux-vomica seed extract [1309678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sphinganine [1947371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium-89 [81638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguinaria canadensis extract [1311079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulopenem etzadroxil [2717834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium palm kernelate [1364906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samidorphan malate [2559613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sapindus mukorossi whole extract [2048121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methyl cocoyl taurate [1364524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stevia rebaudiana whole extract [1313685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoyl lactylate [1370671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spongia officinalis preparation [1311109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertraline hydrochloride [155137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dihydroxycetyl phosphate [1366980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saraca indica bark extract [1862313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia officinalis root extract [1487140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean allergenic extract [891668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl glycol carboxylate [1423793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>star anise oil [1305656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>smallpox vaccine live vaccinia virus [833079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic camphor [1371994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ankle joint preparation [1311247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bicarbonate [36676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methyl stearoyl taurate [1356768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sauromatum giganteum root extract [2697971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samarium Sm 153 lexidronam [177906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sorghum bicolor stem juice [1309939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Selenicereus grandiflorus flower extract [1307597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfadiazine sodium [220087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous tartrate [56701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sisal fiber allergenic extract [851882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunitinib [357977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa bronchus preparation [1311322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stearoamphoacetate [1424268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selegiline [9639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulpiride [10239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ursolate [1366935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-8 sulfate [2175990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinate [1307106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>styrene-acrylamide copolymer (MW 500000) [1598330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfur hexafluoride [1599276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa blood preparation [1311272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cetyl sulfate [1366919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>S-adenosyl-L-methionine disulfate tosylate [2552301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scutellaria lateriflora top extract [1311681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulbutiamine [37317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk allergenic extract [314455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>snow pea extract [1372262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scopolamine hydrobromide [9603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scoparia dulcis leaf extract [2632265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Simaba cedron whole extract [2591818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium succinate anhydrous [1307107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>surfactant protein-D homotrimer, recombinant fragment human [2471087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfur iodide [1311379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sapindus mukorossi fruit extract [1311674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower seed extract [1440241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus agalactiae [1363918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, dibasic, monohydrate [1311342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguisorba officinalis whole extract [1442705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Selaginella tamariscina extract [1314318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ventricle preparation [1488823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium propionate [56513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearic diethanolamide [1314285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syncephalastrum racemosum allergenic extract [968506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa bile duct preparation [1311226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shark preparation [1309513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacubitrilat [1860608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa mesenchyme preparation [1311254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatostatin acetate [236092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenomethionine Se 75 [9133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium carbonate preparation [1311308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-25 [2369829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa large intestine preparation [1361462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-sulfopalmitate [1486522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebacic acid [1427068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saussurea involucrata whole extract [1875366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solfenacin [477364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa thymus preparation [1311263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfurated lime [235569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus salivarius [2393605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate type A [2360540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean seed oil [1309980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacubitril [1656328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Styrax tonkinensis resin [1990419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 4 capsular polysaccharide antigen [854962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spiranthes spiralis root extract [1997455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl sulfosuccinate [2634298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sutimlimab [2591404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa artery preparation [1311207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sudan grass pollen extract [1098455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern flounder allergenic extract [2103223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamide amp [1368215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pyrophosphate [1364532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symplocarpus foetidus root extract [1309983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium folate [1300473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>superoxide dismutase (Cu-Zn) Saccharomyces cerevisiae [1597890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa fallopian tube preparation [1488225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower seed extract [1309391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sargramostim [69634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylsulfathiazole [37289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame oil [1309247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saltbush pollen extract [897316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>squalene oil [253201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-2 phosphate [2549197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin N-(2-acetic acid ethyl ester) [1595299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scutellaria alpina flowering top extract [1539427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate type a corn [1363438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium castorate [2619157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>styramate [89818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stevia eupatoria whole extract [2560110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa cerebral cortex preparation [1311317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sardine, unspecified preparation [1427221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sigesbeckia orientalis whole extract [2461970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl lactylate [1363427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose distearate [1370303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine [901633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium iodide I123 [91531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>segesterone [2055978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver [2606543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dihydrogen phosphate dihydrate [1311311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatropin, E-coli derived [259321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sorbus aucuparia fruit extract [1367305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet violet leaf oil [2371688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemphylium sarciniforme allergenic extract [968130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium safflowerate [2619158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum dulcamara top extract [1331702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>star anise fruit extract [1311682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptococcus pneumoniae immunoserum rabbit [1367194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symphytum officinale whole extract [1492439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sirolimus [35302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch glycolate type a corn [1370595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 12F capsular polysaccharide antigen [854936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacrosidase [214817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sassafra albidum root bark extract [1428423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacituzumab govitecan-hziy [2360530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarilumab [1923319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine [798220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sarcandra glabra whole extract [2610405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos nux-vomica whole extract [1599640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium arsenate [1364794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose cocoate [1370728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shad scale pollen extract [852087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senecio vulgaris extract [1485120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago californica whole extract [2177096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-13 carboxylate [1372934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 23F capsular polysaccharide antigen [854956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptozocin [10114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>star anise whole extract [1660128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strophanthus gratus seed extract [1435638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 20 capsular polysaccharide antigen [854952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos ignatii seed extract [1309692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous fluoride [10030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenomethionine [9644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharomyces boulardii [236782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saussurea costus root extract [1309463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saponaria officinalis root extract [1309462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>snow crab, unspecified preparation [1315123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sakuranin [2383938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl/octyldodecyl citrate crosspolymer [2257292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfated castor oil [2205488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium diacetate [1547632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannate [1370640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearic monoethanolamide [1426353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose octaacetate [37296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spearmint extract [1372258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium thioglycolate [1364940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose octastearate [1543185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver citrate [1306066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sargassum fusiforme extract [1435392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium aminobenzoate [235493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simaba cedron seed extract [1356130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium gualenate [2667891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selpercatinib [2370147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solvent brown 1 [2003383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl acrylate polymer (110000 MW) [2472776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous cation [1314283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium cation [1546278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver cation [1358876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spinacia oleracea root extract [1593610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Simmondsia chinensis whole extract [1369689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium benzotriazolyl butylphenol sulfonate [1358699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauraminopropionate [1603856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa umbilical cord preparation [1311355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sarcomphalus joazeiro bark extract [2636109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sequoia sempervirens bark extract [2534462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium carbonate decahydrate [1362143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sophora flavescens root extract [1307593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl stearate [1426360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sargentodoxa cuneata whole extract [2665343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sterile water [107129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium jambos leaf extract [1307743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stavudine [59763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pantothenate [236917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Santalum album seed oil [1541711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium magnesium fluorosilicate [1431151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium [9853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium borate anhydrous [1805706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean preparation [287515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenate ion [1546366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cholate [2286239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secnidazole [36314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean lecithin [579598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 [2606073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scurrula parasitica top extract [2106426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfasalazine [9524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serdexmethylphenidate [2562176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium decylglucoside hydroxypropylsulfonate [1539812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sevelamer hydrochloride [237125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium perborate monohydrate [1991500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>S-adenosylmethionine synthase isoform type-2 [2262277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-10 phosphate [1927958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan olivate [1309248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spectinomycin [270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sandbur ragweed pollen extract [851955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium taurine laurate [2399553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna pod [2166041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sedum acre whole extract [2591817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scallop allergenic extract [899916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax ornata root extract [1924218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguisorba officinalis top extract [1368868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein [2468231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptodornase [10104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-15 [1367148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sandalore [2373965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium zirconium cyclosilicate [2047628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern bayberry pollen extract [867260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spongia officinalis skeleton extract [1311066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage extract [1354504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamine [1313977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sericin 1 [1607312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scabies lesion lysate (human) [1427216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succimer [3446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenium sulfide [36345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scutellaria baicalensis whole extract [1658441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secretin acetate [408108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfachlorpyridazine sodium [2476009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solvent red 4 [1597292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secukinumab [1599788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scandium chloride [1921562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch, tapioca [2619252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan tristearate [1426397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfurous acid [2266498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sorbus domestica whole extract [2055743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia miltiorrhiza root extract [1307580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 1 capsular polysaccharide antigen [854930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium xylenesulfonate [1364398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium thiosulfate anhydrous [1807514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfuryl fluoride [2289224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium metasilicate [1733690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago canadensis whole extract [1313689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Staphylococcus simulans [1489917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>snow crab allergenic extract [2167805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sea snail preparation [1546397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan monostearate [1363057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl sarcosinate [1364901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sudan red [1648696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia microphylla whole extract [2593414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 [2470232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Semecarpus anacardium fruit extract [1424267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silica, trimethylsilyl capped [1790287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C8-10 alkyl sulfate [1997000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samarium [9549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl myristate [1314286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sapropterin dihydrochloride [753341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cocoamphoacetate [1426829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 [2666309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus canadensis flower extract [1376215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selumetinib sulfate [2361596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hexafluorosilicate [1862868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stanozolol [10032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmeterol xinafoate [72616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium taurodeoxycholate [1364852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Simmondsia chinesis seed extract [1309470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soyethyl morpholinium ethosulfate [1433497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower oil [37422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saposhinikovia divaricata whole extract [1998444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa red blood cell preparation [1311255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinus molle fruit oil [1600748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sarracenia purpurea preparation [349948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cation [1364429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfadimethoxine sodium [1306121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sparfloxacin [18469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bentonite [1366970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Staphylococcus aureus [1311275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium perborate [36702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stephania tetrandra whole extract [2359270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicon disulfide [1805283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shikimic acid [2059172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>S-adenosylmethionine [9504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C12-15 pareth-3 sulfate [1364516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salt cedar pollen extract [852806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfooleate [1426701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine [901628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spinach extract [2099276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum lycocarpum fruit extract [2619424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine [901631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamethoxazole [10180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scopine [2691113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa uterus preparation [1311360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium morrhuate [9892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saiga tatarica horn extract [2589610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern ragweed pollen extract [885750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strychnine [66422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sobrerol [36669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>snowball sand verbena whole extract [1737112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sultopride [37416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium salicylate [2045402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cetostearyl sulfate [1364945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, dibasic, dodecahydrate [1311326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sisomicin sulfate [9807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium luehmannii fruit extract [2621385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotalol [9947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitol, L- [1742749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium [10122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Suaeda maritima flowering top extract [2590692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa capillary tissue preparation [1311315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose monolaurate [1363647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sardine allergenic extract [974129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smallanthus sonchifolius root juice [2623643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarsaparilla preparation [236368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 2 capsular polysaccharide antigen [854950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-21 [1367122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium myristate [1744165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hydrogen sulfite [1366858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cocoyl isethionate [1366839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa esophagus preparation [1311328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicyloyl phytosphingosine [1484765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfadiazine [10171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-12 [1551627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sapindus mukorossi fruit rind extract [1356492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago canadensis flowering top extract [1309928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfaethidole [37324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>styrene/isoprene/styrene block copolymer (styrene/isoprene 15/85) [2383939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sofpironium [2689322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver sulfadiazine [9793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharomyces lysate extract [1426343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugarcane extract [1358491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scutellaria baicalensis root extract [1307750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sumatriptan [37418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch glycolate [1370637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sinomenium acutum stem extract [2055268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sandalwood oil [1309224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solriamfetol [2121751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sanguinarine nitrate [1537754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarcosine [1362906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous chloride,anhydrous [314853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scleranthus annuus whole extract [1799141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sour cherry allergenic extract [1012134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium glycinate [541439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pidolate [1364917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scrophularia ningpoensis root extract [1420980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shiitake mushroom preparation [1362688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hydrolyzed potato starch dodecenylsuccinate [2688020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin sodium monohydrate [1670026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ureter preparation [1311356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>standardized senna concentrate [221166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Speranskia tuberculata whole extract [2375030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylcholine chloride [3565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suxamethonium bromide [121039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,4-sorbitan [1307571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous oxide [1367135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium myreth sulfate [2374347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>seladelpar lysine [2690868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C18 olefin sulfonate [1370195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scolopendra subspinipes preparation [1869800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stem bromelain [2373652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schizochytrium DHA oil [1538275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sitagliptin phosphate [621590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium palmitate [1364910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) [2691168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon oil [41967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ethasulfate [2287560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacituzumab [2360231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acryloyldimethyltaurate-acrylamide copolymer (1:1; 90000-150000 MPA.S) [1366966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>schorl tourmaline [1420979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin [9509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stephania tetrandra root extract [1547755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hydride [1483618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somapacitan-beco [2557394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan dioleate [1374406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium jambos seed extract [1310154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebacate [1427069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum dulcamara stem extract [1310035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl sulfonate [2001128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum tuberosum extract [1594966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium nitrite [9894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemona sessilifolia root extract [1535497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum nigrum whole extract [1358893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic conjugated estrogens, A [253166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa thalamus lateral geniculate nucleus preparation [1311223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cumenesulfonate [1366842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate type B [2475332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinic acid [37255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna leaf extract [485853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium Na-22 [1483727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sheanut oil [1305658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharomyces cerevisiae allergenic extract [350141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicin [36100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemphylium solani allergenic extract [867349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatorelin [236901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia officinalis leaf extract [2697461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, tribasic, monohydrate [1311357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa lymph preparation [1311253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium mannuronate methylsilanol [1860183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sargassum fulvellum extract [1735047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bisulfate monohydrate [2463932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siberian ginseng root extract [259472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa bone preparation [1311274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertindole [41996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium behenate [2000918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfacetamide [10169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfapyridine [10188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver cyanide [1656776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium cumini seed extract [1310091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannic oxide [1363059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bisulfate [1367207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scrophularia nodosa root extract [1373161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesamin [2593413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate [1366851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saralasin acetate [7830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>seractide acetate [1999801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sincalide [9800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra whole extract [1363730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>smooth brome pollen extract [852217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>seractide [1999800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tallowate, beef [1364938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spiny pigweed pollen extract [895919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 7F capsular polysaccharide antigen [854968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lactate [56489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfobetaine [1539813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shellac [1368898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicon [9774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium benzenesulfonate [1313277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>slippery elm bark [259434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoxytrimethylsilane [1367149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium formaldehyde sulfoxylate dihydrate [1592294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearalkonium [1370578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylated gelatin [56790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa joint capsule preparation [1311252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phenyllactate [2479569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebelipase alfa [1726975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium propoxyhydroxypropyl thiosulfate silica [1595884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scopolia carniolica whole extract [1594582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine [798230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sinecatechins [753346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearate [1368706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower oil unsaponifiables [2637413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax officinalis whole extract [2593902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos wallichiana bark extract [1309949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium isostearoyl lactylate [1364897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum nigrum top extract [1310217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>superoxide dismutase (Mn) Saccharomyces cerevisiae [2268034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk, base hydrolyzed (1000 MW) [1426900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sinapis alba whole extract [2180256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium oxybate [9899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saw palmetto fruit extract [477189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine [798226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylcholine iodide [262295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Serenoa preparation [350488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Shigella dysenteriae [1316076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sapindus saponaria fruit extract [2588213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sumatriptan succinate [67158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stibogluconate [8010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 5 capsular polysaccharide antigen [854964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearic acid [1310551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pyruvate [1358847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine [2566291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine [901624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>satraplatin [1733681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfur [10223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sapanisertib [2395271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium c12-14 pareth-3 sulfate [2277807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia sclarea whole extract [1797518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugar beet pollen extract [852132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa renal pelvis preparation [1311269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tallowate [1364939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix alba flower extract [1492934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saquinavir [83395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium percarbonate [1364915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>styrene/ammonium acrylate copolymer (300000 MW) [2586353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic wax (2900 MW) [1872045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa pineal gland preparation [1311078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>styrene [1362878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serdexmethylphenidate chloride [2562177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Soy Proteins [36853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>squalane [1363644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa testicle preparation [1311349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfametrole [37328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix alba leaf extract [1309459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soursop extract [1435098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotrovimab [2550731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl 1-methyl isethionate [1370732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salinomycin [1311566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spermine [1483263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-COV-2 (COVID-19) vaccine, vector non-replicating [2479831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strychnine sulfate [236074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dilauramidoglutamide lysine [2559703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicon dioxide, colloidal [314826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan monocaprylate [2050751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna alata whole extract [1420981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Santalum spicatum oil [1305660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium isostearate [2592629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salinomycin sodium [1812261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>82 strontium [90611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scotch pine pollen extract [900764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silymarin [9794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet gum pollen extract [852627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solifenacin succinate [476588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 14 capsular polysaccharide antigen [854938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sequoiadendron giganteum whole extract [2055746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamerazine [10176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ileum preparation [1311229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Shorea robusta resin [2613760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shea butter [1310571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage leaf allergenic extract [1011627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saxagliptin anhydrous [1546030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium thiosalicylate [91100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dibunate [235860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>surinamine [2606067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chondroitin sulfate (porcine; 5500 MW) [1314213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower oil [9515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scopolamine [9601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia sclarea seed oil [1425356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Serratia marcescens [1426634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia lavandulifolia leaf oil [2469238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium 2-naphthalenesulfonate [1366946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower seed oil glycereth-8 esters [1431715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium behenoyl lactylate [2548235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium selenite [56519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chromate Cr51 [91510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix alba flowering top extract [1310073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium cumini fruit extract [1811016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago virgaurea pollen extract [1309242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfanilylurea [37333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sasa kurilensis whole extract [2537437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfisomidine [10206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samidorphan [2559612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>staphylococcus aureus immunoserum [1427063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>satralizumab-mwge [2391551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spermidine [1483262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chloride dihyrdate [2471089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix alba bark volatile oil [1305659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucralose [1439115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sisomicin [9806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearalkonium hectorite [1372931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicic acid [1311243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix nigra bark extract [1232311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver birch pollen allergenic extract [1306108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa pituitary gland preparation [1311241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamerazine sodium [1306109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>squash allergenic extract [975509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa urinary bladder preparation [1311359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stenotaphrum secundatum whole extract [2590691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch [10046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siraitia grosvenorii fruit extract [1436960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorghum extract [1338933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus thermophilus [2593692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scrophularia ningpoensis whole extract [1490689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>string bean allergenic extract [891676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus viridans group immunoserum rabbit [1367198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sildenafil citrate [221161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicin extract [260012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate type B potato [1364926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selank [2049928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium gentisate [2053265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saussurea involucrata flowering top extract [2001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucralfate malate [1487143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sennoside A&amp;B, calcium salt [267741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-4 phosphate [1592264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa gallbladder preparation [1311234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean germ extract [1370779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicon tetrachloride [1863221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>satralizumab [2391541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver nitrate [9789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, monobasic, anhydrous [349753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium aromaticum seed extract [2391536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa hypothalamus preparation [1311240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium silicate [1363697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate [36709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sinapis arvensis whole extract [1800491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saururus chinensis flower extract [1307789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotagliflozin [2638675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saxagliptin hydrochloride [1043560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose stearate-palmitate ester (75% mono ester) [1427042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saxifraga granulata flowering top extract [1862216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silodrate [1373351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoyl glutamate [1370625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver mono(2-aminoethyl)phosphate [162901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C14-16 olefin sulfonate [1363581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium arsenate, dibasic, heptahydrate [1364796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfachlorpyridazine [2476008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium formaldehyde sulfoxylate [289996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suramin [10256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine [2686924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sennoside B [56161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sufentanil [56795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sorghum bicolor pollen extract [1311406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sitagliptin [593411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Selenicereus grandiflorus whole extract [1673559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>setmelanotide acetate [2469248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sonidegib phosphate [1659192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sevelamer [214824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sphagnum squarrosum extract [1541244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) [2722617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saw palmetto extract [236344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>setmelanotide [2469247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Styphnolobium japonicum root extract [1310022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>semax [2049929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk, acid hydrolyzed (1000 MW) [1356763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) [2610243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selinexor [2178390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguisorba minor root extract [1307575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa rectum preparation [1311343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose monostearate [1363060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sitagliptin hydrochloride [2716481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium polyacrylate (8000 MW) [1366975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sphaeranthus indicus flowering top extract [1547556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>slash pine pollen extract [900731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scleranthus annuus flowering top extract [1310110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soybean oil [9949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatropin (recombinant DNA origin) [314845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salmonella typhi Ty21a live antigen [762595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa rectal mucosa preparation [1804846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa pancreas preparation [1311337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sparganium stoloniferum root extract [1546865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium 2,5-dimethylbenzene-1-sulfonate [1366944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium myristoyl isethionate [1364904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pyrrolidone carboxylate [1364924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stevioside [37106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamethazine sodium [1364374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa conjunctiva preparation [1311320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sec-laureth-9 [2268074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl trisiloxane [2268036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spectinomycin sulfate tetrahydrate [1306069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) [2664725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame seed allergenic extract [901199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic wax (1200 MW) [1426425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hypophosphite [1311313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sempervivum tectorum leaf extract [1310112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulconazole nitrate [56798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium nitroprusside [9895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syringa vulgaris pollen extract [2634236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium borate [36680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salicornia depressa whole extract [2001177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium iodide I131 [91535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium iodate [1422194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Santalum album seed extract [1314224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cocoate [1366928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scomberomorus cavalla extract [1310281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silica dimethyl silylate [1426646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna occidentalis extract [1441658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemona japonica root extract [2632730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sedum acre extract [1330091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium oxide [1366982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salcaprozate sodium [2200637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syrian hamster hair extract [1594965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saposhnikovia divaricata root extract [1305761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium fluoride [9873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sage oil [1305661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinus molle bark extract [1309468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sibutramine hydrochloride [1294535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tyropanoate [282508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-10 [1367147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucroferric oxyhydroxide [1484283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safinamide mesylate [1922449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium caprylate [1311123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hyaluronate [42892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan distearate [2637172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cyclamate [56467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous iodide [1720256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmeterol [36117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Silene laciniata whole extract [2533913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate,monobasic,monohydrate [221125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, dibasic, anhydrous [314838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 33F capsular polysaccharide antigen [854960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotalol hydrochloride [7008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sevoflurane [36453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spanish chestnut extract [1372260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dodecyl sulfate [9871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl methyl taurate [2479046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum dulcamara whole extract [1995250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium carbonate [36685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sour cherry seed oil [1992671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syringa vulgaris whole extract [1314226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic conjugated estrogens, B [618365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sciadopitys verticillata root extract [1592261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum virginianum whole extract [2592979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>swordfish allergenic extract [901283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silodosin [720825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarecycline [2059018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 19F capsular polysaccharide antigen [854948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serum albumin, bovine [1426381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium taurate [1431305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin sodium dihydrate [1305723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium alginate [56446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa hip joint preparation [1311250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin calcium [1362912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweetleaf preparation [283740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemona tuberosa root extract [1606212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stearyl fumarate [1364936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin sodium [281678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl sulfoacetate [314832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Simmondsia chinensis seed wax extract [1307760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-sulfolaurate [1370581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hydroxide [9880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siraitia grosvenorii whole extract [2593688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenious acid [36344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium gluconate [56476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenite [9640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium estrone sulfate [91428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spongilla lacustris extract [1330088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix alba bark extract [1307749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium jambos fruit rind extract [2463730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serine, D- [1742747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium glycerophosphate anhydrous [1423802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>siltuximab [1535218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous chloride dihydrate [2462150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum lycopersicum extract [1368361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 6B capsular polysaccharide antigen [854966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver nitrite [2267702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spelt seed extract [1656419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous 2-ethylhexanoate [1314274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 17F capsular polysaccharide antigen [854942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C14-18 olefin sulfonate [2123366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotatercept-csrk [2678931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salsolinol hydrochloride [1312374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame extract [1358860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus dysgalactiae [1491866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax glabra whole extract [2626495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salsolinol hydrochloride, (+/-)- [2198978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saponaria officinalis whole extract [1313686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate type B corn [2604035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfide nonahydrate [1364569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 [2688626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stinging nettle extract [580119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfate anhydrous [1299926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acexamate [236526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium succinate hexahydrate [1311369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sisymbrium officianale whole extract [1314313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch [1366973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium iothalamate [9886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Staphylococcus epidermidis [1489915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulbenicillin [10168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phenolsulfonate [237124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lactate, L- [2631575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syrian hamster skin extract [852663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dithionite [2056673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanicula europaea extract [1311101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sturgeon, unspecified preparation [2645123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pyogenes [1311281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfite [36723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate dihydrate [314837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silane [2668415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smallanthus sonchifolius whole extract [2387077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 8 capsular polysaccharide antigen [854970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saxagliptin [857974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secretin [9627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spongia tosta [236133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silanamine [1872906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver phosphate [1665220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium P-chloro-m-cresol [1313197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sabinene [2557219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfachrysoidine sodium [236833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stachys officinalis flower top extract [1856257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>subtilisin [1997449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl glutamate [1364850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacituzumab govitecan [2360232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Selenicereus grandiflorus stem extract [1309694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dodecylbenzenesulfonate [1366931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbeth-12 [2534447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium palmitoyl sarcosinate [1726120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samarium oxide [1311105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-6 carboxylate [2471090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sapindus trifoliatus fruit extract [1655992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium polystyrene sulfonate [56512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silanol [1601667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfonmethane [2534463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinus terebinthifolius whole extract [1312728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solvent yellow 18 [2566620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinus terebinthifolius pollen extract [2590688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stachyurus chinensis whole extract [2592980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stellera chamaejasme whole extract [2585255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spermaceti [9968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-5 sulfate [1996994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hinokitiol [1541742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbityl laurate [1483080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tartrate dihydrate [1721438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch glycolate type a potato [1370636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfathiazole [10193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver sulfate [2462500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenium dioxide [1309231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steardimonium hydroxypropyl peg-7 dimethicone phosphate chloride [2564413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia apiana leaf extract [2106427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solasulfone [1551455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium chloride hexahydrate [1594632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitol [9945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa thalamus preparation [1311350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tetrachloroaurate [1366933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenite ion [1546398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia pratenis leaf extract [1650833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugammadex sodium [1726987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet marjoram oil [1305655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium glycerophosphate [1595589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium caproyl lactylate [1491979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syagrus romanzoffiana whole extract [2590693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stillingia sylvatica root extract [1310050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phenylbutyrate [214837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix lutea pollen extract [2590686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna obtusifolia seed extract [1600749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine [2686927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl phosphate [2167142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strophanthus kombe seed extract [2106738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sargassum pallidum extract [2592978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sarcandra glabra top extract [2634553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium triethanolamine tris(dihydrogen phosphate) [2534446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sialyl Lewis A [2619423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium fumarate [56475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suvorexant [1547099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>St. John&apos;s wort extract [258326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spatholobus suberectus stem extract [1661793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic wax (1800 MW) [1426675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver iodide [1423914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicon nitride [1989508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scarlet red [36224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stiripentol [2054968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tartrate [56524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>superoxide dismutase [10245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum nigrum fruit extract [2470130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-stearoyl-sn-glycero-3-phosphocholine [2707701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ironedetate [105673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(2S)-3-phenylpropane-1,2-diol [2557900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chlorite [992920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hydroxypropylsulfonate laurylglucoside-7 crosspolymer [2120184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smallanthus sonchifolius leaf extract [2552300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Swertia japonica extract [1370776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos mitis whole extract [2627242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spearmint allergenic extract [901313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soy acid [1484859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siberian ginseng preparation [319812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Shorea robusta seed butter extract [1808536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symphoricarpos albus fruit extract [1311100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguisorba officinalis leaf extract [1360624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sumbul [350528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C14 olefin sulfonate [1366913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium arsenate, dibasic [1364793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix purpurea bark extract [1492383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scutellaria barbata whole extract [1811253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch glycolate type b potato [1370624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertaconazole nitrate [236601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium adipate [2627782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schizandra preparation [56084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose palmitate [1367150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicones [9778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solketal [2180790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine [901620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver ragweed pollen extract [852306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium coco-sulfate [1366926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose, 6-stearate [1942263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium thiosulfate [36726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simeprevir [1482790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Selaginella lepidophylla whole extract [2560702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower seed allergenic extract [901195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sophora pachycarpa whole extract [2630723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunitinib malate [616275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium palmate [1356710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus mutans [1363920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax ornata whole extract [1999193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunflower pollen extract [852509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-22 [1790090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laurate [1425357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulisobenzone [1311567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa lung preparation [1311330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-2 phosphate [1441535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dithionate [1443001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>squalene [10014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium nervosum flower bud extract [1733672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methyl 2-sulfolaurate [1364522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Simmondsia chinensis leaf extract [1534775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauriminodipropionate [1942335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>senna concentrate [219860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine [798232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium potassium aluminum silicate [2634307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solanum anomalum whole extract [2602285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sinusitisinum [1311385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sclerocarya birrea seed oil [1596688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptococcus pyogenes immunoserum rabbit [1367197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saururus chinensis whole extract [1435868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secretin human, synthetic [606396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C12 olefin sulfonate [1366906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saxagliptin hydrochloride dihydrate [2643444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarolaner [1740360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simoctocog alfa [1729084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine [2566292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfate ion [1426598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorafenib tosylate [597744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix alba whole extract [1801067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selumetinib [2289380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfate [36721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon preparation [1421430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sassafras oil [1309664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharomyces cerevisiae var. boulardii CNCM I-1079 [2704557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver fluoride [1544125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sea scallop allergenic extract [2103230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulbactam [10167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine [2566293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-sec-butyl cyclohexanone [2383930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinic anhydride [1374803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sakuranetin [2263158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stemona tuberosa whole extract [2631990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium benzoate [56455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulindac [10237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroamphoacetate [1307260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>seladelpar [2690869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schisandra chinensis fruit oil [2540130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium copper chlorophyllin A [2583872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scandium iodide [1989390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium perborate tetrahydrate [2104324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium succinate [1311370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-4 [1605200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sarcosinate [1364526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hypochlorite [9881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sandalwood extract [1425087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synephrine [10288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa vagus nerve preparation [1311266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicylate [9522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dichloroacetate [1366930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfuric acid [10231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium myristoyl glutamate [1313693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfobromophthalein sodium [203200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stepronin [2375829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sinapsis arvensis flowering-fruiting top extract [1309471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa solar plexus preparation [1311256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfonated oleic acid [1546402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamethoxypyridazine [10181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stevia serrata flower oil [2479555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acetylated hyaluronate [2198976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamidopropyl betaine [2257291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sargassum muticum extract [1663473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfaquinoxaline [1306111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spirapril [36908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix repens pollen extract [2533912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptokinase [10106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saffron oil [2624695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samidorphan L-malate [2570387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stichopus sea cucumber [1665462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spigelia anthelmia preparation [1310235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sennosides, USP [36387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfacytine [78902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearic acid D7 [1804568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scrophularia buegeriana root extract [1539194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa brainstem preparation [1311212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa superior gastric plexus preparation [1311346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa urethra preparation [1311358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stearoyl lactylate [1366986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium glycolate [1356762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous chloride [37032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chloride, (22)Na [1370679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvadora persica root extract [2462495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl caprylate [1806912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoamphoacetate [1424269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamidoethyl diethylamine [1363699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum melongena whole extract [1722378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitol monooleate [1812934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sea scallop preparation [1426396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>short ragweed pollen extract [896135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa achilles tendon preparation [1311366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa tonsil preparation [1311264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa lymph vessel preparation [2176310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 [2468230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose acetate isobutyrate [1363646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa eye preparation [1311361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfobutylether-beta-cyclodextrin [1426608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucralfate [10156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sonidegib [1659191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa dander preparation [1356131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame oil unsaponifiables [2568106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>star anise extract [1350212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saxifraga stolonifera leaf extract [1307949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Selaginella lepidophylla extract [1793746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sudan III [1426472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tripolyphosphate anhydrous [1487533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salt cedar pollen [852083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silybin [155067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) [2722424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shea butter glycereth-8 esters [1992673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch, wheat [1367109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stigmasterol [10079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sipuleucel-T [997261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago virgaurea whole extract [1658430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium myristoyl sarcosinate [1363987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver carbonate [2462152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>summer flounder allergenic extract [2588813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sepia esculenta whole extract [1729512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sparganium stoloniferium whole extract [1547469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa limbic system preparation [1311244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan trioleate [1363643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sometribove [1427014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbate [1311140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium glutamate [1311588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin sodium anhydrous [1362914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum glaucophyllum whole extract [2717827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>santonin [1311390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silanetriol [1312740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium allylsulfonate [2286255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safinamide [1922448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicylic acid [9525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-7 [1541739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somapacitan [2557373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scoparium [237007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shark cartilage extract [81782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl phosphate [2003334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfathiazole sodium [236084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoyl glutamic acid [1648782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strophanthus kombe whole extract [1492171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stannate [1366867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl fumarate [1370626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl sulfonic acid [2001127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spinosad [299081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selegiline hydrochloride [203137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium selenate [36717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saxifraga stolonifera whole extract [2709110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>segesterone acetate [2055977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cocoyl glutamate [1366834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simaldrate [236730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet vernal grass pollen extract [851898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium diethyl oxalacetate [1364518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stellaria media extract [1371997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sepia esculenta bone preparation [1798446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa intervertebral disc preparation [1311365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa pylorus preparation [1311341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus viridans group [1363919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa cerebrum preparation [1311215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia officinalis whole extract [1442511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl glycinate [2475180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa embryo preparation [1311327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laurylglucosides hydroxypropylsulfonate [2590742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sebetralstat [2717944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spesolimab-sbzo [2610418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suberic acid [2044370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pyroglutamate [235455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sepia officinalis whole extract [1868205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strychnine phosphate [1733682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ovary preparation [1311336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra subsp. canadensis flowering top extract [1309461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 10A capsular polysaccharide antigen [854932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sitosterols [9808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cocoyl sarcosinate [1363989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shortleaf pine pollen extract [852709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanicula europaea top extract [1810566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan sesquioleate [1363058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium monofluorophosphate [56501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sofosbuvir [1484911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra seed oil [2397121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium bromide [1311631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salsola kali whole extract [2590687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>staphylococcus aureus immunoserum, rabbit [1427062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soy sterol [1363446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver maple pollen extract [851866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safrole [2383532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium palmitoyl glutamate [1313695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium caprylyl sulfonate [2565926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamethazine [10178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium octoxynol-2 ethane sulfonate [1366971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, dibasic, dihydrate [1311323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharate [1788997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serratiopeptidase [36434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfaquinoxaline sodium [1306110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl ethoxysulfate [2643470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suzetrigine [2704819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shark liver oil [91472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sufentanil citrate [58964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 19A capsular polysaccharide antigen [854946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bisulfite [36679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>S-benzoylmercaptoacetyltriglycine [194098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silicon dioxide [9771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suprofen [10255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharide isomerate [1314278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine [2566297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-2 [1426352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium starch glycolate Type A potato [1366849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solvent red 27 [1495079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selamectin [1044269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simethicone [9796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine [798228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saccharin calcium anhydrous [1602283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sansevieria trifasciata leaf extract [1735046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sheep sorrel pollen extract [852213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfide anhydrous [2692871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sophora tetraptera flower extract [1435104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schisandra chinensis fruit extract [1311675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ferrocyanide [2383541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa vein preparation [1311210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symphyotrichum oblongifolium whole extract [2571072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saxifraga granulata whole extract [1649351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stearate [1366984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatostatin [9939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae [1363917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cholesteryl sulfate [1366923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silodrate, anhydrous [2398333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugar beet allergenic extract [899359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chloride [9863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamide [1607778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acetate, anhydrous [267453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamidopropyl dimethylamine lactate [1739891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shagbark hickory pollen extract [852221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium aromaticum whole extract [1358892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salt grass pollen extract [852329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soy protein isolate [196238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax glabra tuber extract [2118528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spironolactone [9997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) [2610326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soy sphingolipids [1649138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sophora tonkinensis whole extract [1492933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bis(1,3-dimethylbutyl) sulfosuccinate [2465233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinus molle fruiting top extract [2266751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, dibasic [236719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptomycin sulfate [10110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sophora flavescens whole extract [1442706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strawberry juice [1486794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>staphylococcus epidermidis immunoserum rabbit [1367201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) [2722594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schoenocaulon officinale seed extract [1351787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl triethoxysilane [1367499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum lycopersicum fruiting top extract [1653342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa knee joint preparation [1311367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa sympathetic nerve preparation [1311258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium metavanadate tetrahydrate [1661093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamethizole [10179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk sericin [1652102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium tetradecyl sulfate [9913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra flower extract [1344643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 18C capsular polysaccharide antigen [854944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium anisate [1366968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symphytum tuberosum root extract [1310151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) [2664825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa adrenal cortex preparation [1807130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salmonella enterica subsp. enterica serovar enteritidis [1329877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>siponimod [2121085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharomyces cerevisiae [9511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sorghum bicolor whole extract [1370197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium capryloamphopropionate [1368619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-100 [1367131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sheep wool preparation [1593854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Swertia chirayita whole extract [2180545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sultopride hydrochloride [236185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, tribasic anhydrous [1307158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strophanthus hispidus whole extract [1998615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium polymetaphosphate [1364921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sitocalciferol [2676752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salix babylonica whole extract [1599131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strelitzia nicolai whole extract [2603830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sangre de grado [260039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smallpox Vaccine [9835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C12-14 olefin sulfonate [1366909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotorasib [2550714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylcholine chloride dihydrate [2397714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stachybotrys chartarum allergenic extract [968123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfalene [10175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strawberry seed oil [2359272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>starch, rice [1367117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>samarium Sm-153 lexidronam pentasodium [317675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax regelii root extract [1340181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sapropterin [753340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium palmitoyl proline [1364912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine [2686920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium polyacryloyldimethyl taurate [2634308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>symclosene [2375531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solfenacin succinate [477365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet wormwood pollen extract [2167819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa parathyroid gland preparation [1311348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa tooth preparation [1311354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Styphnolobium japonicum leaf extract [1437505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sultilains [227410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan monopalmitate [1363701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spirulina [487252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa colon preparation [1311268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa spinal cord preparation [1311257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharum officinarum whole extract [1435103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methylenebisnaphthalenesulfonate [2634162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower acid [2056061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>skim milk [1310587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silandrone [2611455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ricinoleate [2569468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbic acid [1311139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scandium [1311273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) [2691192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfachrysoidine [236832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-12 sulfate [1651597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acryloyldimethyltaurate [1366964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium metabisulfite [36696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl ethylhexanoate [1307083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-20 [1367121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phytate [9903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium octyl sulfate [1438636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet marjoram extract [1544271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>skullcap preparation [262263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silybum marianum seed oil [1358002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfide ion [1368379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>succinylcholine [10154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sevelamer carbonate [660890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan [1367146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saralasin [9556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfonated phenol [236718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Styphnolobium japonicum fruit extract [2462661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose syrup [1305546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl dimethicone (400 mpa.s at 50c) [2268863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfur dioxide [1362879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk amino acids [1307143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet cherry allergenic extract [901303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sarracenia purpurea extract [1605249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl fumarate [2700066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spectinomycin hydrochloride [267342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sigesbeckia orientalis flowering top extract [2370875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicyl alcohol [1363054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguisorba officinalis root extract [1307954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharomyces cerevisiae RNA [1336135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>smelt allergenic extract [889669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Securidaca inappendiculata root extract [2634554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bitartrate [89900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfur, colloidal [221083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl heptanoate [1426355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfobromophthalein [10212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spiramycin [9991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfadimethoxine [10172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, monobasic [235496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium cation Sr-89 [2280602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>S-adenosylmethionine sulfate tosylate [9506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon gonadotropin releasing hormone D-Arg6 analog ethyl amide [1546435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 11A capsular polysaccharide antigen [854934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver preparation [9785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium stearoyl glutamate [1364932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Staphylococcus haemolyticus [1489916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sargassum filipendula extract [1426920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schisandra chinensis whole extract [2375529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptomyces griseus allergenic extract [1314592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarcosinate [1370611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siberian elm pollen extract [1299981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-23 [2046120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Santalum spicatum whole extract [2059171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos ignatii whole extract [1663404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra subsp. cerulea fruit extract [1744169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth sulfate [1310569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamoxole [10183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium oxalate [1441659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 9N capsular polysaccharide antigen [854972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoxypropyltrimonium chloride [2630165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syringa oblata whole extract [2686034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium valproate [9919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago decurrens whole extract [2631989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strychnine nitrate [1310185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl alcohol [37071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>semduramicin [1314385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet cherry seed oil [1866226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salsola tragus pollen extract [1314927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium bromate [2534448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steviol [1363645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>surfactant protein-D homotrimer [2471088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methyl oleoyl taurate [1789472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spinach allergenic extract [901317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sildenafil [136411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan monooleate [1363056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schizonepeta tenuifolia flowering top extract [1307639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secobarbital sodium [91110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 22F capsular polysaccharide antigen [854954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium chlorate [1366921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa spleen preparation [1311344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strawberry allergenic extract [892484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium polyacrylate (2500000 MW) [1310536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia hispanica seed extract [1309460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium fluoride f-18 [1311495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>85 strontium [90613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa duodenum preparation [1311325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium citrate dihydrate [221163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa diencephalon preparation [1311324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium peroxide [1366983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>slender ragweed pollen extract [851990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearoyl inulin [2670452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa cartilage preparation [1311248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra flowering top [1307698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Serenoa repens whole extract [1799374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium citrate [56466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic wax (1900 MW) [1427207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl behenate [1313978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulconazole [37319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Shorea stepnoptera seed butter extract [1664624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saccharina latissima extract [1356143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium trideceth sulfate [1372935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose tristearate [1923244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syringa vulgaris flower extract [1307782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesquicarbonate [1370673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfinpyrazone [10205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strychnine phosphate dihydrate [1483264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selenium [9641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-3 [1790091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sibutramine [36514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamidopropyl propylene glycol-dimonium chloride [1808537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pyrophosphate decahydrate [1944687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solifenacin [322167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine [2566296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SIMETHICONE-CELLULOSE [283585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>skatole [1311386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium C12-15 pareth-15 sulfonate [1366911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spigelia marilandica preparation [285164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synthetic yellow iron oxide [1305585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine [2686923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa Peyer&apos;s patch preparation [1311199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scrophularia nodosa extract [1330090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium pertechnetate Tc 99m [10349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>symclosene sodium [2375530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet cherry juice [2587644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>star fruit extract [1655993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl isethionate [1364520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna alata leaf extract [1307824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa temporal lobe preparation [1311347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>smooth sumac pollen extract [1098274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>selexipag [1729002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spirulina maxima preparation [1427123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soy protein-iron complex [91495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Siberian ginseng root [259393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus uberis [1491864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfosalicylate [1370604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatrogon-ghla [2644513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strophanthus hispidus seed extract [1309684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa nasal mucosa preparation [1311334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Syzygium aromaticum fruit extract [1544270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl hydroxypropyl sulfonate [1663748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose tetraisostearate [1356760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spigelia marilandica root extract [1320409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver stearate [2621547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugarcane allergenic extract [1014711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmon calcitonin [36118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salmonella enterica subsp. enterica serovar typhi [1716523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium linoleate [2471869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulopenem [2717833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acrylate [1364499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spearmint oil [1305657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sutimlimab-jome [2591415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium hypophosphite monohydrate [1311312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sirolimus protein-bound [2712352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus equinus [1491865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-20 methacrylate [1541738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax lanceifolia whole extract [2631988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>superoxide dismutase (Saccharomyces cerevisiae) [1804845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Smilax aristolochiaefolia root extract [1309473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salicylamide [9518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Senna leaves [237929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate P32 [91559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet potato allergenic extract [901307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sunvozertinib [2719226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago virgaurea flowering top extract [1309763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Semecarpus anacardium juice [1350214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>scrub pine pollen extract [1013913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium chloride [37175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan sesquiisostearate [1998445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose tetrastearate triacetate [1423791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern yellow jacket venom protein [1297533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>somatrogon [2644503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sucrose dilaurate [1745411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl glycyrrhetinate [1356147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfanilamide [10184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saffron stain [1363716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine [798224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silk, enzyme hydrolyzed (1000 MW) [1366710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sanguinarine [1537755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stachys officinalis extract [1442792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>streptomycin [10109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sparassis crispa fruiting body extract [2621209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-COV-2 (COVID-19) vaccine, vector - Ad26 [2479830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sinapultide [1440288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sepia officinalis juice [1311144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium nonoxynol-4 sulfate [1869625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sedum roseum root extract [1307944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorafenib [495881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa frontal lobe preparation [1311249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Shigella sonnei [1491872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbeth-12 hexaoleate [2185791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium dehydroacetate [1366847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solidago velutina whole extract [2473231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium carbonate monohydrate [1311298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa prostate preparation [1311340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spesolimab [2610417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium carboxymethyl beta-glucan (DS 0.65-0.85) [1600779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa oral mucosa preparation [1311232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>((2s,3s,5s)-2-(2-(2,6-dimethylphenoxy)acetamido)-5-((s)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2h)-yl)butanamido)-1,6-diphenylhexan-3-yl) 3-methyl-2-(2-oxotetrahydropyrimidin-1(2h)-yl)butanoate, (s)- [1599828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>strontium-89 chloride [281890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acrylate/sodium acryloyldimethyltaurate copolymer (4000000 MW) [1855662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa hippocampus preparation [1311251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfisoxazole diolamine [10208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>solvent yellow 29 [2604572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sorbitan isostearate [1310513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shrimp allergenic extract [892592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfated mucopolysaccharides [236768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salsolinol [1311309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sesame seed extract [1310046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salvia officinalis flowering top extract [1370194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa tendon preparation [1311262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl aspartate [1313181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfide [1293719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saquinavir mesylate [859857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>saffron extract [1484904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Saussurea gossipiphora extract [1356704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phenylacetate [56510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Secale cereale whole extract [1663403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulthiame [10240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ascorbate [267366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver acetate [137939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ear preparation [1492941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotatercept [2678930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acetate [56443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serrated swimming crab, cooked preparation [1315122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salcaprozate [2200638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium methylcamphorate [236440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfisoxazole [10207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine [2566294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium o-phenylphenate [1926056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium levulinate [1358174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa meniscus preparation [1544128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>simvastatin [36567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sermorelin [56188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa bone marrow preparation [1311276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>seaweed extract [1370783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Stevia rebaudiuna leaf extract [1307971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schinzophyton rautanenii seed oil [1735510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stannous fluoride dihydrate [1311371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sawtooth oak whole extract [1995249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>serotonin hydrochloride [1356129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>steareth-30 [1366627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium nitrate [36700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa nerve preparation [1311245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scotch spearmint oil [1603524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Solanum dulcamara flower extract [1310051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium laureth-2 sulfate [1364899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sepiapterin [2723056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sepia extract [350376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Strychnos ignatii preparation [285165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa jejunum preparation [1311329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sedum roseum whole extract [1545912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanguinaria canadensis root extract [670544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus oralis [2711539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symphoricarpos albus whole extract [2590694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sanicula europaea leaf extract [1309781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium sulfite, anhydrous [1367221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium acetyltryptophanate [1366816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearalkonium ion [2641608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Scotch broom pollen extract [897499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearamidopropyl PG-dimonium chloride phosphate [1307093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>soy germ [259430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Spanish thyme oil [1310030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Salicornia europaea extract [1372263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spanish sardine preparation [1591914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertaconazole [36435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa placenta preparation [1311338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>synephrine tartrate [236359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Symphytum uplandicum leaf extract [1367399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae type 9V capsular polysaccharide antigen [854974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Silybum marianum whole extract [2671201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sofpironium bromide [2689321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>smallpox vaccine live, New York City Board of Health vaccinia strain [798467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Santalum paniculatum wood oil [2481133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sugar maple pollen extract [895385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Styphnolobium japonicum flower extract [1539193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium S-(2-hydroxy-3-(3-(trihydroxysilyl)propoxy)propyl) sulfurothioate [2389635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>shrimp shell chitin [1788955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium salicylate [9907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium phosphate, tribasic, dodecahydrate [1311345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>S-methyl methanethiosulfonate [2371233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine [798222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secobarbital [9624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sea salt [1311499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ascorbyl phosphate [1364501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarsaparilla root extract [1309670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium ferrocyanide decahydrate [2570734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>spectinomycin sulfate [2640868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium cocoyl glycinate [1424460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>stearyl glucoside [1313979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium 2-acrylamido-2-methyl-1-propane sulfonate/sodium acrylate/n-isopropylacrylamide/trimethyl(3-methacrylamidopropyl)ammonium chloride copolymer [2392632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa corpus luteum preparation [1311321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>s typhi (ty-2 strain) [221158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium potassium tartrate tetrahydrate [1311362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl methyl isethionate [1487156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine [901636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sambucus nigra flower oil [2053443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfaguanidine [10174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa ligament preparation [1546869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein [2606074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa adrenal gland preparation [1311235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>semuloparin [2368733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium oleth sulfate [2700068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium beta-sitosteryl sulfate [1487926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa mammary gland preparation [1311332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Schisandra chinensis seed extract [2109052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>safflower extract [1309390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Sus scrofa cerebellum preparation [1311316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sermorelin acetate [58932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfacetamide sodium [82101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium caseinate [1366917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium isethionate [1364895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauroyl methylaminopropionate [2182890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine [2566295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sclareolide [1426934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium oleanolate [1366853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium lauryl sarcosinate [1366863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sea cucumber extract [1735048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>S [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sodium bromide [1311138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</name>
  <code>C654163</code>  <id>654163</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor</to_name>
    <to_code>T58600</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193948</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>remdesivir [2284718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing RNA polymerase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with RNA polymerase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>SARS-CoV-2 mRNA [EXT]</name>
  <code>C654318</code>  <id>654318</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 mRNA</to_name>
    <to_code>T58935</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194098</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>SLAMF7-directed Antibody Interactions [MoA]</name>
  <code>C652473</code>  <id>652473</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD319-directed Antibody Interactions</to_name>
    <to_code>T47389</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Antibody Interactions</to_name>
    <to_code>T47391</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Signaling Lymphocytic Activation Molecule Family member 7-directed Antibody Interactions</to_name>
    <to_code>T47390</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192337</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elotuzumab [1726104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>SLAMF7-directed Immunostimulatory Antibody [EPC]</name>
  <code>C652474</code>  <id>652474</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>CD319-directed Immunostimulatory Antibody</to_name>
    <to_code>T47393</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Signaling Lymphocytic Activation Molecule Family member 7-directed Immunostimulatory Antibody</to_name>
    <to_code>T47392</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Immunostimulatory Antibody</to_name>
    <to_code>T47394</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192338</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>elotuzumab [1726104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibodies, Monoclonal [M0001357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cytotoxic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SLAMF7-directed Immunostimulatory Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Saliva Excretion [PK]</name>
  <code>C274</code>  <id>275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Saliva Excretion</to_name>
    <to_code>T47705</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000048</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Saliva Production Alteration [PE]</name>
  <code>C30048</code>  <id>30049</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Saliva Production Alteration</to_name>
    <to_code>T47706</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009841</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Saliva Production Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Saliva Production Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Salivation Inhibition [PE]</name>
  <code>C30050</code>  <id>30051</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition</to_name>
    <to_code>T47728</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009842</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Salivation Stimulation [PE]</name>
  <code>C30052</code>  <id>30053</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation</to_name>
    <to_code>T47729</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009843</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride [260036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride anhydrous [2698548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Salivation Stimulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sclerosing Activity [MoA]</name>
  <code>C300410</code>  <id>300410</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity</to_name>
    <to_code>T47970</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020024</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine hydrochloride [1311530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine oleate [24460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine thenoate [236213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 [236545]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 phosphate [2373964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine [24457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium morrhuate [9892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sclerosing Agent [EPC]</name>
  <code>C635233</code>  <id>635233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Agent</to_name>
    <to_code>T47971</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175814</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sclerosing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sclerosing Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sclerosing Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sclerosing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethanolamine [24457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sclerosing Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Sclerosing agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sclerosing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>laureth-9 [236545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sclerosing Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polidocanol [968170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sebaceous Gland Alteration [PE]</name>
  <code>C30324</code>  <id>30325</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sebaceous Gland Alteration</to_name>
    <to_code>T48012</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009978</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sebaceous Gland Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sebaceous Gland Quantity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sebaceous Gland Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sebaceous Gland Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sebaceous Gland Quantity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sebaceous Gland Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sebaceous Gland Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Secretin Receptor Agonists [MoA]</name>
  <code>C300468</code>  <id>300468</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Agonists</to_name>
    <to_code>T48031</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020078</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin acetate [408108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin [9627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Secretin Receptor Antagonists [MoA]</name>
  <code>C300469</code>  <id>300469</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Antagonists</to_name>
    <to_code>T48032</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020079</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Secretin Receptor Interactions [MoA]</name>
  <code>C300467</code>  <id>300467</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Interactions</to_name>
    <to_code>T48033</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020077</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Secretin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Secretin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Secretin-class Hormone [EPC]</name>
  <code>C635232</code>  <id>635232</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin-class Hormone</to_name>
    <to_code>T48036</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Secretin Class Hormone</to_name>
    <to_code>T48035</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175813</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Secretin-class Hormone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Secretin [M0019589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Secretin-class Hormone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Secretin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Secretin-class Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>secretin [9627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Secretin-class Hormone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing secretin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sedatives/Hypnotics [TC]</name>
  <code>C654063</code>  <id>654063</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics</to_name>
    <to_code>T58441</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193842</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprobarbital [17381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam besylate [2383942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam [2383941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexobarbital [5302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eszopiclone [461016]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital sodium [91109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant hydrochloride [2591496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam hydrochloride [71484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital sodium [235404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital [477631]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramelteon [596205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quazepam [35185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tasimelteon [1490468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methaqualone [6823]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem tartrate [221183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyprylon [6910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunitrazepam [4460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam [4501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalbital [19860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutethimide [4903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant [2591497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Selectin Blocker [EPC]</name>
  <code>C654255</code>  <id>654255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selectin Blocker</to_name>
    <to_code>T58783</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194032</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selectin Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selectin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selectin Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>crizanlizumab [2262279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing selective adhesion molecule inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selectin Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Selectin Blockers [MoA]</name>
  <code>C654253</code>  <id>654253</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selectin Blockers</to_name>
    <to_code>T58781</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194033</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selectin Blockers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>P-Selectin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Selective Estrogen Receptor Modulators [MoA]</name>
  <code>C514</code>  <id>515</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators</to_name>
    <to_code>T48068</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000168</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvestrant [282357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene [72143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene [1441386]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene acetate [1442171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene hydrochloride [166551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Selective Progesterone Receptor Modulators [MoA]</name>
  <code>C651256</code>  <id>651256</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Progesterone Receptor Modulators</to_name>
    <to_code>T48071</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed Progesterone Agonist and Antagonist</to_name>
    <to_code>T48069</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone Agonist/Antagonist</to_name>
    <to_code>T48070</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191262</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal acetate [1005920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal [1005921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Selective T Cell Costimulation Blocker [EPC]</name>
  <code>C642425</code>  <id>642425</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Blocker</to_name>
    <to_code>T48072</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182830</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD86-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>belatacept [1112973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD80-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Selective T Cell Costimulation Modulator [EPC]</name>
  <code>C641735</code>  <id>641735</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Modulator</to_name>
    <to_code>T48073</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182159</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD86-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>CD80-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>abatacept [614391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Selective T Cell Costimulation Modulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Modulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective T Cell Costimulation Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Semifluorinated Alkane [EPC]</name>
  <code>C654286</code>  <id>654286</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane</to_name>
    <to_code>T58882</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194071</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Semifluorinated Alkane [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perfluorohexyloctane [2637547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Semifluorinated Alkane [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Fluorinated hydrocarbon (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Semifluorinated Alkane [EXT]</name>
  <code>C654287</code>  <id>654287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane</to_name>
    <to_code>T58882</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194072</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluorohexyloctane [2637547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Hydrocarbons, Fluorinated [M0010695]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sensory System Activity Alteration [PE]</name>
  <code>C635133</code>  <id>635133</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sensory System Activity Alteration</to_name>
    <to_code>T48129</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175727</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sensory System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sensory System Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Local Anesthesia [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serine Proteinase Inhibitors [MoA]</name>
  <code>C516</code>  <id>517</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors</to_name>
    <to_code>T48166</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000169</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine Proteinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>HCV NS3/4A Protease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine Proteinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activator Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine Proteinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine Proteinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Trypsin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine Proteinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Kallikrein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine Proteinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasmin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antithrombin III, human [221062]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brensocatib [2721880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha 1-proteinase inhibitor, human [991743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprotinin [1056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine Proteinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serine/Threonine Kinase Inhibitors [MoA]</name>
  <code>C654140</code>  <id>654140</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine/Threonine Kinase Inhibitors</to_name>
    <to_code>T58550</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193933</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclin-dependent Kinase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mitogen-Activated Protein Kinase Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclin-dependent Kinase 6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type II RAF Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serine/Threonine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>BRAF Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capivasertib [2669967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serine/Threonine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1 Receptor Agonists [MoA]</name>
  <code>C654091</code>  <id>654091</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5-Hydroxytryptamine-1 Receptor Agonists</to_name>
    <to_code>T58497</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT1 Receptor Agonists</to_name>
    <to_code>T58494</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT1 Receptor Agonists</to_name>
    <to_code>T58496</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1 Receptor Agonists</to_name>
    <to_code>T58493</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1 Receptor Agonists</to_name>
    <to_code>T58495</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193868</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin 1 Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1a Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1a Receptor Agonists [MoA]</name>
  <code>C654092</code>  <id>654092</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1a Receptor Agonists</to_name>
    <to_code>T58500</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT1a Receptor Agonists</to_name>
    <to_code>T58501</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1a Receptor Agonists</to_name>
    <to_code>T58498</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT1a Receptor Agonists</to_name>
    <to_code>T58499</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5-Hydroxytryptamine-1a Receptor Agonists</to_name>
    <to_code>T58502</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193869</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1b Receptor Agonists [MoA]</name>
  <code>C635171</code>  <id>635171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1B Receptor Agonists</to_name>
    <to_code>T48197</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1B Receptor Agonists</to_name>
    <to_code>T48198</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1b Receptor Agonists</to_name>
    <to_code>T48196</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists</to_name>
    <to_code>T48199</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1b Receptor Agonists</to_name>
    <to_code>T48194</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1B Receptor Agonists</to_name>
    <to_code>T48195</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175763</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 1d Receptor Agonists [MoA]</name>
  <code>C635172</code>  <id>635172</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1D Receptor Agonists</to_name>
    <to_code>T48202</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1D Receptor Agonists</to_name>
    <to_code>T48201</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1d Receptor Agonists</to_name>
    <to_code>T48203</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1D Receptor Agonists</to_name>
    <to_code>T48204</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1d Receptor Agonists</to_name>
    <to_code>T48200</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists</to_name>
    <to_code>T48205</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175764</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 2c Receptor Agonists [MoA]</name>
  <code>C644811</code>  <id>644811</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2C Receptor Agonists</to_name>
    <to_code>T48209</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-2C Receptor Agonists</to_name>
    <to_code>T48210</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2c Receptor Agonists</to_name>
    <to_code>T48206</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2C Receptor Agonists</to_name>
    <to_code>T48207</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists</to_name>
    <to_code>T48211</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-2c Receptor Agonists</to_name>
    <to_code>T48208</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride anhydrous [1808546]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride hemihydrate [1597623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin [1300701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride [1300700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 3 Receptor Antagonists [MoA]</name>
  <code>C635236</code>  <id>635236</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT3 Receptor Antagonists</to_name>
    <to_code>T48215</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 3 Receptor Antagonists</to_name>
    <to_code>T48213</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists</to_name>
    <to_code>T48216</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-3 Receptor Antagonists</to_name>
    <to_code>T48212</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT3 Receptor Antagonists</to_name>
    <to_code>T48214</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175817</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron [26237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron hydrochloride [142149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 4 Receptor Agonists [MoA]</name>
  <code>C654090</code>  <id>654090</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-4 Receptor Agonists</to_name>
    <to_code>T58490</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Agonists</to_name>
    <to_code>T58488</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT4 Receptor Agonists</to_name>
    <to_code>T58491</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonists</to_name>
    <to_code>T58492</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT4 Receptor Agonists</to_name>
    <to_code>T58489</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193870</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 4 Receptor Antagonists [MoA]</name>
  <code>C635235</code>  <id>635235</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-4 Receptor Antagonists</to_name>
    <to_code>T48218</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 4 Receptor Antagonists</to_name>
    <to_code>T48219</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT4 Receptor Antagonists</to_name>
    <to_code>T48220</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists</to_name>
    <to_code>T48221</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT4 Receptor Antagonists</to_name>
    <to_code>T48217</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175816</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride succinate [2107309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5HT-3 Agonists [MoA]</name>
  <code>C554</code>  <id>555</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Agonists</to_name>
    <to_code>T48222</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000188</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5HT-3 Antagonists [MoA]</name>
  <code>C358</code>  <id>359</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists</to_name>
    <to_code>T48223</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000090</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron [26237]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron hydrochloride [397405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine [1455099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine hydrobromide [1439834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride anhydrous [2119176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron hydrochloride [142149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin 5HT-3 Receptor Interactions [MoA]</name>
  <code>C368</code>  <id>369</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Receptor Interactions</to_name>
    <to_code>T48224</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000095</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin 5HT-3 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin 5HT-3 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5HT-3 Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Activity Alteration [PE]</name>
  <code>C30054</code>  <id>30055</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration</to_name>
    <to_code>T48225</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009844</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Serotonin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone tosylate [2275731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone [2275602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Agonists [MoA]</name>
  <code>C690</code>  <id>691</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists</to_name>
    <to_code>T48226</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000256</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide [6911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan succinate [322249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide maleate [203190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone hydrochloride [2672254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone [2672253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Antagonists [MoA]</name>
  <code>C438</code>  <id>439</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists</to_name>
    <to_code>T48227</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000130</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine hydrochloride [91125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergot preparation [91405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone mesylate [353116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride anhydrous [1362139]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Receptor Interactions [MoA]</name>
  <code>C574</code>  <id>575</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions</to_name>
    <to_code>T48235</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000198</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone [2672253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone hydrochloride [2672254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin tartrate [1791686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin [1791685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine hydrochloride [1721073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Reuptake Inhibitor Anorectic [EPC]</name>
  <code>C635386</code>  <id>635386</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor Anorectic</to_name>
    <to_code>T48236</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175948</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing selective serotonin re-uptake inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with serotonin re-uptake inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Reuptake Inhibitor [EPC]</name>
  <code>C635102</code>  <id>635102</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Serotonin Reuptake Inhibitor</to_name>
    <to_code>T48239</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor (SSRI)</to_name>
    <to_code>T48237</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SSRI</to_name>
    <to_code>T48238</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Reuptake Inhibitor</to_name>
    <to_code>T48241</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Serotonin Reuptake Inhibitor (SSRI)</to_name>
    <to_code>T48240</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175696</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluvoxamine [42355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>citalopram [2556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sertraline [36437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paroxetine [32937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with serotonin re-uptake inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing selective serotonin re-uptake inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>escitalopram [321988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nefazodone [31565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fluoxetine [4493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trazodone [10737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Transporter Interactions [MoA]</name>
  <code>C512</code>  <id>513</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions</to_name>
    <to_code>T48243</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000167</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin Uptake Inhibitors [MoA]</name>
  <code>C396</code>  <id>397</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors</to_name>
    <to_code>T48244</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000109</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram oxalate [353108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate monohydrate [2605948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine mesylate [236189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine besylate [2607741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin hydrochloride [236807]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone [1086769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin [3332]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram [321988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine [1455099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine hydrobromide [1439834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone hydrochloride [1086768]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</name>
  <code>C635157</code>  <id>635157</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)</to_name>
    <to_code>T48253</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SNRI</to_name>
    <to_code>T48252</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin and Norepinephrine Reuptake Inhibitor</to_name>
    <to_code>T48254</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175749</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>milnacipran [588250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levomilnacipran [1433212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desvenlafaxine [734064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venlafaxine [39786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing norepinephrine reuptake inhibitor and serotonin reuptake inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>duloxetine [72625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin and Norepinephrine Reuptake Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Uptake Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</name>
  <code>C635173</code>  <id>635173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1B and 5HT-1D Receptor Agonist</to_name>
    <to_code>T48259</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1b and Serotonin-1d Receptor Agonist</to_name>
    <to_code>T48266</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1b and 5HT-1d Receptor Agonist</to_name>
    <to_code>T48257</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1B and 1D Receptor Agonist</to_name>
    <to_code>T48265</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1B/1D Receptor Agonist</to_name>
    <to_code>T48258</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin (5-HT) 1b/1d Receptor Agonist</to_name>
    <to_code>T48255</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1B and Serotonin-1D Receptor Agonist</to_name>
    <to_code>T48256</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1B/5HT-1D Receptor Agonist</to_name>
    <to_code>T48261</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin (5-HT) 1B/1D Receptor Agonist</to_name>
    <to_code>T48262</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-1b/5HT-1d Receptor Agonist</to_name>
    <to_code>T48264</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b and 1d Receptor Agonist</to_name>
    <to_code>T48263</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b/1d Receptor Agonist</to_name>
    <to_code>T48260</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175765</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>naratriptan [141366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>frovatriptan [228783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolmitriptan [135775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eletriptan [231049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>almotriptan [279645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rizatriptan [88014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sumatriptan [37418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1d Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 1b Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with serotonin 5-hydroxytryptamine-1 receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing serotonin 5-hydroxytryptamine-1 receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin-2c Receptor Agonist [EPC]</name>
  <code>C644812</code>  <id>644812</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-2C Receptor Agonist</to_name>
    <to_code>T48272</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2C Receptor Agonist</to_name>
    <to_code>T48271</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2c Receptor Agonist</to_name>
    <to_code>T48274</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin (5-HT) 2c Receptor Agonist</to_name>
    <to_code>T48267</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2C Receptor Agonist</to_name>
    <to_code>T48273</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-2c Receptor Agonist</to_name>
    <to_code>T48268</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin (5-HT) 2C Receptor Agonist</to_name>
    <to_code>T48269</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonist</to_name>
    <to_code>T48270</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185010</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-2c Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 2c Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with serotonin receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing serotonin receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-2c Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin-3 Receptor Antagonist [EPC]</name>
  <code>C635237</code>  <id>635237</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 3 (5HT3) Receptor Antagonist</to_name>
    <to_code>T48276</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 3 Receptor Antagonist</to_name>
    <to_code>T48275</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-3 Receptor Antagonist</to_name>
    <to_code>T48283</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-3 Receptor Antagonist</to_name>
    <to_code>T48277</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT3 Receptor Antagonist</to_name>
    <to_code>T48281</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT3 Receptor Antagonist</to_name>
    <to_code>T48282</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 3 (5-HT3) Receptor Antagonist</to_name>
    <to_code>T48278</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonist</to_name>
    <to_code>T48279</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 3 (5HT-3) Receptor Antagonist</to_name>
    <to_code>T48280</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175818</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>granisetron [26237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alosetron [85248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with 5-hydroxytryptamine-3-receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing 5-hydroxytryptamine-3-receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ondansetron [26225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dolasetron [68091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-3 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>palonosetron [70561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin-4 Receptor Agonist [EPC]</name>
  <code>C654089</code>  <id>654089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-4 Receptor Agonist</to_name>
    <to_code>T58483</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT4 Receptor Agonist</to_name>
    <to_code>T58484</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 5-Hydroxytryptamine-4 Receptor Agonist</to_name>
    <to_code>T58487</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-4 Receptor Agonist</to_name>
    <to_code>T58485</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT4 Receptor Agonist</to_name>
    <to_code>T58486</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193871</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tegaserod [139778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing serotonin 5-hydroxytryptamine-4 receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with serotonin 5-hydroxytryptamine-4 receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-4 Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prucalopride [2107310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Serotonin-4 Receptor Antagonist [EPC]</name>
  <code>C635234</code>  <id>635234</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 4 Receptor Antagonist</to_name>
    <to_code>T48285</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-4 Receptor Antagonist</to_name>
    <to_code>T48292</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 4 (5HT4) Receptor Antagonist</to_name>
    <to_code>T48287</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT4 Receptor Antagonist</to_name>
    <to_code>T48284</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5HT-4 Receptor Antagonist</to_name>
    <to_code>T48291</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 4 (5-HT4) Receptor Antagonist</to_name>
    <to_code>T48286</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>5-HT4 Receptor Antagonist</to_name>
    <to_code>T48289</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonist</to_name>
    <to_code>T48288</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin subtype 4 (5HT-4) Receptor Antagonist</to_name>
    <to_code>T48290</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175815</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Serotonin-4 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin 4 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin-4 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sex Hormone Receptor Agonists [MoA]</name>
  <code>C606</code>  <id>607</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sex Hormone Receptor Agonists</to_name>
    <to_code>T48384</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000214</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sex Hormone Receptor Antagonists [MoA]</name>
  <code>C346</code>  <id>347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sex Hormone Receptor Antagonists</to_name>
    <to_code>T48385</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000084</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestational Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sex Hormone Synthesis Inhibitors [MoA]</name>
  <code>C635360</code>  <id>635360</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sex Hormone Synthesis Inhibitors</to_name>
    <to_code>T48386</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175922</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sex Hormone Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Shellfish Proteins [EXT]</name>
  <code>C644822</code>  <id>644822</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins</to_name>
    <to_code>T48443</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185020</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oyster, unspecified preparation [1315121]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oyster allergenic extract [973274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shrimp allergenic extract [892592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sea scallop preparation [1426396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>American lobster allergenic extract [1997187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clam allergenic extract [892539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lobster allergenic extract [892561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scallop allergenic extract [899916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Dietary Proteins [M0006342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crab allergenic extract [892610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blue crab preparation [1315126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>northern quahog preparation [1925437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Shorten Conduction System Depolarization Time [PE]</name>
  <code>C31926</code>  <id>31927</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Shorten Conduction System Depolarization Time</to_name>
    <to_code>T48494</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010284</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Shorten Conduction System Repolarization Time [PE]</name>
  <code>C31930</code>  <id>31931</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Shorten Conduction System Repolarization Time</to_name>
    <to_code>T48495</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010286</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Siderophore Iron Chelating Activity [MoA]</name>
  <code>C640528</code>  <id>640528</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Siderophore Iron Chelating Activity</to_name>
    <to_code>T48563</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181001</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sigma Receptor Interactions [MoA]</name>
  <code>C641721</code>  <id>641721</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma Receptor Interactions</to_name>
    <to_code>T48569</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182145</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Agonist [EPC]</name>
  <code>C641725</code>  <id>641725</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Agonist</to_name>
    <to_code>T48571</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonist</to_name>
    <to_code>T48570</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182149</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma-1 Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing sigma-1 receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma-1 Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma-1 Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with sigma-1 receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma-1 Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan [3289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Agonists [MoA]</name>
  <code>C641723</code>  <id>641723</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists</to_name>
    <to_code>T48572</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182147</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Antagonists [MoA]</name>
  <code>C641724</code>  <id>641724</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Antagonists</to_name>
    <to_code>T48573</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182148</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noscapine [7533]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sigma-1 Receptor Interactions [MoA]</name>
  <code>C641722</code>  <id>641722</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Interactions</to_name>
    <to_code>T48574</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182146</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma-1 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sigma-1 Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sigma-1 Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Site of Metabolism [PK]</name>
  <code>C226</code>  <id>227</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Site of Metabolism</to_name>
    <to_code>T48742</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000024</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Site of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Plasma Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Site of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hepatic Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Site of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Renal Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Site of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intestinal Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Site of Metabolism [PK]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Metabolism [PK]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Site of concentration [PK]</name>
  <code>C218</code>  <id>219</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Site of concentration</to_name>
    <to_code>T48743</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000020</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Site of relative exclusion [PK]</name>
  <code>C220</code>  <id>221</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Site of relative exclusion</to_name>
    <to_code>T48744</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000021</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Skeletal Muscle Relaxant [EPC]</name>
  <code>C635144</code>  <id>635144</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxant</to_name>
    <to_code>T48778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175738</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skeletal Muscle Relaxant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skeletal Muscle Relaxant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dantrolene [3105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skeletal Muscle Relaxant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Skeletal muscle relaxant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skeletal Muscle Relaxant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Skeletal Muscle Relaxants [TC]</name>
  <code>C654064</code>  <id>654064</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants</to_name>
    <to_code>T58442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193843</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium besylate [1219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium bromide [66983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium bromide [32521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine iodide [262295]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrazepam [37985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine [10154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium bromide [11153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium chloride [52796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine [10917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium [33742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium [71535]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium chloride [49275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium besylate [136561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium [319864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium [23651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium cation [1546399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type B [2167673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium [1218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium [30077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopamide [2603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine chloride [82115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride [3565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium [7883]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suxamethonium bromide [121039]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride dihydrate [2397714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium bromide [7884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Skin Barrier Activity [PE]</name>
  <code>C31922</code>  <id>31923</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity</to_name>
    <to_code>T48781</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010282</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 100 [1310496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prademagene zamikeracel [2713314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone [324072]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentoquatam [134568]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calamine [106212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Barrier Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Skin Excretion [PK]</name>
  <code>C280</code>  <id>281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Excretion</to_name>
    <to_code>T48808</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000051</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Skin Lightening Agent [EPC]</name>
  <code>C635293</code>  <id>635293</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Lightening Agent</to_name>
    <to_code>T48809</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175855</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Skin Test Antigen [EPC]</name>
  <code>C644087</code>  <id>644087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Test Antigen</to_name>
    <to_code>T48813</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184316</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skin Test Antigen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antigens [M0001407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skin Test Antigen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>purified protein derivative of tuberculin [8948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_diagnose</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skin Test Antigen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skin Test Antigen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tuberculosis Skin Test [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skin Test Antigen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Coccidioides immitis spherule [1549330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Skin Test Antigen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic substance (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skin Test Antigen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Small Interfering RNA [EPC]</name>
  <code>C654071</code>  <id>654071</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Interfering RNA</to_name>
    <to_code>T58453</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>siRNA</to_name>
    <to_code>T58454</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Silencing RNA</to_name>
    <to_code>T58456</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Short interfering RNA</to_name>
    <to_code>T58455</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193848</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Interfering RNA [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>givosiran [2265712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Interfering RNA [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vutrisiran [2604578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Interfering RNA [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patisiran [2053490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Interfering RNA [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>RNA, Small Interfering [M0406100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Interfering RNA [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fitusiran [2709439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Ribonucleic acid, double stranded (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Interfering RNA [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</name>
  <code>C30056</code>  <id>30057</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration</to_name>
    <to_code>T48916</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009845</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Small Intestine Fluid/Electrolyte Alteration [PE]</name>
  <code>C30058</code>  <id>30059</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Alteration</to_name>
    <to_code>T48917</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009846</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Intestine Fluid/Electrolyte Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Absorption Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Intestine Fluid/Electrolyte Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Small Intestine Fluid/Electrolyte Secretion Alteration [PE]</name>
  <code>C30060</code>  <id>30061</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Secretion Alteration</to_name>
    <to_code>T48918</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009847</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Intestine Fluid/Electrolyte Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibition Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Small Intestine Fluid/Electrolyte Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Small Intestine Fluid/Electrolyte Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Smooth Muscle Tone Alteration [PE]</name>
  <code>C31894</code>  <id>31895</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration</to_name>
    <to_code>T48947</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010268</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urethra Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cervical Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverin [23684]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverine hydrochloride [236960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl [10811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl hydrochloride [1115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Smoothened Receptor Antagonists [MoA]</name>
  <code>C643863</code>  <id>643863</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists</to_name>
    <to_code>T48949</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184148</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib [1659191]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vismodegib [1242987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib maleate [2105844]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib [2105845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib phosphate [1659192]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Smoothened Receptor Interactions [MoA]</name>
  <code>C643862</code>  <id>643862</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Interactions</to_name>
    <to_code>T48950</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184147</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Smoothened Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Smoothened Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Bile Acid Cotransporter Interactions [MoA]</name>
  <code>C654177</code>  <id>654177</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Taurocholate Co-transporting Polypeptide Interactions</to_name>
    <to_code>T58623</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NTCP Interactions</to_name>
    <to_code>T58622</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Bile Acid Cotransporter Interactions</to_name>
    <to_code>T58621</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193964</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Bile Acid Cotransporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ileal Bile Acid Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Bile Acid Cotransporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Agonists [MoA]</name>
  <code>C642322</code>  <id>642322</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Agonists</to_name>
    <to_code>T48985</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182727</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Antagonists [MoA]</name>
  <code>C640547</code>  <id>640547</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists</to_name>
    <to_code>T48987</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Blockers</to_name>
    <to_code>T48986</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181004</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riluzole [35623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacemide [33253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Blocker [EPC]</name>
  <code>C654362</code>  <id>654362</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Blocker</to_name>
    <to_code>T59039</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194141</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing sodium channel blocker (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Channel Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Channel Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>suzetrigine [2704819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Channel Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with sodium channel blocker mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Channel Interactions [MoA]</name>
  <code>C538</code>  <id>539</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions</to_name>
    <to_code>T48988</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000180</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Channel Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide [42368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine hydrochloride [2117]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride monohydrate [1298851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine hydrochloride [91188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate [18889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine [23744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride [236539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine [4171]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine [20859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine hydrochloride [259454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide hydrochloride [281189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine hydrochloride [91189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine hydrochloride [2557]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine hydrochloride [203185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine [10391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine [6759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine hydrochloride [227221]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butacaine [1829]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride anhydrous [1375412]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine [592464]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrethrins [8991]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine [259453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate hydrochloride [235398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine [35780]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride anhydrous [2198974]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine [8686]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine hydrochloride [53616]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rufinamide [69036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Channel Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Chloride Symporter Inhibitors [MoA]</name>
  <code>C640548</code>  <id>640548</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors</to_name>
    <to_code>T48994</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181005</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Chloride Symporter Interactions [MoA]</name>
  <code>C648277</code>  <id>648277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Interactions</to_name>
    <to_code>T48995</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188376</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Chloride Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</name>
  <code>C640549</code>  <id>640549</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors</to_name>
    <to_code>T49054</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181006</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Potassium Chloride Symporter Interactions [MoA]</name>
  <code>C648278</code>  <id>648278</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Interactions</to_name>
    <to_code>T49055</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188377</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium Potassium Chloride Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors [MoA]</name>
  <code>C654178</code>  <id>654178</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Taurocholate Co-transporting Polypeptide Inhibitors</to_name>
    <to_code>T58624</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NTCP Inhibitors</to_name>
    <to_code>T58625</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193965</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</name>
  <code>C646960</code>  <id>646960</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitor</to_name>
    <to_code>T49095</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SGLT2 Inhibitor</to_name>
    <to_code>T49093</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Cotransporter 2 Inhibitor</to_name>
    <to_code>T49096</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Transporter 2 Inhibitor</to_name>
    <to_code>T49090</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Cotransporter 2 Inhibitor</to_name>
    <to_code>T49091</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Symporter 2 Inhibitor</to_name>
    <to_code>T49092</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Symporter 2 Inhibitor</to_name>
    <to_code>T49094</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187059</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapagliflozin [1488564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>canagliflozin anhydrous [1546031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing sodium glucose cotransporter subtype 2 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bexagliflozin [2627044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>empagliflozin [1545653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Cotransporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sotagliflozin [2638675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter 1 Inhibitors [MoA]</name>
  <code>C646958</code>  <id>646958</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Transporter 1 Inhibitors</to_name>
    <to_code>T49106</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Cotransporter 1 Inhibitors</to_name>
    <to_code>T49108</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SGLT1 Inhibitors</to_name>
    <to_code>T49105</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Symporter 1 Inhibitors</to_name>
    <to_code>T49107</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 1 Inhibitors</to_name>
    <to_code>T49111</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Cotransporter 1 Inhibitors</to_name>
    <to_code>T49110</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Symporter 1 Inhibitors</to_name>
    <to_code>T49109</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187057</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</name>
  <code>C646959</code>  <id>646959</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Transporter 2 Inhibitors</to_name>
    <to_code>T49116</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SGLT2 Inhibitors</to_name>
    <to_code>T49121</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Cotransporter 2 Inhibitors</to_name>
    <to_code>T49120</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Symporter 2 Inhibitors</to_name>
    <to_code>T49119</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Cotransporter 2 Inhibitors</to_name>
    <to_code>T49118</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Symporter 2 Inhibitors</to_name>
    <to_code>T49117</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors</to_name>
    <to_code>T49122</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187058</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin [1373458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertugliflozin [1992672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertugliflozin pidolate [1992674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin [1488564]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin propanediol [1486966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexagliflozin [2627044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>empagliflozin [1545653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotagliflozin [2638675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter Inhibitors [MoA]</name>
  <code>C646957</code>  <id>646957</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Transporter Inhibitors</to_name>
    <to_code>T49128</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Cotransporter Inhibitors</to_name>
    <to_code>T49130</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SGLT Inhibitors</to_name>
    <to_code>T49131</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Cotransporter Inhibitors</to_name>
    <to_code>T49126</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucose-Sodium Symporter Inhibitors</to_name>
    <to_code>T49129</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter Inhibitors</to_name>
    <to_code>T49132</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Symporter Inhibitors</to_name>
    <to_code>T49127</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187056</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Transporter Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Transporter Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Glucose Transporter Interactions [MoA]</name>
  <code>C648279</code>  <id>648279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter Interactions</to_name>
    <to_code>T49133</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188378</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Glucose Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</name>
  <code>C654273</code>  <id>654273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLC9A3 Inhibitor</to_name>
    <to_code>T58831</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NHE3 Inhibitor</to_name>
    <to_code>T58830</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Antiporter 3 Inhibitor</to_name>
    <to_code>T58832</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Solute Carrier Family 9 Member 3 Inhibitor</to_name>
    <to_code>T58835</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitor</to_name>
    <to_code>T58834</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitor</to_name>
    <to_code>T58829</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 (NHE3) Inhibitor</to_name>
    <to_code>T58833</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194056</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenapanor [2199674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with sodium-hydrogen exchanger isoform 3 transporter inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with cellular transport inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</name>
  <code>C654272</code>  <id>654272</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NHE3 Inhibitors</to_name>
    <to_code>T58825</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Antiporter 3 Inhibitors</to_name>
    <to_code>T58827</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitors</to_name>
    <to_code>T58824</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Solute Carrier Family 9 Member 3 (SLC9A3) Inhibitors</to_name>
    <to_code>T58828</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLC9 A3 Inhibitors</to_name>
    <to_code>T58826</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194057</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Hydrogen Exchanger Interactions [MoA]</name>
  <code>C654271</code>  <id>654271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLC9 Interactions</to_name>
    <to_code>T58821</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>NHE Interactions </to_name>
    <to_code>T58820</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Antiporter Interactions</to_name>
    <to_code>T58822</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Solute Carrier 9 Interactions</to_name>
    <to_code>T58823</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger Interactions</to_name>
    <to_code>T58819</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194058</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sodium-Hydrogen Exchanger Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</name>
  <code>C654</code>  <id>655</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Na-K Exchanging ATPase Interactions</to_name>
    <to_code>T49176</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions</to_name>
    <to_code>T49177</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Na-K ATPase Interactions</to_name>
    <to_code>T49175</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000238</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzonatate [18993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Potassium Exchanging ATPase Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Soluble Guanylate Cyclase Stimulator [EPC]</name>
  <code>C650444</code>  <id>650444</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Soluble Guanylate Cyclase Stimulator</to_name>
    <to_code>T49231</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190485</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Soluble Guanylate Cyclase Stimulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>riociguat [1439816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Soluble Guanylate Cyclase Stimulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vericiguat [2475830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Soluble Guanylate Cyclase Stimulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Guanylate Cyclase Stimulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vasodilator (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Medicinal product acting as vasodilator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Activity Alteration [PE]</name>
  <code>C30062</code>  <id>30063</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Activity Alteration</to_name>
    <to_code>T49304</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009848</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Somatostatin (SRIF) Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Somatostatin (SRIF) Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Alteration [PE]</name>
  <code>C30064</code>  <id>30065</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Alteration</to_name>
    <to_code>T49305</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009849</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Analog [EPC]</name>
  <code>C635342</code>  <id>635342</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Analogue</to_name>
    <to_code>T49306</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Analog</to_name>
    <to_code>T49307</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175904</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Somatostatin [M0020152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pasireotide [1364105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanreotide [68092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing somatostatin analog (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>octreotide [7617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Analog [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Somatostatin analog (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Receptor Agonists [MoA]</name>
  <code>C566</code>  <id>567</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists</to_name>
    <to_code>T49308</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000194</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide acetate [236167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide diaspartate [1364104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide pamoate [1597818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide [1364105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide [68092]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine hydrochloride [2724364]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine [2724363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Receptor Interactions [MoA]</name>
  <code>C614</code>  <id>615</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Interactions</to_name>
    <to_code>T49309</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000218</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotide gallium ga-68 [2199391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotride [2199392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatostatin Secretion Alteration [PE]</name>
  <code>C30066</code>  <id>30067</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatostatin Secretion Alteration</to_name>
    <to_code>T49310</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009850</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Somatostatin (SRIF) Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatostatin Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Somatostatin (SRIF) Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatotropin Receptor Agonists [MoA]</name>
  <code>C612</code>  <id>613</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatotropin Receptor Agonists</to_name>
    <to_code>T49321</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000217</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin [2569562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatotropin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin-tcgd [2569592]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatotropin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Somatotropin Receptor Interactions [MoA]</name>
  <code>C332</code>  <id>333</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatotropin Receptor Interactions</to_name>
    <to_code>T49322</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000077</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Somatotropin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Somatotropin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Special Sensory Systems Activity Alteration [PE]</name>
  <code>C30068</code>  <id>30069</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Special Sensory Systems Activity Alteration</to_name>
    <to_code>T49406</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009851</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Special Sensory Systems Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ocular Smooth Muscle Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Special Sensory Systems Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Intraocular Fluid Pressure Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Special Sensory Systems Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Retinal Pigment Epithelium Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sperm Alteration [PE]</name>
  <code>C30070</code>  <id>30071</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Alteration</to_name>
    <to_code>T49418</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009852</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sperm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Death Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sperm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Spermatogenesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sperm Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octoxynol-9 [54034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sperm Death Alteration [PE]</name>
  <code>C30346</code>  <id>30347</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Death Alteration</to_name>
    <to_code>T49419</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009989</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sperm Death Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sperm Death [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sperm Motility Alteration [PE]</name>
  <code>C30072</code>  <id>30073</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration</to_name>
    <to_code>T49420</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009853</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sperm Motility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sperm Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sperm Motility Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sperm Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride [476316]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine, DL- [1310540]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonoxynol-9 [53750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine [193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride, DL- [1593400]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sperm Motility Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Spermatogenesis Alteration [PE]</name>
  <code>C30074</code>  <id>30075</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Spermatogenesis Alteration</to_name>
    <to_code>T49426</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009854</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Spermatogenesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decrease Spermatogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Spermatogenesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increase Spermatogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sphingosine 1-Phosphate Receptor Interactions [MoA]</name>
  <code>C641380</code>  <id>641380</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>S1P Receptor Interactions</to_name>
    <to_code>T49458</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Interactions</to_name>
    <to_code>T49459</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181814</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sphingosine 1-Phosphate Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</name>
  <code>C641381</code>  <id>641381</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators</to_name>
    <to_code>T49461</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>S1P Receptor Modulators</to_name>
    <to_code>T49460</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181815</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod [1012892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponesimod [2532300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod hydrochloride [1012891]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod lauryl sulfate [2610292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sphingosine 1-phosphate Receptor Modulator [EPC]</name>
  <code>C641382</code>  <id>641382</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-phosphate Receptor Modulator</to_name>
    <to_code>T49462</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181816</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>fingolimod [1012892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ponesimod [2532300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>siponimod [2121085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-Phosphate Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ozanimod [2288236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sphingosine 1-phosphate Receptor Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arterial Vasoconstriction [PE]</name>
  <code>C30076</code>  <id>30077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arterial Vasoconstriction</to_name>
    <to_code>T49550</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009855</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Splanchnic Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arterial Vasodilation [PE]</name>
  <code>C30078</code>  <id>30079</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arterial Vasodilation</to_name>
    <to_code>T49551</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009856</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Splanchnic Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arteriolar Vasoconstriction [PE]</name>
  <code>C634792</code>  <id>634792</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arteriolar Vasoconstriction</to_name>
    <to_code>T49552</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175409</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Splanchnic Arteriolar Vasodilation [PE]</name>
  <code>C634776</code>  <id>634776</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Splanchnic Arteriolar Vasodilation</to_name>
    <to_code>T49553</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175393</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Squalene Monooxygenase Inhibitors [MoA]</name>
  <code>C31888</code>  <id>31889</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Squalene Epoxidase Inhibitors</to_name>
    <to_code>T49599</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Squalene Monooxygenase Inhibitors</to_name>
    <to_code>T49600</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010265</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolnaftate [10637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Squalene Monooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Squalene Monooxygenase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Standardized Animal Hair Allergenic Extract [EPC]</name>
  <code>C644794</code>  <id>644794</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Animal Hair Allergenic Extract</to_name>
    <to_code>T49631</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185003</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat hair extract [248123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Animal Fur [M0370530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Hair Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Animal material diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Animal Hair Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Standardized Animal Skin Allergenic Extract [EPC]</name>
  <code>C644795</code>  <id>644795</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Animal Skin Allergenic Extract</to_name>
    <to_code>T49632</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185004</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cat skin extract [851949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Animal Skin Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Animal material diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Animal Skin Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Standardized Chemical Allergen [EPC]</name>
  <code>C645352</code>  <id>645352</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Chemical Allergen</to_name>
    <to_code>T49633</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185508</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2&apos;-dithiobisbenzothiazole [1306112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>disperse blue 106 [1368171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethyl-p-hydroxybenzoate [1362892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamic aldehyde [1368153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetramethylthiuram monosulfide [1363713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eugenol [4186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cinnamyl alcohol [1362889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>parthenolide [32941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ditiocarb, zinc salt [1427192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzocaine [1399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nickel [1311629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>geraniol [1368875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorquinaldol [2407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-oxydiethylene-2-benzothiazole sulfenamide [1363711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroxycitronellal [1362893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ethylenediamine [4158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc dibutyldithiocarbamate [1426942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diphenylguanidine [1368170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diazolidinylurea [1310602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-MERCAPTOBENZOTHIAZOLE [1306880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Evernia prunastri extract [1352501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosin [1362931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-mercaptobenzothiazole [1358845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tixocortol pivalate [38336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methyldibromo glutaronitrile [1307044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-isopropyl-N-phenyl-4-phenylenediamine [1363710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dibucaine [3339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Peruvian balsam [33219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoeugenol [1363706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzylparaben [19075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methylparaben [29903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bronopol [1114345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imidurea [1368885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amyl cinnamal [1311606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>p-tert-butylphenol-formaldehyde resin (low molecular weight) [1427189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-cyclohexyl-N&apos;-phenyl-1,4-phenylenediamine [1427136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cobalt [1310300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formaldehyde [4530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>quaternium-15 [283678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N,N&apos;-diphenyl-4-phenylenediamine [1363709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gold [1311190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Evernia prunastri extract [1311644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2-bis(4-glycidyloxyphenyl)propane [1368138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lanolin alcohols [1426478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-phenylenediamine [1362740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiram [10517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chromium [2496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>butylparaben [1306937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dipentamethylenethiuram disulfide [1426773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thimerosal [10472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clioquinol [5942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>N-cyclohexyl-2-benzothiazosulfenamide [1306886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylparaben [34706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Chemical Allergen [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Chemical Allergen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Standardized Insect Allergenic Extract [EPC]</name>
  <code>C644796</code>  <id>644796</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Insect Allergenic Extract</to_name>
    <to_code>T49634</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185005</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Insect Venom Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>American house dust mite allergenic extract [1116977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Proteins [M0028968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house dust mite extract, Dermatophagoides pteronyssinus [852826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>European house dust mite allergenic extract [1116979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antigens, Dermatophagoides [M0419493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>house dust mite extract, Dermatophagoides farinae [852810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Insect specific diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Insect Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Standardized Insect Venom Allergenic Extract [EPC]</name>
  <code>C644829</code>  <id>644829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Insect Venom Allergenic Extract</to_name>
    <to_code>T49635</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185021</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western yellow jacket venom protein [1297535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allergens [M0000728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>German wasp venom protein [1297531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Proteins [M0028968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>common wasp venom protein [1297527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow hornet venom protein [1297537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthropod Venoms [M0001758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>southern yellow jacket venom protein [1297533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eastern yellow jacket venom protein [1297529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Apis mellifera preparation [285219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bald-faced hornet venom protein [1297525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Insect Venom Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Insect venom specific diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Insect Venom Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Standardized Pollen Allergenic Extract [EPC]</name>
  <code>C644798</code>  <id>644798</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Pollen Allergenic Extract</to_name>
    <to_code>T49636</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185006</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Histamine Release [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>orchard grass pollen extract [851878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Bermuda grass pollen extract [851906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>meadow fescue grass pollen extract [851918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sweet vernal grass pollen extract [851898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased IgG Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Timothy grass pollen extract [851994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>perennial rye grass pollen extract [852819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pollen [M0017130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Kentucky bluegrass pollen extract [852834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Standardized Pollen Allergenic Extract [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>short ragweed pollen extract [896135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Diagnostic allergen extract (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Standardized Pollen Allergenic Extract [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stem Cell Factor (KIT) Receptor Inhibitors [MoA]</name>
  <code>C300424</code>  <id>300424</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stem Cell Factor (KIT) Inhibitors</to_name>
    <to_code>T49713</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stem Cell Factor (KIT) Receptor Inhibitors</to_name>
    <to_code>T49714</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020034</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stem Cell Factor (KIT) Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Steroid Hormone Receptor Agonists [MoA]</name>
  <code>C542</code>  <id>543</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Hormone Receptor Agonists</to_name>
    <to_code>T49792</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000182</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sex Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Steroid Receptor Antagonists [MoA]</name>
  <code>C502</code>  <id>503</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Receptor Antagonists</to_name>
    <to_code>T49802</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000162</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sex Hormone Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Mineralocorticoid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Steroid Receptor Modulators [MoA]</name>
  <code>C522</code>  <id>523</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Receptor Modulators</to_name>
    <to_code>T49803</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000172</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Receptor Modulators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Receptor Modulators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Selective Progesterone Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Receptor Modulators [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen Receptor Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Steroid Synthesis Inhibitors [MoA]</name>
  <code>C635358</code>  <id>635358</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid Synthesis Inhibitors</to_name>
    <to_code>T49804</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175920</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenal Steroid Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sex Hormone Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Steroid [EPC]</name>
  <code>C654256</code>  <id>654256</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Steroid</to_name>
    <to_code>T58784</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194034</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Steroids [M0020527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Androgen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progesterone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Progestin [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Estrogen [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing steroid (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bile Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Corticosteroid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Steroid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Steroid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sterol Metabolism Alteration [PE]</name>
  <code>C31802</code>  <id>31803</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Metabolism Alteration</to_name>
    <to_code>T49843</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010222</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sterol Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sterol Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Synthesis Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sterol Synthesis Alteration [PE]</name>
  <code>C31804</code>  <id>31805</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Synthesis Alteration</to_name>
    <to_code>T49859</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010223</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sterol Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sterol Synthesis Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sterol Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sterol Synthesis Inhibitors [MoA]</name>
  <code>C30280</code>  <id>30281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sterol Synthesis Inhibitors</to_name>
    <to_code>T49860</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009956</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sterol Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cholesterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sterol Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ergosterol Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulant Laxative [EPC]</name>
  <code>C635231</code>  <id>635231</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulant Laxative</to_name>
    <to_code>T49897</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175812</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Stimulant Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisacodyl [1596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Stimulant Laxative [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Stimulant Laxative [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Large Intestinal Motility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Stimulant Laxative [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deacetylbisacodyl [1872905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Laxative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulant Laxative [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Breast Glandular Development [PE]</name>
  <code>C30080</code>  <id>30081</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development</to_name>
    <to_code>T49898</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009857</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Glandular Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Breast Milk Ejection [PE]</name>
  <code>C30082</code>  <id>30083</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Milk Ejection</to_name>
    <to_code>T49899</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009858</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Breast Milk Secretion [PE]</name>
  <code>C30084</code>  <id>30085</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Breast Milk Secretion</to_name>
    <to_code>T49900</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009859</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Embryonic &amp; Fetal Development [PE]</name>
  <code>C30086</code>  <id>30087</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Embryonic &amp; Fetal Development</to_name>
    <to_code>T49901</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009860</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Embryonic &amp; Fetal Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Ovarian Follicular Phase [PE]</name>
  <code>C30088</code>  <id>30089</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase</to_name>
    <to_code>T49902</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009861</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutropin alfa [388084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urofollitropin [134404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Follicular Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Ovarian Luteal Phase [PE]</name>
  <code>C30090</code>  <id>30091</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Luteal Phase</to_name>
    <to_code>T49903</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009862</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovarian Luteal Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Ovulation [PE]</name>
  <code>C30092</code>  <id>30093</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation</to_name>
    <to_code>T49904</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009863</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Ovulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Penile Development [PE]</name>
  <code>C30094</code>  <id>30095</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development</to_name>
    <to_code>T49905</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009864</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone (micronized) [221168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stanozolol [10032]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Penile Development [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Uterine Menstrual Phase [PE]</name>
  <code>C30096</code>  <id>30097</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Menstrual Phase</to_name>
    <to_code>T49906</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009865</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Uterine Proliferative Phase [PE]</name>
  <code>C30098</code>  <id>30099</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Proliferative Phase</to_name>
    <to_code>T49907</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009866</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulate Uterine Secretory Phase [PE]</name>
  <code>C30100</code>  <id>30101</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Secretory Phase</to_name>
    <to_code>T49908</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009867</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Secretory Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Secretory Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Secretory Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Gastric Acid Secretion [PE]</name>
  <code>C30102</code>  <id>30103</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Acid Secretion</to_name>
    <to_code>T49909</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009868</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Acid Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Gastric Mucous Secretion [PE]</name>
  <code>C30104</code>  <id>30105</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Mucous Secretion</to_name>
    <to_code>T49910</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009869</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Gastric Mucous Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</name>
  <code>C30106</code>  <id>30107</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption</to_name>
    <to_code>T49911</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009870</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>attapulgite [18516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated attapulgite [133050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</name>
  <code>C30108</code>  <id>30109</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion</to_name>
    <to_code>T49912</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009871</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate calcium [82001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate [82003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lubiprostone [623033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deacetylbisacodyl [1872905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate sodium [71722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisacodyl [1596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>di-n-octyl sodium sulfosuccinate [1534779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate potassium [82002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Pancreatic Enzymatic Secretion [PE]</name>
  <code>C30110</code>  <id>30111</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Enzymatic Secretion</to_name>
    <to_code>T49913</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009872</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Enzymatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Enzymatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Enzymatic Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</name>
  <code>C30112</code>  <id>30113</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion</to_name>
    <to_code>T49914</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009873</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin acetate [408108]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin [9627]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Pancreatic Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</name>
  <code>C30114</code>  <id>30115</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption</to_name>
    <to_code>T49915</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009874</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated attapulgite [133050]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol, L- [1742749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>attapulgite [18516]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol [9945]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Absorption [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</name>
  <code>C30116</code>  <id>30117</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion</to_name>
    <to_code>T49916</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009875</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactitol [28395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulation Small Intestine Fluid/Electrolyte Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Stool Bulking Activity [MoA]</name>
  <code>C328</code>  <id>329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GI Bulking Activity</to_name>
    <to_code>T49942</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Contents Bulking Activity</to_name>
    <to_code>T49943</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity</to_name>
    <to_code>T49944</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000075</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malt soup extract [91264]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (100 CPS) [1310583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (4000 CPS) [1297402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stool Bulking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Streptogramin Antibacterial [EPC]</name>
  <code>C634883</code>  <id>634883</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Streptogramin Antibacterial</to_name>
    <to_code>T49962</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175502</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Streptogramin Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Streptogramin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Streptogramin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Streptogramin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptogramins [M0022748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Streptogramin Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Streptogramin Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Anabolism Alteration [PE]</name>
  <code>C30120</code>  <id>30121</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Anabolism Alteration</to_name>
    <to_code>T50016</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009877</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Anabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Anabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Catabolism Alteration [PE]</name>
  <code>C30122</code>  <id>30123</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Catabolism Alteration</to_name>
    <to_code>T50017</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009878</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Catabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Catabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Breakdown [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Contraction Alteration [PE]</name>
  <code>C30124</code>  <id>30125</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Contraction Alteration</to_name>
    <to_code>T50018</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009879</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Contraction Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Contraction Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Contraction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Metabolic Alteration [PE]</name>
  <code>C30118</code>  <id>30119</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration</to_name>
    <to_code>T50019</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009876</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Metabolic Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Anabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Metabolic Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Catabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Metabolic Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Striated Muscle Tone Alteration [PE]</name>
  <code>C635140</code>  <id>635140</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Striated Muscle Tone Alteration</to_name>
    <to_code>T50020</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175734</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Striated Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Striated Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Structural Macromolecules [MoA]</name>
  <code>C634</code>  <id>635</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules</to_name>
    <to_code>T50054</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000228</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 1 [214485]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran [42635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Structural Macromolecules [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Substance P Activity Alteration [PE]</name>
  <code>C30126</code>  <id>30127</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P Activity Alteration</to_name>
    <to_code>T50122</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009880</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Substance P Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Substance P Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Substance P Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</name>
  <code>C635205</code>  <id>635205</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P/Neurokinin-1 Receptor Antagonist</to_name>
    <to_code>T50127</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P/Neurokinin-1 (NK-1) Receptor Antagonist</to_name>
    <to_code>T50126</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175786</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>netupitant [1552337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aprepitant [358255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rolapitant [1665496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neurokinin 1 Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with neurokinin 1 receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing neurokinin 1 receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Substance P/Neurokinin-1 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sucrose-specific Enzyme [EPC]</name>
  <code>C635238</code>  <id>635238</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sucrose-specific Enzyme</to_name>
    <to_code>T50189</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175819</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sucrose-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-Fructofuranosidase [M0071827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sucrose-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sucrose-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sacrosidase [214817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sucrose-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sucrose-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfate Donors [MoA]</name>
  <code>C30334</code>  <id>30335</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfate Donors</to_name>
    <to_code>T50313</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009983</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide Antibacterial [EPC]</name>
  <code>C634884</code>  <id>634884</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antibacterial</to_name>
    <to_code>T50363</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175503</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with sulfonamide structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfacetamide [10169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silver sulfadiazine [9793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfonamides [M0020790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfadiazine [10171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sulfonamide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide Antimicrobial [EPC]</name>
  <code>C634885</code>  <id>634885</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antimicrobial</to_name>
    <to_code>T50364</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175504</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfamethoxazole [10180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfonamides [M0020790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with sulfonamide structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulfisoxazole [10207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sulfonamide (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfonamide [EPC]</name>
  <code>C635318</code>  <id>635318</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide</to_name>
    <to_code>T50366</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonamide-class Agent</to_name>
    <to_code>T50365</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175880</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfonamides [M0020790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Sulfonamide (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonamide [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing sulfonamide (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfone [EPC]</name>
  <code>C635319</code>  <id>635319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfone-class Agent</to_name>
    <to_code>T50368</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfone</to_name>
    <to_code>T50369</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175881</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfones [M0020791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapsone [3108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Sulfone (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sulfur and/or sulfur compound (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfone [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfonylurea [EPC]</name>
  <code>C635001</code>  <id>635001</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonylurea-class Agent</to_name>
    <to_code>T50375</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfonylurea</to_name>
    <to_code>T50376</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175608</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing sulfonylurea (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolazamide [10633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glipizide [4821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glimepiride [25789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>glyburide [4815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Sulfonylurea (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sulfonylurea [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfonylurea Compounds [M0020795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sulfotransferases [PK]</name>
  <code>C250</code>  <id>251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sulfotransferases</to_name>
    <to_code>T50378</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000036</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sunscreening Activity [PE]</name>
  <code>C30128</code>  <id>30129</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity</to_name>
    <to_code>T50410</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009881</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc oxide [11423]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homosalate [91326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octisalate [91327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybenzone [32673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octinoxate [13369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avobenzone [45045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>padimate-O [32786]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxate [288262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminobenzoic acid [74]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sunscreening Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Surfactant Activity [MoA]</name>
  <code>C336</code>  <id>337</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity</to_name>
    <to_code>T50473</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000079</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxychlorosene sodium [221136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol 2-(2-methylbutyrate) [1947503]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dodecyl sulfate [9871]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonoxynol-9 [53750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 stearate [1314849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxychlorosene [32680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril [107784]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol [34693]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-phenylpropanal propylene glycol acetal [1947505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 sorbitan diisostearate [1363615]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>di-n-octyl sodium sulfosuccinate [1534779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calfactant [232539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-4 dilaurate [1363613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-8 dioleate [1363621]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine polypeptide oleate condensate [38624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol propyl ether [1947500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octoxynol-9 [54034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-6 lauramide [1363617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium laureth sulfate [1310569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate calcium [82001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SIMETHICONE-CELLULOSE [283585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poractant alfa [236381]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate [82003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol, (S)- [1663407]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol monostearate [1314411]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine stearate [38625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril palmitate [69782]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simethicone [9796]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate potassium [82002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-120 methyl glucose dioleate [1309363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol diacetate [1427008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate sodium [71722]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-100 stearate [1367120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 410 [1299921]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beractant [46967]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peg-75 lanolin [1363619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Surfactant [EPC]</name>
  <code>C635197</code>  <id>635197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant</to_name>
    <to_code>T50474</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175778</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calfactant [232539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>beractant [46967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>poractant alfa [236381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Alveolar Surface Tension Reduction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Surfactant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Surfactant Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Surfactant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing surfactant (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</name>
  <code>C653576</code>  <id>653576</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2-directed RNA Interaction</to_name>
    <to_code>T50487</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival Motor Neuron-2-directed RNA Interaction</to_name>
    <to_code>T50488</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SMN2-directed RNA Interaction</to_name>
    <to_code>T50490</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival Motor Neuron 2-directed RNA Interaction</to_name>
    <to_code>T50489</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193222</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nusinersen [1863556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Survival Motor Neuron-2-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</name>
  <code>C654278</code>  <id>654278</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SMN2 Splicing Modifier</to_name>
    <to_code>T58847</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2 Splicing Modifier</to_name>
    <to_code>T58846</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival Motor Neuron 2 Splicing Modifier</to_name>
    <to_code>T58848</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194059</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>risdiplam [2390935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Survival of Motor Neuron 2 Splicing Modifier [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</name>
  <code>C654277</code>  <id>654277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival Motor Neuron 2 Splicing Modifiers</to_name>
    <to_code>T58845</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SMN2 Splicing Modifiers</to_name>
    <to_code>T58844</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2 Splicing Modifiers</to_name>
    <to_code>T58843</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194060</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Survival of Motor Neuron 2 Splicing Modifiers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sweat Excretion [PK]</name>
  <code>C278</code>  <id>279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sweat Excretion</to_name>
    <to_code>T50509</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000050</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sympathetic Activity Alteration [PE]</name>
  <code>C635040</code>  <id>635040</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathetic Activity Alteration</to_name>
    <to_code>T50532</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175647</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathetic Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathetic Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic Agent [APC]</name>
  <code>C654130</code>  <id>654130</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Agent</to_name>
    <to_code>T58532</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193910</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphetamine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic-like Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Catecholamine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Releasing Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic Amine Anorectic [EPC]</name>
  <code>C634805</code>  <id>634805</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Amine Anorectic</to_name>
    <to_code>T50533</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175423</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentermine [8152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>diethylpropion [3389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Appetite Suppression [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>benzphetamine [1422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic Amine Anorectic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phendimetrazine [33272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Central nervous system agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sympathomimetic (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Sympathomimetic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic Amine Anorectic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Sympathomimetic-like Agent [EPC]</name>
  <code>C635188</code>  <id>635188</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic-like Agent</to_name>
    <to_code>T50534</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175769</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic-like Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Sympathetic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Sympathomimetic-like Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>modafinil [30125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Sympathomimetic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic-like Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing sympathomimetic (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sympathomimetic-like Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Symporter Interactions [MoA]</name>
  <code>C648276</code>  <id>648276</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Symporter Interactions</to_name>
    <to_code>T50535</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000188375</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Potassium Chloride Symporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Serotonin Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Bile Acid Cotransporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Norepinephrine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium-Glucose Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Symporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dopamine Transporter Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Synaptic Fusion Complex Interactions [MoA]</name>
  <code>C30274</code>  <id>30275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Synaptic Fusion Complex Interactions</to_name>
    <to_code>T50544</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009953</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Synaptic Fusion Complex Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Acetylcholine Release Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Systemic Arterial Vasoconstriction [PE]</name>
  <code>C30250</code>  <id>30251</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasoconstriction</to_name>
    <to_code>T50628</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009941</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Systemic Arterial Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arteriolar Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Systemic Arterial Vasodilation [PE]</name>
  <code>C30248</code>  <id>30249</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation</to_name>
    <to_code>T50629</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009940</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Systemic Arterial Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arteriolar Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloprost [40138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Systemic Arteriolar Vasoconstriction [PE]</name>
  <code>C634793</code>  <id>634793</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arteriolar Vasoconstriction</to_name>
    <to_code>T50630</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175410</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Systemic Arteriolar Vasodilation [PE]</name>
  <code>C634777</code>  <id>634777</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Arteriolar Vasodilation</to_name>
    <to_code>T50631</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175394</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Systemic Venous Vasoconstriction [PE]</name>
  <code>C30130</code>  <id>30131</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasoconstriction</to_name>
    <to_code>T50636</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009882</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Systemic Venous Vasodilation [PE]</name>
  <code>C30132</code>  <id>30133</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation</to_name>
    <to_code>T50637</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009883</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>T Lymphocyte Activity Modulation [PE]</name>
  <code>C641729</code>  <id>641729</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Activity Modulation</to_name>
    <to_code>T50643</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182153</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T Lymphocyte Activity Modulation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Modulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>T Lymphocyte Costimulation Activity Blockade [PE]</name>
  <code>C642424</code>  <id>642424</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Blockade</to_name>
    <to_code>T50644</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182829</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belatacept [1112973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>T Lymphocyte Costimulation Activity Modulation [PE]</name>
  <code>C641730</code>  <id>641730</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Modulation</to_name>
    <to_code>T50645</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000182154</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T Lymphocyte Costimulation Activity Modulation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Blockade [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocyte Costimulation Activity Modulation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</name>
  <code>C653919</code>  <id>653919</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified</to_name>
    <to_code>T50648</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Autologous Cultured T Lymphocytes</to_name>
    <to_code>T50647</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Genetically-modified Cultured T Lymphocytes, Autologous</to_name>
    <to_code>T50646</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193548</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axicabtagene ciloleucel [1987398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisagenlecleucel [1986438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>T [Preparations]</name>
  <code>C288646</code>  <id>288646</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>T [Preparations]</to_name>
    <to_code>T50649</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010602</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m arcitumomab [230435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrodemethoxydiferuloylmethane [1376154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylpentanediyl dibenzoate [1437987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenonitrozole [236186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,3,5,6-tetrafluorophenol [2625644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trillium erectum extract [1310282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichinella spiralis [1426916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tralokinumab-ldrm [2589374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangerine extract [1426364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tert-butyl methacrylate [1489765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terconazole [37806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine isostearate [1789185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toceranib [1145945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tribasic potassium phosphate [236502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrachloroaurate [1370660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine laurylaminopropionate [1996998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toripalimab [2669406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylamine [1999994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymalfasin [38221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trillium chloropetalum whole extract [2534465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tildipirosin [1306059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tramiprosate [1374845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamine ion [1546268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimyristin [1368882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thorium [1534769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turnip allergenic extract [883414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrofurfuryl oleate [1600778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane trioleate [2393534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taiwanofungus camphoratus whole extract [2360031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tagraxofusp [2109055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamine pyrophosphate [10459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin alfa [1367075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>timolol maleate [42933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tofacitinib citrate [1358492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thulium [1311496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triazulenone [38555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taurursodiol [2613950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane [1368881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiaprofenate [618442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracycline [10395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiabendazole [10450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>troglitazone [72610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiopental sodium [282416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teriflunomide [1310520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triprolidine [10849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taenia solium preparation [1348455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telmesteine [85929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tuftsin [1534774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetramethylthiuram monosulfide [1363713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiamulin [1546410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiludronate [57230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylpentanediol-adipic acid-glycerin crosspolymer (25000 MPA.S) [1426831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taraxacum officinale leaf extract [1309287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treprostinil [343048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc-99m red blood cells [1729152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,7,11,15-tetramethyl-1,2,3-hexadecanetriol [1368211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyroglobulin [10565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temafloxacin [37771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrasodium edetate dihydrate [2596173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tubocurarine [10917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taliglucerase alfa [1291609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticarcillin [10591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine laurate [1552047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thujopsis dolabrata leafy twig extract [1312372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2,5-trimethylhexane [2557376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temoporfin [115243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thermomyces lanuginosus allergenic extract [1426629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone acetonide 21-dipotassium phosphate [2389302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Theobroma grandiflorum seed extract [1309260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-tetracosanol [1314259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiafentanil oxalate [2691824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tagetes erecta flower extract [1309474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Turnera diffusa leafy twig extract [1310032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichosanthes kirilowii fruit rind [2106816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tropaeolum majus extract [1425927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyrotropin alfa [4952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiram [10517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangerine peel extract [1305532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron vernix leafy twig extract [1309761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triptorelin pamoate [338529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Terminalia bellirica fruit extract [1368378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triphosphate [1487534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terfenadine [42330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja occidentalis root extract [1309991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium diphosphate [2046778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-tert-butylcyclohexyl acetate [2383539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tacrine hydrochloride [235972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tobacco leaf allergenic extract [852062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tricholoma magnivelare whole extract [2173921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir disoproxil succinate [1928942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Teucrium marum top extract [1368325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine caproyl glutamate [2367430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tannic acid [10328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tourmaline [853142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trandolapril [38454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(2,3,8,8-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone [2396430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toldimfos [2001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolciclate [38372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton rubrum allergenic extract [968413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>titanium dihydride [2585535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tositumomab [263010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichlorotrifluoroethane [38585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triclabendazole [2118525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tigilanol tiglate [2478456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate [2180255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia cordata flower extract [1307716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tribasic sodium phosphate [36710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thysanotus tuberosus flower extract [1807129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triflupromazine hydrochloride [91125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricaprin [1314419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tsuga canadensis bark extract [1310036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telavancin [473837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-tert-butylcyclohexanol [1373206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trigonella foenum-graecum whole extract [1593200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopherol,DL-alpha [402899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiostrepton [1365970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tofisopam [38365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane [1810870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taurine [10337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluoroacetyl tripeptide-2 [2645122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetradecyloctadecyl stearate [1858283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricaine methanesulfonate [1492443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4,5-T dimethylammonium [2370886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium HEDTA [1364567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimeprazine tartrate [164308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine lactate [1312086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trihexyphenidyl [10811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoprim sulfate [221176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetroxoprim [37999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tributyl phosphite [2399030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiethylperazine maleate [71529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxoplasma gondii [1432991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium citrate [253204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiletamine hydrochloride [1535216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc-99m sulfur colloid [1423270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioglycolate [1370627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toremifene citrate [49953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafamidis [1545063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin, human [825006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton antigen [465118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocol acetate [2043280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetradecane [2167852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia tomentosa bud extract [1875950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tetrapanax papyrifer stem extract [2199294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3,3,3-tetrafluoropropene, (1E)- [1494198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tobramycin sulfate [7276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tremelimumab [2619313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrasilane [1359283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teicoplanin [57021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangerine juice [1747710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyrothricin [10968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, trans-(+/-)- [2570563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temafloxacin hydrochloride [295217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temsavir [2675620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja occidentalis leafy twig extract [1309754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trofinetide [2632852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trolamine stearate [1314215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thermus thermophilus extract [1356714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimetrexate [42333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticlopidine hydrochloride [97]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracycline trihydrate [236873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane triisostearate [1539637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triacetoneamine-N-oxyl [10757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taraxacum officinale flower extract [1649016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terbutaline [10368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Torreya nucifera seed oil [1874077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tanacetum annuum flowering top oil [2359269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense whole extract [1999194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tabebuia heterophylla bark extract [1309796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triceteth-4 phosphate [2390629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talc [10323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1,2,2-tetrafluoroethane [1487139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridihexethyl chloride [54421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tapentadol [787390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-12 [1313267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia americana flower extract [1492184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiotropium bromide mono [1552007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrafluoromethane [1368889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trypan blue free acid [1726081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine dioleate [1813434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir alafenamide [1721603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talbutal [89810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiropramide hydrochloride [236681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thymus vulgaris whole extract [1376349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium phosphide [2635085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tabebuia impetiginosa bark extract [1310167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyramine hydrochloride [236897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethylhexanoin [1368189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisotumab vedotin-tftv [2571093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trioxsalen [10844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trachelospermum jasminoides stem extract [2690788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiafentanil [2691823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tegafur [4582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethaphan [10828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrasodium iminodisuccinate [1366937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tartaric acid, DL [1803725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,5,5-trimethylhexanal [2367408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treprostinil diolamine [1927409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temazepam [10355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trehalose isostearate esters [1541743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris(tetramethylhydroxypiperidinol) [1368376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tislelizumab [2677426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymopentin [40230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terpene resin [2640032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiazolylalanine [2046121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-tert-butylcyclohexyl acetate, cis- [2604560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tribulus terrestris flower extract [2636532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-pkrb [2107051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tallow acid, beef [1311640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethadione [10827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>topotecan [57308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioridazine hydrochloride [203165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethyl pentaphenyl trisiloxane [1539814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trihydroxystearin [1310538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamphenicol glycinate [163416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine cocoyl glutaminate [2383342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tasonermin [283746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrolinalyl acetate [2383940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tristearin [1368872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethyl-1,3-pentanediol [1607329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripeptide-29 [2642868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichlorfon [1000581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3-(triethoxysilyl)propylamine [1425088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticarcillin disodium [142447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tasmannia lanceolata leaf extract [2596860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trihexyphenidyl hydrochloride [1115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tussilago farfara whole extract [1652099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tramadol [10689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turnip greens extract [1799153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine sulfate [1655913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopherol acetate [39625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticagrelor [1116632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium sulfosuccinate [1867700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymocyte immunoglobulin [1427178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tylosema esculentum whole extract [2388334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricarbaurinium [236407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetanus toxoid vaccine, inactivated [798306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripalmitin [1368169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triacetyldithranol [38536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tortoise shell bamboo stem oil [2257603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tesamorelin [1044584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tea leaf allergenic extract [2588807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine polypeptide oleate condensate [38624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trenbolone [1484278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terizidone [57047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>troleandomycin [10864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tofacitinib [1357536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraarsenic tetrasulfide [1426938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tadalafil [358263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tremelimumab-actl [2619312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisopropanolamine [1426368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolazoline [10634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioglycolic acid triethanolamine [2360233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tribulus terrestris extract [1370988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymol [10553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichloroacetaldehyde [38574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tinospora cordifolia whole extract [2048119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tert-butyl alcohol [1363061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terodiline [37815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>troxerutin [38893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thallous chloride Tl201 [91588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trihydroxypalmitamidohydroxypropyl myristyl ether [1314292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium [2571856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trazodone hydrochloride [82112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terbinafine hydrochloride [235838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trypsin [10890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trientine tetrahydrochloride [2611541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane triacrylate [1426813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tuberculin, bovine [1648418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolu balsam [1116238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticlopidine [10594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triflupromazine [10805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone [2359257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichosanthes cucumerina seed extract [1310068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja occidentalis bark extract [1307585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tapinarof [2602286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turkey feather extract [1594963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>TEA-dodecylbenzenesulfonate [1313771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymocyte immunoglobulin, equine [1427177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-9 [1312368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talazoparib tosylate [2099703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraethyl silicate [2594593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc-99m pyrophosphate [1488368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tipiracil hydrochloride [1670303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylenediaminetetraacetic acid [1789184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thallium sulfate [1309339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolrestat [38386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triptorelin [38782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl stearate [1368187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tributyl citrate [1314417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrakis(1-isocyano-2-methoxy-2-methyl-propane)-copper(i) tetrafluoroborate [1306061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tranexamic acid [10691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triacontanyl PVP (WP-660) [1366228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turkey allergenic extract [975119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyroid, porcine [235479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tall oil [1364132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenecteplase [259280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tylophora indica root extract [1309825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tedizolid phosphate [1540824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropisetron hydrochloride [235997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tert-butylbenzoic acid (mixed isomers) [2671582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocilizumab [612865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4,5-T-isopropyl [2383538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricaprylin [1314420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenapanor [2199674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracycline phosphate complex [2105975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab [224905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tamarix gallica whole extract [2055742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia cordata, whole extract [1432477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theodrenaline [31958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tedizolid [1540825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tabebuia impetiginosa whole extract [1356705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja occidentalis preparation [317687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine monododecyl ether [2276304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolazamide [10633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiopental [10493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethoxysilylpropyl steardimonium chloride [2263159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thymus serpyllum extract [1328313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tulathromycin [1309314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toldimfos sodium [2001183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thujopsis dolabrata whole extract [1312371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris(PPG-3 benzyl ether) citrate [1649135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethylene glycol [1368702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisulfapyrimidine [38802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine cacodylate [2359271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone enanthate [37859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>timolol anhydrous [1546004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluoperazine hydrochloride [91130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-6 [1426365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone acetonide [10761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine myristate [2599619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trout allergenic extract [882482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton tonsurans allergenic extract [1098619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyropanoate [10960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treponema pallidum immunoserum rabbit [1367200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiotaurine [1368888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsiloxysilicate (M-Q 0.6-0.8) [1426677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tucatinib [2361285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terpinyl acetate [1312739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiagabine hydrochloride [236875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tussilago farfara extract [1312369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium 99m [90650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiocolchicoside [38085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyroid (beef) [325521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tromethamine hydrochloride [1311534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Teucrium scorodonia flowering top extract [1310057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tizanidine [57258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisopropylamine [2373440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamsulosin [77492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tertatolol hydrochloride [236374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymomodulin [38217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiludronic acid [11476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terpineol [1368180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraselmis chui extract [2636731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taurursodiol dihydrate [2665620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamine mononitrate [10456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tinospora cordifolia stem extract [1806913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrazepam [37985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trehalose [1311373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tavaborole [1543173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiosulfate [1546411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamterene [10763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tremella fuciformis fruiting body extract [1358890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,2,4-trihydroxybenzene [2107302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichoderma harzianum allergenic extract [968197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>TICK-BORN ENCEPHALITIS VACC [236736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tromantadine hydrochloride [236459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4,5-T triethylammonium [2608946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tomato allergenic extract [892499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron succedaneum whole extract [1491738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethaphan camsylate [38680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapeptide-6 [1592892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tranylcypromine sulfate [91119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyrosine [10962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine hydriodide [1942478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tremella fuciformis whole extract [1539416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiludronate disodium [83153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>titanium [1305547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taxifolin [2700758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,3,5-triethylbenzene [2475073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrabenazine [10390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taiwanofungus camphoratus mycelium extract [2593693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-zzxf [2382599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tertatolol [37840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropatepine hydrochloride [236190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium dicarboxymethyl alaninate, L- [1598336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toltrazuril [1535930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tarlatamab-dlle [2682955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilinolenin [1655560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioredoxin [1314275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocotrienol, alpha [1424648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temozolomide [37776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapeptide-15 [1986806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl neopentanoate [1368164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tapentadol hydrochloride [857492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teprotumumab [2274803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymol iodide [89717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tabebuia impetiginosa leaf extract [1536454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tuna preparation [1651872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsiloxysilicate (M-Q 1.0-1.2) [1370733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazobactam [37617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirilazad [72467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tick-borne encephalitis purified antigen [2583637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia extract [236361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teriparatide acetate [114260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tomato seed oil [1431285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tacrolimus monohydrate [484288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trametinib dimethyl sulfoxide [1425098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl alcohol [1371366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiotropium bromide monohydrate [1298831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridihexethyl [38617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tezacaftor [1999382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tacrolimus [42316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triepoxycyclohexasilane [1941993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tivozanib [2534233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone propionate [10382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamphenicol [10463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopheryl retinoate [1313259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triprolidine hydrochloride [71534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tin monoarsenide [1989396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thonzylamine [1360721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triolein, 1-C-14 [2629643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Timothy grass pollen extract [851994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trametes versicolor strain CM-101 extract [2569483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tabanus nigrovittatus extract [2590185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>totarol [1600439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone [10379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tripterygium wilfordii whole extract [1440289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiemonium [236188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyroid, ovine [1442996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone decanoate [37858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir disoproxil [300195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine lauryl sulfate [1363986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telmisartan [73494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thallium [1311633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tall oil acid [1492942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tanacetum vulgare flower extract [2003582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia cordata wood extract [1312724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trachyspermum ammi flower extract [2601108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thenyldiamine [38025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapeptide-3 [2045118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron vernicifluum fruit rind wax [1314847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telotristat ethyl [1872441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethylene amine [2383536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton mentagrophytes allergenic extract [867357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trepibutone [44532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafluprost [1244607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theophylline anhydrous [91178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoxybenzene [325518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tylosin [995505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Terminalia chebula fruit extract [1311683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazobactam sodium [221167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tilidine [10597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilaciclib dihydrochloride [2479691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terodiline hydrochloride [235839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiropramide [38315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafasitamab-cxix [2387334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m pertechnetate [1489762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrocurcumin .beta.-o-glucuronide [2670454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trovafloxacin [115552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymus gland-calf [236876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiosalicylic acid [322165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioglycerol [1363062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>3,5,5-trimethylhexyl acetate [2395767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>transforming growth factor beta 2 [1370419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testolactone [10378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triacetin [10756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tylosin phosphate [1363719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Triticum polonicum seed extract [1541724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(4-(trifluoromethoxy)phenyl)urea [2169961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine benzoate [1363997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimetazidine [10826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turnip-rooted chervil oil [1988422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tromantadine [38868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tragacanth [1368197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolbutamide sodium [221173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone hexacetonide [38546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Torilis japonica whole extract [1600750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl trimellitate [1426289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tibolone [38260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tesamorelin acetate [1044583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tetanus Antitoxin [10385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trioctyldodecyl citrate [1356150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tea leaf extract [968498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Typhonium giganteum stem extract [2673303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamarind juice [2043325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichloroethylene [2534464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamine disulfide [38041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocilizumab-bavi [2680283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetanus toxin [1735049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium uridine 5&apos;-triphosphate dihydrate [2642211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Theobroma grandiflorum seed butter extract [1307605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraethylammonium hydroxide hexahydrate [2173092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m exametazime [1431726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triflusal [38655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thonzonium bromide [221171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja occidentalis whole extract [1358891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tagraxofusp-erzs [2109054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tea tree oil [69627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m tilmanocept [1373391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium HEDTA monohydrate [2462144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tilidine hydrochloride [82109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tegaserod [139778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tepotinib [2477103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triptorelin acetate [236538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymus extracts [10562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turmeric root extract [2695722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tylvalosin [1368469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetradecene [1314225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thymus citriodorus leaf extract [1370676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trazodone [10737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tecovirimat monohydrate [2055677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton mentagrophytes antigen [465062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethobenzamide hydrochloride [57227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tree of heaven pollen extract [851890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamylal sodium [203201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiaprofenic acid [38253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m medronate [1488818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioproperazine [10498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toremifene [38409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tomato juice [1307149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>titanium dioxide [38323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiletamine [1535217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tarlatamab [2682954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thonzylamine hydrochloride [1360720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tubocurarine chloride [82115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tantalum [1311490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taxillus chinensis top extract [2107063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimetazidine dihydrochloride [235779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>threonic acid, DL- [1547557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymoxamine hydrochloride [235778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-qyyp [2280730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tretinoin microsphere [221175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tegaserod maleate [339270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-oysk [2375543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium repens flower extract [1309929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Theobroma cacao whole extract [1429955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane triethylhexanoate [1314295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropicamide [10869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimeprazine [10825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telithromycin [274786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-tert-butylhydroquinone [1362739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsilyl treated diimethiconol-trimethylsiloxysilicate crosspolymer (40-60 WW) [1537759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioguanine [10485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiobutabarbital [38077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiopropazate [38133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane tricaprylate-tricaprate [1313271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyme preparation [319823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiapride [10588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thujopsis dolabrata wood oil [2174383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tebentafusp [2590743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telotristat [1872382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tribulus terrestris fruit extract [1311579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymine [1368871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin, bovine [2264114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triazolam [10767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir [117466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir anhydrous [1546017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopherol [1236136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telotristat etiprate [1872448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theofibrate [236713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiotropium [69120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapeptide-21 [1314296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triphosphoric acid, sodium salt [1364528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamoxifen citrate [40137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamarack pollen extract [900131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>topiramate [38404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetradecamethylhexasiloxane [1428858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiagabine [31914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tylophora indica leaf extract [1482793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trenbolone acetate [1484277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tabtoxin [2590695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecane [1811766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tulobuterol hydrochloride [235841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tacalcitol [291204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense pollen extract [1340182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiodipropionic acid [2046122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoprim lactate [235855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thymus vulgaris leaf extract [1307658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone [10759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>THALLIUM CATION TL-201 (1+) [1546430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine [38623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisiloxane [1368190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-5 [1371912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricalcium phosphate [47628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrolinalool [2373947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tixocortol pivalate [38336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiemonium methylsulfate [38265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tipranavir [190548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethoxysilane [2634293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tezepelumab-ekko [2587790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tezepelumab [2587789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocainide [42359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetanus immune globulin, human [91603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripolyphosphate ion [1546409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisilane [2176729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolvaptan [358257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thaumatococcus daniellii fruit extract [1424462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tramadol hydrochloride [82110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymostimulin [38233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyrotropin-releasing hormone [10580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teclistamab-cqyv [2619425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talinolol [37546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiothixene [10510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiethylperazine [10471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thurfyl salicylate [237144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Townsendia exscapa whole extract [2590696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thaumatin [1666108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine oleate [1788982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir disoproxil fumarate [322248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense pollen extract [2102052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl ethyleneglycol monoether [2548930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricaine [1370418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirzepatide [2601723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tislelizumab-jsgr [2677425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine phosphate [2287550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoprim hydrochloride [259281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiliroside [1423792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tagetes minuta flower oil [1366331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tinospora capillipes root extract [1546866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triclocarban [38609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenoxicam [37790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron radicans leaf extract [1309758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimebutine [10819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine tristearate [2391150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolfenamic acid [38377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>threonic acid, L- [1549112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisocetyl citrate [1601596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m sestamibi [1482913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron diversilobum whole extract [2533914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolterodine [119565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolbutamide [10635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyme allergenic extract [974527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylphloroglucinol [38716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>timolol [10600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thimerosal [10472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tramazoline [38453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethyl citrate [1310554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethylamine [1307097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tert-butyl methylphenoxy phenol [2397690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talactoferrin alfa [1425932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioctate [618060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tadenan [37534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>timolol hemihydrate [221172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoxycaprylylsilane [1314293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trapidil [10735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talampicillin napsylate [235836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripalmitolein [2667254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsiloxysilicate (M-Q 0.66) [1426948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taurolidine [2670453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilaciclib [2479690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tilmicosin phosphate [1294593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichlormethiazide [10772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tivozanib hydrochloride [2534245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-dttb [2289225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tilmicosin [38278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tilbroquinol [166718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine 2-cyclohexyl-4,6-dinitrophenolate [1552576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telaprevir [1102261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichinella britovi [1368365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>troclosene [1537576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiosalicylate [91099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiamulin fumarate [1314589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trelstar pamoate [905060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricaprylyl citrate [1314421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirofiban [73137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tribulus terrestris root extract [1306058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telisotuzumab vedotin-tllv [2714236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsilane [1314250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichloroacetate [618564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisotumab [2571095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toripalimab-tpzi [2669407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine cocoyl glutamate [1653328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thymus oil [1309479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrozoline hydrochloride [57983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethoxysilylpropyl steardimonium [2471303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Triticum aestivum extract [1311122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopheryl acid succinate,D-alpha [314875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium repens pollen extract [1363563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treosulfan [38508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tioclomarol [163426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichoderma harzianam extract [968184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taletrectinib adipate [2716920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trofosfamide [38865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron diversilobum leaf extract [1310042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tussilago petasites [350530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theophylline [10438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Typhonium giganteum whole extract [1999320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tizanidine hydrochloride [236460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teplizumab-mzwv [2621881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tradescantia occidentalis whole extract [2533915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichlorofluoromethane [38578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teniposide [10362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turmeric oil [1373037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia x europaea flower extract [1309823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tussilago farfara flower bud extract [2540131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triiodide ion [1546364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triceteareth-4-phosphate [1811770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine acetate [2360432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tropaeolum majus flowering top extract [1664625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsilyl treated diimethiconol-trimethylsiloxysilicate crosspolymer (45-55 WW) [2174101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethoxysilylethyl polydimethylsiloxyethyl hexyl dimethicone [2566288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraselmis suecica extract [2262006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tribehenin PEG-20 esters [1312647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tipiracil [1670304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymopentin acetate [236769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tanacetum coccineum flower extract [2283225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theophylline sodium glycinate [155075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tinidazole [10612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tecovirimat [2055104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropisetron [27392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrobisdemethoxydiferuloylmethane [1376153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>torsemide [38413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tributyl phosphate [1314418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Torreya nucifera whole extract [1312732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tea tree extract [436163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tripleurospermum inodorum whole extract [1866509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahexyldecyl ascorbate [1309254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimipramine maleate [71532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisodecyl trimellitate [1732390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tinzaparin [69646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine stearate [38625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thallous cation Tl-201 [1546370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talimogene laherparepvec [1721264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>6-tert-butyl-3-methyl-2,4-dinitroanisole [2360131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron pubescens shoot extract [1370734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tuna allergenic extract [892503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone undecanoate [37864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethylene glycoldimethacrylate [2472322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioctic acid [6417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-3 [1943166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiphenamil [38150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-dkst [2103478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4,6,8-tetramethyltetraphenylcyclotetrasiloxane, (2.alpha.,4.alpha.,6.beta.,8.beta.)- [2550704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-8 [1801136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tinospora sinensis stem extract [2593687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tbo-filgrastim [1433764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripelennamine hydrochloride [91063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiopronin [6765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocainide monohydrochloride [142145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrofosmin [1311569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocotrienols [578285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazemetostat hydrobromide [2274379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theobromine [10437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolperisone [10639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tanacetum parthenium flower extract [1309476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichosanthes kirilowii seed extract [2592983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trolamine salicylate [38866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolmetin [10636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-tert-butylcyclohexyl acetate [2289005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyrosine disodium dihydrate [2642193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thrombin [10528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talinexomer [2670341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiotepa [10473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tranylcypromine [10734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylamine hydrochloride [1999993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tussilago farfara flower extract [1309480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tovorafenib [2682434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricetin [1994358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamine hydrochloride [235355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopheryl nicotinate, D-.alpha. [1359091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylolpropane tricaprate [1314294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tixagevimab [2587300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turmeric extract [1114883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolterodine tartrate [221174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tripterygium wilfordii root extract [1360625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolonium chloride [10638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiadilon [38249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taraxacum officinale whole extract [1311305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichomonas vaginalis preparation [1441656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triamcinolone diacetate [10762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tormentil [237060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-tert-butylcyclohexanyl acetate, trans- [2374918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tigolaner [2698199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia tomentosa whole extract [2171267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisopurine [38136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tulathromycin A [1437806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiocyanate [1427067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turoctocog alfa [1737557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taletrectinib [2716919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>three-lobe sage extract [1534776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium arvense whole extract [2536136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>turpentine [10938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tebentafusp-tebn [2590744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine tris(dihydrogen phosphate) [1811017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilaureth-4 phosphate [1370423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trapa bicornis seed extract [1872048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocophersolan [159151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangerine allergenic extract [1011412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tasimelteon [1490468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triarachidin [1655558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temocillin [37775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terazosin [37798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thuringiensin [1648507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracycline hydrochloride [142446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Terminalia chebula whole extract [2048120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsilyl trihydrogen silicate [2606512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telisotuzumab vedotin [2721996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terbutaline sulfate [10369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Telopea speciosissima flower extract [1807128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tabasco pepper extract [1721694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafasitamab [2387211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trospium chloride [38891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimipramine [10834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tartrate [1314221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripelennamine [10847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris(PPG-3 benzyl ether) [1649136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimipramine mesylate [236189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylsiloxysilicate (M-Q 0.8-1.0) [1426676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimetrexate glucuronate [38725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tellurium tetrachloride [1863222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirilazad mesylate hydrate [59827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium dicarboxymethyl alaninate [1598337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Terminalia arjuna whole extract [2592072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tea leaf oil [1309477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tricyclodecenyl propionate [1659916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripe preparation [1350210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>typha orientalis whole extract [2637685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisotumab vedotin [2571094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tungsten [1667702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetramethylchromanol glucose [2671243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trovafloxacin mesylate [221177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tianeptine [38252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Teucrium scorodonia whole extract [1549111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tacrine [10318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine lauroyl glutamate [2690988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris(N-hydroxyethyl)hexahydrotriazine [2560229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tropaeolum majus flower extract [1369396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tissue respiratory factor [325522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydropiperine [1661433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tellurium [1311384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tobramycin [10627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamoxifen [10324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tragacanth allergenic extract [1232630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trometamol citrate [2166044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine glutamate [1743375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tinzaparin sodium,porcine [235995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ticovirimat monohydrate [2055103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Teucrium marum extract [1341385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazemetostat [2274378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrachloroaurate ion [1546431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoxybenzylidene pentanedione [1925205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tagetes erecta whole extract [1539415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium ethylenediamine disuccinate [1364530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilaurin [1368880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichoderma viride allergenic extract [968401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triphosphoric acid [1364529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>titanium carbide [1989495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Turnera diffusa leaf extract [1591919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrozoline [37935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafamidis meglumine [1727003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tanacetum vulgare whole extract [1797519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>travoprost [283809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamsulosin hydrochloride [236495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terpin hydrate [89916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris-BHT mesitylene [1428857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theanine [38022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terlipressin [57048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropatepine [38876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theobromine sod salicylate [236926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron pubescens whole extract [1999726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamanu oil [1373444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tribenoside [38557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>threonine, DL- [1987478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tepotinib hydrochloride [2477104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talampicillin [10322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tartaric acid [37578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapetide-4 [1998745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trametes versicolor fruiting body extract [1370985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolnaftate [10637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyroid (USP) [10572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilinolein [1655559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium nitrilotriacetate [1735050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioguanine anhydrous [1546005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teriparatide [32915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thonzonium [237058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terpinolene [2380832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenofovir alafenamide fumarate [1721604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taenia saginata preparation [1426377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tribulus [1423345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teferrol [37744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluridine [10803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracaine hydrochloride [91189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-Trimethylammonioethyl methacrylate [2539175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-6 phosphate [1995551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trabectedin [1716278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tixocortol [57257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,2,2-trifluoroacetophenone [1371443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m bicisate [114918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyramine [10958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirbanibulin [2471078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanaolamine phenylbenzimidazole sulfonate [2000917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thallous acetate [2048725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifarotene [2205637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teduglutide [1364468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trideceth-10 [1314305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trypan blue [10878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluperidol hydrochloride [236140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone (micronized) [221168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toluene [1311381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracaine [10391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tansy oil [1488822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tetragonia tetragonoides whole extract [2567332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toloxatone [38382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thenoate lithium [236587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tsuga canadensis leaf oil [2533916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tyloxapol [38998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tulobuterol [38967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tilia platyphyllos flower extract [1539192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trichloroacetic acid [10773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talquetamab [2644447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terbium [1367186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trillium erectum root extract [1310103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapeptide-2 [2399545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafenoquine [2054023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tylophora indica whole extract [1361463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxoplasma gondii DNA [2530891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tribehenin [1426386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telbivudine [474128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethenylmethylsilane [2474633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tybamate [62178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1,1,2-tetrafluorochloroethane [2689143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triclosan [10795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamylal [10464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tibezonium iodide [237141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telisotuzumab [2714237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrapropyl orthosilicate [1314229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiothixene hydrochloride [91135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Terminalia catappa leaf extract [1860072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triprolidine tannate [1099727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trametinib [1425099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-terpineol, (+)- [1803668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thermus thermophilus lysate [1306060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone isocaproate [75806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trospium [236778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tioxolone [2059173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tepraloxydim [2549831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thalidomide [10432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamarind seed extract [1307969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyme oil [90950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethobenzamide [38685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tert-butyl acetate [2668412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telavancin hydrochloride [864624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teplizumab [2621880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrachlorodibenzodioxin [2120182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1,3-tri(3-tert-butyl-4-hydroxy-6-methylphenyl)butane [1872247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja occidentalis leaf extract [1309810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tigecycline [384455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tryptophan [10898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab deruxtecan [2267582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tromethamine [10865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trehalose dihydrate [1311372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talazoparib [2099704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton verrucosum [1310905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiobutabarbital sodium [314874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiratricol [13982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>threonate [1547558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone cypionate [835827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tioconazole [38298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tuberculin [10908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tofersen [2634995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trans-3-isocamphylcyclohexanol [2397710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-tert-butylcyclohexanol, cis- [2045941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tenapanor hydrochloride [2199673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tretinoin [10753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiotropium bromide, anhydrous [2462023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tetracoccosporium paxianum allergenic extract [968502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraethylammonium hydroxide [1648695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethanolamine hydrochloride [1368178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>temsirolimus [657797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichothecium roseum allergenic extract [968426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trehalulose [1428856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyrotropin [10579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioctic acid amide [1597391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethylbenzenepropanol [1376097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treponemic skin canker preparation, human [1367174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolmetin sodium [42935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taurate [1431306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazarotene [83947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tahitian vanilla bean extract [2586080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiophene [154876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocilizumab-anoh [2705421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocilizumab-aazg [2679427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thymidine [1372538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium edetate [105745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiadenol [38248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Typha angustifolia stem extract [2699679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluperidol [10804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichosporon cutaneum allergenic extract [1426665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tulipa kaufmanniana bulb extract [1739227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>theaflavin [38021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teclistamab [2619426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tiotropium bromide [393575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tisagenlecleucel [1986438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamarind extract [1649129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tartaric acid, D- [1371315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>teprotumumab-trbw [2274802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolazoline hydrochloride [235450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trientine hydrochloride [235370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taraxacum palustre root extract [1309985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Theridion curassavicum preparation [1311091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talquetamab-tgvs [2644448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tropolone [1368873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tylvalosin tartrate [1368468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>troclosene sodium [1537575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisostearin [1426662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taxus baccata fruit extract [1314222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocamphyl [60906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tralokinumab [2589225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton (fungus) [328140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1,3-tris(2-chloroethoy)propane [2044897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triheptanoin [1313234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tildrakizumab-asmn [2053449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taraxacum sinicum whole extract [2592981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripelennamine citrate [71533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1,1,1-triethoxyethane [2474630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taxus baccata whole extract [1876512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichophyton schoenleinii allergenic extract [968422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>technetium Tc 99m disofenin [37665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron preparation [285166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trisodium citrate anhydrous [1310549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trientine [10798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichilia emetica seed butter [1722377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tildrakizumab [2053436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripeptide-10 citrulline [1664430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triolein [1368168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tapioca starch allergenic extract [901346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tsuga canadensis whole extract [2531132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-anns [2174802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>taurine deoxycholate [1364853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trilostane [38668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>topotecan hydrochloride [266573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tranilast [57330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tsuga canadensis flower bud extract [1309813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triclofos sodium [104696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tantalum carbide [1989395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triphenylmethane [2287153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tag alder pollen extract [851902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetradecyl hydrogen sulfate (ester) [1370424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trastuzumab-strf [2700714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris(tetramethylhydroxypiperidinol) citrate [1368375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisononanoin [1427124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tris(trimethylsiloxy)phenylsilane [1799152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tall oat grass pollen extract [1006506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,6,10-trimethyl-9-undecenal [2378834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Taraxacum mongolicum extract [1541740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trametes versicolor whole extract [1435105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triethoxy(3-isocyanatopropyl)silane [2371689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>talniflumate [236770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron pubescens leaf extract [1309673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>toceranib phosphate [1145944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Toxicodendron succedaneum fruit wax [2618721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triclofos [38610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tin [10603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trandolaprilat [1546379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl lactate [1487115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrasodium glutamate diacetate [1312373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trichosanthes kirilowii root extract [1310082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tylosin tartrate [996012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tocopheryl glucoside [2667746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>triisostearyl citrate [1539636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tartrazine [1305578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terazosin hydrochloride [235224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetanus immune globulin [1727875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium repens whole extract [2001815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>testosterone 17-phenylpropionate [37855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrasodium diethylenetriaminepentamethylenephosphonate [1995243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiamine [10454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolcapone [72937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tafenoquine succinate [2054091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tirofiban hydrochloride [253202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tinzaparin sodium [104466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thioridazine [10502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimethoprim [10829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>threonine [10524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimebutine maleate salt [262296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tridecyl salicylate [1421431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetraxetan [2260905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrahydrodiferuloylmethane [1362136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>transforming growth factor beta 1 [1426465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tangeretin [2682551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tanacetum vulgare top extract [1311054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thuja plicata leaf extract [1309746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tritoqualine [38810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>treprostinil sodium [342691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense leaf extract [1364991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tripotassium glycyrrhizinate [1359425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2,4,5-T-trolamine [1947504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terazosin hydrochloride anhydrous [1299927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Trifolium pratense flower extract [1310039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Tetradium ruticarpum fruit extract [1311684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terbinafine [37801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>2-tert-butylcyclohexyloxybutanol [1860086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trifluoperazine [10800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>T [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Thymus mastichina flowering top oil [1369565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>T-Calcium Channel Receptor Antagonists [MoA]</name>
  <code>C300456</code>  <id>300456</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists</to_name>
    <to_code>T50656</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020066</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T-Calcium Channel Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>TRH Activity Alteration [PE]</name>
  <code>C30134</code>  <id>30135</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRH Activity Alteration</to_name>
    <to_code>T50937</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009884</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>TRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased TRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>TRH Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased TRH Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>TRH Secretion Alteration [PE]</name>
  <code>C30138</code>  <id>30139</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRH Secretion Alteration</to_name>
    <to_code>T50938</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009886</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>TRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased TRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>TRH Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased TRH Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>TRPM8 Thermoreceptor Agonist [EPC]</name>
  <code>C654389</code>  <id>654389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transient Receptor Potential Melastatin 8 Agonist</to_name>
    <to_code>T59080</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRPM8 Thermoreceptor Agonist</to_name>
    <to_code>T59079</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194172</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>TRPM8 Thermoreceptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>TRPM8 Thermoreceptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>TRPM8 Thermoreceptor Agonists [MoA]</name>
  <code>C654388</code>  <id>654388</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transient Receptor Potential Melastatin 8 Agonists</to_name>
    <to_code>T59078</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRPM8 Thermoreceptor Agonists</to_name>
    <to_code>T59077</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194173</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tear Excretion [PK]</name>
  <code>C276</code>  <id>277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tear Excretion</to_name>
    <to_code>T51225</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000049</value>
  </property>
 </concept>
 <concept root="true" >
  <namespace>MED-RT</namespace>
  <name>Terminology Extensions for Classification [EXT]</name>
  <code>C1</code>  <id>1</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Terminology Extensions for Classification</to_name>
    <to_code>T1</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193784</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fruit Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Lipoglycopeptides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Platinum-containing Compounds [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viruses, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Methylated Sulfonamides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pyrophosphate Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Epidermal [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>SARS-CoV-2 mRNA [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaccines, Tick-Borne Encephalitis [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cyclic Pyranopterin Monophosphate [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Meat Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Semifluorinated Alkane [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Shellfish Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmacological Chaperone [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Non-Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nucleoside Analog [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Amphenicols [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Current Non-smoker [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus-specific Hyperimmune Globulins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous, Genetically-modified [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nut Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus mRNA [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Poultry Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glinides [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Grain Proteins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fish Proteins, Dietary [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Autologous [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Terminology Extensions for Classification [EXT]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cells, Cultured, Allogeneic [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Testicular Endocrine Activity Alteration [PE]</name>
  <code>C30140</code>  <id>30141</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration</to_name>
    <to_code>T51449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009887</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Testicular Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Dihydrotestosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Testicular Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Dihydrotestosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Testicular Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Testicular Endocrine Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Testosterone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testolactone [10378]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin [50610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutamide [4508]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilutamide [31805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Testicular Endocrine Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tetracycline-class Antibacterial [EPC]</name>
  <code>C635376</code>  <id>635376</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antibacterial</to_name>
    <to_code>T51497</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175938</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>omadacycline [2059269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tigecycline [384455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antibacterial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eravacycline [2055906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antibacterial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetracyclines [M0021223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with tetracycline structure and antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing tetracycline (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tetracycline-class Antimicrobial [EPC]</name>
  <code>C634886</code>  <id>634886</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline Class Antimicrobial</to_name>
    <to_code>T51498</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antimicrobial</to_name>
    <to_code>T51499</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175505</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing tetracycline (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>demeclocycline [3154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetracycline [10395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxytetracycline anhydrous [1545999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with tetracycline structure and antibacterial mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimicrobial Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetracyclines [M0021223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_prevent</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Antimicrobial [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tetracycline-class Drug [EPC]</name>
  <code>C635320</code>  <id>635320</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Drug</to_name>
    <to_code>T51500</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175882</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline [3640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antibacterial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sarecycline [2059018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxycycline anhydrous [1545992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetracyclines [M0021223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>minocycline [6980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tetracycline-class Drug [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Antimicrobial [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with tetracycline structure and antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing tetracycline (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tetracycline-class Drug [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thalidomide Analog [EPC]</name>
  <code>C643694</code>  <id>643694</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thalidomide Analog</to_name>
    <to_code>T51588</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thalidomide Analogue</to_name>
    <to_code>T51587</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184014</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thalidomide Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thalidomide Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thalidomide [M0021267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thalidomide Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>lenalidomide [342369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thalidomide Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pomalidomide [1369713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Thalidomide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thalidomide Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept root="true" >
  <namespace>MED-RT</namespace>
  <name>Therapeutic Categories [TC]</name>
  <code>C637747</code>  <id>637747</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Categories</to_name>
    <to_code>T51616</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178293</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antispasticity Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Genitourinary Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antineoplastic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Products/Modifiers/Volume Expanders [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Skeletal Muscle Relaxants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Immunological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anxiolytics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dental and Oral Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bipolar Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Dermatological Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-inflammatory Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cardiovascular Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidementia Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimyasthenic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Blood Glucose Regulators [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antiparkinson Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Otic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anticonvulsants [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Diagnostic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anti-infective Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ophthalmic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inflammatory Bowel Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Metabolic Bone Disease Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Stimulant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antimigraine Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Analgesics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sedatives/Hypnotics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Enzyme Replacements/Modifiers [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormonal Agents, Suppressant [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central Nervous System Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Gastrointestinal Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anesthetics [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidotes, Deterrents, and Toxicologic Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antigout Agents [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Therapeutic Categories [TC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antirheumatic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</name>
  <code>C654065</code>  <id>654065</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes</to_name>
    <to_code>T58443</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>TC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193844</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate, anhydrous [267453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer [1716203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oil (containing omega-3 acids) [2053495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride anhydrous [1311539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenate [36717]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate [39954]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium folate [1300473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E d-alpha [220892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paricalcitol [73710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, dodecahydrate [1311345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride hexahydrate [221118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenious acid [36344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, monohydrate [1311357]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxsil [77754]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine hydrochloride [6538]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamine [4885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tribasic sodium phosphate [36710]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate magnesium [1549106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine hydrochloride, (+)- [1539210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc chloride [39937]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper Cu-64 [2200143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium chloride [712]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, D- [1742746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate anhydrous [1299928]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ferric gluconate complex [261435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenine [290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, DL- [1729154]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine, DL- [1546161]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine [6536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium [1895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron [90176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium dihydrate [2611697]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine chloride [1311519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitexin [2684982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic anhydrous [1307158]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride tetrahydrate [2003593]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triphosphate sodium [236509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolic acid [1025342]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin sodium [2109051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine acetate [6537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper [2837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E acetate [2531274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine hydrochloride [1744461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha tocopherol [237099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium anhydrous [2279515]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine [1091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E DL-alpha [220893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dihydrogen phosphate [236560]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate [58300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol calcium succinate, DL- [2598017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc nicotinate [236834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregnenolone [114052]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asfotase alfa [1720259]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin tetrabutyrate [2106328]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine 5-mo-phos disod [236785]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine [426]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate [56443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate, heptahydrate [1311282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate [1592257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium [1925820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer sorbitex calcium [2204723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate anhydrous [1792467]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin [9346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride monohydrate [2678349]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate trihydrate [1440975]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-alanine [61]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E [11256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aminobenzoate [1010241]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine hydrochloride [89918]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate glucosamine [1592256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium chloride [2200142]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine,DL- [236948]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate monohydrate [1309410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine monohydrate [1314248]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lactate [56489]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutein [11359]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aspartate [18254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium [9641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine [2106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine [8156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxytol [473387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine [11017]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folic acid [4511]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Therapeutic Nutrients/Minerals/Electrolytes [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thermoreceptor Interactions [MoA]</name>
  <code>C654387</code>  <id>654387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thermoreceptor Interactions</to_name>
    <to_code>T59076</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194174</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thermoreceptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>TRPM8 Thermoreceptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thiazide Diuretic [EPC]</name>
  <code>C634801</code>  <id>634801</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide Diuretic</to_name>
    <to_code>T51666</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide-class Diuretic</to_name>
    <to_code>T51665</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175419</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorothiazide [2396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydrochlorothiazide [5487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>hydroflumethiazide [5495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Thiazide diuretic (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>polythiazide [8565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Sodium Chloride Symporter Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiazides [M0471776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bendroflumethiazide [1369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thiazide-like Diuretic [EPC]</name>
  <code>C634802</code>  <id>634802</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide-like Diuretic</to_name>
    <to_code>T51667</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175420</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide-like Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metolazone [6916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide-like Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>indapamide [5764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide-like Diuretic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Diuresis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazide-like Diuretic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>chlorthalidone [2409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Thiazide diuretic (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazide-like Diuretic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thiazolidinedione [EPC]</name>
  <code>C639682</code>  <id>639682</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazolidinedione</to_name>
    <to_code>T51672</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiazolidinedione-class Agent</to_name>
    <to_code>T51671</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180190</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazolidinedione [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiazolidinediones [M0447306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazolidinedione [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing thiazolidinedione (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazolidinedione [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Thiazolidinedione (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazolidinedione [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pioglitazone [33738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thiazolidinedione [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rosiglitazone [84108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thiopurine methyltransferase [PK]</name>
  <code>C254</code>  <id>255</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thiopurine methyltransferase</to_name>
    <to_code>T51749</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000038</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thioxanthene [EPC]</name>
  <code>C635154</code>  <id>635154</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thioxanthene</to_name>
    <to_code>T51795</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thioxanthene-class Agent</to_name>
    <to_code>T51794</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175748</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thioxanthene [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thioxanthenes [M0021388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thrombin Inhibitors [MoA]</name>
  <code>C30294</code>  <id>30295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors</to_name>
    <to_code>T51834</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009963</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desirudin [114934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate [1037042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran [1546356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate mesylate [1037041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thrombolytic Agent [EPC]</name>
  <code>C634919</code>  <id>634919</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombolytic Agent</to_name>
    <to_code>T51856</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175526</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombolytic Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urokinase [11055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombolytic Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thrombolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombolytic Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Thrombolytic agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thrombopoiesis Stimulating Agent [EPC]</name>
  <code>C637822</code>  <id>637822</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoiesis Stimulating Agent</to_name>
    <to_code>T51875</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178368</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoiesis Stimulating Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with thrombopoietin receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoiesis Stimulating Agent [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing thrombopoietin receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thrombopoietin Receptor Agonist [EPC]</name>
  <code>C635427</code>  <id>635427</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonist</to_name>
    <to_code>T51876</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175973</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eltrombopag [711942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Megakaryocyte Maturation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Platelet Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing thrombopoietin receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>romiplostim [805452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with thrombopoietin receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thrombopoietin Receptor Agonists [MoA]</name>
  <code>C635422</code>  <id>635422</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists</to_name>
    <to_code>T51877</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175968</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag maleate [2045727]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag choline [2675185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romiplostim [805452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thrombopoietin Receptor Interactions [MoA]</name>
  <code>C635421</code>  <id>635421</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Interactions</to_name>
    <to_code>T51878</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175967</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thrombopoietin Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thrombopoietin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thymic Stromal Lymphopoietin Blocker [EPC]</name>
  <code>C654224</code>  <id>654224</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TSLP Blocker</to_name>
    <to_code>T58727</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blocker</to_name>
    <to_code>T58726</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194010</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thymic Stromal Lymphopoietin Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tezepelumab [2587789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thymic Stromal Lymphopoietin Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunoglobulin IgG2 (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thymic Stromal Lymphopoietin Blockers [MoA]</name>
  <code>C654225</code>  <id>654225</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TSLP Blockers</to_name>
    <to_code>T58729</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blockers</to_name>
    <to_code>T58728</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194011</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab [2587789]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymic Stromal Lymphopoietin Blockers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thymidine Phosphorylase Inhibitor [EPC]</name>
  <code>C651986</code>  <id>651986</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitor</to_name>
    <to_code>T51924</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191870</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tipiracil [1670304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with thymidine phosphorylase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing thymidine phosphorylase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thymidine Phosphorylase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thymidine Phosphorylase Inhibitors [MoA]</name>
  <code>C651985</code>  <id>651985</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitors</to_name>
    <to_code>T51925</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191869</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil hydrochloride [1670303]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil [1670304]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidine Phosphorylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thymidylate Synthetase Inhibitors [MoA]</name>
  <code>C374</code>  <id>375</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors</to_name>
    <to_code>T51935</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000098</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thymidylate Synthetase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Gland Activity Alteration [PE]</name>
  <code>C30144</code>  <id>30145</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Gland Activity Alteration</to_name>
    <to_code>T51992</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009889</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Iodination Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodine Organification Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Gland Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodine Uptake Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide I123 [91531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Gland Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Iodination Alteration [PE]</name>
  <code>C30146</code>  <id>30147</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Iodination Alteration</to_name>
    <to_code>T51993</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009890</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Iodination Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Iodination Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Iodination [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor Agonists [MoA]</name>
  <code>C652</code>  <id>653</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists</to_name>
    <to_code>T51994</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000237</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Receptor Agonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor Antagonists [MoA]</name>
  <code>C622</code>  <id>623</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor Antagonists</to_name>
    <to_code>T51995</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000222</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor beta Agonist [EPC]</name>
  <code>C654349</code>  <id>654349</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>THR-beta Agonist</to_name>
    <to_code>T59005</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRβ Agonist</to_name>
    <to_code>T59010</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor β Agonist</to_name>
    <to_code>T59007</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor-β Agonist</to_name>
    <to_code>T59009</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonist</to_name>
    <to_code>T59004</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>THR-β Agonist</to_name>
    <to_code>T59006</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor-beta Agonist</to_name>
    <to_code>T59008</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194131</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Receptor beta Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>resmetirom [2677894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Receptor beta Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Receptor beta Agonists [MoA]</name>
  <code>C654348</code>  <id>654348</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>THR-β Agonists</to_name>
    <to_code>T58999</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor-beta Agonists</to_name>
    <to_code>T59001</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRβ Agonists</to_name>
    <to_code>T59003</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor-β Agonists</to_name>
    <to_code>T59002</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonists</to_name>
    <to_code>T58997</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>THR-beta Agonists</to_name>
    <to_code>T58998</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor β Agonists</to_name>
    <to_code>T59000</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194132</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Receptor beta Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Secretion Alteration [PE]</name>
  <code>C30148</code>  <id>30149</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Secretion Alteration</to_name>
    <to_code>T52024</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009891</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Thyroid Hormone Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Synthesis Inhibitor [EPC]</name>
  <code>C635356</code>  <id>635356</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitor</to_name>
    <to_code>T52025</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175918</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propylthiouracil [8794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>methimazole [6835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Synthesis Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antithyroid agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Hormone Synthesis Inhibitors [MoA]</name>
  <code>C635355</code>  <id>635355</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitors</to_name>
    <to_code>T52026</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175917</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Hormone Synthesis Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Iodide Peroxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Hormone Synthesis Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyroid Stimulating Hormone [EPC]</name>
  <code>C635387</code>  <id>635387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyroid Stimulating Hormone</to_name>
    <to_code>T52031</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175949</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Stimulating Hormone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Thyrotrophin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Stimulating Hormone [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotropin [M0021496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Stimulating Hormone [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing thyrotrophin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyroid Stimulating Hormone [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thyrotropin alfa [4952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Thyrotropin Releasing Hormone Alteration [PE]</name>
  <code>C30136</code>  <id>30137</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Thyrotropin Releasing Hormone Alteration</to_name>
    <to_code>T52054</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRH Alteration</to_name>
    <to_code>T52053</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009885</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyrotropin Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>TRH Activity Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Thyrotropin Releasing Hormone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>TRH Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tick-Borne Encephalitis Vaccine [EPC]</name>
  <code>C654380</code>  <id>654380</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tick-Borne Encephalitis Vaccine</to_name>
    <to_code>T59068</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194159</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccines, Inactivated [M0023305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vaccine product containing Tick-borne encephalitis virus antigen (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Antibody Production [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tick-Borne Encephalitis Vaccine [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaccines, Tick-Borne Encephalitis [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</name>
  <code>C654372</code>  <id>654372</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Factor Pathway Inhibitor Antagonist</to_name>
    <to_code>T59059</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TFPI Antagonist</to_name>
    <to_code>T59060</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194160</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>concizumab [2708333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tissue Factor Pathway Inhibitor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</name>
  <code>C654371</code>  <id>654371</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Factor Pathway Inhibitor Antagonists</to_name>
    <to_code>T59057</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TFPI Antagonists</to_name>
    <to_code>T59058</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194161</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab [2708333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Factor Pathway Inhibitor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tissue Plasminogen Activator Inhibitors [MoA]</name>
  <code>C31884</code>  <id>31885</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activator Inhibitors</to_name>
    <to_code>T52202</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TPA Inhibitors</to_name>
    <to_code>T52201</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010263</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activator Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activator Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tissue Plasminogen Activators [MoA]</name>
  <code>C660</code>  <id>661</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators</to_name>
    <to_code>T52211</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000241</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide [1311089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urokinase [11055]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide sodium [1746523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenecteplase [259280]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide, bovine lung [1788946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue Plasminogen Activators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tissue-nonspecific Alkaline Phosphatase [EPC]</name>
  <code>C651981</code>  <id>651981</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue-nonspecific Alkaline Phosphatase</to_name>
    <to_code>T52216</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191865</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>asfotase alfa [1720259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkaline Phosphatase [M0000712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing hydrolase (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Alkaline phosphatase (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tissue-nonspecific Alkaline Phosphatase [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 1 Inhibitor [EPC]</name>
  <code>C635329</code>  <id>635329</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 1 Inhibitor</to_name>
    <to_code>T52379</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175891</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing topoisomerase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with topoisomerase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 1 Inhibitors [MoA]</name>
  <code>C635328</code>  <id>635328</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 1 Inhibitors</to_name>
    <to_code>T52380</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175890</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 2 Inhibitors [MoA]</name>
  <code>C300478</code>  <id>300478</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors</to_name>
    <to_code>T52381</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020088</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase 2 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin mesylate [2709213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase 4 Inhibitors [MoA]</name>
  <code>C300477</code>  <id>300477</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors</to_name>
    <to_code>T52382</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020087</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase Inhibitor [EPC]</name>
  <code>C635002</code>  <id>635002</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitor</to_name>
    <to_code>T52383</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175609</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>irinotecan [51499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etoposide [4179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with topoisomerase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>topotecan [57308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing topoisomerase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Anthracycline Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mitoxantrone [7005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Topoisomerase Inhibitors [MoA]</name>
  <code>C530</code>  <id>531</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>DNA Gyrase Inhibitors</to_name>
    <to_code>T52385</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitor</to_name>
    <to_code>T52384</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors</to_name>
    <to_code>T52386</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000176</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Topoisomerase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valrubicin [31435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tracheobronchial Stretch Receptor Alteration [PE]</name>
  <code>C30150</code>  <id>30151</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tracheobronchial Stretch Receptor Alteration</to_name>
    <to_code>T52465</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009892</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tracheobronchial Stretch Receptor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tracheobronchial Stretch Receptor Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Tracheobronchial Stretch Receptor Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Transcription Factor Activity [MoA]</name>
  <code>C662</code>  <id>663</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity</to_name>
    <to_code>T52542</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000242</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hormone Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Farnesoid X Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Hypoxia-inducible Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cytochrome P450 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Peroxisome Proliferator-activated Receptor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription Factor Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aryl Hydrocarbon Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol citrate [2694282]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol [2694283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription Factor Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Transcription to RNA Alteration [PE]</name>
  <code>C30152</code>  <id>30153</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription to RNA Alteration</to_name>
    <to_code>T52627</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009893</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription to RNA Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription to RNA Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Post-transcriptional RNA Interaction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transcription to RNA Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Transcription to RNA [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib [2665204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription to RNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib dihydrochloride monohydrate [2665205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transcription to RNA Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Translation Alteration [PE]</name>
  <code>C30154</code>  <id>30155</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Translation Alteration</to_name>
    <to_code>T52699</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009894</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Translation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Translation Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Protein Synthesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen sodium [2637346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Translation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen [2637345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Translation Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Transpeptidase Inhibitors [MoA]</name>
  <code>C31788</code>  <id>31789</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpepsidase Inhibitors</to_name>
    <to_code>T52711</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors</to_name>
    <to_code>T52712</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>penicillin binding protein Inhibitors</to_name>
    <to_code>T52710</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>PBP inhibitors</to_name>
    <to_code>T52709</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010215</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin [1591901]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur hydrochloride [1311520]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phenethicillin [132907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin [4448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin [26797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam hydrochloride [236202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem etzadroxil [2717834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbenicillin [10168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefatrizine [2179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin napsylate [235836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome sulfate [236104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol calcium [1424675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin sodium [236787]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam [2188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin [10322]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temocillin [37775]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium [235750]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome [27130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefetamet [20482]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin [2181306]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium monohydrate [1309402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur sodium [1370372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin [18609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin magnesium [235825]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur [1311521]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem [2717833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethicillin [33277]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin sodium [1591924]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol [1424676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transpeptidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Transthyretin Stabilizer [EPC]</name>
  <code>C654356</code>  <id>654356</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin Stabilizer</to_name>
    <to_code>T59033</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194134</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin Stabilizer [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin Stabilizers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin Stabilizer [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acoramidis [2698312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Transthyretin Stabilizers [MoA]</name>
  <code>C654355</code>  <id>654355</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin Stabilizers</to_name>
    <to_code>T59032</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194135</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis [2698312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin Stabilizers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Transthyretin-directed RNA Interaction [EPC]</name>
  <code>C654070</code>  <id>654070</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TTR-directed RNA Interaction</to_name>
    <to_code>T58452</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin-directed RNA Interaction</to_name>
    <to_code>T58451</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193849</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>inotersen [2099289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Aminolevulinate Synthase 1-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased RNA Integrity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>patisiran [2053490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eplontersen [2671939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Transthyretin-directed RNA Interaction [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vutrisiran [2604578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antisense oligonucleotide (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Transthyretin-directed RNA Interaction [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</name>
  <code>C654373</code>  <id>654373</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor</to_name>
    <to_code>T59061</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194142</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Topoisomerase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>gepotidacin [2709212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased DNA Replication [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with topoisomerase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tricyclic Antidepressant [EPC]</name>
  <code>C635160</code>  <id>635160</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TCA</to_name>
    <to_code>T52876</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tricyclic Antidepressant (TCA)</to_name>
    <to_code>T52877</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tricyclic Antidepressant</to_name>
    <to_code>T52878</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175752</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Tricyclic antidepressant (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amoxapine [722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>imipramine [5691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heterocyclic Compounds, 3-Ring [M0010294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desipramine [3247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clomipramine [2597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nortriptyline [7531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>trimipramine [10834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antidepressive Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>protriptyline [8886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxepin [3638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tricyclic Antidepressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>amitriptyline [704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Triglyceride Metabolism Alteration [PE]</name>
  <code>C30156</code>  <id>30157</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Triglyceride Metabolism Alteration</to_name>
    <to_code>T52945</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009895</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triglyceride Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triglyceride Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triglyceride Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Lipogenesis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triglyceride Metabolism Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Lipolysis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen [2637345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triglyceride Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen sodium [2637346]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triglyceride Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triglyceride Metabolism Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Triterpenoid Antifungal [EPC]</name>
  <code>C654180</code>  <id>654180</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Triterpenoid Antifungal</to_name>
    <to_code>T58627</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193966</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triterpenoid Antifungal [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ibrexafungerp [2560213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triterpenoid Antifungal [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Glucan Synthase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Triterpenoid Antifungal [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triterpenes [M0022020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antifungal mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Triterpenoid Antifungal [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Kinases Inhibitors [MoA]</name>
  <code>C654081</code>  <id>654081</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinases Inhibitors</to_name>
    <to_code>T58469</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRKs Inhibitors</to_name>
    <to_code>T58470</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193859</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib sulfate [2104548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</name>
  <code>C654312</code>  <id>654312</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRKA Inhibitors</to_name>
    <to_code>T58923</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinase A Inhibitors</to_name>
    <to_code>T58924</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors</to_name>
    <to_code>T58922</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194094</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</name>
  <code>C654313</code>  <id>654313</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRKB Inhibitors</to_name>
    <to_code>T58926</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors</to_name>
    <to_code>T58925</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinase B Inhibitors</to_name>
    <to_code>T58927</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194095</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</name>
  <code>C654314</code>  <id>654314</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Kinase C Inhibitors</to_name>
    <to_code>T58930</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors</to_name>
    <to_code>T58928</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TRKC Inhibitors</to_name>
    <to_code>T58929</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194096</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Trypsin Inhibitors [MoA]</name>
  <code>C572</code>  <id>573</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Trypsin Inhibitors</to_name>
    <to_code>T53185</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000197</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha 1-proteinase inhibitor, human [991743]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Trypsin Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tryptophan Hydroxylase Inhibitor [EPC]</name>
  <code>C653674</code>  <id>653674</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitor</to_name>
    <to_code>T53193</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193303</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing tryptophan hydroxylase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with tryptophan hydroxylase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tryptophan Hydroxylase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>telotristat [1872382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tryptophan Hydroxylase Inhibitors [MoA]</name>
  <code>C653673</code>  <id>653673</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitors</to_name>
    <to_code>T53194</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193302</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat [1872382]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat ethyl [1872441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat etiprate [1872448]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tryptophan Hydroxylase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tuberculosis Skin Test [EPC]</name>
  <code>C644086</code>  <id>644086</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tuberculosis Skin Test</to_name>
    <to_code>T53229</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184315</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_diagnose</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tuberculosis Skin Test [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tuberculosis Skin Test [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antigens, Bacterial [M0001408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tuberculosis Skin Test [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Cell-mediated Immunity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tuberculosis Skin Test [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>purified protein derivative of tuberculin [8948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tubulin Agent [APC]</name>
  <code>C654123</code>  <id>654123</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Agent</to_name>
    <to_code>T58525</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193911</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tubulin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vinca Alkaloid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tubulin Agent [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Inhibiting Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tubulin Inhibiting Agent [EPC]</name>
  <code>C635286</code>  <id>635286</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Inhibiting Agent</to_name>
    <to_code>T53303</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175848</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tubulin Inhibiting Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>griseofulvin [5021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tubulin Inhibiting Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Mitosis [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tubulin Inhibiting Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Microtubule Inhibition [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with microtubule inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Inhibiting Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing microtubule inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Inhibiting Agent [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tubulin Interactions [MoA]</name>
  <code>C31870</code>  <id>31871</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions</to_name>
    <to_code>T53304</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010256</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tubulin Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine sulfate [11199]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine [11198]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podophyllin [8462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine [11202]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine sulfate [11203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Blocker [EPC]</name>
  <code>C635003</code>  <id>635003</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor (TNF) Blocker</to_name>
    <to_code>T53315</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocker</to_name>
    <to_code>T53316</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF Blocker</to_name>
    <to_code>T53317</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Blocker</to_name>
    <to_code>T53318</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175610</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-adbm [2103477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>etanercept [214555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>golimumab [819300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab [327361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab [191831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-bwwd [2612153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-aaty [2639649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>infliximab-dyyb [1790539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>adalimumab-ryvk [2677776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>certolizumab pegol [709271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with immunomodulator mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing immunomodulator (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</name>
  <code>C634831</code>  <id>634831</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity</to_name>
    <to_code>T53339</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF Blocker</to_name>
    <to_code>T53337</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF Receptor Blocking Activity</to_name>
    <to_code>T53338</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175451</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>RANK Ligand Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor Receptor Interactions [MoA]</name>
  <code>C30268</code>  <id>30269</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF Receptor Interactions</to_name>
    <to_code>T53340</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Interactions</to_name>
    <to_code>T53341</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009950</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tumor Necrosis Factor Receptor Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acemannan [1426875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor Receptor Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</name>
  <code>C30270</code>  <id>30271</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF-a Receptor Blocking Activity</to_name>
    <to_code>T53343</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF-alpha Receptor Blocking Activity</to_name>
    <to_code>T53344</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity</to_name>
    <to_code>T53345</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175446</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</name>
  <code>C30272</code>  <id>30273</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor beta Receptor Blocking Activity</to_name>
    <to_code>T53351</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF-beta Receptor Blocking Activity</to_name>
    <to_code>T53349</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TNF-b Receptor Blocking Activity</to_name>
    <to_code>T53350</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175447</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor Necrosis Factor beta Receptor Blocking Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tumor-derived Autologous T Cell Immunotherapy [EPC]</name>
  <code>C654320</code>  <id>654320</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tumor-derived Autologous T Cell Immunotherapy</to_name>
    <to_code>T58938</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194099</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Type I interferon Receptor Antagonist [EPC]</name>
  <code>C654184</code>  <id>654184</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonist</to_name>
    <to_code>T58639</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I IFN Receptor Antagonist</to_name>
    <to_code>T58640</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193967</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Type I interferon Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Type I interferon Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>anifrolumab [2565265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Type I interferon Receptor Antagonists [MoA]</name>
  <code>C654186</code>  <id>654186</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I IFN Receptor Antagonists</to_name>
    <to_code>T58643</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonists</to_name>
    <to_code>T58642</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193968</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab-fnia [2565276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab [2565265]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type I interferon Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Type II RAF Kinase Inhibitors [MoA]</name>
  <code>C654340</code>  <id>654340</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Type II RAF Kinase Inhibitors</to_name>
    <to_code>T58975</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194133</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Type II RAF Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Typical Antipsychotic [EPC]</name>
  <code>C639655</code>  <id>639655</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Typical Antipsychotic</to_name>
    <to_code>T53484</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180182</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>MED-RT</from_namespace><from_name>Typical Antipsychotic [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Typical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>thiothixene [10510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_TC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Typical Antipsychotic [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Antipsychotic Agent [TC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Typical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pimozide [8331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Typical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>haloperidol [5093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Typical Antipsychotic [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>molindone [7019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anti-psychotic agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Typical Antipsychotic [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tyrosine Kinase 2 Inhibitor [EPC]</name>
  <code>C654260</code>  <id>654260</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TYK2 Inhibitor</to_name>
    <to_code>T58791</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitor</to_name>
    <to_code>T58790</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194043</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase 2 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>deucravacitinib [2612087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing Janus kinase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with Janus kinase inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tyrosine Kinase 2 Inhibitors [MoA]</name>
  <code>C654261</code>  <id>654261</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitors</to_name>
    <to_code>T58792</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>TYK2 Inhibitors</to_name>
    <to_code>T58793</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194044</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase 2 Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proline-rich Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Tyrosine Kinase Inhibitors [MoA]</name>
  <code>C300386</code>  <id>300386</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors</to_name>
    <to_code>T53498</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020001</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Bruton&apos;s Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Janus Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Focal Adhesion Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Tyrosine Kinase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Receptor Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib hydrochloride [1364953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib [2044896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acalabrutinib [1986808]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib tosylate [2641596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib [2714502]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib [1363268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib hydrochloride [1727454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanubrutinib [2262435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib monohydrate [1314319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunvozertinib [2719226]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib hydrochloride [2714501]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib s-malate [1363267]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib hydrochloride [2183103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib [2534233]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib [2641595]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib disodium [2055929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tyrosine Kinase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>U [Preparations]</name>
  <code>C288647</code>  <id>288647</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>U [Preparations]</to_name>
    <to_code>T53521</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010603</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uranyl nitrate [1858851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uridine [11017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-srlf [2717063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ultramarine violet [1858076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Uncaria tomentosa root extract [1435280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ulipristal acetate [1005920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uracil [10995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ubiquinol [39085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Uncaria tomentosa leaf extract [1358480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ubrogepant [2268216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ursodiol [11065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>umbralisib tosylate [2478438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus rubra pollen allergenic extract [1426632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urea sulfate [1539374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urokinase [11055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Uncaria tomentosa whole extract [1874893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Umbellularia californica whole extract [2539937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecylenoyl glycine [1426671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urea [14C] [253158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urea [11002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus davidiana root extract [1309993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ustilago maydis extract [1427134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecylenic acid [10989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>unithiol [10991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urea c-13 [226724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ursolate [1370661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica dioica leaf extract [1309281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecylcrylene dimethicone (10000 MW) [1739228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ubiquinone Q2 [1423925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulkenia DHA oil [1430391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-hmny [2725083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica preparation [319816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica urens homeopathic preparation [285167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ublituximab [2626349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uridine 5-mo-phos disod [236785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecylenic acid monoethanolamide [1314232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus glabra pollen extract [2369372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ursolic acid [1426931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>10-undecenal [2378832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>unoprostone [1546408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ultralente insulin, beef-pork [235281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>umirolimus [1942479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecanedioic acid [2044371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica dioica root extract [1307579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>umeclidinium bromide [1487512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Uncaria sinensis whole preparation [1314584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ultralente insulin, human [221110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-aauz [2702602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica dioica subsp. dioica leaf extract [2267408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undeceth-5 [1733673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ubiquinone [10975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Uncaria gambir whole extract [1539191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-aekn [2705377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Utah juniper pollen extract [852597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Umbellularia californica leaf extract [1864070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ursadiol [2045735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus procera flowering twig extract [1309483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-stba [2700389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urofollitropin [134404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulex europaeus whole extract [2002714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus procera whole extract [1800490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uranyl nitrate hexahydrate [1313279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>umbralisib [2478439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Undaria pinnatifida extract [1355807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undeceth-7 [1356141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uric acid [1427088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-ttwe [2705553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uranium [10999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecylenate [314881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uridine triphosphate sodium [236509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Usnea barbata extract [1426661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecyl alcohol [1310537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-auub [2700665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecyl ethyleneglycol monoether [1540879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uracil mustard [10996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus glabra whole extract [2055748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab [847083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica urens leaf extract [1307566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulmus rubra bark extract [1309484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecane [1811767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ulipristal [1005921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ultramarine blue [1311650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Uncaria rhynchophylla stem [1309283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ustilago maydis antigen [467329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ultralente insulin, beef [235282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urethane [1420982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulva lactuca extract [1338620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uranium cation (6+) [1546269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urapidil [39230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>uridine triacetate [1665222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Umbilicus rupestris extract [2049224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica urens extract [1370792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulex europaeus flower extract [1324594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulva compressa protein (acid hydrolyzed, 300-5000 MW) [1314301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>urea hydrochloride [1862866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>usnic acid [1546707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ustekinumab-kfce [2705577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>upadacitinib [2196092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ursodeoxycholate [62427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Urtica dioica preparation [350490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>undecylenoyl phenylalanine [1716524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ublituximab-xiiy [2626348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ulva compressa extract [1426782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>umeclidinium [1487514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>U [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ubidecarenone [21406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases Inducers [MoA]</name>
  <code>C650048</code>  <id>650048</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT Inducers</to_name>
    <to_code>T53522</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases (UGT) Inducers</to_name>
    <to_code>T53523</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inducers</to_name>
    <to_code>T53524</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190117</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UDP Glucuronosyltransferases Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UDP Glucuronosyltransferases Inhibitors [MoA]</name>
  <code>C651275</code>  <id>651275</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases (UGT) Inhibitors</to_name>
    <to_code>T53525</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inhibitors</to_name>
    <to_code>T53527</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT Inhibitors</to_name>
    <to_code>T53526</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191269</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UDP Glucuronosyltransferases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UDP Glucuronosyltransferases Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A Inducers [MoA]</name>
  <code>C654245</code>  <id>654245</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A Inducers</to_name>
    <to_code>T58765</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases-1A Inducers</to_name>
    <to_code>T58764</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A Inducers</to_name>
    <to_code>T58763</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194035</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT1A Inducers [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A Inhibitors [MoA]</name>
  <code>C651276</code>  <id>651276</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A Inhibitors</to_name>
    <to_code>T53544</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A Inhibitors</to_name>
    <to_code>T53543</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases-1A Inhibitors</to_name>
    <to_code>T53542</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191270</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT1A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT1A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT1A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT1A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT1A Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A1 Inducers [MoA]</name>
  <code>C654246</code>  <id>654246</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP glucuronosyltransferase family 1 member A1 Inducers</to_name>
    <to_code>T58767</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inducers</to_name>
    <to_code>T58766</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP-Glucuronosyltransferase 1A1 Inducers</to_name>
    <to_code>T58768</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194036</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inducers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A1 Inhibitors [MoA]</name>
  <code>C651278</code>  <id>651278</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors</to_name>
    <to_code>T53547</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-1A1 Inhibitors</to_name>
    <to_code>T53545</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A1 Inhibitors</to_name>
    <to_code>T53546</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191272</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir heminonahydrate [1600437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A3 Inhibitors [MoA]</name>
  <code>C651281</code>  <id>651281</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A3 Inhibitors</to_name>
    <to_code>T53548</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-1A3 Inhibitors</to_name>
    <to_code>T53549</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A3 Inhibitors</to_name>
    <to_code>T53550</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191275</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A4 Inhibitors [MoA]</name>
  <code>C651282</code>  <id>651282</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-1A4 Inhibitors</to_name>
    <to_code>T53552</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A4 Inhibitors</to_name>
    <to_code>T53551</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A4 Inhibitors</to_name>
    <to_code>T53553</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191276</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A4 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A6 Inhibitors [MoA]</name>
  <code>C651283</code>  <id>651283</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-1A6 Inhibitors</to_name>
    <to_code>T53554</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A6 Inhibitors</to_name>
    <to_code>T53555</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A6 Inhibitors</to_name>
    <to_code>T53556</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191277</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A6 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT1A9 Inhibitors [MoA]</name>
  <code>C651284</code>  <id>651284</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors</to_name>
    <to_code>T53559</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-1A9 Inhibitors</to_name>
    <to_code>T53558</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-1A9 Inhibitors</to_name>
    <to_code>T53557</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191278</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT1A9 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT2B Inhibitors [MoA]</name>
  <code>C651277</code>  <id>651277</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-2B Inhibitors</to_name>
    <to_code>T53560</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferases-2B Inhibitors</to_name>
    <to_code>T53561</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B Inhibitors</to_name>
    <to_code>T53562</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191271</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT2B Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B7 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>UGT2B Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B15 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT2B15 Inhibitors [MoA]</name>
  <code>C651280</code>  <id>651280</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-2B15 Inhibitors</to_name>
    <to_code>T53564</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-2B15 Inhibitors</to_name>
    <to_code>T53563</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B15 Inhibitors</to_name>
    <to_code>T53565</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191274</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B15 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B15 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>UGT2B7 Inhibitors [MoA]</name>
  <code>C651279</code>  <id>651279</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UDP Glucuronosyltransferase-2B7 Inhibitors</to_name>
    <to_code>T53567</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT-2B7 Inhibitors</to_name>
    <to_code>T53566</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B7 Inhibitors</to_name>
    <to_code>T53568</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191273</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B7 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B7 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B7 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>UGT2B7 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ubiquitin Ligase Inhibitors [MoA]</name>
  <code>C300474</code>  <id>300474</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ubiquitin Ligase Inhibitors</to_name>
    <to_code>T53602</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020084</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ubiquitin Ligase Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>E3 Ubiquitin Ligase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ubiquitin Ligase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ultrasound Contrast Activity [MoA]</name>
  <code>C31876</code>  <id>31877</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity</to_name>
    <to_code>T53635</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010259</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflutren [283753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur hexafluoride [1599276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflexane [1540828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin microspheres, human [1370439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultrasound Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ultraviolet A Radiation Absorption [MoA]</name>
  <code>C31794</code>  <id>31795</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorbs UVA Radiation</to_name>
    <to_code>T53636</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorbs Ultraviolet A Radiation</to_name>
    <to_code>T53637</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet A Radiation Absorption</to_name>
    <to_code>T53638</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010218</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole [1426903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet A Radiation Absorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoctrizole [1310510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet A Radiation Absorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ultraviolet B Radiation Absorption [MoA]</name>
  <code>C31796</code>  <id>31797</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet B Radiation Absorption</to_name>
    <to_code>T53641</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorbs UVB Radiation</to_name>
    <to_code>T53640</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Absorbs Ultraviolet B Radiation</to_name>
    <to_code>T53639</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010219</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoctrizole [1310510]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet B Radiation Absorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole [1426903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ultraviolet B Radiation Absorption [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Umbilical Lint Excretion [PK]</name>
  <code>C286</code>  <id>287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Umbilical Lint Excretion</to_name>
    <to_code>T53644</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000054</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</name>
  <code>C641387</code>  <id>641387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist</to_name>
    <to_code>T53648</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonist</to_name>
    <to_code>T53646</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate (NMDA) Receptor Antagonist</to_name>
    <to_code>T53647</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181821</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dextromethorphan [3289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with N-methyl-D-aspartate receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uncompetitive NMDA Receptor Antagonists [MoA]</name>
  <code>C641385</code>  <id>641385</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive N-methyl-D-aspartate Receptor Antagonists</to_name>
    <to_code>T53649</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists</to_name>
    <to_code>T53650</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000181819</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncompetitive NMDA Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uncouplers [MoA]</name>
  <code>C488</code>  <id>489</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncouplers</to_name>
    <to_code>T53654</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000155</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncouplers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncouplers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uncouplers [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Unfractionated Heparin [EPC]</name>
  <code>C634855</code>  <id>634855</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Unfractionated Heparin</to_name>
    <to_code>T53679</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175474</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Unfractionated Heparin [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heparin [M0010187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Unfractionated Heparin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Heparin (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Unfractionated Heparin [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing heparin (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Unfractionated Heparin [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>heparin, porcine [235473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Unknown Cellular or Molecular Interaction [MoA]</name>
  <code>C30196</code>  <id>30197</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction</to_name>
    <to_code>T53696</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009915</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri [285156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenate [314881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric subsulfate solution [24912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifarotene [2205637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K [11258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edaravone [1921877]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer free acid [2710444]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine [784649]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus [6205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin alfa [4952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic [1111]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus crispatus [2054188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine [3022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine [2054023]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota spores, live-brpk [2636536]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate [36702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium permanganate [8604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclosan [10795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar extract [90735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (1500 MPA.S at 1%) [1312606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>borage oil [68905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halothane [5095]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin [6398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium undecylenate [1744166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus delbrueckii subsp. bulgaricus [100272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phensuximide [33309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 6000 [1314384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride f-18 [1311495]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentosan polysulphate sodium [134413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifileucel [2675860]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate tetrahydrate [2104324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revakinagene taroretcel [2708830]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revakinagene taroretcel-lwey [2708831]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha,alpha-dibromo-d-camphor [1858362]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (2000 CPS at 1%) [1299925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobacillic acid [2002583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil, light [577312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine [50749]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acidulated phosphate fluoride [236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlorofluoromethane [38578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirfenidone [1592254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trioxide [18330]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, bovine [2264114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine bitartrate [81990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calamine [106212]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin sulfate [1987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadexomer iodine [20012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypsin [10890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat&apos;s claw preparation [285223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxybate [2387308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide I123 [91531]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K3 [6728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenic acid [10989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose [27244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota spores, live [2636537]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon beta-1a [1546168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin alfa [1367075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursodiol [11065]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide acetate [2176311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etretinate [4182]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisacodyl [1596]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>helium [5140]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boric acid [1700]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>birch triterpenes [2675583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorine [1310123]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casanthranol [66870]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine [50675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (5000 CPS at 1%) [1307084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactase [41397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine hydrochloride [82130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oil of garlic [1309210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paraldehyde [7909]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sul hemipenthy [259379]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plerixafor [733003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor oil [1297880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium nitrate [25544]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin hydrochloride [82036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 1000 [1368863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxybate [2387307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride [10030]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluorohexyloctane [2637547]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine maleate [860647]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazinamide [8987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crotamiton [21766]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine hydrochloride [50676]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri subsp. reuteri F275 [2668424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol sodium phosphate [52549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus helveticus [1310845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum [1673942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloe extract [91263]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc pyrithione [39952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextranomer [22708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus GG [602811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexachlorophene [5293]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil [6972]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lasmiditan [2256930]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone hydrochloride [736680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrogen [7456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobenzone [17145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyacetone [3430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone [233698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podofilox [8463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoquinol [3435]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinamate [24474]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine [6694]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 8000 [1307312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K1 [8308]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine [3820]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoniazid [6038]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol [29491]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl hydrochloride [1115]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea preparation [228041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine succinate [2054091]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (4000 CPS at 1%) [1307036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenol [33290]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus bifidus [236855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diroximel fumarate [2261783]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar pitch volatiles [90732]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin microsphere [221175]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyllin copper complex [82242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamabrom [54365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed preparation [360375]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>devil&apos;s claw preparation [236279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>witch hazel [89821]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parachlorophenol [14982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>standardized enzyme lactase [221165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum 299 [2706643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium oxybate [2387309]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl [10811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide [2176312]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, human [825006]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine hydrochloride [82015]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ingenol mebutate [1242806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor (natural) [1298738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane [42736]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 4000 [1310594]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 200 [1368864]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lactate [215247]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate hydrochloride [235398]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginseng preparation [325526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle extract [283579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>feverfew extract [114203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane hydrochloride [1294534]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer sodium [2710445]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin [78903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer [2710434]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc undecylenate [89748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus BCMC 12130 [2639942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofinetide [2632852]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium undecylenate [89746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine hydrochloride [1426886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen peroxide [5499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heavy mineral oil [258439]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxybate [9899]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor [1952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloral hydrate [2344]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloperidone [73178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride [9873]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon [11363]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus [6204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ligilactobacillus salivarius [2110033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone tosylate [2275731]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl chloride [4141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liquefied phenol [239351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus [100278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talc [10323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonia spirit, aromatic [317201]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine hydrochloride [58130]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus casei [1592255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin [10528]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride dihydrate [1311371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone [2275602]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 20000 [1747569]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxamniquine [7778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Cellular or Molecular Interaction [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Unknown Physiological Effect [PE]</name>
  <code>C30216</code>  <id>30217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect</to_name>
    <to_code>T53697</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009925</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflexane [1540828]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crisaborole [1865953]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate [36702]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline sulfate [42836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium permanganate [8604]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclosan [10795]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir phosphate [259275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrogen [7456]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viltolarsen [2389840]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus crispatus [2054188]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine [3022]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium [1362690]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus helveticus [1310845]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum [1673942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric sulfate [24913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus [6205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus GG [602811]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazinamide [8987]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri [285156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab [2391541]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenate [314881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri subsp. reuteri F275 [2668424]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyllin copper complex [82242]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlorofluoromethane [38578]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>devil&apos;s claw preparation [236279]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate tetrahydrate [2104324]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline [110]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubidecarenone [21406]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (2000 CPS at 1%) [1299925]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflutren [283753]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobacillic acid [2002583]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus delbrueckii subsp. bulgaricus [100272]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine polypeptide oleate condensate [38624]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (4000 CPS at 1%) [1307036]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus bifidus [236855]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab [2387211]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (1500 MPA.S at 1%) [1312606]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota, live [2626724]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium undecylenate [1744166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir heminonahydrate [1600437]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc undecylenate [89748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus BCMC 12130 [2639942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium [1903]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginseng preparation [325526]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab-mwge [2391551]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle extract [283579]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>feverfew extract [114203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenic acid [10989]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose [27244]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icodextrin [140480]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec-rokl [2641674]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium I 131 [82097]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parachlorophenol [14982]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>standardized enzyme lactase [221165]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine bitartrate [81990]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum 299 [2706643]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal [9471]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir [260101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadexomer iodine [20012]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypsin [10890]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate anhydrous [1310549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fecal microbiota, live-jslm [2626728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus [100278]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur hexafluoride [1599276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus casei [1592255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (5000 CPS at 1%) [1307084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactase [41397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus [6204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ligilactobacillus salivarius [2110033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium undecylenate [89746]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succimer [3446]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine hydrochloride [1426886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec [2641675]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab-cxix [2387334]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen peroxide [5499]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium edetate [105745]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Unknown Physiological Effect [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Urate Transporter 1 Inhibitor [EPC]</name>
  <code>C652477</code>  <id>652477</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>URAT1 Inhibitor</to_name>
    <to_code>T53749</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RST Inhibitor</to_name>
    <to_code>T53753</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Solute Carrier Family 22 Member 12 Inhibitor</to_name>
    <to_code>T53755</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid Transporter 1 Inhibitor</to_name>
    <to_code>T53757</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>URAT-1 Inhibitor</to_name>
    <to_code>T53750</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OAT4L Inhibitor</to_name>
    <to_code>T53752</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter-1 Inhibitor</to_name>
    <to_code>T53758</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid Transporter-1 Inhibitor</to_name>
    <to_code>T53756</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLC22A12 Inhibitor</to_name>
    <to_code>T53754</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitor</to_name>
    <to_code>T53759</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 4-like Inhibitor</to_name>
    <to_code>T53751</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192341</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Urate Transporter 1 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Uricosuric agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Urate Transporter 1 Inhibitors [MoA]</name>
  <code>C652476</code>  <id>652476</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>OAT4L Inhibitors</to_name>
    <to_code>T53768</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitors</to_name>
    <to_code>T53770</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>URAT-1 Inhibitors</to_name>
    <to_code>T53760</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid Transporter-1 Inhibitors</to_name>
    <to_code>T53766</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Solute Carrier Family 22 Member 12 Inhibitors</to_name>
    <to_code>T53764</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>RST Inhibitors</to_name>
    <to_code>T53763</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>URAT1 Inhibitors</to_name>
    <to_code>T53761</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter-1 Inhibitors</to_name>
    <to_code>T53762</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>SLC22A12 Inhibitors</to_name>
    <to_code>T53765</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Organic Anion Transporter 4-like Inhibitors</to_name>
    <to_code>T53767</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid Transporter 1 Inhibitors</to_name>
    <to_code>T53769</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192340</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lesinurad [1731031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urate Transporter 1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Urease Inhibitor [EPC]</name>
  <code>C635004</code>  <id>635004</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitor</to_name>
    <to_code>T53778</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175611</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Urease Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acetohydroxamic acid [16728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Urease Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with enzyme inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Anti-infective agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Urease Inhibitors [MoA]</name>
  <code>C634448</code>  <id>634448</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitors</to_name>
    <to_code>T53780</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitor</to_name>
    <to_code>T53779</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175087</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohydroxamic acid [16728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohydroxamic acid [16728]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Urease Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Urethra Smooth Muscle Tone Alteration [PE]</name>
  <code>C30318</code>  <id>30319</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Urethra Smooth Muscle Tone Alteration</to_name>
    <to_code>T53800</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009975</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Urethra Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Urethra Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Urethra Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uric Acid-specific Enzyme [EPC]</name>
  <code>C635063</code>  <id>635063</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid Specific Enzyme</to_name>
    <to_code>T53813</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid-specific Enzyme</to_name>
    <to_code>T53814</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175670</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uric Acid-specific Enzyme [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Urate oxidase (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uric Acid-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pegloticase [1011650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uric Acid-specific Enzyme [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urate Oxidase [M0022307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uric Acid-specific Enzyme [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>rasburicase [283821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with hydrolase mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uric Acid-specific Enzyme [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uricosuric Activity [PE]</name>
  <code>C30158</code>  <id>30159</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uricosuric Activity</to_name>
    <to_code>T53815</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009896</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lesinurad [1731031]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uricosuric Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uricosuric Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uricosuric Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uterine Function Alteration [PE]</name>
  <code>C30160</code>  <id>30161</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Function Alteration</to_name>
    <to_code>T54025</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009897</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Proliferative Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Menstrual Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Secretory Phase Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uterine Menstrual Phase [PE]</name>
  <code>C30162</code>  <id>30163</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Menstrual Phase</to_name>
    <to_code>T54033</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009898</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Menstrual Phase [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Uterine Menstrual Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Menstrual Phase [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Menstrual Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uterine Proliferative Phase Alteration [PE]</name>
  <code>C30164</code>  <id>30165</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Proliferative Phase Alteration</to_name>
    <to_code>T54040</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009899</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Proliferative Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Uterine Proliferative Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Proliferative Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Proliferative Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uterine Secretory Phase Alteration [PE]</name>
  <code>C30166</code>  <id>30167</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Secretory Phase Alteration</to_name>
    <to_code>T54045</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009900</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Secretory Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inhibit Uterine Secretory Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Secretory Phase Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Stimulate Uterine Secretory Phase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Uterine Smooth Muscle Contraction or Tone [PE]</name>
  <code>C30168</code>  <id>30169</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Uterine Smooth Muscle Contraction or Tone</to_name>
    <to_code>T54046</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009901</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Smooth Muscle Contraction or Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Uterine Smooth Muscle Contraction or Tone [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Uterine Smooth Muscle Contraction or Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>V [Preparations]</name>
  <code>C288648</code>  <id>288648</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>V [Preparations]</to_name>
    <to_code>T54075</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010604</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vasoactive intestinal peptide [1942960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valnemulin [2604036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valganciclovir hydrochloride [283815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinbarbital [89811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vachellia farnesiana flower extract [1363469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K [11258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viscum album preparation [350489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin E acetate [2531274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velvetleaf huckleberry allergenic extract [2102487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vindesine [11204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanilla bean extract [2275721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitexin [2684982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vespa crabro preparation [1426670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitreoscilla lysate extract [2623998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinorelbine tartrate [114527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vilazodone hydrochloride [1086768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola tricolor extract [1371996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium myrtillus fruiting top extract [1311685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>volanesorsen sodium [2637346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbena extract [259380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vespula vulgaris whole extract [2709111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanillyl-N-nonylamide [39371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venlafaxine [39786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valley oak pollen extract [1111024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valerate [1370574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera fruit oil [1309486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis extract [730907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vaccinia virus strain New York City Board of Health live antigen [1492300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valacyclovir hydrochloride [236081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vibrio cholerae serotype Ogawa [100534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vancomycin hydrochloride [66955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vat violet 2 [2620179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinblastine [11198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viltolarsen [2389840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vadadustat [2679296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viloxazine hydrochloride [142143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vigna radiata extract [1428842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voretigene neparvovec-rzyl [1995538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vasopressin (USP) [11149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum thapsus leaf extract [1545042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vipera berus venom [1310462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veronica officinalis flowering top extract [1309952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium corymbosum whole extract [1859766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium angustifolium leaf extract [1307739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>verapamil [11170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valacyclovir hydrochloride monohydrate [2604686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinyl neodecanoate [2369641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verticillium albo-atrum allergenic extract [968467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanillyl butyl ether [1313189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varenicline tartrate [636674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitex negundo fruit extract [2592984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinpocetine [24506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velaglucerase alfa [901805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola odorata extract [1370786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vachellia farnesiana whole extract [1873116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin B complex [11251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vindesine sulfate [11205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vasicinone [2673585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbena officinalis extract [1425404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vedolizumab [1538097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin D [11253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veronicastrum virginicum root extract [259367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valoctocogene roxaparvovec-rvox [2641609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola philippica whole extract [2103289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venlafaxine besylate monohydrate [2605948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vildagliptin [596554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera pollen extract [2669695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin E d-alpha [220892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vandetanib [1098413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vardenafil hydrochloride [307306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viburnum opulus whole extract [2001816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vosoritide [2586354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbena officinalis leaf extract [2370871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vonoprazan fumarate [2604576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valproate [40254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velafermin [1317116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valencene [2569979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium vitis-idaea leaf extract [1314238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum thapsus extract [1334750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vericiguat [2475830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veronica officinalis whole extract [2119174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vamorolone [2669799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vismodegib [1242987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin MK7 [2001758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vecuronium bromide [11153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum densiflorum whole extract [1546363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanadyl sulfate [39364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vincamine [11201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venlafaxine hydrochloride [235988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viridiflorol [2374348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitex negundo whole extract [2601109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vigabatrin [14851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinburnine [57954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voxelotor [2265678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella zoster virus glycoprotein E [1986821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella-zoster virus vaccine live (Oka-Merck) strain [1292422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viscum album fruiting top extract [1311096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vidarabine anhydrous [2108659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbena officinalis flowering top extract [1309829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vilazodone [1086769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valeric acid [1546454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Valeriana officinalis whole extract [1537753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera leaf extract [1373038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera root oil [1865837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vilobelimab [2639620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K3 [6728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium myrtillus whole extract [1370109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella-zoster immune globulin [39385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valproic acid [11118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vidarabine [11194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola odorata flowering top extract [1307540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vilanterol [1424884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vincetoxicum atratum whole extract [2583629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viburnum lantana flower bud extract [2055750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valnemulin hydrochloride [2604037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum album root extract [1309682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valganciclovir [275891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vernonia appendiculata leaf extract [1433190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vatinoxan hydrochloride [2601583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vernonia appendiculata whole extract [2711361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>virginiamycin [11232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinyl dimethicone/methicone silsesquioxane crosspolymer [1855101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinyl acetate [1368177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viburnum prunifolium bark extract [1309955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinorelbine [39541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vibrio cholerae serotype Inaba [100533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>veal allergenic extract [1012026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum densiflorum flower extract [1495206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitex trifolia fruit extract [1311686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velvet grass pollen extract [852514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitex rotundifolia fruit extract [2390759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinyltrimethylsilyloxy silicate [2167853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum viride whole extract [2168395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>veralipride [39468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voclosporin [2475166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valbenazine tosylate [1923002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera whole extract [1358481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinylpyrrolidone-hexadecene copolymer [1551570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>versetamide [1370642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valerian oil [2593176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorasidenib [2690647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viscum album fruit extract [1310131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vetiveria zizanioides root extract [1309956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum album preparation [285168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vanilla planifolia leaf extract [2284287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitex agnus-castus whole extract [1441400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanilla bean allergenic extract [901291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinyldimethyl/trimethylsiloxysilicate sterile dimethicone crosspolymer [1788822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>von Willebrand factor, human [826072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vortioxetine hydrobromide [1439834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vibrio cholerae [1432992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valine [11115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin A [11246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanillin [1368176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera fruit rind [1992555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium myrtillus leaf extract [1309257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>verapamil hydrochloride [203138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venlafaxine besylate [2607741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola mandshurica flower extract [2385105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vecuronium [71535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velagliflozin proline [2665881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium myrtillus anthocyanosides extract [1926519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vatinoxan [2601584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viloxazine [11196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vernicia fordii seed oil [1488263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola patrinii whole extract [2586083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanzacaftor [2701431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varenicline [591622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viburnum opulus bark extract [1809840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin A palmitate [35406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valsartan [69749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vanilla planifolia seed extract [2590916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veronica beccabunga whole extract [2534466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vibrio cholerae CVD 103-HGR strain live antigen [1812935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Varicella Virus Vaccine Live (Oka-Merck) strain [805486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velagliflozin [2665880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viscum album leaf extract [1310003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vigna radiata whole extract [2533230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viscum album whole extract [1313973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vibegron [2472254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitex negundo flower extract [2360230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella zoster virus glycoprotein E, recombinant [1986820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viburnum opulus root [1309820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vaborbactam [1945213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera anthocyanins extract [1599641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>1-vinyl-2-pyrrolidone [1307764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valdecoxib [278567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera flowering top extract [1309485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K1 [8308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vonicog alfa [1812589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>verteporfin [118886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium macrocarpon whole extract [1794167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum viride root extract [1309737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vaccinia virus [1668221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium vitis-idaea fruit oil [2051582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>verdinexor [2539289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vincristine sulfate [11203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola adunca whole extract [2641893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola odorata leaf extract [1364407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vestronidase alfa [1989819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>volanesorsen [2637345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorapaxar [1537034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorasidenib citrate [2690648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vortioxetine [1455099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veronicastrum virginicum whole extract [2591819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Voacanga africana seed extract [1372477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera seed extract [1307966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vutrisiran [2604578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin MK6 [2607025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valbenazine [1918219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinblastine sulfate [11199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valacyclovir [73645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vanilla planifolia flower extract [1793747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorapaxar sulfate [1537050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valrubicin [31435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamine E acetate [1114513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viquidil hydrochloride [236343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera leaf oil [1742477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velmanase alfa-tycv [2630724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viscum album stem extract [2055749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vipivotide tetraxetan [2597054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanillylamine [156075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vaccinium angustifolium whole extract [1540240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voretigene neparvovec [1995537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin E [11256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin B6 [42954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valoctocogene roxaparvovec [2641610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vincristine [11202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum viride preparation [285240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>viquidil [39580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voriconazole [121243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vorinostat [194337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vat yellow 4 [2621121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vitis vinifera stem extract [2604575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum densiflorum flowering top extract [1368326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vutrisiran sodium [2605574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin A myristate [1813433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vincetoxicum atratum root extract [2053444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>varicella zoster immune globulin (human) [485576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Virola sebifera resin [1310276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veronica officinalis leaf extract [1801821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vardenafil hydrochloride trihydrate [1309396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanadium [11121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vemurafenib [1147220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venison allergenic extract [882488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vincristine sulfate liposome [1304990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valerian root extract [253206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanilla planifolia oil [1484502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin D3 [1244014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vancomycin [11124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vinca minor extract [1318233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>voxilaprevir [1939323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vanillin 2,3-butanediol acetal, cis- [1371314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velmanase alfa [2630725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K7 [2276893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vonoprazan [2604577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vimseltinib [2705378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vincristine liposome [1304991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vestronidase alfa-vjbk [1989818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valepotriate [236857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum phlomoides flower extract [1309716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>venetoclax [1747556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbena hastata top extract [1719248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vilanterol trifenatate [1424883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinylpyrrolidone-eicosene copolymer [1544135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vardenafil [306674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vetiver oil [1307788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin B12 [11248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum album whole extract [1663405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Verbascum densiflorum leaf extract [1307970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinyl chloride [1995489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>von Willebrand factor [11274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola japonica extract [2106425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin E DL-alpha [220893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Vanilla planifolia whole extract [1921560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>velpatasvir [1799206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vecuronium cation [1546399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Veratrum nigrum flowering top extract [1488817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K2 [42781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>V [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Viola odorata flower extract [2533917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>VEGFR1 Inhibitors [MoA]</name>
  <code>C300421</code>  <id>300421</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR1 Inhibitors</to_name>
    <to_code>T54117</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020031</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>VEGFR2 Inhibitors [MoA]</name>
  <code>C300422</code>  <id>300422</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2 Inhibitors</to_name>
    <to_code>T54118</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020032</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>VEGFR3 Inhibitors [MoA]</name>
  <code>C300423</code>  <id>300423</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR3 Inhibitors</to_name>
    <to_code>T54119</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020033</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vaccine [APC]</name>
  <code>C654125</code>  <id>654125</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaccine</to_name>
    <to_code>T58527</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193912</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Influenza A Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Haemophilus Influenzae B Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Corynebacterium Diphtheriae Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Human Papillomavirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Rotavirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Rotavirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Human Adenovirus Type 4 Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Human Adenovirus Type 7 Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Hepatitis A Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Rubella Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Salmonella Typhi Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Yellow Fever Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Bordetella Pertussis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Mumps Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Bacillus Anthracis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Measles Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Salmonella Typhi Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Japanese Encephalitis Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Pneumococcal Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pneumococcal 21-valent Conjugate Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Herpes Zoster Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Respiratory Syncytial Virus mRNA Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Rabies Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Meningococcal Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Influenza B Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Clostridium Tetani Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>COVID-19 mRNA Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Poliovirus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Vaccinia Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Tick-Borne Encephalitis Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Live Attenuated Varicella Zoster Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaccine [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Inactivated Hepatitis B Virus Vaccine [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vaccines, Tick-Borne Encephalitis [EXT]</name>
  <code>C654379</code>  <id>654379</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaccines, Tick-Borne Encephalitis</to_name>
    <to_code>T59067</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194162</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vaginal Function Alteration [PE]</name>
  <code>C30170</code>  <id>30171</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration</to_name>
    <to_code>T54228</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009902</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaginal Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaginal Function Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Secretion Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienestrol [3368]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Function Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vaginal Muscle Tone Alteration [PE]</name>
  <code>C30172</code>  <id>30173</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Muscle Tone Alteration</to_name>
    <to_code>T54229</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009903</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaginal Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vaginal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaginal Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vaginal Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vaginal Secretion Alteration [PE]</name>
  <code>C30174</code>  <id>30175</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vaginal Secretion Alteration</to_name>
    <to_code>T54233</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009904</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaginal Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vaginal Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vaginal Secretion Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vaginal Secretion [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Alterations [PE]</name>
  <code>C300387</code>  <id>300387</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Alterations</to_name>
    <to_code>T54317</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020002</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Alterations [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Permeability Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Alterations [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Alterations [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Alterations [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Inhibitor [EPC]</name>
  <code>C653914</code>  <id>653914</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitor</to_name>
    <to_code>T54350</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGF Inhibitor</to_name>
    <to_code>T54349</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193543</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ranibizumab [595060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab-tnjn [2700660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept [1232150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>aflibercept-mrbb [2706479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bevacizumab [253337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing angiogenesis inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Inhibitors [MoA]</name>
  <code>C653913</code>  <id>653913</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors</to_name>
    <to_code>T54352</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGF Inhibitors</to_name>
    <to_code>T54351</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193542</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab [2204915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab-dbll [2204916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziv-aflibercept [1304475]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-yszy [2715399]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-boav [2725885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab [2591519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-mrbb [2706479]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-ayyh [2696256]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab-svoa [2591584]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</name>
  <code>C650990</code>  <id>650990</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist</to_name>
    <to_code>T54356</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor-2 Antagonist</to_name>
    <to_code>T54355</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR-2 Antagonist</to_name>
    <to_code>T54353</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2 Antagonist</to_name>
    <to_code>T54354</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ramucirumab [1535922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing angiogenesis inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with angiogenesis inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions [MoA]</name>
  <code>C650986</code>  <id>650986</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2-directed Antibody Interactions</to_name>
    <to_code>T54357</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions</to_name>
    <to_code>T54359</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR-2-directed Antibody Interactions</to_name>
    <to_code>T54358</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191005</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody [EPC]</name>
  <code>C650989</code>  <id>650989</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR-2-directed Antibody</to_name>
    <to_code>T54362</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody</to_name>
    <to_code>T54363</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor-2-directed Antibody</to_name>
    <to_code>T54361</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR 2-directed Antibody</to_name>
    <to_code>T54360</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with angiogenesis inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing angiogenesis inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor 2-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</name>
  <code>C300392</code>  <id>300392</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors</to_name>
    <to_code>T54365</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Inhibitor</to_name>
    <to_code>T54364</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020007</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR3 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGFR1 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</name>
  <code>C635055</code>  <id>635055</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGF-directed Antibody Interactions</to_name>
    <to_code>T54391</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions</to_name>
    <to_code>T54392</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178291</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Endothelial Growth Factor-directed Antibody [EPC]</name>
  <code>C635056</code>  <id>635056</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VEGF-directed Antibody</to_name>
    <to_code>T54393</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody</to_name>
    <to_code>T54394</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178292</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with angiogenesis inhibitor mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing angiogenesis inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Endothelial Growth Factor-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Growth Alteration [PE]</name>
  <code>C300388</code>  <id>300388</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Alteration</to_name>
    <to_code>T54398</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020003</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Growth Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Increase [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Growth Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Growth Decrease [PE]</name>
  <code>C300390</code>  <id>300390</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease</to_name>
    <to_code>T54400</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Angiogenesis Inhibition</to_name>
    <to_code>T54399</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020005</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab-dbll [2204916]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab [2204915]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Decrease [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Growth Increase [PE]</name>
  <code>C300389</code>  <id>300389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Growth Increase</to_name>
    <to_code>T54401</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020004</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Permeability Alteration [PE]</name>
  <code>C31858</code>  <id>31859</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Permeability Alteration</to_name>
    <to_code>T54409</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010250</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Permeability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Permeability Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Permeability [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Sclerosing Activity [PE]</name>
  <code>C30176</code>  <id>30177</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity</to_name>
    <to_code>T54411</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009905</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talc [10323]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium morrhuate [9892]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine [24457]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 [236545]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 phosphate [2373964]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine oleate [24460]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine thenoate [236213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine hydrochloride [1311530]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Sclerosing Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Smooth Muscle Tone Alteration [PE]</name>
  <code>C31896</code>  <id>31897</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Smooth Muscle Tone Alteration</to_name>
    <to_code>T54412</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010269</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Smooth Muscle Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vascular Smooth Muscle Tone [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vascular Tone Alteration [PE]</name>
  <code>C30178</code>  <id>30179</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Tone Alteration</to_name>
    <to_code>T54415</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009906</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Smooth Muscle Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vascular Tone Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant [1148138]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant acetate [1294605]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vascular Tone Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration [PE]</name>
  <code>C30180</code>  <id>30181</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration</to_name>
    <to_code>T54440</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009907</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoactive Intestinal Polypeptide (VIP) Activity Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased VIP Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasoconstriction [PE]</name>
  <code>C30182</code>  <id>30183</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction</to_name>
    <to_code>T54441</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009908</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine hydrochloride [1744461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab [2055641]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab-gnlm [2058868]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argipressin [1098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droxidopa [1489913]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab-flyo [2055640]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ether [1363043]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II acetate, human [2204740]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab [2058846]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II [1999003]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasoconstrictor [EPC]</name>
  <code>C652790</code>  <id>652790</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstrictor</to_name>
    <to_code>T54442</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192562</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoconstrictor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vasopressor (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoconstrictor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoconstrictor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>oxymetazoline [7812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasoconstrictor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>angiotensin II [1999003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasodilation [PE]</name>
  <code>C30184</code>  <id>30185</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation</to_name>
    <to_code>T54443</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009909</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arterial Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine hydrochloride [236481]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetiedil [20609]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil [27403]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib [2044896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine sulfate [82042]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flosequinan [25089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil [19836]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil tartrate [289912]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine [51253]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine hydrochloride [284157]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythritol [1369563]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riociguat [1439816]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclandelate [2970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib disodium [2055929]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroprusside [7476]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil hydrochloride [235934]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine [6756]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resveratrol [1000492]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urapidil [39230]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrous oxide [7486]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetiedil citrate [236204]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasodilator [EPC]</name>
  <code>C635378</code>  <id>635378</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilator</to_name>
    <to_code>T54444</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175940</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nitrate Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Soluble Guanylate Cyclase Stimulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Arteriolar Vasodilator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vasodilator (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitroprusside [7476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nitric oxide [7442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasodilator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Prostacycline [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Analog [EPC]</name>
  <code>C635343</code>  <id>635343</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Analogue</to_name>
    <to_code>T54448</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Analog</to_name>
    <to_code>T54449</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175905</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>desmopressin [3251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vasopressins [M0022562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing antidiuretic hormone (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Antidiuretic hormone (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Agonist [EPC]</name>
  <code>C654263</code>  <id>654263</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonist</to_name>
    <to_code>T58795</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194045</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vasopressin receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terlipressin [57048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with vasopressin receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Cardiovascular agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Agonists [MoA]</name>
  <code>C654262</code>  <id>654262</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonists</to_name>
    <to_code>T58794</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194046</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terlipressin [57048]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Antagonist [EPC]</name>
  <code>C637830</code>  <id>637830</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonist</to_name>
    <to_code>T54450</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178376</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vasopressin receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with vasopressin receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin Receptor Antagonists [MoA]</name>
  <code>C300434</code>  <id>300434</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists</to_name>
    <to_code>T54451</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020044</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V3 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin Receptor Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atosiban acetate [2680385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atosiban [59639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V1 Receptor Antagonists [MoA]</name>
  <code>C653533</code>  <id>653533</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V1A Receptor Antagonists</to_name>
    <to_code>T54452</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V1 Receptor Antagonists</to_name>
    <to_code>T54453</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193179</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V1 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V2 Receptor Antagonist [EPC]</name>
  <code>C653535</code>  <id>653535</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonist</to_name>
    <to_code>T54454</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193181</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin V2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tolvaptan [358257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vasopressin V2 Receptor Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V2 Receptor Antagonists [MoA]</name>
  <code>C653532</code>  <id>653532</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonists</to_name>
    <to_code>T54455</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193178</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolvaptan [358257]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V2 Receptor Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vasopressin V3 Receptor Antagonists [MoA]</name>
  <code>C653534</code>  <id>653534</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V3 Receptor Antagonists</to_name>
    <to_code>T54457</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vasopressin V1B Receptor Antagonists</to_name>
    <to_code>T54456</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193180</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Venom Neutralization [MoA]</name>
  <code>C643675</code>  <id>643675</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization</to_name>
    <to_code>T54501</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184010</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus adamanteus antivenin [885185]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus scutulatus antivenin [885189]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Latrodectus mactans antivenin [89887]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus atrox antivenin [885187]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 (equine) [2101270]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>North American coral snake antivenin [979384]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Agkistrodon piscivorus antivenin [885183]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Centruroides (scorpion) immune F(ab&apos;)2 (equine) [1119986]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 [2101271]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venom Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Venous Vasoconstriction [PE]</name>
  <code>C30186</code>  <id>30187</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasoconstriction</to_name>
    <to_code>T54511</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009910</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Venous Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Venous Vasoconstriction [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasoconstriction [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Venous Vasodilation [PE]</name>
  <code>C30188</code>  <id>30189</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation</to_name>
    <to_code>T54512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009911</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Venous Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Systemic Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Venous Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Penile Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Venous Vasodilation [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pulmonary Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetranitrate [7992]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Venous Vasodilation [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ventilatory Gas Flow Alteration [PE]</name>
  <code>C30190</code>  <id>30191</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventilatory Gas Flow Alteration</to_name>
    <to_code>T54515</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009912</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ventilatory Gas Flow Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Ventilatory Gas Flow [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Ventilatory Gas Flow Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Ventilatory Gas Flow [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ventricular Depolarization [PE]</name>
  <code>C30192</code>  <id>30193</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Depolarization</to_name>
    <to_code>T54516</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009913</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Ventricular Repolarization [PE]</name>
  <code>C30194</code>  <id>30195</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization</to_name>
    <to_code>T54540</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009914</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Ventricular Repolarization [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</name>
  <code>C650830</code>  <id>650830</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitor</to_name>
    <to_code>T54622</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190856</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tetrabenazine [10390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with vesicular monoamine transporter 2 inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vesicular monoamine transporter 2 inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>valbenazine [1918219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Central nervous system agent (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</name>
  <code>C650829</code>  <id>650829</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors</to_name>
    <to_code>T54623</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000190855</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine tosylate [1923002]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter Antagonists [MoA]</name>
  <code>C637787</code>  <id>637787</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VMAT Antagonists</to_name>
    <to_code>T54624</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Antagonists</to_name>
    <to_code>T54625</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178333</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter Antagonists [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter 2 Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vesicular Monoamine Transporter Interactions [MoA]</name>
  <code>C637786</code>  <id>637786</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Interactions</to_name>
    <to_code>T54627</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>VMAT Interactions</to_name>
    <to_code>T54626</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000178332</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vesicular Monoamine Transporter Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vesicular Monoamine Transporter Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vinca Alkaloid [EPC]</name>
  <code>C635005</code>  <id>635005</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vinca Alkaloid</to_name>
    <to_code>T54694</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175612</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vinca Alkaloid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinblastine [11198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vinca Alkaloid [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vinca alkaloid (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vinca Alkaloid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vinca Alkaloids [M0022674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vinca Alkaloid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vincristine [11202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vinca Alkaloid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vinorelbine [39541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing alkaloid (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vinca Alkaloid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Viral Envelope Interactions [MoA]</name>
  <code>C300479</code>  <id>300479</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Interactions</to_name>
    <to_code>T54730</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020089</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Viral Envelope Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Fusion Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Viral Envelope Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Viral Envelope Wrapping Protein Inhibitors [MoA]</name>
  <code>C654077</code>  <id>654077</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors</to_name>
    <to_code>T58463</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193860</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat monohydrate [2055677]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticovirimat monohydrate [2055103]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir sodium [2625652]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Viral Envelope Wrapping Protein Interactions [MoA]</name>
  <code>C654076</code>  <id>654076</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Interactions</to_name>
    <to_code>T58462</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193861</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Viral Envelope Wrapping Protein Interactions [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Envelope Wrapping Protein Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Viral Therapy [APC]</name>
  <code>C654289</code>  <id>654289</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Viral Therapy</to_name>
    <to_code>T58884</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194073</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Viral Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adeno-associated Virus Vector-based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Viral Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adeno-associated Virus Vector [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Viral Therapy [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adenovirus Vector-Based Gene Therapy [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Virus Neutralization [MoA]</name>
  <code>C643674</code>  <id>643674</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization</to_name>
    <to_code>T54774</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184009</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine, inactivated [845525]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 2 (MEF-1) [763098]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster immune globulin [39385]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bebtelovimab [2592360]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 1 (Mahoney) [763096]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin [22178]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin, human [1997443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B immune globulin [26744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human vaccinia immune globulin [597392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated [1300779]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster immune globulin (human) [485576]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus vaccine inactivated, type 3 (Saukett) [763100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus Neutralization [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Virus-specific Hyperimmune Globulins [EXT]</name>
  <code>C643879</code>  <id>643879</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus-specific Hyperimmune Globulins</to_name>
    <to_code>T54775</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000184152</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Virus-specific Hyperimmune Globulins [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hepatitis B hyperimmune globulin [M0131598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Virus-specific Hyperimmune Globulins [EXT]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cytomegalovirus-specific hyperimmune globulin [M0132945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human vaccinia immune globulin [597392]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus-specific Hyperimmune Globulins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B immune globulin [26744]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus-specific Hyperimmune Globulins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MeSH</from_namespace><from_name>Immunoglobulins [M0011122]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus-specific Hyperimmune Globulins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin, human [1997443]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Virus-specific Hyperimmune Globulins [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Viruses, Genetically-modified [EXT]</name>
  <code>C651806</code>  <id>651806</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Viruses, Genetically-modified</to_name>
    <to_code>T54777</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EXT</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191722</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin A [EPC]</name>
  <code>C635388</code>  <id>635388</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin A-class Agent</to_name>
    <to_code>T54797</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin A</to_name>
    <to_code>T54798</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175950</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin A [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin A [11246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin A [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Retinol (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin A [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin A [M0022788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin A [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing retinol (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin B Complex Member [EPC]</name>
  <code>C635120</code>  <id>635120</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B Complex Member</to_name>
    <to_code>T54814</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175714</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B Complex Member [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vitamin B and/or vitamin B derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B Complex Member [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Complex [M0022792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B Complex Member [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vitamin B and/or vitamin B derivative (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B Complex Member [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>4-aminobenzoic acid [74]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin B12 Analog [EPC]</name>
  <code>C635344</code>  <id>635344</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B 12 Analog</to_name>
    <to_code>T54819</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12 Analog</to_name>
    <to_code>T54820</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12 Analogue</to_name>
    <to_code>T54817</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B 12 Analogue</to_name>
    <to_code>T54818</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175906</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B12 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B12 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 12 [M0022794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vitamin B12 and/or vitamin B12 derivative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing vitamin B12 and/or vitamin B12 derivative (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin B12 [EPC]</name>
  <code>C635389</code>  <id>635389</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12</to_name>
    <to_code>T54822</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12-class Agent</to_name>
    <to_code>T54821</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175951</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B12 [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin B12 [11248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B12 [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vitamin B12 and/or vitamin B12 derivative (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B12 [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 12 [M0022794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B12 [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vitamin B12 and/or vitamin B12 derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin B6 Analog [EPC]</name>
  <code>C653096</code>  <id>653096</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B 6 Analogue</to_name>
    <to_code>T54823</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B6 Analog</to_name>
    <to_code>T54826</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B6 Analogue</to_name>
    <to_code>T54825</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B 6 Analog</to_name>
    <to_code>T54824</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000192800</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B6 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 6 [M0018248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B6 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin B6 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pyridoxine [684879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing vitamin B and/or vitamin B derivative (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B6 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vitamin B6 and/or vitamin B6 derivative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B6 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin C [EPC]</name>
  <code>C654005</code>  <id>654005</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin C-class Agent</to_name>
    <to_code>T54827</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin C</to_name>
    <to_code>T54828</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193618</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin C [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ascorbic acid [1151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin C [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascorbic Acid [M0001797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin D Analog [EPC]</name>
  <code>C635287</code>  <id>635287</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analogue</to_name>
    <to_code>T54830</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analog</to_name>
    <to_code>T54829</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175849</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcipotriene [29365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin D [M0022797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paricalcitol [73710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Vitamin D and/or vitamin D derivative (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing vitamin D and/or vitamin D derivative (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin D [EPC]</name>
  <code>C635390</code>  <id>635390</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D</to_name>
    <to_code>T54835</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D-class Agent</to_name>
    <to_code>T54834</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175952</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vitamin D and/or vitamin D derivative (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>cholecalciferol [2418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin D [M0022797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vitamin D and/or vitamin D derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin D2 Analog [EPC]</name>
  <code>C635345</code>  <id>635345</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analog</to_name>
    <to_code>T54846</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analogue</to_name>
    <to_code>T54845</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175907</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D2 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxercalciferol [11516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D2 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D2 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergocalciferols [M0007651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D2 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>paricalcitol [73710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing ergocalciferol (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Ergocalciferol (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin D3 Analog [EPC]</name>
  <code>C635346</code>  <id>635346</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analogue</to_name>
    <to_code>T54856</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analog</to_name>
    <to_code>T54857</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175908</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D3 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholecalciferol [M0004229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D3 Analog [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>analogs &amp; derivatives [M0030233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D3 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcitriol [1894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin D3 Analog [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>calcifediol anhydrous [1855064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing colecalciferol (medicinal product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Colecalciferol (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin K Antagonist [EPC]</name>
  <code>C634857</code>  <id>634857</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Antagonist</to_name>
    <to_code>T54878</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175476</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K Antagonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>warfarin [11289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K Antagonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Antagonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin K Epoxide Reductase Inhibitors [MoA]</name>
  <code>C506</code>  <id>507</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors</to_name>
    <to_code>T54882</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000164</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin potassium [82118]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin sodium [114194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin K Inhibitors [MoA]</name>
  <code>C635418</code>  <id>635418</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Inhibitors</to_name>
    <to_code>T54885</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175964</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K Inhibitors [MoA]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Epoxide Reductase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin K [EPC]</name>
  <code>C639683</code>  <id>639683</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K-class Agent</to_name>
    <to_code>T54887</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K</to_name>
    <to_code>T54888</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000180191</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing vitamin K and/or vitamin K derivative (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Vitamin K and/or vitamin K derivative (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin K [M0022806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin K [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K1 [8308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin Uptake and Modification Alteration [PE]</name>
  <code>C30232</code>  <id>30233</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin Uptake and Modification Alteration</to_name>
    <to_code>T54894</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PE</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000009932</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin Uptake and Modification Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin Uptake and Modification Alteration [PE]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Vitamin Uptake and Modification [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin Uptake and Modification Alteration [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Vitamin or Mineral [APC]</name>
  <code>C654097</code>  <id>654097</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin or Mineral</to_name>
    <to_code>T58507</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>APC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193877</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Calcium [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Provitamin D2 Compound [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B12 [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin K [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Nicotinic Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B Complex Member [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D3 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D2 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin C [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin B6 Analog [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin D [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Parenteral Iron Replacement [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Vitamin A [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Vitamin or Mineral [APC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Potassium Salt [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Voltage-gated Calcium Channel Receptor Antagonists [MoA]</name>
  <code>C300457</code>  <id>300457</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Voltage-gated Calcium Channel Receptor Antagonists</to_name>
    <to_code>T54945</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000020067</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Volume of distribution [PK]</name>
  <code>C216</code>  <id>217</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Volume of distribution</to_name>
    <to_code>T54946</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000019</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>W [Preparations]</name>
  <code>C288649</code>  <id>288649</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>W [Preparations]</to_name>
    <to_code>T54967</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010605</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wood tar hydrocarbon distillate [1537751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white mustard seed allergenic extract [2102844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat middlings extract [1427080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white wax [11327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white bryony extract [236988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watermelon seed oil [1747703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape juice [1429968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white sweetclover top extract [1996983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western juniper pollen extract [852589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>winged elm whole extract [1657759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat bran allergenic extract [1012140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>whortleberry substance [581386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wild oat whole extract [1657725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat pollen extract [867361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Waltheria indica leaf extract [1370105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wasabi preparation [1009447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western sycamore pollen extract [852750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>whole eriodictyon californicum extract [1432475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water [11295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white kidney bean allergenic extract [1012179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white ash pollen extract [852450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wing scale pollen extract [852074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western black willow pollen extract [1014755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wasp venoms [11291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white fish allergenic extract [901265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wormwood sage pollen extract [852007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wasabi root extract [1309429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape allergenic extract [892317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>walnut allergenic extract [314470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wood ant preparation [1311080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white mulberry pollen extract [852669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>whey protein hydrolysate [2266754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western ragweed pollen extract [851985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white seedless grape allergenic extract [904815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white hickory pollen extract [852193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white mulberry extract [1307721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white oak bark extract [1319902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wild thyme extract [2286806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white spirit type 1 [1301854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat germ oil unsaponifiables [2594592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watermelon preparation [260014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western yellow jacket venom protein [1297535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat sprout extract [1482550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>West Nile virus [1316080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white pepper allergenic extract [1011633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>West Indian lemongrass oil [1305654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>warfarin sodium [114194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western waterhemp pollen extract [851934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wasp venom protein [260051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white (mexican) dock pollen extract [1014743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Withania somnifera root extract [1309279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>winter savory oil [2105837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white oak pollen extract [852294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Withania somnifera flower extract [1307643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat smut allergenic extract [852797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wormwood extract [1309324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Withania somnifera leaf extract [1307587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>warfarin [11289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat dextrin [637366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>whole Melia azederach extract [1432474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white pine oil [1306057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water birch pollen extract [852166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat bran extract [1427046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>whole wheat allergenic extract [901299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white poplar whole extract [1657755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white rice extract [1315124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Wolfiporia cocos sclerotium extract [2697972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>withanolide D [2604033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Wyethia helenioides root extract [1310148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Wolfiporia extensa whole extract [1803878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white catfish allergenic extract [971166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Withania somnifera whole extract [1876359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white poplar pollen extract [852382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watercress preparation [287516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>witch hazel [89821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Whey Proteins [1723989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>weakleaf bur ragweed pollen extract [1117083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white sweet clover pollen extract [1014735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water, O-18 [1551628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white kidney bean extract [616546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat germ preparation [314896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white currant fruit extract [2045113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white alder pollen extract [851910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>winterfat pollen extract [852613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western white pine pollen extract [900743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white pepper oil [1442510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white willow pollen extract [1484986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>warfarin potassium [82118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat germ oil [72385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wild yam extract [237020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wine grape extract [1307718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water oak pollen extract [1013944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watermelon seed extract [1716106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white-tailed deer hair extract [895538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat preparation [1441652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wogonin [2001619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wormwood oil [1305653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western wheatgrass pollen extract [852659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watercress allergenic extract [1011418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>western larch pollen extract [2166614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>water, O-15 [1427071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>walnut oil [1337618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>watermelon allergenic extract [901258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white mustard seed extract [1486503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>wheat gluten extract [1370781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>W [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>white tea extract [1651698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Warfarin Reversal Agent [EPC]</name>
  <code>C635420</code>  <id>635420</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Warfarin Reversal Agent</to_name>
    <to_code>T55028</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175966</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Warfarin Reversal Agent [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vitamin K1 [8308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Warfarin Reversal Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Reversed Anticoagulation Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>Warfarin Reversal Agent [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Increased Prothrombin Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>X [Preparations]</name>
  <code>C288650</code>  <id>288650</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>X [Preparations]</to_name>
    <to_code>T55235</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010606</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthoxylum clava-herculus bark extract [1863581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylose [11378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xenon-133 [259282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylenesulfonate [1370601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xenon-129, hyperpolarized [2626220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xenon [11363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylityl sesquicaprylate [2589609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xymenynic acid [2556902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthium sibiricum fruit extract [1994296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylene [1311378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanomeline [2694828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylazine hydrochloride [1366222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanthinol [89795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylitylglucoside [1314249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthoxylum clava-herculus whole extract [1863582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xamoterol fumarate [82133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xerophyllum asphodeloides extract [1318234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xenon-129 [2626219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanthan gum [1307815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanomeline tartrate [2694829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthium sibiricum whole extract [1991791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylometazoline [39841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylazine [1099660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xibornol [39823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanthine [1311085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthium extract [1318237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthium strumarium fruit extract [1311687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylitan [1356678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xamoterol [39801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylometazoline hydrochloride [54220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xylitol [11377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xanthium strumarium leaf extract [2637753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xipamide [11371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>xanthinol niacinate [11358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>X [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Xoimenia americana seed extract [2268032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>X-Ray Contrast Activity [MoA]</name>
  <code>C31874</code>  <id>31875</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Radiocontrast Activity</to_name>
    <to_code>T55263</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity</to_name>
    <to_code>T55264</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010258</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate sodium [3321]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium sulfate [1331]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate meglumine [5971]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoic acid [1546223]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopromide [27781]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iothalamate [9886]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate [3319]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioversol [27792]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate meglumine [3320]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxilan [27793]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iomeprol [2606484]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iohexol [5956]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate [5973]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate [5970]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate meglumine [66895]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethiodized oil [4125]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobitridol [87639]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopamidol [5966]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate sodium [66896]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iso-sulfan blue [27863]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamic acid [1546451]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodixanol [27729]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>X-Ray Contrast Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Xanthine Oxidase Inhibitor [EPC]</name>
  <code>C635104</code>  <id>635104</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitor</to_name>
    <to_code>T55281</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175698</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>allopurinol [519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>febuxostat [73689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with xanthine oxidase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Xanthine Oxidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing xanthine oxidase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Xanthine Oxidase Inhibitors [MoA]</name>
  <code>C590</code>  <id>591</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitors</to_name>
    <to_code>T55282</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000206</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol sodium [80566]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febuxostat [73689]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol [519]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Xanthine Oxidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Y [Preparations]</name>
  <code>C288651</code>  <id>288651</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Y [Preparations]</to_name>
    <to_code>T55359</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010607</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow-fever virus [221182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yucca extract [259283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yucca filamentosa extract [1342492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yucca schidigera stem [2376938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yohimbine hydrochloride [133041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yohimbine [220982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow dock pollen extract [852209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>169 ytterbium [90719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yucca schidigera extract [1425403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yucca root [283587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow phenolphthalein [314784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yttrium bromide [1313761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yellow Fever Vaccine [89890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yucca glauca root extract [1312084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yeast, beta-D-glucan [2563625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ytterbium oxide [1311103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow pine pollen extract [852716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow jacket venom protein [285170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yarrow flower extract [1309259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yucca schidigera root extract [1307701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow hornet venom [124431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow hornet venom protein [1297537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow sweet clover pollen extract [1014447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ytterbium [1311498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yersinia enterocolitica [1426679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Yersinia pestis [1432993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellowfin tuna allergenic extract [2102488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yohimbe bark preparation [236801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yttrium fluoride [1313762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>YUCATAN MINIATURE PIG LDLR GENE DISRUPTED BY A LDLR-NEO RDNA CONSTRUCT IN EXON 4 [2204568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow birch pollen extract [899550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow OB [1874282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yellow fever virus strain 17D-204 live antigen [804187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yttrium iodide [1313763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yttrium [1534770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Y [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>yeast mannan preparation [1311129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Z [Preparations]</name>
  <code>C288652</code>  <id>288652</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Z [Preparations]</to_name>
    <to_code>T55412</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>HC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010608</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zopapogene imadenovec [2723361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum piperitum fruit pulp extract [1311581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zirconium oxide [39972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum armatum var. armatum fruit extract [1311688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zeatin [1440227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc lactate [1305755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc gluconate [58300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc succinate [1875229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc [11416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc nicotinate [236834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zuclopenthixol [114176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zein [1314423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zoledronic acid anhydrous [1546014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc acetate [58295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc pidolate [1426280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zeaxanthin [39918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zilpaterol [1727538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zuclopenthixol decanoate [58339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc citrate [236911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zotepine [40003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolpidem tartrate [221183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc picrate [1546362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum fagara whole extract [2665291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc peroxide [1431227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zea mays subsp. mays whole extract [1484280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc dibutyldithiocarbamate [1426942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc sulfate, heptahydrate [1311282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc acetylmethionate [1370110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zostera marina whole extract [1798359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc glycinate [1306063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc carbonate [39935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanidatamab-hrii [2698200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc picolinate [58301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc methionine sulfate [1426409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolazepam [1535252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziprasidone [115698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zafirlukast [114970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(3Z)-hex-3-en-1-yl methyl carbonate [2557369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zedoary oil [1918040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum schinifolium fruit extract [2049548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc carbobenzoxy-.beta.-alanyltaurinate [2168092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zilpaterol hydrochloride [1727537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc gluconate trihydrate [1440975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zonisamide [39998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc ascorbate [1549114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum americanum bark extract [1310155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc undecylenate [89748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zopapogene imadenovec-drba [2723360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum bungeanum fruit extract [1360629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zizia aurea root extract [1719247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zucchini extract [1649134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc valerate [1546360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc phenolsulfonate [89831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolazepam hydrochloride [1999183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zizia aurea whole extract [2591605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc sulfate monohydrate [1309410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziprasidone hydrochloride [1294533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zenocutuzumab [2699588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolbetuximab [2695869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc myristate [1313975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziprasidone hydrochloride, monohydrate [284925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc ricinoleate [1367132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zuclopenthixol dihydrochloride [102546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc alum [2360431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zucchini allergenic extract [2588250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziprasidone hydrochloride anhydrous [1362139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zingiber moutanum flowering top extract [1421436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zalcitabine [3363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum piperitum fruit rind extract [1435637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanidatamab [2698198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zaleplon [74667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc phosphate [1602285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zaire ebolavirus envelope glycoprotein [2624742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zaocys dhumnades preparation [2586082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zinnia elegans whole extract [2533918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zingerone [2199325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zofenopril calcium [259493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zirconium cyclosilicate ion [2583873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziconotide acetate [486126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zileuton [40575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zingiber officinale whole extract [1372563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zingiber cassumunar root extract [1305630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc phosphate tetrahydrate [1602284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc, chelated [253210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ziziphus jujuba var. spinosa seed extract [2565690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc glycinate citrate [1306062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc sulfate [39954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc laurate [1426399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zoledronic acid [77655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>(9Z)-9-octadecenyl acetate [1995480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum nitidum root extract [1365708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zipeprol [39969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zofenopril [39990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein [2624741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc citrate trihydrate [1371907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc iodide [1921759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zomepirac [39994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanamivir [69722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc valerate dihydrate [1309408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc orotate [11422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolmitriptan [135775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziftomenib [2725985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zingiberensis saponin I [2676753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zilucoplan sodium [2672492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc stearate [1310553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ziziphus extract [1426423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zanubrutinib [2262435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc phosphide [1594583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zuclopenthixol acetate [58338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zomepirac sodium [58331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zirconium [1534771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc chloride [39937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zavegepant [2637955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zingiber cassumunar root oil [1541712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc sulfate anhydrous [1299928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc bromide [88188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum bungeanum whole extract [1369690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc palmitate [1551459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zeaxanthin, meso- [2531030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zirconium carbonate hydroxide oxide [1921889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc methionine [60761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zidovudine [11413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zopiclone [40001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc oxide [11423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zongertinib [2721604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolbetuximab-clzb [2695870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zeltnera venusta whole flowering extract [1945471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc picrate nonahydrate [1546361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc sulfide [1733817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zilucoplan [2672489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum schinifolium whole extract [1358886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc-DTPA [11431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zeranol [1368476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziconotide [68503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zostera marina seed extract [1803001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum piperitum whole extract [1489551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zantedeschia aethiopica flower extract [2591604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zavegepant hydrochloride [2637956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc pyrithione [39952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum zanthoxyloides bark extract [1597624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziprasidone mesylate [353116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zuranolone [2669905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc hydroxide [42279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolpidem [39993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc aspartate [236142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zenocutuzumab-zbco [2699587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Zanthoxylum bungeanum fruit rind extract [1367687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zinc cation [1546264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ziv-aflibercept [1304475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zeolite A [2281673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Z [Preparations]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>Ziziphus jujuba var. inermis whole extract [2570735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</name>
  <code>C654248</code>  <id>654248</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire EBOV GP-directed Antibody Interactions</to_name>
    <to_code>T58772</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions</to_name>
    <to_code>T58771</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194037</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab [2472152]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</name>
  <code>C654247</code>  <id>654247</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody</to_name>
    <to_code>T58769</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire EBOV GP-directed Antibody</to_name>
    <to_code>T58770</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194038</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ansuvimab [2472152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing monoclonal antibody (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with antiviral mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Monoclonal antibody (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>Zero Order [PK]</name>
  <code>C294</code>  <id>295</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>Zero Order</to_name>
    <to_code>T55512</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>PK</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000058</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha Glucosidase Inhibitors [MoA]</name>
  <code>C510</code>  <id>511</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Glucosidase Inhibitors</to_name>
    <to_code>T55681</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Alpha-glucosidase Inhibitor</to_name>
    <to_code>T55679</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Glucosidase Inhibitors</to_name>
    <to_code>T55680</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000166</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acarbose [16681]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglitol [30009]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-1 Adrenergic Agonist [EPC]</name>
  <code>C645955</code>  <id>645955</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Agonist</to_name>
    <to_code>T55691</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Receptor Agonist</to_name>
    <to_code>T55690</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000186105</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-1 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenylephrine [8163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-1 Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha1-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing alpha adrenergic receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with alpha adrenergic receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Agonist [EPC]</name>
  <code>C634945</code>  <id>634945</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Receptor Agonist</to_name>
    <to_code>T55704</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Agonist</to_name>
    <to_code>T55705</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175552</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing alpha adrenergic receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine [3966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with alpha adrenergic receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-1 Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Central alpha-2 Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>apraclonidine [14845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine [3992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pseudoephedrine [8896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>brimonidine [134615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>midodrine [6963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Blocker [EPC]</name>
  <code>C634946</code>  <id>634946</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Receptor Inhibitor</to_name>
    <to_code>T55707</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Antagonist</to_name>
    <to_code>T55706</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Blocker</to_name>
    <to_code>T55708</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175553</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>doxazosin [49276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phentolamine [8153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dapiprazole [22298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>phenoxybenzamine [8149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvedilol [20352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing alpha adrenergic receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>alfuzosin [17300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>silodosin [720825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic alpha-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tamsulosin [77492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>prazosin [8629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>terazosin [37798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with alpha adrenergic receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic Decongestant [EPC]</name>
  <code>C635395</code>  <id>635395</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Decongestant</to_name>
    <to_code>T55709</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175957</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Decongestant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with alpha adrenergic receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing alpha adrenergic receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic Decongestant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic and beta-Adrenergic Agonist [EPC]</name>
  <code>C635105</code>  <id>635105</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Adrenergic and beta Adrenergic Agonist</to_name>
    <to_code>T55710</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed alpha-Adrenergic and beta-Adrenergic Receptor Agonist</to_name>
    <to_code>T55714</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed alpha Adrenergic and beta Adrenergic Agonist</to_name>
    <to_code>T55712</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed alpha-Adrenergic and beta-Adrenergic Agonist</to_name>
    <to_code>T55713</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Receptor Agonist</to_name>
    <to_code>T55716</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mixed alpha Adrenergic and beta Adrenergic Receptor Agonist</to_name>
    <to_code>T55715</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Adrenergic and beta Adrenergic Receptor Agonist</to_name>
    <to_code>T55719</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Agonist</to_name>
    <to_code>T55720</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha and beta Adrenergic Receptor Agonist</to_name>
    <to_code>T55711</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha/beta Adrenergic Agonist</to_name>
    <to_code>T55717</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha and beta Adrenergic Agonist</to_name>
    <to_code>T55718</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175699</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic and beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with alpha-adrenergic and beta-adrenergic agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing adrenergic receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Adrenergic and beta-Adrenergic Blocker [EPC]</name>
  <code>C635391</code>  <id>635391</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Blocker</to_name>
    <to_code>T55722</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha/beta-Adrenergic Blocking Agent</to_name>
    <to_code>T55721</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175953</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Adrenergic and beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Alpha/beta-adrenergic blocking agent (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing adrenergic neurone blocker (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Adrenergic and beta-Adrenergic Blocker [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Galactosidase A Pharmacological Chaperone [EPC]</name>
  <code>C654068</code>  <id>654068</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Gal A Pharmacological Chaperone</to_name>
    <to_code>T58449</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Galactosidase A Pharmacological Chaperone</to_name>
    <to_code>T58448</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000193850</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Galactosidase A Pharmacological Chaperone [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Pharmacological Chaperone [EXT]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Glucosidase Inhibitor [EPC]</name>
  <code>C634952</code>  <id>634952</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Glucosidase Inhibitor</to_name>
    <to_code>T55764</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175559</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acarbose [16681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with alpha-glucosidase inhibitor mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>miglitol [30009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha Glucosidase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Glucosidase Inhibitor [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing alpha-glucosidase inhibitor (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Hydroxy Acid [EPC]</name>
  <code>C635280</code>  <id>635280</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Hydroxy Acid</to_name>
    <to_code>T55770</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175842</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Hydroxy Acid [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxy Acids [M0010745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>alpha-Hydroxy Acid [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ammonium lactate [215247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Acid (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Hydroxy Acid [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>alpha-Particle Emitting Activity [MoA]</name>
  <code>C646938</code>  <id>646938</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Particle Emitting Activity</to_name>
    <to_code>T55812</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000187052</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radium Ra-223 cation [1745075]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>alpha-Particle Emitting Activity [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta Lactamase Inhibitor [EPC]</name>
  <code>C635368</code>  <id>635368</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Lactamase Inhibitor</to_name>
    <to_code>T56026</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitor</to_name>
    <to_code>T56027</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175930</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sulbactam [10167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>clavulanic acid [21216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>avibactam [1603834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>durlobactam [2639089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vaborbactam [1945213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>tazobactam [37617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta Lactamase Inhibitor [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>relebactam anhydrous [2268500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with beta-lactam structure and antibacterial mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing enzyme inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitor [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta Lactamase Inhibitors [MoA]</name>
  <code>C582</code>  <id>583</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Lactamase Inhibitors</to_name>
    <to_code>T56028</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors</to_name>
    <to_code>T56029</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000000202</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanic acid [21216]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durlobactam [2639089]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam [2184137]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazobactam [37617]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazobactam sodium [221167]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam anhydrous [2268500]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>CI_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vaborbactam [1945213]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam monohydrate [2184136]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Lactamase Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta Tubulin Interactions [MoA]</name>
  <code>C31878</code>  <id>31879</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Tubulin Interactions</to_name>
    <to_code>T56030</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000010260</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta Tubulin Interactions [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Agonist [EPC]</name>
  <code>C634948</code>  <id>634948</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Agonist</to_name>
    <to_code>T56032</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Receptor Agonist</to_name>
    <to_code>T56031</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175555</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta3-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>epinephrine [3992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing beta adrenergic receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>dobutamine [3616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>isoproterenol [6054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with beta adrenergic receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta2-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>ephedrine [3966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta-Adrenergic Blocker [EPC]</name>
  <code>C634949</code>  <id>634949</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Receptor Inhibitor</to_name>
    <to_code>T56033</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-Adrenergic Blocker</to_name>
    <to_code>T56034</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175556</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>landiolol [2712070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>timolol anhydrous [1546004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing beta adrenergic receptor antagonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nadolol [7226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>metoprolol [6918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>nebivolol [31555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>propranolol [8787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>acebutolol [149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>esmolol [49737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carteolol [2116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>carvedilol [20352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with beta adrenergic receptor antagonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>betaxolol [1520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>bisoprolol [19484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levobunolol [1813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>atenolol [1202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta-Antagonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>labetalol [6185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta-Adrenergic Blocker [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>pindolol [8332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta2-Adrenergic Agonist [EPC]</name>
  <code>C635198</code>  <id>635198</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta2-Adrenergic Agonist</to_name>
    <to_code>T56172</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-2 Adrenergic Agonist</to_name>
    <to_code>T56169</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-2 Adrenergic Receptor Agonist</to_name>
    <to_code>T56170</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta2-Adrenergic Receptor Agonist</to_name>
    <to_code>T56171</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175779</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>formoterol [25255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing beta-2 adrenergic receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>albuterol [435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta2-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vilanterol [1424884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levalbuterol [237159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>salmeterol [36117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>arformoterol [304962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta2-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>olodaterol [1546059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>beta3-Adrenergic Agonist [EPC]</name>
  <code>C644810</code>  <id>644810</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta3-Adrenergic Receptor Agonist</to_name>
    <to_code>T56174</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-3 Adrenergic Receptor Agonist</to_name>
    <to_code>T56173</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta-3 Adrenergic Agonist</to_name>
    <to_code>T56175</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>beta3-Adrenergic Agonist</to_name>
    <to_code>T56176</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000185008</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta3-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>mirabegron [1300786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta3-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Adrenergic beta3-Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta3-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>vibegron [2472254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>beta3-Adrenergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Bladder Contractility [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing beta adrenergic receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta3-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with beta adrenergic receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>beta3-Adrenergic Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</name>
  <code>C642963</code>  <id>642963</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid A Agonist</to_name>
    <to_code>T56997</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonist</to_name>
    <to_code>T57002</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid-A Agonist</to_name>
    <to_code>T56999</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid-A Receptor Agonist</to_name>
    <to_code>T57003</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid A Receptor Agonist</to_name>
    <to_code>T57004</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA-A Receptor Agonist</to_name>
    <to_code>T57001</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA-A Agonist</to_name>
    <to_code>T57000</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Agonist</to_name>
    <to_code>T56998</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000183360</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zaleplon [74667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</name>
  <code>C654303</code>  <id>654303</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulator</to_name>
    <to_code>T58904</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid A Receptor Positive Modulator</to_name>
    <to_code>T58903</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000194083</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>zolpidem [39993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Receptor Positive Modulators [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</name>
  <code>C635167</code>  <id>635167</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA-ergic Agonist</to_name>
    <to_code>T57012</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>GABAergic Agonist</to_name>
    <to_code>T57013</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid (GABA)-ergic Agonist</to_name>
    <to_code>T57014</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid-ergic Agonist</to_name>
    <to_code>T57015</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175759</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA B Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Substance with gamma-aminobutyric acid receptor agonist mechanism of action (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>GABA A Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing gamma-aminobutyric acid receptor agonist (product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Aminobutyric Acid A Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>gamma-Aminobutyric Acid-ergic Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>baclofen [1292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>gamma-Ray Emitting Activity [MoA]</name>
  <code>C635306</code>  <id>635306</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>gamma-Ray Emitting Activity</to_name>
    <to_code>T57065</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175868</value>
  </property>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>l-Thyroxine [EPC]</name>
  <code>C635383</code>  <id>635383</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>T4</to_name>
    <to_code>T57292</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Thyroxine (T4)</to_name>
    <to_code>T57293</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Thyroxine</to_name>
    <to_code>T57295</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Thyroxine-containing Agent</to_name>
    <to_code>T57294</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175945</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Thyroxine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Levothyroxine (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Thyroxine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing levothyroxine (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Thyroxine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroxine [M0021504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Thyroxine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>levothyroxine [10582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>l-Triiodothyronine [EPC]</name>
  <code>C635384</code>  <id>635384</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Triiodothyronine (T3)</to_name>
    <to_code>T57298</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Triiodothyronine</to_name>
    <to_code>T57299</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>T3</to_name>
    <to_code>T57296</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>l-Triiodothyronine-containing Agent</to_name>
    <to_code>T57297</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175946</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Triiodothyronine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Product containing liothyronine (medicinal product)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_SC</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Triiodothyronine [EPC]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triiodothyronine [M0021977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Triiodothyronine [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>liothyronine [10814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>l-Triiodothyronine [EPC]</from_name>
   <to_namespace>SNOMED CT US Edition</to_namespace><to_name>Liothyronine (substance)</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>mTOR Inhibitor Immunosuppressant [EPC]</name>
  <code>C635018</code>  <id>635018</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mammalian Target of Rapamycin Inhibitor Immunosuppressant</to_name>
    <to_code>T57374</to_code>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitor Immunosuppressant</to_name>
    <to_code>T57375</to_code>
     <preferred>true</preferred>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175625</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_PE</name>
   <from_namespace>MED-RT</from_namespace><from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Decreased Immunologic Activity [PE]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>sirolimus [35302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>mTOR Inhibitor Immunosuppressant [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>everolimus [141704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Immunosuppressant (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing protein kinase inhibitor (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitor Immunosuppressant [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>mTOR Inhibitors [MoA]</name>
  <code>C635017</code>  <id>635017</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors</to_name>
    <to_code>T57377</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Mammalian Target of Rapamycin Inhibitors</to_name>
    <to_code>T57376</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>MoA</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000175624</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temsirolimus [657797]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mTOR Inhibitors [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
 </concept>
 <concept>
  <namespace>MED-RT</namespace>
  <name>mu-Opioid Receptor Agonist [EPC]</name>
  <code>C651983</code>  <id>651983</id>
  <status>ACTIVE</status>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Preferred Term</name>
   <to_namespace>MED-RT</to_namespace><to_name>mu-Opioid Receptor Agonist</to_name>
    <to_code>T57544</to_code>
     <preferred>true</preferred>
  </synonym>
  <synonym>
  <namespace>MED-RT</namespace>
  <name>Synonym</name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonist</to_name>
    <to_code>T57543</to_code>
  </synonym>
  <property>
  <content>MED-RT</content>
  <name>CTY</name>
   <value>EPC</value>
  </property>
  <property>
  <content>MED-RT</content>
  <name>NUI</name>
   <value>N0000191867</value>
  </property>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>MED-RT</from_namespace><from_name>mu-Opioid Receptor Agonist [EPC]</from_name>
   <to_namespace>RxNorm R</to_namespace><to_name>eluxadoline [1653781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FDASPL</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>has_MoA</name>
   <from_namespace>MED-RT</from_namespace><from_name>mu-Opioid Receptor Agonist [EPC]</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>Opioid mu-Receptor Agonists [MoA]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Substance with opioid receptor agonist mechanism of action (substance)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mu-Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Parent Of</name>
   <from_namespace>SNOMED CT US Edition</from_namespace><from_name>Product containing opioid receptor agonist (product)</from_name>
   <to_namespace>MED-RT</to_namespace><to_name>mu-Opioid Receptor Agonist [EPC]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
 </concept>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) [2599921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) [M000743425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>(2-naphthyloxy)acetic acid [2685740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-naphthoxyacetic acid [M0052564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>(all-Z)-4,7,10,13,16-docosapentaenoic acid [1360626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cis-7,10,13,16,19-docosapentaenoic acid [M000636321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>(phthalocyaninato(2-)) copper [1424646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phthalocyanine blue [M0064693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.,.beta.-methylene adenosine 5&apos;-diphosphate [2552302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha,beta-methyleneadenosine 5&apos;-diphosphate [M0515143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.-chlorohydrin, (+/-)- [2396781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Chlorohydrin [M0000786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.-phellandrene [2530131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha phellandrene [M0046925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.alpha.-terpinene [2542349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-terpinene [M0313696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-D-glucouronic acid [2569975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>β-D-glucopyranuronic acid [M000742009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-carophyllene alcohol [2590728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caryolan-1-ol [M0528470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-caryophyllene oxide [2395801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caryophyllene oxide [M0504385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-eudesmol [2562544]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-eudesmol [M0145546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-glucogallin [2595941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucogallin [M0167990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.beta.-ionone [2371702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-ionone [M0051759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.delta.-tocopherol [2109747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>delta-tocopherol [M0456620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>.gamma.-tocopherol [2368126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-Tocopherol [M0022801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,1-difluoroethane [1305515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,1-difluoroethane [M0164920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,10-decanediol [1309235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,10-decanediol [M0304741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2,4-trihydroxybenzene [2107302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxyhydroquinone [M0060473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2,6-hexanetriol [1362577]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2,6-hexanetriol [M0350374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-benzisothiazoline-3-one [1368198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-benzisothiazoline-3-one [M0065179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-dibromo-3-chloropropane [1367191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-dibromo-3-chloropropane [M0050445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol 2000 [2473374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>DMG-PEG 2000 [M000640633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [1424655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [M0493572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-dioleoyl-sn-glycero-3-phosphocholine [1424656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-dioleoyl-sn-glycero-3-phosphocholine [M0587112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-dipalmitoylphosphatidylcholine [1926948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-Dipalmitoylphosphatidylcholine [M0023172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-distearoyllecithin [1426933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-distearoyl-sn-glycero-3-phosphocholine [M000645177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-distearoyllecithin [1426933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-distearoyllecithin [M0056861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-hexanediol [1362584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-hexanediol [M0305031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-naphthoquinone [1661328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-naphthoquinone [M0121191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-octanediol [1363571]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-octanediol [M0529442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,2-propanedithiol [2281674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-dimercaptopropane [M0193386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3,5-triethylbenzene [2475073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3,5-triethylbenzene [M0506273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-benzenedisulfonic acid [2391135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-benzenedisulfonic acid [M0259499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-butadiene [2548035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-butadiene [M0099583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-butylene glycol [1310542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-butylene glycol [M0091649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-cyclohexadiene [2691092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-cyclohexadiene [M0105106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-dibromo-5,5-dimethylhydantoin [2368732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-dibromo-5,5-dimethylhydantoin [M0158666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-dichloro-2-propanol [1305516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-dichloro-2-propanol [M0103864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-dimethylol-5,5-dimethylhydantoin [1310543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-dimethylol-5,5-dimethylhydantoin [M0157423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-dimethylurea [1358483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-dimethylurea [M0069625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,3-propanediol [1363030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3-propanediol [M0123739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,4-benzoquinone [319868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinone [M0045630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,4-diphenyl-1,3-butadiene [1739233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,4-diphenylbutadiene [M0060312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,4-naphthoquinone [1602556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,4-naphthoquinone [M0108385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,5-pentanediol [1362880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,5-pentanediol [M0090711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,6-hexamethylene diisocyanate [1428547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,6-hexamethylene diisocyanate [M0064409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1,9-decadiene [1729153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,9-decadiene [M0428649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-(3,5-bis(trifluoromethyl)phenyl)ethanol [2053486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-(3,5-bis(trifluoromethyl)phenyl)ethanol [M000629282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-aminocyclopropanol [2645303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-aminocyclopropanol [M0062774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-butene [1362691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-butene [M0163352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-butyl oleate [1368213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-butyl oleate [M0299400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-chloro-2-methyl-1-propene [2469243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-chloro-2-methylpropene [M0147685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-chloronaphthalene [2673865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-chloronaphthalene [M0098543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-hexadecene [1313219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetene [M0056478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-kestose [2590592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-kestose [M0196231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-methyl-2-pyrrolidinone [1305552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-methylpyrrolidone [M0116284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-methylhydantoin [1729875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-methylhydantoin [M0100303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-myristylpicolinium [1425941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-myristylpicolinium [M0154491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-naphthalenesulfonic acid [1442718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-naphthalenesulfonic acid [M0398958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-naphthol [1740233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-naphthol [M0093636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-octacosanol [12166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-octacosanol [M0129543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-octanesulfonic acid [1592897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-octanesulfonic acid [M0124309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-octanol [1487826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Octanol [M0029709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-octen-3-ol [2395763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-octen-3-ol [M0116708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-octen-3-yl acetate [2395768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-octen-3-yl acetate [M000732372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine [2593177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-palmitoyl-2-linoleoylphosphatidylcholine [M0155985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) [1440971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-palmitoyl-2-oleoyl--sn-glycero-3-(phospho-rac-(1-glycerol)) [M0393687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-phenylazo-2-naphthylamine [1430252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-phenylazo-2-naphthylamine [M0128134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-phenylethanol [2001176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylphenyl carbinol [M0042474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-propanol [1362872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Propanol [M0000657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-propoxy-2-propanol [1358844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-propoxy-2-propanol [M0157700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>1-vinyl-2-pyrrolidone [1307764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-vinyl-2-pyrrolidinone [M0125879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>10-hydroxycapric acid [1368622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>10-hydroxydecanoic acid [M000634970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>10-hydroxystearic acid [2476630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>10-hydroxystearic acid [M0191683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>12-(9-anthroyloxy)stearic acid [1922739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>12-(9-anthroyloxy)stearic acid [M0087321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>12-oxooctadecanoic acid [1733689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>12-oxooctadecanoic acid [M0257991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>169 ytterbium [90719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ytterbium-169 [M000627582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>17-alpha-Hydroxyprogesterone [M0028774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2&apos;-deoxyadenosine [2642189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2&apos;-deoxyadenosine [M0162235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2&apos;-deoxyguanosine [2642210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxyguanosine [M0006006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2&apos;-fucosyllactose [1733688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2&apos;-fucosyllactose [M0098723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2&apos;-hydroxyacetophenone [1664428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2&apos;-hydroxyacetophenone [M0232734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2&apos;-dithiobisbenzothiazole [1306112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibenzothiazyl disulfide [M0090559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2,4,4,6,8,8-heptamethylnonane [1362933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,2,4,4,6,8,8-heptamethylnonane [M0164659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2,4,4,6,8,8-heptamethylnonane [1362933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isohexadecane [M000642791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2-bis(4-glycidyloxyphenyl)propane [1368138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bisphenol A diglycidyl ether [M0071615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,3,5,6-tetrafluorophenol [2625644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,3,5,6-tetrafluorophenol [M0132147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,3-dichloro-5,6-dicyanobenzoquinone [2288812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dichlorodicyanobenzoquinone [M0040918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,3-dihydroxybenzoic acid [1727169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,3-dihydroxybenzoic acid [M0053570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,3-dimercapto-1-propanesulfonic acid [1546352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Unithiol [M0022297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,3-pentanedione [2693283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,3-pentanedione [M0060758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,4-diaminophenoxyethanol [1740235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(2&apos;,4&apos;-diaminophenoxy)ethanol [M0101568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,4-dichlorophenoxyacetic acid, sodium salt [1371448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,4-Dichlorophenoxyacetic Acid, Sodium Salt [M0329500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,5-diaminotoluene [1482535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,5-diaminotoluene [M0050420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,5-diaminotoluene sulfate [1482534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,5-diaminotoluene sulfate [M0309909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,6-dimethyl-5-heptenal [1552361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,6-dimethyl-5-heptenal [M000617039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,6-dimethyloctan-2-ol [2700155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,6-dimethyloctan-2-ol [M0528492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-(2-aminoethoxy)ethanol [1737111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(2-aminoethoxy)ethanol [M0286895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-(N-morpholino)ethanesulfonic acid [2360130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(N-morpholino)ethanesulfonic acid [M0045657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-(perfluorohexyl)ethanol [1986349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>6-2 fluorotelomer alcohol [M000753346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-acrylamido-2-methyl-1-propanesulfonic acid [2109231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-acrylamido-2-methylpropanesulfonate [M0157933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-amino-1,3-propanediol [2467839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>serinol [M0196208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-amino-1-butanol [2588247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-amino-1-butanol [M0049110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-amino-2-methyl-1-propanol [1310544]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-amino-2-methyl-1-propanol [M0049164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-amino-5-nitrothiazole [1665683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-amino-5-nitrothiazole [M0107208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-aminophenol [1740241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-aminophenol [M0089741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-benzylheptanol [1489294]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-benzylheptanol [M0580896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-bromo-2-nitroethanol [1648134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-bromo-2-nitroethanol [M0269936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-bromobutane [1922903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-bromobutane [M0090569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-bromobutane, (S)- [1922902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-bromobutane, (S)-isomer [M0317577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-butoxyethanol [2385885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-butoxyethanol [M0067557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-carboxyethyl acrylate [2286249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-acryloyloxypropionic acid [M0158088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-deoxyglucose [1733674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxyglucose [M0006004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-diethylaminoethanol [1433902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-diethylaminoethanol [M0050531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-ethoxyethanol [1314365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ethoxyethanol [M0075980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-ethylhexanoic acid [1305517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ethylhexanoic acid [M0120998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-ethylhexanol [2394645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ethylhexanol [M0105132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-ethylhexyl acrylate [1432294]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ethylhexyl acrylate [M0111669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-ethylhexyl stearate [1368886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ethylhexyl stearate [M0427563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-hydroxydecanoate [1486028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-hydroxydecanoate [M0083211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-hydroxydecanoic acid [1486027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-hydroxydecanoic acid [M0083212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-hydroxyethyl acrylate [1314328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-hydroxyethyl acrylate [M0109831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-hydroxyethyl methacrylate [1362692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxyethyl methacrylate [M0046330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-hydroxypropyl methacrylate [2204914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-hydroxypropyl methacrylate [M0094420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-ketogluconate [1869045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ketogluconate [M0051907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-mercaptobenzothiazole [1358845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>captax [M0047196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-mercaptoethanesulfonic acid [1546354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coenzyme M [M0023195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-methacryloyloxyethyl phosphorylcholine [2584546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methacryloyloxyethyl phosphorylcholine [M0192238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-methoxy-1-propanol [2380833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methoxypropanol [M0243326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-methyl-4-isothiazolin-3-one [1367166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methyl-4-isothiazolin-3-one [M0057852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-methyl-4-isothiazolin-3-one hydrochloride [1804258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methyl-4-isothiazolin-3-one hydrochloride [M0311478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-methyl-4-phenyl-2-butanol [2289004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methyl-4-phenyl-2-butanol [M0580614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-methylbutyric acid [2281310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methylbutanoic acid [M0071945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-n-octyl-4-isothiazolin-3-one [1362738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-n-octyl-4-isothiazolin-3-one [M0108356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-naphthalenesulfonate [1366947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-naphthalenesulfonate [M0528371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-nitropropane [2372437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-nitropropane [M0066748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-octanol [1362615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-octanol [M0186068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-octyl cyanoacrylate [2533837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-octyl cyanoacrylate [M000645446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-octyl cyanoacrylate [2533837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octyl 2-cyanoacrylate [M0264527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-phenylphenol [236677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-phenylphenol [M0045414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-pyrrolidone [1358473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrrolidinones [M0018278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-pyrrolidone [1358473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-pyrrolidone [M0091749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-tert-butylhydroquinone [1362739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-tert-butylhydroquinone [M0070836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>24-homo-1,25-dihydroxyvitamin D3 [M0148765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3&apos;-hydroxyacetophenone [2560214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3&apos;-hydroxyacetophenone [M0548672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3,3&apos;-diindolylmethane [1603521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,3&apos;-diindolylmethane [M0066345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3,7,11,15-tetramethyl-1,2,3-hexadecanetriol [1368211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,7,11,15-tetramethyl-1,2,3-hexadecanetriol [M0496243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3,7-dimethyl-1-octanol [1601994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,7-dimethyloctan-1-ol [M0175466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3,7-dimethyloct-6-en-3-ol [2671293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,7-dimethyloct-6-en-3-ol [M0528478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3,7-dimethyloctane-1,7-diol [1313707]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,7-dimethyloctane-1,7-diol [M0528481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-((L-menthyl)oxy)propane-1,2-diol [1314260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menthoxypropanediol [M000679088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-(3-methyl-2-thienyl)acrylic acid [2475074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-(3-methyl-2-thienyl)acrylic acid [M0144102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-(triethoxysilyl)propylamine [1425088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amino-propyl-triethoxysilane [M0454360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-O-ethylascorbic acid [1373720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-O-ethylascorbic acid [M000600965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-aminophenol [1435285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-aminophenol [M0156323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-carene [2395760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-carene [M0095767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-dimethylaminopropylamine [1661327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-dimethylaminopropylamine [M0060296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-hexenyl acetate, (3Z)- [1426376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cis-3-hexenyl acetate [M0591557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-hexenyl salicylate, cis- [2359262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cis-3-hexenyl salicylate [M0079744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-iodo-2-propynylbutylcarbamate [1426467]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-iodo-2-propynylbutylcarbamate [M0277631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-iodobenzylguanidine [14448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-Iodobenzylguanidine [M0029373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-n-butylphthalide [1484499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-n-butylphthalide [M0088431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-phenyl propionic acid [2627300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-phenylpropionic acid [M0108150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>3-phenyl-1-propanol [2479688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-phenyl-1-propanol [M0544318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4,4&apos;-dinitrocarbanilide [1546355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4,4&apos;-dinitrocarbanilide [M0118224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-(p-hydroxyphenyl)-2-butanone [1860422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>raspberry ketone [M0108790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-acetylanisole [2612428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-acetylanisole [M0133543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-allyl-2,6-dimethoxyphenol [1423781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-allyl-2,6-dimethoxyphenol [M0290837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-amino-2-hydroxytoluene [1740236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-amino-2-hydroxytoluene [M0533417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminobenzoate [618974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>para-Aminobenzoates [M0568273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminobenzoic acid [74]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-Aminobenzoic Acid [M0015714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminohippuric acid [7832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-Aminohippuric Acid [M0015718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminomethylbenzoic acid [14852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-aminomethylbenzoic acid [M0065124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminophenol [1435279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-aminophenol [M0087507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-anisic acid [1426595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-anisic acid [M0045608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-coumaric acid [1485787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-coumaric acid [M0479802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-cresyl acetate [14997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-cresyl acetate [M0050158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-cymene [15002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-cymene [M0050260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-dimethylaminophenol [15027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-dimethylaminophenol [M0073886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-dimethylaminophenol hydrochloride [236930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-dimethylaminophenol hydrochloride [M0314143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-hydroxybenzoic acid [1649527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-hydroxybenzoic acid [M0115095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-hydroxybenzyl alcohol [2045942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-hydroxybenzyl alcohol [M0071029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-hydroxybutyric acid [1546380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-hydroxybutyric acid [M0288532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-hydroxycyclophosphamide [2675983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-hydroxycyclophosphamide [M0059325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-methyl anisole [1313261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-methyl anisole [M0052248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol [1314261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol [M0528469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-methyl-3-decen-5-ol [2557379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-methyl-3-decen-5-ol [M0547074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-methyl-5-thiazoleethanol [2692023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(4-methyl-1,3-thiazol-5-yl)ethanol [M0059687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-methylaminorex, cis-(+/-)- [2665286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-methylaminorex, cis-(+-)-isomer [M0307355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-nonylphenol [1788868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-nonylphenol [M0123288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylbutyric acid [1546447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-phenylbutyric acid [M0204041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylenediamine [1362740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-phenylenediamine [M0094616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-phenylenediamine [1362740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-aminoaniline [M000765690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-tert-butylcyclohexanol [1373206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-tert-butylcyclohexanol [M0557227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-tert-butylcyclohexyl acetate [2289005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-tert-butylcyclohexyl acetate [M0581830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-bromo-4-chloro-3-indolyl phosphate [2665337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-bromo-4-chloro-3-indoxyl phosphate [M0108637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-bromo-5-nitro-1,3-dioxane [1364947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-bromo-5-nitro-1,3-dioxane [M0546458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-chloro-2-methyl-4-isothiazolin-3-one [1367119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-chloro-2-methyl-4-isothiazolin-3-one [M0057724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-hydroxylysine [1368166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxylysine [M0010770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-hydroxylysine [1368166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Hydroxylysine [M000638470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-hydroxytryptophan [94]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Hydroxytryptophan [M0010787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-methoxypsoralen [15842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Methoxypsoralen [M0079571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-methoxytryptamine [1426888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Methoxytryptamine [M0013607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-methyl-8-hydroxyquinoline [15850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-methyl-8-hydroxyquinoline [M0100232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-methyldeoxycytidine [2642190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-methyldeoxycytidine [M0066662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>5-methyltetrahydrofolic acid [1313966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N(5)-methyltetrahydrofolic acid [M0047913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>6-O-palmitoylascorbic acid [1088438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>6-O-palmitoylascorbic acid [M0098286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>6-aminocaproic acid [99]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminocaproic Acid [M0023260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>7-aminodesacetoxycephalosporanic acid [1990418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-aminodesacetoxycephalosporanic acid [M0062780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>7-dehydrocholesterol [1362616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-dehydrocholesterol [M0066889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>82 rubidium [1546434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rubidium-82 [M000628005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>82 strontium [90611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strontium-82 [M000628013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>85 strontium [90613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strontium-85 [M000628014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>9,10-anthraquinone [1482551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>9,10-anthraquinone [M0126292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>99 molybdenum [90574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molybdenum-99 [M000628041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ABCB4 protein, human [2117853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ABCB4 protein, human [M0452338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ABT-925 [1661017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ABT-925 [M0589804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>African Pygeum extract [580117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pygeum extract [M000744240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Agrimonia pilosa leaf extract [2697821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Agrimonia pilosa leaf [M000744830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alcaligenes faecalis [1316425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcaligenes faecalis [M0441454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Allura red AC dye [1310600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allura Red AC Dye [M0047789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe emodin [2561527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aloe emodin [M0007303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alpinia oxyphylla fruit extract [2592957]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alpinia oxyphylla fruit extract [M0409349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alpinia oxyphylla fruit extract [2592957]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>yi-zhi [M0505862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alteromonas macleodii [1551569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alteromonas macleodii [M000669606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Amanita phalloides [1858554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amanita phalloides [M000686954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Amorphophallus konjac root extract [1537210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amorphophallus konjac root extract [M000745031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anaerococcus tetradius [1592903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaerococcus tetradius [M0016246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Anaplasma phagocytophilum [2168766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaplasma phagocytophilum [M0425509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ancylostoma caninum [2469251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancylostoma caninum [M0001096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Andrographis paniculata top extract [1998719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Andrographis paniculata top extract [M000757327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Andrographis paniculata whole extract [1534766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Andrographis paniculata extract [M000753653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica pubescens root extract [1307573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>duhuo [M000602382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis root extract [1307866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>angelicae sinensis extract [M0130196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aphanizomenon flos-aquae [1310848]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aphanizomenon flos-aquae [M000674040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arctostaphylos uva-ursi leaf extract [1306212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arctostaphylos uva-ursi leaf [M000744341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica flowers extract [283674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arnicae flos extract [M000742825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica montana flower extract [1306166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arnicae flos extract [M000742825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica montana flower extract [1306166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arnica montana flower [M000742887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arthrospira platensis [1321355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthrospira platensis [M000672958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Asian ginseng extract [1370774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asian ginseng [M000744128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus flavus var. oryzae [1329940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillus oryzae [M0001858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillus fumigatus [M0001854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus ruber [1324086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillus ruber [M000688678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus propinquus root extract [1309814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Huang Qi [M0089313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Azadirachta indica seed oil [1305648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neem oil [M0043031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Connaught strain [76469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>BCG Connaught [M0231751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus amyloliquefaciens [2359256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus amyloliquefaciens [M000608759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus anthracis [1595882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus anthracis [M0002103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus cereus [1311112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus cereus [M0002104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus clausii [2600050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus clausii [M000608879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus coagulans [1310844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus coagulans [M000608852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus firmus [1316426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus firmus [M000609256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus subtilis [1311119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus subtilis [M0002107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bacillus thuringiensis [1800077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus thuringiensis [M0002109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella bacilliformis [1544930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella bacilliformis [M0448531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella clarridgeiae [1544931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella clarridgeiae [M000670680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella elizabethae [1544932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella elizabethae [M000670676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella henselae [1544933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella henselae [M0027644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella quintana [1544934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella quintana [M0027642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella vinsonii [1544935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella vinsonii [M000670643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bartonella washoensis [1544936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella washoeensis [M000670638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bifidobacterium animalis [1550045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bifidobacterium animalis [M000608776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bifidobacterium bifidum [285148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bifidobacterium bifidum [M000608781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bifidobacterium breve [2110011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bifidobacterium breve [M000608780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bifidobacterium longum [1150096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bifidobacterium longum [M000608760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Blastocystis hominis [1599565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastocystis hominis [M0025639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis [1608803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bordetella pertussis [M0002822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bordetella pertussis pertactin vaccine, inactivated [1300184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pertactin [M0188326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Borrelia burgdorferi [1426882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia burgdorferi [M0373374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bos taurus gallstone preparation [1737793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>niuhuang [M0570960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brassica napus oil [1306159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rapeseed Oil [M000631665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brevibacterium stationis [1310908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corynebacterium stationis [M000669419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brucea javanica fruit extract [2619328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucea javanica fruit extract [M000742985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brucella abortus [1540822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucella abortus [M0002987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Brucella melitensis [1318470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucella melitensis [M0026340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Burkholderia mallei [1648417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burkholderia mallei [M0441792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>complement C1s inhibitor, human [M0486530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (recombinant) [1599831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>conestat alfa [M0572376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor [1599832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Complement C1 Inhibitor Protein [M0476632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>CJC-1295 [1805005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>CJC 1295 [M0487015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cajanius cajan leaf extract [1421433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cajanus cajan leaf [M000745616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Calendula officinalis flower extract [1309289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calendula officinalis flower [M000742765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Campylobacter jejuni [1435992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter jejuni [M0024627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candida albicans [M0003257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida parapsilosis [1310914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candida parapsilosis [M000626565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida torresii [1343912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candida torresii [M000691585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cannabis sativa seed oil [1305550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hempseed oil [M000747265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleoresin capsicum [M0374910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Carbopol 981 [1311164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbopol 981 [M0506419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Centella asiatica extract [1310164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Centella asiatica extract [M0517955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chamaemelum nobile flower extract [1306194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chamomillae romanae flos [M000743814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chlamydia trachomatis [1318474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia trachomatis [M0004109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chlamydomonas reinhardtii [2637877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydomonas reinhardtii [M0025618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Citrobacter koseri [1544937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citrobacter koseri [M0425449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clematis hexapetala whole extract [1594579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radix clematidis whole [M000745808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clostridioides difficile [1534764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridioides difficile [M0025018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clostridium botulinum [1811178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium botulinum [M0004636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Clostridium perfringens [1318475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium perfringens [M0004638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Coptis chinensis root extract [1376211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coptidis rhizoma extract [M0279414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Corymbia citriodora leaf oil [1306137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oil of lemon eucalyptus [M000765466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Coxiella burnetii [1432987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coxiella burnetii [M0025830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cryptosporidium parvum [1322778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptosporidium parvum [M0025578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cullen corylifolium fruit extract [1311580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cullen corylifolium fruit [M000745628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cullen corylifolium whole extract [1808601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cullen corylifolium whole [M000745629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cynara scolymus leaf extract [1322547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>artichoke leaf [M000743826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D &amp; C green 5 [1311171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D &amp; C green 5 [M0414110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D &amp; C red no. 27 [1311172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D &amp; C Red No. 27 [M0016618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C blue no. 4 [1426460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D &amp; C blue no.4 [M0049563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C green no. 8 [1426464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyranine [M0046336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C orange no. 4 [1426468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-naphthol orange [M0063479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C red no. 28 [1310707]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,4,5,7-tetrabromo-4,5,6,7-tetrachlorofluorescein disodium salt [M0549587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C red no. 30 [1311176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>CI 73360 [M0554645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C red no. 34 [1437986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D&amp;C Red No. 34 [M0544498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D&amp;C yellow no.11 [1305581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D.C. Yellow dye No. 11 [M0088135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D.C. red no. 33 [1310601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D.C. Red No. 33 [M0130186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D.C. red no. 36 [1426926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D.C. Red No. 36 [M0138532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Diisononyl adipate [2533838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diisononyl adipate [M0144785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Dirofilaria immitis [1597621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dirofilaria immitis [M0006553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea preparation [228041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinacea extract [M000751158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea purpurea aerial parts extract [477531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinacea purpurea flowering top extract [M000751168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea purpurea extract [260025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinacea purpurea extract [M000751161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea purpurea flowering top extract [1307637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinacea purpurea flowering top extract [M000751168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea purpurea flowering top water [2602283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinacea purpurea flowering top water [M000751169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea purpurea root extract [259513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinacea purpurea root extract [M000751166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ehrlichia canis [1608966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ehrlichia canis [M0425489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Entamoeba histolytica [1316053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Entamoeba histolytica [M0007459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Enterobacter aerogenes [1544929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacter aerogenes [M0355772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Enterobacter cloacae [1491010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacter cloacae [M0025803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Enterococcus faecalis [10098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterococcus faecalis [M0020571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Enterococcus faecium [1943794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterococcus faecium [M0025816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ephedra sinica root extract [1724424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ephedra root [M000758418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Epstein-Barr virus [1316054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesvirus 4, Human [M0007615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eriobotrya japonica leaf extract [1310088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>loquat leaf [M000744689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Escherichia coli [350202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli [M0007732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eucalyptus oil [59087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eucalyptus globulus Oil [M000642319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eucalyptus oil [59087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eucalyptus Oil [M000641009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eucommia ulmoides bark extract [1309788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eucommiae cortex [M000768111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Euphrasia officinalis leaf extract [2274241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Euphrasia officinalis leaf extract [M000744616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>European elderberry extract [1311531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>black elderberry extract [M000744426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Evans blue [4191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Evans Blue [M0007985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Evernia prunastri extract [1352501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oakmoss, absolute [M0130459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>FD&amp;C blue #2 lake [1307695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>FDC blue lake no.2 [M0084144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>FD&amp;C yellow no. 6 [1305574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>yellow 6 [M000611733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>FD&amp;C yellow no. 6 [1305574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt [M0047642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Forsythia suspensa fruit extract [1311590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lianqiao [M000764658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Francisella tularensis [1432988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Francisella tularensis [M0008816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Frangula alnus bark extract [1310063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Frangula alnus bark [M000744610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Frangula purshiana bark extract [1350209]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cascara Sagrada [M0003578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Galphimia glauca flowering top extract [1346618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Galphimia glauca flowering top [M000745636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gastrodia elata tuber extract [2462454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrodia elata tuber [M000745639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gastrodia elata whole extract [2359266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrodia elata whole [M000745638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Gentiana lutea root extract [1307945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gentian root extract [M000743912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Giardia lamblia [1439028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardia lamblia [M0025623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ginkgo biloba extract [236809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ginkgo biloba extract [M0174492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza glabra extract [1370435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycyrrhiza glabra extract [M000756821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza inflata root extract [1307598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycyrrhiza glabra extract [M000756821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Glycyrrhiza uralensis root extract [2266490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycyrrhiza glabra extract [M000756821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>HC blue no. 2 [2386334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HC Blue No. 2 [M0152410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>HC red no. 3 [2469246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HC Red No. 3 [M0152408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>HC yellow no. 4 [2179013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-((2-(2-hydroxyethoxy)-4-nitrophenyl)amino)ethanol [M0231944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>HC yellow no. 5 [1428873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HC yellow No. 5 [M0524325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae [1364467]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus influenzae [M0009741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Haemophilus influenzae type b [50937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus influenzae type b [M0029308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Helicobacter pylori [1318501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter pylori [M0025164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Houttuynia cordata flowering top extract [1309469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Houttuynia cordata flowering top [M000745674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Houttuynia cordata top extract [2001175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Houttuynia cordata top [M000745673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Houttuynia cordata whole extract [1358899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Houttuynia cordata extract [M0409351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Houttuynia cordata whole extract [1358899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Houttuynia cordata whole [M000745672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>IR-3535 [1737733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>IR 3535 [M0540393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Japanese encephalitis virus [1439114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Encephalitis Virus, Japanese [M0007343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Klebsiella pneumoniae [1311061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella pneumoniae [M0012060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kluyveromyces marxianus [1804172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kluyveromyces marxianus [M000702925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Korean ginseng root extract [259471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asian ginseng [M000744128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 16 vaccine [798264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>L1 protein, Human papillomavirus type 16 [M0174855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 18 vaccine [798266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>L1 protein, Human papillomavirus type 18 [M0459059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>L1 protein, human papillomavirus type 6 vaccine [798268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>L1 protein, Human papillomavirus type 6 [M0241783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus casei [1592255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lacticaseibacillus casei [M0012164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus paracasei [2375526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lacticaseibacillus paracasei [M000608763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus [100278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lacticaseibacillus rhamnosus [M0483655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum [1673942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus plantarum [M0460813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus [6205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus acidophilus [M0012162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus crispatus [2054188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus crispatus [M000608857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus delbrueckii subsp. bulgaricus [100272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus bulgaricus [M000609731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus gasseri [2462497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus gasseri [M000608827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus helveticus [1310845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus helveticus [M0483652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactococcus lactis [2466983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactococcus lactis [M0020572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Legionella pneumophila [1491870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionella pneumophila [M0025782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lentilactobacillus kefiri [2626886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactobacillus kefiri [M000666304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Levilactobacillus brevis [2377030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levilactobacillus brevis [M0483647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Levisticum officinale [1862596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levisticum officinale [M0385599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ligilactobacillus salivarius [2110033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ligilactobacillus salivarius [M000608825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ligusticum sinense subsp. chuanxiong root extract [1309803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chuangxiong extract [M0266230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus fermentum [2471430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Limosilactobacillus fermentum [M0483651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri [285156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Limosilactobacillus reuteri [M0483654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Listeria monocytogenes [1491871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeria monocytogenes [M0012615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lonicera japonica flower extract [1307753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lonicerae flos [M0593843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Magadi soda [1367411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magadi soda [M0092978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Marrubium vulgare extract [1424909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Marrubium vulgare extract [M000745640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Melissa officinalis leaf extract [1307836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lemon balm leaf extract [M000744066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Melissa officinalis leaf extract [1307836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>melissae folium [M000744065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Momordica charantia fruit extract [1306885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bitter melon fruit [M000744072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Monascus purpureus [1442200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Monascus purpureus [M0401384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Morganella morganii [1311228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morganella morganii [M0328484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Morus alba leaf extract [1309988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morus alba leaf [M000758325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mycobacterium bovis [1320629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium bovis [M0014285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mycobacterium phlei [1310907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium phlei [M0014291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mycobacterium tuberculosis [1492936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium tuberculosis [M0014292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mycoplasma pneumoniae [1360621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma pneumoniae [M0014309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N,N&apos;-diphenyl-4-phenylenediamine [1363709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N,N&apos;-diphenyl-4-phenylenediamine [M0046056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N,N-dimethylacrylamide [1371317]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N,N-dimethylacrylamide [M0260065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-(3-(dimethylamino)propyl)octadecanamide [1364376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(3-(dimethylamino)propyl)octadecanamide [M0458981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-(hydroxyethyl)ethylenediaminetriacetic acid [1364568]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(hydroxyethyl)ethylenediaminetriacetic acid [M0085998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-acetyl-glucosamine thiazoline [2597521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetylglucosamine thiazoline [M0469224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-acetylcarnosine [1796119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetylcarnosine [M0104402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-acetylmethionine [1426463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetylmethionine [M0048891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-acetyltryptophan [1368212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetyltryptophan [M0048924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-acetyltyrosine [31005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetyltyrosine [M0085582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-acetylvaline [2604632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetylvaline [M0156434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-caproylsphingosine [1603859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-caproylsphingosine [M0267117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-cyclohexyl-2-benzothiazosulfenamide [1306886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiohexam [M0129199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-cyclohexyl-N&apos;-phenyl-1,4-phenylenediamine [1427136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-cyclohexyl-N&apos;-phenyl-p-phenylenediamine [M0502826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-dodecyl .beta.-D-maltoside [2178066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyl-beta-D-maltoside [M0120216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-ethylurea [2047170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylurea [M0051026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-hydroxysuccinimide [1368884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-hydroxysuccinimide [M0041619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-isopropyl-N-phenyl-4-phenylenediamine [1363710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-isopropyl-N-phenyl-4-phenylenediamine [M0063300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-isopropyl-N-phenyl-4-phenylenediamine [1363710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-isopropyl-N&apos;-phenyl-1,4-phenylenediamine [M000634739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-lactoylethanolamine [1424270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-lactoylethanolamine [M0498900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-lauroylproline [1728290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-lauroylproline [M0575977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-methylephedrine [1311545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-methylephedrine [M0123568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-monoacetylcystine [2267406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-monoacetylcystine [M0097484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-oxydiethylene-2-benzothiazole sulfenamide [1363711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-oxydiethylene-2-benzothiazole sulfenamide [M0101963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>N-valyltryptophan [1425405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-valyltryptophan [M0155193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>NADH [7222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>NADH [M0014404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Neisseria meningitidis [7288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neisseria meningitidis [M0014555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Nigella sativa seed oil [1431150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nigella sativa oil [M000633812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Norwalk virus [1747300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norwalk virus [M0015005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ocimum tenuiflorum leaf oil [2048350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocimum tenuiflorum leaf oil [M000757524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ocimum tenuiflorum top extract [1311561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocimum tenuiflorum top extract [M000757526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ocimum tenuiflorum whole extract [1722381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocimum tenuiflorum whole extract [M000757527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Olea europaea leaf extract [1307955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olive leaf extract [M000747787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OspA protein [54214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>OspA protein [M0195354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-30-dipolyhydroxystearate [1363570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>PEG-30-dipolyhydroxystearate [M000608961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-40 stearate [1314849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>PEG 40 monostearate [M000595503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PPG-11 stearyl ether [1426946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxypropylene 11 stearyl ether [M0420442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PPG-15 [2637755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxypropylene 15 stearyl ether [M0420443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PPG-15 stearyl ether [1313178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxypropylene 15 stearyl ether [M0420443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PPG-3 [1796120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tripropylene glycol [M0582183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Panax notoginseng root extract [1365707]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>San-Chi [M0090096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pasteurella multocida [1437221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella multocida [M0025810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium brevicompactum [1426666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillium brevicompactum [M000703203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillium glabrum [1328760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillium glabrum [M000708314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peptostreptococcus anaerobius [1311307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptostreptococcus anaerobius [M000666804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Peruvian balsam [33219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peruvian balsam [M0084028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phellinus linteus mycelium extract [1312717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phellinus linteus mycelium [M000745671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Phormidium persicinum [1425936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudanabaena persicina [M000663818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Plantago ovata seed extract [1309942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ispaghula seed [M000744201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Plantago seed [82088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ispaghula seed [M000744201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Plantago seed [82088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plantago Seed [M0018070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Plasmodium malariae [1432989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plasmodium malariae [M0017000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pleospora betae allergenic extract [852756]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phoma betae [M000703024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Podophyllum hexandrum root extract [2630722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Podophyllum hexandrum root [M000745790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Podophyllum hexandrum whole extract [2636601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinopodophyllum hexandrum whole [M000745788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Polygala senega root extract [1310087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>senegae radix [M000744283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Prevotella intermedia [2591816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prevotella intermedia [M0028039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Propionibacterium acnes [1310910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propionibacterium acnes [M0017762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Propionibacterium avidum [1310909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cutibacterium avidum [M000674983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Proteus inconstans [1310846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus inconstans [M000663856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Proteus mirabilis [1310903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus mirabilis [M0017901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Proteus rettgeri [2002418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Providencia rettgeri [M000663850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Proteus vulgaris [1316073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus vulgaris [M0017902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Prunus armeniaca leaf extract [1487507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prunus armeniaca leaf [M000744762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Prunus armeniaca seed extract [1309458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prunus armeniaca seed [M000743799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Prunus serotina bark extract [1307851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>wild cherry bark extract [M0495556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pseudomonas aeruginosa [1310913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas aeruginosa [M0017953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Pueraria montana var. lobata root extract [1309751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puerariae radix [M000745675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>QS-21 [2002417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>QS 21 [M0211084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>RNA [9394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>RNA [M0019139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rauwolfia alkaloids [9152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rauwolfia Alkaloids [M0018533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rehmannia glutinosa root extract [1309220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rehmannia root [M000744254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin [35465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rho(D) Immune Globulin [M0027215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rho(D) Immune Globulin [M0027215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rickettsia prowazekii [1744460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia prowazekii [M0019099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rickettsia rickettsii [1482546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia rickettsii [M0019100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>S-adenosylmethionine [9504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>S-Adenosylmethionine [M0019322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>S-adenosylmethionine sulfate tosylate [9506]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>S-Adenosylmethionine Sulfate Tosylate [M0019323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>S-benzoylmercaptoacetyltriglycine [194098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>S-benzoylmercaptoacetyltriglycine [M0287596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-COV-2 (COVID-19) vaccine, vector - Ad26 [2479830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ad26COVS1 [M000742885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 [2470232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Elasomeran [M000757965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) [2610243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>BNT162B2 Omicron [M000759677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) [2610243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>famtozinameran [M000759649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 [2468230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tozinameran [M000753666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 [2468230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>BNT162 Vaccine [M000747629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 [2606073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>NVX-CoV2373 adjuvated lipid nanoparticle [M000742050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saccharomyces boulardii [M000608778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces cerevisiae [9511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saccharomyces cerevisiae [M0019330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salmonella enterica subsp. enterica serovar enteritidis [1329877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella enteritidis [M0019390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salvia hispanica seed extract [1309460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salvia hispanica seed extract [M000745231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Salvia miltiorrhiza root extract [1307580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dan-shen root extract [M0092772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sambucus canadensis flower extract [1376215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>American elderberry flower [M000744428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sambucus nigra flower extract [1344643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sambucus nigra flower extract [M000744429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sambucus nigra flower oil [2053443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sambucus nigra flower oil [M000757991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sambucus nigra seed oil [2397121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sambucus nigra seed oil [M000757992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Schizandra preparation [56084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>schizandrin [M0057146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Scutellaria baicalensis root extract [1307750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ougon [M0359562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Senna leaf extract [485853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Senna Leaf [M000744288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Senna pod [2166041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Senna Pods [M000744287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Serratia marcescens [1426634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia marcescens [M0019689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Shigella dysenteriae [1316076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shigella dysenteriae [M0019772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Shigella sonnei [1491872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shigella sonnei [M0019774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Siberian ginseng root extract [259472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eleutherococci extract [M000743830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>St. John&apos;s wort extract [258326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>herba hyperici [M000743974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>St. John&apos;s wort extract [258326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saint John&apos;s wort extract [M000743977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Staphylococcus aureus [1311275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus aureus [M0020431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Staphylococcus epidermidis [1489915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus epidermidis [M0020432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Staphylococcus haemolyticus [1489916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus haemolyticus [M0425670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Staphylococcus simulans [1489917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus simulans [M000659914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Stemphylium solani allergenic extract [867349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stemphylium solani [M000705290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus agalactiae [1363918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus agalactiae [M0020570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus dysgalactiae [1491866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus dysgalactiae [M000659211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus mutans [1363920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus mutans [M0020573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus oralis [2711539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus oralis [M0029018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pneumoniae [1363917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus pneumoniae [M0020574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus pyogenes [1311281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus pyogenes [M0020575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus salivarius [2393605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus salivarius [M000608853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus thermophilus [2593692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus thermophilus [M0460997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus uberis [1491864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcus uberis [M000658852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Streptococcus viridans group [1363919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Viridans Streptococci [M0405412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Sudan III [1426472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sudan III [M0102605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Terminalia chebula fruit extract [1311683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chebulae fruit [M000743816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tinospora cordifolia stem extract [1806913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guduchi stem extract [M000757568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tinospora cordifolia whole extract [2048119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guduchi [M000757565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Toxoplasma gondii [1432991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasma gondii [M0021731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tribulus terrestris extract [1370988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tribulus extract [M000744328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tribulus terrestris fruit extract [1311579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tribulus terrestris fruit [M000744434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichinella spiralis [1426916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichinella spiralis [M0026061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton (fungus) [328140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichophyton [M0021932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton verrucosum [1310905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichophyton verrucosum [M000704846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ulva lactuca extract [1338620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ulva lactuca [M000765201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Uncaria rhynchophylla stem [1309283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gou-teng [M0232048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vaccinium myrtillus leaf extract [1309257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccinium myrtillus leaf [M000745828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Vibrio cholerae [1432992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vibrio cholerae [M0022653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>West Indian lemongrass oil [1305654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lemongrass oil [M0150017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>West Nile virus [1316080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>West Nile virus [M0022929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Yersinia enterocolitica [1426679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Yersinia enterocolitica [M0023095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Yersinia pestis [1432993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Yersinia pestis [M0023097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ziziphus extract [1426423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>jujube extract [M000744366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abacavir sulfate [M0398226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abacavir sulfate, (+)- [M000758039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(+-)-abacavir sulfate [M000758050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abaloparatide [1921069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abaloparatide [M000604476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abarelix [301739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abarelix [M0412551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abatacept [M0442852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abciximab [83929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abciximab [M0227707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abemaciclib [1946825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abemaciclib [M000596583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abetimus [1311600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abetimus [M0443426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abetimus sodium [1311599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abetimus sodium [M0582737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone [1100072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abiraterone [M0237229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone acetate [1100071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abiraterone Acetate [M0562608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abobotulinumtoxinA [M0538303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abrocitinib [2591476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>abrocitinib [M000655680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acalabrutinib [1986808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acalabrutinib [M000614544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate [82819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acamprosate [M0128674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate calcium [152761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acamprosate Calcium [M0128672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acarbose [16681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acarbose [M0070912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acebutolol [M0000100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acebutolol Hydrochloride [M0331293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acecarbromal [16688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acecarbromal [M0081274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine [2721766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aceclidine [M0224858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine hydrochloride [2721767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aceclidine hydrochloride [M0476803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aceclofenac [M0158444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceglutamide [1426379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aceglutamide [M0100174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceglutamide aluminum [1426378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aceglutamide aluminum [M0042963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acemannan [1426875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acemannan [M0162908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acemetacin [16695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acemetacin [M0087620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acenocoumarol [154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acenocoumarol [M0000105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acepromazine [155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acepromazine [M0000107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acepromazine maleate [1114057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acepromazine Maleate [M0330684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceprometazine [161203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aceprometazine [M0075950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acesulfame [1310546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetosulfame [M0048866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acesulfame potassium [1310545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acesulfame potassium [M0309536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaldehyde [1311137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetaldehyde [M0000111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetamide [2475952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetamide [M0096876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetaminophen [M0000115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetanilide [162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetanilide [M0000122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetate [164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetates [M0000125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetazolamide [M0000127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic acid [168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetic Acid [M0028791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic anhydride [1370450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetic anhydride [M0099680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetohexamide [M0000136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohydroxamic acid [16728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetohydroxamic acid [M0048858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetoin [2683094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetoin [M0000137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetone [178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetone [M0000142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetophenazine [M0262855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetophenazine maleate [M0423829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenone [2467143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetophenone [M0116334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetoxolone [16784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetylglycyrrhetinic acid [M0061122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetoxolone aluminum [268907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetylglycyrrhetinic acid, aluminum salt [M0312186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl arginine [2469242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetyl-L-arginine [M0040025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl aspartic acid [1872378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetylaspartic acid [M0040206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl cedrene [2289006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetyl cedrene [M0243501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl coenzyme A [1490796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetyl Coenzyme A [M0000158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl dipeptide-1 cetyl ester [1374852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetyltyrosyl-arginine cetyl ester [M000622999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl hexapeptide-8 [1314329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide [M0586966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetyl sulfisoxazole [M0046886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine [193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcarnitine [M0000161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcellulose [1425216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetylcellulose [M0046362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcholine [M0000165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcholine Chloride [M0049840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholinesterase [195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcholinesterase [M0000169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcysteine [M0000171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcysteine Sodium [M0331341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylcysteine Zinc [M0331336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyldigitoxin [132871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetyldigitoxin [M0000181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyldigoxins [199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetyldigoxins [M0000182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylene [200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylene [M0000186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylglucosamine [1362871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-Acetylglucosamine [M000764947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylglucosamine [1362871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-Acetyl-D-Glucosamine [M000764948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylglucosamine [1362871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acetylglucosamine [M0000189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylsalicylic acid [1858285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetylsalicylsalicylic acid [M0048913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyltributyl citrate [1362881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acetyltributylcitrate [M0494749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyltributyl citrate [1362881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-acetyltributylcitrate [M0063878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acexamic acid [15978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>6-acetylaminocaproic acid [M0070739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acid blue 25 [2178278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acid Blue 25 [M0537736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acid blue 80 [2563676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acid blue 80 [M0397140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acid green 50 [2532534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acid green 50 [M0585829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acid green 50 [2532534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>green 5 [M0082870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acid red 337 [2621122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acid red 337 [M0569099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acid violet 43 [1426422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acid Violet 43 [M0427561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acidulated phosphate fluoride [236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidulated Phosphate Fluoride [M0000226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acipimox [16817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acipimox [M0089804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acitretin [M0026177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclarubicin [239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aclacinomycin [M0057251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclarubicin [239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aclarubicin [M0023487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aclidinium bromide [M0538292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitate [1721299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aconitate [M000636804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconite [242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aconite [M0000234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrocitric Acid [M000642249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Achilleic Acid [M000642244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboxyglutaconic Acid [M000642245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Equisetic Acid [M000642248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citridinic Acid [M000642247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aconitic Acid [M0000235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitic acid [1721298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citridic Acid [M000642246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aconitine [1441664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aconitine [M0000236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis [2698312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>attruby [M000768748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acriflavine [249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acriflavine [M0000250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acriflavine [249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,6-diamino-10-methylacridinium chloride [M000750903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acriflavine hydrochloride [1664337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,6-diamino-10-methylacridinium chloride hydrochloride [M0316859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acriflavine hydrochloride [1664337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acriflavine chloride [M0316863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acrivastine [M0128312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrylamide [1368125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acrylamide [M0029842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrylate [1364500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acrylate [M0462159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrylic acid [1368626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>acrylic acid [M0111473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Activated Charcoal [M0003992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acyclovir [M0000326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acyclovir Sodium [M0000327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adagrasib [2625882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adagrasib [M000750450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adalimumab [M0422769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adalimumab-adbm [M000638622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adalimumab-atto [M000638621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adapalene [M0175560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adefovir [M0150266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adefovir dipivoxil [M0278180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenine [290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenine [M0000347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenosine [M0000377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenosine Monophosphate [M0000389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5&apos;-Adenylic Acid [M0585210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenosine Phosphate Disodium [M0584265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenosine Triphosphate [M0000395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adiphenine [333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adiphenine [M0225321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adipic acid [17050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adipic acid [M0095028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trastuzumab-DM1 Conjugate [M000644821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ado-Trastuzumab Emtansine [M0548409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adrafinil [45938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adrafinil [M0077767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adrenalone [17073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adrenalone [M0119882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adrenalone hydrochloride [236364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>adrenalone hydrochloride [M0321354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aducanumab [2557217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aducanumab [M000608738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aducanumab-avwa [2557218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aducanumab-avwa [M000767498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>advantame [1591894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(N-(3-(3-hydroxy-4-methoxyphenyl) propyl)-alpha-aspartyl)-L-phenylalanine 1-methyl ester [M0571172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide [2262250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>afamelanotide [M0528740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide acetate [2278002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>afamelanotide acetate [M000675719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Afatinib [M0561143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Afatinib Maleate [M000641345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Afatinib Dimaleate [M000623445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflatoxin B1 [2282017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aflatoxin B1 [M0025321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aflibercept [M0527034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afoxolaner [1442093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>afoxolaner [M000595012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase alfa [2691830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>agalsidase alfa [M0374692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase beta [338817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>agalsidase beta [M0430431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agar [397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Agar [M0000553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agaric acid [1441428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>agaric acid [M0057678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ajmalicine [17205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>raubasine [M0047444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ajmaline [423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ajmaline [M0000613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine [426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alanine [M0000619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanylglutamine [1359422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alanylglutamine [M0153017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alarelin [2641623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alarelin [M000732187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alatrofloxacin [M0278267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alatrofloxacin mesylate [M0423832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Albendazole [M0024161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albiglutide [1534763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>albiglutide [M000606728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Albumin, Human [M000630561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Albuterol [M0000631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Albuterol Sulfate [M0000633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albutrepenonacog alfa [1743992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>albutrepenonacog alfa [M000631085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcaftadine [1000082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alcaftadine [M0557151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alclometasone dipropionate [M0075625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcuronium [460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcuronium [M0000669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcuronium chloride [66852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcuronium Chloride [M0330741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aldesleukin [M0220038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldioxa [23161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aldioxa [M0067845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldosterone [1312358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aldosterone [M0000686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alectinib [M000599954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alefacept [M0374901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alemtuzumab [117055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alemtuzumab [M0253968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate [46041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alendronate [M0028852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate sodium [203152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alendronate Sodium [M0329075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfacalcidol [12062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alfacalcidol [M0051654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfatradiol [1926478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alfatradiol [M0509901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfaxalone [1544577]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alphaxalone [M0049068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil [480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alfentanil [M0024147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfentanil hydrochloride [203203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alfentanil Hydrochloride [M0329444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alfuzosin [M0137486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alfuzosin hydrochloride [M0137484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>algestone [595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Algestone [M0000801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alginate [1370451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alginates [M0000707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alginic acid [17305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alginic Acid [M0053297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alglucerase [M0191473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucosidase alfa [629565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alglucosidase alfa [M0497623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alirocumab [1659152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alirocumab [M0572338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aliskiren [M0414194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alitretinoin [81864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alitretinoin [M0270158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alizapride [17311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alizapride [M0105043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>all-trans-retinol [1367187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinol [M0370269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin [508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allantoin [M0000725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allethrin [513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allethrin [M000652137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allethrin [513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allethrins [M0000732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allo-2-hydroxycitric acid [2369353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allo-2-hydroxycitric acid [M0310126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allobarbital [516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allobarbital [M0225316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alloin [17354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alloin [M0049044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol [519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allopurinol [M0000745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alloxan [2466730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alloxan [M0000748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allspice oil [2373647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimenta oil [M0129054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allyl .alpha.-ionone [2396431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allyl alpha-ionone [M0518180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allyl alcohol [2385331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allyl alcohol [M0049050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allyl methacrylate [2203551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allyl methacrylate [M0108492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allyl sulfide [17376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allyl sulfide [M0115824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allylestrenol [525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Allylestrenol [M0000752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allylthiourea [1318494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allylthiourea [M0054903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alminoprofen [17387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alminoprofen [M0090409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almitrine [528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Almitrine [M0024158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almitrine dimesylate [529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Almitrine Dimesylate [M0329453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond oil [1305638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>almond oil [M0187501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>almotriptan [M0363903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>almotriptan malate [M0397885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin [1368001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alogliptin [M0511100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloglutamol [17392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aloglutamol [M0059955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alosetron [M0240025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alosetron hydrochloride [M0326799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloxiprin [17393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aloxiprin [M0056680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpelisib [2169285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alpelisib [M000641348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha 1-antitrypsin [535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha 1-Antitrypsin [M0000780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha glucosidase [2475361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Glucosidases [M0000794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha ionone [1859172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-ionone [M0058513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha tocopherol [237099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Tocopherol [M0370590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha tocopherol [237099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>d-alpha Tocopherol [M0584000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-D-galactosidase enzyme [259351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Galactosidase [M0000793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-asarone [2375532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-asarone [M000623342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-cyclodextrin [1362882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-cyclodextrin [M0101690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-damascone [2398332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-damascone [M0480475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-hexylcinnamaldehyde [1311811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexyl cinnamic aldehyde [M0214024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-hexylcinnamaldehyde [1311811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-hexylcinnamaldehyde [M0549015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-isobutylphenethyl alcohol [1720936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-methyl-1-phenylpentan-2-ol [M0118005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-isomethylionone [1368186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-isomethylionone [M0479055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-ketoglutaric acid [17511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Ketoglutaric Acid [M0094667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-methylbenzyl acetate [2374917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-methylbenzyl acetate [M0580679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-pinene [2362183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-pinene [M0047005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-terpineol [1371307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-terpineol [M0066974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Tocopherol Acetate [M0515672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Tocopherol Succinate [M0104481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopheryloxyacetic acid [1995481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid [M0470340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherylquinone [1376149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tocopherylquinone [M0043000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine [594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alphaprodine [M0000798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alphaprodine hydrochloride [7433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alphaprodine Hydrochloride [M0330746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alprazolam [M0000806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alprenolol [M0000809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alprenolol Hydrochloride [M0000810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alprostadil [M0000811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alseroxylon [599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alseroxylon [M0018532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tissue Plasminogen Activator [M0016991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>althiazide [17599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>althiazide [M0049073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altrenogest [1314612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>altrenogest [M0080712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Altretamine [M0010310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alum, ammonium [2101717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum ammonium sulfate [M0166065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alum, potassium [221456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alum [M000644324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum [1311504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum [M0000824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum acetate [17609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum acetate [M0061147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum acetotartrate [46239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum acetotartrate [M0122330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum aspirin [611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum acetylsalicylate [M000608349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum Chloride [M0056682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum Chloride, Anhydrous [M000637063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum Chloride Hexahydrate [M0311273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chlorohydrate [17610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum chlorhydrate [M0067386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum flufenamate [17612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum flufenamate [M0090244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum fluoride [2273602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum fluoride [M0100930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum Hydroxide [M0000825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Algeldrate [M0000826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxyphosphate [1423457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum hydroxyphosphate [M0188691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>almasilate [M0579966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum magnesium silicate [M0102749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum nitrate [2360133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum nitrate [M0144419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum oxide [615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum Oxide [M0000828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum phosphate [17618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum phosphate [M0059957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum potassium sulfate [54989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium aluminum sulfate [M0206881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum sesquichlorohydrate [543375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum sesquichlorohydrate [M0528650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum silicate [1362917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aluminum Silicates [M0000833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum starch octenylsuccinate [1426415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum starch octenylsuccinate [M0443410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum stearate [46243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum monostearate [M0098165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum sulfate [17621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum sulfate [M0123153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum tristearate [1363698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminum tristearate [M0098166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alverine [17627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alverine [M0056687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alverine citrate [71767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alverine citrate [M0311275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan [480639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alvimopan [M0378030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alvimopan anhydrous [1516803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alvimopan anhydrous [M0585619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amantadine [M0000847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amantadine Hydrochloride [M0330750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amantadine Sulfate [M0000848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amaranth dye [1433189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amaranth Dye [M0000852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium chloride [624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ambenonium Chloride [M0000853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amber [1311393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amber [M0027940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambergris [1311494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ambergris [M0027941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrein [2584842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ambrein [M0200332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrisentan [358274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ambrisentan [M0442173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambroxol [625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ambroxol [M0000855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambroxol acefyllinate [236595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ambroxol-theophylline-7-acetate [M0207191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambroxol-theophylline-7-acetate [186010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ambroxol-theophylline-7-acetate [M0207191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amcinonide [M0059961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amdinocillin [M0000876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin pivoxil [627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amdinocillin Pivoxil [M0000877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amentoflavone [2643210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amentoflavone [M0057258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amezinium [17665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amezinium [M0090031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amidoline [17684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amidoline [M0043196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine [2106338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amifampridine [M0066295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine phosphate [2106337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amifampridine Phosphate [M000621461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine [4126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amifostine [M0007867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine anhydrous [1545987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amifostine Anhydrous [M0585621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amikacin [M0000903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amikacin Sulfate [M0000904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amiloride [M0000906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amiloride Hydrochloride [M0330756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amiloride Hydrochloride, Anhydrous [M0330757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloxate [1426854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-(4-methoxyphenyl)-2-propenoic acid 3-methylbutyl ester [M0208414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminacrine [645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminacrine [M0000909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminacrine hydrochloride [81949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminacrine Hydrochloride [M0000910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminaphthone [46276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aminaftone [M0066071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amineptin [17698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amineptin [M0058027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminobutyric acid [70582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminobutyric Acid [M0000941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminoglutethimide [M0000944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminohippurate sodium [203194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminohippurate Sodium [M0432631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinate [155002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Aminolaevulinate [M0000952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid [683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminolevulinic Acid [M0000951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid hydrochloride [261715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminolevulinic Acid Hydrochloride [M0477089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminopentamide [1006397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aminopentamide [M0059974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminopentamide, sulfate [1006396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aminopentamide, sulfate [M0311958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminophylline [M0000959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminopterin [1440264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminopterin [M0000962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminopterin sodium [1440263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminopterin Sodium [M0331223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminopyrine [695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminopyrine [M0000965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoquinuride [17747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aminoquinuride [M0056695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aminosalicylic Acid [M0000970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amiodarona [M0433211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amiodarone [M0000973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amiodarone Hydrochloride [M0582739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amisulpride [46303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amisulpride [M0058773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitraz [17763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amitraz [M0063921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amitriptyline [M0000975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amitriptyline Hydrochloride [M0330766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab [2549199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amivantamab [M000750521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab-vmjw [2549198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amivantamab-vmjw [M000767494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amlexanox [M0132876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amlodipine [M0026284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amlodipine Besylate [M0373070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonia [1299884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ammonia [M0000981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium [709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ammonium [M0000984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium acetate [1362883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium acetate [M0070783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium bromide [1313309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium bromide [M0146471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium carbonate [1310190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium carbonate [M0120586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium carbonate [1310190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diammonium carbonate [M0582730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium chloride [712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ammonium Chloride [M0000983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium ferrous sulfate [17784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium ferrous sulfate [M0115039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium hydroxide [1362884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ammonium Hydroxide [M0062804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium iodide [1720161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium iodide [M0587077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lactate [215247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ammonium Lactate [M0582740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lauryl sulfate [1424667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyl sulfate, ammonium salt [M0317994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium molybdate [17789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium molybdate [M0077893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium phosphate [17792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium phosphate [M0083381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium phosphate, dibasic [1427061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diammonium phosphate [M0315932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium phosphate,monobasic [314493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monoammonium phosphate [M0315931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium stearate [1312975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium stearate [M0582741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium sulfate [1362695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ammonium Sulfate [M0000986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium thiocyanate [2109607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ammonium thiocyanate [M0088065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium thioglycolate [1482632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-mercaptoacetate, monoammonium salt [M0313431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amobarbital [M0001000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amobarbital Sodium [M0330770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amodiaquine [720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amodiaquine [M0001005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amodiaquine hydrochloride [314495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amodiaquine Hydrochloride [M0496322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amonafide [1440270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amonafide [M0112303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amorolfine [17804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amorolfine [M0116983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amorolfine hydrochloride [293865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amorolfin hydrochloride [M0321110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol [2667256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amosulalol [M0101358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoxapine [M0001008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyampicillin [M000642250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoxicillin [M0001009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoxicillin Anhydrous [M0585624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoxicillin Sodium [M0330772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoxicillin Trihydrate [M000636809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amphetamine [M0001012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amphetamine Sulfate [M0331305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetaminil [17813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amphetaminil [M0263091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amphotericin B [M0001021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amphotericin B Colloidal Dispersion [M0001024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amphotericin B lipid complex [M000642922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>liposomal amphotericin B [M0487802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin [42527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amphotericin [M000636813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ampicillin [M0001025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ampicillin Sodium [M0330775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ampicillin Trihydrate [M0330776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amprenavir [M0250495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprolium [1006654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amprolium [M0001031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amsacrine [739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amsacrine [M0001039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amygdalin [1371051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amygdalin [M0001043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl acetate [1370452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amyl acetate [M0047453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyl Nitrite [M0001045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylase [743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amylases [M0001046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylmetacresol [236248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amylmetacresol [M0538347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylocaine [40660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amylocaine [M0065148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylocaine hydrochloride [235793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>amylocaine hydrochloride [M0312917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylopectin [1368128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amylopectin [M0001054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anagrelide [M0075629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anagrelide hydrochloride [M0477127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anakinra [M0494869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anastrozole [84857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anastrozole [M0238999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ancestim [140502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ancestim [M0276004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ancrod [772]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancrod [M0001092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>andexanet alfa [2045114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>andexanet alfa [M000613281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Androstenedione [M0001113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androsterone [1312359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Androsterone [M0001116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anethole [17881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anethole [M0049202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anethole trithione [820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anethole Trithione [M0001171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angelicin [2690789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>angelicin [M0058141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II [1999003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angiotensin II [M0001202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anhydrous Dextrose [M0582743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous lactose [1307662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anhydrous Lactose [M0582744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anhydrous Tacrolimus [M0329463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anhydrous Zinc Acetate [M0331306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrovitamin A [2669473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anhydrovitamin A [M0098856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anidulafungin [M0436249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab [2565265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anifrolumab [M0586364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anileridine [17933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anileridine [M0263104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anileridine hydrochloride [235413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anileridine hydrochloride [M0327430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aniline [1441546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aniline [M0081119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aniracetam [17939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aniracetam [M0111076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anise oil [90926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anise oil [M000743808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anise seed extract [1309292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anise [M0399424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anise seed extract [1309292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anisi fructus [M000743809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anisindione [M0056374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisole [2594597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anisole [M0169221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anistreplase [M0024829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisyl acetate [2605801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anisyl acetate [M0580700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisyl alcohol [1424668]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anisyl alcohol [M0183628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>annatto extract [1313764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>annatto [M0152834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab [2472152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ansuvimab [M000742065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab-zykl [2472151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ebanga [M000742066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antazoline [M0001292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antazoline Hydrochloride [M0330778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antazoline Phosphate [M0001293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthralin [M0001305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anti-inhibitor coagulant complex [M0180470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>F8 protein, human [M0209555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>recombinant factor VIII SQ [M0388864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antilymphocyte immunoglobulin [973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antilymphocyte Immunoglobulin [M0001463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antimony [1311407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antimony [M0001472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antimony pentasulfide [1337969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>antimony pentasulfide [M0167832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antimony potassium tartrate [981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antimony Potassium Tartrate [M0001473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antimony trioxide [2477431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>antimony trioxide [M0113565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antimony trisulfide [1316091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>antimony trisulfide [M0177013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antipyrine [M0001499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antithrombin III [1009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antithrombin III [M0001509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apaflurane [1368129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>heptafluoropropane [M000755025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apaflurane [1368129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apaflurane [M0247820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apalutamide [M0573548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apazone [1029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apazone [M0001566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apigenin [1368130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apigenin [M0357150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apiole [314506]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apiole [M0414249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apixaban [M0512702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apocarotenal [1376342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apocarotenal [M0046234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine [1043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apomorphine [M0001603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine hydrochloride [71225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apomorphine Hydrochloride [M0331311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apraclonidine [M0067410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apraclonidine hydrochloride [M0399744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apremilast [1492727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>apremilast [M0492206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(2R)-(1R)-3,5-bis(Trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine [M000641045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprepitant [358255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aprepitant [M0447596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apricot extract [1353891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prunus armeniaca fruit [M000744763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprindine [1054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aprindine [M0001626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprinocarsen [2634355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aprinocarsen [M0469884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprobarbital [17381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>allylpropymal [M0049060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprocitentan [2679059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aprocitentan [M000655474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprotinin [1056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aprotinin [M0011905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aqua regia [1537801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aqua regia [M0077745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aquaporin-1 [2463337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aquaporin 1 [M0195494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aquaporin-4 [2370867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aquaporin 4 [M0241190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arachidic acid [1716331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arachidic acid [M0248917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arachidonic acid [1368624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arachidonic Acid [M0025459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arbekacin [26397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arbekacin [M0100125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arbekacin sulfate [237044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arbekacin sulfate [M0423889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arbutamine [61609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arbutamine [M0205855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arbutamine hydrochloride [236829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arbutamine hydrochloride [M0423890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arbutin [1367175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arbutin [M0001660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ardeparin [M0246448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ardeparin sodium [M0246447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arformoterol [M0398106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argan oil [1305642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>argan oil [M0554329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>argatroban [M0100029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>argatroban anhydrous [M000744045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine [1091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arginine [M0001683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aspartate [18254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arginine aspartate [M0083613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine glutamate [114464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arginine glutamate [M0082577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine hydrochloride [89918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arginine Hydrochloride [M0582747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argipressin [1098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arginine Vasopressin [M0001691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argon [1368133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Argon [M0001693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol [2694283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arimoclomol [M0466770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aripiprazole [M000602020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aripiprazole lauroxil [M000613234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>armodafinil [641465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Armodafinil [M0497249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aromadendrin [1601985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aromadedrin [M0214420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenate [1375924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arsenate [M0365391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic [1111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic [M0001723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic acid [1375923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arsenic acid [M0085283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trichloride [2533832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arsenic trichloride [M0144186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic triiodide [1309691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arsenic triiodide [M0523715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trioxide [18330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic Trioxide [M0049263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trisulfide [1667210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arsenic trisulfide [M0133048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenite ion [1546382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arsenite [M0063967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemether [18343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Artemether [M0102449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemisinin [2367409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>artemisinin [M0098515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artesunate [18346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroartemisinine-12-alpha-succinate [M000640560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artesunate [18346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Artesunate [M0118766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artesunate [18346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Succinyl Dihydroartemisinin [M000640561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine [592464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carticaine [M0003566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib [2584304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asciminib [M000634985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib hydrochloride [2584303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asciminib hydrochloride [M000675720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid 2-sulfate [1370459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ascorbic acid 2-sulfate [M0042371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascorbic Acid [M0001797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbyl glucoside [1306933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ascorbic acid 2-O-glucoside [M0179812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine [784649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asenapine [M0513342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine maleate [860647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asenapine maleate [M0176757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asfotase alfa [1720259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asfotase alfa [M0571868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asiatic acid [1551574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asiatic acid [M0067469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asiaticoside [18405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asiaticoside [M0045500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asparaginase erwinia chrysanthemi, recombinant-rywn [M000767497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi [1431738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asparaginase erwinia chrysanthemi recombinant [M000750563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asparaginase [M0001815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparagine [1157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asparagine [M0001818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartame [1311524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspartame [M0001821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate [42543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspartate [M0001841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspartate Magnesium Hydrochloride [M000638399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartic acid [1169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspartic Acid [M0001836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspirin [M0001864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astaxanthin [18451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>astaxanthine [M0047832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astemizole [42328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Astemizole [M0025303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>asunaprevir [M0573379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atazanavir [M000616894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atazanavir Sulfate [M0445555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atenolol [M0001900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>atezolizumab [M000618590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atipamezole [18475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>atipamezole [M0144628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atogepant [2571813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>atogepant [M000751648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atoltivimab [2461338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>atoltivimab [M000742068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atoltivimab-ebgn [2461430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>atoltivimab-ebgn [M000767503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine [38400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atomoxetine [M0124112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine hydrochloride [353103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atomoxetine Hydrochloride [M0124111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atorvastatin [M0179294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atorvastatin Calcium [M0324841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atorvastatin Calcium Anhydrous [M0589476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atorvastatin Calcium Trihydrate [M000642807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atorvastatin Calcium Hydrate [M000638387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atosiban [59639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>atosiban [M0136046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atovaquone [M0173858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium [1218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atracurium [M0001922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atracurium besylate [1219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atracurium Besylate [M0330821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atrasentan [2710449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrasentan [M0393223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atrasentan [2710449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid [M000642028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atrasentan hydrochloride [2710448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrasentan Hydrochloride [M000642029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atropine [M0001931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atropine Sulfate [M0001935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>attapulgite [18516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>attapulgite [M0086580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Auranofin [M0001971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aurothioglucose [M0009526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothiomalate [42547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aurothiomalate [M0009528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol [2645108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avacincaptad pegol [M000769129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacopan [2572100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avacopan [M000633038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avanafil [M0551615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(1S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinyl)ethanamine [M000734106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avatrombopag [M000597517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avelumab [M000619738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avibactam [M0576517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avilamycin [1661561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avilamycin [M0049299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aviscumine [2591797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aviscumine [M0464895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avobenzone [45045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avobenzone [M0142852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avotermin [1427086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>avotermin [M0558305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab [2691526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>axatilimab [M000741480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axicabtagene ciloleucel [1987398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>axicabtagene ciloleucel [M000645968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axitinib [1242999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Axitinib [M0489638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azacitidine [M0002060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azaperone [2601502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azaperone [M0002062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azatadine [M0049306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azatadine maleate [M0309651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azathioprine [M0002065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azathioprine Sodium [M0331325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azelaic acid [M0055275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azelastine [M0075361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azelastine hydrochloride [M0314382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin [18609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azidocillin [M0263147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azilsartan [M0511612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azilsartan medoxomil [M0556713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azintamide [402580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azintamid [M0058166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azithromycin [M0027129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azithromycin Dihydrate [M0329138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azithromycin Monohydrate [M0329139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin [1266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azlocillin [M0002078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin sodium [203836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Azlocillin Sodium [M0580899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azosemide [18651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azosemide [M0069534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aztreonam [M0002090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azulene [2675343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>azulene [M0047123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bacampicillin [M0058171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bacampicillin hydrochloride [M0423891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bacitracin A [M0086887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacitracin [M0002112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin methylene disalicylate [1363718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bacitracin methylenedisalicylic acid [M0080627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacitracin Zinc Complex [M0330826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Baclofen [M0002117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baicalein [1592893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>baicalein [M0049342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baicalin [1440261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>baicalin [M0114730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bakuchiol [1368134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bakuchiol [M0060030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir [2197842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>baloxavir [M000644948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir marboxil [2099995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>baloxavir marboxil [M000644949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>balsalazide [M0116205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>balsalazide disodium [M0398356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambermycins [1367176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moenomycin [M0378450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambermycins [1367176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bambermycins [M0002165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bambuterol [M0137788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bambuterol hydrochloride [M0423909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamethan [1321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamethan [M0225262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamethan sulfate [102345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamethan sulfate [M0423910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamifylline [18752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamifylline [M0049349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamifylline hydrochloride [236152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamifylline hydrochloride [M0309661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine [18753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamipine [M0075117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamipine lactate [236530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamipine lactate [M0314352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamlanivimab [2463114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamlanivimab [M000741830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bampine hydrochloride [236519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bamipine monohydrochloride [M0314350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbexaclone [46795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>barbexaclone [M0057012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Barbital [M0002175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baricitinib [2047232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>baricitinib [M000603439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium [1311067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Barium [M0002178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium carbonate [1305530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>barium carbonate [M0049351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium chloride [1311065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>barium chloride [M0083817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium chloride, dihydrate [1311064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>barium chloride, dihydrate [M0316068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium chromate [1307797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>barium chromate [M0460630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium oxide [1307801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>barium oxide [M0208320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barium sulfate [1331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Barium Sulfate [M0002181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>basic aluminum carbonate gel [M0084241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic blue 1 [2263063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>setoglaucine [M0102875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic fuchsin [1535513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>basic fuchsin [M0084889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic fuchsin [1535513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rosaniline base [M000633626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic red 46 [2669797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>basic red 46 [M0144967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic red 51 [1812082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Basic Red 51 [M000595155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basil oil [1362135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>basil oil [M0145728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basiliximab [196102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Basiliximab [M0292349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene [1441386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bazedoxifene [M0535317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene acetate [1442171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bazedoxifene acetate [M0414851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bebtelovimab [2592360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bebtelovimab [M000751841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>becaplermin [115238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Becaplermin [M0195683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclamide [18846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beclamide [M0058175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beclomethasone 17-monopropionate [M0180921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beclomethasone [M0002258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beclomethasone Dipropionate [M0002259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline [1364504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bedaquiline [M0492968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline fumarate [1364503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bedaquiline fumarate [M0584913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beef tallow preparation [1368135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tallow [M0061662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beeswax [1356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beeswax [M0115179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>behenic acid [1368203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>behenic acid [M0050815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>belantamab mafodotin [M000654577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belatacept [1112973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Belatacept [M0498618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belimumab [1092437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>belimumab [M0500056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belinostat [1543543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>belinostat [M0519759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Belladonna Alkaloids [M0002300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil [2564025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>belumosudil [M000750558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belzutifan [2567226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>belzutifan [M000754192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bemiparin [M0366857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemisiose [1734014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bemisiose [M0230052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemotrizinol [1306115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bemotrizinol [M000601427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemotrizinol [1306115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bis-ethylhexyloxyphenol methoxyphenyl triazine [M0404686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid [M0585021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benactyzine [1361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benactyzine [M0002303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benazepril [M0130973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benazepril hydrochloride [M0399464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benazeprilat [M0148101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bencyclane [1367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bencyclane [M0002307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bencyclane fumarate [258328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bencyclane Fumarate [M0002308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine [134547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bendamustine [M0042082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine hydrochloride [1114693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bendamustine Hydrochloride [M0307744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bendroflumethiazide [M0002310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benfluorex [18880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benfluorex [M0041824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benfluorex hydrochloride [235953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benfluorex hydrochloride [M0307699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benorilate [1372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benorilate [M0225326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate [18889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benoxinate [M0046757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benoxinate hydrochloride [235398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benoxinate hydrochloride [M0308992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benperidol [M0002314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benphothiamine [18891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benphothiamine [M0061935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benproperine [236749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benproperine [M0454030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benproperine pamoate [236750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benproperine pamoate [M0477218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benralizumab [1989100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benralizumab [M0572760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benserazide [1374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benserazide [M0002315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentiromide [18896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bentiromide [M0049427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentonite [1375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bentonite [M0002317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bentoquatam [134568]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bentoquatam [M0049361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzaldehyde [1314334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzaldehyde [M0100558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzalkonium [1378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzalkonium [M0002321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzalkonium chloride [1379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzalkonium Chloride [M0002322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzarone [18923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzarone [M0045624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzbromarone [1385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzbromarone [M0002331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzene [1311295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzene [M0002332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzenesulfinic acid [2637735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzenesulfinic acid [M0386372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzenesulfonate [1313278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzenesulfonate [M0101055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzenesulfonic acid [993243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzenesulfonic acid [M0101058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzethonium [1390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzethonium [M0002337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzethonium chloride [40036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzethonium Chloride [M0002339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine [2690627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>memogain [M0545683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzilic acid [1430394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzilic acid [M000768100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzimidazole [1362885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzimidazole [M0097720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzonidazole [M0055210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoate [70589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzoate [M0002352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzocaine [M0002353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzocaine Hydrochloride [M0330835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzododecinium bromide [1311594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyldodecylbenzylammonium bromide [M0312740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoic acid 2-(2,4,6-trichlorophenyl)hydrazide [2286251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzoic acid 2-(2,4,6-trichlorophenyl)hydrazide [M0057693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoic acid [18989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzoic Acid [M0029415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoic anhydride [1998050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzoic anhydride [M0269409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoin resin [1406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzoin [M0002361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzonatate [18993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzonatate [M0094700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzophenone [18997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzophenone [M0137698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzophenone-2 [1315125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,2&apos;,4,4&apos;-tetrahydroxybenzophenone [M0108696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzopyrene [2534454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzo(a)pyrene [M0002349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzotriazole [2385339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzotriazole [M0060034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoxiquine [314521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzoxiquine [M000755854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoxonium chloride [46949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzoxonium chloride [M0061957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoyl peroxide [1418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzoyl Peroxide [M0002375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzphetamine [M0002381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquercin [117896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzquercin [M0255953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzquinamide [M0263111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzquinamide hydrochloride [M0423972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzothiazide [M0045527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benztropine [M0002383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzatropine Methanesulfonate [M0045522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzydamine [1425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzydamine [M0002384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzydamine hydrochloride [81963]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzydamine Hydrochloride [M0330843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl acetate [1487188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzyl acetate [M0134479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl alcohol [1426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzyl Alcohol [M0029566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl benzoate [19044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzyl benzoate [M0049438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl chloride [1311516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzyl chloride [M0075970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl cinnamate [1649557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzyl cinnamate [M0518155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl salicylate [1362907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzyl salicylate [M0118631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylamine [2374339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzylamine [M0097154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylparaben [19075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzylparaben [M0161515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylpenicilloyl polylysine [19079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzylpenicilloyl G polylysine [M0423989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzylthiouracil [19084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzylthiouracil [M0071606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine [863035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bepotastine [M0281815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine besilate [658552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bepotastine besilate [M0499606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bepridil [M0024153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beractant [46967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beractant [M0195691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berberine [1437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berberine [M0002396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer sodium [2710445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>berdazimer sodium [M000736470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bergamot oil [1305651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bergamot oil [M0186940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berotralstat [2467540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>berotralstat [M000733815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beryllium [1310252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beryllium [M0002405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beryllium fluoride [2599581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beryllium fluoride [M0109898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beryllium sulfate tetrahydrate [2603751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beryllium sulfate, tetrahydrate [M0314277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>besifloxacin [M0518848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta carotene [19143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta Carotene [M0028611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta sitosterol [47070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sitosterol, (3beta)-isomer [M0316380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta tocopherol [1792723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-Tocopherol [M0022800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-d-glucose [M000766583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-alanine [61]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-Alanine [M0023212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-escin [1476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-Escin [M0007734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-pinene [1923811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-pinene [M0056560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-resorcylic acid [1368632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-resorcylic acid [M0068680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-thujaplicin [1312538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-thujaplicin [M0054219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betadex [1362685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betadex [M0098264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betahistine [1511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betahistine [M0002430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betahistine hydrochloride [81964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betahistine Hydrochloride [M0330845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betahistine mesylate [71468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betahistine Mesylate [M0330844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine [1512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betaine [M0002435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine citrate [160460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betaine citrate [M0069548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine hydrochloride [81965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betaine Hydrochloride [M0002436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betamethasone [M0002437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betamethasone acetate [M0582748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betamethasone benzoate [M0065187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betamethasone-17,21-dipropionate [M0057280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>augmented betamethasone dipropionate [M0424589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betamethasone sodium phosphate [M0092825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betamethasone Valerate [M0002438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betaxolol [M0024177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Betaxolol Hydrochloride [M0024179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bethanechol [M0028052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bethanechol Chloride [M0028053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanidine [1523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bethanidine [M0002444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanidine sulfate [81966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bethanidine Sulfate [M0002445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betibeglogene autotemcel [2610349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betibeglogene autotemcel [M000754950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betrixaban [1927851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betrixaban [M0538517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betulin [2467840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betulin [M0043133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betulonic acid [2375519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betulonic acid [M0303267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bevacizumab [M0443627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bevacizumab-awwb [M000638602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexagliflozin [2627044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bexagliflozin [M000732733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bexarotene [M0250478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bezafibrate [1525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bezafibrate [M0002449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bezlotoxumab [1855048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bezlotoxumab [M000626245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicalutamide [83008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bicalutamide [M0151653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicarbonate ion [1546277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrogen Carbonate [M0330851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biclotymol [236268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,2-methylenebis(4-chloro-3-methyl-isopropylphenol) [M0527012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir [1999660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bictegravir [M000633187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir sodium [1999661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bictegravir sodium [M000750758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifemelane [47111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bifemelane [M0099904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifenthrin [2475177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bifenthrin [M0262239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bifonazole [M0111352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biguanide [1918319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biguanides [M0002471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bilberry extract [125929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccinium myrtillus extract [M0198248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bilberry extract [125929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bilberry fruit [M000745827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bile salts [1540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bile Salts [M0002476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimatoprost [283810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bimatoprost [M0395184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab [2668041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bimekizumab [M000640589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>binetrakin [1426682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-4 [M0024266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>binimetinib [2049122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>binimetinib [M000604033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bioallethrin [19338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bioallethrin [M0070027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biotin [1588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biotin [M0002565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biperiden [M0002568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biperiden Hydrochloride [M0330860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>biperiden lactate [M0110997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bis(1,10-phenanthroline)copper(2+) ion [1797117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bis(1,10-phenanthroline)copper(2+) ion [M0063518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisabolol [19461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bisabolol [M0045571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisacodyl [1596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bisacodyl [M0002606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisdequalinium [19464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bisdequalinium [M0065197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisdequalinium diacetate [236889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bisdequalinium diacetate [M0312931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisdisulizole disodium [1811859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disodium phenyl dibenzimidazole tetrasulfonate [M0489073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bismuth [M0002611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth aluminate [40762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth aluminate [M0180211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth carbonate [19469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth carbonate [M0105204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth oxide [19472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth trioxide [M0103394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth oxide [19472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth oxide [M0103396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth oxychloride [1311517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth oxychloride [M0130354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth phosphate [2600775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth phosphate [M0109682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth subcarbonate [M0091693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth tripotassium dicitrate [M0043532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth subgallate [M0042662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth subnitrate [M0056592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth subsalicylate [M0065203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth tribromophenate [47180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bismuth tribromophenate [M0045662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bisoprolol [M0026256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bisoprolol Fumarate [M0026258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisphenol A [1433347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bisphenol A [M0049526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol [19499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bitolterol [M0058195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol mesylate [47187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bitolterol mesylate [M0311551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitter fennel extract [1372008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foeniculum vulgare fruit [M000744611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitter fennel extract [1372008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>foeniculi amari fructus [M000743907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bivalirudin [M0201405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bivalirudin trifluoroacetate [M000757310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>black cohosh root extract [M000744829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh root extract [259511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>black cohosh root extract [M000744829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black currant oil [73891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>black currant oil [M0225415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black pepper oil [1309201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>black pepper oil [M000759085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black widow spider venom [1310459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>black widow spider venom [M0116106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bleomycin [M0002657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bleomicina [M0460670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bleomycin Sulfate [M0330861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blinatumomab [1597258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>blinatumomab [M0498704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blueberry extract [1549329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>blueberry extract [M000755567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide [M0500464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boldenone [2289408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>boldenone [M0062055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boldenone undecylenate [2289409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>boldenone undecylenate [M0041527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bone meal [19596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bone meal [M0089963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bopindolol [M0109948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>borage oil [68905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>borage oil [M0212456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boric acid [1700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>boric acid [M0101858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bornaprine [19610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bornaprine [M0048189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bornaprine hydrochloride [235767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bornaprine hydrochloride [M0309440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>borneol [1368202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>borneol [M0079497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bornyl acetate [1491978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bornyl acetate [M0194242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>borogluconate [1370421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>borogluconate [M0105764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boron [1705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Boron [M0002831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boron gluconate [259357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>boron gluconate [M0443288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boron nitride [1363426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>boron nitride [M0067928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bortezomib [M0350110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boscalid [1735163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide [M0547313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan [75207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bosentan [M000640413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bosentan Anhydrous [M0585634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan monohydrate [498193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bosentan Monohydrate [M000637175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bosutinib [M0446825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulinum Toxins, Type A [M0028703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type B [2167673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>botulinum B toxin [M000637182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bourgeonal [2584844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bourgeonal [M0448445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bovine cartilage extract [47295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bovine cartilage extract [M0049782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brain-derived neurotrophic factor [47324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain-Derived Neurotrophic Factor [M0028612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide [2176312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bremelanotide [M0500526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brensocatib [2721880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brensocatib [M000742248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brentuximab Vedotin [M0551563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bretylium [M0131477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bretylium Tosylate [M0002920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexanolone [2121777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brexanolone [M000640001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brexpiprazole [M000598439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexucabtagene autoleucel [2387277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brexucabtagene autoleucel [M000752913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brigatinib [M000632371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brilliant blue FCF [1310605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brilliant blue [M0049566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brilliant blue FCF [1310605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>C.I. 42090 [M000623311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brilliant blue G [1998867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coomassie Brilliant Blue [M0045838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brilliant green [19698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brilliant green [M0049572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine [134615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brimonidine [M000603395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine tartrate [39171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brimonidine Tartrate [M0065049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brincidofovir [2599518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brincidofovir [M0517473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brinzolamide [194881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brinzolamide [M0289415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brivaracetam [1739745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brivaracetam [M0497062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brivudine [59161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brivudine [M0073782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brodalumab [1872251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brodalumab [M0572544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brodimoprim [19727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brodimoprim [M0112453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab [2204915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brolucizumab [M000635524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bromazepam [M0002929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromelains [1752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>EC 3.4.22.33 [M000738565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromelains [1752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bromelains [M0002933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bromfenac [M0150453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium bromfenac [M0323319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromhexine [1753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bromhexine [M0002938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromhexine hydrochloride [1601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bromhexine Hydrochloride [M0330882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromine [1311476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bromine [M0002942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bromocriptine [M0002948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-Bromoergocryptine Mesylate [M0002949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bromodiphenhydramine [M0057705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bromodiphenhydramine hydrochloride [M0311457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromopride [19768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bromopride [M0061964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol [19777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bromperidol [M0049599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol decanoate [186024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bromperidol decanoate [M0207267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brompheniramine [M0002955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brompheniramine Maleate [M0330884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bronopol [1114345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bronopol [M0049616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brotizolam [19790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brotizolam [M0075325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brovanexine [19791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brovanexine [M0059120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bruceantin [2693987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bruceantin [M0043202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brucine [2181419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brucine [M0222862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>buclizine [M0135650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>buclizine dihydrochloride [M0322518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Budesonide [M0029420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine [19832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>budipine [M0087452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine hydrochloride [236892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>budipine hydrochloride [M0087451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bufexamac [1796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bufexamac [M0003003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil [19836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>buflomedil [M0056294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil hydrochloride [235934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>buflomedil hydrochloride [M0311190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumadizone [19847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bumadizone [M0263109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bumetanide [M0003024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bunazosin [19850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bunazosin [M0069474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bunazosin hydrochloride [236888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bunazosin hydrochloride [M0313593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bupivacaine [M0003045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bupivacaine Hydrochloride [M0330885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bupranolol [M0003051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Buprenorphine [M0003054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Buprenorphine Hydrochloride [M0330887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bupropion [M0025361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bupropion Hydrochloride [M0025362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab [2043855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>burosumab [M000643404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab-twza [2043854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crysvita [M000646878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buserelin [1825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Buserelin [M0003073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buserelin acetate [42569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Buserelin Acetate [M0330888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Buspirone [M0003077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Buspirone Hydrochloride [M0350950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Busulfan [M0003079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital [477631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>secbutabarbital [M0225337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital sodium [91109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>secbutabarbital sodium [M0424050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butacaine [1829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butacaine [M0198300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butacaine sulfate [133044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butacaine sulfate [M0424051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butafosfan [819929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butafosfan [M000624886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalamine [180806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butalamine [M0185234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalamine hydrochloride [236155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butalamine hydrochloride [M0539448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalbital [19860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butalbital [M0045538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butamben [19861]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butamben [M0045723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butamben picrate [221067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butamben picrate [M0424053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butamirate [19862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butamirate [M0049635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butamirate citrate [382677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(2-(diethylamino)ethoxy)ethyl-2-phenylbutyrate citrate [M0049632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butane [1310550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butane [M0135635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butenafine [M0185247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butenafine hydrochloride [M0185246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butethamate citrate [156762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butethamate citrate [M0049638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buthiazide [19882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>buthiazide [M0054684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butibufen [19880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butibufen [M0060077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butobarbital [M0089832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butoconazole [M0067615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butoconazole nitrate [M0067614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butorphanol [M0003094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butorphanol Tartrate [M0003095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butriptyline [19895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butriptyline [M0263144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butriptyline hydrochloride [324004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butriptyline hydrochloride [M0424070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyl acetate [1362908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butyl acetate [M0049649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyl alcohol [1310579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Butanol [M0029707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyl chloride [19900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butyl chloride [M0049659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyl salicylate [1859244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butyl salicylate [M0476139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyl stearate [1363628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butyl stearate [M0127609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylated hydroxyanisole [1362900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butylated Hydroxyanisole [M0003104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylated hydroxytoluene [1848]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butylated Hydroxytoluene [M0003105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butylparaben [M0114834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylscopolamine [1085787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butylscopolammonium Bromide [M0003107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylscopolamine bromide [1851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butylscopolammonium Bromide [M0003107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylvinal [19928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butylvinal [M0061011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyrate [596718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butyrate [M0003110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyric acid [1362696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Butyric Acid [M0029881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butyrospermol acetate [1995483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butyrospermol acetate [M0467626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buzepide metiodide [19943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>buzepide metiodide [M0076046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cabazitaxel [M0550309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cabergoline [M0136060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cabotegravir [M000623417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir sodium [2475076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cabotegravir sodium [M000754357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib [1363268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cabozantinib [M0558240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadexomer iodine [20012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cadexomer iodine [M0116196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadmium [1362694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cadmium [M0003131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadmium chloride [1863268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cadmium Chloride [M0028677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadmium fluoride [2600776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cadmium fluoride [M0526154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadmium iodide [1311081]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cadmium iodide [M0198110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadmium sulfate [1368145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cadmium sulfate [M0112534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadmium sulfide [1368199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cadmium sulfide [M0107366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cafedrine [47589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cafedrine [M0043472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeic acid [1311397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caffeic acid [M0119464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Caffeine [M0003138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caffeine citrate [M0086282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cajuput oil [1309211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cajuput oil [M0214200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calaspargase pegol [M000602361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calaspargase pegol-mknl [M000663354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol [1889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcifediol [M0003141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcifediol Anhydrous [M0585635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene [29365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcipotriene [M0155262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcitonin [M0003145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcitriol [M0003148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium [1895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium [M0003153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium acetate [M0331741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium alginate [47610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Alginate [M0310538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium aluminosilicate [1313228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Aluminosilicate [M000606823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium arsenate [1333425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium arsenate [M0133049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium ascorbate [142407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium ascorbate [M0540124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium aspartate [287637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Aspartate [M0330805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium bicarbonate [1373352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium bicarbonate [M0099054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium borogluconate [1370420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>borogluconate, calcium salt [M0320063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium bromide [195983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium bromide [M0292053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbimide [1902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Carbimide [M0330580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Carbonate [M0003155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chlorate dihydrate [1542454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium chlorate dihydrate [M0241285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Chloride [M0003166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Chloride, Anhydrous [M0581837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Chloride Dihydrate [M000636837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Citrate [M0028810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate malate [73409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium citrate malate [M0223270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium cyclamate [155015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Cyclamate [M0331213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dobesilate [1904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Dobesilate [M0003167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium fluoride [1905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Fluoride [M0003170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium formate [1362747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formic acid, calcium salt [M0318890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium fructoborate [2600351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium fructoborate [M0494123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium galactogluconate bromide [47617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium galactogluconate bromide [M0069565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium glubionate [M0124587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glucarate [1907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Saccharate [M0009319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium glucoheptonate [M0051275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Gluconate [M0003171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Glycerophosphate [M0009421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium hydroxide [1910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Hydroxide [M0003172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium ipodate [1911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Ipodate [M0011699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium lactate [M0285443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levulinic acid, calcium salt [M0319505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium monofluorophosphate [2463340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium monofluorophosphate [M0060389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxalate [1485048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Oxalate [M0003175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxalate monohydrate [1485047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Oxalate Monohydrate (1:1) [M0330902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxide [28728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lime [M0066622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium palmitate [2637681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Palmitate [M0028751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pangamate [1917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium pangamate [M0275347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Pantothenate [M0015822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium peroxide [1426443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium peroxide [M0356702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate [M0073809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, dihydrate [M0314121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, monobasic, anhydrous [M0466453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pidolate [87393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium pidolate [M0245338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium polycarbophil [M0095966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polystyrene sulfonate product [47630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polystyrene sulfonic acid, homopolymer, calcium salt [M0308259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polysulfide [2256949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lime sulfur [M0051992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium propionate [1426453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium propionate [M0094456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pyrophosphate [1362901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Pyrophosphate [M0003179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium saccharate anhydrous [2636533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Saccharate Anhydrous [M0574147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium silicate [1311526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium silicate [M0098430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rhenanite [M0205435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium stearate [47633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium stearate [M0098167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfate [1925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Sulfate [M0003183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfate, anhydrous [1328529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Sulfate, Anhydrous [M0003188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfate, dihydrate [1310465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Sulfate Dihydrate [M0331331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfate, dihydrate [1310465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Sulfate (1:1), Dihydrate [M000642843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfate, hemihydrate [1310466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Sulfate, Hemihydrate [M0003190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sulfide [90521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium sulfide [M0104899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium threonate [273888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium threonate [M0350297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium valproate [1927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Calcium Valproate [M0022499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calenduloside E [1428039]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calenduloside E [M0539715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calfactant [232539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calfactant [M0301241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>californium [2571855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Californium [M0003203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calomel [1311098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calomel [M0065215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cambendazole [1951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cambendazole [M0003231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>campesterol [20129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>campesterol [M0075918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphene [2395761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>camphene [M0071632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor [1952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Camphor [M0003240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphoric acid 1-methyl ester [30193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>camphoric acid 1-methyl ester [M0374750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camylofin hydrochloride [236175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>camylofin hydrochloride [M0308658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camylofine [20136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>camylofine [M0045767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin [1373458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canagliflozin [M0550188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canagliflozin, Anhydrous [M000613688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>canakinumab [M0536437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>candesartan [M0217705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>candesartan cilexetil [M0208739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor [1656052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cangrelor [M0421877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cangrelor tetrasodium [1656051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cangrelor tetrasodium [M000645452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabichromene [2585216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cannabichromene [M0056407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cannabidiol [M0003266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabigerol [2464938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cannabigerol [M0112336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabigerolic acid [2279518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cannabigerolic acid [M0264172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabinol [1976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cannabinol [M0003268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canola oil [1309202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canola Oil [M000625875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canrenoate potassium [1981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canrenoate Potassium [M0003281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canrenoic acid [81971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canrenoic Acid [M0330907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canrenone [1982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canrenone [M0003283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantharidin [1984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cantharidin [M0003285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canthaxanthin [42348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Canthaxanthin [M0025364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Capecitabine [M0287377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capivasertib [2669967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>capivasertib [M000675721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab [2110605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caplacizumab [M0590061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab-yhdp [2110604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cablivi [M000654894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>capmatinib [M000626242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib hydrochloride [2362259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>capmatinib dihydrochloride monohydrate [M000747011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin [78903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Capreomycin [M0003304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin sulfate [1987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Capreomycin Sulfate [M0003303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caprolactone [1998122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caprolactone [M0333785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capromab pendetide [136300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Capromab Pendetide [M0265650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capromorelin [1986787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Capromorelin [M0451668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caprylhydroxamic acid [1307145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octanohydroxamic acid [M0049707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capryloyl salicylic acid [1492035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>capryloyl salicylic acid [M000605046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Capsaicin [M0003308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captan [1368147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Captan [M0003318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captodiamine [89812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>captodiamine [M0479846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Captopril [M0003319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen [20191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caramiphen [M0045604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen edisylate [133053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caramiphen edisylate [M000603095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caraway oil [M0272984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carazolol [M0062870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbachol [1999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbachol [M0003323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbadox [1314339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbadox [M0003326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbamazepine [M0003328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbamide Peroxide [M0053504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamoylcholine [1546387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbamylcholine [M0003324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbarson [20206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbarson [M0102609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbaryl [9724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbaryl [M0019707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbazochrome [2011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbazochrome [M0198343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbazochrome sodium sulfonate [20209]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbazochrome sodium sulfonate [M0424590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbenicillin [M0003339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbenicillin Disodium [M0330918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbenicillin indanyl sodium [M0263157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin phenyl sodium [42580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbenicillin Phenyl Sodium [M0330924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenoxolone [2017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbenoxolone [M0003342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenoxolone sodium [2018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbenoxolone Sodium [M0003343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane [20217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbetapentane [M0070843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane citrate [283547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbetapentane citrate [M0313731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane tannate [221070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbetapentane tannate [M0313730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbidopa [M0003345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbimazole [2020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbimazole [M0003346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbinoxamine [M0045779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbinoxamine maleate [M0308663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbocysteine [2023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbocysteine [M0003348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbocysteine-lysine [1427149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbocysteine-lysine [M0107349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbomer [235535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbomer [M0456569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbomer homopolymer type B (allyl pentaerythritol or allyl sucrose crosslinked) [1732380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbomer 934p [M0049740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbomer-934 [1307830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbomer-934 [M0049742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbomer-940 [1362909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbopol 940 [M0049747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon black [2032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbon Black [M0003366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon dioxide [2034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbon Dioxide [M0003369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon disulfide [1311478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbon Disulfide [M0003370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon monoxide [2037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbon Monoxide [M0003372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbon tetrachloride [2383337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbon Tetrachloride [M0003376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboplatin [M0024707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboprost [M0003399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carboprost tromethamine [M0173737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose [2062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboxymethyl Cellulose [M000613712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium [491498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboxymethylcellulose Sodium [M0003407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxypolymethylene [20298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carboxypolymethylene [M0049756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbromal [2067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbromal [M0225268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbutamide [2068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbutamide [M0003414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cardiotoxin III, Naja naja atra [2043924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cardiotoxin III, Naja naja atra [M0219088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carfilzomib [1302966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carfilzomib [M0516378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carglumic acid [401713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carglumic acid [M0520883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cariprazine [M0527151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine hydrochloride [1721073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cariprazine hydrochloride [M0527152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carisoprodol [M0003488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carminic acid [1368643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carminic Acid [M000613705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carmustine [M0003490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnauba wax [1307833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carnauba wax [M0086600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine [2106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carnitine [M0003493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnosine [1362697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carnosine [M0003535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnosine hydrochloride [1370593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carnosine Hydrochloride [M0583187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carpipramine [20342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carpipramine [M0049776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carpipramine dihydrochloride [289326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carpipramine dihydrochloride [M0309749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carprofen [20343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carprofen [M0049898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carrageenan [1368862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carrageenan [M0003555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carteolol [M0003563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carteolol Hydrochloride [M0003565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvacrol [1998840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carvacrol [M0198268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carvedilol [M0127291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvone [1427075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carvone [M0049777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caryophyllene [1368148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>caryophyllene [M0083228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carzenide [20355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carzenide [M0042315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casanthranol [66870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Casanthranol [M0003581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cascara sagrada [66869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cascara Sagrada [M0003578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Caseins [M0003590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casimersen [2480096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>casimersen [M000750391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casirivimab [2465242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>casirivimab [M000740265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Caspofungin [M0414530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Caspofungin Acetate [M0466859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>castor oil [2129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Castor Oil [M0003604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat&apos;s claw preparation [285223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cat&apos;s claw extract [M000744394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>catalase [2133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Catalase [M0003613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>catechin [1367177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Catechin [M0003638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cathine [32022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cathine [M000633814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cathine [32022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norpseudoephedrine [M0046817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cathine hydrochloride [236860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norpseudoephedrine hydrochloride [M0309038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>causticum preparation [1311056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Causticum [M0465982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedazuridine [2384449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cedazuridine [M000654977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedazuridine [2384449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(4R)-2&apos;-deoxy-2&apos;,2&apos;-difluoro-3,4,5,6-tetrahydrouridine [M000654978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedrene [2632411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cedrene [M0040490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cedrol [1670019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cedrol [M0210791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefaclor [M0003713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))- [M000642256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefaclor Anhydrous [M0585637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephadroxyl [M000642254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-Hydroxycephalexin [M000642253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefadroxil [M0003714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))- [M000642255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefadroxil Anhydrous [M0585638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefadroxil Monohydrate [M000638404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefamandole [M0003716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefamandole nafate [M0060087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefatrizine [2179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefatrizine [M0003717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefazolin [M0003718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefazolin Sodium [M0351014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefdinir [M0159248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-(2 (2-Aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid [M000640854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefditoren [M0198635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefditoren pivoxil [M0161357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefepime [M0127410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefepime Hydrochloride [M0424218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefetamet [20482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefetamet [M0136998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefiderocol [M000623712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefiderocol Sulfate Tosylate [M000764250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefixime [M0328108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefixime Anhydrous [M0585639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefmetazole [M0023575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefmetazole Sodium [M0351019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefodizime [20485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefodizime [M0103520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefonicid [2183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefonicid [M0024188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefonicid monosodium [266801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefonicid Monosodium [M0329459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefoperazone [M0003720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefoperazone Sodium [M0351007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceforanide [M0059859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefotaxime [M0003722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefotaxime Sodium [M0330933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefotetan [M0023580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefotetan Disodium [M0351043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam [2188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefotiam [M0023572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam hydrochloride [236202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefotiam Hydrochloride [M0351050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin [1591901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefovecin [M0505642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefoxitin [M0003724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefoxitin Sodium [M0351046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome [27130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefpirome [M0116918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome sulfate [236104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefpirome Sulfate [M0443266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefpodoxime [M0150936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefpodoxime Proxetil [M0150927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefprozil [M0147833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin [2190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefsulodin [M0003727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin sodium [267417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefsulodin Sodium [M0330934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftaroline [M0515950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftaroline Fosamil [M0515961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))- [M000642257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftazidime [M0003729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftazidime Anhydrous [M0585640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftazidime Pentahydrate [M000638405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftibuten [M0153553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur [1311521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftiofur [M0151563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur hydrochloride [1311520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftiofur hydrochloride [M0323365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur sodium [1370372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftiofur sodium [M0323366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftizoxime [M0023550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftizoxime Sodium [M0351052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftobiprole [M0410581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftobiprole medocaril [M0491785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftolozane [M0594225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceftolozane sulfate [M000600991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftriaxone [M0003731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftriaxone, Disodium Salt, Hemiheptahydrate [M000641353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftriaxone Sodium [M0330935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ceftriaxone, Disodium Salt [M000641352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cefuroxime [M0003733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cefuroxime axetil [M0121148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Celecoxib [M0276185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Celiprolol [M0026215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Celiprolol Hydrochloride [M0350549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulase [2219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulase [M0003782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulose [2221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulose [M0003790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulose acetate phthalate [1425215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cellulose acetate phthalate [M0058224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulose sodium phosphate [342965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium cellulose phosphate [M0442668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulose sulfate [2642135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cellulose sulfate [M0073824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cellulose, oxidized [2481135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulose, Oxidized [M0003793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cemiplimab [M000644354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin [2104332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cenegermin [M000668714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin-bkbj [2104331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cenegermin-bkbj [M000668728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cenobamate [M000677197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))- [M000642258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephalexin [M0003820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephalexin Hydrochloride [M0330938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephalexin Monohydrate [M000638406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephaloridine [2233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephaloridine [M0003824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephalothin [M0003828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Cephalothin [M0351072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephapirin [M0003832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephapirin Sodium [M0003833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephradine [M0003834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceramide 2 [1426448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-stearoylsphinganine [M0440305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceramide 3 [1362741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceramide 3 [M0070056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceramide 6 II [1314307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(alpha-hydroxyoctadecanoyl)phytosphingosine [M0490181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceric oxide [1673068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceric oxide [M0096625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceritinib [M0592196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerium [1367178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerium [M0003917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cerivastatin [M0228730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cerivastatin sodium [M0397904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerliponase alfa [1922436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cerliponase alfa [M000634456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Certolizumab Pegol [M0507051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin [152610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>certoparin [M0356901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin sodium [152612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>certoparin sodium [M0356902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceruletide diethylamine [20024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ceruletide diethylamine [M0101746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cesium [1310121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cesium [M0003950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cesium chloride [20599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cesium chloride [M0090602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetalkonium chloride [47907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetalkonium chloride [M0311978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceteareth 20 [1311619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetomacrogol 1000 [M0003966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetearyl alcohol [1425218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetearyl alcohol [M0377676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetearyl glucoside [1425219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetearyl glucoside [M0537714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetearyl isononanoate [1312361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexadecyl isononanoate [M0465723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetiedil [20609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetiedil [M0049814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetiedil citrate [236204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetiedil citrate (1:1) [M0309759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine [20610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetirizine [M0026321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine hydrochloride [203150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetirizine Dihydrochloride [M0026323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetostearyl alcohol [1307840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetostearyl alcohol [M0055876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrimide [288088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetrimide [M0045340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrimides [2284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetrimides [M0003967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrimonium [20614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetrimonium [M000640323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrimonium bromide [288999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetrimonium Bromide [M0308521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrimonium chloride [1311525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetrimonium Chloride [M0308519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetromonium methosulfate [2056289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetrimonium Methyl Sulfate [M0308522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetrorelix [M0173811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetrorelix acetate [M0443287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetuximab [318341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetuximab [M0422675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyl alcohol [20615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetyl alcohol [M0046310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyl lactate [1368150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetyl lactate [M0168952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyl myristoleate [1314343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetyl myristoleate [M0232077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyl oleate [1306182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palmityl oleate [M0355299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyl palmitate [1311485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetyl palmitate [M0049816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyl sulfate [1366920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetyl sulfate [M0042717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetyldimethylethylammonium bromide [1427238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cetyldimethylethylammonium bromide [M0569102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium [2286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetylpyridinium [M0003973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium chloride [2287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetylpyridinium Chloride [M0003974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetylpyridinium chloride anhydrous [1311527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cetylpyridinium Chloride Anhydrous [M0585641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cevimeline [M0164858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride [260036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cevimeline hydrochloride [M0376470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chalcone [2592960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chalcone [M0003983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chamomile extract [1309226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chamomile extract [M000744828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chamomile flower oil [1309221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chamomile Oil [M0329026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Charcoal [M0003993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chaste tree preparation [236664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chaste tree fruit [M000743805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chenodeoxycholate [42588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chenodeoxycholate [M0004031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chenodeoxycholic acid [2323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chenodeoxycholic Acid [M0004029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chitosan [59038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chitosan [M0049825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chitosan medium molecular weight (200-800 MPA.S) [1368152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chitosan [M0049825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlophedianol [21254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clofedanol [M0055935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlophedianol hydrochloride [1014329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clofedanol hydrochloride [M0311115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloral hydrate [2344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chloral Hydrate [M0004114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorambucil [M0004118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramine-T [20762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramine-T [M0066217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramine-T anhydrous [1593148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramine-T anhydrous [M000620351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramine-T trihydrate [1592902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramine-T trihydrate [M000645156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chloramphenicol [M0004121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramphenicol palmitate [M0096609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramphenicol succinate sodium [M0316637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramphenicol stearate [M0100175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloramphenicol succinate [M0085881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorcyclizine [M0224706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlordiazepoxide [M0004133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlordiazepoxide Hydrochloride [M0330625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorfenethazine [20785]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorfenethazine [M0043566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorhexidine [M0004138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorhexidine Acetate [M0004139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorhexidine gluconate [M0056759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorhexidine Hydrochloride [M0004140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloric acid [1546391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloric acid [M0079464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorine [1310122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorine [M0004144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorine [1310122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorine Gas [M000638846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorine dioxide [20799]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorine dioxide [M0084108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormadinone [78904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlormadinone [M0330629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormadinone acetate [2369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlormadinone Acetate [M0004147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlormethiazole [M0004156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlormezanone [M0004158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroacetate [48008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroacetate [M000629536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroacetic acid [2374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroacetic acid [M0049836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorobutanol [2378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorobutanol [M0004163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorocitric acid [2462207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorocitric acid [M0102439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorocresol [20823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorocresol [M0049862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorocresol [20823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-methyl-4-chlorophenol [M0504456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroform [1362698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chloroform [M0004164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorogenic acid [1311387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorogenic Acid [M0004165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorokojic acid [2199653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-chloromethyl-5-hydroxy-4-pyranone [M0300501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloromethyl methyl ether [1312362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloromethyl methyl ether [M0198272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyll [2388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorophyll [M0004175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyllin [20852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorophyllin [M0049930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyllin copper complex [82242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorophyllin [M0049930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine [20859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroprocaine [M0045735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine hydrochloride [53616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroprocaine hydrochloride [M0308643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloropropylate [1435282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloropropylate [M0045801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloropyramine [20861]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloropyramine [M0045806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloropyramine hydrochloride [236457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloropyramine hydrochloride [M0424335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chloroquine [M0004182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroquine diphosphate [M0081184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chloroquine Sulfate [M0353850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothen [59695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorothen [M0140355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotheophylline [236872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>8-chlorotheophylline [M0095498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorothiazide [M0004186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorotrianisene [M0004187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorous acid [1543755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorous acid [M0174466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroxine [M0045392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxylenol [20877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chloroxylenol [M0049944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorozotocin [1362886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>CHLZ [M0176718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorozotocin [1362886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorozotocin [M0049947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorphenesin [M0004189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorphenesin carbamate [M0064078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine [2400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorpheniramine [M0004190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine maleate [142429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorpheniramine Maleate [M0004192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine tannate [221075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorpheniramine Tannate [M0423769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenoxamine [20881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorphenoxamine [M0262605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenoxamine hydrochloride [235422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorphenoxamine hydrochloride [M0327289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorproethazine [59860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorproethazine [M0152807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorproethazine hydrochloride [236297]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorproethazine hydrochloride [M0323426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorpromazine [M0004198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorpromazine Hydrochloride [M0363614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorpropamide [M0004204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorprothixene [M0004207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorquinaldol [2407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorquinaldol [M0004208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlortetracycline [2408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlortetracycline [M0004211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlortetracycline hydrochloride [42545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlortetracycline Hydrochloride [M0330638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorthalidone [M0004215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthenoxazin [20891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorthenoxazin [M0049957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorzoxazone [M0004217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholate [1426483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholate [M0029992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholecalciferol [M0004229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecystokinin [2420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholecystokinin [M0004235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesterol [2438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholesterol [M0004268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesteryl chloride [1606197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-chlorocholest-5-ene [M0166975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesteryl nonanoate [1362887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cholesteryl nonanoate [M0060146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesteryl oleate [1368200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cholesteryl oleate [M0062919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesteryl sulfate [1366924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cholesteryl sulfate [M0049977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholestyramine Resin [M0004278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholic acid [1440856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholic Acid [M0029428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline [2449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choline [M0004283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline bitartrate [2451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choline Bitartrate [M0004284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline chloride [1425426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choline Chloride [M0004285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline citrate [2453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choline Citrate [M0004286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline hydroxide [1311084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choline Hydroxide [M000613687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline magnesium trisalicylate [215799]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>choline magnesium trisalicylate [M0069124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>choline salicylate [M0064085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin 4-sulfate [1314214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chondroitin 4-Sulfate [M0330651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin 6-sulfate [2268212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chondroitin 6-Sulfate [M0330652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chondroitin Sulfate, Sodium Salt [M0330659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chondroitin Sulfates [M0004318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chorionic Gonadotropin [M0009545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromic chloride [21009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromic chloride [M0079730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium Cr-51 [1306065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chromium-51 [M000627901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chromium [M0004385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium dioxide [1312546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromium dioxide [M0150875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium nicotinic acid complex [137732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromium nicotinic acid complex [M0269164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium oxide [1363045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromic oxide [M0081017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromium picolinate [M0096708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium polynicotinate [700888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromium polynicotinate [M000613726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium trioxide [1539810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromium trioxide [M0092351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromocarb diethylamine [48064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromocarb diethylamine [M0098532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromonar [2508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chromonar [M0004398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromonar hydrochloride [81980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chromonar Hydrochloride [M0330662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromous chloride [21032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chromous chloride [M0067636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chrysanthemic acid, (+/-)- [2289244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chrysanthemic acid [M0049983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chrysarobin [1860418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chrysarobin [M0062007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chrysin [1362888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chrysin [M0128116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chrysosplenetin [1545792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chrysosplenetin [M0571122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chymopapain [2525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chymopapain [M0004458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chymosin [9248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chymosin [M0018781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chymotrypsin [2530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chymotrypsin [M0004462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ciclesonide [M0332803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cicletanine [21914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cicletanine [M0114776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cicletanine hydrochloride [235874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cicletanine hydrochloride [M0478416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ciclopirox [M0057995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ciclopirox Olamine [M0057987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cicloxilic acid [21095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cicloxilic acid [M0070857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine [M000640704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cidofovir [M0164905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cidofovir Anhydrous [M0585102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cifenline [21099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cifenline [M0100508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cifostodine [2477852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cifostodine [M0071682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cilastatin [M0023687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cilastatin Sodium [M0023688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cilazapril [M0026294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilgavimab [2587306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cilgavimab [M000744506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cilostazol [M0132637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cimetidine [M0004479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cimetidine Hydrochloride [M0423990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cinacalcet [M000616896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cinacalcet Hydrochloride [M0452505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinametic acid [21113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinametic acid [M0050015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinidon-ethyl [2472310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinidon-ethyl [M0507983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinitapride [21125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinitapride [M0131853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamate [1368650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cinnamates [M0004490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamedrine [21130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamedrine [M0108580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamic acid [2621720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamic acid [M0318054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamic acid [2621720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-Propenoic acid, 3-phenyl- [M000642431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamic aldehyde [1368153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trans-cinnamaldehyde [M0311985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamic aldehyde [1368153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamaldehyde [M0060175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil, bark [1305634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamon oil, bark [M0497750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil, bark [1305634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamomi corticis aetheroleum [M000743822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil, leaf [1309227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamon oil, leaf [M0497753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamyl alcohol [1362889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnamyl alcohol [M0074746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnarizine [2549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cinnarizine [M0004492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cinoxacin [M0004495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxate [288262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinoxate [M0070988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofibrate [21149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ciprofibrate [M0071666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ciprofloxacin [M0004498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ciprofloxacin Hydrochloride [M0361510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cisapride [M0029858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium [319864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cisatracurium [M0415709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisatracurium besylate [136561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cisatracurium besylate [M0266251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cisplatin [M0004505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citalopram [M0023529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citalopram Hydrobromide [M000643213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citicoline [997602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytidine Diphosphate Choline [M0005571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citiolone [21171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citiolone [M0040624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citraconic acid [1435287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citraconic acid [M0198359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citral [1362890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citral [M0050030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrate [114200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citrate [M0028795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid [21183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citric Acid [M0028793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid monohydrate [221079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citric Acid Monohydrate [M000638653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citric Acid, Anhydrous [M0582742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citronella oil [1309376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citronella oil [M0206266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citronellal [1424876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citronellal [M0281213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citronellic acid [2693285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citronellic acid [M0523579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citronellyl acetate [2056062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citronellyl acetate [M0121489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citronellyl nitrile, (+/-) [2388134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citronellyl nitrile [M0078107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrulline [2567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citrulline [M0004523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrulline malate [2707558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citrulline malate [M0193424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrus pectin [581398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citrus pectin [M0592144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cladribine [M0026332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clarithromycin [M0026249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clascoterone [2474340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clascoterone [M000675722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clavulanate [M0372713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clavulanate Potassium [M0329136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanic acid [21216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clavulanic Acid [M0029416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clebopride [21224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clebopride [M0062933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clebopride maleate [236701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clebopride maleate [M0424314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clemastine [M0004551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clemastine Fumarate [M0004553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemizolpenicillin [21226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clemizolpenicillin [M0097486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clenbuterol [2580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clenbuterol [M0004556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clevidipine [M0303812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clidinium [M0154918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clidinium bromide [M0323559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>climbazole [191566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>climbazole [M0281379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clindamycin [M0004561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clindamycin Hydrochloride [M0004562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clindamycin palmitate [M0040632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clindamycin palmitate hydrochloride [M0307448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clindamycin phosphate [M0050042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clinoptilolite [2624891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clinoptilolite [M0221376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clioquinol [M0011656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clobazam [M0059171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Phenyl-5-methyl-8-chloro-1,2,4,5- tetrahydro-2,4-diketo-3H-1,5-benzodiazepine [M000642449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobenzorex [21244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clobenzorex [M0040633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobenzorex hydrochloride [236205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clobenzorex hydrochloride [M0307449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clobetasol [M0004578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clobetasol Propionate [M0069222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasone butyrate [21246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clobetasone butyrate [M0056773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobutinol [21247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clobutinol [M0067642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobutinol hydrochloride [235956]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clobutinol hydrochloride [M0424329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloconazole hydrochloride [236864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>croconazole hydrochloride [M0320874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clocortolone [M0045819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clocortolone pivalate [M0050050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clodronate disodium [1546871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clodronate Disodium [M0475707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clodronic acid [3350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clodronic Acid [M0006270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clofarabine [M0186928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clofazimine [M0004579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofexamide [21255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clofexamide [M0045822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofezone [183877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clofezone [M0198302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clofibrate [M0004582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofoctol [21264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clofoctol [M0070859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clomethiazole edisylate [M0106858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clomiphene [M0004586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clomiphene Citrate [M0004595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clomipramine [M0004598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clomipramine Hydrochloride [M0004600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clomocycline [M0050056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clonazepam [M0004601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clonidine [M0004605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clonidine Hydrochloride [M0004608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonixin [2601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clonixin [M0004617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopamide [2603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clopamide [M0004620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloperastine [2104180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cloperastine [M0120036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloperastine hydrochloride [2104181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cloperastine hydrochloride [M0321360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel [32968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clopidogrel [M0155432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidogrel bisulfate [236991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clopidogrel Bisulfate [M0424331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopidol [1367179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clopidol [M0004624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloprednol [21285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cloprednol [M0058256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloprostenol [2606]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cloprostenol [M0004625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloprostenol sodium [204179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cloprostenol Sodium [M0351575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopyralid [1995248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clopyralid [M0058315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlorazepate [M0004627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clorazepate Dipotassium [M0004628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clorazepic Acid [M000642450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorophene [21290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clorophene [M0045798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorsulon [28303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clorsulon [M0065144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clostebol [61686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clostebol [M0206366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clothianidin [2665345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clothianidin [M0458704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clothiapine [2620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clothiapine [M0224730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clotiazepam [M0224719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clotrimazole [M0004642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove allergenic extract [899724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flos caryophylli [M000743005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clove Oil [M0007942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cloxacillin [M0004647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzathine cloxacillin [M0049364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cloxacillin Sodium [M0004648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxazolam [21311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cloxazolam [M0047119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clozapine [M0004649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX (recombinant), glycopegylated [1990855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nonacog beta pegol [M000598885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX recombinant immunoglobulin G1 fusion protein [1535944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eftrenonacog alfa [M000634510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coal Tar [M0004660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cobalt [M0004662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt oxide [2606479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobalt oxide [M0168594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt sulfate [1362742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobalt sulfate [M0086545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobaltous chloride [1426884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobaltous chloride [M0069227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobaltous nitrate [1423923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobaltous nitrate [M0085674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobaltous nitrate hexahydrate [1423922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobaltous nitrate hexahydrate [M0316612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobamamide [21373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobamamide [M0040899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cobicistat [M0558562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib [1722365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cobimetinib [M000600135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cocaine [M0004670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine esterase [2463110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocaine esterase [M0072960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cocaine Hydrochloride [M0330572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocamidopropyl betaine [1311576]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocamidopropyl betaine [M0207065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocamidopropyl hydroxysultaine [1363593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocamidopropyl hydroxysultaine [M0366635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocamidopropylamine oxide [1363576]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocamidopropylamine oxide [M0524413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coccidioidin [2660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidin [M0004675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coco diethanolamide [1305724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coconut diethanolamide [M0114664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coco-betaine [1367422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocobetaine [M0114666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocoa butter [M0148723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coconut oil [1309239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coconut Oil [M0110437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoyl isethionate [1366840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cocoyl isethionate [M0332849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cod Liver Oil [M0004699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Codeine [M0004700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Codeine Phosphate [M0330573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coenzyme A [1314344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coenzyme A [M0004712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>colchiceine [M0060189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colchicine [M0004732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colesevelam [M0278679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colesevelam Hydrochloride [M0278678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colestipol [M0004739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colestipol Hydrochloride [M0423709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril [107784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>colfosceril [M0136064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril palmitate [69782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>colfosceril palmitate [M0217563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>colistinmethanesulfonic acid [M0045829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>colistimethate sodium [M0424351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistin [2709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colistin [M0004767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistin sulfate [2710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colistin Sulfate [M0004768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagen [2714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen [M0004775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagen type I [1426856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Type I [M0004788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagen type II [2471083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Type II [M0004777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagen type V [2667828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Type V [M0004781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microbial Collagenase [M0004633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase [58939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagenases [M0026363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab [2708333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>concizumab [M0576494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>concizumab-mtci [2708340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>concizumab [M0576494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coniferyl alcohol [1309334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coniferyl alcohol [M0056128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coniine [1313334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coniine [M0050092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>conivaptan [M0387075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>conivaptan hydrochloride [M0539700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copanlisib [1945077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copanlisib [M000595256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper EDTA [1366888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Copper EDTA [M0007063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper [2837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Copper [M0005152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper carbonate [1427055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copper carbonate [M0228709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper gluconate [2839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Copper Gluconate [M0009329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper naphthenate [1373349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copper naphthenate [M0243911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper oxodotreotide CU-64 [2396442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copper dotatate CU-64 [M000750673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper oxodotreotide CU-64 [2396442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>64Cu-DOTATATE [M0578040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper sulfate [21579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Copper Sulfate [M0028776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cordycepin [1989289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cordycepin [M0162242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coriander oil [1309241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coriander oil [M000626637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn oil [2854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corn Oil [M0005174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn starch [1039062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cornstarch [M0020434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticorelin ovine [74671]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>corticorelin ovine [M0227300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticorelin ovine triflutate [74670]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>corticorelin ovine triflutate [M0227299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenocorticotropic Hormone [M0000499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin-releasing hormone [214461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corticotropin-Releasing Hormone [M0005218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone succinate [M000645353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone hemisuccinate [M0050132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cortisone [M0005219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cortisone Acetate [M0064106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortivazol [21660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cortivazol [M0047799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corydine [2593178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>corydine [M0184617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corynoxeine [2562545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>corynoxeine [M0154563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cosibelimab [M000768670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cosibelimab [M000768670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>costus root oil [1309387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>costus root oil [M0050142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosyntropin [2890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cosyntropin [M0005246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed oil [1309243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cottonseed Oil [M0005252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coumaran [1855075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coumaran [M0127166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coumarin [2898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coumarin [M0095579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coxsackieviruses B [1668274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coxsackieviruses B [M0005271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crataegus extract [21716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crataegus fruit [M000744669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creatine [2907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Creatine [M0005292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creatine ethyl ester [2058850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>creatine ethyl ester [M0537707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creatinine [2913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Creatinine [M0005300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creosol [1362910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>creosol [M0084670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>creosote [2915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Creosote [M0005306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cresatin [21732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cresatin [M0064108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cresol [62130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cresol [M0209179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crinecerfont [M000758004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crisaborole [1865953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crisaborole [M000621199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizanlizumab [2262279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crizanlizumab [M000626420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crizotinib [M0553416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crocin [2262278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crocin [M0092917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>croconazole [21753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>croconazole [M0114646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crofelemer [M0543100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromoglycate [2921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cromoglycate [M0006575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cromolyn [M0330463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cromolyn Sodium [M0006576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>croscarmellose sodium [1310573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Croscarmellose Sodium [M0545273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crospovidone [1310706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crospovidone [M0351816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crotamiton [21766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crotamiton [M0047173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>croton oil [1309665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Croton Oil [M0005359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cryptenamine [42618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptenamine [M0017922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cucurbitacin B [2688460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cucurbitacin B [M0122413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cuminaldehyde [2177095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cuminaldehyde [M0050179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric acetate [1311216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cupric acetate [M0064113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric chloride [21833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cupric chloride [M0094997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric chloride [21833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cupric chloride anhydrous [M000620302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric citrate [2394040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copper(II) citrate [M0289798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric glycinate [1428217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cupric glycinate [M0070085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric nitrate [2371954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copper(II) nitrate [M0505839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric oxide [21837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cupric oxide [M0097675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cuprous chloride [1423796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cuprous chloride [M0091501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cuprous oxide [21842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cuprous oxide [M0040693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>curcumin [2955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Curcumin [M0005421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>curdlan [1313047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>curdlan [M0115736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyamemazine [21877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyamemazine [M0091578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclacillin [M0005445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclamate [2969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclamates [M0005446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclamen aldehyde [1376343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclamen aldehyde [M0050214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclandelate [2970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclandelate [M0005451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclic AMP [1314330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclic AMP [M0000378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclizine [M0005457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclizine Hydrochloride [M0005458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloadiphenine [21945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cycloadiphenine [M0050219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloadiphenine hydrochloride [289372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cycloadiphenine hydrochloride [M0309856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloastragenol [2398144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cycloastragenol [M0169258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobarbital [2978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclobarbital [M0224832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclobenzaprine [M0045849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclobenzaprine hydrochloride [M0308678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobutyrol [21954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclobutyrol [M0041545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclodextrins [1426609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclodextrins [M0005463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclodrine [1855092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclodrine [M0043660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclofenil [2983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclofenil [M0005465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclohexane [1367180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclohexane [M0005468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclohexanol [2099711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclohexanol [M0005470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclohexanone [2362166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclohexanone [M0111080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclomethicone 5 [1305744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decamethylcyclopentasiloxane [M0295835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclomethicone [1307080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclomethicone [M0468417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclomethycaine [21990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclomethycaine [M0061252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclonium [21993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclonium [M0092870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentamine [59094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclopentamine [M0061245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentanone [2557363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclopentanone [M0050237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopenthiazide [3000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclopenthiazide [M0005482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclopentolate [3001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclopentolate [M0005484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytophosphane [M000638429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclophosphamide [M0005485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclophosphane [M000638428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclophosphamide Anhydrous [M0585642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclophosphamide Monohydrate [M000638430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate [M000642260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cycloserine [M0005492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyclosporine [M0025279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclothiazide [M0045761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycrimine [22037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cycrimine [M0059182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cymene [2584847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cymenes [M000649347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cypermethrin [2590266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cypermethrin [M0067698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyprodenate [22051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyprodenate [M0040042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyproheptadine [M0005519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproterone [3014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyproterone [M0005524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproterone acetate [22054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyproterone Acetate [M0026384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cystamine [1426401]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystamine [M0005528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine [3022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cysteamine [M0005535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine bitartrate [81990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cysteamine Bitartrate [M0005537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine hydrochloride [1426886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cysteamine Hydrochloride [M0330592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteine [3024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cysteine [M0005539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteine hydrochloride [221086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cysteine Hydrochloride [M0333361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cystine [3036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystine [M0005555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytarabine [M0005564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytisine [1723152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cytisine [M0045860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin [22178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cytomegalovirus-specific hyperimmune globulin [M0132945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytomegalovirus immune globulin, human [1997443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cytomegalovirus-specific hyperimmune globulin [M0132945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytosine [1372540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytosine [M0005618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>d-alpha-Tocopheryl Acetate [M000613565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran [1546356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dabigatran [M0553211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate [1037042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dabigatran Etexilate [M0423372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate mesylate [1037041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dabigatran Etexilate Mesylate [M0557657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dabrafenib [M0574231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dacarbazine [M0005636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>daclatasvir [M0570243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>daclatasvir dihydrochloride [M000742105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Daclizumab [M0252703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib [2058849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dacomitinib [M0581236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dactinomycin [M0005644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dalbavancin [M0443425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfampridine [897018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-Aminopyridine [M0024148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dalfopristin [M0293796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalotuzumab [1432293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dalotuzumab [M0570171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dalteparin [M0027162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dalteparin Sodium [M0027163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>danaparoid [M0394366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>danaparoid sodium [M0424429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Danazol [M0005648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>danicopan [M000750807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danofloxacin [1358488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>danofloxacin [M0187500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danofloxacin mesylate [1358487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>danofloxacin mesylate [M0477522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danthron [22293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>danthron [M0045328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dantrolene [M0005658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dantrolene Sodium [M0005659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin [1488564]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dapagliflozin [M0522017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole [22298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dapiprazole [M0108254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole hydrochloride [235757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dapiprazole hydrochloride [M0108253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>daprodustat [M000639112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dapsone [M0005661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Daptomycin [M0026638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab [1721947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>daratumumab [M0555283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darbepoetin alfa [283838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Darbepoetin alfa [M0374902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant [2591497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>daridorexant [M000655638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin [136198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>darifenacin [M0265416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin hydrobromide [485417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>darifenacin hydrobromide [M0584930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>darolutamide [M000618029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Darunavir [M0461844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir ethanolate [644682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Darunavir Ethanolate [M0501231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darutoside [1859167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>darutoside [M0173893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dasabuvir [M0594121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib [475342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dasatinib [M0470497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide [M0591540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasiglucagon [2535233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dasiglucagon [M000738332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Daunorubicin [M0005683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Daunorubicin Hydrochloride [M0361543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deacetylbisacodyl [1872905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydroxydiphenyl-pyridyl methane [M0041929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deanol [3116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deanol [M0005699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deanol aceglutamate [48780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deanol aceglutamate [M0127378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deanol acetamidobenzoate [22361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deanol acetamidobenzoate [M0045932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deanol bisorcate [236194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deanol Bisorcate [M0485009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>debrisoquin [3118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Debrisoquin [M0005709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decamethrin [22374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decamethrin [M0067744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decan-4-olide [1424652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decan-4-olide [M0284749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decanal [1484495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decanaldehyde [M0075685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decanoic acid [22380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decanoic acid [M0097900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decanoyl N-methylglucamide [2045461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decanoyl-N-methylglucamide [M0124774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Decitabine [M0062824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-Deoxyazacytidine [M000639779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decoquinate [1314345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Decoquinate [M0005738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decyl acetate [2391549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decyl acetate [M000768697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decyl glucoside [1311572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>decyl glucoside [M0491032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib [2714502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>defactinib [M0589114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deferasirox [M0490722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferiprone [11645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deferiprone [M0130907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deferoxamine [M0005750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desferrioxamine B Mesylate [M0005751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide [1311089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>defibrotide [M0112022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide sodium [1746523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>defibrotide sodium [M000637136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide, bovine lung [1788946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>defibrotide [M0112022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deflazacort [M0077553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix [475230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>degarelix [M0470370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix acetate [835863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>degarelix [M0470370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydroabietic acid [1432977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dehydroabietic acid [M0062050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydroacetic acid [1312367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dehydroacetic acid [M0089316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrocholate [42625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dehydrocholate [M0005764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrocholic acid [3141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dehydrocholic Acid [M0005762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydroemetine [3142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dehydroemetine [M0229928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydroemetine hydrochloride [236465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dehydroemetine hydrochloride [M0424411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrosanol [22427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dehydrosanol [M0055369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>delafloxacin [M000609991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec [2641675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>delandistrogene moxeparvovec [M000769157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec-rokl [2641674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>delandistrogene moxeparvovec [M000769157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delavirdine [M0029713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delavirdine Mesylate [M0329069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>delgocitinib [M000675729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delmopinol [60451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>delmopinol [M0199265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>demecarium [M0424412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>demecarium bromide [M0262949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Demeclocycline [M0005801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Demeclocycline Hydrochloride [M0005802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demegestone [22483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>demegestone [M0057329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demelverin [236795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>demelverin [M0052239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denatonium [1546417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>denatonium [M000642594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denatonium benzoate [1313232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>denatonium benzoate [M0093789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denaverine [22503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>denaverine [M0042387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denaverine hydrochloride [236794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>denaverine hydrochloride [M0307837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denileukin diftitox [214470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>denileukin diftitox [M0292631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab [993449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Denosumab [M0493770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deoxycholate [42627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxycholate [M0005994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deoxycholic acid [3194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxycholic Acid [M0005992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deoxycholic acid, monosodium salt [1367220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxycholic Acid, Monosodium Salt [M0331377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deoxycytidine [2642208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxycytidine [M0005997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deoxyribonucleases [3210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxyribonucleases [M0006014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dequalinium [3226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dequalinium [M0006040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dequalinium chloride [3120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dequalinium Chloride [M0006039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deracoxib [356834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deracoxib [M0446830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deserpidine [M0262623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2,2,2-Tetrafluoroethyl difluoromethyl ether [M000641191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desflurane [M0151698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desipramine [M0006074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desipramine Hydrochloride [M0330514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desirudin [114934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>desirudin [M0167430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deslanoside [M0006076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>desloratadine [M0337021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslorelin [1311744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deslorelin [M0182319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslorelin acetate [1311743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deslorelin acetate [M0182318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmeninol [1738095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-hydroxy-gamma-methylmercaptobutyric acid [M0052206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deamino Arginine Vasopressin [M0474041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desmopressin Acetate [M0330516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desogestrel [M0026028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desonide [M0006084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desoximetasone [M0006085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone [3256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desoxycorticosterone [M0006087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone acetate [258333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desoxycorticosterone Acetate [M0006086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone pivalate [22537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deoxycortone pivalate [M0071704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desvenlafaxine [M0230088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desvenlafaxine Succinate [M0521993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>detajmium [82665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>detajmium [M0110209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>detajmium bitartrate [236784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>detajmium bitartrate [M0320509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>detomidine [22672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>detomidine [M0122426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>detomidine hydrochloride [48928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>detomidine hydrochloride [M0321572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deucravacitinib [M000752606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>deutetrabenazine [M000620323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>devil&apos;s claw preparation [236279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>devil&apos;s claw preparation [M000743959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexamethasone [M0006099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexamethasone acetate [M0069246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexamethasone Isonicotinate [M0006100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexamethasone 21-phosphate [M0045158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexamethasone sodium phosphate [M0045153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexamethasone trimethyl acetate [M0077730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexbrompheniramine [M0064163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexbrompheniramine maleate [M0064161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexchlorpheniramine [M0070905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexchlorpheniramine maleate [M0070901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexetimide [3267]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexetimide [M0006102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexfenfluramine [M0030010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexfenfluramine Hydrochloride [M0331384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexketoprofen [M000645824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexketoprofen trometamol [M0303241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexlansoprazole [M0525973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexlansoprazole Sesquihydrate [M0583263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexmedetomidine [M0140432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexmedetomidine Hydrochloride [M0332427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexmethylphenidate [M000616897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexmethylphenidate Hydrochloride [M0514652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexpanthenol [22701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>panthenol [M000623221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexpanthenol [22701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dexpanthenol [M0050390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane [42736]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexrazoxane [M0018537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane hydrochloride [1294534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dexrazoxane Hydrochloride [M0583107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 1 [214485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dextran 1 [M0583034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextran 40 [M0006108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextran 70 [M0006110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextran 75 [M0006111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran [42635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextran [M0006131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran sulfate [40068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextran Sulfate [M0024857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextranomer [22708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dextranomer [M0061270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextroamphetamine [M0006134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextroamphetamine Sulfate [M0006133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextromethorphan [M0006138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextromethorphan Hydrobromide [M0330518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextromethorphan Hydrochloride [M0330519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromoramide [3290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextromoramide [M0006142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromoramide tartrate [104959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextromoramide Tartrate [M0485042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucose Monohydrate [M0330320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextrothyroxine [M0006144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextrothyroxine Sodium [M0373453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dezocine [22713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dezocine [M0056650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diacetylrhein [22759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diacerein [M0084472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diamond [1362686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diamond [M0027335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatomaceous earth [1362874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diatomaceous Earth [M0012033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate [3319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo- [M000642283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate [3319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diatrizoate [M0006219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate [3319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amidotrezoate [M000642284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate meglumine [3320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diatrizoate Meglumine [M0006224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoate sodium [3321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Diatrizoate [M0006220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diatrizoic acid [1546223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diatrizoic Acid [M0067051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diazepam [M0006229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazolidinylurea [1310602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diazolidinylurea [M0131047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diazoxide [M0006242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, anhydrous [2632249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, dibasic, anhydrous [M0424490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, anhydrous [2632249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, dibasic, dihydrate [M0466449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, dihydrate [2632248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, dibasic, dihydrate [M0466449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic potassium phosphate [55018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium phosphate (K2-HPO4) [M0312115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibekacin [3328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dibekacin [M0006245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin [3332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibenzepin [M0224735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin hydrochloride [236807]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibenzepin hydrochloride [M0477653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzyl ether [1747705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibenzyl ether [M0205998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzylidene sorbitol [1307141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibenzylidene sorbitol [M0256007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibromopropamidine isethionate [M0050451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibrompropamidine [M0151760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dibucaine [M0006256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyl adipate [1367137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibutyl adipate [M0500705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyl maleate [1491007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibutyl maleate [M0138530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyl phthalate [1362873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dibutyl Phthalate [M0006258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyl sebacate [1363700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibutyl sebacate [M0156197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyltin [2183101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>di-n-butyltin [M0157694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyltin dilaurate [2183100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibutyltin dilaurate [M0055886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibutyltin oxide [2391139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dibutyltin oxide [M0097915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicalcium phosphate [253163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, dibasic, anhydrous [M0424490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicalcium phosphate [253163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium phosphate, dibasic, dihydrate [M0466449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicalcium silicate [2586586]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dicalcium silicate [M0061281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicetylphosphate [1314346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dicetylphosphate [M0042833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichloralphenazone [22892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dichloralantipyrine [M0050481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichloroacetic acid [155021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dichloroacetic Acid [M0006267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorobenzyl alcohol [22906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dichlorobenzyl alcohol [M0052220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorodifluoromethane [50110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dichlorodifluoromethane [M0051168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorofluoromethane [1426470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dichlorofluoromethane [M0141160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorophen [3351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,2&apos;-methylenebis(4-chlorophenol) [M000676694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorophen [3351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dichlorophen [M0006277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorotetrafluoroethane [124848]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Freon 114 [M0051174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dichlorphenamide [M0006280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclazuril [1368201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diclazuril [M0161741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diclofenac [M0006284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac diethylammonium [236125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diclofenac diethylamine [M000626340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac epolamine [40968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diclofenac hydroxyethylpyrrolidine [M0176789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diclofenac Potassium [M0006286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diclofenac Sodium [M0006287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloran [22895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dicloran [M0045387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dicloxacillin [M0006293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dicloxacillin Sodium [M0330532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicobalt edetate [288331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dicobalt edetate [M0091051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dictamnine [2685302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dictamnine [M0086729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dicumarol [M0002610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dicyclomine [M0006314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dicyclomine Hydrochloride [M0006316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Didanosine [M0024535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didecyldimethylammonium [1425983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>didecyldimethylammonium [M0088420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didecyldimethylammonium bromide [2469250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>didecyldimethylammonium bromide [M0317133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didecyldimethylammonium chloride [1011450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>didecyldimethylammonium chloride [M0317134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didodecyl phosphate [1593447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>didodecyl phosphate [M0149787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didodecyldimethylammonium bromide [2373436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>didodecyldimethylammonium bromide [M0322383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienestrol [3368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dienestrol [M0006320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dienogest [M0081095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>19-norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17alpha)- [M000645442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethanolamine [1362911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethanolamine [M0073876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethanolamine fusidate [22971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethanolamine fusidate [M0061283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethyl azelate [2464291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethyl azelate [M0173691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethyl malonate [2395765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethyl malonate [M0051022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethyl phthalate [1362921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethyl phthalate [M0050544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethyl sulfate [1428869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethyl sulfate [M0058061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylamine salicylate [162592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethylamine salicylate [M0086284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylamino hydroxybenzoyl hexyl benzoate [1426392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethylamino hydroxybenzoyl hexyl benzoate [M000605619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diethylcarbamazine [M0006347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diethylcarbamazine Citrate [M0006348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethyldithiocarbamate [1427193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diethyldithiocarbamate [M0006351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylene glycol [1429928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethylene glycol [M0061284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylene glycol distearate [1486708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethylene glycol distearate [M0050537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylene glycol monobutyl ether [1552575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>butyl carbitol [M0045727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylene glycol monoethyl ether [1311147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbitol [M0055387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylene glycol monomethyl ether [1538383]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethylene glycol monomethyl ether [M0138854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylhexyl adipate [1306945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diethylhexyladipate [M0494748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diethylpropion [M0006355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diethylpropion Hydrochloride [M0006356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stilbestrol [M000650122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diethylstilbestrol [M0006357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethyltoluamide [3129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>DEET [M0005744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difebarbamate [23020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>difebarbamate [M0050546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>difelikefalin [M000681404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difemerine [163406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>difemerine [M0092279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>difenoxin [M0262367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>difenoxin hydrochloride [M0327236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diflorasone [M0424431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diflorasone diacetate [M0062999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflubenzuron [1665336]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diflubenzuron [M0006469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflucortolone [3392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diflucortolone [M0006366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflucortolone valerate [23035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diflucortolone valerate [M0061287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diflunisal [M0006367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difluprednate [23043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>difluprednate [M0065341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>digitalin [M0106986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Digitoxin [M0006383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Digoxin [M0006386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin antibodies Fab fragments [203223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>digoxin antibodies Fab fragments [M0143483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihematoporphyrin ether [23066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihematoporphyrin Ether [M0026307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydralazine [M0006389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydralazine Sulfate [M0485087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocapsaicin [2166037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydrocapsaicin [M0060270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydrocodeine [M0063004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydrocodeine bitartrate [M0424449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergocornine [M0006403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergocornine Mesylate [M0330440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergocristine [M0006404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergocristine Monomesylate [M0330438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergocryptine [M0006405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergocryptine Mesylate [M0330439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergotamine [M0006401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergotamine Mesylate [M0330548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroergotoxine [M0006406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydromyrcenol [1659907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydromyrcenol [M0538294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrostreptomycin [1549540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydrostreptomycin [M0006416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrostreptomycin sulfate [1549556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydrostreptomycin Sulfate [M0006415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydrotachysterol [M0006417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyacetone [3430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dihydroxyacetone [M0006419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum aminoacetate [23162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydroxyaluminum aminoacetate [M0050607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dihydroxyaluminum sodium carbonate [M0066335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxybutyl ether [14699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4,4&apos;-oxydi-2-butanol [M0041012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diisopropanolamine [1362922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diisopropanolamine [M0166907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diisopropyl adipate [1363600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diisopropyl adipate [M0140328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diisopropyl sebacate [1363601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diisopropyl sebacate [M0145000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diisopropylamine [1362925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diisopropylamine [M0050650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diisopropylamine dichloroacetate [1727556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diisopropylamine dichloroacetate [M0041029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diloxanide [67182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diloxanide [M0046155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diloxanide furoate [23203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diloxanide furoate [M0046158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diltiazem [M0006434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diltiazem Hydrochloride [M0353529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diltiazem Malate [M0006435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimenhydrinate [M0006438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimercaprol [M0006441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaptosuccinic acid [2475951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,3-Dimercaptosuccinic Acid [M0585828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 20 [1366227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethicone 20 [M0019886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone [324072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethicone [M0458139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethindene [3449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimethindene [M0006449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethindene maleate [258334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimethindene Maleate [M0330454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethoxydiphenylsilane [2199635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphenyldimethoxysilane [M0516055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl 4-phthalate [1736744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl 4-phthalate [M0045945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl diallyl ammonium chloride [2398835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diallyldimethylammonium chloride [M0495362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl disulfide [1999573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl disulfide [M0075705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl ether [1313349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl ether [M0103656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl fumarate [1373478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimethyl Fumarate [M0157348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl glutarate [2393529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl glutarate [M0184636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,5-dimethylisosorbide [M0119549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl succinate [2393581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl succinate [M0158324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl sulfate [2205404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl sulfate [M0050712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl sulfoxide [3455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimethyl Sulfoxide [M0006456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethylacetamide [1368874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethylacetamide [M0062145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethylamine [1745413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethylamine [M0106352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethylamphetamine [1362926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimetamfetamine [M000634958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethylamphetamine [1362926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethylamphetamine [M0044797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyldodecylbenzylammonium [1311593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyldodecylbenzylammonium [M0064248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium chloride [1426625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium chloride [M000625904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimetridazole [1600136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimetridazole [M0006468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimyristoylphosphatidylcholine [1362902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dimyristoylphosphatidylcholine [M0006471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimyristoylphosphatidylglycerol [1427048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimyristoyl phosphatidylglycerol [M0552451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimyristoylphosphatidylglycerol [1427048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimyristoylphosphatidylglycerol [M0043503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinitolmide [1487907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dinitolmide [M0006472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprost [3477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dinoprost [M0023416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprost tromethamine [23321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dinoprost tromethamine [M0056434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dinoprostone [M0023405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dinutuximab [M000654639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dioctyl adipate [2684993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dioctyl adipate [M0062159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dioctyl maleate [1356765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dioctyl maleate [M0465726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diosmetin [1314347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diosmetin [M0118511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diosmin [3489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diosmin [M0006496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dioxane [2383534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,4-dioxane [M0084336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dioxolane [2383339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formal glycol [M0056890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dioxybenzone [23350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dioxybenzone [M0046048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipentamethylenethiuram disulfide [1426773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>bis(1-piperidylthiocarbonyl)disulfide [M0041832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diperodon [59247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diperodon [M0088137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diperodon hydrochloride [133043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HCl of diperodon [M0317093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphemanil methylsulfate [23364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphemanil methylsulfate [M0091021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphenhydramine [M0006508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphenhydramine Citrate [M0330460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphenhydramine Hydrochloride [M0006507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphenidol [M0046072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphenidol hydrochloride [M0308758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphenoxylate [M0006512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphenoxylate Hydrochloride [M0006513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenyl ether [2391140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenyl ether [M0099009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylamine [1363044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphenylamine [M0006515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylguanidine [1368170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphenylguanidine [M0090001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylpyraline [23386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphenylpyraline [M0054943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenylpyraline hydrochloride [203155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphenylpyraline hydrochloride [M0310957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria antitoxin [3510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria Antitoxin [M0006521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria toxoid vaccine, inactivated [798304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria Toxoid [M0006523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipipanone [23405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dipipanone [M0050789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dipivefrin [M0064267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dipivefrin hydrochloride [M0312742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipotassium aspartate [2397119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dipotassium Aspartate [M0330803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipotassium glycyrrhizinate [1367264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dipotassium Glycyrrhizinate [M0029246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipropizine [23419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dipropizine [M0109761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipropizine, (S)-isomer [52014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levodropropizine [M0320467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipropylacetamide [23420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dipropylacetamide [M0045784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyridamole [3521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dipyridamole [M0006533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyrithione [1362743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dipyrithione [M0100598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyrone [3523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noramidopyrine Methanesulfonate Sodium [M000638436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyrone [3523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dipyrone [M0006535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipyrone magnesium [236464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metamizole magnesium [M0083554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>direct black 19 [2289222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>direct black 19 [M0141469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>direct blue 1 [2563143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>C.I. direct blue 1 [M0053355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>direct red 81 [2686947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Direct Red 81 [M0172358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dirithromycin [M0152375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirlotapide [1592684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dirlotapide [M0511637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diroximel fumarate [2261783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diroximel fumarate [M000757121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disilver oxide [1368701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disilver oxide [M0119885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium aspartate [2619780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disodium Aspartate [M0330812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium cocoamphodiacetate [1364461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disodium cocoamphodiacetate [M0522992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium cocoamphodipropionate [1366877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disodium cocoamphodipropionate [M0581557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium latamoxef [258330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moxalactam Disodium [M0351097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium laureth sulfosuccinate [1366891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disodium laureth sulfosuccinate [M000633744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium phthalate [2274243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phthalic acid, disodium salt [M0319519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium pyrophosphate [267798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disodium pyrophosphate [M0308257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disopyramide [M0006581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disopyramide Phosphate [M0330465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disperse blue 106 [1368171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disperse blue 106 [M0141027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disperse blue 3 [1812081]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disperse Blue 3 [M0501063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disperse red 15 [2395759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disperse red 15 [M0272495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>distearoylphosphatidylcholine, DL- [1426932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-distearoyllecithin [M0056861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>distearyldimonium [1311550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyldioctadecylammonium [M0065383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>distearyldimonium chloride [1311552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyldioctadecylammonium chloride [M0312975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>distigmine [3551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>distigmine [M0224849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disulfiram [3554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disulfiram [M0006600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ditiocarb, zinc salt [1427192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ditiocarb, Zinc Salt [M0006350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valproic Acid, Sodium Salt (2:1) [M000642454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Divalproex Sodium [M0329594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divinylbenzene [1788842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>divinyl benzene [M0046235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dobutamine [M0006696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dobutamine Hydrochloride [M0330490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docetaxel [M0184558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docetaxel Anhydrous [M0585054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docosahexaenoate [73]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docosahexaenoate [M0006700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docosahexaenoic acid [144450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docosahexaenoic Acids [M0006701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docosanol [594680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>docosanol [M0054012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate [82003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docusate [M0491450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate calcium [82001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docusate Calcium [M0331385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate potassium [82002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docusate Potassium [M0006492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate sodium [71722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Docusate Sodium [M0331389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecanedioic acid [2635087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecanedioic acid [M0111872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecanol [1362875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dodecanol [M0012265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecyl ethyleneglycol monoether [2643152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Laureth [M0053312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecyl gallate [1596928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauryl gallate [M0051953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecyl sulfate [1362927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyl sulfate [M0092648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecylamine [1648137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecylamine [M0045066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecylbenzenesulfonic acid [1094060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecylbenzenesulfonic acid [M0041212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodecylphosphocholine [2567015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecylphosphocholine [M0092376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dodicin [1362744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodicin [M0045204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dofetilide [49247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dofetilide [M0175350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dolasetron [M0167721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dolasetron mesylate [M0167723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolomite [23622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dolomite [M0090661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir sodium [1433867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dolutegravir sodium [M0586940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domiphen [23623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>domiphen [M0050825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domiphen bromide [49255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>domiphen bromide [M0050824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone [3626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Domperidone [M0006752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domperidone maleate [236099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Domperidone Maleate [M0330403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab [2687966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>donanemab [M000765871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil [135447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Donepezil [M0206795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil hydrochloride [236559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Donepezil Hydrochloride [M0206791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dopamine [M0006756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dopamine Hydrochloride [M0006757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopexamine [23638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dopexamine [M0134272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopexamine hydrochloride [235768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dopexamine hydrochloride [M0322431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doramectin [73455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>doramectin [M0223567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>doravirine [M000599356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doripenem [M0260551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid [M000641382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dornase alfa [M0227369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide [60207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dorzolamide [M0173578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide hydrochloride [236065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dorzolamide hydrochloride [M0324545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab [2539967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dostarlimab [M000752546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab-gxly [2539968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dostarlimab-gxly [M000750516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dotatate [1797118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dotatate [M000750674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dotatate gallium ga-68 [676679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gallium Ga 68 dotatate [M0501639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dotatate gallium ga-68 [676679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>68Ga-DOTATOC [M0558217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dothiepin [M0006770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dothiepin Hydrochloride [M0331397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium [23651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>doxacurium [M0141617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxacurium chloride [49275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>doxacurium chloride [M0141616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxapram [M0006779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxapram Hydrochloride [M0006780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxazosin [M0026251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxazosin Mesylate [M0329258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxepin [M0006782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxepin Hydrochloride [M0330406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1 alpha-hydroxyergocalciferol [M0125569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxorubicin [M0006784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxorubicin Hydrochloride [M0006787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin liposome [214525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>liposomal doxorubicin [M0417713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))- [M000642413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alpha-6-Deoxyoxytetracycline [M000642414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxycycline [M0006789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxycycline Calcium [M0006792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxycycline Hyclate [M0104501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxycycline [M0006789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Doxylamine [M0006795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>doxylamine succinate [M0108466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dragon&apos;s blood extract [1372005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dragon&apos;s blood [M0516794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole [1426903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benazol P [M0104389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole [1426903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>drometrizole [M0353828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drometrizole trisiloxane [1992874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>drometrizole trisiloxane [M0491031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dromostanolone [23678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dromostanolone [M0263246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dromostanolone propionate [23683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dromostanolone propionate [M0050834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dronabinol [M0021229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone [233698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dronedarone [M0304036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Droperidol [M0006807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drospirenone [11636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>drospirenone [M0107880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverin [23684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>drotaverin [M0046796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverine hydrochloride [236960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>drotaverin hydrochloride [M0309016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>drotrecogin alfa activated [M0380081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droxicam [23687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>droxicam [M0140799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droxidopa [1489913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Droxidopa [M0023229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dulaglutide [1551291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dulaglutide [M0557773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duloxetine [M0162461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duloxetine Hydrochloride [M0473681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dupilumab [1876376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dupilumab [M0586196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durapatite [49334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Durapatite [M0027020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durlobactam [2639089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>durlobactam [M000744887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>durvalumab [M000625805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dutasteride [M0281571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-1(2H)-isoquinolinone [M0591925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>duvelisib [M000611168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine [23744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dyclonine [M0262506]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine hydrochloride [91188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dyclonine hydrochloride [M0327264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dydrogesterone [3706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dydrogesterone [M0006900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dymanthine [2274100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dymanthine [M0050854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyphylline [M0006910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dysprosium [1311482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysprosium [M0006933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ebanol [2383933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ebanol [M0496587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ebastine [23796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ebastine [M0162527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ecallantide [M0499198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecamsule [1544124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ecamsule [M0500228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echothiophate Iodide [M0006980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Econazole [M0006989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Econazole Nitrate [M0330414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ectoine [1426644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ectoine [M0132603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab [591781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eculizumab [M0461005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edaravone [1921877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edaravone [M0046983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edaravone [1921877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Phenyl-3-methyl-5-pyrazolone [M000640902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edaravone [1921877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylmethylpyrazolone [M000640901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium [1903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edetate Disodium Calcium [M0007061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edetic Acid, Disodium Salt [M0330416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edetic Acid [M0007067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetol [1314349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,1&apos;,1&apos;&apos;,1&apos;&apos;&apos;-(ethylenedinitrilo)tetra-2-propanol [M0056237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edodekin alfa [1371906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edodekin Alfa [M000642660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edotreotide gallium ga-68 [2199391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>edotreotide gallium ga-68 [M000622416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban [1599538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>edoxaban [M0549958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban tosylate [1599564]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>edoxaban tosylate [M000638090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxudine [49428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>edoxudin [M0079426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrecolomab [80726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edrecolomab [M0350230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrecolomab [80726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>MAb 17-1A [M000654645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edrophonium [M0007057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edrophonium Chloride [M0007059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efalizumab [356988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>efalizumab [M0447098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>efavirenz [M0258297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa [2587717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>efgartigimod alfa [M000750731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>efinaconazole [M0584821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim [2612526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eflapegrastim [M000749788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflapegrastim-xnst [2612537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eflapegrastim-xnst [M000767505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eflornithine [M0000787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eflornithine Hydrochloride [M0330745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efloxate [23852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>efloxate [M0047039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egtazic acid [1742992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Egtazic Acid [M0007133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eicosapentaenoic acid [90]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eicosapentaenoic Acid [M0023259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eicosenoic acid [1374399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eicosenoic acid [M0573855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(6R)-6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol [M000640889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elacestrant [M000640888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant dihydrochloride [2628473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elacestrant dihydrochloride [M000640898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elafibranor [M000629003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elagolix [M0534044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elagolix sodium [M000677559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase [2059219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elapegademase [M000667006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase-lvlr [2059218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elapegademase-lvlr [M000667161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elastin [1730435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Elastin [M0007152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elbasvir [M000595362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elder extract [317808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elder flower [M000744280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elderberry fruit [260053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elderberry fruit [M000744281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elderberry preparation [319834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elderberry extract [M000744279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eletriptan [M0297676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eletriptan hydrobromide [M0297671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eleuthero preparation [1368902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eleutherococci extract [M000743830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elexacaftor [M000677538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eliglustat [M0592238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eliglustat tartrate [M0592239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ellagic acid [1043181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ellagic Acid [M0007238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elosulfase alfa [1489914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elosulfase alfa [M000637196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elotuzumab [1726104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elotuzumab [M0542262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eltrombopag [M0511065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eluxadoline [1653781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eluxadoline [M0588002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elvitegravir [1306286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>elvitegravir [M0526043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab [2104604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emapalumab [M000665595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab-lzsg [2104603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emapalumab-lzsg [M000666000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>embutramide [2464539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>embutramide [M0165065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine [28144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emedastine [M0127598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine difumarate [221094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emedastine difumarate [M0321892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emepronium [3816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emepronium [M0007264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emepronium bromide [71481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emepronium Bromide [M0351160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emepronium carrageenate [23944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emepronium carrageenate [M0134066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine [3820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emetine [M0007281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine hydrochloride [82015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emetine Hydrochloride [M0330432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab [1989794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emicizumab [M000618664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab-kxwh [1989795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emicizumab-kxwh [M000639048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emodepside [354606]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emodepside [M0443265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>empagliflozin [1545653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>empagliflozin [M0571248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emtricitabine [276237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emtricitabine [M0337569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emu oil [1309389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>emu Oil [M0577244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enalapril [M0007330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enalapril Maleate [M0331398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enalaprilat [M0024167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enalaprilat Anhydrous [M0329455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enalaprilat Dihydrate [M000629535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate [M000642353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib [1940332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enasidenib [M000635157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide [42368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Encainide [M0025437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide hydrochloride [281189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Encainide Hydrochloride [M0329408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encorafenib [2049106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>encorafenib [M000609752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>endothelial growth factor A, vascular [2642870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vascular Endothelial Growth Factor A [M0356369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enflurane [M0007446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin [2277607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enfortumab vedotin [M000653311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enfuvirtide [M0274523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enilconazole [1442172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enilconazole [M0068167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(2S,3S,5R)-3-methyl-3-((3-methyltriazol-3-ium-1-yl)methyl)-4,4,7-trioxo-4&apos;6-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate [M000680199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enmetazobactam [M000680197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enobosarm [2168587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ostarine [M0543612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enoxacin [M0023652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enoxaparin [M0027160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enoxaparin sodium [M000741484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoximone [49626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enoximone [M0026327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enrofloxacin [24192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enrofloxacin [M0150025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib [2712546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ensartinib [M000646263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensifentrine [2687215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ensifentrine [M0501301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensulizole [13714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ensulizole [M0483581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entacapone [60307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>entacapone [M0193491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir [306266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>entecavir [M0370336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir anhydrous [1546027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anhydrous entecavir [M000758487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entrectinib [2197862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>entrectinib [M000617577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzacamene [1311507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enzacamene [M0116894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>enzalutamide [M0577955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eosine yellowish [1310593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eosine Yellowish-(YS) [M0007531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ephedrine [M0007539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ephedrine Hydrochloride [M0485313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ephedrine Sulfate [M0485311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epicatechin [2641822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epicatechin [M0003643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epidermal growth factor [1427158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epidermal Growth Factor [M0007549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epigallocatechin gallate [24246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epigallocatechin gallate [M0132653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epinastine [M0150487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine hydrochloride [236961]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epinastine hydrochloride [M0323320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epinephrine [M0007583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epinephrine Bitartrate [M0362233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epinephrine Hydrochloride [M0007582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epinephrine sulfate [M0111193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epinephryl borate [M0069653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epirubicin [M0023488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epirubicin Hydrochloride [M0329520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone [M000640866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eplerenone [M0371594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eplontersen [M000768284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen sodium [2671940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eplontersen sodium [M000768285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa [105694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epoetin Alfa [M0028770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin beta [105695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epoetin beta [M0271774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epomediol [24263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epomediol [M0098590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epoprostenol [M0017816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epoprostenol Sodium [M0017819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoxiconazole [2593180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epoxiconazole [M0284102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprazinone HCl [236310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eprazinone hydrochloride [M0477779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprazinone [24272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eprazinone [M0050904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprinomectin [1006619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eprinomectin [M0265917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eprosartan [M0187027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprozinol [24274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eprozinol [M0065458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epsiprantel [24285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>epsiprantel [M0168955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eptacog alfa [M0528711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>recombinant FVIIa [M0270811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eptifibatide [M0229697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptinezumab [2282660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eptinezumab [M000644917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>equol, (+-)- [1492341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(+-)-Isomer of Equol [M0310001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline [2055906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eravacycline [M000606732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline dihydrochloride [2055907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eravacycline dihydrochloride [M000758490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erbium [1311483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erbium [M0007649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erdafitinib [M000614131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdosteine [24305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erdosteine [M0139505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdosteine [24305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>S-(2-(N-3-(2-oxo-tetrahydrothienyl)acetamido))thioglycolic acid [M000753288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erenumab [2045613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erenumab [M000615688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erenumab-aooe [2045614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erenumab-aooe [M000644901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin D 2 [M0007650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergoloid Mesylates [M0007657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergonovine [M0007653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergonovine Maleate [M0069657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergot alkaloids [4023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergot Alkaloids [M0007656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergotamine [M0007662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergotamine Tartrate [M0330442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergothioneine [1314350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ergothioneine [M0007666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eribulin [M0473224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eribulin mesylate [M0554982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erlotinib [M0350388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erlotinib Hydrochloride [M0493669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ertapenem [M0414190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ertapenem Sodium [M0477784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertugliflozin [1992672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ertugliflozin [M0571291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythritol [1369563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythritol [M0007685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrityl Tetranitrate [M0007686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythromycin [M0007715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythromycin Estolate [M0007723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythromycin Ethylsuccinate [M0023980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erythromycin glucoheptonate [M0092609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erythromycin lactobionate [M0056871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythromycin Phosphate [M0007717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>erythromycin stearate [M0057778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrosine [4061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrosine [M0007727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escin [4065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escin [M0007735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram [321988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escitalopram [M0406596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram oxalate [353108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escitalopram Oxalate [M000643214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esculin [1314351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esculin [M0007736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine [2119365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esketamine [M000647133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eslicarbazepine [M0572254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eslicarbazepine acetate [M0374531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>esmolol [M0111364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>esmolol hydrochloride [M0356988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esomeprazole [M0427109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esomeprazole Magnesium [M0579617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esomeprazole Sodium [M0579612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esomeprazole Strontium [M0583260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estazolam [M0007763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estetrol [2539031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estetrol [M0007767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estradiol 3-benzoate [M0200617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estradiol [M0007772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estradiol 17 beta-cypionate [M0050935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estradiol Hemihydrate [M0330337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estradiol Valerate [M0065463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine [4089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estramustine [M0007783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate [105556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estramustinphosphate [M0007785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate sodium [4090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estramustine Phosphate Sodium [M0007784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estriol [4094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estriol [M0007788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estriol succinate [24416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estriol succinate [M0053947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estrogens [M0007795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estrogens, Conjugated (USP) [M0007792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjugated Equine Estrogens [M0405163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estrogens, Esterified (USP) [M0441790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Estrone [M0007798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estropipate [M0055026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eszopiclone [461016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eszopiclone [M0463158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etanercept [M0276736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etanercept-szzs [M000638603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide [1876119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>velcalcetide [M0587922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide [1876119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etelcalcetide [M000623447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide hydrochloride [1876122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etelcalcetide hydrochloride [M000636942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eteplirsen [1810569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eteplirsen [M000622394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etesevimab [2477854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etesevimab [M000742088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacridine [4106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethacridine [M0007806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacridine lactate [4107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethacridine Lactate [M0007807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethacrynate Sodium [M0330353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethacrynic Acid [M0007812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol [4110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethambutol [M0007814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol hydrochloride [142435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethambutol Hydrochloride [M0007816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethamivan [24453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethamivan [M0263261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethamsylate [4112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethamsylate [M0007819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanethiol [1314352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethanethiol [M0050959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanol [448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethanol [M0000653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine [24457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethanolamine [M0029475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine oleate [24460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethanolamine oleate [M0103493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine oleate [24460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monoethanolamine oleate [M0393808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine [24464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethaverine [M0050961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethaverine hydrochloride [235229]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethaverine hydrochloride [M0310011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethchlorvynol [4118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethchlorvynol [M0007824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethenzamide [24468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethenzamide [M0070963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinamate [24474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethinamate [M0262973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethinyl Estradiol [M0007862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethiodized oil [4125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethiodized Oil [M0007866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethionamide [4127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethionamide [M0007869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethisterone [4129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethisterone [M0007872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoglucid [4132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethoglucid [M0007884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine [24484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethoheptazine [M0262514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethohexadiol [1362891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethohexadiol [M0046120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethopabate [1314353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethopabate [M0007886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethopropazine hydrochloride [6541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>profenamine hydrochloride [M0475948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethosuximide [M0007887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethotoin [M0224736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoxazene [41078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethoxazene [M0066396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoxyquin [1314354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethoxyquin [M0007889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethybenztropine [1358000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethybenztropine [M0089667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl acetate [1314355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl acetate [M0050978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl acetoacetate [1603474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl acetoacetate [M0083486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl acrylate [1859382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl acrylate [M0121381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl anthranilate [2396756]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl anthranilate [M000617040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl butyrate [1314356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl butyrate [M0132450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl caproate [2476631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl hexanoate [M0212146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl cellulose [1310565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl cellulose [M0061318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl chloride [4141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethyl Chloride [M0007893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl cyanoacrylate [1608793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl 2-cyanoacrylate [M0092958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl cysteine [24513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl cysteine [M0099558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl cysteine hydrochloride [236634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl cysteine hydrochloride [M0319390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ether [1363043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ether [M0007827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ferulate [1420983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl ferulate [M0260162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl hexyl salicylate [236880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl hexyl salicylate [M0518358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl isovalerate [1314357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl isovalerate [M0452046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl lactate [1427072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl lactate [M0065477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl lauroyl arginate hydrochloride [1426162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethyl lauroyl arginate hydrochloride [M000737581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl levulinate [1313748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl levulinate [M0538026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl linoleate [24522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl linoleate [M0051020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl linolenate [1483807]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl linolenate [M0119121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl loflazepate [24524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl loflazepate [M0094367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl maltol [1314359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl maltol [M0148780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl methylphenylglycidate [1546209]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl methylphenylglycidate [M0069270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl nitrate [1314360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl nitrate [M0438845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl nitrite [1921585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl nitrite [M0101894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl oleate [1314361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl oleate [M0103089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl palmitate [1306938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl palmitate [M0051023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl perfluorobutyl ether [1540871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethoxynonafluorobutane [M0404070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl pyruvate [1539968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl pyruvate [M0134727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl salicylate [1546423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl salicylate [M0123872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl sebacate [1426475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl sebacate [M0093794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl stearate [1368181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl stearate [M0086603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl sulfate [1665664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl sulfate [M000608460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl valerate [1312574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl valerate [M000635893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl vanillin [1311571]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl vanillin [M0133349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl-p-hydroxybenzoate [1362892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl-p-hydroxybenzoate [M0059268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylbenzene [1540523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylbenzene [M0046113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylene [1314362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylene [M0110502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylene brassylate [1314363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylene brassylate [M0509668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylene dodecanedioate [2604565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylene dodecanedioate [M0573022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylene glycol [1314364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethylene Glycol [M0029474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylene oxide [1368154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethylene Oxide [M0007902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine [4158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>edamine [M0098306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine [4158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylenediamine [M0098309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylenediamine [4158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethane-1,2-diamine [M0521130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylestrenol [4162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethylestrenol [M0007907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylhexyl palmitate [1426380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylhexyl palmitate [M0100623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylhexylglycerin [1367134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylhexylglycerin [M0516372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylmorphine [4166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethylmorphine [M0007912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnicotinate [236122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylnicotinate [M0113050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine [156240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylnorepinephrine [M0046099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylnorepinephrine hydrochloride [M0308787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol [24591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethynodiol [M0063121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ethynodiol Diacetate [M0007919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine [4171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etidocaine [M0007923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etidronate [M0020101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etidronate Disodium [M0020099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etidronic Acid [M0020098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etifoxine [24441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etifoxine [M0042618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etifoxine hydrochloride [236215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etifoxine hydrochloride [M0477832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etilefrine [4169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etilefrine [M0007916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etilefrine hydrochloride [235960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etilefrine Hydrochloride [M0330371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etilevodopa [1421444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etilevodopa [M0460318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etodolac [M0026281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofamide [24607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etofamide [M0055455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofenamate [24608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etofenamate [M0064304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofibrate [24609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etofibrate [M0054708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofylline [24611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etofylline [M0052870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etomidate [M0007928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etonogestrel [14584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etonogestrel [M0130651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etoposide [M0007930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etoposide phosphate [M0170292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoricoxib [307296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etoricoxib [M0382298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod [2668045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etrasimod [M000678342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>etravirine [M0420447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etretinate [4182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Etretinate [M0007934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eucalyptol [21116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eucalyptol [M0055349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eucalyptol [21116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cineole [M000641008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eugenol [M0007941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>europium [1311484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Europium [M0007958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evening primrose oil [203219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>evening primrose oil [M0091678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>everolimus [141704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Everolimus [M000602394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evinacumab [2478335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>evinacumab [M000634681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evinacumab-dgnb [2478646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>evinacumab-dgnb [M000767487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evodiamine [2199291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>evodiamine [M0142130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evolocumab [1665684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>evolocumab [M000633757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exagamglogene autotemcel [2671667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>exagamglogene autotemcel [M000767005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exametazime [62153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>exametazime [M0209364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exemestane [258494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>exemestane [M0158502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Exendin-4 [M000640237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Exenatide [M0199975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ezetimibe [M0422151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezogabine [1112990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ezogabine [M0266905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX [4249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor IX [M0008141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX complex [1670383]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor IX [M0008141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII [M0008144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VIII [M0008146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>F8 protein, human [M0209555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIIa [4256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VIIa [M0024390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor X [M0008154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII [4271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor XIII [M0008160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Famciclovir [M0168276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Famotidine [M0024121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fanolesomab [1314371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monoclonal antibody anti-SSEA-1 [M0370916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab [2591519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>faricimab [M000758186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>farnesal [1484497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>farnesal [M0224512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>farnesol [1362903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Farnesol [M0008233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>farnesyl acetate [1487114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>farnesyl acetate [M0250632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fast green FCF stain [1310705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fast Green FCF [M0051051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fatty acids, omega-6 [1495153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatty Acids, Omega-6 [M0197024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febantel [24805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>febantel [M0067998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febarbamate [24807]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>febarbamate [M0044032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febuprol [24809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>febuprol [M0048729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febuxostat [73689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Febuxostat [M0224789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fedratinib [M000599365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fedratinib hydrochloride [M000675733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Felbamate [M0136828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(3-Carbamoyloxy-2-phenyl-propyl) carbamate [M000642497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbinac [262307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-biphenylylacetic acid [M0311968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Felodipine [M0024118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felypressin [4319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Felypressin [M0008307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenamiphos [1869713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenamiphos [M0043406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbendazole [4325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenbendazole [M0008324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbufen [24830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenbufen [M0056461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbutrazate [158507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenbutrazate [M0059272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline [4327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fendiline [M0008325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline hydrochloride [236767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fendiline Hydrochloride [M0478137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenethylline [24840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenethylline [M0045603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenfluramine [M0008328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenfluramine Hydrochloride [M0008329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenipentol [24846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenipentol [M0062194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenofibrate [M0017618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenofibric acid [M0047980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoldopam [M0028173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoldopam Mesylate [M0329176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoprofen [M0008332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoprofen Calcium [M0330378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoprofen Dihydrate, Calcium Salt [M000639940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol [4333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoterol [M0008335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol hydrobromide [203124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fenoterol Hydrobromide [M0329001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoverine [24855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenoverine [M0139077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoxazoline [24856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenoxazoline [M0120329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoxazoline hydrochloride [236387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenoxazoline hydrochloride [M0321395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenozolone [24860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenozolone [M0046257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenproporex [24867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenproporex [M0085875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenspiride [4335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenspiride [M0225164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenspiride hydrochloride [236281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenspiride hydrochloride [M0478164]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl [4337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fentanyl [M0008338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl citrate [142436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fentanyl Citrate [M0330379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenticonazole [24876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenticonazole [M0103857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fenugreek seed meal [M0157637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>feprazone [8673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feprazone [M0017544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric ammonium citrate [24897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric ammonium citrate [M0061343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric carboxymaltose [1433693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric carboxymaltose [M0512898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric chloride [24898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric chloride [M0082915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric chloride hexahydrate [1323279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric chloride hexahydrate [M0315780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric citrate [1594675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric citrate [M0084509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric citrate anhydrous [2539966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric citrate [M0084509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric derisomaltose [2274394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric derisomaltose [M000750269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric ferricyanide [2604034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric ferricyanide [M0151417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric hydroxide [1428835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric hydroxide [M0075448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric maltol [2539932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric maltol [M0171987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric nitrate [1363046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric nitrate [M0084487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide [1310572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric oxide [M0040645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide [1310572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>supraparamagnetic iron oxide [M000736154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric phosphate [24910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric phosphate [M0109685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric pyrophosphate [1607976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric pyrophosphate [M0140764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric subsulfate solution [24912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric subsulfate solution [M0092762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric sulfate [24913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric sulfate [M0083447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrocyanide [2383540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexacyanoferrate II [M0073983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrosoferric oxide [1310708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ferrosoferric Oxide [M0091115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous ascorbate [4356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ferrous Ascorbate [M0001798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous bisglycinate [1102188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous bisglycinate [M0497735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous chloride [24940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous chloride [M0093928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous disulfide [1544140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrite [M0057577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous fumarate [24941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous fumarate [M0099196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous gluconate [24942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous gluconate [M0058413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous lactate [136034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous lactate [M0264942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous oxide [1363047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous oxide [M0105655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous phosphate [107056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous phosphate [M0508673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous succinate [24946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous succinate [M0079657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate [24947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous sulfate [M0074816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfide [1724430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferrous sulfide [M0078880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferulic acid [1368647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferulic acid [M0046263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxides [72901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferumoxides [M0180129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxsil [77754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferumoxsil [M0234870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxytol [473387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ferumoxytol [M0582921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine [797195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fesoterodine [M0518591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine fumarate [797196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fesoterodine fumarate [M0529041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>feverfew extract [114203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>feverfew extract [M000744306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fexinidazole [M0115392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine [87636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fexofenadine [M0245918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine hydrochloride [236474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fexofenadine hydrochloride [M0245917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fezolinetant [2637134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fezolinetant [M000619374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibrinogen [M0008430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibroblast growth factor 7 [1789471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibroblast Growth Factor 7 [M0168688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibroblast growth factor-1 [1591916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibroblast Growth Factor 1 [M0024768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ficusin [2103294]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ficusin [M0008462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidaxomicin [1111103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fidaxomicin [M0055551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim [68442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Filgrastim [M0028831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-sndz [1605064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Filgrastim-sndz [M000638599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>finafloxacin [M0560479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Finasteride [M0027324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finerenone [2562811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>finerenone [M000608077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod [1012892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fingolimod [M0259277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod hydrochloride [1012891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fingolimod Hydrochloride [M0259274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fipronil [1433761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fipronil [M0219481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>firocoxib [473298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>firocoxib [M0468235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fisetin [2667741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fisetin [M0068970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fish Oils [M0008518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fitusiran [2709439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fitusiran [M000653377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavin-adenine dinucleotide [1314412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flavin-Adenine Dinucleotide [M0008169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavodic acid [25060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flavodic acid [M0042568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavodic acid, disodium salt [288862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flavodic acid, disodium salt [M0307863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavone [1536070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flavone [M0128117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flavoxate [M0008552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flavoxate Hydrochloride [M0008554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flécaïne [M000638460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flecainide [M0008556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flecainide Acetate [M0330385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fleroxacin [M0025289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flibanserin [1665509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flibanserin [M0257768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floctafenine [4444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>floctafenine [M0224727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flopropione [25082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flopropione [M0063696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floralozone [2557368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>floralozone [M000757365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetaben [2571857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-(N-methylamino)-4&apos;-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene [M0519968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetaben f-18 [1492940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>18F-florbetaben [M0561703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetapir F-18 [1427224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>florbetapir F 18 [M0553881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florbetapir [1427225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>florbetapir [M0541263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>florfenicol [25086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>florfenicol [M0108821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flortaucipir F-18 [2372689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(18F)flortaucipir [M000645553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flortaucipir [2571858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole [M000597219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flosequinan [25089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flosequinan [M0136718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin [4448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Floxacillin [M0008575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Floxuridine [M0008626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flubendazole [25096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flubendazole [M0070980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluciclovine F-18 [1796118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluciclovine F-18 [M0453315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone acetonide [103447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluclorolone acetonide [M0262509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucloronide [190410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flucloronide [M0262510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluconazole [M0024111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flucytosine [M0008576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fludarabine [M0082555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fludarabine phosphate [M0125188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fludrocortisone [M0008577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fludrocortisone acetate [M0533470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flufenamic acid [4453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flufenamic Acid [M0008579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluindione [50097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluindione [M0068620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flumazenil [M0008585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumequine [25112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flumequine [M0060382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flumethasone [M0008586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flumethasone pivalate [M0047203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flumethiazide [M0499369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine [4459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flunarizine [M0008587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunarizine hydrochloride [82019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flunarizine Hydrochloride [M0330270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flunisolide [M0051093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flunisolide [M0051093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flunisolide hemihydrate [M0310023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunitrazepam [4460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flunitrazepam [M0008590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunixin [25121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flunixin [M0063142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunixin meglumine [25122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flunixin meglumine [M0063145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluocinolone [M0108491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluocinolone Acetonide [M0008592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluocinonide [M0008593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortin butyl ester [25127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluocortin butyl ester [M0058420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone [4463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluocortolone [M0008594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone caproate [4464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluocortolone Caproate [M0008595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone pivalate [4465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluocortolone Pivalate [M0008596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorapatite [1313343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluorapatite [M0084099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein [25138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluorescein [M0029368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein dilaurate [25142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluorescein dilaurate [M0107106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein sodium [57789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluorescein Sodium [M0354230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorescein sodium [57789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disodium Fluorescein [M0329115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorexon stain [25161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluorexon [M0051100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorine [1310123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluorine [M0008618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodeoxyglucose F18 [1362737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluorodeoxyglucose F18 [M0029360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodopa F-18 [2571853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluorodopa F 18 [M0127845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorodopa [2571852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluorodopa [M000633380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluorometholone [M0008628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluorouracil [M0008631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluoxetine [M0008635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluoxetine Hydrochloride [M0351280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluoxymesterone [M0008638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flupenthixol [M0008640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flupenthixol decanoate [M0051138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluphenazine [M0008641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluphenazine depot [M0058428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluphenazine enanthate [M0068531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluphenazine Hydrochloride [M0354107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupirtine [25193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flupirtine [M0105473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupirtine maleate [236774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flupirtine maleate (1:1) [M0320006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluprednidene acetate [25194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluprednidene acetate [M0262508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluprednisolone [4497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluprednisolone [M0008643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluralaner [1538098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluralaner [M000598974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flurandrenolone [M0008644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam [4501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flurazepam [M0008645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam hydrochloride [71484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flurazepam Hydrochloride [M0330277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flurbiprofen [M0008647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flurbiprofen Sodium [M0478669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluspirilene [4507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluspirilene [M0008650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutamide [4508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flutamide [M0008651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutemetamol F-18 [1486025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(18F)flutemetamol [M0585402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutemetamol [1486026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flutemetamol [M0585401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluticasone [M000602354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluticasone furoate [M0514058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluticasone Propionate [M000603403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutrimazole [61773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>flutrimazole [M0206908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate [M000640613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluvastatin [M0179302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluvastatin Sodium [M0324842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluvoxamine [M0025397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fluvoxamine Maleate [M0351235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folate [62356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folate [M0519540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folic acid [4511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid [M0008658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Follicle Stimulating Hormone [M0008869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>follitropin alfa [M0573064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>follitropin beta [M0573063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomepizole [15226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fomepizole [M0055591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fominoben [183875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fominoben [M0198289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen [85763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fomivirsen [M0241240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen sodium [314633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fomivirsen sodium [M0399326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomocain [25231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fomocain [M0263281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fonazine [50138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fonazine [M0262676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fonazine mesylate [50139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fonazine mesylate [M0262674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fondaparinux [M0403648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux sodium [322154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fondaparinux Sodium [M0407592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Formaldehyde [M0008753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Formalin [M0372970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formate [1362748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formate [M0096525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formestane [15070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formestane [M0063242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formic acid [4537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formic acid [M0096528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formic acid, sodium salt [2376943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formic acid, sodium salt [M0318878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Formoterol [M0059794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Formoterol Fumarate [M0311929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>forsythiaside [2670319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>forsythiaside [M0162091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir [358262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosamprenavir [M0388439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir calcium [402365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosamprenavir calcium [M0468769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant [1731071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosaprepitant [M0534898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosaprepitant dimeglumine [754763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosaprepitant dimeglumine [M0529251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foscarnet [M0026166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trisodium Phosphonoformate [M000642657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foscarnet Sodium [M0026167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foscarnet Trisodium Salt [M000642656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosdenopterin [2531288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cyclic pyranopterin monophosphate [M0546600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosdenopterin [2531288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosdenopterin [M000744568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosfestrol [M0046203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fosfomycin [M0008779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fosfomycin Trometamol Salt [M0008781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfructose [2119172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fructose-1,6-diphosphate [M0092971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fosinopril [M0026315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fosinopril Sodium [M0026317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosinoprilat [M0135833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosphenytoin [M0127036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fosphenytoin sodium [M0127035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fospropofol [828682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fospropofol [M0583186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fospropofol disodium [813021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fospropofol disodium [M0448056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib [2044896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fostamatinib [M0537319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib disodium [2055929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fostamatinib disodium hydrate [M000752671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir [2380373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fostemsavir [M000648415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>framycetin [4556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Framycetin [M0008812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>framycetin sulfate [235749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neomycin B Sulfate [M0363010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab [2056691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fremanezumab [M000613774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fremanezumab-vfrm [2056690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fremanezumab-vfrm [M000646874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>frovatriptan [M0281019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan succinate [322249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>frovatriptan succinate [M0407975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fructooligosaccharide [259372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fructooligosaccharide [M0299655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fructose [4570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fructose [M0008855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fruquintinib [M000598337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fucose [2466731]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fucose [M0008873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvestrant [282357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fulvestrant [M0397101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvic acid [1314310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fulvic acid [M0046304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fumagillin [1926480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fumagillin [M0086333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fumarate [70598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fumarates [M0008880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fumaric acid [25389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fumarate dianion [M000742748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fumaric acid [25389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fumaric acid [M0100168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fumitory extract [236156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fumariae herba [M000743910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Furazolidone [M0008899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Furosemide [M0008900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fursultiamin [4604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fursultiamin [M0008902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fusafungin [25437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fusafungin [M0062215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fusel oil [2287733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fusel oil [M0051226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fusidate sodium [9874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fusidate Sodium [M0330301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fusidic acid [4608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fusidic Acid [M0008910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>futibatinib [M000743967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gabapentin [M0119421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gabapentin enacarbil [M0534581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobenate dimeglumine [68173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadobenic acid, dimeglumine salt [M0324761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobenate dimeglumine [68173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadobenic acid [M0177858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadobutrol [84990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadobutrol [M0239381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadodiamide [41144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadodiamide [M0178725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadofosveset [1364290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadofosveset [M000639045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadofosveset trisodium [1364289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadofosveset trisodium [M0458591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadolinium [1310171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gadolinium [M0008930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadolinium oxide [1311118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadolinium oxide [M0096617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopentetate dimeglumine [25486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gadopentetate Dimeglumine [M0329085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopiclenol [2618720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadopiclenol [M000679592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadopiclenol [2618720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gadolinium 2,2&apos;,2&apos;&apos;-(3,6,9,15-tetraazabicyclo(9.3.1)pentadeca-1(15),11,13-triene-3,6,9-triyl)tris(5-((2,3-dihydroxypropyl)amino)-5-oxopentanoate) [M000679593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoterate meglumine [1421151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadoterate meglumine [M0196199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoteridol [25483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadoteridol [M0172747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoversetamide [228833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadoversetamide [M0291274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gadoxetate disodium [637320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gadoxetic acid disodium [M0198898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galactoarabinan [1425353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>arabinogalactan [M0047317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galactose [4626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Galactose [M0008938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Galantamine [M0008951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Galanthamine Hydrobromide [M0330309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab [2058846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>galcanezumab [M000644915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab-gnlm [2058868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>galcanezumab-gnlm [M000646876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallamine [4638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallamine [M0008953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallamine triethiodide [4639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallamine Triethiodide [M0008954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallic acid [1311389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallic Acid [M0008960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium 67 citrate [272758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gallium citrate (1:1); 67Ga-labeled [M0327733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium GA-68 gozetotide [2586016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC)) [M0587030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium GA-68 gozetotide [2586016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>68Ga-PSMA [M000650846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium GA-68 gozetotide [2586016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gallium 68 PSMA-11 [M000750569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium [1310124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallium [M0008961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium nitrate [25544]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gallium nitrate [M0088700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium-67 [1546372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallium-67 [M000627955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil [4648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallopamil [M0008964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil hydrochloride [439837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gallopamil Hydrochloride [M0482974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galsulfase [578033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>galsulfase [M0496234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamboge [89698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gamboge [M0499454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamithromycin [1113697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamithromycin [M0550265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-aminobutyric acid [4617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-Aminobutyric Acid [M0008927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-cyclodextrin [1366989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-cyclodextrin [M0081435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-interferon [1421648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon-gamma [M0011490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-linolenic acid [25605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-Linolenic Acid [M0027133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-methacryloxypropyltrimethoxysilane [2386843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methacryloxypropyltrimethoxysilane [M0068281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-oryzanol [25608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-oryzanol [M0060738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gamma-terpinene [2393523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-terpinene [M0070425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganaxolone [2604689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ganaxolone [M0274194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ganciclovir [M0024168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ganciclovir Sodium [M0024169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ganirelix [M0169271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ganirelix acetate [M0499456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gardenia yellow extract [2632124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gardenia yellow [M0161192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gardenoside [2585534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gardenoside [M0158681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gastric mucins [4698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastric Mucins [M0009008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gatifloxacin [M0209340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gefitinib [M0444984]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gelatin [4716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gelatin [M0009052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gellan gum (low acyl) [1420964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gellan gum [M0139025]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gemcitabine [M000754277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gemcitabine Hydrochloride [M0585172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemeprost [12449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gemeprost [M0075715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gemfibrozil [M0023484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gemifloxacin [M0370050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid [M000641396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gemifloxacin Mesylate [M0468774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gemtuzumab Ozogamicin [M0483090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>genistein [25696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Genistein [M0029441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gentamicin [M0580977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gentamicin Sulfate [M0009170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gentian Violet [M0009174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentisic acid [1368641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,5-dihydroxybenzoic acid [M0056827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepefrine [41157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gepefrine [M0131929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone [2672253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gepirone [M0119304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gepotidacin [M000624677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geranial [2119367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>geranial [M0309828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geraniol [1368875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>geraniol [M0051261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geranyl acetate [1807120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>geranyl acetate [M0395796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geranylgeranylacetone [1362746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetraprenylacetone [M000633537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>geranylgeranylacetone [1362746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>geranylgeranylacetone [M0097855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>germanium [4784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Germanium [M0009205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>germanium dioxide [1309238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>germanium oxide [M0120621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gestodene [25734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gestodene [M0103314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gestonorone caproate [4791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gestonorone Caproate [M0009215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gestrinone [4792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gestrinone [M0009218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gestronol [4793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gestronol [M0009216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib [2105806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gilteritinib [M000619671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ginger extract [M000744390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger root [125921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rhizoma zingiberis [M000744386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginsenoside [349656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ginsenosides [M0062224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givinostat [2678889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>givinostat [M0577518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran [2265712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>givosiran [M000647559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glabridin [1603522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glabridin [M0279872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib [2105845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glasdegib [M000599270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>copolymer I (synthetic peptide) [M0077052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glatiramer [M000603608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(T,G)-A-L [M0077056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer acetate [84375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glatiramer Acetate [M000603606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glaucine [1368876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glaucine [M0046271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glecaprevir [M000636259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gleptoferron [1855078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gleptoferron [M0114398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glibornuride [102846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glibornuride [M0198293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gliclazide [4816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gliclazide [M0009266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glimepiride [M0161111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gliotoxin [1661743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gliotoxin [M0009277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glipizide [M0009278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gliquidone [25793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gliquidone [M0056903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glofitamab [M000753407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucagon [M0009314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucametacin [25834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucametacin [M0056167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucarpidase [1242127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucarpidase [M000646718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucarpidase [1242127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carboxypeptidase G2 [M0018075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluceptate [50470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucoheptonate [M0051278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(1-6)-alpha-glucomannan [M0079557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluconate [70599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D-gluconate [M000623299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluconic acid [2475956]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gluconic acid [M0096893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gluconolactone [25842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-glucono-1,5-lactone [M0056469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucosamine [M0009332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucosamine Sulfate [M0009333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose 1,6-bisphosphate [2565267]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucose-1,6-bisphosphate [M0066481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucose [M0009339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose oxidase [1427073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucose Oxidase [M0009344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose pentaacetate [1792129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucose pentaacetate [M0274371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose-6-phosphate [1541246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucose-6-Phosphate [M0028730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosyl hesperidin [1433192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucosyl hesperidin [M0468233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucuronate [1426907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucuronate [M0095418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucuronic acid [1426906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucuronic Acid [M0095420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucuronolactone [1535222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glucuronolactone [M0046169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamate [70602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutamate [M0028012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamic acid [25916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutamic Acid [M0028010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamine [4885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutamine [M0009383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutaral [4888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutaral [M0009386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutarate [1943800]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutarates [M0009387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutaric acid [1943799]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glutaric acid [M0109300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutathione [4890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutathione [M0009388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutathione disulfide [25953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutathione Disulfide [M0029384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutethimide [4903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glutethimide [M0009406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glyburide [M0009265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceran polyricinoleic acid ester [1541750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glyceran polyricinoleic acid ester [M0093384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycerol [M0009417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerol formal [1311689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycerol formal [M0084377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerol phenylbutyrate [1368451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycerol phenylbutyrate [M0571227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl 1,2-dioleate [1426915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-dioleoylglycerol [M000622965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl 1-laurate [1990422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monoglycerol laurate [M0074879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl 1-laurate [1990422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monolaurin [M0074881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl arachidonate [1427076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-arachidonyl monoglyceride [M0086812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl behenate [1305749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glyceryl behenate [M0229060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl caprylate [1307152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glyceryl monocaprylate [M000623322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl monolaurate [314647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycerol monolaurate [M0074876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl monostearate [1311165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glyceryl monostearate [M0138717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyceryl palmitostearate [1423683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>precirol [M0053400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerylphosphorylcholine [4918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycerylphosphorylcholine [M0009450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycidyl acrylate [1735329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,3-epoxypropyl acrylate [M0172793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycidyl methacrylate [1869700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycidyl methacrylate [M0051321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine [4919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycine [M0009451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine hydrochloride [1311532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycine Hydrochloride [M0331190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine propionyl-L-carnitine [2669317]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycine propionyl l-carnitine [M000594420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycocholic acid [1426482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycocholic Acid [M0009454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycofurol [1427078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycofurol [M0070225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycogen [1426910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycogen [M0009459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycol salicylate [26051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycol salicylate [M0075189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycolate [70603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycolate [M0484987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycolic acid [587318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycolic acid [M0098075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycoprotein hormones, alpha subunit [1427201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycoprotein Hormones, alpha Subunit [M0023540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycopyrrolate [M0009495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium [1546438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycopyrronium [M000682997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium tosylate [2052857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycopyrronium tosylate [M000647209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycosine [2359267]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycosine [M0062230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycylglycine [1362904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycylglycine [M0009507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycyrrhetinic acid [1311506]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycyrrhetinic Acid [M0009508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycyrrhizic acid [26143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycyrrhizic Acid [M0029245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glymidine [102848]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glymidine [M0198145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyoxal [4967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glyoxal [M0009511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyphosate [1800093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glyphosate [M0056912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gold [M0009521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold keratinate [50598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gold keratinate [M0041814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gold Sodium Thiomalate [M0009527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiosulfate [9876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gold Sodium Thiosulfate [M0020105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>golimumab [M0521570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golodirsen [2267207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>golodirsen [M000738613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golotimod [2367440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>golotimod [M0444429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonadotropin-Releasing Hormone [M0012446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonadorelin Acetate [M0331413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonadorelin Hydrochloride [M0331412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin [50610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goserelin [M0026217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goserelin Acetate [M0373293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gozetotide [2588949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>PSMA-11 [M000762343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gramicidin [5011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gramicidin [M0009601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron [26237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granisetron [M0026935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>granisetron hydrochloride [142149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granisetron Hydrochloride [M0329234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grape seed extract [237116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Grape Seed Extract [M0528092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grape seed proanthocyanidins [283566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Grape Seed Proanthocyanidins [M0528926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapefruit seed extract [259449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>grapefruit seed extract [M000747484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grapiprant [1862951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>grapiprant [M0513563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>grazoprevir [M0581079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>grazoprevir anhydrous [M000634943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grepafloxacin [83719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>grepafloxacin [M0203132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grepafloxacin hydrochloride [236862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>grepafloxacin hydrochloride [M0401903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Griseofulvin [M0009641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaiac [1373150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guaiac [M0009667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaiacol [5031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guaiacol [M0009668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaiacolsulfonic acid [26288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guaiacolsulfonic acid [M0061685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaiazulene [26290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guaiazulene [M0045508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guaifenesin [M0009669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaiol [2542348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guaiol [M0443331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanabenz [M0009672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanabenz Acetate [M0330233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guanadrel [M0046181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guanadrel sulfate [M0308811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanethidine [M0009675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanethidine Monosulfate [M0330236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanethidine Sulfate [M0350959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanfacine [M0024935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanfacine Hydrochloride [M0350963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine [50675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanidine [M0029365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine hydrochloride [50676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanidine Hydrochloride [M0329107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanine [1372539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanine [M0009679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanosine [1591890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guanosine [M0009684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guar gum [26344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guar gum [M0051358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guggul lipids [283568]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gugulipid [M0070231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gugulu extract [26346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guggulu extract [M0070234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guselkumab [1928588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guselkumab [M000594859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hafnium [1534767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hafnium [M0009743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halazepam [26412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halazepam [M0055489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halazone [59838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halazone [M0151607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Halcinonide [M0009756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halobetasol [M0438588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halobetasol propionate [M0177553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine [50749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halofantrine [M0081385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine hydrochloride [58130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halofantrine hydrochloride [M0450251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halometasone [26416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halometasone [M0111181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halometasone monohydrate [237025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>halometasone monohydrate [M0450253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haloperidol [M0009771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>haloperidol decanoate [M0104068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloprogin [26422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>haloprogin [M0263282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halothane [5095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Halothane [M0009773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>harpagoside [2048124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>harpagoside [M0103253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hawthorn leaf with flower extract [1309793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>crataegus extract [M0050155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hawthorn preparation [155097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hawthorn extract [M000744670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hectorite [1367162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hectorite [M0061374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hederagenin [2045115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hederagenin [M0085532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>helicidine [233562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>helicidine [M0303729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>helium [5140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helium [M0010005]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hematoporphyrin [5164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematoporphyrin [M0010060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heme arginate [26506]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>heme arginate [M0140322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemicellulase [26514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hemicellulase [M0080451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemin [5175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemin [M0010079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemp [1788846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemp [M0003274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparan sulfate [2603494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heparitin Sulfate [M0010194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heparin [M0010187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>calcium heparin [M0049688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Heparin [M0010188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparinoids [5228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heparinoids [M0010193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis A virus [1491862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis A virus [M0010208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B immune globulin [26744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hepatitis B hyperimmune globulin [M0131598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis B virus [1427211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B virus [M0010218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hepatitis C virus [1491863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C virus [M0024691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heptaminol [5254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heptaminol [M0010242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heptaminol hydrochloride [236294]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heptaminol Hydrochloride [M0330241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heptanal [2360434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>heptanal [M0133976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heptane [2472186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heptanes [M0010243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heroin [3304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heroin [M0006166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heroin hydrochloride [81994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heroin Hydrochloride [M0330523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesvirus 1, Human [M0027488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 2, human [1318479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesvirus 2, Human [M0027487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 3, human [11131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesvirus 3, Human [M0022527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 5, human [1316104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesvirus 5, Human [M0005606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 6, human [2167553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesvirus 6, Human [M0023992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hesperadin [1552358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hesperadin [M0450517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hesperetin [1314255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hesperetin [M0060438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hesperidin [5281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hesperidin [M0010288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hesperidin methylchalcone [72086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hesperidin methylchalcone [M0102639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin [26797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hetacillin [M0262683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hetastarch [M0010761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexachlorophene [5293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexachlorophene [M0010306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexacosanoic acid [1997245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexacosanoic acid [M0068090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexadecanal [2049630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexadecanal [M0041912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexadecanamide [159085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexadecanamide [M0062252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexadecane [2167851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-hexadecane [M0051408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexafluorenium [26826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexafluorenium [M0046315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexafluorenium bromide [53017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexafluorenium bromide [M0046311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexafluorosilicate [1862869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexafluorosilicate [M0046040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexametaphosphate [1487531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexametaphosphate [M0046316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexamethylcyclotrisiloxane [1994321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexamethylcyclotrisiloxane [M0081928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexamethyldisilazane [1986434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexamethylsilazane [M0082902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexamethyldisiloxane [1311540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disiloxane [M0165422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexamethyldisiloxane [1311540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexamethyldisiloxane [M0065557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexamidine [26849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexamidine [M0071011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexamidine diisethionate [1939371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexamidine diisethionate [M0519741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexaminolevulinate hydrochloride [1426871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexaminolevulinate hydrochloride [M0579461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexane [1999411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-hexane [M0086689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexapeptide-11 [1996982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phe-Val-Ala-Pro-Phe-Pro [M0585622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexetidine [5301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexetidine [M0010320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexobarbital [5302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexobarbital [M0010321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexobendine [5303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexobendine [M0010324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexocyclium [26867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexocyclium [M0065562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexocyclium methylsulfate [235430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexocyclium methylsulfate [M0313010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexoprenaline [5307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexoprenaline [M0010329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexoprenaline sulfate [258331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexoprenaline Sulfate [M0351214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexyl 5-aminolevulinate [1426872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-aminolevulinic acid hexyl ester [M0378672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexyl decanoate [1313706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexyl decanoate [M0504650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexyl laurate [1367126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexyl laurate [M0503540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexyl salicylate [1421892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexyl salicylate [M0518360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexylcaine [26879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexylcaine [M0046190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexylcaine hydrochloride [1546032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexylcaine hydrochloride [M0308817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexyldecanol [1363575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexyldecanol [M0528104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexylene glycol [1305548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hexylene glycol [M0057801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexylresorcinol [5321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexylresorcinol [M0010341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>high fructose corn syrup [1310511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>High Fructose Corn Syrup [M0593348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>high-density polyethylene [1424910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>High-Density Polyethylene [M0333841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hippurate [1923620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hippurate [M0096456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hippuric acid [1923619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hippuric acid [M0096457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hirudin [1546205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hirudin [M0010382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine [5333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histamine [M0010390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine dihydrochloride [142136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histamine Dihydrochloride [M0010392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine hydrochloride [350466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histamine Hydrochloride [M000638464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine phosphate [26925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>histamine phosphate [M0089478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histidinal, L- [2621896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>histidinal [M0133993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histidine [5340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histidine [M0010400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histoplasmin [5363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmin [M0010433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>histrelin [M0093413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>holmium [1311388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Holmium [M0010492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>holy basil leaf extract [1860076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>holy basil leaf extract [M000744082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homarine [1426930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>homarine [M0056931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>homatropine [M0263115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>homatropine methylbromide [M0157819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homosalate [91326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>homosalate [M0167938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>honokiol [2562546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>honokiol [M0047074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hordenine [27120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hordenine [M0051458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horehound extract [1426436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Marrubium vulgare extract [M000745640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>horse chestnut seed [260020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>horse chestnut seed [M000743971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chorionic Gonadotropin, Human [M0411989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human enterovirus A [1668271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterovirus A, Human [M0385393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human papillomavirus [1311095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Human Papillomavirus Viruses [M000598251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human parvovirus B19 virus [1368364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parvovirus B19, Human [M0025480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>humulene [2266811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>humulene [M0125911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>huperzine A [2267703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>huperzine A [M0143991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyaluronic Acid [M0010664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyaluronan [M0357381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase [5464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyaluronoglucosaminidase [M0010666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydantoin [1721294]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydantoins [M0010672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydracrylic acid [2673464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydracrylic acid [M0099152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydralazine [M0010676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydralazine Hydrochloride [M0010678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrobromic acid [1426869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrobromic Acid [M0027243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochloric acid [5486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrochloric Acid [M0010701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrochlorothiazide [M0010703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrocodone [M0010704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrocodone Bitartrate [M0010706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrocortisone [M0010707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone aceponate [M0176269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone acetate [M0076886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone-17-butyrate [M0051478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone cypionate [M0093097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone 17-butyrate 21-propionate [M0102624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone sodium phosphate [M0118924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cortisol succinate, sodium salt [M0309845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrocortisone valerate [M0115554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroflumethiazide [M0010713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrofluoric acid [5496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrofluoric Acid [M0010714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen [5497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrogen [M0010716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen cyanide [1367183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrogen Cyanide [M0010712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen peroxide [5499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydrogen Peroxide [M0010718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen sulfite [1366859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrogen sulfite [M0125104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroiodic acid [27208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroiodic acid [M0055977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydromorphone [M0006409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydromorphone Hydrochloride [M0352944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinidine [27220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroquinidine [M0063018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinidine hydrochloride [236160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroquinidine hydrochloride [M0488225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinine [2468435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroquinine [M000633818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroquinone [M0099980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroquinones [M0010734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrotalcite [27221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydrotalcite [M0055979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxide ion [1314279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxide ion [M0098577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxocobalamin [M0010744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyamphetamine hydrobromide [82066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyamphetamine Hydrobromide [M0015730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxychloroquine [M0010751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxychloroquine Sulfate [M0330264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxycitric acid [1312602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxycitric acid [M0051512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxycitronellal [1362893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxycitronellal [M0074831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyestrones [5530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyestrones [M0010760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose [27244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxyethylcellulose [M0042813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl ethylcellulose [1722035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl-2-hydroxyethylcellulose [M0186949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl ethylcellulose [1722035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl(hydroxyethyl)cellulose [M0435029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl starch 130-0.4 [1363352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyethyl Starch 130-0.4 [M0579394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethylpiperazine ethane sulfonic acid [1312611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HEPES [M0010239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyisohexyl 3-cyclohexene carboxaldehyde [1426621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxyisohexyl 3-cyclohexene carboxaldehyde [M0243505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>17 alpha-Hydroxyprogesterone Caproate [M0074009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyproline [1311548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trans-4-hydroxy-L-proline [M000746909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyproline [1311548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyproline [M0010778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (1600000 WAMW) [2048727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropyl cellulose (type H) [M000644828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (type H) [1811461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropyl cellulose (type H) [M000644828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose, unspecified [1804020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropylcellulose [M0051638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl gamma-cyclodextrin [1601114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropyl-gamma-cyclodextrin [M0152340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl gamma-cyclodextrin [1601114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(2-hydroxypropyl)-gamma-cyclodextrin [M0508893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methacrylate [2468433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropyl methacrylate [M0102062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose phthalate [1363587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropyl methylcellulose phthalate [M0151006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl-alpha-cyclodextrin [1442707]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropyl-alpha-cyclodextrin [M0152338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropylbetadex (0.58-0.68 MS) [1363608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-Hydroxypropyl-beta-cyclodextrin [M0152341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropylcellulose [27291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropylcellulose [M0051638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxytyrosol [1314227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(3,4-dihydroxyphenyl)ethanol [M0047896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxytyrosol [1314227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxytyrosol [M0047899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyurea [M0010790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyzine [M0010792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyzine Dihydrochloride [M0331417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyzine Hydrochloride [M0010795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydroxyzine Pamoate [M0331416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hygromycin B [1426887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hygromycin B [M0010798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hylan G-F 20 [284637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hylan G-F 20 [M0441627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hylan [27306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hylan [M0142537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hymecromone [5556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hymecromone [M0010801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyoscyamine [M0331322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyoscyamine Hydrobromide [M0583021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyoscyamine Sulfate [M0331323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyoscyamine Sulfate Anhydrous [M0583022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypericin [1546455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypericin [M0046211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypochlorite [1483317]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypochlorite [M0010893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypochlorous acid [1483316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypochlorous Acid [M0010892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypotaurine [2597523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypotaurine [M0045090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100 MPA.S) [1300444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2208 (100 MPA.S) [M0589365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (15000 MPA.S) [1300445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2208 (15000 MPA.S) [M0589367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (3 MPA.S) [1300446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2208 (3 MPA.S) [M0589369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (4000 mpa.s) [1299222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2906 (4000 mpa.s) [M0589358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (50 MPA.S) [1297881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2906 (50 MPA.S) [M0589356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15 MPA.S) [1300450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (15 MPA.S) [M0589373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15000 MPA.S) [1300451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (15000 MPA.S) [M0589384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (3 MPA.S) [1300449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (3 MPA.S) [M0589372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (4000 MPA.S) [1300455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (4000 mpa.s) [M0589398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (5 MPA.S) [1300452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (5 MPA.S) [M0589391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (50 MPA.S) [1300453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (50 MPA.S) [M0589392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (6 cps) [1300454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hypromellose 2910 (6 cps) [M0589397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose [27334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypromellose [M0589823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose acetate succinate [2645263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxypropylmethylcellulose acetate succinate [M0139120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab [2043283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibalizumab [M0460791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab-uiyk [2043313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibalizumab-uiyk [M000675446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate [115264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ibandronate [M0197523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate sodium [236916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ibandronate Sodium [M000629520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronic acid [115265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ibandronic Acid [M0197524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine [51253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibopamine [M0080783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine hydrochloride [284157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibopamine hydrochloride [M0488262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp [2560213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibrexafungerp [M000737384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibritumomab tiuxetan [M0382512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibrutinib [M0576729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ibuprofen [M0010965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>solufenum [M0065869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ibuprofen, Sodium Salt [M0330149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutamoren mesylate [1805437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibutamoren mesylate [M0578056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibutilide [M0184268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ibutilide fumarate [M0184267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icariin [1788871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>icariin [M0158708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant [1148138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>icatibant [M0180524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant acetate [1294605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>icatibant acetate [M0324906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ichthammol [5645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ichthammol [M0236368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icodextrin [140480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Icodextrin [M0275943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icosapent ethyl [1304974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>eicosapentaenoic acid ethyl ester [M0108217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Idarubicin [M0023493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Idarubicin Hydrochloride [M0023495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarucizumab [1716191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>idarucizumab [M000601774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarucizumab [1716191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ADABI-FAB [M000654059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idebenone [51296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>idebenone [M0111395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idecabtagene vicleucel [2536430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>idecabtagene vicleucel [M000745279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>idelalisib [M0592589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Idoxuridine [M0010989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idrocilamide [19729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>idrocilamide [M0045673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idursulfase [644101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>idursulfase [M0507693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil [27403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ifenprodil [M0056488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifenprodil tartrate [289912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ifenprodil tartrate [M0311231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ifosfamide [M0010999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ilomastat [1368877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ilomastat [M0305265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloperidone [73178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iloperidone [M0217926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloprost [40138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iloprost [M0024894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imatinib [M0424454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imatinib Mesylate [M0391958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imdevimab [2465249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imdevimab [M000740285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imepitoin [2600779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imepitoin [M000598231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat [2685236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imetelstat [M0545573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidacloprid [1251576]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imidacloprid [M0219479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imidapril [M0179259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imidapril hydrochloride [M0490675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidazole [2472898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imidazole [M0095023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidazole-2-hydroxybenzoate [27438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imidazole-2-hydroxybenzoate [M0127471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidazolidinone [2565925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylene urea [M0046117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidocarb [1740237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imidocarb [M0011050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidocarb dipropionate [1740238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imidocarb dipropionate [M0099455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>imiglucerase [M0239290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iminodisuccinate [1366938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iminodisuccinate [M0369055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imipenem [M0023689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imipenem, Anhydrous [M0329530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imipramine [M0011056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imipramine Hydrochloride [M0330160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imipramine Pamoate [M000643221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Imiquimod [M0158430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin A [1426454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoglobulin A [M0011000]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G [5666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoglobulin G [M0376295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunoglobulins, Intravenous [M0025515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imperialine [1860087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peiminine [M0136763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amrinone [M0001038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>inavolisib [M000758681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inclisiran [2588243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ALN-PCSsc [M000626058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>incobotulinumtoxinA [M0552662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol [1114326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indacaterol [M0498679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indanazoline [27492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indanazoline [M0089655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indanazoline hydrochloride [292036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indanazoline hydrochloride [M0317381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indapamide [M0011207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indeloxazine [1311673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indeloxazine [M0075088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indeloxazine hydrochloride [1311672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indeloxazine hydrochloride [M0314344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indican [2463933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indican [M0011222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indigo [1426889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indigo [M0011228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indigo carmine [227312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>FD&amp;C Blue No. 2 [M0585830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indigo carmine [227312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indigo Carmine [M0011229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indigotindisulfonate [325514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indigotindisulfonate [M0515721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indigotindisulfonic acid [1546441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(1,3-Dihydro-3-oxo-5-sulpho-2H-indol-2-ylidene)-3- oxoindoline-5-sulphonic acid [M000638472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir [114289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indinavir [M0028961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir sulfate [203153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indinavir Sulfate [M0329078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 chloride [42987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indium trichloride, 111In-labeled [M0314297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetate disodium [259268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indium-DTPA [M0006867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium In-111 pentetreotide [1724429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indium In 111 pentetreotide [M0326202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium [1362699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indium [M0011230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indium-111 [90540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indium-111 [M000628077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indobufen [27518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indobufen [M0074020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indocyanine green [5775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indocyanine Green [M0011235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indole [1311224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indole [M0096122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indole-3-carbinol [2598119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>indole-3-carbinol [M0066561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indomethacin [M0011240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indoramin [5784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indoramin [M0011253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab [2373951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>inebilizumab [M000654361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab-cdon [2373950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>MEDI-551 [M000620389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infigratinib [2550729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>infigratinib [M000738608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infigratinib [2550729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea [M0569496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infliximab [M0282056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infliximab-abda [M000638601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infliximab-dyyb [M000638600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus [1312375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza A virus [M0015475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza B virus [1312376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza B virus [M0015476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ingenol mebutate [1242806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ingenol mebutate [M0556885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inosine [1483575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inosine [M0011366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inosine pranobex [6048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inosine Pranobex [M0011778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inosinic acid [5832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inosinic Acid [M0011370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inosinic acid [5832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inosine Monophosphate [M0011369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inositol [5833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inositol [M0011374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inositol niacinate [27604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inositol Niacinate [M0046559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen [2099289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inotersen [M000646654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotuzumab ozogamicin [1942950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inotuzumab Ozogamicin [M0482497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin degludec [M0573376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin detemir [139825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin Detemir [M0274330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin Glargine [M0361589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin Glargine-aglr [M000754114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-yfgn [2563969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Semglee [M000751185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin glulisine [M0456627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane [1605101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin, Isophane [M0011436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isophane insulin, beef [M0423934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isophane insulin, beef-pork [M0423753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isophane Insulin, Human [M0423933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isophane insulin, pork [M0423932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin Lispro [M0556909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, protamine zinc, beef [M0423930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, protamine zinc, beef-pork [M0423929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, human [236646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, protamine zinc, human [M0465329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, regular, beef-pork [M0423851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin, Regular, Human [M0423852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin, Regular, Pork [M0423949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin-like growth factor 2 [1728770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insulin-Like Growth Factor II [M0011435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon alfa-2a [M0023693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon alfa-2b [M0023695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n1 [202912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>interferon alfa-n1 [M0025713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n3 [612937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon Alfa-n3 [M0521744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>interferon alfacon-1 [M0144715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon beta-1a [M0230367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon beta-1b [M0129586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>interferon gamma-1b [M0329535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon-beta [4381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interferon-beta [M0025715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-1, beta [2176735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-1beta [M0011502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-10 [1311299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-10 [M0025510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-11 [1311380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-11 [M0026381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-12 [1309680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-12 [M0027969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-3 [1311225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-3 [M0011508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-4 [5891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-4 [M0024266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-5 [1367184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-5 [M0024267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-6 [1367185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-6 [M0024272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-7 [1367202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-7 [M0024273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interleukin-9 [1309465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Interleukin-9 [M0025726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intrinsic factor [5920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intrinsic Factor [M0011611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inulin [5924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inulin [M0011618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>invert sugar [27712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>invert sugar [M0051714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-123 [1426748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-Iodobenzylguanidine, 123I Labeled [M0331309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iobenguane (131I) [M0029375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobitridol [87639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iobitridol [M0245926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iocetamic acid [183830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iocetamic acid [M0198136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodamide [5928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodamide [M0011626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-123 [1361657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodine-123 [M000627484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iodinated glycerol [M0064569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine I-131 [1546394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodine-131 [M000627491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodine [M0011640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodine-125 [M000627486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-131-tositumomab [234449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tositumomab I-131 [M0305901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodipamide [5936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodipamide [M0011648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodixanol [27729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iodixanol [M0130699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoform [27748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iodoform [M0055992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodophors [596712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodophors [M0011665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoquinol [3435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iodoquinol [M0006424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoxamid [51471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iodoxamate [M0263291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioflupane I-123 [1426874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>123I-ioflupane [M0509567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioflupane [2571854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ioflupane [M0509566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iohexol [5956]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iohexol [M0011673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iomeprol [2606484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iomeprol [M0161850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopamidol [5966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iopamidol [M0011680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopanoic acid [5967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iopanoic Acid [M0011683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopentol [27779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iopentol [M0151714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iophendylate [5968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iophendylate [M0011684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopromide [27781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iopromide [M0115091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iota-carrageenan [2565488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iota-Carrageenan [M0003556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate [5970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iothalamate [M0011687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamate meglumine [5971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iothalamate Meglumine [M0011685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iothalamic acid [1546451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iothalamic Acid [M0011688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iotrolan [51474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iotrolan [M0103391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioversol [27792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ioversol [M0154765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate [5973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ioxaglate [M0011691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate meglumine [66895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ioxaglate Meglumine [M0011694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglate sodium [66896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ioxaglate Sodium [M0011695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxaglic acid [1426458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ioxaglic Acid [M0011693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ioxilan [27793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ioxilan [M0155895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipecac [M0011696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipilimumab [1094833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipilimumab [M000626138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate [5976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipodate [M0011700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate [5976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iopodate [M000638473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipodate sodium [9887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipodate Sodium [M0011701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipratropium [M0014399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipratropium Bromide [M0330049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipratropium Bromide Anhydrous [M0585403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ipratropium Bromide Monohydrate [M000638477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iprazochrome [51486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iprazochrome [M0054699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipriflavone [51487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ipriflavone [M0071058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iprindole [5979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iprindole [M0011703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iproniazid [5981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iproniazid [M0011704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan [2671061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iptacopan [M000768037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-N-Butyl-3-((2&apos;-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one [M000640706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irbesartan [M0216909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iridium [1311131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iridium [M0011709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irinotecan [M0147530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irinotecan Hydrochloride [M0398524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron [90176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron [M0011718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iron pentacarbonyl [M0051775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron protein succinylate [27823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iron protein succinylate [M0155218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sorbitex [27824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>citric acid, iron, sorbitol drug combination [M0051790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron succinyl milk protein complex [27825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iron succinyl protein complex [M000642789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron succinyl milk protein complex [27825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iron succinyl milk protein complex [M000642788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron(III)-Hydroxide Sucrose Complex [M000641030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ferric Oxide, Saccharated [M0051786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron-dextran complex [5992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron-Dextran Complex [M0011724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab [2282018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isatuximab [M000635520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab-irfc [2282019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarclisa [M000682658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isavuconazole [M0496090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazonium sulfate [1608321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isavuconazonium sulfate [M000605299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isethionic acid [1364896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isethionic Acid [M0011736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iso-sulfan blue [27863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iso-sulfan blue [M0084883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoaminile [27866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoaminile [M0056968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoamyl acetate [1368172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoamyl acetate [M0074029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoamyl cinnamate [2046779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoamyl cinnamate [M0518174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoamyl salicylate [1940006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoamyl salicylate [M0055534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoascorbic acid [1356145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoascorbic acid [M0046353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobornyl acetate [2398330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pichtosin [M0057553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobornyl acrylate [1603858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isobornyl acrylate [M0592490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobutane [1363040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isobutanes [M0003088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobutyl acetate [1603476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isobutyl acetate [M0117027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobutyl alcohol [1363048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isobutyl alcohol [M0120594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobutylene [2099712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isobutylene [M0051801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobutylparaben [1364296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isobutylparaben [M0445670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isobutyramide [1653517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isobutyramide [M0095740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isocarboxazid [M0011750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocetane [1987477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isocetane [M000642790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoceteth 20 [1368878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoceteth 20 [M0560715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole [27901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoconazole [M0074040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole nitrate [203157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoconazole nitrate [M0314185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocorynoxeine [2562547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>corynoxeine, (16E,20alpha)-isomer [M0323527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isodecyl alcohol [2361827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isodecyl alcohol [M0552369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine [6023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoetharine [M0011760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine mesylate [6024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoetharine Mesylate [M0011761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoeugenol [1363706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoeugenol [M0111440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoeugenyl acetate [2393779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methoxy-4-prop-1-enylphenyl acetate [M0352281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflupredone [1546449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>9-fluoroprednisolone [M0056879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflupredone acetate [1364586]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoflupredone acetate [M0180323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoflurane [M0011763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurophate [6027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoflurophate [M0011764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isolan [1807442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isolan [M0051822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoleucine [6033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoleucine [M0011766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isomalt [1363717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D-Glucitol, 6-O-alpha-D-glucopyranosyl-, mixture with 1-O-alpha-D-glucopyranosyl-D-mannitol [M0066784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isomaltitol [2600777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isomaltitol [M0051824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isomaltulose [2607148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isomaltulose [M0051828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isomaltulose anhydrous [2607147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isomaltulose [M0051828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isometheptene [27946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isometheptene [M0051833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isomethyleugenol [1423782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isomethyleugenol [M0097858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoniazid [6038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoniazid [M0011772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopentane [1368703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopentane [M0183855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isophorone diisocyanate [2626882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isophorone diisocyanate [M0064461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoprene [1364275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoprene [M0046356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopropamide iodide [M0225328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropanolamine [1736006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monoisopropanolamine [M0052486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl acetate [1599636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopropyl acetate [M0189370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl alcohol [797541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-Propanol [M0029450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl myristate [27985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopropyl myristate [M0051850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl palmitate [1311179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopropyl palmitate [M0046357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl unoprostone [135313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopropyl unoprostone [M0196669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropylphenylbutanal [2383935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopropylphenylbutanal [M000627247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoproterenol [M0011781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoproterenol Hydrochloride [M0011782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoproterenol Sulfate [M0011783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopulegol [1314235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isopulegol [M0364827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isorhynchophylline [2562548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isorhyncophylline [M0149537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isosorbide [M0011786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isosorbide Dinitrate [M0011788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isosorbide-5-mononitrate [M0096187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isospaglumic acid [236303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isospaglumic acid [M0088582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isostearate [1424880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isostearate [M0121756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isostearic acid [1424879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isostearic acid [M0121757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isostearyl alcohol [1362928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isostearyl alcohol [M0086306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isothipendyl [28012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isothipendyl [M0051873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isothipendyl hydrochloride [235726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isothipendyl hydrochloride [M0540408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isotretinoin [M0023831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxaflutole [1371313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>isoxaflutole [M0372201]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoxsuprine [M0011809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isoxsuprine Hydrochloride [M0011810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ispaghula extract [82089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ispaghula [M0018071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ispaghula husk [104129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ispaghula husk [M000744203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Isradipine [M0026221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>istradefylline [2199015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>istradefylline [M0288908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Itraconazole [M0027131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ivabradine [M0234009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one [M000640894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ivacaftor [M0541284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ivermectin [M0011815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ivosidenib [M000643826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ixabepilone [M0473543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib [1723735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ixazomib [M000602996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixekizumab [1745099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ixekizumab [M0572546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jasmine oil [1309240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>jasmine oil [M0154736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jasmone [2557370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>jasmone [M0228787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jojoba wax [1309258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>jojoba wax [M0106871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin [6084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Josamycin [M0023921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin propionate [28069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>josamycin propionate [M0127809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jujube fruit extract [1424897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>jujube fruit [M000744364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>jujube seed extract [2106744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>jujube seed [M000744367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>juniper berry oil [1309245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>juniper berry oil [M0296339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>juniper tar [6086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>juniper tar [M0173197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kamala extract [28116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>kamala [M0045101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kanamycin A [M0011918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kanamycin [M0011917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kanamycin Sulfate [M0011919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kaolin [6102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kaolin [M0011925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Karaya Gum [M0011928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kebuzone [28198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>kebuzone [M0263311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>keracyanin [28165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>keracyanin [M0074046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kerosene [1311375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kerosene [M0011978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketamine [M0011982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketamine Hydrochloride [M0351823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketanserin [6131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketanserin [M0011983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketazolam [28181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ketazolam [M0042539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketoconazole [M0011987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketoprofen [M0011996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ketoprofen lysine [M0095125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac [35827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketorolac [M0112721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketorolac Tromethamine [M0140754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen [6146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketotifen [M0012002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen fumarate [11404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ketotifen Fumarate [M0361710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>khellin [6147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Khellin [M0012004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kinetin [16054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kinetin [M0047855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kininogenase [6095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kallikreins [M0011897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kojic acid [1426451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>kojic acid [M0058523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Labetalol [M0012098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Labetalol Hydrochloride [M0463248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lachesine [28381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lachesine [M0046409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lachesine chloride [103231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lachesine chloride [M0308900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacidipine [28382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lacidipine [M0167569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-benzyl-2-acetamido-3-methoxypropionamide [M000642505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lacosamide [M0356576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactase [41397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactase [M0180448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactate [114202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactate [M0028797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactic Acid [M0028796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid, D- [1742994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D-Lactic Acid [M0585514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid, L- [2462499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>L-Lactic Acid [M0585517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactitol [28395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lactitol [M0063325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacto-N-neotetraose [1733678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lacto-N-neotetraose [M0060568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobacillic acid [2002583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phytomonic acid [M0092142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobionate [1426414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lactobionate [M0047256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobionic acid [1426413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lactobionic acid [M0047257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactoferrin [1425933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactoferrin [M0012165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactoperoxidase [1310514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactoperoxidase [M0012176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactose [6211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactose [M0012177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactulose [M0012186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laidlomycin [1546426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>laidlomycin [M0055540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lamivudine [M0028682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lamotrigine [M0137818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanadelumab [2055641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanadelumab [M000627305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanatoside C [27929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanatoside C [M0070197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>landiolol [M0354483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanolin [6227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lanolin [M0012212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanosterol [1442199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lanosterol [M0012213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide [68092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanreotide [M0167728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide acetate [236167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanreotide acetate [M0324152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lansoprazole [M0583189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanthanum [1311070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lanthanum [M0012214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanthanum carbonate [234416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanthanum carbonate [M0305838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanthanum chloride [1596140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanthanum chloride [M0091719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanthanum oxide [1311114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lanthanum oxide [M0271388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib [480167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lapatinib [M0473129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib ditosylate [481474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lapatinib Ditosylate [M0473529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laponite [1314219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>laponite [M0516314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapyrium [28456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lapyrium [M0122338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lard [1857906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lard [M0093539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>larotrectinib [M000641197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lasalocid [1364397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lasalocid [M0012243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lasmiditan [2256930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lasmiditan [M0553297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost [43611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Latanoprost [M0195347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprostene bunod [1988390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>latanoprostene bunod [M000619618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latex [1314891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Latex [M0012254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-23 [1367165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyl tricosaoxyethylene glycol ether [M000638053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-4 [393540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetraethylene Glycol Dodecyl Ether [M000640730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-4 [393540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Laureth-4 [M000633317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-7 [1363566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Laureth-7 [M0589380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauric acid [1363435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauric acid [M0096079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauric acid diethanolamide [1363705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauric acid diethanolamide [M0148332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauric acid methyl ester [1362932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauric acid methyl ester [M0236774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laurocapram [1603852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>laurocapram [M0108100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauromacrogols [386055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lauromacrogol [M000622245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauroyl sarcosinate [1370618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauroyl sarcosine [M000623027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laurtrimonium [1427083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyltrimethylammonium [M0079409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laurtrimonium chloride [1427082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyl trimethyl ammonium chloride [M0314919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauryl PCA [1427202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauryl pidolate [M000749981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauryl PEG-PPG-18-18 methicone [1427186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauryl PEG-PPG-18-18 methicone [M0522945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauryl acetate [2175690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauryl acetate [M0129313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauryl lactate [2044274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eutanol G [M0113322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lauryl methacrylate [2586067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauryl methacrylate [M0537682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lavender oil [28486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lavender oil [M0132819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lazertinib [M000735045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide [M000735046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lead [6260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lead [M0012267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lead acetate [1423667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lead acetate [M0051957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lead carbonate [1545043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lead carbonate [M0127398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lead chloride [2534460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lead chloride [M0094995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lead sulfide [1549104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lead sulfide [M0069861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lead tetroxide [1593125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lead tetroxide [M0091362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab [2693758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lebrikizumab [M0561965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab-lbkz [2693778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lebrikizumab [M0561965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab [2626143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lecanemab [M000758827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab-irmb [2626142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lecanemab-irmb [M000767500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecithin [8214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lecithins [M0507090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ledipasvir [M0591686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lefamulin [M000648830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leflunomide [27169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leflunomide [M0132172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemborexant [2272403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lemborexant [M000655318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon oil [1309253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lemon oil [M0486115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lenacapavir [M000768395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lenalidomide [M0479831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>leniolisib [M000639685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenograstim [70167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lenograstim [M0219654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, lente, beef [M0423952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, lente, human [M0423953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, lente, pork [M0423954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lenvatinib [M0575909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib mesylate [1604346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lenvatinib mesylate [M000747066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lepirudin [M0222237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leptin [1441651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leptin [M0328567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lercanidipine [M0167715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lercanidipine hydrochloride [M0324284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lesinurad [1731031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lesinurad [M000600400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letermovir [1988648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>letermovir [M000594403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>letibotulinumtoxinA [M000768802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>letibotulinumtoxinA [M000768802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letosteine [28554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>letosteine [M0070262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letrozole [72965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Letrozole [M000640349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucine [6308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leucine [M0012372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucocyanidin [28574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>leucocyanidin [M0041767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leucovorin [M0004519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Citrovorum Factor [M0004520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leuprolide [M0025473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leuprolide Acetate [M0329431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetyl-L-leucine [M000634952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levacetylleucine [2375522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levacetylleucine [M000768789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol [237159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levalbuterol [M0359590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol hydrochloride [237160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levalbuterol Hydrochloride [M0359592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levallorphan [6370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levallorphan [M0012429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole [6371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levamisole [M0012431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole hydrochloride [227227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levamisole Hydrochloride [M0330203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine [2376944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levamlodipine [M0537995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levetiracetam [M0374035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol [1813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levobunolol [M0003033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol hydrochloride [227212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levobunolol Hydrochloride [M0350563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine [259453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levobupivacaine [M0452926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine hydrochloride [259454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levobupivacaine Hydrochloride [M0463378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine [28627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levocabastine [M0136782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine hydrochloride [1294532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levocabastine hydrochloride [M0322588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine [42955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levocarnitine [M000596392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine [356887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levocetirizine [M0446925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine dihydrochloride [402349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levocetirizine dihydrochloride [M0463380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levodopa [6375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levodopa [M0012434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levofloxacin [M0329513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levofloxacin Anhydrous [M0583083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin [877015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levoleucovorin [M0544494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate [1592257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>L-methyl folate [M000618790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levomefolate calcium [M0570045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-methyltetrahydrofolate [M0047916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolic acid [1025342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levomefolic acid [M000633337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levomepromazine maleate [M0069018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl [237005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levomethadyl [M0583179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl acetate hydrochloride [82043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levomethadyl Acetate Hydrochloride [M0013547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levomilnacipran [M0585166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levomilnacipran Hydrochloride [M000643426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corbadrine [M0013657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonorgestrel [6373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levonorgestrel [M0025734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levopropoxyphene [6377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levopropoxyphene [M0017769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levopropoxyphene napsylate [402519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levopropoxyphene Napsylate Hydrate [M000611936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levorphanol [M0012437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levorphanol Tartrate [M0012439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levosimendan [73107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levosimendan [M0206268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroxine [M0021504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Levothyroxine Sodium [M0373450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levulinic acid [6379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>levulinic acid [M0100761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>licorice [42769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycyrrhiza glabra extract [M000756821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidamidine [28701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lidamidine [M0075216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lidocaine [M0012483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lidocaine Hydrochloride [M0012489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidoflazine [6390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lidoflazine [M0012491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifileucel [2675860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lifileucel [M000767405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifitegrast [1801820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lifitegrast [M0588814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>light green SF yellowish [1305579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Light green SF [M0066615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ligustrazine [2676952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetramethylpyrazine [M0069117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>limonene [28730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Limonene [M0051997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>limonene oxide [1992035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>limonene-1,2-epoxide [M0092703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>limonene, (+)- [1426476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(+)-Limonene [M0310231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>limonene, (+/-)- [1426477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Limonene [M0051997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>limonene, (-)- [1426777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Limonene, (S)-isomer [M0310232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>linaclotide [M0514430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linagliptin [1100699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linagliptin [M0554626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linalool oxide [1941462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>linalool oxide [M000600266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linalool, (+-)- [1368896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>linalool, (+-)-isomer [M0313676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linalyl acetate [1735331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>linalyl acetate [M0201043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin [6398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lincomycin [M0012521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin hydrochloride [82036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lincomycin Hydrochloride [M0330077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lindane [M000641931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hexachlorocyclohexane [M0002334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linezolid [M0257529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linoleate [70611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linoleate [M0029359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linoleic acid [6400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linoleic Acid, (Z,Z)-Isomer [M0329094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linoleic acid [6400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linoleic Acid [M0029355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linoleic acids, conjugated [382272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linoleic Acids, Conjugated [M0444636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenate [595958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linolenate [M0027127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linolenic Acid [M000638649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linseed oil [6404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Linseed Oil [M0012533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>linzagolix [M000747709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liothyronine [M000640383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triiodothyronine [M0021977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liothyronine Sodium [M000640384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lipase [6406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lipase [M0012545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lipegfilgrastim [1440046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lipegfilgrastim [M0579965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liraglutide [475968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liraglutide [M0405743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine [700810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lisdexamfetamine [M0583181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine dimesylate [673579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lisdexamfetamine Dimesylate [M0502623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lisinopril [M0026771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisuride [6446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lisuride [M0012616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisuride maleate [6553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lisuride Maleate [M0330082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithium [M0012622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium acetate [52103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium acetate [M0471676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium bromide [1310187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium bromide [M0121619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithium Carbonate [M0025374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium chloride [1311533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithium Chloride [M0027208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium citrate [M0192307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium gluconate [52106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium gluconate [M0096888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide [1546376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium hydroxide [M0091594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium hydroxide monohydrate [M0317759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium orotate [M0066623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium succinate [28817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium succinate [M0115582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium sulfate [28818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lithium sulfate [M0152954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liver extract [6459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Extracts [M0012648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lixisenatide [M0549617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lobeline [6464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lobeline [M0012663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>locust bean gum extract [1424898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>locust bean gum [M0068235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lodoxamide [M0314600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lodoxamide tromethamine [M0077622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofepramine [6465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lofepramine [M0012673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofepramine hydrochloride [6294]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lofepramine Hydrochloride [M0330088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lofexidine [M0085278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lofexidine hydrochloride [M0316518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lomefloxacin [M0150494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lomefloxacin hydrochloride [M0323321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomifylline [164423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lomifylline [M0099100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lomitapide [M0545577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lomustine [M0012676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonafarnib [2467553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lonafarnib [M0297075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin [2569562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lonapegsomatropin [M000757894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin-tcgd [2569592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lonapegsomatropin-tcgd [M000767489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonazolac [28876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lonazolac [M0068239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonazolac calcium salt [52162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lonazolac calcium salt [M0313426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine [2540964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>loncastuximab tesirine [M000738749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine-lpyl [2540965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>loncastuximab tesirine-lpyl [M000767499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>long pepper extract [1364404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>long pepper extract [M000757535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loperamide [M0012692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loperamide Hydrochloride [M0330089]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lopinavir [M0558541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loprazolam mesylate [235846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triazulenone mesylate [M0314097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>loracarbef [M0154876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loratadine [28889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loratadine [M0026329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lorazepam [M0012696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin [1300701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lorcaserin [M0520419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lorlatinib [M000613649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lormetazepam [M0081520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lornoxicam [20890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lornoxicam [M0165390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Losartan [M0029400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Losartan Potassium [M0351838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loteprednol [M0424549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loteprednol Etabonate [M0174971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lotilaner [1998841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lotilaner [M000739426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loureirin B [2469244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>loureirin B [M0492267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lovastatin [M0012707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovotibeglogene autotemcel [2671958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lovotibeglogene autotemcel [M000767009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>low-density polyethylene [1426403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Low-Density Polyethylene [M0333842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loxapine [M0012711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loxapine Hydrochloride [M0583035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loxapine Succinate [M0330093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxoprofen [28908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>loxoprofen [M0120978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxoprofen sodium dihydrate [259486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate dihydrate [M0120976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lubiprostone [623033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lubiprostone [M0493211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lucinactant [1293254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lucinactant [M0487844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lufenuron [83586]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>fluphenacur [M0191651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>luliconazole [M0511591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lumacaftor [M0594275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumasiran [2467140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lumasiran [M000747190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone [2275602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lumateperone [M000732387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone tosylate [2275731]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lumateperone tosylate [M000732388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumbrokinase [2665339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lumbrokinase [M0221990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lumefantrine [M0267388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luprostiol [2583725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>luprostenol [M0142138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lurasidone [M0517365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lurasidone Hydrochloride [M000604584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lurbinectedin [M000636192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept [2262544]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>luspatercept [M000634232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept-aamt [2262543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>luspatercept-aamt [M000676599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lusutrombopag [M000622539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutein [11359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lutein [M0023055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luteinizing hormone [6383]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Luteinizing Hormone [M0012444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>177Lu-DOTA-octreotate [M000618700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lutetium Lu 177 dotatate [M0415931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pluvicto [M000620798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium [1534772]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lutetium [M0012765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lyapolate [29006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lyapolate [M0053259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lycopene [29008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lycopene [M0064500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lymecycline [6513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymecycline [M0012776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lymphocyte immune globulin, anti-thymocyte globulin [1011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antithymoglobulin [M0001465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lymphocyte immune globulin, anti-thymocyte globulin, equine [91601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine) [M0454797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lynestrenol [6529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lynestrenol [M0012829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lypressin [6531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lypressin [M0012831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lyral [1420141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyral [M0578060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine [6536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysine [M0012835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine acetate [6537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysine Acetate [M0330097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine clonixinate [78127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lysine clonixinate [M0099434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine hydrochloride [6538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysine Hydrochloride [M0330098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysophosphatidic acid [1793921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lysophosphatidic acid [M0102311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysozyme, chicken egg white [1426864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hen egg lysozyme [M0381192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>m-phenylenediamine [1435286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-phenylenediamine [M0052185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macelignan [1872381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>macelignan [M0486938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin [1999420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>macimorelin [M0586808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macimorelin acetate [1999419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>macimorelin acetate [M000675453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macitentan [1442132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>macitentan [M0527878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>madecassic acid [1551573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>madecassic acid [M0041940]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>madecassoside [87855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>madecassoside [M0246430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mafenide [M0012880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-Homosulfanilamide [M000642438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mafenide Acetate [M0012881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maftivimab [2461339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maftivimab [M000742071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maftivimab-ebgn [2461432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maftivimab-ebgn [M000767496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magaldrate [M0066636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesite [2475179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesite [M000633640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium [M0012884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium acetate [314718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium acetate [M000679485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium ascorbate [1311396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Ascorbate [M0001799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium ascorbyl phosphate [1425918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium ascorbate-2-phosphate [M0311542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Aspartate [M0330804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium carbonate [M0047042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chlorate [1605084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium chlorate [M0104574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Chloride [M0023974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium citrate [M0286260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Disodium EDTA [M0362591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium fluoride [1435860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium fluoride [M0098413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium gluconate [M0096889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium diglycinate [M0241413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Hydroxide [M0012887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium iodide [1992669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium iodide [M0497948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium lauryl sulfate [1489922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecyl sulfate, magnesium salt [M0317998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium nitrate [1362814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium nitrate [M0069716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium orotate [139233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium orotate [M0272863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Oxide [M0012888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium peroxide [1666106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium peroxide [M0506992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium phosphate [M0097125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium phosphate, dibasic [M0319020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, monobasic [1731599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium phosphate (2:1) [M0319019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium phosphate, tribasic, pentahydrate [M0578285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium pidolate [116240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Pidolate [M0018280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Salicylate [M0019364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium silicate [1310566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium silicate [M0046286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium stearate [1310567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium stearate [M0098168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Sulfate [M0012889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate heptahydrate [236741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Sulfate, Heptahydrate [M0330102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnesium trisilicate [M0041943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium valproate [134422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Valproate [M0022505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnolol [2562549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>magnolol [M0047073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malachite green [896038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>malachite green [M0046422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malathion [6606]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malathion [M0012917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maleate [1426331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maleate [M0095871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maleic acid [1426330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maleic acid [M0095873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maleic anhydride [1362876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maleic Anhydride [M0012925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malic acid [29209]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>malic acid [M0095933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malondialdehyde [1657018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malondialdehyde [M0012949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltitol [1363049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maltitol [M0056494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltobionate [2605591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maltobionate [M0049792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltobionic acid [2605590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maltobionic acid [M000638735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltodextrin [1363050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maltodextrin [M0052045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltol [1362894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maltol [M0052047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltose [1311261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maltose [M0012956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maltotetraose [2641823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maltotetraose [M0054853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malvin [1309703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>malvin [M0487711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mandarin oil [1305716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mandarin oil [M000768543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mandelic acid [29256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mandelic acid [M0114477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangafodipir [236987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mangafodipir [M0473859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangafodipir trisodium, anhydrous [221119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mangafodipir trisodium, anhydrous [M0443226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese [6623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Manganese [M0012987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese carbonate [1314366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese carbonate [M0131869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese chloride [M0084556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese dioxide [29263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese dioxide [M0066648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese gluconate [M0096890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese oxide [M0089161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hausmannite [M000644446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese phosphate [1313302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese phosphate [M0360171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese sulfate [29268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manganese sulfate [M0118909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangiferin [1362895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mangiferin [M0061463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango bark extract [1925438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mangifera indica bark [M000745669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango bark extract [1925438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mangifera indica extract [M0486009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mango extract [1426332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mango extract [M000755687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mangostin [2619910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mangostin [M0075503]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manidipine [M0153214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>manidipine dihydrochloride [M0323452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mannitol [M0012995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannose [6633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mannose [M0013001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maprotiline [M0013021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maprotiline Hydrochloride [M0330109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maprotiline Mesylate [M0330110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat [2571074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maralixibat [M000757784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maraviroc [620216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maraviroc [M0493371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marbofloxacin [69256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>marbofloxacin [M0214511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margaric acid [1987137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>margaric acid [M0060611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab [2473851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>margetuximab [M000630868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maribavir [2586068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maribavir [M0350667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maritime pine extract [1368708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pycnogenols [M0081987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maropitant [715869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maropitant [M0507934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maropitant citrate [818233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>maropitant citrate [M0507935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab [2697133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>marstacimab [M000678219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>masoprocol [227239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Masoprocol [M0014961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>matrine [2049547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Matrine [M0105670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mavacamten [M000644816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mavorixafor [M0546508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mazindol [M0013149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meadowfoam oil [1309256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meadowfoam oil [M0503971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mebendazole [M0013158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebeverine [29410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mebeverine [M0046424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebeverine hydrochloride [235827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mebeverine hydrochloride [M0308913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebhydrolin napadisylate [22822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diazoline [M0084026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebhydroline [29411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mebhydroline [M0046467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebrofenin [1311500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mebrofenin [M000744450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mecamylamine [M0013160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecasermin [274403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mecasermin [M0337463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mechlorethamine [M0013168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mechlorethamine Hydrochloride [M0013174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclizine [M0013180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclizine Hydrochloride [M0013182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclocycline [29418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meclocycline [M0262717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclocycline sulfosalicylate [203162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meclocycline sulfosalicylate [M0430314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclofenamate [M0473864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclofenamate Sodium [M000623543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamic acid [6678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclofenamic Acid [M0013184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenoxate [2228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclofenoxate [M0003816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenoxate hydrochloride [236572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meclofenoxate Hydrochloride [M0424109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mecobalamin [M0071953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecysteine [29426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mecysteine [M0068308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecysteine hydrochloride [235828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mecysteine hydrochloride [M0313443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medazepam [M0013187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medetomidine [52016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medetomidine [M0140434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medetomidine hydrochloride [29428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medetomidine Hydrochloride [M0333581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medifoxamine [29434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>medifoxamine [M0105224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medifoxamine fumarate [236781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>medifoxamine fumarate [M0319991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medigoxin [6686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medigoxin [M0013272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrogestone [6690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medrogestone [M0013278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medroxyprogesterone [M0013279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medroxyprogesterone Acetate [M0026185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>medrysone [M0263316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mefenamic Acid [M0013283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenorex [29444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mefenorex [M0040574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenorex hydrochloride [236179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mefenorex hydrochloride [M0307435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine [6694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mefloquine [M0024162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine hydrochloride [82130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mefloquine Hydrochloride [M0024163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefruside [6696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mefruside [M0013288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Megestrol [M0013296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Megestrol Acetate [M0028721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine [6704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meglumine [M0013297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine antimoniate [319866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meglumine Antimoniate [M0428130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine antimoniate [319866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-Methylglucamine Antimonate [M000640802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine iodamide [29455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>iodamide meglumine [M000636961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine iodipamide [29456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meglumine iodipamide [M0049480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine iotroxinate [52527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meglumine iotroxinate [M0059368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine ioxithalamate [29459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meglumine ioxithalamate [M0041964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melamine [1603851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>melamine [M0058547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melarsomine [1012534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>melarsomine [M0205183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melarsomine dihydrochloride [1012533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>melarsomine dihydrochloride [M0473938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melatonin [6711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melatonin [M0013319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melengestrol [1537799]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melengestrol [M0013322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melengestrol acetate [1537798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melengestrol Acetate [M0013321]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melitracen [446248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>melitracene [M0046428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meloxicam [41493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meloxicam [M0180716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melphalan [M0013330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide [2531369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>melflufen [M0589708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide [2531369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>L-melphalanyl-p-L-fluorophenylalanine ethyl ester [M0462263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine [6719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Memantine [M0013333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine hydrochloride [236685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Memantine Hydrochloride [M0464878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol [29491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menadiol [M0081632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadione sodium bisulfite [52551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menadione Sodium Bisulfite [M0047743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menatetrenone [29495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menatetrenone [M0097218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menfegol [31575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menfegol [M0093443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menhaden oil [2467841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menhaden oil [M0103297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group A polysaccharide [29501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meningococcal group A polysaccharide [M0127318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meningococcal group C polysaccharide [29503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meningococcal group C polysaccharide [M0113838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol [6750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menthol [M0013417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol glucuronide [2704947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menthol glucuronide [M0131003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthyl acetate, (-)- [2048710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menthyl acetate [M000768544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate [107770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mepenzolate [M0424551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate bromide [52560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mepenzolate bromide [M0308917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meperidine [M0013427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meperidine Hydrochloride [M0330121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenesin [6755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mephenesin [M0013429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine [6756]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mephentermine [M0013430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephentermine sulfate [82042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mephentermine Sulfate [M0013431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mephenytoin [M0013432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mephobarbital [M0013433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol [29518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mepindolol [M0064522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mepirodipine [M0144623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine [6759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mepivacaine [M0013436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine hydrochloride [203185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mepivacaine Hydrochloride [M0330123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepolizumab [1720597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mepolizumab [M0397468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprednisone [29523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meprednisone [M0052100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meprobamate [M0013438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meptazinol [6761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meptazinol [M0013440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meptazinol hydrochloride [11347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meptazinol Hydrochloride [M0330124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequinol [15080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mequinol [M0054736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mequitazine [M0048135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meradimate [91324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menthyl anthranilate [M0370142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>merbromin [6762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Merbromin [M0013442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mercaptopurine [M0023263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercuric chloride [1311634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mercuric Chloride [M0013447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercuric cyanide [1311110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mercuric cyanide [M0119794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercuric iodide [1426941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mercuric iodide, red [M0085433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercuric oxide [29545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mercuric oxide [M0071938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercuric sulfate [1311475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mercuric sulfate [M0091523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercuric sulfide [1311278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cinnabar [M0105596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercurius solubilis preparation [1310193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mercurius solubilis [M000740086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercury [6769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mercury [M0013448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercury, ammoniated [29542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mercuric chloride, ammoniated [M0091529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meropenem [M0165499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid [M000641389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mersalyl [6774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mersalyl [M0013455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesalamine [M0029386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesna [44]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesna [M0023193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesoridazine [M0013483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesterolone [6781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesterolone [M0013486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mestranol [6782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mestranol [M0013488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesulfen [29584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mesulfen [M0058555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaclazepam [614654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metaclazepam [M0110854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaclazepam hydrochloride [29590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metaclazepam hydrochloride [M0481962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metacresol [1367170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-cresol [M0124405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaflumizone [1489918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metaflumizone [M0521041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metamizole sodium [1537943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noramidopyrine Methanesulfonate Sodium [M000638436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metanil yellow [1305576]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metanil yellow [M0046446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metaproterenol [M0015386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metaproterenol Sulfate [M0015385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metaraminol [M0013526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metaraminol Bitartrate [M0350574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metavanadate [596548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metavanadate [M0022509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metaxalone [M0057494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metergoline [6834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metergoline [M0013569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metformin [M0013535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metformin Hydrochloride [M000604093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine [155080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methacholine [M0024755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacholine chloride [40165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methacholine Chloride [M0024753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacrylate [1424906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methacrylates [M0013538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacrylic acid [1424905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methacrylic acid [M0052190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methacycline [6812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methacycline [M0013539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methadone [M0013541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methadone Hydrochloride [M0333590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadyl acetate [6814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methadyl Acetate [M0013546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methamphetamine [M0013551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methamphetamine Hydrochloride [M0013552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methampicillin [29629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methampicillin [M0046566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methampicillin sodium [273443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methampicillin, sodium salt [M0474168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandriol [6817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methandriol [M0013553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methandrostenolone [6818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methandrostenolone [M0013554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methane [2598120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methane [M0013556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methanesulfonic acid [1426387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methanesulfonic acid [M0133193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methanol [1310568]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methanol [M0000655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methantheline [M0224681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methantheline Bromide [M0224680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene [6822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methapyrilene [M0013559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methaqualone [6823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methaqualone [M0013560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metharbital [6825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metharbital [M0225297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methazolamide [M0013561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methdilazine [M0130254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methdilazine hydrochloride [M0322077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methenamine [M0013566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methenamine hippurate [M0057805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methenamine mandelate [M0079831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenolone [6833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methenolone [M0013568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenolone acetate [29653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methenolone acetate [M0103240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenolone enanthate [29654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methenolone enanthate [M0092246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin [2181306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methicillin [M0013570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methicillin Sodium [M0330129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methimazole [M0013573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methionine [6837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methionine [M0013575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methixene [29682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methixene [M0046452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methixene hydrochloride [258230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methixene hydrochloride [M0308923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methocarbamol [M0013584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital [6847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methohexital [M0013589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methohexital sodium [91185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methohexital Sodium [M0330134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methotrexate [M0013595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methotrexate Sodium [M0330136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methotrimeprazine [M0013597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxamine [6853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methoxamine [M0013598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxamine hydrochloride [203187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methoxamine Hydrochloride [M0350565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methoxsalen [M0013600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy PEG-22/dodecyl glycol polymer [1940007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methoxy PEG 22 dodecyl glycol copolymer [M0593980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy polyethylene glycol-epoetin beta [729596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methoxy polyethylene glycol-epoetin beta [M000613696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxychlor [2598123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methoxychlor [M0013601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyflurane [6857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methoxyflurane [M0013605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyisopropanol [2462502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-methoxy-2-propanol [M0308955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyphenamine [29704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methoxyphenamine [M0046501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxyphenamine hydrochloride [451944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methoxyphenamine hydrochloride [M0308936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-Methylscopolamine [M0029432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-Methylscopolamine Bromide [M0329031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-Methylscopolamine Nitrate [M0329033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methsuximide [M0263332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methyclothiazide [M0013609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 2-furoate [2384442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl 2-furoate [M000762081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 2-nonynoate [2384443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-nonynoic acid methyl ester [M0156883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 5-aminolevulinate [337068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl 5-aminolevulinate [M0451457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl abietate [2465733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl abietate [M0086961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl acrylate [1367155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl acrylate [M0109830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl anthranilate [29742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl anthranilate [M0116815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl benzoate [1314316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl benzoate [M0130179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl blue [2176448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methyl Blue [M0371167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl bromide [29746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl bromide [M0046604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl chloride [1305751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methyl Chloride [M0013610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl cinnamate [1367156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl cinnamate [M0084649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl dihydrojasmonate [1307050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyldihydrojasmonate [M0486840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl glucose [2174505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylglucoside, (alpha-D)-isomer [M0317107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl glucose dioleate [1421621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl glucose dioleate [M0589126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl heptine carbonate [1313237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl heptine carbonate [M0079779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl hydroxyurea [1665338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl hydroxyurea [M0068793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl isobutyl ketone [1362929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl isobutyl ketone [M0047019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl lactate [1310580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl lactate [M0091552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl methacrylate-glycol dimethacrylate crosspolymer [1312390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl methacrylate-glycol dimethacrylate crosspolymer [M0568494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl oleate [1734017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl oleate [M0047218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl orange [1551460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl orange [M0263223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl palmitate [1486520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl palmitate [M0071102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl paraoxon [1793922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylparaoxon [M0052363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl phenylacetate [2699422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl phenylacetate [M0083659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl ricinoleate [1541746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl ricinoleate [M0046637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl salicylate [M0102760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylal [2385338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethoxymethane [M0125672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium [29829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylbenzethonium [M0046444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium chloride [1796444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylbenzethonium chloride [M000609992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylcellulose [M0013620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldibromo glutaronitrile [1307044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,2-dibromo-2,4-dicyanobutane [M0118009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldiethanolamine [1371054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-methyldiethanolamine [M0052273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methyldopa [M0013626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate [6877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methyldopate [M0013627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylene Blue [M0013629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene chloride [1311537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylene Chloride [M0013630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene diphosphonate [29844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylene diphosphonate [M0089278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene glycol [1797646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylene glycol [M000596338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine [6883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylergonovine [M0013636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine maleate [84158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylergonovine Maleate [M0237343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylethyl ketone [1363708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylethyl ketone [M0046613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyleugenol [1368373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyleugenol [M0046616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylinositol [1435864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylinositol [M0505073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylinositol [1435864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pinitol [M0076997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylmethacrylate [29897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylmethacrylate [M0029998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone [29899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylnaltrexone [M0100795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone bromide [979111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naltrexone methylbromide [M0100792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnicotinate [29900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyl nicotinate [M0052354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylparaben [29903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylparaben [M0064549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylparaben sodium [1310557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylparaben, sodium salt [M0312799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylphenidate [M0013660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylphenidate Hydrochloride [M0351724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylprednisolone [M0013662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylprednisolone aceponate [M0209242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylprednisolone Acetate [M0040839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methylprednisolone sodium phosphate [M0064552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methylprednisolone Sodium Succinate [M0013666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylsulfonylmethane [23247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dimethyl sulfone [M0085668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methyltestosterone [M0013667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyprylon [6910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>methyprylon [M0224669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide [6911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methysergide [M0013673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide maleate [203190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methysergide Maleate [M0352828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metipranolol [M0021985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metoclopramide [M0013679]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metoclopramide Dihydrochloride [M0330027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metoclopramide Hydrochloride [M0330028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine [29950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metocurine [M0102459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine iodide [203206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metocurine iodide [M0102457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metolazone [M0013684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metomidate [1311585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metomidate [M0224678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metopimazine [29954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metopimazine [M0046673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metoprolol [M0013686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metoprolol Succinate [M0355564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metoprolol Tartrate [M0350812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metreleptin [1491625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metreleptin [M0372828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metrizamide [6920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metrizamide [M0013690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metronidazole [M0013695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>benzoylmetronidazole [M0108393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metronidazole Monohydrochloride [M000642439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metronidazole Hydrochloride [M0013696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metylperon [29961]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metylperon [M0052452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metylperon hydrochloride [289623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>metylperon hydrochloride [M0310342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrapone [6923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metyrapone [M0013712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metyrosine [M0329127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mevalonolactone [1442202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mevalonolactone [M0064561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mexiletine [M0013719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mexiletine Hydrochloride [M0013720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mezlocillin [M0013722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mezlocillin Sodium [M0351112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mianserin [M0013724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mianserin Hydrochloride [M0330033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mibefradil [M0167272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mibefradil Dihydrochloride [M0167270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mica [1362896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mica [M0058580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin [325887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Micafungin [M0414899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin sodium [487070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Micafungin Sodium [M000637200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Miconazole [M0013758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Miconazole Nitrate [M0330034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>microcrystalline cellulose [1000577]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>microcrystalline cellulose [M0284606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micronomicin [29996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>micronomicin [M0113544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Midazolam [M0013843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Midazolam Hydrochloride [M0353521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Midazolam Maleate [M0013846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>midecamycin [M0086944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>midecamycin diacetate [M0500082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Midodrine [M0013860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Midodrine Hydrochloride [M0352408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>midostaurin [M0165591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mifepristone [M0024116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat [2054252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>migalastat [M0238105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat hydrochloride [2054264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>migalastat hydrochloride [M0589389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglitol [30009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>miglitol [M0132575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglustat [402316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>miglustat [M0461235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milbemycin oxime [68730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>milbemycin oxime [M0211535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mild silver protein [30021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mild silver protein [M0040287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle extract [283579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>milk-thistle extract [M000744297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle fruit extract [284153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>milkthistle fruit [M000744298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle seed extract [259274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>milkthistle fruit [M000744298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Milnacipran [M0138607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Milnacipran Hydrochloride [M0481961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Milrinone [M0029839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Milrinone Lactate [M0029840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miltefosine [1494066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>miltefosine [M0117341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minaprine [30031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>minaprine [M0048328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minaprine hydrochloride [236400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>minaprine dihydrochloride [M0309456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minaxolone [1495077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>minaxolone [M0074100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil [6972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mineral Oil [M0013895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Minocycline [M0013912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Minocycline Hydrochloride [M0330036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Minoxidil [M0013916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>minoxidil sulfate [M000634815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>minoxidil sulfate ester [M0118275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mintlactone [1724822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mintlactone [M0364825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miocamycin [6985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Miocamycin [M0023981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen [1367839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mipomersen [M0524310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen sodium [1367838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mipomersen sodium [M0580908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mirabegron [M0510156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirdametinib [2705551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mirdametinib [M000752212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mirikizumab [M000735585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miristalkonium chloride [236394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zephiramine [M0047734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mirtazapine [M0107850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mirvetuximab soravtansine [M000617500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>misoprostol [42331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Misoprostol [M0025309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mitapivat [M000655787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat sulfate [2595574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mitapivat sulfate [M000755347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitobronitol [6996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mitobronitol [M0013936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mitomycin [M0013948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mitotane [M0013951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mitoxantrone [M0013954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mitoxantrone Hydrochloride [M0330040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mitoxantrone [M0013954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium [30077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mivacurium [M0141623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mivacurium chloride [52796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mivacurium Chloride [M0141622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mizolastine [61455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mizolastine [M0204949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib [2570736]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mobocertinib [M000754564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moclobemide [30121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moclobemide [M0106138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Benzhydrylsulfinylacetamide [M000640715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Modafinil [M0140282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modified fluid gelatins [52853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>modified fluid gelatins [M0085678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moexipril [M0162643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moexipril hydrochloride [M0397933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moexiprilat [M0165510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mofebutazone [30202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mofebutazone [M0042918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mofezolac [11469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mofezolac [M0155057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mogamulizumab [M0557771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab-kpkc [2054077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mogamulizumab-kpkc [M000677560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molasses [1307820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molasses [M0013982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molgramostim [70161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>molgramostim [M0219646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molidustat [2637535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>molidustat [M000613288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molindone [M0013989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molindone Hydrochloride [M0330042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molnupiravir [2587901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>molnupiravir [M000740325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molsidomine [7023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molsidomine [M0014003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molybdate ion [1546395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>molybdate ion [M0322080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molybdenum [7024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molybdenum [M0014004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molybdenum trichloride [2664834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>molybdenum trichloride [M000636864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib [2665204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide [M0542244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mometasone [M0424552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mometasone Furoate [M0152540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mometasone Furoate Monohydrate [M0398665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monensin [1368208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Monensin [M0014007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monensin sodium [2719468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Monensin Sodium [M0330043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium phosphate (K-H2PO4) [M0312117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobenzone [17145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monobenzone [M0048999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobutyl maleate [2001495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monobutyl maleate [M0509684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monoethyl fumarate [52882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl fumarate [M0169698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monofluorophosphate [52885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monofluorophosphate [M0060390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monomenthyl glutarate [1489548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monomenthyl glutarate [M0468707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monomethyl fumarate [1546433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monomethyl fumarate [M0496490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monooctanoin [30198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monooctanoin [M0084569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monoolein [1311678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monoolein [M0047848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monophosphoryl lipid A [1363051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monophosphoryl lipid A [M0139357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monosulfiram [30206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>monosulfiram [M0054875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>montelukast [M0247416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>montelukast sodium [M0326949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montmorrillonite [1425919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Montmorrillonite [M0002318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morantel [1368900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morantel [M0014057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morantel tartrate [1368899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morantel Tartrate [M0014058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morazone [30218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>morazone [M0054031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mordant yellow 10 [2567331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mordant Yellow 10 [M0464224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moricizine [M0024900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moricizine Hydrochloride [M0333637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morniflumate [30225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>morniflumate [M0090196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moroxydine [30227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moroxydine [M0046694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moroxydine hydrochloride [1291996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moroxydine monohydrochloride [M0308974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morphine [M0014064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Morphine Sulfate [M0014066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morpholine [1368870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>morpholine [M0113608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosapride [135091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mosapride [M0173454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxalactam [7069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moxalactam [M0014142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxaverine [52918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moxaverine [M0045568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxaverine hydrochloride [236673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moxaverine hydrochloride [M0308604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox [2099295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>immunotoxin HA22 [M0537316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox-tdfk [2099305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moxetumomab pasudotox-tdfk [M000668452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxidectin [1047072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moxidectin [M0317480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moxifloxacin [M0273433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moxifloxacin Hydrochloride [M0273432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxisylyte [10561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moxisylyte [M0021466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxonidine [30257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>moxonidine [M0127943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mucins [7076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucins [M0014159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mucopolysaccharide polysulfate [30320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mucopolysaccharide polysulfate [M0149548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mumps virus [1426911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mumps virus [M0014204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mupirocin [M0025454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonic Acid [M000642441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mupirocin Calcium [M000642442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muramidase [7094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muramidase [M0014214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muromonab-CD3 [M0025653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muscone [1606471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>muscone [M0097774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>musk ketone [1438530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>musk ketone [M0098790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>musk xylene [1921875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>musk xylene [M0098786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mustard oil [1360631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>mustard oil [M0090057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycophenolate Mofetil [M0174120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycophenolate Mofetil Hydrochloride [M0443227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycophenolate Sodium [M0556402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycophenolic Acid [M0014304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myo-inositol trispyrophosphate [1791813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myo-inositol trispyrophosphate [M0505851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myrcene [2166047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myrcene [M0497184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myricetin [1368374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myricetin [M0119385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myristate [1313976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myristate [M0029412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myristic acid [1356758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myristic Acid [M0029411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myristyl alcohol [1362897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myristyl alcohol [M0075264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myristyl lactate [1363720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myristyl lactate [M0185360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myristyl nicotinate [1425406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myristyl nicotinate [M0497260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myrrh extract [67257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myrrh resin [M0593165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myrrh oil [1309206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myrrh oil [M0062396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myrtecaine [59082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myrtecaine [M0058593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>myrtol [174965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>myrtol [M0156528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>n-butyl acrylate [1313770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-butyl acrylate [M0101399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>n-butyl lactate [1435572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-butyl lactate [M0296239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>n-decyl alcohol [1363052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-decyl alcohol [M0093718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>n-dodecane [1314271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-dodecane [M0050817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>n-tris((hydroxymethyl)methyl)-3-aminopropanesulfonic acid [2584542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid [M0487672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nabilone [M0058596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nabumetone [M0109014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec [2644436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nadofaragene firadenovec [M000769158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec-vncg [2644435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nadofaragene firadenovec [M000769158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nadolol [M0014411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol [31462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nadoxolol [M0048342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol hydrochloride [236178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nadoxolol hydrochloride [M0309460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nadroparin [M0026848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nafarelin [M0026219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nafarelin Acetate [M0329373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nafcillin [M0014418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nafcillin Sodium [M0330054]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafronyl [7236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nafronyl [M0014423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafronyloxalate [7237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nafronyloxalate [M0014424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftazone [31475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naftazone [M0046701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine [31476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naftifine [M0093247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine hydrochloride [91293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naftifine hydrochloride [M0093245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nalbuphine [M0014433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nalbuphine Hydrochloride [M0330056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine [1876597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naldemedine [M000633339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nalidixic Acid [M0014437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nalmefene [M0116997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nalmefene hydrochloride [M0321111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol [1551777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naloxegol [M000595327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naloxone [M0014441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naloxone Hydrochloride [M0330064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naltrexone [M0014445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naltrexone Hydrochloride [M0462922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nandrolone [M0014452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>19-Nortestosterone Decanoate [M000641026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nandrolone Decanoate [M0044317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate [M000641027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nandrolone phenpropionate [M0052553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naphazoline [M0014455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naphazoline Hydrochloride [M0330068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naphazoline Nitrate [M0462902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphtha [1923814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naphtha [M0045647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphthalene [1311149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naphthalene [M0099457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphtho(2,1-b)furan [2557371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naphtho(2,1-b)furan [M0202672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphthoquine [1721293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naphthoquine [M000639689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naproxen [M0014467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Naproxen Sodium [M0582735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>narasin [1314370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>narasin [M0061498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naratriptan [M0278097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naratriptan hydrochloride [M0327812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naringenin [1368173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naringenin [M0046705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naringin [31538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naringin [M0046707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naringin sodium [236396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naringin sodium [M0463291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Natalizumab [M0443607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Natamycin [M0016866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nateglinide [M0353981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine [M000641343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nattokinase [53553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nattokinase [M0152203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natural graphite [90249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graphite [M0009618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naxitamab [2474039]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naxitamab [M000750602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naxitamab-gqgk [2474235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>naxitamab-gqgk [M000767502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol [31555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nebivolol [M0149652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol hydrochloride [236883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nebivolol Hydrochloride [M0476683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>necitumumab [1723738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>necitumumab [M0520260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil [31563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nedocromil [M0026945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil sodium [266663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nedocromil Sodium [M0329237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedosiran [2675287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nedosiran [M000758073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nefazodone [M0147142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nefazodone hydrochloride [M0323136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefopam [7285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nefopam [M0014549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefopam hydrochloride [4324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nefopam Hydrochloride [M0014548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nelarabine [M0359430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nelfinavir [M0029531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir mesylate [266565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nelfinavir Mesylate [M0329047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nemolizumab [M000628116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab-ilto [2691309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nemolizumab [M000628116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neodymium [1311480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neodymium [M0014563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neodymium oxide [1311107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neodymium oxide [M0491488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neohesperidin dihydrochalcone [1312741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neohesperidin dihydrochalcone [M0061501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neomycin [M0014565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neomycin Sulfate [M0014566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neon [7301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neon [M0014567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neostigmine [M0014615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neostigmine Bromide [M0351163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neostigmine Methylsulfate [M0014616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neotame [1367111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neotame [M0357909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nepafenac [298665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nepafenac [M0370991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neral [1484865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neral [M0309827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neratinib [M0543872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib maleate [1940642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neratinib maleate [M000677561]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerol [2274605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nerol [M0051260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerolidol [2371699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nerolidol [M0112379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerve growth factor [7327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nerve Growth Factor [M0328210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neryl acetate [2395766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>geraniol acetate, (Z)-isomer [M0321480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Natriuretic Peptide, Brain [M0029829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>netarsudil [M000639151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Netilmicin [M0014673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Netilmicin Sulfate [M0014674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netupitant [1552337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>netupitant [M0496224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neurotensin [2590652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurotensin [M0014773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neurotrophin 3 [1363714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurotrophin 3 [M0328215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neurotrophin 4 [1426704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>neurotrophin 4 [M0199703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nevirapine [M0029429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nevirapine Hemihydrate [M0592535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>new coccine [1364276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ponceau 4R [M0052594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niacin [M0014807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niacinamide [M0014833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nialamide [7394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nialamide [M0014817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niaprazine [31722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>niaprazine [M0075521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicarbazin [1311583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicarbazin [M0014819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicardipine [M0014820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicardipine Hydrochloride [M0463037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicergoline [7398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicergoline [M0014823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel [1311629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nickel [M0014825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel acetate [1313176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nickel acetate [M0305999]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel sulfate [31738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nickel sulfate [M0095105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nickel sulfate hexahydrate [1368214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nickel sulfate hexahydrate [M0318606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niclosamide [7402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niclosamide [M0014827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicoboxil [235788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nicoboxil [M0448607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicofuranose [104486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nicofuranose [M0262724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicorandil [M0029846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide adenine dinucleotide (NAD) [1044975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>NAD [M0014403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide ribotide [2262276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicotinamide Mononucleotide [M0014835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicotine [M0014836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine bitartrate [1306107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicotine Bitartrate [M0014837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicotine Polacrilex [M0148788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nicotinic acid benzyl ester [M0085275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinuric acid [1994363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nicotinuric acid [M0043075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinyl alcohol [7414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nicotinyl Alcohol [M0014841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nifedipine [M0014847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niflumic acid [7418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niflumic Acid [M0014850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifuratel [7419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nifuratel [M0014851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifuroxazide [31782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nifuroxazide [M0060690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifurpipone [1311582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nifurpipone [M0262727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifurtimox [7421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nifurtimox [M0014852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifurzide [31786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nifurzide [M0095082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nikethamide [7424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nikethamide [M0014858]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nilotinib [M0482811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nilotinib hydrochloride anhydrous [M000754508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nilotinib hydrochloride hydrate [M0557041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilutamide [31805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nilutamide [M0075929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nilvadipine [M0107753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimesulide [53694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nimesulide [M0059866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nimodipine [M0014859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimorazole [7427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nimorazole [M0014861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nintedanib [M0549010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib esylate [1592736]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nintedanib esylate [M0579827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niobium [1426867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niobium [M0014863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>niraparib [M0541827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirmatrelvir [2587892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nirmatrelvir [M000750527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nirogacestat [M000734587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirsevimab [2642401]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nirsevimab [M000737307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nisoldipine [M0024120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitarsone [1311555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nitarsone [M0064597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nitazoxanide [M0123653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitenpyram [341379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nitenpyram [M0438113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nitisinone [M0207118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrazepam [M0014875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrendipine [7441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrendipine [M0014876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric acid [1311391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitric Acid [M0027104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitric Oxide [M0014877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide synthase [2627243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitric Oxide Synthase [M0028375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide synthase type III [2627245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitric Oxide Synthase Type III [M0284725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrite ion [1546424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrites [M0014884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrocellulose [1425879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrocellulose [M0004801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrofurantoin [M0014893]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrofurantoin, Monohydrate [M0329960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrofurazone [M0014896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrogen [7456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrogen [M0014897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitroglycerin [M0009426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trinitrin [M0009430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroprusside [7476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitroprusside [M0014916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrous oxide [7486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nitrous Oxide [M0014927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroxoline [31901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nitroxoline [M0046773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nivolumab [M0585694]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nizatidine [M0025273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noggin, human [1858662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>NOG protein, human [M0439735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nomegestrol [31930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nomegestrol [M0137481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nomegestrol acetate [53744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nomegestrol acetate [M0115853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nomifensine [7500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nomifensine [M0014947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nomifensine maleate [262302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nomifensine Maleate [M0353764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonanal [1314253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nonanal [M0052706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonathymulin [1946823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymic Factor, Circulating [M0021445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonivamide [31945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nonivamide [M0121593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonivamide [31945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vanillyl-N-nonylamide [M0047714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonoxynol, 4-sulfate, ammonium salt [1367076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nonoxynol, 4-Sulfate, Ammonium Salt [M0329328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonoxynol-9 [53750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nonoxynol-9 [M0026039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonylphenol [1591892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nonylphenol [M0084412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nordazepam [3155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nordazepam [M0005804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norelgestromin [M0417269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norepinephrine [M0014964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norepinephrine Bitartrate [M0329978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethandrolone [7513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norethandrolone [M0014968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norethindrone [M0014969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norethindrone Acetate [M0082292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norethindrone enanthate [M0082450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norethynodrel [M0014977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfenefrine [31988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norfenefrine [M0046779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfenefrine hydrochloride [236468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norfenefrine hydrochloride [M0309006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norfloxacin [M0014980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norflurane [1311560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norflurane [M0174110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>norgestimate [M0068439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrel [7518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norgestrel [M0014981]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrienone [7519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Norgestrienone [M0014986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>normethadone [32009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>normethadone [M0047649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nortriptyline [M0015002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nortriptyline Hydrochloride [M0350572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noscapine [7533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noscapine [M0015008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>novobiocin [7538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Novobiocin [M0015020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>novobiocin sodium [82057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Novobiocin Sodium [M0329989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noxythiolin [7543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noxythiolin [M0015024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nuciferine [2667817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nuciferine [M0052757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nusinersen [1863556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nusinersen [M000597138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nylidrin [M0015132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nylidrin Hydrochloride [M0015133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylon 12 [1358484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nylon 12 [M0110520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nystatin [M0015146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystose [2590651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>nystose [M0128197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>o-cymen-5-ol [1364387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>o-cymen-5-ol [M0500704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>o-phenanthroline [1872047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,10-phenanthroline [M0084304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>o-phthalaldehyde [7602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>o-Phthalaldehyde [M0015158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>o-toluenesulfonamide [2049864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-toluenesulfonamide [M0060966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>o-xylene [1313248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-xylene [M0086127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obeticholic acid [1798288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>obeticholic acid [M0437911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obidoxime [42826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obidoxime [M0015163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obidoxime chloride [7605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obidoxime Chloride [M0015162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obiltoxaximab [1746906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>obiltoxaximab [M000622268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obinutuzumab [974779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>obinutuzumab [M0582537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obinutuzumab [974779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>afutuzumab [M000655147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oclacitinib [1487006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oclacitinib [M0593865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab [1876366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ocrelizumab [M0527347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocriplasmin [29998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>microplasmin [M0154009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octadecane [1790648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octadecane [M0079514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octadecenedioic acid [1427184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octadecenedioic acid [M0520994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octadecyl palmitate [1494196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octadecyl palmitate [M0094011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octadecyl trimethyl ammonium chloride [1426372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octadecyl trimethyl ammonium chloride [M0513483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octadecyltrimethylammonium [1426373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octadecyltrimethylammonium [M0501199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octanoic acid [20178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octanoic acid [M0098908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octenidine [2119240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octenidine [M0105602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octenidine hydrochloride [2119239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octenidine hydrochloride [M0320024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octenyl succinate [1442197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octenyl succinate [M0091623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octinoxate [13369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octylmethoxycinnamate [M0303849]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octinoxate [13369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethylhexyl methoxycinnamate [M0505683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octisalate [91327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-ethylhexyl salicylate [M0270415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octocrylene [77674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octocrylene [M0234633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octodrine [236867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octodrine [M000653342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Octopamine [M0014995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octotropine methylbromide [M0263119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octoxynol [32301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Octoxynol [M0026938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octoxynol-9 [54034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Octoxynol-9 [M0026939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Octreotide [M0023526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Octreotide Acetate [M0329524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octyl acetate [2048711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octyl acetate [M0165939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octyl dodecanol [1367124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octyl dodecanol [M0427564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octyl triazone [1314657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octyl triazone [M0440093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octyldodecyl stearoyl stearate [1356148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octyldodecyl stearoyl stearate [M0427562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octylonium [32311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octylonium [M0062095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octyltriethoxysilane [1310586]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octyltriethoxysilane [M0503781]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odesivimab [2461340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>odesivimab [M000742074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odesivimab-ebgn [2461434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>odesivimab-ebgn [M000767504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat [2563966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>odevixibat [M000743972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofatumumab [712566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ofatumumab [M0519657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ofloxacin [M0023430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oil of garlic [1309210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>garlic oil [M0504711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oil of niaouli [1309375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niaouli oil [M0061370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oil of niaouli [1309375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oleogomenol [M0061371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaflur [2712235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olaflur [M0479677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olanzapine [M0204623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olanzapine Pamoate [M0535637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olaparib [M0537510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olaratumab [M000595454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleamide [2680311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleylamide [M0093787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleandomycin [7629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oleandomycin [M0015246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleanolic acid [1426254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oleanolic Acid [M0015248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleate [70616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oleate [M0028735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleic acid [7631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oleic Acid [M0028734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleth-3-phosphate [1314374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleth-3-phosphate [M0284377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleth-5 [1314375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleth-5 [M0284379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleuropein [2376830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleuropein [M0043494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleyl alcohol [1310603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleyl alcohol [M0055646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleyl oleate [1426427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleyl oleate [M0182557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleylamide [1368883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleylamide [M0093787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen [2701418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olezarsen [M000768666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine [2392230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oliceridine [M000632397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olipudase alfa [2610407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olipudase alfa [M000619347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olive leaf extract [435657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olive leaf extract [M000747787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olive oil [1309250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olive Oil [M000605827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olivine [1368210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olivine [M0106200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olmesartan [M0403284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olmesartan Medoxomil [M0257341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol [1546059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olodaterol [M0546842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine [135391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olopatadine [M0202081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine hydrochloride [236599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Olopatadine Hydrochloride [M0325753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olsalazine [M0101640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olsalazine sodium [M0319609]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olutasidenib [2623641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>olutasidenib [M000737791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine [1546446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cephalotaxine [M0041843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine mepesuccinate [27100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Homoharringtonine [M0041919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>omadacycline [M000598114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab [302379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Omalizumab [M0387411]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omaveloxolone [2631931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>omaveloxolone [M000682257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ombitasvir [M0594216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatty Acids, Omega-3 [M0023885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Omeprazole [M0015293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Omeprazole Magnesium [M0583258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Omeprazole Sodium [M0583257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag isopropyl [2612690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>omidenepag isopropyl [M000653526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole [32411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>omoconazole [M0144314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole mononitrate [134933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>omoconazole nitrate [M0322971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>onabotulinum toxin A [M000646223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec [2170226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>onasemnogene abeparvovec [M000767493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec-xioi [2170225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>onasemnogene abeparvovec-xioi [M000746487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ondansetron [M0026254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ondansetron Hydrochloride [M0329262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opicapone [2362167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>opicapone [M0546492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opipramol [7674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opipramol [M0015335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opipramol hydrochloride [82062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opipramol Hydrochloride [M0329996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opium [M0015344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oprelvekin [139994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oprelvekin [M0274767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orange oil [1309230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>orange oil [M0231129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orbifloxacin [995897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>orbifloxacin [M0250643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orgotein [32526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>orgotein [M0046546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>origanum oil [1308067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>origanum oil [M0093519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oritavancin [M0438261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orlistat [37925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-((3-Hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate [M000640701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orlistat [37925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Orlistat [M0155332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ormetoprim [32533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ormetoprim [M0262729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornidazole [7701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ornidazole [M0015428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornipressin [7703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ornipressin [M0015429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornithine [7704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,5-Diaminopentanoic Acid [M000642424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornithine [7704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ornithine [M0015430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornithine alpha-ketoglutarate [1482634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ornithine alpha-ketoglutarate [M0042601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornithine, (L)-isomer [314709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ornithine, (L)-Isomer [M000638480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornithylaspartate [32541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ornithylaspartate [M0043784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orotic acid [7712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Orotic Acid [M0015446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Orphenadrine [M0015454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Orphenadrine Citrate [M0015455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Orphenadrine Hydrochloride [M0329877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orthoclase [2593183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>orthoclase [M0065746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orthocresol [2266810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-cresol [M0105192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir [260101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oseltamivir [M0282076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir carboxylate [1546279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oseltamivir carboxylate [M0529581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osilodrostat [M0551461]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>osimertinib [M000603988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>osimertinib mesylate [M000757075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osmium [1311130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osmium [M0015491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ospemifene [M0305127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osteum [32559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>osteum [M0060740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osthol [1547630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>osthol [M0135014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>otilonium bromide [54216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>octylonium bromide [M0062092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ouabain [7762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ouabain [M0015582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovalbumin [1314593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovalbumin [M0015587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaceprol [28068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxaceprol [M0059388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxacillin [M0015618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxacillin Sodium [M0329879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxalate [1441660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxalates [M0015622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxalic acid [1427058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxalic Acid [M0029413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxaliplatin [M0095550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaloacetate [1661330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxaloacetate [M0029990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaloacetic acid [1661329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxaloacetic Acid [M0329072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxamniquine [7778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxamniquine [M0015634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxandrolone [M0015635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxantel [1871175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxantel [M0044456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxantel pamoate [1871176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxantel pamoate [M0112783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxaprozin [M0052829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxatomide [54236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxatomide [M0064632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxazepam [M0015637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxcarbazepine [M0109945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxeladin [32626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxeladin [M0047027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxeladin citrate [54239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxeladin citrate [M0309121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxerutins [67187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxerutin [M0047695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxetorone [32633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxetorone [M0058635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxetorone fumarate [54243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxetorone fumarate [M0058632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxfendazole [32634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxfendazole [M0057032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxibendazole [1009342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxibendazole [M0057526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxiconazole [M0077862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxiconazole nitrate [M0077860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxidronic acid [1546448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>hydroxymethanediphosphonic acid [M0093500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxilofrine [32639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxilofrine [M0085979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxilofrine hydrochloride [236554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxilofrine hydrochloride [M0316660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiracetam [32645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxiracetam [M0120871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxitropium [32649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxitropium [M0068480]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxitropium bromide [54270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxitropium bromide [M0068478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxolamine [32658]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxolamine [M0052842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxolamine citrate [59053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxolamine citrate [M0310441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxolinic acid [7798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxolinic Acid [M0015656]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxothiazolidinecarboxylic acid [1926836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-oxothiazolidine-4-carboxylic acid [M0094190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxprenolol [M0015659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxprenolol Hydrochloride [M0329900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>cholinophyllin [M0060158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gamma-Hydroxybutyrate [M0020114]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybenzone [32673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxybenzone [M0046741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxybutynin [M0046961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxybutynin hydrochloride [M0309102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxychlorosene [32680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxychlorosene [M0069365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxychlorosene sodium [221136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxychlorosene sodium [M0313580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxycodone [M0015664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxycodone Hydrochloride [M0329901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxycodone terephthalate [M0065750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyfedrine [7805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyfedrine [M0015670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxygen [M0015671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxymetazoline [M0015681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxymetazoline Hydrochloride [M0582451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxymetholone [M0015682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymethurea [2673587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carbamol [M0049715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxymorphone [M0015684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxymorphone Hydrochloride [M0352949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxypaeoniflora [2562550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxypaeoniflora [M0137375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxypertine [7815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxypertine [M0224683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyphenbutazone [7816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyphenbutazone [M0015686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyphencyclimine [32698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxyphencyclimine [M0262977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyphencyclimine hydrochloride [91164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxyphencyclimine hydrochloride [M0327386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyphenisatin [8136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyphenisatin [M0015688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyphenonium [7818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyphenonium [M0015691]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyphenonium bromide [42833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyphenonium Bromide [M0015692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxypolygelatine [32699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oxypolygelatine [M0043551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline [110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyquinoline [M0023266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline potassium sulfate (2:1) [266832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyquinoline Potassium Sulfate (2:1) [M0329510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxyquinoline sulfate [42836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxyquinoline Sulfate [M0329511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytetracycline [M0015698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytetracycline, Anhydrous [M0581119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytetracycline Calcium [M0015699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytetracycline Dihydrate [M000638481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytetracycline Hydrochloride [M0329915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin [7824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oxytocin [M0015703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ozanimod [M000618106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ozenoxacin [M000599022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozone [2289011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ozone [M0015711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-aminohippurate [42837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-Aminohippurate [M0015719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-anisaldehyde [1940008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-anisaldehyde [M0083631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-hydroxyamphetamine [7839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-Hydroxyamphetamine [M0015728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-menthane-3,8-diol [2385886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-menthane-3,8-diol [M0047569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>p-methylaminophenol sulfate [2625121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>p-Methylaminophenol sulfate [M0312397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paclitaxel [M0026156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel poliglumex [2473230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paclitaxel poliglumex [M0496577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Albumin-Bound Paclitaxel [M000602078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pacritinib [M0573950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>padimate A [1363712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>padimate A [M0062806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>padimate-O [32786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>padimate-O [M0124233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafolacianine [2586857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pafolacianine [M000753612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pafuramidine [718967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pafuramidine [M0504256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palbociclib [M0483974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palifermin [196319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palifermin [M0521761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paliperidone [M0211957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paliperidone Palmitate [M0546009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palivizumab [M0288015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palladium [1311279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palladium [M0015772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palm kernel oil [1309252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palm kernel oil [M000624739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palm oil [32809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palm Oil [M0123738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palmatine [1314367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palmatine [M0046941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palmidrol [2001986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palmidrol [M0047861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palmitate [1370621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palmitates [M0015777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palmitic acid [1426390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palmitic Acid [M0028750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palmitoleate [2475954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palmitoleate [M0052885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palmitoleic acid [2475955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palmitoleic acid [M0052886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palonosetron [M0221985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron [70561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one [M000642093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palonosetron hydrochloride [397405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palonosetron Hydrochloride [M0452615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palovarotene [2663954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Palovarotene [M0542895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamabrom [54365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pamabrom [M0190827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pamidronate [M0071565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pamidronate Disodium [M0313839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Hydroxy-3-aminopropane-1,1-diphosphonic acid [M000637083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panaxynol [2676953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>panaxynol [M0070178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancreatin [7880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatin [M0015807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium [7883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancuronium [M0015813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancuronium bromide [7884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancuronium Bromide [M0015814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pangamic acid [7886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pangamic acid [M0275348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panitumumab [263034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panitumumab [M0484911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat [1603350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panobinostat [M0540392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantethine [32863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pantethine [M0046963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>DL-panthenol [M000636967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>panthenol [M000623221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenyl ethyl ether [1356484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>panthenyl ethyl ether [M0121642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantolactone [1427237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pantolactone [M0046939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pantoprazole [M0177102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pantoprazole Sodium [M0397768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid [7891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pantothenic Acid [M0015824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papain [7892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Papain [M0015826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaveretum [7894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Papaveretum [M0015346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Papaverine [M0015830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>papaverine codecarboxylate [M0058643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Papaverine Hydrochloride [M0331238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>para-cresol [2467144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-cresol [M0101528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parachlorophenol [14982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-chlorophenol [M0093086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paraffin [7906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paraffin [M0015864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paraldehyde [7909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paraldehyde [M0015876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paramethadione [32894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paramethadione [M0047469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paramethasone [7910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paramethasone [M0015883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paramethasone acetate [32895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paramethasone acetate [M0100441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parasorbic acid [1998743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>parasorbic acid [M0046930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parathyroid Hormone [M0015931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parecoxib [279950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>parecoxib [M0364955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parecoxib sodium [279951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>parecoxib sodium [M0364956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paregoric [M0068594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pareptide [2619909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pareptide [M0082948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pargyline [7930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pargyline [M0015951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pargyline hydrochloride [82069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pargyline Hydrochloride [M0015952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paricalcitol [73710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paricalcitol [M0224873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paritaprevir [M000604260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>paritaprevir dihydrate [M000758137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>parnaparin [M0216081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paromomycin [M0015969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paromomycin Sulfate [M0015971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxetine [M0026386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxetine Hydrochloride [M0329211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxetine Hydrochloride Anhydrous [M0582617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxetine Hydrochloride Hemihydrate [M000638648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parthenium hysterophorus extract [1432796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parthenium hysterophorus extract [M0509385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parthenolide [32941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>parthenolide [M0043371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide [1364105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pasireotide [M0507457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>passiflora incarnata flowering top extract [1309979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Passiflora incarnata [M000609497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patent blue violet [32950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfan blue [M0052916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patent blue violet [32950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>patent blue V [M000633413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer [1716203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>patiromer [M000608356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran [2053490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>patisiran [M000617065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pazopanib [M0506157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peanut Oil [M000625851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pectin [32987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methoxypectin [M000640253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pefloxacin [M0023653]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pefloxacin Mesylate [M0331239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peg-8 distearate [1363622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peg-8 distearate [M0515885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegademase bovine [59768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegademase bovine [M0146358]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaptanib [498509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegaptanib [M0479289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaptanib sodium [594119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegaptanib sodium [M000597563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegaspargase [M0125979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegbovigrastim [1746487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegbovigrastim [M000655006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegcetacoplan [2557372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegcetacoplan [M000746697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim [338036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegfilgrastim [M0426131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginesatide [1248798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peginesatide [M0555240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peginterferon alfa-2a [M0263641]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peginterferon alfa-2b [M0374956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon beta-1a [1546168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peginterferon beta-1a [M0390176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegloticase [1011650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pegloticase [M0099035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase [2046360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegvaliase [M000645883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase-pqpz [2046361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegvaliase-pqpz [M000675439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pegvisomant [M0360672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pelargonic acid [2054104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pelargonic acid [M0052930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lambrolizumab [M000655068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pembrolizumab [M0586473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemetrexed [M0227083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemetrexed Disodium [M000603406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pemigatinib [M000731978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pemirolast [M0155363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pemirolast potassium salt [M0323588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemivibart [2677789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pemivibart [M000768208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemoline [M0016107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penbutolol [M0016117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penbutolol Sulfate [M0016118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>penciclovir [M0151646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penconazole [2593184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>penconazole [M0230655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penfluridol [7974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penfluridol [M0016119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillamine [M0016122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin G [M0016133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin G Benzathine [M0016138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin G Potassium [M0333926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin G Procaine [M0016139]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin G Sodium [M0016134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin V [M0016142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>penicillin V benzathine [M0065190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penicillin V Potassium [M0329812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicilloyl polylysine [2667743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>penicilloyl polylysine [M0043992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pennyroyal oil [1309213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pennyroyal oil [M0077863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penoxsulam [1482792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>penoxsulam [M0490289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>penpulimab [M000754562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentadecanoic acid [1987138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentadecanoic acid [M0300580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol [33055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentaerythritol [M0052946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) [1369405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) [M000635711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetranitrate [7992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentaerythritol Tetranitrate [M0016166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentagastrin [7993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentagastrin [M0016168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentamidine [M0016169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentamidine Isethionate [M0016170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentane [1311563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentane [M0103514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentastarch [816249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentastarch [M0514687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentazocine [M0016179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentazocine Hydrochloride [M0329815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentazocine Lactate [M0329814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate calcium trisodium [132879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentetate Calcium Trisodium [M0006872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate calcium trisodium [132879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ca-DTPA [M000638439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate zinc trisodium [408077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentetate Zinc Trisodium [M0006871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetic acid [3690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentetic Acid [M0006866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetreotide [69893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentetreotide [M0218093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentifylline [33086]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentifylline [M0051419]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentigide [1362920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pentigide [M0120080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentobarbital [M0016182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentobarbital Sodium [M0329816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentosan polysulfate [155046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentosan Polysulfate [M0016193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentosan polysulphate sodium [134413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentosan Polysulphate Sodium [M0016189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentostatin [M0023987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deoxycoformycin [M000642654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentoxifylline [M0016198]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentylenetetrazole [8015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pentylenetetrazole [M0016203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peoniflorin [2288155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peoniflorin [M0064660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint oil [33094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peppermint oil [M0064661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pepsin A [8016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pepsin A [M0016204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peptide-T [2644766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptide T [M0024099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peptones [8040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptones [M0016245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peracetic acid [2045732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peracetic Acid [M0016248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir [619693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>peramivir [M0494052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perampanel [M0549034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine [8042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perazine [M0016251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflenapent [2474632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perfluoropentane [M0052979]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflexane [1540828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perflexane [M0210692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflunafene [2462501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perfluorodecalin [M0052977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluorohexyloctane [2637547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perfluorohexyl-octan [M0303928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluoromethylcyclopentane [2048724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perfluoromethylcyclopentane [M0297611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluoromethyldecalin [1986868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perfluoromethyldecalin [M0113371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluorooctyl triethoxysilane [1312743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyltriethoxysilan [M0505918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluoroperhydrophenanthrene [1540875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perfluoroperhydrophenanthrene [M000637141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perflutren [283753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perflutren [M0126329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pergolide [M0016279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pergolide Mesylate [M0329825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perhexiline [8050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perhexiline [M0016281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perhexiline maleate [33169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perhexiline maleate [M0080750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>periciazine [M0224673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perillaldehyde [1426913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perillaldehyde [M0103490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perindopril [M0129811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perindopril tert-butylamine [M000750737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perindopril Erbumine [M0322048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perindoprilat [M0151553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perlite [1858075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perlite [M0044017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permanganate [1923815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>permanganate [M0140338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Permethrin [M0056353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peroxidase [1600930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peroxidase [M0014331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perphenazine [M0016378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>perphenazine enanthate [M0092045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertussis vaccine [8080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pertussis Vaccine [M0016424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab [1298944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pertuzumab [M0466011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>petrolatum [8091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Petrolatum [M0016435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pexidartinib [M000608730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib hydrochloride [2183103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pexidartinib hydrochloride [M000675742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phellodendrine [2622304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phellodendrine [M0212593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacemide [33253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenacemide [M0046910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacetin [8113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenacetin [M0016487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazocine [8119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenazocine [M0016492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazocine hydrobromide [104979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenazocine Hydrobromide [M0329828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenazopyridine [M0016493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenazopyridine Hydrochloride [M0474762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phendimetrazine [M0263376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phendimetrazine hydrochloride [M0327552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phendimetrazine tartrate [M0263372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenelzine [M0016502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenelzine Sulfate [M0351800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethicillin [33277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenethicillin [M0263003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethylamine [1309741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenethylamine [M0093420]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethylamine hydrochloride [1364287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenethylamine hydrochloride [M0318218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenformin [8129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenformin [M0016508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenindamine [M0046968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenindamine tartrate [M0309106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindione [8130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenindione [M0016509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheniramine [M0016510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pheniramine aminosalicylate [M0063524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheniramine Maleate [M0329832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenmetrazine [M0016512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenmetrazine Hydrochloride [M0331241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenobarbital [M0016514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital quinidine [54620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenobarbital quinidine [M0103773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenobarbital Sodium [M0331275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenol [33290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenol [M0029379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenolate sodium [1495317]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenolate Sodium [M0331242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenolphthalein [155122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenolphthalein [M0029852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenolsulfonphthalein [8141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenolsulfonphthalein [M0016521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoperidine [8143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenoperidine [M0016522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoperidine hydrochloride [106508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenoperidine Hydrochloride [M0329833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenothrin [33303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenothrin [M0048373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxyacetic acid [1426335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenoxyacetic acid [M0372200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenoxybenzamine [M0016529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenoxybenzamine Hydrochloride [M0016530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxyethanol [89552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenoxyethanol [M0046914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenprocoumon [M0016532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phensuximide [33309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phensuximide [M0262748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phentermine [M0016536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phentermine Hydrochloride [M0016537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phentolamine [M0016538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phentolamine Mesylate [M0016539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenyl salicylate [M0085946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl-n-tert-butylnitrone [2694077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenyl-N-tert-butylnitrone [M0093330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylacetaldehyde [1367159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylacetaldehyde [M0060768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylacetate [70619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylacetate [M0084149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylacetic acid [33332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylacetic acid [M0084151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine [8156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylalanine [M0016544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylbutazone [M0016548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutyrate [81647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-phenylbutyrate [M0204039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylephrine [M0016556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylephrine Hydrochloride [M0016557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylephrine Tannate [M0423770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylethyl alcohol [8126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylethyl Alcohol [M0016505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylethyl resorcinol [1313724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-(1-phenylethyl)-1,3-benzenediol [M0500701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylhydrazine [8167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylhydrazine [M0095935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylhydrazine hydrochloride [292726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylhydrazine hydrochloride [M0318821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylisothiocyanate [1368174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylisothiocyanate [M0046991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylmercuric acetate [1426778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylmercuric Acetate [M0016568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanol [2475178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-phenylpropanol [M0405079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylpropanolamine [M0016572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylpropanolamine Hydrochloride [M0016571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenyltoloxamine [M0053083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenytoin [M0016580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenytoin Sodium [M0016579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phloretin [1368167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phloretin [M0016612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phlorhizin [1362735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phlorhizin [M0016615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phloroglucinol [8196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phloroglucinol [M0016616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pholcodine [33431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pholcodine [M0053095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pholedrine [33432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pholedrine [M0047723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphatidylinositols [8217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phosphatidylinositols [M0016648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphite [1793924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phosphites [M0027051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphocellulose [33504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phosphocellulose [M0053118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphocysteamine [8226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phosphocysteamine [M0005531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phospholipase D1 [2608530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phospholipase D1 [M0278152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphonic acid [1427087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phosphonic acid [M0571030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphoramidic acid [1312381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phosphoramidic acid [M0057093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphoric acid [8259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phosphoric acid [M0095805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphorus 32 [258478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phosphorus-32 [M000627837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphorus [8263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phosphorus [M0016721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phosphorylcholine [2585444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phosphorylcholine [M0016734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phthalylsulfathiazole [33632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phthalylsulfathiazole [M0263391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Physostigmine [M0016815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>physostigmine salicylate [M0087468]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phytase [1043631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>6-Phytase [M0016817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phytic acid [8302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phytic Acid [M0016819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phytol [2046119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phytol [M0016825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phytosphingosine [1363444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>D-ribo-phytosphingosine [M0512232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phytosphingosine [1363444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phytosphingosine [M0059553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phytosterols [8310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phytosterols [M0016830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pibrentasvir [M000636260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picaridin [1737729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>picaridin [M0464174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picolinic acid [33684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>picolinic acid [M0096711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picosulfate sodium [33688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>picosulfate sodium [M0047418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picrate [1443000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>picrate [M0047674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picric acid [1320642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>picric acid [M0047676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picrotoxin [2539172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Picrotoxin [M0016843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pidotimod [40450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pidotimod [M0178639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat F-18 [2556616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(18F)DCFPyL [M0574278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat F-18 [2556616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid [M0574277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piflufolastat F-18 [2556616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>18F-JK-PSMA-7 [M000732947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pigment blue 16 [1999764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phthalocyanine [M0061585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piketoprofen [82910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piketoprofen [M0140278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pilocarpine [M0016860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pilocarpine Hydrochloride [M0331262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pilocarpine Nitrate [M0331261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimagedine [1311670]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimagedine [M0045554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimagedine hydrochloride [1311669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimagedine hydrochloride [M0308589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin [1791685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimavanserin [M0498685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin tartrate [1791686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimavanserin tartrate [M0529250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimecrolimus [M0301096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimethixene [33712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimethixene [M0045352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimobendan [1110783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pimobendan [M0123429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pimozide [M0016871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinacidil [33717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pinacidil [M0029848]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinaverium [33724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pinaverium [M0060791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinaverium bromide [54743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pinaverium bromide [M0060790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pindolol [M0016872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pioglitazone [M0168845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pioglitazone Hydrochloride [M0357823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipamperone [M0047214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipamperone dihydrochloride [M0309166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipazetate hydrochloride [236487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipazethate monohydrochloride [M0313053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipazethate [33740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipazethate [M0065813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium [33742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pipecuronium [M0026260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipecuronium bromide [66983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pipecuronium Bromide [M0026262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipemidic acid [8337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pipemidic Acid [M0016881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipenzolate [33743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipenzolate [M0045434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipenzolate bromide [202840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipenzolate bromide [M0308563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacetazine [8338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperacetazine [M0185262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperacillin [M0016883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperacillin Sodium [M0351116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperazine [M0107342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperazine adipate [M0047007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperazine citrate [M0049217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine dihydrochloride [2562175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperazine Dihydrochloride [M000637134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperazine Hexahydrate [M0320235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperazine Hydrate [M0320238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperazine Phosphate [M0320239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperazine Sulfate [M0320240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate [59064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperidolate [M0055684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperidolate hydrochloride [102170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperidolate hydrochloride [M0311092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperine [1311146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperine [M0053196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperocaine [33752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperocaine [M0079803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonal [33753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piperonal [M0047010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonyl butoxide [8345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piperonyl Butoxide [M0016887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pipobroman [M0016890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipothiazine [M0225190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipothiazine palmitate [M0224740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipoxolan [33758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pipoxolan [M0040125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piprozoline [33761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piprozoline [M0044132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piracetam [8351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piracetam [M0016891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirarubicin [33764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirarubicin [M0088759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol [33767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirbuterol [M0053542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol acetate [221142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirbuterol acetate [M0310597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenoxine [228080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirenoxine [M0045705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pirenzepine [M0016894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piretanide [33770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piretanide [M0064705]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirfenidone [1592254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirfenidone [M0247347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil [8353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piribedil [M0016896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil mesylate [236380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piribedil Mesylate [M0329862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirinitramide [8354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pirinitramide [M0016897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirlimycin [1367292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirlimycin [M0105291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroctone olamine [33783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piroctone olamine [M0149235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Piroxicam [M0016899]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piroxicam cinnamate [M0160368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>piroxicam-beta-cyclodextrin [M0169417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pirtobrutinib [M000758060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pitavastatin [M0422150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pitavastatin lactone [M000620322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin calcium [861640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pitavastatin calcium [M000644827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pitolisant [M0506516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivalic acid [1426868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pivalic acid [M0047205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pivampicillin [M0016927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pivampicillin Hydrochloride [M0351120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivmecillinam hydrochloride [102745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pivmecillinam Hydrochloride [M0475062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pizotyline [8373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pizotyline [M0016929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plant stanol ester [259320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>plant stanol ester [M0361357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasma protein fraction [33835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>plasma protein fraction [M0053214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasmin [4388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibrinolysin [M0008432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>platelet glycoprotein VI [2637677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>platelet membrane glycoprotein VI [M0258349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>platinic chloride [1549109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>platinic chloride [M0452057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>platinum [1311280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Platinum [M0017026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>plazomicin [M0577850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>plecanatide [M0589195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plerixafor [733003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>plerixafor [M0544665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plicamycin [M0013935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plutonium [1600135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plutonium [M0017052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podofilox [8463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Podophyllotoxin [M0017087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podophyllin [8462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Podophyllin [M0017086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polaprezinc [M0171658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin [2174090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polatuzumab vedotin [M000609223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin-piiq [2174091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polatuzumab vedotin [M000609223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poldine [33926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poldine [M0263377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poldine methylsulfate [33927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poldine methylsulfate [M0096976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>policosanol [69440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>policosanol [M0215534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>policresulen [54908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>policresulen [M000613285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecylnonaoxyethylene glycol monoether [M0170384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polidocanol [M0053330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nonaethylene Glycol Monododecyl Ether [M000640724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetraethyleneglycol Lauryl Ether [M000640727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyoxyethylenedodecyl Ether [M000640726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Laureth-4 [M000633317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyoxyethylene-4-dodecyl Ether [M000640725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-Dodecyl-omega-hydroxypoly(oxy-1,2ethanediyl) [M000640728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidronium chloride [1426891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyquaternium 1 [M0163489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polihexanide [1373041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polihexanide [M0098301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polihexanide hydrochloride [1790898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polihexanide hydrochloride [M0098302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poliovirus [1427212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poliovirus [M0027120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poloxalene [1314414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poloxalene [M0017132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poloxamer 188 [155152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poloxamer 188 [M0030096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poloxamer 338 [1364384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poloxamer 338 [M0030093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poloxamer 407 [155155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poloxamer 407 [M0030099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poloxamer [155156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poloxamer [M0030100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poly(lactide) [1424562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poly(lactide) [M0104212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poly(sodium vinyl sulfonate) [52259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lyapolate sodium [M0053254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poly(sodium vinyl sulfonate) [52259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poly(sodium vinyl sulfonate) [M0588895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poly(vinylpyrrolidone-co-vinyl-acetate) [1311488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poly(vinylpyrrolidone-co-vinyl-acetate) [M0354712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyaminopropyl biguanide [1314381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyaminopropylbiguanide [M0177450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polybutester [2049679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polybutester [M0140324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polydatin [1364277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polydatin [M0162499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polydextrose [1363053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polydextrose [M0103576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyestradiol [M0078059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyestradiol phosphate [M0053249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 1000 [1368863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 1000 [M0017175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 2000 [1364383]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 2000 [M0017178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 2000 [1364383]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>PEG 2000 [M000759092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 300 [8513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 300 [M0017179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 3350 [M0527780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 400 [8514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 400 [M0017180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 4000 [1310594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 4000 [M0017181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 6000 [1314384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyethylene Glycol 6000 [M0017176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 8000 [1307312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyethylene glycol 8000 [M0017177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycols [8516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyethylene Glycols [M0017182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylenes [8519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyethylenes [M0017186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polygalacturonic acid [1918053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polygalacturonic acid [M0044159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polygeline [8521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polygeline [M0017190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyglyceryl-3 methylglucose distearate [2476007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyglyceryl-3-methylglucose-distearate [M0443333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyglyceryl-6 isostearate [2118918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyglyceryl-6 isostearate [M0525805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyglyceryl-6-dioleate [1431309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyglyceryl-6-dioleate [M0458992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyglycolic acid [2466981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyglycolic Acid [M0017195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polylactic acid-polyglycolic acid copolymer [1309726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polylactic Acid-Polyglycolic Acid Copolymer [M0127831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polylactic acid-polyglycolic acid copolymer [1309726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poly-L-lactic-polyglycolic Acid [M0578483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymetaphosphate [1364922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polymetaphosphate [M0053860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polymyxin B [M0017214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polymyxin B Sulfate [M0017213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polynoxylin [34188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polynoxylin [M0044167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyoxyethylene-24-cholesteryl ether [1362898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxyethylene-24-cholesteryl ether [M0102340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyoxyl 35 castor oil [1309246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxyl 35 castor oil [M000613560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyoxyl 40 stearate [1426432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxyethylene 40 stearate [M0518122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyquaternium-7 (70-30 acrylamide-DADMAC; 1600 kD) [1426394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyquaternium-7 [M0417750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysaccharide-K [1804843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polysaccharide-K [M0056531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysorbate 20 [8559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polysorbate 20 [M0017251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysorbate 40 [1367265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polysorbate 40 [M0187166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysorbate 80 [8560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polysorbate 80 [M0017252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysorbates [8561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polysorbates [M0017253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polystyrene sulfonate [1546437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polystyrene sulfonate [M0044353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polystyrene sulfonic acid [1546436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polystyrene sulfonic acid [M0044355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysulfated glycosaminoglycan [1085955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycosaminoglycan polysulfate [M0061843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polytetrafluoroethylene [1358182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polytetrafluoroethylene [M0017264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polythiazide [M0017269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyvinyl acetate [1541597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyvinyl acetate [M0060809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyvinyl alcohol [8570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyvinyl Alcohol [M0017272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pomalidomide [M0441603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomegranate fruit extract [1246101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pomegranate [M0400768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomegranate fruit rind extract [1311658]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pomegranate fruit rind [M000742808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomiferin [2593691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pomiferin [M0450688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ponatinib [M0558593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib hydrochloride [1364953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ponatinib hydrochloride [M0588224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponazuril [298983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ponazuril [M0371914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponesimod [2532300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ponesimod [M0547425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pongamol [1426400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pongamol [M0527361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poractant alfa [236381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poractant alfa [M0467669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>porfimer sodium [333848]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porfimer Sodium [M0372990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>posaconazole [M0265888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posterior pituitary hormones [8366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pituitary Hormones, Posterior [M0016919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potash [1370422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potash [M0508255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium [8588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium [M0017374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Acetate [M0028800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Aminobenzoate [M0568283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ascorbyl tocopheryl phosphate [1427199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium ascorbyl tocopheryl phosphate [M0182814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aspartate [8589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Aspartate [M0330800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium azeloyl diglycinate [1366229]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium azeloyl diglycinate [M000630748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium benzoate [54991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Benzoate [M0002351]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium bicarbonate [M0086591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium bitartrate [M000768736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bromate [34298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium bromate [M0072049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bromide [34299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium bromide [M0117052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium carbonate [34300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium carbonate [M0113634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium cetyl phosphate [1367140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium cetyl phosphate [M0525809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chlorate [59203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium chlorate [M0079463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Chloride [M0017376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chromate(VI) [34303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium chromate(VI) [M0089032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Citrate [M0028812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate anhydrous [1374802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Citrate Anhydrous [M0329194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium cyanide [1923819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Cyanide [M0017377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium dichromate [8595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Dichromate [M0017379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium guaiacolsulfonate [91275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>guaiacolsulfonate potassium [M0061683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium hydroxide [34311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium hydroxide [M0095120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodate [34312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium iodate [M0118670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Iodide [M0017380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium laurate [1808535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauric acid, potassium salt [M0318825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium magnesium aspartate [1793925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Magnesium Aspartate [M0017384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium metabisulfite [1362899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium metabisulfite [M0046572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium nitrate [34316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium nitrate [M0081527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium nitrite [1365705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium nitrite [M0122652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium orotate [8602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Orotate [M0015447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium oxide [1599267]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium oxide [M0187193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium perchlorate [34318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium perchlorate [M0053367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium permanganate [8604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Permanganate [M0017385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phenethicillin [132907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium phenethicillin [M0263002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium phosphate [M0060816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium sodium tartrate [1311363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium potassium tartrate [M0524134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium sorbate [8606]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Potassium Sorbate [M0020166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium sulfate [34323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium sulfate [M0098949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium tartrate [55024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium tartrate [M0094757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium tellurite [1921888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium tellurate(IV) [M0087907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium thiocyanate [1427066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>potassium thiocyanate [M0055060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium triiodide [1376155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lugol&apos;s solution [M0055829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Povidone [M0017402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Povidone-Iodine [M0017404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Jeuveau [M000653717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>practolol [8620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Practolol [M0017428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pradofloxacin [1367269]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pradofloxacin [M0494206]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prajmaline [8622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prajmaline [M0017433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prajmalium bitartrate [236896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prajmalium Bitartrate [M0017434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>10-propargyl-10-deazaaminopterin [M0377231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pralatrexate [M0499331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pralidoxime [M0092337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pralidoxime chloride [M0317913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pralidoxime iodide [M0317918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pralidoxime mesylate [M0317910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralmorelin [1492039]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>growth hormone-releasing peptide-2 [M0242639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralsetinib [2394936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pralsetinib [M000677939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pramipexole [M0170120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-Amino-6-propylaminotetrahydrobenzothiazole [M000640807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole dihydrochloride [236747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pramipexole Dihydrochloride [M000640808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramiverine [190433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pramiverine [M0262765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pramlintide [M0274643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pramlintide acetate [M0446725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pramoxine [M0047166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pramoxine hydrochloride [M0309148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praseodymium [1311481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Praseodymium [M0017436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dehydroepiandrosterone [M0005765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel [613391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prasugrel [M0362841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasugrel hydrochloride [847020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prasugrel Hydrochloride [M000603803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pravastatin [M0025879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pravastatin Sodium [M0329324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prazepam [M0017437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Praziquantel [M0017438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prazosin [M0017441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prazosin Hydrochloride [M0544014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednazoline [168651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednazoline [M0124680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednicarbate [M0108246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednimustine [8637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prednimustine [M0017459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prednisolone [M0017460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone acetate [M0055043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone phosphate [M0053389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone sodium metasulphobenzoate [M0312118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone 21-3-sulfobenzoate [M0060819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone sodium phosphate [M0310547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone sodium succinate [M0076033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednisolone tebutate [M0053385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prednisone [M0017465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednylidene [12473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prednylidene [M0110615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregabalin [M0214473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregna-4,17-diene-3,16-dione [1088591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pregna-4,17-diene-3,16-dione [M0081057]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregnenolone [114052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnenolone [M0017516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prenylamine [8674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prenylamine [M0017547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prenylamine lactate [34407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prenylamine lactate [M0151091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pretomanid [2198359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pretomanid [M0366096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prezatide [1368533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycyl-histidyl-lysine [M0075195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pridinol [34479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pridinol [M0053665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pridinol monomesylate [55092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pridinol mesylate [M0310624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prifinium [236174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prifinium [M0443665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine [8686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prilocaine [M0017571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine hydrochloride [2557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prilocaine Hydrochloride [M0017570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primaquine [M0017573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primaquine Phosphate [M0017575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desoxyphenobarbital [M000642451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primidone [M0017580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primycin [2479689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>primycin [M0053415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pristinamycin [66958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pristinamycin [M0375364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Probenecid [M0017601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Probucol [M0017604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procainamide [M0017605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procainamide Hydrochloride [M0017608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procaine [M0017615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procaine Hydrochloride [M0475887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procarbazine [M0017616]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procarbazine Hydrochloride [M0331268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaterol [34530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procaterol [M0026203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaterol hydrochloride [58918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procaterol Hydrochloride [M0026207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prochlorperazine [M0017619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prochlorperazine Edisylate Salt [M0017620]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prochlorperazine Maleate [M0354121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyanidin A2 [2631026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>procyanidin A2 [M0538182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procyclidine [M0017638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Procyclidine Hydrochloride [M0475950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>profenamine [4134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>profenamine [M0225290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proflavine [8723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proflavine [M0017666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proflavine hemisulfate [8724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proflavine Hemisulfate [M0017667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>profluralin [2665290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>profluralin [M0089669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progabide [34568]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>progabide [M0069177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Progesterone [M0017672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proglumetacin [34769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proglumetacin [M0072058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proglumide [8730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proglumide [M0017675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil [2382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proguanil [M0004166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil hydrochloride [142428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proguanil Hydrochloride [M0004168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prolactin [1426890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prolactin [M0017689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prolinal [2569079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prolinal [M0133536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proline [8737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proline [M0017693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prolintane [34604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prolintane [M0047249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prolintane hydrochloride [235831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prolintane hydrochloride [M0309178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Promazine [M0017696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Promazine Hydrochloride [M0017698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promegestone [8744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Promegestone [M0017703]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promestriene [34625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>promestriene [M0061599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Promethazine [M0017706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Promethazine Hydrochloride [M0017709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propafenone [M0017736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propafenone Hydrochloride [M0352002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine [34633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propamidine [M0047180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine isethionate [34634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propamidine isethionate [M0135077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propane [1362877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propane [M0017740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propanidid [8758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propanidid [M0017743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propantheline [M0017746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propantheline Bromide [M0351182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine [34905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proxymetacaine [M0047456]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proparacaine hydrochloride [227778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proxymetacaine hydrochloride [M0309258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propentofylline [34644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propentofylline [M0100402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propicillin [34649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propicillin [M0262768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propicillin potassium [236615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propicillin potassium [M0476020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propinox [76273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propinox [M0231218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiolactone [1311565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propiolactone [M0017758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propiomazine [M0224690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propionaldehyde [2359273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propionaldehyde [M0047182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propionamide [1366667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propionamide [M0106698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propionate [121047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propionates [M0017759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propionic acid [34658]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propionic acid [M0094462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiverine [55175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propiverine [M0064951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiverine hydrochloride [55176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propiverine hydrochloride [M0312891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propofol [M0024130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propolis [8783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propolis [M0017766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dextropropoxyphene [M0017770]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propoxyphene Hydrochloride [M0353504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propoxyphene napsylate [M0225271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propranolol [M0017773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol glycol [2105554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propranolol glycol [M0060827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propranolol Hydrochloride [M0017776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propyl acetate [1649519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propyl acetate [M0086973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propyl gallate [1311134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propyl Gallate [M0017779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene [1314239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylene [M0061602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene carbonate [1363696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylene carbonate [M0133458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol [34693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propylene Glycol [M0029618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol alginate [1361656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylene glycol alginate ester [M0115966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol dinitrate [2370146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylene glycol dinitrate [M0097795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol methyl ether [1367160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylene glycol methyl ether [M0046597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene oxide [1368175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylene oxide [M0053451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylhexedrine [8792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylhexedrine [M0225274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylhexedrine hydrochloride [236461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylhexedrine hydrochloride [M0326403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propyliodone [8793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propyliodone [M0017783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylparaben [34706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propylparaben [M0048132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propylthiouracil [M0017784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propyphenazone [34710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propyphenazone [M0053469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proquazone [2669456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proquazone [M0057649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proscillaridin [8795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proscillaridin [M0017785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protamine Sulfate [M0017843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamines [8826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protamines [M0017844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamone [453012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protamone [M0461937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protease [8031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptide Hydrolases [M0016225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protein C [8834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protein C [M0017852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protein S [34822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protein S [M0026253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothionamide [8871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prothionamide [M0017903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothipendyl [55244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prothipendyl [M0189053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothipendyl hydrochloride [236710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prothipendyl hydrochloride [M0325280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prothrombin [1441688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prothrombin [M0017904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protocatechualdehyde [1362689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>protocatechualdehyde [M0047224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protriptyline [M0017928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protriptyline Hydrochloride [M0329791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proxibarbal [83885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proxibarbal [M0224594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proxigermanium [158660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>propagermanium [M0183145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proximadiol [2562551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proximadiol [M0057129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proxyphylline [34906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>proxyphylline [M0044223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>prucalopride [M0360790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prussian blue insoluble [24902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric ferrocyanide [M0040190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudoephedrine [M0007541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudoephedrine Hydrochloride [M0423710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoisocytidine [34930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pseudoisocytidine [M0059590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psyllium [M0018067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pulegone [2393774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pulegone [M0118596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pullulan [1425878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pullulan [M0053517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pumice [1989334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pumice [M0046470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pummelo extract [1363624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pummelo extract [M000766820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>purified protein derivative of tuberculin [8948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purified Protein Derivative of Tuberculin [M0022102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrantel [M0018221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrantel Pamoate [M0018222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrantel Tartrate [M0018223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazinamide [8987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrazinamide [M0018224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazon [1874547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrazon [M0047240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrethrins [8991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrethrins [M0018228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridinolcarbamate [8997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridinolcarbamate [M0018235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridostigmine [M0018237]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridostigmine Bromide [M0018238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal [9002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridoxal [M0018240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal phosphate [9004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridoxal Phosphate [M0018242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridoxine [M0018247]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyridoxine Hydrochloride [M0329794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrilamine [M0018251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mepyramine Maleate [M0018252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrimethamine [M0018253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrisuccideanol [35097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrisuccideanol [M0054534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrithione [35100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrithione [M0052791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrithioxin [9020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrithioxin [M0018266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyritinol hydrochloride [236508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyritinol Hydrochloride [M0539884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrodifenium bromide [9021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrodifenium bromide [M0224839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrogallol [9022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrogallol [M0018267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyroglutamate [155060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyroglutamate [M0018281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyroligneous acid [1535931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyroligneous acid [M000609128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrophosphate [1364533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrophosphate [M0569649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrophosphoric acid [1546425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>diphosphoric acid [M0279078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrophyllite [2636602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>aluminosilicate [M0140739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrrole [1338938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrroles [M0018276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrrolidine [2585446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrrolidine [M0101472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrrolidonecarboxylic acid [9036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyrrolidonecarboxylic Acid [M0018279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyruvaldehyde [1373350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyruvaldehyde [M0018286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyruvate [72031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyruvate [M0028720]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyruvic acid [35161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyruvic Acid [M0028719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrvinium [35163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrvinium [M0083058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrvinium pamoate [55347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrvinium pamoate [M0083055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quaternium-15 [283678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quaternium-15 [M0069795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quaternium-22 [1426897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quaternium-22 [M0295287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quazepam [35185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quazepam [M0084146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quercetin [9060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quercetin [M0018327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quetiapine [M0189762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quetiapine Fumarate [M0398083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinacrine [M0018330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinacrine Dihydrochloride [M0329675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinacrine Monohydrochloride [M0018332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinagolide [76887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinagolide [M0135075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinagolide hydrochloride [236233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinagolide hydrochloride [M0389329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinapril [M0122104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid [M000640973]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinapril Hydrochloride [M0400670]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinaprilat [M0153856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinate [1427233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinate [M0018340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinestradol [M0058722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinestrol [M0018337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinethazone [M0144624]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinfamide [35216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinfamide [M0087079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinhydrone [1344799]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinhydrone [M0045716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinic acid [1427232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinic Acid [M0018339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinidine [M0018341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinidine bisulfate [M0054748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinidine gluconate [M0066906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinidine polygalacturonate [M0136289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinidine Sulfate [M0018342]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinine [M0018346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinine Bisulfate [M0018347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinine Hydrochloride [M0018348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Quinine Sulfate [M0018349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinoline yellow [1305564]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinoline yellow [M0071662]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupramine [35242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinupramine [M0091320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quinupristin [M0293792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib [2643048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>quizartinib [M0541030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabacfosadine [2003595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rabacfosadine [M0524829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit anti-human T-lymphocyte globulin [107044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>anti-thymocyte globulin (rabbit) [M000638200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rabeprazole [M0583264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rabeprazole Sodium [M0397730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabies virus [1648419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rabies virus [M0018368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racecadotril [16738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>racecadotril [M0141397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Racemethionine [M0013577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine [66887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Racepinephrine [M0007589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Racepinephrine Hydrochloride [M0583087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ractopamine [1311677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ractopamine [M0168987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ractopamine hydrochloride [1311676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ractopamine hydrochloride [M0324340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radium [1546450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radium [M0018449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>radium chloride Ra-223 [1424174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>radium Ra 223 dichloride [M0584818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raffinose [1362905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raffinose [M0018455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene [72143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raloxifene [M0112968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene hydrochloride [166551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raloxifene Hydrochloride [M0112969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir [719872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raltegravir [M0508784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir potassium [1235585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raltegravir Potassium [M000604085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltitrexed [196239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>raltitrexed [M0188215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramelteon [596205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ramelteon [M0480272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ramipril [M0026184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ramiprilat [M0149113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ramucirumab [M000762505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ranibizumab [M0481787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ranibizumab-nuna [M000751974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ranitidine [M0018469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ranitidine bismuth citrate [M0198352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ranitidine Hydrochloride [M0353202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ranolazine [M0156295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium [262100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rapacuronium [M0366636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rapacuronium bromide [228530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rapacuronium bromide [M0220825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rasagiline [M0100095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasburicase [283821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rasburicase [M0443962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab [2107301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ravulizumab [M000646382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raxibacumab [1366567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>raxibacumab [M0537511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>razoxane [9154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Razoxane [M0018535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rebaudioside A [1667222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rebaudioside A [M0084861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reboxetine [M0201546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reboxetine Mesylate [M0201545]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>red yeast rice [232540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>red yeast rice [M0301244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reductic acid [2593372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>reductic acid [M0177148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regadenoson [640062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>regadenoson [M0495792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regenerated cellulose [2000577]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rayon, purified [M0058723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>regorafenib [M0558795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>relatlimab [M000755046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam [2184137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>relebactam [M000638094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam anhydrous [2268500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>relebactam anhydrous [M000638095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>relugolix [M0561735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remdesivir [2284718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>remdesivir [M000650470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L [2700765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>remestemcel-l [M000741509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L-rknd [2700764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prochymal [M000741510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil [73032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Remifentanil [M0194769]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil hydrochloride [236540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Remifentanil Hydrochloride [M0194768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remimazolam [2383941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>remimazolam [M0557318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remoxipride [35350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Remoxipride [M0026320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remoxipride hydrochloride [235832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Remoxipride Hydrochloride [M0329310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rennet [35360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rennet [M0084582]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>repaglinide [M0196126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repotrectinib [2670644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>repotrectinib [M000735658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reproterol [35373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>reproterol [M0063597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resacetophenone [2685741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>resacetophenone [M0369276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rescinnamine [9259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rescinnamine [M0225306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reserpine [M0018861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reslizumab [1746889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>reslizumab [M0504747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmethrin [35380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>resmethrin [M0262438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>resmetirom [M0594314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol [35382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>resorcinol [M0098657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol monoacetate [2106739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>resorcinol monoacetate [M0163214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus immune globulin intravenous [119246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>respiratory syncytial virus immune globulin intravenous [M0259186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resveratrol [1000492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Resveratrol [M0165532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retapamulin [642274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retapamulin [M0496256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>reteplase [M0232706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinaldehyde [2268087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinaldehyde [M0018957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinaldehyde [2268087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>11-trans-Retinal [M000743797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinamide [1367161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retinamide [M0153729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retinol acetate [M0053635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinyl linoleate [1370677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retinyl linoleate [M0137412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinyl propionate [1356759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retinyl propionate [M0155948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinyl retinoate [1373727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retinyl retinoate [M0522845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revefenacin [2102775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>revefenacin [M000646592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>reviparin [M0248310]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>reviparin-sodium [M0248311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>revumenib [M000765723]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin [2639155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rezafungin [M000646842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhamnose [1872246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhamnose [M0019003]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhenium [1667763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhenium [M0019004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhodamine B [1362930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rhodamine B [M0094768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhodinol [1986339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,7-dimethyl-7-octen-1-ol [M0528489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhodium [1311402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhodium [M0019042]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhynchophylline [2562552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rhyncophylline [M0149539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ribavirin [M0019062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ribociclib [M000595784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flavin Mononucleotide [M0008652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium [1925820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flavin Mononucleotide Sodium Salt [M0330281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin [9346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin [M0019064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin tetrabutyrate [2106328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>riboflavin tetrabutyrate [M0053652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribose [1314858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ribose [M0019077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rice bran oil [1309223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rice Bran Oil [M0145529]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ricinoleic acid [35605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ricinoleic acid [M0096472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifabutin [M0026934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifampin [M0019110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifamycin SV [35616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rifamycin SV [M0081464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifamycins [9385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifamycins [M0019113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rifapentine [M0069928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rifaximin [M0126046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilmenidine [55679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rilmenidine [M0100916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilmenidine phosphate [236379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rilmenidine Phosphate [M0100911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilonacept [763450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rilonacept [M0524772]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rilpivirine [M0482137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rilpivirine Hydrochloride [M000603537]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riluzole [35623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riluzole [M0029347]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rimabotulinumtoxinB [M0253447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine [9386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rimantadine [M0019119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine hydrochloride [82093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rimantadine Hydrochloride [M0351818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rimegepant [M000646819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rimegepant sulfate [M000738430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rimexolone [M0061816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimiterol [9388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rimiterol [M0224688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riociguat [1439816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>riociguat [M0538040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-(4-Bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea [M000734592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ripretinib [M000734591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab [2166040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>risankizumab [M000631319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab-rzaa [2166132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>skyrizi [M000653637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Risdiplam [M000647143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate [M000642267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Risedronate [M000641257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate [M000642268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Risedronic Acid, Monosodium Salt [M000638381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Risedronate Sodium [M000602344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronic acid [55685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Risedronic Acid [M000603388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Risperidone [M0028338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine [9392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ritodrine [M0019137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritodrine hydrochloride [105470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ritodrine Hydrochloride [M0475060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ritonavir [M0028918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rituximab [M0244307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivaroxaban [1114195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rivaroxaban [M0501463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine [183379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rivastigmine [M0196402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine tartrate [994808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>RivastigmineTartrate [M0398521]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rizatriptan [M0246872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rizatriptan benzoate [M0402183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>robenacoxib [1250203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>robenacoxib [M0549130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>robenidine [1311554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Robenidine [M0019227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>robenidine hydrochloride [1311553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Robenidine Hydrochloride [M0019229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium [68139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocuronium [M0171457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rocuronium bromide [32521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocuronium Bromide [M0171458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rofecoxib [232158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rofecoxib [M0300376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roflumilast [1091836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Roflumilast [M0385343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rolapitant [M0582062]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolitetracycline [9462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rolitetracycline [M0019254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>romidepsin [M0519758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romifidine [1091919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>romifidine [M0205197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romiplostim [805452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>romiplostim [M0526799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab [2123126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>romosozumab [M0585030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab-aqqg [2123180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>evenity [M000653518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ronidazole [1535498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ronidazole [M0019258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole [72302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ropinirole [M0135070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole hydrochloride [236553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ropinirole hydrochloride [M0322477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine [35780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ropivacaine [M0113809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride [236539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ropivacaine Monohydrochloride [M0320807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosaniline hydrochloride [1535512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rosaniline hydrochloride [M0316395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal [9471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rose Bengal [M0019269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rose bengal sodium I 131 [82097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rose Bengal Sodium I 131 [M0019271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosemary oil [90945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rosemary oil [M0152210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate [M000639464]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosiglitazone [M0237199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosiglitazone Maleate [M0398223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosin [1362931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rosin [M0062020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosmarinate [2531312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosmarinic Acid [M000763254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosmarinic acid [2531311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosmarinic Acid [M000763254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosoxacin [35797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rosoxacin [M0075544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosuvastatin [M0382713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosuvastatin Calcium [M0402344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotenone [1366666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rotenone [M0019281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rotigotine [M0507664]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxarsone [1314413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Roxarsone [M0019285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxatidine [114817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>roxatidine [M0152121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxatidine acetate [35803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>roxatidine acetate [M0152123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxatidine acetate hydrochloride [236543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>roxatidine acetate hydrochloride [M0152122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxithromycin [9478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Roxithromycin [M0023927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab [2642274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rozanolixizumab [M000644074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubella virus [1365969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rubella virus [M0019295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubidium [1311489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rubidium [M0019296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubidium chloride [1367087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rubidium chloride [M0101892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rubidium iodide [2634902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rubidium iodide [M0188630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rucaparib [M0585719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rufinamide [69036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rufinamide [M0213280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruscogenin [35890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ruscogenin [M0059632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruthenium [1534768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ruthenium [M0019313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rutin [9500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rutin [M0019316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rutin sodium sulfate [236445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>rutin sulfate, monosodium salt, monohydrogen [M0323725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ruxolitinib [M0549299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ruxolitinib phosphate [M000752739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sabinene [2557219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sabinene [M0107834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharide isomerate [1314278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>saccharide isomerate [M000752971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharin [9509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saccharin [M0019327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharin calcium [1362912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saccharin Calcium [M0019328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saccharin sodium [281678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saccharin Sodium [M0361498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan [2360232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sacituzumab govitecan [M000618569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacrosidase [214817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sacrosidase [M0445458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacubitril [1656328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sacubitril [M000620407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safflower oil [9515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Safflower Oil [M0019344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>safinamide [M0403007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>safinamide methanesulfonate [M0244891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safrole [2383532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Safrole [M0019345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sakuranetin [2263158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sakuranetin [M0261711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salcaprozate sodium [2200637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salcaprozate sodium [M0542222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicin [36100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salicin [M0047403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicin extract [260012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>willow bark [M0399913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicin extract [260012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>willow bark extract [M000744271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicyl alcohol [1363054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salicyl alcohol [M0056242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salicylamide [M0097881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salicylates [M0019362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salicylic Acid [M0029886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin [1311566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salinomycin [M0055726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmeterol [M000603386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmeterol Xinafoate [M000602359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>recombinant salmon calcitonin [M0446947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salmon calcitonin [M0092392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon gonadotropin releasing hormone D-Arg6 analog ethyl amide [1546435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-oxo-pro-his-trp-ser-tyr-gly-trp-leu-pro-glynh2 [M0164268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon oil [41967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salmon oil [M0096056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salicylsalicylic acid [M0062507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsolinol [1311309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>salsolinol [M0111390]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samarium Sm 153 lexidronam [177906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>samarium Sm-153 lexidronam [M0171702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samarium Sm153 [196342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Samarium-153 [M000627549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samarium [9549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Samarium [M0019408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samarium oxide [1311105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>samarium oxide [M0332093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-carboxamido-4-hydroxynaltrexone [M000616134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sandalore [2373965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sandalore [M000645421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sandalwood oil [1309224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sandalwood oil [M0206336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sangre de grado [260039]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sangre de grado [M0401063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sanguinarine [1537755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sanguinarine [M0047429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sanguinarine nitrate [1537754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sanguinarine nitrate [M0309239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>santonin [1311390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Santonin [M0019417]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapanisertib [2395271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sapanisertib [M000655303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sapropterin [M0044450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>6R-L-erythro-5,6,7,8-tetrahydrobiopterin [M000636947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5,6,7,8-tetrahydrobiopterin [M000642663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin dihydrochloride [753341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sapropterin dihydrochloride [M0517997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saquinavir [M0028681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saquinavir Monomethanesulfonate [M0329184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saralasin [9556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saralasin [M0019423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saralasin acetate [7830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Saralasin Acetate [M0019422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarcosine [1362906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcosine [M0019445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sarecycline [M000646219]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sargramostim [M0216684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarilumab [1923319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sarilumab [M000599011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarolaner [1740360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sarolaner [M000636978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab [2391541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>satralizumab [M000677956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab-mwge [2391551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>satralizumab-mwge [M000767486]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satraplatin [1733681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>satraplatin [M0437778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto extract [236344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>saw palmetto extract [M0121688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto fruit extract [477189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>saw palmetto extract [M0121688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin [857974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>saxagliptin [M0488193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scandium [1311273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scandium [M0019467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scandium chloride [1921562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>scandium chloride [M0539580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scarlet red [36224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>C.I. Solvent Red 24 [M0053724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scarlet red [36224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scarlet Red [M0053728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sclareolide [1426934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sclareolide [M0283904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scopolamine [M0553271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scopolamine Hydrobromide [M0019553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebacic acid [1427068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sebacic acid [M0057150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebelipase alfa [1726975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sebelipase alfa [M000613220]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebetralstat [2717944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sebetralstat [M000761589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secnidazole [36314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>secnidazole [M0066920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital [9624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Secobarbital [M0019587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital sodium [91110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Secobarbital Sodium [M0475524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secretin [9627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Secretin [M0019589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secukinumab [1599788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>secukinumab [M0554163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>segesterone acetate [2055977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Segesterone acetate [M000675401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar [2690869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>seladelpar [M000744228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selamectin [1044269]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>selamectin [M0371163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selank [2049928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selank [M0408941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selegiline [M0019601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selegiline Hydrochloride, (R)-Isomer [M0329708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenious acid [36344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenious Acid [M0328356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenite [9640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenite [M0027223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium [9641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenium [M0019604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium dioxide [1309231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenium Dioxide [M0317736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>selenium disulfide [M0085381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenocysteine [1549332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenocysteine [M0026231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenomethionine Se 75 [9133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenomethionine Se 75 [M0019606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenomethionine [9644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Selenomethionine [M0019607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>selexipag [M0514408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>selinexor [M000595474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>selpercatinib [M000738427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>selumetinib [M0557447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semax [2049929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Semax [M0139469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semduramicin [1314385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>semduramicin [M0197356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>semuloparin [2368733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>semuloparin [M0570002]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sennoside A&amp;B, Calcium Salt [M0308088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sennoside A&amp;B [M0043615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sennosides [M000650121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sericin 1 [1607312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sericin-1 [M0053773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serine [9671]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serine [M0019675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin [56188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sermorelin [M0026330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin acetate [58932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sermorelin Acetate [M0026331]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serotonin [1311214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serotonin [M0019683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serratiopeptidase [36434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>serratiopeptidase [M0078974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sertaconazole [M0169568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole nitrate [236601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sertaconazole nitrate [M0475542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sertindole [M0182004]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sertraline [M0029930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sertraline Hydrochloride [M0329071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serum albumin, bovine [1426381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Albumin, Bovine [M0019693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sesame oil [1309247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sesame Oil [M0019701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sesamin [2593413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sesamin [M0153023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>setmelanotide [2469247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>setmelanotide [M000620282]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sevelamer [M0358988]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sevelamer Carbonate [M0497765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sevelamer Hydrochloride [M0358989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sevoflurane [M0053801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shark cartilage extract [81782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>shark cartilage extract [M0288651]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shellac [1368898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>shellac [M0045063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>shikimic acid [2059172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shikimic Acid [M0019775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sialyl Lewis A [2619423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>CA-19-9 Antigen [M0027621]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sibutramine [M0162538]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sibutramine hydrochloride [M0323994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silanol [1601667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silanol [M0219436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sildenafil [M0265894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sildenafil Citrate [M0327633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silicic acid [1311243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silicic Acid [M0019853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silicon [9774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silicon [M0019854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silicon dioxide [9771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silicon Dioxide [M0019851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silicon nitride [1989508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silicon nitride [M0101919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silicon tetrachloride [1863221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silicon tetrachloride [M0118636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silicones [9778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silicones [M0019861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silodosin [M0505454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siltuximab [1535218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>siltuximab [M0490040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver [2606543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silver [M0019867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver acetate [137939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver acetate [M0269663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver carbonate [2462152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver carbonate [M0103283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver chloride [1314846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver chloride [M0113551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver fluoride [1544125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver fluoride [M0274131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver iodide [1423914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver iodide [M0096626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver mono(2-aminoethyl)phosphate [162901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver mono(2-aminoethyl)phosphate [M0088448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silver Nitrate [M0019869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver phosphate [1665220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver phosphate [M0117203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silver Sulfadiazine [M0019872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfide [1549110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>silver sulfide [M0060861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silybin [155067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silybin [M0019880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silymarin [9794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Silymarin [M0019873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Simeprevir [M0526124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simethicone [9796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Simethicone [M0019885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simetone [1658655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-methoxy-4-ethylamino-6-ethylamino-1,3,5-triazine [M0553714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>simoctocog alfa (Nuwiq) [M000758077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Simvastatin [M0029425]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sinapultide [1440288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sinapultide [M0292630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sincalide [9800]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sincalide [M0019891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>siponimod [M0582238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sipuleucel-T [997261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sipuleucel-T [M0499901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sirolimus [M0029863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sisomicin [9806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sisomicin [M0019903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sisomicin sulfate [9807]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sisomicin Sulfate [M0019904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin [593411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sitagliptin [M0480815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin phosphate [621590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sitagliptin Phosphate [M0498840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitosterols [9808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sitosterols [M0019907]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>skatole [1311386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skatole [M0019919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sobrerol [36669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sobrerol [M0044341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium Na-22 [1483727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium-22 [M000627814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium [9853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium [M0020091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate [56443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Acetate [M0028799]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate trihydrate [237108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Acetate Trihydrate [M000638655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate, anhydrous [267453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Acetate, Anhydrous [M0331277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetyltryptophanate [1366816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N-acetyltryptophanate sodium [M0048922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acexamate [236526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium acexamate [M0070737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium adipate [2627782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium adipate [M0095027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium alginate [56446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Alginate [M0310540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium arsenate [1364794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium arsenate [M0053853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium arsenate, dibasic [1364793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>disodium arsenate [M0310678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Ascorbate [M0330790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbyl phosphate [1364501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium ascorbyl phosphate [M0551587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzenesulfonate [1313277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium benzenesulfonate [M0101056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Benzoate [M0029887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Bicarbonate [M0026757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bisulfate [1367207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium bisulfate [M0311701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bisulfate monohydrate [2463932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium bisulfate, monohydrate [M0311697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bisulfite [36679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium bisulfite [M0053854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium borate [36680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium borate [M0056248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bromide [1311138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium bromide [M0090372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium caprylate [1311123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium caprylate [M0098906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium carbonate [36685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium carbonate [M0047386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium carbonate decahydrate [1362143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium carbonate decahydrate [M0047387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium caseinate [1366917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Caseinate [M0003595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chlorate [1366921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium chlorate [M0101889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Chloride [M0020094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride, (22)Na [1370679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Chloride, (22)Na [M0020095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chlorite [992920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium chlorite [M0041846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium cholate [2286239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Cholate [M0029995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chromate Cr51 [91510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium chromate(VI), 51Cr-labeled cpd [M0318041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Citrate [M0267243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Monosodium Citrate [M000640942]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trisodium Citrate Dihydrate [M0582746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium cocoyl isethionate [1366839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium cocoyl isethionate [M0332850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium copper chlorophyllin [1366841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chlorophyllin, sodium copper complex [M000636966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium cyclamate [56467]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Cyclamate [M0005448]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dehydroacetate [1366847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium dehydroacetate [M0089315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium diacetate [1547632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium diacetate [M0545846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dichloroacetate [1366930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Dichloroacetate [M0006266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dithionate [1443001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium dithionate [M0046061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dithionite [2056673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Dithionite [M0006617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dodecyl sulfate [9871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Dodecyl Sulfate [M0020097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dodecylbenzenesulfonate [1366931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>dodecylbenzenesulfonic acid, sodium salt [M0307560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estrone sulfate, sodium salt [M0313389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride [9873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Fluoride [M0020103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium formaldehyde sulfoxylate [289996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>formaldehydesulfoxylate, monosodium salt [M0311371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fumarate [56475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium fumarate [M0100167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium gluconate [56476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium gluconate [M0096891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium glutamate [1311588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Glutamate [M0020104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium glycerophosphate [1595589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium glycerophosphate [M0094375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium glycolate [1356762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycolic acid, monosodium salt [M0319124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium gualenate [2667891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Na salt of azulene SN [M0320265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hexafluorosilicate [1862868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium fluorosilicate [M0556533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Hyaluronate [M0357382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hydride [1483618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium hydride [M0516491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hydrogen sulfite [1366858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium hydrogen sulfite [M0569865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hydroxide [9880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Hydroxide [M0020107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hydroxymethylglycinate [1367223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium hydroxymethylglycinate [M0544173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Hypochlorite [M0020109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypophosphite [1311313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium hypophosphite [M0053864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypophosphite monohydrate [1311312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium hypophosphite monohydrate [M0310682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodate [1422194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium iodate [M0100877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Iodide [M0020110]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iothalamate [9886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Iothalamate [M0330182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ironedetate [105673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ferric sodium edetate [M0071437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium isethionate [1364895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Isethionate [M0011737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lactate [56489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Lactate [M0028809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium laurate [1425357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lauric acid, sodium salt [M0318833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium laureth sulfate [1310569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium laureth sulfate [M0362836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lauriminodipropionate [1942335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium lauriminodipropionate [M0105717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lauroyl sarcosinate [1364901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sarkosyl [M0084357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium metabisulfite [36696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium metabisulfite [M0046576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium metasilicate [1733690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium metasilicate [M0084581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium methyl oleoyl taurate [1789472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oleoylmethyltaurine sodium [M0315635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium molybdate(VI) [36699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium molybdate(VI) [M0083179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium monofluorophosphate [56501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium monofluorophosphate [M0060391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium morrhuate [9892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Morrhuate [M0020112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitrate [36700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium nitrate [M0099190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitrite [9894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Nitrite [M0020113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Nitroprusside [M0329967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium octyl sulfate [1438636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium octyl sulfate [M0534608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oleanolate [1366853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ursolic Acid Sodium Salt [M000758441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxalate [1441659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Oxalate [M0329888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxide [1366982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium oxide [M0254336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxybate [9899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Oxybate [M0020115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium palmitate [1364910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Palmitate [M0028752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium palmitoyl sarcosinate [1726120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>palmitoyl sarcosine, sodium salt [M0312645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium perborate [36702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium perborate [M0089822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium percarbonate [1364915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium percarbonate [M0106855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium peroxide [1366983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium peroxide [M0139196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pertechnetate Tc 99m [10349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Pertechnetate Tc 99m [M0021100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pertechnetate Tc 99m [10349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pertechnetate Sodium [M0418362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phenylacetate [56510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phenylacetic acid, sodium salt [M0316191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phenylbutyrate [214837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>4-phenylbutyric acid, sodium salt [M0325828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate [M0069638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phosphoric acid, disodium salt [M0313613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate, dibasic (anhydrous) [M0581491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate, dibasic (anhydrous) [M0581491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate monobasic anhydrous [M0583142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate, monobasic [M0313614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate monobasic anhydrous [M0583142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, dodecahydrate [1311345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium phosphate, tribasic, dodecahydrate [M0308395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phytate [9903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Phytate [M0016821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polymetaphosphate [1364921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium polymetaphosphate [M0053862]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polystyrene sulfonic acid, homopolymer, sodium salt [M0308258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium propionate [56513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium propionate [M0094460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium pyrophosphate [1364532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium pyrophosphate [M0044345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Salicylate [M0020117]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium sarcosinate [1364526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Sarcosinate [M0019446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenate [36717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Selenate [M0077028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenite [56519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Selenite [M0027224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium silicate [1363697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium silicate [M0047391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium starch glycolate [1366851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium starch glycolate [M0139236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium stearate [1366984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium stearate [M0537895]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium stearoyl lactylate [1366986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearoyl-2-lactylic acid, sodium salt [M0319339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium stearyl fumarate [1364936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium stearyl fumarate [M0509632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium stibogluconate [8010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antimony Sodium Gluconate [M0001475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium sulfate [36721]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium sulfate [M0058743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium sulfide [1293719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium sulfide [M0103836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium sulfide anhydrous [2692871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium sulfide [M0103836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium sulfide nonahydrate [1364569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium sulfide nonahydrate [M000633558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium sulfite [36723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium sulfite [M0083911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tartrate [56524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium tartrate [M0094759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium taurodeoxycholate [1364852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Taurodeoxycholate [M0021071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetrachloroaurate [1366933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>gold tetrachloride, acid, sodium salt [M0315827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Tetradecyl Sulfate [M0020118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thioglycolate [1364940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-mercaptoacetate, monosodium salt [M0313430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate [36726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium thiosulfate [M0068706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate anhydrous [1807514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium thiosulfate anhydrous [M000623643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tripolyphosphate anhydrous [1487533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium tripolyphosphate anhydrous [M000636954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tyropanoate [282508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Tyropanoate [M0353576]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valproate Sodium [M0022500]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium zirconium cyclosilicate [2047628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sodium zirconium cyclosilicate [M000605059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofosbuvir [1484911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sofosbuvir [M0551450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solanine [1745416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Solanine [M0020136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solasulfone [1551455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>solasulfone [M0054811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin [322167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Solifenacin [M0407671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin succinate [476588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Solifenacin Succinate [M0554458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>solriamfetol [M000637168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>solriamfetol hydrochloride [M000675750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solvent red 27 [1495079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>oil red O [M0057063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somapacitan [2557373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>somapacitan [M000750676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somapacitan-beco [2557394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>somapacitan-beco [M000767495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatostatin [9939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Somatostatin [M0020152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>somatrem [M0028840]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon [2644503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>somatrogon [M000758367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sometribove [1427014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sometribove [M0282067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib [1659191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sonidegib [M000598380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sorafenib [M0446095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sorafenib Tosylate [M0493144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbic acid [1311139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sorbic Acid [M0020168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan monolaurate [1363055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan monolaurate [M0063643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan monooleate [1363056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan monooleate [M0070418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan monopalmitate [1363701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan monopalmitate [M0171039]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan monostearate [1363057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan monostearate [M0053882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan sesquioleate [1363058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan sesquioleate [M0163968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan trioleate [1363643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan trioleate [M0047400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitan tristearate [1426397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sorbitan tristearate [M0509245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol [9945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sorbitol [M0020169]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotagliflozin [2638675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol [M0578166]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sotalol [M0020177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sotalol Hydrochloride [M0020176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sotatercept [M0537365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotorasib [2550714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sotorasib [M000739281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotrovimab [2550731]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sotrovimab [M000742086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy sterol [1363446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>soysterol [M0104118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soybean Oil [M0020187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sparfloxacin [M0170192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sparsentan [M000655671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin [270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spectinomycin [M0000292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin hydrochloride [267342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spectinomycin Hydrochloride [M000613692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spermaceti [9968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>spermaceti [M0053886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spermidine [1483262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spermidine [M0020287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spermine [1483263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spermine [M0020288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab [2610417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>spesolimab [M000743574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sphinganine [1947371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sphinganine [M0047380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinosad [299081]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>spinosad [M0372203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiramycin [9991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spiramycin [M0023923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiramycin [9991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>demycarosylturimycin H [M0067757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>spirapril [M0149125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spironolactone [M0020352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>squalane [1363644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>squalane [M0072078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>squalene [10014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Squalene [M0020400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannic oxide [1363059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stannic oxide [M0131933]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous chloride [37032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stannous chloride [M0081014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous chloride dihydrate [2462150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stannous chloride dihydrate [M000613556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous chloride,anhydrous [314853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stannous chloride anhydrous [M0583141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride [10030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tin Difluoride [M0021554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous tartrate [56701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stannous tartrate [M0094760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stanozolol [10032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stanozolol [M0020415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>starch [10046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Starch [M0020435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stavudine [M0027323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearalkonium chloride [1310555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N,N-dimethyl-N-octadecylbenzylammonium chloride [M0321898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearamidoethyl diethylamine [1363699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearamidoethyl diethylamine [M0236680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearamine [1313977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearylamine [M0053912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearate [1368706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stearates [M0020466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>steareth-10 [1367147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poly(oxyethylene) (10) stearyl ether [M000637137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>steareth-20 [1367121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>polyoxyethylene 20-stearyl ether [M0127863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>steareth-30 [1366627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>poly(oxyethylene) (30) stearyl ether [M000732368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearic acid [1310551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearic acid [M0098170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearyl alcohol [37071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearyl alcohol [M0053909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearyl glycyrrhetinate [1356147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearyl glycyrrhetinate [M0061640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearyl heptanoate [1426355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearyl heptanoate [M0582182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stearyl stearate [1426360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stearyl stearate [M0523920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stem bromelain [2373652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stem bromelain [M0242372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stepronin [2375829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stepronin [M0108093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>steviol [1363645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>steviol [M0058753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stevioside [37106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stevioside [M0058754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stigmasterol [10079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stigmasterol [M0020535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stiripentol [2054968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>stiripentol [M0075555]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptodornase [10104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptodornase [M0006008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptokinase [M0020580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptomycin [M0020595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptomycin Sulfate [M0329735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptozocin [M0020600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium [10122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strontium [M0020618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium chloride [37175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>strontium chloride [M0085394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium chloride hexahydrate [1594632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>strontium chloride hexahydrate [M0316535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium nitrate [1356142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>strontium nitrate [M0273777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium-89 [81638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strontium-89 [M000628015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium-89 chloride [281890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>strontium chloride, 89Sr-labeled [M0316540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strychnine [66422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strychnine [M0020628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strychnine nitrate [1310185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strychnine Nitrate [M0020629]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>styrene [1362878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Styrene [M0029766]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>styrene/isoprene/styrene block copolymer [2385109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>styrene-isoprene-styrene block copolymer [M0577659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suberic acid [2044370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>suberic acid [M0047477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>subtilisin [1997449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Subtilisin [M0328357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succimer [3446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Succimer [M0006442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinate [1307106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Succinate [M0029383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinic acid [37255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Succinic Acid [M0029380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinic anhydride [1374803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>succinic anhydride [M0099681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylated gelatin [56790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>succinylated gelatin [M0167019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine [10154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Succinylcholine [M0020712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine chloride [3565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Suxamethonium Chloride [M0020711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylcholine iodide [262295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Succinylcholine Iodide [M0020713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succinylsulfathiazole [37289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>succinylsulfathiazole [M0053950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sucralfate [M0020717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralose [1439115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trichlorosucrose [M0086527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucroferric oxyhydroxide [M000607814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose [10159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sucrose [M0020722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose acetate isobutyrate [1363646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose acetate isobutyrate [M0043686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose cocoate [1370728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose cocoate [M0543619]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose distearate [1370303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose distearate [M0123240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose monolaurate [1363647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose monolaurate [M0069427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose monostearate [1363060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose monostearate [M0069428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose octaacetate [37296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose octaacetate [M0087855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucrose palmitate [1367150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sucrose monopalmitate [M0123242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sudan red [1648696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sudan red [M0102594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil [56795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sufentanil [M0026423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil citrate [58964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sufentanil Citrate [M0329215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugammadex [1726988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sugammadex [M0497520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugammadex sodium [1726987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sugammadex Sodium [M0521536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulbactam [M0020733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulbactam pivoxyl [M0109877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulbactam Sodium [M0020734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbenicillin [10168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulbenicillin [M0020736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbutiamine [37317]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulbutiamine [M0098527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulconazole [M0103413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulconazole nitrate [M0103412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfabenzamide [37320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfabenzamide [M0105293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfacetamide [M0020737]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfacetamide Sodium [M0329612]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfacetamide Monosodium Salt [M000642435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfachlorpyridazine [2476008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfachlorpyridazine [M0020739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfacytine [M0262780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfadiazine [M0020740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadimethoxine [10172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfadimethoxine [M0020742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfadoxine [M0020743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfaethidole [37324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfaethidole [M0263388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfaguanidine [10174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfaguanidine [M0020744]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfalene [10175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfalene [M0020745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamerazine [10176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfamerazine [M0020746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethazine [10178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfamethazine [M0020748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfamethizole [M0020749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfamethoxazole [M0020750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxypyridazine [10181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfamethoxypyridazine [M0020751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfametrole [37328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfametrole [M0058763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamoxole [10183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfamoxole [M0020753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfanilamide [10184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfanilamide [M0112101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfanilylurea [37333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfanilylurea [M0053960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfapyridine [M0020757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfaquinoxaline [1306111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfaquinoxaline [M0020758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfasalazine [M0019365]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfate ion [1426598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfates [M0020761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfathiazole [M0046785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfathiazole Sodium [M000641001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfinpyrazone [M0020776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisomidine [10206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfisomidine [M0020778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfisoxazole [M0020779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfisoxazole Diolamine [M0020780]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfobetaine [1539813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfobetaine [M0464615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfobromophthalein [10212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfobromophthalein [M0020785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfobromophthalein sodium [203200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfobromophthalein Sodium [M0361430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfobutylether-beta-cyclodextrin [1426608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>SBE4-beta-cyclodextrin [M0245826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfobutylether-beta-cyclodextrin [1426608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>betadex sulfobutyl ether sodium [M000645087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur [10223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfur [M0020797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur dioxide [1362879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfur Dioxide [M0020801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur hexafluoride [1599276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulfur Hexafluoride [M0020802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfuric acid [10231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfuric acid [M0103037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfuryl fluoride [2289224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulfuryl fluoride [M0140442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulindac [M0020810]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulisobenzone [1311567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulisobenzone [M0053995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem [2717833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulopenem [M0220732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulpiride [10239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sulpiride [M0020813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulthiame [10240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sulthiame [M0224692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sultilains [227410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sultilains [M0080099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sultopride [37416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sultopride [M0058775]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sultopride hydrochloride [236185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sultopride Hydrochloride [M0311708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sumatriptan [M0027392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sumatriptan Succinate [M0027393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunflower oil [37422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunflower Oil [M000625852]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunitinib [M0448793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunitinib Malate [M0496689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunvozertinib [2719226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sunvozertinib [M000769118]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>superoxide dismutase [10245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Superoxide Dismutase [M0020832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suprofen [10255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Suprofen [M0020851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suramin [10256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Suramin [M0020853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sutimlimab [2591404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>sutimlimab [M000655311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>suvorexant [M0549250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suxamethonium bromide [121039]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Suxamethonium Bromide [M0020715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>suzetrigine [M000768716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sweet cherry allergenic extract [901303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sweet Cherries [M000602180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>symclosene [2375531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>symclosene [M0147085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>symclosene sodium [2375530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>symclosene sodium [M0323133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synephrine [10288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synephrine [M0020958]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic beeswax [2462009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beeswax, synthetic [M0320931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estrogens, conjugated synthetic A [M0497261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>estrogens, conjugated synthetic B [M0497267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tabtoxin [2590695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tabtoxin [M0044965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacalcitol [291204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tacalcitol [M0315459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine [10318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tacrine [M0021008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine hydrochloride [235972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tacrine Hydrochloride [M0021011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tacrolimus [M0025261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tadalafil [M0431130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadenan [37534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tadenan [M0521884]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafamidis [1545063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafamidis [M0543569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafamidis meglumine [1727003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafamidis meglumine [M0543570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab [2387211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafasitamab [M000654379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab-cxix [2387334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafasitamab-cxix [M000767492]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine [2054023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafenoquine [M0355080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine [2054023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafenoquine succinate [M0465286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine succinate [2054091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafenoquine succinate [M0465286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafluprost [1244607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tafluprost [M0466141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tagraxofusp [M000598712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp-erzs [2109054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tagraxofusp-erzs [M000659598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talactoferrin alfa [1425932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talactoferrin alfa [M0504489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin [10322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Talampicillin [M0021018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib [2099704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talazoparib [M0591483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talbutal [89810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talbutal [M0413630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talc [10323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Talc [M0021021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>taletrectinib [M000753948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taliglucerase alfa [1291609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>taliglucerase alfa [M0574668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talimogene laherparepvec [M000647036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talinolol [37546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talinolol [M0057914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tall oil [1364132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tall oil [M0462250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talniflumate [236770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talniflumate [M0470191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab [2644447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>talquetamab [M000768387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tamoxifen [M0021024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tamoxifen Citrate [M0373246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tamsulosin [M0234193]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide [M000640717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tamsulosin Hydrochloride [M0397906]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangeretin [2682551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tangeretin [M0164309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tangerine peel extract [1305532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>chenpi [M0556842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tannic acid [10328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tannic acid [M000762332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tannic acid [10328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tannins [M0021034]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tantalum [1311490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tantalum [M0021035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tapentadol [M0515162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tapentadol Hydrochloride [M0538318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapinarof [2602286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tapinarof [M0573307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapinarof [2602286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2-isopropyl-5-(2-phenylethenyl)benzene-1,3-diol [M000648087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab [2682954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tarlatamab [M000769125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tartaric acid [37578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tartaric acid [M0094762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tartrate [1314221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tartrate [M0094761]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tartrazine [1305578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tartrazine [M0021053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tasimelteon [1490468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tasimelteon [M0456071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurine [10337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Taurine [M0021065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurine deoxycholate [1364853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Taurine Deoxycholate [M0021073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurolidine [2670453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>taurolidine [M0059673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurursodiol [2613950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ursodoxicoltaurine [M0099280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tavaborole [1543173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tavaborole [M0501305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taxifolin [2700758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>taxifolin [M0044418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tazarotene [M0230113]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tazemetostat [M000647635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat hydrobromide [2274379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tazemetostat hydrobromide [M000750866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazobactam [37617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tazobactam [M0127405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazobactam sodium [221167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tazobactam Sodium [M0589094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tbo-Filgrastim [M000638527]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tea tree oil [69627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tea Tree Oil [M0328581]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tebentafusp [M000752826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium 99m [90650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium 99m [M0021094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m arcitumomab [230435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>technetium Tc-99m arcitumomab [M0296262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m bicisate [114918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>technetium Tc 99m bicisate [M0165908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m disofenin [37665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Disofenin [M0029352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m exametazime [1431726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Exametazime [M0029240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m medronate [1488818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Medronate [M0021098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m pertechnetate [1489762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Pertechnetate [M0021106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m sestamibi [1482913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Sestamibi [M0026183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc 99m tilmanocept [1373391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran [M0394765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc-99m pyrophosphate [1488368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Pyrophosphate [M0025434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium Tc-99m sulfur colloid [1423270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium Tc 99m Sulfur Colloid [M0021107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>technetium [2571856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Technetium [M0021093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tecovirimat [M0537233]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat monohydrate [2055677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tecovirimat monohydrate [M000757948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tedizolid [M0542249]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tedizolid phosphate [M0548441]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teduglutide [1364468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>teduglutide [M0479116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teferrol [37744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>teferrol [M0060902]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegafur [4582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tegafur [M0008871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tegaserod [M0274190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tegaserod maleate [M0433030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teicoplanin [57021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Teicoplanin [M0026325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telaprevir [M0466818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telavancin [M0468816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telavancin hydrochloride [M0585819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Telbivudine [M0469133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin [2721996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telisotuzumab vedotin [M000654539]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telithromycin [274786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telithromycin [M0333148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tellurium [1311384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tellurium [M0021135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tellurium tetrachloride [1863222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tellurium tetrachloride [M0111366]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmesteine [85929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telmesteine [M0241640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Telmisartan [M0223750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat [1872382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telotristat [M000599125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat ethyl [1872441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telotristat ethyl [M000634864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat etiprate [1872448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>telotristat etiprate [M000599126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>temafloxacin [M0154422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>temafloxacin hydrochloride [M0323514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Temazepam [M0021137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temocillin [37775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>temocillin [M0098594]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temoporfin [115243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>temoporfin [M0195871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Temozolomide [M0136562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temsirolimus [657797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>temsirolimus [M0498543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tenapanor [M000607773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenecteplase [259280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tenecteplase [M0335155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Teniposide [M0021161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tenofovir [M0254881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide [1721603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tenofovir alafenamide [M0587794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil [300195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tenofovir Disoproxil [M000613540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tenofovir Disoproxil Fumarate [M0407969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenoxicam [37790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tenoxicam [M0102060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab [2621880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>teplizumab [M0539176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tepotinib [M000734273]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-(1-(3-(5-((1-Methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)benzyl)-6-oxo-1,6-dihydro-3-pyridazinyl)benzonitrile [M000734274]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepraloxydim [2549831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tepraloxydim [M0549630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab [2274803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>teprotumumab [M000617200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab-trbw [2274802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>teprotumumab-trbw [M000767501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terazosin [M0528343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terazosin hydrochloride [M0321569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terazosin hydrochloride anhydrous [M0584929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terbinafine [M000640352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terbinafine Hydrochloride [M0398072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbium [1367186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terbium [M0021175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline [10368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terbutaline [M0021177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline sulfate [10369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terbutaline Sulfate [M0021178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terconazole [37806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terconazole [M0114183]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terfenadine [M0025307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriflunomide [1310520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>teriflunomide [M0519665]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Teriparatide [M0028836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Teriparatide Acetate [M0028838]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terizidone [57047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terizidone [M0262785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terlipressin [57048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Terlipressin [M0058831]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline [37815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terodiline [M0056258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline hydrochloride [235839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terodiline hydrochloride [M0311188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terpin hydrate [89916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terpin hydrate [M0309295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terpinolene [2380832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terpinolene [M0088126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terpinyl acetate [1312739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>terpinyl acetate [M0072101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tert-butyl acetate [2668412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tert-butyl acetate [M0237478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tert-butyl alcohol [1363061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tert-Butyl Alcohol [M0029708]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol [37840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tertatolol [M0047291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol hydrochloride [236374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tertatolol hydrochloride [M0309189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tesamorelin [M0509739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testolactone [10378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testolactone [M0021194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone 17-phenylpropionate [37855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>testosterone 17-phenylpropionate [M0108644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testosterone [M0021196]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>testosterone 17 beta-cypionate [M0065909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>testosterone decanoate [M0123493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>testosterone enanthate [M0045776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>testosterone isocaproate [M0230109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testosterone Propionate [M0021197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>testosterone undecanoate [M0056567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxin [1735049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus Toxin [M0021202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus Toxoid [M0021204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetraarsenic tetrasulfide [1426938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetraarsenic tetrasulfide [M0529020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetrabenazine [M0021208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine [10391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetracaine [M0021210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrachlorodibenzodioxin [2120182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetrachlorodibenzodioxin [M000617494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrachlorodibenzodioxin [2120182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,3,7,8-Tetrachlorodibenzo-p-dioxin [M000616959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetracycline [M0021216]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetracycline Hydrochloride [M0329644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetradecane [2167852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-tetradecane [M0083226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetraethylammonium hydroxide [1648695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetraethylammonium Hydroxide [M0329102]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrafluoromethane [1368889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetrafluoromethane [M0533151]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrodiferuloylmethane [1362136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetrahydrocurcumin [M0253320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrolinalool [2373947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2,6-dimethyl-6-octanol [M0528490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetrahydrozoline [M0047589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetrahydrozoline hydrochloride [M0309299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetramethylthiuram monosulfide [1363713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetramethylthiuram monosulfide [M0105157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrapeptide-15 [1986806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>endomorphin 2 [M0274738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetraxetan [2260905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid [M0193869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrazepam [37985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetrazepam [M0046648]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetroxoprim [37999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tetroxoprim [M0080841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezacaftor [1999382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tezacaftor [M000639510]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab [2587789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tezepelumab [M000636298]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab-ekko [2587790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tezepelumab-ekko [M000767488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thalidomide [M0021267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallium [1311633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thallium [M0021268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallium sulfate [1309339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thallium sulfate [M0061680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallous acetate [2048725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thallium acetate [M0088101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thallous chloride Tl201 [91588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thallium chloride, (201)Tl-labeled [M0317353]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theaflavin [38021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>theaflavin [M0157445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theanine [38022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>theanine [M0086236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thenyldiamine [38025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thenyldiamine [M0047600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theobromine [10437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Theobromine [M0021284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theodrenaline [31958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>theodrenaline [M0043466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Theophylline [M0021287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Theophylline Anhydrous [M0587176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Theophylline Sodium Glycinate [M0021290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiabendazole [M0021313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiafentanil [2691823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiafentanil [M0441707]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine [M0021318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiamine disulfide [M0060936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiamine hydrochloride [M000742570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Mononitrate [M0021319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Pyrophosphate [M0021323]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamphenicol [10463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamphenicol [M0021328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamphenicol glycinate [163416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiamphenicol glycinate [M0092383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamylal [M0021329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamylal Sodium [M0476443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiethylperazine [M0021336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiethylperazine Malate [M0021337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thimerosal [10472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thimerosal [M0021339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiobutabarbital [M0045334]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiocolchicoside [38085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiocolchicoside [M0045288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioctic acid [6417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thioctic Acid [M0012565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioctic acid amide [1597391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>lipoamide [M0060587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiocyanate [1427067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiocyanate [M0099575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiodipropionic acid [2046122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiodipropionic acid [M0060949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioglycerol [1363062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thioglycerol [M0054190]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thioguanine [M0021356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thioguanine Anhydrous [M0584976]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiopental [M0021364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiopental Sodium [M0376292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiophene [154876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiophenes [M0021371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopropazate [38133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiopropazate [M0262950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioproperazine [10498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thioproperazine [M0225304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thioridazine [M0021377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thioridazine Hydrochloride [M0361678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiosalicylic acid [322165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiosalicylic acid [M0407663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiostrepton [1365970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiostrepton [M0021380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiosulfate [1546411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiosulfates [M0021382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotaurine [1368888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiotaurine [M0503106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiotepa [M0021343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiothixene [M0021384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiphenamil [38150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thiphenamil [M0054234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiram [10517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiram [M0021389]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thonzonium bromide [221171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thonzonium bromide [M000619716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thonzylamine [1360721]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thonzylamine [M0262803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thonzylamine hydrochloride [1360720]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thonzylamine monohydrochloride [M0327346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thorium [1534769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thorium [M0021412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>threonate [1547558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>threonate [M0374427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>threonic acid, DL- [1547557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>threonic acid, dl- [M000637064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>threonic acid, L- [1549112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>threonic acid, l- [M000637065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>threonine [10524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Threonine [M0021415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin [10528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombin [M0021424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin alfa [1367075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>recombinant human thrombin [M0501718]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thulium [1311496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thulium [M0021442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thuringiensin [1648507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thuringiensin [M0186845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymalfasin [38221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymalfasin [M0086869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme oil [90950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymus vulgaris oil [M000744436]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme oil [90950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thyme oil [M000744309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymidine [1372538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymidine [M0021446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymine [1368871]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymine [M0021455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymol [10553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymol [M0021457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymol [10553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>carvacrol [M0198268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymomodulin [38217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thymomodulin [M0145377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymopentin [40230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymopentin [M0024918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymostimulin [38233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>thymostimulin [M0098698]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymoxamine hydrochloride [235778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moxisylyte Hydrochloride [M0474459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymus extracts [10562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thymus Extracts [M0021467]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroglobulin [M0021472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid (USP) [M0021483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin [10579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotropin [M0021496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin alfa [4952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotropin Alfa [M0534260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin-releasing hormone [10580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotropin-Releasing Hormone [M0021497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiadenol [38248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiadenol [M0045693]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiadilon [38249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiadilon [M0082147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiagabine [M0164774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiagabine Hydrochloride [M0164768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiamulin [1546410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiamulin [M0062587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiamulin fumarate [1314589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiamulin fumarate [M0312444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tianeptine [38252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tianeptine [M0144175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiapride [10588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiapride [M0572218]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiaprofenic acid [38253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiaprofenic acid [M0075913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tibolone [M0089071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticagrelor [1116632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ticagrelor [M0513890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ticarcillin [M0021517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ticarcillin Disodium [M0476614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine [10594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ticlopidine [M0021526]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine hydrochloride [97]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ticlopidine Hydrochloride [M0021525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiemonium methylsulfate [38265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiemonium methylsulfate [M0074287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tigecycline [M0305009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tilbroquinol [166718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tilbroquinol [M0113814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildipirosin [1306059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tildipirosin [M0578946]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab [2053436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tildrakizumab [M000606544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiletamine [1535217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiletamine [M0021530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiletamine hydrochloride [1535216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiletamine Hydrochloride [M0351825]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tilidine [10597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tilidine [M0021533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tilidine hydrochloride [82109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tilidine Hydrochloride [M0329667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiliroside [1423792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiliroside [M0147990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tilmicosin [38278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tilmicosin [M0148552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate [57230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiludronate [M0163475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate disodium [83153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiludronate disodium [M0324037]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronic acid [11476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiludronic acid [M0163477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Timolol [M0021546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol [M000642429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Timolol Hemihydrate [M000638570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Timolol Maleate [M0021551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tin [10603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tin [M0021552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinidazole [M0021569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinzaparin [M0216743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinzaparin Sodium [M0398364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioclomarol [163426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tioclomarol [M0092428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioconazole [38298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tioconazole [M0074291]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiopronin [6765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiopronin [M0013445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiotropium [M0213717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tiotropium Bromide [M0458357]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioxolone [2059173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tioxolon [M0054210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil [1670304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tipiracil [M000626008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipranavir [190548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tipranavir [M0278998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiratricol [13982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,3&apos;,5-triiodothyroacetic acid [M0056269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirbanibulin [2471078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tirbanibulin [M000744224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirilazad [72467]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tirilazad [M0151122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirilazad [72467]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methyl-, (16alpha)-, monomethanesulfonate [M000645186]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirilazad mesylate hydrate [59827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tirilazad mesylate hydrate [M0323345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tirofiban [M0211213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tirofiban Hydrochloride [M0326022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiropramide [38315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tiropramide [M0098137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirzepatide [2601723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tirzepatide [M000646994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisagenlecleucel [1986438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tisagenlecleucel [M000641063]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tislelizumab [M000734928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tislelizumab [M000734928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisopurine [38136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tisopurine [M0047625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin [2571094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tisotumab vedotin [M000734100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>titanium [1305547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Titanium [M0021596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>titanium carbide [1989495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>titanium carbide [M0253952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>titanium dioxide [38323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>titanium dioxide [M0054248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib [2534233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tivozanib [M0551297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixagevimab [2587300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tixagevimab [M000744508]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixocortol [57257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tixocortol [M0121683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixocortol pivalate [38336]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tixocortol pivalate [M0071279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tizanidine [M0081344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tizanidine hydrochloride [M0081343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobramycin [M0021611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobramycin Sulfate [M0021610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tocainide [M0025410]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tocainide Monohydrochloride [M0329391]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocamphyl [60906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tocamphyl [M0201917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toceranib phosphate [1145944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>toceranib phosphate [M0538270]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tocilizumab [M0488127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol [1236136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tocopherols [M0022803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocophersolan [159151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tocophersolan [M0062589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl nicotinate, D-.alpha. [1359091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tocopheryl nicotinate [M0059695]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl nicotinate, D-.alpha. [1359091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha-tocopheryl nicotinate [M0059696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl retinoate [1313259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tocopheryl retinoate [M0143370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocotrienol, alpha [1424648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tocotrienol, alpha [M0218688]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocotrienols [578285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tocotrienols [M0370452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib [1357536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tofacitinib [M0456724]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib citrate [1358492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tofacitinib citrate [M0585168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofersen [2634995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tofersen [M000736317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofisopam [38365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tofisopam [M0059701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolazamide [M0021626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolazoline [M0021628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolazoline Hydrochloride [M0331290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolbutamide [M0021630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolcapone [72937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3,4-Dihydroxy-5&apos;-methyl-5-nitrobenzophenone [M000642026]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolcapone [72937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolcapone [M0182081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolciclate [38372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tolciclate [M0060960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolfenamic acid [38377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tolfenamic acid [M0054268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolmetin [M0021631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolmetin Sodium [M0329544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolnaftate [10637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolnaftate [M0021633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolonium chloride [10638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolonium Chloride [M0021634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toloxatone [38382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>toloxatone [M0056580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolperisone [10639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolperisone [M0021637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolrestat [38386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tolrestat [M0120716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine [119565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolterodine [M0260056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine tartrate [221174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolterodine Tartrate [M0386986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toltrazuril [1535930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>toltrazuril [M0111498]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolu balsam [1116238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolu balsam [M0095759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toluene [1311381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toluene [M0021638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolvaptan [358257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tolvaptan [M0299851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Topiramate [M0148600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Topotecan [M0029340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Topotecan Hydrochloride [M0329084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toremifene [M0026287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toremifene Citrate [M0026288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>toripalimab [M000678569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>toripalimab [M000678569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea [M000641952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsemide [M0086132]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>totarol [1600439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>totarol [M0210533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tourmaline [853142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tourmaline [M000640732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tovorafenib [M000766352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trabectedin [1716278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trabectedin [M0453081]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tragacanth [M0021756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab [2589225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tralokinumab [M0575947]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tramadol [M0021764]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tramadol Hydrochloride [M0515248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramazoline [38453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tramazoline [M0046867]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib [1425099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trametinib [M0575714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramiprosate [1374845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tramiprosate [M0041505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trandolapril [M0147889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trandolaprilat [M0169475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranexamic acid [10691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tranexamic Acid [M0021767]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranilast [57330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tranilast [M0059240]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>transforming growth factor beta 1 [1426465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Transforming Growth Factor beta1 [M0024760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>transforming growth factor beta 2 [1370419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Transforming Growth Factor beta2 [M0024759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tranylcypromine [M0021846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tranylcypromine Sulfate [M0476865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trapidil [M0021847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trastuzumab [M0291428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trastuzumab deruxtecan [M000654401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trazimera [M000648511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>travoprost [283809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Travoprost [M0403483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone [10737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trazodone [M0021855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trazodone hydrochloride [82112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trazodone Hydrochloride [M0021856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trehalose [1311373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trehalose [M0021860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trehalulose [1428856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trehalulose [M0124304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab [2619313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ticilimumab [M000654733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tremelimumab [2619313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tremelimumab [M0519601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trenbolone [1484278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trenbolone [M000597834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trenbolone acetate [1484277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trenbolone Acetate [M0021871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treosulfan [38508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>treosulfan [M0069890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trepibutone [44532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-(2&apos;,4&apos;,5&apos;-triethoxybenzoyl)propionic acid [M0062642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil [343048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>treprostinil [M0388956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil diolamine [1927409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>treprostinil diolamine [M0588813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>treprostinil sodium [342691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>treprostinil sodium [M0403885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-all-trans-Retinoic Acid [M0021880]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tretinoin [10753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tretinoin [M0021879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetin [10756]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triacetin [M0021888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetoneamine-N-oxyl [10757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triacetoneamine-N-Oxyl [M0021889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triacetyldithranol [38536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triacetyldithranol [M0044676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone [10759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triamcinolone [M0021894]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone acetonide [10761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triamcinolone Acetonide [M0021897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone diacetate [10762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triamcinolone diacetate [M0095841]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamcinolone hexacetonide [38546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triamcinolone hexacetonide [M0047762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triamterene [10763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triamterene [M0021904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triazolam [10767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triazolam [M0021910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triazulenone [38555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triazulenone [M0073636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tribasic sodium phosphate [36710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>phosphoric acid, trisodium salt [M0044806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tribenoside [38557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tribenoside [M0263401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tributyl citrate [1314417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tributyl citrate [M0118881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tributyl phosphate [1314418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tributyl phosphate [M0054314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tributyl phosphite [2399030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tributyl phosphite [M0495562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricaine [1370418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tricaine [M0044687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricalcium phosphate [47628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tricalcium phosphate [M0069864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricaprin [1314419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tricaprin [M0056583]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricaprylin [1314420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tricaprylin [M0044692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triceteareth-4-phosphate [1811770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triceteareth-4-phosphate [M0574157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tricetin [1994358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tricetin [M0443939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlorfon [1000581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichlorfon [M0021916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlormethiazide [10772]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichlormethiazide [M0021917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichloroacetaldehyde [38574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trichloroacetaldehyde [M0075570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichloroacetic acid [10773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichloroacetic Acid [M0021920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichloroethylene [2534464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichloroethylene [M0021923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlorofluoromethane [38578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trichlorofluoromethane [M0047660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trichlorotrifluoroethane [38585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,1,1-trichloro-2,2,2-trifluoroethane [M0047666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclabendazole [2118525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triclabendazole [M0117690]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclocarban [38609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triclocarban [M0054336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclofos [38610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triclofos [M0045368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclofos sodium [104696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triclofos, monosodium salt [M0308544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triclosan [10795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triclosan [M0021945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tridecane [1811766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tridecane [M0247890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tridihexethyl [38617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tridihexethyl [M0046885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tridihexethyl chloride [54421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tridihexylethyl chloride [M0309067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine [10798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trientine [M0021952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trientine hydrochloride [235370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trientine Hydrochloride [M0539407]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine [38623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine [M0054348]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine acetate [2360432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine acetate [M0310820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine hydrochloride [1368178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine hydrochloride [M0310829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine lauryl sulfate [1363986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine lauryl sulfate [M0130455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine phosphate [2287550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine phosphate [M0310819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine polypeptide oleate condensate [38624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine polypeptide oleate condensate [M0042870]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine stearate [38625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine stearate [M0064912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethanolamine sulfate [1655913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethanolamine sulfate [M0310830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethoxysilane [2634293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethoxysilane [M0513223]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethyl citrate [1310554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ethyl citrate [M0079741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethylamine [1307097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethylamine [M0065965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethylene glycol [1368702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethylene glycol [M0092649]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethylene glycoldimethacrylate [2472322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethylene glycol dimethacrylate [M0075276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triethylhexanoin [1368189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triethylhexanoin [M000633768]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifarotene [2205637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trifarotene [M000646400]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine [10800]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trifluoperazine [M0021955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluoperazine hydrochloride [91130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trifluoperazine Hydrochloride [M0354143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluperidol [10804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trifluperidol [M0021961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflupromazine [10805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triflupromazine [M0021962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trifluridine [10803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trifluridine [M0021960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triflusal [38655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triflusal [M0065977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triheptanoin [1313234]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triheptanoin [M0524318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl [10811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trihexyphenidyl [M0021972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trihexyphenidyl hydrochloride [1115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trihexyphenidyl Hydrochloride [M0021971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triisopropanolamine [1426368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triisopropanolamine [M0157846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>2&apos;-((5-(4-Methyl-1-piperazinyl)-2-pyridinyl)amino)-7&apos;,8&apos;-dihydro-6&apos;H-spiro(cyclohexane-1,9&apos;-pyrazino(1&apos;,2&apos;:1,5)pyrrolo(2,3-d)pyrimidin)-6&apos;-one [M000735531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaciclib [2479690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trilaciclib [M000735530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilaurin [1368880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trilaurin [M0045681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilinolein [1655559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trilinolein [M0054381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilinolenin [1655560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trilinolenin [M0265643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trilostane [38668]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trilostane [M0055078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimebutine [10819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimebutine [M0021980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimebutine maleate salt [262296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimebutine Maleate Salt [M0351710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine [10825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimeprazine [M0021986]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimeprazine tartrate [164308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimeprazine tartrate [M0098319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetazidine [10826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimetazidine [M0021987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetazidine dihydrochloride [235779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimetazidine Dihydrochloride [M0476912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethadione [10827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimethadione [M0021989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan [10828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimethaphan [M0021990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethaphan camsylate [38680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimethaphan camsylate [M0068796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethobenzamide [38685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimethobenzamide [M0262805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethoprim [10829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimethoprim [M0021991]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethylamine [1999994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimethylamine [M0080511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethylolpropane [1368881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimethylolpropane [M0069446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethylolpropane triacrylate [1426813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimethylolpropane triacrylate [M0090541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimethylphloroglucinol [38716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>1,3,5-trimethoxybenzene [M0064920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate [42333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimetrexate [M0025316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimetrexate glucuronate [38725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimetrexate glucuronate [M0158006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine [10834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimipramine [M0021995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine maleate [71532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimipramine Maleate [M0329556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimipramine mesylate [236189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trimipramine Mesylate [M0329557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trimyristin [1368882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trimyristin [M0111540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triolein [1368168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triolein [M0022006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trioxsalen [10844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trioxsalen [M0022009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripalmitin [1368169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tripalmitin [M0047681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine [10847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tripelennamine [M0022012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine citrate [71533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tripelennamine Citrate [M0022013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tripelennamine hydrochloride [91063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tripelennamine Hydrochloride [M0329564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triphenylmethane [2287153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triphenylmethane [M0135788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triphosphate [1487534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triphosphate [M0309228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triphosphoric acid [1364529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triphosphoric acid [M0047397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triphosphoric acid, sodium salt [1364528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>triphosphoric acid, sodium salt [M0309226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine [10849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triprolidine [M0022015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triprolidine hydrochloride [71534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triprolidine Hydrochloride [M0329573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin [38782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triptorelin [M0026318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triptorelin Pamoate [M0429053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>triptorelin pamoate [338529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triptorelin Embonate [M000638647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate [253204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trisodium citrate [M0443286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium citrate anhydrous [1310549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sodium Citrate, Anhydrous [M0582745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisodium nitrilotriacetate [1735050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trisodium Nitrilotriacetate [M0014882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tristearin [1368872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tristearin [M0078926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trisulfapyrimidine [38802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trisulfapyrimidine [M0063702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tritoqualine [38810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tritoqualine [M0044812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troclosene [1537576]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>troclosene [M0058312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troclosene sodium [1537575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>troclosene, sodium salt [M0311588]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofinetide [2632852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trofinetide [M000678658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trofosfamide [38865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trofosfamide [M0044822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troglitazone [72610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Troglitazone [M000640328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trolamine salicylate [38866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trolamine salicylate [M0101970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troleandomycin [10864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Troleandomycin [M0021890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromantadine [38868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tromantadine [M0045285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromantadine hydrochloride [236459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tromantadine hydrochloride [M0308504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tromethamine [10865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tromethamine [M0022030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropatepine [38876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tropatepine [M0060985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropicamide [10869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tropicamide [M0022036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropisetron [27392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>(3 alpha-Tropanyl)-1H-indole-3-carboxylic Acid Ester [M000640856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropisetron [27392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Indole-3-carboxylic Acid Tropine Ester [M000640857]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropisetron [27392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tropisetron [M0132280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropisetron hydrochloride [235997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tropisetron Hydrochloride [M0443267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tropolone [1368873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tropolone [M0022040]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trospium chloride [38891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trospium chloride [M0044367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trovafloxacin [115552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>trovafloxacin [M0214301]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>troxerutin [38893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>troxerutin [M0047701]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypan blue [10878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypan Blue [M0022059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trypsin [10890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypsin [M0022078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tryptophan [10898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tryptophan [M0022088]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tuberculin [10908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculin [M0022103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine [10917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tubocurarine [M0022137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tubocurarine chloride [82115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tubocurarine Chloride [M0022138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine [M000743513]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tucatinib [2361285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tucatinib [M000731911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tuftsin [1534774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuftsin [M0022144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tulathromycin [1309314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tulathromycin [M0466009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tulobuterol [38967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tulobuterol [M0056604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tulobuterol hydrochloride [235841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tulobuterol hydrochloride [M0311251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tungsten [1667702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tungsten [M0022158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turmeric extract [1114883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>turmeric extract [M0059721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turmeric oil [1373037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>turmeric extract [M0059721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turmeric root extract [2695722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>turmeric extract [M0059721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turoctocog alfa [1737557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>turoctocog alfa [M0580444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turpentine [10938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Turpentine [M0022172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>turpentine [10938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Turpentine, Oil [M000629497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tybamate [62178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tybamate [M0262806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tylosin [995505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tylosin [M0023982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tylosin tartrate [996012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tylosin Tartrate [M0023983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyloxapol [38998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tyloxapol [M0067043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tylvalosin [1368469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>tylvalosin [M0541553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>typhoid Vi polysaccharide vaccine, S typhi Ty2 strain [807219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vi polysaccharide vaccine, typhoid [M0161214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyramine [10958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyramine [M0022194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyropanoate [10960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyropanoate [M0022199]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyrosine [10962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyrosine [M0022203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tyrothricin [10968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyrothricin [M0022209]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubidecarenone [21406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ubiquinone [M0022211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubidecarenone [21406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>coenzyme Q10 [M0083834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubiquinol [39085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ubiquinol [M0044835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubiquinone Q2 [1423925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ubiquinone Q2 [M0084299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ublituximab [2626349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ublituximab [M000631756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ubrogepant [2268216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ubrogepant [M000628168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal [1005921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ulipristal [M0249843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ulipristal acetate [1005920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ulipristal acetate [M0554383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, beef [235282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, ultralente, beef [M0423955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultralente insulin, human [221110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>insulin, ultralente, human [M0423956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ultramarine blue [1311650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ultramarine (pigment) [M0054474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umbralisib [2478439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>umbralisib [M000641103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umeclidinium [1487514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>umeclidinium [M0584827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>umirolimus [1942479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>umirolimus [M0507755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecane [1811767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>undecane [M0079515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenate [314881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Undecylenates [M0585556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>undecylenic acid [10989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>undecylenic acid [M0533241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>unithiol [10991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Unithiol [M0022297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>upadacitinib [2196092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>upadacitinib [M000646360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uracil [10995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uracil [M0022302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uracil mustard [10996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uracil Mustard [M0022303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uranium [10999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uranium [M0022305]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uranyl nitrate [1858851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uranyl Nitrate [M0022306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urapidil [39230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>urapidil [M0064935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urea [11002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urea [M0022315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urethane [1420982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethane [M0022330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uric acid [1427088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uric Acid [M0022340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine [11017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uridine [M0022344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>uridine triacetate [1665222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>uridine triacetate [M000620292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urofollitropin [134404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urofollitropin [M0013388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>urokinase [11055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urokinase-Type Plasminogen Activator [M0022396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursodiol [11065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ursodeoxycholic Acid [M0022413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ursolic acid [1426931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ursolic Acid [M0047035]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>usnic acid [1546707]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>usnic acid [M0198345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ustekinumab [847083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ustekinumab [M0490173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vaborbactam [1945213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vaborbactam [M000642916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vaccinia virus [1668221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaccinia virus [M0022462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vadadustat [2679296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vadadustat [M000638543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir [73645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valacyclovir [M0224608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valacyclovir hydrochloride [236081]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valacyclovir Hydrochloride [M0224607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valbenazine [1918219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>valbenazine [M000613296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valdecoxib [278567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>valdecoxib [M0360234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valencene [2569979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>valencene [M0493635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valerate [1370574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valerates [M0022494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valerian oil [2593176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>valerian essential oil [M000744346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valerian root extract [253206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valeriana extract [M000744345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valeric acid [1546454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>n-pentanoic acid [M0116541]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir [275891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valganciclovir [M0334922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valganciclovir hydrochloride [283815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valganciclovir Hydrochloride [M0398071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valine [11115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valine [M0022497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valnemulin [2604036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>valnemulin [M0302264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec [2641610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valoctocogene Roxaparvovec [M000758457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valoctocogene roxaparvovec-rvox [2641609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valoctocogene Roxaparvovec [M000758457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproate [40254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valproate [M0022502]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valproic Acid [M0022501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valproic acid [11118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Propylisopropylacetic Acid [M000642455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valrubicin [31435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>valrubicin [M0065971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>valsartan [69749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Valsartan [M0217346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vamorolone [2669799]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vamorolone [M000648789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanadium [11121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vanadium [M0022516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanadyl sulfate [39364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vanadyl sulfate [M0105150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin [11124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vancomycin [M0022517]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vancomycin hydrochloride [66955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vancomycin Hydrochloride [M0022518]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vandetanib [1098413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vandetanib [M0421253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanillin [1368176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vanillin [M0262491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vanillylamine [156075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vanillylamine [M0044855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil [306674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vardenafil [M0387383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride [307306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vardenafil Hydrochloride [M0574172]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vardenafil hydrochloride trihydrate [1309396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vardenafil Hydrochloride Trihydrate [M0574171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline [591622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Varenicline [M0485421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varenicline tartrate [636674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Varenicline Tartrate [M0540610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella zoster virus glycoprotein E [1986821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>glycoprotein E, varicella-zoster virus [M0159511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>varicella-zoster immune globulin [39385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>varicella-zoster immune globulin [M0097167]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasicinone [2673585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vasicinone [M0149112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasoactive intestinal peptide [1942960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vasoactive Intestinal Peptide [M0022549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vasopressin (USP) [M0494241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vasopressin (USP) [11149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vasopressins [M0022562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vat yellow 4 [2621121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vat Yellow 4 [M0178955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vatinoxan [2601584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vatinoxan [M000675753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vatinoxan hydrochloride [2601583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vatinoxan hydrochloride [M000655487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium [71535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vecuronium [M0022573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vecuronium bromide [11153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vecuronium Bromide [M0022572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vedolizumab [1538097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vedolizumab [M0539116]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velafermin [1317116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>velafermin [M0498699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velagliflozin [2665880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>velagliflozin [M000644530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>velpatasvir [1799206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>velpatasvir [M000613522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vemurafenib [1147220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vemurafenib [M0558887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venetoclax [1747556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>venetoclax [M000614617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine [39786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venlafaxine [M0136964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>venlafaxine hydrochloride [235988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venlafaxine Hydrochloride [M0136959]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>veralipride [39468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>veralipride [M0089171]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil [11170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Verapamil [M0022608]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verapamil hydrochloride [203138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Verapamil Hydrochloride [M0541970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verdinexor [2539289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>verdinexor [M000600782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vericiguat [2475830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vericiguat [M000613267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>verteporfin [118886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Verteporfin [M0258373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vestronidase alfa [1989819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vestronidase alfa [M000675458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vestronidase alfa-vjbk [1989818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vestronidase Alfa-Vjbk [M000675459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vibegron [2472254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vibegron [M000618709]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vidarabine [11194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vidarabine [M0022659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vigabatrin [14851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vigabatrin [M0328364]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilanterol [1424884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vilanterol [M0547788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone [1086769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vilazodone [M0477866]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilazodone hydrochloride [1086768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vilazodone Hydrochloride [M0560395]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vildagliptin [596554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vildagliptin [M0486919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vilobelimab [2639620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vilobelimab [M000733659]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine [11196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Viloxazine [M0022667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viloxazine hydrochloride [142143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Viloxazine Hydrochloride [M0329607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viltolarsen [2389840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>viltolarsen [M000677290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine [11198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vinblastine [M0022672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinblastine sulfate [11199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vinblastine Sulfate [M0373265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinburnine [57954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vinburnine [M0066385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincamine [11201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vincamine [M0022675]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine [11202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vincristine [M0022676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vincristine sulfate [11203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vincristine Sulfate [M0022677]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vindesine [11204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vindesine [M0022680]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vindesine sulfate [11205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vindesine Sulfate [M0329487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine [39541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vinorelbine [M0097344]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinorelbine tartrate [114527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vinorelbine Tartrate [M0097343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinpocetine [24506]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vinpocetine [M0062184]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinyl acetate [1368177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vinyl acetate [M0057943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vinyl chloride [1995489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vinyl Chloride [M0022683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viquidil [39580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>viquidil [M0263200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>virginiamycin [11232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virginiamycin [M0022742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>viridiflorol [2374348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>viridiflorol [M0549851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vismodegib [1242987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vismodegib [M0558800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A [11246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin A [M0022788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin A palmitate [35406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>retinol palmitate [M0063601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B complex [11251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Complex [M0022792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B complex [11251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>B Vitamins [M000642489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B12 [11248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 12 [M0022794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin B6 [42954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 6 [M0018248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin D [11253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin D [M0022797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin E [11256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E [M0022802]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K [11258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin K [M0022806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K1 [8308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin K 1 [M0016826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K2 [42781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin K 2 [M0022807]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin K3 [6728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin K 3 [M0022805]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin MK6 [2607025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menaquinone 6 [M0125359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitamin MK7 [2001758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>menaquinone 7 [M0173250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vitexin [2684982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vitexin [M0101916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voclosporin [2475166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>voclosporin [M0527077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>volanesorsen [2637345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Volanesorsen [M000645077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>von Willebrand factor [11274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Factor [M0022850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vonoprazan [2604577]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vonoprazan [M000609957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorapaxar [1537034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vorapaxar [M0523308]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorasidenib [2690647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vorasidenib [M000747519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voriconazole [121243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Voriconazole [M0268951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vorinostat [194337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vorinostat [M0288128]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine [1455099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vortioxetine [M0586839]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vortioxetine hydrobromide [1439834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vortioxetine Hydrobromide [M0588225]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>vosoritide [2586354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>vosoritide [M000653306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxelotor [2265678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>voxelotor [M000645587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>voxilaprevir [1939323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>voxilaprevir [M000632352]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin [11289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warfarin [M0022871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin potassium [82118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warfarin Potassium [M0022872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>warfarin sodium [114194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warfarin Sodium [M0022873]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wasp venoms [11291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wasp Venoms [M0022877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>water [11295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Water [M0022883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wheat germ oil [72385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>wheat germ oil [M0143154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>whole wheat allergenic extract [901299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wheat Flour [M000754496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wine grape extract [1307718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>whole grape extract [M000757544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>withanolide D [2604033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>withanolide D [M0055813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>wogonin [2001619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>wogonin [M0226921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xamoterol [39801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xamoterol [M0026277]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xamoterol fumarate [82133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xamoterol Fumarate [M0026279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline [2694828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>xanomeline [M0202814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanomeline tartrate [2694829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>xanomeline tartrate [M0202813]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanthan gum [1307815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>xanthan gum [M0043217]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanthine [1311085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xanthine [M0029424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xanthinol niacinate [11358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xanthinol Niacinate [M0023047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon [11363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xenon [M0023058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-129 [2626219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xenon-129 [M000627497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xenon-133 [259282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xenon-133 [M000627504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xibornol [39823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>xibornol [M0044892]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xipamide [11371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xipamide [M0023068]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylazine [1099660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xylazine [M0023071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylazine hydrochloride [1366222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xylazine Hydrochloride [M0329491]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylene [1311378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xylene [M0023073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylitol [11377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xylitol [M0023075]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline [39841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>xylometazoline [M0054607]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylometazoline hydrochloride [54220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>xylometazoline hydrochloride [M0310881]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>xylose [11378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xylose [M0023076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yarrow flower extract [1309259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Achillea millefolium flower [M000744069]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yellow OB [1874282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>yellow OB [M0106869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine [220982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Yohimbine [M0023104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yohimbine hydrochloride [133041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Yohimbine Hydrochloride [M0476584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ytterbium [1311498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ytterbium [M0023108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>yttrium [1534770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Yttrium [M0023109]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zafirlukast [114970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zafirlukast [M0173494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zalcitabine [3363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zalcitabine [M0024532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zaleplon [74667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zaleplon [M0227287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanamivir [69722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zanamivir [M0217195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab [2698198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zanidatamab [M000763017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanidatamab-hrii [2698200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zanidatamab [M000763017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanubrutinib [2262435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide [M000734585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zanubrutinib [2262435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zanubrutinib [M000646711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zavegepant [2637955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>BMS 742413 [M0589454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zeatin [1440227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zeatin [M0023121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zeaxanthin [39918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zeaxanthin [M0047729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zeaxanthin, meso- [2531030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>meso-zeaxanthin [M0390787]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zein [1314423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zein [M0023123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab [2699588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zenocutuzumab [M000654482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zenocutuzumab-zbco [2699587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zenocutuzumab [M000654482]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zeranol [1368476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zeranol [M0023124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide [68503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ziconotide [M0210279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziconotide [68503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>omega-conopeptide MVIIA [M000645453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zidovudine [11413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zidovudine [M0023377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zileuton [40575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zileuton [M0175142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilpaterol [1727538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zilpaterol [M0452020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zilucoplan [2672489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zilucoplan [M000752066]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc [11416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc [M0023131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc acetate [58295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc Acetate [M0028798]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc aspartate [236142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc aspartate [M000646605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc bromide [88188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc bromide [M0247257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc carbonate [39935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc carbonate [M0111455]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc chloride [39937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc chloride [M0067083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc dibutyldithiocarbamate [1426942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc dibutyldithiocarbamate [M0068844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc gluconate [58300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc gluconate [M0487534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc glycinate [1306063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc glycinate [M0067084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc hydroxide [42279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc hydroxide [M0149638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc iodide [1921759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc iodide [M0094763]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc methionine [60761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc methionine [M0201134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc methionine sulfate [1426409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc methionine sulfate [M000634823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc orotate [11422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc Orotate [M0015449]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc oxide [11423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc Oxide [M0023133]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc phosphate [1602285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc phosphate [M0128877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc phosphide [1594583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc phosphide [M0054613]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc picolinate [58301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc picolinate [M0096710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc pyrithione [39952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>pyrithione zinc [M0055920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc stearate [1310553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc stearate [M0377371]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate [39954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc Sulfate [M0028716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfate, heptahydrate [1311282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc Sulfate, Heptahydrate [M0329188]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc sulfide [1733817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zinc sulfide [M0098312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zinc-DTPA [11431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zinc-DTPA [M000638438]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zingerone [2199325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zingerone [M0061733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zipeprol [39969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zipeprol [M0061020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone [115698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ziprasidone [M0243639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride [1294533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ziprasidone hydrochloride [M0326878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziprasidone hydrochloride, monohydrate [284925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ziprasidone hydrochloride, monohydrate [M000637181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zirconium [1534771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zirconium [M0023146]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zirconium oxide [39972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zirconium oxide [M0091757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ziv-aflibercept [1304475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>ZIV-aflibercept [M0581795]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zofenopril [39990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zofenopril [M0130994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam [1535252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zolazepam [M0023149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolazepam hydrochloride [1999183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zolazepam Hydrochloride [M0353134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab [2695869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zolbetuximab [M000655078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab [2695869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>claudiximab [M0590488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolbetuximab-clzb [2695870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zolbetuximab [M000655078]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid [77655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zoledronic Acid [M0234600]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zoledronic acid anhydrous [1546014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zoledronic Acid Anhydrous [M0234599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolmitriptan [135775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zolmitriptan [M0237257]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem [39993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zolpidem [M0140872]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zolpidem tartrate [221183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zolpidem Tartrate [M0398706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zomepirac [39994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zomepirac [M0074328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zomepirac sodium [58331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zomepirac sodium [M0314213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>3-Sulfamoylmethyl-1,2-benzisoxazole [M000642447]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zonisamide [39998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zonisamide [M0077929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zopiclone [40001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zopiclone [M0075579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zotepine [40003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zotepine [M0077882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuclopenthixol [114176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zuclopenthixol [M0004623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuclopenthixol acetate [58338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>clopenthixol acetate ester [M0167711]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuclopenthixol acetate [58338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zuclopenthixol acetate [M000634896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuclopenthixol decanoate [58339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zuclopenthixole decanoate [M0094504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>Synonym Of</name>
   <from_namespace>RxNorm R</from_namespace><from_name>zuranolone [2669905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>zuranolone [M000655789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>NLMUMLS</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>17-alpha-hydroxyprogesterone [5542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenocarcinoma [M0000355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2,2-bis(4-hydroxy-3-tert-butylphenyl)propane [2267021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenocarcinoma [M0000355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>2-phenylpropanal propylene glycol acetal [1947505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism [M0010845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets [M0019095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>24-homo-1,25-dihydroxyvitamin D3 [1423458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4,6-bis(1-methylpentyl)resorcinol [2719298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne [M000636800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>4-aminobenzoic acid [74]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>6-aminocaproic acid [99]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ADAMTS13, recombinant [2670285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enzyme Replacement Therapy [M0533570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ADAMTS13, recombinant-krhn [2670286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enzyme Replacement Therapy [M0533570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Agkistrodon piscivorus antivenin [885183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Frostbite [M0008850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aloe vera preparation [318340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Alternaria alternata allergenic extract [901845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity, Immediate [M0010854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Angelica sinensis preparation [328141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica extract [144377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Contusions [M0005130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica extract [144377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myalgia [M0577885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Arnica extract [144377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus [1182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus fumigatus allergenic extract [466192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus niger allergenic extract [1742530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aspergillus terreus allergenic extract [314324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Astragalus preparation [319818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis [M0010205]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Aureobasidium pullulans var. pullutans allergenic extract [852102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG Vaccine [1344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Montreal strain [314513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>BCG, live, Tice strain [221050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Bermuda grass pollen extract [851906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Botrytis cinerea allergenic extract [466195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>C1 esterase inhibitor (human) [809864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedemas, Hereditary [M0502559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans [1963]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Candida albicans allergenic extract [214355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia [M0014687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum extract [319780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Capsicum oleoresin [235787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia [M0014687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Centruroides (scorpion) immune F(ab&apos;)2 (equine) [1119986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scorpion Stings [M0585473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cephalosporium roseum extract [1925834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chaetomium globosum allergenic extract [466197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Chrysonilia sitophila allergenic extract [314411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cladosporium herbarum allergenic extract [466198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Cochliobolus sativus allergenic extract [852398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 (equine) [2101270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalidae immune F(ab&apos;)2 [2101271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus adamanteus antivenin [885185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus atrox antivenin [885187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Crotalus scutulatus antivenin [885189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Curvularia inequalis allergenic extract [999438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia [M0000757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>D-biotin [314583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metabolism, Inborn Errors [M0013496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>DIGITALIS,POWDERED [484908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Digitalis preparation [91235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Echinacea preparation [228041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Eurotium herbariorum allergenic extract [999450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Fusarium oxysporum vasinfectum allergenic extract [867228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ginkgo biloba extract [236809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Memory Disorders [M0013349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Johnson grass pollen extract [852136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>June grass pollen extract [851965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Juniperus communis fruit extract [1310189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Kentucky bluegrass pollen extract [852834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus casei [1592255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus GG [602811]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lacticaseibacillus rhamnosus [100278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum 299 [2706643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactiplantibacillus plantarum [1673942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus [6204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus BCMC 12130 [2639942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus acidophilus [6205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus bifidus [236855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus crispatus [2054188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus delbrueckii subsp. bulgaricus [100272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Lactobacillus helveticus [1310845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Latrodectus mactans antivenin [89887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spider Bites [M0001654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Ligilactobacillus salivarius [2110033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri [285156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Limosilactobacillus reuteri subsp. reuteri F275 [2668424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Mucor plumbeus allergenic extract [314415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>North American coral snake antivenin [979384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>OPIUM, POWDERED [221135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-100 stearate [1367120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>PEG-4 dilaurate [1363613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spirochaetales Infections [M0020349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Penicillin [70618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus arrhizus allergenic extract [314443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhizopus stolonifer allergenic extract [967721]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rho(D) immune globulin, human [1789837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rh Isoimmunization [M0018993]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Rhodotorula rubra allergenic extract [867321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein [2606074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) [2610326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) [2691168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) [2610243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) [2691192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 [2606073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 [2666309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 [2688626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>SIMETHICONE-CELLULOSE [283585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Saccharomyces boulardii [236782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Soy Proteins [36853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Tetanus Antitoxin [10385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Timothy grass pollen extract [851994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichoderma viride allergenic extract [968401]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichophyton mentagrophytes allergenic extract [867357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Trichothecium roseum allergenic extract [968426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein [2624741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ebola Virus, Zaire [M0383755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir [190521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abacavir sulfate [221052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abaloparatide [1921069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abametapir [2475532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pediculus [M0016087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abarelix [301739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abatacept [614391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abciximab [83929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abemaciclib [1946825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone [1100072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms, Castration-Resistant [M0579765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abiraterone acetate [1100071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms, Castration-Resistant [M0579765]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abobotulinumtoxinA [860168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>abrocitinib [2591476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acalabrutinib [1986808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate [82819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acamprosate calcium [152761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acarbose [16681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol [149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acebutolol hydrochloride [142130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine [2721766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Presbyopia [M0017556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclidine hydrochloride [2721767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Presbyopia [M0017556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceclofenac [16689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acemannan [1426875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Feline [M0025292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aceprometazine [161203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Deprivation [M0019965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetaminophen [161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetanilide [162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetanilide [162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syncope [M0020955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide [167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Altitude Sickness [M0000819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Altitude Sickness [M0000819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetazolamide sodium [91406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic acid [168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic acid [168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetic acid [168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohexamide [173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetohydroxamic acid [16728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine [16735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetophenazine maleate [91127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Fistula [M0024667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocardia Infections [M0014935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetyl sulfisoxazole [40595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine [193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride [476316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine hydrochloride, DL- [1593400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcarnitine, DL- [1310540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine [194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Compassion Fatigue [M000602637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Compassion Fatigue [M000602637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcholine chloride [20814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis [M0001053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine [197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchiectasis [M0002968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis [M0001053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine amide [1591923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchiectasis [M0002968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchiectasis [M0002968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis [M0001053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine magnesium [1809634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchiectasis [M0002968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine sodium [237163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis [M0001053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchiectasis [M0002968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis [M0001053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylcysteine zinc [1490795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acetylsalicylate sodium [314293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Fever [M0019009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acitretin [16818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium [1303098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Disease, Chronic Obstructive [M0384655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium [1303098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aclidinium bromide [1303097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Disease, Chronic Obstructive [M0384655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoltremon [2716801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis [2698312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis [2698312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiomyopathies [M0014337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis hydrochloride [2698313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acoramidis hydrochloride [2698313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiomyopathies [M0014337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acrivastine [19959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated attapulgite [133050]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uremia [M0022319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxemia [M0021721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>activated charcoal [272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster Ophthalmicus [M0010281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epstein-Barr Virus Infections [M0029738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chickenpox [M0004041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Encephalitis, Herpes Simplex [M0328381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Labialis [M0010278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir [281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Genitalis [M0010276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster Ophthalmicus [M0010281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epstein-Barr Virus Infections [M0029738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chickenpox [M0004041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Encephalitis, Herpes Simplex [M0328381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Labialis [M0010278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>acyclovir sodium [81944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Genitalis [M0010276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adagrasib [2625882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab [327361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aacf [2640849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aaty [2639649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adaz [2641642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-adbm [2103477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-afzb [2619155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-aqvh [2640387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-atto [2103479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-bwwd [2612153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-fkjp [2640402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hidradenitis Suppurativa [M0026548]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adalimumab-ryvk [2677776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adapalene [60223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir [16521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adefovir dipivoxil [141400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenine [290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Atrioventricular Nodal Reentry [M0020998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine [296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wolff-Parkinson-White Syndrome [M0022990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wolff-Parkinson-White Syndrome [M0022990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Atrioventricular Nodal Reentry [M0020998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine monophosphate [309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wolff-Parkinson-White Syndrome [M0022990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Atrioventricular Nodal Reentry [M0020998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine phosphate disodium [1306123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wolff-Parkinson-White Syndrome [M0022990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>adenosine triphosphate [318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Atrioventricular Nodal Reentry [M0020998]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ado-trastuzumab emtansine [1371041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aducanumab [2557217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aducanumab-avwa [2557218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide [2262250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protoporphyria, Erythropoietic [M0026013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamelanotide acetate [2278002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protoporphyria, Erythropoietic [M0026013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afamitresgene autoleucel [2690256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Synovial [M0020963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib [1430438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>afatinib dimaleate [1430441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept [1232150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-ayyh [2696256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-ayyh [2696256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-boav [2725885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-boav [2725885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-mrbb [2706479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-mrbb [2706479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-yszy [2715399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aflibercept-yszy [2715399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase alfa [2691830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>agalsidase beta [338817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fabry Disease [M0001191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine [426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alanine, DL- [1546161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin [141440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alatrofloxacin mesylate [221054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichuriasis [M0021941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hymenolepiasis [M0010803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxocariasis [M0021726]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurocysticercosis [M0029731]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Echinococcosis [M0006960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Necatoriasis [M0014540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancylostomiasis [M0001101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clonorchiasis [M0004618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albendazole [430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opisthorchiasis [M0015338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albiglutide [1534763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoalbuminemia [M0404823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Diseases [M0012014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human, USP [828529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypovolemia [M0328462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoalbuminemia [M0404823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Diseases [M0012014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin human-kjda [2054166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypovolemia [M0328462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoalbuminemia [M0404823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypovolemia [M0328462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,aggregated [317176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypovolemia [M0328462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoalbuminemia [M0404823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albumin,microsphere human serum [314302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol [435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albuterol sulfate [142153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>albutrepenonacog alfa [1743992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcaftadine [1000082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone [108088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alclometasone dipropionate [17268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alcohol, x-ray exposed (1000 rad) [1368126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Complex Regional Pain Syndromes [M0328368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aldesleukin [70223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib [1727455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alectinib hydrochloride [1727454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alefacept [299635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alemtuzumab [117055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate [46041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate [46041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate sodium [203152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronate sodium [203152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronic acid [236083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alendronic acid [236083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin [17300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alfuzosin hydrochloride [46043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alginate [1370451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alginic acid [17305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Diseases [M0012644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucerase [46049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Splenic Diseases [M0020368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alglucosidase alfa [629565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycogen Storage Disease Type II [M0009470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alirocumab [1659152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alirocumab [1659152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atherosclerosis [M0001903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren [325646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aliskiren hemifumarate [732498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alitretinoin [81864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alitretinoin [81864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin [508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Abnormalities [M0019926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin [508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin, (+)- [1739978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Abnormalities [M0019926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allantoin, (+)- [1739978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, false ragweed pollen [314365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allergenic extract, pigweed, spiny, pollen [314428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen [2626471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat [2626470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic processed thymus tissue [2626460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immune Reconstitution [M000625869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogeneic processed thymus tissue-agdc [2626459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immune Reconstitution [M000625869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allogenic bone-marrow-derived mesenchymal stem cells [2700761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Reaction [M0009579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol [519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>allopurinol sodium [80566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almond allergenic extract [892507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan [279645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>almotriptan malate [283792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloe extract [91263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloe extract [91263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aloe extract [91263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin [1368001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alogliptin benzoate [1368000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Pain [M0024135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron [85248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alosetron hydrochloride [85247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Pain [M0024135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpelisib [2169285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpelisib [2169285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms, Male [M0027832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha 1-proteinase inhibitor, human [991743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>alpha 1-Antitrypsin Deficiency [M0029552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha tocopherol [237099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha,alpha-dibromo-d-camphor [1858362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tooth Diseases [M0021674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha,alpha-dibromo-d-camphor [1858362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol acetate [1046243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol calcium succinate, DL- [2598017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol linoleate, D- [1427235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate [39626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, D- [1426447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alpha-tocopherol succinate, DL- [2370134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Agoraphobia [M0000579]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprazolam [596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol [597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprenolol hydrochloride [81947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Valve Stenosis [M0018143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impotence, Vasculogenic [M0028121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetralogy of Fallot [M0021243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoplastic Left Heart Syndrome [M0027929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tricuspid Atresia [M0028123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aortic Coarctation [M0001549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ductus Arteriosus, Patent [M0006877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alprostadil [598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aortic Arch Syndromes [M0001546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stroke [M0328070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intracranial Embolism and Thrombosis [M0333623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>alteplase [8410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arterial Occlusive Diseases [M0001730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>altretamine [5296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum acetate [17609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum acetate [17609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum carbonate [89858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride [46241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dental Caries [M0005854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dental Caries [M0005854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride anhydrous [1608145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chloride hexahydrate [17611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dental Caries [M0005854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum chlorohydrate [17610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide [612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide gel [613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide sulfate (Al(OH)(SO4)) [1806902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum hydroxide, dried (USP) [81948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aluminum magnesium silicate [17614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease, Secondary [M0015968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine [620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Akathisia, Drug-Induced [M0025992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Akathisia, Drug-Induced [M0025992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease, Secondary [M0015968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine hydrochloride [282415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease, Secondary [M0015968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amantadine sulfate [621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Akathisia, Drug-Induced [M0025992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium [623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambenonium chloride [624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ambrisentan [358274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amcinonide [17652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Typhus [M0022192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amdinocillin [626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine [2106338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lambert-Eaton Myasthenic Syndrome [M0023968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifampridine phosphate [2106337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lambert-Eaton Myasthenic Syndrome [M0023968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine [4126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries, Experimental [M0018383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amifostine anhydrous [1545987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries, Experimental [M0018383]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Infections [M0003806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin [641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin liposomal [2059180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium avium Complex [M0023507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Infections [M0003806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate [643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amikacin sulfate, liposomal [2059179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium avium Complex [M0023507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyuria [M0017271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride [644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride [142424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyuria [M0017271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyuria [M0017271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiloride hydrochloride, anhydrous [1298837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminoglutethimide [677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Hormone-Dependent [M0014599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid [683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Actinic [M0518969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminolevulinic acid hydrochloride [261715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Actinic [M0518969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline [689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline dihydrate [1298965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminophylline hydrate [388049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aminosalicylic acid [7833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone [703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amiodarone hydrochloride [203114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline [704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline hydrochloride [203168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline oxide [236734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amitriptyline pamoate [235737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab [2549199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amivantamab-vmjw [2549198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlexanox [46307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ulcer [M0022226]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine [17767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine benzoate [2184116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amlodipine besylate [104416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonia spirit, aromatic [317201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Unconsciousness [M0022251]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonia spirit, aromatic [317201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Bites and Stings [M0011381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium chloride [712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metabolic Diseases [M0013493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium chloride [712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Water-Electrolyte Imbalance [M0022901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium lactate [215247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ichthyosis Vulgaris [M0024611]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ammonium molybdate [17789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital [719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amobarbital sodium [1314242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol [2667256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amosulalol hydrochloride [2667255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychophysiologic Disorders [M0018036]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxapine [722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin [723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin anhydrous [1297882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin sodium [267360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amoxicillin trihydrate [133008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine [725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate [221057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine aspartate monohydrate [405812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine saccharate [540810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphetamine sulfate [81952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fungemia [M0025155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Cryptococcal [M0025746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paracoccidioidomycosis [M0015861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sporotrichosis [M0020384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B [732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zygomycosis [M0029826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fungemia [M0025155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paracoccidioidomycosis [M0015861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Cryptococcal [M0025746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zygomycosis [M0029826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sporotrichosis [M0020384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B colloidal dispersion [101299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis [M0003258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Cryptococcal [M0025746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B lipid complex [2001759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paracoccidioidomycosis [M0015861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Cryptococcal [M0025746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zygomycosis [M0029826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sporotrichosis [M0020384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fungemia [M0025155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amphotericin B liposomal [236594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin (anhydrous) [221058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin [733]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin sodium [81953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ampicillin trihydrate [203115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amprenavir [228656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amyl nitrite [742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>amylase / lipase / protease [392491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Exocrine Pancreatic Insufficiency [M0015801]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anacaulase [2626723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>escharase [M0116856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anacaulase-bcdb [2626722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>escharase [M0116856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytosis [M0021429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide [596724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytosis [M0021429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anagrelide hydrochloride [236612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryopyrin-Associated Periodic Syndromes [M0527944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anakinra [72435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anastrozole [84857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>andexanet alfa [2045114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>androstenedione [784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Weakness [M0028272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II [1999003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>angiotensin II acetate, human [2204740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous dextrose [349730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous tacrolimus [235991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anhydrous zinc acetate [1299637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Abscess [M0028122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anidulafungin [341018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab [2565265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuropsychiatric Systemic Lupus Erythematosus [M0335427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anifrolumab-fnia [2565276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuropsychiatric Systemic Lupus Erythematosus [M0335427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Embolism [M0007248]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Occlusion [M0005192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisindione [17941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anisotropine [89780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anistreplase [40028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab [2472152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ebola Virus, Zaire [M0383755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ansuvimab-zykl [2472151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ebola Virus, Zaire [M0383755]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline [865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline hydrochloride [81954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline phosphate [866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline sulfate [2680384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antazoline sulfate [2680384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthralin [873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin [1722336]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anthrax immune globulin, human [1722335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>anti-inhibitor coagulant complex [314504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated [1741397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant) pegylated-exei [2275722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein [2631084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl [2631083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor (recombinant), PEGylated-aucl [2055654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human [203083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant [1300486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, human recombinant residues 743-1636 deleted [1300485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine B-domain truncated recombinant [1592899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antihemophilic factor, porcine [221060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antipyrine [1001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antithrombin III, human [221062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antithrombin III Deficiency [M0029883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antithrombin III, human [221062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Veno-Occlusive Disease [M0010204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>antithrombin III, human [221062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Disseminated Intravascular Coagulation [M0006587]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apalutamide [1999574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apixaban [1364430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine [1043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apomorphine hydrochloride [71225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine [14845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apraclonidine hydrochloride [91350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>apremilast [1492727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprobarbital [17381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprocitentan [2679059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aprotinin [1056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin [87866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ardeparin sodium [87865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol [304962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol tartrate [668284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol tartrate [668284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arformoterol tartrate [668284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban [15202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>argatroban anhydrous [1546207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine [1091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkalosis [M0000714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine [1091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aminobenzoate [1010241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aminobenzoate [1010241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkalosis [M0000714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aspartate [18254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkalosis [M0000714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine aspartate [18254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine hydrochloride [89918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkalosis [M0000714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine hydrochloride [89918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, D- [1742746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, D- [1742746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkalosis [M0000714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, DL- [1729154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alkalosis [M0000714]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arginine, DL- [1729154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol [2694283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niemann-Pick Disease, Type C [M0335789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol [2694283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurodegenerative Diseases [M0029135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol citrate [2694282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Niemann-Pick Disease, Type C [M0335789]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arimoclomol citrate [2694282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurodegenerative Diseases [M0029135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole [89013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aripiprazole lauroxil [1673265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>armodafinil [641465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Wake Disorders [M000601712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic [1111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Promyelocytic, Acute [M0023830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>arsenic trioxide [18330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Promyelocytic, Acute [M0023830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemether [18343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>artemether [18343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine [592464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>articaine hydrochloride [2117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib [2584304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asciminib hydrochloride [2584303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyrosinemias [M0328654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scurvy [M0019569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methemoglobinemia [M0013565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ascorbic acid [1151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds, Penetrating [M0023024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine [784649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine [784649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine [784649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine maleate [860647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asenapine maleate [860647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asfotase alfa [1720259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatasia [M0010915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholelithiasis [M0004241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase Erwinia chrysanthemi (recombinant)-rywn [2561249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asparaginase [1156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholelithiasis [M0004241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartate magnesium hydrochloride [1167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspartic acid [1169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Fever [M0019009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aspirin [1191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astemizole [42328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astemizole [42328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>astemizole [42328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>asunaprevir [1652103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir [343047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atazanavir sulfate [358299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atenolol [1202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Small Cell Lung Carcinoma [M0520106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Alveolar Soft Part [M0027463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab [1792776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Small Cell Lung Carcinoma [M0520106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atezolizumab-tqjs [2693883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Alveolar Soft Part [M0027463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atidarsagene autotemcel [2677916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukodystrophy, Metachromatic [M0012416]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atogepant [2571813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine [38400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atomoxetine hydrochloride [353103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin [83367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium [83366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium anhydrous [2569977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium propylene glycol solvate [1483793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atorvastatin calcium trihydrate [1297766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis, Cerebral [M0025573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atovaquone [60212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atrasentan [2710449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteinuria [M0017891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinoatrial Block [M0019897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine [1223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinoatrial Block [M0019897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>atropine sulfate [153971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>attapulgite [18516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>auranofin [1227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aurothioglucose [4980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol [2645108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Geographic Atrophy [M0534465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacincaptad pegol sodium [2645107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Geographic Atrophy [M0534465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avacopan [2572100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [M0528192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa [2565814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acid Maltase Deficiency [M0535557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa [2565814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycogen Storage Disease Type II [M0009470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa-ngpt [2565813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycogen Storage Disease Type II [M0009470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avalglucosidase alfa-ngpt [2565813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acid Maltase Deficiency [M0535557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avanafil [1291301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erectile Dysfunction [M0011178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avapritinib [2272107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag [2045726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avatrombopag maleate [2045727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avelumab [1875534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam [1603834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avibactam sodium [1603833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avobenzone [45045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib [2714515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovary Cancer [M0015592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>avutometinib potassium [2714514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovary Cancer [M0015592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab [2691526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chronic Graft-Versus-Host Disease [M000759408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axatilimab-csfr [2691528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chronic Graft-Versus-Host Disease [M000759408]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>axitinib [1242999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Sideroblastic [M0001141]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelomonocytic, Chronic [M0023835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azacitidine [1251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Refractory [M0001138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ear Diseases [M0006941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine [18600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ear Diseases [M0006941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azatadine maleate [58275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine [1256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azathioprine sodium [267476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelaic acid [18602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine [18603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azelastine hydrochloride [235824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin [18609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azidocillin sodium [236787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan [1091643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan kamedoxomil [1294597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azilsartan medoxomil [1091642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neisseriaceae Infections [M0025673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin [18631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neisseriaceae Infections [M0025673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin anhydrous [1299904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neisseriaceae Infections [M0025673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin dihydrate [253155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neisseriaceae Infections [M0025673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin monohydrate [1298839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neisseriaceae Infections [M0025673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azithromycin sodium dihydrogen phosphate [2679612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin [1266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin [1266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin [1266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin sodium [203836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin sodium [203836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>azlocillin sodium [203836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometritis [M0007414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>aztreonam [1272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin [18687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacampicillin hydrochloride [327584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin A [1986366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin [1291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bacitracin zinc [11417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal Cord Injuries [M0020312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal Cord Ischemia [M0328309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal Cord Neoplasms [M0020313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hiccup [M0010343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelitis, Transverse [M0014322]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trigeminal Neuralgia [M0021966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Huntington Disease [M0010660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylolysis [M0020379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Palsy [M0003888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baclofen [1292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir [2197842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir marboxil [2099995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza A virus [M0015475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baloxavir marboxil [2099995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza B virus [M0015476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide [18747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>balsalazide disodium [153718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol [18751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emphysema [M0007311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bambuterol hydrochloride [235862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emphysema [M0007311]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bamlanivimab [2463114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital [1325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barbital sodium [235404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>baricitinib [2047232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barnidipine hydrochloride [283819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>barnidipine hydrochloride [283819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>basic aluminum carbonate gel [18789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene [1441386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bazedoxifene acetate [1442171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bebtelovimab [2592360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 breakthrough infections [M000750345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>becaplermin [115238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone 17-monopropionate [1546384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone [1347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate [1348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beclomethasone dipropionate monohydrate [253156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline [1364504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline [1364504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Multidrug-Resistant [M0027284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bedaquiline fumarate [1364503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Multidrug-Resistant [M0027284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beech pollen extract [852419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beets preparation [319826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab [2387844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin [2387834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belantamab mafodotin-blmf [2387833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belimumab [1092437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belinostat [1543543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, T-Cell, Peripheral [M0025095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna alkaloids [1359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna extract, USP [89781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belladonna leaf extract [314517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil [2564025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belumosudil mesylate [2565692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>belzutifan [2567226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Hippel-Lindau Disease [M0010373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin [280611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bemiparin sodium [436195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atherosclerosis [M0001903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bempedoic acid [2282403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemia Type II [M0010819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril [18867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazepril hydrochloride [235758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benazeprilat [1546196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine [134547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine [134547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine hydrochloride [1114693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendamustine hydrochloride [1114693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bendroflumethiazide [1369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benperidol [1373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benralizumab [1989100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine [2690627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzgalantamine gluconate [2690626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone [2001352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzhydrocodone hydrochloride [2122776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child, Preschool [M0004082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child [M0004045]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benznidazole [18994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chagas Disease [M0022076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oral Ulcer [M0028634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine [1399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Earache [M0006949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Earache [M0006949]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oral Ulcer [M0028634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzocaine hydrochloride [1049105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzonatate [18993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzonatate [18993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hiccup [M0010343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoyl peroxide [1418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzoyl peroxide [1418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine [1422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzphetamine hydrochloride [142425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide [19041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzquinamide hydrochloride [91272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzthiazide [19008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine [1424]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benztropine mesylate [18927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl alcohol [1426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>benzyl alcohol [1426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Labialis [M0010278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine [863035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepotastine besilate [658552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil [1436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bepridil hydrochloride [235752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beractant [46967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beractant [46967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infant, Premature [M0011288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Carcinoma [M0025699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Esophagus [M0332429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Stomach [M0333444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Tract Cancer [M0332162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Pleural Mesothelioma [M000731650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa [2723752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Carcinoma [M0025699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Esophagus [M0332429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Stomach [M0333444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Tract Cancer [M0332162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Pleural Mesothelioma [M000731650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berahyaluronidase alfa-pmph [2723755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer [2710434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molluscum Contagiosum [M0013995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer free acid [2710444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molluscum Contagiosum [M0013995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>berdazimer sodium [2710445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molluscum Contagiosum [M0013995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec [2637758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beremagene geperpavec-svdt [2637757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>besifloxacin [819911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-D-glucopyranose [1442190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-alanine [61]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>beta-lactoglobulin (bovine) [2722644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Human Papillomavirus Infection [M000757603]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine [1512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Homocystinuria [M0010516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine citrate [160460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Homocystinuria [M0010516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaine hydrochloride [81965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Homocystinuria [M0010516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone [1514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone acetate [1516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone benzoate [1517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate [19254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone dipropionate, augmented [215664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone sodium phosphate [203220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betamethasone valerate [227897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol [1520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betaxolol hydrochloride [142144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol [19257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bethanechol chloride [47088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>betibeglogene autotemcel [2610349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-Thalassemia [M0025960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab [253337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-adcd [2627648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-awwb [2046138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-bvzr [2268037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-maly [2599041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-nwgd [2712044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovary Cancer [M0015592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Cancer [M0482643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bevacizumab-tnjn [2700660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bexarotene [233272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, T-Cell, Cutaneous [M0025093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bezlotoxumab [1855048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bicalutamide [83008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir [1999660]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bictegravir sodium [1999661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bifonazole [19295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bile salts [1540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemia Type II [M0010819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimatoprost [283810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab [2668041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bimekizumab-bkzx [2668080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>binimetinib [2049122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biotin [1588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metabolism, Inborn Errors [M0013496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biotin [1588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden [1589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden hydrochloride [91154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>biperiden lactate [19377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>birch triterpenes [2675583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epidermolysis Bullosa [M0007557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisacodyl [1596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth [1599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth hydroxide [235954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcarbonate [19475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subcitrate [47181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subgallate [19476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subnitrate [19477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth subsalicylate [19478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bismuth-formic-iodide [237148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Diseases [M0020542]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol [19484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bisoprolol fumarate [142146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol [19499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol [19499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol mesylate [47187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bitolterol mesylate [47187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin [60819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bivalirudin trifluoroacetate [2380556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>black cohosh extract [236665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Teratocarcinoma [M0027472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choriocarcinoma [M0004339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin [1622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Teratocarcinoma [M0027472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bleomycin sulfate [1621]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choriocarcinoma [M0004339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>blinatumomab [1597258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boceprevir [1102129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol [19605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bopindolol hydrogen malonate [236903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>borage oil [68905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boric acid [1700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunburn [M0020814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boric acid [1700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Bites and Stings [M0011381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>boric acid [1700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diaper Rash [M0006208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bortezomib [358258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan [75207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan anhydrous [1468845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosentan monohydrate [498193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib [1307619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bosutinib monohydrate [1314319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2 [1722697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin A immune FAB2, equine [1722696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2 [1722684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin B immune FAB2, equine [1722683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2 [1722699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin C immune FAB2, equine [1722698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2 [1722701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin D immune FAB2, equine [1722700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2 [1722703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin E immune FAB2, equine [1722702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2 [1722705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin F immune FAB2, equine [1722704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2 [1722707]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum neurotoxin G immune FAB2, equine [1722706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type A [1712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type B [2167673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cervical Dystonia [M0381453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulinum toxin type B [2167673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulism immune globulin IV human [544488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>botulism immune globulin IV human [544488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infant [M0011265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide [2176312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoactive Sexual Desire Disorder [M0029725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bremelanotide acetate [2176311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoactive Sexual Desire Disorder [M0029725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brensocatib [2721880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchiectasis [M0002968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brentuximab vedotin [1147320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large-Cell, Immunoblastic [M0025080]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium [19685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bretylium tosylate [1737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexanolone [2121777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression, Postpartum [M0028442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexpiprazole [1658314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brexucabtagene autoleucel [2387277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brigatinib [1921217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine [134615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brimonidine tartrate [39171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brincidofovir [2599518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Smallpox [M0019977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brinzolamide [194881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brivaracetam [1739745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brodalumab [1872251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab [2204915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wet Macular Degeneration [M0534746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brolucizumab-dbll [2204916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wet Macular Degeneration [M0534746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromazepam [1749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Pain [M0542422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac [19737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Pain [M0542422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromfenac sodium [47364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroleptic Malignant Syndrome [M0014713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenoma [M0000367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Galactorrhea [M0008935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperprolactinemia [M0010850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine [1760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperprolactinemia [M0010850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Galactorrhea [M0008935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroleptic Malignant Syndrome [M0014713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenoma [M0000367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromocriptine mesylate [142426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine [19759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromodiphenhydramine hydrochloride [91065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol [19777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol [19777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol decanoate [186024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bromperidol decanoate [186024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine [1767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine maleate [142427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>brompheniramine tannate [405414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine [59636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buclizine hydrochloride [91070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammatory Bowel Diseases [M0023374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide (11.beta.,16.alpha.(S)) [1367172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budesonide [19831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammatory Bowel Diseases [M0023374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine [19832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>budipine hydrochloride [236892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil [19836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Arterial Disease [M0490511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buflomedil hydrochloride [235934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Arterial Disease [M0490511]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Acute [M0012015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Edema [M0018125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bumetanide [1808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine [1815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride [267396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupivacaine hydrochloride anhydrous [1375412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia [M0020996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol [1817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia [M0020996]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupranolol hydrochloride [236806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heroin Dependence [M0010272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine [1819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heroin Dependence [M0010272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buprenorphine hydrochloride [203841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion [42347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrobromide [993548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>bupropion hydrochloride [203204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab [2043855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets, X-Linked Hypophosphatemic [M0577258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>burosumab-twza [2043854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets, X-Linked Hypophosphatemic [M0577258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intellectual Disability [M0013414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone [1827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intellectual Disability [M0013414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>buspirone hydrochloride [203116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>busulfan [1828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital [477631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butabarbital sodium [91109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butacaine [1829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butalbital [19860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine [47461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butenafine hydrochloride [236558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butobarbital [19874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole [19884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butoconazole nitrate [47464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol [1841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butorphanol tartrate [203170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>butylparaben [1306937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabazitaxel [996051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperprolactinemia [M0010850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenoma [M0000367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabergoline [47579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir [2475077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabotegravir sodium [2475076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib [1363268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cabozantinib s-malate [1363267]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cadexomer iodine [20012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections and Mycoses [M0002125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine [1886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine citrate [20033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caffeine monohydrate [236112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol [2121416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calaspargase pegol-mknl [2121417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoparathyroidism [M0010912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcifediol anhydrous [1855064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial Hypophosphatemic Rickets [M0577083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene [29365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcipotriene hydrate [1299898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteitis Deformans [M0015507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteogenesis Imperfecta [M0015534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitonin [1311287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism [M0010845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets [M0019095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcitriol [1894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium acetate [214342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium carbonate [1897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride [1901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride anhydrous [1667640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride dihydrate [221068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride monohydrate [2678349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride monohydrate [2678349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride monohydrate [2678349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium chloride monohydrate [2678349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate [47613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium citrate anhydrous [2106283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dihydrogen phosphate [236560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium dihydrogen phosphate [236560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glubionate [25806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluceptate [47618]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spider Bites [M0001654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate [1908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spider Bites [M0001654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetany [M0021207]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium gluconate monohydrate [1298846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium glycerophosphate [1909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium lactate [47622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium levulinate [47624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium oxybate [2387307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cataplexy [M0003627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium pantothenate [1918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate [1919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, dihydrate [1310463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium phosphate, monobasic, anhydrous [1426444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diverticulitis, Colonic [M0006631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium polycarbophil [20063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium sodium phosphate [2288215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium undecylenate [89746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections and Mycoses [M0002125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium undecylenate [89746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calcium valproate [1927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calfactant [232539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol [1424676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>calteridol calcium [1424675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor (natural) [1298738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tooth Diseases [M0021674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor (natural) [1298738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor [1952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tooth Diseases [M0021674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor [1952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor oil [1297880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>camphor oil [1297880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tooth Diseases [M0021674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin [1373458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canagliflozin anhydrous [1546031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryopyrin-Associated Periodic Syndromes [M0527944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mevalonate Kinase Deficiency [M0501212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>canakinumab [853491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial Mediterranean Fever [M0016320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan [214354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>candesartan cilexetil [135481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety [M0001531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cannabidiol [2045371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Myoclonic [M0328686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantharidin [1984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molluscum Contagiosum [M0013995]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cantharidin [1984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capecitabine [194000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capivasertib [2669967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab [2110605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombotic thrombocytopenic purpura, acquired [M0531362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caplacizumab-yhdp [2110604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombotic thrombocytopenic purpura, acquired [M0531362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib [2362165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capmatinib hydrochloride [2362259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin [78903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin [78903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin sulfate [1987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capreomycin sulfate [1987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia [M0014687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>capsaicin [1992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartter Syndrome [M0002194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>captopril [1998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen [20191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caramiphen edisylate [133053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caraway oil [1309373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carazolol [20192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbachol [1999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Restless Legs Syndrome [M0018926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trigeminal Neuralgia [M0021966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Complex Partial [M0025874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mood Disorders [M0029642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamazepine [2002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hearing Disorders [M0009926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomatitis [M0020550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intracranial Hypertension [M0029084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gingivitis [M0009245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkeratosis, Epidermolytic [M0026530]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbamide peroxide [47686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontitis [M0016341]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin [2015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin disodium [258332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin indanyl sodium [56461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin phenyl sodium [42580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin phenyl sodium [42580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbenicillin phenyl sodium [42580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane [20217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane citrate [283547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbetapentane tannate [221070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa [2019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbidopa anhydrous [1545982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine [20220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine maleate [91066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carbinoxamine tannate [405970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Neoplasms [M0007750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Neoplasms [M0025244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Marrow Diseases [M0002788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboplatin [40048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Germ Cell and Embryonal [M0014592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fetal Death [M0008392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abortion, Incomplete [M0000033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost [2051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fetal Death [M0008392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abortion, Incomplete [M0000033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboprost tromethamine [20259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose [2062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Experimental [M0014595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Diseases [M0016360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Diseases [M0022426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose calcium [1307734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%) [1371909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 38 MPA.S at 2%) [2257286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 400 MPA.S at 1%) [1653793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 50-100 MPA.S at 1% ) [1597390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.7 carboxymethyl substitutions per saccharide; 600 MPA.S at 2 %) [1812763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 130 MPA.S at 4%) [2632123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium (0.9 carboxymethyl substitution per saccharide; 600 MPA.S at 2 %) [2099296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carboxymethylcellulose sodium [491498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carfilzomib [1302966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carglumic acid [401713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperammonemia [M0356710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine [1667655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine hydrochloride [1721073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cariprazine hydrochloride [1721073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carisoprodol [2101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma [M0003424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Medulloblastoma [M0013281]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carmustine [2105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ependymoma [M0007536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine [2106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine chloride [1311519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carnitine hydrochloride, (+)- [1539210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carprofen [20343]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol [2116]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carteolol hydrochloride [142132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol [20352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>carvedilol phosphate [668310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casanthranol [66870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged [1440973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caseins [1440974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casimersen [2480096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>casirivimab [2465242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin [140108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>caspofungin acetate [282363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat skin extract [851949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat&apos;s claw preparation [285223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat&apos;s claw preparation [285223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cat&apos;s claw preparation [285223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor [2176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefaclor anhydrous [1450910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil [2177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil anhydrous [1545975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hemihydrate [1297878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil hydrate [407888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefadroxil monohydrate [204175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole [2178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefamandole nafate [20473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefatrizine [2179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin [2180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefazolin sodium [203171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir [25037]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefdinir monohydrate [1306064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren [83682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefditoren pivoxil [72611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime [20481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefepime hydrochloride [236058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefetamet [20482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol [2265702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefiderocol sulfate tosylate [2265863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime [25033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefixime anhydrous [1546021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole [2182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefmetazole sodium [203140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefodizime [20485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Genital Diseases, Female [M0009154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone [2184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Genital Diseases, Female [M0009154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoperazone sodium [227214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceforanide [20486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Inflammatory Disease [M0000460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fusobacterium Infections [M0008917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime [2186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Inflammatory Disease [M0000460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotaxime sodium [203117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fusobacterium Infections [M0008917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fusobacterium Infections [M0008917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan [2187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fusobacterium Infections [M0008917]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotetan disodium [203141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam [2188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefotiam hydrochloride [236202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin [1591901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefovecin sodium [1591924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin [2189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefoxitin sodium [203118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome [27130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpirome sulfate [236104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxella Infections [M0449415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maxillary Sinusitis [M0023883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Community-Acquired Infections [M0026784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime [20489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxella Infections [M0449415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maxillary Sinusitis [M0023883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Community-Acquired Infections [M0026784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefpodoxime proxetil [47835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil [19552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefprozil anhydrous [1546020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin [2190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin [2190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin sodium [267417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefsulodin sodium [267417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline [1040005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil [1040004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftaroline fosamil acetate [1743286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime [2191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime anhydrous [1545984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime pentahydrate [235552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftazidime sodium [221071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten [20492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftibuten dihydrate [1297879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur [1311521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur hydrochloride [1311520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftiofur sodium [1370372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Inflammatory Disease [M0000460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime [2192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftizoxime sodium [82126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Inflammatory Disease [M0000460]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus aureus Infection [M000622263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteremia [M0025156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus Aureus Pneumonia [M0520214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole [2691333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methicillin-Resistant Staphylococcus aureus [M0518983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus aureus Infection [M000622263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methicillin-Resistant Staphylococcus aureus [M0518983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteremia [M0025156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftobiprole medocaril sodium [2691334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus Aureus Pneumonia [M0520214]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane [1597609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftolozane sulfate [1597608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroidaceae Infections [M0025669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enteritis [M0007466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proctocolitis [M0017633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epididymitis [M0007560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone [2193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epididymitis [M0007560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enteritis [M0007466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proctocolitis [M0017633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroidaceae Infections [M0025669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceftriaxone sodium [203172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime [2194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime axetil [20493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lyme Disease [M0012774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cefuroxime sodium [204144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenomatous Polyposis Coli [M0017238]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celecoxib [140587]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol [20498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>celiprolol hydrochloride [203145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab [2058826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cemiplimab-rwlc [2058825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin [2104332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenegermin-bkbj [2104331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cenobamate [2265690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin [2231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin anhydrous [1299782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin hydrochloride [281942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Moraxellaceae Infections [M0449414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalexin monohydrate [215948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin [2236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephalothin sodium [9860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin [2238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin benzathine [1294563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephapirin sodium [42562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cephradine [2239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ceritinib [1535457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin [596723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerivastatin sodium [221072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cerliponase alfa [1922436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuronal Ceroid-Lipofuscinoses [M0014734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certolizumab pegol [709271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin [152610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>certoparin sodium [152612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine [20610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine [20610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine hydrochloride [203150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetirizine hydrochloride [203150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix [68147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Hyperstimulation Syndrome [M0025157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetrorelix acetate [259338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Hyperstimulation Syndrome [M0025157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cetuximab [318341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline [44281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride [260036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride anhydrous [2698548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cevimeline hydrochloride anhydrous [2698548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sjögren-Mikulicz syndrome [M0531130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxemia [M0021721]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uremia [M0022319]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>charcoal [2296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cherry juice [1307717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloral hydrate [2344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choriocarcinoma [M0004339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Waldenstrom Macroglobulinemia [M0012865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytosis [M0021429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorambucil [2346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol [2348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol palmitate [20767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol sodium succinate [47998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol stearate [20768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloramphenicol succinate [20769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine [2354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorcyclizine hydrochloride [235725]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide [2356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlordiazepoxide hydrochloride [203173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine [2358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine acetate [2359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine diacetate [133054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine gluconate [20791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorhexidine hydrochloride [2361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloride ion [153974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormethiazole [2372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlormezanone [2373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyllin copper complex [82242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorophyllin copper complex [82242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine [20859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroprocaine hydrochloride [53616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Avian [M0012911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine [2393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Discoid [M0012756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Discoid [M0012756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Avian [M0012911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine hydrochloride [451796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Avian [M0012911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Discoid [M0012756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine phosphate [20863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Avian [M0012911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Discoid [M0012756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroquine sulfate [203119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulonephritis [M0009300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide [2396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulonephritis [M0009300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorothiazide sodium [91217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorotrianisene [2397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chloroxine [20875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin [2399]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorphenesin carbamate [20880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine [2400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine [2400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine maleate [142429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine maleate [142429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine polistirex [221074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine polistirex [221074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine tannate [221075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpheniramine tannate [221075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit and Disruptive Behavior Disorders [M0029636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child Behavior Disorders [M0004052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria, Acute Intermittent [M0026010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hiccup [M0010343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine [2403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hiccup [M0010343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit and Disruptive Behavior Disorders [M0029636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child Behavior Disorders [M0004052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria, Acute Intermittent [M0026010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpromazine hydrochloride [104728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorpropamide [2404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene [2406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia, Paranoid [M0019494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorprothixene hydrochloride [91133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia, Paranoid [M0019494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorthalidone [2409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulonephritis [M0009300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chlorzoxazone [2410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiovascular Diseases [M0003473]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoparathyroidism [M0010912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholecalciferol [2418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial Hypophosphatemic Rickets [M0577083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholesterol [2438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutrition Disorders [M0015120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholestyramine resin [2447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cholic acid [1440856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zellweger Syndrome [M0023373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline [2449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choline Deficiency [M0004290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Fever [M0019009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choline salicylate [20974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate (shark) [1789516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate (shark) [1789516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate A sodium [476847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate A sodium [476847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (bovine) [1299929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (bovine) [1299929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (porcine) [1366974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (porcine) [1366974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (shark) [1358172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium (shark) [1358172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate sodium [1605114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, bovine [1306129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, bovine [1306129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, porcine [1306202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfate, porcine [1306202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cartilage Diseases [M0003568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chondroitin sulfates [2473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptorchidism [M0005384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>choriogonadotropin alfa [283550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptorchidism [M0005384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chorionic gonadotropin [4986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromic phosphate P32 [121070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion, Malignant [M0024554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromic phosphate P32 [121070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium [2496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>chromium picolinate [59308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus [M0006148]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclesonide [274964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox [21090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciclopirox olamine [52172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Retinitis [M0026791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir [83171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cidofovir anhydrous [1546007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Retinitis [M0026791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Infectious [M0001745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin [2540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilastatin sodium [82128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Infectious [M0001745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilazapril [21102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilgavimab [2587306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pre-Exposure Prophylaxis [M0587497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intermittent Claudication [M0011515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft Occlusion, Vascular [M0009575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cilostazol [21107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciltacabtagene autoleucel [2594775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine [2541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cimetidine hydrochloride [91251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism, Primary [M0471516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parathyroid Neoplasms [M0015932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet [407990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism, Secondary [M0010846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism, Secondary [M0010846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism, Primary [M0471516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinacalcet hydrochloride [384379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parathyroid Neoplasms [M0015932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon oil [1309229]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinnamon preparation [285245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxacin [2550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cinoxate [288262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa [2667433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycogen Storage Disease Type II [M0009470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cipaglucosidase alfa-atga [2667434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glycogen Storage Disease Type II [M0009470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery [M0006913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Infectious [M0001745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Typhoid Fever [M0022185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin [2551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Infectious [M0001745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Typhoid Fever [M0022185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery [M0006913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin hydrochloride [81981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery [M0006913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Typhoid Fever [M0022185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Infectious [M0001745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ciprofloxacin lactate [235851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride [35255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroparesis [M0027865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroparesis [M0027865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisapride monohydrate [221077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Astrocytoma [M0001891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Small Cell [M0027519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Neoplasms [M0007750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesothelioma, Cystic [M0027490]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma, Amelanotic [M0027563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cisplatin [2555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram [2556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citalopram hydrobromide [221078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citrate [114200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid [21183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid [21183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid monohydrate [221079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid monohydrate [221079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, 1-stearyl ester [1435636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, 1-stearyl ester [1435636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>citric acid, anhydrous [221946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cladribine [44157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clarithromycin [21212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate [48203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanate potassium [831418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanic acid [21216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanic acid [21216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clavulanic acid [21216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine [2578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clemastine fumarate [142430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine [233603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clevidipine butyrate [977863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammatory Bowel Diseases [M0023374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium [21232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammatory Bowel Diseases [M0023374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clidinium bromide [48212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycetales Infections [M0000289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin [2582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycetales Infections [M0000289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin hydrochloride [81982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycetales Infections [M0000289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate [21235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycetales Infections [M0000289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin palmitate hydrochloride [91075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycetales Infections [M0000289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clindamycin phosphate [797272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acneiform Eruptions [M0026528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lichenoid Eruptions [M0026574]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clioquinol [5942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folliculitis [M0008668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobazam [21241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol [2590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clobetasol propionate [21245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone [21249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clocortolone pivalate [21250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofarabine [44151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leprosy, Lepromatous [M0023793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium avium-intracellulare Infection [M0023509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leprosy, Borderline [M0023792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofazimine [2592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyoderma Gangrenosum [M0026573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clofibrate [2594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomethiazole edisylate [20802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Male [M0011306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene [2596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomiphene citrate [142431]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Male [M0011306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine [2597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomipramine hydrochloride [81984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucellosis [M0002989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline [21272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucellosis [M0002989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clomocycline sodium [102758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Restless Legs Syndrome [M0018926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysarthria [M0006911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia [M0014687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tic Disorders [M0021514]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonazepam [2598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Myoclonic [M0328686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol-Induced Disorders, Nervous System [M0328091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine [2599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol-Induced Disorders, Nervous System [M0328091]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clonidine hydrochloride [142432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clopamide [2603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloperastine [2104180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloperastine hydrochloride [2104181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloprednol [21285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate [2353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepate dipotassium [2607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clorazepic acid [235408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotiazepam [2622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Cruris [M000680557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Corporis [M000680577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloticasone [2719926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clotrimazole [2623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove oil [7624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clove preparation [1364295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin [2625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Joint Diseases [M0011860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin benzathine [1043213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Joint Diseases [M0011860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Joint Diseases [M0011860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cloxacillin sodium [9864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>clozapine [2626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX (recombinant), glycopegylated [1990855]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX, human [221099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor IX, human-lans [2643192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor VIIa (recombinant)-jncw [2386863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human [1426166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor X, human-lans [2643194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor XIII a-subunit (recombinant) [1488293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coagulation factor Xa (recombinant), inactivated-zhzo [2045125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar [2635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar extract [90735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar extract [90735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar pitch volatiles [90732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>coal tar pitch volatiles [90732]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobalt [1310300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobicistat [1306284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib [1722365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cobimetinib fumarate [1722380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine [2653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocaine hydrochloride [81985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa butter [21389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoa extract [1373895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cocoamphodiacetate [1364462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Manifestations [M0019938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Night Blindness [M0015129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerophthalmia [M0023065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin A Deficiency [M0022791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets [M0019095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism [M0010845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cod liver oil [2669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine [2670]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhyd [236131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine anhydrous [1545976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine camsyl [236236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine hydrochloride [1115966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate [2672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine phosphate anhydrous [1652891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine polistirex [235412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>codeine sulfate [91104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchiceine [2174385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial Mediterranean Fever [M0016320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis, Biliary [M0012640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial Mediterranean Fever [M0016320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colchicine [2683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis [M0001053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam [141626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colesevelam hydrochloride [141625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol [2685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colestipol hydrochloride [104485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril [107784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infant, Newborn [M0011285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril [107784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril palmitate [69782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infant, Newborn [M0011285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colfosceril palmitate [69782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate [2708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colistimethate sodium [48305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Penile Induration [M0016159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase Clostridium histolyticum [898492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dupuytren Contracture [M0006891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase [58939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>collagenase [58939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloid sulfur [89767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloid sulfur [89767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloid sulfur [89767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloid sulfur [89767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>colloidal oatmeal [221082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>common sagebrush pollen extract [852020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan [302285]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyponatremia [M0010911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>conivaptan hydrochloride [1294548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyponatremia [M0010911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copanlisib [1945077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Follicular [M0012818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>copper gluconate [2839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn allergenic extract [892547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn pollen extract [852015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corn smut allergenic extract [314488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasms, Infantile [M0020204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Optic Neuritis [M0015359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin [376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Optic Neuritis [M0015359]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasms, Infantile [M0020204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>corticotropin, human [1535213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisol succinate [21651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choroiditis [M0004350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomyositis [M0006061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic [M0567378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Exfoliative [M0006047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone [2878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choroiditis [M0004350]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Exfoliative [M0006047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic [M0567378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomyositis [M0006061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cortisone acetate [21655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab [2717511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cosibelimab-ipdl [2717512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cottonseed allergenic extract [852440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cranberry preparation [125933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crinecerfont [2701386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crisaborole [1865953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crizotinib [1148495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crofelemer [1364449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Food Hypersensitivity [M0008686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammatory Bowel Diseases [M0023374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn [42612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mastocytosis [M0013098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mastocytosis [M0013098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammatory Bowel Diseases [M0023374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cromolyn sodium [3538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Food Hypersensitivity [M0008686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crotamiton [21766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crotamiton [21766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scabies [M0019458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab [2686619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>crovalimab-akkz [2686620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric chloride [21833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cupric oxide [21837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclacillin [2968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclandelate [2970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dizziness [M0006639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine [2977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dizziness [M0006639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine hydrochloride [155017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dizziness [M0006639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine lactate [91071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dizziness [M0006639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclizine tartrate [235771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine [21949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclobenzaprine hydrochloride [52101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinoblastoma [M0018961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Nephritis [M0012759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Ewing [M0019433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic, Autoimmune [M0001127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burkitt Lymphoma [M0003058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Red-Cell Aplasia, Pure [M0018667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemosiderosis [M0010179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide [3002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Waldenstrom Macroglobulinemia [M0012865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burkitt Lymphoma [M0003058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Red-Cell Aplasia, Pure [M0018667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemosiderosis [M0010179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Waldenstrom Macroglobulinemia [M0012865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Ewing [M0019433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic, Autoimmune [M0001127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinoblastoma [M0018961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Nephritis [M0012759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide anhydrous [1545988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinoblastoma [M0018961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Nephritis [M0012759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Ewing [M0019433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic, Autoimmune [M0001127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burkitt Lymphoma [M0003058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Red-Cell Aplasia, Pure [M0018667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemosiderosis [M0010179]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Waldenstrom Macroglobulinemia [M0012865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide lyophilized [221085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mixed-Cell [M0012821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinoblastoma [M0018961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burkitt Lymphoma [M0003058]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclophosphamide monohydrate [2679071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cycloserine [3007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine [3008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulosclerosis, Focal Segmental [M0009302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulosclerosis, Focal Segmental [M0009302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine microemulsion [484788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclosporine, modified [236077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulosclerosis, Focal Segmental [M0009302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyclothiazide [22033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nelson Syndrome [M0014557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paraparesis, Spastic [M0023856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesias [M0014140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine [3013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nelson Syndrome [M0014557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paraparesis, Spastic [M0023856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesias [M0014140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine hydrochloride [104592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesias [M0014140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nelson Syndrome [M0014557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cyproheptadine pyrid phos [236525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paraparesis, Spastic [M0023856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine [3022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystinosis [M0005556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine bitartrate [81990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystinosis [M0005556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cysteamine hydrochloride [1426886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystinosis [M0005556]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine [3041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningeal Neoplasms [M0013360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningeal Neoplasms [M0013360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>cytarabine liposome [968804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>d-alpha-tocopheryl acetate [1441649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate [1037042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deep Vein Thrombosis [M0328963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate [1037042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate mesylate [1037041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabigatran etexilate mesylate [1037041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deep Vein Thrombosis [M0328963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib [1424911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dabrafenib mesylate [1425222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Medullary [M0027507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibrosarcoma [M0008451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacarbazine [3098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Islet Cell [M0027504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir [1606218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclatasvir dihydrochloride [1606217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daclizumab [190353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib [2058849]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dacomitinib anhydrous [2058848]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gestational Trophoblastic Disease [M0398989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Ewing [M0019433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinoblastoma [M0018961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wilms Tumor [M0014630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choriocarcinoma [M0004339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dactinomycin [3100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin [1539239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin hydrochloride [1541465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin hydrochloride [1541465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalbavancin hydrochloride [1541465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfampridine [897018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gait Disorders, Neurologic [M0328402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfampridine [897018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalfopristin [229369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin [67109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dalteparin sodium [82137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>damoctocog alfa pegol [2055655]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid [78484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danaparoid sodium [103843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danazol [3102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibrocystic Breast Disease [M0008440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dandelion pollen extract [852079]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>danicopan [2678952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravascular Hemolysis [M000616280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal Cord Injuries [M0020312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Hyperthermia [M0012932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroleptic Malignant Syndrome [M0014713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Palsy [M0003888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene [3105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Palsy [M0003888]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal Cord Injuries [M0020312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Hyperthermia [M0012932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dantrolene sodium [3106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroleptic Malignant Syndrome [M0014713]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin [1488564]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapagliflozin propanediol [1486966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole [22298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mydriasis [M0024307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapiprazole hydrochloride [235757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mydriasis [M0024307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daprodustat [2628210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polychondritis, Relapsing [M0017161]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leprosy, Lepromatous [M0023793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dapsone [3108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteremia [M0025156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daptomycin [22299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab [1721947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daratumumab-fihj [2375130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darbepoetin alfa [283838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant [2591497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chronic Insomnia [M0334962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daridorexant hydrochloride [2591496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chronic Insomnia [M0334962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin [136198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Overactive [M0461241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin [136198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin hydrobromide [485417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Overactive [M0461241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darifenacin hydrobromide [485417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darolutamide [2180325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir [460132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir ethanolate [644682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir hydrate [2637854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>darunavir propylene glycolate [2670599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir [1597381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasabuvir sodium monohydrate [1600438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib [475342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib [475342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasatinib anhydrous [1546019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dasiglucagon [2535233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan [2703033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>datopotamab deruxtecan-dlnk [2703034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin [3109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate [1364321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin citrate liposome [221087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin hydrochloride [81992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daunorubicin liposomal [214468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>daxibotulinumtoxinA-lanm [2612452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>decitabine [15657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelodysplastic Syndromes [M0014324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib [2714502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovary Cancer [M0015592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defactinib hydrochloride [2714501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovary Cancer [M0015592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferasirox [614373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron Overload [M0028592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferiprone [11645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron Overload [M0028592]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Diseases [M0005177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemochromatosis [M0010098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine [3131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases [M0002776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases [M0002776]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Diseases [M0005177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deferoxamine mesylate [3132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemochromatosis [M0010098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide [1311089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Veno-Occlusive Disease [M0010204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide sodium [1746523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Veno-Occlusive Disease [M0010204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>defibrotide, bovine lung [1788946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Veno-Occlusive Disease [M0010204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deflazacort [22396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix [475230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>degarelix acetate [835863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dehydrated alcohol [1310469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Complex Regional Pain Syndromes [M0328368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus aureus Infection [M000622263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas aeruginosa Infection [M000622265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin [1927663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas aeruginosa Infection [M000622265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus aureus Infection [M000622263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delafloxacin meglumine [1927662]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec [2641675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delandistrogene moxeparvovec-rokl [2641674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine [83816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delavirdine mesylate [142152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>delgocitinib [2721163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eczema [M0007049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium [107771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demecarium bromide [22482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Typhoid Fever [M0022185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphogranuloma Venereum [M0012812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline [3154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inappropriate ADH Syndrome [M0011185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inappropriate ADH Syndrome [M0011185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphogranuloma Venereum [M0012812]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Typhoid Fever [M0022185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Mycoplasma [M0017072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>demeclocycline hydrochloride [81993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denileukin diftitox-cxdl [2700746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>T-cell lymphoma 1A [M0531243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab [993449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bbdz [2715382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporotic Fractures [M0545012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bbdz [2715382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bmwo [2717851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-bnht [2717527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-dssb [2725498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-kyqq [2725924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-nxxp [2723334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>denosumab-qbde [2725562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deserpidine [62174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesias [M0014140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desflurane [27340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine [3247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance-Related Disorders [M0029657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance-Related Disorders [M0029657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine dibudinate [1099738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance-Related Disorders [M0029657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desipramine hydrochloride [203174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deslanoside [3248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desloratadine [275635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Insipidus, Neurogenic [M0328375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin [3251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Insipidus, Neurogenic [M0328375]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desmopressin acetate [42634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menstruation Disturbances [M0013402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desogestrel [22656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desonide [3254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoximetasone [3255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desoxycorticosterone pivalate [22537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine [734064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine fumarate monohydrate [1487366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>desvenlafaxine succinate [683693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deucravacitinib [2612087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parapsoriasis en Plaques [M0015910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib [2716558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia Areata [M0000760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deuruxolitinib phosphate [2716557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia Areata [M0000760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tardive Dyskinesia [M000612971]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>deutetrabenazine [1876905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chorea [M0004335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>devil&apos;s claw preparation [236279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis [M0001741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>devil&apos;s claw preparation [236279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anorexia [M0001278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>devil&apos;s claw preparation [236279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone [3264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate [22690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone acetate anhydrous [2378841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone isonicotinate [3265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone phosphate [235486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone sodium phosphate [48933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexamethasone trimethyl acetate [22694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine [22696]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine maleate [48936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexbrompheniramine tannate [686390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine [22697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine maleate [54828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexchlorpheniramine tannate [353104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine [3268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexfenfluramine hydrochloride [155142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen [237162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Musculoskeletal Pain [M0549551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Musculoskeletal Pain [M0549551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexketoprofen trometamol [233386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole [816346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexlansoprazole sesquihydrate [2673463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine [48937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmedetomidine hydrochloride [228054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate [352372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexmethylphenidate hydrochloride [353105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane [42736]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dexrazoxane hydrochloride [1294534]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 1 [214485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 40 [3272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 70 [3274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran 75 [3275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextran [42635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextranomer [22708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine [3288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine saccharate [221088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextroamphetamine sulfate [3287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan [3289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrobromide [102490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydrochloride [267251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan hydroiodide [539765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan polistirex [236146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextromethorphan tannate [259262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose hydrous [1297771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrose monohydrate [1299920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine [3292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dextrothyroxine sodium [40070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dezocine [22713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>di-n-octyl sodium sulfosuccinate [1534779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazepam [3322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide [3327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphagia [M0010847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diazoxide choline [2711542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphagia [M0010847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, dihydrate [2632248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, dihydrate [2632248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic calcium phosphate, dihydrate [2632248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic potassium phosphate [55018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic potassium phosphate [55018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibasic sodium phosphate heptahydrate [221090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin [3332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibenzepin hydrochloride [236807]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibromopropamidine isethionate [22862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharitis [M0002658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibrompropamidine [22865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharitis [M0002658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Irritant [M0026484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine [3339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunburn [M0020814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunburn [M0020814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Irritant [M0026484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dibucaine hydrochloride [235402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dichlorphenamide [3353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photophobia [M0328261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac [3355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis [M0011970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photophobia [M0328261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis [M0011970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac potassium [81997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photophobia [M0328261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diclofenac sodium [203214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis [M0011970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin [3356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicloxacillin sodium [267257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dictamnine [2685302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicumarol [1598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine [3361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dicyclomine hydrochloride [152021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>didanosine [3364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienestrol [3368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrophic Vaginitis [M0549100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienestrol [3368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vulvar Lichen Sclerosus [M0012079]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dienogest [22968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Eosinophilia [M0018131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Elephantiasis, Filarial [M0007230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine [3384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loiasis [M0012661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Eosinophilia [M0018131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Elephantiasis, Filarial [M0007230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylcarbamazine citrate [203175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Loiasis [M0012661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion [3389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylpropion hydrochloride [81998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma [M0003424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diethylstilbestrol [3390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin [2569089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difelikefalin acetate [2569090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin [23024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>difenoxin hydrochloride [235373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone [91311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflorasone diacetate [23033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diflunisal [3393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitalin [1923401]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digitoxin [3403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin [3407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin antibodies Fab fragments [203223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>digoxin antibodies Fab fragments [203223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine [3409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sul hemipenthy [259379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydralazine sulfate [235959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine [23088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrocodeine bitartrate [104966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine [3415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocornine mesylate [42644]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine [3416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocristine monomesylate [42645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine [3417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergocryptine mesylate [42646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine [3418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine mesylate [203176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotamine tartrate [236680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroergotoxine [3419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomalacia [M0015543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets [M0019095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism [M0010845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydrotachysterol [3429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyacetone [3430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypopigmentation [M0026547]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dihydroxyaluminum sodium carbonate [23163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diloxanide [67182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoebiasis due to Entamoeba histolytica [M0525104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diloxanide furoate [23203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amoebiasis due to Entamoeba histolytica [M0525104]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem [3443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem hydrochloride [203211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem malate [81999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diltiazem maleate [314592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimenhydrinate [3444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lead Poisoning [M0012268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic Poisoning [M0328100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimercaprol [3445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mercury Poisoning, Nervous System [M0328124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 100 [1310496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Abnormalities [M0019926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone 410 [1299921]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethicone [324072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Abnormalities [M0019926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Spasm, Diffuse [M0023299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dimethyl isosorbide [1426599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gestational Trophoblastic Disease [M0398989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fetal Death [M0008392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinoprostone [3478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dinutuximab [1606274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sneezing [M0019990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine [3498]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sneezing [M0019990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine citrate [82004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sneezing [M0019990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine diacefyllinate [236260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sneezing [M0019990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine hydrochloride [1362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenhydramine tannate [360283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sneezing [M0019990]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol [23370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenidol hydrochloride [47877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate [3500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphenoxylate hydrochloride [82005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diphtheria antitoxin [3510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin [23410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dipivefrin hydrochloride [203156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Community-Acquired Infections [M0026784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tonsillitis [M0021666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dirithromycin [23437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diroximel fumarate [2261783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diroximel fumarate [2261783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clinically Isolated Syndrome, CNS Demyelinating [M0513855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>diroximel fumarate [2261783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Secondary Progressive [M0334287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium citrate sesquihydrate [2049608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium citrate sesquihydrate [2049608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium hydrogen phosphate dehydrate [1311230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disodium latamoxef [258330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide [3541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disopyramide phosphate [203178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>disulfiram [3554]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Complex Partial [M0025874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>divalproex sodium [266856]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mood Disorders [M0029642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dl-alpha tocopheryl acetate [317841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine [3616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dobutamine hydrochloride [203121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel [72962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docetaxel anhydrous [1299922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docosanol [594680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blister [M0002668]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate [82003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate calcium [82001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate potassium [82002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>docusate sodium [71722]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dofetilide [49247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dofetilide [49247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dofetilide [49247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dog skin extract [894987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron [68091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Nausea and Vomiting [M0029915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolasetron mesylate [29398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Nausea and Vomiting [M0029915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir [1433868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dolutegravir sodium [1433867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domestic cow skin extract [852256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domiphen [23623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tooth Diseases [M0021674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>domiphen bromide [49255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tooth Diseases [M0021674]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab [2687966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer&apos;s Disease, Focal Onset [M0333961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab [2687966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delirium, Dementia, Amnestic, Cognitive Disorders [M0029645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab-azbt [2687965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delirium, Dementia, Amnestic, Cognitive Disorders [M0029645]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donanemab-azbt [2687965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer&apos;s Disease, Focal Onset [M0333961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil [135447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donepezil hydrochloride [236559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel [2642217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>donislecel-jujn [2642260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Diseases [M0012014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine [3628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Diseases [M0012014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dopamine hydrochloride [82010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doravirine [2055755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV-1 [M0023859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone [2721194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Glioma [M0337531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dordaviprone hydrochloride [2721193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Glioma [M0337531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doripenem [119771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dornase alfa [337623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide [60207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dorzolamide hydrochloride [236065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab [2539967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Carcinoma [M0025699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dostarlimab-gxly [2539968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Carcinoma [M0025699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin [3634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dothiepin hydrochloride [142133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercapnia [M0010816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance-Related Disorders [M0029657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram [3637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Hypersensitivity [M0018896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercapnia [M0010816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance-Related Disorders [M0029657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxapram hydrochloride [82011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Hypersensitivity [M0018896]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin [49276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxazosin mesylate [39173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin [3638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxepin hydrochloride [203179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxercalciferol [11516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism [M0010845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wilms Tumor [M0014630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin [3639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Neoplasms [M0012652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesothelioma [M0013485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wilms Tumor [M0014630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride [142433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wilms Tumor [M0014630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxorubicin hydrochloride liposome [466523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Relapsing Fever [M0018746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline [3640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Relapsing Fever [M0018746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline anhydrous [1545992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Relapsing Fever [M0018746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline calcium [82012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Relapsing Fever [M0018746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hyclate [23663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Relapsing Fever [M0018746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline hydrochloride [236647]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Relapsing Fever [M0018746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxycycline monohydrate [203122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine [3642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate [23665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antiemetic Effect [M0556137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>doxylamine succinate, (R)- [2622915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antitussive Agents [M0001516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dried sodium phosphate [1366977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anorexia [M0001278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronabinol [10402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone [233698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone [233698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dronedarone hydrochloride [736680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droperidol [3648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverin [23684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Renal Colic [M0529415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverin [23684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Functional Gastrointestinal Disorders [M0443706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverine hydrochloride [236960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Renal Colic [M0529415]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotaverine hydrochloride [236960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Functional Gastrointestinal Disorders [M0443706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa (activated), lyophilized [353106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>drotrecogin alfa [352374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>droxidopa [1489913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dulaglutide [1551291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Musculoskeletal Pain [M0549551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine [72625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duloxetine hydrochloride [476250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Musculoskeletal Pain [M0549551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dupilumab [1876376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>durvalumab [1919503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dutasteride [228790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>duvelisib [2058509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine [23744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Pain [M0008124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyclonine hydrochloride [91188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Pain [M0008124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dydrogesterone [3706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menstruation Disturbances [M0013402]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>dyphylline [3714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecallantide [658708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedemas, Hereditary [M0502559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esotropia [M0007762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>echothiophate iodide [3740]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole [3743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>econazole nitrate [142434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esotropia [M0007762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ecothiopate [89778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab [591781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atypical Hemolytic Uremic Syndrome [M0532727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab [591781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab [591781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemoglobinuria, Paroxysmal [M0010136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aagh [2706334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atypical Hemolytic Uremic Syndrome [M0532727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aagh [2706334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aagh [2706334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemoglobinuria, Paroxysmal [M0010136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aeeb [2706347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atypical Hemolytic Uremic Syndrome [M0532727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aeeb [2706347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eculizumab-aeeb [2706347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemoglobinuria, Paroxysmal [M0010136]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edaravone [1921877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyotrophic Lateral Sclerosis [M0001056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate calcium disodium [1903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Manganese Poisoning [M0328121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium [3539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Manganese Poisoning [M0328121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetate disodium, anhydrous [1299924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edetic acid [3755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban [1599538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban [1599538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban tosylate [1599564]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edoxaban tosylate [1599564]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium [3752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium cation [1546421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>edrophonium chloride [3754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efalizumab [356988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efavirenz [195085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa [2587717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-fcab [2587719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efgartigimod alfa-qvfc [2639944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>efinaconazole [1539753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertrichosis [M0010874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine [569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypanosomiasis, African [M0022074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertrichosis [M0010874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eflornithine hydrochloride [81945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypanosomiasis, African [M0022074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg extract [1315115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>egg yolk phospholipids [314605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant [2628469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elacestrant dihydrochloride [2628473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eladocagene exuparvovec [2698762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aromatic amino acid decarboxylase deficiency [M0531898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eladocagene exuparvovec-tneq [2698765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aromatic amino acid decarboxylase deficiency [M0531898]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elafibranor [2684941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Biliary Cholangitis [M0012639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix [2049846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Pain [M0024135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elagolix sodium [2049847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Pain [M0024135]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elamipretide [2725600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Barth Syndrome [M0529363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elamipretide hydrochloride [2725599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Barth Syndrome [M0529363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase [2059219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Severe combined immunodeficiency due to adenosine deaminase deficiency [M0525307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elapegademase-lvlr [2059218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Severe combined immunodeficiency due to adenosine deaminase deficiency [M0525307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elbasvir [1734628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan [231049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide [360288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eletriptan hydrobromide monohydrate [2198973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elexacaftor [2256951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat [1547220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eliglustat tartrate [1547219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elinzanetant [2725511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elivaldogene autotemcel [2612527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenoleukodystrophy [M0000501]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elosulfase alfa [1489914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucopolysaccharidosis IV [M0014173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elotuzumab [1726104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab [2644880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elranatamab-bcmm [2644881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag [711942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Aplastic [M0001120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag choline [2675185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag choline [2675185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Aplastic [M0001120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Aplastic [M0001120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eltrombopag olamine [735651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eluxadoline [1653781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>elvitegravir [1306286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab [2104604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphohistiocytosis, Hemophagocytic [M0023960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emapalumab-lzsg [2104603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphohistiocytosis, Hemophagocytic [M0023960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine [28144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emedastine difumarate [221094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine [3820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fascioloidiasis [M0008246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine [3820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine hydrochloride [82015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emetine hydrochloride [82015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fascioloidiasis [M0008246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab [1989794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emicizumab-kxwh [1989795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>empagliflozin [1545653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>emtricitabine [276237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartter Syndrome [M0002194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril [3827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartter Syndrome [M0002194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalapril maleate [203123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartter Syndrome [M0002194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat [3829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartter Syndrome [M0002194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat anhydrous [1545989]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enalaprilat dihydrate [2672730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib [1940332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enasidenib mesylate [1940331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide [42368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encainide hydrochloride [281189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>encorafenib [2049106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enflurane [3920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab [2268307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin [2277607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfortumab vedotin-ejfv [2268306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enfuvirtide [139896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacter cloacae [M0025803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas aeruginosa [M0017953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella pneumoniae [M0012060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enmetazobactam [2675985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus mirabilis [M0017901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxacin [3925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin [67108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enoxaparin sodium [221095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib [2712546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensartinib hydrochloride [2712547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ensifentrine [2687215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Disease, Chronic Obstructive [M0384655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entacapone [60307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir [306266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir [306266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entecavir anhydrous [1546027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>entrectinib [2197862]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>enzalutamide [1307298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab [2637392]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epcoritamab-bysp [2637395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine [3966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrate [283561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine hydrochloride [91165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine sulfate [91166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ephedrine tannate [221096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine [39684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinastine hydrochloride [236961]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Airway Obstruction [M0000610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine [3992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Airway Obstruction [M0000610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine bitartrate [203180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Airway Obstruction [M0000610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine hydrochloride [362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Airway Obstruction [M0000610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephrine sulfate [1249590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Airway Obstruction [M0000610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epinephryl borate [24255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin [3995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epirubicin hydrochloride [203213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplerenone [298869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure, Systolic [M0502059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen [2671939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyneuropathy, Familial [M0336469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen sodium [2671940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyneuropathy, Familial [M0336469]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eplontersen sodium [2671940]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa [105694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoetin alfa-epbx [2047589]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura [M0018178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis [M0001734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol [8814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis [M0001734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura [M0018178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>epoprostenol sodium [104463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan [83515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eprosartan mesylate [236878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptacog alfa activated [253149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eptifibatide [75635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>equine diphtheria antitoxin [91602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline [2055906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eravacycline dihydrochloride [2055907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erdafitinib [2123125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickets [M0019095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergocalciferol [4018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoparathyroidism [M0010912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergoloid mesylates, USP [4024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cognitive Decline [M000618663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine [4021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergonovine maleate [24313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergot preparation [91405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine [4025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ergotamine tartrate [42676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liposarcoma [M0012597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin [1045453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eribulin mesylate [1045452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liposarcoma [M0012597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib [337525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erlotinib hydrochloride [477320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Abscess [M0028122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem [325642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abdominal Abscess [M0028122]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ertapenem sodium [353107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythrityl tetranitrate [4040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin [4053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin estolate [4055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin ethylsuccinate [4056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin gluceptate [24346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin lactobionate [24347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin phosphate [4058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stearate [24351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethritis [M0022336]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythrasma [M0007683]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>erythromycin stinoprate [236847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram [321988]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>escitalopram oxalate [353108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine [2119365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Treatment-Resistant [M0556716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esketamine hydrochloride [2119366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Treatment-Resistant [M0556716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine [1482502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures, Focal [M0335931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eslicarbazepine acetate [1482501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures, Focal [M0335931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol [49737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esmolol hydrochloride [203222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole [283742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium [283562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium dihydrate [1601995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole magnesium trihydrate [2688630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole sodium [1294569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>esomeprazole strontium [1435522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estazolam [4077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol 3-benzoate [60661]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol [4083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol acetate [405416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol cypionate [1000146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol hemihydrate [236859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estradiol valerate [24395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine [4089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate [105556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estramustine phosphate sodium [4090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens [4100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, conjugated (USP) [4099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrogens, esterified (USP) [214549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estrone [4103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>estropipate [33747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eszopiclone [461016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept [214555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etanercept-szzs [2103480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide [1876119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism, Secondary [M0010846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etelcalcetide hydrochloride [1876122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism, Secondary [M0010846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eteplirsen [1810569]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etesevimab [2477854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronavirus Infections [M0027585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Acute [M0012015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Edema [M0018125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynate sodium [4108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Acute [M0012015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Edema [M0018125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethacrynic acid [4109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol [4110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol [4110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol [4110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol hydrochloride [142435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol hydrochloride [142435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections, Nontuberculous [M0014288]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethambutol hydrochloride [142435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanol [448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Complex Regional Pain Syndromes [M0328368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine [24457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Varices [M0007743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine hydrochloride [1311530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Varices [M0007743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine oleate [24460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal and Gastric Varices [M0007742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethanolamine thenoate [236213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Varices [M0007743]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethchlorvynol [4118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinamate [24474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethinyl estradiol [4124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethionamide [4127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethionamide [4127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine [24484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethoheptazine citrate [235416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethopropazine hydrochloride [6541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethosuximide [4135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Complex Partial [M0025874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethotoin [4136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl chloride [4141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ether [1363043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ether [1363043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Larva Migrans [M0012221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ether [1363043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethyl ether [1363043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hiccup [M0010343]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylestrenol [4162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Underweight [M0468047]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylestrenol [4162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylestrenol [4162]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine [156240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethylnorepinephrine hydrochloride [289080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ethynodiol diacetate [4170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine [4171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidocaine hydrochloride [227221]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ossification, Heterotopic [M0015505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate [42682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate disodium [9872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ossification, Heterotopic [M0015505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate tetrasodium [1364894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate tetrasodium [1364894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ossification, Heterotopic [M0015505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronate tetrasodium [1364894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etidronic acid [1356715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ossification, Heterotopic [M0015505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etodolac [24605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etofylline [24611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Ischemia [M0003886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head Injuries, Closed [M0025173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etomidate [4177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histiocytosis [M0023956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trophoblastic Neoplasms [M0022033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Ewing [M0019433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide [4179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histiocytosis [M0023956]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Ewing [M0019433]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trophoblastic Neoplasms [M0022033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etoposide phosphate [24614]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etranacogene dezaparvovec [2626727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etranacogene dezaparvovec-drlb [2626768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod [2668045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etrasimod arginine [2668046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etravirine [475969]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>etretinate [4182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>eugenol [4186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evolocumab [1665684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>evolocumab [1665684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atherosclerosis [M0001903]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exagamglogene autotemcel [2671667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Sickle Cell [M0001140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exemestane [258494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>exenatide [60548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemia Type II [M0010819]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezetimibe [341248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipidemia, Familial Combined [M0010832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ezogabine [1112990]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX [4249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor IX complex [1670383]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombasthenia [M0021418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII [4254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human [1426164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human [1426164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human [1426164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombasthenia [M0021418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human [1426164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human-lans [2643196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human-lans [2643196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombasthenia [M0021418]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human-lans [2643196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VII, human-lans [2643196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII [4257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIII, human [826070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor VIIa [4256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor X [4262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII [4271]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>factor XIII, human [1091605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blood Loss, Surgical [M0024551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>false ragweed pollen extract [851938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fam-trastuzumab deruxtecan-nxki [2267574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fam-trastuzumab deruxtecan-nxki [2267574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Genitalis [M0010276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Labialis [M0010278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Zoster [M0010280]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famciclovir [68099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chickenpox [M0004041]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>famotidine [4278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab [2591519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab [2591519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Age-Related Macular Degeneration [M000647189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab-svoa [2591584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Age-Related Macular Degeneration [M000647189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>faricimab-svoa [2591584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>febuxostat [73689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib [2197490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fedratinib hydrochloride [2197594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Complex Partial [M0025874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felbamate [24812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>felodipine [4316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbendazole [4325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenbendazole [4325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline [4327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline [4327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline hydrochloride [236767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fendiline hydrochloride [236767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Autistic Disorder [M0001983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine [4328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Autistic Disorder [M0001983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenfluramine hydrochloride [82018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate [8703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibrate micronized [221100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenofibric acid [24852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam [24853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Renovascular [M0010868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Renovascular [M0010868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoldopam mesylate [203151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen [4331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoprofen calcium [267171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol [4333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenoterol hydrobromide [203124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl [4337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl citrate [142436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fentanyl hydrochloride [1652097]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed meal [282436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Digestive System Abnormalities [M0006373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed preparation [360375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed preparation [360375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed preparation [360375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fenugreek seed preparation [360375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Digestive System Abnormalities [M0006373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric ammonium citrate [24897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric ammonium citrate [24897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hypochromic [M0001131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric citrate [1594675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric citrate [1594675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric derisomaltose [2274394]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric maltol [2539932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iron-Refractory Iron Deficiency Anemia [M0562685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide [1310572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide [1310572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide yellow [1305582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric oxide yellow [1305582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric subsulfate solution [24912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferric sulfate [24913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic Poisoning [M0328100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous fumarate [24941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous fumarate [24941]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous gluconate [24942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous gluconate [24942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate [24947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate [24947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate,dried [259346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferrous sulfate,dried [259346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxsil [77754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ferumoxytol [473387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine [797195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fesoterodine fumarate [797196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>feverfew extract [114203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>feverfew extract [114203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexinidazole [2564146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypanosomiasis, African [M0022074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine [87636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine [87636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine hydrochloride [236474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fexofenadine hydrochloride [236474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fezolinetant [2637134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fiber [70727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutrition Disorders [M0015120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Afibrinogenemia [M0000532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen [4385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Afibrinogenemia [M0000532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen, human [2264108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen,I-125 [314623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Afibrinogenemia [M0000532]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fibrinogen,I-125 [314623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidanacogene elaparvovec [2681011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidanacogene elaparvovec-dzkt [2681020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidaxomicin [1111103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fidaxomicin [1111103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim [68442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-aafi [2057198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-ayow [2595942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-sndz [1605064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>filgrastim-txid [2700365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chemotherapy-Induced Febrile Neutropenia [M0579828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas aeruginosa Infection [M000622265]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finafloxacin [1598641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hirsutism [M0010381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>finasteride [25025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia [M0000757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod [1012892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod hydrochloride [1012891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fingolimod lauryl sulfate [2610292]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oil (containing omega-3 acids) [2053495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholestasis, Intrahepatic [M0004262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue Syndrome, Chronic [M0024027]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fish oils [4419]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocturia [M0022376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate [4440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysuria [M0491855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocturia [M0022376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flavoxate hydrochloride [142437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysuria [M0491855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flaxseed extract [318224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide [4441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flecainide acetate [42686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fleroxacin [42322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flibanserin [1665509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoactive Sexual Desire Disorder [M0029725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flosequinan [25089]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin [4448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin magnesium [235825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium [235750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxacillin sodium monohydrate [1309402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>floxuridine [4488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flubendazole [25096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parasitic Diseases [M0015919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone [108091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluclorolone acetonide [103447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fungemia [M0025155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Cryptococcal [M0025746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluconazole [4450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis [M0003258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Cryptococcal [M0025746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flucytosine [4451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chromoblastomycosis [M0004392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine [24698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludarabine phosphate [25102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone [4452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenocortical Hyperfunction [M0000483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Addison Disease [M0000346]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fludrocortisone acetate [165516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenocortical Hyperfunction [M0000483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumazenil [4457]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diaper Rash [M0006208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otomycosis [M0549022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eczema [M0007049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone [4458]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diaper Rash [M0006208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otomycosis [M0549022]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethasone pivalate [25113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eczema [M0007049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flumethiazide [89911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide [25120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide anhydrous [1546428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunisolide hemihydrate [1298840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flunitrazepam [4460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chronic Insomnia [M0334962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone [25126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinolone acetonide [4461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocinonide [4462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone [4463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone caproate [4464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluocortolone pivalate [4465]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorine [1310123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone [4491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorometholone acetate [221101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis [M0011970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rectal Neoplasms [M0018657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluorouracil [4492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Basal Cell [M0003431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine [4493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxetine hydrochloride [227224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedema [M0001197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluoxymesterone [4494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol [4495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupenthixol decanoate [25188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flupentixol hydrochloride [235742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine [4496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine decanoate [25190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine enanthate [30129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluphenazine hydrochloride [203207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluprednisolone [4497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurandrenolide [4500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam [4501]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurazepam hydrochloride [71484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Miosis [M0024306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen [4502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Miosis [M0024306]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flurbiprofen sodium [91351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluspirilene [4507]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutamide [4508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hirsutism [M0010381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutamide [4508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone [41126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone furoate [705022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluticasone propionate [50121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>flutrimazole [61773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomycoses [M0006059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin [41127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvastatin sodium [72875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine [42355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fluvoxamine maleate [203143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folic acid [4511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>folic acid [4511]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone [227518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follicle stimulating hormone, porcine [1594665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin alfa [386938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>follitropin beta [25357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomepizole [15226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomepizole [15226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen [85763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Retinitis [M0026791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fomivirsen sodium [314633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Retinitis [M0026791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux [321208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux sodium [322154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fondaparinux sodium [322154]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formaldehyde [4530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formalin [314636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol [25255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate [236216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate dihydrate [998038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>formoterol fumarate dihydrate [998038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir [358262]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosamprenavir calcium [402365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarbidopa [2695774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Genitalis [M0010276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet [33562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Genitalis [M0010276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foscarnet sodium [57529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosdenopterin [2531288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molybdenum Cofactor Deficiency, Complementation Group A [M0565672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosdenopterin hydrobromide [2531287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Molybdenum Cofactor Deficiency, Complementation Group A [M0565672]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma [M0003424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol [25284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma [M0003424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfestrol tetrasodium [281876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin [4550]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosfomycin tromethamine [142135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril [50166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinopril sodium [227278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosinoprilat [1546393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>foslevodopa [2695775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin [72236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fosphenytoin sodium [82806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib [2044896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostamatinib disodium [2055929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir [2380373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fostemsavir tromethamine [2380374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan [228783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>frovatriptan succinate [322249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fruquintinib [2670179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>fulvestrant [282357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections, Animal [M0019394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furazolidone [4601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enteritis [M0007466]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Acute [M0012015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Edema [M0018125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>furosemide [4603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>futibatinib [2628190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intrahepatic Cholangiocarcinoma [M000605293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin [25480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia, Postherpetic [M0480692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia, Postherpetic [M0480692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gabapentin enacarbil [1101333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine [4637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galantamine hydrobromide [860693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab [2058846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galcanezumab-gnlm [2058868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium GA-68 gozetotide [2586016]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Positron-Emission Tomography [M0021646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium [1310124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Positron-Emission Tomography [M0021646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallium nitrate [25544]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil [4648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gallopamil hydrochloride [439837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>galsulfase [578033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucopolysaccharidosis VI [M0014176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganaxolone [2604689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Retinitis [M0026791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir [4678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganciclovir sodium [82131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Retinitis [M0026791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix [35825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Hyperstimulation Syndrome [M0025157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ganirelix acetate [259264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Hyperstimulation Syndrome [M0025157]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin [228476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin anhydrous [1546025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gatifloxacin hemihydrate [1999763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gefitinib [328134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Pancreatic Ductal [M0352972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine [12574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Pancreatic Ductal [M0352972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemcitabine hydrochloride [236234]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemfibrozil [4719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumococcal [M0017071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Community-Acquired Infections [M0026784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin [138099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumococcal [M0017071]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Community-Acquired Infections [M0026784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemifloxacin mesylate [402429]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelomonocytic, Acute [M0023837]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gemtuzumab ozogamicin [1294580]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis, Tuberculous [M0022129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Infections [M0003806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin [1596450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Infections [M0003806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis, Tuberculous [M0022129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentamicin sulfate [1870193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet [4778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gentian violet cation [1546369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone [2672253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepirone hydrochloride [2672254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin [2709212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gepotidacin mesylate [2709213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib [2105806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gilteritinib fumarate [2105823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginger extract [285241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginseng preparation [325526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erectile Dysfunction [M0011178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ginseng preparation [325526]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givinostat [2678889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran [2265712]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria, Acute Hepatic [M0562918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>givosiran sodium [2265859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria, Acute Hepatic [M0562918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib [2105845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glasdegib maleate [2105844]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer [214582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glatiramer acetate [84375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glecaprevir [1940635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glimepiride [25789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glipizide [4821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab [2639782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glofitamab-gxbm [2639781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon (rDNA) [261716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon [4832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucagon hydrochloride [253170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucarpidase [1242127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diverticulitis, Colonic [M0006631]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glucose Intolerance [M0027356]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucomannan [11454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sprains and Strains [M0020394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine [4845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sprains and Strains [M0020394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine hydrochloride [236608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate [4847]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sprains and Strains [M0020394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucosamine sulfate potassium chloride [1789517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sprains and Strains [M0020394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoglycemia [M0010901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glucose [4850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamic acid [25916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Short Bowel Syndrome [M0019794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutamine [4885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Short Bowel Syndrome [M0019794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutaral [4888]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glutethimide [4903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide [4815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glyburide, micronized [217364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycerin [4910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine [4919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine [4919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine hydrochloride [1311532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycine hydrochloride [1311532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycolic acid [587318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Diseases [M0018918]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrrolate [4955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium [1546438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>glycopyrronium tosylate [2052857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold [1311190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiomalate [4981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiosulfate [9876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic Poisoning [M0328100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gold sodium thiosulfate [9876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goldenseal extract [1372255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Signs and Symptoms, Digestive [M0019846]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goldenseal extract [1372255]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Signs and Symptoms, Respiratory [M0019847]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golimumab [819300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>golodirsen [2267207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Cysts [M0015589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin [6384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Cysts [M0015589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin acetate [204193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Cysts [M0015589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin diacetate tetrahydrate [1298838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Cysts [M0015589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gonadorelin hydrochloride [204194]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin [50610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>goserelin acetate [203146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gotu kola extract [319837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Insufficiency [M0022591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gozetotide [2588949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Positron-Emission Tomography [M0021646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gramicidin [5011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>gramicidin [5011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir [1734630]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>grazoprevir anhydrous [1871173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Capitis [M0021564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin [5021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Capitis [M0021564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin microsize [91077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Capitis [M0021564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>griseofulvin, ultramicrocrystalline [217398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guafacine hydrochloride [862004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pharyngitis [M0016483]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Whooping Cough [M0022977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Laryngitis [M0012236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guaifenesin [5032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz [5033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanabenz acetate [227225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel [26296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanadrel sulfate [91239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine [5036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine monosulfate [82023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanethidine sulfate [203181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine [40114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanfacine hydrochloride [203142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine [50675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Weakness [M0028272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine [50675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lambert-Eaton Myasthenic Syndrome [M0023968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine hydrochloride [50676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Weakness [M0028272]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guanidine hydrochloride [50676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lambert-Eaton Myasthenic Syndrome [M0023968]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>guselkumab [1928588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halazepam [26412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halcinonide [5084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol [41208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halobetasol propionate [45318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine [50749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine [50749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Vivax [M0025572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine [50749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine hydrochloride [58130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine hydrochloride [58130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halofantrine hydrochloride [58130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Vivax [M0025572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child Behavior Disorders [M0004052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol [5093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child Behavior Disorders [M0004052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol decanoate [26420]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Child Behavior Disorders [M0004052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloperidol lactate [217483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>haloprogin [26422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>halothane [5095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heavy mineral oil [258439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heavy mineral oil [258439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intestinal Obstruction [M0011575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>helium [5140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Positive-Pressure Respiration, Intrinsic [M0027702]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemin [5175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyrosinemias [M0328654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hemin [5175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria, Acute Intermittent [M0026010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin [5224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin calcium [20044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium [9877]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, bovine [236025]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin sodium, porcine [314659]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, bovine [1856273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cerebral Infarction [M0003885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>heparin, porcine [235473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>herpesvirus 1, human [1316105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin [26797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bites, Human [M0002617]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Infectious [M0017477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetacillin potassium [1299048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypovolemia [M0328462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hetastarch [5531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Hemorrhagic [M0019784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexachlorophene [5293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Communicable Diseases [M0004868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hexachlorophene [5293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine [5333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine [5333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine dihydrochloride [142136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine dihydrochloride [142136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine hydrochloride [350466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine hydrochloride [350466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine phosphate [26925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histamine phosphate [26925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin [50975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>histrelin acetate [1294622]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine [27084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine hydrobromide [235428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>homatropine methylbromide [27085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hops extract [259266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>house dust allergenic extract [852519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptorchidism [M0005384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>human chorionic gonadotropin [340705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>huperzine A [2267703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronate [62372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronate [62372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronic acid [5463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase [5464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, bovine [578350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, human recombinant [1300478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase, ovine [486164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-fihj [2375132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-ocsq [2693451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-oysk [2119708]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-qvfc [2639946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-tqjs [2693885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyaluronidase-zzxf [2382595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine [5470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydralazine hydrochloride [82027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrochlorothiazide [5487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone [5489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone bitartrate [142439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone hydrochloride [236931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone polistirex [221107]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone resin complex [314667]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocodone tannate [597355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone [5492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone aceponate [41277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone acetate [27197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone butyrate [103468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone cypionate [163524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone probutate [27196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium phosphate [235482]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone sodium succinate [235483]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Hyperplasia, Congenital [M0000487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrocortisone valerate [27199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulonephritis [M0009300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroflumethiazide [5495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrogen peroxide [5499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydrolyzed casein (enzymatic; 1000 MW) [1812932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone [3423]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydromorphone hydrochloride [203177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroquinone [5509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperpigmentation [M0026546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Pernicious [M0001137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin [5514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Pernicious [M0001137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin acetate [236302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxocobalamin hydrochloride [1947247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Pernicious [M0001137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine [5521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria Cutanea Tarda [M0026011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Porphyria Cutanea Tarda [M0026011]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxychloroquine sulfate [153972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (1500 MPA.S at 1%) [1312606]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (2000 CPS at 1%) [1299925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (4000 CPS at 1%) [1307036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose (5000 CPS at 1%) [1307084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyethyl cellulose [27244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenocarcinoma [M0000355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone acetate [1101886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenocarcinoma [M0000355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyprogesterone caproate (USP) [12488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyproline [1311548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (type H) [1811461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (type H) [1811461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl cellulose (type H) [1811461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratoconjunctivitis Sicca [M0011966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2208 [1363585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropyl methylcellulose 2910 [1363586]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropylcellulose [27291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxypropylcellulose [27291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Neoplasms [M0022431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukocytosis [M0012413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyurea [5552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine [5553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine hydrochloride [154987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hydroxyzine pamoate [203182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hygromycin B [1426887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parasitemia [M0027759]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hylan G-F 20 [284637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis, Knee [M0030009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraoperative Complications [M0011598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tremor [M0021869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine [153970]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraoperative Complications [M0011598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tremor [M0021869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine hydrobromide [1047802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraoperative Complications [M0011598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tremor [M0021869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate [1225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tremor [M0021869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sialorrhea [M0019820]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraoperative Complications [M0011598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hyoscyamine sulfate anhydrous [1742407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypochlorite [1483317]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypochlorous acid [1483316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100 MPA.S) [1300444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (100000 MPA.S) [1300448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (15000 MPA.S) [1300445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (3 MPA.S) [1300446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2208 (4000 CPS) [1300447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (4000 mpa.s) [1299222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2906 (50 MPA.S) [1297881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15 MPA.S) [1300450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (15000 MPA.S) [1300451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (3 MPA.S) [1300449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (4000 MPA.S) [1300455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (5 MPA.S) [1300452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (50 MPA.S) [1300453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose 2910 (6 cps) [1300454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>hypromellose [27334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab [2043283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibalizumab-uiyk [2043313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate [115264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronate sodium [236916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibandronic acid [115265]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine [51253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Congestive Heart Failure [M0502050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibopamine hydrochloride [284157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Congestive Heart Failure [M0502050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp [2560213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrexafungerp citrate [2560215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Follicular [M0012818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibritumomab tiuxetan [262323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Low-Grade [M0025077]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Waldenstrom Macroglobulinemia [M0012865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibrutinib [1442981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Premenstrual Syndrome [M0017534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen [5640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Premenstrual Syndrome [M0017534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen lysine [36761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Premenstrual Syndrome [M0017534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibuprofen, sodium salt [1429044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide [41289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ibutilide fumarate [51256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant [1148138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedemas, Hereditary [M0502559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icatibant acetate [1294605]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedemas, Hereditary [M0502559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ichthammol [5645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Insect Bites and Stings [M0011381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ichthammol [5645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Poison Ivy [M0017098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ichthammol [5645]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icodextrin [140480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icodextrin [140480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>icodextrin [140480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin [5650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarubicin hydrochloride [82124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idarucizumab [1716191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idecabtagene vicleucel [2536430]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idelalisib [1544460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis, Dendritic [M0011963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idoxuridine [5653]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>idursulfase [644101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucopolysaccharidosis II [M0025232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ifosfamide [5657]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloperidone [73178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloperidone [73178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iloprost [40138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelodysplastic-Myeloproliferative Diseases [M0504879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mastocytosis, Systemic [M0405932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatofibrosarcoma [M0027452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib [282388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blast Crisis [M0002638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatofibrosarcoma [M0027452]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mastocytosis, Systemic [M0405932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelodysplastic-Myeloproliferative Diseases [M0504879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imatinib mesylate [284924]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imdevimab [2465249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>COVID-19 [M000732426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat [2685236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelodysplastic Syndromes [M0014324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imetelstat sodium [2685237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelodysplastic Syndromes [M0014324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril [60245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imidapril hydrochloride [259335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Splenic Diseases [M0020368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiglucerase [84959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Diseases [M0012644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacteriaceae Infections [M0007472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem [5690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacteriaceae Infections [M0007472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem anhydrous [1545986]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacteriaceae Infections [M0007472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipenem monohydrate [2184135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine [5691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine hydrochloride [150816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imipramine pamoate [91118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Condylomata Acuminata [M0004994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Actinic [M0518969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imiquimod [59943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Basal Cell [M0003431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant [2725912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>imlunestrant tosylate [2725911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - dira [2706382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - dira [2706382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Immunodeficiency Diseases [M000650094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - ifas [2102433]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - kthm [2726012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - kthm [2726012]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Immunodeficiency Diseases [M000650094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - slra [2123035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin intravenous (human) - stwk [2672094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - hipp [2167145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) - klhw [2196290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immune globulin subcutaneous (human) [617615]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G [5666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G [5666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Immunodeficiency Diseases [M000650094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulin G, human [1426680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [M0328266]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic, Autoimmune [M0001127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomyositis [M0006061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytomegalovirus Infections [M0005604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Syncytial Virus Infections [M0027589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sepsis [M0028155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>immunoglobulins, intravenous [42386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Guillain-Barre Syndrome [M0017242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiomyopathy, Dilated [M0003463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone [738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Cardiogenic [M0019783]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inamrinone lactate [91236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiomyopathy, Dilated [M0003463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inavolisib [2695422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inclisiran [2588243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholesterol, LDL [M0012591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inclisiran [2588243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inclisiran sodium [2588259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inclisiran sodium [2588259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholesterol, LDL [M0012591]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>incobotulinumtoxinA [1000104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol [1114326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol [1114326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol maleate [1114325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indacaterol maleate [1114325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indapamide [5764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir [114289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir anhydrous [1546024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indinavir sulfate [203153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ductus Arteriosus, Patent [M0006877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin [5781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tendinopathy [M0483885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ductus Arteriosus, Patent [M0006877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tendinopathy [M0483885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium [1294612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ductus Arteriosus, Patent [M0006877]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>indomethacin sodium trihydrate [258329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tendinopathy [M0483885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab [2373951]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuromyelitis Optica [M0014730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inebilizumab-cdon [2373950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuromyelitis Optica [M0014730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infigratinib [2550729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholangiocarcinoma [M0027512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab [191831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-abda [1927283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-axxq [2266523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-dyyb [1790539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>infliximab-qbtx [2103476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/11/2021 (H3N2) antigen [2605723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza A Virus, H3N2 Subtype [M0491454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/6/2021 (H3N2) antigen [2605083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza A Virus, H3N2 Subtype [M0491454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Darwin/9/2021 (H3N2) antigen [2593854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza A Virus, H3N2 Subtype [M0491454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>influenza A virus A/Delaware/55/2019 (H1N1) antigen [2605724]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza A Virus, H1N1 Subtype [M0491451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ingenol mebutate [1242806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Actinic [M0518969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen [2099289]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloid Neuropathies, Familial [M0026861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotersen sodium [2099290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloid Neuropathies, Familial [M0026861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>inotuzumab ozogamicin [1942950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart protamine, human [352385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart, human [51428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-szjj [2705729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin aspart-xjhz [2720519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin degludec [1670007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine [274783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glargine-aglr [2589006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin glulisine, human [400008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef [317235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, beef-pork [317598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, human [253181]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin isophane, pork [221108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro [86009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro protamine, human [314684]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin lispro-aabc [2376838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef [235284]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, beef-pork [235283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, prompt zinc, pork [235286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef [235278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, beef-pork [314685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, protamine zinc, pork [235279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Reperfusion Injury [M0023777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef [314686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Ketoacidosis [M0025687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Ketoacidosis [M0025687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Reperfusion Injury [M0023777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, beef-pork [235275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Ketoacidosis [M0025687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Reperfusion Injury [M0023777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, human [253182]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Ketoacidosis [M0025687]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Reperfusion Injury [M0023777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>insulin, regular, pork [221109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2a [5879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Carcinoid Syndrome [M0012930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphomatoid Granulomatosis [M0012824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Condylomata Acuminata [M0004994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic [M0018187]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Genitalis [M0010276]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-2b [5880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Condylomata Acuminata [M0004994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-3n,human leukocyte derived [314687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfa-n3 [612937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Condylomata Acuminata [M0004994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon alfacon-1 [59744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1a [75917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon beta-1b [72257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteopetrosis [M0015549]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>interferon gamma-1b [5882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antibody Deficiency Syndrome [M0011154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Immunologic Deficiency Syndromes [M0011155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>intramuscular immunoglobulin [108067]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheochromocytoma [M0016586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iobenguane I-131 [2053281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paraganglioma [M0015869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-131 [1546415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperthyroidism [M0010871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodide ion I-131 [1546415]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodinated glycerol [27723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine [5933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Diseases [M0021478]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-125 [253341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodine-131-tositumomab [234449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoquinol [3435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystinuria [M0005557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoquinol [3435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastocystis Infections [M0025568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iodoquinol [3435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Amebic [M0006914]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iopanoic acid [5967]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperthyroidism [M0010871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipecac [5975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipilimumab [1094833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium [7213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide [203212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide anhydrous [1445143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium bromide monohydrate [1309404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ipratropium cation [1546373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan [2671061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iptacopan hydrochloride [2671062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irbesartan [83818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rectal Neoplasms [M0018657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasm Metastasis [M0014577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan [51499]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasm Metastasis [M0014577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>irinotecan hydrochloride [153329]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rectal Neoplasms [M0018657]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron [90176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron [90176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Restless Legs Syndrome [M0018926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron carbonyl [262150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron sucrose [24909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron,peptonized [235272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron,peptonized [235272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron-dextran complex [5992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>iron-dextran complex [5992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab [2282018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isatuximab-irfc [2282019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isavuconazole [1720882]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucormycosis [M0014180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isocarboxazid [6011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole [27901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole [27901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole [27901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginitis [M0022488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole nitrate [203157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole nitrate [203157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginitis [M0022488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoconazole nitrate [203157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine [6023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine [6023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine hydrochloride [102397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine hydrochloride [102397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine mesylate [6024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoetharine mesylate [6024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurane [6026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Asthmaticus [M0020462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurophate [6027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoflurophate [6027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoniazid [6038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoniazid [6038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Dyskinesia [M0002488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholelithiasis [M0004241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide [89784]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenitis [M0006886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenitis [M0006886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholelithiasis [M0004241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroenteritis [M0009018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Dyskinesia [M0002488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropamide iodide [6051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl unoprostone [135313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isopropyl unoprostone [135313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Hemorrhagic [M0019784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adams-Stokes Syndrome [M0000337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol [6054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adams-Stokes Syndrome [M0000337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Hemorrhagic [M0019784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol hydrochloride [82030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adams-Stokes Syndrome [M0000337]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiac Output, Low [M0003453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Hemorrhagic [M0019784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoproterenol sulfate [82031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide [6057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Spasm, Diffuse [M0023299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Spasm, Diffuse [M0023299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide dinitrate [6058]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Spasm, Diffuse [M0023299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isosorbide mononitrate [28004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isotretinoin [6064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis [M0001734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboangiitis Obliterans [M0021426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine [6066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis [M0001734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboangiitis Obliterans [M0021426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isoxsuprine hydrochloride [82033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>isradipine [33910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>istradefylline [2199015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptococcosis [M0005381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paracoccidioidomycosis [M0015861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis [M0012333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sporotrichosis [M0020384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>itraconazole [28031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zygomycosis [M0029826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine [1649480]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivabradine hydrochloride [1649479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivacaftor [1243041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strongyloidiasis [M0020615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mansonelliasis [M0013012]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichuriasis [M0021941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Elephantiasis [M0007229]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scabies [M0019458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onchocerciasis [M0015295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivermectin [6069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ivosidenib [2049873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixabepilone [337523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib [1723735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixazomib citrate [1723734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ixekizumab [1745099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin [6084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>josamycin propionate [28069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A [1727573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin A sulfate [1300476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Encephalopathy [M0010200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Encephalopathy [M0010200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin [6099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Encephalopathy [M0010200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serratia Infections [M0025671]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kanamycin sulfate [203183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kaolin [6102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kaolin light [104100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>karaya gum [6111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kava preparation [285228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kava preparation [285228]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>kelp preparation [285155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypothyroidism [M0010948]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine [6130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketamine hydrochloride [203184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paracoccidioidomycosis [M0015861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis [M0012333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acanthamoeba Keratitis [M0024241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoconazole [6135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen [6142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketoprofen lysine [28199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac [35827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photophobia [M0328261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketorolac tromethamine [28200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen [6146]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ketotifen fumarate [11404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol [6185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>labetalol hydrochloride [202693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacidipine [28382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lacosamide [623400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactase [41397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactose Intolerance [M0012180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactic acid [28393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactobacillic acid [2002583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Encephalopathy [M0010200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lactulose [6218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamivudine [68244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mood Disorders [M0029642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lamotrigine [28439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol [2712070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol hydrochloride [2712069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol hydrochloride [2712069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>landiolol hydrochloride [2712069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide [68092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroendocrine Tumors [M0027590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide [68092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide acetate [236167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroendocrine Tumors [M0027590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lanreotide acetate [236167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lansoprazole [17128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib [480167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lapatinib ditosylate [481474]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laronidase [392509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucopolysaccharidosis I [M0012558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasm Metastasis [M0014577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib [2105628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Resistance, Neoplasm [M0028386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib sulfate [2104548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasm Metastasis [M0014577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>larotrectinib sulfate [2104548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Resistance, Neoplasm [M0028386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lasmiditan [2256930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine with Aura [M0328363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lasmiditan [2256930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine without Aura [M0328367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost [43611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>latanoprost acid [2675687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>laureth-9 phosphate [2373964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Varicose Veins [M0022531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib [2691150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lazertinib mesylate [2691151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab [2693758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lebrikizumab-lbkz [2693778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab [2626143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecanemab-irmb [2626142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lecithin [8214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mental Fatigue [M0008256]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ledipasvir [1591922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin [2198944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lefamulin acetate [2198943]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leflunomide [27169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leflunomide [27169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemborexant [2272403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lemon extract [1364291]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir [2625651]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV-1 [M0023859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenacapavir sodium [2625652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV-1 [M0023859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myelodysplastic Syndromes [M0014324]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenalidomide [342369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib [2633005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Immunodeficiency Diseases [M000650094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leniolisib phosphate [2633006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Immunodeficiency Diseases [M000650094]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef [235280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, beef-pork [314682]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, human [314683]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lente insulin, pork [93108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib [1603296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib mesylate [1604346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lenvatinib mesylate [1604346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lepirudin [237057]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine [135056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lercanidipine hydrochloride [153679]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lesinurad [1731031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperuricemia [M0402804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA [2689280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letibotulinumtoxinA-wlbg [2689282]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>letrozole [72965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin [6313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leucovorin calcium [225852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leiomyoma [M0012316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide [42375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leiomyoma [M0012316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide acetate [203217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leiomyoma [M0012316]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>leuprolide mesylate [2595041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precocious Puberty, Central [M0563087]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol [237159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol hydrochloride [237160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levalbuterol tartrate [487066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole [6371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole hydrochloride [227227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamisole phosphate [1535214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine [2376944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levamlodipine maleate [2377031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myoclonic Epilepsy, Juvenile [M0328258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levetiracetam [114477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol [353497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobetaxolol hydrochloride [261718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol [1813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobunolol hydrochloride [227212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine [259453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levobupivacaine hydrochloride [259454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine [28627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocabastine hydrochloride [1294532]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine [42955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine fumarate [360300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine hydrochloride [1426681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocarnitine tartrate [1364375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine [356887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine [356887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine [356887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine dihydrochloride [402349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine dihydrochloride [402349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levocetirizine dihydrochloride [402349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levodopa [6375]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maxillary Sinusitis [M0023883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin [82122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Maxillary Sinusitis [M0023883]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levofloxacin anhydrous [1546009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acanthamoeba Keratitis [M0024241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis [M0012333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoketoconazole [2588846]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paracoccidioidomycosis [M0015861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin [877015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin calcium [979509]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin calcium pentahydrate [1648126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levoleucovorin disodium [2107308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate [1592257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate [1592257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate calcium [1028454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate glucosamine [1592256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate glucosamine [1592256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate magnesium [1549106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolate magnesium [1549106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolic acid [1025342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomefolic acid [1025342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomepromazine maleate [160372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl [237005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomethadyl acetate hydrochloride [82043]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran [1433212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levomilnacipran hydrochloride [1433211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levonordefrin [132889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oral Ulcer [M0028634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol [6378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levorphanol tartrate [153973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine [10582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium [40144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>levothyroxine sodium anhydrous [1372638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mouth Diseases [M0014130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Diseases [M0007747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine [6387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mouth Diseases [M0014130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction [M0028090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Diseases [M0007747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride [142440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Paroxysmal [M0021001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Diseases [M0007747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mouth Diseases [M0014130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lidocaine hydrochloride anhydrous [1299236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifileucel [2675860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lifitegrast [1801820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linaclotide [1307404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linagliptin [1100699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin [6398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin [6398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin hydrochloride [82036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lincomycin hydrochloride [82036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lindane [1388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scabies [M0019458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linezolid [190376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms [M0014585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipidemias [M0010830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linolenic acid [52071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sjogren&apos;s Syndrome [M0019911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab [2719416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linvoseltamab-gcpt [2719477]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibroid Uterus [M0012317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix [2621019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix choline [2621020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibroid Uterus [M0012317]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>linzagolix choline [2621020]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine [10814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liothyronine sodium [142448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>liquefied phenol [239351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine [700810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine [700810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Binge Drinking [M0573245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine dimesylate [673579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisdexamfetamine dimesylate [673579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Binge Drinking [M0573245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril [29046]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisinopril anhydrous [1546022]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lisocabtagene maraleucel [2479136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium [6448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium aspartate [746070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium carbonate [42351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium citrate [52105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium hydroxide monohydrate [1298832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium orotate [28815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conduct Disorder [M0029628]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lithium silicate [2691100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lixisenatide [1440051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide [52151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratoconjunctivitis [M0011965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lodoxamide tromethamine [28859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratoconjunctivitis [M0011965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine [28863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lofexidine hydrochloride [235853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin [28872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomefloxacin hydrochloride [235762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide [1364479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomitapide mesylate [1364478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Neoplasms [M0004817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lomustine [6466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin [2569562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Growth Hormone Deficiency With Pituitary Anomalies [M0567932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonapegsomatropin-tcgd [2569592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Growth Hormone Deficiency With Pituitary Anomalies [M0567932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine [2540964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loncastuximab tesirine-lpyl [2540965]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lonoctocog alfa [1796377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Diseases, Functional [M0004815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide [6468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Diseases, Functional [M0004815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loperamide hydrochloride [82038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery, Bacillary [M0006916]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lopinavir [195088]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Joint Diseases [M0011860]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loracarbef [28981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Genital Diseases, Female [M0009154]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loratadine [28889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loratadine [28889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Catatonia [M0003634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorazepam [6470]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin [1300701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride [1300700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride anhydrous [1808546]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorcaserin hydrochloride hemihydrate [1597623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lorlatinib [2103164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaplastic Lymphoma Kinase [M0228330]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lormetazepam [28894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertrophy, Left Ventricular [M0026394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan [52175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertrophy, Left Ventricular [M0026394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>losartan potassium [203160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Viral [M0005023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol [237027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Viral [M0005023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loteprednol etabonate [52177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovastatin [6472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lovotibeglogene autotemcel [2671958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemoglobin, Sickle [M0010127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine [6475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine hydrochloride [91138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>loxapine succinate [6476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lubiprostone [623033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lubiprostone [623033]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea [M0021562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luliconazole [1482680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumacaftor [1655922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone [2275602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumateperone tosylate [2275731]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lumefantrine [847728]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone [1040028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurasidone hydrochloride [1040027]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lurbinectedin [2374729]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Small Cell Lung Carcinoma [M0520106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept [2262544]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>luspatercept-aamt [2262543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lusutrombopag [2054984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 dotatate [1999335]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroendocrine Tumors [M0027590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutetium Lu 177 vipivotide tetraxetan [2597053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate-Specific Antigen [M0026444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lutropin alfa [388084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine [6536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine acetate [6537]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine hydrochloride [6538]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>lysine monohydrate [1314248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>macitentan [1442132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide [6572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mafenide acetate [6573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hernia, Hiatal [M0010264]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magaldrate [29151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium [6574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium acetate tetrahydrate [317246]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium amino acid chelate [486895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate [142131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium aspartate anhydrous [1792467]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium carbonate [29155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium cation [1426853]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride [6579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride anhydrous [1311539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride hexahydrate [221118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium chloride tetrahydrate [2003593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium citrate [52356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium disodium EDTA [1422486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium gluconate [52358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium glycinate [476818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Metabolic Diseases [M0013493]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Hemorrhage [M0010153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium hydroxide [6581]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxide [6582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium oxybate [2387308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cataplexy [M0003627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate [29164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate anhydrous [1657484]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate dibasic trihydrate [237119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, dibasic [1482795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium phosphate, tribasic, pentahydrate [1313280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate [52364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Seborrheic [M0026535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium salicylate tetrahydrate [253186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium stearate [1310567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephritis [M0014626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pre-Eclampsia [M0017443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate [6585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eclampsia [M0006985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephritis [M0014626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pre-Eclampsia [M0017443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eclampsia [M0006985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate anhydrous [1311625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eclampsia [M0006985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pre-Eclampsia [M0017443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephritis [M0014626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate dihydrate [2107060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torsades de Pointes [M0024685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephritis [M0014626]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pre-Eclampsia [M0017443]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eclampsia [M0006985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium sulfate monohydrate [1311259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium trisilicate [29170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Magnesium Deficiency [M0012886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnesium valproate [134422]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnolol [2562549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antioxidant Activity [M000679029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnolol [2562549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroprotection [M000596409]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>magnolol [2562549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malathion [6606]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malt soup extract [91264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>malt soup extract [91264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese [6623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese chloride [29261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese dioxide [29263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese gluconate [52403]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese monoxide [1728312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manganese sulfate [29268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine [29275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>manidipine hydrochloride [259487]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anuria [M0001524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oliguria [M0015284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol [6628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperuricemia [M0402804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema, Cardiac [M0007053]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Edema [M0018125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anuria [M0001524]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oliguria [M0015284]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Diseases [M0017828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Edema [M0002876]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Acute [M0012015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Craniocerebral Trauma [M0009821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mannitol hexanitrate [89792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysthymic Disorder [M0028689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cocaine-Related Disorders [M0029669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline [6646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cocaine-Related Disorders [M0029669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline hydrochloride [203126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysthymic Disorder [M0028689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bulimia [M0003021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cocaine-Related Disorders [M0029669]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maprotiline mesylate [236328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysthymic Disorder [M0028689]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat [2571074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maralixibat chloride [2571073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>maraviroc [620216]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab [2473851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>margetuximab-cmkb [2473850]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab [2697133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab [2697133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab-hncq [2697132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>marstacimab-hncq [2697132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>masoprocol [227239]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis [M0011970]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavacamten [2600867]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cardiomyopathy, Hypertrophic Obstructive [M000644373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>WHIM syndrome [M0531158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infections [M0011294]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mavorixafor [2684021]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogammaglobulinemia [M0000552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Dystrophy, Duchenne [M0014253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mazindol [6664]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancylostomiasis [M0001101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mebendazole [6672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichuriasis [M0021941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine [6673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecamylamine hydrochloride [91240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion, Malignant [M0024554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasm Metastasis [M0014577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine [6674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion, Malignant [M0024554]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasm Metastasis [M0014577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mechlorethamine hydrochloride [155036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine [6676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclizine hydrochloride [82041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate [588003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylarthritis [M0374010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meclofenamate sodium [6677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylarthritis [M0374010]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Pernicious [M0001137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mecobalamin [29421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medazepam [6680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutrition Disorders [M0015120]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Diseases [M0012644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chylothorax [M0004457]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sprue, Tropical [M0020397]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medium chain triglycerides [1310578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Celiac Disease [M0003736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medronate disodium [317599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoventilation [M0010951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone [6691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medroxyprogesterone acetate [1000112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoventilation [M0010951]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleritis [M0023773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>medrysone [29439]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Hypersensitivity [M0006829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Premenstrual Syndrome [M0017534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefenamic acid [6693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine [6694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine [6694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Vivax [M0025572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine [6694]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine hydrochloride [82130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Vivax [M0025572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine hydrochloride [82130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mefloquine hydrochloride [82130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cachexia [M0003126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol [6703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anorexia [M0001278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Neoplasms [M0025700]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cachexia [M0003126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>megestrol acetate [29451]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anorexia [M0001278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine [6704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine [6704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meglumine [6704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Cutaneous [M0025563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melatonin [6711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Jet Lag Syndrome [M0328614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melatonin [6711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seasonal Affective Disorder [M0025286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meloxicam [41493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meloxicam [41493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan [6718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide [2531369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan flufenamide hydrochloride [2531370]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhabdomyosarcoma [M0019001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>melphalan hydrochloride [235857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine [6719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>memantine hydrochloride [236685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol [29491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoprothrombinemias [M0010925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menadiol sodium phosphate [52549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoprothrombinemias [M0010925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol [6750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol [6750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol glucuronide [2704947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol glucuronide [2704947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol, (+)- [1648123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>menthol, (+)- [1648123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate [107770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepenzolate bromide [52560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine [6754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meperidine hydrochloride [103755]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Temporal Lobe [M0007578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Post-Traumatic [M0007580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephenytoin [6757]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mephobarbital [6758]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol [29518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol [29518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol sulfate [236904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepindolol sulfate [236904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepirodipine [39879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine [6759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepivacaine hydrochloride [203185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mepolizumab [1720597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meprobamate [6760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequinol [15080]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lentigo [M0012354]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic [M0567378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mequitazine [29528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine [103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mercaptopurine anhydrous [1546028]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Appendicitis [M0001610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Haemophilus [M0013367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Pneumococcal [M0013370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem [29561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Pneumococcal [M0013370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Appendicitis [M0001610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Haemophilus [M0013367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritonitis [M0016367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>meropenem anhydrous [1546029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proctitis [M0017632]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sigmoid Diseases [M0019836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesalamine [52582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesna [44]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesna [44]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine [6779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mesoridazine besylate [203186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol [7688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaproterenol sulfate [6804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol [6805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaraminol bitartrate [6806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metaxalone [59078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin [6809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metformin hydrochloride [235743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone [6813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methadone hydrochloride [218337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine [6816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methamphetamine hydrochloride [82044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methampicillin [29629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methampicillin sodium [273443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Dyskinesia [M0002488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatitis [M0015809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline [6821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatitis [M0015809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methantheline bromide [91163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Dyskinesia [M0002488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene [6822]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methapyrilene hydrochloride [235721]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methaqualone [6823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metharbital [6825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methazolamide [6826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eczema [M0007049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Allergic Contact [M0026474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pityriasis Rosea [M0026580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine [29648]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eczema [M0007049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Allergic Contact [M0026474]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methdilazine hydrochloride [91121]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pityriasis Rosea [M0026580]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteriuria [M0002143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine [6832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteriuria [M0002143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine hippurate [29652]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine mandelate [161623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteriuria [M0002143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine sulfosalicylate [235562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteriuria [M0002143]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine sulfosalicylate [235562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine sulfosalicylate [235562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methenamine sulfosalicylate [235562]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin [2181306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin [2181306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcus aureus Infection [M000622263]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methicillin sodium [267073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Crisis [M0021477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methimazole [6835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methocarbamol [6845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choriocarcinoma [M0004339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydatidiform Mole [M0010673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Neoplasms [M0007750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate [6851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Choriocarcinoma [M0004339]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hydatidiform Mole [M0010673]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Neoplasms [M0007750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrexate sodium [287734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteosarcoma [M0019439]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine [6852]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methotrimeprazine hydrochloride [91124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxsalen [6854]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitiligo [M0022818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methoxy polyethylene glycol-epoetin beta [729596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine [89785]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine bromide [56092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methscopolamine nitrate [857649]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methsuximide [47858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyclothiazide [6860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulonephritis [M0009300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl 5-aminolevulinate [337068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Actinic [M0518969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl aminolevulinate hydrochloride [1300479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Actinic [M0518969]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acute Pain [M0551476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sprains and Strains [M0020394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Contusions [M0005130]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis [M0001741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyl salicylate [29787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium chloride [1796444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diaper Rash [M0006208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylbenzethonium chloride [1796444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (100 CPS) [1310583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (100 CPS) [1310583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (4000 CPS) [1297402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose (4000 CPS) [1297402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylcellulose [6873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa [6876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopa anhydrous [1545996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyldopate hydrochloride [91241]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithiasis [M0029982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methemoglobinemia [M0013565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue [6878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithiasis [M0029982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methemoglobinemia [M0013565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue anhydrous [2198975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cyanosis [M0005442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Simplex [M0010279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithiasis [M0029982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methemoglobinemia [M0013565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylene blue cation [1546414]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine [6883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylergonovine maleate [84158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone [29899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylnaltrexone bromide [979111]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate [6901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylphenidate hydrochloride [203188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurologic Manifestations [M0014716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematologic Diseases [M0010044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone [6902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurologic Manifestations [M0014716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematologic Diseases [M0010044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone aceponate [62136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurologic Manifestations [M0014716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematologic Diseases [M0010044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone acetate [155323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematologic Diseases [M0010044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurologic Manifestations [M0014716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium phosphate [29917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurologic Manifestations [M0014716]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematologic Diseases [M0010044]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methylprednisolone sodium succinate [203189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erectile Dysfunction [M0011178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyltestosterone [6904]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methyprylon [6910]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide [6911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vascular Headaches [M0022536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>methysergide maleate [203190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vascular Headaches [M0022536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol [10824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metipranolol hydrochloride [314731]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Nausea and Vomiting [M0029915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroparesis [M0027865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide [6915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroparesis [M0027865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide dihydrochloride [267035]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Nausea and Vomiting [M0029915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroparesis [M0027865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Nausea and Vomiting [M0029915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoclopramide hydrochloride [267036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metocurine iodide [203206]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metolazone [6916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol [6918]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol fumarate [102313]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol succinate [221124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metoprolol tartrate [203191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metreleptin [1491625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lipodystrophy [M0012562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Vaginitis [M0021930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole [6922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Vaginitis [M0021930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole benzoate [103866]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Vaginitis [M0021930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterocolitis, Pseudomembranous [M0007479]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abscess [M0000059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metronidazole hydrochloride [82047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>metyrosine [266604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheochromocytoma [M0016586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine [6926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mexiletine hydrochloride [142138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin [6927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mezlocillin sodium [82048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin [6929]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mianserin hydrochloride [203127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil [83213]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mibefradil dihydrochloride [83214]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin [325887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin [325887]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>micafungin sodium [487070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole [6932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miconazole nitrate [42790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam [6960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam hydrochloride [203128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midazolam maleate [142441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin [30005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midecamycin diacetate [236200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine [6963]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension, Orthostatic [M0010929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midodrine hydrochloride [993491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mastocytosis, Systemic [M0405932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>midostaurin [1919083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematologic Neoplasms [M0028786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy, Ectopic [M0017499]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningeal Neoplasms [M0013360]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mifepristone [6964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperglycemia [M0010824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat [2054252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fabry Disease [M0001191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>migalastat hydrochloride [2054264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fabry Disease [M0001191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglitol [30009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miglustat [402316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle extract [283579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis, Chronic [M0010227]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milk thistle extract [283579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran [588250]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milnacipran hydrochloride [30003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone [52769]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>milrinone lactate [155120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miltefosine [1494066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miltefosine [1494066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis [M0012333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miltefosine [1494066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Cutaneous [M0025563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil [6972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil [6972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intestinal Obstruction [M0011575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil, light [577312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mineral oil, light [577312]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intestinal Obstruction [M0011575]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tularemia [M0022145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline [6980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tularemia [M0022145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rocky Mountain Spotted Fever [M0019235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minocycline hydrochloride [6979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil [6984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia [M0000757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia [M0000757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate [1651695]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>minoxidil sulfate ester [1926479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia [M0000757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>miocamycin [6985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen [1367839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipidemia, Familial Combined [M0010832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mipomersen sodium [1367838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipidemia, Familial Combined [M0010832]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Overactive [M0461241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirabegron [1300786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirdametinib [2705551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurofibroma, Plexiform [M0027553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab [2668384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirikizumab-mrkz [2668385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine [15996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirtazapine hemihydrate [1992054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine [2621548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Ovarian Epithelial [M0532551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine-gynx [2621549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine-gynx [2621549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Ovarian Epithelial [M0532551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mirvetuximab soravtansine-gynx [2621549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyruvate Kinase Deficiency of Red Cells [M0565158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat [2594468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat sulfate [2595574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitapivat sulfate [2595574]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyruvate Kinase Deficiency of Red Cells [M0565158]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenocarcinoma [M0000355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitomycin [632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitotane [7004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenocortical Carcinoma [M0027496]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone [7005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mitoxantrone hydrochloride [203129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib [2570736]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mobocertinib succinate [2570737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Apnea, Obstructive [M0328295]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>modafinil [30125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril [30131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexipril hydrochloride [236066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moexiprilat [1546358]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mogamulizumab [2054068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone [7019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molindone hydrochloride [82051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>molybdenum [7024]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nutritional and Metabolic Diseases [M0015124]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib [2665204]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>momelotinib dihydrochloride monohydrate [2665205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone [108118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate [30145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mometasone furoate monohydrate [153374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic potassium phosphate [55019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobasic sodium phosphate, dihydrate [1311286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>monobenzone [17145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitiligo [M0022818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast [88249]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>montelukast sodium [115713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine [40169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moricizine hydrochloride [221126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspnea [M0006931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine [7052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspnea [M0006931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine hydrochloride [235751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine sulfate [30236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspnea [M0006931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspnea [M0006931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>morphine tartrate [235774]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab [2625122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Follicular [M0012818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mosunetuzumab-axgb [2625125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Follicular [M0012818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide [2664896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematopoietic Stem Cell Mobilization [M0029153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>motixafortide acetate [2664897]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hematopoietic Stem Cell Mobilization [M0029153]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxalactam [7069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox [2099295]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxetumomab pasudotox-tdfk [2099305]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxidectin [1047072]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onchocerciasis, Ocular [M0024245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin [139462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride [228750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>moxifloxacin hydrochloride monohydrate [1926505]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mugwort sage pollen extract [852029]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin [42372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mupirocin calcium [221128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>muromonab-CD3 [42405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate [265323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil [68149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate mofetil hydrochloride [237112]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolate sodium [408142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>mycophenolic acid [7145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabilone [31447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nabumetone [31448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadofaragene firadenovec [2644436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Cancer [M0332202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadolol [7226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol [31462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadoxolol hydrochloride [236178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nadroparin [67031]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin [28656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafarelin acetate [203147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin [7233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium [9893]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nafcillin sodium monohydrate [485026]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine [31476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine [31476]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine hydrochloride [91293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naftifine hydrochloride [91293]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine [7238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalbuphine hydrochloride [154985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine [1876597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naldemedine tosylate [1876598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalidixic acid [7240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene [31479]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nalmefene hydrochloride [236069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol [1551777]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxegol oxalate [1593586]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone [7242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride [203192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naloxone hydrochloride dihydrate [1010598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone [7243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opioid-Related Disorders [M0014475]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naltrexone hydrochloride [105069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone [7244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone decanoate [31494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nandrolone phenpropionate [31495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline [7247]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperemia [M0010821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperemia [M0010821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline hydrochloride [82054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperemia [M0010821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naphazoline nitrate [235810]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen [7258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Back Pain [M0002115]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toothache [M0021704]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naproxen sodium [142442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan [141366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naratriptan hydrochloride [236690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab [354770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab-sztn [2725169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natalizumab-sztn [2725169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharitis [M0002658]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis [M0003258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptococcosis [M0005381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microsporidiosis [M0025685]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Fungal [M0024239]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blastomycosis [M0002647]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratitis [M0011962]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aspergillosis [M0001850]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sporotrichosis [M0020384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidioidomycosis [M0004676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Vaginitis [M0021930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>natamycin [7268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histoplasmosis [M0010434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nateglinide [274332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>naxitamab [2474039]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroblastoma [M0014699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol [31555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nebivolol hydrochloride [236883]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>necitumumab [1723738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil [31563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil [31563]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil sodium [266663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedocromil sodium [266663]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedosiran [2675287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperoxaluria, Primary [M0010843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nedosiran sodium [2675288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperoxaluria, Primary [M0010843]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone [31565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nefazodone hydrochloride [236082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelarabine [274771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, T-Cell [M0023815]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir [134527]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nelfinavir mesylate [266565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab [2691310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prurigo [M0017934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nemolizumab-ilto [2691309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prurigo [M0017934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin [7299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Encephalopathy [M0010200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatic Encephalopathy [M0010200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neomycin sulfate [7300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine [7315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine bromide [82055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neostigmine methylsulfate [7316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nepafenac [298665]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Pain [M0542422]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nerandomilast [2725523]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Idiopathic Pulmonary Fibrosis [M0511887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib [1940643]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>neratinib maleate [1940642]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nesiritide [19666]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspnea, Paroxysmal [M0006932]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil [1992864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil mesylate [1992863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netarsudil mesylate [1992863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ocular Hypertension [M0015213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin [7337]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>netilmicin sulfate [203193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine [53654]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nevirapine hemihydrate [2462459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacin [7393]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niacinamide [7405]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine [7396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicardipine hydrochloride [235230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niclosamide [7402]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicorandil [31748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinamide hydriodide [317251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine [7407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotine polacrilex [31765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tobacco Use Disorder [M0021604]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid benzyl ester [31767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nicotinic acid propyl ester [236738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nifedipine [7417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Chronic-Phase [M0023823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib [662281]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Chronic-Phase [M0023823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib d-tartrate [2715454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Chronic-Phase [M0023823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride [1804015]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Chronic-Phase [M0023823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib hydrochloride monohydrate [2701416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Chronic-Phase [M0023823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilotinib tartrate [2698561]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilutamide [31805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma [M0003424]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilutamide [31805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nilvadipine [53692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimodipine [7426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Subarachnoid Hemorrhage [M0020646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimorazole [7427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Head and Neck [M0332484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimorazole [7427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Infections [M0021928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nimorazole [7427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoxia [M0001285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib [1592737]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Idiopathic Pulmonary Fibrosis [M0511887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nintedanib esylate [1592736]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Idiopathic Pulmonary Fibrosis [M0511887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab [2712693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nipocalimab-aahu [2712692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib [1918231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Cancer [M0482643]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate [2637447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peritoneal Neoplasms [M0016362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>niraparib tosylate monohydrate [2640208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fallopian Tube Neoplasms [M0008173]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirmatrelvir [2587892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronavirus Infections [M0027585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat [2670631]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desmoid Tumors [M0027451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nirogacestat hydrobromide [2670632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Desmoid Tumors [M0027451]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris, Variant [M0001181]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nisoldipine [7435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptosporidiosis [M0005385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitazoxanide [31819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitisinone [61805]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyrosinemias [M0328654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myoclonic Seizures [M000621444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrazepam [7440]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrendipine [7441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitric oxide [7442]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin [7454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, macrocrystals [235559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurantoin, monohydrate [221129]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Skin Infections [M0020427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrofurazone [7455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrogen [7456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eclampsia [M0006985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraoperative Complications [M0011598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Spasm, Diffuse [M0023299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroglycerin [4917]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrous oxide [7486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrous oxide [7486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome [M0018891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitrous oxide [7486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infarction [M0011293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nitroxoline [31901]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab [1597876]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Small Cell Lung Carcinoma [M0520106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Lymphoma, Adult [M0551753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Neoplasms [M0007750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-nvhy [2700791]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Neoplasms [M0012021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nivolumab-rmbw [2596770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nizatidine [42319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept [2682678]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Cancer [M0332202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nogapendekin alfa inbakicept-pmln [2682677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Cancer [M0332202]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia B [M0004363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nonacog alfa [1300488]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoprothrombinemias [M0010925]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noradrenaline hydrochloride [2256931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nordazepam [3155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norelgestromin [326374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine [7512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine bitartrate [7508]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norepinephrine, DL- [1657875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone [7514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone acetate [31983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethindrone enanthate [31984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norethynodrel [7515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norfloxacin [7517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestimate [31994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrienone [7519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>norgestrienone [7519]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometriosis [M0007413]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline [7531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enuresis [M0007497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nortriptyline hydrochloride [203130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>noscapine [7533]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nusinersen [1863556]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Atrophy, Spinal [M0014250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis [M0001734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin [7595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboangiitis Obliterans [M0021426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis [M0001734]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboangiitis Obliterans [M0021426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nylidrin hydrochloride [82060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>nystatin [7597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat bran [253190]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oat smut allergenic extract [349978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oats preparation [285251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obecabtagene autoleucel [2698195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [M0023809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obeticholic acid [1798288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholangitis [M0004228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obiltoxaximab [1746906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obiltoxaximab [1746906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obiltoxaximab [1746906]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obinutuzumab [974779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>obinutuzumab [974779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Follicular [M0012818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab [1876366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocrelizumab-ocsq [2693449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ocriplasmin [29998]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinal Diseases [M0018945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine [1311141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine hydrochloride [1744461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octopamine hydrochloride [1744461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octotropine methylbromide [17945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenoma [M0000367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pituitary Neoplasms [M0016922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide [7617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pituitary Neoplasms [M0016922]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenoma [M0000367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>octreotide acetate [221130]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat [2563966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>odevixibat sesquihydrate [2563978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofatumumab [712566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Ulcer [M0005185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Bacterial [M0005021]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatitis [M0017835]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media, Suppurative [M0015566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis [M0005558]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epididymitis [M0007560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ofloxacin [7623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oil of garlic [1309210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaflur [2712235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dentin Sensitivity [M0005954]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaflur [2712235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Decalcification, Pathologic [M0005712]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine [61381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate [1294588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olanzapine pamoate monohydrate [885604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaparib [1597582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olaratumab [1855735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oleandomycin [7629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen [2701418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipidemias [M0010830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen [2701418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial hyperchylomicronemia syndrome [M0532950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen sodium [2701417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipidemias [M0010830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olezarsen sodium [2701417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Familial hyperchylomicronemia syndrome [M0532950]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine [2392230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acute Pain [M0551476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oliceridine fumarate [2392633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acute Pain [M0551476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olipudase alfa [2610407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysosomal Storage Diseases [M0025150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olipudase alfa-rpcp [2610406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lysosomal Storage Diseases [M0025150]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan [321064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olmesartan medoxomil [118463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol [1546059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol [1546059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol hydrochloride [1546396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olodaterol hydrochloride [1546396]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine [135391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olopatadine hydrochloride [236599]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine [32385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olsalazine sodium [104123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>olutasidenib [2623641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine [1546446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Accelerated Phase [M0023822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omacetaxine [1546446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Chronic-Phase [M0023823]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline [2059269]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline tosylate [2059268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline tosylate [2059268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omadacycline tosylate [2059268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab [302379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omalizumab-igec [2725997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omaveloxolone [2631931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Friedreich Ataxia [M0008844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir [1597371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ombitasvir heminonahydrate [1600437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omega-3 fatty acids [4301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole [7646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole magnesium [236486]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omeprazole sodium [1792108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag [2612691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraocular Pressure [M0011596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omidenepag isopropyl [2612690]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraocular Pressure [M0011596]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole [32411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole [32411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis [M0003258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole mononitrate [134933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis [M0003258]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>omoconazole mononitrate [134933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Overactive [M0461241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onabotulinumtoxinA [860189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec [2170226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Atrophy, Spinal [M0014250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onasemnogene abeparvovec-xioi [2170225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscular Atrophy, Spinal [M0014250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron [26225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride [203148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ondansetron hydrochloride anhydrous [2119176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholism [M0000661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>onion extract [1370469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opicapone [2362167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium [7676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>opium tincture [221134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin [1547611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oritavancin diphosphate [1549827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orlistat [37925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornidazole [7701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ornidazole [7701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Infections [M0021928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine [7715]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine citrate [7716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orphenadrine hydrochloride [202723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>orris allergenic extract [314753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir [260101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oseltamivir phosphate [259275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat [2286252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osilodrostat phosphate [2286253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib [1721560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>osimertinib mesylate [1721559]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrophy [M0001929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspareunia [M0006926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ospemifene [1370971]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause [M0013380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oteseconazole [2602577]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ovine digoxin immune fab [1745257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin [7773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteomyelitis [M0015544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cellulitis [M0003788]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxacillin sodium [9898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaliplatin [32592]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxamniquine [7778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxamniquine [7778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schistosomiasis mansoni [M0019484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emaciation [M0007242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxandrolone [7779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Growth Disorders [M0009654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin [32613]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin potassium [660767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin potassium [660767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxaprozin potassium [660767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxazepam [7781]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxcarbazepine [32624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole [32638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxiconazole nitrate [56226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol [7801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxprenolol hydrochloride [203131]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxtriphylline [20976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybate [2387302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cataplexy [M0003627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybenzone [32673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysuria [M0491855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin [32675]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysuria [M0491855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Neurogenic [M0002636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxybutynin chloride [54251]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone [7804]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone hydrochloride [82063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxycodone terephthalate [159821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Insufficiency [M0018897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gangrene [M0008989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Embolism, Air [M0007250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Fibrosis [M0018134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Diseases, Obstructive [M0012746]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Decompression Sickness [M0005736]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxygen [7806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carbon Monoxide Poisoning [M0003373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline [7812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetazoline hydrochloride [106101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymetholone [7813]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone [7814]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxymorphone hydrochloride [82064]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline [7821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline anhydrous [1545999]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline calcium [82065]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline dihydrate [266974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytetracycline hydrochloride [4780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin [7824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>oxytocin acetate [1733680]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postpartum Hemorrhage [M0010156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod [2288236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Acute Relapsing [M0334289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Acute Relapsing [M0334289]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozanimod hydrochloride [2288235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ozenoxacin [1994739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel [56946]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paclitaxel protein-bound [486610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib [2595243]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pacritinib citrate [2595242]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>padimate-O [32786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palbociclib [1601374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palifermin [196319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mucositis [M0482523]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone [679314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paliperidone palmitate [858045]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palivizumab [194279]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Syncytial Virus Infections [M0027589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palopegteriparatide [2693635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoparathyroidism [M0010912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>palovarotene [2663954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ossification, Heterotopic [M0015505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine [2724363]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paltusotine hydrochloride [2724364]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamabrom [54365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Premenstrual Syndrome [M0017534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteolysis [M0015536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate [11473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteolysis [M0015536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronate disodium [105443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pamidronic acid [1546406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteolysis [M0015536]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pancreatin [7880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panitumumab [263034]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat [1603350]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panobinostat lactate [1603349]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol [1044977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Healing [M0023016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Healing [M0023016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>panthenol triacetate, (+)- [1426597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole (as pantoprazole sodium sesquihydrate) [236632]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole [40790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantoprazole sodium [253191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid [7891]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pantothenic acid, (+-)- [2394646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B Deficiency [M0022793]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erectile Dysfunction [M0011178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arterial Occlusive Diseases [M0001730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Ischemia [M0003886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine [7895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Ischemia [M0003886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arterial Occlusive Diseases [M0001730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erectile Dysfunction [M0011178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine codecarboxylate [158387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Ischemia [M0003886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arterial Occlusive Diseases [M0001730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erectile Dysfunction [M0011178]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaverine hydrochloride [203132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>papaya extract [1992412]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paraldehyde [7909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delirium [M0005774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paraldehyde [7909]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypoparathyroidism [M0010912]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parathyroid hormone [1427222]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypocalcemia [M0010891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Intractable [M0015750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paregoric [32926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspnea [M0006931]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paricalcitol [73710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperparathyroidism [M0010845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir [1597373]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paritaprevir dihydrate [1600436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parnaparin [69528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin [7934]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptosporidiosis [M0005385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryptosporidiosis [M0005385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paromomycin sulfate [66912]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine [32937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride [235830]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride anhydrous [1311626]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine hydrochloride, hemihydrate [1298842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phobic Disorders [M0016622]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>paroxetine mesylate [436212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley extract [317857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>parsley seed oil [1309236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide [1364105]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide diaspartate [1364104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pasireotide pamoate [1597818]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cushing Syndrome [M0005427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer [1716203]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patiromer sorbitex calcium [2204723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran [2053490]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran lipid complex [2284711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium [2053491]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>patisiran sodium lipid complex [2284710]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyloidosis, Hereditary, Transthyretin-Related [M0568082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib [714438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Neoplasms [M0020121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pazopanib hydrochloride [732187]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peanut oil [18235]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Weight Gain [M0023778]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pecan pollen extract [852272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin [7960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pefloxacin mesylate [262299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegademase bovine [59768]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Severe Combined Immunodeficiency [M0025203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphocytic, Chronic, B-Cell [M0023808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blast Crisis [M0002638]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegaspargase [34132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegcetacoplan [2557372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim [338036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-apgf [2469333]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-bmez [2260702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-cbqv [2102692]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-fpgk [2613761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-jmdb [2048018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegfilgrastim-pbbk [2602779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2a [120608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon alfa-2b [253453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peginterferon beta-1a [1546168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegloticase [1011650]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegunigalsidase alfa [2637446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fabry Disease [M0001191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegunigalsidase alfa-iwxj [2637445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fabry Disease [M0001191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase [2046360]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylketonurias [M0016567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvaliase-pqpz [2046361]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylketonurias [M0016567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pegvisomant [278739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acromegaly [M0000261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Stomach [M0333444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Esophagus [M0332429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Carcinoma [M0025699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Pleural Mesothelioma [M000731650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microsatellite Instability [M0496890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Tract Cancer [M0332162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ureteral Neoplasms [M0022326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab [1547545]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethral Neoplasms [M0022333]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Carcinoma [M0025699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Transitional Cell [M0003445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Stomach [M0333444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Squamous Cell [M0003444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Esophagus [M0332429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Biliary Tract Cancer [M0332162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Cancer [M000655646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ureteral Neoplasms [M0022326]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Pleural Mesothelioma [M000731650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microsatellite Instability [M0496890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pembrolizumab-pmph [2723753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed [68446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Pleural Mesothelioma [M000731650]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mesothelioma [M0013485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed dipotassium [2699334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium [282443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium hemipentahydrate [2056898]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed disodium heptahydrate [1666923]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed monohydrate [2590669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Mesothelial [M0027535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemetrexed tromethamine anhydrous [2604776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemigatinib [2359268]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholangiocarcinoma [M0027512]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast [19551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemirolast potassium [259318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Narcolepsy [M0014471]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pemoline [7966]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol [7973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penbutolol sulfate [82070]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpesviridae Infections [M0010285]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Labialis [M0010278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penciclovir [59839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epstein-Barr Virus Infections [M0029738]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penfluridol [7974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penfluridol [7974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystinuria [M0005557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis, Biliary [M0012640]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatolenticular Degeneration [M0010235]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mercury Poisoning [M0013450]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillamine [7975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lead Poisoning [M0012268]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rat-Bite Fever [M0018507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix Infections [M0007678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G [7980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pericarditis [M0016303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Fever [M0019009]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rat-Bite Fever [M0018507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix Infections [M0007678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G benzathine [7982]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pericarditis [M0016303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pericarditis [M0016303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix Infections [M0007678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rat-Bite Fever [M0018507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G potassium [203133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix Infections [M0007678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Subacute Bacterial [M0007394]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rat-Bite Fever [M0018507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pericarditis [M0016303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G procaine [7983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pericarditis [M0016303]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Listeriosis [M0012614]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis [M0007392]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Empyema [M0007327]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix Infections [M0007678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rat-Bite Fever [M0018507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin G sodium [9900]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus anthracis [M0002103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V [7984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix rhusiopathiae [M0460785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus anthracis [M0002103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix rhusiopathiae [M0460785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V benzathine [18926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus anthracis [M0002103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix rhusiopathiae [M0460785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V calcium [236517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erysipelothrix rhusiopathiae [M0460785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spirochaetales Infections [M0020349]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pasteurella Infections [M0016001]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anthrax [M0001315]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Actinomycosis [M0000290]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacillus anthracis [M0002103]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Botulism [M0002845]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumococcal Infections [M0017055]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningococcal Infections [M0013373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diphtheria [M0006520]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penicillin V potassium [203195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab [2712542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nasopharyngeal Carcinoma [M0532800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>penpulimab-kcqx [2712646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nasopharyngeal Carcinoma [M0532800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentaerythritol tetranitrate [7992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine [7994]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypanosomiasis [M0022072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trypanosomiasis [M0022072]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leishmaniasis, Visceral [M0012335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentamidine isethionate [7995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine [8001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine hydrochloride [104973]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentazocine lactate [203196]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentetate calcium trisodium [132879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heavy Metal Poisoning, Nervous System [M0328325]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital [8004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentobarbital sodium [203085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentosan polysulphate sodium [134413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystitis, Interstitial [M0028208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentosan polysulphate sodium [134413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flank Pain [M0353868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentostatin [8011]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Neuropathies [M0006162]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gangrene [M0008989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vasculitis [M0022540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intermittent Claudication [M0011515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Angiopathies [M0006156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Ischemia [M0003886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Cerebral [M0025571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stroke [M0328070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impotence, Vasculogenic [M0028121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pentoxifylline [8013]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombosis [M0021435]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint oil [33094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peppermint oil [33094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eczema [M0007049]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir [619693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>peramivir anhydrous [1598096]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perampanel [1356552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine [8042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine [8042]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine dimalonate [236771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perazine dimalonate [236771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perfluorohexyloctane [2637547]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide [8047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pergolide mesylate [8048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Aggression [M0000572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>periciazine [8766]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril [54552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril arginine [1600711]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindopril erbumine [72260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perindoprilat [1546400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scabies [M0019458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>permethrin [33199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torticollis [M0021710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reye Syndrome [M0018992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine [8076]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Huntington Disease [M0010660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Torticollis [M0021710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reye Syndrome [M0018992]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>perphenazine enanthate [33212]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Huntington Disease [M0010660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab [1298944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pertuzumab-zzxf [2382597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib [2183102]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giant Cell Tumor of Tendon Sheath [M000612030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pexidartinib hydrochloride [2183103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giant Cell Tumor of Tendon Sheath [M000612030]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacemide [33253]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Complex Partial [M0025874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacetin [8113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenacetin [8113]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine [8120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenazopyridine hydrochloride [203197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine [33272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine hydrochloride [297716]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phendimetrazine tartrate [58157]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine [8123]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenelzine sulfate [8124]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenethicillin [33277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine [33283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenindamine tartrate [221137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine [8132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine aminosalicylate [159340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pheniramine maleate [266959]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine [8133]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenmetrazine hydrochloride [203198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperbilirubinemia [M0010811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Benign Neonatal [M0328386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital [8134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures, Febrile [M0005138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures, Febrile [M0005138]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Benign Neonatal [M0328386]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenobarbital sodium [82077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperbilirubinemia [M0010811]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenol [33290]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheochromocytoma [M0016586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine [8149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neck Obstruction [M0002634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheochromocytoma [M0016586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenoxybenzamine hydrochloride [71512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neck Obstruction [M0002634]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenprocoumon [8150]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phensuximide [33309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine [8152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine hydrochloride [82078]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentermine resin [221138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Necrosis [M0014544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine [8153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extravasation of Diagnostic and Therapeutic Materials [M0008076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phentolamine mesylate [227240]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Necrosis [M0014544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyl salicylate [36122]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine [8156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine [8156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Food Hypersensitivity [M0008686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine [8156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine [8156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine,DL- [236948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine,DL- [236948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Food Hypersensitivity [M0008686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine,DL- [236948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylalanine,DL- [236948]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone [8160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone piperazine [236354]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylbutazone sodium [236529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine [8163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine bitartrate [91167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine hydrochloride [8164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus Ani [M0017936]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylephrine tannate [221139]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine [8175]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine bitartrate [221140]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenylpropanolamine hydrochloride [3266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis [M0019019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine [33408]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine citrate [221141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine citrate [221141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine polistirex [236792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine polistirex [236792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine resin complex [314786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenyltoloxamine resin complex [314786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Temporal Lobe [M0007578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin [8183]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Temporal Lobe [M0007578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>phenytoin sodium [71227]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine [8299]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine salicylate [33656]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma [M0009260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>physostigmine sulfate [106047]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pibrentasvir [1940636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>picosulfate sodium [33688]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mydriasis [M0024307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine [8328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mydriasis [M0024307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine hydrochloride [235426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Angle-Closure [M0024213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mydriasis [M0024307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerostomia [M0023067]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pilocarpine nitrate [103244]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Head and Neck Neoplasms [M0009818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin [1791685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin [1791685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin [1791685]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hallucinations [M0009762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin tartrate [1791686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimavanserin tartrate [1791686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hallucinations [M0009762]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimecrolimus [321952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Huntington Disease [M0010660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pimozide [8331]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pinacidil [33717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pindolol [8332]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone [33738]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pioglitazone hydrochloride [259319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone [33739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipamperone dihydrochloride [289159]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacetazine [8338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin [8339]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin anhydrous [1546000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pelvic Infection [M0000459]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperacillin sodium [203134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine [8340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine adipate [33746]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine citrate [342992]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hexahydrate [271743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine hydrate [67518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine phosphate [54749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nematode Infections [M0014560]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperazine sulfate [1549138]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonyl butoxide [8345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scabies [M0019458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piperonyl butoxide [8345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipobroman [8347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipothiazine [8348]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pipotiazine palmitate [235745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol HCl [235447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol HCl [235447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol [33767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol [33767]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol acetate [221142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirbuterol acetate [221142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine [8352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine hydrochloride [235775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine hydrochloride [235775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirenzepine hydrochloride [235775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirfenidone [1592254]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Fibrosis [M0018134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil [8353]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piribedil mesylate [236380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam [8356]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunburn [M0020814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunburn [M0020814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam cinnamate [33787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>piroxicam-beta-cyclodextrin [68115]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sunburn [M0020814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pirtobrutinib [2629338]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin [861634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin calcium [861640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin calcium [861640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin calcium [861640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin magnesium [2001252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin magnesium [2001252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin magnesium [2001252]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin sodium [1944734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin sodium [1944734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitavastatin sodium [1944734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant [2197878]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Disorders [M0019966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pitolisant hydrochloride [2197879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Disorders [M0019966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin [8372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pivampicillin hydrochloride [42553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasma protein fraction [33835]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock [M0019782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasminogen [2557200]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plasminogen Deficiency, Type I [M0567197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plasminogen, human-tvmh [2557201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plasminogen Deficiency, Type I [M0567197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin [2049549]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plazomicin sulfate [2052872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plecanatide [1873752]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plerixafor [733003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plerixafor [733003]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Testicular Neoplasms [M0021192]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>plicamycin [6995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podofilox [8463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podophyllin [8462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Papilloma [M0015836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>podophyllin [8462]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Condylomata Acuminata [M0004994]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pressure Ulcer [M0005739]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polaprezinc [2179843]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin [2174090]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polatuzumab vedotin-piiq [2174091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polidocanol [968170]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Varicose Veins [M0022531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol [34119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyestradiol phosphate [34120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 300 [8513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 300 [8513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 3350 [221147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 400 [8514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycol 400 [8514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyethylene glycols [8516]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteremia [M0025156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B [8536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Diseases [M0009033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Externa [M0015562]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteremia [M0025156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polymyxin B sulfate [388]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysaccharide iron complex [105669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polysaccharide iron complex [105669]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glomerulonephritis [M0009300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure [M0025974]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polythiazide [8565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>polyvalent Crotalidae antivenin [91596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Snake Bites [M0019987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pomalidomide [1369713]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib [1364347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponatinib hydrochloride [1364953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid [M0012396]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ponesimod [2532300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>poractant alfa [236381]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Distress Syndrome, Newborn [M0018890]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>posaconazole [282446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Oral [M0003261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium acetate [54987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibrosis [M0008453]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomyositis [M0006061]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium aminobenzoate [142141]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bicarbonate [34296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium bitartrate [223779]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium chloride [8591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithiasis [M0029982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate [54993]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lithiasis [M0029982]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium citrate monohydrate [221149]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium gluconate [89903]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium guaiacolsulfonate [91275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cough [M0005255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sporotrichosis [M0020384]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium iodide [8597]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium ion [1318915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium oxybate [2387309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cataplexy [M0003627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phenethicillin [132907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate [34322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate dibasic trihydrate [2475957]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium phosphate dibasic trihydrate [2475957]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Seborrheic [M0026535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium salicylate [235418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium undecylenate [1744166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>potassium,chelated [259277]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Viral [M0026098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomycoses [M0006059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Viral [M0024246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Parasitic [M0019937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone (K-30) simethicone emulsion [1305760]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Viral [M0026098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Parasitic [M0019937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomycoses [M0006059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Viral [M0024246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K12 [1305759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Viral [M0026098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomycoses [M0006059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Viral [M0024246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Parasitic [M0019937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K30 [1297406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Viral [M0026098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomycoses [M0006059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Viral [M0024246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Parasitic [M0019937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone K90 [1310497]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Parasitic [M0019937]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatomycoses [M0006059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Viral [M0024246]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone [8610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Viral [M0026098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Communicable Diseases [M0004868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>povidone-iodine [8611]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab [2663938]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protein-Losing Enteropathies [M0017886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pozelimab-bbfg [2663939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protein-Losing Enteropathies [M0017886]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Genetic [M0019934]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blepharospasm [M0002660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prabotulinumtoxinA-xvfs [2117869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strabismus [M0020559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>practolol [8620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prademagene zamikeracel [2713314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prademagene zamikeracel [2713314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epidermolysis Bullosa Dystrophica [M0024601]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralatrexate [662019]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, T-Cell, Peripheral [M0025095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime [34345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime cation [1546365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime cation [1546365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime cation [1546365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime chloride [55322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime iodide [55052]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralidoxime mesylate [55053]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pralsetinib [2394936]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole [746741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole dihydrochloride [236747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramipexole dihydrochloride [236747]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide [139953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramlintide acetate [356773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine [34347]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fissure in Ano [M0008525]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pramoxine hydrochloride [57555]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspareunia [M0006926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Vulgaris [M0012753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone [3143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sexual and Gender Disorders [M0029661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspareunia [M0006926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Vulgaris [M0012753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prasterone sodium sulfate [1366962]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sexual and Gender Disorders [M0029661]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin [42463]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pravastatin sodium [203144]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcohol Withdrawal Delirium [M0000652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazepam [8627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cysticercosis [M0005552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Opisthorchiasis [M0015338]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clonorchiasis [M0004618]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intestinal Diseases, Parasitic [M0011570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>praziquantel [8628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schistosomiasis [M0019481]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin [8629]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prazosin hydrochloride [203210]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Foot Dermatoses [M0008722]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Dermatoses [M0012283]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Dermatoses [M0008112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hand Dermatoses [M0009782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednicarbate [34369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone [8638]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone acetate [34372]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone phosphate [34374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium metasulphobenzoate [268872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium phosphate [55062]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone sodium succinate [55063]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis [M0022445]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisolone tebutate [34376]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adrenal Insufficiency [M0000484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Systemic [M0012757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Collagen Diseases [M0004792]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Contact [M0006052]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Serum Sickness [M0019699]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis [M0021487]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Berylliosis [M0002404]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic, Autoimmune [M0001127]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iritis [M0011717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic [M0567378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigus [M0016112]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Synovitis [M0020964]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoidosis [M0019426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rheumatic Diseases [M0019014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prednisone [8640]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuralgia, Postherpetic [M0480692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibromyalgia [M0008454]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pregabalin [187832]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal Cord Injuries [M0020312]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pretomanid [2198359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Extensively Drug-Resistant Tuberculosis [M0509462]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine [8686]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prilocaine hydrochloride [2557]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Vivax [M0025572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine [8687]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Vivax [M0025572]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primaquine phosphate [8689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tremor [M0021869]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>primidone [8691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pristinamycin [66958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probenecid [8698]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurosyphilis [M0014771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>probucol [8699]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide [8700]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Premature Complexes [M0028234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procainamide hydrochloride [155056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine [8701]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procaine hydrochloride [106558]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine [8702]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procarbazine hydrochloride [66925]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine [8704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine edisylate [8705]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine maleate [8706]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prochlorperazine mesylate [235739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine [8718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinsonian Disorders [M0328250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>procyclidine hydrochloride [142443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinsonian Disorders [M0328250]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>profenamine [4134]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone [8727]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amenorrhea [M0000887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Hemorrhage [M0022428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endometrial Hyperplasia [M0007412]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>progesterone, micronized [259409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility, Female [M0011304]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil [2382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil [2382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>proguanil hydrochloride [142428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine [8742]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promazine hydrochloride [142444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine [8745]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine dioxide [236815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrobromide [485608]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Motion Sickness [M0014105]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>promethazine hydrochloride [142445]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urticaria [M0022414]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone [8754]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propafenone hydrochloride [203135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine [34633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine [34633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine isethionate [34634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis [M0005015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propamidine isethionate [34634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatitis [M0015809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethral Diseases [M0022332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline [8761]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peptic Ulcer [M0016211]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urethral Diseases [M0022332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatitis [M0015809]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propantheline bromide [8762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine [8770]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propiomazine hydrochloride [6232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delirium [M0005774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol [8782]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychomotor Agitation [M0018023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Delirium [M0005774]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Status Epilepticus [M0020463]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propofol lipid emulsion [2559907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propolis [8783]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene [8785]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene hydrochloride [71517]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propoxyphene napsylate [8786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal and Gastric Varices [M0007742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Essential Tremor [M0328393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheochromocytoma [M0016586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol [8787]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pheochromocytoma [M0016586]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Essential Tremor [M0328393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propranolol hydrochloride [82084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal and Gastric Varices [M0007742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol 2-(2-methylbutyrate) [1947503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol [34693]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol diacetate [1427008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol monostearate [1314411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol propyl ether [1947500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylene glycol, (S)- [1663407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylhexedrine [8792]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylhexedrine hydrochloride [236461]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiration Disorders [M0018879]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>propylthiouracil [8794]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Crisis [M0021477]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine hydrochloride [236471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamine sulfate (USP) [8825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Postoperative Complications [M0017367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protamines [8826]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protein C, human-lans [2643198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protein C Deficiency [M0029882]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline [8886]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Affective Disorders, Psychotic [M0000522]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>protriptyline hydrochloride [203199]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride [2107310]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>prucalopride succinate [2107309]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine [8896]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine hydrochloride [91168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine polistirex [407885]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine sulfate [91169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pseudoephedrine tannate [221151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium [8928]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium hydrocolloid [314809]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhoids [M0010177]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>psyllium seed coatings,blond [314812]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichuriasis [M0021941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancylostomiasis [M0001101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel [8984]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oesophagostomiasis [M0015232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oesophagostomiasis [M0015232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancylostomiasis [M0001101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel pamoate [8985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichuriasis [M0021941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascariasis [M0001785]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Oesophagostomiasis [M0015232]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichuriasis [M0021941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobiasis [M0026142]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrantel tartrate [2197593]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ancylostomiasis [M0001101]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazinamide [8987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrazinamide [8987]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrethrins [8991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrethrins [8991]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scabies [M0019458]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine [9000]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Abnormalities, Drug-Induced [M0000014]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridostigmine bromide [9001]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis [M0014279]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal phosphate [9004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal phosphate [9004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxal phosphate [9004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 6 Deficiency [M0378655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine [684879]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 6 Deficiency [M0378655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine hydrochloride [203164]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 6 Deficiency [M0378655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyridoxine phosphoserinate [236803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin B 6 Deficiency [M0378655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine [9009]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine maleate [82091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Perennial [M0019020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pruritus [M0017935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrilamine tannate [221152]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Conjunctivitis, Allergic [M0005017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>pyrimethamine [9010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quazepam [35185]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quercetin [9060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quercetin [9060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatigue [M0008254]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quercetin [9060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quercetin [9060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Food Hypersensitivity [M0008686]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Autistic Disorder [M0001983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine [51272]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder, Major [M0006031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quetiapine fumarate [221153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Autistic Disorder [M0001983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine [9061]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinacrine monohydrochloride [82092]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril [35208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinapril hydrochloride [235759]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinaprilat [1546359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestradol [35215]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinestrol [9066]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinethazone [59743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine [9068]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine bisulfate [55377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine gluconate [35220]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine polygalacturonate [41875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinidine sulfate [9069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine [9071]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine ascorbate [236327]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine bisulfate [9073]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine dihydrochloride [388472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine hydrochloride [9074]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine salicylate [1426899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Babesiosis [M0002099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinine sulfate [9075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quinupristin [229367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib [2643048]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>quizartinib dihydrochloride [2643049]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myeloid, Acute [M0023827]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabbit skin extract [867315]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole [114979]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rabeprazole sodium [226868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diaper Rash [M0006208]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racemethionine [9100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Toxicity [M0006855]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Airway Obstruction [M0000610]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anaphylaxis [M0001076]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Block [M0009945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypotension [M0010927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Septic [M0019786]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>racepinephrine hydrochloride [314610]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene [72143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raloxifene hydrochloride [166551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir [719872]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>raltegravir potassium [1235585]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramelteon [596205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramipril [35296]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramiprilat [1546377]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Neoplasms [M0020544]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ramucirumab [1535922]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab [595060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinal Vein Occlusion [M0018952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinal Vein Occlusion [M0018952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-eqrn [2612673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Retinal Vein Occlusion [M0018952]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Retinopathy [M0006163]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranibizumab-nuna [2602351]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Edema [M0508696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine [9143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine bismuth citrate [55471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis, Peptic [M0007754]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Zollinger-Ellison Syndrome [M0023152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranitidine hydrochloride [203136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ranolazine [35829]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline [134748]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasagiline mesylate [577300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasburicase [283821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tumor Lysis Syndrome [M0023515]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rasburicase [283821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperuricemia [M0402804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab [2107301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atypical Hemolytic Uremic Syndrome [M0532727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab [2107301]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab-cwvz [2107316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atypical Hemolytic Uremic Syndrome [M0532727]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ravulizumab-cwvz [2107316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paroxysmal Nocturnal Hemoglobinuria [M0010137]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine [60842]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depression [M0006028]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reboxetine mesylate [60841]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant antihemophilic factor VIII [253151]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cryoglobulinemia [M0005376]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypereosinophilic Syndrome [M0026741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycosis Fungoides [M0014314]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Macular Degeneration [M0012875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis [M0014197]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocytopenia [M0021428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brain Neoplasms [M0002885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Hairy Cell [M0012387]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemangioma [M0010031]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ileal Neoplasms [M0011024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sezary Syndrome [M0019760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Kaposi [M0019437]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombocythemia, Essential [M0021427]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>recombinant interferon beta-1b [72258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis D [M0005790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>redtop grass pollen extract [851870]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib [1312397]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>regorafenib monohydrate [1371319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab [2596773]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relatlimab-rmbw [2596772]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam [2184137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam [2184137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam [2184137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam anhydrous [2268500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam anhydrous [2268500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam anhydrous [2268500]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam monohydrate [2184136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam monohydrate [2184136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyelonephritis [M0018195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relebactam monohydrate [2184136]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>relugolix [2472778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostate Cancer [M0017834]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remdesivir [2284718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remdesivir [2284718]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronavirus Infections [M0027585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L [2700765]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remestemcel-L-rknd [2700764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remibrutinib [2724365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chronic Spontaneous Urticaria [M000646533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil [73032]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>remifentanil hydrochloride [236540]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>repaglinide [73044]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rescinnamine [9259]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reserpine [9260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesias [M0014140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reslizumab [1746889]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fatty Liver [M0008275]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fibrosis, Liver [M0012637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resmetirom [2677894]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nonalcoholic Steatohepatitis [M0590230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol [35382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resorcinol [35382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>respiratory syncytial virus pre-fusion F glycoprotein mRNA [2685002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Syncytial Virus Infections [M0027589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>resveratrol [1000492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Herpes Labialis [M0010278]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retapamulin [642274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retapamulin [642274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impetigo [M0011174]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retatrutide [2722410]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction [M0028090]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reteplase [76895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab [2632981]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retifanlimab-dlwr [2632980]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Merkel Cell [M0023505]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis [M0006046]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Night Blindness [M0015129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Xerophthalmia [M0023065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin A Deficiency [M0022791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>retinol acetate [35400]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Photosensitivity Disorders [M0016756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revefenacin [2102775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Disease, Chronic Obstructive [M0384655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin [75960]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>reviparin sodium [75961]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib [2698325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>revumenib citrate [2698326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia [M0012382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin [2639155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Invasive [M0541978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin [2639155]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin acetate [2639156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Invasive [M0541978]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rezafungin acetate [2639156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidemia [M0542149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhubarb preparation [91266]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhynchophylline [2562552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Antiparkinson Agents [M0001494]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rhynchophylline [2562552]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroprotective Agents [M0028008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Virus Diseases [M0022758]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenovirus Infections, Human [M0000405]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>West Nile Fever [M0022928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribavirin [9344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Syncytial Virus Infections [M0027589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib [1873916]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ribociclib succinate [1873978]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate [1925821]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium [1925820]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium anhydrous [2279515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin 5&apos;-phosphate sodium dihydrate [2611697]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin [9346]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin sodium [2109051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riboflavin tetrabutyrate [2106328]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Riboflavin Deficiency [M0019065]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium avium-intracellulare Infection [M0023509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifabutin [55672]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucellosis [M0002989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leprosy [M0012361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Bacterial [M0025747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifampin [9384]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis [M0022106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifamycin sodium [236475]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifamycins [9385]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Latent Tuberculosis [M0524639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifapentine [35617]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tuberculosis, Pulmonary [M0022131]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rifaximin [35619]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilonacept [763450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilonacept [763450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Genetic Diseases, Inborn [M0385531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine [1102270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilpivirine hydrochloride [1102287]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riluzole [35623]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyotrophic Lateral Sclerosis [M0001056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rilzabrutinib [2722398]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dystonia [M0006935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimabotulinumtoxinB [860178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neck Pain [M0029032]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine [9386]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimantadine hydrochloride [82093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Influenza, Human [M0011309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine with Aura [M0328363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant [2282307]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine without Aura [M0328367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine with Aura [M0328363]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine without Aura [M0328367]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimegepant sulfate [2282322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rimexolone [55681]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveitis, Anterior [M0022446]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>riociguat [1439816]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ripretinib [2369389]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab [2166040]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risankizumab-rzaa [2166132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risdiplam [2390935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spinal muscular atrophy, Jerash type [M0530176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate [73056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium [60334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium anhydrous [1926958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium anhydrous [1926958]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium hemi-pentahydrate [1356127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium hemi-pentahydrate [1356127]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium monohydrate [1356128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risedronate sodium monohydrate [1356128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Autistic Disorder [M0001983]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dementia [M0005797]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>risperidone [35636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tourette Syndrome [M0009230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib [2641595]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia Areata [M0000760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritlecitinib tosylate [2641596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alopecia Areata [M0000760]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ritonavir [85762]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microscopic Polyangiitis [M0523398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab [121191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-abbs [2105824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microscopic Polyangiitis [M0523398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microscopic Polyangiitis [M0523398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-arrx [2472325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granulomatosis with Polyangiitis [M0022908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, B-Cell [M0025074]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Microscopic Polyangiitis [M0523398]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rituximab-pvvr [2273510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Mantle-Cell [M0328571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivaroxaban [1114195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivaroxaban [1114195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine [183379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rivastigmine tartrate [994808]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan [88014]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rizatriptan benzoate [237082]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rofecoxib [232158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysmenorrhea [M0006924]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rofecoxib [232158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roflumilast [1091836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Disease, Chronic Obstructive [M0384655]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant [1665496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rolapitant hydrochloride [1673367]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, T-Cell, Peripheral [M0025095]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romidepsin [877510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, T-Cell, Cutaneous [M0025093]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romiplostim [805452]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Purpura, Thrombocytopenic, Idiopathic [M0025253]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab [2123126]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>romosozumab-aqqg [2123180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b [2587059]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropeginterferon alfa-2b-njft [2587060]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole [72302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropinirole hydrochloride [236553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine [35780]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride [236539]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride anhydrous [2198974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ropivacaine hydrochloride monohydrate [1298851]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain, Postoperative [M0015751]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone [84108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosiglitazone maleate [253198]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin [301542]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rosuvastatin calcium [323828]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rotigotine [616739]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Restless Legs Syndrome [M0018926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxithromycin [9478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>roxithromycin [9478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionnaires&apos; Disease [M0012293]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab [2642274]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rozanolixizumab-noli [2642273]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myasthenia Gravis, Generalized [M0335255]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib [1862579]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rucaparib camsylate [1862578]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>rufinamide [69036]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib [1193326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Myelofibrosis [M0519745]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ruxolitinib phosphate [1193325]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Polycythemia Vera [M0017168]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sabinene [2557219]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deodorants [M0005987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab [2360231]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan [2360232]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacituzumab govitecan-hziy [2360530]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Triple Negative Breast Neoplasms [M0583085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacrosidase [214817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Digestive System Diseases [M0006374]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sacrosidase [214817]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Congenital Abnormalities [M0000013]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide [1922448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>safinamide mesylate [1922449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sage extract [1354504]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylamide [9518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Seborrheic [M0026535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylate [9522]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Seborrheic [M0026535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salicylic acid [9525]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin [1311566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin [1311566]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidiosis [M0004678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin sodium [1812261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salinomycin sodium [1812261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coccidiosis [M0004678]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol [36117]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmeterol xinafoate [72616]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercalcemia [M0010814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteitis Deformans [M0015507]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salmon calcitonin [36118]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteogenesis Imperfecta [M0015534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis [M0001741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>salsalate [36108]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Fever [M0008421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan L-malate [2570387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan L-malate [2570387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan L-malate [2570387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Manic Episode [M000733987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Manic Episode [M000733987]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>samidorphan [2559612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin [753340]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylketonurias [M0016567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sapropterin dihydrochloride [753341]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Phenylketonurias [M0016567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir [83395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saquinavir mesylate [859857]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline [2059018]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarecycline hydrochloride [2059038]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Precursor Cell Lymphoblastic Leukemia-Lymphoma [M0502706]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sargramostim [69634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sarilumab [1923319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab [2391541]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuromyelitis Optica [M0014730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>satralizumab-mwge [2391551]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuromyelitis Optica [M0014730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto extract [236344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saw palmetto extract [236344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin [857974]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin anhydrous [1546030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride [1043560]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>saxagliptin hydrochloride dihydrate [2643444]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Diseases [M0004814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diverticulitis [M0006630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Paralysis [M0008125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery [M0006913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iridocyclitis [M0024287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine [9601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease, Postencephalitic [M0015967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dysentery [M0006913]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Facial Paralysis [M0008125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease, Postencephalitic [M0015967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Iridocyclitis [M0024287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colonic Diseases [M0004814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>scopolamine hydrobromide [9603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diverticulitis [M0006630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sebetralstat [2717944]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angioedemas, Hereditary [M0502559]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secnidazole [36314]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital [9624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secobarbital sodium [91110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secukinumab [1599788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>secukinumab [1599788]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Psoriatic [M0023901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar [2690869]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Biliary Cholangitis [M0012639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>seladelpar lysine [2690868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Biliary Cholangitis [M0012639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline [9639]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selegiline hydrochloride [203137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenious acid [36344]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium [9641]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium chloride [2200142]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Capitis [M0021564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selenium sulfide [36345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dandruff [M0577887]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selexipag [1729002]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selinexor [2178390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selpercatinib [2370147]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib [2289380]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurofibromatosis 1 [M0014710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>selumetinib sulfate [2361596]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neurofibromatosis 1 [M0014710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>senna concentrate [219860]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennoside A&amp;B, calcium salt [267741]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sennosides, USP [36387]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colic [M0004742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sepiapterin [2723056]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphenylalaninaemia [M0335856]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate [2562176]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>serdexmethylphenidate chloride [2562177]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Attention Deficit Disorder with Hyperactivity [M0001943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin [56188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emaciation [M0007242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin [56188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin acetate [58932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Infertility [M0011302]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sermorelin acetate [58932]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Emaciation [M0007242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole [36435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertaconazole nitrate [236601]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertindole [41996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline [36437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Feeding and Eating Disorders [M000601696]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obsessive-Compulsive Disorder [M0015170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sertraline hydrochloride [155137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer [214824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphosphatemia [M0506086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer carbonate [660890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphosphatemia [M0506086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevelamer hydrochloride [237125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphosphatemia [M0506086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sevoflurane [36453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>short ragweed pollen extract [896135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine [36514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride [1294535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sibutramine hydrochloride monohydrate [221160]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Obesity [M0015159]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impotence, Vasculogenic [M0028121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil [136411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sildenafil citrate [221161]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impotence, Vasculogenic [M0028121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silodosin [720825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siltuximab [1535218]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Castleman Disease [M0009222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver [2606543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne [M000636800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver [2606543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dental Caries [M0005854]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver acetate [137939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver acetate [137939]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Viral [M0026098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma [M0009605]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver nitrate [9789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>silver sulfadiazine [9793]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir [1482790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simeprevir sodium [1484518]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simethicone [9796]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Flatulence [M0008543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemophilia A [M0010149]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>von Willebrand Diseases [M0022853]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simoctocog alfa [1729084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Factor VII Deficiency [M0008145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertriglyceridemia [M0023401]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypercholesterolemia [M0010818]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperlipoproteinemias [M0010833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>simvastatin [36567]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Artery Disease [M0502868]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Secondary Progressive [M0334287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>siponimod [2121085]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sipuleucel-T [997261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perivascular Epithelioid Cell Neoplasms [M0511442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus [35302]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphangioleiomyomatosis [M0027421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphangioleiomyomatosis [M0027421]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sirolimus protein-bound [2712352]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Perivascular Epithelioid Cell Neoplasms [M0511442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin [593411]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin hydrochloride [2716481]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sitagliptin phosphate [621590]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>smooth brome pollen extract [852217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate [56443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate [56443]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyponatremia [M0010911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate, anhydrous [267453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyponatremia [M0010911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetate, anhydrous [267453]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetylated hyaluronate [2198976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium acetylated hyaluronate [2198976]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium alginate [56446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia [M0001119]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Common Cold [M0004864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scurvy [M0019569]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tyrosinemias [M0328654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Methemoglobinemia [M0013565]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ascorbate [267366]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds, Penetrating [M0023024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperammonemia [M0356710]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium benzoate [56455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Headache [M0009824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heartburn [M0009980]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyspepsia [M0006927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Drug Overdose [M0568790]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Arrest [M0009938]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium bicarbonate [36676]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastroesophageal Reflux [M0009024]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dehydration [M0005757]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds and Injuries [M0023019]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shock, Hemorrhagic [M0019784]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dry Eye Syndromes [M0023637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Edema [M0024096]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium chloride [9863]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyponatremia [M0010911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate [56466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Calculi [M0022362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urination Disorders [M0022377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis, Renal Tubular [M0000215]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium citrate dihydrate [221163]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Calculi [M0022362]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium dihydrogen phosphate dihydrate [1311311]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium estrone sulfate [91428]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ferric gluconate complex [261435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pregnancy Complications, Hematologic [M0017476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium ferric gluconate complex [261435]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Iron-Deficiency [M0028144]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride [9873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium fluoride f-18 [1311495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis [M0015552]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium folate [1300473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Megaloblastic [M0001134]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium folate [1300473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Folic Acid Deficiency [M0008663]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds [M0023018]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hyaluronate [42892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Ulcer [M0019944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wound Infection [M0023017]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium hypochlorite [9881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide I123 [91531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide I123 [91531]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperthyroidism [M0010871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wounds, Nonpenetrating [M0023023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lacerations [M0356719]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperthyroidism [M0010871]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium iodide [9884]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium lactate [56489]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acidosis [M0000213]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium morrhuate [9892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Varicose Veins [M0022531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium morrhuate [9892]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal and Gastric Varices [M0007742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Malignant [M0010861]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraoperative Complications [M0011598]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium nitroprusside [9895]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium oxybate [9899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cataplexy [M0003627]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phenylbutyrate [214837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cystic Fibrosis [M0005551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phenylbutyrate [214837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Sickle Cell [M0001140]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phenylbutyrate [214837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>beta-Thalassemia [M0025960]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phenylbutyrate [214837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myeloproliferative Disorders [M0014332]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate [36709]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate dihydrate [314837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic [236719]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, anhydrous [314838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dihydrate [1311323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, dodecahydrate [1311326]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, dibasic, monohydrate [1311342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic [235496]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, monobasic, anhydrous [349753]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic anhydrous [1307158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, dodecahydrate [1311345]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate, tribasic, monohydrate [1311357]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypophosphatemia [M0026730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium phosphate,monobasic,monohydrate [221125]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urological Manifestations [M0328644]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium polystyrene sulfonate [56512]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Keratosis, Seborrheic [M0026535]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scalp Dermatoses [M0019465]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Warts [M0022875]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium salicylate [9907]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium selenate [36717]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Deficiency Diseases [M0005753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Varicose Veins [M0022531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium tetradecyl sulfate [9913]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal and Gastric Varices [M0007742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate [36726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic Poisoning [M0328100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate [36726]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate anhydrous [1807514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium thiosulfate anhydrous [1807514]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arsenic Poisoning [M0328100]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Complex Partial [M0025874]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Absence [M0007577]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium valproate [9919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mood Disorders [M0029642]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sodium zirconium cyclosilicate [2047628]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkalemia [M0010828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofosbuvir [1484911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofosbuvir [1484911]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium [2689322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sweating [M0020923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium [2689322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium bromide [2689321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperhidrosis [M0010826]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sofpironium bromide [2689321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sweating [M0020923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin [322167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Overactive [M0461241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin [322167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin succinate [476588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder, Overactive [M0461241]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solifenacin succinate [476588]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence, Urge [M0461242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol [2121751]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleepiness [M000640180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>solriamfetol hydrochloride [2121750]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleepiness [M000640180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prader-Willi Syndrome [M0017431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dwarfism [M0006897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrem [56570]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cachexia [M0003126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon [2644503]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Growth Disorders [M0009654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatrogon-ghla [2644513]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Growth Disorders [M0009654]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cachexia [M0003126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dwarfism [M0006897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noonan Syndrome [M0014957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prader-Willi Syndrome [M0017431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin (recombinant DNA origin) [314845]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Turner Syndrome [M0022170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cachexia [M0003126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prader-Willi Syndrome [M0017431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Turner Syndrome [M0022170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dwarfism [M0006897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin [61148]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noonan Syndrome [M0014957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cachexia [M0003126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prader-Willi Syndrome [M0017431]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Turner Syndrome [M0022170]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Noonan Syndrome [M0014957]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>somatropin, E-coli derived [259321]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dwarfism [M0006897]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib [1659191]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sonidegib phosphate [1659192]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Neoplasms [M0019939]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib [495881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Hepatocellular [M0010236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorafenib tosylate [597744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol [9945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol [9945]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol, L- [1742749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sorbitol, L- [1742749]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Poisoning [M0017099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol [9947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Fibrillation [M0022595]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Fibrillation [M0001926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Ventricular [M0026083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Atrial Flutter [M0001927]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotalol hydrochloride [7008]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tachycardia, Supraventricular [M0021006]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept [2678930]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Arterial Hypertension [M000649540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotatercept-csrk [2678931]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Arterial Hypertension [M000649540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotorasib [2550714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sotrovimab [2550731]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronavirus Infections [M0027585]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soy protein isolate [196238]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean lecithin [579598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malnutrition [M0015121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean oil [9949]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>soybean preparation [287515]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Salmonella Infections [M0019393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparfloxacin [18469]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sparsentan [2630535]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteinuria [M0017891]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spearmint extract [1372258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin [270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin [270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin hydrochloride [267342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin hydrochloride [267342]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate [2640868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate [2640868]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate tetrahydrate [1306069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spectinomycin sulfate tetrahydrate [1306069]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab [2610417]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spesolimab-sbzo [2610418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spinosad [299081]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lice Infestations [M0016085]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spiny pigweed pollen extract [895919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spirapril [36908]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperaldosteronism [M0010808]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hirsutism [M0010381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypokalemia [M0010909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>spironolactone [9997]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>standardized enzyme lactase [221165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lactose Intolerance [M0012180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride [10030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gingivitis [M0009245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride [10030]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride dihydrate [1311371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Periodontal Diseases [M0016328]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous fluoride dihydrate [1311371]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gingivitis [M0009245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leg Ulcer [M0012286]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Burns [M0003064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Radiation Injuries [M0018380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Surgical Wound Infection [M0020904]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stannous iodide [1720256]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stavudine [59763]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>stiripentol [2054968]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Seizures [M0019597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arterial Occlusive Diseases [M0001730]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptokinase [10106]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tularemia [M0022145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucellosis [M0002989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin [10109]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tularemia [M0022145]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Endocarditis, Bacterial [M0007393]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycobacterium Infections [M0014287]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Brucellosis [M0002989]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Plague [M0016945]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptomycin sulfate [10110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Islet Cell [M0027504]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>streptozocin [10114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hodgkin Disease [M0010484]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium cation Sr-89 [2280602]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Musculoskeletal Pain [M0549551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>strontium-89 chloride [281890]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>succimer [3446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lead Poisoning, Nervous System, Childhood [M0328531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomatitis [M0020550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate [10156]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomach Ulcer [M0020546]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Duodenal Ulcer [M0006885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophagitis [M0007753]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastritis [M0009015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomatitis [M0020550]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucralfate malate [1487143]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sucroferric oxyhydroxide [1484283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperphosphatemia [M0506086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil [56795]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sufentanil citrate [58964]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet allergenic extract [899359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sugar beet pollen extract [852132]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam [10167]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam pivoxyl [166010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acinetobacter Infections [M0000230]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbactam sodium [82100]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Proteus Infections [M0017900]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulbenicillin [10168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole [37319]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Cutaneous [M0003260]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulconazole nitrate [56798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfabenzamide [37320]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginitis [M0022488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Ulcer [M0005185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ear Diseases [M0006941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide [10169]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Ulcer [M0005185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ear Diseases [M0006941]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacetamide sodium [82101]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfacytine [78902]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocardia Infections [M0014935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacteriaceae Infections [M0007472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine [10171]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Meningitis, Meningococcal [M0013369]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocardia Infections [M0014935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacteriaceae Infections [M0007472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadiazine sodium [220087]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>AIDS-Related Opportunistic Infections [M0025965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfadoxine [10173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria, Falciparum [M0025570]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethizole [10179]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocardia Infections [M0014935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Enterobacteriaceae Infections [M0007472]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Pneumocystis [M0017073]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydiaceae Infections [M0004111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Toxoplasmosis [M0021732]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfamethoxazole [10180]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfanilamide [10184]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pemphigoid, Bullous [M0016111]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis Herpetiformis [M0006048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfapyridine [10188]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pyoderma Gangrenosum [M0026573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colitis, Ulcerative [M0004771]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfasalazine [9524]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfate ion [1426598]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginitis [M0022488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole [10193]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginitis [M0022488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Negative Bacterial Infections [M0025725]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfathiazole sodium [236084]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gram-Positive Bacterial Infections [M0025728]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gout [M0009557]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfinpyrazone [10205]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Fistula [M0024667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocardia Infections [M0014935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole [10207]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Corneal Ulcer [M0005185]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nocardia Infections [M0014935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Otitis Media [M0015563]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Fistula [M0024667]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trachoma [M0021752]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfisoxazole diolamine [10208]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur [10223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur [10223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur [10223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur [10223]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur, colloidal [221083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rosacea [M0019267]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur, colloidal [221083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur, colloidal [221083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulfur, colloidal [221083]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Seborrheic [M0019584]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bursitis [M0003070]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tendinopathy [M0483885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Inflammation [M0011307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spondylitis, Ankylosing [M0020377]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Gouty [M0023372]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulindac [10237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Shoulder Pain [M0029777]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem [2717833]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sulopenem etzadroxil [2717834]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan [37418]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Migraine Disorders [M0013864]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sumatriptan succinate [67158]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cluster Headache [M0004652]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroendocrine Tumors [M0027590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib [357977]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neuroendocrine Tumors [M0027590]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Stromal Tumors [M0452911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunitinib malate [616275]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>sunvozertinib [2719226]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suvorexant [1547099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>suzetrigine [2704819]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acute Pain [M0551476]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, A [253166]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Neoplasms [M0017833]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menorrhagia [M0013382]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Primary Ovarian Insufficiency [M0025370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>synthetic conjugated estrogens, B [618365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Menopause, Premature [M0013381]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine [10318]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrine hydrochloride [235972]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus [42316]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tacrolimus monohydrate [484288]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Impotence, Vasculogenic [M0028121]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tadalafil [358263]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension, Pulmonary [M0010865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab [2387211]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafasitamab-cxix [2387334]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Large B-Cell, Diffuse [M0025086]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine [2054023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafenoquine succinate [2054091]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malaria [M0012910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tafluprost [1244607]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp [2109055]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histiocytic Disorders, Malignant [M0023965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tagraxofusp-erzs [2109054]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histiocytic Disorders, Malignant [M0023965]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin [10322]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talampicillin napsylate [235836]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib [2099704]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talazoparib tosylate [2099703]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talc [10323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pleural Effusion [M0017043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talc [10323]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumothorax [M0017083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib [2716919]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taletrectinib adipate [2716920]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taliglucerase alfa [1291609]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gaucher Disease [M0009048]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talimogene laherparepvec [1721264]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab [2644447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>talquetamab-tgvs [2644448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gynecomastia [M0009717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen [10324]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Precocious [M0018083]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gynecomastia [M0009717]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamoxifen citrate [40137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pancreatic Neoplasms [M0015803]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin [77492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tamsulosin hydrochloride [236495]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol [787390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapentadol hydrochloride [857492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tapinarof [2602286]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab [2682954]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tarlatamab-dlle [2682955]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Cancer [M0012750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tasimelteon [1490468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Disorders, Circadian Rhythm [M0328300]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurursodiol [2613950]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyotrophic Lateral Sclerosis [M0001056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>taurursodiol dihydrate [2665620]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyotrophic Lateral Sclerosis [M0001056]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tavaborole [1543173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tavaborole [1543173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazarotene [83947]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat [2274378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Epithelioid [M0019429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tazemetostat hydrobromide [2274379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma, Epithelioid [M0019429]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tbo-filgrastim [1433764]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neutropenia [M0014782]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp [2590743]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveal Melanoma [M0530955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tebentafusp-tebn [2590744]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uveal Melanoma [M0530955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab [2619426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teclistamab-cqyv [2619425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat [2055104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Smallpox [M0019977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tecovirimat monohydrate [2055677]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Smallpox [M0019977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid [1540825]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tedizolid phosphate [1540824]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teduglutide [1364468]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Short Bowel Syndrome [M0019794]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod [139778]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tegaserod maleate [339270]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Constipation [M0005043]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C [M0010234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telaprevir [1102261]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis C, Chronic [M0029252]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin [473837]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia [M0017064]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telavancin hydrochloride [864624]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telbivudine [474128]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab [2714237]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin [2721996]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telisotuzumab vedotin-tllv [2714236]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telithromycin [274786]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telmisartan [73494]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat [1872382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat [1872382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Carcinoid Syndrome [M0012930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat ethyl [1872441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Carcinoid Syndrome [M0012930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat ethyl [1872441]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat etiprate [1872448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diarrhea [M0006212]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>telotristat etiprate [1872448]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Malignant Carcinoid Syndrome [M0012930]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reproductive Tract Infections [M0555175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin [37771]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temafloxacin hydrochloride [295217]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Reproductive Tract Infections [M0555175]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Panic Disorder [M0025297]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temazepam [10355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temocillin [37775]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioblastoma [M0009269]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temozolomide [37776]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>temsirolimus [657797]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor [2199674]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenapanor hydrochloride [2199673]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Irritable Bowel Syndrome [M0004816]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenecteplase [259280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Thrombosis [M0005194]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenecteplase [259280]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Small Cell [M0027519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Lymphoid [M0012388]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teniposide [10362]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lung Neoplasms [M0012749]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir [117466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide [1721603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir alafenamide fumarate [1721604]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir anhydrous [1546017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir anhydrous [1546017]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil [300195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil [300195]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV [M0010470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B [M0010210]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV [M0010470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil fumarate [322248]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV Infections [M0023997]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil succinate [1928942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV [M0010470]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenofovir disoproxil succinate [1928942]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hepatitis B, Chronic [M0029244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tenonitrozole [236186]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichomonas Infections [M0021928]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab [2621880]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teplizumab-mzwv [2621881]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 1 [M0006152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib [2477103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brain-associated small-cell lung cancer antigen [M0172222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tepotinib hydrochloride [2477104]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>brain-associated small-cell lung cancer antigen [M0172222]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab [2274803]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graves Ophthalmopathy [M0009625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teprotumumab-trbw [2274802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graves Ophthalmopathy [M0009625]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin [37798]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride [235224]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Prostatic Hyperplasia [M0017830]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terazosin hydrochloride anhydrous [1299927]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Retention [M0024540]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Capitis [M0021564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine [37801]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Capitis [M0021564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Onychomycosis [M0021567]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbinafine hydrochloride [235838]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Chronic Mucocutaneous [M0003259]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline [10368]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terbutaline sulfate [10369]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terconazole [37806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terconazole [37806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases [M0019929]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic [M0567378]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terfenadine [42330]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Allergic, Seasonal [M0009814]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriflunomide [1310520]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Sclerosis, Relapsing-Remitting [M0328152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide [32915]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>teriparatide acetate [114260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoporosis, Postmenopausal [M0024020]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline [37815]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>terodiline hydrochloride [235839]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol [37840]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tertatolol hydrochloride [236374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin [1044584]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV-Associated Lipodystrophy Syndrome [M0419385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tesamorelin acetate [1044583]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>HIV-Associated Lipodystrophy Syndrome [M0419385]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testolactone [10378]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone (micronized) [221168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone (micronized) [221168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone (micronized) [221168]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone [10379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone cypionate [835827]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone decanoate [37858]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone enanthate [37859]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone isocaproate [75806]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone propionate [10382]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Puberty, Delayed [M0018082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypogonadism [M0010905]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>testosterone undecanoate [37864]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin [1727875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus immune globulin, human [91603]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetanus toxoid vaccine, inactivated [798306]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tetanus [M0021200]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Huntington Disease [M0010660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrabenazine [10390]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperkinesis [M0010829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine [10391]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracaine hydrochloride [91189]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella Infections [M0002189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline [10395]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella Infections [M0002189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline hydrochloride [142446]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella Infections [M0002189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline phosphate complex [2105975]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Campylobacter Infections [M0003245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoplasma Infections [M0014307]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rickettsia Infections [M0019098]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gonorrhea [M0009553]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Granuloma Inguinale [M0009606]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chlamydia Infections [M0004107]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psittacosis [M0015434]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Syphilis [M0020966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bartonella Infections [M0002189]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helicobacter Infections [M0025165]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cholera [M0004244]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Borrelia Infections [M0002836]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetracycline trihydrate [236873]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Chancroid [M0003985]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperemia [M0010821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline [37935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sinusitis [M0019901]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyperemia [M0010821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrahydrozoline hydrochloride [57983]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Rhinitis, Vasomotor [M0019023]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrazepam [37985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tetrazepam [37985]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab [2587789]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tezepelumab-ekko [2587790]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leprosy [M0012361]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lupus Erythematosus, Discoid [M0012756]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Nodosum [M0007682]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Multiple Myeloma [M0014195]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stomatitis, Aphthous [M0020551]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Behcet Syndrome [M0002296]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Crohn Disease [M0005335]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Graft vs Host Disease [M0009578]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Erythema Multiforme [M0007681]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Waldenstrom Macroglobulinemia [M0012865]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thalidomide [10432]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Histiocytosis, Langerhans-Cell [M0010406]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theobromine [10437]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theobromine sod salicylate [236926]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline [10438]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline anhydrous [91178]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchial Spasm [M0002967]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis [M0002972]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Asthma [M0001885]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bradycardia [M0002863]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>theophylline sodium glycinate [155075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Apnea [M0001589]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dracunculiasis [M0006796]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trichinellosis [M0021915]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Helminthiasis [M0010007]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Larva Migrans [M0012221]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiabendazole [10450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Strongyloidiasis [M0020615]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beriberi [M0002399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Deficiency [M0021320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine [10454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wernicke Encephalopathy [M0022921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beriberi [M0002399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Deficiency [M0021320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine disulfide [38041]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wernicke Encephalopathy [M0022921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beriberi [M0002399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Deficiency [M0021320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine hydrochloride [235355]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wernicke Encephalopathy [M0022921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beriberi [M0002399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Deficiency [M0021320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine mononitrate [10456]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wernicke Encephalopathy [M0022921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alcoholic Neuropathy [M0328092]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Beriberi [M0002399]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pellagra [M0016099]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thiamine Deficiency [M0021320]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamine pyrophosphate [10459]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Wernicke Encephalopathy [M0022921]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal [10464]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiamylal sodium [203201]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine [10471]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vertigo [M0022633]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiethylperazine maleate [71529]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nausea [M0014528]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thimerosal [10472]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital [38077]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiobutabarbital sodium [314874]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleep Initiation and Maintenance Disorders [M0011403]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Eosinophilic, Acute [M0023829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Basophilic, Acute [M0023828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine [10485]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Neutrophilic, Chronic [M0023824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Myelogenous, Chronic, BCR-ABL Positive [M0023821]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Eosinophilic, Acute [M0023829]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Basophilic, Acute [M0023828]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioguanine anhydrous [1546005]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leukemia, Neutrophilic, Chronic [M0023824]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental [10493]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intracranial Hypertension [M0029084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiopental sodium [282416]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intracranial Hypertension [M0029084]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine [10502]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thioridazine hydrochloride [203165]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Adenocarcinoma [M0000355]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Neoplasms [M0002635]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sarcoma [M0019428]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiotepa [10473]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma [M0012817]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene [10510]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia [M0019489]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Schizophrenia Spectrum and Other Psychotic Disorders [M0029660]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thiothixene hydrochloride [91135]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psychotic Disorders [M0018060]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin [10528]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin alfa [1367075]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, bovine [2264114]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thrombin, human [825006]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hemorrhage [M0010152]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyme preparation [319823]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thymol [10553]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vomiting [M0022844]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroglobulin [10565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (USP) [10572]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myxedema [M0014379]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyrotoxicosis [M0021495]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroiditis, Autoimmune [M0021488]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyroid (beef) [325521]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Goiter [M0009516]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>thyrotropin alfa [4952]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thyroid Neoplasms [M0021485]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine [31914]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiagabine hydrochloride [236875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety [M0001531]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hot Flashes [M0029082]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sweating [M0020923]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tibolone [38260]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Sleeplessness [M0334961]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin [10591]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Soft Tissue Infections [M0027697]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticarcillin disodium [142447]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine [10594]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intracranial Embolism and Thrombosis [M0333623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticlopidine hydrochloride [97]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intracranial Embolism and Thrombosis [M0333623]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>ticovirimat monohydrate [2055103]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Smallpox [M0019977]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Legionellosis [M0012292]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Clostridium Infections [M0004637]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Bacterial [M0026097]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Klebsiella Infections [M0012059]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteremia [M0025156]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pneumonia, Bacterial [M0027639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Haemophilus Infections [M0009740]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacteroides Infections [M0002147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Escherichia coli Infections [M0007733]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Streptococcal Infections [M0020568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tigecycline [384455]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab [2053436]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tildrakizumab-asmn [2053449]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Psoriasis [M0017975]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate [57230]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiludronate disodium [83153]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Paget Disease, Extramammary [M0015741]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol [10600]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol anhydrous [1546004]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol hemihydrate [221172]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina Pectoris [M0001180]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glaucoma, Open-Angle [M0009261]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>timolol maleate [42933]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giardiasis [M0009224]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Protozoan Infections [M0017926]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vaginosis, Bacterial [M0025299]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinidazole [10612]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amebiasis [M0000878]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin [69646]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium [104466]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Venous Thrombosis [M0029908]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboembolism [M0021430]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tinzaparin sodium,porcine [235995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Embolism [M0018126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioconazole [38298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Candidiasis, Vulvovaginal [M0003262]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioconazole [38298]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Mycoses [M0014313]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium [69120]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide [393575]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide mono [1552007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide mono [1552007]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide monohydrate [1298831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide monohydrate [1298831]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Emphysema [M0018129]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tiotropium bromide, anhydrous [2462023]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bronchitis, Chronic [M0384773]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tioxolone [2059173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acne Vulgaris [M0000231]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil [1670304]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipiracil hydrochloride [1670303]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Colorectal Neoplasms [M0023329]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tipranavir [190548]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Acquired Immunodeficiency Syndrome [M0000245]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban [73137]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Unstable [M0001182]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myocardial Infarction [M0014340]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirofiban hydrochloride [253202]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Coronary Disease [M0005191]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tirzepatide [2601723]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab [2677426]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Squamous Cell Carcinoma [M0563029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tislelizumab-jsgr [2677425]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Esophageal Squamous Cell Carcinoma [M0563029]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab [2571095]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin [2571094]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tisotumab vedotin-tftv [2571093]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of the Uterine Cervix [M0003943]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib [2534233]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tivozanib hydrochloride [2534245]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Renal Cell [M0003442]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tixagevimab [2587300]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pre-Exposure Prophylaxis [M0587497]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Low Back Pain [M0026008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trigeminal Neuralgia [M0021966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine [57258]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Cramp [M0014234]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Spasticity [M0014243]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Low Back Pain [M0026008]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Myositis [M0014368]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trigeminal Neuralgia [M0021966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tizanidine hydrochloride [236460]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Muscle Rigidity [M0014242]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Infections [M0003806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin [10627]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Tract Infections [M0022373]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Central Nervous System Infections [M0003806]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Skin Diseases, Infectious [M0019935]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pseudomonas Infections [M0017955]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bacterial Infections [M0002126]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Respiratory Tract Infections [M0018919]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Septicemia [M0019666]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Eye Infections, Bacterial [M0024228]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bone Diseases, Infectious [M0002779]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Intraabdominal Infections [M0549889]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tobramycin sulfate [7276]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Staphylococcal Infections [M0020423]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trigeminal Neuralgia [M0021966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide [42359]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arrhythmias, Cardiac [M0001715]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocainide monohydrochloride [142145]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Trigeminal Neuralgia [M0021966]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giant Cell Arteritis [M0021147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab [612865]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytokine Release Syndrome [M000647345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytokine Release Syndrome [M000647345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-aazg [2679427]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giant Cell Arteritis [M0021147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytokine Release Syndrome [M000647345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-anoh [2705421]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giant Cell Arteritis [M0021147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Giant Cell Arteritis [M0021147]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocilizumab-bavi [2680283]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cytokine Release Syndrome [M000647345]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol acetate [39625]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopherol,DL-alpha [402899]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Alzheimer Disease [M0000842]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Vitamin E Deficiency [M0022804]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anemia, Hemolytic [M0001123]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tocopheryl acid succinate,D-alpha [314875]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dyskinesia, Drug-Induced [M0006920]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib [1357536]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofacitinib citrate [1358492]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofersen [2634995]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Amyotrophic lateral sclerosis 1 [M0525108]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofisopam [38365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Substance Withdrawal Syndrome [M0020676]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tofisopam [38365]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Anxiety Disorders [M0001533]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazamide [10633]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboangiitis Obliterans [M0021426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis Obliterans [M0001735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Causalgia [M0003692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Persistent Fetal Circulation Syndrome [M0016380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline [10634]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Causalgia [M0003692]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Persistent Fetal Circulation Syndrome [M0016380]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasm [M0020203]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arteriosclerosis Obliterans [M0001735]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thrombophlebitis [M0021432]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Peripheral Vascular Diseases [M0025176]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Raynaud Disease [M0018534]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Scleroderma, Systemic [M0019543]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolazoline hydrochloride [235450]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Thromboangiitis Obliterans [M0021426]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide [10635]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolbutamide sodium [221173]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetes Mellitus, Type 2 [M0006155]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolcapone [72937]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Parkinson Disease [M0015963]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin [10636]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Rheumatoid [M0001750]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Arthritis, Juvenile [M0001748]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolmetin sodium [42935]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Osteoarthritis [M0015509]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolnaftate [10637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Pedis [M0021566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolnaftate [10637]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Tinea Versicolor [M0021568]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine [119565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine [119565]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine tartrate [221174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Bladder Diseases [M0002630]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolterodine tartrate [221174]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Urinary Incontinence [M0022370]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tolvaptan [358257]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hyponatremia [M0010911]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsies, Partial [M0007566]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy, Tonic-Clonic [M0007573]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Spasms, Infantile [M0020204]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Epilepsy [M0007564]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>FMTSME</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lennox Gastaut Syndrome [M0590747]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topiramate [38404]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Bipolar Disorder [M0002571]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Small Cell Lung Carcinoma [M0520106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Small Cell [M0027519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan [57308]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Uterine Cervical Neoplasms [M0003944]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Small Cell [M0027519]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ovarian Neoplasms [M0015593]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Small Cell Lung Carcinoma [M0520106]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>topotecan hydrochloride [266573]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene [38409]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Hormone-Dependent [M0014599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Neoplasms, Hormone-Dependent [M0014599]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toremifene citrate [49953]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab [2669406]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nasopharyngeal Carcinoma [M0532800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>toripalimab-tpzi [2669407]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nasopharyngeal Carcinoma [M0532800]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Acute [M0012015]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Nephrotic Syndrome [M0014639]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ascites [M0001791]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liver Cirrhosis [M0012636]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pulmonary Edema [M0018125]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Edema [M0007051]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>torsemide [38413]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Kidney Failure, Chronic [M0012016]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tositumomab [263010]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Lymphoma, Non-Hodgkin [M0012822]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tovorafenib [2682434]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Glioma [M0009271]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trabectedin [1716278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Liposarcoma [M0012597]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trabectedin [1716278]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Leiomyosarcoma [M0012318]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tragacanth [1368197]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypersensitivity [M0010851]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab [2589225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tralokinumab-ldrm [2589374]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Dermatitis, Atopic [M0006050]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol [10689]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tramadol hydrochloride [82110]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Pain [M0015742]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib [1425099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib [1425099]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib dimethyl sulfoxide [1425098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Melanoma [M0013309]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trametinib dimethyl sulfoxide [1425098]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Carcinoma, Non-Small-Cell Lung [M0003440]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Ventricular Dysfunction, Left [M0027729]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Diabetic Nephropathies [M0006160]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolapril [38454]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Heart Failure [M0009953]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trandolaprilat [1546379]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Hypertension [M0010859]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranexamic acid [10691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Blood Coagulation Disorders, Inherited [M0376236]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranexamic acid [10691]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Subarachnoid Hemorrhage [M0020646]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine [10734]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Depressive Disorder [M0006033]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>tranylcypromine sulfate [91119]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Stress Disorders, Post-Traumatic [M0020602]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trapidil [10735]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Angina, Stable [M0552684]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab [224905]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab deruxtecan [2267582]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-anns [2174802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-anns [2174802]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dkst [2103478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dkst [2103478]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dttb [2289225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-dttb [2289225]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-oysk [2375543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-oysk [2375543]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-pkrb [2107051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-pkrb [2107051]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-qyyp [2280730]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Gastrointestinal Neoplasms [M0009038]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Neoplasms [M0002910]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Breast Cancer [M0002909]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifier>
  </association>
  <association>
  <namespace>MED-RT</namespace>
  <name>may_treat</name>
   <from_namespace>RxNorm R</from_namespace><from_name>trastuzumab-strf [2700714]</from_name>
   <to_namespace>MeSH</to_namespace><to_name>Cancer of Stomach [M0333444]</to_name>
   <qualifier>  <content>MED-RT</content>
  <name>Authority</name>
    <value>MEDRT</value></qualifie